data_2jmz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jmz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.63 0 N-CA-C 107.67 -1.233 . . . . 72.21 107.67 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.32 156.82 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.786 2.034 . . . . 72.35 110.345 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.12 158.93 27.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.025 0.441 . . . . 64.21 110.404 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.412 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.7 t80 -53.23 -36.98 61.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.743 1.617 . . . . 74.32 114.008 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.87 4.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.08 1.752 . . . . 71.33 110.995 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.38 124.16 70.28 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 107.51 -1.293 . . . . 64.3 107.51 162.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.17 156.82 42.97 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.463 2.109 . . . . 73.22 113.399 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.64 -5.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.786 1.634 . . . . 73.3 113.604 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.0 m-85 47.64 76.87 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.625 1.57 . . . . 75.34 113.158 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.69 160.19 0.95 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.814 -0.63 . . . . 74.24 110.065 168.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 0.32 0.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.712 1.205 . . . . 74.14 112.255 167.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.13 -16.85 9.72 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.883 2.073 . . . . 75.03 111.507 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.23 38.29 7.32 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.787 0.708 . . . . 64.14 112.457 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -16.42 64.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.717 1.377 . . . . 71.14 114.717 -167.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.269 31.3 mm 35.85 66.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.66 2.784 . . . . 64.25 110.514 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 151.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 127.965 2.506 . . . . 75.34 108.59 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.93 127.0 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.214 2.605 . . . . 74.04 107.779 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.23 -41.4 24.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.245 0.618 . . . . 75.22 111.386 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.44 -41.44 85.01 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.006 -0.886 . . . . 54.21 111.136 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.7 -40.97 92.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.661 1.23 . . . . 73.55 110.674 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.16 13.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.992 0.917 . . . . 72.41 108.845 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.16 -50.9 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.131 -0.692 . . . . 74.25 109.131 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.35 -32.45 73.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.461 1.028 . . . . 71.01 112.028 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.6 tttt -48.18 -47.13 35.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.366 0.984 . . . . 75.45 108.874 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.6 -43.71 75.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.494 -0.928 . . . . 74.13 108.494 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.93 -22.03 66.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.24 0.927 . . . . 73.4 112.132 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -93.9 -20.02 20.42 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.298 1.439 . . . . 74.45 112.507 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.46 -52.59 4.26 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 120.378 1.445 . . . . 74.35 107.701 173.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.13 43.02 1.12 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.891 2.076 . . . . 74.45 108.23 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -54.24 -42.18 69.6 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.923 1.689 . . . . 74.31 109.205 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -65.17 -27.89 69.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.849 0.86 . . . . 75.12 111.862 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.87 -5.16 58.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.004 1.721 . . . . 74.33 112.291 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.3 mt -59.47 95.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 120.829 1.65 . . . . 74.23 108.951 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -81.0 142.88 32.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.965 -1.495 . . . . 75.44 106.965 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.46 150.26 26.99 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.487 -1.301 . . . . 71.35 107.487 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.4 170.58 16.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.765 0.826 . . . . 72.45 108.805 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.19 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.58 0.752 . . . . 74.24 110.093 168.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.91 2.62 2.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.918 1.287 . . . . 74.51 112.457 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.56 46.46 54.94 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 125.919 1.723 . . . . 72.54 111.351 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.64 -100.26 0.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.126 -0.694 . . . . 74.14 109.126 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.4 112.44 1.08 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.343 1.925 . . . . 71.0 108.721 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.05 159.3 42.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.136 1.774 . . . . 73.44 108.418 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.6 mt -142.48 142.22 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 106.608 -1.627 . . . . 70.13 106.608 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 133.45 43.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.987 0.915 . . . . 71.32 108.788 165.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.95 12.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.799 -0.637 . . . . 73.33 110.573 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.59 -22.31 16.78 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.208 0.913 . . . . 63.04 112.184 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.97 -25.38 59.91 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.844 1.258 . . . . 71.45 112.454 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 57' ' ' ILE . 4.4 mm-40 -68.35 -22.97 64.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.461 1.028 . . . . 74.44 110.558 167.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.56 -6.42 0.12 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.952 1.464 . . . . 75.24 114.952 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.403 ' H ' ' C ' ' A' ' 55' ' ' GLU . 24.5 mt -45.78 143.81 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 128.377 2.671 . . . . 74.32 110.997 -172.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -102.86 134.76 45.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.3 0.955 . . . . 73.53 112.137 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.33 148.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.802 1.641 . . . . 74.15 107.581 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -69.99 112.84 6.67 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.436 -1.69 . . . . 74.23 106.436 165.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.43 -166.42 1.15 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.126 -1.435 . . . . 52.35 107.126 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.42 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -151.0 159.62 44.45 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.709 -1.589 . . . . 75.31 106.709 167.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.91 116.76 29.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.966 1.306 . . . . 64.15 110.374 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.404 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.7 ttpm? -57.32 -26.79 61.48 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.865 1.666 . . . . 75.24 113.148 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.25 -22.21 64.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.638 1.575 . . . . 74.53 112.453 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m -149.1 10.47 0.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.159 0.984 . . . . 71.54 112.436 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt 54.3 49.37 18.68 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.848 1.309 . . . . 75.13 109.542 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.7 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.876 1.27 . . . . 73.44 108.636 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.96 124.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.046 -1.835 . . . . 74.22 106.046 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.15 179.49 7.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.831 1.652 . . . . 75.13 107.758 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.97 168.83 19.14 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.967 0.907 . . . . 63.21 110.679 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.55 175.78 13.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.643 -1.243 . . . . 74.51 107.643 140.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.28 136.78 44.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.697 1.199 . . . . 75.31 108.72 168.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.89 157.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.742 1.217 . . . . 73.5 107.77 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.4 mt -117.99 -43.65 2.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.261 0.624 . . . . 73.5 110.815 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -138.18 165.02 27.71 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.773 -1.204 . . . . 74.2 109.325 169.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.56 168.13 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.862 1.265 . . . . 71.32 108.924 173.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -135.7 155.6 50.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.798 1.239 . . . . 74.35 109.116 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.07 144.68 38.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.548 -1.278 . . . . 75.51 107.548 167.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.03 169.01 18.42 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.181 1.393 . . . . 73.25 107.774 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.92 147.41 27.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.224 -1.028 . . . . 75.11 108.224 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.91 149.32 34.02 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 125.757 1.623 . . . . 74.34 107.335 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -144.64 131.88 20.64 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.393 -1.706 . . . . 75.21 106.393 159.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.81 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.379 -1.088 . . . . 51.05 110.379 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 123.73 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.057 -0.719 . . . . 74.02 109.057 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 149.17 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.64 -0.874 . . . . 74.33 108.64 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 mm -79.48 138.88 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.205 1.802 . . . . 72.54 106.993 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -122.95 43.7 2.86 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.742 0.817 . . . . 72.21 112.527 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mt -46.33 114.79 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 C-N-CA 126.894 2.077 . . . . 73.32 106.747 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.6 169.17 11.23 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.721 -1.585 . . . . 74.03 106.721 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.7 p -133.9 171.94 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.136 -0.977 . . . . 74.21 108.927 157.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.82 -38.4 64.54 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.314 -0.866 . . . . 75.53 111.986 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.413 HD21 ' CG ' ' A' ' 138' ' ' ASP . 41.1 m-80 -72.31 20.03 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.469 2.307 . . . . 74.14 112.473 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 49.23 27.08 1.71 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 128.1 2.56 . . . . 75.44 113.065 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 159.89 24.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 120.85 -1.156 . . . . 74.11 108.437 163.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -170.37 167.08 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.98 1.712 . . . . 73.14 107.928 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.572 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -146.75 174.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 127.145 2.178 . . . . 73.23 107.88 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.13 1.88 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.861 -0.792 . . . . 72.32 108.861 -171.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.02 174.37 10.66 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.061 0.944 . . . . 73.3 112.58 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 168.95 8.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.156 2.182 . . . . 73.32 111.684 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.95 -33.27 24.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.364 -0.606 . . . . 74.45 109.364 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -91.63 39.27 1.0 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.787 0.835 . . . . 71.42 110.872 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -91.78 123.03 64.48 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.208 -1.377 . . . . 75.12 110.077 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.77 124.15 12.35 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.159 2.573 . . . . 63.01 110.412 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.28 173.69 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.746 1.619 . . . . 73.13 108.336 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.69 149.64 34.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.049 0.54 . . . . 74.52 110.761 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.12 164.38 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.973 1.309 . . . . 74.24 109.735 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.81 35.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.082 0.944 . . . . 75.24 108.474 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -109.1 78.06 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.812 -1.551 . . . . 73.41 106.812 153.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.38 14.96 6.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.511 1.524 . . . . 74.12 113.319 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.46 -24.48 3.2 Favored Glycine 0 CA--C 1.521 0.435 0 O-C-N 120.795 -1.191 . . . . 72.11 111.713 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.98 143.32 26.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.552 -1.277 . . . . 71.14 107.552 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.77 -1.937 . . . . 70.14 105.77 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 tp -125.93 159.24 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.653 -0.869 . . . . 73.13 108.653 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.91 119.49 33.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.207 1.803 . . . . 73.03 109.28 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.58 179.64 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.262 1.025 . . . . 71.03 110.688 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.6 139.57 34.95 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.62 1.968 . . . . 72.02 110.719 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.24 -41.07 36.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.397 1.479 . . . . 71.54 113.26 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.44 -19.94 65.14 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.932 1.242 . . . . 75.33 113.469 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.5 -22.79 30.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.697 0.799 . . . . 75.41 111.161 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.16 63.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 128.398 2.679 . . . . 75.32 111.527 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.42 -170.73 2.71 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.023 -1.048 . . . . 72.25 111.704 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.82 -1.55 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.106 2.162 . . . . 75.11 113.661 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.25 9.19 22.64 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-O 117.439 -1.756 . . . . 75.21 111.764 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 147.68 44.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.84 2.32 . . . . 74.51 108.988 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -94.89 105.09 16.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.241 -1.392 . . . . 74.2 107.241 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.42 118.13 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.601 1.16 . . . . 72.41 109.329 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.38 140.28 56.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.5 -0.75 . . . . 72.54 109.072 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.32 158.0 76.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.854 1.262 . . . . 73.34 111.079 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.54 161.32 42.51 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.669 2.246 . . . . 73.14 110.229 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 -145.59 0.33 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.318 -1.364 . . . . 74.11 107.318 166.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.99 -82.02 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.465 1.506 . . . . 74.23 109.06 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.486 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.02 0.43 35.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.888 1.675 . . . . 73.41 110.356 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 p -138.02 -172.91 3.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.428 1.491 . . . . 74.45 110.879 -151.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -125.98 143.26 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.187 -1.783 . . . . 75.42 106.187 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.8 177.53 7.8 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.901 -1.124 . . . . 75.54 108.023 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.1 145.7 41.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.897 1.279 . . . . 74.2 107.98 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.413 ' CG ' HD21 ' A' ' 93' ' ' ASN . 32.4 t0 -142.12 153.97 44.52 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.872 2.069 . . . . 72.13 109.933 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 142.02 27.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 118.463 -0.779 . . . . 72.44 110.078 -164.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.7 t -77.32 -5.56 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 114.567 1.321 . . . . 72.12 114.567 -163.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.516 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.32 -88.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 127.748 2.419 . . . . 65.21 116.108 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.516 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -85.95 128.58 34.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.901 2.08 . . . . 74.05 109.594 -175.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.01 99.07 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.032 1.333 . . . . 63.52 111.103 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.454 ' CD ' ' HZ2' ' A' ' 142' ' ' LYS . 11.6 pt-20 -152.65 -169.44 3.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.219 2.608 . . . . 74.22 110.102 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.91 179.56 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.028 1.731 . . . . 74.14 110.107 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.6 163.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.927 2.091 . . . . 74.42 106.442 159.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.01 137.02 37.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.93 -1.878 . . . . 73.04 105.93 161.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.41 142.96 27.59 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.865 0.757 . . . . 73.3 110.058 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -146.82 24.35 1.2 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.847 0.749 . . . . 74.34 112.705 -157.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.88 -111.64 3.39 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 110.318 -1.113 . . . . 63.15 110.318 -155.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -134.23 164.82 26.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.595 -1.631 . . . . 74.41 106.595 157.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.09 160.48 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.171 2.188 . . . . 72.35 109.13 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -142.93 151.53 41.06 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.495 1.118 . . . . 75.32 109.684 -168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.23 -178.76 6.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.764 -1.199 . . . . 72.42 107.764 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.3 mt -128.25 175.75 8.22 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.974 1.845 . . . . 75.12 110.995 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.3 m -128.41 92.05 3.36 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.391 -2.448 . . . . 75.25 104.391 159.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.66 80.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 101.651 -3.463 . . . . 72.35 101.651 166.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -76.5 -15.31 59.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.31 1.053 . . . . 74.32 111.218 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.53 -44.52 62.07 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.915 1.686 . . . . 73.25 109.885 -153.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.3 t30 -125.07 5.06 7.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.202 0.601 . . . . 75.34 111.933 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.415 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 34.9 m170 52.15 36.75 19.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.939 0.791 . . . . 64.33 111.941 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.42 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 2.9 p -147.43 142.42 26.99 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.378 -1.451 . . . . 75.22 107.571 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -142.86 170.2 16.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.544 1.065 . . . . 75.32 110.349 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.26 137.93 24.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 107.008 -1.478 . . . . 74.21 107.008 160.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.25 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.314 1.045 . . . . 72.03 108.574 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.72 -168.19 23.67 Favored Glycine 0 N--CA 1.462 0.403 0 CA-C-N 118.555 0.616 . . . . 74.42 111.729 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.42 169.54 8.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.348 1.574 . . . . 74.34 110.318 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.31 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 C-N-CA 128.018 2.527 . . . . 63.31 113.272 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.423 1.089 . . . . 75.31 112.146 169.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.73 177.11 23.92 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 125.596 1.57 . . . . 73.41 111.432 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.572 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.0 m-85 -117.81 139.92 50.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 126.426 1.89 . . . . 74.43 108.104 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.39 99.31 9.98 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.572 3.149 . . . . 71.12 107.604 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.06 3.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.133 0.573 . . . . 72.43 110.246 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.43 148.93 49.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.227 -1.027 . . . . 73.35 108.227 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.76 166.74 13.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.06 -1.459 . . . . 62.41 107.06 158.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.415 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 92.2 p . . . . . 0 N--CA 1.441 -0.922 0 C-N-CA 119.777 -0.769 . . . . 61.32 111.1 171.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.672 0 N-CA-C 108.362 -0.977 . . . . 74.55 108.362 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.78 153.48 21.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.702 2.401 . . . . 75.24 109.608 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.66 163.3 28.02 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.37 0.668 . . . . 61.24 111.71 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -54.96 -38.59 67.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.088 1.355 . . . . 74.44 113.252 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -96.74 9.3 42.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.946 1.698 . . . . 72.31 112.412 -165.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.22 124.13 85.84 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.677 -1.601 . . . . 73.45 106.677 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -55.46 126.31 22.08 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.16 2.574 . . . . 71.43 111.287 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 pt -98.4 119.33 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.688 -1.227 . . . . 74.23 107.688 162.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -78.13 78.99 4.6 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.326 1.45 . . . . 72.33 107.942 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.86 164.18 1.23 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.1 p -54.06 -36.16 62.81 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.168 0.44 . . . . 74.23 111.317 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.13 -22.55 48.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.413 0.685 . . . . 71.31 112.188 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.02 40.54 7.99 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.08 1.324 . . . . 65.44 110.774 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -10.35 52.31 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.906 1.076 . . . . 74.32 113.906 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.317 13.5 mm 52.23 30.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 125.575 2.607 . . . . 72.52 112.077 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.39 149.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.829 -1.532 . . . . 74.43 108.692 -172.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -62.17 122.7 16.23 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.306 -1.739 . . . . 65.14 106.306 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -50.14 -37.85 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.437 1.095 . . . . 74.43 111.087 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 -0.9 89.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.825 -0.986 . . . . 63.12 114.205 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.27 -47.56 6.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.758 1.779 . . . . 75.34 110.365 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -47.14 -53.49 12.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.945 1.298 . . . . 72.22 110.46 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.1 -42.67 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.525 -0.761 . . . . 62.14 110.486 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -24.82 64.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 119.042 -1.063 . . . . 74.53 111.302 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -41.44 70.47 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.135 0.974 . . . . 73.21 110.628 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.85 -40.06 66.01 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.341 -1.314 . . . . 72.12 108.933 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -56.05 -37.18 68.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.414 1.915 . . . . 74.41 112.436 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -31.36 64.32 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.718 -1.134 . . . . 73.11 111.275 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -90.23 -49.34 6.61 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 121.195 1.816 . . . . 75.45 108.28 -178.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 2.5 m-30 -94.44 39.31 1.09 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.773 2.029 . . . . 72.12 108.333 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -57.02 -31.92 65.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.065 1.346 . . . . 73.22 111.95 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -61.5 -35.51 77.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.722 1.209 . . . . 64.31 110.996 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.12 9.45 40.86 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.092 1.357 . . . . 74.51 112.105 -165.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.7 124.0 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.829 -1.545 . . . . 64.42 106.829 167.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -122.37 114.79 21.24 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.07 1.748 . . . . 74.45 107.496 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.64 146.72 28.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.004 -1.109 . . . . 74.23 108.004 168.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.47 172.46 13.76 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.835 0.854 . . . . 75.44 108.811 168.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.39 73.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 75.45 109.338 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.5 -6.28 35.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.785 1.234 . . . . 75.44 112.499 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.71 15.67 33.55 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.136 -0.977 . . . . 74.13 114.698 156.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.01 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.481 1.912 . . . . 71.44 111.892 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.77 121.43 2.19 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.064 2.269 . . . . 63.44 109.174 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -130.76 164.73 24.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.383 1.873 . . . . 71.14 109.906 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.4 mt -142.26 138.98 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.291 2.236 . . . . 74.25 106.191 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.61 129.52 36.53 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.56 1.544 . . . . 60.24 109.719 166.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.74 16.84 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.264 1.425 . . . . 74.31 111.034 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.4 57.33 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.973 -1.079 . . . . 54.22 113.392 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -77.84 -10.78 59.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.928 1.364 . . . . 74.14 113.311 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -63.58 -33.65 76.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.663 1.12 . . . . 74.42 109.479 168.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 51.14 13.84 0.18 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.93 2.092 . . . . 74.32 113.183 -166.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mt -61.12 126.34 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.29 1.036 . . . . 74.24 108.472 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -83.33 144.22 29.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.637 1.175 . . . . 75.43 110.389 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -127.75 150.78 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.792 1.637 . . . . 64.23 107.663 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -62.26 118.34 7.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.015 -1.846 . . . . 74.54 106.015 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -141.92 146.59 35.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.603 -2.74 . . . . 60.32 103.603 -172.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 126.99 54.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 126.211 1.805 . . . . 74.45 106.128 -171.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.82 121.23 16.87 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.266 -1.013 . . . . 74.31 108.266 172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -85.39 -20.29 30.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.665 0.786 . . . . 75.25 112.084 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -34.1 65.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.816 0.846 . . . . 65.51 111.033 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -135.93 8.83 3.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.683 0.793 . . . . 73.24 112.141 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.6 mt 57.02 47.84 16.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.8 1.64 . . . . 71.42 112.51 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 148.48 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.372 1.469 . . . . 72.45 108.964 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.6 144.2 11.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.033 -1.84 . . . . 72.21 106.033 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.66 -167.96 2.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.116 2.567 . . . . 72.41 107.052 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.8 153.4 42.56 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.258 -2.126 . . . . 65.44 105.258 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -153.99 162.6 41.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.127 1.371 . . . . 71.43 108.14 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -85.64 179.45 7.09 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.854 1.262 . . . . 72.51 112.828 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.62 155.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.917 2.087 . . . . 74.11 106.725 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.49 -42.68 1.63 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.868 0.867 . . . . 74.44 111.706 -170.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -127.08 -166.05 1.55 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.57 -0.9 . . . . 74.13 108.57 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -157.84 161.86 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.702 -1.962 . . . . 74.53 105.702 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -147.08 143.14 28.11 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.536 0.734 . . . . 75.23 110.025 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.4 143.62 26.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.237 0.926 . . . . 75.31 109.538 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -146.38 162.02 39.11 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.847 -1.538 . . . . 75.34 106.847 166.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -85.1 156.01 21.25 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.133 -0.979 . . . . 74.15 108.694 172.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -136.32 163.35 30.64 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.009 2.124 . . . . 74.41 108.307 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 p -167.12 104.29 0.55 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.991 -1.485 . . . . 74.32 106.991 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.73 27.22 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.41 -0.9 . . . . 74.42 113.791 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 94.77 4.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.537 1.535 . . . . 64.21 109.459 -168.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.44 153.01 29.97 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.126 -1.064 . . . . 74.32 108.126 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 mm -79.06 131.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.386 1.874 . . . . 64.32 106.974 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -116.83 82.35 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.578 -1.638 . . . . 74.25 106.578 166.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -61.95 137.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.856 -1.905 . . . . 74.23 105.856 162.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -110.8 168.13 9.71 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.645 -1.613 . . . . 73.51 106.645 162.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.76 170.87 15.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.878 1.217 . . . . 75.42 109.361 159.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -58.32 -24.52 59.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.359 1.436 . . . . 74.22 111.962 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.21 -0.9 2.79 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.643 1.177 . . . . 72.35 112.259 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.93 13.75 8.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 128.149 2.58 . . . . 74.21 111.927 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 157.47 28.01 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 124.848 1.259 . . . . 75.51 108.205 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.71 171.17 17.23 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.661 1.585 . . . . 61.32 107.408 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.456 HG21 ' CE1' ' A' ' 171' ' ' PHE . 5.1 pt -147.53 173.09 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 126.664 1.986 . . . . 74.13 107.908 -174.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 104.5 4.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.422 -0.955 . . . . 71.33 108.422 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.15 166.97 27.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.302 1.041 . . . . 63.22 111.442 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -89.52 1.48 55.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 116.157 1.91 . . . . 61.35 116.157 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 96.33 -23.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 1 C-N-CA 138.787 6.835 . . . . 74.55 111.639 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -113.58 37.58 3.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.937 2.495 . . . . 73.22 110.238 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -101.0 139.36 20.44 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 125.04 1.336 . . . . 74.22 108.963 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.54 123.54 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.505 2.137 . . . . 75.31 110.53 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.94 173.55 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 72.34 109.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -119.62 139.71 51.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.103 . . . . 72.22 111.084 -168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.13 162.81 19.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.858 1.263 . . . . 72.54 110.103 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.4 p -95.48 105.99 18.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.261 0.351 . . . . 65.22 111.04 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -81.12 78.3 7.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.448 -1.686 . . . . 65.35 106.448 162.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 6.2 m 60.22 6.04 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.522 2.045 . . . . 75.51 116.522 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.32 -31.32 1.56 Allowed Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.712 -1.242 . . . . 73.34 110.057 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.7 142.7 36.89 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.362 -2.088 . . . . 74.14 105.362 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.05 132.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.577 -0.898 . . . . 61.34 108.577 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.24 152.31 48.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.81 1.644 . . . . 73.13 106.677 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.19 115.75 30.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.029 1.332 . . . . 73.44 109.61 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.52 175.26 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.745 0.818 . . . . 75.33 110.901 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -79.97 143.17 34.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.587 1.155 . . . . 72.42 109.226 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.0 -29.1 41.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.629 0.974 . . . . 74.32 113.629 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -24.26 65.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.14 -0.975 . . . . 75.53 112.661 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -86.74 -27.4 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.372 1.069 . . . . 74.13 111.927 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -71.43 61.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 127.921 2.488 . . . . 55.31 109.836 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.457 ' C ' ' H ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -83.47 -178.08 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.01 1.324 . . . . 74.22 108.509 170.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.48 0.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 127.364 2.266 . . . . 63.45 113.9 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -80.39 -18.88 70.25 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 117.506 -1.719 . . . . 65.11 111.989 170.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.56 169.82 12.08 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.214 2.007 . . . . 72.52 111.67 -163.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -124.0 119.09 28.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 126.256 1.822 . . . . 72.32 108.153 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -93.74 127.46 45.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.149 0.979 . . . . 73.24 108.776 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -67.8 115.58 7.52 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.906 -1.146 . . . . 75.42 107.906 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.4 154.42 59.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.386 1.074 . . . . 73.22 111.476 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 141.35 96.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.94 2.427 . . . . 75.35 110.138 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -113.48 -173.98 2.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.786 -1.19 . . . . 74.34 107.786 153.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -37.79 -64.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.189 1.796 . . . . 74.33 111.22 -168.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -120.59 -5.44 9.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.772 0.829 . . . . 74.34 112.122 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 p -125.33 -178.58 4.27 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.668 1.587 . . . . 64.42 111.67 -164.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 tp -100.39 147.25 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 O-C-N 120.171 -1.581 . . . . 72.43 107.574 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -137.94 -175.0 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.751 2.02 . . . . 72.51 107.938 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.47 157.93 40.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.266 1.427 . . . . 72.34 107.649 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -153.87 159.3 41.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.692 1.597 . . . . 75.23 108.14 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.8 147.7 23.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.07 0.948 . . . . 63.25 110.605 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.97 -0.67 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.998 1.111 . . . . 72.51 113.998 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 26.51 -77.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.044 2.938 . . . . 71.53 117.062 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.464 ' H ' HG13 ' A' ' 141' ' ' ILE . 17.0 tppt? -103.21 117.29 34.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.049 1.74 . . . . 74.14 108.028 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.32 131.2 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.184 -1.043 . . . . 43.33 108.184 169.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -153.06 -179.45 7.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.942 1.697 . . . . 74.25 107.494 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.29 133.85 39.31 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.007 -0.738 . . . . 61.42 109.007 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.98 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.682 1.193 . . . . 64.31 108.494 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.29 113.39 14.34 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.447 -0.946 . . . . 62.11 108.447 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -128.72 135.32 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.074 1.35 . . . . 73.41 108.582 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -133.77 29.6 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.272 -0.893 . . . . 74.24 109.684 -161.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -126.86 -163.91 11.59 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.362 1.934 . . . . 42.24 111.411 -161.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -87.0 153.41 21.57 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.021 -1.281 . . . . 74.23 110.752 173.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.2 153.63 34.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 126.729 2.012 . . . . 73.23 107.877 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -142.47 154.38 44.48 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.344 1.058 . . . . 74.43 108.985 -170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.95 163.94 27.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.167 1.387 . . . . 73.13 108.288 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.73 140.13 42.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.943 1.701 . . . . 72.41 111.164 -163.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 48.4 p -91.37 -46.68 7.89 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.576 0.954 . . . . 74.41 113.576 -156.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 2.7 t 23.12 64.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 130.111 3.364 . . . . 71.24 113.97 175.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.1 0.05 15.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.486 1.114 . . . . 73.41 113.511 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -34.91 41.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.352 -0.981 . . . . 62.33 108.352 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -127.94 -8.91 5.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.203 1.401 . . . . 73.21 113.712 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.57 23.96 14.25 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.475 1.91 . . . . 63.23 111.154 -175.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 p -141.36 164.84 29.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.342 2.657 . . . . 74.22 107.248 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -151.39 175.92 11.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.824 1.193 . . . . 73.22 110.372 165.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.1 mm -109.37 126.17 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 74.21 108.831 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.21 160.46 43.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.729 0.812 . . . . 71.11 110.241 169.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.13 -165.11 25.5 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.167 -1.573 . . . . 53.14 109.167 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -100.72 172.83 6.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.111 1.455 . . . . 75.52 110.267 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.11 -85.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.177 2.591 . . . . 73.35 111.972 -171.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.88 -12.1 8.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.912 1.285 . . . . 74.55 112.878 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.06 174.59 39.31 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 122.877 1.265 . . . . 65.54 112.628 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.456 ' CE1' HG21 ' A' ' 97' ' ' ILE . 12.7 m-85 -121.18 154.5 36.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.454 2.702 . . . . 64.35 106.801 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.67 32.58 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.355 -1.35 . . . . 60.41 107.355 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.59 174.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 118.579 0.627 . . . . 74.41 109.651 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -72.42 155.2 40.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.111 0.564 . . . . 74.53 109.672 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -144.11 49.3 1.36 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.697 2.399 . . . . 62.41 108.644 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.538 0.5 0 O-C-N 120.098 -1.626 . . . . 72.23 107.159 176.301 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.391 0 N-CA-C 106.069 -1.826 . . . . 61.33 106.069 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.01 157.54 24.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.177 0.991 . . . . 75.14 109.557 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.38 -176.67 0.79 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.187 1.395 . . . . 73.43 110.947 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.447 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 14.4 t80 -84.67 -33.57 23.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.547 1.139 . . . . 72.11 113.169 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.81 38.53 1.71 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 72.11 110.197 -162.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -117.19 112.61 39.65 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 125.039 1.336 . . . . 74.12 110.947 -153.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.56 127.41 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.99 1.793 . . . . 74.32 113.557 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -100.36 24.53 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.626 1.97 . . . . 75.22 112.95 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 29.78 66.09 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.341 2.257 . . . . 75.34 115.403 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -53.17 155.59 2.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.315 -0.866 . . . . 65.33 111.507 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -43.62 61.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.51 1.124 . . . . 74.13 109.172 169.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.09 -47.34 77.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.105 0.962 . . . . 74.35 110.722 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.81 26.91 3.7 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.767 1.175 . . . . 74.3 112.65 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.68 -27.61 66.55 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.264 1.532 . . . . 72.5 114.118 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 mm 48.17 63.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.861 1.264 . . . . 73.24 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 147.97 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.903 1.281 . . . . 75.52 108.121 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -65.27 122.69 17.69 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.97 -1.493 . . . . 72.11 106.97 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.7 tt -46.55 -44.75 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 124.995 1.318 . . . . 64.45 110.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.447 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -70.54 -26.3 74.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-O 118.577 -1.124 . . . . 74.12 111.685 -173.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.41 -53.17 14.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.461 1.631 . . . . 63.33 109.716 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -43.87 -48.77 8.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.779 1.232 . . . . 73.43 109.555 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.88 -44.9 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 118.361 -0.828 . . . . 74.2 111.645 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -65.03 -32.82 74.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.737 2.062 . . . . 71.2 111.585 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -40.49 65.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.714 1.606 . . . . 73.43 110.965 171.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -76.74 -36.66 56.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.492 1.517 . . . . 72.32 109.632 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -63.66 -41.77 98.15 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.334 1.879 . . . . 74.2 110.774 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -24.42 64.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.497 -0.752 . . . . 60.13 111.281 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -82.35 -59.19 2.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.996 -1.483 . . . . 72.35 106.996 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -100.63 41.84 1.15 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.943 0.897 . . . . 75.11 109.949 -162.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -32.2 67.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.564 0.745 . . . . 74.52 111.772 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -73.83 -22.17 59.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.832 0.678 . . . . 75.2 112.832 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 t -90.04 -1.41 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.62 1.568 . . . . 74.44 111.59 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 96.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 124.744 1.217 . . . . 63.23 107.793 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -79.99 161.5 25.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.059 -1.089 . . . . 73.35 108.059 162.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -126.17 154.31 43.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.433 -1.692 . . . . 73.25 106.433 160.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.41 179.38 7.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.009 0.924 . . . . 62.24 110.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.84 -25.54 63.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.4 0.68 . . . . 73.22 111.442 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -77.53 -13.85 59.81 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.873 -1.142 . . . . 74.13 111.346 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.96 55.69 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 120.441 -1.412 . . . . 61.51 112.35 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -52.35 -83.46 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.471 1.909 . . . . 73.5 112.874 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.82 107.32 0.64 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-O 117.977 -1.457 . . . . 75.44 110.131 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -123.31 162.34 22.89 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.107 1.453 . . . . 73.31 111.447 170.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mt -146.73 132.33 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.414 2.686 . . . . 74.21 103.952 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 126.8 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.104 -1.072 . . . . 75.44 108.104 164.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.83 13.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.142 1.377 . . . . 73.24 111.6 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.46 -31.57 36.32 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.291 -0.88 . . . . 75.53 113.472 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.37 -19.41 65.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.741 1.216 . . . . 63.44 112.721 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.81 -25.89 66.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.832 0.742 . . . . 73.41 110.87 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.5 36.02 25.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.752 1.221 . . . . 75.11 111.992 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -89.34 135.08 26.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.352 -1.351 . . . . 75.52 107.352 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.73 154.27 19.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.445 0.64 . . . . 73.31 109.305 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -132.89 148.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 125.663 1.585 . . . . 75.32 107.911 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -75.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.688 1.995 . . . . 75.35 110.349 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.16 173.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.047 2.539 . . . . 73.52 108.454 165.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -136.75 140.75 42.8 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.195 -0.94 . . . . 70.31 109.854 -174.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -87.5 121.01 29.39 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 126.064 1.745 . . . . 65.11 109.091 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -70.76 -27.81 64.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.72 0.808 . . . . 74.21 112.076 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -50.5 -42.03 54.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.075 1.35 . . . . 71.32 110.897 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -134.1 16.78 3.8 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.622 0.769 . . . . 55.14 111.357 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.28 49.57 17.6 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.771 1.228 . . . . 74.35 112.464 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.54 154.48 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.555 1.542 . . . . 74.43 109.529 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.98 145.77 8.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.52 -1.289 . . . . 74.01 107.52 165.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -141.06 -168.5 2.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.545 1.938 . . . . 73.23 107.774 163.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -92.24 149.14 21.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.439 -0.948 . . . . 72.12 108.439 153.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -154.13 152.69 30.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.627 2.371 . . . . 73.32 106.571 167.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -84.36 175.66 9.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.428 1.091 . . . . 74.24 109.938 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.69 141.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.829 2.052 . . . . 75.4 106.324 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD21 ' H ' ' A' ' 158' ' ' GLU . 1.9 mm? -111.74 -45.67 3.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.703 0.401 . . . . 74.11 112.03 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.38 144.83 49.83 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.53 -0.915 . . . . 71.25 108.53 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.87 158.7 8.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.393 1.477 . . . . 75.52 108.054 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -132.05 152.75 51.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.208 1.003 . . . . 75.42 108.953 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -149.53 152.53 35.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.764 -0.828 . . . . 74.32 108.764 165.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -150.08 167.96 25.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.094 1.757 . . . . 75.34 106.946 166.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -105.41 143.97 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.044 -1.035 . . . . 75.22 108.223 171.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -142.64 156.19 45.04 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.3 0.5 . . . . 75.12 111.25 -160.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -156.94 125.85 5.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 75.43 109.788 164.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.51 179.52 37.96 Favored Glycine 0 N--CA 1.465 0.587 0 N-CA-C 110.184 -1.167 . . . . 71.54 110.184 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -81.03 140.04 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.876 -0.779 . . . . 64.14 110.236 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.65 157.87 32.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.161 1.384 . . . . 74.24 107.625 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mm -79.67 141.6 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.678 1.191 . . . . 72.32 108.77 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -123.66 86.28 2.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.341 1.456 . . . . 73.41 107.519 158.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.8 mt -62.77 101.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.521 -1.659 . . . . 55.44 106.521 148.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.38 172.99 13.04 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.899 -1.519 . . . . 73.21 106.899 163.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -138.56 171.04 14.95 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.704 -1.247 . . . . 74.22 108.574 163.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -71.15 -25.17 62.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.539 2.336 . . . . 74.34 110.938 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -59.86 -11.24 5.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.93 1.692 . . . . 75.11 111.578 164.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 63.15 33.05 14.75 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.173 2.989 . . . . 73.3 111.617 -167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -75.43 173.43 10.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 118.231 -1.388 . . . . 73.54 109.474 161.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.39 164.29 19.7 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.983 1.713 . . . . 75.45 106.522 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.489 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -132.25 -179.93 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.068 -1.086 . . . . 75.51 108.068 165.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.2 m -149.87 118.92 6.71 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.011 -1.68 . . . . 72.2 108.949 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -166.25 172.13 11.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.963 -1.017 . . . . 65.32 111.261 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 m -79.43 147.61 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.095 -1.076 . . . . 71.12 108.095 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -10.21 54.29 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.165 1.172 . . . . 75.02 114.165 -161.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.4 38.19 3.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.661 2.785 . . . . 73.12 110.156 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -82.63 140.95 44.43 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.071 -0.966 . . . . 63.43 109.525 159.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.02 118.53 5.63 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.124 3.216 . . . . 70.2 111.274 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.65 -166.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 120.876 -1.14 . . . . 74.54 110.128 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -135.07 134.68 40.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.747 1.219 . . . . 71.13 108.733 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.31 166.58 28.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 126.107 1.763 . . . . 73.41 107.944 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -89.9 143.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.096 0.475 . . . . 74.22 110.309 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -115.02 86.74 2.51 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.224 -1.769 . . . . 73.43 106.224 155.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.65 17.76 8.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.097 0.959 . . . . 63.53 113.407 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.43 -26.85 4.3 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.652 1.12 . . . . 71.05 111.187 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 148.62 32.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.557 -1.646 . . . . 74.31 106.557 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.7 t -85.32 114.46 25.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.46 40.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.89 -0.782 . . . . 74.34 108.89 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.67 120.02 36.22 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.87 2.068 . . . . 73.05 106.996 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.65 175.26 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.691 1.596 . . . . 74.42 109.803 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -78.03 144.5 36.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.53 -0.544 . . . . 70.33 109.53 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.03 22.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 72.23 112.201 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -17.29 62.99 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.151 1.167 . . . . 73.5 114.151 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.6 mtm -96.99 -15.24 21.18 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.161 0.985 . . . . 74.35 112.071 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.61 63.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.949 1.699 . . . . 75.31 109.217 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.63 176.82 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 74.4 109.291 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.36 -37.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.278 1.831 . . . . 70.34 112.721 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.79 11.03 63.09 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.419 -1.767 . . . . 64.31 114.185 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.15 169.9 8.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 121.018 2.409 . . . . 72.2 108.814 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -118.16 105.42 11.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 123.907 0.883 . . . . 74.54 109.182 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.0 125.69 39.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.32 108.795 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.63 123.46 19.36 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 72.53 107.067 173.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.85 157.74 56.54 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.694 1.598 . . . . 74.54 111.883 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.97 159.72 50.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.387 2.725 . . . . 74.45 111.8 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -141.81 -178.04 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.626 -1.62 . . . . 73.23 106.626 156.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -24.74 -67.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.318 2.647 . . . . 64.55 113.266 -170.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.68 -10.0 9.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.185 0.994 . . . . 43.52 113.447 165.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 p -131.3 148.15 52.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.818 1.19 . . . . 75.41 111.571 -162.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.94 143.31 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.263 -1.384 . . . . 73.42 107.263 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -142.91 -176.91 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.813 1.645 . . . . 74.11 108.391 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mt -125.38 165.46 18.34 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.413 1.101 . . . . 73.13 108.538 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -154.56 157.71 38.68 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 103.593 -2.743 . . . . 71.33 103.593 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.39 -177.7 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.026 1.33 . . . . 75.14 109.279 168.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.259 72.0 t -112.6 2.56 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.793 1.237 . . . . 75.54 111.904 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.1 pt 24.83 -70.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 130.422 3.489 . . . . 73.34 117.719 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.403 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.7 tptt -116.14 118.51 33.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.181 1.393 . . . . 74.01 107.462 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.43 119.53 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.998 -1.482 . . . . 65.23 106.998 156.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.14 -176.08 4.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.005 1.722 . . . . 75.32 107.816 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -130.76 159.93 35.84 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.155 -0.966 . . . . 74.32 109.868 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.12 165.22 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.781 1.633 . . . . 74.21 107.794 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -122.7 71.02 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.086 1.354 . . . . 74.52 108.843 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.64 154.76 25.96 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.879 1.272 . . . . 74.52 110.798 -167.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.33 24.96 2.27 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.306 -0.871 . . . . 73.55 112.358 -172.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.58 -138.94 9.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 125.173 1.368 . . . . 62.44 111.942 -155.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -117.86 155.22 30.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.907 -1.146 . . . . 72.11 107.907 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.59 152.41 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.958 1.303 . . . . 74.41 109.928 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -142.57 168.81 18.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.062 1.345 . . . . 75.43 108.492 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -154.74 175.03 14.23 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.803 -1.184 . . . . 74.02 107.803 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 tp -135.14 119.39 17.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.781 1.173 . . . . 74.2 110.508 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.9 m -84.12 118.56 24.18 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.791 -0.818 . . . . 73.51 108.791 169.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 t -125.98 94.93 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.433 -2.062 . . . . 73.22 105.433 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.409 ' H ' HD21 ' A' ' 75' ' ' LEU . 4.3 pt-20 -80.35 -8.65 59.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.336 -0.852 . . . . 75.34 113.236 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -88.55 -59.05 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.74 1.257 . . . . 74.02 108.454 -156.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.07 112.57 13.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 101.687 -3.449 . . . . 74.22 101.687 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.424 ' CG ' ' HA ' ' A' ' 176' ' ' SER . 23.8 m170 -69.31 50.39 0.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.606 1.962 . . . . 73.34 112.03 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.478 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -151.67 140.1 20.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.02 2.128 . . . . 54.04 108.697 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.432 ' CD1' ' HB1' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.81 178.79 8.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.077 1.351 . . . . 75.32 111.121 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.19 135.79 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.481 -1.674 . . . . 74.41 106.481 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.08 159.85 43.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.682 -1.229 . . . . 71.41 107.682 160.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 140.47 -165.22 26.14 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.817 1.198 . . . . 74.24 111.043 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -110.91 170.65 7.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.365 1.078 . . . . 75.4 111.002 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.99 -80.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.146 2.578 . . . . 64.34 112.574 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.32 -3.95 8.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.477 . . . . 64.44 114.051 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 84.38 176.94 51.2 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 122.141 0.856 . . . . 72.53 111.927 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.489 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 3.8 m-85 -127.76 146.86 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.187 2.595 . . . . 74.14 106.2 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -95.56 132.0 41.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 119.21 -0.424 . . . . 74.32 110.69 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.4 m -145.71 167.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.19 0.996 . . . . 74.31 109.633 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 71.3 m -63.02 142.81 58.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.167 1.787 . . . . 70.23 110.286 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.432 ' HB1' ' CD1' ' A' ' 163' ' ' TYR . . . -141.84 39.89 1.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.568 1.147 . . . . 75.42 111.623 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.424 ' HA ' ' CG ' ' A' ' 161' ' ' HIS . 70.9 m . . . . . 0 N--CA 1.457 -0.108 0 O-C-N 121.704 -0.622 . . . . 74.1 111.558 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.518 0 N-CA-C 108.024 -1.102 . . . . 73.43 108.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.49 151.82 21.78 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.253 1.421 . . . . 71.33 109.471 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.4 49.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.691 -0.686 . . . . 61.12 110.366 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -48.26 -31.51 6.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.651 1.98 . . . . 74.03 113.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -104.78 15.35 28.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.641 1.976 . . . . 74.31 112.23 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -79.46 114.24 43.65 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.551 -1.277 . . . . 72.54 107.551 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.02 136.33 29.37 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.422 2.748 . . . . 64.21 113.064 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.35 88.61 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.43 -1.322 . . . . 64.52 107.43 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -48.21 83.6 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.233 2.613 . . . . 73.43 113.347 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -65.44 163.97 14.76 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.243 1.017 . . . . 74.33 109.478 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 t -60.21 -39.77 87.74 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 119.027 -0.511 . . . . 73.21 109.812 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.9 -38.48 22.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.702 -0.799 . . . . 73.44 109.275 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.18 43.78 0.9 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 114.958 0.743 . . . . 74.53 114.958 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -8.66 23.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.135 1.902 . . . . 74.05 116.135 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.289 7.8 mm 61.49 25.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-O 124.648 2.166 . . . . 74.34 112.49 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 152.78 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 125.426 1.49 . . . . 74.54 108.915 -170.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.09 130.18 43.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.968 1.707 . . . . 75.53 108.851 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.7 tt -53.49 -33.43 21.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.23 1.412 . . . . 74.32 112.892 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . -94.83 -13.67 52.36 Favored Glycine 0 C--O 1.219 -0.818 0 CA-C-O 117.28 -1.845 . . . . 62.23 112.782 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -73.47 -49.72 25.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.346 2.573 . . . . 65.24 109.073 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -49.2 -56.95 7.65 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.193 1.397 . . . . 74.23 109.568 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG21 ' HA2' ' A' ' 26' ' ' GLY . 34.4 m -67.6 -38.77 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 117.504 -1.236 . . . . 73.24 110.371 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -34.55 73.57 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 121.462 1.937 . . . . 61.43 111.334 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.1 pttt -52.25 -42.03 63.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.748 1.219 . . . . 75.02 111.249 171.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.8 m-85 -78.04 -47.25 18.81 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 117.703 -1.141 . . . . 64.34 110.507 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -53.86 -30.77 47.08 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.598 1.999 . . . . 74.43 112.358 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -57.94 4.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.528 1.531 . . . . 74.43 110.091 170.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -68.57 -58.33 4.44 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.802 -1.555 . . . . 75.3 106.802 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -86.81 40.17 0.89 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.494 1.517 . . . . 55.11 108.443 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -34.73 68.76 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.788 -1.195 . . . . 73.33 111.498 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.04 -28.19 65.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.272 0.471 . . . . 71.13 112.272 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.6 m -73.37 -2.1 20.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.721 0.637 . . . . 74.32 112.721 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.58 114.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.97 1.308 . . . . 71.23 109.433 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -114.06 113.33 24.6 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.492 -1.669 . . . . 74.3 106.492 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -73.45 142.18 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.045 -1.835 . . . . 72.4 106.045 164.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.96 176.78 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.571 -0.9 . . . . 74.13 108.571 159.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 -35.04 77.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.328 1.451 . . . . 73.52 112.306 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.2 -8.73 18.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.512 1.125 . . . . 72.52 112.67 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 7.82 64.37 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 127.939 2.685 . . . . 74.54 112.664 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.85 -83.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.977 1.711 . . . . 64.04 111.902 -160.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.48 101.49 1.13 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.623 -1.098 . . . . 54.21 111.805 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -108.16 163.35 13.24 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.598 0.823 . . . . 75.51 109.977 163.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.8 mt -145.45 143.54 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.427 1.891 . . . . 63.41 106.599 166.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.53 131.95 34.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.696 1.598 . . . . 64.02 111.148 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.82 -3.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.099 1.36 . . . . 75.24 112.768 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.95 -21.58 52.79 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 120.02 1.282 . . . . 54.11 114.627 -168.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -69.08 -5.41 21.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.759 1.224 . . . . 71.31 113.896 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.57 -19.29 62.01 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 119.649 -1.907 . . . . 74.33 112.201 164.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 m120 45.02 33.62 1.09 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.237 1.815 . . . . 75.1 112.576 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.56 169.04 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.595 1.958 . . . . 74.21 106.972 159.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.5 158.06 45.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.134 0.974 . . . . 72.31 109.151 166.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.03 157.14 33.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 126.138 1.775 . . . . 75.03 108.68 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 152.31 44.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.184 0.992 . . . . 75.2 108.56 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.1 p -147.53 -168.83 3.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 125.608 1.563 . . . . 72.45 106.96 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -152.3 137.71 17.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.066 -1.021 . . . . 74.21 108.742 177.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.6 114.9 18.88 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.426 -0.953 . . . . 72.42 108.426 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -61.83 -27.5 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.361 . . . . 74.23 111.25 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -35.67 -51.52 0.66 Allowed 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 129.324 3.05 . . . . 74.22 112.017 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.5 m -147.58 12.17 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.163 1.785 . . . . 74.54 110.694 -160.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt 52.82 41.93 31.82 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.447 1.499 . . . . 74.41 111.144 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.5 pt -96.61 173.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.261 1.024 . . . . 75.13 109.488 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.17 147.35 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.76 -1.57 . . . . 73.2 106.76 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -147.83 172.17 14.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 74.32 108.442 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -126.81 144.78 50.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.529 1.532 . . . . 63.31 107.168 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 161.56 35.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.312 0.645 . . . . 72.53 110.841 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -82.02 -35.24 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.239 0.829 . . . . 74.22 113.239 -170.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 mt 63.75 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 128.131 2.573 . . . . 74.51 109.685 -155.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 mt -142.53 -65.63 0.4 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.227 1.811 . . . . 63.43 106.4 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -127.75 164.27 22.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.6 1.56 . . . . 74.44 111.258 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.24 172.59 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.52 1.928 . . . . 70.01 109.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -141.58 137.48 31.96 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.298 1.039 . . . . 73.51 110.163 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -129.16 131.92 47.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.043 1.337 . . . . 74.14 110.989 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -141.92 176.28 9.06 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 73.13 109.593 166.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.75 148.16 31.93 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.741 1.216 . . . . 75.24 109.268 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -142.75 160.06 41.04 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.231 0.923 . . . . 73.45 112.677 -167.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.79 109.67 1.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.32 1.448 . . . . 74.14 110.441 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.31 -171.45 35.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.874 1.216 . . . . 74.43 112.426 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -90.07 151.85 21.43 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.949 -1.324 . . . . 72.42 110.729 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.6 mt -130.77 153.94 48.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.104 1.362 . . . . 73.34 108.941 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.98 130.85 35.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.396 -1.335 . . . . 71.3 107.396 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -121.51 77.94 1.39 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.459 1.504 . . . . 73.45 107.304 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -70.2 103.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.775 2.03 . . . . 75.11 107.594 166.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -85.1 163.76 18.59 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.106 -1.442 . . . . 72.22 107.106 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -136.38 167.76 20.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.389 0.995 . . . . 74.11 108.441 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.4 ttmt -58.67 -30.07 67.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.563 -1.336 . . . . 75.23 113.113 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -73.25 15.39 0.23 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.71 1.141 . . . . 73.31 112.283 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 92' ' ' LYS . 8.3 mmt180 47.69 35.47 4.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 128.776 2.83 . . . . 74.44 110.885 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -73.63 167.32 21.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.002 -1.11 . . . . 74.23 108.002 157.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -170.93 161.12 6.93 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.46 1.904 . . . . 74.11 106.199 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -143.69 169.26 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 129.833 3.253 . . . . 65.33 109.268 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.4 m -153.33 98.56 2.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.543 1.537 . . . . 71.22 110.564 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.64 173.25 16.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.733 1.613 . . . . 74.42 109.921 -170.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -68.83 167.93 14.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.267 1.027 . . . . 72.53 112.619 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.09 -46.61 67.33 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.841 -0.537 . . . . 75.12 110.608 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.1 38.87 1.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.439 -0.948 . . . . 64.2 108.439 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -84.26 134.62 42.84 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.315 -0.994 . . . . 73.24 108.315 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.48 133.62 38.0 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.258 1.972 . . . . 73.44 111.111 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 178.78 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.825 1.65 . . . . 73.12 108.554 167.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -116.48 142.65 46.59 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.572 -0.705 . . . . 72.34 109.704 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.77 165.15 32.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.44 1.496 . . . . 73.14 109.52 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 133.44 40.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.922 1.289 . . . . 74.45 107.91 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -122.66 74.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.109 1.364 . . . . 74.32 107.518 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m 65.85 7.64 4.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.975 1.31 . . . . 74.51 113.679 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.3 -9.71 4.4 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.312 0.958 . . . . 51.41 112.053 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -101.3 117.52 35.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.042 -1.836 . . . . 71.21 106.042 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.07 126.54 28.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.404 -1.332 . . . . 64.5 107.404 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.91 140.5 49.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.074 1.749 . . . . 74.11 107.084 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.15 131.61 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.115 -1.068 . . . . 74.42 108.115 166.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.2 pt -145.59 -167.09 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.78 2.032 . . . . 73.43 107.997 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.76 143.5 27.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.887 1.275 . . . . 74.12 110.091 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.63 -35.67 42.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.213 1.405 . . . . 73.14 113.125 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -17.6 64.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.216 1.191 . . . . 71.25 114.216 -172.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -25.57 28.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.489 1.116 . . . . 73.54 111.575 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t -72.18 63.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 128.805 2.842 . . . . 72.31 110.492 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -78.63 -178.42 5.88 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.029 -1.044 . . . . 74.44 109.152 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.52 -13.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.309 1.843 . . . . 75.54 113.755 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.73 4.38 66.05 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.559 -1.69 . . . . 72.34 113.435 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.09 135.53 39.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 120.275 2.038 . . . . 75.12 106.657 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -76.87 122.48 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.772 -1.566 . . . . 75.55 106.772 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.65 147.49 6.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.541 -1.651 . . . . 75.43 106.541 164.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.87 136.33 35.36 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.517 -1.29 . . . . 75.34 107.517 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.83 154.51 76.04 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 124.568 1.147 . . . . 74.5 111.608 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.6 150.49 31.56 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.562 2.175 . . . . 75.0 108.548 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -123.69 -171.05 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.148 -1.797 . . . . 73.43 106.148 161.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -40.63 -68.58 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.311 1.445 . . . . 74.03 112.72 -168.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -120.95 -1.37 9.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.859 1.664 . . . . 72.54 111.266 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 64.3 p -139.94 165.51 27.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.131 0.878 . . . . 75.44 111.199 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -79.33 155.03 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.431 -1.322 . . . . 72.25 107.431 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.42 -178.04 5.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.272 1.429 . . . . 73.22 107.307 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.64 149.39 47.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.387 -1.709 . . . . 73.33 106.387 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -147.91 131.37 16.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.193 1.797 . . . . 73.41 106.729 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -62.44 157.2 20.69 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.211 0.46 . . . . 73.23 109.951 -176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.76 2.1 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.993 1.717 . . . . 73.14 111.807 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.6 pt 24.11 -86.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 128.985 2.914 . . . . 74.14 115.366 170.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.448 ' H ' HG13 ' A' ' 141' ' ' ILE . 34.5 ttpt -97.03 109.41 22.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.35 1.46 . . . . 72.41 107.44 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 p -110.76 119.07 58.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.883 -1.154 . . . . 61.45 107.883 164.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -133.77 -178.54 5.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.774 1.63 . . . . 75.34 108.558 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.66 136.1 52.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.084 0.954 . . . . 75.12 108.485 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.4 m -94.04 162.17 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.102 -1.073 . . . . 74.0 108.102 167.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 151.09 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.226 1.011 . . . . 73.42 108.488 159.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -159.07 131.8 6.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.513 1.051 . . . . 74.12 109.851 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -142.35 59.71 1.45 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.204 -0.935 . . . . 74.23 110.048 -167.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.96 -131.82 3.33 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.168 1.366 . . . . 75.02 112.703 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -114.84 161.7 17.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.074 1.35 . . . . 64.31 109.438 168.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.92 156.04 39.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 125.464 1.505 . . . . 74.44 109.05 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.53 159.29 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.509 -0.923 . . . . 74.34 108.509 -168.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -148.38 173.5 13.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.101 -1.074 . . . . 73.12 108.101 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -131.73 134.92 46.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.226 1.41 . . . . 75.23 109.324 -163.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.3 m -70.85 -50.64 33.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 118.562 -0.732 . . . . 72.44 112.096 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 t 24.58 68.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.561 2.745 . . . . 74.1 111.385 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.35 -6.16 44.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.255 1.026 . . . . 75.42 112.516 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.88 -58.59 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.083 1.753 . . . . 75.04 108.874 -163.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -119.36 -1.12 10.81 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.024 1.33 . . . . 70.32 112.923 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.9 m170 58.67 28.3 17.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.536 1.535 . . . . 74.25 112.17 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.453 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 22.2 p -141.64 140.82 33.36 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.378 -1.451 . . . . 72.31 111.208 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.417 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -134.89 175.16 9.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.705 1.202 . . . . 75.23 111.717 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.2 mm -107.14 122.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 N-CA-C 106.95 -1.5 . . . . 71.1 106.95 168.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.48 160.33 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.511 0.725 . . . . 72.53 109.245 170.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 137.37 -167.34 24.77 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 109.865 -1.294 . . . . 64.13 109.865 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -112.3 167.26 10.57 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 121.332 -1.099 . . . . 75.33 109.277 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 64.62 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.226 1.811 . . . . 74.11 112.38 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.04 -15.73 7.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.488 1.04 . . . . 72.54 112.787 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 174.6 46.61 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 123.286 1.492 . . . . 73.32 113.254 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 97' ' ' ILE . 12.8 m-85 -127.32 147.28 50.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.186 2.594 . . . . 73.23 106.949 -172.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.62 112.66 24.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.903 -1.517 . . . . 74.22 106.903 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.33 175.97 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.888 1.675 . . . . 74.13 109.045 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -61.08 138.59 58.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.842 0.857 . . . . 72.24 110.18 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' ' CD2' ' A' ' 163' ' ' TYR . . . -124.18 57.93 1.21 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 128.976 2.91 . . . . 65.24 107.473 169.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 105.315 -2.105 . . . . 75.4 105.315 -171.85 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 109.518 -0.549 . . . . 63.43 109.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -98.51 160.98 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.431 1.892 . . . . 73.32 110.233 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 154.76 30.64 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 123.211 0.605 . . . . 60.11 111.247 170.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -50.33 -32.09 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.353 1.861 . . . . 73.42 114.494 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -105.45 12.73 31.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.584 . . . . 70.43 112.946 -164.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -79.81 132.62 60.43 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.769 1.227 . . . . 73.31 108.974 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.49 149.55 90.55 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.551 2.834 . . . . 74.22 113.732 162.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 pt -114.47 -5.15 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.143 1.777 . . . . 73.45 112.862 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 55.53 73.38 0.43 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.452 1.024 . . . . 74.24 111.342 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.44 159.64 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.676 -0.64 . . . . 70.31 109.364 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 m -56.56 -34.03 66.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.379 -0.819 . . . . 73.44 112.247 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -86.93 -28.98 22.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.694 0.679 . . . . 72.03 110.295 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.05 41.32 1.97 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.717 1.151 . . . . 72.12 114.493 166.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.88 -27.14 62.99 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 115.209 1.559 . . . . 74.12 115.209 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mm 45.77 73.97 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.564 2.345 . . . . 74.45 108.69 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 174.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.791 2.036 . . . . 71.41 108.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.4 135.59 33.44 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.187 1.395 . . . . 73.32 107.811 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 tt -55.38 -28.75 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.079 -1.013 . . . . 72.43 112.08 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.86 -14.51 57.86 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 116.465 -2.297 . . . . 72.51 114.845 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -66.2 -50.01 65.32 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.122 2.461 . . . . 74.51 108.327 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -56.54 -59.17 5.38 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.626 1.97 . . . . 74.45 108.47 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG11 ' CE1' ' A' ' 33' ' ' PHE . 69.1 t -56.77 -47.33 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.135 -0.484 . . . . 73.53 111.166 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -41.69 74.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.824 0.85 . . . . 75.11 110.809 -176.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -51.32 45.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.351 1.06 . . . . 74.04 109.328 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.64 -43.87 65.34 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.152 0.981 . . . . 73.34 108.449 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CE1' HG11 ' A' ' 29' ' ' VAL . 3.4 m-85 -56.01 -38.74 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.323 1.42 . . . . 71.41 111.895 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -83.51 -22.45 32.48 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.507 1.123 . . . . 74.41 111.124 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -88.27 -58.65 2.48 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.969 -1.493 . . . . 75.42 106.969 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -91.88 45.91 1.25 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 129.192 2.997 . . . . 75.2 108.313 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -34.86 64.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.225 -0.922 . . . . 73.32 111.226 172.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -77.99 6.2 8.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.425 . . . . 74.12 112.979 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -106.29 -9.88 16.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 117.179 -1.391 . . . . 74.41 111.322 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.29 99.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 120.089 1.313 . . . . 73.02 108.618 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -85.2 159.84 20.03 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.72 -0.844 . . . . 64.31 108.72 160.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -136.48 133.74 36.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.889 -2.263 . . . . 72.24 104.889 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.77 177.3 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.755 0.659 . . . . 62.3 109.459 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -40.6 77.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.343 1.457 . . . . 63.45 112.237 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -19.54 63.43 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.362 -0.836 . . . . 73.05 111.46 174.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.43 65.1 1.7 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 107.775 -2.13 . . . . 75.04 107.775 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.64 -100.7 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.698 -1.964 . . . . 75.12 105.698 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.49 120.34 1.17 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.992 -2.043 . . . . 65.21 107.992 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -139.16 162.21 35.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.839 0.819 . . . . 72.43 110.092 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.2 mt -143.93 139.99 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 126.508 1.923 . . . . 64.15 105.85 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.75 133.11 35.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.497 1.519 . . . . 71.15 109.163 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.32 4.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 125.841 1.657 . . . . 73.3 112.169 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.07 -10.82 7.52 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.855 1.207 . . . . 75.31 114.173 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.16 -15.74 56.42 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.337 -1.684 . . . . 65.53 112.507 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.45 -12.66 61.84 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.981 1.264 . . . . 75.2 113.407 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.53 -2.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.894 2.078 . . . . 73.11 113.705 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 141.33 16.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.169 1.387 . . . . 72.42 107.477 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.99 157.03 22.02 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.021 0.828 . . . . 63.11 109.547 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.23 144.54 28.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 126.645 1.978 . . . . 73.24 107.337 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -63.77 130.63 44.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.602 -1.629 . . . . 75.43 106.602 165.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.1 p -136.74 -169.18 2.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.632 -1.618 . . . . 75.24 106.632 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.4 OUTLIER -146.17 143.76 29.5 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.31 -1.367 . . . . 65.03 107.31 171.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -86.41 116.22 24.42 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 124.964 1.306 . . . . 73.53 108.357 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.92 -27.98 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.676 0.79 . . . . 74.52 111.876 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.67 -22.42 65.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.637 0.653 . . . . 74.01 112.288 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m -137.57 3.0 2.5 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.746 1.218 . . . . 72.41 112.628 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.47 35.84 24.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.493 1.497 . . . . 64.43 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.47 154.91 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.203 1.801 . . . . 71.41 109.41 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.95 129.53 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.458 -1.682 . . . . 74.42 106.458 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -148.68 178.79 8.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.721 1.608 . . . . 74.14 108.443 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -105.77 150.1 25.84 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.465 -1.397 . . . . 74.22 109.287 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.6 160.11 39.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 169.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -92.4 -17.93 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.048 0.758 . . . . 64.5 113.048 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mt 58.7 147.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.883 2.073 . . . . 75.43 109.429 -160.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.14 -57.24 2.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.996 0.919 . . . . 75.21 108.7 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -129.76 150.76 50.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.364 0.983 . . . . 75.14 110.298 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.55 168.28 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 125.188 1.395 . . . . 73.32 109.204 176.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -135.44 153.2 51.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.177 0.991 . . . . 75.44 109.788 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.94 142.82 29.08 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.374 0.67 . . . . 71.11 109.612 169.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.47 156.64 47.91 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.403 -1.703 . . . . 75.11 106.403 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -84.24 159.18 21.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.117 -1.438 . . . . 74.22 107.117 165.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -139.9 153.94 47.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.196 0.998 . . . . 75.31 110.201 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -149.93 152.9 35.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.77 -0.826 . . . . 72.4 108.77 139.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.17 -171.66 32.13 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 109.394 -1.482 . . . . 64.13 109.394 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 120.31 30.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.757 -1.201 . . . . 74.04 107.757 170.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 160.58 15.96 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.617 -1.253 . . . . 73.0 107.617 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mm -79.34 140.71 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.162 1.385 . . . . 75.12 107.651 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -126.81 58.23 1.42 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.197 0.599 . . . . 74.43 110.287 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.9 mt -63.34 116.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 105.62 -1.993 . . . . 63.45 105.62 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -94.98 155.48 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 105.384 -2.08 . . . . 64.35 105.384 163.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -125.44 169.17 12.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.883 1.273 . . . . 74.51 108.221 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -67.57 -11.14 57.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.588 -1.32 . . . . 72.43 111.814 -172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -3.23 53.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.661 1.585 . . . . 72.44 113.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.09 12.77 8.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.701 1.6 . . . . 75.43 111.571 -171.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -68.09 165.57 17.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.262 -1.014 . . . . 75.44 108.262 163.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -173.19 164.14 4.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.768 2.027 . . . . 72.43 109.027 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.463 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 2.3 pt -144.84 165.99 11.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.033 2.133 . . . . 73.53 107.54 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -140.34 97.87 3.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.841 0.857 . . . . 75.51 109.256 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.84 172.25 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.762 1.625 . . . . 73.41 111.547 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.4 p -61.03 154.61 22.25 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.991 1.316 . . . . 75.53 110.754 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -74.14 -26.15 60.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.465 -0.772 . . . . 71.12 111.369 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -97.72 37.74 1.36 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.623 0.647 . . . . 64.43 110.054 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -90.94 123.38 64.92 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-O 117.807 -1.092 . . . . 73.51 108.108 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.67 139.01 61.48 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.659 1.573 . . . . 64.4 111.094 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.56 -162.3 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.766 1.627 . . . . 71.32 108.772 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -134.02 133.09 40.84 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.223 1.009 . . . . 71.05 110.56 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.45 161.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.383 1.473 . . . . 74.21 109.414 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.24 120.95 28.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.518 1.151 . . . . 60.1 110.751 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.37 77.51 9.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.264 1.826 . . . . 74.24 106.159 150.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.2 17.01 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.655 1.354 . . . . 71.35 114.655 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.48 -28.55 3.99 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 124.919 1.247 . . . . 64.55 111.398 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.06 20.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.635 -2.358 . . . . 74.44 104.635 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.55 134.7 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.288 -1.004 . . . . 74.5 108.288 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 153.18 48.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.501 -1.296 . . . . 71.43 107.501 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.63 114.16 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.377 1.471 . . . . 73.21 109.499 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -136.73 174.03 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.769 2.028 . . . . 73.54 108.596 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.03 148.78 21.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.073 0.851 . . . . 74.33 110.912 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.48 -29.21 9.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.207 1.803 . . . . 64.34 114.162 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.01 1.277 . . . . 61.22 111.928 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 22.6 mtm -87.35 -19.91 27.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.185 0.994 . . . . 71.14 111.613 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 t -71.19 63.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 129.516 3.126 . . . . 64.04 112.239 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -78.5 -179.95 6.69 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.764 -1.835 . . . . 65.42 110.35 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.49 -10.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.652 2.381 . . . . 75.34 113.995 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.88 -3.01 83.63 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 124.629 1.109 . . . . 61.23 112.892 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.89 152.65 31.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.45 -1.685 . . . . 72.33 106.45 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.62 131.68 55.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.645 -1.613 . . . . 74.35 106.645 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -106.89 126.84 62.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.793 0.837 . . . . 72.42 108.803 -168.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.57 122.35 17.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.674 1.19 . . . . 73.41 108.884 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.19 155.83 70.6 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 113.348 0.87 . . . . 73.12 113.348 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.33 151.97 82.25 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.549 2.166 . . . . 75.15 111.006 167.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HB2' HD21 ' A' ' 136' ' ' ASN . 0.0 OUTLIER -121.69 -160.34 0.86 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.007 1.723 . . . . 74.31 106.806 158.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -48.28 -61.58 1.92 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.316 1.046 . . . . 62.1 110.858 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -121.0 -17.86 7.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.088 1.355 . . . . 74.55 112.843 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -140.59 170.84 15.03 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.426 1.09 . . . . 75.54 110.742 -165.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -79.91 154.34 4.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.867 0.841 . . . . 73.2 110.662 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 131' ' ' LYS . 15.5 m-80 -143.89 -171.42 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.179 1.792 . . . . 74.45 106.829 166.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.1 mt -125.28 168.88 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.419 -0.956 . . . . 72.42 108.419 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.83 161.99 40.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.812 0.845 . . . . 64.15 110.937 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -74.7 140.68 44.33 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 127.32 2.248 . . . . 70.43 110.693 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.54 1.03 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.023 1.329 . . . . 75.23 112.61 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.7 pt 24.33 -75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 129.882 3.273 . . . . 73.42 117.238 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.468 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -93.12 126.09 38.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.909 2.484 . . . . 74.23 109.537 -170.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.18 121.91 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.316 0.646 . . . . 74.31 110.505 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.75 -171.9 0.49 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.238 3.015 . . . . 74.01 109.445 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.9 p -132.29 174.25 10.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.827 2.051 . . . . 74.31 107.98 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.0 m -110.18 -178.25 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.439 -1.319 . . . . 75.21 107.439 151.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.46 113.65 15.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.783 -1.562 . . . . 64.23 106.783 168.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -129.99 160.88 32.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.356 1.462 . . . . 73.14 109.806 -165.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.17 47.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.344 1.458 . . . . 74.13 109.663 -162.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -117.17 -150.57 9.23 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.964 1.745 . . . . 75.41 110.212 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -98.0 157.1 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.793 0.796 . . . . 75.14 109.797 159.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 19.2 pt -122.08 151.26 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 126.537 1.935 . . . . 75.11 107.929 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -136.87 151.18 48.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.791 1.236 . . . . 75.35 111.118 -170.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.0 -177.85 6.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.913 0.885 . . . . 75.34 111.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.76 121.98 9.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.311 1.844 . . . . 70.44 107.772 -152.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.53 -37.09 32.19 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-O 116.13 -1.891 . . . . 74.25 114.72 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p 24.61 73.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.771 2.028 . . . . 75.52 112.708 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 12.3 pt-20 -66.02 -10.06 36.33 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.492 -1.38 . . . . 74.1 113.602 -170.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.52 -72.37 0.17 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.825 2.05 . . . . 72.14 106.066 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.83 -19.25 17.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.685 1.594 . . . . 73.15 111.729 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 158' ' ' GLU . 51.4 m170 48.31 39.72 12.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.062 2.145 . . . . 72.24 112.658 -162.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.421 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 14.0 p -152.48 143.92 23.37 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.043 1.292 . . . . 74.43 109.32 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.465 ' CD2' ' HB3' ' A' ' 175' ' ' ALA . 4.0 p90 -136.08 172.88 12.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.488 1.515 . . . . 65.44 110.082 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.2 mm -103.32 138.26 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.915 -1.513 . . . . 64.53 106.915 157.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -163.15 160.23 23.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.048 0.939 . . . . 74.53 110.295 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 131.17 -163.02 23.63 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.279 1.418 . . . . 55.34 110.731 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -104.9 170.26 7.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.0 1.9 . . . . 72.54 112.049 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 56.9 -72.42 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 129.695 3.198 . . . . 75.32 111.685 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.62 -14.98 8.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.469 1.508 . . . . 75.45 113.493 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.04 171.75 9.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 122.726 1.181 . . . . 74.43 112.412 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.463 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 39.0 m-85 -126.49 144.78 50.75 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 126.861 2.064 . . . . 75.34 109.118 -170.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.9 114.57 13.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.26 1.424 . . . . 72.23 108.243 166.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.92 -179.29 3.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.618 0.767 . . . . 75.53 110.789 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -72.65 144.25 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.79 0.836 . . . . 75.22 108.951 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . . . -145.52 60.87 1.28 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.291 1.836 . . . . 74.14 109.425 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.238 0.466 0 CA-C-O 122.427 1.108 . . . . 64.23 111.466 -179.566 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.613 0 N-CA-C 106.048 -1.834 . . . . 63.0 106.048 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -113.93 178.09 4.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.774 1.63 . . . . 75.21 109.548 172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.17 -169.21 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.183 1.793 . . . . 71.01 113.667 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t80 -94.29 -45.67 7.39 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.947 1.299 . . . . 74.24 109.931 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.33 -0.41 56.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.434 1.493 . . . . 75.42 112.058 -167.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 156.6 76.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.03 -1.044 . . . . 75.31 110.579 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -92.92 143.8 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.334 3.356 . . . . 74.31 113.351 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.26 -2.0 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.325 1.231 . . . . 72.11 114.325 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 53.71 73.41 0.38 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.454 1.101 . . . . 74.52 111.974 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.64 162.83 1.06 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.476 -0.765 . . . . 73.4 109.596 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.9 t -49.03 -40.39 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.108 0.963 . . . . 61.34 110.732 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -81.24 -20.59 40.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.282 0.845 . . . . 74.34 113.282 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.21 28.93 8.25 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.518 1.056 . . . . 65.45 113.041 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -15.34 63.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 118.37 2.73 . . . . 72.34 118.37 -163.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 mm 43.79 78.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.014 2.525 . . . . 74.42 109.643 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.3 154.16 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.631 1.973 . . . . 72.22 107.487 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' H ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -62.26 129.63 41.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.889 1.276 . . . . 73.54 107.584 171.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -53.19 -39.4 34.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 109.569 -0.53 . . . . 72.41 109.569 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -46.19 -59.71 4.99 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 125.014 1.292 . . . . 74.5 111.337 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 24' ' ' ASN . 38.5 tp10 -69.14 -48.55 62.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.197 -0.906 . . . . 72.42 110.454 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -45.7 -53.1 9.89 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.554 1.142 . . . . 74.31 109.614 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.7 -45.36 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.485 -0.779 . . . . 74.53 109.486 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.412 ' CG ' ' HZ3' ' A' ' 34' ' ' LYS . 25.7 t70 -59.87 -37.94 80.75 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.842 -1.161 . . . . 73.35 113.223 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -55.96 -38.13 69.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.903 1.681 . . . . 74.54 110.784 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 15.8 m-85 -73.84 -49.17 26.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.19 1.396 . . . . 75.23 108.638 172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.18 -37.98 62.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.177 1.808 . . . . 73.24 113.301 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HZ3' ' CG ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -76.21 -30.34 57.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.01 -0.995 . . . . 71.1 111.829 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -85.08 -52.11 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 2.0 m-30 -93.5 41.36 1.08 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.716 2.007 . . . . 74.21 108.256 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -27.79 68.57 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.576 -1.328 . . . . 71.34 112.142 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -62.42 -27.98 69.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.944 1.698 . . . . 75.53 113.304 168.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.346 1.858 . . . . 75.15 112.86 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.3 mt -66.39 89.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.976 1.262 . . . . 70.24 109.764 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -79.71 161.27 25.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.992 1.717 . . . . 74.44 108.528 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -143.32 122.28 12.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.05 1.34 . . . . 73.2 108.884 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.92 169.76 17.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.651 -0.87 . . . . 75.44 108.651 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -54.47 34.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.91 2.084 . . . . 75.14 111.137 -173.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.04 3.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.356 1.462 . . . . 60.14 113.295 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.67 18.99 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 126.927 2.204 . . . . 73.34 110.853 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -86.0 -99.97 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.409 1.084 . . . . 74.44 108.156 -173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.01 111.01 0.68 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-O 117.754 -1.581 . . . . 73.41 110.726 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -114.19 164.6 13.65 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.229 1.514 . . . . 75.51 111.537 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mt -145.36 144.04 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 128.125 2.57 . . . . 74.32 105.266 164.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -83.06 114.7 21.47 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.81 -1.182 . . . . 74.02 107.81 166.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.96 13.59 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.854 0.862 . . . . 74.2 109.98 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.93 -31.91 82.41 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 120.19 -1.569 . . . . 62.4 111.334 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.64 -1.51 7.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.719 1.208 . . . . 72.3 114.245 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -74.67 -18.25 60.56 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.872 -0.518 . . . . 75.0 111.088 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.29 18.85 11.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.24 2.216 . . . . 52.02 113.624 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -82.33 131.03 34.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.292 -1.373 . . . . 75.1 107.292 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -96.67 161.58 13.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.362 1.465 . . . . 63.15 109.476 173.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.87 149.58 19.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.722 1.609 . . . . 75.13 108.72 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -68.99 121.43 16.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.278 -1.379 . . . . 75.52 107.278 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 163' ' ' TYR . 0.4 OUTLIER -117.81 -177.55 3.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.044 1.338 . . . . 54.42 108.384 171.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.2 OUTLIER -137.71 132.22 32.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.369 -1.715 . . . . 74.11 106.369 169.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.17 106.35 13.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.321 -0.992 . . . . 72.34 108.321 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 71.5 tttt -55.84 -18.55 8.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.327 1.851 . . . . 73.14 113.984 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.95 -34.55 78.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.448 1.099 . . . . 74.3 112.121 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.3 m -125.51 -1.55 7.46 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.054 0.942 . . . . 73.03 112.501 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.81 44.09 17.41 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.122 -0.986 . . . . 75.45 110.487 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 pt -108.6 157.24 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.941 1.696 . . . . 74.45 109.151 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.65 128.71 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.03 -1.47 . . . . 73.25 107.03 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -135.71 175.21 9.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.491 1.116 . . . . 75.52 112.758 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.62 96.64 3.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.245 -2.131 . . . . 74.24 105.245 -157.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -125.14 172.0 9.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.079 0.952 . . . . 73.42 110.575 -165.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -116.28 153.08 32.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.93 0.786 . . . . 75.31 109.382 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.56 154.77 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.798 -1.186 . . . . 70.32 107.798 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 -20.62 6.75 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.918 0.781 . . . . 65.4 112.639 169.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -161.7 163.74 29.56 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.2 -1.563 . . . . 71.25 108.478 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.97 161.25 32.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.095 0.958 . . . . 65.15 109.11 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -135.7 149.34 49.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.38 1.072 . . . . 74.31 110.416 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -146.2 142.24 28.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.124 0.875 . . . . 75.35 110.527 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -146.17 163.19 36.17 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.288 2.235 . . . . 74.25 107.274 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -107.48 156.4 19.02 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.612 -1.255 . . . . 74.5 107.612 164.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -153.64 163.08 40.6 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.975 1.31 . . . . 72.02 108.82 -166.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -151.67 113.92 4.53 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.116 -1.809 . . . . 75.32 106.116 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.52 -146.54 5.31 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 117.095 -2.479 . . . . 62.05 112.209 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 104.54 8.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.407 1.883 . . . . 72.41 107.801 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.69 162.91 20.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.73 1.612 . . . . 74.31 106.887 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 mm -79.5 135.25 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 127.057 2.143 . . . . 73.11 107.37 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -125.4 79.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.635 -1.617 . . . . 74.54 106.635 161.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.21 141.07 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.345 -2.094 . . . . 75.11 105.345 152.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -115.16 164.28 14.43 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.621 -1.992 . . . . 71.42 105.621 163.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -136.02 169.73 17.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.822 1.192 . . . . 74.23 108.909 166.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.06 -21.63 66.3 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.675 -1.265 . . . . 73.22 112.759 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -66.49 -1.13 3.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.366 1.866 . . . . 65.24 112.72 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.3 22.41 10.75 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.025 1.73 . . . . 72.54 111.358 -165.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.79 168.71 19.33 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.865 -0.791 . . . . 63.43 108.865 163.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 174.6 163.15 0.22 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 129.05 2.94 . . . . 73.32 110.401 -167.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 3.0 pt -140.12 172.49 12.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.723 1.209 . . . . 71.33 110.436 -170.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 97' ' ' ILE . 27.1 m -152.27 94.82 1.97 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.124 0.969 . . . . 75.03 109.713 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.11 177.59 10.91 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 128.408 2.683 . . . . 73.33 109.261 -174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.9 p -78.4 171.49 15.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 120.649 1.568 . . . . 63.04 110.657 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -69.91 -19.67 63.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.13 0.972 . . . . 74.21 111.371 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -109.64 38.02 2.48 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.422 -0.799 . . . . 73.44 110.761 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -107.15 133.72 20.2 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.868 -0.79 . . . . 72.44 108.868 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.32 118.1 5.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.671 2.914 . . . . 74.21 113.251 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.35 -179.32 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.664 1.586 . . . . 71.44 109.954 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.17 144.72 49.17 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.223 0.92 . . . . 72.34 111.15 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 pt -134.88 165.49 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.112 0.965 . . . . 73.32 109.871 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.1 p -94.42 110.02 21.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.968 0.507 . . . . 64.34 109.666 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -85.8 81.35 8.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.578 -2.008 . . . . 73.43 105.578 167.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.1 32.47 4.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.473 1.109 . . . . 74.14 113.196 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.25 -9.42 42.36 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.693 -1.059 . . . . 55.41 114.339 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -84.5 131.21 34.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 119.389 1.595 . . . . 70.24 106.881 167.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.08 117.78 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.039 -1.467 . . . . 71.43 107.039 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 151.19 45.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.885 1.274 . . . . 75.44 108.65 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.2 121.3 44.92 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.53 1.132 . . . . 72.54 109.683 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.6 pt -140.74 -175.96 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.789 0.836 . . . . 74.23 110.498 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -92.87 142.91 26.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.198 1.399 . . . . 72.25 108.704 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.11 65.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.35 0.977 . . . . 60.0 113.544 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -32.32 66.14 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.196 1.362 . . . . 71.22 112.596 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -23.85 36.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.563 1.145 . . . . 73.02 112.195 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.97 64.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.029 2.532 . . . . 74.51 111.653 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.79 -179.77 7.11 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.425 -1.422 . . . . 71.12 111.878 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -55.59 -9.86 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 128.421 2.689 . . . . 74.43 114.005 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.71 -15.97 79.92 Favored Glycine 0 CA--C 1.523 0.59 0 O-C-N 121.279 -0.888 . . . . 51.33 111.554 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.33 164.87 13.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.634 1.217 . . . . 73.21 108.92 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 13.1 m-85 -113.41 137.9 50.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.218 -1.401 . . . . 74.0 107.218 167.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.4 132.46 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.613 -1.255 . . . . 70.21 107.613 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.41 124.53 23.42 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.5 -0.926 . . . . 73.13 108.5 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.33 154.5 81.04 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.899 1.68 . . . . 72.33 110.096 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.57 149.43 84.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.401 1.401 . . . . 63.3 110.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -120.62 -145.39 0.36 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.568 -1.641 . . . . 73.33 106.568 149.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.85 -70.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.145 1.378 . . . . 73.32 111.155 -162.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -120.09 -2.79 10.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.596 0.758 . . . . 74.23 112.764 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 167.32 21.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.434 1.093 . . . . 75.32 111.257 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.2 tp -78.84 156.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.139 0.971 . . . . 74.4 108.686 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.93 -173.76 3.89 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 127.601 2.361 . . . . 73.51 107.226 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.6 mt -135.43 136.52 41.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.387 -2.079 . . . . 74.41 105.387 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -133.7 153.98 51.29 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.717 -1.216 . . . . 70.43 107.717 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 18.1 tt0 -96.77 136.87 36.7 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.841 2.056 . . . . 74.43 107.88 -161.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.296 46.9 t -79.98 1.05 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 114.479 1.288 . . . . 73.21 114.479 -158.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.7 pt 26.61 -98.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.158 2.583 . . . . 74.24 115.405 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.403 ' H ' HG13 ' A' ' 141' ' ' ILE . 22.5 ttpt -90.56 122.5 33.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.411 -1.43 . . . . 73.34 108.067 173.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.62 117.49 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.251 -1.388 . . . . 73.31 107.251 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.83 -165.57 2.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.832 1.653 . . . . 73.44 108.909 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 p -121.92 171.33 9.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.017 1.327 . . . . 71.3 110.179 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.56 131.75 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.712 -1.218 . . . . 63.3 107.712 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.02 109.54 17.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.374 -1.343 . . . . 75.33 107.374 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -133.23 136.18 45.43 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.802 2.041 . . . . 72.03 106.909 -163.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -140.63 43.86 1.85 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.784 -0.572 . . . . 75.54 110.233 -155.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.81 8.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.391 0.996 . . . . 74.55 112.897 -165.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.15 155.52 24.95 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.977 -0.719 . . . . 74.01 110.408 165.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.4 pt -132.36 147.21 32.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 127.712 2.405 . . . . 74.13 106.961 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.4 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 3.5 m-85 -132.79 164.68 26.28 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.786 -1.19 . . . . 75.0 107.786 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -153.66 177.39 11.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.528 -1.286 . . . . 73.35 107.528 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.9 mt -140.56 163.81 31.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.719 1.145 . . . . 73.42 110.819 -167.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.1 m -118.58 110.38 17.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.926 1.691 . . . . 73.33 107.054 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.2 77.72 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.808 2.043 . . . . 70.53 106.808 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.378 10.9 pt-20 -72.87 2.2 7.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.109 1.364 . . . . 75.21 113.995 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.5 -56.61 11.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 128.438 2.695 . . . . 71.13 109.74 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.6 t30 -133.24 -4.33 3.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.128 0.971 . . . . 72.43 111.861 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.4 m80 66.65 21.34 10.65 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.284 1.434 . . . . 73.5 112.219 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.418 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 4.5 p -142.22 139.73 32.09 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.486 -0.931 . . . . 74.23 108.486 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -137.82 176.64 8.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.876 0.87 . . . . 75.03 110.281 -175.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.8 mm -98.76 120.1 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 165.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.26 133.79 24.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.947 -1.131 . . . . 65.43 107.947 167.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.54 177.05 33.3 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.723 2.106 . . . . 72.44 108.065 168.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -75.34 178.74 5.63 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.366 -2.255 . . . . 74.32 110.622 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.61 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.079 1.752 . . . . 70.32 112.468 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -122.13 -8.5 8.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.433 1.893 . . . . 75.05 114.177 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 88.1 164.13 39.91 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.549 1.547 . . . . 73.32 113.482 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 97' ' ' ILE . 9.1 m-85 -108.19 159.66 16.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.32 1.448 . . . . 74.11 109.044 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -102.1 102.08 12.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.215 1.806 . . . . 73.13 106.7 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.74 177.08 6.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.243 1.017 . . . . 75.15 109.684 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 75.0 m -66.55 139.15 57.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.472 -0.936 . . . . 72.2 108.472 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.12 39.63 3.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.033 2.533 . . . . 75.15 109.28 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.691 -0.855 . . . . 74.43 108.691 177.715 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 109.312 -0.625 . . . . 74.23 109.312 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.73 166.69 10.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.281 3.032 . . . . 71.35 109.016 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 178.97 1.2 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.165 1.386 . . . . 74.02 112.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -75.84 -34.33 60.08 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.427 -0.796 . . . . 75.04 110.522 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.45 25.53 11.56 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.678 1.228 . . . . 74.52 112.436 -161.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.05 126.39 82.04 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 125.36 1.464 . . . . 70.3 109.141 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -67.14 102.76 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.33 2.687 . . . . 63.11 108.89 168.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 pt -78.17 140.88 16.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.818 1.19 . . . . 71.43 108.964 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.14 83.32 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.525 -1.657 . . . . 74.54 106.525 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.8 mt -58.97 154.7 14.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.72 -0.845 . . . . 71.12 108.72 168.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -61.92 -20.4 63.73 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.2 -0.313 . . . . 72.43 110.188 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.74 -29.65 70.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.633 1.973 . . . . 61.43 112.736 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.88 4.61 67.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.238 1.399 . . . . 72.43 112.314 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.19 -39.36 72.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.632 1.716 . . . . 63.51 115.073 -156.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mm 57.02 96.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 127.73 2.412 . . . . 64.44 108.841 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 157.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.679 -1.971 . . . . 62.41 105.679 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -67.04 119.25 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.581 -1.637 . . . . 63.54 106.581 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -50.79 -35.85 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.292 0.637 . . . . 75.44 110.153 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.38 -30.94 63.97 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-O 118.2 -1.334 . . . . 72.33 112.734 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -63.36 -55.91 20.63 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 119.917 1.858 . . . . 75.35 108.894 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -48.48 -49.61 34.97 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 125.341 1.456 . . . . 65.42 110.397 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.33 -40.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 118.087 -0.958 . . . . 73.13 110.109 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -64.58 -29.38 70.4 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 120.723 1.601 . . . . 72.54 110.873 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -43.85 52.67 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.871 1.268 . . . . 72.22 110.335 170.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.6 -46.18 22.95 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.325 -1.321 . . . . 75.35 110.03 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 8.4 m-85 -54.85 -34.32 62.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 122.182 2.264 . . . . 74.45 113.08 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -84.81 -22.39 29.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.637 1.175 . . . . 74.54 110.616 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -63.29 1.32 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.701 -1.222 . . . . 75.05 107.701 172.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -84.26 39.77 0.73 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.184 2.594 . . . . 75.43 109.192 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.5 -36.74 55.85 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 70.03 111.181 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -71.05 -13.49 62.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.306 1.842 . . . . 75.14 113.381 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.06 5.76 26.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.268 1.427 . . . . 75.23 112.379 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 105.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.518 -1.29 . . . . 71.43 107.518 171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -103.85 107.18 17.94 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.051 0.541 . . . . 72.41 109.72 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -70.69 154.7 41.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.745 -0.835 . . . . 73.11 108.745 168.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -113.85 171.64 7.47 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.246 1.818 . . . . 73.42 107.181 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -54.26 21.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.185 1.794 . . . . 65.55 111.239 -175.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.35 -18.79 65.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.82 0.848 . . . . 64.41 111.381 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.27 -1.78 22.35 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.867 1.699 . . . . 71.11 113.643 160.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -50.46 -79.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.305 1.842 . . . . 63.03 111.81 -164.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.48 110.43 2.85 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.055 -1.618 . . . . 73.33 109.055 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -110.62 168.78 9.21 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.233 1.013 . . . . 74.33 109.635 165.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mt -143.91 136.22 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.97 -1.863 . . . . 74.21 105.97 166.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.2 125.32 26.62 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.677 -0.86 . . . . 75.42 108.677 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.27 3.85 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.914 0.885 . . . . 74.51 110.768 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.22 -31.23 72.78 Favored Glycine 0 CA--C 1.524 0.65 0 O-C-N 121.331 -0.856 . . . . 72.15 113.188 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -60.45 -13.63 14.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.565 1.182 . . . . 64.15 113.025 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.62 -21.09 37.38 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.98 -1.075 . . . . 73.14 111.662 167.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.93 24.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.677 2.391 . . . . 73.33 113.441 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.32 113.66 9.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.773 -1.566 . . . . 75.43 106.773 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -79.16 150.78 31.61 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.162 0.585 . . . . 75.21 110.97 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.36 157.83 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.65 1.58 . . . . 64.1 108.296 170.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -63.6 110.27 1.94 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.751 -1.944 . . . . 74.24 105.751 162.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.57 175.65 5.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.107 1.363 . . . . 75.44 107.807 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.416 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -149.95 120.72 7.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.452 -1.314 . . . . 63.53 107.452 174.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.82 118.67 17.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.202 -0.936 . . . . 71.33 109.547 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -63.86 -31.74 73.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.588 0.355 . . . . 74.51 110.989 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -41.74 6.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.164 1.785 . . . . 75.21 111.692 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -136.91 15.59 3.07 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 74.24 111.399 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.5 47.6 8.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.834 1.654 . . . . 74.41 112.51 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.06 160.54 3.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 124.875 1.27 . . . . 74.22 108.434 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.86 149.68 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.801 -1.555 . . . . 74.44 106.801 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -178.69 7.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.287 2.235 . . . . 62.05 110.227 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -124.98 130.96 53.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.047 1.339 . . . . 73.4 107.715 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -151.6 160.04 43.82 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.403 1.081 . . . . 65.34 108.78 163.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -83.36 178.11 8.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.152 0.981 . . . . 75.54 110.687 163.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -95.12 170.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.848 2.059 . . . . 72.34 106.194 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.66 -61.71 1.49 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.044 -1.465 . . . . 73.31 107.044 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -126.72 152.11 47.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.941 -1.133 . . . . 73.14 107.941 -171.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.17 159.74 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 125.46 1.504 . . . . 70.12 107.646 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -137.84 156.31 48.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.733 0.813 . . . . 75.41 112.071 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.7 139.54 26.61 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.394 1.478 . . . . 74.42 111.521 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -148.5 155.8 41.62 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.161 0.984 . . . . 72.13 108.901 168.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -79.62 153.28 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.818 -1.176 . . . . 72.52 109.248 170.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.94 157.37 43.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.605 1.562 . . . . 74.12 108.538 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 p -161.96 97.45 1.04 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.141 0.976 . . . . 60.45 111.681 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.2 -172.78 45.76 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.675 -1.266 . . . . 63.51 112.652 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -85.05 116.15 23.27 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.132 0.573 . . . . 74.42 110.845 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.79 165.83 12.1 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.863 1.665 . . . . 74.14 109.214 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.91 134.4 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 126.053 1.741 . . . . 73.34 109.669 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -123.61 82.82 2.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.995 -1.483 . . . . 74.34 106.995 164.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.8 mt -57.96 132.6 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.173 -2.158 . . . . 74.44 105.173 153.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -106.08 166.0 10.82 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.119 -1.808 . . . . 74.51 106.119 159.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.09 169.89 16.48 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.579 1.081 . . . . 63.24 109.558 165.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -63.82 -25.24 68.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.071 -1.018 . . . . 60.34 112.022 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.94 -0.17 0.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.196 2.598 . . . . 55.5 113.133 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 59.85 22.46 11.4 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 127.06 2.144 . . . . 72.52 111.333 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 2.6 ttm180 -75.64 163.52 27.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.213 -0.929 . . . . 73.22 108.756 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 167.99 4.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.636 0.775 . . . . 75.31 110.093 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.474 HG21 ' CE1' ' A' ' 171' ' ' PHE . 4.8 pt -147.97 178.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.998 1.719 . . . . 62.21 110.993 -173.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.7 m -149.99 103.48 3.21 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.639 1.576 . . . . 72.33 110.788 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.11 169.54 17.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 119.584 -1.947 . . . . 73.13 112.615 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -62.22 144.91 54.89 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.198 1.399 . . . . 74.24 109.203 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.95 -20.72 64.21 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.651 -1.281 . . . . 52.53 112.143 -169.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -101.12 39.65 1.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.353 1.461 . . . . 54.0 110.672 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.69 143.08 25.7 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.16 -1.588 . . . . 74.24 109.729 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.75 137.24 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.014 2.476 . . . . 71.13 111.842 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.17 -177.4 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.915 1.686 . . . . 73.43 108.376 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.28 141.92 51.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.382 1.446 . . . . 75.33 111.303 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.36 171.32 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.858 1.263 . . . . 73.52 109.644 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.1 p -103.32 96.65 6.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.819 0.848 . . . . 73.1 111.005 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -82.29 89.06 6.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.325 -2.102 . . . . 73.33 105.325 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 44.13 44.51 6.39 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.05 1.34 . . . . 75.32 112.012 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.15 -31.81 8.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 118.097 -1.391 . . . . 74.22 113.608 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -79.51 144.94 33.5 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 119.798 1.799 . . . . 74.11 108.063 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.18 123.06 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.937 -1.134 . . . . 75.5 107.937 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 tp -123.06 159.47 28.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.664 -0.865 . . . . 72.02 108.664 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.46 104.05 11.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.438 1.495 . . . . 64.11 110.875 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 pt -129.96 -178.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.178 0.991 . . . . 65.02 112.136 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.16 134.52 34.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.343 0.974 . . . . 71.43 108.808 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.68 -38.44 55.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.861 1.06 . . . . 73.21 113.861 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 1.5 pp20? -67.19 -16.7 64.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.817 1.043 . . . . 75.04 113.817 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 35.6 mtt -83.16 -25.18 32.1 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.773 0.829 . . . . 71.01 110.436 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.35 62.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 127.754 2.422 . . . . 75.51 109.453 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 24.7 mmtp -79.72 -174.17 4.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.416 1.087 . . . . 74.41 108.707 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.79 -12.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.249 2.22 . . . . 73.22 113.38 167.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.91 -4.76 89.63 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 117.97 -1.461 . . . . 72.01 112.063 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -132.14 172.39 12.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.909 1.854 . . . . 62.21 110.834 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 9.4 m-85 -116.66 119.45 35.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.171 1.788 . . . . 74.15 106.346 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 tp -83.19 130.32 35.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.851 -1.166 . . . . 72.12 107.851 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -70.73 116.46 11.06 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.146 -1.057 . . . . 72.41 108.146 170.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.8 153.09 63.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.224 1.41 . . . . 75.2 112.035 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 153.61 52.4 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.602 2.201 . . . . 73.53 110.867 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.69 179.24 6.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.053 2.541 . . . . 73.44 107.218 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -25.41 -67.08 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.499 2.32 . . . . 75.51 113.911 -169.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -120.35 -0.55 10.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.381 1.872 . . . . 74.04 111.298 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.0 p -143.21 -171.27 3.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.211 1.004 . . . . 73.32 111.972 -154.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.47 153.17 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.855 -1.165 . . . . 63.0 107.855 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -145.8 -175.64 4.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.604 2.761 . . . . 73.31 106.163 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.99 161.27 19.65 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.724 1.21 . . . . 74.33 110.377 170.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -148.13 152.91 38.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.277 2.231 . . . . 74.45 106.804 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 19.2 mt-10 -77.13 147.4 36.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.689 1.595 . . . . 74.32 110.029 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.13 1.04 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.012 0.745 . . . . 73.15 113.012 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 29.47 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 128.161 2.584 . . . . 75.43 116.176 170.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.507 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.3 tppt? -100.33 128.36 46.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 120.804 -1.185 . . . . 73.01 107.942 174.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.65 128.21 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.64 -1.245 . . . . 75.53 107.64 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.55 -177.75 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.406 2.282 . . . . 64.53 107.216 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.9 p -117.86 170.44 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.964 -1.085 . . . . 70.42 109.339 167.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.21 124.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 107.003 -1.48 . . . . 75.24 107.003 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -86.16 114.35 22.93 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.904 1.229 . . . . 73.43 107.826 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -120.16 139.16 53.04 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.645 1.578 . . . . 74.35 107.299 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.55 81.92 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.502 -0.925 . . . . 74.32 108.502 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.83 -121.06 1.12 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.13 1.824 . . . . 62.41 111.273 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -136.84 152.57 50.41 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.232 -1.157 . . . . 73.24 109.703 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.3 pt -116.82 156.3 18.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.363 1.865 . . . . 74.45 108.267 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -138.14 150.92 47.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.841 1.257 . . . . 73.31 107.942 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -129.08 166.5 19.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.744 0.702 . . . . 74.53 109.96 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 127.16 42.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.111 1.365 . . . . 71.43 108.894 -170.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.5 m -71.08 -58.0 3.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.758 -0.639 . . . . 60.43 110.773 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.2 t 25.94 64.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 129.516 3.126 . . . . 71.32 112.567 -170.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -72.58 0.17 11.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.923 1.689 . . . . 74.14 113.027 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.19 -70.65 0.32 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.964 1.305 . . . . 74.12 108.526 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -93.6 0.31 56.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.615 0.766 . . . . 74.51 111.151 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.9 m170 65.21 26.48 12.31 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.736 2.014 . . . . 70.02 111.835 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 40.2 p -145.16 167.09 23.6 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.915 -1.115 . . . . 74.11 109.952 -175.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.37 171.4 17.25 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.779 1.632 . . . . 73.33 109.527 176.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.6 mm -105.84 119.46 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.619 -1.252 . . . . 72.33 107.619 167.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -150.82 146.7 26.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.176 0.99 . . . . 74.35 109.977 171.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.64 177.88 23.26 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 128.063 2.744 . . . . 63.44 109.015 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -73.46 166.55 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.238 -1.742 . . . . 73.31 110.347 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 70.01 -71.7 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.617 2.367 . . . . 63.2 114.808 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.28 -19.27 5.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.772 1.229 . . . . 73.41 114.241 165.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 164.22 40.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.969 2.223 . . . . 44.1 113.62 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.486 ' CE1' ' HD2' ' A' ' 95' ' ' ARG . 56.6 m-85 -104.18 151.99 22.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.855 2.062 . . . . 72.12 108.302 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.22 111.71 23.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.785 2.034 . . . . 71.33 106.936 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.27 166.97 20.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 119.065 0.848 . . . . 74.22 110.472 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.3 t -66.25 139.97 58.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.281 1.432 . . . . 64.21 109.841 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . . . -137.3 70.36 1.4 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.32 2.648 . . . . 75.32 106.969 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.469 0.487 0 O-C-N 119.964 -1.71 . . . . 73.05 111.821 -171.545 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.028 0.442 . . . . 71.04 111.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -106.2 -178.03 3.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 129.538 3.135 . . . . 72.35 109.376 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.0 -156.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.472 1.109 . . . . 72.54 112.342 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.6 t80 -103.1 -30.58 10.64 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 71.44 110.414 164.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -116.72 29.67 7.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.768 2.427 . . . . 73.43 110.785 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -100.71 134.73 20.36 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.734 -0.839 . . . . 62.32 108.734 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.09 138.21 25.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.819 2.346 . . . . 74.14 112.921 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.5 pt -102.11 7.09 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 114.974 1.472 . . . . 64.4 114.974 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 36.28 74.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.287 1.835 . . . . 73.11 114.226 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 152.42 2.35 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.471 -0.937 . . . . 74.25 108.471 164.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -54.41 -36.19 63.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.193 0.451 . . . . 74.41 111.459 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.0 -19.53 62.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.958 1.303 . . . . 71.42 112.657 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.56 18.23 33.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 117.961 -1.466 . . . . 71.23 112.643 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -38.38 64.93 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.601 1.7 . . . . 75.22 113.821 -167.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.81 96.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.448 2.699 . . . . 73.32 108.977 -170.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.25 146.87 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.414 -1.699 . . . . 75.23 106.414 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.95 135.96 53.21 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.415 1.886 . . . . 63.14 108.079 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 tt -51.3 -43.08 28.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.443 1.097 . . . . 63.1 110.812 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.48 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -71.36 -41.21 59.29 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-O 117.961 -1.466 . . . . 45.23 110.377 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -58.06 -44.06 87.25 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 120.78 2.29 . . . . 74.5 112.167 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.89 -59.71 4.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.656 1.582 . . . . 73.02 109.06 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.4 -44.54 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.402 -0.363 . . . . 64.1 110.589 -171.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.24 -32.14 73.47 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.171 -0.956 . . . . 75.01 109.608 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -50.83 -52.54 40.37 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.43 -0.794 . . . . 74.2 109.882 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -66.21 -41.81 89.63 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.768 -1.197 . . . . 65.43 107.768 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.71 -31.0 70.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.78 1.627 . . . . 70.22 112.827 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -19.03 32.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 125.387 1.475 . . . . 74.21 111.696 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -94.92 -63.75 1.14 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.269 -1.752 . . . . 75.02 106.269 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.02 43.28 0.77 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.355 2.662 . . . . 71.32 108.585 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -50.89 -40.28 56.22 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.395 1.478 . . . . 73.14 110.187 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -59.02 -35.5 73.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.593 1.157 . . . . 74.1 112.965 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 m -77.17 -6.08 51.6 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.636 1.175 . . . . 72.31 113.768 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -65.37 95.26 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 119.807 1.185 . . . . 72.41 108.749 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -79.18 157.11 27.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.303 -1.74 . . . . 64.1 106.303 163.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -126.77 145.9 50.44 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.266 -2.124 . . . . 73.22 105.266 159.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.75 177.43 8.67 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.111 0.882 . . . . 62.33 110.332 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -49.23 -50.02 40.38 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.229 2.212 . . . . 61.2 111.911 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -70.66 -9.28 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.061 1.344 . . . . 73.11 112.137 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.37 56.18 2.89 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 127.235 2.35 . . . . 72.2 109.447 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -85.37 -100.19 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.609 -1.256 . . . . 75.22 107.609 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.85 123.77 0.99 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 107.79 -2.124 . . . . 74.43 107.79 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 160.35 41.34 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.276 1.538 . . . . 74.42 110.93 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -143.2 149.71 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.822 2.049 . . . . 70.42 106.637 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.81 135.24 37.78 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.031 1.332 . . . . 63.52 109.575 165.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.09 25.52 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.33 2.252 . . . . 75.43 109.592 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.67 1.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 127.788 2.613 . . . . 63.32 115.694 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.06 -10.92 13.42 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.429 2.615 . . . . 72.41 114.785 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -28.44 63.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 121.347 1.885 . . . . 74.33 111.846 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 11.87 2.24 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.821 1.648 . . . . 72.32 113.339 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 mt -67.53 127.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.694 1.598 . . . . 73.23 109.48 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -94.6 142.83 26.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.564 1.146 . . . . 63.34 110.384 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.26 152.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.244 2.218 . . . . 74.02 106.961 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -68.49 105.67 2.29 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.265 -1.754 . . . . 70.43 106.265 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -96.36 -176.48 3.66 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.852 -1.166 . . . . 73.43 107.852 167.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -143.73 141.91 30.69 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.572 -1.64 . . . . 75.11 106.572 171.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.76 96.0 9.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -55.45 -21.21 15.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.644 0.778 . . . . 74.02 112.823 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -44.48 1.43 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.075 2.15 . . . . 75.35 112.024 167.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -139.03 0.91 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.088 0.955 . . . . 61.03 112.336 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mt 63.92 59.84 1.08 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.193 1.797 . . . . 73.44 110.743 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.73 153.09 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.768 1.627 . . . . 71.21 109.254 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.8 138.98 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.965 -1.124 . . . . 75.55 107.965 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -144.26 172.36 13.03 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.062 1.745 . . . . 72.23 107.977 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.34 131.68 54.33 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.286 -1.375 . . . . 74.11 107.286 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.3 mmpt? -141.33 155.74 45.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.587 -1.634 . . . . 75.43 106.587 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.71 124.42 49.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.95 0.795 . . . . 74.22 110.478 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.61 154.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.103 2.161 . . . . 73.4 109.084 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.2 -50.43 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.02 1.728 . . . . 74.5 110.504 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -134.2 160.04 39.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.0 1.727 . . . . 75.25 110.418 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.98 161.22 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 74.12 109.441 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.04 154.84 46.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.848 1.259 . . . . 75.03 110.417 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 148.78 19.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.378 0.99 . . . . 74.01 111.092 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -141.16 169.35 17.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.152 -1.425 . . . . 73.42 107.152 157.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -89.36 154.26 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.901 -1.148 . . . . 74.11 107.901 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -148.17 156.89 43.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.178 -1.045 . . . . 73.13 108.178 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -149.02 117.38 6.47 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.131 -1.433 . . . . 73.52 107.131 162.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.07 -179.1 44.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.382 -1.39 . . . . 52.34 112.057 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 98.98 11.7 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.515 1.126 . . . . 75.31 110.207 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.16 153.79 29.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.105 -1.442 . . . . 74.4 107.105 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.9 139.16 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.522 -0.918 . . . . 65.21 108.522 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HE2' ' OE1' ' A' ' 96' ' ' GLU . 48.8 tttm -130.54 70.69 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.476 1.51 . . . . 75.35 107.243 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.44 148.04 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 105.269 -2.123 . . . . 74.24 105.269 161.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 167.75 10.51 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 105.309 -2.108 . . . . 72.43 105.309 162.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.2 p -135.86 168.2 19.76 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.933 0.788 . . . . 72.11 109.696 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -24.17 67.65 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.728 1.149 . . . . 75.23 112.741 -168.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.31 4.38 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.043 1.337 . . . . 73.11 111.615 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 60.08 26.49 15.84 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.859 2.063 . . . . 72.45 112.229 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.45 173.09 11.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -177.61 167.28 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.854 1.662 . . . . 74.51 107.92 -175.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.508 HG22 ' CE1' ' A' ' 171' ' ' PHE . 2.8 pt -141.82 171.4 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 125.834 1.654 . . . . 72.4 108.688 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.92 101.28 3.02 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.776 -1.194 . . . . 74.55 107.776 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 168.62 24.7 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.874 1.27 . . . . 53.2 110.083 -171.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.9 p -58.29 147.5 30.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.215 1.006 . . . . 72.34 110.37 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.94 -16.33 63.72 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.002 0.741 . . . . 73.52 113.002 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -117.01 39.49 3.22 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.767 1.627 . . . . 75.12 110.563 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -77.57 131.22 71.73 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.77 -1.109 . . . . 75.2 110.262 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.4 101.12 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 125.026 3.817 . . . . 74.34 112.903 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.68 178.25 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.005 1.722 . . . . 75.4 109.783 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -122.85 139.21 54.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.557 -0.714 . . . . 73.13 111.144 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.78 163.98 35.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.591 1.156 . . . . 74.31 110.54 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.6 t -88.65 121.09 30.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.081 1.419 . . . . 63.5 111.676 172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.51 78.0 1.81 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.32 1.848 . . . . 73.11 106.854 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m 69.75 0.8 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.235 1.569 . . . . 72.42 115.235 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.76 -33.68 1.39 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.08 -1.608 . . . . 74.12 109.08 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.73 131.27 35.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.97 1.308 . . . . 62.44 108.525 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.04 99.0 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.31 -1.367 . . . . 73.35 107.31 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.37 161.49 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.393 0.677 . . . . 73.55 109.372 172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.95 126.42 49.94 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.762 2.025 . . . . 74.22 107.989 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.6 pt -149.54 176.99 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.926 1.291 . . . . 75.13 110.442 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.32 142.03 45.19 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.793 1.237 . . . . 74.34 108.434 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.8 20.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.998 0.919 . . . . 75.31 112.612 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.31 -11.38 60.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.928 1.24 . . . . 75.12 113.827 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.7 mmt -82.11 -28.43 32.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.921 1.237 . . . . 71.24 111.103 169.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.1 t -75.49 63.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 128.728 2.811 . . . . 74.03 111.585 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 124' ' ' GLY . 12.3 mmmt -79.16 -178.34 6.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.072 -1.017 . . . . 75.22 109.6 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.34 0.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 128.092 2.557 . . . . 73.51 114.033 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -99.32 -1.88 56.77 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 117.768 -1.573 . . . . 44.41 112.693 174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.63 136.35 46.44 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 106.414 -1.699 . . . . 62.33 106.414 -163.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.66 109.94 21.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.824 1.25 . . . . 75.02 108.973 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.69 133.1 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.456 1.102 . . . . 74.45 108.714 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.3 132.21 46.08 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.028 -0.73 . . . . 73.5 109.028 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.426 HG23 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -126.28 155.87 73.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.357 1.863 . . . . 74.53 110.143 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.38 145.14 37.76 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.988 1.792 . . . . 74.44 109.382 172.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 -158.99 0.67 Allowed 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.976 -1.12 . . . . 73.33 107.976 167.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.51 -62.28 1.75 Allowed 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.89 0.876 . . . . 72.2 111.203 -160.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.3 0.69 9.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.799 1.037 . . . . 74.34 113.799 166.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.7 p -122.36 -167.02 1.49 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.51 1.524 . . . . 75.53 110.12 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.97 156.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.741 1.216 . . . . 72.25 107.778 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -144.87 -176.69 5.18 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.729 2.012 . . . . 72.42 108.406 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.1 mt -118.42 161.78 19.41 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.072 1.349 . . . . 73.45 108.148 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -152.02 154.84 36.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.569 1.548 . . . . 72.14 106.976 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -88.65 144.74 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.264 1.426 . . . . 71.43 108.918 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 -1.33 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 73.43 113.38 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 142' ' ' LYS . 4.1 pt 31.86 -76.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 129.171 2.989 . . . . 75.32 117.112 173.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.507 ' H ' HG13 ' A' ' 141' ' ' ILE . 39.7 ttmt -118.28 131.75 56.33 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.991 1.716 . . . . 73.3 108.459 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.65 121.72 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.634 1.174 . . . . 74.12 108.331 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -145.14 -169.47 3.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.361 1.464 . . . . 73.31 108.057 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -135.27 166.07 23.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.547 1.139 . . . . 74.4 109.572 -171.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.55 129.85 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.907 -1.516 . . . . 74.13 106.907 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.88 113.89 19.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.679 -1.971 . . . . 73.52 105.679 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.507 ' C ' HD21 ' A' ' 149' ' ' ASN . 28.8 t80 -127.6 132.64 49.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.131 1.772 . . . . 74.23 108.864 -165.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.507 HD21 ' C ' ' A' ' 148' ' ' TYR . 2.4 m120 -134.16 42.07 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.263 -0.898 . . . . 72.43 109.8 -157.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.0 -175.38 15.17 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.478 1.513 . . . . 70.42 111.44 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -72.15 147.46 46.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.72 -0.845 . . . . 75.25 108.72 161.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 27.7 pt -124.7 127.08 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.533 1.933 . . . . 72.52 106.472 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -112.83 162.12 16.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.815 -1.179 . . . . 73.41 107.815 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.28 164.09 35.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 73.14 109.601 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 67.5 mt -120.31 164.22 16.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.876 1.27 . . . . 73.34 111.137 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.7 m -101.31 -34.04 9.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.258 -1.337 . . . . 74.21 112.703 -164.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 17.5 t 24.52 74.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 130.325 3.45 . . . . 75.44 111.548 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -78.81 -9.0 59.31 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.307 -0.871 . . . . 75.44 112.043 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -62.15 1.75 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.116 2.166 . . . . 75.14 108.594 -168.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -120.73 5.17 10.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.639 0.977 . . . . 71.03 113.639 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m170 52.97 23.9 3.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.673 1.589 . . . . 74.14 112.267 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -149.11 136.89 20.49 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 119.542 -1.974 . . . . 73.32 108.878 176.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.419 ' CE1' ' CG2' ' A' ' 173' ' ' VAL . 3.7 p90 -141.15 167.56 21.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.829 0.852 . . . . 74.41 110.981 -173.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 mm -103.12 134.13 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 124.37 1.068 . . . . 74.45 108.423 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.43 138.4 14.44 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.517 1.527 . . . . 73.45 108.702 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.72 170.96 20.35 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 125.338 1.446 . . . . 52.5 109.631 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -72.39 164.14 26.83 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.821 -1.988 . . . . 74.3 109.917 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 68.59 -74.47 0.08 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.474 2.309 . . . . 73.2 114.934 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -121.45 -15.65 8.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.316 1.446 . . . . 65.4 112.442 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 74.89 161.64 8.85 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 122.332 0.962 . . . . 73.12 114.128 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.508 ' CE1' HG22 ' A' ' 97' ' ' ILE . 19.1 m-85 -112.01 163.53 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.761 2.425 . . . . 45.41 107.228 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.57 117.19 29.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.062 0.846 . . . . 73.34 108.917 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.419 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 26.8 m -97.03 173.11 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 119.862 1.21 . . . . 71.51 108.989 173.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.0 m -66.56 147.83 52.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.107 -1.072 . . . . 64.44 108.107 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.79 159.99 25.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.943 0.897 . . . . 53.21 108.62 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 106.35 -1.722 . . . . 74.14 106.35 152.196 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 106.678 -1.601 . . . . 64.54 106.678 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.8 mp -88.33 157.9 18.59 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.752 0.821 . . . . 75.43 109.985 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.68 156.3 20.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.456 1.102 . . . . 53.1 111.13 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.04 -40.13 60.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.07 1.348 . . . . 74.13 112.63 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.63 1.9 54.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.267 -0.873 . . . . 73.32 112.714 -165.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' OE1' ' HE2' ' A' ' 167' ' ' LYS . 11.8 mm-40 -77.95 140.29 62.26 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 120.592 1.542 . . . . 73.24 111.336 -164.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.19 133.74 13.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.771 2.314 . . . . 73.32 112.056 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 pt -102.99 -2.09 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.163 1.171 . . . . 72.42 114.163 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 55.48 66.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.591 1.156 . . . . 74.23 112.391 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -58.25 153.31 15.47 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.683 -0.636 . . . . 74.32 110.709 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 m -62.98 -31.79 72.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.486 1.514 . . . . 75.34 113.288 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -28.67 41.47 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.26 0.936 . . . . 74.24 110.352 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.1 13.56 5.89 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.419 -0.656 . . . . 62.23 112.73 159.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -45.5 -53.33 9.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 127.705 2.402 . . . . 75.35 113.575 -171.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.8 mm 56.69 111.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.842 2.457 . . . . 75.44 107.907 -157.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.98 161.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.702 -1.592 . . . . 73.23 106.702 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -71.14 129.79 39.84 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.279 1.032 . . . . 71.52 108.946 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 tt -48.68 -42.44 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.824 1.65 . . . . 72.1 110.839 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.66 -47.47 61.6 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.268 -1.295 . . . . 54.01 110.966 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -57.41 -46.62 83.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.345 1.573 . . . . 75.44 110.877 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.71 -55.59 32.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.058 0.943 . . . . 75.33 110.449 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG11 ' CE1' ' A' ' 33' ' ' PHE . 52.6 t -56.83 -45.23 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.322 1.049 . . . . 75.42 110.057 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.93 -34.7 79.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.265 1.026 . . . . 63.03 111.501 -167.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 8.4 ttpt -51.96 -53.3 42.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.472 1.109 . . . . 72.35 108.545 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 29.4 m-85 -70.68 -34.19 71.72 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 118.967 -0.54 . . . . 74.41 109.723 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.423 ' CE1' HG11 ' A' ' 29' ' ' VAL . 3.5 m-30 -63.74 -39.54 94.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.088 1.313 . . . . 75.13 111.337 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -42.26 74.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.788 1.235 . . . . 73.03 110.535 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -78.95 -53.84 6.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.312 0.645 . . . . 75.41 109.49 -173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.79 42.48 1.1 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.439 2.296 . . . . 75.31 107.028 -170.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.96 -34.34 59.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.666 -1.272 . . . . 75.05 111.521 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -60.21 -35.26 75.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.181 0.992 . . . . 74.41 112.406 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.48 -0.91 43.93 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.597 1.159 . . . . 74.3 112.91 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.77 94.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.394 -1.336 . . . . 64.23 107.394 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -79.54 154.9 28.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.792 -1.188 . . . . 75.11 107.792 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -111.88 156.96 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.086 -1.079 . . . . 72.01 108.086 160.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.33 168.78 12.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.955 -1.128 . . . . 60.3 107.955 159.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -59.57 -48.35 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.93 0.892 . . . . 71.35 109.39 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.09 -3.47 13.4 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.707 1.002 . . . . 54.53 113.707 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.87 20.84 45.15 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 121.302 -0.874 . . . . 75.44 114.187 159.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.73 -86.02 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.14 1.776 . . . . 74.03 110.14 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.43 125.42 2.73 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.074 1.321 . . . . 45.22 110.263 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -136.82 169.91 16.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 72.43 111.452 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 mt -144.47 144.5 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.289 2.235 . . . . 74.41 106.398 164.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.91 125.8 34.26 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.217 1.407 . . . . 71.43 109.684 167.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.91 8.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.809 0.844 . . . . 74.34 111.054 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.22 -40.65 60.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.52 1.054 . . . . 63.3 112.346 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -9.3 2.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.239 2.216 . . . . 75.15 114.402 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -70.05 -22.36 63.09 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.474 1.034 . . . . 72.03 112.588 170.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.13 7.03 3.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 120.125 1.33 . . . . 73.44 114.27 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.02 118.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.649 1.18 . . . . 74.24 108.117 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -85.44 155.17 21.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.411 1.1 . . . . 74.34 110.184 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.9 tt -135.07 155.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.652 1.981 . . . . 73.24 107.732 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.9 mmpt? -69.4 118.94 12.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.709 -1.589 . . . . 74.44 106.709 167.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -110.73 -175.98 2.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.59 -2.004 . . . . 72.2 105.59 165.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 125.14 16.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.331 -1.729 . . . . 74.45 106.331 172.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -73.72 99.52 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.921 -1.14 . . . . 74.24 107.921 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -54.89 -23.23 17.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 124.849 1.26 . . . . 74.34 112.08 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -26.31 24.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.06 1.344 . . . . 75.23 112.605 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.0 m -144.95 16.43 1.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.482 1.113 . . . . 73.0 112.361 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp 53.41 45.6 28.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.835 1.198 . . . . 73.23 111.37 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -113.95 159.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.28 1.032 . . . . 75.24 109.945 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.7 mm -79.32 142.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.92 -1.511 . . . . 74.11 106.92 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -131.31 162.27 30.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.984 1.374 . . . . 65.24 110.667 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.07 127.96 36.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.207 -2.146 . . . . 71.12 105.207 165.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.43 148.26 25.51 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 117.005 -1.474 . . . . 74.01 107.823 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.97 161.73 18.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 122.351 2.342 . . . . 74.03 111.307 168.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.92 165.67 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.947 -1.501 . . . . 62.24 106.947 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.9 mt -127.28 -42.75 1.67 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.493 1.517 . . . . 73.45 110.771 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -134.58 154.83 51.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.409 1.458 . . . . 75.35 110.231 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.62 162.06 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.884 1.674 . . . . 74.44 108.404 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -137.31 158.94 43.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.478 1.111 . . . . 74.14 110.567 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HD2' ' CD2' ' A' ' 151' ' ' HIS . 3.8 tpp85 -142.07 145.99 34.95 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.761 1.624 . . . . 74.52 107.159 172.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -147.53 151.58 36.57 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.887 -1.153 . . . . 74.51 107.887 160.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.96 140.91 47.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.631 -0.878 . . . . 74.41 108.631 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -144.76 150.05 36.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.878 1.671 . . . . 73.13 107.268 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.2 p -143.38 138.27 29.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 104.979 -2.23 . . . . 63.13 104.979 155.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.6 -178.4 35.73 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 120.781 1.628 . . . . 74.11 111.11 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 119.53 30.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.491 -0.417 . . . . 74.01 110.812 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -88.88 164.59 15.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.986 1.314 . . . . 73.01 108.209 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mm -78.35 142.63 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 106.615 -1.624 . . . . 72.13 106.615 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -133.04 74.65 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.423 -1.695 . . . . 72.45 106.423 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.1 mt -78.01 121.51 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.683 -2.34 . . . . 73.45 104.683 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 m -107.62 164.48 12.19 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.687 -1.598 . . . . 73.32 106.687 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -132.84 175.09 9.66 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.84 0.745 . . . . 65.31 111.306 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -66.34 -22.65 66.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.9 -1.125 . . . . 72.12 112.448 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -69.71 -1.07 8.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.889 0.876 . . . . 72.14 112.514 170.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 57.75 25.26 11.65 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.443 -1.411 . . . . 73.54 110.187 -162.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.24 24.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.491 -1.3 . . . . 64.52 107.491 165.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -161.42 162.01 30.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.443 -0.947 . . . . 74.41 108.443 -166.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -148.42 160.18 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.74 1.216 . . . . 74.43 110.268 174.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.91 96.52 2.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.172 1.389 . . . . 74.2 109.917 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.19 -179.86 7.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.14 2.176 . . . . 74.01 109.836 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 p -68.47 165.81 18.18 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.22 0.918 . . . . 71.21 111.323 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.28 -24.26 64.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.923 -0.486 . . . . 75.34 110.54 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -115.56 81.05 1.52 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.189 1.396 . . . . 74.03 107.896 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 156.72 76.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.691 -0.631 . . . . 75.12 111.427 150.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -89.48 149.82 5.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.27 3.313 . . . . 73.13 115.93 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.91 -173.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 111.459 -2.61 . . . . 73.42 107.7 -174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -132.55 141.18 48.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.468 -1.696 . . . . 65.52 112.288 -171.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.73 157.82 26.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.015 0.926 . . . . 74.3 110.047 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.01 105.64 12.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.455 1.121 . . . . 72.21 109.24 173.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -76.37 66.68 2.47 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 107.155 -1.424 . . . . 73.35 107.155 148.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 1.0 OUTLIER 70.26 -15.13 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.989 2.515 . . . . 60.43 115.375 170.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.24 -21.08 0.12 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 126.288 1.899 . . . . 75.12 109.025 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -78.46 144.54 35.69 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 105.362 -2.088 . . . . 71.22 105.362 166.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -102.04 95.53 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.503 1.521 . . . . 73.2 107.835 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.3 154.46 17.18 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.833 1.253 . . . . 73.22 108.671 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -114.05 111.84 22.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.51 1.524 . . . . 73.12 111.881 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.09 179.39 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.214 1.005 . . . . 70.31 111.231 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -99.26 148.49 24.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.081 1.752 . . . . 75.44 109.936 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.4 -26.8 65.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 118.102 0.41 . . . . 73.51 110.385 -161.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.66 67.34 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.313 -0.867 . . . . 64.12 113.231 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.6 -29.64 46.19 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.328 1.051 . . . . 73.12 112.086 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 t -73.83 63.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.508 2.323 . . . . 74.15 109.89 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -78.78 178.17 8.12 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.435 1.094 . . . . 74.53 108.187 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.03 -20.94 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.077 1.751 . . . . 65.22 113.666 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.18 -2.78 87.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.876 -1.513 . . . . 52.52 113.439 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.12 159.71 16.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.459 2.129 . . . . 72.34 111.039 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.5 103.53 11.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.72 1.608 . . . . 71.54 109.066 170.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.87 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.53 1.532 . . . . 73.41 107.327 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.13 115.36 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.789 -0.819 . . . . 74.43 108.789 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 pt -102.56 154.03 37.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 123.297 0.639 . . . . 73.22 110.766 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.7 138.26 28.81 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.117 1.878 . . . . 72.5 107.944 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.63 175.46 5.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.313 -1.366 . . . . 74.23 107.313 162.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -25.06 -61.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.873 2.069 . . . . 75.11 115.246 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -121.05 1.19 10.34 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.704 1.202 . . . . 75.44 113.077 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -143.74 -175.36 4.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.853 2.061 . . . . 74.35 109.353 -139.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -120.11 147.99 23.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.87 -1.159 . . . . 70.53 107.87 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -137.1 -178.18 5.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.856 2.462 . . . . 73.04 106.896 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.51 164.4 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.836 1.254 . . . . 75.23 108.115 168.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -156.85 159.12 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.183 -1.784 . . . . 73.22 106.183 167.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -104.29 138.16 41.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.103 1.361 . . . . 70.5 109.325 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.08 -0.27 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 114.146 1.165 . . . . 74.51 114.146 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 25.93 -89.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 127.029 2.131 . . . . 73.22 114.924 174.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -92.65 113.23 25.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.257 -0.902 . . . . 72.41 109.267 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.14 144.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.36 -0.978 . . . . 73.32 108.36 156.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -156.2 -172.14 3.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.904 2.482 . . . . 72.33 106.291 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -124.53 142.76 51.09 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.869 -1.16 . . . . 73.34 107.869 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.46 -179.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.628 1.171 . . . . 73.42 108.566 166.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -126.39 138.31 53.54 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.982 2.513 . . . . 75.45 106.75 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.49 151.23 31.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.448 1.099 . . . . 73.05 109.111 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.98 78.27 0.45 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.245 -1.761 . . . . 74.23 106.245 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -151.27 23.78 0.97 Allowed Glycine 0 N--CA 1.468 0.822 0 CA-C-N 113.807 -1.542 . . . . 74.5 113.886 -164.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.408 ' CD2' ' HD2' ' A' ' 79' ' ' ARG . 54.7 m80 54.77 -179.29 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.479 0.712 . . . . 74.43 110.962 -151.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.2 pt -145.78 160.19 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.703 2.401 . . . . 73.2 106.699 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -137.21 147.52 45.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.197 1.799 . . . . 73.21 108.617 -166.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -147.7 167.56 24.33 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.669 1.122 . . . . 70.0 111.56 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.5 126.48 31.18 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 127.987 2.515 . . . . 73.53 108.149 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.6 m -61.61 -53.32 57.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.102 0.561 . . . . 74.23 112.46 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.305 3.5 t 24.38 64.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 128.018 2.527 . . . . 65.24 112.385 -164.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -79.2 0.06 29.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.958 1.303 . . . . 75.33 111.472 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -64.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.919 1.688 . . . . 71.12 110.887 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.7 -0.31 14.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.253 0.621 . . . . 63.1 111.841 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.2 m80 61.95 27.89 16.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.453 1.901 . . . . 73.3 110.734 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.1 143.22 24.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.619 1.568 . . . . 73.15 108.123 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.6 -179.38 6.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.199 1.0 . . . . 74.32 111.261 -173.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.73 124.01 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 107.631 -1.248 . . . . 74.21 107.631 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.79 146.07 21.69 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.801 0.44 . . . . 75.21 110.528 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.91 -169.06 32.45 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 108.326 -1.91 . . . . 74.33 108.326 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.431 ' HE2' ' OE1' ' A' ' 13' ' ' GLU . 74.0 mttt -99.51 177.84 5.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 119.879 1.839 . . . . 73.01 110.039 162.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 60.26 -78.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 129.198 2.999 . . . . 74.24 113.037 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.57 -8.1 8.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.326 1.45 . . . . 75.51 113.866 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 67.4 153.04 0.3 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.106 1.336 . . . . 75.5 114.92 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 97' ' ' ILE . 43.9 m-85 -107.55 159.01 16.76 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.048 2.139 . . . . 70.54 108.662 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -96.58 74.58 2.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 127.11 2.164 . . . . 74.01 109.184 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.03 171.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.827 -0.546 . . . . 72.21 110.687 -164.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 m -71.18 159.24 35.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.073 0.549 . . . . 75.14 110.676 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -136.03 165.49 25.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.587 2.755 . . . . 64.45 108.028 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 119.063 0.847 . . . . 74.41 109.655 150.523 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.666 -0.864 . . . . 74.41 108.666 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.5 157.13 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.943 1.697 . . . . 74.42 109.437 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.5 159.4 30.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.636 0.775 . . . . 71.52 112.024 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.1 t80 -54.52 -39.76 67.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.955 1.702 . . . . 65.15 112.916 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -101.59 19.82 17.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.238 1.815 . . . . 71.24 110.952 -170.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -77.64 121.61 84.55 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.223 -2.14 . . . . 74.42 105.223 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.6 138.51 54.62 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 120.52 0.813 . . . . 71.01 110.302 171.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 pt -108.54 143.25 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 122.647 1.213 . . . . 75.42 108.164 160.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.3 99.41 9.25 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.925 -2.62 . . . . 74.13 103.925 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 1.8 mm? -52.45 165.77 0.23 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.186 -0.672 . . . . 74.24 109.186 166.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -48.89 -43.93 39.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.526 0.73 . . . . 64.22 109.516 166.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.71 -35.66 80.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.329 0.492 . . . . 72.54 112.329 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.0 9.12 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.243 0.925 . . . . 73.13 112.13 -171.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -20.96 15.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.49 1.516 . . . . 74.21 114.955 -170.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mm 46.95 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 128.35 2.66 . . . . 74.41 110.631 -168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.2 144.29 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 114.841 -1.072 . . . . 73.42 108.383 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -61.78 126.3 26.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 105.913 -1.884 . . . . 75.03 105.913 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -49.89 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 73.32 108.953 165.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -56.65 -57.42 19.6 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-O 117.941 -1.477 . . . . 65.52 112.521 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -52.46 -51.57 58.64 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.486 1.914 . . . . 71.14 111.384 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.93 -52.04 61.87 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 125.837 1.655 . . . . 74.2 109.778 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 73.4 t -76.86 -36.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.891 -1.05 . . . . 75.33 110.443 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 34' ' ' LYS . 11.4 t0 -62.06 -36.05 80.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.661 0.664 . . . . 71.23 111.724 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -55.04 -42.69 72.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.323 1.049 . . . . 73.34 109.94 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -67.02 -43.99 81.4 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.1 -1.0 . . . . 75.11 110.093 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -60.07 -33.35 71.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.894 1.225 . . . . 71.34 112.497 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -64.99 -61.5 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.282 1.433 . . . . 74.23 109.514 171.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -73.23 -47.85 39.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.714 -1.217 . . . . 73.51 107.714 -166.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -94.66 40.78 1.09 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.228 1.411 . . . . 63.01 109.887 -172.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.08 -39.88 29.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.042 -1.036 . . . . 65.13 111.636 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -72.07 -22.79 61.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.993 0.738 . . . . 72.14 112.993 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -85.99 -2.28 58.14 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.722 0.809 . . . . 74.25 111.822 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.4 mt -62.88 101.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.954 -1.499 . . . . 72.15 106.954 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.58 162.22 25.46 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.12 -1.437 . . . . 72.44 107.12 161.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.88 145.47 47.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.577 -1.638 . . . . 72.13 106.577 163.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 175.24 10.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.469 -0.567 . . . . 74.04 109.469 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -61.33 -45.09 95.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.363 1.065 . . . . 74.14 108.584 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.39 -19.79 66.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.355 0.662 . . . . 75.01 110.5 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 36.19 6.1 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 120.972 -1.08 . . . . 73.22 111.489 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 3.7 t80 -78.05 -86.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.595 1.158 . . . . 74.31 109.908 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.87 121.82 2.02 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.07 -2.012 . . . . 25.31 108.07 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.26 163.65 33.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.539 1.17 . . . . 72.2 112.231 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mt -143.98 140.04 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.72 -1.585 . . . . 73.41 106.72 172.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.6 134.75 33.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.625 1.17 . . . . 71.25 109.883 172.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.01 23.09 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.767 2.027 . . . . 70.14 111.581 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.06 -7.13 8.12 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.393 -1.226 . . . . 73.34 115.69 -175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -98.67 -27.92 13.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.38 1.59 . . . . 71.23 113.128 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.93 -23.65 33.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.304 1.002 . . . . 64.23 111.971 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.83 15.01 3.55 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.149 1.38 . . . . 70.41 112.867 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.97 101.31 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.568 1.147 . . . . 74.51 108.269 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.35 118.68 7.79 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.829 1.252 . . . . 74.01 110.009 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 14.1 tt -98.33 160.18 3.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 125.05 1.34 . . . . 72.21 107.751 165.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.01 124.19 22.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.731 -1.581 . . . . 74.34 106.731 168.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -128.92 178.77 6.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.558 1.143 . . . . 72.21 108.116 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -153.42 127.53 9.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.143 -0.688 . . . . 74.21 109.143 -171.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.73 112.35 20.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.943 -1.503 . . . . 74.44 106.943 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.66 -20.39 55.81 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 113.28 0.845 . . . . 74.34 113.28 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.61 -19.9 2.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.083 2.153 . . . . 73.22 112.682 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -154.04 20.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.418 0.554 . . . . 75.1 111.301 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.16 54.36 6.07 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.272 -1.517 . . . . 73.12 112.158 -167.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 pt -101.26 169.85 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.106 1.363 . . . . 65.44 108.627 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.25 150.09 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.853 1.261 . . . . 71.52 108.634 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -157.63 174.07 15.9 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.94 2.496 . . . . 75.35 107.65 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -87.85 145.67 25.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.257 -1.386 . . . . 73.31 107.257 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -148.79 144.72 27.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.347 -1.353 . . . . 72.44 107.347 164.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -78.14 -175.15 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.857 1.208 . . . . 73.01 112.19 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.5 152.04 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.087 2.155 . . . . 72.1 107.241 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.07 -40.76 3.87 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 113.346 0.869 . . . . 72.04 113.346 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -145.8 164.85 30.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.691 -1.225 . . . . 72.53 107.691 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.43 165.99 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.744 -1.206 . . . . 74.13 107.744 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -130.93 175.47 9.04 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.909 0.884 . . . . 74.5 108.943 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.48 145.92 5.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.03 1.732 . . . . 74.12 106.925 154.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HE3' ' CD2' ' A' ' 47' ' ' PHE . 5.4 ttmt -148.48 166.42 28.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.885 -1.154 . . . . 74.11 107.885 166.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 43.2 tttt -93.45 157.5 16.18 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.524 -0.735 . . . . 74.21 109.538 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.13 147.55 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.074 1.35 . . . . 73.21 109.634 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -143.39 117.9 9.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 160.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.52 -146.6 4.65 Favored Glycine 0 N--CA 1.463 0.481 0 N-CA-C 109.911 -1.276 . . . . 74.12 109.911 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 119.21 29.3 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.036 -1.459 . . . . 74.42 110.277 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.16 153.98 17.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 121.547 1.976 . . . . 74.23 106.78 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -79.94 139.79 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 126.784 2.033 . . . . 74.34 108.513 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -124.65 84.47 2.28 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.733 1.613 . . . . 73.35 106.748 161.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -75.2 112.13 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.005 -1.85 . . . . 73.54 106.005 162.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -75.24 178.46 5.76 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.568 -0.901 . . . . 73.43 108.568 167.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -146.19 177.11 9.24 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.61 -1.306 . . . . 74.11 109.336 154.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.1 ttmt -60.41 -27.28 67.33 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 119.503 -1.998 . . . . 72.23 113.568 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.68 18.62 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.888 1.222 . . . . 75.53 112.752 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER 58.59 15.76 3.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.728 2.411 . . . . 73.03 111.415 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ttm105 -68.49 170.49 8.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.754 2.022 . . . . 74.0 108.463 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -176.17 172.1 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.155 1.382 . . . . 74.4 109.491 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.531 HG22 ' CE1' ' A' ' 171' ' ' PHE . 3.8 pt -143.09 178.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.011 1.324 . . . . 74.52 107.838 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 98.11 2.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.723 -0.843 . . . . 73.42 108.723 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.79 173.21 17.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.691 1.596 . . . . 74.32 110.218 -172.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.3 p -74.26 163.7 27.5 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.1 -1.0 . . . . 72.0 111.551 -173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.4 -16.46 62.96 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.287 0.847 . . . . 74.42 113.287 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -116.72 38.82 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.97 0.805 . . . . 72.24 108.893 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -89.99 129.76 44.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 117.921 -1.038 . . . . 64.22 109.613 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -60.35 126.6 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.747 3.631 . . . . 73.52 111.293 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.91 175.96 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.693 1.597 . . . . 74.24 109.123 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.79 134.68 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.494 -0.754 . . . . 63.22 111.067 -169.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.96 161.58 40.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.451 1.501 . . . . 74.03 109.059 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 p -87.4 127.01 35.21 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 119.416 -0.326 . . . . 74.54 110.743 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HE3' HD11 ' A' ' 114' ' ' LEU . 2.3 ttmt -104.97 75.99 1.22 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.025 -1.472 . . . . 75.43 107.025 165.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m 59.51 16.98 5.66 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.857 1.663 . . . . 72.11 114.562 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -38.6 1.42 Allowed Glycine 0 N--CA 1.448 -0.536 0 O-C-N 120.682 -1.262 . . . . 61.21 110.194 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.76 148.86 31.3 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.359 -1.349 . . . . 74.11 107.359 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.19 117.51 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.699 -1.593 . . . . 73.25 106.699 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.426 HD11 ' HE3' ' A' ' 109' ' ' LYS . 4.7 tp -105.19 132.94 50.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.076 -1.083 . . . . 75.2 108.076 166.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -81.75 125.79 31.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.235 -1.024 . . . . 74.51 108.235 161.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.45 -179.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.48 1.512 . . . . 75.54 109.21 169.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.28 145.3 24.55 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.998 0.919 . . . . 73.02 109.285 -172.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -42.55 -47.11 5.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.637 1.975 . . . . 74.41 113.762 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -32.63 54.43 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.917 0.887 . . . . 71.23 113.053 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.2 mtt -75.6 -26.41 57.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.985 0.514 . . . . 74.54 112.159 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.259 5.7 t -79.11 63.2 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.695 2.398 . . . . 73.1 112.319 -169.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.547 ' HG3' ' H ' ' A' ' 124' ' ' GLY 0.259 0.0 OUTLIER -79.43 175.09 10.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 131.07 3.748 . . . . 72.13 111.632 -174.65 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.259 5.9 p -57.88 1.67 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 126.535 1.934 . . . . 71.12 114.616 167.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.547 ' H ' ' HG3' ' A' ' 122' ' ' LYS . . . -108.28 -1.84 33.37 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.772 2.606 . . . . 24.31 111.495 171.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 156.44 21.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.88 1.84 . . . . 64.54 108.02 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.6 104.97 12.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.517 -1.29 . . . . 74.11 107.517 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 tt -81.33 136.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.401 -0.818 . . . . 75.42 109.821 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.57 129.35 38.08 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.225 -0.898 . . . . 75.33 109.099 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 161.21 60.74 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.693 1.997 . . . . 74.12 111.164 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.55 173.04 14.98 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.726 2.284 . . . . 73.32 110.639 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -134.49 -134.8 0.16 Allowed 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 120.865 -1.147 . . . . 71.13 108.665 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -51.94 -84.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.609 1.164 . . . . 72.32 108.871 169.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -121.22 0.89 10.2 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.727 1.611 . . . . 74.31 112.431 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 p -131.58 151.34 51.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.879 0.872 . . . . 75.52 112.515 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.1 147.29 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -145.78 -176.21 5.04 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.704 2.002 . . . . 71.11 107.543 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.82 166.23 16.61 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -154.26 140.79 18.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.765 -1.198 . . . . 73.54 107.765 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.8 141.34 46.21 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.528 -1.286 . . . . 64.24 107.528 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.48 -23.48 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.529 1.531 . . . . 75.05 113.89 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.6 pt 47.19 -53.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 131.664 3.986 . . . . 60.43 116.398 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -140.28 132.51 28.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.689 2.395 . . . . 74.3 106.827 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.76 131.01 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 107.806 -1.183 . . . . 75.42 107.806 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.14 -164.79 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.932 1.293 . . . . 73.23 108.149 171.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 p -146.9 162.27 39.02 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.322 1.049 . . . . 72.31 109.517 -162.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.51 171.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 127.388 2.275 . . . . 73.24 108.687 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.48 92.41 3.42 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.051 -1.092 . . . . 73.44 108.051 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -97.63 136.91 37.33 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.509 2.723 . . . . 75.43 108.719 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -134.54 73.34 1.48 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.024 -1.473 . . . . 74.23 107.024 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.2 -159.24 7.84 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.086 0.85 . . . . 73.42 112.912 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -102.29 154.25 19.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.8 -0.815 . . . . 74.23 108.8 163.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.65 154.23 26.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.279 1.832 . . . . 74.31 107.295 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.423 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -153.38 160.28 42.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.599 0.76 . . . . 74.35 109.69 173.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -131.74 146.03 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.098 2.159 . . . . 75.54 107.524 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.91 143.85 27.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.904 1.684 . . . . 74.25 112.718 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 83.14 3.63 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.392 -1.336 . . . . 70.14 107.392 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.21 76.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 106.145 -1.798 . . . . 74.13 106.145 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.02 -5.19 20.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.769 -0.582 . . . . 73.2 111.694 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.26 -63.97 0.95 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.901 2.08 . . . . 75.41 107.631 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -125.53 -4.85 7.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.716 2.406 . . . . 71.52 111.861 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 54.18 25.86 6.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.256 2.223 . . . . 65.31 112.775 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.402 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 11.4 p -141.49 153.68 45.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.883 1.273 . . . . 64.53 109.11 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.42 ' CD1' ' HB1' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -163.7 178.07 8.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.412 1.085 . . . . 75.21 111.208 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.9 122.21 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.204 1.402 . . . . 73.24 109.317 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.04 154.93 43.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.56 1.144 . . . . 74.3 110.054 173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.51 -171.61 21.88 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.589 -0.605 . . . . 74.32 111.589 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -91.55 166.68 12.71 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.484 -1.598 . . . . 73.21 110.015 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 61.36 -76.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 129.693 3.197 . . . . 74.43 112.032 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.89 -13.77 8.18 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.417 1.487 . . . . 74.15 112.561 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.86 171.0 18.9 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.033 1.301 . . . . 73.31 112.42 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.531 ' CE1' HG22 ' A' ' 97' ' ' ILE . 68.8 m-85 -112.12 157.09 21.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.737 3.615 . . . . 73.2 105.322 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -103.9 110.81 23.09 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.108 -1.812 . . . . 64.31 106.108 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.13 175.19 6.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.619 -0.882 . . . . 74.23 108.619 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 155.24 16.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.01 -0.737 . . . . 72.23 109.01 168.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 163' ' ' TYR . . . -146.78 47.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.866 2.066 . . . . 71.5 107.012 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.297 -1.001 . . . . 61.32 108.297 -171.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 109.844 -0.428 . . . . 74.45 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.74 158.6 26.86 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.413 1.485 . . . . 71.51 110.919 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 159.53 21.37 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.052 0.541 . . . . 54.01 112.238 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -49.29 -49.34 44.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.111 1.764 . . . . 74.34 113.84 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -98.77 45.87 1.0 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.182 2.593 . . . . 72.24 109.424 -167.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 167' ' ' LYS . 65.5 mm-40 -109.47 110.11 59.97 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.55 1.54 . . . . 74.03 107.926 169.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -51.71 134.69 47.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.516 2.811 . . . . 74.33 113.3 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 pt -96.33 -2.79 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 114.452 1.278 . . . . 73.24 114.452 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 49.56 70.43 0.49 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.01 1.277 . . . . 72.33 113.587 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.0 159.03 0.94 Allowed 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.865 -1.147 . . . . 71.3 110.925 167.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -53.87 -45.09 70.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.082 -1.081 . . . . 61.01 108.082 168.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.76 -4.53 9.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.133 1.373 . . . . 75.04 114.184 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.72 12.5 66.49 Favored Glycine 0 CA--C 1.523 0.584 0 O-C-N 120.287 -1.508 . . . . 65.33 112.237 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -4.9 14.42 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.009 2.225 . . . . 74.0 117.009 -156.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.1 mm 27.39 87.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 130.802 3.641 . . . . 73.23 110.117 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.24 145.53 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.616 -1.624 . . . . 71.23 106.616 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.26 130.71 44.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 128.108 2.563 . . . . 75.02 105.044 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -48.72 -43.4 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.434 0.694 . . . . 74.21 110.318 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' A' ' 29' ' ' VAL . . . -86.37 -4.9 83.12 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.49 -1.728 . . . . 50.21 114.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -82.54 -45.37 14.75 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.761 1.78 . . . . 74.42 108.788 167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -55.49 -55.43 31.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.275 0.63 . . . . 74.53 109.653 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 22.8 m -65.78 -34.76 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 118.428 -0.796 . . . . 64.22 110.186 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -45.73 72.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.923 1.238 . . . . 75.11 110.893 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.07 -37.48 53.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.765 0.826 . . . . 74.34 110.011 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -83.77 -45.01 13.81 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.564 -1.207 . . . . 64.12 110.829 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -54.72 -30.23 55.51 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 121.825 2.102 . . . . 74.04 112.708 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -94.36 -11.04 30.76 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.783 1.233 . . . . 74.41 112.495 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 17.6 mttm -95.89 -63.91 1.11 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.001 -1.111 . . . . 74.32 108.001 168.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.456 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 4.8 m-30 -84.84 39.73 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.185 2.994 . . . . 74.12 108.419 -168.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -49.52 -45.66 47.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.07 2.548 . . . . 74.41 109.506 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -62.88 -35.1 78.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.967 0.907 . . . . 73.43 110.925 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 t -79.87 -7.95 59.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.823 2.049 . . . . 55.23 113.42 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.39 107.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.961 -1.126 . . . . 73.34 107.961 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -84.49 155.21 22.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.626 -1.62 . . . . 75.23 106.626 162.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -121.21 135.05 55.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 164.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.79 176.96 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 125.665 1.853 . . . . 74.42 110.679 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.58 -38.5 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.666 1.987 . . . . 72.43 111.801 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.67 52.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.681 0.793 . . . . 73.12 111.738 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.68 12.76 62.11 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.785 1.66 . . . . 73.32 112.644 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.84 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.157 1.783 . . . . 75.54 111.423 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.76 124.96 2.55 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 118.263 -1.299 . . . . 50.25 110.406 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -140.71 166.32 25.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.456 1.128 . . . . 75.24 111.219 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -146.07 135.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.946 2.098 . . . . 75.45 106.636 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.19 128.97 36.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.396 0.678 . . . . 71.53 110.253 167.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.86 9.54 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.043 0.937 . . . . 64.34 111.268 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.07 -16.2 59.5 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 120.785 -1.197 . . . . 64.14 114.416 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -68.81 -32.42 72.12 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.261 1.53 . . . . 72.24 111.81 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.57 -13.09 38.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.479 0.582 . . . . 71.5 112.31 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.84 19.83 10.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.205 2.202 . . . . 74.52 112.756 172.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.24 119.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.905 1.282 . . . . 74.45 108.506 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -88.79 142.52 27.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.181 0.992 . . . . 74.21 111.5 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.7 tt -133.64 154.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.411 1.884 . . . . 74.04 108.641 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -73.01 126.73 30.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 110.133 -0.321 . . . . 71.41 110.133 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.04 166.84 16.23 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.562 1.945 . . . . 75.22 108.198 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.56 154.61 46.88 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.933 -1.506 . . . . 74.32 106.933 179.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.68 141.12 46.84 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 118.632 -1.227 . . . . 73.35 108.377 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -86.14 -22.9 26.81 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.583 -0.698 . . . . 75.33 112.019 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.7 -50.04 66.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.671 1.988 . . . . 73.15 110.64 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.0 m -141.27 9.6 2.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.567 1.947 . . . . 71.43 110.794 -162.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.05 52.17 15.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.207 2.203 . . . . 71.41 111.12 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.06 -175.62 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.352 0 O-C-N 124.185 0.928 . . . . 73.43 109.688 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mm -116.86 125.42 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 127.528 2.331 . . . . 75.44 104.883 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -142.85 169.27 17.89 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.869 1.268 . . . . 72.3 108.776 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -110.0 143.58 39.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.625 1.57 . . . . 74.44 110.011 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -150.92 168.08 25.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.657 1.983 . . . . 74.15 107.252 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -93.49 172.23 8.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.12 0.968 . . . . 70.15 110.38 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.04 144.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 105.507 -2.034 . . . . 73.24 105.507 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.8 -34.41 6.46 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.538 0.524 . . . . 73.52 111.217 -172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -144.44 137.75 27.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.97 1.259 . . . . 74.2 108.77 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.96 167.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 124.403 1.064 . . . . 72.11 109.714 168.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -138.13 159.96 40.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.321 1.048 . . . . 74.03 109.685 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -153.57 140.68 19.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.441 1.496 . . . . 74.3 108.881 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -146.1 161.38 40.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.846 -1.168 . . . . 73.32 107.846 165.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -92.02 146.47 23.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.073 -1.084 . . . . 75.34 108.073 168.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -152.33 145.68 24.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.775 0.83 . . . . 74.31 110.007 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -142.33 114.8 8.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.854 1.662 . . . . 71.02 109.281 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.06 40.78 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.441 1.019 . . . . 71.42 111.528 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.547 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.05 142.55 36.43 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 122.122 -0.634 . . . . 75.02 110.353 -174.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -127.69 160.38 31.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.81 1.644 . . . . 74.25 108.375 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.08 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.035 2.134 . . . . 73.1 108.229 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -128.78 75.23 1.63 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 159.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.3 mt -62.85 139.33 21.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.943 -2.243 . . . . 74.41 104.943 158.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -114.33 172.0 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.699 -1.593 . . . . 72.41 106.699 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 p -136.91 175.81 9.28 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.919 -1.113 . . . . 72.45 110.566 162.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -62.51 -25.69 68.15 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.619 -0.676 . . . . 74.53 111.669 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.95 7.79 2.96 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.877 1.271 . . . . 74.25 112.969 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.56 20.58 7.74 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.216 1.407 . . . . 75.02 110.818 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -71.38 161.92 30.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.661 1.185 . . . . 64.1 108.058 166.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -176.17 171.0 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.003 0.921 . . . . 70.21 108.902 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.506 HG22 ' CE1' ' A' ' 171' ' ' PHE . 1.3 pt -145.82 170.92 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.722 1.609 . . . . 73.12 110.65 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -148.09 95.23 2.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.278 1.431 . . . . 74.35 109.428 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.94 177.82 10.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.938 1.695 . . . . 74.2 110.498 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 p -66.62 164.02 17.65 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.569 1.148 . . . . 64.31 110.638 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.265 1.1 p-80 -68.51 -24.31 64.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.513 0.931 . . . . 62.12 113.513 173.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.93 36.49 2.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.229 1.377 . . . . 64.54 111.336 -168.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -88.17 137.52 31.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.922 -1.037 . . . . 65.44 110.156 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.69 125.42 13.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.208 2.606 . . . . 73.22 111.194 172.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.87 -173.79 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.569 1.947 . . . . 74.52 108.361 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -129.02 140.35 51.67 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.882 0.764 . . . . 74.35 111.146 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.26 172.45 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.961 1.305 . . . . 74.42 108.1 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 p -87.55 144.76 26.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.934 0.873 . . . . 70.33 112.2 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -118.21 80.37 1.51 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.617 -1.623 . . . . 73.54 106.617 158.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 m 62.51 8.58 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.34 1.456 . . . . 71.43 114.339 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.63 -20.3 3.3 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 120.839 -1.163 . . . . 74.14 111.314 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.17 136.73 37.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.23 -2.137 . . . . 75.25 105.23 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.12 117.76 18.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.219 -1.771 . . . . 72.0 106.219 164.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.63 138.99 53.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.508 1.523 . . . . 74.11 108.969 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.14 122.64 39.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.212 1.405 . . . . 74.12 109.314 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.9 pt -142.66 -178.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.76 1.224 . . . . 64.5 110.944 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.61 145.61 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.196 1.398 . . . . 72.11 110.704 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.87 45.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.801 1.64 . . . . 74.41 112.868 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -28.08 68.89 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.706 -1.246 . . . . 74.44 112.002 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -32.02 39.52 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.375 0.67 . . . . 73.55 112.323 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.296 7.9 p -76.92 63.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.507 1.123 . . . . 74.41 111.414 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 124' ' ' GLY . 9.4 mmmt -79.39 -175.34 4.66 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.698 1.199 . . . . 75.42 108.522 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.53 -0.61 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.564 1.546 . . . . 73.23 112.991 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -90.45 -1.13 75.21 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.506 -1.163 . . . . 55.53 112.229 170.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.09 175.91 8.04 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.732 1.766 . . . . 73.02 110.596 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.93 104.52 7.85 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.755 -1.942 . . . . 73.01 105.755 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.36 129.7 37.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.262 -1.755 . . . . 75.52 106.262 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -69.72 127.8 34.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.228 -1.397 . . . . 74.53 107.228 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.99 159.95 56.64 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.332 1.053 . . . . 74.52 112.81 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.89 145.1 49.72 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.219 1.946 . . . . 74.12 109.393 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.91 -167.8 1.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.498 -1.667 . . . . 72.32 106.498 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -24.07 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 128.595 2.758 . . . . 71.25 111.639 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -122.27 0.05 9.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.632 2.086 . . . . 73.42 116.632 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.5 p -138.07 169.23 18.15 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.2 0.6 . . . . 74.34 111.482 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.88 150.75 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.956 -1.09 . . . . 74.35 109.553 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -142.59 -176.64 4.94 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.293 1.837 . . . . 74.32 109.289 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.23 161.17 15.49 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.766 1.227 . . . . 75.11 111.915 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -158.02 136.0 10.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.254 1.822 . . . . 72.52 107.819 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.52 153.64 43.2 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.046 0.938 . . . . 72.13 110.341 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -93.25 -2.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 71.54 112.955 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.6 pt 25.49 -91.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 128.023 2.529 . . . . 65.1 116.149 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.453 ' H ' HG13 ' A' ' 141' ' ' ILE . 2.8 ttmm -88.06 122.73 31.99 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.355 1.462 . . . . 74.21 107.46 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.97 102.83 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.709 -1.219 . . . . 74.1 107.709 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -131.57 -173.9 3.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 74.32 108.003 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 p -125.21 168.31 13.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.043 0.937 . . . . 64.14 110.013 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.37 174.07 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.276 2.231 . . . . 74.31 106.476 168.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -123.21 105.77 10.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.018 -1.475 . . . . 71.14 107.018 165.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -100.5 136.96 39.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.871 1.268 . . . . 73.31 110.096 -168.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.52 51.51 1.92 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.258 0.623 . . . . 74.42 109.994 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.09 -113.96 1.6 Allowed Glycine 0 N--CA 1.463 0.484 0 O-C-N 121.091 -1.006 . . . . 64.55 111.568 -167.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -139.7 157.51 45.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.428 1.891 . . . . 73.44 107.491 170.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.1 pt -124.55 153.97 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.281 1.432 . . . . 73.21 109.396 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -148.72 165.88 30.08 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.819 1.648 . . . . 73.33 107.533 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -167.41 167.73 13.61 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.983 -0.747 . . . . 74.35 108.983 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.26 115.41 16.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.436 2.295 . . . . 74.42 108.501 -163.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.4 m -74.35 119.46 18.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.914 -1.513 . . . . 71.13 106.914 159.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 159' ' ' ASP . 15.0 t -122.1 73.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.753 -2.314 . . . . 74.35 104.753 171.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.96 -3.08 3.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.221 1.408 . . . . 73.55 113.642 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 157' ' ' VAL . 9.0 m-20 -103.06 -42.11 5.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.686 2.394 . . . . 71.05 108.264 -173.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.476 ' C ' ' H ' ' A' ' 162' ' ' THR . 1.9 t30 -146.73 79.98 1.53 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.981 -2.229 . . . . 72.41 104.981 -168.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.25 13.94 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.701 2.401 . . . . 73.21 112.958 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 160' ' ' ASN . 13.1 p -132.65 124.1 27.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.456 2.702 . . . . 74.43 106.602 -172.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 172.94 13.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.851 0.461 . . . . 74.24 112.186 -164.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 mm -108.0 121.49 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 106.925 -1.509 . . . . 74.32 106.925 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -146.98 152.68 39.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.58 -0.526 . . . . 70.22 109.58 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.82 -160.73 25.76 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.045 -1.222 . . . . 64.31 110.045 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 13' ' ' GLU . 67.8 mttt -109.31 171.53 7.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.125 0.962 . . . . 73.43 110.946 172.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.01 -73.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.64 2.776 . . . . 75.22 112.301 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -121.49 -11.05 8.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.417 1.887 . . . . 74.34 113.587 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.67 7.99 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 122.522 1.068 . . . . 62.54 111.868 -167.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CE1' HG22 ' A' ' 97' ' ' ILE . 35.6 m-85 -108.61 156.61 19.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.771 2.429 . . . . 71.4 105.753 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -100.48 113.62 26.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.394 -1.335 . . . . 73.12 107.394 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.9 m -144.13 -177.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.632 1.173 . . . . 74.44 109.662 -163.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.08 126.85 31.59 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.302 -0.874 . . . . 73.53 110.685 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -107.23 48.36 0.84 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.727 1.611 . . . . 42.41 107.403 156.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.674 -1.232 . . . . 72.1 107.674 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 108.594 -0.891 . . . . 72.14 108.594 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -98.44 -13.76 20.41 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 115.894 1.812 . . . . 75.11 115.894 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 96.63 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 1 C-N-CA 132.777 4.431 . . . . 72.44 111.644 -166.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.39 -39.83 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.651 2.78 . . . . 73.34 109.545 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.96 26.83 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.118 2.167 . . . . 61.53 110.026 -170.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.24 111.8 36.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 127.146 2.178 . . . . 73.53 108.777 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 106.31 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.443 2.762 . . . . 73.12 108.651 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.45 167.87 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.582 1.083 . . . . 72.54 110.142 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -128.21 64.48 1.4 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.477 1.111 . . . . 73.32 111.61 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -45.63 150.71 0.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 120.425 -1.422 . . . . 75.12 112.624 161.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -15.0 53.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.768 1.292 . . . . 51.15 112.98 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.44 -18.28 22.51 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.181 0.9 . . . . 72.21 112.62 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.87 38.32 8.75 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.125 1.345 . . . . 70.43 111.043 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.94 -18.62 64.42 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.614 1.207 . . . . 64.1 113.301 -170.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mm 47.85 87.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 128.488 2.715 . . . . 75.41 109.863 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 150.31 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 72.22 106.996 -170.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -61.08 130.26 45.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.729 -1.211 . . . . 73.13 107.729 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -53.73 -39.34 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.301 0.501 . . . . 75.04 110.018 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 10.27 63.95 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.833 -0.982 . . . . 74.11 114.26 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -55.45 3.75 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.785 1.793 . . . . 64.41 108.689 153.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -48.56 -52.58 22.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.733 1.613 . . . . 74.42 109.435 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.709 -0.678 . . . . 74.22 110.916 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -30.46 70.9 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 120.914 -1.116 . . . . 71.44 110.871 -173.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -52.37 -49.7 63.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.294 0.952 . . . . 75.44 109.17 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -66.09 -43.55 86.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.04 -1.096 . . . . 74.53 108.04 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.54 -35.47 72.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.132 1.333 . . . . 74.45 112.388 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -83.22 -15.26 51.09 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.935 1.294 . . . . 75.24 111.704 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -97.98 -59.19 1.81 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.341 -1.355 . . . . 72.53 107.341 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -91.47 44.01 1.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.354 2.661 . . . . 74.14 107.808 -173.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -48.33 -45.12 34.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 125.738 1.615 . . . . 75.15 109.537 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -19.8 61.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.713 -0.66 . . . . 74.24 112.469 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 m -85.82 0.26 53.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.819 1.248 . . . . 61.34 112.45 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.68 94.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.15 1.341 . . . . 75.11 108.212 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -79.59 169.69 17.64 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.912 -1.144 . . . . 74.11 107.912 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.72 154.98 48.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.85 -1.537 . . . . 71.33 106.85 163.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -81.87 171.82 14.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.312 1.007 . . . . 62.35 110.437 159.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -45.45 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.28 2.632 . . . . 63.23 110.995 175.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -64.03 -10.06 19.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.275 1.43 . . . . 74.42 112.28 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.01 7.59 57.34 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 127.383 2.421 . . . . 63.22 112.696 163.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.39 -82.06 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.452 1.901 . . . . 75.54 110.625 -163.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.96 129.48 2.72 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.897 -1.681 . . . . 64.31 108.897 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -142.59 161.89 36.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.076 0.938 . . . . 74.41 111.263 167.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.0 145.98 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.167 -2.161 . . . . 74.33 105.167 164.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.45 123.28 29.54 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.027 0.931 . . . . 75.0 108.89 165.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.89 8.5 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.652 0.381 . . . . 73.14 111.35 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.28 -18.91 61.29 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 120.789 -1.194 . . . . 70.34 113.654 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.4 -13.52 60.73 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.872 1.669 . . . . 75.05 112.49 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 57' ' ' ILE . 64.5 mm-40 -61.87 -22.14 65.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.531 0.732 . . . . 63.55 110.312 163.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 63.3 -10.55 0.11 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 128.057 2.543 . . . . 64.3 114.185 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 55' ' ' GLU . 94.4 mt -43.71 113.98 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.8 2.44 . . . . 71.1 109.544 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -77.02 144.01 38.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.006 -0.543 . . . . 74.53 110.041 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.6 tt -112.02 156.65 13.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.041 1.736 . . . . 75.51 107.859 163.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -66.88 93.35 0.26 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.449 -1.315 . . . . 73.43 107.449 164.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -71.39 173.8 7.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.805 -1.554 . . . . 74.4 106.805 165.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -140.39 151.59 45.07 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.656 -1.903 . . . . 74.11 106.817 166.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -101.22 114.22 27.99 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.822 1.249 . . . . 72.41 108.212 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -70.4 -29.47 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.34 1.856 . . . . 75.34 112.024 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -48.19 73.79 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.065 1.346 . . . . 64.54 110.74 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 t -125.39 8.06 7.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.539 0.736 . . . . 75.02 111.63 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt 66.41 51.73 1.15 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.606 1.562 . . . . 74.24 110.961 170.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -123.97 154.35 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.242 0.617 . . . . 61.45 110.137 -171.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.92 131.93 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.421 1.488 . . . . 73.43 107.04 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.36 178.04 7.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.344 1.458 . . . . 60.21 108.961 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -139.08 122.37 17.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.805 -1.184 . . . . 75.32 108.387 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.518 ' CE ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -138.58 147.02 42.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.858 0.863 . . . . 74.51 108.801 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -77.33 147.33 36.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.144 0.578 . . . . 75.21 110.898 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.69 164.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.072 -1.085 . . . . 75.52 108.072 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -117.7 -50.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.902 1.281 . . . . 75.05 110.078 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.343 3.1 ttm180 -116.98 -176.69 3.03 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 119.061 0.846 . . . . 74.11 111.779 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.71 145.98 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 107.924 -1.139 . . . . 73.52 107.924 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.481 ' HE1' HG22 ' A' ' 156' ' ' THR . 98.2 m95 -118.4 156.11 29.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.42 1.088 . . . . 74.45 109.717 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.01 136.13 11.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.567 0.747 . . . . 75.12 108.986 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -145.02 160.96 40.54 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.896 -1.52 . . . . 72.04 106.896 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 148.59 22.74 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.903 -1.123 . . . . 72.52 108.407 173.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -143.9 154.07 42.96 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.955 1.302 . . . . 74.42 110.093 -163.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -153.9 154.73 34.4 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.047 -0.723 . . . . 72.11 109.047 154.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.38 -170.14 21.03 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.347 1.451 . . . . 73.42 110.672 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -86.53 125.43 33.76 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.674 1.19 . . . . 75.41 110.523 -171.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.11 165.85 10.93 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.94 -1.504 . . . . 75.14 106.94 171.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.8 mm -81.43 149.49 4.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.396 1.478 . . . . 75.21 108.146 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -127.45 79.9 1.92 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.722 2.009 . . . . 74.34 107.7 165.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mt -61.81 130.98 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.623 -1.992 . . . . 74.43 105.623 150.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -114.5 162.94 16.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.28 -1.748 . . . . 75.55 106.28 157.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 p -135.61 169.96 16.71 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.591 -0.892 . . . . 75.13 108.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -38.38 55.57 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.678 -1.264 . . . . 75.41 111.877 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -0.98 7.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.493 1.517 . . . . 75.23 111.747 -172.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.6 mmt-85 61.49 24.33 14.45 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 126.936 2.094 . . . . 73.45 110.258 -167.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' CD ' ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -73.87 168.18 19.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.961 -1.126 . . . . 72.33 107.961 160.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 177.55 162.42 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.27 2.628 . . . . 64.54 107.812 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.574 HG22 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -147.18 177.26 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.945 2.098 . . . . 75.53 109.338 -174.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -145.67 74.94 1.41 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.177 0.513 . . . . 73.31 111.489 -167.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.56 163.57 32.58 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 119.522 -1.986 . . . . 75.14 112.271 -165.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 p -68.85 161.28 28.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.516 0.726 . . . . 72.13 110.696 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.09 14.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.422 0.897 . . . . 75.13 113.422 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.18 39.16 3.58 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.153 1.797 . . . . 75.51 110.8 159.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -84.99 125.88 69.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.674 -1.155 . . . . 74.22 109.451 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -63.6 114.77 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.21 3.274 . . . . 74.41 111.231 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.58 162.62 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.819 -1.178 . . . . 72.34 107.819 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -101.39 140.68 35.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.841 0.856 . . . . 73.24 109.151 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.49 164.07 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.996 0.918 . . . . 75.31 109.882 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.03 120.64 31.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.846 -1.168 . . . . 71.22 107.846 173.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.38 81.27 2.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.862 -2.273 . . . . 72.31 104.862 169.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 m 56.45 17.61 3.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.206 1.002 . . . . 71.42 113.52 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.18 1.27 47.99 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.064 -1.022 . . . . 70.44 114.062 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.89 160.3 26.08 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 105.763 -1.94 . . . . 74.14 105.763 150.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.46 145.1 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.822 -0.807 . . . . 74.11 108.822 170.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -142.06 170.9 14.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.986 1.315 . . . . 74.1 107.701 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -112.83 138.26 49.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.794 0.838 . . . . 72.44 108.844 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 pt -142.52 179.28 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.169 1.388 . . . . 71.34 108.81 171.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -72.04 132.06 43.74 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 107.597 -1.261 . . . . 53.34 107.597 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -43.23 -35.11 1.32 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.861 1.665 . . . . 75.24 113.163 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.4 67.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.817 1.247 . . . . 74.42 112.516 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.0 -31.91 56.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.033 -1.042 . . . . 75.13 111.266 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 t -76.57 62.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.124 1.769 . . . . 75.33 110.345 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -86.72 -177.09 6.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.603 1.561 . . . . 72.0 108.534 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.82 0.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.859 2.064 . . . . 64.54 113.704 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.63 -13.43 80.04 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.366 -1.797 . . . . 70.12 112.479 167.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -124.3 170.15 11.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.839 1.819 . . . . 73.31 110.031 -166.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 139' ' ' GLU . 7.6 m-85 -112.86 155.62 24.34 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.391 1.476 . . . . 75.42 108.396 165.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.73 166.83 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.624 2.369 . . . . 74.03 107.589 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 112.26 22.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.85 1.26 . . . . 74.23 110.958 -166.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.54 161.43 41.56 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 124.737 1.215 . . . . 75.0 113.191 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.01 154.84 33.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.887 1.725 . . . . 70.0 109.732 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -117.91 -156.69 0.65 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.1 -1.444 . . . . 74.45 107.1 162.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -59.32 -57.75 11.63 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 122.986 0.514 . . . . 74.32 111.391 -166.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -121.52 0.48 9.95 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.522 0.934 . . . . 74.13 113.522 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -139.35 -173.96 3.74 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.504 1.522 . . . . 74.01 111.027 -160.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.4 149.38 15.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.51 1.124 . . . . 75.34 109.529 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -143.28 -178.32 5.8 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.996 2.118 . . . . 72.33 108.533 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 mt -118.39 165.81 13.42 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.277 1.031 . . . . 72.4 109.386 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -153.96 147.87 25.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.89 1.276 . . . . 63.41 111.116 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 32.5 tt0 -97.38 148.36 23.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.345 1.858 . . . . 73.34 111.166 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.19 2.17 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.725 0.639 . . . . 74.41 112.725 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.5 pt 24.68 -88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 127.522 2.329 . . . . 74.14 116.112 171.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -90.43 124.55 35.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.493 1.517 . . . . 63.52 108.088 175.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.14 122.5 56.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.43 -0.581 . . . . 74.0 109.43 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.88 -167.96 2.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 127.351 2.26 . . . . 73.11 107.436 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -122.45 172.17 8.55 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.555 1.142 . . . . 74.12 109.76 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.36 161.81 22.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 130.565 3.546 . . . . 71.33 104.559 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.59 133.5 51.03 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.792 -1.558 . . . . 71.43 106.792 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -144.18 155.55 43.95 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.815 0.734 . . . . 72.53 111.587 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.39 47.21 0.75 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.535 0.607 . . . . 72.45 111.884 -169.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.44 -122.7 2.29 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.585 -0.697 . . . . 63.34 114.342 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -124.34 160.57 27.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.127 0.971 . . . . 74.11 109.491 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 pt -135.04 155.55 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.578 1.951 . . . . 74.34 108.239 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -138.87 168.52 19.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.522 1.929 . . . . 75.0 107.226 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -164.62 167.34 19.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.741 1.155 . . . . 75.24 109.921 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.3 tp -137.7 113.62 9.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.275 1.583 . . . . 75.1 115.275 -149.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.481 HG22 ' HE1' ' A' ' 78' ' ' TRP . 69.1 p -55.88 -50.85 69.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.427 1.491 . . . . 75.32 114.016 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.3 t 24.55 68.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 129.5 3.12 . . . . 73.43 112.012 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.3 -5.69 58.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.106 -1.406 . . . . 71.22 111.928 -168.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -47.08 74.29 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.52 2.328 . . . . 72.22 110.91 -175.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -125.83 1.34 7.4 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.863 0.69 . . . . 74.42 112.863 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.9 m170 55.83 30.39 15.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.022 0.929 . . . . 75.22 111.81 -169.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.436 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.8 p -151.49 154.9 37.46 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.065 1.302 . . . . 75.4 110.372 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -153.23 174.95 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.595 1.089 . . . . 72.15 111.542 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 mm -99.29 124.23 52.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 73.24 108.916 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.4 157.69 36.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.561 1.545 . . . . 64.25 108.742 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.37 -170.35 23.91 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.912 2.672 . . . . 74.42 107.953 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -89.71 167.28 13.02 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.639 -1.506 . . . . 73.33 111.346 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.19 -74.53 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.652 2.381 . . . . 73.11 114.132 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.77 -10.02 8.78 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.531 1.932 . . . . 52.52 112.541 171.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.82 165.85 29.57 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 122.673 1.152 . . . . 62.22 112.382 -168.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.574 ' CE1' HG22 ' A' ' 97' ' ' ILE . 14.7 m-85 -105.07 158.05 16.83 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.519 2.728 . . . . 74.25 105.943 172.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -87.78 108.62 19.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.186 -2.153 . . . . 74.31 105.186 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 178.5 2.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.427 1.091 . . . . 62.12 108.708 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -80.68 153.2 28.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.389 1.475 . . . . 52.1 110.277 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.41 -158.35 0.85 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.439 1.896 . . . . 74.32 107.737 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.237 0.417 1 C-N-CA 132.625 4.37 . . . . 54.22 104.758 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.259 0 N-CA-C 108.257 -1.016 . . . . 75.02 108.257 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.0 tp -102.09 -16.67 16.34 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.599 1.333 . . . . 74.41 114.599 -150.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.72 160.57 0.15 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 130.799 3.639 . . . . 74.35 112.319 -161.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 8.9 t80 -80.59 -49.0 11.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.667 1.587 . . . . 74.4 111.076 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -93.97 70.57 3.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.364 -2.088 . . . . 71.1 105.364 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.58 116.93 8.5 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 104.747 -2.316 . . . . 74.51 104.747 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.89 124.36 13.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.33 2.687 . . . . 73.42 111.774 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 pt -97.0 10.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.382 0.882 . . . . 74.01 113.382 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 38.66 72.73 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.471 1.508 . . . . 74.43 112.612 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 157.57 0.43 Allowed 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.173 -1.047 . . . . 73.51 108.173 167.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -17.6 48.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.103 0.779 . . . . 72.42 113.103 -169.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.29 -52.93 4.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.557 1.143 . . . . 74.12 109.953 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.87 55.46 0.1 OUTLIER Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.025 1.298 . . . . 65.41 113.496 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -22.7 66.33 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.665 1.732 . . . . 74.51 115.373 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.292 47.8 mm 38.68 46.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 130.121 3.368 . . . . 75.14 112.409 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.33 154.41 3.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.912 1.285 . . . . 74.24 108.013 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.06 124.69 23.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.409 1.084 . . . . 64.1 108.471 168.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -39.24 14.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 123.218 0.607 . . . . 71.51 111.081 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -53.53 -50.94 51.21 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.747 -0.941 . . . . 54.41 110.747 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.61 -38.88 77.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.263 1.025 . . . . 73.41 111.952 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -57.29 -56.13 25.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.012 0.925 . . . . 75.44 109.401 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.74 -38.51 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.475 -0.784 . . . . 72.43 109.522 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -36.91 84.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.148 1.34 . . . . 62.51 110.514 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -40.79 60.63 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.554 1.141 . . . . 74.32 110.281 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.2 -43.99 26.98 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 124.687 1.195 . . . . 73.4 109.309 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.0 -22.23 62.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.871 2.123 . . . . 75.54 113.063 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -100.0 -10.37 21.68 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.547 1.539 . . . . 75.34 112.058 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -65.36 1.02 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.962 -1.866 . . . . 75.02 105.962 163.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -82.83 41.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.686 3.194 . . . . 72.11 110.074 -167.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.33 -30.23 68.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.387 1.875 . . . . 73.31 110.2 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -69.64 -21.13 63.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.159 1.784 . . . . 72.23 112.534 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.28 6.32 48.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.652 1.581 . . . . 72.41 112.271 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.69 84.18 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.652 1.215 . . . . 73.55 109.645 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.48 120.6 24.68 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.243 -1.762 . . . . 73.35 106.243 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -88.62 157.55 18.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.76 -1.941 . . . . 75.33 105.76 155.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.03 178.47 8.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.232 -1.396 . . . . 64.5 107.232 164.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.22 -36.88 83.33 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.656 1.182 . . . . 62.41 110.527 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -14.07 33.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.149 1.38 . . . . 74.32 112.586 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.16 33.41 26.32 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.143 2.306 . . . . 65.22 111.067 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.521 ' CD1' ' HE3' ' A' ' 80' ' ' LYS . 3.4 t80 -79.95 -90.97 0.05 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.036 1.334 . . . . 75.32 108.46 -171.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.19 128.16 2.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.087 -2.005 . . . . 73.45 108.087 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -139.99 168.51 19.64 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.719 1.208 . . . . 74.32 109.026 166.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 mt -149.22 143.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.543 2.337 . . . . 62.52 105.51 168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.38 130.48 37.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.369 1.468 . . . . 52.34 108.295 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.39 -2.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.907 0.883 . . . . 72.04 112.596 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.88 -20.38 52.9 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.535 1.061 . . . . 63.13 115.37 -169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -63.15 -20.52 65.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 128.111 2.564 . . . . 75.41 114.045 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.16 -20.16 62.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.662 0.785 . . . . 72.13 111.357 172.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.14 3.29 1.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.001 2.121 . . . . 74.41 113.685 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.05 138.42 15.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.381 1.472 . . . . 65.21 108.794 172.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.84 167.52 10.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.463 1.125 . . . . 75.01 110.635 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.5 tt -135.38 160.28 40.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 125.714 1.606 . . . . 73.21 108.041 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -81.77 132.88 35.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.312 -1.736 . . . . 75.11 106.312 168.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.37 -174.08 3.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.963 -0.754 . . . . 71.32 108.963 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -138.1 139.54 39.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.401 -1.703 . . . . 73.13 106.401 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.52 107.71 19.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.529 -1.286 . . . . 71.43 107.529 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 3.7 ttpm? -56.49 -23.71 41.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.869 1.268 . . . . 73.13 111.607 173.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -23.06 5.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.473 1.909 . . . . 75.44 112.772 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -149.6 14.27 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.325 1.05 . . . . 73.15 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 37.7 53.82 1.48 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.217 1.807 . . . . 71.15 111.838 -163.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.2 pt -105.98 155.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.707 0.803 . . . . 74.3 109.366 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.7 mm -85.04 130.72 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.829 -1.545 . . . . 75.14 106.829 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.33 166.97 23.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.219 1.007 . . . . 74.45 112.238 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.89 113.0 25.24 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.732 2.013 . . . . 71.15 107.7 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -125.0 167.21 15.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.959 0.903 . . . . 75.44 109.824 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' A' ' 74' ' ' ILE . 8.0 ttm180 -106.22 177.36 4.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.4 0.68 . . . . 75.31 110.228 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.418 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 64.4 mt -113.49 153.55 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 105.423 -2.066 . . . . 74.13 105.423 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.34 -58.52 1.7 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.799 1.239 . . . . 74.23 108.435 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.25 14.7 mtm180 -128.1 159.34 35.4 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.227 1.411 . . . . 74.51 112.756 -174.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.97 165.66 31.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.385 1.474 . . . . 71.43 108.149 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.549 ' HE1' ' CG2' ' A' ' 156' ' ' THR . 68.4 m95 -139.07 163.73 31.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.926 0.49 . . . . 74.42 111.283 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.04 135.87 31.48 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.083 0.953 . . . . 74.52 110.592 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tppp? -142.95 141.45 31.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.031 -1.84 . . . . 71.54 106.031 162.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -86.51 152.38 22.7 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.689 0.795 . . . . 70.11 109.961 -163.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 110.21 3.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.913 -0.773 . . . . 74.24 108.913 169.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.95 46.35 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.394 0.543 . . . . 70.03 111.849 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.573 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.75 121.87 25.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.787 -0.82 . . . . 74.54 108.787 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.18 172.58 7.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.151 -1.796 . . . . 75.01 106.151 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mm -79.15 160.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.418 1.887 . . . . 75.11 107.912 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -137.27 79.64 1.76 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.1 -1.444 . . . . 72.31 107.1 157.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.4 mt -67.12 135.5 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 104.456 -2.424 . . . . 71.13 104.456 158.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -118.22 175.36 5.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.244 1.418 . . . . 73.15 107.311 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -142.33 176.84 8.68 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.919 1.236 . . . . 72.32 112.654 164.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -53.66 -35.17 60.74 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.307 1.043 . . . . 74.12 111.854 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.85 11.0 1.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.785 2.034 . . . . 73.34 111.677 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 47.37 33.54 2.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.153 1.781 . . . . 71.15 111.394 -166.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -83.48 168.35 16.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.818 -1.178 . . . . 71.14 107.818 165.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 179.24 163.55 0.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.5 1.92 . . . . 75.12 107.666 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.514 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 2.0 pt -139.65 172.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.844 2.057 . . . . 74.52 110.201 -174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -137.81 99.67 3.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.34 1.856 . . . . 74.51 107.118 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.88 167.5 28.12 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.756 -0.59 . . . . 74.52 110.347 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 p -75.84 162.38 28.19 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.317 -0.864 . . . . 71.1 110.697 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.74 38.74 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.678 0.791 . . . . 73.25 112.736 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -157.47 37.04 0.28 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.963 0.801 . . . . 73.31 110.065 149.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -75.15 137.02 72.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 119.721 -1.862 . . . . 74.42 110.453 -174.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.35 121.92 9.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.229 2.619 . . . . 74.12 111.483 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.7 -177.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.914 1.286 . . . . 71.43 109.064 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -128.32 137.06 51.77 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.174 0.99 . . . . 73.4 108.894 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.82 167.6 15.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.511 1.124 . . . . 74.54 108.564 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 143.16 34.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.499 0.666 . . . . 62.0 111.797 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.14 53.99 0.8 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.384 1.074 . . . . 72.22 108.748 163.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER 96.36 -0.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 130.856 3.662 . . . . 75.53 114.328 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.75 -11.41 3.69 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.714 -0.955 . . . . 63.12 110.714 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -86.37 161.32 18.75 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 125.419 1.488 . . . . 74.43 112.713 161.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.49 106.64 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.036 1.334 . . . . 71.43 108.962 -166.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.59 158.58 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.214 1.006 . . . . 73.04 108.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -114.44 121.05 42.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.615 1.966 . . . . 74.23 107.037 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 pt -140.71 178.32 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.293 1.037 . . . . 74.42 109.826 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -77.37 140.39 39.93 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.087 1.755 . . . . 71.21 109.867 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.38 -29.81 61.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.198 1.399 . . . . 73.3 112.384 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -31.49 72.19 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.93 -0.481 . . . . 73.11 111.154 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -25.87 42.46 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.507 1.123 . . . . 75.44 111.316 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -72.75 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.3 2.24 . . . . 74.51 111.416 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.51 -178.35 5.78 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.933 -1.104 . . . . 74.32 108.962 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.18 -2.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 129.565 3.146 . . . . 75.34 114.569 166.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.88 -15.92 57.13 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.285 -1.509 . . . . 74.23 111.734 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.35 140.69 51.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.473 1.636 . . . . 73.13 107.954 -160.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.71 117.68 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.643 1.177 . . . . 71.14 107.944 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 tt -82.88 142.99 12.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.044 -0.725 . . . . 74.32 109.044 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.21 121.43 21.22 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.51 -0.922 . . . . 73.24 108.51 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.93 145.61 41.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.696 1.199 . . . . 72.34 110.296 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 148.01 47.39 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.999 1.799 . . . . 75.04 107.516 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -120.93 -169.81 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.346 -1.724 . . . . 74.14 106.346 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -34.53 -72.24 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.922 1.689 . . . . 74.31 112.17 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.48 1.31 10.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.655 1.182 . . . . 64.31 113.217 171.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.2 p -130.47 153.8 48.43 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.967 1.307 . . . . 72.14 112.263 -165.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 tp -84.33 147.46 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.163 -1.421 . . . . 71.4 107.163 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -147.7 -174.86 4.66 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.877 2.071 . . . . 75.3 107.693 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.0 mt -131.25 159.98 36.23 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.354 1.462 . . . . 71.02 108.007 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -149.37 159.0 44.65 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.886 0.874 . . . . 72.24 110.122 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.83 140.27 29.87 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.745 2.418 . . . . 73.05 109.975 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -81.89 -3.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.212 1.405 . . . . 74.11 113.461 -170.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.3 pt 25.05 -89.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 127.494 2.318 . . . . 74.34 115.6 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.422 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -89.82 105.4 17.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.821 1.648 . . . . 74.02 107.844 170.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.81 148.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.135 -1.061 . . . . 64.01 108.135 154.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.3 -162.63 0.76 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.359 2.664 . . . . 74.11 107.661 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -131.26 162.12 30.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.162 1.785 . . . . 72.55 109.561 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.63 -169.16 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.601 1.561 . . . . 74.12 109.455 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.01 132.47 41.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.991 2.116 . . . . 74.42 106.535 161.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.95 143.31 36.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.82 1.191 . . . . 72.05 110.489 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.53 30.74 1.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.969 0.729 . . . . 65.41 112.969 -163.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.59 -136.03 4.21 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.593 1.092 . . . . 54.44 111.739 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -99.25 170.06 8.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.384 -1.068 . . . . 74.02 109.824 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.3 pt -118.34 -73.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.037 -1.468 . . . . 73.53 107.037 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 78.98 170.29 0.18 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.535 2.334 . . . . 74.12 107.553 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -162.91 153.96 17.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.425 1.49 . . . . 71.2 107.439 -170.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -123.04 141.21 52.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.457 1.103 . . . . 74.24 111.133 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.549 ' CG2' ' HE1' ' A' ' 78' ' ' TRP . 44.7 p -79.49 -70.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.751 0.657 . . . . 75.41 110.183 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t 43.11 73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.664 2.386 . . . . 65.22 111.844 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.05 -0.48 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 74.33 113.314 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.94 -38.72 83.2 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.599 -0.519 . . . . 73.44 109.599 -166.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 5.5 t30 -138.52 7.98 2.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.871 1.269 . . . . 71.41 111.99 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.5 m170 54.02 29.32 9.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.505 1.122 . . . . 74.12 111.424 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.422 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 2.3 p -142.91 144.77 32.56 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.628 -1.92 . . . . 73.33 109.135 178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.8 167.17 26.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.067 0.765 . . . . 75.35 113.067 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.2 mm -85.85 137.19 21.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 106.407 -1.701 . . . . 74.42 106.407 164.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -153.87 143.08 21.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.801 1.24 . . . . 75.31 108.072 162.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.55 -173.32 22.87 Favored Glycine 0 N--CA 1.462 0.431 0 C-N-CA 123.881 0.753 . . . . 54.35 111.585 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -90.95 167.87 12.09 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.47 -1.606 . . . . 74.12 110.261 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.08 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.542 2.337 . . . . 75.31 114.201 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.514 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 43.0 mt-10 -121.77 -7.94 8.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.558 1.143 . . . . 72.42 112.339 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.26 170.33 14.7 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 122.844 1.247 . . . . 73.42 111.874 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.514 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 12.8 m-85 -120.72 147.91 44.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.968 2.507 . . . . 74.31 106.98 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.79 103.94 16.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.542 -1.651 . . . . 73.35 106.542 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.24 177.88 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.398 1.479 . . . . 65.21 109.176 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.8 t -67.34 144.4 55.86 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.47 2.708 . . . . 72.04 109.77 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -123.96 166.13 16.24 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.681 2.793 . . . . 75.21 107.013 162.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 106.613 -1.625 . . . . 72.42 106.613 160.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.102 -1.073 . . . . 62.13 108.102 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.41 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 72.42 110.508 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.05 152.97 43.78 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.763 -0.653 . . . . 70.53 109.804 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.6 t80 -53.81 -31.12 47.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.449 1.5 . . . . 75.02 112.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.45 ' CG ' ' HZ2' ' A' ' 167' ' ' LYS . 2.3 p-10 -103.93 14.67 30.28 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.753 1.221 . . . . 71.22 113.459 -171.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.34 119.96 79.28 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 106.013 -1.847 . . . . 75.5 106.013 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.0 139.79 75.43 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-N 120.427 1.188 . . . . 73.01 112.437 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.0 pt -90.21 140.3 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.022 -1.103 . . . . 73.23 108.022 161.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -102.43 83.26 2.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.409 -1.7 . . . . 73.3 106.409 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.3 164.59 18.08 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.308 0.575 . . . . 74.4 109.987 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.5 t -56.02 -39.34 71.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.095 0.958 . . . . 73.31 110.216 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -33.37 34.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.265 0.939 . . . . 55.53 111.089 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.68 46.07 2.37 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.865 0.745 . . . . 62.41 112.271 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -35.9 69.43 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.68 1.24 . . . . 71.35 111.72 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.4 mm 45.87 86.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 128.283 2.633 . . . . 74.15 107.325 -163.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.72 152.0 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.63 -1.618 . . . . 73.52 106.63 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.29 135.24 56.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.283 1.833 . . . . 65.13 109.351 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.491 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -50.9 -54.81 8.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.825 -1.176 . . . . 75.23 107.825 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -55.49 -45.19 84.89 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.944 -1.263 . . . . 74.35 109.944 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -71.83 -42.96 66.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.077 1.351 . . . . 73.03 112.599 -173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -52.4 -49.26 64.82 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 122.038 0.923 . . . . 74.14 109.552 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.436 ' CG2' ' CE2' ' A' ' 153' ' ' TYR . 92.7 t -72.79 -42.1 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.836 -1.075 . . . . 74.13 109.886 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.24 -38.36 73.67 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.332 0.515 . . . . 72.1 111.289 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.8 -43.14 76.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.276 1.03 . . . . 74.41 109.347 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.39 -47.09 62.46 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 117.491 -1.242 . . . . 74.03 108.767 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.6 -38.2 66.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.447 1.476 . . . . 75.44 110.994 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -78.05 -30.82 50.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.837 -1.078 . . . . 74.41 111.781 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.43 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.5 ttmm -78.97 -63.12 1.49 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.742 -1.577 . . . . 72.0 106.742 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.33 39.77 0.53 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.266 2.627 . . . . 72.45 109.732 -172.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.81 -38.29 67.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 120.533 -1.354 . . . . 75.43 110.784 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -74.47 -12.85 60.6 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.198 0.814 . . . . 73.05 113.198 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -93.95 0.01 55.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.842 1.257 . . . . 74.52 112.32 174.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.59 95.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 119.638 1.108 . . . . 72.44 108.099 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -78.94 147.75 32.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.152 -1.425 . . . . 71.52 107.152 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 130.75 48.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.043 -2.577 . . . . 70.21 104.043 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 144.66 35.71 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.094 -1.817 . . . . 73.43 106.094 171.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.5 -40.26 86.46 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.124 1.769 . . . . 75.41 112.196 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.98 -5.8 28.83 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.214 1.006 . . . . 74.0 112.27 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.77 56.41 1.16 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 126.731 2.11 . . . . 50.11 110.24 160.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -120.33 -97.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.338 1.055 . . . . 73.12 109.048 -172.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.11 137.71 3.02 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.986 1.755 . . . . 62.42 109.855 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -150.01 170.55 18.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.185 0.992 . . . . 73.14 111.448 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 mt -149.26 144.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.085 2.154 . . . . 74.14 106.608 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 122.53 31.06 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.248 1.819 . . . . 61.2 108.889 168.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 54' ' ' ASN . 2.2 pp -135.19 14.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.766 1.227 . . . . 70.54 111.876 -174.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 17.72 0.14 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.082 1.801 . . . . 73.44 114.69 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -119.75 -13.1 9.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 129.873 3.269 . . . . 75.54 111.022 -177.005 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.29 -20.92 65.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.361 0.982 . . . . 75.45 110.903 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.1 19.19 2.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.571 1.948 . . . . 74.24 113.068 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.33 148.36 12.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.32 1.448 . . . . 73.51 107.52 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -115.67 140.85 48.81 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.682 -0.858 . . . . 72.51 108.682 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.49 158.65 18.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.555 1.542 . . . . 75.23 107.71 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -66.01 145.21 56.14 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.968 -1.123 . . . . 73.15 107.968 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.72 -179.29 5.96 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.735 1.614 . . . . 70.23 107.795 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.98 121.85 7.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.842 -1.161 . . . . 72.54 109.417 173.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.84 114.63 9.1 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.507 1.123 . . . . 63.32 108.93 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HE2' ' CG2' ' A' ' 162' ' ' THR . 18.0 mttt -62.35 -21.25 65.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.236 0.828 . . . . 75.21 113.236 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -37.8 -47.16 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.12 2.168 . . . . 75.34 109.807 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.4 17.71 2.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.53 1.132 . . . . 74.43 110.575 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 48.93 49.33 19.46 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.027 1.285 . . . . 75.2 112.222 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.74 149.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.544 1.538 . . . . 75.44 107.934 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.77 144.49 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.595 -1.261 . . . . 75.44 107.595 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -148.96 -177.58 5.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.194 2.197 . . . . 65.32 111.881 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.01 162.22 13.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.904 2.082 . . . . 73.31 109.991 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 149.95 22.69 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.909 -1.119 . . . . 75.0 111.572 156.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -78.9 162.54 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.974 -0.751 . . . . 75.13 108.974 159.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -94.09 168.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.208 1.803 . . . . 74.34 106.756 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.19 -58.31 2.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.265 1.826 . . . . 75.2 108.94 168.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -128.76 155.98 44.26 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.757 -0.59 . . . . 74.33 110.873 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.39 163.4 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 126.179 1.791 . . . . 55.21 108.331 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.35 176.72 8.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.84 1.656 . . . . 70.04 109.631 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -169.08 148.14 3.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.972 1.709 . . . . 75.44 109.168 163.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -142.43 169.99 16.55 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.605 1.562 . . . . 72.33 107.538 156.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 151' ' ' HIS . 80.5 tttt -91.41 152.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.711 -0.618 . . . . 72.33 109.408 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -146.93 147.89 31.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.439 0.696 . . . . 74.22 110.103 -170.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -157.7 126.84 5.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.444 -1.317 . . . . 75.12 107.444 155.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.52 -177.78 42.34 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.052 0.842 . . . . 75.25 112.56 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.593 ' H ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.89 127.47 32.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.03 -0.688 . . . . 74.11 110.86 171.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.96 157.98 17.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.848 -1.168 . . . . 75.52 107.848 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -78.57 133.68 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.217 -1.401 . . . . 74.33 107.217 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -119.74 84.52 2.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.005 1.383 . . . . 75.15 107.645 164.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.67 130.39 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.143 -2.169 . . . . 73.21 105.143 154.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 4.9 m -100.15 -175.71 3.02 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 105.979 -1.86 . . . . 73.34 105.979 161.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 90' ' ' THR . 12.0 p -146.95 170.29 17.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.654 1.982 . . . . 74.2 108.716 165.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -56.92 -28.1 61.68 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.169 1.349 . . . . 73.54 112.433 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -72.3 3.4 4.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.623 0.971 . . . . 54.54 113.623 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 57.05 18.8 4.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.68 1.592 . . . . 72.32 111.591 -164.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 160.72 32.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.447 -1.686 . . . . 74.31 106.447 161.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.83 164.19 5.11 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.47 2.308 . . . . 72.41 106.857 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.453 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 4.5 pt -146.77 170.15 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 125.512 1.525 . . . . 74.33 108.521 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.358 0.0 OUTLIER -151.63 96.49 2.26 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 126.624 1.97 . . . . 73.53 113.3 -175.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.411 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -161.79 179.4 8.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.153 1.781 . . . . 74.21 110.291 -166.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 p -66.72 166.92 12.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.959 0.885 . . . . 74.43 110.837 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.39 -14.13 62.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.533 -0.729 . . . . 73.15 112.239 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -125.15 37.88 4.3 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.741 1.616 . . . . 71.51 111.566 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.411 ' CG ' HD22 ' A' ' 99' ' ' LEU . 1.1 p-80 -76.77 141.74 68.94 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.076 -0.964 . . . . 74.11 108.487 164.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -70.92 127.24 13.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.308 3.339 . . . . 72.21 113.525 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.39 -177.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.279 1.831 . . . . 65.04 110.685 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -131.45 126.87 36.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.986 2.114 . . . . 73.41 108.502 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.51 163.02 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.244 0.929 . . . . 72.45 109.967 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.56 104.79 10.4 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.019 0.914 . . . . 74.23 110.612 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -86.01 79.85 9.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 104.248 -2.501 . . . . 74.41 104.248 161.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 55.45 19.65 3.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.428 1.269 . . . . 74.05 114.428 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.79 -0.89 41.88 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.168 -0.958 . . . . 74.55 113.642 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -91.66 129.11 37.69 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.075 -2.194 . . . . 75.33 105.075 156.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.24 130.37 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 74.24 108.885 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.42 148.44 42.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.892 0.877 . . . . 75.21 110.476 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -103.72 123.83 47.76 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.352 1.461 . . . . 71.51 111.289 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.51 -178.34 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.318 1.447 . . . . 74.54 111.325 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -86.27 145.38 26.97 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.634 1.974 . . . . 73.53 109.336 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -39.6 -51.75 2.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.228 2.211 . . . . 73.41 112.245 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -56.12 -21.43 22.34 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.521 1.528 . . . . 74.02 114.604 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.3 mtt -93.48 -19.21 21.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.279 1.032 . . . . 75.03 111.387 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 t -78.88 62.0 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 127.677 2.391 . . . . 74.32 109.277 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.76 -176.95 5.66 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.324 -0.86 . . . . 74.21 109.987 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.52 -11.47 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 126.413 1.885 . . . . 74.51 113.701 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.69 -3.11 71.59 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.536 -1.147 . . . . 72.54 112.965 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -123.98 145.7 49.01 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.956 1.878 . . . . 73.43 108.798 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -112.95 114.52 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.907 1.283 . . . . 72.14 107.682 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.5 tt -89.46 134.5 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.8 1.24 . . . . 74.0 108.944 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -69.72 107.26 3.4 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.837 -0.801 . . . . 73.13 108.837 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.46 157.81 39.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.909 1.284 . . . . 73.25 110.281 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.35 152.28 66.16 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.818 1.012 . . . . 65.3 110.13 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -119.82 178.82 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 156.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -23.81 -67.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.273 3.029 . . . . 75.25 114.888 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -120.88 -13.4 8.64 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.166 0.894 . . . . 74.01 113.389 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -139.07 168.66 19.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.253 -0.905 . . . . 73.51 110.834 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -78.33 156.89 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.778 -0.823 . . . . 65.33 108.778 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 -176.14 4.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.118 2.967 . . . . 71.11 105.441 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 mp -113.61 167.58 10.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.572 1.949 . . . . 70.44 109.07 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -157.54 154.27 28.31 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.676 -1.602 . . . . 70.43 106.676 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.93 141.34 28.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.699 1.2 . . . . 61.23 108.58 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.6 -22.2 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 114.735 1.384 . . . . 72.31 114.735 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.2 pt 50.52 -49.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 130.115 3.366 . . . . 74.42 118.013 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.78 133.19 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 131.466 3.906 . . . . 75.15 107.773 -161.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.64 109.31 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.379 -0.6 . . . . 75.23 109.379 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -151.11 -175.71 5.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.369 1.068 . . . . 73.43 108.969 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 134.65 47.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.473 1.109 . . . . 55.21 108.102 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.48 -176.14 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.811 -1.181 . . . . 72.34 107.811 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.71 155.93 30.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.419 -1.326 . . . . 74.54 107.419 152.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -147.6 162.0 40.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.065 0.946 . . . . 74.1 108.649 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.87 78.36 0.33 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.055 -1.461 . . . . 74.13 107.055 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.85 25.59 0.2 Allowed Glycine 0 N--CA 1.474 1.227 0 N-CA-C 118.966 2.346 . . . . 73.31 118.966 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 71.8 m80 61.13 159.78 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.403 2.281 . . . . 65.31 111.813 -167.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.5 pt -145.7 155.26 13.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.638 1.575 . . . . 75.33 108.594 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -156.42 168.68 26.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.881 0.472 . . . . 74.34 111.199 171.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -146.21 162.79 37.27 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.727 2.811 . . . . 74.32 106.726 -173.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.15 153.96 34.04 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.578 -1.326 . . . . 72.34 112.162 -163.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 -38.78 10.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.057 -0.974 . . . . 74.34 113.339 -162.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.257 2.1 t 22.89 64.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 129.567 3.147 . . . . 74.15 113.487 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -78.15 1.63 20.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.241 -0.912 . . . . 72.51 112.453 -169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -89.6 -48.27 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.638 2.775 . . . . 73.0 109.298 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -132.64 -3.61 3.31 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.103 0.779 . . . . 73.13 113.103 -173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 69.03 8.44 6.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.143 1.377 . . . . 74.44 113.982 161.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.442 ' CG2' ' HE2' ' A' ' 64' ' ' LYS . 39.1 p -140.77 158.06 44.52 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.389 2.276 . . . . 75.42 107.248 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -144.86 -175.68 4.77 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.731 -1.23 . . . . 73.24 110.77 172.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.96 111.95 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.853 1.261 . . . . 75.52 108.081 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.47 158.47 44.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.131 1.373 . . . . 71.34 108.496 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.15 -158.06 25.15 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 107.379 -2.288 . . . . 74.41 107.379 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.45 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 19.1 mttt -112.32 172.39 6.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.017 1.408 . . . . 73.24 111.212 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.58 -69.43 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.867 3.267 . . . . 72.41 114.164 -174.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -122.89 -11.0 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.783 2.033 . . . . 75.11 113.694 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.88 159.54 3.17 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 122.533 1.074 . . . . 73.11 112.119 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 97' ' ' ILE . 26.5 m-85 -104.38 156.1 18.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.752 2.021 . . . . 72.45 109.26 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -89.27 79.89 6.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.194 1.798 . . . . 73.23 107.599 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.97 176.8 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.58 -1.267 . . . . 74.55 107.58 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.16 155.63 38.27 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.008 2.123 . . . . 73.21 111.049 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.56 39.78 1.17 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.05 2.54 . . . . 73.32 108.605 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 108.326 -0.99 . . . . 74.3 108.326 179.497 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 N-CA-C 108.503 -0.925 . . . . 75.14 108.503 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.77 160.2 30.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.072 1.749 . . . . 75.32 109.802 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.24 149.7 44.32 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.802 -0.444 . . . . 71.2 109.802 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -44.45 -39.51 4.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.903 1.681 . . . . 74.44 113.549 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -97.22 7.8 45.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.388 1.075 . . . . 74.01 113.088 -166.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.25 121.73 84.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.517 -1.29 . . . . 71.33 107.517 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.11 141.92 95.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.569 1.239 . . . . 61.44 112.336 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 pt -96.38 -8.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.369 0.877 . . . . 73.33 113.369 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 54.63 69.33 0.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.479 1.133 . . . . 75.35 110.075 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.3 mt -55.1 160.58 2.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.7 -0.682 . . . . 74.55 109.595 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -53.35 -40.54 64.99 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.736 0.814 . . . . 71.4 109.755 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.01 -37.38 84.67 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.265 1.026 . . . . 75.11 112.786 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.68 41.15 7.38 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.065 -1.022 . . . . 55.11 110.548 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.77 -11.95 61.26 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.786 0.835 . . . . 74.35 113.192 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.9 mm 40.57 70.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.97 2.908 . . . . 71.23 109.112 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.83 149.83 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 112.82 -1.991 . . . . 74.25 107.928 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.26 135.37 47.42 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.791 1.236 . . . . 74.31 109.52 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.69 -4.24 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.221 1.809 . . . . 75.04 114.556 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.62 -9.86 12.15 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-O 116.769 -2.129 . . . . 72.14 113.488 165.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -78.33 -49.71 13.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.278 2.039 . . . . 75.44 109.799 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -39.6 -54.88 1.95 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.202 1.801 . . . . 75.43 109.797 165.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -73.16 -30.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.976 -1.465 . . . . 74.15 110.379 -174.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.12 -31.83 73.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.512 -1.368 . . . . 73.12 111.125 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -52.2 61.09 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.361 0.664 . . . . 75.33 109.478 168.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -66.13 -44.18 84.96 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 117.57 -1.205 . . . . 62.33 109.24 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -54.41 -39.56 67.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 121.876 2.126 . . . . 75.42 112.786 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -27.33 56.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.74 -1.124 . . . . 74.32 111.509 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 3.8 mtpt -86.39 -59.93 2.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.456 -1.683 . . . . 74.02 106.456 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 3.8 m-30 -88.98 39.93 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.762 2.825 . . . . 73.25 108.769 -168.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.59 -35.09 71.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.598 -1.314 . . . . 74.23 112.089 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -31.11 72.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 72.41 112.816 172.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 m -79.56 -9.44 59.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.15 1.78 . . . . 53.32 111.246 -175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.05 102.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.373 0 N-CA-C 106.554 -1.647 . . . . 74.23 106.554 168.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.81 167.27 12.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.389 -1.337 . . . . 74.24 107.389 158.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 145.64 45.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.212 -2.144 . . . . 72.55 105.212 167.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -78.3 168.83 19.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.29 -1.744 . . . . 75.13 106.29 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -33.09 74.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.496 0.718 . . . . 61.41 110.51 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.14 -0.35 18.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.426 0.899 . . . . 75.23 113.426 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.29 17.87 51.51 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 126.023 1.773 . . . . 61.14 113.259 161.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.96 -95.35 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.461 1.905 . . . . 74.43 109.974 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.51 129.07 1.41 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.783 -1.727 . . . . 63.13 108.783 -167.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -137.75 157.99 45.3 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 124.402 0.707 . . . . 71.33 109.487 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mt -139.36 141.83 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 104.97 -2.234 . . . . 74.35 104.97 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.38 137.28 32.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.678 0.791 . . . . 64.42 109.697 167.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.56 17.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.402 1.481 . . . . 73.22 112.748 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.97 -38.01 10.04 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.259 -0.745 . . . . 73.54 113.517 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -78.17 -6.23 54.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.202 1.501 . . . . 75.33 113.763 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' ' 57' ' ' ILE . 56.6 mm-40 -64.35 -26.96 68.7 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.361 1.437 . . . . 74.23 110.323 168.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 m120 58.76 -4.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.971 2.108 . . . . 73.32 114.318 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 55' ' ' GLU . 93.5 mt -47.8 132.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 128.234 2.614 . . . . 62.3 108.058 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.75 150.57 22.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.255 1.026 . . . . 73.22 110.192 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.8 150.96 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.91 2.084 . . . . 74.43 107.014 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -61.77 120.7 11.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.844 -0.799 . . . . 75.13 108.844 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -114.18 -179.49 3.65 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.77 1.228 . . . . 73.44 108.505 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.471 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -143.4 146.82 33.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.291 -1.374 . . . . 74.23 107.291 159.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.4 112.83 24.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.368 0.531 . . . . 72.4 109.952 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.38 -24.1 67.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.184 0.994 . . . . 75.25 112.384 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.7 -43.37 5.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.725 2.41 . . . . 74.42 111.733 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.96 18.88 1.79 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.247 1.019 . . . . 75.2 111.521 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp 39.72 66.12 0.62 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.312 2.245 . . . . 71.12 112.056 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 pt -121.02 156.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.958 1.703 . . . . 74.12 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.2 mm -86.57 126.18 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 126.989 2.116 . . . . 73.14 106.631 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -140.46 171.18 14.5 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.084 1.753 . . . . 73.11 107.842 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -112.76 141.1 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.975 1.71 . . . . 72.33 107.43 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 151.6 38.11 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.323 -0.861 . . . . 75.21 109.385 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -79.2 173.73 12.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.625 -0.88 . . . . 75.02 108.625 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.8 151.74 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.058 -1.46 . . . . 75.11 107.058 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -106.29 -41.93 5.19 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 117.645 -1.169 . . . . 75.23 110.385 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtm-85 -140.08 149.69 43.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.433 1.469 . . . . 75.21 111.427 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.97 155.9 7.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.451 1.501 . . . . 70.04 108.54 170.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -130.74 150.26 52.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.0 1.32 . . . . 75.01 109.045 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -151.84 140.64 20.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.973 0.909 . . . . 74.01 110.208 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -153.92 163.75 39.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.608 1.163 . . . . 74.14 108.81 163.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -92.37 139.68 30.35 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 120.808 -1.182 . . . . 74.25 110.148 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -134.46 168.36 19.08 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.327 1.451 . . . . 75.53 109.901 -165.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.75 109.09 1.6 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.195 -0.907 . . . . 72.21 111.338 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.82 -173.53 36.53 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.256 1.389 . . . . 74.34 112.49 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -86.64 109.33 19.09 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.314 -0.521 . . . . 74.03 111.336 -171.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.75 168.65 19.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.77 -0.826 . . . . 74.52 108.77 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.12 130.35 35.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.06 2.144 . . . . 60.13 108.185 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -115.8 85.57 2.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.09 -1.448 . . . . 71.43 107.09 161.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -66.26 120.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 104.008 -2.59 . . . . 75.42 104.008 153.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -104.5 164.58 11.65 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.469 -1.678 . . . . 74.53 106.469 161.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.5 p -134.03 170.24 15.94 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.05 -1.031 . . . . 70.44 109.758 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -65.06 -27.72 68.98 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.109 1.764 . . . . 74.23 110.46 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -68.25 1.04 3.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.927 1.691 . . . . 75.12 111.536 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 55.82 29.67 14.42 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.085 2.154 . . . . 74.54 111.785 -172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.476 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt-85 -75.84 168.49 19.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 118.224 -1.39 . . . . 73.43 109.085 162.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.6 169.26 18.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.916 1.385 . . . . 75.52 108.573 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.491 HG21 ' CE1' ' A' ' 171' ' ' PHE . 1.2 pt -146.16 169.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.959 2.104 . . . . 74.12 110.804 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 m -146.86 98.16 3.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.082 1.353 . . . . 64.05 110.454 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.71 174.93 13.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.065 1.746 . . . . 70.14 111.098 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 167.58 10.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.229 1.012 . . . . 74.4 110.935 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -70.14 -31.86 69.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.03 -0.73 . . . . 62.01 109.03 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -101.44 38.87 1.51 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 73.3 112.493 -168.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -107.91 143.52 27.5 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 120.801 -1.187 . . . . 74.43 110.882 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.46 125.65 12.01 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.986 3.124 . . . . 75.33 112.368 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.64 168.83 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.743 0.817 . . . . 75.32 108.866 168.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.32 140.68 37.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.351 0.66 . . . . 74.42 110.554 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.55 158.45 37.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.332 1.453 . . . . 74.53 108.275 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.6 p -88.78 134.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.122 0.963 . . . . 72.12 108.962 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 77.33 1.03 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.368 -1.716 . . . . 74.53 106.368 161.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 59.32 21.17 9.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 70.45 113.069 167.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.34 -19.84 5.94 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.211 -0.772 . . . . 72.14 111.693 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -87.15 141.11 28.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 104.4 -2.444 . . . . 73.54 104.4 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -86.72 139.6 17.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.677 -1.264 . . . . 74.52 108.051 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.92 159.95 37.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.953 -1.499 . . . . 74.22 106.953 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -126.18 112.2 15.51 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.333 1.053 . . . . 62.05 109.573 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.65 174.83 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.511 1.124 . . . . 74.11 111.111 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -76.84 136.31 38.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 117.862 -1.066 . . . . 72.44 109.489 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.03 -32.73 16.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 55.53 113.304 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.3 -16.29 63.53 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.192 1.553 . . . . 70.04 115.192 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.8 mtt -84.0 -28.09 27.97 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.446 0.566 . . . . 73.22 110.707 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.5 t -76.14 61.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 127.496 2.318 . . . . 62.43 109.786 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -91.63 -171.8 3.02 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.537 1.135 . . . . 74.43 108.079 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.61 -9.02 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.34 1.456 . . . . 74.42 114.236 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.89 2.36 69.32 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 116.793 -2.115 . . . . 73.41 113.495 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.78 135.56 43.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 121.12 2.46 . . . . 74.01 108.999 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -79.59 118.91 21.87 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.518 -0.919 . . . . 74.14 108.518 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.08 126.06 42.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.574 -1.269 . . . . 74.52 107.574 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.96 141.1 56.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.838 -0.801 . . . . 74.51 108.838 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.52 158.8 72.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.402 1.081 . . . . 74.24 112.013 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.56 150.7 31.96 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.621 2.214 . . . . 74.32 108.365 171.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.32 -174.77 3.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 105.869 -1.9 . . . . 73.21 105.869 162.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -28.33 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.267 2.227 . . . . 74.5 112.195 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.12 -3.47 9.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.227 1.811 . . . . 75.4 111.414 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 p -133.71 158.79 42.38 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.649 0.659 . . . . 61.42 111.581 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.91 152.88 4.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.937 -1.135 . . . . 74.42 107.937 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.37 179.86 6.69 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.575 1.95 . . . . 73.23 107.367 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.11 162.42 19.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.869 1.267 . . . . 74.13 107.914 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -150.52 160.19 43.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.258 -1.386 . . . . 75.31 107.258 158.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.09 -179.75 0.32 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.026 1.731 . . . . 73.53 109.699 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.47 1.66 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.165 1.786 . . . . 73.04 112.08 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.9 pt 26.51 -80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 128.235 2.614 . . . . 72.2 116.684 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.456 ' H ' HG13 ' A' ' 141' ' ' ILE . 16.3 tppt? -109.84 119.28 38.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.895 1.278 . . . . 73.54 108.157 173.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.65 115.71 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.659 1.219 . . . . 75.41 109.005 164.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.62 -172.29 2.45 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.203 2.601 . . . . 71.0 106.971 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.9 p -128.86 166.82 18.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.059 1.344 . . . . 75.1 110.893 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.77 124.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.024 0.93 . . . . 74.33 109.721 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.92 101.72 11.89 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.561 -0.903 . . . . 75.04 108.561 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.463 ' C ' HD21 ' A' ' 149' ' ' ASN . 9.3 t80 -107.38 133.62 51.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.056 0.942 . . . . 74.54 109.196 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.463 HD21 ' C ' ' A' ' 148' ' ' TYR . 1.3 m-80 -124.55 59.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.794 -1.188 . . . . 73.12 107.794 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -124.64 -166.68 12.48 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.683 2.087 . . . . 74.12 110.681 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.34 156.27 18.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.799 -0.815 . . . . 60.3 108.799 166.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 49.8 pt -136.02 152.79 30.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.177 1.391 . . . . 74.21 108.06 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -144.31 153.27 41.83 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.715 1.206 . . . . 75.42 109.201 -163.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -141.56 174.59 10.42 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.861 -0.525 . . . . 73.33 109.684 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.18 109.82 10.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.028 1.731 . . . . 74.23 109.261 -157.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -76.71 121.0 22.66 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.169 -1.789 . . . . 71.31 106.169 169.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 t -130.24 87.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.635 -1.617 . . . . 74.31 106.635 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -21.49 63.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.903 1.681 . . . . 71.51 113.031 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -95.72 -51.17 4.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.217 1.407 . . . . 64.42 110.045 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -124.23 103.58 8.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 101.715 -3.439 . . . . 75.5 101.715 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -66.94 28.55 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.794 0.838 . . . . 73.34 113.018 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.471 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 1.4 p -153.95 124.93 7.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.066 2.147 . . . . 55.1 107.727 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -129.92 166.02 20.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.299 1.44 . . . . 71.43 110.912 -169.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.17 135.05 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.214 -1.032 . . . . 73.21 108.214 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.77 29.33 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.509 1.124 . . . . 73.22 110.066 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.01 -156.61 22.25 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.565 0.621 . . . . 73.43 111.893 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -110.09 167.39 10.21 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.998 -1.295 . . . . 75.11 111.54 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.89 -76.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.718 2.807 . . . . 73.53 112.699 -165.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.31 -13.32 8.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.97 1.708 . . . . 74.3 113.641 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.36 176.53 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 123.294 1.496 . . . . 74.44 112.686 -173.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.491 ' CE1' HG21 ' A' ' 97' ' ' ILE . 8.7 m-85 -124.11 149.47 46.17 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.408 3.083 . . . . 73.11 104.874 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.37 81.04 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.802 -1.184 . . . . 75.23 107.802 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.0 m -88.49 179.87 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 O-C-N 121.78 -0.575 . . . . 73.44 110.58 -171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.59 158.45 23.06 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.794 -0.566 . . . . 74.23 110.443 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -144.28 175.13 10.31 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.992 2.117 . . . . 72.3 109.288 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.327 -0.99 . . . . 63.05 108.327 157.443 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.405 0 N-CA-C 107.767 -1.197 . . . . 62.51 107.767 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.47 -177.42 4.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.474 -0.565 . . . . 74.54 109.474 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -166.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.219 1.408 . . . . 74.23 112.036 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -94.78 -50.38 5.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.434 1.494 . . . . 63.52 110.316 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.94 50.16 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.414 2.285 . . . . 61.14 108.094 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.02 131.84 19.03 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 106.936 -1.505 . . . . 73.1 106.936 -165.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -79.95 132.71 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.015 1.81 . . . . 72.25 112.305 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 pt -98.56 -6.16 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.904 0.882 . . . . 73.22 113.032 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 57.01 84.2 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.982 1.713 . . . . 64.32 112.135 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.29 156.66 1.12 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.833 164.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.9 t -55.54 -35.03 65.23 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 122.979 0.512 . . . . 72.55 109.855 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.75 -29.96 68.47 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.647 0.779 . . . . 64.04 112.297 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.21 36.21 7.2 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.194 1.378 . . . . 74.24 111.605 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -17.02 64.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.352 1.241 . . . . 75.3 114.352 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm 43.32 93.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 128.523 2.729 . . . . 72.31 111.19 -166.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.87 145.54 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.63 -1.623 . . . . 74.14 107.792 174.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.26 131.49 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 128.069 2.548 . . . . 72.33 108.396 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -49.92 -48.68 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.495 0.718 . . . . 74.1 110.526 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 29' ' ' VAL . . . -86.81 4.56 86.19 Favored Glycine 0 C--O 1.221 -0.656 0 CA-C-O 116.986 -2.008 . . . . 75.44 113.419 -173.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -86.68 -53.35 4.99 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.512 1.656 . . . . 72.31 108.582 162.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -52.78 -54.42 34.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.765 1.226 . . . . 73.51 109.302 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 21.7 m -65.89 -33.4 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-O 117.753 -1.117 . . . . 74.31 110.174 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -41.92 95.99 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 121.545 1.975 . . . . 70.3 111.569 -173.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.89 -40.23 60.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.462 0.705 . . . . 73.42 110.469 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -77.68 -46.49 21.79 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.353 -1.308 . . . . 63.51 109.873 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -54.95 -36.07 64.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 122.517 2.417 . . . . 72.35 112.354 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -17.4 46.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.383 1.073 . . . . 74.34 113.204 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -88.54 -61.22 1.76 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.195 -1.409 . . . . 74.31 107.195 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -84.13 40.78 0.78 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.912 2.085 . . . . 71.34 108.726 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -50.95 -34.54 29.15 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 127.045 2.138 . . . . 75.03 110.706 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.95 -22.8 59.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.573 1.949 . . . . 74.32 113.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m -94.07 0.8 56.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.222 1.809 . . . . 74.34 112.157 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.16 101.02 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.595 0.758 . . . . 74.11 109.301 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.67 169.69 17.61 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.403 1.081 . . . . 73.32 110.244 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.65 132.3 27.22 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.996 1.319 . . . . 70.12 108.757 164.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -79.6 169.77 17.52 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.395 2.278 . . . . 72.32 110.017 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.01 -37.43 79.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.913 1.685 . . . . 74.24 109.867 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.72 -15.59 62.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.571 0.748 . . . . 74.4 111.827 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.35 3.18 57.66 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 126.313 1.911 . . . . 74.23 113.811 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -57.73 -87.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 129.172 2.989 . . . . 71.33 111.123 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.72 125.89 2.99 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.107 1.336 . . . . 74.31 109.964 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -136.3 168.39 19.5 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.393 1.077 . . . . 74.42 109.861 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.8 mt -146.08 153.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 127.182 2.193 . . . . 73.14 106.202 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 143.27 27.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.672 1.589 . . . . 75.41 109.553 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.66 -24.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 114.834 -2.508 . . . . 75.44 113.675 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 23.15 -72.67 0.0 OUTLIER Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.949 3.166 . . . . 62.13 115.927 159.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -13.12 15.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.883 3.273 . . . . 75.52 115.288 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.66 -20.37 65.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.189 0.596 . . . . 62.3 110.519 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.37 31.6 17.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.302 1.841 . . . . 73.21 113.283 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.9 mt -82.96 123.06 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.513 1.125 . . . . 74.34 108.821 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -86.39 143.46 27.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.382 1.473 . . . . 75.43 110.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.86 159.13 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.259 -1.756 . . . . 75.44 106.259 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -63.78 140.38 58.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.405 -0.961 . . . . 73.25 108.405 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 p -139.61 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.962 0.505 . . . . 75.43 110.446 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.12 141.67 24.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.349 -0.845 . . . . 75.41 108.875 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 110.28 15.02 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.371 -1.344 . . . . 72.44 107.371 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -64.59 -16.98 63.55 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.638 0.775 . . . . 72.42 111.724 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -15.62 63.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.51 1.124 . . . . 74.01 113.941 171.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -155.59 6.01 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.38 0.991 . . . . 74.43 113.519 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.94 51.54 15.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.073 2.149 . . . . 73.52 111.636 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 pt -119.35 152.58 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.362 2.265 . . . . 73.03 108.76 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.37 145.25 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.315 -0.995 . . . . 74.24 108.315 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -150.67 178.03 9.49 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.138 2.575 . . . . 70.52 109.284 -166.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.18 157.78 17.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.873 1.669 . . . . 64.12 108.638 163.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.58 160.77 41.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.116 -0.99 . . . . 72.14 110.139 154.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.549 HH11 ' CD2' ' A' ' 75' ' ' LEU . 7.0 tmm_? -98.95 131.31 45.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.212 1.005 . . . . 73.11 110.268 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.64 156.53 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.943 1.297 . . . . 73.31 109.02 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.549 ' CD2' HH11 ' A' ' 73' ' ' ARG . 55.9 mt -123.75 -51.7 1.81 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.969 1.308 . . . . 70.01 110.889 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -135.43 163.81 29.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.079 1.352 . . . . 75.41 108.895 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.26 167.95 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.298 1.039 . . . . 73.54 108.974 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -137.71 151.24 48.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.712 1.205 . . . . 70.52 109.281 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -142.04 144.5 33.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.926 1.29 . . . . 75.35 109.929 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -144.83 158.98 43.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.751 -1.574 . . . . 64.03 106.751 165.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -89.96 151.26 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.955 -1.128 . . . . 74.32 107.955 167.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -146.8 154.79 41.78 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.468 1.507 . . . . 74.25 110.367 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.93 111.87 3.05 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.461 -1.311 . . . . 75.32 107.461 167.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.63 -160.02 33.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.619 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' N ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -113.89 117.23 30.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.481 1.112 . . . . 74.21 108.738 -173.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.4 165.13 11.99 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.587 1.155 . . . . 63.41 107.987 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 mm -78.85 132.76 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.458 1.903 . . . . 75.3 107.377 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -128.22 59.68 1.5 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.942 1.697 . . . . 74.21 107.357 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.89 133.73 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.91 -2.256 . . . . 64.15 104.91 162.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -117.2 164.2 15.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.319 -1.734 . . . . 74.44 106.319 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.2 p -137.03 169.64 17.43 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 121.73 -0.606 . . . . 73.04 110.492 -168.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -60.99 -28.93 69.38 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 73.23 110.727 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.92 3.43 10.18 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.365 1.466 . . . . 74.51 112.521 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 59.28 13.13 2.92 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.473 1.909 . . . . 75.31 113.114 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -71.41 162.56 29.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 118.318 -1.353 . . . . 73.43 107.487 166.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -156.69 176.64 12.46 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 128.274 2.63 . . . . 73.3 106.463 171.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.441 ' C ' ' HG1' ' A' ' 98' ' ' THR . 1.7 pt -141.75 -179.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.637 1.575 . . . . 75.53 109.996 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.441 ' HG1' ' C ' ' A' ' 97' ' ' ILE . 28.5 m -150.56 97.35 2.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.58 1.152 . . . . 75.33 110.287 168.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.39 174.47 11.35 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.426 1.49 . . . . 74.32 111.035 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -73.17 172.74 10.53 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.342 0.974 . . . . 74.23 108.65 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -77.36 7.53 5.21 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.06 -1.025 . . . . 72.55 112.001 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.42 39.24 2.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.245 0.929 . . . . 71.4 111.297 -167.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -99.13 137.58 20.45 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 117.059 -1.448 . . . . 75.03 112.368 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.23 94.93 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 124.317 3.344 . . . . 74.34 113.666 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.18 178.82 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.138 0.975 . . . . 73.43 109.192 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.48 134.26 50.98 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.499 -0.751 . . . . 75.53 110.791 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.01 155.86 38.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.106 1.362 . . . . 72.02 109.398 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -86.32 125.7 33.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.261 0.553 . . . . 54.31 110.945 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -98.4 89.43 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.525 -2.028 . . . . 73.41 105.525 153.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.98 31.16 8.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.789 1.236 . . . . 63.1 113.603 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.66 -8.32 39.96 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.432 -1.205 . . . . 72.35 113.951 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 159.83 27.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 104.651 -2.351 . . . . 65.42 104.651 160.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.262 7.3 p -106.93 104.35 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.093 0.957 . . . . 63.33 109.953 170.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -91.29 160.08 15.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.73 1.612 . . . . 75.34 107.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.62 115.2 20.43 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.336 1.854 . . . . 75.1 108.039 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 pt -143.85 172.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.753 1.621 . . . . 74.13 109.468 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.16 143.75 26.87 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.386 0.539 . . . . 73.11 111.565 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.71 -27.65 65.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.587 -0.72 . . . . 75.05 112.815 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -29.22 68.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.636 1.107 . . . . 73.5 111.953 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -79.58 -32.54 41.98 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.095 1.358 . . . . 74.43 111.661 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.99 63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 130.381 3.473 . . . . 71.42 110.906 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -95.93 -169.24 1.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.351 1.06 . . . . 75.14 108.991 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.0 -7.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.653 -1.279 . . . . 73.24 114.106 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.39 -12.81 69.32 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 117.799 -1.556 . . . . 62.34 111.687 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.06 119.63 35.36 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 121.132 2.466 . . . . 71.04 107.07 -164.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.37 115.52 21.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -79.9 159.24 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.405 1.082 . . . . 75.5 109.96 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.03 129.95 36.98 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.592 1.557 . . . . 73.43 110.883 167.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.5 155.44 47.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.811 1.645 . . . . 74.05 110.195 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -68.51 156.36 65.84 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.5 2.134 . . . . 72.01 110.313 165.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -141.04 -176.96 4.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.828 1.651 . . . . 75.13 107.634 164.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -25.17 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.014 2.526 . . . . 74.12 112.506 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -120.17 -4.95 9.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.325 -0.845 . . . . 73.55 113.091 170.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.6 p -132.67 170.06 15.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.24 1.382 . . . . 75.52 111.333 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.06 157.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.531 -0.731 . . . . 73.22 109.161 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.03 -177.25 4.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.587 2.755 . . . . 74.33 106.558 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 88.4 mt -126.12 160.86 29.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.162 0.985 . . . . 74.1 110.666 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -154.05 158.61 40.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.858 1.663 . . . . 65.12 111.858 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -106.04 150.65 25.54 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.226 1.411 . . . . 74.51 109.699 -172.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.6 1.28 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.907 1.283 . . . . 74.23 113.72 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.4 pt 24.82 -86.8 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 127.459 2.304 . . . . 74.3 116.655 171.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -99.34 123.17 43.39 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 126.841 2.056 . . . . 71.21 107.811 172.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.47 119.97 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.388 -1.338 . . . . 74.32 107.388 170.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.25 -166.04 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.62 1.968 . . . . 75.24 108.196 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 p -133.18 165.22 25.29 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.047 1.739 . . . . 71.02 109.311 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.57 -175.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.182 1.393 . . . . 73.14 108.668 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -136.86 68.96 1.41 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.529 1.157 . . . . 75.5 109.394 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.21 133.56 36.03 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.019 -1.051 . . . . 71.43 111.029 -169.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -136.03 69.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.944 -1.132 . . . . 73.21 107.944 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.82 -120.56 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 74.31 110.115 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -121.73 163.28 19.34 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.002 -0.705 . . . . 73.13 110.041 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.55 147.02 28.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 127.379 2.272 . . . . 75.15 106.563 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -141.4 164.53 29.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.356 0.662 . . . . 72.44 109.296 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.52 171.47 18.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 119.537 -0.268 . . . . 72.44 111.519 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.6 118.4 19.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.928 1.691 . . . . 74.53 109.413 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 57.6 m -73.08 112.77 9.43 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.025 -1.472 . . . . 74.44 107.025 166.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.94 75.41 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.516 -2.031 . . . . 70.43 105.516 169.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.11 -0.15 38.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.71 2.404 . . . . 75.32 114.134 -162.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.93 -77.32 0.1 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 128.283 2.633 . . . . 71.22 110.995 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -105.39 5.52 31.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.839 1.655 . . . . 74.0 111.694 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.6 m80 50.29 34.4 8.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.969 2.507 . . . . 64.41 112.035 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 p -148.51 155.33 41.01 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.425 1.89 . . . . 71.11 108.304 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -159.25 -168.13 2.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.256 1.022 . . . . 75.43 109.772 178.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.48 141.38 14.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 105.89 -1.893 . . . . 75.55 105.89 155.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -144.71 148.85 34.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 73.43 109.398 149.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 144.3 -165.92 27.32 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.109 -0.994 . . . . 61.33 112.119 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -111.26 166.82 10.77 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 119.708 -2.054 . . . . 72.22 111.232 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.24 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 128.319 2.648 . . . . 74.12 112.667 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 44.8 mt-10 -121.84 -18.34 7.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.689 1.196 . . . . 70.34 112.75 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.29 158.66 21.24 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.829 1.204 . . . . 70.04 113.537 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 95' ' ' ARG . 78.7 m-85 -105.29 154.42 20.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 127.096 2.158 . . . . 73.02 109.686 -174.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.5 75.99 5.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.084 0.953 . . . . 62.44 108.448 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -93.5 178.92 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.832 1.253 . . . . 74.43 110.315 -173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.0 m -65.8 161.99 19.75 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.278 -0.889 . . . . 73.32 110.111 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -143.79 39.43 1.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.199 1.8 . . . . 75.15 108.295 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 107.825 -1.176 . . . . 74.34 107.825 175.279 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.517 0 N-CA-C 106.125 -1.805 . . . . 74.35 106.125 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.07 167.2 22.0 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.584 1.154 . . . . 72.3 109.582 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -140.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.659 0.784 . . . . 71.13 111.84 172.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.436 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 5.5 t80 -120.73 -38.97 2.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.618 1.567 . . . . 74.33 112.012 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.85 30.55 6.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.645 1.178 . . . . 73.3 111.496 -163.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 144.9 29.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 O-C-N 121.507 -0.746 . . . . 65.04 111.993 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.15 141.72 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.272 2.648 . . . . 74.12 113.786 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 pt -114.66 16.84 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.981 1.104 . . . . 75.41 113.981 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 34.92 68.83 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.225 2.21 . . . . 73.01 113.964 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.0 mt -56.15 155.73 6.31 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.153 -0.684 . . . . 54.41 109.153 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -61.86 -27.2 68.62 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.186 -0.321 . . . . 72.41 111.166 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.38 -59.06 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.347 -0.612 . . . . 64.53 109.347 169.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.59 32.47 0.61 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.943 1.735 . . . . 71.14 111.219 -170.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 -11.27 59.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.299 -1.706 . . . . 70.53 114.933 -166.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 16.9 mm 44.58 74.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 127.205 2.202 . . . . 71.45 110.196 175.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.02 148.51 18.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 125.279 1.432 . . . . 64.53 108.789 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.67 131.75 50.02 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.846 2.458 . . . . 74.32 109.591 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.04 -57.57 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.731 1.613 . . . . 75.22 109.035 175.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -58.95 -45.9 94.46 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-O 118.395 -1.225 . . . . 61.43 110.057 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.4 -57.07 13.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.966 1.706 . . . . 65.24 111.636 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -47.74 -54.55 11.85 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.949 1.7 . . . . 75.35 110.334 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.475 HG22 ' CZ ' ' A' ' 153' ' ' TYR . 74.0 t -70.56 -43.45 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.055 -0.975 . . . . 61.41 110.552 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.93 -31.87 73.31 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 118.937 -1.105 . . . . 72.34 112.151 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -50.21 -46.91 54.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.449 1.5 . . . . 75.11 109.785 169.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -69.61 -44.54 70.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.907 -0.775 . . . . 75.13 108.907 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -58.26 -28.47 64.95 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.369 1.441 . . . . 74.2 112.301 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -85.0 -25.31 27.78 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 125.582 1.553 . . . . 64.44 112.58 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -93.97 -58.02 2.37 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.998 -1.853 . . . . 71.04 105.998 175.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -86.63 43.76 1.1 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.78 2.032 . . . . 73.35 108.943 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -49.59 -38.04 30.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 127.324 2.249 . . . . 75.42 111.255 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -95.08 -2.75 49.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.433 0.901 . . . . 71.53 113.433 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -82.1 -6.98 59.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.009 0.822 . . . . 71.02 112.365 165.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.07 99.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 119.579 1.081 . . . . 70.43 108.612 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -85.4 108.08 17.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.665 1.986 . . . . 74.31 107.741 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.53 124.72 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.412 -1.699 . . . . 74.41 106.412 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.94 137.82 37.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.92 -1.511 . . . . 74.02 106.92 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -65.73 -42.7 90.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.997 -0.281 . . . . 75.32 111.552 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -120.58 58.07 0.95 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.606 -1.627 . . . . 72.24 106.606 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.21 -133.83 1.55 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.174 -0.77 . . . . 65.13 111.174 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -101.27 0.42 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.083 0.772 . . . . 72.32 113.083 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.98 104.11 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 108.51 -1.836 . . . . 62.12 108.51 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -126.27 171.15 11.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.3 1.84 . . . . 75.24 111.249 -170.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mt -138.22 133.85 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.25 -2.129 . . . . 74.1 105.25 166.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 122.32 22.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.454 -1.684 . . . . 63.13 106.454 160.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.306 2.4 pp -126.84 23.92 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 123.091 1.424 . . . . 74.43 109.593 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -26.63 69.51 Favored Glycine 0 CA--C 1.523 0.555 0 O-C-N 120.537 -1.352 . . . . 72.22 112.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -12.41 61.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.186 1.794 . . . . 75.24 115.402 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.15 -14.75 63.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.011 1.278 . . . . 74.43 113.235 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 m120 60.77 11.26 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.266 2.626 . . . . 72.32 114.004 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.49 130.26 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.953 -1.092 . . . . 72.51 108.832 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.92 154.1 20.03 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.562 1.145 . . . . 74.41 110.976 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.79 150.19 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.129 2.172 . . . . 71.34 108.005 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.86 109.81 6.71 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.272 -1.381 . . . . 73.4 107.272 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -99.01 -175.2 2.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.058 1.743 . . . . 71.22 107.274 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 128.56 32.43 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.801 -1.926 . . . . 72.1 105.801 164.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -80.47 97.13 6.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.971 -1.492 . . . . 72.51 106.971 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -50.88 -23.15 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 117.835 -1.079 . . . . 75.12 112.543 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -43.05 -38.83 2.47 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.025 1.73 . . . . 72.23 113.483 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -142.82 15.12 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.767 1.227 . . . . 74.23 110.54 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt 56.57 44.59 23.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.987 1.315 . . . . 72.42 111.423 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -111.04 152.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.712 1.605 . . . . 74.33 108.521 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.14 118.33 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 106.477 -1.675 . . . . 75.11 106.477 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -144.36 175.8 9.83 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.5 1.52 . . . . 71.24 109.334 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.52 141.02 29.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.641 -1.287 . . . . 64.1 111.327 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 154.89 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.6 1.96 . . . . 74.32 108.686 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -91.21 156.71 17.64 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.181 -1.044 . . . . 71.24 108.181 168.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.52 154.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.793 1.237 . . . . 74.3 108.697 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.0 -52.12 2.81 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.904 1.682 . . . . 64.45 110.615 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.521 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 32.2 mtt85 -134.12 162.05 33.18 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.465 -0.772 . . . . 75.43 110.01 -171.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.1 155.96 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.548 1.539 . . . . 74.22 108.436 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.64 166.24 20.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.324 1.45 . . . . 74.44 108.165 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -137.4 143.94 42.17 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 73.24 109.224 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -141.21 164.46 30.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 130.161 3.384 . . . . 74.23 108.819 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -116.74 159.0 22.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.06 -1.65 . . . . 75.23 111.264 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -150.67 155.59 39.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.803 0.811 . . . . 75.53 113.164 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 117.58 2.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.428 1.891 . . . . 73.13 106.4 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.88 -165.23 32.07 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.607 1.549 . . . . 55.2 113.733 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -93.2 129.89 39.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.423 0.689 . . . . 74.44 110.513 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.9 mt -111.26 159.55 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.476 1.11 . . . . 74.51 109.702 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.21 135.17 26.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.967 1.307 . . . . 71.13 107.842 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -128.78 81.15 2.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.484 1.914 . . . . 75.22 105.961 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.97 110.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.19 -2.522 . . . . 73.12 104.19 158.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -85.98 162.57 18.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 161.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -142.88 164.69 29.4 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.371 1.869 . . . . 72.12 107.313 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 94' ' ' ARG . 28.8 ttmt -63.78 -26.83 68.81 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.449 -0.782 . . . . 75.34 112.205 -159.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -74.42 27.35 0.08 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.527 1.931 . . . . 72.2 111.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 92' ' ' LYS . 2.6 mmt180 50.77 14.48 0.18 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.195 2.198 . . . . 75.2 113.641 -168.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.591 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 14.3 ttm105 -85.82 162.09 18.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.806 -1.184 . . . . 73.54 108.766 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 9.8 pt-20 -175.72 168.3 3.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.985 -1.007 . . . . 74.14 110.793 -168.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.477 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 8.4 pt -140.6 178.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.782 1.633 . . . . 73.14 109.179 -174.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.07 97.28 2.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.319 -1.734 . . . . 74.5 106.319 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.94 162.44 41.31 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 74.31 111.087 -172.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 m -70.25 153.16 43.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.747 -1.205 . . . . 73.34 107.747 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -73.64 -13.37 60.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.556 0.947 . . . . 75.52 113.556 -167.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.29 37.75 2.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.284 1.04 . . . . 71.44 109.564 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -97.03 129.84 31.36 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.925 1.29 . . . . 74.35 107.65 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.69 148.72 87.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.871 2.381 . . . . 74.42 112.359 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 m -144.53 169.13 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 129.565 3.146 . . . . 75.05 107.933 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -107.87 141.52 39.36 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.651 -0.655 . . . . 74.34 109.682 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.62 159.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.199 1.4 . . . . 64.31 109.042 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.454 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 17.2 t -93.39 134.66 35.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.197 1.475 . . . . 72.23 110.31 169.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -103.36 85.44 2.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 111.96 -2.382 . . . . 74.3 106.167 157.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.45 27.42 8.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.683 1.193 . . . . 61.24 113.66 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 119.32 -14.69 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.284 -1.287 . . . . 75.31 113.145 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 176.49 9.74 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.721 1.261 . . . . 73.44 108.009 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.43 118.89 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.894 1.278 . . . . 74.52 108.064 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 158.79 24.75 Favored 'General case' 0 CA--C 1.526 0.03 0 C-N-CA 123.988 0.915 . . . . 72.14 108.931 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.59 115.92 23.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.89 2.476 . . . . 74.34 104.505 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.7 177.69 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.704 1.202 . . . . 74.53 109.258 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -94.07 153.67 18.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.859 0.754 . . . . 75.23 111.324 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.0 -22.95 42.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.977 1.311 . . . . 73.33 113.758 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -60.16 -43.67 95.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.958 1.254 . . . . 74.23 111.132 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.15 -22.95 57.77 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.224 0.92 . . . . 74.41 113.438 -170.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.21 62.87 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.904 2.081 . . . . 74.34 111.004 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -78.98 -177.95 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.054 1.342 . . . . 73.03 110.162 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -58.6 -4.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 127.573 2.349 . . . . 74.3 114.163 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 15.87 10.05 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.754 2.121 . . . . 74.54 112.155 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.2 159.27 34.79 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.487 1.643 . . . . 75.51 107.498 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -119.91 110.61 16.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.34 -0.985 . . . . 53.25 108.34 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.32 138.93 19.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 124.813 1.245 . . . . 71.41 108.438 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 108' ' ' SER . 11.1 m-85 -75.49 136.0 40.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.559 -0.904 . . . . 71.01 108.559 171.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.0 151.94 79.84 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 124.207 1.003 . . . . 74.33 112.735 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.35 138.32 29.9 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.106 2.537 . . . . 70.22 108.91 170.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -120.92 -157.47 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.524 2.329 . . . . 75.04 105.848 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -37.86 -74.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.179 1.792 . . . . 75.01 112.507 -169.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -121.4 -1.0 9.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.17 0.896 . . . . 72.54 113.24 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.6 p -123.64 169.93 10.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 124.636 1.174 . . . . 75.0 110.541 -168.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 tp -81.66 157.81 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.223 -0.658 . . . . 74.41 109.223 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.6 -176.54 5.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.078 2.951 . . . . 75.34 106.708 174.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.1 161.72 14.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.456 -1.313 . . . . 74.21 107.456 156.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -154.99 108.39 2.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.456 1.502 . . . . 74.12 108.135 173.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.02 144.73 33.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 129.929 3.292 . . . . 72.4 113.266 -162.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.2 t -77.5 0.41 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.561 1.144 . . . . 74.01 113.599 -170.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.2 pt 27.64 -75.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 118.078 2.621 . . . . 74.31 118.078 167.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.445 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.48 128.89 56.33 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.607 1.563 . . . . 73.05 107.986 170.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.27 131.5 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.683 -1.229 . . . . 74.0 107.683 167.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.67 171.62 14.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.318 1.847 . . . . 75.11 108.42 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.49 138.79 50.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.49 -168.41 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.668 1.187 . . . . 73.42 108.569 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -136.65 135.59 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.068 -1.456 . . . . 75.42 107.068 167.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.4 ' C ' HD21 ' A' ' 149' ' ' ASN . 1.1 t80 -142.55 134.73 27.45 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.581 0.753 . . . . 74.34 110.233 -170.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.4 HD21 ' C ' ' A' ' 148' ' ' TYR . 1.5 m-80 -138.1 70.89 1.39 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.756 -1.942 . . . . 74.11 105.756 -167.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.09 -166.61 12.14 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.524 1.059 . . . . 75.11 112.393 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -88.42 157.29 18.73 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.965 -1.315 . . . . 55.11 109.413 165.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 pt -126.55 170.34 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.609 1.564 . . . . 72.14 111.16 170.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.475 ' CZ ' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.9 147.69 13.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.156 -1.424 . . . . 73.42 107.156 -170.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -118.93 158.24 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.537 0.735 . . . . 65.3 110.692 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 19.7 tp -117.38 137.57 52.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.459 1.503 . . . . 72.43 109.231 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.521 ' HG1' ' HB2' ' A' ' 76' ' ' ARG . 22.8 m -68.29 -59.47 3.18 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.353 0.597 . . . . 74.24 110.306 -167.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.325 3.2 t 40.67 67.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 128.975 2.91 . . . . 75.1 112.694 -170.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.61 -11.88 61.19 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.499 -0.773 . . . . 71.41 110.934 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -65.2 0.7 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.3 1.04 . . . . 74.54 109.682 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.13 2.34 12.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.137 0.575 . . . . 74.21 112.27 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.6 m170 54.99 31.34 15.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.402 1.481 . . . . 72.13 111.887 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.69 151.62 33.99 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.643 -1.286 . . . . 64.03 110.291 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -154.8 172.53 17.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.591 1.156 . . . . 75.45 110.511 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.12 124.95 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.026 1.73 . . . . 72.34 108.929 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.93 148.46 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.726 0.811 . . . . 53.21 109.907 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 151.12 -175.47 30.04 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.26 -1.136 . . . . 74.3 110.26 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -90.94 166.05 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.307 -1.702 . . . . 74.21 110.24 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.06 -68.23 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 130.587 3.555 . . . . 75.1 113.054 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.591 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 12.7 mt-10 -122.06 -18.06 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.632 1.973 . . . . 75.35 114.174 175.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 79.29 166.74 32.49 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 124.249 0.928 . . . . 74.35 111.816 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 25.3 m-85 -121.06 155.26 34.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.139 2.576 . . . . 75.45 105.774 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.03 141.14 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.833 -1.173 . . . . 75.13 107.833 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . 0.273 46.0 t -135.27 175.82 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.966 1.306 . . . . 75.23 107.6 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 52.7 m -95.89 133.61 39.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.324 1.45 . . . . 65.45 110.565 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -115.13 173.78 6.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.883 1.673 . . . . 54.33 107.108 168.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.466 0.375 0 C-N-CA 126.057 1.743 . . . . 64.5 110.134 160.268 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 109.614 -0.513 . . . . 74.14 109.614 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.64 170.62 9.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.693 1.597 . . . . 75.35 110.041 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.75 162.33 19.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.445 -0.784 . . . . 72.04 111.927 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.452 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 13.6 t80 -47.65 -42.55 24.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.259 2.224 . . . . 74.04 113.538 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.97 16.34 26.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.462 1.483 . . . . 74.12 112.779 -160.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -86.98 120.16 71.41 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.946 2.099 . . . . 75.33 110.481 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -56.77 145.37 83.37 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.385 2.723 . . . . 72.13 113.981 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -107.87 -10.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.232 1.413 . . . . 71.51 113.156 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 56.14 79.43 0.17 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.393 1.077 . . . . 72.51 110.665 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 155.74 2.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.173 -0.954 . . . . 71.25 109.551 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.09 -38.32 51.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.011 0.925 . . . . 64.44 110.362 169.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.09 -17.05 61.0 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.355 0.872 . . . . 53.14 113.355 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.07 33.7 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 118.486 -1.175 . . . . 73.41 113.142 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.32 -33.06 63.0 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.253 1.575 . . . . 74.34 115.253 -159.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mm 49.21 88.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.294 2.238 . . . . 74.14 110.121 -167.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 148.09 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.95 2.5 . . . . 74.04 107.588 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.64 141.41 58.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.713 1.605 . . . . 74.14 108.143 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.472 HG12 ' HH ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -50.39 -51.67 17.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 169.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.452 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -57.23 -53.5 44.27 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 118.003 -1.443 . . . . 73.11 110.116 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -60.54 -43.86 96.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 1.166 . . . . 61.24 112.433 -173.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -58.4 -56.61 19.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.777 0.831 . . . . 70.15 109.34 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.411 HG23 ' CZ ' ' A' ' 153' ' ' TYR . 54.8 t -70.93 -41.69 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.983 -0.553 . . . . 72.32 109.973 -172.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -29.69 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.1 -0.953 . . . . 72.23 111.855 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.1 -43.88 78.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.3 1.864 . . . . 73.3 111.273 172.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 20.0 m-85 -67.64 -43.22 80.85 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.24 -34.88 75.86 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.407 1.458 . . . . 75.43 112.679 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -47.35 66.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.057 1.299 . . . . 74.21 108.928 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.7 mtpp -76.43 -56.9 4.21 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.31 -1.737 . . . . 74.43 106.31 -169.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.1 m-30 -91.32 40.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.39 1.876 . . . . 74.42 107.759 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -37.43 68.63 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 121.165 -0.96 . . . . 73.24 111.453 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.56 81.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.485 1.914 . . . . 71.35 110.382 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -80.51 0.26 34.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.628 1.571 . . . . 71.22 113.354 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.78 99.22 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.19 161.34 26.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.295 -1.372 . . . . 71.42 107.295 162.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.37 142.21 47.12 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.888 -1.523 . . . . 70.53 106.888 171.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.15 176.71 9.42 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.991 0.807 . . . . 73.13 110.315 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.28 -12.71 60.94 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.426 1.49 . . . . 70.33 111.693 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.47 5.45 17.71 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.978 -1.076 . . . . 74.31 111.359 162.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 30.21 77.28 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 126.922 2.201 . . . . 55.3 113.234 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CE2' ' HD2' ' A' ' 80' ' ' LYS . 2.6 t80 -77.02 -100.12 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.342 1.857 . . . . 71.24 109.47 -170.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.84 127.95 2.02 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.915 -1.274 . . . . 72.41 109.915 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -155.47 161.41 40.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.164 0.982 . . . . 71.15 111.067 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.44 133.19 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.835 -1.913 . . . . 75.23 105.835 170.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.22 133.45 47.96 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.872 -1.158 . . . . 73.02 107.872 163.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.06 17.71 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.648 0.779 . . . . 75.31 109.785 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.89 8.66 4.34 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 126.083 1.802 . . . . 73.53 113.979 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.88 -15.41 14.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.691 1.596 . . . . 74.12 109.661 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.16 -34.09 69.92 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.198 0.999 . . . . 73.32 110.338 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 58.9 14.11 3.14 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.301 1.963 . . . . 71.23 116.301 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.84 127.65 29.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 127.977 2.511 . . . . 74.14 109.276 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -82.32 141.04 33.2 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.546 0.688 . . . . 74.2 111.372 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.9 153.57 17.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 127.848 2.459 . . . . 75.2 106.675 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -72.19 110.7 6.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.592 -1.633 . . . . 74.15 106.592 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 171.42 7.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.17 -1.419 . . . . 61.43 107.17 -174.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.25 122.7 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.337 -1.356 . . . . 74.44 107.337 -168.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.5 108.22 18.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.893 -1.151 . . . . 75.33 107.893 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 21.5 ttpp -51.48 -31.42 23.47 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.424 1.49 . . . . 74.23 112.789 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.76 -28.38 15.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.765 2.826 . . . . 74.5 112.957 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 t -150.05 23.06 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.461 -0.774 . . . . 74.32 111.487 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.87 40.2 8.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.414 1.485 . . . . 73.45 112.18 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.81 -172.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.8 0.84 . . . . 74.42 110.095 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -116.92 135.7 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.298 2.239 . . . . 75.5 105.79 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.02 167.51 21.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.113 2.165 . . . . 73.5 107.182 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -101.2 118.92 37.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.231 -1.766 . . . . 74.3 106.231 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -133.37 163.77 28.6 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.122 -1.436 . . . . 75.33 107.122 170.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -95.61 -160.92 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.293 0.951 . . . . 74.43 110.512 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -132.62 146.26 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 105.572 -2.01 . . . . 73.2 105.572 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.65 -45.52 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.507 1.123 . . . . 64.43 111.191 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.21 -1.556 . . . . 71.32 108.417 -173.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.14 158.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.991 -0.744 . . . . 71.35 108.991 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -129.11 179.33 5.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.587 1.555 . . . . 73.52 108.914 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -170.7 146.21 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.322 1.849 . . . . 73.03 108.982 158.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD2' ' CE2' ' A' ' 47' ' ' PHE . 71.9 tttt -143.8 166.5 24.74 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.618 1.567 . . . . 75.04 107.455 164.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -89.02 165.65 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.46 -1.4 . . . . 72.43 109.223 168.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -150.64 158.17 43.83 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.839 1.255 . . . . 75.34 109.9 -170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 p -155.13 123.98 6.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.65 1.18 . . . . 61.32 107.848 160.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.8 178.19 35.51 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 120.036 1.289 . . . . 74.2 114.167 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.618 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.87 100.85 8.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.334 0.654 . . . . 74.31 110.789 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.13 152.13 23.61 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.81 -1.181 . . . . 75.44 107.81 167.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.93 137.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.791 1.636 . . . . 61.22 108.943 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -117.5 80.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.427 -1.715 . . . . 74.3 106.868 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.6 137.25 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.848 -1.908 . . . . 73.13 105.848 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.7 m -117.31 171.83 7.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.079 -1.822 . . . . 74.12 106.079 159.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -139.32 172.85 12.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.911 1.284 . . . . 74.22 109.106 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -63.7 -29.27 70.52 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.063 -1.023 . . . . 71.25 110.742 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.64 2.48 5.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.113 1.365 . . . . 75.51 113.945 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 62.58 16.69 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.494 1.518 . . . . 64.14 111.8 -168.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -70.0 153.46 43.19 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.814 -1.18 . . . . 54.32 107.814 168.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.57 163.29 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.942 1.697 . . . . 75.51 107.564 -170.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.587 HG22 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -148.96 172.64 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.02 1.728 . . . . 74.13 108.955 -170.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.3 m -146.12 92.43 2.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.666 -1.235 . . . . 70.12 107.666 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.88 170.21 18.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.315 1.446 . . . . 74.51 110.832 -172.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 p -70.19 166.99 18.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.964 1.256 . . . . 72.31 112.15 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.3 1.4 p-80 -67.84 -31.62 71.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.22 -0.925 . . . . 63.53 111.348 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -100.18 39.94 1.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.832 2.453 . . . . 72.33 111.293 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -95.3 128.36 38.82 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.609 -1.186 . . . . 75.54 111.829 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.46 121.77 8.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.551 2.834 . . . . 74.21 111.042 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.76 177.12 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.776 1.631 . . . . 75.02 108.752 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -112.43 149.53 32.44 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.179 -0.951 . . . . 75.13 111.545 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.46 170.32 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 126.006 1.722 . . . . 75.24 108.458 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 p -96.05 137.09 35.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.075 0.94 . . . . 73.21 110.261 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 79.8 1.87 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.776 -1.564 . . . . 74.43 106.776 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 65.42 4.01 2.56 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.196 1.184 . . . . 75.12 114.196 172.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -21.89 2.43 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 120.173 -1.579 . . . . 71.11 112.139 -169.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -102.66 160.58 14.45 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.148 1.379 . . . . 64.41 107.893 -171.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 t -112.91 119.24 60.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.378 -1.712 . . . . 75.13 106.378 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.67 137.2 48.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.445 -0.946 . . . . 44.24 108.445 -170.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -84.0 134.56 34.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.271 1.028 . . . . 72.44 109.519 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 pt -147.78 -179.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.454 1.502 . . . . 72.3 109.717 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -79.38 134.04 36.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.408 1.083 . . . . 74.41 110.225 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.37 -30.75 30.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.328 1.051 . . . . 63.33 113.04 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.65 -26.14 68.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.285 1.857 . . . . 75.54 113.625 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 36.7 mmt -80.89 -26.36 36.89 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.39 1.076 . . . . 74.04 111.554 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.95 63.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.006 2.522 . . . . 63.02 111.468 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 124' ' ' GLY . 66.7 mmtt -78.96 -177.72 5.71 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.898 -1.126 . . . . 75.13 109.063 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.98 1.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.34 1.856 . . . . 72.02 112.964 159.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -90.11 -3.96 72.31 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 116.614 -2.214 . . . . 73.14 112.444 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 166.74 21.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.134 1.967 . . . . 74.41 107.734 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -98.38 155.74 17.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.011 -0.995 . . . . 73.0 108.79 163.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.8 tt -122.21 131.37 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.388 1.075 . . . . 74.14 109.462 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.7 117.77 13.7 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 118.585 -0.721 . . . . 74.31 109.909 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 pp -129.4 157.06 77.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.639 1.175 . . . . 75.42 112.99 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.31 147.3 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.57 2.18 . . . . 75.11 109.563 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.42 -178.36 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.262 -1.384 . . . . 74.14 107.262 163.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -24.12 -71.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.464 2.706 . . . . 73.44 112.802 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -121.01 1.22 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.382 2.673 . . . . 74.42 113.85 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.1 p -128.61 -173.88 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.828 1.651 . . . . 74.23 112.723 -168.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.25 157.45 5.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.868 -1.16 . . . . 72.04 107.868 166.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -140.92 -177.34 5.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.307 2.243 . . . . 71.54 107.209 165.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.76 157.66 18.36 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.555 1.142 . . . . 73.01 110.074 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.306 39.5 p30 -142.79 164.67 29.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 114.396 1.258 . . . . 70.42 114.396 162.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -95.26 146.1 24.59 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.063 1.745 . . . . 73.24 107.5 -171.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -98.14 0.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 113.749 1.018 . . . . 75.03 113.749 -160.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 pt 35.31 -53.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 1 C-N-CA 133.019 4.528 . . . . 75.31 120.064 169.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -144.68 133.51 22.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.301 2.64 . . . . 75.12 107.908 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.96 127.28 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.263 1.03 . . . . 75.2 108.318 166.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -140.22 -158.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.392 1.477 . . . . 71.44 107.579 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -139.7 152.49 46.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.386 1.074 . . . . 73.04 108.952 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m -102.59 139.1 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.505 -1.665 . . . . 73.53 106.505 161.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.21 92.8 9.09 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.752 1.614 . . . . 74.43 106.972 166.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.415 ' C ' HD21 ' A' ' 149' ' ' ASN . 8.4 t80 -96.81 139.41 32.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.183 0.993 . . . . 75.14 111.345 -168.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.415 HD21 ' C ' ' A' ' 148' ' ' TYR . 3.6 m-80 -140.69 67.01 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.742 -1.577 . . . . 71.41 106.742 -165.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.0 -172.51 12.83 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 123.72 0.676 . . . . 75.13 111.99 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -81.3 144.47 31.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.178 -0.675 . . . . 71.42 109.178 162.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.54 158.18 34.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 127.638 2.375 . . . . 73.45 108.665 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HH ' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -153.81 164.85 37.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.912 -0.773 . . . . 75.43 108.912 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -129.15 147.83 51.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.342 1.457 . . . . 75.22 108.994 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.14 153.81 17.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.539 . . . . 74.12 110.686 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m -107.71 37.83 2.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.722 0.809 . . . . 74.03 111.615 -165.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.85 101.93 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 119.881 -1.762 . . . . 62.2 109.542 -172.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.59 -6.09 57.76 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.49 1.116 . . . . 64.45 110.311 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.35 -67.25 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.779 1.232 . . . . 74.23 108.58 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 6.5 t30 -112.13 4.43 17.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.753 0.821 . . . . 74.34 111.418 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.13 35.1 25.08 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.218 1.007 . . . . 71.23 109.592 -169.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.27 150.78 27.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.947 1.699 . . . . 75.33 108.57 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.67 -178.57 6.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.064 1.302 . . . . 74.12 110.555 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.2 mm -113.36 143.27 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.381 1.472 . . . . 75.14 108.634 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.34 38.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.341 1.056 . . . . 61.05 110.223 165.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 132.58 -169.2 22.45 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 119.035 0.834 . . . . 61.51 112.569 166.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -85.7 167.41 15.31 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.083 1.442 . . . . 74.41 111.841 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.45 -73.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.142 2.977 . . . . 71.23 113.762 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.21 -14.22 7.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.239 1.815 . . . . 73.24 112.493 175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 68.89 160.67 2.12 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 126.484 1.992 . . . . 64.03 112.571 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.587 ' CE1' HG22 ' A' ' 97' ' ' ILE . 37.5 m-85 -106.6 151.06 25.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.379 2.272 . . . . 74.21 107.07 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.6 129.56 34.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.407 -1.331 . . . . 71.54 107.407 162.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.01 176.34 7.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.419 -1.326 . . . . 72.03 107.419 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.2 t -65.98 164.52 15.01 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.644 -0.873 . . . . 74.32 108.644 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.38 132.9 20.81 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.544 -1.65 . . . . 70.41 106.544 164.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 106.436 -1.69 . . . . 75.43 106.436 159.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.475 0 N-CA-C 106.407 -1.701 . . . . 60.42 106.407 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt -101.89 166.65 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.572 1.549 . . . . 74.25 109.588 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -173.85 0.56 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.031 1.332 . . . . 73.31 110.858 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.86 -31.85 59.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.492 1.117 . . . . 75.24 111.062 171.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.96 31.64 6.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.714 2.405 . . . . 73.31 111.051 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -88.43 133.38 36.6 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.619 -1.252 . . . . 64.22 107.619 157.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.57 152.45 59.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.211 1.274 . . . . 75.1 113.676 168.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.04 -17.03 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 73.44 114.658 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.37 74.62 0.27 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.943 1.354 . . . . 74.15 111.755 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 mt -53.85 163.64 0.7 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.991 -1.004 . . . . 73.11 109.504 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -56.07 -36.37 68.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.676 -0.64 . . . . 71.23 110.266 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.96 -18.73 63.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.684 0.794 . . . . 74.44 112.948 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.3 44.85 26.85 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 125.436 1.493 . . . . 74.23 109.574 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.792 1.034 . . . . 63.32 113.792 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 mm 48.54 102.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.799 2.44 . . . . 61.23 109.987 -160.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.5 142.99 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.676 -1.601 . . . . 73.51 106.676 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.38 123.94 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.028 2.531 . . . . 73.04 106.989 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -51.18 -44.78 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 70.02 111.511 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.26 -27.53 73.59 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.938 -0.924 . . . . 74.23 111.751 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -73.94 -44.39 55.1 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.832 1.316 . . . . 74.03 110.079 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -53.86 -53.45 52.35 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.597 1.159 . . . . 75.01 109.115 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.455 HG12 ' CE1' ' A' ' 33' ' ' PHE . 93.0 t -56.51 -48.77 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.25 0.62 . . . . 75.02 111.033 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.13 -32.23 73.83 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.907 -1.12 . . . . 71.2 112.864 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.543 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.1 -36.74 19.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.742 1.217 . . . . 73.35 110.79 171.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 35.1 m-85 -84.79 -45.69 12.11 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.69 -0.856 . . . . 73.22 108.69 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 29' ' ' VAL . 3.6 m-30 -68.43 -21.42 64.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.603 1.547 . . . . 73.41 111.62 -169.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 9.9 mtpt -86.87 -16.91 34.66 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.174 1.39 . . . . 74.41 112.029 172.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -57.43 2.18 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 120.587 1.539 . . . . 64.21 108.153 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.4 m-30 -86.12 40.01 0.85 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.125 1.77 . . . . 65.43 108.245 -174.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 33.0 mttt -49.99 -44.41 50.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.032 1.333 . . . . 62.54 108.639 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -56.63 -25.15 52.44 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 126.535 1.934 . . . . 73.23 114.229 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -112.93 12.39 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.645 1.578 . . . . 75.25 112.057 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.33 106.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.842 -1.54 . . . . 74.32 106.842 159.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.16 152.98 25.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.5 -0.926 . . . . 71.12 108.5 164.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -118.32 142.25 47.7 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.635 -2.358 . . . . 74.3 104.635 158.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.52 159.02 20.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.308 -1.738 . . . . 74.24 106.308 156.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.71 -37.7 85.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.253 1.421 . . . . 75.14 110.285 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.16 -27.47 61.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.167 0.987 . . . . 71.55 111.151 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.04 5.37 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.043 1.306 . . . . 74.25 114.432 159.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.9 -86.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.642 1.177 . . . . 63.41 110.726 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.48 137.04 4.76 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 120.795 -1.19 . . . . 74.24 110.539 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -142.62 167.77 21.3 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.98 0.89 . . . . 75.4 111.026 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.25 140.15 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.95 2.1 . . . . 74.12 105.464 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 126.96 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.169 1.788 . . . . 70.41 108.737 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.96 -3.51 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.845 1.258 . . . . 74.12 111.63 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.05 -16.61 57.77 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 120.373 1.442 . . . . 73.13 113.294 -170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -23.95 66.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.461 1.131 . . . . 75.54 112.712 171.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.74 -15.16 26.36 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.546 1.538 . . . . 73.22 113.169 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.48 6.34 3.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.642 1.577 . . . . 73.11 114.924 173.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.49 148.44 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.907 2.083 . . . . 74.24 107.448 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.04 158.4 25.9 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.398 1.094 . . . . 73.01 110.96 169.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.25 161.28 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 129.027 2.931 . . . . 65.22 107.382 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -75.11 152.06 38.57 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.124 -0.985 . . . . 75.41 109.416 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -145.18 -171.91 3.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.703 0.801 . . . . 72.41 109.25 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 137.53 34.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.075 -1.454 . . . . 72.31 107.075 168.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.97 113.38 19.14 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.777 -1.194 . . . . 71.32 107.777 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.31 -29.87 71.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.341 0.656 . . . . 74.24 112.195 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -30.69 5.68 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.676 1.991 . . . . 73.33 112.732 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.28 11.53 1.74 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.437 0.695 . . . . 65.31 111.956 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.36 46.36 26.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.279 1.431 . . . . 64.55 112.252 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.0 163.28 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 126.086 1.754 . . . . 75.22 109.827 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.68 148.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.816 1.246 . . . . 73.15 109.281 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.91 -179.39 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.936 1.695 . . . . 61.3 110.741 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.17 172.26 10.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.341 1.456 . . . . 72.3 110.896 155.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 170.02 16.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.591 1.556 . . . . 65.15 108.226 141.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -99.46 -19.47 16.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.75 1.22 . . . . 73.23 113.846 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 mt 64.1 155.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.01 1.724 . . . . 74.42 110.145 -163.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.14 -63.89 1.29 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.6 -1.63 . . . . 73.0 106.6 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -130.21 152.45 49.62 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.9 0.88 . . . . 75.35 110.267 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.49 153.74 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 107.373 -1.344 . . . . 74.53 107.373 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.78 153.86 50.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.557 1.543 . . . . 74.24 108.184 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -145.36 160.39 41.61 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.753 -0.832 . . . . 73.31 108.753 173.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -151.83 161.47 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.733 -1.58 . . . . 75.53 106.733 162.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -91.29 150.13 21.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.427 -1.421 . . . . 71.31 109.286 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -141.63 164.43 30.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.145 0.978 . . . . 74.2 108.982 -177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -157.4 127.66 6.35 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.97 -1.863 . . . . 72.15 105.97 150.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.22 -169.14 37.48 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.873 1.215 . . . . 75.31 110.208 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.53 146.7 32.5 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.096 -0.65 . . . . 75.12 109.462 178.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.16 163.58 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.994 -1.484 . . . . 73.53 106.994 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.0 mm -78.86 132.78 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.975 -0.75 . . . . 74.54 108.975 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -111.37 80.59 1.33 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.965 -1.865 . . . . 73.42 105.965 169.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.48 123.94 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.175 -2.528 . . . . 73.54 104.175 158.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.3 m -114.68 161.89 17.53 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 105.906 -1.887 . . . . 73.25 105.906 160.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -139.75 163.35 32.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.949 1.299 . . . . 75.41 108.061 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.94 -27.76 61.43 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.899 1.227 . . . . 73.04 112.072 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -60.5 -8.16 2.59 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.229 1.811 . . . . 73.15 112.253 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 65.08 13.58 8.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.435 2.294 . . . . 75.52 110.977 -161.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 154.56 38.05 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.31 -1.367 . . . . 75.3 107.31 170.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.01 168.78 13.52 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.744 2.018 . . . . 74.52 108.744 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -152.08 -168.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.907 1.683 . . . . 75.34 110.452 -173.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.55 132.98 17.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 112.757 0.651 . . . . 75.35 112.757 169.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 159.31 41.47 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.826 1.25 . . . . 74.15 110.417 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.6 m -72.15 -0.12 11.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.262 1.208 . . . . 72.41 114.262 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 102' ' ' ASP 0.306 0.1 OUTLIER 96.19 -61.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 1 C-N-CA 132.399 4.28 . . . . 74.12 107.66 -155.695 . . . . . . . . 5 4 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.542 ' H ' ' CD2' ' A' ' 101' ' ' HIS . 81.1 m-20 -92.93 82.57 4.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.202 -1.777 . . . . 74.22 106.202 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -124.38 136.5 27.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.077 1.751 . . . . 73.5 107.938 158.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.08 134.21 33.41 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.162 2.574 . . . . 73.13 110.719 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.66 -172.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.955 1.302 . . . . 73.45 108.065 168.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -124.85 141.35 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.609 1.55 . . . . 65.02 110.644 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.76 163.11 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.666 1.186 . . . . 74.15 109.808 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 p -82.4 127.96 33.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.873 0.733 . . . . 73.34 109.298 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 92.9 4.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.396 -2.816 . . . . 73.45 103.396 154.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m 66.22 -13.73 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.43 2.692 . . . . 62.32 116.78 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.65 -0.24 4.99 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.547 0.594 . . . . 74.01 111.675 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 148.37 31.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.297 -1.001 . . . . 73.12 108.297 156.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.45 127.31 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.928 1.291 . . . . 74.2 107.809 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 tp -126.59 158.89 35.08 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.357 1.063 . . . . 73.3 108.376 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -124.2 106.02 9.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.846 2.459 . . . . 75.44 109.655 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -140.02 169.84 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.914 2.486 . . . . 74.01 109.317 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.81 144.81 29.88 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.353 0.661 . . . . 74.45 110.466 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.11 61.72 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.923 1.083 . . . . 74.43 113.923 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -21.98 65.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.998 0.919 . . . . 55.13 112.123 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.3 mtm -89.65 -26.87 20.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.516 1.053 . . . . 73.24 112.337 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.79 62.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 128.733 2.813 . . . . 62.01 110.698 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 124' ' ' GLY . 13.7 mmtp -79.86 -174.51 4.43 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.063 1.345 . . . . 72.54 109.536 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.09 0.22 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 127.142 2.177 . . . . 74.13 113.034 166.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -88.66 -3.52 77.41 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.96 1.743 . . . . 73.22 112.998 169.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.32 169.73 10.64 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.364 1.082 . . . . 71.43 111.887 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.17 113.13 18.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.905 2.882 . . . . 73.02 107.213 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.93 136.83 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.467 1.107 . . . . 74.25 108.672 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -72.49 121.86 20.32 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.833 -0.803 . . . . 70.25 108.833 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.24 150.26 69.39 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.635 1.174 . . . . 74.31 111.472 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.28 138.19 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.49 2.793 . . . . 64.25 109.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -167.57 1.87 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.682 -1.599 . . . . 75.01 106.682 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -23.25 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 129.386 3.075 . . . . 75.11 112.317 -160.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -120.68 0.33 10.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.044 2.537 . . . . 74.43 110.134 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 48.8 p -139.01 165.3 27.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.368 1.067 . . . . 71.14 112.71 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -79.31 156.34 4.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.625 0.726 . . . . 74.52 109.67 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -139.48 -175.86 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.017 2.127 . . . . 72.5 107.981 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 89.6 mt -114.78 164.55 13.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.498 -0.927 . . . . 63.11 108.498 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -151.26 158.73 44.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.13 -1.063 . . . . 62.04 108.13 160.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -92.01 152.27 20.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.286 0.634 . . . . 75.31 109.346 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.01 1.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.241 1.416 . . . . 72.21 112.696 -168.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.478 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.9 pt 24.74 -83.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 128.325 2.65 . . . . 74.13 116.232 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.478 ' H ' HG13 ' A' ' 141' ' ' ILE . 8.2 tppt? -95.24 123.3 38.67 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.039 1.336 . . . . 74.21 108.225 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.21 104.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 123.606 1.67 . . . . 74.44 109.226 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.65 -156.28 0.75 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.965 1.706 . . . . 73.21 106.517 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -131.13 167.47 19.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.568 1.547 . . . . 73.14 108.232 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.59 178.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.708 1.603 . . . . 62.03 106.928 160.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -122.13 137.71 54.72 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.659 -1.237 . . . . 75.22 107.659 160.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.402 ' C ' HD21 ' A' ' 149' ' ' ASN . 44.6 t80 -141.53 134.11 28.43 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.523 1.929 . . . . 75.52 109.699 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.402 HD21 ' C ' ' A' ' 148' ' ' TYR . 2.7 m120 -132.45 28.07 4.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.377 1.444 . . . . 75.11 112.85 -160.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -132.94 -170.6 12.51 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.798 1.19 . . . . 55.32 110.953 -164.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.433 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 72.9 m80 -74.36 149.09 40.72 Favored 'General case' 0 CA--C 1.522 -0.107 0 O-C-N 121.033 -1.275 . . . . 72.31 109.704 168.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 25.6 pt -108.52 149.79 11.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 125.499 1.52 . . . . 74.22 107.661 173.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.51 147.14 52.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.857 1.263 . . . . 71.33 110.714 -161.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -144.81 152.49 40.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.249 1.019 . . . . 63.43 109.476 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.19 119.69 25.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.142 1.377 . . . . 75.53 108.767 -166.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -37.39 87.03 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.285 1.217 . . . . 61.21 114.285 -166.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.8 t 25.24 73.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.202 2.601 . . . . 72.13 113.971 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.13 -3.45 39.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.847 -1.158 . . . . 75.35 113.558 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.26 -61.18 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.841 1.256 . . . . 72.41 108.981 -165.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -108.48 -10.27 15.29 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.112 1.365 . . . . 72.41 111.839 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.0 m170 52.43 21.81 1.88 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.314 1.846 . . . . 75.54 112.152 -166.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -142.18 153.72 44.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.822 -1.174 . . . . 73.5 109.007 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 179.39 9.25 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.868 1.267 . . . . 74.0 111.035 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.3 mm -105.63 137.12 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.783 -1.562 . . . . 73.23 106.783 168.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.59 153.65 30.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.484 1.114 . . . . 75.12 108.463 169.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 136.51 -161.7 25.04 Favored Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.947 1.249 . . . . 74.23 112.254 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -101.82 170.48 8.12 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.167 1.984 . . . . 74.11 111.743 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.06 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.162 3.385 . . . . 75.03 112.51 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -121.66 -13.05 8.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.364 1.466 . . . . 74.43 112.108 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.2 176.47 39.14 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 122.782 1.212 . . . . 71.01 111.322 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.558 ' CE1' HG23 ' A' ' 97' ' ' ILE . 6.4 m-85 -123.84 161.39 25.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.405 2.282 . . . . 73.05 107.053 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.3 10.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.276 -1.75 . . . . 74.51 106.276 -171.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.12 173.26 12.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.586 0.63 . . . . 72.14 110.133 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.87 129.68 42.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.145 -1.428 . . . . 74.23 107.145 162.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.3 171.59 8.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.575 -2.009 . . . . 71.43 105.575 144.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.534 0.363 0 CA-C-N 119.083 0.856 . . . . 71.22 109.754 145.573 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.939 -0.553 . . . . 72.13 109.999 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -84.17 171.0 13.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.326 1.05 . . . . 75.33 110.887 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.07 156.75 17.17 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.801 -1.187 . . . . 73.13 110.679 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.0 t80 -44.75 -51.79 9.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.262 2.625 . . . . 74.24 110.439 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.97 10.3 19.35 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.189 0.811 . . . . 75.3 113.189 -167.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.23 118.56 72.77 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.375 -1.713 . . . . 62.31 106.375 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -66.53 130.48 23.73 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.437 2.091 . . . . 63.54 109.839 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 pt -93.29 160.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 73.55 109.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CE1' ' HA ' ' A' ' 169' ' ' GLU . 50.6 m-85 -114.85 72.9 0.8 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.084 -1.08 . . . . 74.33 108.084 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.48 160.38 5.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.073 -1.421 . . . . 74.45 108.592 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.05 -44.82 51.77 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.907 0.755 . . . . 64.34 109.731 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -94.31 -17.59 22.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.74 -0.664 . . . . 74.04 112.087 -168.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.04 32.74 4.56 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 121.444 -0.785 . . . . 61.42 113.851 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.59 -17.58 64.15 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.568 1.321 . . . . 73.43 114.568 -170.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 mm 39.73 92.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 129.041 2.936 . . . . 74.45 111.992 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 154.25 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.465 1.106 . . . . 72.22 108.455 -176.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -64.45 130.65 44.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.066 -1.457 . . . . 64.24 107.066 173.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.69 -46.91 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 122.489 1.138 . . . . 73.31 108.627 169.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.476 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -48.73 -64.7 3.04 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 128.484 2.945 . . . . 63.54 110.616 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -54.96 -49.05 72.34 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.014 2.126 . . . . 74.12 111.38 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -54.62 -49.19 71.09 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.787 0.835 . . . . 74.51 111.244 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.458 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 55.9 t -80.8 -38.27 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.983 -1.008 . . . . 73.12 109.45 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -55.17 -45.27 75.72 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.474 0.579 . . . . 65.33 110.68 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -31.07 70.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.783 -1.198 . . . . 74.21 112.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.91 -55.96 7.28 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 116.334 -1.793 . . . . 75.22 109.187 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.45 -44.43 45.67 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 123.104 2.683 . . . . 73.53 112.125 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -74.2 -18.87 60.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.126 2.17 . . . . 75.33 111.896 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -67.76 0.78 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.159 -2.163 . . . . 74.32 105.159 166.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -79.77 39.65 0.43 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.469 2.708 . . . . 72.41 110.999 -167.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -59.79 -28.05 67.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.211 -0.931 . . . . 61.41 111.52 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.46 -23.17 65.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.217 1.407 . . . . 74.45 113.222 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.85 8.05 28.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.812 1.245 . . . . 75.35 111.186 -168.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.22 96.81 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.087 -1.079 . . . . 74.21 108.087 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.78 157.56 27.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.432 -0.951 . . . . 74.54 108.432 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.09 157.7 18.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.632 -1.618 . . . . 71.25 106.632 168.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 169.31 17.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.771 -1.104 . . . . 61.1 109.556 163.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -63.04 1.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.777 2.031 . . . . 61.21 108.68 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -59.57 -21.15 59.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.041 1.336 . . . . 74.11 111.179 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.57 -26.86 2.63 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.208 -1.329 . . . . 74.02 114.168 155.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -25.39 -85.5 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.812 3.245 . . . . 73.31 114.699 -162.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.54 128.28 2.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.232 -1.547 . . . . 53.2 109.232 -166.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -153.6 162.55 41.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.875 1.337 . . . . 75.02 111.245 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -150.73 129.84 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.78 1.632 . . . . 73.45 107.419 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.86 130.62 43.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.024 0.829 . . . . 62.12 109.472 162.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -134.0 16.24 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.163 0.985 . . . . 72.41 111.284 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.98 -29.95 36.33 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.876 2.179 . . . . 74.25 114.433 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -69.68 -24.62 63.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.929 1.291 . . . . 64.24 113.925 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.97 -10.09 12.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.93 1.241 . . . . 74.31 113.805 -174.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.44 14.67 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.441 2.696 . . . . 74.33 115.119 173.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mt -68.75 117.59 11.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.484 1.114 . . . . 75.33 108.575 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.24 157.43 23.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.488 1.137 . . . . 74.11 110.24 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.8 tt -153.29 153.13 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.228 -1.768 . . . . 73.32 106.228 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -67.32 106.35 2.04 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.78 0.718 . . . . 73.04 109.561 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -87.44 172.79 9.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.418 1.087 . . . . 72.35 108.18 165.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.3 OUTLIER -141.83 136.74 30.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.069 -1.826 . . . . 72.21 106.069 167.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.57 119.36 24.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.345 -0.983 . . . . 74.25 108.345 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -63.15 -24.03 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 75.34 111.235 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.08 -33.48 2.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 128.541 2.736 . . . . 74.33 111.81 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 m -157.71 10.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.855 1.262 . . . . 63.23 112.768 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mp 55.75 54.32 8.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.423 1.489 . . . . 75.42 110.751 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.43 158.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.216 1.807 . . . . 74.25 109.619 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 119.73 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.086 1.354 . . . . 75.22 108.686 -164.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -132.4 157.74 43.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.833 1.253 . . . . 73.05 112.038 -168.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -104.85 106.84 17.51 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 126.322 1.849 . . . . 75.33 108.378 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.585 ' HB3' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -151.72 141.23 21.64 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.403 -1.702 . . . . 74.42 106.403 -174.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.91 175.06 6.79 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.098 -1.001 . . . . 74.11 110.936 -166.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.0 mt -97.44 148.49 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.052 1.741 . . . . 73.31 108.147 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.98 -55.2 2.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.214 -0.661 . . . . 74.14 109.214 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.421 HH12 ' CD ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -119.63 152.2 37.45 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.051 -1.03 . . . . 75.51 109.812 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.73 158.88 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.225 1.81 . . . . 72.01 107.546 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -129.53 175.68 8.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.031 1.333 . . . . 74.01 108.046 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.553 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 1.5 tmm_? -173.66 152.27 2.03 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.938 1.695 . . . . 74.0 109.297 157.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -140.61 161.72 37.09 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.161 2.185 . . . . 73.34 107.376 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -95.26 148.07 22.8 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.196 -0.94 . . . . 75.1 109.46 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -144.91 156.19 43.85 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.735 1.214 . . . . 74.04 108.949 -171.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -159.77 106.01 1.63 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.187 0.995 . . . . 63.11 109.784 165.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.69 -178.11 45.26 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.423 -0.671 . . . . 63.2 111.423 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.601 ' H ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.18 138.25 34.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.458 -0.782 . . . . 73.21 110.37 170.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.02 159.8 18.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.234 1.413 . . . . 75.52 109.399 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mm -83.51 139.97 16.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.624 1.169 . . . . 75.41 107.977 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -129.27 77.35 1.78 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.655 2.382 . . . . 75.21 106.662 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.1 138.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.896 -1.89 . . . . 64.52 105.896 159.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.1 m -119.06 155.29 31.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.407 -2.072 . . . . 74.1 105.407 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 p -131.78 171.76 13.12 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.794 -1.191 . . . . 62.25 108.361 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -56.5 -27.81 58.21 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.759 1.392 . . . . 75.14 114.759 -166.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.42 0.49 19.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.912 2.085 . . . . 75.4 113.935 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 61.49 17.79 8.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.256 1.423 . . . . 74.11 111.89 -163.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.59 158.82 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.064 -1.828 . . . . 75.31 106.064 159.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.82 163.59 1.43 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 128.342 2.657 . . . . 73.11 106.298 -171.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -145.36 169.04 7.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.816 1.646 . . . . 74.13 106.629 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.48 100.33 3.85 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.156 0.889 . . . . 74.34 109.954 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.54 168.87 26.05 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.506 -0.746 . . . . 72.35 112.612 -165.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.8 m -60.44 156.04 16.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.943 1.297 . . . . 73.54 107.784 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -73.64 6.11 3.39 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.219 -0.926 . . . . 74.32 111.013 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -136.86 36.93 2.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.063 1.345 . . . . 62.21 109.652 -171.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -105.7 129.29 24.89 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 126.071 1.748 . . . . 73.42 108.48 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -65.88 152.7 80.77 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.552 2.168 . . . . 74.33 114.096 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.18 173.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.531 2.732 . . . . 73.41 108.055 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.59 137.63 53.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.388 1.075 . . . . 73.34 108.556 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.99 162.42 36.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.848 1.259 . . . . 75.52 108.705 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.94 108.45 19.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.613 -0.884 . . . . 74.51 108.613 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -78.3 69.09 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.021 -1.474 . . . . 75.11 107.021 162.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 59.64 13.46 3.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.97 1.47 . . . . 75.32 114.97 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.93 -18.99 5.28 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 120.817 -1.177 . . . . 73.43 112.103 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.55 144.86 33.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.634 -1.988 . . . . 72.22 105.634 162.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -88.45 145.36 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.97 -0.752 . . . . 73.31 108.97 167.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.02 146.7 25.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.211 1.404 . . . . 74.44 108.153 -173.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -102.02 131.59 48.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 118.517 -0.754 . . . . 65.3 110.666 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.9 pt -143.14 -178.81 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.147 1.779 . . . . 74.12 108.625 168.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -78.37 156.15 29.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.781 -1.199 . . . . 75.21 112.989 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.66 -48.33 39.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.823 2.449 . . . . 72.03 111.128 164.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.37 -8.84 28.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.073 1.138 . . . . 75.13 114.073 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.1 mmt -94.31 -38.58 10.93 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.714 1.205 . . . . 73.11 110.968 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.11 60.93 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.853 1.661 . . . . 73.41 109.12 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -81.66 -171.86 3.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.618 1.567 . . . . 75.4 109.433 -178.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.07 -0.62 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 126.3 1.84 . . . . 72.2 113.045 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -89.03 -14.19 61.05 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 116.838 -2.09 . . . . 73.35 112.206 171.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.82 179.64 4.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.786 2.293 . . . . 61.31 108.726 -163.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.48 136.71 53.65 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.475 0.71 . . . . 75.41 111.753 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 tt -111.4 150.15 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.36 1.464 . . . . 72.24 109.335 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.49 103.47 15.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.2 1.0 . . . . 73.25 110.689 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.08 156.72 36.77 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.185 0.994 . . . . 74.14 111.168 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.77 154.08 38.67 Favored 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.486 -1.39 . . . . 74.02 108.486 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -119.38 -157.33 0.69 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.437 -2.06 . . . . 75.34 105.437 162.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -48.5 -71.27 0.07 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.531 1.132 . . . . 62.54 111.863 -171.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -120.37 0.12 10.5 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.874 1.669 . . . . 74.34 111.635 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.8 p -131.82 -172.55 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.217 1.807 . . . . 71.34 111.045 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.85 157.05 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.119 -1.437 . . . . 74.55 107.119 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -136.38 179.19 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.523 -1.658 . . . . 74.25 106.523 167.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 mp -108.06 162.19 14.27 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.672 0.749 . . . . 74.24 109.892 168.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -148.05 160.61 42.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.183 2.593 . . . . 72.22 107.687 171.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 140.48 43.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.621 1.968 . . . . 73.35 109.606 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.258 33.8 t -78.62 1.46 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 130.075 3.35 . . . . 74.14 115.005 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.443 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.4 pt 25.07 -70.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 130.096 3.358 . . . . 73.53 117.681 167.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.443 ' H ' HG13 ' A' ' 141' ' ' ILE . 9.8 ttmt -117.72 125.16 50.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.516 2.727 . . . . 74.32 107.467 172.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.77 128.36 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.397 -1.705 . . . . 74.25 106.397 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -143.14 -179.23 6.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.964 1.706 . . . . 73.12 107.902 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 p -134.2 157.07 47.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.306 1.042 . . . . 74.41 110.878 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 m -127.24 -175.57 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.849 1.66 . . . . 71.11 108.717 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.88 133.36 43.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.704 1.201 . . . . 74.04 109.963 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . 0.535 ' C ' HD21 ' A' ' 149' ' ' ASN . 1.3 t80 -146.95 124.61 11.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 122.481 0.312 . . . . 73.4 110.758 -165.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.535 HD21 ' C ' ' A' ' 148' ' ' TYR . 1.9 m120 -130.27 52.55 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.477 -0.765 . . . . 72.34 109.265 -162.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.78 -179.65 34.73 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.681 -0.968 . . . . 71.21 110.681 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' HIS . . . . . 0.553 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 69.6 m80 -65.18 144.67 57.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.064 1.346 . . . . 75.12 113.045 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.5 pt -129.56 156.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.535 2.334 . . . . 74.23 109.018 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.91 163.73 37.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.26 1.024 . . . . 73.23 110.301 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.53 -91.06 0.54 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.669 -1.234 . . . . 74.03 107.669 -172.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.7 mt 159.6 161.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 1 C-N-CA 133.274 4.63 . . . . 73.21 107.66 174.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -83.71 -82.93 0.15 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 167.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.524 ' CG1' ' HZ2' ' A' ' 72' ' ' LYS . 48.9 t 56.93 64.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 124.145 1.926 . . . . 73.43 110.688 -171.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 76' ' ' ARG . 3.0 pt-20 -81.54 0.23 39.04 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 113.467 -1.697 . . . . 73.41 114.039 -171.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.463 ' HB3' ' HE3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -86.16 -46.23 10.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.973 0.909 . . . . 74.23 110.453 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.45 -23.73 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.487 1.115 . . . . 73.54 110.228 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 53.67 21.26 2.53 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 128.47 2.708 . . . . 73.24 113.411 -159.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.442 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.1 p -149.89 151.81 34.05 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.088 -1.633 . . . . 64.32 111.743 -174.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.473 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.3 p90 -149.06 178.97 8.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.885 1.274 . . . . 75.31 111.285 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.95 119.01 58.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 C-N-CA 124.785 1.234 . . . . 70.42 108.859 171.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.39 158.41 43.69 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.098 -1.001 . . . . 71.31 110.806 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 142.42 -158.76 27.04 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.611 1.101 . . . . 63.44 110.646 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -99.55 176.53 5.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.785 1.293 . . . . 74.05 110.678 166.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.54 -91.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 128.559 2.743 . . . . 73.04 111.657 -168.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.449 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -122.78 -1.96 8.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.676 2.39 . . . . 72.41 113.366 176.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 82.66 165.9 37.85 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.382 1.468 . . . . 51.43 114.34 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' A' ' 97' ' ' ILE . 66.0 m-85 -108.68 151.78 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.823 2.449 . . . . 75.53 107.609 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.68 102.96 15.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.124 -1.435 . . . . 72.0 107.124 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.2 m -130.76 176.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 118.535 0.607 . . . . 75.35 111.457 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -68.6 145.8 53.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.14 110.652 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -138.15 62.95 1.55 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.711 2.804 . . . . 73.21 107.092 168.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.532 0.28 0 O-C-N 120.357 -1.464 . . . . 71.13 109.103 174.738 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtm . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 106.345 -1.724 . . . . 73.13 106.345 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.34 173.65 11.38 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.284 0.564 . . . . 72.25 110.695 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 m -81.21 -63.04 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.414 1.086 . . . . 64.2 108.524 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.04 -150.37 1.83 Allowed Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.702 -1.359 . . . . 73.02 109.702 171.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 60.99 -174.18 0.13 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.62 1.168 . . . . 74.44 110.384 -166.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.4 84.48 0.1 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.125 1.77 . . . . 74.0 111.39 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.04 -169.03 39.42 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.477 1.513 . . . . 75.54 112.864 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -177.44 170.75 2.04 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 128.078 2.551 . . . . 72.21 107.67 165.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.32 156.82 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.786 2.034 . . . . 72.35 110.345 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.12 158.93 27.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.025 0.441 . . . . 64.21 110.404 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.412 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.7 t80 -53.23 -36.98 61.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.743 1.617 . . . . 74.32 114.008 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.87 4.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.08 1.752 . . . . 71.33 110.995 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.38 124.16 70.28 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 107.51 -1.293 . . . . 64.3 107.51 162.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.17 156.82 42.97 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.463 2.109 . . . . 73.22 113.399 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.64 -5.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.786 1.634 . . . . 73.3 113.604 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.0 m-85 47.64 76.87 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.625 1.57 . . . . 75.34 113.158 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.69 160.19 0.95 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.814 -0.63 . . . . 74.24 110.065 168.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 0.32 0.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.712 1.205 . . . . 74.14 112.255 167.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.13 -16.85 9.72 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.883 2.073 . . . . 75.03 111.507 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.23 38.29 7.32 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.787 0.708 . . . . 64.14 112.457 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -16.42 64.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.717 1.377 . . . . 71.14 114.717 -167.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.269 31.3 mm 35.85 66.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.66 2.784 . . . . 64.25 110.514 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 151.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 127.965 2.506 . . . . 75.34 108.59 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.93 127.0 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.214 2.605 . . . . 74.04 107.779 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.23 -41.4 24.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.245 0.618 . . . . 75.22 111.386 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.412 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.44 -41.44 85.01 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.006 -0.886 . . . . 54.21 111.136 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.7 -40.97 92.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.661 1.23 . . . . 73.55 110.674 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.16 13.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.992 0.917 . . . . 72.41 108.845 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.16 -50.9 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.131 -0.692 . . . . 74.25 109.131 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.35 -32.45 73.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.461 1.028 . . . . 71.01 112.028 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.6 tttt -48.18 -47.13 35.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.366 0.984 . . . . 75.45 108.874 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.6 -43.71 75.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.494 -0.928 . . . . 74.13 108.494 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.93 -22.03 66.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.24 0.927 . . . . 73.4 112.132 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -93.9 -20.02 20.42 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.298 1.439 . . . . 74.45 112.507 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.46 -52.59 4.26 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 120.378 1.445 . . . . 74.35 107.701 173.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.13 43.02 1.12 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.891 2.076 . . . . 74.45 108.23 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -54.24 -42.18 69.6 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.923 1.689 . . . . 74.31 109.205 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -65.17 -27.89 69.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.849 0.86 . . . . 75.12 111.862 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.87 -5.16 58.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.004 1.721 . . . . 74.33 112.291 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.3 mt -59.47 95.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 120.829 1.65 . . . . 74.23 108.951 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -81.0 142.88 32.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.965 -1.495 . . . . 75.44 106.965 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.46 150.26 26.99 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.487 -1.301 . . . . 71.35 107.487 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.4 170.58 16.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.765 0.826 . . . . 72.45 108.805 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.19 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.58 0.752 . . . . 74.24 110.093 168.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.91 2.62 2.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.918 1.287 . . . . 74.51 112.457 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.56 46.46 54.94 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 125.919 1.723 . . . . 72.54 111.351 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.64 -100.26 0.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.126 -0.694 . . . . 74.14 109.126 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.4 112.44 1.08 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.343 1.925 . . . . 71.0 108.721 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.05 159.3 42.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.136 1.774 . . . . 73.44 108.418 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.6 mt -142.48 142.22 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 106.608 -1.627 . . . . 70.13 106.608 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 133.45 43.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.987 0.915 . . . . 71.32 108.788 165.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -129.95 12.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.799 -0.637 . . . . 73.33 110.573 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.59 -22.31 16.78 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.208 0.913 . . . . 63.04 112.184 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.97 -25.38 59.91 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.844 1.258 . . . . 71.45 112.454 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 57' ' ' ILE . 4.4 mm-40 -68.35 -22.97 64.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.461 1.028 . . . . 74.44 110.558 167.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.56 -6.42 0.12 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.952 1.464 . . . . 75.24 114.952 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.403 ' H ' ' C ' ' A' ' 55' ' ' GLU . 24.5 mt -45.78 143.81 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 128.377 2.671 . . . . 74.32 110.997 -172.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -102.86 134.76 45.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.3 0.955 . . . . 73.53 112.137 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.4 tt -104.33 148.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.802 1.641 . . . . 74.15 107.581 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -69.99 112.84 6.67 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.436 -1.69 . . . . 74.23 106.436 165.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.43 -166.42 1.15 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.126 -1.435 . . . . 52.35 107.126 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.42 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -151.0 159.62 44.45 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.709 -1.589 . . . . 75.31 106.709 167.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.91 116.76 29.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.966 1.306 . . . . 64.15 110.374 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.404 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.7 ttpm? -57.32 -26.79 61.48 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.865 1.666 . . . . 75.24 113.148 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.25 -22.21 64.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.638 1.575 . . . . 74.53 112.453 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m -149.1 10.47 0.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.159 0.984 . . . . 71.54 112.436 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt 54.3 49.37 18.68 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.848 1.309 . . . . 75.13 109.542 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.7 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.876 1.27 . . . . 73.44 108.636 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.96 124.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.046 -1.835 . . . . 74.22 106.046 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.15 179.49 7.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.831 1.652 . . . . 75.13 107.758 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.97 168.83 19.14 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.967 0.907 . . . . 63.21 110.679 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.55 175.78 13.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.643 -1.243 . . . . 74.51 107.643 140.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.28 136.78 44.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.697 1.199 . . . . 75.31 108.72 168.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.89 157.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.742 1.217 . . . . 73.5 107.77 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.4 mt -117.99 -43.65 2.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.261 0.624 . . . . 73.5 110.815 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -138.18 165.02 27.71 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.773 -1.204 . . . . 74.2 109.325 169.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.56 168.13 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.862 1.265 . . . . 71.32 108.924 173.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -135.7 155.6 50.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.798 1.239 . . . . 74.35 109.116 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.07 144.68 38.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.548 -1.278 . . . . 75.51 107.548 167.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.03 169.01 18.42 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.181 1.393 . . . . 73.25 107.774 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.92 147.41 27.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.224 -1.028 . . . . 75.11 108.224 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.91 149.32 34.02 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 125.757 1.623 . . . . 74.34 107.335 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -144.64 131.88 20.64 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.393 -1.706 . . . . 75.21 106.393 159.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.81 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.379 -1.088 . . . . 51.05 110.379 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 123.73 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.057 -0.719 . . . . 74.02 109.057 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 149.17 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.64 -0.874 . . . . 74.33 108.64 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 mm -79.48 138.88 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.205 1.802 . . . . 72.54 106.993 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -122.95 43.7 2.86 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.742 0.817 . . . . 72.21 112.527 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.8 mt -46.33 114.79 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 C-N-CA 126.894 2.077 . . . . 73.32 106.747 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.6 169.17 11.23 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.721 -1.585 . . . . 74.03 106.721 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.7 p -133.9 171.94 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.136 -0.977 . . . . 74.21 108.927 157.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.82 -38.4 64.54 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.314 -0.866 . . . . 75.53 111.986 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.413 HD21 ' CG ' ' A' ' 138' ' ' ASP . 41.1 m-80 -72.31 20.03 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.469 2.307 . . . . 74.14 112.473 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 49.23 27.08 1.71 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 128.1 2.56 . . . . 75.44 113.065 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 159.89 24.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 120.85 -1.156 . . . . 74.11 108.437 163.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -170.37 167.08 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.98 1.712 . . . . 73.14 107.928 166.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.572 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -146.75 174.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 127.145 2.178 . . . . 73.23 107.88 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.13 1.88 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.861 -0.792 . . . . 72.32 108.861 -171.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.02 174.37 10.66 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.061 0.944 . . . . 73.3 112.58 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 168.95 8.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.156 2.182 . . . . 73.32 111.684 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.95 -33.27 24.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.364 -0.606 . . . . 74.45 109.364 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -91.63 39.27 1.0 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.787 0.835 . . . . 71.42 110.872 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -91.78 123.03 64.48 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.208 -1.377 . . . . 75.12 110.077 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.77 124.15 12.35 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.159 2.573 . . . . 63.01 110.412 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.28 173.69 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.746 1.619 . . . . 73.13 108.336 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.69 149.64 34.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.049 0.54 . . . . 74.52 110.761 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.12 164.38 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.973 1.309 . . . . 74.24 109.735 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.81 35.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.082 0.944 . . . . 75.24 108.474 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -109.1 78.06 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.812 -1.551 . . . . 73.41 106.812 153.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.38 14.96 6.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.511 1.524 . . . . 74.12 113.319 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.46 -24.48 3.2 Favored Glycine 0 CA--C 1.521 0.435 0 O-C-N 120.795 -1.191 . . . . 72.11 111.713 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.98 143.32 26.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.552 -1.277 . . . . 71.14 107.552 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.77 -1.937 . . . . 70.14 105.77 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 tp -125.93 159.24 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.653 -0.869 . . . . 73.13 108.653 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.91 119.49 33.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.207 1.803 . . . . 73.03 109.28 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.58 179.64 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.262 1.025 . . . . 71.03 110.688 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.6 139.57 34.95 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.62 1.968 . . . . 72.02 110.719 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.24 -41.07 36.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.397 1.479 . . . . 71.54 113.26 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.44 -19.94 65.14 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.932 1.242 . . . . 75.33 113.469 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.5 -22.79 30.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.697 0.799 . . . . 75.41 111.161 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.16 63.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 128.398 2.679 . . . . 75.32 111.527 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.42 -170.73 2.71 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.023 -1.048 . . . . 72.25 111.704 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.82 -1.55 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.106 2.162 . . . . 75.11 113.661 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.25 9.19 22.64 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-O 117.439 -1.756 . . . . 75.21 111.764 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 147.68 44.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.84 2.32 . . . . 74.51 108.988 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -94.89 105.09 16.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.241 -1.392 . . . . 74.2 107.241 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.42 118.13 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.601 1.16 . . . . 72.41 109.329 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.38 140.28 56.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.5 -0.75 . . . . 72.54 109.072 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.32 158.0 76.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.854 1.262 . . . . 73.34 111.079 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.54 161.32 42.51 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.669 2.246 . . . . 73.14 110.229 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 -145.59 0.33 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.318 -1.364 . . . . 74.11 107.318 166.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.99 -82.02 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.465 1.506 . . . . 74.23 109.06 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.486 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.02 0.43 35.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.888 1.675 . . . . 73.41 110.356 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 p -138.02 -172.91 3.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.428 1.491 . . . . 74.45 110.879 -151.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -125.98 143.26 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.187 -1.783 . . . . 75.42 106.187 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.8 177.53 7.8 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.901 -1.124 . . . . 75.54 108.023 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.1 145.7 41.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.897 1.279 . . . . 74.2 107.98 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.413 ' CG ' HD21 ' A' ' 93' ' ' ASN . 32.4 t0 -142.12 153.97 44.52 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.872 2.069 . . . . 72.13 109.933 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 142.02 27.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 118.463 -0.779 . . . . 72.44 110.078 -164.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.7 t -77.32 -5.56 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 114.567 1.321 . . . . 72.12 114.567 -163.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.516 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.32 -88.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 127.748 2.419 . . . . 65.21 116.108 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.516 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -85.95 128.58 34.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.901 2.08 . . . . 74.05 109.594 -175.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.01 99.07 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.032 1.333 . . . . 63.52 111.103 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.454 ' CD ' ' HZ2' ' A' ' 142' ' ' LYS . 11.6 pt-20 -152.65 -169.44 3.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.219 2.608 . . . . 74.22 110.102 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.91 179.56 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.028 1.731 . . . . 74.14 110.107 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.6 163.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.927 2.091 . . . . 74.42 106.442 159.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.01 137.02 37.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.93 -1.878 . . . . 73.04 105.93 161.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.41 142.96 27.59 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.865 0.757 . . . . 73.3 110.058 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -146.82 24.35 1.2 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.847 0.749 . . . . 74.34 112.705 -157.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.88 -111.64 3.39 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 110.318 -1.113 . . . . 63.15 110.318 -155.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -134.23 164.82 26.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.595 -1.631 . . . . 74.41 106.595 157.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 20.7 pt -127.09 160.48 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.171 2.188 . . . . 72.35 109.13 174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -142.93 151.53 41.06 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.495 1.118 . . . . 75.32 109.684 -168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.23 -178.76 6.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.764 -1.199 . . . . 72.42 107.764 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.3 mt -128.25 175.75 8.22 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.974 1.845 . . . . 75.12 110.995 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.3 m -128.41 92.05 3.36 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.391 -2.448 . . . . 75.25 104.391 159.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.66 80.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 101.651 -3.463 . . . . 72.35 101.651 166.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -76.5 -15.31 59.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.31 1.053 . . . . 74.32 111.218 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.53 -44.52 62.07 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.915 1.686 . . . . 73.25 109.885 -153.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.3 t30 -125.07 5.06 7.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.202 0.601 . . . . 75.34 111.933 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.415 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 34.9 m170 52.15 36.75 19.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.939 0.791 . . . . 64.33 111.941 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.42 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 2.9 p -147.43 142.42 26.99 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.378 -1.451 . . . . 75.22 107.571 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -142.86 170.2 16.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.544 1.065 . . . . 75.32 110.349 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.26 137.93 24.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 107.008 -1.478 . . . . 74.21 107.008 160.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.25 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.314 1.045 . . . . 72.03 108.574 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 134.72 -168.19 23.67 Favored Glycine 0 N--CA 1.462 0.403 0 CA-C-N 118.555 0.616 . . . . 74.42 111.729 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.42 169.54 8.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.348 1.574 . . . . 74.34 110.318 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.31 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 C-N-CA 128.018 2.527 . . . . 63.31 113.272 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.423 1.089 . . . . 75.31 112.146 169.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.73 177.11 23.92 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 125.596 1.57 . . . . 73.41 111.432 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.572 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.0 m-85 -117.81 139.92 50.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 126.426 1.89 . . . . 74.43 108.104 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.39 99.31 9.98 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.572 3.149 . . . . 71.12 107.604 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.06 3.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.133 0.573 . . . . 72.43 110.246 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.43 148.93 49.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.227 -1.027 . . . . 73.35 108.227 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.76 166.74 13.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.06 -1.459 . . . . 62.41 107.06 158.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.415 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 92.2 p -149.27 -149.68 0.31 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.777 -0.769 . . . . 61.32 111.1 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.7 p -149.41 -106.3 0.07 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.851 2.06 . . . . 64.14 107.059 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -88.81 112.06 3.89 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 108.027 -2.029 . . . . 55.21 108.027 165.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.311 0.1 OUTLIER 68.23 -172.03 0.19 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.178 1.391 . . . . 74.32 112.03 159.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.64 81.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.763 -1.211 . . . . 74.41 109.343 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 50.02 56.28 8.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.903 2.481 . . . . 72.42 115.88 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.36 -48.66 12.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.845 1.424 . . . . 74.44 114.845 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.9 m170 31.71 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.679 2.791 . . . . 74.33 114.279 -163.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -104.29 90.41 3.55 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.499 0.72 . . . . 74.21 109.895 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.77 -128.22 0.22 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.488 1.115 . . . . 73.22 110.034 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.083 1.353 . . . . 74.22 110.02 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.812 -0.81 . . . . 64.34 108.812 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 152.19 178.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 130.412 3.485 . . . . 74.54 107.998 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -108.7 -54.34 2.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.739 1.216 . . . . 64.11 108.466 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.42 -139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.947 -1.661 . . . . 64.31 108.947 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 -70.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.865 -1.531 . . . . 75.41 106.865 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 t0 59.16 -171.94 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.98 1.312 . . . . 74.12 109.629 -169.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.82 -160.87 13.85 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.334 -0.853 . . . . 62.23 112.885 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 161.8 165.94 0.02 OUTLIER 'General case' 0 C--O 1.242 0.672 0 C-N-CA 129.704 3.201 . . . . 74.55 108.362 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.78 153.48 21.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.702 2.401 . . . . 75.24 109.608 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.66 163.3 28.02 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.37 0.668 . . . . 61.24 111.71 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -54.96 -38.59 67.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.088 1.355 . . . . 74.44 113.252 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -96.74 9.3 42.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.946 1.698 . . . . 72.31 112.412 -165.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.22 124.13 85.84 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.677 -1.601 . . . . 73.45 106.677 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -55.46 126.31 22.08 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.16 2.574 . . . . 71.43 111.287 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 pt -98.4 119.33 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.688 -1.227 . . . . 74.23 107.688 162.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -78.13 78.99 4.6 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.326 1.45 . . . . 72.33 107.942 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.9 mt -55.86 164.18 1.23 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 170.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.1 p -54.06 -36.16 62.81 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.168 0.44 . . . . 74.23 111.317 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.13 -22.55 48.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.413 0.685 . . . . 71.31 112.188 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.02 40.54 7.99 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.08 1.324 . . . . 65.44 110.774 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -10.35 52.31 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.906 1.076 . . . . 74.32 113.906 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.317 13.5 mm 52.23 30.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 125.575 2.607 . . . . 72.52 112.077 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.39 149.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.829 -1.532 . . . . 74.43 108.692 -172.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -62.17 122.7 16.23 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.306 -1.739 . . . . 65.14 106.306 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -50.14 -37.85 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.437 1.095 . . . . 74.43 111.087 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 -0.9 89.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.825 -0.986 . . . . 63.12 114.205 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.27 -47.56 6.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.758 1.779 . . . . 75.34 110.365 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -47.14 -53.49 12.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.945 1.298 . . . . 72.22 110.46 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.1 -42.67 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.525 -0.761 . . . . 62.14 110.486 -178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -24.82 64.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 119.042 -1.063 . . . . 74.53 111.302 -176.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -41.44 70.47 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.135 0.974 . . . . 73.21 110.628 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.85 -40.06 66.01 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.341 -1.314 . . . . 72.12 108.933 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -56.05 -37.18 68.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.414 1.915 . . . . 74.41 112.436 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -31.36 64.32 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.718 -1.134 . . . . 73.11 111.275 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -90.23 -49.34 6.61 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 121.195 1.816 . . . . 75.45 108.28 -178.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 2.5 m-30 -94.44 39.31 1.09 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.773 2.029 . . . . 72.12 108.333 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -57.02 -31.92 65.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.065 1.346 . . . . 73.22 111.95 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -61.5 -35.51 77.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.722 1.209 . . . . 64.31 110.996 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.12 9.45 40.86 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.092 1.357 . . . . 74.51 112.105 -165.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.7 124.0 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.829 -1.545 . . . . 64.42 106.829 167.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -122.37 114.79 21.24 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.07 1.748 . . . . 74.45 107.496 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.64 146.72 28.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.004 -1.109 . . . . 74.23 108.004 168.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.47 172.46 13.76 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.835 0.854 . . . . 75.44 108.811 168.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.39 73.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 75.45 109.338 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.5 -6.28 35.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.785 1.234 . . . . 75.44 112.499 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.71 15.67 33.55 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.136 -0.977 . . . . 74.13 114.698 156.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.01 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.481 1.912 . . . . 71.44 111.892 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.77 121.43 2.19 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.064 2.269 . . . . 63.44 109.174 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -130.76 164.73 24.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.383 1.873 . . . . 71.14 109.906 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.4 mt -142.26 138.98 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.291 2.236 . . . . 74.25 106.191 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.61 129.52 36.53 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.56 1.544 . . . . 60.24 109.719 166.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.74 16.84 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.264 1.425 . . . . 74.31 111.034 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.4 57.33 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.973 -1.079 . . . . 54.22 113.392 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -77.84 -10.78 59.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.928 1.364 . . . . 74.14 113.311 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -63.58 -33.65 76.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.663 1.12 . . . . 74.42 109.479 168.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 51.14 13.84 0.18 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.93 2.092 . . . . 74.32 113.183 -166.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mt -61.12 126.34 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.29 1.036 . . . . 74.24 108.472 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -83.33 144.22 29.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.637 1.175 . . . . 75.43 110.389 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -127.75 150.78 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.792 1.637 . . . . 64.23 107.663 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -62.26 118.34 7.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.015 -1.846 . . . . 74.54 106.015 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -141.92 146.59 35.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.603 -2.74 . . . . 60.32 103.603 -172.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 126.99 54.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 126.211 1.805 . . . . 74.45 106.128 -171.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.82 121.23 16.87 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.266 -1.013 . . . . 74.31 108.266 172.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -85.39 -20.29 30.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.665 0.786 . . . . 75.25 112.084 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -34.1 65.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.816 0.846 . . . . 65.51 111.033 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -135.93 8.83 3.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.683 0.793 . . . . 73.24 112.141 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.6 mt 57.02 47.84 16.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.8 1.64 . . . . 71.42 112.51 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 148.48 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.372 1.469 . . . . 72.45 108.964 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.6 144.2 11.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.033 -1.84 . . . . 72.21 106.033 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.66 -167.96 2.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.116 2.567 . . . . 72.41 107.052 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.8 153.4 42.56 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.258 -2.126 . . . . 65.44 105.258 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -153.99 162.6 41.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.127 1.371 . . . . 71.43 108.14 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -85.64 179.45 7.09 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.854 1.262 . . . . 72.51 112.828 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.62 155.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.917 2.087 . . . . 74.11 106.725 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.49 -42.68 1.63 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.868 0.867 . . . . 74.44 111.706 -170.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -127.08 -166.05 1.55 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.57 -0.9 . . . . 74.13 108.57 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -157.84 161.86 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.702 -1.962 . . . . 74.53 105.702 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -147.08 143.14 28.11 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.536 0.734 . . . . 75.23 110.025 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.4 143.62 26.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.237 0.926 . . . . 75.31 109.538 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -146.38 162.02 39.11 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.847 -1.538 . . . . 75.34 106.847 166.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -85.1 156.01 21.25 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.133 -0.979 . . . . 74.15 108.694 172.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -136.32 163.35 30.64 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.009 2.124 . . . . 74.41 108.307 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 p -167.12 104.29 0.55 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.991 -1.485 . . . . 74.32 106.991 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.73 27.22 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.41 -0.9 . . . . 74.42 113.791 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 94.77 4.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.537 1.535 . . . . 64.21 109.459 -168.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.44 153.01 29.97 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.126 -1.064 . . . . 74.32 108.126 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 mm -79.06 131.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.386 1.874 . . . . 64.32 106.974 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -116.83 82.35 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.578 -1.638 . . . . 74.25 106.578 166.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -61.95 137.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.856 -1.905 . . . . 74.23 105.856 162.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -110.8 168.13 9.71 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.645 -1.613 . . . . 73.51 106.645 162.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.76 170.87 15.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.878 1.217 . . . . 75.42 109.361 159.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -58.32 -24.52 59.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.359 1.436 . . . . 74.22 111.962 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.21 -0.9 2.79 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.643 1.177 . . . . 72.35 112.259 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.93 13.75 8.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 128.149 2.58 . . . . 74.21 111.927 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 157.47 28.01 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 124.848 1.259 . . . . 75.51 108.205 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.71 171.17 17.23 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.661 1.585 . . . . 61.32 107.408 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.456 HG21 ' CE1' ' A' ' 171' ' ' PHE . 5.1 pt -147.53 173.09 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 126.664 1.986 . . . . 74.13 107.908 -174.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 104.5 4.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.422 -0.955 . . . . 71.33 108.422 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.15 166.97 27.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.302 1.041 . . . . 63.22 111.442 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -89.52 1.48 55.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 116.157 1.91 . . . . 61.35 116.157 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 96.33 -23.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 1 C-N-CA 138.787 6.835 . . . . 74.55 111.639 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -113.58 37.58 3.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.937 2.495 . . . . 73.22 110.238 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -101.0 139.36 20.44 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 125.04 1.336 . . . . 74.22 108.963 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.54 123.54 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.505 2.137 . . . . 75.31 110.53 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.94 173.55 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 72.34 109.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -119.62 139.71 51.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.103 . . . . 72.22 111.084 -168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.13 162.81 19.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.858 1.263 . . . . 72.54 110.103 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 94.4 p -95.48 105.99 18.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.261 0.351 . . . . 65.22 111.04 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -81.12 78.3 7.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.448 -1.686 . . . . 65.35 106.448 162.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 6.2 m 60.22 6.04 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.522 2.045 . . . . 75.51 116.522 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.32 -31.32 1.56 Allowed Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.712 -1.242 . . . . 73.34 110.057 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.7 142.7 36.89 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.362 -2.088 . . . . 74.14 105.362 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.05 132.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.577 -0.898 . . . . 61.34 108.577 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.24 152.31 48.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.81 1.644 . . . . 73.13 106.677 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.19 115.75 30.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.029 1.332 . . . . 73.44 109.61 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.52 175.26 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.745 0.818 . . . . 75.33 110.901 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -79.97 143.17 34.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.587 1.155 . . . . 72.42 109.226 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.0 -29.1 41.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.629 0.974 . . . . 74.32 113.629 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -24.26 65.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.14 -0.975 . . . . 75.53 112.661 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -86.74 -27.4 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.372 1.069 . . . . 74.13 111.927 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -71.43 61.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 127.921 2.488 . . . . 55.31 109.836 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.457 ' C ' ' H ' ' A' ' 124' ' ' GLY . 0.6 OUTLIER -83.47 -178.08 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.01 1.324 . . . . 74.22 108.509 170.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.48 0.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 127.364 2.266 . . . . 63.45 113.9 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -80.39 -18.88 70.25 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 117.506 -1.719 . . . . 65.11 111.989 170.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.56 169.82 12.08 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.214 2.007 . . . . 72.52 111.67 -163.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -124.0 119.09 28.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 126.256 1.822 . . . . 72.32 108.153 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -93.74 127.46 45.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.149 0.979 . . . . 73.24 108.776 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -67.8 115.58 7.52 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.906 -1.146 . . . . 75.42 107.906 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.4 154.42 59.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.386 1.074 . . . . 73.22 111.476 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.78 141.35 96.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.94 2.427 . . . . 75.35 110.138 172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -113.48 -173.98 2.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.786 -1.19 . . . . 74.34 107.786 153.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -37.79 -64.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.189 1.796 . . . . 74.33 111.22 -168.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -120.59 -5.44 9.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.772 0.829 . . . . 74.34 112.122 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 p -125.33 -178.58 4.27 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.668 1.587 . . . . 64.42 111.67 -164.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 tp -100.39 147.25 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 O-C-N 120.171 -1.581 . . . . 72.43 107.574 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -137.94 -175.0 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.751 2.02 . . . . 72.51 107.938 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 18.9 mt -129.47 157.93 40.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.266 1.427 . . . . 72.34 107.649 174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -153.87 159.3 41.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.692 1.597 . . . . 75.23 108.14 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.8 147.7 23.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.07 0.948 . . . . 63.25 110.605 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.97 -0.67 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.998 1.111 . . . . 72.51 113.998 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.464 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 26.51 -77.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.044 2.938 . . . . 71.53 117.062 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.464 ' H ' HG13 ' A' ' 141' ' ' ILE . 17.0 tppt? -103.21 117.29 34.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.049 1.74 . . . . 74.14 108.028 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.32 131.2 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.184 -1.043 . . . . 43.33 108.184 169.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -153.06 -179.45 7.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.942 1.697 . . . . 74.25 107.494 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.29 133.85 39.31 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.007 -0.738 . . . . 61.42 109.007 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.98 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.682 1.193 . . . . 64.31 108.494 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.29 113.39 14.34 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.447 -0.946 . . . . 62.11 108.447 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -128.72 135.32 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.074 1.35 . . . . 73.41 108.582 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -133.77 29.6 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.272 -0.893 . . . . 74.24 109.684 -161.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -126.86 -163.91 11.59 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.362 1.934 . . . . 42.24 111.411 -161.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -87.0 153.41 21.57 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.021 -1.281 . . . . 74.23 110.752 173.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.2 153.63 34.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 126.729 2.012 . . . . 73.23 107.877 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -142.47 154.38 44.48 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.344 1.058 . . . . 74.43 108.985 -170.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.95 163.94 27.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.167 1.387 . . . . 73.13 108.288 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.73 140.13 42.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.943 1.701 . . . . 72.41 111.164 -163.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 48.4 p -91.37 -46.68 7.89 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.576 0.954 . . . . 74.41 113.576 -156.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 2.7 t 23.12 64.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 130.111 3.364 . . . . 71.24 113.97 175.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.1 0.05 15.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.486 1.114 . . . . 73.41 113.511 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -34.91 41.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.352 -0.981 . . . . 62.33 108.352 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -127.94 -8.91 5.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.203 1.401 . . . . 73.21 113.712 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.57 23.96 14.25 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.475 1.91 . . . . 63.23 111.154 -175.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 p -141.36 164.84 29.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.342 2.657 . . . . 74.22 107.248 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -151.39 175.92 11.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.824 1.193 . . . . 73.22 110.372 165.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.1 mm -109.37 126.17 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 74.21 108.831 168.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.21 160.46 43.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.729 0.812 . . . . 71.11 110.241 169.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.13 -165.11 25.5 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.167 -1.573 . . . . 53.14 109.167 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -100.72 172.83 6.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.111 1.455 . . . . 75.52 110.267 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.11 -85.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.177 2.591 . . . . 73.35 111.972 -171.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.88 -12.1 8.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.912 1.285 . . . . 74.55 112.878 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.06 174.59 39.31 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 122.877 1.265 . . . . 65.54 112.628 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.456 ' CE1' HG21 ' A' ' 97' ' ' ILE . 12.7 m-85 -121.18 154.5 36.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.454 2.702 . . . . 64.35 106.801 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.67 32.58 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.355 -1.35 . . . . 60.41 107.355 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.59 174.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 118.579 0.627 . . . . 74.41 109.651 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -72.42 155.2 40.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.111 0.564 . . . . 74.53 109.672 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -144.11 49.3 1.36 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.697 2.399 . . . . 62.41 108.644 172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.4 m -79.87 108.4 13.42 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.098 -1.626 . . . . 72.23 107.159 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.6 p -60.77 8.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.045 2.938 . . . . 60.54 116.088 -169.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.32 45.8 10.89 Favored Glycine 0 CA--C 1.524 0.656 0 O-C-N 120.507 -1.37 . . . . 72.34 110.852 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.41 164.65 28.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.042 -1.466 . . . . 53.54 107.042 160.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . 0.257 5.9 tt 66.05 121.86 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.81 1.644 . . . . 74.41 113.232 171.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -148.07 167.74 24.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.807 1.643 . . . . 74.13 109.058 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -153.29 178.11 10.12 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.301 1.44 . . . . 65.32 107.404 164.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -135.83 149.83 49.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.562 1.945 . . . . 71.25 107.358 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.98 52.38 0.44 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.606 -1.257 . . . . 73.25 107.606 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 63.63 178.24 0.16 Allowed 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.84 1.656 . . . . 71.52 109.51 -141.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 . . . . . 0 C--O 1.242 0.671 0 CA-C-O 117.094 -1.431 . . . . 71.23 108.423 -178.821 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.015 -0.517 . . . . 74.51 110.684 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m120 80.77 -179.56 0.08 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.23 1.812 . . . . 73.55 112.615 154.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 m -123.29 -33.48 3.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.167 1.787 . . . . 64.24 110.148 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.11 -73.6 0.46 Allowed Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.146 -1.582 . . . . 72.23 109.146 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -64.8 159.35 22.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.345 0.593 . . . . 74.14 110.187 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.17 169.12 18.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.936 -1.505 . . . . 72.23 106.936 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.43 -167.2 12.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.17 1.367 . . . . 62.44 112.273 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.94 155.07 40.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.069 -1.826 . . . . 61.33 106.069 140.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.01 157.54 24.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.177 0.991 . . . . 75.14 109.557 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.38 -176.67 0.79 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.187 1.395 . . . . 73.43 110.947 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.447 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 14.4 t80 -84.67 -33.57 23.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.547 1.139 . . . . 72.11 113.169 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.81 38.53 1.71 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 72.11 110.197 -162.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -117.19 112.61 39.65 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 125.039 1.336 . . . . 74.12 110.947 -153.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.56 127.41 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.99 1.793 . . . . 74.32 113.557 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -100.36 24.53 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.626 1.97 . . . . 75.22 112.95 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 29.78 66.09 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.341 2.257 . . . . 75.34 115.403 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -53.17 155.59 2.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.315 -0.866 . . . . 65.33 111.507 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -43.62 61.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.51 1.124 . . . . 74.13 109.172 169.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.09 -47.34 77.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.105 0.962 . . . . 74.35 110.722 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.81 26.91 3.7 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.767 1.175 . . . . 74.3 112.65 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.68 -27.61 66.55 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.264 1.532 . . . . 72.5 114.118 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 mm 48.17 63.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.861 1.264 . . . . 73.24 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 147.97 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.903 1.281 . . . . 75.52 108.121 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -65.27 122.69 17.69 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.97 -1.493 . . . . 72.11 106.97 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.7 tt -46.55 -44.75 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 124.995 1.318 . . . . 64.45 110.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.447 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -70.54 -26.3 74.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-O 118.577 -1.124 . . . . 74.12 111.685 -173.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.41 -53.17 14.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.461 1.631 . . . . 63.33 109.716 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -43.87 -48.77 8.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.779 1.232 . . . . 73.43 109.555 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.88 -44.9 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 118.361 -0.828 . . . . 74.2 111.645 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -65.03 -32.82 74.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.737 2.062 . . . . 71.2 111.585 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -40.49 65.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.714 1.606 . . . . 73.43 110.965 171.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -76.74 -36.66 56.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.492 1.517 . . . . 72.32 109.632 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -63.66 -41.77 98.15 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.334 1.879 . . . . 74.2 110.774 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -24.42 64.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.497 -0.752 . . . . 60.13 111.281 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -82.35 -59.19 2.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.996 -1.483 . . . . 72.35 106.996 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -100.63 41.84 1.15 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.943 0.897 . . . . 75.11 109.949 -162.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -32.2 67.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.564 0.745 . . . . 74.52 111.772 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -73.83 -22.17 59.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.832 0.678 . . . . 75.2 112.832 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 t -90.04 -1.41 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.62 1.568 . . . . 74.44 111.59 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 96.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 124.744 1.217 . . . . 63.23 107.793 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -79.99 161.5 25.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.059 -1.089 . . . . 73.35 108.059 162.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -126.17 154.31 43.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.433 -1.692 . . . . 73.25 106.433 160.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.41 179.38 7.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.009 0.924 . . . . 62.24 110.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.84 -25.54 63.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.4 0.68 . . . . 73.22 111.442 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -77.53 -13.85 59.81 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.873 -1.142 . . . . 74.13 111.346 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.96 55.69 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 120.441 -1.412 . . . . 61.51 112.35 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -52.35 -83.46 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.471 1.909 . . . . 73.5 112.874 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.82 107.32 0.64 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-O 117.977 -1.457 . . . . 75.44 110.131 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -123.31 162.34 22.89 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.107 1.453 . . . . 73.31 111.447 170.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mt -146.73 132.33 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.414 2.686 . . . . 74.21 103.952 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 126.8 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.104 -1.072 . . . . 75.44 108.104 164.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.83 13.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.142 1.377 . . . . 73.24 111.6 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.46 -31.57 36.32 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.291 -0.88 . . . . 75.53 113.472 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.37 -19.41 65.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.741 1.216 . . . . 63.44 112.721 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.81 -25.89 66.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.832 0.742 . . . . 73.41 110.87 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.5 36.02 25.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.752 1.221 . . . . 75.11 111.992 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -89.34 135.08 26.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.352 -1.351 . . . . 75.52 107.352 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.73 154.27 19.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.445 0.64 . . . . 73.31 109.305 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -132.89 148.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 125.663 1.585 . . . . 75.32 107.911 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -75.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.688 1.995 . . . . 75.35 110.349 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.16 173.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.047 2.539 . . . . 73.52 108.454 165.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.492 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -136.75 140.75 42.8 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.195 -0.94 . . . . 70.31 109.854 -174.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -87.5 121.01 29.39 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 126.064 1.745 . . . . 65.11 109.091 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -70.76 -27.81 64.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.72 0.808 . . . . 74.21 112.076 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -50.5 -42.03 54.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.075 1.35 . . . . 71.32 110.897 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -134.1 16.78 3.8 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.622 0.769 . . . . 55.14 111.357 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.28 49.57 17.6 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.771 1.228 . . . . 74.35 112.464 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.54 154.48 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.555 1.542 . . . . 74.43 109.529 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.98 145.77 8.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.52 -1.289 . . . . 74.01 107.52 165.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -141.06 -168.5 2.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.545 1.938 . . . . 73.23 107.774 163.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -92.24 149.14 21.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.439 -0.948 . . . . 72.12 108.439 153.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -154.13 152.69 30.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.627 2.371 . . . . 73.32 106.571 167.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -84.36 175.66 9.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.428 1.091 . . . . 74.24 109.938 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.69 141.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.829 2.052 . . . . 75.4 106.324 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD21 ' H ' ' A' ' 158' ' ' GLU . 1.9 mm? -111.74 -45.67 3.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.703 0.401 . . . . 74.11 112.03 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.38 144.83 49.83 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.53 -0.915 . . . . 71.25 108.53 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -108.87 158.7 8.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.393 1.477 . . . . 75.52 108.054 176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -132.05 152.75 51.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.208 1.003 . . . . 75.42 108.953 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -149.53 152.53 35.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.764 -0.828 . . . . 74.32 108.764 165.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -150.08 167.96 25.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.094 1.757 . . . . 75.34 106.946 166.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -105.41 143.97 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.044 -1.035 . . . . 75.22 108.223 171.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -142.64 156.19 45.04 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.3 0.5 . . . . 75.12 111.25 -160.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -156.94 125.85 5.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 75.43 109.788 164.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.51 179.52 37.96 Favored Glycine 0 N--CA 1.465 0.587 0 N-CA-C 110.184 -1.167 . . . . 71.54 110.184 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -81.03 140.04 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.876 -0.779 . . . . 64.14 110.236 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.65 157.87 32.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.161 1.384 . . . . 74.24 107.625 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mm -79.67 141.6 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.678 1.191 . . . . 72.32 108.77 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -123.66 86.28 2.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.341 1.456 . . . . 73.41 107.519 158.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.8 mt -62.77 101.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.521 -1.659 . . . . 55.44 106.521 148.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.38 172.99 13.04 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.899 -1.519 . . . . 73.21 106.899 163.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -138.56 171.04 14.95 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.704 -1.247 . . . . 74.22 108.574 163.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -71.15 -25.17 62.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.539 2.336 . . . . 74.34 110.938 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -59.86 -11.24 5.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.93 1.692 . . . . 75.11 111.578 164.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 63.15 33.05 14.75 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.173 2.989 . . . . 73.3 111.617 -167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -75.43 173.43 10.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 118.231 -1.388 . . . . 73.54 109.474 161.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.39 164.29 19.7 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.983 1.713 . . . . 75.45 106.522 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.489 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -132.25 -179.93 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.068 -1.086 . . . . 75.51 108.068 165.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.2 m -149.87 118.92 6.71 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.011 -1.68 . . . . 72.2 108.949 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -166.25 172.13 11.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.963 -1.017 . . . . 65.32 111.261 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 m -79.43 147.61 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.095 -1.076 . . . . 71.12 108.095 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -10.21 54.29 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.165 1.172 . . . . 75.02 114.165 -161.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.4 38.19 3.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.661 2.785 . . . . 73.12 110.156 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -82.63 140.95 44.43 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.071 -0.966 . . . . 63.43 109.525 159.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.02 118.53 5.63 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.124 3.216 . . . . 70.2 111.274 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.65 -166.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 120.876 -1.14 . . . . 74.54 110.128 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -135.07 134.68 40.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.747 1.219 . . . . 71.13 108.733 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.31 166.58 28.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 126.107 1.763 . . . . 73.41 107.944 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -89.9 143.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.096 0.475 . . . . 74.22 110.309 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -115.02 86.74 2.51 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.224 -1.769 . . . . 73.43 106.224 155.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.65 17.76 8.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.097 0.959 . . . . 63.53 113.407 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.43 -26.85 4.3 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.652 1.12 . . . . 71.05 111.187 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 148.62 32.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.557 -1.646 . . . . 74.31 106.557 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.7 t -85.32 114.46 25.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.46 40.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.89 -0.782 . . . . 74.34 108.89 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.67 120.02 36.22 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.87 2.068 . . . . 73.05 106.996 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.65 175.26 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.691 1.596 . . . . 74.42 109.803 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -78.03 144.5 36.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.53 -0.544 . . . . 70.33 109.53 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.03 22.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 72.23 112.201 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -17.29 62.99 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.151 1.167 . . . . 73.5 114.151 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.6 mtm -96.99 -15.24 21.18 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.161 0.985 . . . . 74.35 112.071 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.61 63.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.949 1.699 . . . . 75.31 109.217 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.63 176.82 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 74.4 109.291 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.36 -37.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.278 1.831 . . . . 70.34 112.721 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.79 11.03 63.09 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.419 -1.767 . . . . 64.31 114.185 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.15 169.9 8.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 121.018 2.409 . . . . 72.2 108.814 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -118.16 105.42 11.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 123.907 0.883 . . . . 74.54 109.182 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.0 125.69 39.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 74.32 108.795 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.63 123.46 19.36 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 72.53 107.067 173.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.85 157.74 56.54 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.694 1.598 . . . . 74.54 111.883 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.97 159.72 50.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.387 2.725 . . . . 74.45 111.8 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -141.81 -178.04 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.626 -1.62 . . . . 73.23 106.626 156.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -24.74 -67.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.318 2.647 . . . . 64.55 113.266 -170.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.68 -10.0 9.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.185 0.994 . . . . 43.52 113.447 165.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 p -131.3 148.15 52.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.818 1.19 . . . . 75.41 111.571 -162.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.94 143.31 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.263 -1.384 . . . . 73.42 107.263 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -142.91 -176.91 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.813 1.645 . . . . 74.11 108.391 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.8 mt -125.38 165.46 18.34 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.413 1.101 . . . . 73.13 108.538 177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -154.56 157.71 38.68 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 103.593 -2.743 . . . . 71.33 103.593 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -61.39 -177.7 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.026 1.33 . . . . 75.14 109.279 168.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.259 72.0 t -112.6 2.56 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.793 1.237 . . . . 75.54 111.904 176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.1 pt 24.83 -70.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 130.422 3.489 . . . . 73.34 117.719 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.403 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.7 tptt -116.14 118.51 33.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.181 1.393 . . . . 74.01 107.462 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.43 119.53 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.998 -1.482 . . . . 65.23 106.998 156.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.14 -176.08 4.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.005 1.722 . . . . 75.32 107.816 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -130.76 159.93 35.84 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.155 -0.966 . . . . 74.32 109.868 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -117.12 165.22 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.781 1.633 . . . . 74.21 107.794 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -122.7 71.02 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.086 1.354 . . . . 74.52 108.843 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -81.64 154.76 25.96 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.879 1.272 . . . . 74.52 110.798 -167.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.33 24.96 2.27 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.306 -0.871 . . . . 73.55 112.358 -172.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.58 -138.94 9.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 125.173 1.368 . . . . 62.44 111.942 -155.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -117.86 155.22 30.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.907 -1.146 . . . . 72.11 107.907 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.59 152.41 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.958 1.303 . . . . 74.41 109.928 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -142.57 168.81 18.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.062 1.345 . . . . 75.43 108.492 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -154.74 175.03 14.23 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.803 -1.184 . . . . 74.02 107.803 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 tp -135.14 119.39 17.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.781 1.173 . . . . 74.2 110.508 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.9 m -84.12 118.56 24.18 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.791 -0.818 . . . . 73.51 108.791 169.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 t -125.98 94.93 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.433 -2.062 . . . . 73.22 105.433 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.409 ' H ' HD21 ' A' ' 75' ' ' LEU . 4.3 pt-20 -80.35 -8.65 59.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.336 -0.852 . . . . 75.34 113.236 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -88.55 -59.05 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.74 1.257 . . . . 74.02 108.454 -156.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.07 112.57 13.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 101.687 -3.449 . . . . 74.22 101.687 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.424 ' CG ' ' HA ' ' A' ' 176' ' ' SER . 23.8 m170 -69.31 50.39 0.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.606 1.962 . . . . 73.34 112.03 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.478 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -151.67 140.1 20.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.02 2.128 . . . . 54.04 108.697 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.432 ' CD1' ' HB1' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.81 178.79 8.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.077 1.351 . . . . 75.32 111.121 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.7 mm -112.19 135.79 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.481 -1.674 . . . . 74.41 106.481 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.08 159.85 43.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.682 -1.229 . . . . 71.41 107.682 160.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 140.47 -165.22 26.14 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.817 1.198 . . . . 74.24 111.043 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -110.91 170.65 7.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.365 1.078 . . . . 75.4 111.002 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.99 -80.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.146 2.578 . . . . 64.34 112.574 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.32 -3.95 8.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.477 . . . . 64.44 114.051 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 84.38 176.94 51.2 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 122.141 0.856 . . . . 72.53 111.927 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.489 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 3.8 m-85 -127.76 146.86 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.187 2.595 . . . . 74.14 106.2 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -95.56 132.0 41.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 119.21 -0.424 . . . . 74.32 110.69 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.4 m -145.71 167.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.19 0.996 . . . . 74.31 109.633 -169.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 71.3 m -63.02 142.81 58.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.167 1.787 . . . . 70.23 110.286 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.432 ' HB1' ' CD1' ' A' ' 163' ' ' TYR . . . -141.84 39.89 1.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.568 1.147 . . . . 75.42 111.623 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.424 ' HA ' ' CG ' ' A' ' 161' ' ' HIS . 70.9 m -60.06 124.29 19.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.704 -0.622 . . . . 74.1 111.558 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.8 p -59.18 -23.02 61.87 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.966 1.099 . . . . 74.12 113.966 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.19 118.2 5.5 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 106.898 -2.481 . . . . 54.32 106.898 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 14.6 t -64.8 -179.9 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.189 1.396 . . . . 74.31 110.302 175.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.9 tp 63.45 -89.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.256 1.822 . . . . 65.21 111.582 167.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -140.97 134.24 29.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.306 -2.479 . . . . 72.44 104.306 163.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -149.42 167.12 27.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.504 1.922 . . . . 72.44 106.614 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.77 154.49 44.28 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.753 0.821 . . . . 74.5 110.255 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.37 142.31 58.46 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.546 -0.909 . . . . 71.42 108.546 167.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.69 -170.74 2.99 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.035 1.334 . . . . 73.13 107.933 164.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.8 t60 . . . . . 0 C--O 1.248 0.979 0 N-CA-C 106.281 -1.748 . . . . 72.1 106.281 169.485 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.798 -0.445 . . . . 73.43 109.798 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -56.84 163.26 2.0 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.337 1.855 . . . . 74.43 108.838 160.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.5 t -69.64 -59.89 2.67 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.46 -0.775 . . . . 73.33 109.434 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.84 -133.17 7.5 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 104.678 -3.369 . . . . 75.52 104.678 -158.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -115.82 -79.37 0.59 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.531 -1.285 . . . . 74.2 107.531 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -153.17 160.77 42.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.195 0.598 . . . . 75.13 110.732 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.67 172.83 45.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.696 -1.762 . . . . 60.22 108.696 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -158.78 164.46 35.79 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.596 1.558 . . . . 73.43 108.024 162.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.49 151.82 21.78 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.253 1.421 . . . . 71.33 109.471 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.4 49.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.691 -0.686 . . . . 61.12 110.366 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -48.26 -31.51 6.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.651 1.98 . . . . 74.03 113.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -104.78 15.35 28.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.641 1.976 . . . . 74.31 112.23 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -79.46 114.24 43.65 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.551 -1.277 . . . . 72.54 107.551 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.02 136.33 29.37 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.422 2.748 . . . . 64.21 113.064 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.35 88.61 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.43 -1.322 . . . . 64.52 107.43 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -48.21 83.6 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.233 2.613 . . . . 73.43 113.347 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -65.44 163.97 14.76 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.243 1.017 . . . . 74.33 109.478 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 t -60.21 -39.77 87.74 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 119.027 -0.511 . . . . 73.21 109.812 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.9 -38.48 22.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.702 -0.799 . . . . 73.44 109.275 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.18 43.78 0.9 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 114.958 0.743 . . . . 74.53 114.958 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -8.66 23.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.135 1.902 . . . . 74.05 116.135 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.289 7.8 mm 61.49 25.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-O 124.648 2.166 . . . . 74.34 112.49 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 152.78 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 125.426 1.49 . . . . 74.54 108.915 -170.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.09 130.18 43.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.968 1.707 . . . . 75.53 108.851 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.7 tt -53.49 -33.43 21.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.23 1.412 . . . . 74.32 112.892 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.423 ' HA2' HG21 ' A' ' 29' ' ' VAL . . . -94.83 -13.67 52.36 Favored Glycine 0 C--O 1.219 -0.818 0 CA-C-O 117.28 -1.845 . . . . 62.23 112.782 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -73.47 -49.72 25.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.346 2.573 . . . . 65.24 109.073 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -49.2 -56.95 7.65 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.193 1.397 . . . . 74.23 109.568 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG21 ' HA2' ' A' ' 26' ' ' GLY . 34.4 m -67.6 -38.77 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 117.504 -1.236 . . . . 73.24 110.371 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -34.55 73.57 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 121.462 1.937 . . . . 61.43 111.334 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.1 pttt -52.25 -42.03 63.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.748 1.219 . . . . 75.02 111.249 171.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.8 m-85 -78.04 -47.25 18.81 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 117.703 -1.141 . . . . 64.34 110.507 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -53.86 -30.77 47.08 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.598 1.999 . . . . 74.43 112.358 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -57.94 4.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.528 1.531 . . . . 74.43 110.091 170.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -68.57 -58.33 4.44 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.802 -1.555 . . . . 75.3 106.802 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -86.81 40.17 0.89 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.494 1.517 . . . . 55.11 108.443 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -34.73 68.76 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.788 -1.195 . . . . 73.33 111.498 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.04 -28.19 65.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.272 0.471 . . . . 71.13 112.272 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.6 m -73.37 -2.1 20.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.721 0.637 . . . . 74.32 112.721 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.58 114.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.97 1.308 . . . . 71.23 109.433 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -114.06 113.33 24.6 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.492 -1.669 . . . . 74.3 106.492 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -73.45 142.18 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.045 -1.835 . . . . 72.4 106.045 164.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.96 176.78 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.571 -0.9 . . . . 74.13 108.571 159.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 -35.04 77.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.328 1.451 . . . . 73.52 112.306 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.2 -8.73 18.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.512 1.125 . . . . 72.52 112.67 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 7.82 64.37 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 127.939 2.685 . . . . 74.54 112.664 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.85 -83.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.977 1.711 . . . . 64.04 111.902 -160.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.48 101.49 1.13 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.623 -1.098 . . . . 54.21 111.805 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -108.16 163.35 13.24 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.598 0.823 . . . . 75.51 109.977 163.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.8 mt -145.45 143.54 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.427 1.891 . . . . 63.41 106.599 166.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.53 131.95 34.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.696 1.598 . . . . 64.02 111.148 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.82 -3.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.099 1.36 . . . . 75.24 112.768 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.95 -21.58 52.79 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 120.02 1.282 . . . . 54.11 114.627 -168.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -69.08 -5.41 21.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.759 1.224 . . . . 71.31 113.896 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.57 -19.29 62.01 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 119.649 -1.907 . . . . 74.33 112.201 164.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 m120 45.02 33.62 1.09 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.237 1.815 . . . . 75.1 112.576 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.56 169.04 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.595 1.958 . . . . 74.21 106.972 159.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.5 158.06 45.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.134 0.974 . . . . 72.31 109.151 166.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.03 157.14 33.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 126.138 1.775 . . . . 75.03 108.68 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 152.31 44.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.184 0.992 . . . . 75.2 108.56 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.1 p -147.53 -168.83 3.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 125.608 1.563 . . . . 72.45 106.96 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -152.3 137.71 17.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.066 -1.021 . . . . 74.21 108.742 177.476 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.6 114.9 18.88 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.426 -0.953 . . . . 72.42 108.426 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -61.83 -27.5 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.361 . . . . 74.23 111.25 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -35.67 -51.52 0.66 Allowed 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 129.324 3.05 . . . . 74.22 112.017 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.5 m -147.58 12.17 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.163 1.785 . . . . 74.54 110.694 -160.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt 52.82 41.93 31.82 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.447 1.499 . . . . 74.41 111.144 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.5 pt -96.61 173.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.261 1.024 . . . . 75.13 109.488 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.17 147.35 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.76 -1.57 . . . . 73.2 106.76 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -147.83 172.17 14.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 74.32 108.442 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -126.81 144.78 50.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.529 1.532 . . . . 63.31 107.168 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 161.56 35.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.312 0.645 . . . . 72.53 110.841 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -82.02 -35.24 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.239 0.829 . . . . 74.22 113.239 -170.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 mt 63.75 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 128.131 2.573 . . . . 74.51 109.685 -155.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.2 mt -142.53 -65.63 0.4 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.227 1.811 . . . . 63.43 106.4 -164.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -127.75 164.27 22.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.6 1.56 . . . . 74.44 111.258 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.24 172.59 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.52 1.928 . . . . 70.01 109.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -141.58 137.48 31.96 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.298 1.039 . . . . 73.51 110.163 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -129.16 131.92 47.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.043 1.337 . . . . 74.14 110.989 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -141.92 176.28 9.06 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 73.13 109.593 166.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.75 148.16 31.93 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.741 1.216 . . . . 75.24 109.268 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -142.75 160.06 41.04 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.231 0.923 . . . . 73.45 112.677 -167.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.79 109.67 1.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.32 1.448 . . . . 74.14 110.441 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.31 -171.45 35.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.874 1.216 . . . . 74.43 112.426 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -90.07 151.85 21.43 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.949 -1.324 . . . . 72.42 110.729 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.6 mt -130.77 153.94 48.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.104 1.362 . . . . 73.34 108.941 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.98 130.85 35.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.396 -1.335 . . . . 71.3 107.396 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -121.51 77.94 1.39 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.459 1.504 . . . . 73.45 107.304 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -70.2 103.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.775 2.03 . . . . 75.11 107.594 166.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -85.1 163.76 18.59 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.106 -1.442 . . . . 72.22 107.106 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -136.38 167.76 20.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.389 0.995 . . . . 74.11 108.441 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.4 ttmt -58.67 -30.07 67.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.563 -1.336 . . . . 75.23 113.113 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -73.25 15.39 0.23 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.71 1.141 . . . . 73.31 112.283 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 92' ' ' LYS . 8.3 mmt180 47.69 35.47 4.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 128.776 2.83 . . . . 74.44 110.885 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -73.63 167.32 21.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.002 -1.11 . . . . 74.23 108.002 157.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -170.93 161.12 6.93 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.46 1.904 . . . . 74.11 106.199 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.536 HG21 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -143.69 169.26 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 129.833 3.253 . . . . 65.33 109.268 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.4 m -153.33 98.56 2.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.543 1.537 . . . . 71.22 110.564 -175.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.64 173.25 16.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.733 1.613 . . . . 74.42 109.921 -170.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -68.83 167.93 14.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.267 1.027 . . . . 72.53 112.619 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.09 -46.61 67.33 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.841 -0.537 . . . . 75.12 110.608 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.1 38.87 1.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.439 -0.948 . . . . 64.2 108.439 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -84.26 134.62 42.84 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.315 -0.994 . . . . 73.24 108.315 174.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.48 133.62 38.0 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.258 1.972 . . . . 73.44 111.111 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 178.78 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.825 1.65 . . . . 73.12 108.554 167.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -116.48 142.65 46.59 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.572 -0.705 . . . . 72.34 109.704 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.77 165.15 32.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.44 1.496 . . . . 73.14 109.52 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 133.44 40.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.922 1.289 . . . . 74.45 107.91 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -122.66 74.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.109 1.364 . . . . 74.32 107.518 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m 65.85 7.64 4.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.975 1.31 . . . . 74.51 113.679 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.3 -9.71 4.4 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.312 0.958 . . . . 51.41 112.053 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -101.3 117.52 35.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.042 -1.836 . . . . 71.21 106.042 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.07 126.54 28.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.404 -1.332 . . . . 64.5 107.404 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.91 140.5 49.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.074 1.749 . . . . 74.11 107.084 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.15 131.61 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.115 -1.068 . . . . 74.42 108.115 166.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.2 pt -145.59 -167.09 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.78 2.032 . . . . 73.43 107.997 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.76 143.5 27.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.887 1.275 . . . . 74.12 110.091 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.63 -35.67 42.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.213 1.405 . . . . 73.14 113.125 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -17.6 64.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.216 1.191 . . . . 71.25 114.216 -172.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -25.57 28.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.489 1.116 . . . . 73.54 111.575 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 t -72.18 63.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 128.805 2.842 . . . . 72.31 110.492 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -78.63 -178.42 5.88 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.029 -1.044 . . . . 74.44 109.152 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.52 -13.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.309 1.843 . . . . 75.54 113.755 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.73 4.38 66.05 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.559 -1.69 . . . . 72.34 113.435 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.09 135.53 39.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 120.275 2.038 . . . . 75.12 106.657 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -76.87 122.48 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.772 -1.566 . . . . 75.55 106.772 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.65 147.49 6.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.541 -1.651 . . . . 75.43 106.541 164.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.87 136.33 35.36 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.517 -1.29 . . . . 75.34 107.517 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.83 154.51 76.04 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 124.568 1.147 . . . . 74.5 111.608 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.6 150.49 31.56 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.562 2.175 . . . . 75.0 108.548 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -123.69 -171.05 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.148 -1.797 . . . . 73.43 106.148 161.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -40.63 -68.58 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.311 1.445 . . . . 74.03 112.72 -168.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -120.95 -1.37 9.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.859 1.664 . . . . 72.54 111.266 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 64.3 p -139.94 165.51 27.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.131 0.878 . . . . 75.44 111.199 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -79.33 155.03 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.431 -1.322 . . . . 72.25 107.431 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.42 -178.04 5.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.272 1.429 . . . . 73.22 107.307 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.64 149.39 47.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.387 -1.709 . . . . 73.33 106.387 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -147.91 131.37 16.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.193 1.797 . . . . 73.41 106.729 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -62.44 157.2 20.69 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.211 0.46 . . . . 73.23 109.951 -176.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 78.7 t -93.76 2.1 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.993 1.717 . . . . 73.14 111.807 -171.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.448 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.6 pt 24.11 -86.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 128.985 2.914 . . . . 74.14 115.366 170.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.448 ' H ' HG13 ' A' ' 141' ' ' ILE . 34.5 ttpt -97.03 109.41 22.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.35 1.46 . . . . 72.41 107.44 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 p -110.76 119.07 58.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.883 -1.154 . . . . 61.45 107.883 164.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -133.77 -178.54 5.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.774 1.63 . . . . 75.34 108.558 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.66 136.1 52.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.084 0.954 . . . . 75.12 108.485 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.4 m -94.04 162.17 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.102 -1.073 . . . . 74.0 108.102 167.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 151.09 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.226 1.011 . . . . 73.42 108.488 159.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -159.07 131.8 6.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.513 1.051 . . . . 74.12 109.851 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -142.35 59.71 1.45 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.204 -0.935 . . . . 74.23 110.048 -167.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.96 -131.82 3.33 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.168 1.366 . . . . 75.02 112.703 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -114.84 161.7 17.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.074 1.35 . . . . 64.31 109.438 168.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.92 156.04 39.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 125.464 1.505 . . . . 74.44 109.05 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -146.53 159.29 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.509 -0.923 . . . . 74.34 108.509 -168.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -148.38 173.5 13.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.101 -1.074 . . . . 73.12 108.101 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -131.73 134.92 46.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.226 1.41 . . . . 75.23 109.324 -163.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.3 m -70.85 -50.64 33.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 118.562 -0.732 . . . . 72.44 112.096 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 t 24.58 68.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.561 2.745 . . . . 74.1 111.385 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.35 -6.16 44.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.255 1.026 . . . . 75.42 112.516 -166.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.88 -58.59 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.083 1.753 . . . . 75.04 108.874 -163.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -119.36 -1.12 10.81 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.024 1.33 . . . . 70.32 112.923 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.9 m170 58.67 28.3 17.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.536 1.535 . . . . 74.25 112.17 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.453 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 22.2 p -141.64 140.82 33.36 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.378 -1.451 . . . . 72.31 111.208 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.417 ' CD2' ' CB ' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -134.89 175.16 9.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.705 1.202 . . . . 75.23 111.717 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.2 mm -107.14 122.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 N-CA-C 106.95 -1.5 . . . . 71.1 106.95 168.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.48 160.33 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.511 0.725 . . . . 72.53 109.245 170.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 137.37 -167.34 24.77 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 109.865 -1.294 . . . . 64.13 109.865 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -112.3 167.26 10.57 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 121.332 -1.099 . . . . 75.33 109.277 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 64.62 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.226 1.811 . . . . 74.11 112.38 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.04 -15.73 7.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.488 1.04 . . . . 72.54 112.787 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 174.6 46.61 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 123.286 1.492 . . . . 73.32 113.254 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 97' ' ' ILE . 12.8 m-85 -127.32 147.28 50.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.186 2.594 . . . . 73.23 106.949 -172.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.62 112.66 24.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.903 -1.517 . . . . 74.22 106.903 173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.33 175.97 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.888 1.675 . . . . 74.13 109.045 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -61.08 138.59 58.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.842 0.857 . . . . 72.24 110.18 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.417 ' CB ' ' CD2' ' A' ' 163' ' ' TYR . . . -124.18 57.93 1.21 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 128.976 2.91 . . . . 65.24 107.473 169.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 42.4 m -103.29 110.96 23.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.315 -2.105 . . . . 75.4 105.315 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 7.7 t -50.11 -57.82 6.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.909 1.684 . . . . 74.42 110.839 -174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.7 48.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.376 0 N-CA-C 108.144 -1.982 . . . . 63.33 108.144 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.4 p -101.76 131.78 47.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.204 1.401 . . . . 74.42 109.021 -166.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 42.6 tp 65.24 -51.93 0.35 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.601 2.76 . . . . 70.24 113.218 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 73.2 158.77 0.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.442 2.697 . . . . 71.04 112.027 -171.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . 0.496 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 23.7 t-160 46.15 -138.13 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.662 1.585 . . . . 72.11 108.884 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.496 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 52.1 t-80 -126.74 143.56 51.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.942 -1.503 . . . . 75.35 106.942 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -137.6 152.4 49.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.625 -1.25 . . . . 73.54 107.625 154.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -79.72 139.18 37.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.0 1.72 . . . . 74.12 106.744 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 . . . . . 0 C--O 1.254 1.302 0 N-CA-C 108.099 -1.075 . . . . 65.11 108.099 -170.053 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 118.398 -0.81 . . . . 75.21 110.946 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.53 162.47 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.728 2.011 . . . . 73.44 111.217 -161.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.9 m -75.67 -65.98 0.83 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.144 -0.687 . . . . 72.51 109.144 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.76 71.19 0.68 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.515 -0.634 . . . . 73.34 111.515 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -80.97 52.14 1.7 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.616 1.166 . . . . 75.24 112.724 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -128.08 153.23 47.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.114 -1.809 . . . . 72.14 106.114 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.57 -172.57 28.75 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.397 -1.439 . . . . 51.14 109.545 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 163.92 164.23 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.81 2.844 . . . . 63.43 109.518 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -98.51 160.98 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.431 1.892 . . . . 73.32 110.233 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 154.76 30.64 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 123.211 0.605 . . . . 60.11 111.247 170.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -50.33 -32.09 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.353 1.861 . . . . 73.42 114.494 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -105.45 12.73 31.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.584 . . . . 70.43 112.946 -164.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -79.81 132.62 60.43 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.769 1.227 . . . . 73.31 108.974 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.49 149.55 90.55 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.551 2.834 . . . . 74.22 113.732 162.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 pt -114.47 -5.15 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.143 1.777 . . . . 73.45 112.862 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 55.53 73.38 0.43 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.452 1.024 . . . . 74.24 111.342 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.44 159.64 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.676 -0.64 . . . . 70.31 109.364 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 m -56.56 -34.03 66.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.379 -0.819 . . . . 73.44 112.247 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -86.93 -28.98 22.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.694 0.679 . . . . 72.03 110.295 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.05 41.32 1.97 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.717 1.151 . . . . 72.12 114.493 166.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.88 -27.14 62.99 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 115.209 1.559 . . . . 74.12 115.209 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mm 45.77 73.97 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.564 2.345 . . . . 74.45 108.69 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 174.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.791 2.036 . . . . 71.41 108.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.4 135.59 33.44 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.187 1.395 . . . . 73.32 107.811 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 tt -55.38 -28.75 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.079 -1.013 . . . . 72.43 112.08 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.86 -14.51 57.86 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 116.465 -2.297 . . . . 72.51 114.845 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -66.2 -50.01 65.32 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.122 2.461 . . . . 74.51 108.327 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -56.54 -59.17 5.38 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.626 1.97 . . . . 74.45 108.47 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG11 ' CE1' ' A' ' 33' ' ' PHE . 69.1 t -56.77 -47.33 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.135 -0.484 . . . . 73.53 111.166 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -41.69 74.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.824 0.85 . . . . 75.11 110.809 -176.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -51.32 45.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.351 1.06 . . . . 74.04 109.328 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.64 -43.87 65.34 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.152 0.981 . . . . 73.34 108.449 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.415 ' CE1' HG11 ' A' ' 29' ' ' VAL . 3.4 m-85 -56.01 -38.74 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.323 1.42 . . . . 71.41 111.895 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -83.51 -22.45 32.48 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.507 1.123 . . . . 74.41 111.124 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -88.27 -58.65 2.48 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.969 -1.493 . . . . 75.42 106.969 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.5 m-30 -91.88 45.91 1.25 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 129.192 2.997 . . . . 75.2 108.313 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -34.86 64.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.225 -0.922 . . . . 73.32 111.226 172.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -77.99 6.2 8.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.425 . . . . 74.12 112.979 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -106.29 -9.88 16.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 117.179 -1.391 . . . . 74.41 111.322 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.29 99.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 120.089 1.313 . . . . 73.02 108.618 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -85.2 159.84 20.03 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.72 -0.844 . . . . 64.31 108.72 160.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -136.48 133.74 36.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.889 -2.263 . . . . 72.24 104.889 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.77 177.3 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.755 0.659 . . . . 62.3 109.459 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -40.6 77.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.343 1.457 . . . . 63.45 112.237 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -19.54 63.43 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.362 -0.836 . . . . 73.05 111.46 174.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.43 65.1 1.7 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 107.775 -2.13 . . . . 75.04 107.775 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.64 -100.7 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.698 -1.964 . . . . 75.12 105.698 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.49 120.34 1.17 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.992 -2.043 . . . . 65.21 107.992 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -139.16 162.21 35.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.839 0.819 . . . . 72.43 110.092 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.2 mt -143.93 139.99 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 126.508 1.923 . . . . 64.15 105.85 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.75 133.11 35.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.497 1.519 . . . . 71.15 109.163 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.32 4.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 125.841 1.657 . . . . 73.3 112.169 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.07 -10.82 7.52 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.855 1.207 . . . . 75.31 114.173 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.16 -15.74 56.42 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.337 -1.684 . . . . 65.53 112.507 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.45 -12.66 61.84 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.981 1.264 . . . . 75.2 113.407 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.53 -2.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.894 2.078 . . . . 73.11 113.705 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 141.33 16.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.169 1.387 . . . . 72.42 107.477 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.99 157.03 22.02 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.021 0.828 . . . . 63.11 109.547 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.23 144.54 28.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 126.645 1.978 . . . . 73.24 107.337 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -63.77 130.63 44.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.602 -1.629 . . . . 75.43 106.602 165.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.1 p -136.74 -169.18 2.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.632 -1.618 . . . . 75.24 106.632 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.4 OUTLIER -146.17 143.76 29.5 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.31 -1.367 . . . . 65.03 107.31 171.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -86.41 116.22 24.42 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 124.964 1.306 . . . . 73.53 108.357 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.92 -27.98 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.676 0.79 . . . . 74.52 111.876 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.67 -22.42 65.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.637 0.653 . . . . 74.01 112.288 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m -137.57 3.0 2.5 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.746 1.218 . . . . 72.41 112.628 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.47 35.84 24.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.493 1.497 . . . . 64.43 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.47 154.91 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.203 1.801 . . . . 71.41 109.41 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.95 129.53 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.458 -1.682 . . . . 74.42 106.458 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -148.68 178.79 8.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.721 1.608 . . . . 74.14 108.443 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -105.77 150.1 25.84 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.465 -1.397 . . . . 74.22 109.287 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.6 160.11 39.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 169.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -92.4 -17.93 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.048 0.758 . . . . 64.5 113.048 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mt 58.7 147.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.883 2.073 . . . . 75.43 109.429 -160.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.14 -57.24 2.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.996 0.919 . . . . 75.21 108.7 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -129.76 150.76 50.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.364 0.983 . . . . 75.14 110.298 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -112.55 168.28 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 125.188 1.395 . . . . 73.32 109.204 176.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -135.44 153.2 51.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.177 0.991 . . . . 75.44 109.788 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.94 142.82 29.08 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.374 0.67 . . . . 71.11 109.612 169.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.47 156.64 47.91 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.403 -1.703 . . . . 75.11 106.403 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -84.24 159.18 21.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.117 -1.438 . . . . 74.22 107.117 165.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -139.9 153.94 47.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.196 0.998 . . . . 75.31 110.201 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -149.93 152.9 35.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.77 -0.826 . . . . 72.4 108.77 139.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.17 -171.66 32.13 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 109.394 -1.482 . . . . 64.13 109.394 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.5 120.31 30.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.757 -1.201 . . . . 74.04 107.757 170.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 160.58 15.96 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.617 -1.253 . . . . 73.0 107.617 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mm -79.34 140.71 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.162 1.385 . . . . 75.12 107.651 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -126.81 58.23 1.42 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.197 0.599 . . . . 74.43 110.287 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.9 mt -63.34 116.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 105.62 -1.993 . . . . 63.45 105.62 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -94.98 155.48 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 105.384 -2.08 . . . . 64.35 105.384 163.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -125.44 169.17 12.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.883 1.273 . . . . 74.51 108.221 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -67.57 -11.14 57.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.588 -1.32 . . . . 72.43 111.814 -172.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -3.23 53.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.661 1.585 . . . . 72.44 113.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.09 12.77 8.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.701 1.6 . . . . 75.43 111.571 -171.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -68.09 165.57 17.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.262 -1.014 . . . . 75.44 108.262 163.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -173.19 164.14 4.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.768 2.027 . . . . 72.43 109.027 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.463 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 2.3 pt -144.84 165.99 11.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.033 2.133 . . . . 73.53 107.54 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -140.34 97.87 3.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.841 0.857 . . . . 75.51 109.256 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.84 172.25 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.762 1.625 . . . . 73.41 111.547 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.4 p -61.03 154.61 22.25 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.991 1.316 . . . . 75.53 110.754 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -74.14 -26.15 60.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.465 -0.772 . . . . 71.12 111.369 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -97.72 37.74 1.36 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.623 0.647 . . . . 64.43 110.054 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -90.94 123.38 64.92 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-O 117.807 -1.092 . . . . 73.51 108.108 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.67 139.01 61.48 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.659 1.573 . . . . 64.4 111.094 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.56 -162.3 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.766 1.627 . . . . 71.32 108.772 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -134.02 133.09 40.84 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.223 1.009 . . . . 71.05 110.56 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.45 161.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.383 1.473 . . . . 74.21 109.414 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.24 120.95 28.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.518 1.151 . . . . 60.1 110.751 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.37 77.51 9.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.264 1.826 . . . . 74.24 106.159 150.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.2 17.01 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.655 1.354 . . . . 71.35 114.655 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.48 -28.55 3.99 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 124.919 1.247 . . . . 64.55 111.398 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.06 20.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.635 -2.358 . . . . 74.44 104.635 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.55 134.7 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.288 -1.004 . . . . 74.5 108.288 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.39 153.18 48.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.501 -1.296 . . . . 71.43 107.501 176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -112.63 114.16 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.377 1.471 . . . . 73.21 109.499 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -136.73 174.03 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.769 2.028 . . . . 73.54 108.596 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.03 148.78 21.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.073 0.851 . . . . 74.33 110.912 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.48 -29.21 9.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.207 1.803 . . . . 64.34 114.162 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.01 1.277 . . . . 61.22 111.928 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 22.6 mtm -87.35 -19.91 27.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.185 0.994 . . . . 71.14 111.613 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 t -71.19 63.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 129.516 3.126 . . . . 64.04 112.239 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -78.5 -179.95 6.69 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.764 -1.835 . . . . 65.42 110.35 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.49 -10.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.652 2.381 . . . . 75.34 113.995 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.88 -3.01 83.63 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 124.629 1.109 . . . . 61.23 112.892 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.89 152.65 31.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.45 -1.685 . . . . 72.33 106.45 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.62 131.68 55.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.645 -1.613 . . . . 74.35 106.645 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -106.89 126.84 62.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.793 0.837 . . . . 72.42 108.803 -168.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.57 122.35 17.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.674 1.19 . . . . 73.41 108.884 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.19 155.83 70.6 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 113.348 0.87 . . . . 73.12 113.348 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.33 151.97 82.25 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.549 2.166 . . . . 75.15 111.006 167.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HB2' HD21 ' A' ' 136' ' ' ASN . 0.0 OUTLIER -121.69 -160.34 0.86 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.007 1.723 . . . . 74.31 106.806 158.54 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -48.28 -61.58 1.92 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.316 1.046 . . . . 62.1 110.858 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -121.0 -17.86 7.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.088 1.355 . . . . 74.55 112.843 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -140.59 170.84 15.03 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.426 1.09 . . . . 75.54 110.742 -165.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -79.91 154.34 4.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.867 0.841 . . . . 73.2 110.662 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.442 HD21 ' HB2' ' A' ' 131' ' ' LYS . 15.5 m-80 -143.89 -171.42 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.179 1.792 . . . . 74.45 106.829 166.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.1 mt -125.28 168.88 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.419 -0.956 . . . . 72.42 108.419 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.83 161.99 40.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.812 0.845 . . . . 64.15 110.937 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -74.7 140.68 44.33 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 127.32 2.248 . . . . 70.43 110.693 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.54 1.03 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.023 1.329 . . . . 75.23 112.61 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.468 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.7 pt 24.33 -75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 129.882 3.273 . . . . 73.42 117.238 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.468 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -93.12 126.09 38.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.909 2.484 . . . . 74.23 109.537 -170.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.18 121.91 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.316 0.646 . . . . 74.31 110.505 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.75 -171.9 0.49 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.238 3.015 . . . . 74.01 109.445 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.9 p -132.29 174.25 10.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.827 2.051 . . . . 74.31 107.98 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.0 m -110.18 -178.25 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.439 -1.319 . . . . 75.21 107.439 151.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.46 113.65 15.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.783 -1.562 . . . . 64.23 106.783 168.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -129.99 160.88 32.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.356 1.462 . . . . 73.14 109.806 -165.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.17 47.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.344 1.458 . . . . 74.13 109.663 -162.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -117.17 -150.57 9.23 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.964 1.745 . . . . 75.41 110.212 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -98.0 157.1 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.793 0.796 . . . . 75.14 109.797 159.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 19.2 pt -122.08 151.26 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 126.537 1.935 . . . . 75.11 107.929 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -136.87 151.18 48.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.791 1.236 . . . . 75.35 111.118 -170.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.0 -177.85 6.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.913 0.885 . . . . 75.34 111.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.76 121.98 9.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.311 1.844 . . . . 70.44 107.772 -152.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.53 -37.09 32.19 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-O 116.13 -1.891 . . . . 74.25 114.72 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p 24.61 73.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.771 2.028 . . . . 75.52 112.708 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 12.3 pt-20 -66.02 -10.06 36.33 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.492 -1.38 . . . . 74.1 113.602 -170.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.52 -72.37 0.17 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.825 2.05 . . . . 72.14 106.066 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.83 -19.25 17.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.685 1.594 . . . . 73.15 111.729 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 158' ' ' GLU . 51.4 m170 48.31 39.72 12.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.062 2.145 . . . . 72.24 112.658 -162.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.421 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 14.0 p -152.48 143.92 23.37 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.043 1.292 . . . . 74.43 109.32 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.465 ' CD2' ' HB3' ' A' ' 175' ' ' ALA . 4.0 p90 -136.08 172.88 12.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.488 1.515 . . . . 65.44 110.082 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.2 mm -103.32 138.26 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.915 -1.513 . . . . 64.53 106.915 157.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -163.15 160.23 23.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.048 0.939 . . . . 74.53 110.295 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 131.17 -163.02 23.63 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.279 1.418 . . . . 55.34 110.731 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -104.9 170.26 7.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.0 1.9 . . . . 72.54 112.049 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 56.9 -72.42 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 129.695 3.198 . . . . 75.32 111.685 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.62 -14.98 8.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.469 1.508 . . . . 75.45 113.493 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.04 171.75 9.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 122.726 1.181 . . . . 74.43 112.412 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.463 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 39.0 m-85 -126.49 144.78 50.75 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 126.861 2.064 . . . . 75.34 109.118 -170.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.9 114.57 13.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.26 1.424 . . . . 72.23 108.243 166.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.92 -179.29 3.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.618 0.767 . . . . 75.53 110.789 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -72.65 144.25 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.79 0.836 . . . . 75.22 108.951 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.465 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . . . -145.52 60.87 1.28 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.291 1.836 . . . . 74.14 109.425 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.7 p -76.96 172.23 13.51 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 122.427 1.108 . . . . 64.23 111.466 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -53.83 128.91 31.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.979 0.912 . . . . 74.12 109.039 168.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.9 -63.63 5.09 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.282 -0.727 . . . . 62.24 111.282 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 p -80.31 165.31 22.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 74.31 111.241 171.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 21.8 tp -66.56 -53.02 39.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.436 1.094 . . . . 75.44 110.509 168.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 60.39 28.47 18.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.613 1.565 . . . . 70.12 113.035 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -136.38 111.15 8.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.424 -1.325 . . . . 72.2 107.424 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.22 -170.75 0.11 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.014 1.325 . . . . 55.11 111.683 -173.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.16 -72.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.276 1.43 . . . . 72.54 107.683 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' A' ' 186' ' ' HIS . 2.4 t60 -144.63 -160.17 1.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.209 -1.404 . . . . 75.42 107.209 162.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.527 ' H ' ' CG ' ' A' ' 185' ' ' HIS . 1.7 t-80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 125.123 1.369 . . . . 72.33 110.131 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 120.534 0.207 . . . . 73.32 110.84 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -135.77 158.21 44.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.771 2.029 . . . . 74.22 107.298 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 m -71.18 -25.95 62.75 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.013 -0.429 . . . . 52.05 109.948 166.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.59 145.88 8.4 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 108.647 -1.781 . . . . 73.33 108.647 -168.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -140.31 -178.97 5.73 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.073 2.149 . . . . 72.24 105.858 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -103.86 -174.49 2.56 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.909 -1.145 . . . . 73.31 107.909 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.35 168.92 13.29 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 124.664 1.126 . . . . 73.42 110.958 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.23 174.8 3.29 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 128.781 2.832 . . . . 63.0 106.048 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -113.93 178.09 4.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.774 1.63 . . . . 75.21 109.548 172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.17 -169.21 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.183 1.793 . . . . 71.01 113.667 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.466 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t80 -94.29 -45.67 7.39 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.947 1.299 . . . . 74.24 109.931 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.33 -0.41 56.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.434 1.493 . . . . 75.42 112.058 -167.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 156.6 76.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.03 -1.044 . . . . 75.31 110.579 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -92.92 143.8 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.334 3.356 . . . . 74.31 113.351 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.26 -2.0 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.325 1.231 . . . . 72.11 114.325 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 53.71 73.41 0.38 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.454 1.101 . . . . 74.52 111.974 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.64 162.83 1.06 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.476 -0.765 . . . . 73.4 109.596 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.9 t -49.03 -40.39 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.108 0.963 . . . . 61.34 110.732 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -81.24 -20.59 40.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.282 0.845 . . . . 74.34 113.282 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.21 28.93 8.25 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.518 1.056 . . . . 65.45 113.041 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -15.34 63.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 118.37 2.73 . . . . 72.34 118.37 -163.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 mm 43.79 78.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.014 2.525 . . . . 74.42 109.643 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.3 154.16 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.631 1.973 . . . . 72.22 107.487 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.475 ' HB2' ' H ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -62.26 129.63 41.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.889 1.276 . . . . 73.54 107.584 171.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -53.19 -39.4 34.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 109.569 -0.53 . . . . 72.41 109.569 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.466 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -46.19 -59.71 4.99 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 125.014 1.292 . . . . 74.5 111.337 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' H ' ' HB2' ' A' ' 24' ' ' ASN . 38.5 tp10 -69.14 -48.55 62.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.197 -0.906 . . . . 72.42 110.454 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -45.7 -53.1 9.89 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.554 1.142 . . . . 74.31 109.614 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.8 t -69.7 -45.36 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.485 -0.779 . . . . 74.53 109.486 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.412 ' CG ' ' HZ3' ' A' ' 34' ' ' LYS . 25.7 t70 -59.87 -37.94 80.75 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.842 -1.161 . . . . 73.35 113.223 -175.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -55.96 -38.13 69.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.903 1.681 . . . . 74.54 110.784 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 15.8 m-85 -73.84 -49.17 26.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.19 1.396 . . . . 75.23 108.638 172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.18 -37.98 62.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.177 1.808 . . . . 73.24 113.301 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HZ3' ' CG ' ' A' ' 30' ' ' ASP . 0.5 OUTLIER -76.21 -30.34 57.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.01 -0.995 . . . . 71.1 111.829 179.005 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -85.08 -52.11 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.413 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 2.0 m-30 -93.5 41.36 1.08 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.716 2.007 . . . . 74.21 108.256 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -27.79 68.57 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.576 -1.328 . . . . 71.34 112.142 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -62.42 -27.98 69.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.944 1.698 . . . . 75.53 113.304 168.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.346 1.858 . . . . 75.15 112.86 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.3 mt -66.39 89.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.976 1.262 . . . . 70.24 109.764 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -79.71 161.27 25.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.992 1.717 . . . . 74.44 108.528 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -143.32 122.28 12.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.05 1.34 . . . . 73.2 108.884 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.92 169.76 17.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.651 -0.87 . . . . 75.44 108.651 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -54.47 34.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.91 2.084 . . . . 75.14 111.137 -173.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.04 3.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.356 1.462 . . . . 60.14 113.295 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.67 18.99 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 126.927 2.204 . . . . 73.34 110.853 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -86.0 -99.97 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.409 1.084 . . . . 74.44 108.156 -173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.01 111.01 0.68 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-O 117.754 -1.581 . . . . 73.41 110.726 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -114.19 164.6 13.65 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.229 1.514 . . . . 75.51 111.537 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mt -145.36 144.04 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 128.125 2.57 . . . . 74.32 105.266 164.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -83.06 114.7 21.47 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.81 -1.182 . . . . 74.02 107.81 166.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.96 13.59 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.854 0.862 . . . . 74.2 109.98 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.93 -31.91 82.41 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 120.19 -1.569 . . . . 62.4 111.334 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.64 -1.51 7.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.719 1.208 . . . . 72.3 114.245 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -74.67 -18.25 60.56 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.872 -0.518 . . . . 75.0 111.088 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.29 18.85 11.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.24 2.216 . . . . 52.02 113.624 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -82.33 131.03 34.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.292 -1.373 . . . . 75.1 107.292 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -96.67 161.58 13.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.362 1.465 . . . . 63.15 109.476 173.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.87 149.58 19.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.722 1.609 . . . . 75.13 108.72 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -68.99 121.43 16.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.278 -1.379 . . . . 75.52 107.278 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 163' ' ' TYR . 0.4 OUTLIER -117.81 -177.55 3.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.044 1.338 . . . . 54.42 108.384 171.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.2 OUTLIER -137.71 132.22 32.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.369 -1.715 . . . . 74.11 106.369 169.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.17 106.35 13.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.321 -0.992 . . . . 72.34 108.321 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 71.5 tttt -55.84 -18.55 8.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.327 1.851 . . . . 73.14 113.984 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.95 -34.55 78.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.448 1.099 . . . . 74.3 112.121 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.3 m -125.51 -1.55 7.46 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.054 0.942 . . . . 73.03 112.501 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.81 44.09 17.41 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.122 -0.986 . . . . 75.45 110.487 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 pt -108.6 157.24 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.941 1.696 . . . . 74.45 109.151 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.65 128.71 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.03 -1.47 . . . . 73.25 107.03 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -135.71 175.21 9.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.491 1.116 . . . . 75.52 112.758 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.62 96.64 3.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.245 -2.131 . . . . 74.24 105.245 -157.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -125.14 172.0 9.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.079 0.952 . . . . 73.42 110.575 -165.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -116.28 153.08 32.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.93 0.786 . . . . 75.31 109.382 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.56 154.77 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.798 -1.186 . . . . 70.32 107.798 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 -20.62 6.75 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.918 0.781 . . . . 65.4 112.639 169.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -161.7 163.74 29.56 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.2 -1.563 . . . . 71.25 108.478 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.97 161.25 32.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.095 0.958 . . . . 65.15 109.11 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -135.7 149.34 49.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.38 1.072 . . . . 74.31 110.416 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -146.2 142.24 28.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.124 0.875 . . . . 75.35 110.527 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -146.17 163.19 36.17 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.288 2.235 . . . . 74.25 107.274 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.7 tttm -107.48 156.4 19.02 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.612 -1.255 . . . . 74.5 107.612 164.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -153.64 163.08 40.6 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.975 1.31 . . . . 72.02 108.82 -166.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -151.67 113.92 4.53 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.116 -1.809 . . . . 75.32 106.116 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.52 -146.54 5.31 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 117.095 -2.479 . . . . 62.05 112.209 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 104.54 8.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.407 1.883 . . . . 72.41 107.801 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.69 162.91 20.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.73 1.612 . . . . 74.31 106.887 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.8 mm -79.5 135.25 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 127.057 2.143 . . . . 73.11 107.37 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -125.4 79.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.635 -1.617 . . . . 74.54 106.635 161.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.0 mt -59.21 141.07 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.345 -2.094 . . . . 75.11 105.345 152.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -115.16 164.28 14.43 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.621 -1.992 . . . . 71.42 105.621 163.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -136.02 169.73 17.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.822 1.192 . . . . 74.23 108.909 166.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.06 -21.63 66.3 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.675 -1.265 . . . . 73.22 112.759 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -66.49 -1.13 3.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.366 1.866 . . . . 65.24 112.72 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.3 22.41 10.75 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.025 1.73 . . . . 72.54 111.358 -165.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.79 168.71 19.33 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.865 -0.791 . . . . 63.43 108.865 163.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 174.6 163.15 0.22 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 129.05 2.94 . . . . 73.32 110.401 -167.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 3.0 pt -140.12 172.49 12.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.723 1.209 . . . . 71.33 110.436 -170.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 97' ' ' ILE . 27.1 m -152.27 94.82 1.97 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.124 0.969 . . . . 75.03 109.713 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.11 177.59 10.91 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 128.408 2.683 . . . . 73.33 109.261 -174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.9 p -78.4 171.49 15.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 120.649 1.568 . . . . 63.04 110.657 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -69.91 -19.67 63.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.13 0.972 . . . . 74.21 111.371 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -109.64 38.02 2.48 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.422 -0.799 . . . . 73.44 110.761 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -107.15 133.72 20.2 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.868 -0.79 . . . . 72.44 108.868 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.32 118.1 5.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.671 2.914 . . . . 74.21 113.251 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.35 -179.32 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.664 1.586 . . . . 71.44 109.954 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.17 144.72 49.17 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.223 0.92 . . . . 72.34 111.15 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 pt -134.88 165.49 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.112 0.965 . . . . 73.32 109.871 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.1 p -94.42 110.02 21.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.968 0.507 . . . . 64.34 109.666 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -85.8 81.35 8.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.578 -2.008 . . . . 73.43 105.578 167.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.1 32.47 4.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.473 1.109 . . . . 74.14 113.196 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.25 -9.42 42.36 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.693 -1.059 . . . . 55.41 114.339 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -84.5 131.21 34.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 119.389 1.595 . . . . 70.24 106.881 167.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.08 117.78 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.039 -1.467 . . . . 71.43 107.039 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 151.19 45.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.885 1.274 . . . . 75.44 108.65 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.2 121.3 44.92 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.53 1.132 . . . . 72.54 109.683 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 15.6 pt -140.74 -175.96 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.789 0.836 . . . . 74.23 110.498 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -92.87 142.91 26.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.198 1.399 . . . . 72.25 108.704 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.11 65.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.35 0.977 . . . . 60.0 113.544 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -32.32 66.14 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.196 1.362 . . . . 71.22 112.596 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -23.85 36.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.563 1.145 . . . . 73.02 112.195 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.97 64.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.029 2.532 . . . . 74.51 111.653 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.79 -179.77 7.11 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.425 -1.422 . . . . 71.12 111.878 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 p -55.59 -9.86 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 128.421 2.689 . . . . 74.43 114.005 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.71 -15.97 79.92 Favored Glycine 0 CA--C 1.523 0.59 0 O-C-N 121.279 -0.888 . . . . 51.33 111.554 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.33 164.87 13.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.634 1.217 . . . . 73.21 108.92 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 13.1 m-85 -113.41 137.9 50.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.218 -1.401 . . . . 74.0 107.218 167.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.4 132.46 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.613 -1.255 . . . . 70.21 107.613 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.41 124.53 23.42 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.5 -0.926 . . . . 73.13 108.5 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.33 154.5 81.04 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.899 1.68 . . . . 72.33 110.096 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.57 149.43 84.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.401 1.401 . . . . 63.3 110.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -120.62 -145.39 0.36 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.568 -1.641 . . . . 73.33 106.568 149.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.85 -70.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.145 1.378 . . . . 73.32 111.155 -162.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -120.09 -2.79 10.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.596 0.758 . . . . 74.23 112.764 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 167.32 21.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.434 1.093 . . . . 75.32 111.257 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.2 tp -78.84 156.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.139 0.971 . . . . 74.4 108.686 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.93 -173.76 3.89 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 127.601 2.361 . . . . 73.51 107.226 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 40.6 mt -135.43 136.52 41.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.387 -2.079 . . . . 74.41 105.387 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -133.7 153.98 51.29 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.717 -1.216 . . . . 70.43 107.717 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 18.1 tt0 -96.77 136.87 36.7 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.841 2.056 . . . . 74.43 107.88 -161.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.296 46.9 t -79.98 1.05 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 114.479 1.288 . . . . 73.21 114.479 -158.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.7 pt 26.61 -98.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.158 2.583 . . . . 74.24 115.405 172.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.403 ' H ' HG13 ' A' ' 141' ' ' ILE . 22.5 ttpt -90.56 122.5 33.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.411 -1.43 . . . . 73.34 108.067 173.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.62 117.49 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.251 -1.388 . . . . 73.31 107.251 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.83 -165.57 2.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.832 1.653 . . . . 73.44 108.909 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 p -121.92 171.33 9.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.017 1.327 . . . . 71.3 110.179 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.3 m -130.56 131.75 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.712 -1.218 . . . . 63.3 107.712 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.02 109.54 17.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.374 -1.343 . . . . 75.33 107.374 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -133.23 136.18 45.43 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.802 2.041 . . . . 72.03 106.909 -163.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -140.63 43.86 1.85 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.784 -0.572 . . . . 75.54 110.233 -155.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.81 8.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.391 0.996 . . . . 74.55 112.897 -165.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.15 155.52 24.95 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.977 -0.719 . . . . 74.01 110.408 165.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.4 pt -132.36 147.21 32.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 127.712 2.405 . . . . 74.13 106.961 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.4 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 3.5 m-85 -132.79 164.68 26.28 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.786 -1.19 . . . . 75.0 107.786 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -153.66 177.39 11.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.528 -1.286 . . . . 73.35 107.528 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.9 mt -140.56 163.81 31.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.719 1.145 . . . . 73.42 110.819 -167.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.1 m -118.58 110.38 17.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.926 1.691 . . . . 73.33 107.054 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.2 77.72 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.808 2.043 . . . . 70.53 106.808 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.378 10.9 pt-20 -72.87 2.2 7.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.109 1.364 . . . . 75.21 113.995 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.5 -56.61 11.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 128.438 2.695 . . . . 71.13 109.74 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.6 t30 -133.24 -4.33 3.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.128 0.971 . . . . 72.43 111.861 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.4 m80 66.65 21.34 10.65 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.284 1.434 . . . . 73.5 112.219 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.418 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 4.5 p -142.22 139.73 32.09 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.486 -0.931 . . . . 74.23 108.486 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -137.82 176.64 8.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.876 0.87 . . . . 75.03 110.281 -175.636 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.8 mm -98.76 120.1 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 165.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.26 133.79 24.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.947 -1.131 . . . . 65.43 107.947 167.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.54 177.05 33.3 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.723 2.106 . . . . 72.44 108.065 168.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -75.34 178.74 5.63 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.366 -2.255 . . . . 74.32 110.622 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.61 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.079 1.752 . . . . 70.32 112.468 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -122.13 -8.5 8.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.433 1.893 . . . . 75.05 114.177 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 88.1 164.13 39.91 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.549 1.547 . . . . 73.32 113.482 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 97' ' ' ILE . 9.1 m-85 -108.19 159.66 16.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.32 1.448 . . . . 74.11 109.044 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -102.1 102.08 12.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.215 1.806 . . . . 73.13 106.7 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.74 177.08 6.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.243 1.017 . . . . 75.15 109.684 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 75.0 m -66.55 139.15 57.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.472 -0.936 . . . . 72.2 108.472 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.12 39.63 3.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.033 2.533 . . . . 75.15 109.28 172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.1 p -59.76 130.78 48.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.691 -0.855 . . . . 74.43 108.691 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.1 p -77.65 168.11 20.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.139 0.427 . . . . 75.12 110.721 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.43 111.74 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 126.476 1.989 . . . . 73.11 109.917 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 172.77 0.12 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.876 2.47 . . . . 55.32 112.645 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 36.3 tp -56.88 -67.54 0.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.148 0.979 . . . . 75.23 110.744 -172.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -157.38 -35.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.666 0.667 . . . . 75.33 112.619 159.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 12.5 t60 57.98 22.77 9.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.65 2.78 . . . . 75.13 115.194 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.08 179.86 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.508 -0.745 . . . . 74.45 111.449 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -85.34 -61.64 1.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.509 -0.552 . . . . 75.21 109.509 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -72.27 155.94 39.65 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.336 1.065 . . . . 75.4 110.97 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 C--O 1.248 1.009 0 C-N-CA 130.775 3.63 . . . . 62.25 101.486 -174.535 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.675 -0.491 . . . . 73.05 109.675 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -153.88 0.16 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 71.22 110.234 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 m 75.62 15.38 2.67 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.526 1.93 . . . . 75.33 110.562 -167.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.99 19.18 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 1 C-N-CA 131.298 4.285 . . . . 62.31 117.089 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -136.54 87.04 2.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.481 1.912 . . . . 72.02 106.043 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -149.82 178.48 8.86 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.787 2.435 . . . . 71.34 109.383 -160.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.29 -132.95 7.9 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.554 1.074 . . . . 71.45 110.725 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 155.4 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.845 3.258 . . . . 74.23 109.312 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.73 166.69 10.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.281 3.032 . . . . 71.35 109.016 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 178.97 1.2 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.165 1.386 . . . . 74.02 112.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -75.84 -34.33 60.08 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.427 -0.796 . . . . 75.04 110.522 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.45 25.53 11.56 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.678 1.228 . . . . 74.52 112.436 -161.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.05 126.39 82.04 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 125.36 1.464 . . . . 70.3 109.141 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -67.14 102.76 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.33 2.687 . . . . 63.11 108.89 168.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 pt -78.17 140.88 16.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.818 1.19 . . . . 71.43 108.964 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.14 83.32 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.525 -1.657 . . . . 74.54 106.525 -177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.8 mt -58.97 154.7 14.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.72 -0.845 . . . . 71.12 108.72 168.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -61.92 -20.4 63.73 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.2 -0.313 . . . . 72.43 110.188 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.74 -29.65 70.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.633 1.973 . . . . 61.43 112.736 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.88 4.61 67.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.238 1.399 . . . . 72.43 112.314 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.19 -39.36 72.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.632 1.716 . . . . 63.51 115.073 -156.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mm 57.02 96.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 127.73 2.412 . . . . 64.44 108.841 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 157.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.679 -1.971 . . . . 62.41 105.679 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -67.04 119.25 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.581 -1.637 . . . . 63.54 106.581 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -50.79 -35.85 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.292 0.637 . . . . 75.44 110.153 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.38 -30.94 63.97 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-O 118.2 -1.334 . . . . 72.33 112.734 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -63.36 -55.91 20.63 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 119.917 1.858 . . . . 75.35 108.894 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -48.48 -49.61 34.97 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 125.341 1.456 . . . . 65.42 110.397 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -76.33 -40.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 118.087 -0.958 . . . . 73.13 110.109 -174.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -64.58 -29.38 70.4 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 120.723 1.601 . . . . 72.54 110.873 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -43.85 52.67 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.871 1.268 . . . . 72.22 110.335 170.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.6 -46.18 22.95 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.325 -1.321 . . . . 75.35 110.03 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.405 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 8.4 m-85 -54.85 -34.32 62.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 122.182 2.264 . . . . 74.45 113.08 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -84.81 -22.39 29.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.637 1.175 . . . . 74.54 110.616 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -63.29 1.32 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.701 -1.222 . . . . 75.05 107.701 172.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -84.26 39.77 0.73 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.184 2.594 . . . . 75.43 109.192 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.5 -36.74 55.85 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 70.03 111.181 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -71.05 -13.49 62.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.306 1.842 . . . . 75.14 113.381 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.06 5.76 26.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.268 1.427 . . . . 75.23 112.379 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 105.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.518 -1.29 . . . . 71.43 107.518 171.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -103.85 107.18 17.94 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.051 0.541 . . . . 72.41 109.72 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -70.69 154.7 41.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.745 -0.835 . . . . 73.11 108.745 168.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -113.85 171.64 7.47 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.246 1.818 . . . . 73.42 107.181 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -54.26 21.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.185 1.794 . . . . 65.55 111.239 -175.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.35 -18.79 65.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.82 0.848 . . . . 64.41 111.381 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.27 -1.78 22.35 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.867 1.699 . . . . 71.11 113.643 160.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -50.46 -79.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.305 1.842 . . . . 63.03 111.81 -164.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.48 110.43 2.85 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.055 -1.618 . . . . 73.33 109.055 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -110.62 168.78 9.21 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.233 1.013 . . . . 74.33 109.635 165.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mt -143.91 136.22 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.97 -1.863 . . . . 74.21 105.97 166.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.2 125.32 26.62 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.677 -0.86 . . . . 75.42 108.677 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.27 3.85 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.914 0.885 . . . . 74.51 110.768 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.22 -31.23 72.78 Favored Glycine 0 CA--C 1.524 0.65 0 O-C-N 121.331 -0.856 . . . . 72.15 113.188 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -60.45 -13.63 14.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.565 1.182 . . . . 64.15 113.025 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.62 -21.09 37.38 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.98 -1.075 . . . . 73.14 111.662 167.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.93 24.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.677 2.391 . . . . 73.33 113.441 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.32 113.66 9.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.773 -1.566 . . . . 75.43 106.773 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -79.16 150.78 31.61 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.162 0.585 . . . . 75.21 110.97 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.6 tt -112.36 157.83 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.65 1.58 . . . . 64.1 108.296 170.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -63.6 110.27 1.94 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.751 -1.944 . . . . 74.24 105.751 162.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.57 175.65 5.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.107 1.363 . . . . 75.44 107.807 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.416 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -149.95 120.72 7.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.452 -1.314 . . . . 63.53 107.452 174.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.82 118.67 17.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.202 -0.936 . . . . 71.33 109.547 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -63.86 -31.74 73.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.588 0.355 . . . . 74.51 110.989 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -41.74 6.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.164 1.785 . . . . 75.21 111.692 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -136.91 15.59 3.07 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 74.24 111.399 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.5 47.6 8.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.834 1.654 . . . . 74.41 112.51 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.06 160.54 3.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 124.875 1.27 . . . . 74.22 108.434 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.86 149.68 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.801 -1.555 . . . . 74.44 106.801 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -178.69 7.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.287 2.235 . . . . 62.05 110.227 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -124.98 130.96 53.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.047 1.339 . . . . 73.4 107.715 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -151.6 160.04 43.82 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.403 1.081 . . . . 65.34 108.78 163.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -83.36 178.11 8.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.152 0.981 . . . . 75.54 110.687 163.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -95.12 170.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.848 2.059 . . . . 72.34 106.194 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.66 -61.71 1.49 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.044 -1.465 . . . . 73.31 107.044 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -126.72 152.11 47.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.941 -1.133 . . . . 73.14 107.941 -171.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.17 159.74 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 125.46 1.504 . . . . 70.12 107.646 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -137.84 156.31 48.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.733 0.813 . . . . 75.41 112.071 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.7 139.54 26.61 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.394 1.478 . . . . 74.42 111.521 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -148.5 155.8 41.62 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.161 0.984 . . . . 72.13 108.901 168.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -79.62 153.28 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.818 -1.176 . . . . 72.52 109.248 170.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.94 157.37 43.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.605 1.562 . . . . 74.12 108.538 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 p -161.96 97.45 1.04 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.141 0.976 . . . . 60.45 111.681 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.2 -172.78 45.76 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.675 -1.266 . . . . 63.51 112.652 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -85.05 116.15 23.27 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.132 0.573 . . . . 74.42 110.845 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.79 165.83 12.1 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.863 1.665 . . . . 74.14 109.214 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.91 134.4 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 126.053 1.741 . . . . 73.34 109.669 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -123.61 82.82 2.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.995 -1.483 . . . . 74.34 106.995 164.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.8 mt -57.96 132.6 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.173 -2.158 . . . . 74.44 105.173 153.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -106.08 166.0 10.82 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.119 -1.808 . . . . 74.51 106.119 159.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.09 169.89 16.48 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.579 1.081 . . . . 63.24 109.558 165.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -63.82 -25.24 68.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.071 -1.018 . . . . 60.34 112.022 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.94 -0.17 0.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.196 2.598 . . . . 55.5 113.133 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 59.85 22.46 11.4 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 127.06 2.144 . . . . 72.52 111.333 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.486 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 2.6 ttm180 -75.64 163.52 27.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.213 -0.929 . . . . 73.22 108.756 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 167.99 4.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.636 0.775 . . . . 75.31 110.093 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.474 HG21 ' CE1' ' A' ' 171' ' ' PHE . 4.8 pt -147.97 178.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.998 1.719 . . . . 62.21 110.993 -173.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 17.7 m -149.99 103.48 3.21 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.639 1.576 . . . . 72.33 110.788 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.11 169.54 17.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 119.584 -1.947 . . . . 73.13 112.615 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -62.22 144.91 54.89 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.198 1.399 . . . . 74.24 109.203 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.95 -20.72 64.21 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.651 -1.281 . . . . 52.53 112.143 -169.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -101.12 39.65 1.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.353 1.461 . . . . 54.0 110.672 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.69 143.08 25.7 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.16 -1.588 . . . . 74.24 109.729 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.75 137.24 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.014 2.476 . . . . 71.13 111.842 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.17 -177.4 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.915 1.686 . . . . 73.43 108.376 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.28 141.92 51.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.382 1.446 . . . . 75.33 111.303 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.36 171.32 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.858 1.263 . . . . 73.52 109.644 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.1 p -103.32 96.65 6.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.819 0.848 . . . . 73.1 111.005 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -82.29 89.06 6.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.325 -2.102 . . . . 73.33 105.325 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 44.13 44.51 6.39 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.05 1.34 . . . . 75.32 112.012 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.15 -31.81 8.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 118.097 -1.391 . . . . 74.22 113.608 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -79.51 144.94 33.5 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 119.798 1.799 . . . . 74.11 108.063 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.18 123.06 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.937 -1.134 . . . . 75.5 107.937 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 tp -123.06 159.47 28.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.664 -0.865 . . . . 72.02 108.664 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.46 104.05 11.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.438 1.495 . . . . 64.11 110.875 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 pt -129.96 -178.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.178 0.991 . . . . 65.02 112.136 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.16 134.52 34.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.343 0.974 . . . . 71.43 108.808 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.68 -38.44 55.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.861 1.06 . . . . 73.21 113.861 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 1.5 pp20? -67.19 -16.7 64.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.817 1.043 . . . . 75.04 113.817 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 35.6 mtt -83.16 -25.18 32.1 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.773 0.829 . . . . 71.01 110.436 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.35 62.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 127.754 2.422 . . . . 75.51 109.453 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 24.7 mmtp -79.72 -174.17 4.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.416 1.087 . . . . 74.41 108.707 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.79 -12.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.249 2.22 . . . . 73.22 113.38 167.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.91 -4.76 89.63 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 117.97 -1.461 . . . . 72.01 112.063 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -132.14 172.39 12.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.909 1.854 . . . . 62.21 110.834 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.427 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 9.4 m-85 -116.66 119.45 35.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.171 1.788 . . . . 74.15 106.346 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 tp -83.19 130.32 35.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.851 -1.166 . . . . 72.12 107.851 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -70.73 116.46 11.06 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.146 -1.057 . . . . 72.41 108.146 170.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.8 153.09 63.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.224 1.41 . . . . 75.2 112.035 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 153.61 52.4 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.602 2.201 . . . . 73.53 110.867 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.69 179.24 6.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.053 2.541 . . . . 73.44 107.218 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -25.41 -67.08 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.499 2.32 . . . . 75.51 113.911 -169.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -120.35 -0.55 10.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.381 1.872 . . . . 74.04 111.298 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.0 p -143.21 -171.27 3.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.211 1.004 . . . . 73.32 111.972 -154.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.47 153.17 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.855 -1.165 . . . . 63.0 107.855 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -145.8 -175.64 4.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.604 2.761 . . . . 73.31 106.163 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.99 161.27 19.65 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.724 1.21 . . . . 74.33 110.377 170.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -148.13 152.91 38.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.277 2.231 . . . . 74.45 106.804 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.427 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 19.2 mt-10 -77.13 147.4 36.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.689 1.595 . . . . 74.32 110.029 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.13 1.04 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.012 0.745 . . . . 73.15 113.012 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 29.47 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 128.161 2.584 . . . . 75.43 116.176 170.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.3 tppt? -100.33 128.36 46.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 120.804 -1.185 . . . . 73.01 107.942 174.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.65 128.21 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.64 -1.245 . . . . 75.53 107.64 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.55 -177.75 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.406 2.282 . . . . 64.53 107.216 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.9 p -117.86 170.44 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.964 -1.085 . . . . 70.42 109.339 167.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.21 124.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 107.003 -1.48 . . . . 75.24 107.003 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -86.16 114.35 22.93 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.904 1.229 . . . . 73.43 107.826 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -120.16 139.16 53.04 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.645 1.578 . . . . 74.35 107.299 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.55 81.92 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.502 -0.925 . . . . 74.32 108.502 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.83 -121.06 1.12 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.13 1.824 . . . . 62.41 111.273 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -136.84 152.57 50.41 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.232 -1.157 . . . . 73.24 109.703 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.3 pt -116.82 156.3 18.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.363 1.865 . . . . 74.45 108.267 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -138.14 150.92 47.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.841 1.257 . . . . 73.31 107.942 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -129.08 166.5 19.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.744 0.702 . . . . 74.53 109.96 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 127.16 42.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.111 1.365 . . . . 71.43 108.894 -170.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.5 m -71.08 -58.0 3.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.758 -0.639 . . . . 60.43 110.773 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.2 t 25.94 64.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 129.516 3.126 . . . . 71.32 112.567 -170.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -72.58 0.17 11.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.923 1.689 . . . . 74.14 113.027 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.19 -70.65 0.32 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.964 1.305 . . . . 74.12 108.526 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -93.6 0.31 56.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.615 0.766 . . . . 74.51 111.151 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.9 m170 65.21 26.48 12.31 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.736 2.014 . . . . 70.02 111.835 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.416 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 40.2 p -145.16 167.09 23.6 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.915 -1.115 . . . . 74.11 109.952 -175.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.404 ' CD1' ' HB3' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.37 171.4 17.25 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.779 1.632 . . . . 73.33 109.527 176.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.6 mm -105.84 119.46 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.619 -1.252 . . . . 72.33 107.619 167.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -150.82 146.7 26.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.176 0.99 . . . . 74.35 109.977 171.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.64 177.88 23.26 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 128.063 2.744 . . . . 63.44 109.015 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -73.46 166.55 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.238 -1.742 . . . . 73.31 110.347 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 70.01 -71.7 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.617 2.367 . . . . 63.2 114.808 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.28 -19.27 5.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.772 1.229 . . . . 73.41 114.241 165.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 164.22 40.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.969 2.223 . . . . 44.1 113.62 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.486 ' CE1' ' HD2' ' A' ' 95' ' ' ARG . 56.6 m-85 -104.18 151.99 22.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.855 2.062 . . . . 72.12 108.302 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.22 111.71 23.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.785 2.034 . . . . 71.33 106.936 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.27 166.97 20.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 119.065 0.848 . . . . 74.22 110.472 -169.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.3 t -66.25 139.97 58.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.281 1.432 . . . . 64.21 109.841 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . . . -137.3 70.36 1.4 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.32 2.648 . . . . 75.32 106.969 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.0 t -111.59 50.0 0.86 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.964 -1.71 . . . . 73.05 111.821 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . 0.251 97.5 p 60.33 59.8 2.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.597 1.959 . . . . 64.33 110.924 -174.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.55 80.75 0.12 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 125.343 1.449 . . . . 72.35 111.938 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.7 p 56.95 -172.63 0.08 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.991 2.516 . . . . 74.41 112.492 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 13.4 tp -128.73 26.39 5.58 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.051 -1.031 . . . . 73.23 113.028 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 95.84 165.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.945 3.298 . . . . 73.12 109.527 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.22 143.52 33.26 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.166 -0.959 . . . . 71.25 110.023 163.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.36 -102.7 0.28 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 116.868 -1.539 . . . . 54.22 110.181 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -142.31 95.86 2.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.497 1.953 . . . . 71.55 112.123 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.63 156.41 43.64 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.005 1.322 . . . . 71.03 108.231 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.2 m170 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 130.153 3.381 . . . . 74.24 107.696 -176.213 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 119.452 -0.308 . . . . 70.24 110.203 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 m120 54.12 -174.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.835 2.854 . . . . 65.25 113.144 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -103.54 -5.04 23.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.945 1.698 . . . . 61.05 111.018 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.67 2.2 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.427 -1.069 . . . . 63.21 110.427 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 56.8 -79.29 0.01 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.096 2.158 . . . . 75.31 110.773 -168.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.7 167.05 31.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.505 1.522 . . . . 74.11 109.305 -172.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.06 165.54 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.162 -0.775 . . . . 73.01 111.162 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -172.92 -174.45 1.09 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.347 1.859 . . . . 71.04 111.448 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -106.2 -178.03 3.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 129.538 3.135 . . . . 72.35 109.376 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.0 -156.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.472 1.109 . . . . 72.54 112.342 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.48 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.6 t80 -103.1 -30.58 10.64 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 71.44 110.414 164.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -116.72 29.67 7.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.768 2.427 . . . . 73.43 110.785 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -100.71 134.73 20.36 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.734 -0.839 . . . . 62.32 108.734 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.09 138.21 25.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.819 2.346 . . . . 74.14 112.921 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 28.5 pt -102.11 7.09 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 114.974 1.472 . . . . 64.4 114.974 -172.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 36.28 74.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.287 1.835 . . . . 73.11 114.226 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 152.42 2.35 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.471 -0.937 . . . . 74.25 108.471 164.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -54.41 -36.19 63.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.193 0.451 . . . . 74.41 111.459 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.0 -19.53 62.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.958 1.303 . . . . 71.42 112.657 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.56 18.23 33.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 117.961 -1.466 . . . . 71.23 112.643 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -38.38 64.93 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.601 1.7 . . . . 75.22 113.821 -167.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.81 96.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.448 2.699 . . . . 73.32 108.977 -170.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.25 146.87 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.414 -1.699 . . . . 75.23 106.414 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.95 135.96 53.21 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.415 1.886 . . . . 63.14 108.079 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.4 tt -51.3 -43.08 28.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.443 1.097 . . . . 63.1 110.812 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.48 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -71.36 -41.21 59.29 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-O 117.961 -1.466 . . . . 45.23 110.377 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -58.06 -44.06 87.25 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 120.78 2.29 . . . . 74.5 112.167 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.89 -59.71 4.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.656 1.582 . . . . 73.02 109.06 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.9 t -68.4 -44.54 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.402 -0.363 . . . . 64.1 110.589 -171.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.24 -32.14 73.47 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.171 -0.956 . . . . 75.01 109.608 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -50.83 -52.54 40.37 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.43 -0.794 . . . . 74.2 109.882 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -66.21 -41.81 89.63 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.768 -1.197 . . . . 65.43 107.768 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -60.71 -31.0 70.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.78 1.627 . . . . 70.22 112.827 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -19.03 32.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 125.387 1.475 . . . . 74.21 111.696 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -94.92 -63.75 1.14 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.269 -1.752 . . . . 75.02 106.269 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -82.02 43.28 0.77 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.355 2.662 . . . . 71.32 108.585 -173.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -50.89 -40.28 56.22 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.395 1.478 . . . . 73.14 110.187 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -59.02 -35.5 73.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.593 1.157 . . . . 74.1 112.965 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 m -77.17 -6.08 51.6 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.636 1.175 . . . . 72.31 113.768 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -65.37 95.26 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 119.807 1.185 . . . . 72.41 108.749 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -79.18 157.11 27.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.303 -1.74 . . . . 64.1 106.303 163.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -126.77 145.9 50.44 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.266 -2.124 . . . . 73.22 105.266 159.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.75 177.43 8.67 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.111 0.882 . . . . 62.33 110.332 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -49.23 -50.02 40.38 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.229 2.212 . . . . 61.2 111.911 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -70.66 -9.28 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.061 1.344 . . . . 73.11 112.137 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.37 56.18 2.89 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 127.235 2.35 . . . . 72.2 109.447 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -85.37 -100.19 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.609 -1.256 . . . . 75.22 107.609 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.85 123.77 0.99 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 107.79 -2.124 . . . . 74.43 107.79 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 160.35 41.34 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.276 1.538 . . . . 74.42 110.93 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -143.2 149.71 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.822 2.049 . . . . 70.42 106.637 172.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.81 135.24 37.78 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.031 1.332 . . . . 63.52 109.575 165.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.09 25.52 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.33 2.252 . . . . 75.43 109.592 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.67 1.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 127.788 2.613 . . . . 63.32 115.694 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.06 -10.92 13.42 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.429 2.615 . . . . 72.41 114.785 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -28.44 63.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 121.347 1.885 . . . . 74.33 111.846 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 11.87 2.24 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.821 1.648 . . . . 72.32 113.339 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 mt -67.53 127.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.694 1.598 . . . . 73.23 109.48 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -94.6 142.83 26.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.564 1.146 . . . . 63.34 110.384 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.26 152.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.244 2.218 . . . . 74.02 106.961 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -68.49 105.67 2.29 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.265 -1.754 . . . . 70.43 106.265 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -96.36 -176.48 3.66 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.852 -1.166 . . . . 73.43 107.852 167.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.45 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -143.73 141.91 30.69 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.572 -1.64 . . . . 75.11 106.572 171.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.76 96.0 9.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -55.45 -21.21 15.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.644 0.778 . . . . 74.02 112.823 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -44.48 1.43 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.075 2.15 . . . . 75.35 112.024 167.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -139.03 0.91 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.088 0.955 . . . . 61.03 112.336 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mt 63.92 59.84 1.08 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.193 1.797 . . . . 73.44 110.743 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.73 153.09 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.768 1.627 . . . . 71.21 109.254 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.8 138.98 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.965 -1.124 . . . . 75.55 107.965 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -144.26 172.36 13.03 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.062 1.745 . . . . 72.23 107.977 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.34 131.68 54.33 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.286 -1.375 . . . . 74.11 107.286 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.43 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.3 mmpt? -141.33 155.74 45.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.587 -1.634 . . . . 75.43 106.587 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.71 124.42 49.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.95 0.795 . . . . 74.22 110.478 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.61 154.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.103 2.161 . . . . 73.4 109.084 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.2 -50.43 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.02 1.728 . . . . 74.5 110.504 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -134.2 160.04 39.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.0 1.727 . . . . 75.25 110.418 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.98 161.22 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 74.12 109.441 -177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.04 154.84 46.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.848 1.259 . . . . 75.03 110.417 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 148.78 19.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.378 0.99 . . . . 74.01 111.092 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -141.16 169.35 17.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.152 -1.425 . . . . 73.42 107.152 157.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -89.36 154.26 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.901 -1.148 . . . . 74.11 107.901 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -148.17 156.89 43.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.178 -1.045 . . . . 73.13 108.178 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -149.02 117.38 6.47 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.131 -1.433 . . . . 73.52 107.131 162.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.07 -179.1 44.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.382 -1.39 . . . . 52.34 112.057 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 98.98 11.7 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.515 1.126 . . . . 75.31 110.207 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.16 153.79 29.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.105 -1.442 . . . . 74.4 107.105 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.9 139.16 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.522 -0.918 . . . . 65.21 108.522 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HE2' ' OE1' ' A' ' 96' ' ' GLU . 48.8 tttm -130.54 70.69 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.476 1.51 . . . . 75.35 107.243 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.44 148.04 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 105.269 -2.123 . . . . 74.24 105.269 161.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 167.75 10.51 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 105.309 -2.108 . . . . 72.43 105.309 162.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.2 p -135.86 168.2 19.76 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.933 0.788 . . . . 72.11 109.696 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -24.17 67.65 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.728 1.149 . . . . 75.23 112.741 -168.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.31 4.38 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.043 1.337 . . . . 73.11 111.615 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 60.08 26.49 15.84 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.859 2.063 . . . . 72.45 112.229 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.45 173.09 11.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 165.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -177.61 167.28 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.854 1.662 . . . . 74.51 107.92 -175.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.508 HG22 ' CE1' ' A' ' 171' ' ' PHE . 2.8 pt -141.82 171.4 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 125.834 1.654 . . . . 72.4 108.688 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.92 101.28 3.02 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.776 -1.194 . . . . 74.55 107.776 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 168.62 24.7 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.874 1.27 . . . . 53.2 110.083 -171.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.9 p -58.29 147.5 30.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.215 1.006 . . . . 72.34 110.37 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.94 -16.33 63.72 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.002 0.741 . . . . 73.52 113.002 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -117.01 39.49 3.22 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.767 1.627 . . . . 75.12 110.563 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -77.57 131.22 71.73 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.77 -1.109 . . . . 75.2 110.262 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.4 101.12 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 125.026 3.817 . . . . 74.34 112.903 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.68 178.25 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.005 1.722 . . . . 75.4 109.783 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -122.85 139.21 54.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.557 -0.714 . . . . 73.13 111.144 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.78 163.98 35.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.591 1.156 . . . . 74.31 110.54 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.6 t -88.65 121.09 30.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.081 1.419 . . . . 63.5 111.676 172.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.51 78.0 1.81 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.32 1.848 . . . . 73.11 106.854 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m 69.75 0.8 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.235 1.569 . . . . 72.42 115.235 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.76 -33.68 1.39 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.08 -1.608 . . . . 74.12 109.08 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.73 131.27 35.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.97 1.308 . . . . 62.44 108.525 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.04 99.0 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.31 -1.367 . . . . 73.35 107.31 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.37 161.49 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.393 0.677 . . . . 73.55 109.372 172.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.95 126.42 49.94 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.762 2.025 . . . . 74.22 107.989 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.6 pt -149.54 176.99 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.926 1.291 . . . . 75.13 110.442 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.32 142.03 45.19 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.793 1.237 . . . . 74.34 108.434 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.8 20.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.998 0.919 . . . . 75.31 112.612 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.31 -11.38 60.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.928 1.24 . . . . 75.12 113.827 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.7 mmt -82.11 -28.43 32.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.921 1.237 . . . . 71.24 111.103 169.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.1 t -75.49 63.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 128.728 2.811 . . . . 74.03 111.585 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 124' ' ' GLY . 12.3 mmmt -79.16 -178.34 6.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.072 -1.017 . . . . 75.22 109.6 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.34 0.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 128.092 2.557 . . . . 73.51 114.033 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -99.32 -1.88 56.77 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 117.768 -1.573 . . . . 44.41 112.693 174.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.63 136.35 46.44 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 106.414 -1.699 . . . . 62.33 106.414 -163.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.66 109.94 21.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.824 1.25 . . . . 75.02 108.973 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.69 133.1 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.456 1.102 . . . . 74.45 108.714 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.3 132.21 46.08 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.028 -0.73 . . . . 73.5 109.028 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.426 HG23 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -126.28 155.87 73.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.357 1.863 . . . . 74.53 110.143 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.38 145.14 37.76 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.988 1.792 . . . . 74.44 109.382 172.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 -158.99 0.67 Allowed 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.976 -1.12 . . . . 73.33 107.976 167.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.51 -62.28 1.75 Allowed 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.89 0.876 . . . . 72.2 111.203 -160.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.3 0.69 9.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.799 1.037 . . . . 74.34 113.799 166.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.7 p -122.36 -167.02 1.49 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.51 1.524 . . . . 75.53 110.12 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.97 156.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.741 1.216 . . . . 72.25 107.778 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -144.87 -176.69 5.18 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.729 2.012 . . . . 72.42 108.406 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.1 mt -118.42 161.78 19.41 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.072 1.349 . . . . 73.45 108.148 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -152.02 154.84 36.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.569 1.548 . . . . 72.14 106.976 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -88.65 144.74 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.264 1.426 . . . . 71.43 108.918 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 -1.33 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 73.43 113.38 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 142' ' ' LYS . 4.1 pt 31.86 -76.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 129.171 2.989 . . . . 75.32 117.112 173.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' H ' HG13 ' A' ' 141' ' ' ILE . 39.7 ttmt -118.28 131.75 56.33 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.991 1.716 . . . . 73.3 108.459 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.65 121.72 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.634 1.174 . . . . 74.12 108.331 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -145.14 -169.47 3.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.361 1.464 . . . . 73.31 108.057 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -135.27 166.07 23.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.547 1.139 . . . . 74.4 109.572 -171.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.55 129.85 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.907 -1.516 . . . . 74.13 106.907 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.88 113.89 19.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.679 -1.971 . . . . 73.52 105.679 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.507 ' C ' HD21 ' A' ' 149' ' ' ASN . 28.8 t80 -127.6 132.64 49.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.131 1.772 . . . . 74.23 108.864 -165.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.507 HD21 ' C ' ' A' ' 148' ' ' TYR . 2.4 m120 -134.16 42.07 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.263 -0.898 . . . . 72.43 109.8 -157.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.0 -175.38 15.17 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.478 1.513 . . . . 70.42 111.44 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -72.15 147.46 46.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.72 -0.845 . . . . 75.25 108.72 161.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 27.7 pt -124.7 127.08 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.533 1.933 . . . . 72.52 106.472 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -112.83 162.12 16.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.815 -1.179 . . . . 73.41 107.815 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.28 164.09 35.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 73.14 109.601 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 67.5 mt -120.31 164.22 16.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.876 1.27 . . . . 73.34 111.137 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.7 m -101.31 -34.04 9.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.258 -1.337 . . . . 74.21 112.703 -164.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 17.5 t 24.52 74.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 130.325 3.45 . . . . 75.44 111.548 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -78.81 -9.0 59.31 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.307 -0.871 . . . . 75.44 112.043 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -62.15 1.75 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.116 2.166 . . . . 75.14 108.594 -168.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -120.73 5.17 10.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.639 0.977 . . . . 71.03 113.639 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m170 52.97 23.9 3.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.673 1.589 . . . . 74.14 112.267 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -149.11 136.89 20.49 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 119.542 -1.974 . . . . 73.32 108.878 176.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.419 ' CE1' ' CG2' ' A' ' 173' ' ' VAL . 3.7 p90 -141.15 167.56 21.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.829 0.852 . . . . 74.41 110.981 -173.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 mm -103.12 134.13 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 124.37 1.068 . . . . 74.45 108.423 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.43 138.4 14.44 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.517 1.527 . . . . 73.45 108.702 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.72 170.96 20.35 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 125.338 1.446 . . . . 52.5 109.631 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -72.39 164.14 26.83 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.821 -1.988 . . . . 74.3 109.917 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 68.59 -74.47 0.08 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.474 2.309 . . . . 73.2 114.934 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -121.45 -15.65 8.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.316 1.446 . . . . 65.4 112.442 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 74.89 161.64 8.85 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 122.332 0.962 . . . . 73.12 114.128 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.508 ' CE1' HG22 ' A' ' 97' ' ' ILE . 19.1 m-85 -112.01 163.53 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.761 2.425 . . . . 45.41 107.228 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.57 117.19 29.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.062 0.846 . . . . 73.34 108.917 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.419 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 26.8 m -97.03 173.11 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 119.862 1.21 . . . . 71.51 108.989 173.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.0 m -66.56 147.83 52.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.107 -1.072 . . . . 64.44 108.107 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.79 159.99 25.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.943 0.897 . . . . 53.21 108.62 161.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.7 m -164.97 176.92 8.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.35 -1.722 . . . . 74.14 106.35 152.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 p -68.93 164.68 21.63 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.96 1.255 . . . . 61.52 109.267 150.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 26.36 98.71 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 129.46 3.41 . . . . 61.34 113.78 145.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.3 p -40.07 126.43 2.1 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.603 1.561 . . . . 70.35 110.752 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.8 tt -40.17 -51.34 2.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.54 1.936 . . . . 74.24 110.902 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 153.2 41.05 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.943 1.697 . . . . 72.52 108.446 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.92 168.5 21.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.248 1.419 . . . . 72.33 108.44 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -166.03 117.75 1.05 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.238 -1.023 . . . . 75.33 108.238 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -127.33 139.38 52.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.829 -1.545 . . . . 74.12 106.829 168.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -146.99 -22.28 0.41 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.285 0.634 . . . . 74.1 112.128 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 C-N-CA 127.132 2.173 . . . . 65.23 107.631 156.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 105.082 -2.192 . . . . 62.22 105.082 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.5 m120 30.59 88.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 128.216 2.606 . . . . 75.23 111.894 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.0 m -25.05 -60.62 0.06 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.54 2.736 . . . . 63.44 112.799 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.73 123.41 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.257 -1.137 . . . . 73.41 110.257 166.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -110.51 179.46 4.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.445 1.098 . . . . 74.55 110.723 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.9 123.28 20.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.653 -1.24 . . . . 73.1 107.653 166.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.3 174.0 36.16 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 108.939 -1.664 . . . . 73.0 108.939 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 166.27 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 128.334 2.654 . . . . 64.54 106.678 -163.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.8 mp -88.33 157.9 18.59 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.752 0.821 . . . . 75.43 109.985 -175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.68 156.3 20.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.456 1.102 . . . . 53.1 111.13 172.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.04 -40.13 60.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.07 1.348 . . . . 74.13 112.63 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.63 1.9 54.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.267 -0.873 . . . . 73.32 112.714 -165.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' OE1' ' HE2' ' A' ' 167' ' ' LYS . 11.8 mm-40 -77.95 140.29 62.26 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 120.592 1.542 . . . . 73.24 111.336 -164.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.19 133.74 13.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.771 2.314 . . . . 73.32 112.056 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 pt -102.99 -2.09 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.163 1.171 . . . . 72.42 114.163 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 55.48 66.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.591 1.156 . . . . 74.23 112.391 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.7 mt -58.25 153.31 15.47 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.683 -0.636 . . . . 74.32 110.709 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 m -62.98 -31.79 72.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.486 1.514 . . . . 75.34 113.288 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -28.67 41.47 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.26 0.936 . . . . 74.24 110.352 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.1 13.56 5.89 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.419 -0.656 . . . . 62.23 112.73 159.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -45.5 -53.33 9.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 127.705 2.402 . . . . 75.35 113.575 -171.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.8 mm 56.69 111.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.842 2.457 . . . . 75.44 107.907 -157.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.98 161.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.702 -1.592 . . . . 73.23 106.702 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -71.14 129.79 39.84 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.279 1.032 . . . . 71.52 108.946 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 tt -48.68 -42.44 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.824 1.65 . . . . 72.1 110.839 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.66 -47.47 61.6 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.268 -1.295 . . . . 54.01 110.966 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -57.41 -46.62 83.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.345 1.573 . . . . 75.44 110.877 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.71 -55.59 32.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.058 0.943 . . . . 75.33 110.449 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG11 ' CE1' ' A' ' 33' ' ' PHE . 52.6 t -56.83 -45.23 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.322 1.049 . . . . 75.42 110.057 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.93 -34.7 79.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.265 1.026 . . . . 63.03 111.501 -167.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 8.4 ttpt -51.96 -53.3 42.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.472 1.109 . . . . 72.35 108.545 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.454 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 29.4 m-85 -70.68 -34.19 71.72 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 118.967 -0.54 . . . . 74.41 109.723 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.423 ' CE1' HG11 ' A' ' 29' ' ' VAL . 3.5 m-30 -63.74 -39.54 94.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.088 1.313 . . . . 75.13 111.337 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -42.26 74.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.788 1.235 . . . . 73.03 110.535 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -78.95 -53.84 6.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.312 0.645 . . . . 75.41 109.49 -173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.79 42.48 1.1 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.439 2.296 . . . . 75.31 107.028 -170.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.96 -34.34 59.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.666 -1.272 . . . . 75.05 111.521 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -60.21 -35.26 75.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.181 0.992 . . . . 74.41 112.406 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.48 -0.91 43.93 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.597 1.159 . . . . 74.3 112.91 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.77 94.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.394 -1.336 . . . . 64.23 107.394 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -79.54 154.9 28.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.792 -1.188 . . . . 75.11 107.792 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -111.88 156.96 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.086 -1.079 . . . . 72.01 108.086 160.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.33 168.78 12.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.955 -1.128 . . . . 60.3 107.955 159.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -59.57 -48.35 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.93 0.892 . . . . 71.35 109.39 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.09 -3.47 13.4 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.707 1.002 . . . . 54.53 113.707 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.87 20.84 45.15 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 121.302 -0.874 . . . . 75.44 114.187 159.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.73 -86.02 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.14 1.776 . . . . 74.03 110.14 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.43 125.42 2.73 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.074 1.321 . . . . 45.22 110.263 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -136.82 169.91 16.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 72.43 111.452 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.5 mt -144.47 144.5 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.289 2.235 . . . . 74.41 106.398 164.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.91 125.8 34.26 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.217 1.407 . . . . 71.43 109.684 167.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.91 8.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.809 0.844 . . . . 74.34 111.054 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.22 -40.65 60.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.52 1.054 . . . . 63.3 112.346 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -9.3 2.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.239 2.216 . . . . 75.15 114.402 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -70.05 -22.36 63.09 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.474 1.034 . . . . 72.03 112.588 170.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.13 7.03 3.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 120.125 1.33 . . . . 73.44 114.27 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.02 118.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.649 1.18 . . . . 74.24 108.117 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -85.44 155.17 21.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.411 1.1 . . . . 74.34 110.184 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.9 tt -135.07 155.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.652 1.981 . . . . 73.24 107.732 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.9 mmpt? -69.4 118.94 12.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.709 -1.589 . . . . 74.44 106.709 167.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -110.73 -175.98 2.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.59 -2.004 . . . . 72.2 105.59 165.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 125.14 16.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.331 -1.729 . . . . 74.45 106.331 172.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -73.72 99.52 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.921 -1.14 . . . . 74.24 107.921 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -54.89 -23.23 17.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 124.849 1.26 . . . . 74.34 112.08 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -26.31 24.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.06 1.344 . . . . 75.23 112.605 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.0 m -144.95 16.43 1.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.482 1.113 . . . . 73.0 112.361 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp 53.41 45.6 28.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.835 1.198 . . . . 73.23 111.37 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -113.95 159.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.28 1.032 . . . . 75.24 109.945 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.7 mm -79.32 142.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.92 -1.511 . . . . 74.11 106.92 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -131.31 162.27 30.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.984 1.374 . . . . 65.24 110.667 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.07 127.96 36.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.207 -2.146 . . . . 71.12 105.207 165.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.43 148.26 25.51 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 117.005 -1.474 . . . . 74.01 107.823 172.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.97 161.73 18.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 122.351 2.342 . . . . 74.03 111.307 168.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.3 mp -80.92 165.67 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.947 -1.501 . . . . 62.24 106.947 166.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 17.9 mt -127.28 -42.75 1.67 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.493 1.517 . . . . 73.45 110.771 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -134.58 154.83 51.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.409 1.458 . . . . 75.35 110.231 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -123.62 162.06 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.884 1.674 . . . . 74.44 108.404 177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -137.31 158.94 43.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.478 1.111 . . . . 74.14 110.567 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HD2' ' CD2' ' A' ' 151' ' ' HIS . 3.8 tpp85 -142.07 145.99 34.95 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.761 1.624 . . . . 74.52 107.159 172.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -147.53 151.58 36.57 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.887 -1.153 . . . . 74.51 107.887 160.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.96 140.91 47.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.631 -0.878 . . . . 74.41 108.631 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -144.76 150.05 36.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.878 1.671 . . . . 73.13 107.268 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.2 p -143.38 138.27 29.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 104.979 -2.23 . . . . 63.13 104.979 155.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.6 -178.4 35.73 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 120.781 1.628 . . . . 74.11 111.11 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 119.53 30.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.491 -0.417 . . . . 74.01 110.812 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -88.88 164.59 15.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.986 1.314 . . . . 73.01 108.209 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mm -78.35 142.63 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 106.615 -1.624 . . . . 72.13 106.615 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -133.04 74.65 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.423 -1.695 . . . . 72.45 106.423 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.1 mt -78.01 121.51 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.683 -2.34 . . . . 73.45 104.683 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 m -107.62 164.48 12.19 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.687 -1.598 . . . . 73.32 106.687 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -132.84 175.09 9.66 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.84 0.745 . . . . 65.31 111.306 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -66.34 -22.65 66.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.9 -1.125 . . . . 72.12 112.448 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -69.71 -1.07 8.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.889 0.876 . . . . 72.14 112.514 170.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 57.75 25.26 11.65 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.443 -1.411 . . . . 73.54 110.187 -162.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.24 24.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.491 -1.3 . . . . 64.52 107.491 165.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -161.42 162.01 30.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.443 -0.947 . . . . 74.41 108.443 -166.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -148.42 160.18 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.74 1.216 . . . . 74.43 110.268 174.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.91 96.52 2.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.172 1.389 . . . . 74.2 109.917 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.19 -179.86 7.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.14 2.176 . . . . 74.01 109.836 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 p -68.47 165.81 18.18 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.22 0.918 . . . . 71.21 111.323 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.28 -24.26 64.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.923 -0.486 . . . . 75.34 110.54 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -115.56 81.05 1.52 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.189 1.396 . . . . 74.03 107.896 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 156.72 76.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.691 -0.631 . . . . 75.12 111.427 150.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -89.48 149.82 5.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.27 3.313 . . . . 73.13 115.93 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -156.91 -173.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 111.459 -2.61 . . . . 73.42 107.7 -174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -132.55 141.18 48.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.468 -1.696 . . . . 65.52 112.288 -171.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.73 157.82 26.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.015 0.926 . . . . 74.3 110.047 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.01 105.64 12.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.455 1.121 . . . . 72.21 109.24 173.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -76.37 66.68 2.47 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 107.155 -1.424 . . . . 73.35 107.155 148.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 1.0 OUTLIER 70.26 -15.13 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.989 2.515 . . . . 60.43 115.375 170.13 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.24 -21.08 0.12 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 126.288 1.899 . . . . 75.12 109.025 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -78.46 144.54 35.69 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 105.362 -2.088 . . . . 71.22 105.362 166.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -102.04 95.53 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.503 1.521 . . . . 73.2 107.835 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.3 154.46 17.18 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.833 1.253 . . . . 73.22 108.671 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -114.05 111.84 22.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.51 1.524 . . . . 73.12 111.881 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.09 179.39 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.214 1.005 . . . . 70.31 111.231 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -99.26 148.49 24.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.081 1.752 . . . . 75.44 109.936 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.4 -26.8 65.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 118.102 0.41 . . . . 73.51 110.385 -161.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.66 67.34 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.313 -0.867 . . . . 64.12 113.231 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.6 -29.64 46.19 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.328 1.051 . . . . 73.12 112.086 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.4 t -73.83 63.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.508 2.323 . . . . 74.15 109.89 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -78.78 178.17 8.12 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.435 1.094 . . . . 74.53 108.187 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.03 -20.94 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.077 1.751 . . . . 65.22 113.666 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.18 -2.78 87.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.876 -1.513 . . . . 52.52 113.439 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.12 159.71 16.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.459 2.129 . . . . 72.34 111.039 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.5 103.53 11.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.72 1.608 . . . . 71.54 109.066 170.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.87 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.53 1.532 . . . . 73.41 107.327 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.13 115.36 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.789 -0.819 . . . . 74.43 108.789 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 pt -102.56 154.03 37.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 123.297 0.639 . . . . 73.22 110.766 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.7 138.26 28.81 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.117 1.878 . . . . 72.5 107.944 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.63 175.46 5.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.313 -1.366 . . . . 74.23 107.313 162.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -25.06 -61.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.873 2.069 . . . . 75.11 115.246 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -121.05 1.19 10.34 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.704 1.202 . . . . 75.44 113.077 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -143.74 -175.36 4.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.853 2.061 . . . . 74.35 109.353 -139.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -120.11 147.99 23.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.87 -1.159 . . . . 70.53 107.87 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -137.1 -178.18 5.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.856 2.462 . . . . 73.04 106.896 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.51 164.4 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.836 1.254 . . . . 75.23 108.115 168.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -156.85 159.12 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.183 -1.784 . . . . 73.22 106.183 167.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -104.29 138.16 41.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.103 1.361 . . . . 70.5 109.325 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.1 t -71.08 -0.27 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 114.146 1.165 . . . . 74.51 114.146 -172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 25.93 -89.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 127.029 2.131 . . . . 73.22 114.924 174.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -92.65 113.23 25.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.257 -0.902 . . . . 72.41 109.267 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.14 144.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.36 -0.978 . . . . 73.32 108.36 156.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -156.2 -172.14 3.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.904 2.482 . . . . 72.33 106.291 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -124.53 142.76 51.09 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.869 -1.16 . . . . 73.34 107.869 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.46 -179.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.628 1.171 . . . . 73.42 108.566 166.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -126.39 138.31 53.54 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.982 2.513 . . . . 75.45 106.75 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.49 151.23 31.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.448 1.099 . . . . 73.05 109.111 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.98 78.27 0.45 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.245 -1.761 . . . . 74.23 106.245 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -151.27 23.78 0.97 Allowed Glycine 0 N--CA 1.468 0.822 0 CA-C-N 113.807 -1.542 . . . . 74.5 113.886 -164.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.408 ' CD2' ' HD2' ' A' ' 79' ' ' ARG . 54.7 m80 54.77 -179.29 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.479 0.712 . . . . 74.43 110.962 -151.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.2 pt -145.78 160.19 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.703 2.401 . . . . 73.2 106.699 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -137.21 147.52 45.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.197 1.799 . . . . 73.21 108.617 -166.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -147.7 167.56 24.33 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.669 1.122 . . . . 70.0 111.56 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.5 126.48 31.18 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 127.987 2.515 . . . . 73.53 108.149 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.6 m -61.61 -53.32 57.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.102 0.561 . . . . 74.23 112.46 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.305 3.5 t 24.38 64.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 128.018 2.527 . . . . 65.24 112.385 -164.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -79.2 0.06 29.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.958 1.303 . . . . 75.33 111.472 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -64.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.919 1.688 . . . . 71.12 110.887 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.7 -0.31 14.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.253 0.621 . . . . 63.1 111.841 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.2 m80 61.95 27.89 16.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.453 1.901 . . . . 73.3 110.734 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.1 143.22 24.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.619 1.568 . . . . 73.15 108.123 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.6 -179.38 6.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.199 1.0 . . . . 74.32 111.261 -173.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.73 124.01 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 107.631 -1.248 . . . . 74.21 107.631 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.79 146.07 21.69 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.801 0.44 . . . . 75.21 110.528 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.91 -169.06 32.45 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 108.326 -1.91 . . . . 74.33 108.326 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.431 ' HE2' ' OE1' ' A' ' 13' ' ' GLU . 74.0 mttt -99.51 177.84 5.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 119.879 1.839 . . . . 73.01 110.039 162.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 60.26 -78.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 129.198 2.999 . . . . 74.24 113.037 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.57 -8.1 8.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.326 1.45 . . . . 75.51 113.866 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 67.4 153.04 0.3 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.106 1.336 . . . . 75.5 114.92 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 97' ' ' ILE . 43.9 m-85 -107.55 159.01 16.76 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.048 2.139 . . . . 70.54 108.662 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -96.58 74.58 2.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 127.11 2.164 . . . . 74.01 109.184 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.2 m -105.03 171.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.827 -0.546 . . . . 72.21 110.687 -164.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 m -71.18 159.24 35.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.073 0.549 . . . . 75.14 110.676 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -136.03 165.49 25.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.587 2.755 . . . . 64.45 108.028 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.9 t -164.43 168.7 18.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.063 0.847 . . . . 74.41 109.655 150.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.6 p -72.65 -56.85 4.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.061 1.744 . . . . 64.42 113.508 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -138.31 76.28 0.36 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 107.431 -2.267 . . . . 65.0 107.431 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.2 p 57.74 -166.65 0.14 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.626 1.97 . . . . 74.22 111.737 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.55 -71.35 0.22 Allowed 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.105 -0.997 . . . . 75.34 108.697 171.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 66.56 155.21 0.09 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.405 2.282 . . . . 73.03 112.771 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 60.6 m170 32.88 62.45 0.35 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.003 2.121 . . . . 74.41 112.283 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -50.73 -54.97 18.93 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.419 1.266 . . . . 75.25 114.419 -159.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -165.19 -65.67 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.612 -1.255 . . . . 75.43 107.612 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -77.14 169.97 17.37 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.167 0.587 . . . . 71.44 109.623 166.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 127.783 2.433 . . . . 75.5 111.039 143.555 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.959 -0.386 . . . . 65.15 109.959 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -117.24 -143.32 0.37 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 106.109 -1.811 . . . . 65.3 106.109 164.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 m 79.48 -43.39 0.29 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.396 2.278 . . . . 75.41 108.424 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.13 73.5 0.71 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.927 -1.669 . . . . 64.54 108.927 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.251 2.0 t60 54.45 -156.53 0.22 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.993 1.317 . . . . 71.1 110.106 -159.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -145.62 124.35 12.59 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.195 1.398 . . . . 74.1 109.057 -171.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.73 162.69 9.25 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 111.245 -0.742 . . . . 72.24 111.245 170.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.64 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.138 1.375 . . . . 74.41 108.666 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.5 157.13 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.943 1.697 . . . . 74.42 109.437 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.5 159.4 30.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.636 0.775 . . . . 71.52 112.024 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.553 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.1 t80 -54.52 -39.76 67.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.955 1.702 . . . . 65.15 112.916 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -101.59 19.82 17.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.238 1.815 . . . . 71.24 110.952 -170.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -77.64 121.61 84.55 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.223 -2.14 . . . . 74.42 105.223 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.6 138.51 54.62 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 120.52 0.813 . . . . 71.01 110.302 171.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 pt -108.54 143.25 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 122.647 1.213 . . . . 75.42 108.164 160.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -103.3 99.41 9.25 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.925 -2.62 . . . . 74.13 103.925 -173.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 1.8 mm? -52.45 165.77 0.23 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.186 -0.672 . . . . 74.24 109.186 166.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -48.89 -43.93 39.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.526 0.73 . . . . 64.22 109.516 166.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.71 -35.66 80.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.329 0.492 . . . . 72.54 112.329 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.0 9.12 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.243 0.925 . . . . 73.13 112.13 -171.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -20.96 15.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.49 1.516 . . . . 74.21 114.955 -170.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mm 46.95 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 128.35 2.66 . . . . 74.41 110.631 -168.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.2 144.29 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 114.841 -1.072 . . . . 73.42 108.383 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -61.78 126.3 26.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 105.913 -1.884 . . . . 75.03 105.913 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -49.89 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 73.32 108.953 165.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -56.65 -57.42 19.6 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-O 117.941 -1.477 . . . . 65.52 112.521 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -52.46 -51.57 58.64 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.486 1.914 . . . . 71.14 111.384 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.93 -52.04 61.87 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 125.837 1.655 . . . . 74.2 109.778 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 73.4 t -76.86 -36.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.891 -1.05 . . . . 75.33 110.443 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 34' ' ' LYS . 11.4 t0 -62.06 -36.05 80.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.661 0.664 . . . . 71.23 111.724 -178.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -55.04 -42.69 72.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.323 1.049 . . . . 73.34 109.94 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -67.02 -43.99 81.4 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.1 -1.0 . . . . 75.11 110.093 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -60.07 -33.35 71.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.894 1.225 . . . . 71.34 112.497 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -64.99 -61.5 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.282 1.433 . . . . 74.23 109.514 171.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -73.23 -47.85 39.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.714 -1.217 . . . . 73.51 107.714 -166.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -94.66 40.78 1.09 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.228 1.411 . . . . 63.01 109.887 -172.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.08 -39.88 29.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.042 -1.036 . . . . 65.13 111.636 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -72.07 -22.79 61.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.993 0.738 . . . . 72.14 112.993 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -85.99 -2.28 58.14 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.722 0.809 . . . . 74.25 111.822 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.4 mt -62.88 101.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.954 -1.499 . . . . 72.15 106.954 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.58 162.22 25.46 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.12 -1.437 . . . . 72.44 107.12 161.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.88 145.47 47.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.577 -1.638 . . . . 72.13 106.577 163.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 175.24 10.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.469 -0.567 . . . . 74.04 109.469 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -61.33 -45.09 95.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.363 1.065 . . . . 74.14 108.584 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.39 -19.79 66.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.355 0.662 . . . . 75.01 110.5 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 36.19 6.1 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 120.972 -1.08 . . . . 73.22 111.489 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.46 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 3.7 t80 -78.05 -86.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.595 1.158 . . . . 74.31 109.908 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.87 121.82 2.02 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.07 -2.012 . . . . 25.31 108.07 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.26 163.65 33.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.539 1.17 . . . . 72.2 112.231 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mt -143.98 140.04 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.72 -1.585 . . . . 73.41 106.72 172.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.6 134.75 33.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.625 1.17 . . . . 71.25 109.883 172.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.01 23.09 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.767 2.027 . . . . 70.14 111.581 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.06 -7.13 8.12 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.393 -1.226 . . . . 73.34 115.69 -175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -98.67 -27.92 13.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.38 1.59 . . . . 71.23 113.128 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.93 -23.65 33.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.304 1.002 . . . . 64.23 111.971 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.83 15.01 3.55 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.149 1.38 . . . . 70.41 112.867 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.97 101.31 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.568 1.147 . . . . 74.51 108.269 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.35 118.68 7.79 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.829 1.252 . . . . 74.01 110.009 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 14.1 tt -98.33 160.18 3.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 125.05 1.34 . . . . 72.21 107.751 165.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.01 124.19 22.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.731 -1.581 . . . . 74.34 106.731 168.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -128.92 178.77 6.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.558 1.143 . . . . 72.21 108.116 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -153.42 127.53 9.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.143 -0.688 . . . . 74.21 109.143 -171.564 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.73 112.35 20.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.943 -1.503 . . . . 74.44 106.943 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.66 -20.39 55.81 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 113.28 0.845 . . . . 74.34 113.28 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.61 -19.9 2.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.083 2.153 . . . . 73.22 112.682 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -154.04 20.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.418 0.554 . . . . 75.1 111.301 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.16 54.36 6.07 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.272 -1.517 . . . . 73.12 112.158 -167.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 pt -101.26 169.85 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.106 1.363 . . . . 65.44 108.627 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.25 150.09 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.853 1.261 . . . . 71.52 108.634 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -157.63 174.07 15.9 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.94 2.496 . . . . 75.35 107.65 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -87.85 145.67 25.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.257 -1.386 . . . . 73.31 107.257 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -148.79 144.72 27.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.347 -1.353 . . . . 72.44 107.347 164.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -78.14 -175.15 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.857 1.208 . . . . 73.01 112.19 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.5 152.04 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.087 2.155 . . . . 72.1 107.241 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.07 -40.76 3.87 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 113.346 0.869 . . . . 72.04 113.346 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -145.8 164.85 30.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.691 -1.225 . . . . 72.53 107.691 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.43 165.99 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.744 -1.206 . . . . 74.13 107.744 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -130.93 175.47 9.04 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.909 0.884 . . . . 74.5 108.943 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.48 145.92 5.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.03 1.732 . . . . 74.12 106.925 154.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HE3' ' CD2' ' A' ' 47' ' ' PHE . 5.4 ttmt -148.48 166.42 28.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.885 -1.154 . . . . 74.11 107.885 166.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 80' ' ' LYS . 43.2 tttt -93.45 157.5 16.18 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.524 -0.735 . . . . 74.21 109.538 174.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.13 147.55 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.074 1.35 . . . . 73.21 109.634 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -143.39 117.9 9.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 160.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.52 -146.6 4.65 Favored Glycine 0 N--CA 1.463 0.481 0 N-CA-C 109.911 -1.276 . . . . 74.12 109.911 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.5 119.21 29.3 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.036 -1.459 . . . . 74.42 110.277 174.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.16 153.98 17.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 121.547 1.976 . . . . 74.23 106.78 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -79.94 139.79 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 126.784 2.033 . . . . 74.34 108.513 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -124.65 84.47 2.28 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.733 1.613 . . . . 73.35 106.748 161.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.3 mt -75.2 112.13 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.005 -1.85 . . . . 73.54 106.005 162.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -75.24 178.46 5.76 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.568 -0.901 . . . . 73.43 108.568 167.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -146.19 177.11 9.24 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.61 -1.306 . . . . 74.11 109.336 154.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.1 ttmt -60.41 -27.28 67.33 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 119.503 -1.998 . . . . 72.23 113.568 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.68 18.62 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.888 1.222 . . . . 75.53 112.752 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.434 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER 58.59 15.76 3.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.728 2.411 . . . . 73.03 111.415 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ttm105 -68.49 170.49 8.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.754 2.022 . . . . 74.0 108.463 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -176.17 172.1 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.155 1.382 . . . . 74.4 109.491 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.531 HG22 ' CE1' ' A' ' 171' ' ' PHE . 3.8 pt -143.09 178.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.011 1.324 . . . . 74.52 107.838 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 98.11 2.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.723 -0.843 . . . . 73.42 108.723 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.79 173.21 17.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.691 1.596 . . . . 74.32 110.218 -172.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.3 p -74.26 163.7 27.5 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.1 -1.0 . . . . 72.0 111.551 -173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.4 -16.46 62.96 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.287 0.847 . . . . 74.42 113.287 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -116.72 38.82 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.97 0.805 . . . . 72.24 108.893 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -89.99 129.76 44.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 117.921 -1.038 . . . . 64.22 109.613 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -60.35 126.6 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.747 3.631 . . . . 73.52 111.293 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.91 175.96 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.693 1.597 . . . . 74.24 109.123 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.79 134.68 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.494 -0.754 . . . . 63.22 111.067 -169.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.96 161.58 40.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.451 1.501 . . . . 74.03 109.059 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 53.2 p -87.4 127.01 35.21 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 119.416 -0.326 . . . . 74.54 110.743 177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HE3' HD11 ' A' ' 114' ' ' LEU . 2.3 ttmt -104.97 75.99 1.22 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.025 -1.472 . . . . 75.43 107.025 165.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m 59.51 16.98 5.66 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.857 1.663 . . . . 72.11 114.562 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -38.6 1.42 Allowed Glycine 0 N--CA 1.448 -0.536 0 O-C-N 120.682 -1.262 . . . . 61.21 110.194 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.76 148.86 31.3 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.359 -1.349 . . . . 74.11 107.359 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.19 117.51 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.699 -1.593 . . . . 73.25 106.699 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.426 HD11 ' HE3' ' A' ' 109' ' ' LYS . 4.7 tp -105.19 132.94 50.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.076 -1.083 . . . . 75.2 108.076 166.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -81.75 125.79 31.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.235 -1.024 . . . . 74.51 108.235 161.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.45 -179.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.48 1.512 . . . . 75.54 109.21 169.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.28 145.3 24.55 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.998 0.919 . . . . 73.02 109.285 -172.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -42.55 -47.11 5.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.637 1.975 . . . . 74.41 113.762 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -32.63 54.43 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.917 0.887 . . . . 71.23 113.053 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.2 mtt -75.6 -26.41 57.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.985 0.514 . . . . 74.54 112.159 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.259 5.7 t -79.11 63.2 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.695 2.398 . . . . 73.1 112.319 -169.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.547 ' HG3' ' H ' ' A' ' 124' ' ' GLY 0.259 0.0 OUTLIER -79.43 175.09 10.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 131.07 3.748 . . . . 72.13 111.632 -174.65 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.259 5.9 p -57.88 1.67 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 126.535 1.934 . . . . 71.12 114.616 167.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.547 ' H ' ' HG3' ' A' ' 122' ' ' LYS . . . -108.28 -1.84 33.37 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.772 2.606 . . . . 24.31 111.495 171.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 156.44 21.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.88 1.84 . . . . 64.54 108.02 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.6 104.97 12.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.517 -1.29 . . . . 74.11 107.517 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 tt -81.33 136.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.401 -0.818 . . . . 75.42 109.821 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.57 129.35 38.08 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.225 -0.898 . . . . 75.33 109.099 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 161.21 60.74 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.693 1.997 . . . . 74.12 111.164 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.55 173.04 14.98 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.726 2.284 . . . . 73.32 110.639 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -134.49 -134.8 0.16 Allowed 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 120.865 -1.147 . . . . 71.13 108.665 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -51.94 -84.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.609 1.164 . . . . 72.32 108.871 169.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -121.22 0.89 10.2 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.727 1.611 . . . . 74.31 112.431 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 p -131.58 151.34 51.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.879 0.872 . . . . 75.52 112.515 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.1 147.29 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -145.78 -176.21 5.04 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.704 2.002 . . . . 71.11 107.543 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.7 mt -124.82 166.23 16.61 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -154.26 140.79 18.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.765 -1.198 . . . . 73.54 107.765 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.8 141.34 46.21 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.528 -1.286 . . . . 64.24 107.528 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.0 t -70.48 -23.48 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.529 1.531 . . . . 75.05 113.89 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.6 pt 47.19 -53.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 131.664 3.986 . . . . 60.43 116.398 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -140.28 132.51 28.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.689 2.395 . . . . 74.3 106.827 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.76 131.01 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 107.806 -1.183 . . . . 75.42 107.806 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.14 -164.79 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.932 1.293 . . . . 73.23 108.149 171.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 p -146.9 162.27 39.02 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.322 1.049 . . . . 72.31 109.517 -162.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.51 171.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 127.388 2.275 . . . . 73.24 108.687 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.48 92.41 3.42 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.051 -1.092 . . . . 73.44 108.051 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -97.63 136.91 37.33 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.509 2.723 . . . . 75.43 108.719 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -134.54 73.34 1.48 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.024 -1.473 . . . . 74.23 107.024 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.2 -159.24 7.84 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.086 0.85 . . . . 73.42 112.912 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -102.29 154.25 19.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.8 -0.815 . . . . 74.23 108.8 163.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.65 154.23 26.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.279 1.832 . . . . 74.31 107.295 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.423 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -153.38 160.28 42.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.599 0.76 . . . . 74.35 109.69 173.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -131.74 146.03 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.098 2.159 . . . . 75.54 107.524 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.91 143.85 27.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.904 1.684 . . . . 74.25 112.718 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 83.14 3.63 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.392 -1.336 . . . . 70.14 107.392 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.21 76.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 106.145 -1.798 . . . . 74.13 106.145 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.02 -5.19 20.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.769 -0.582 . . . . 73.2 111.694 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.26 -63.97 0.95 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.901 2.08 . . . . 75.41 107.631 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -125.53 -4.85 7.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.716 2.406 . . . . 71.52 111.861 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 54.18 25.86 6.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.256 2.223 . . . . 65.31 112.775 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.402 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 11.4 p -141.49 153.68 45.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.883 1.273 . . . . 64.53 109.11 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.42 ' CD1' ' HB1' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -163.7 178.07 8.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.412 1.085 . . . . 75.21 111.208 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.9 122.21 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.204 1.402 . . . . 73.24 109.317 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.04 154.93 43.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.56 1.144 . . . . 74.3 110.054 173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.51 -171.61 21.88 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.589 -0.605 . . . . 74.32 111.589 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -91.55 166.68 12.71 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.484 -1.598 . . . . 73.21 110.015 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 61.36 -76.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 129.693 3.197 . . . . 74.43 112.032 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.89 -13.77 8.18 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.417 1.487 . . . . 74.15 112.561 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.86 171.0 18.9 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.033 1.301 . . . . 73.31 112.42 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.531 ' CE1' HG22 ' A' ' 97' ' ' ILE . 68.8 m-85 -112.12 157.09 21.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.737 3.615 . . . . 73.2 105.322 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -103.9 110.81 23.09 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.108 -1.812 . . . . 64.31 106.108 170.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.13 175.19 6.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.619 -0.882 . . . . 74.23 108.619 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 155.24 16.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.01 -0.737 . . . . 72.23 109.01 168.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.42 ' HB1' ' CD1' ' A' ' 163' ' ' TYR . . . -146.78 47.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.866 2.066 . . . . 71.5 107.012 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 p -66.42 119.02 10.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.297 -1.001 . . . . 61.32 108.297 -171.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 62.2 p -68.37 30.21 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.034 1.734 . . . . 71.31 113.197 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.54 64.17 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.149 -1.361 . . . . 74.01 115.427 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.6 173.25 6.41 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.784 1.792 . . . . 73.31 109.377 171.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 45.8 tp 70.5 147.01 0.07 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.528 2.731 . . . . 75.53 111.377 168.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 79.97 1.8 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.923 -1.139 . . . . 64.21 107.923 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 65.32 174.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.853 2.061 . . . . 75.21 114.214 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 54.3 -157.91 0.19 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.984 1.714 . . . . 73.54 110.094 -165.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.7 t60 56.94 48.06 16.54 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.502 1.921 . . . . 75.15 110.811 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 156.2 28.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.194 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.5 m170 . . . . . 0 C--O 1.246 0.903 0 C-N-CA 127.429 2.291 . . . . 75.22 105.755 167.843 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 mtm . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 107.526 -1.287 . . . . 75.32 107.526 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 13.5 4.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.05 1.13 . . . . 72.22 114.05 -165.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.9 m 91.59 -38.13 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.98 2.112 . . . . 64.01 110.472 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.66 61.93 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 120.163 1.347 . . . . 73.22 115.576 158.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 78.8 130.52 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.602 3.161 . . . . 70.14 110.633 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 58.28 -176.65 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.522 1.929 . . . . 74.24 109.494 -156.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.1 75.88 0.41 Allowed Glycine 0 C--N 1.336 0.559 0 O-C-N 121.291 -0.881 . . . . 71.15 111.08 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.94 136.41 15.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.968 1.307 . . . . 74.45 109.844 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.74 158.6 26.86 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.413 1.485 . . . . 71.51 110.919 -167.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 159.53 21.37 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.052 0.541 . . . . 54.01 112.238 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -49.29 -49.34 44.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.111 1.764 . . . . 74.34 113.84 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -98.77 45.87 1.0 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.182 2.593 . . . . 72.24 109.424 -167.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 167' ' ' LYS . 65.5 mm-40 -109.47 110.11 59.97 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.55 1.54 . . . . 74.03 107.926 169.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -51.71 134.69 47.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.516 2.811 . . . . 74.33 113.3 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 pt -96.33 -2.79 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 114.452 1.278 . . . . 73.24 114.452 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 49.56 70.43 0.49 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.01 1.277 . . . . 72.33 113.587 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.0 159.03 0.94 Allowed 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.865 -1.147 . . . . 71.3 110.925 167.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -53.87 -45.09 70.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.082 -1.081 . . . . 61.01 108.082 168.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.76 -4.53 9.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.133 1.373 . . . . 75.04 114.184 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.72 12.5 66.49 Favored Glycine 0 CA--C 1.523 0.584 0 O-C-N 120.287 -1.508 . . . . 65.33 112.237 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -4.9 14.42 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.009 2.225 . . . . 74.0 117.009 -156.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.1 mm 27.39 87.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 130.802 3.641 . . . . 73.23 110.117 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.24 145.53 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.616 -1.624 . . . . 71.23 106.616 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.26 130.71 44.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 128.108 2.563 . . . . 75.02 105.044 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -48.72 -43.4 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.434 0.694 . . . . 74.21 110.318 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' A' ' 29' ' ' VAL . . . -86.37 -4.9 83.12 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.49 -1.728 . . . . 50.21 114.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -82.54 -45.37 14.75 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.761 1.78 . . . . 74.42 108.788 167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -55.49 -55.43 31.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.275 0.63 . . . . 74.53 109.653 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 22.8 m -65.78 -34.76 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 118.428 -0.796 . . . . 64.22 110.186 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -45.73 72.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.923 1.238 . . . . 75.11 110.893 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.07 -37.48 53.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.765 0.826 . . . . 74.34 110.011 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -83.77 -45.01 13.81 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.564 -1.207 . . . . 64.12 110.829 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -54.72 -30.23 55.51 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 121.825 2.102 . . . . 74.04 112.708 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -94.36 -11.04 30.76 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.783 1.233 . . . . 74.41 112.495 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 17.6 mttm -95.89 -63.91 1.11 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.001 -1.111 . . . . 74.32 108.001 168.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.456 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 4.8 m-30 -84.84 39.73 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.185 2.994 . . . . 74.12 108.419 -168.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -49.52 -45.66 47.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.07 2.548 . . . . 74.41 109.506 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -62.88 -35.1 78.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.967 0.907 . . . . 73.43 110.925 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 t -79.87 -7.95 59.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.823 2.049 . . . . 55.23 113.42 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.39 107.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.961 -1.126 . . . . 73.34 107.961 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -84.49 155.21 22.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.626 -1.62 . . . . 75.23 106.626 162.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -121.21 135.05 55.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 164.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.79 176.96 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 125.665 1.853 . . . . 74.42 110.679 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.58 -38.5 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.666 1.987 . . . . 72.43 111.801 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.67 52.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.681 0.793 . . . . 73.12 111.738 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.68 12.76 62.11 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.785 1.66 . . . . 73.32 112.644 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.84 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.157 1.783 . . . . 75.54 111.423 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.76 124.96 2.55 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 118.263 -1.299 . . . . 50.25 110.406 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -140.71 166.32 25.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.456 1.128 . . . . 75.24 111.219 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -146.07 135.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.946 2.098 . . . . 75.45 106.636 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.19 128.97 36.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.396 0.678 . . . . 71.53 110.253 167.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.86 9.54 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.043 0.937 . . . . 64.34 111.268 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.07 -16.2 59.5 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 120.785 -1.197 . . . . 64.14 114.416 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -68.81 -32.42 72.12 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.261 1.53 . . . . 72.24 111.81 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.57 -13.09 38.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.479 0.582 . . . . 71.5 112.31 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.84 19.83 10.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.205 2.202 . . . . 74.52 112.756 172.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.24 119.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.905 1.282 . . . . 74.45 108.506 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -88.79 142.52 27.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.181 0.992 . . . . 74.21 111.5 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.7 tt -133.64 154.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.411 1.884 . . . . 74.04 108.641 -174.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -73.01 126.73 30.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 110.133 -0.321 . . . . 71.41 110.133 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.04 166.84 16.23 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.562 1.945 . . . . 75.22 108.198 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.56 154.61 46.88 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.933 -1.506 . . . . 74.32 106.933 179.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.68 141.12 46.84 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 118.632 -1.227 . . . . 73.35 108.377 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -86.14 -22.9 26.81 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.583 -0.698 . . . . 75.33 112.019 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.7 -50.04 66.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.671 1.988 . . . . 73.15 110.64 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.0 m -141.27 9.6 2.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.567 1.947 . . . . 71.43 110.794 -162.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.05 52.17 15.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.207 2.203 . . . . 71.41 111.12 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.06 -175.62 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.352 0 O-C-N 124.185 0.928 . . . . 73.43 109.688 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mm -116.86 125.42 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 127.528 2.331 . . . . 75.44 104.883 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -142.85 169.27 17.89 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.869 1.268 . . . . 72.3 108.776 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -110.0 143.58 39.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.625 1.57 . . . . 74.44 110.011 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -150.92 168.08 25.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.657 1.983 . . . . 74.15 107.252 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -93.49 172.23 8.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.12 0.968 . . . . 70.15 110.38 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.04 144.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 105.507 -2.034 . . . . 73.24 105.507 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.8 -34.41 6.46 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.538 0.524 . . . . 73.52 111.217 -172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -144.44 137.75 27.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.97 1.259 . . . . 74.2 108.77 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.96 167.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 124.403 1.064 . . . . 72.11 109.714 168.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -138.13 159.96 40.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.321 1.048 . . . . 74.03 109.685 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -153.57 140.68 19.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.441 1.496 . . . . 74.3 108.881 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -146.1 161.38 40.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.846 -1.168 . . . . 73.32 107.846 165.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -92.02 146.47 23.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.073 -1.084 . . . . 75.34 108.073 168.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -152.33 145.68 24.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.775 0.83 . . . . 74.31 110.007 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -142.33 114.8 8.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.854 1.662 . . . . 71.02 109.281 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.06 40.78 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.441 1.019 . . . . 71.42 111.528 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.547 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.05 142.55 36.43 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 122.122 -0.634 . . . . 75.02 110.353 -174.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -127.69 160.38 31.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.81 1.644 . . . . 74.25 108.375 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.5 mm -80.08 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.035 2.134 . . . . 73.1 108.229 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -128.78 75.23 1.63 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 159.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.3 mt -62.85 139.33 21.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.943 -2.243 . . . . 74.41 104.943 158.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -114.33 172.0 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.699 -1.593 . . . . 72.41 106.699 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 p -136.91 175.81 9.28 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.919 -1.113 . . . . 72.45 110.566 162.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -62.51 -25.69 68.15 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.619 -0.676 . . . . 74.53 111.669 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.95 7.79 2.96 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.877 1.271 . . . . 74.25 112.969 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.56 20.58 7.74 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.216 1.407 . . . . 75.02 110.818 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -71.38 161.92 30.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.661 1.185 . . . . 64.1 108.058 166.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -176.17 171.0 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.003 0.921 . . . . 70.21 108.902 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.506 HG22 ' CE1' ' A' ' 171' ' ' PHE . 1.3 pt -145.82 170.92 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.722 1.609 . . . . 73.12 110.65 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -148.09 95.23 2.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.278 1.431 . . . . 74.35 109.428 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.94 177.82 10.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.938 1.695 . . . . 74.2 110.498 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 p -66.62 164.02 17.65 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.569 1.148 . . . . 64.31 110.638 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.265 1.1 p-80 -68.51 -24.31 64.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.513 0.931 . . . . 62.12 113.513 173.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.93 36.49 2.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.229 1.377 . . . . 64.54 111.336 -168.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -88.17 137.52 31.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.922 -1.037 . . . . 65.44 110.156 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.69 125.42 13.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.208 2.606 . . . . 73.22 111.194 172.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.87 -173.79 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.569 1.947 . . . . 74.52 108.361 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -129.02 140.35 51.67 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.882 0.764 . . . . 74.35 111.146 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.26 172.45 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.961 1.305 . . . . 74.42 108.1 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 p -87.55 144.76 26.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.934 0.873 . . . . 70.33 112.2 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -118.21 80.37 1.51 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.617 -1.623 . . . . 73.54 106.617 158.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 m 62.51 8.58 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.34 1.456 . . . . 71.43 114.339 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.63 -20.3 3.3 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 120.839 -1.163 . . . . 74.14 111.314 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.17 136.73 37.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.23 -2.137 . . . . 75.25 105.23 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.12 117.76 18.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.219 -1.771 . . . . 72.0 106.219 164.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.63 138.99 53.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.508 1.523 . . . . 74.11 108.969 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.14 122.64 39.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.212 1.405 . . . . 74.12 109.314 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.9 pt -142.66 -178.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.76 1.224 . . . . 64.5 110.944 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.61 145.61 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.196 1.398 . . . . 72.11 110.704 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.87 45.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.801 1.64 . . . . 74.41 112.868 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -28.08 68.89 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.706 -1.246 . . . . 74.44 112.002 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -32.02 39.52 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.375 0.67 . . . . 73.55 112.323 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.296 7.9 p -76.92 63.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.507 1.123 . . . . 74.41 111.414 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 124' ' ' GLY . 9.4 mmmt -79.39 -175.34 4.66 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.698 1.199 . . . . 75.42 108.522 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.53 -0.61 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.564 1.546 . . . . 73.23 112.991 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -90.45 -1.13 75.21 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.506 -1.163 . . . . 55.53 112.229 170.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.09 175.91 8.04 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.732 1.766 . . . . 73.02 110.596 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.93 104.52 7.85 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.755 -1.942 . . . . 73.01 105.755 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.36 129.7 37.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.262 -1.755 . . . . 75.52 106.262 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -69.72 127.8 34.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.228 -1.397 . . . . 74.53 107.228 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.99 159.95 56.64 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.332 1.053 . . . . 74.52 112.81 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.89 145.1 49.72 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.219 1.946 . . . . 74.12 109.393 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.91 -167.8 1.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.498 -1.667 . . . . 72.32 106.498 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -24.07 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 128.595 2.758 . . . . 71.25 111.639 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -122.27 0.05 9.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.632 2.086 . . . . 73.42 116.632 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.5 p -138.07 169.23 18.15 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.2 0.6 . . . . 74.34 111.482 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.88 150.75 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.956 -1.09 . . . . 74.35 109.553 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -142.59 -176.64 4.94 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.293 1.837 . . . . 74.32 109.289 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.23 161.17 15.49 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.766 1.227 . . . . 75.11 111.915 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -158.02 136.0 10.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.254 1.822 . . . . 72.52 107.819 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.52 153.64 43.2 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.046 0.938 . . . . 72.13 110.341 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -93.25 -2.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 71.54 112.955 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.6 pt 25.49 -91.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 128.023 2.529 . . . . 65.1 116.149 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.453 ' H ' HG13 ' A' ' 141' ' ' ILE . 2.8 ttmm -88.06 122.73 31.99 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.355 1.462 . . . . 74.21 107.46 172.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.97 102.83 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.709 -1.219 . . . . 74.1 107.709 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -131.57 -173.9 3.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 74.32 108.003 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 p -125.21 168.31 13.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.043 0.937 . . . . 64.14 110.013 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.37 174.07 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.276 2.231 . . . . 74.31 106.476 168.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -123.21 105.77 10.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.018 -1.475 . . . . 71.14 107.018 165.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -100.5 136.96 39.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.871 1.268 . . . . 73.31 110.096 -168.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.52 51.51 1.92 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.258 0.623 . . . . 74.42 109.994 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.09 -113.96 1.6 Allowed Glycine 0 N--CA 1.463 0.484 0 O-C-N 121.091 -1.006 . . . . 64.55 111.568 -167.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -139.7 157.51 45.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.428 1.891 . . . . 73.44 107.491 170.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.1 pt -124.55 153.97 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.281 1.432 . . . . 73.21 109.396 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -148.72 165.88 30.08 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.819 1.648 . . . . 73.33 107.533 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -167.41 167.73 13.61 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.983 -0.747 . . . . 74.35 108.983 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.26 115.41 16.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.436 2.295 . . . . 74.42 108.501 -163.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.4 m -74.35 119.46 18.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.914 -1.513 . . . . 71.13 106.914 159.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 159' ' ' ASP . 15.0 t -122.1 73.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.753 -2.314 . . . . 74.35 104.753 171.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.96 -3.08 3.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.221 1.408 . . . . 73.55 113.642 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 157' ' ' VAL . 9.0 m-20 -103.06 -42.11 5.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.686 2.394 . . . . 71.05 108.264 -173.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.476 ' C ' ' H ' ' A' ' 162' ' ' THR . 1.9 t30 -146.73 79.98 1.53 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.981 -2.229 . . . . 72.41 104.981 -168.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.25 13.94 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.701 2.401 . . . . 73.21 112.958 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 160' ' ' ASN . 13.1 p -132.65 124.1 27.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.456 2.702 . . . . 74.43 106.602 -172.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 172.94 13.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.851 0.461 . . . . 74.24 112.186 -164.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 mm -108.0 121.49 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 106.925 -1.509 . . . . 74.32 106.925 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -146.98 152.68 39.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.58 -0.526 . . . . 70.22 109.58 172.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.82 -160.73 25.76 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.045 -1.222 . . . . 64.31 110.045 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 13' ' ' GLU . 67.8 mttt -109.31 171.53 7.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.125 0.962 . . . . 73.43 110.946 172.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.01 -73.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.64 2.776 . . . . 75.22 112.301 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -121.49 -11.05 8.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.417 1.887 . . . . 74.34 113.587 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.67 7.99 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 122.522 1.068 . . . . 62.54 111.868 -167.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CE1' HG22 ' A' ' 97' ' ' ILE . 35.6 m-85 -108.61 156.61 19.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.771 2.429 . . . . 71.4 105.753 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -100.48 113.62 26.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.394 -1.335 . . . . 73.12 107.394 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.9 m -144.13 -177.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.632 1.173 . . . . 74.44 109.662 -163.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.08 126.85 31.59 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.302 -0.874 . . . . 73.53 110.685 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -107.23 48.36 0.84 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.727 1.611 . . . . 42.41 107.403 156.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.27 157.76 28.14 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.674 -1.232 . . . . 72.1 107.674 171.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.5 m -57.92 152.18 16.69 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.157 0.503 . . . . 75.33 110.238 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -70.03 -52.68 17.62 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.544 -1.422 . . . . 73.53 109.544 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 62.8 p -89.87 145.84 24.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.647 -0.872 . . . . 63.43 108.647 169.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.8 tp -33.48 -71.35 0.06 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 128.642 2.777 . . . . 74.31 114.317 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.8 m80 59.89 169.71 0.08 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.216 1.406 . . . . 70.34 113.143 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 46.42 75.41 0.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.819 2.048 . . . . 74.33 113.213 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 84.42 94.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 1 C-N-CA 131.964 4.106 . . . . 73.2 109.956 -168.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -61.13 154.03 24.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.102 -0.954 . . . . 64.35 109.857 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.59 175.41 1.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.114 1.766 . . . . 74.32 113.025 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 124.593 1.157 . . . . 73.45 109.267 -178.602 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 117.207 -1.378 . . . . 75.54 111.4 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p30 49.02 -161.03 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.274 1.429 . . . . 62.22 112.95 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.8 m -141.86 -47.42 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.954 1.302 . . . . 75.05 109.625 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.91 129.97 1.07 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 119.668 1.122 . . . . 73.03 110.632 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 m170 -81.85 -22.49 36.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.475 1.11 . . . . 75.42 111.828 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.68 -144.88 0.32 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.334 1.054 . . . . 72.44 110.271 -175.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.87 179.65 41.66 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 120.874 1.67 . . . . 75.4 114.658 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -174.15 -177.21 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.283 2.633 . . . . 72.14 108.594 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 tp -98.44 -13.76 20.41 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 115.894 1.812 . . . . 75.11 115.894 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 96.63 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 1 C-N-CA 132.777 4.431 . . . . 72.44 111.644 -166.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.39 -39.83 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.651 2.78 . . . . 73.34 109.545 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.96 26.83 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.118 2.167 . . . . 61.53 110.026 -170.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.24 111.8 36.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 127.146 2.178 . . . . 73.53 108.777 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 106.31 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.443 2.762 . . . . 73.12 108.651 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.45 167.87 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.582 1.083 . . . . 72.54 110.142 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -128.21 64.48 1.4 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.477 1.111 . . . . 73.32 111.61 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -45.63 150.71 0.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 120.425 -1.422 . . . . 75.12 112.624 161.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -15.0 53.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.768 1.292 . . . . 51.15 112.98 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.44 -18.28 22.51 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.181 0.9 . . . . 72.21 112.62 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.87 38.32 8.75 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.125 1.345 . . . . 70.43 111.043 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.94 -18.62 64.42 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.614 1.207 . . . . 64.1 113.301 -170.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mm 47.85 87.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 128.488 2.715 . . . . 75.41 109.863 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 150.31 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 72.22 106.996 -170.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -61.08 130.26 45.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.729 -1.211 . . . . 73.13 107.729 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -53.73 -39.34 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.301 0.501 . . . . 75.04 110.018 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 10.27 63.95 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.833 -0.982 . . . . 74.11 114.26 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -55.45 3.75 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.785 1.793 . . . . 64.41 108.689 153.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -48.56 -52.58 22.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.733 1.613 . . . . 74.42 109.435 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.709 -0.678 . . . . 74.22 110.916 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -30.46 70.9 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 120.914 -1.116 . . . . 71.44 110.871 -173.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -52.37 -49.7 63.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.294 0.952 . . . . 75.44 109.17 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -66.09 -43.55 86.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.04 -1.096 . . . . 74.53 108.04 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.54 -35.47 72.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.132 1.333 . . . . 74.45 112.388 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -83.22 -15.26 51.09 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.935 1.294 . . . . 75.24 111.704 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -97.98 -59.19 1.81 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.341 -1.355 . . . . 72.53 107.341 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -91.47 44.01 1.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.354 2.661 . . . . 74.14 107.808 -173.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -48.33 -45.12 34.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 125.738 1.615 . . . . 75.15 109.537 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -19.8 61.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.713 -0.66 . . . . 74.24 112.469 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 m -85.82 0.26 53.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.819 1.248 . . . . 61.34 112.45 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.68 94.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.15 1.341 . . . . 75.11 108.212 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -79.59 169.69 17.64 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.912 -1.144 . . . . 74.11 107.912 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.72 154.98 48.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.85 -1.537 . . . . 71.33 106.85 163.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -81.87 171.82 14.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.312 1.007 . . . . 62.35 110.437 159.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -45.45 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.28 2.632 . . . . 63.23 110.995 175.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -64.03 -10.06 19.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.275 1.43 . . . . 74.42 112.28 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.01 7.59 57.34 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 127.383 2.421 . . . . 63.22 112.696 163.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.39 -82.06 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.452 1.901 . . . . 75.54 110.625 -163.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.96 129.48 2.72 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.897 -1.681 . . . . 64.31 108.897 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -142.59 161.89 36.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.076 0.938 . . . . 74.41 111.263 167.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.0 145.98 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.167 -2.161 . . . . 74.33 105.167 164.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.45 123.28 29.54 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.027 0.931 . . . . 75.0 108.89 165.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.89 8.5 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.652 0.381 . . . . 73.14 111.35 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.28 -18.91 61.29 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 120.789 -1.194 . . . . 70.34 113.654 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.4 -13.52 60.73 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.872 1.669 . . . . 75.05 112.49 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' C ' ' H ' ' A' ' 57' ' ' ILE . 64.5 mm-40 -61.87 -22.14 65.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.531 0.732 . . . . 63.55 110.312 163.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 63.3 -10.55 0.11 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 128.057 2.543 . . . . 64.3 114.185 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 55' ' ' GLU . 94.4 mt -43.71 113.98 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.8 2.44 . . . . 71.1 109.544 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -77.02 144.01 38.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.006 -0.543 . . . . 74.53 110.041 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.6 tt -112.02 156.65 13.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.041 1.736 . . . . 75.51 107.859 163.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -66.88 93.35 0.26 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.449 -1.315 . . . . 73.43 107.449 164.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -71.39 173.8 7.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.805 -1.554 . . . . 74.4 106.805 165.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -140.39 151.59 45.07 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.656 -1.903 . . . . 74.11 106.817 166.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -101.22 114.22 27.99 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.822 1.249 . . . . 72.41 108.212 -176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -70.4 -29.47 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.34 1.856 . . . . 75.34 112.024 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -48.19 73.79 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.065 1.346 . . . . 64.54 110.74 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 t -125.39 8.06 7.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.539 0.736 . . . . 75.02 111.63 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt 66.41 51.73 1.15 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.606 1.562 . . . . 74.24 110.961 170.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -123.97 154.35 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.242 0.617 . . . . 61.45 110.137 -171.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.92 131.93 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.421 1.488 . . . . 73.43 107.04 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.36 178.04 7.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.344 1.458 . . . . 60.21 108.961 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -139.08 122.37 17.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.805 -1.184 . . . . 75.32 108.387 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.518 ' CE ' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -138.58 147.02 42.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.858 0.863 . . . . 74.51 108.801 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -77.33 147.33 36.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.144 0.578 . . . . 75.21 110.898 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.8 mp -71.69 164.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.072 -1.085 . . . . 75.52 108.072 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -117.7 -50.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.902 1.281 . . . . 75.05 110.078 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.343 3.1 ttm180 -116.98 -176.69 3.03 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 119.061 0.846 . . . . 74.11 111.779 -177.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.71 145.98 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 107.924 -1.139 . . . . 73.52 107.924 170.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.481 ' HE1' HG22 ' A' ' 156' ' ' THR . 98.2 m95 -118.4 156.11 29.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.42 1.088 . . . . 74.45 109.717 -178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.01 136.13 11.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.567 0.747 . . . . 75.12 108.986 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -145.02 160.96 40.54 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.896 -1.52 . . . . 72.04 106.896 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 148.59 22.74 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.903 -1.123 . . . . 72.52 108.407 173.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -143.9 154.07 42.96 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.955 1.302 . . . . 74.42 110.093 -163.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -153.9 154.73 34.4 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.047 -0.723 . . . . 72.11 109.047 154.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.38 -170.14 21.03 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.347 1.451 . . . . 73.42 110.672 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -86.53 125.43 33.76 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.674 1.19 . . . . 75.41 110.523 -171.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.11 165.85 10.93 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.94 -1.504 . . . . 75.14 106.94 171.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.8 mm -81.43 149.49 4.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.396 1.478 . . . . 75.21 108.146 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -127.45 79.9 1.92 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.722 2.009 . . . . 74.34 107.7 165.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 38.9 mt -61.81 130.98 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.623 -1.992 . . . . 74.43 105.623 150.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -114.5 162.94 16.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.28 -1.748 . . . . 75.55 106.28 157.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 p -135.61 169.96 16.71 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.591 -0.892 . . . . 75.13 108.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -38.38 55.57 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.678 -1.264 . . . . 75.41 111.877 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -0.98 7.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.493 1.517 . . . . 75.23 111.747 -172.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.6 mmt-85 61.49 24.33 14.45 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 126.936 2.094 . . . . 73.45 110.258 -167.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' CD ' ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -73.87 168.18 19.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.961 -1.126 . . . . 72.33 107.961 160.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 177.55 162.42 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.27 2.628 . . . . 64.54 107.812 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.574 HG22 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -147.18 177.26 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.945 2.098 . . . . 75.53 109.338 -174.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -145.67 74.94 1.41 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.177 0.513 . . . . 73.31 111.489 -167.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.56 163.57 32.58 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 119.522 -1.986 . . . . 75.14 112.271 -165.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 p -68.85 161.28 28.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.516 0.726 . . . . 72.13 110.696 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.09 14.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.422 0.897 . . . . 75.13 113.422 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.18 39.16 3.58 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.153 1.797 . . . . 75.51 110.8 159.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -84.99 125.88 69.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.674 -1.155 . . . . 74.22 109.451 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -63.6 114.77 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.21 3.274 . . . . 74.41 111.231 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.58 162.62 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.819 -1.178 . . . . 72.34 107.819 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -101.39 140.68 35.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.841 0.856 . . . . 73.24 109.151 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.49 164.07 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.996 0.918 . . . . 75.31 109.882 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.03 120.64 31.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.846 -1.168 . . . . 71.22 107.846 173.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.38 81.27 2.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.862 -2.273 . . . . 72.31 104.862 169.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 m 56.45 17.61 3.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.206 1.002 . . . . 71.42 113.52 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.18 1.27 47.99 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.064 -1.022 . . . . 70.44 114.062 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.89 160.3 26.08 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 105.763 -1.94 . . . . 74.14 105.763 150.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.46 145.1 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.822 -0.807 . . . . 74.11 108.822 170.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -142.06 170.9 14.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.986 1.315 . . . . 74.1 107.701 173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -112.83 138.26 49.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.794 0.838 . . . . 72.44 108.844 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 pt -142.52 179.28 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.169 1.388 . . . . 71.34 108.81 171.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -72.04 132.06 43.74 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 107.597 -1.261 . . . . 53.34 107.597 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -43.23 -35.11 1.32 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.861 1.665 . . . . 75.24 113.163 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.4 67.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.817 1.247 . . . . 74.42 112.516 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.0 -31.91 56.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.033 -1.042 . . . . 75.13 111.266 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.4 t -76.57 62.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.124 1.769 . . . . 75.33 110.345 -173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -86.72 -177.09 6.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.603 1.561 . . . . 72.0 108.534 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.82 0.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.859 2.064 . . . . 64.54 113.704 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.63 -13.43 80.04 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.366 -1.797 . . . . 70.12 112.479 167.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -124.3 170.15 11.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.839 1.819 . . . . 73.31 110.031 -166.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 139' ' ' GLU . 7.6 m-85 -112.86 155.62 24.34 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.391 1.476 . . . . 75.42 108.396 165.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.73 166.83 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.624 2.369 . . . . 74.03 107.589 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 112.26 22.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.85 1.26 . . . . 74.23 110.958 -166.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.54 161.43 41.56 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 124.737 1.215 . . . . 75.0 113.191 -174.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.01 154.84 33.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.887 1.725 . . . . 70.0 109.732 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -117.91 -156.69 0.65 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.1 -1.444 . . . . 74.45 107.1 162.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -59.32 -57.75 11.63 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 122.986 0.514 . . . . 74.32 111.391 -166.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -121.52 0.48 9.95 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.522 0.934 . . . . 74.13 113.522 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -139.35 -173.96 3.74 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.504 1.522 . . . . 74.01 111.027 -160.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.4 149.38 15.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.51 1.124 . . . . 75.34 109.529 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -143.28 -178.32 5.8 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.996 2.118 . . . . 72.33 108.533 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 mt -118.39 165.81 13.42 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.277 1.031 . . . . 72.4 109.386 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.9 p-10 -153.96 147.87 25.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.89 1.276 . . . . 63.41 111.116 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 32.5 tt0 -97.38 148.36 23.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.345 1.858 . . . . 73.34 111.166 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.19 2.17 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.725 0.639 . . . . 74.41 112.725 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.435 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.5 pt 24.68 -88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 127.522 2.329 . . . . 74.14 116.112 171.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -90.43 124.55 35.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.493 1.517 . . . . 63.52 108.088 175.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.14 122.5 56.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.43 -0.581 . . . . 74.0 109.43 170.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.88 -167.96 2.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 127.351 2.26 . . . . 73.11 107.436 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -122.45 172.17 8.55 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.555 1.142 . . . . 74.12 109.76 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.36 161.81 22.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 130.565 3.546 . . . . 71.33 104.559 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.59 133.5 51.03 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.792 -1.558 . . . . 71.43 106.792 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -144.18 155.55 43.95 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.815 0.734 . . . . 72.53 111.587 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.39 47.21 0.75 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.535 0.607 . . . . 72.45 111.884 -169.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.44 -122.7 2.29 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.585 -0.697 . . . . 63.34 114.342 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -124.34 160.57 27.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.127 0.971 . . . . 74.11 109.491 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 11.6 pt -135.04 155.55 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.578 1.951 . . . . 74.34 108.239 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -138.87 168.52 19.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.522 1.929 . . . . 75.0 107.226 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -164.62 167.34 19.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.741 1.155 . . . . 75.24 109.921 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.3 tp -137.7 113.62 9.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.275 1.583 . . . . 75.1 115.275 -149.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.481 HG22 ' HE1' ' A' ' 78' ' ' TRP . 69.1 p -55.88 -50.85 69.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.427 1.491 . . . . 75.32 114.016 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.3 t 24.55 68.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 129.5 3.12 . . . . 73.43 112.012 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.3 -5.69 58.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.106 -1.406 . . . . 71.22 111.928 -168.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -47.08 74.29 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.52 2.328 . . . . 72.22 110.91 -175.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -125.83 1.34 7.4 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.863 0.69 . . . . 74.42 112.863 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.9 m170 55.83 30.39 15.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.022 0.929 . . . . 75.22 111.81 -169.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.436 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.8 p -151.49 154.9 37.46 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.065 1.302 . . . . 75.4 110.372 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -153.23 174.95 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.595 1.089 . . . . 72.15 111.542 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 mm -99.29 124.23 52.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 73.24 108.916 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.4 157.69 36.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.561 1.545 . . . . 64.25 108.742 169.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.37 -170.35 23.91 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.912 2.672 . . . . 74.42 107.953 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -89.71 167.28 13.02 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.639 -1.506 . . . . 73.33 111.346 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.19 -74.53 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.652 2.381 . . . . 73.11 114.132 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.77 -10.02 8.78 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.531 1.932 . . . . 52.52 112.541 171.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.82 165.85 29.57 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 122.673 1.152 . . . . 62.22 112.382 -168.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.574 ' CE1' HG22 ' A' ' 97' ' ' ILE . 14.7 m-85 -105.07 158.05 16.83 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.519 2.728 . . . . 74.25 105.943 172.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -87.78 108.62 19.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.186 -2.153 . . . . 74.31 105.186 169.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 178.5 2.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.427 1.091 . . . . 62.12 108.708 -175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -80.68 153.2 28.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.389 1.475 . . . . 52.1 110.277 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -137.41 -158.35 0.85 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.439 1.896 . . . . 74.32 107.737 167.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 78.7 p 95.04 138.93 0.02 OUTLIER 'General case' 0 C--O 1.237 0.417 1 C-N-CA 132.625 4.37 . . . . 54.22 104.758 -165.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.8 m -65.84 -11.06 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.453 0.908 . . . . 71.2 113.453 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.91 -122.49 28.88 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 108.403 -1.879 . . . . 62.54 108.403 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 76.4 p 45.73 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.47 1.908 . . . . 73.33 111.508 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 67.79 -74.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 74.34 111.581 -172.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 123.04 25.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.574 -1.269 . . . . 71.42 107.574 -171.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 127.44 8.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.03 -1.044 . . . . 73.11 109.943 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.268 27.7 p-80 42.84 -152.65 0.02 OUTLIER 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.136 1.774 . . . . 73.13 111.855 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -107.98 -63.58 1.3 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.433 -0.951 . . . . 72.0 108.433 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.98 133.3 9.82 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.326 -0.62 . . . . 71.34 109.326 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 . . . . . 0 C--O 1.244 0.786 0 C-N-CA 126.153 1.781 . . . . 74.01 109.362 171.681 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.464 0 N-CA-C 107.098 -1.445 . . . . 72.31 107.098 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -149.93 134.96 17.9 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.279 -1.378 . . . . 73.23 107.279 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.1 m -65.25 -62.77 1.34 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.583 0.753 . . . . 74.42 109.202 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.96 -72.58 0.07 OUTLIER Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.741 -1.343 . . . . 75.3 109.741 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 m170 70.29 97.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.163 2.185 . . . . 75.11 108.186 -164.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.37 131.89 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.369 -0.832 . . . . 75.31 109.423 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.02 147.96 18.55 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 124.025 0.821 . . . . 55.03 111.07 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -151.06 172.68 15.36 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.925 1.69 . . . . 75.02 108.257 166.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.0 tp -102.09 -16.67 16.34 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.599 1.333 . . . . 74.41 114.599 -150.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.72 160.57 0.15 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 130.799 3.639 . . . . 74.35 112.319 -161.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 8.9 t80 -80.59 -49.0 11.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.667 1.587 . . . . 74.4 111.076 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -93.97 70.57 3.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.364 -2.088 . . . . 71.1 105.364 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.58 116.93 8.5 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 104.747 -2.316 . . . . 74.51 104.747 -169.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.89 124.36 13.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.33 2.687 . . . . 73.42 111.774 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 pt -97.0 10.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.382 0.882 . . . . 74.01 113.382 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 38.66 72.73 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.471 1.508 . . . . 74.43 112.612 178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 157.57 0.43 Allowed 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.173 -1.047 . . . . 73.51 108.173 167.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -17.6 48.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.103 0.779 . . . . 72.42 113.103 -169.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.29 -52.93 4.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.557 1.143 . . . . 74.12 109.953 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.87 55.46 0.1 OUTLIER Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.025 1.298 . . . . 65.41 113.496 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -22.7 66.33 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.665 1.732 . . . . 74.51 115.373 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.292 47.8 mm 38.68 46.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 130.121 3.368 . . . . 75.14 112.409 -171.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.33 154.41 3.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.912 1.285 . . . . 74.24 108.013 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.06 124.69 23.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.409 1.084 . . . . 64.1 108.471 168.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -39.24 14.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 123.218 0.607 . . . . 71.51 111.081 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -53.53 -50.94 51.21 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.747 -0.941 . . . . 54.41 110.747 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.61 -38.88 77.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.263 1.025 . . . . 73.41 111.952 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -57.29 -56.13 25.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.012 0.925 . . . . 75.44 109.401 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.74 -38.51 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.475 -0.784 . . . . 72.43 109.522 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -36.91 84.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.148 1.34 . . . . 62.51 110.514 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -40.79 60.63 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.554 1.141 . . . . 74.32 110.281 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.2 -43.99 26.98 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 124.687 1.195 . . . . 73.4 109.309 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -60.0 -22.23 62.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.871 2.123 . . . . 75.54 113.063 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -100.0 -10.37 21.68 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.547 1.539 . . . . 75.34 112.058 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -65.36 1.02 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.962 -1.866 . . . . 75.02 105.962 163.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -82.83 41.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.686 3.194 . . . . 72.11 110.074 -167.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.33 -30.23 68.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.387 1.875 . . . . 73.31 110.2 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -69.64 -21.13 63.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.159 1.784 . . . . 72.23 112.534 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.28 6.32 48.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.652 1.581 . . . . 72.41 112.271 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.69 84.18 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.652 1.215 . . . . 73.55 109.645 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.48 120.6 24.68 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.243 -1.762 . . . . 73.35 106.243 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -88.62 157.55 18.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.76 -1.941 . . . . 75.33 105.76 155.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.03 178.47 8.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.232 -1.396 . . . . 64.5 107.232 164.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.22 -36.88 83.33 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.656 1.182 . . . . 62.41 110.527 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -14.07 33.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.149 1.38 . . . . 74.32 112.586 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.16 33.41 26.32 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.143 2.306 . . . . 65.22 111.067 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.521 ' CD1' ' HE3' ' A' ' 80' ' ' LYS . 3.4 t80 -79.95 -90.97 0.05 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.036 1.334 . . . . 75.32 108.46 -171.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.19 128.16 2.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.087 -2.005 . . . . 73.45 108.087 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -139.99 168.51 19.64 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.719 1.208 . . . . 74.32 109.026 166.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.2 mt -149.22 143.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.543 2.337 . . . . 62.52 105.51 168.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.38 130.48 37.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.369 1.468 . . . . 52.34 108.295 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.39 -2.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.907 0.883 . . . . 72.04 112.596 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.88 -20.38 52.9 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.535 1.061 . . . . 63.13 115.37 -169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -63.15 -20.52 65.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 128.111 2.564 . . . . 75.41 114.045 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.16 -20.16 62.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.662 0.785 . . . . 72.13 111.357 172.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.14 3.29 1.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.001 2.121 . . . . 74.41 113.685 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.05 138.42 15.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.381 1.472 . . . . 65.21 108.794 172.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.84 167.52 10.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.463 1.125 . . . . 75.01 110.635 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.5 tt -135.38 160.28 40.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 125.714 1.606 . . . . 73.21 108.041 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -81.77 132.88 35.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.312 -1.736 . . . . 75.11 106.312 168.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.37 -174.08 3.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.963 -0.754 . . . . 71.32 108.963 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -138.1 139.54 39.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.401 -1.703 . . . . 73.13 106.401 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.52 107.71 19.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.529 -1.286 . . . . 71.43 107.529 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 3.7 ttpm? -56.49 -23.71 41.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.869 1.268 . . . . 73.13 111.607 173.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -23.06 5.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.473 1.909 . . . . 75.44 112.772 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -149.6 14.27 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.325 1.05 . . . . 73.15 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 37.7 53.82 1.48 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.217 1.807 . . . . 71.15 111.838 -163.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.2 pt -105.98 155.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.707 0.803 . . . . 74.3 109.366 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.7 mm -85.04 130.72 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.829 -1.545 . . . . 75.14 106.829 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.33 166.97 23.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.219 1.007 . . . . 74.45 112.238 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.89 113.0 25.24 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.732 2.013 . . . . 71.15 107.7 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -125.0 167.21 15.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.959 0.903 . . . . 75.44 109.824 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' A' ' 74' ' ' ILE . 8.0 ttm180 -106.22 177.36 4.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.4 0.68 . . . . 75.31 110.228 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.418 ' H ' ' HG2' ' A' ' 73' ' ' ARG . 64.4 mt -113.49 153.55 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 105.423 -2.066 . . . . 74.13 105.423 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.34 -58.52 1.7 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.799 1.239 . . . . 74.23 108.435 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . 0.25 14.7 mtm180 -128.1 159.34 35.4 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.227 1.411 . . . . 74.51 112.756 -174.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 m -133.97 165.66 31.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.385 1.474 . . . . 71.43 108.149 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.549 ' HE1' ' CG2' ' A' ' 156' ' ' THR . 68.4 m95 -139.07 163.73 31.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.926 0.49 . . . . 74.42 111.283 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.04 135.87 31.48 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.083 0.953 . . . . 74.52 110.592 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tppp? -142.95 141.45 31.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.031 -1.84 . . . . 71.54 106.031 162.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -86.51 152.38 22.7 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.689 0.795 . . . . 70.11 109.961 -163.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 110.21 3.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.913 -0.773 . . . . 74.24 108.913 169.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.95 46.35 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.394 0.543 . . . . 70.03 111.849 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.573 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.75 121.87 25.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.787 -0.82 . . . . 74.54 108.787 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.18 172.58 7.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.151 -1.796 . . . . 75.01 106.151 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.2 mm -79.15 160.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.418 1.887 . . . . 75.11 107.912 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -137.27 79.64 1.76 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.1 -1.444 . . . . 72.31 107.1 157.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 48.4 mt -67.12 135.5 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 104.456 -2.424 . . . . 71.13 104.456 158.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -118.22 175.36 5.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.244 1.418 . . . . 73.15 107.311 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -142.33 176.84 8.68 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.919 1.236 . . . . 72.32 112.654 164.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -53.66 -35.17 60.74 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.307 1.043 . . . . 74.12 111.854 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.85 11.0 1.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.785 2.034 . . . . 73.34 111.677 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 47.37 33.54 2.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.153 1.781 . . . . 71.15 111.394 -166.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -83.48 168.35 16.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.818 -1.178 . . . . 71.14 107.818 165.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 179.24 163.55 0.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.5 1.92 . . . . 75.12 107.666 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.514 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 2.0 pt -139.65 172.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.844 2.057 . . . . 74.52 110.201 -174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -137.81 99.67 3.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.34 1.856 . . . . 74.51 107.118 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.88 167.5 28.12 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.756 -0.59 . . . . 74.52 110.347 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 p -75.84 162.38 28.19 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.317 -0.864 . . . . 71.1 110.697 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.74 38.74 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.678 0.791 . . . . 73.25 112.736 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -157.47 37.04 0.28 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.963 0.801 . . . . 73.31 110.065 149.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -75.15 137.02 72.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 119.721 -1.862 . . . . 74.42 110.453 -174.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.35 121.92 9.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.229 2.619 . . . . 74.12 111.483 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.7 -177.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.914 1.286 . . . . 71.43 109.064 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -128.32 137.06 51.77 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.174 0.99 . . . . 73.4 108.894 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.9 pt -141.82 167.6 15.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.511 1.124 . . . . 74.54 108.564 178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 143.16 34.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.499 0.666 . . . . 62.0 111.797 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -115.14 53.99 0.8 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.384 1.074 . . . . 72.22 108.748 163.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER 96.36 -0.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 130.856 3.662 . . . . 75.53 114.328 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.75 -11.41 3.69 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.714 -0.955 . . . . 63.12 110.714 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -86.37 161.32 18.75 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 125.419 1.488 . . . . 74.43 112.713 161.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.5 t -106.49 106.64 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.036 1.334 . . . . 71.43 108.962 -166.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.59 158.58 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.214 1.006 . . . . 73.04 108.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -114.44 121.05 42.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.615 1.966 . . . . 74.23 107.037 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 pt -140.71 178.32 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.293 1.037 . . . . 74.42 109.826 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -77.37 140.39 39.93 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.087 1.755 . . . . 71.21 109.867 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.38 -29.81 61.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.198 1.399 . . . . 73.3 112.384 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -31.49 72.19 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.93 -0.481 . . . . 73.11 111.154 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -25.87 42.46 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.507 1.123 . . . . 75.44 111.316 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -72.75 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.3 2.24 . . . . 74.51 111.416 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.51 -178.35 5.78 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.933 -1.104 . . . . 74.32 108.962 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.18 -2.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 129.565 3.146 . . . . 75.34 114.569 166.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.88 -15.92 57.13 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.285 -1.509 . . . . 74.23 111.734 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.35 140.69 51.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.473 1.636 . . . . 73.13 107.954 -160.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.71 117.68 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.643 1.177 . . . . 71.14 107.944 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 tt -82.88 142.99 12.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.044 -0.725 . . . . 74.32 109.044 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -74.21 121.43 21.22 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.51 -0.922 . . . . 73.24 108.51 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -120.93 145.61 41.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.696 1.199 . . . . 72.34 110.296 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 148.01 47.39 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.999 1.799 . . . . 75.04 107.516 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -120.93 -169.81 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.346 -1.724 . . . . 74.14 106.346 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -34.53 -72.24 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.922 1.689 . . . . 74.31 112.17 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.48 1.31 10.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.655 1.182 . . . . 64.31 113.217 171.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.2 p -130.47 153.8 48.43 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.967 1.307 . . . . 72.14 112.263 -165.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 tp -84.33 147.46 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.163 -1.421 . . . . 71.4 107.163 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -147.7 -174.86 4.66 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.877 2.071 . . . . 75.3 107.693 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.0 mt -131.25 159.98 36.23 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.354 1.462 . . . . 71.02 108.007 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -149.37 159.0 44.65 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.886 0.874 . . . . 72.24 110.122 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.83 140.27 29.87 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.745 2.418 . . . . 73.05 109.975 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -81.89 -3.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.212 1.405 . . . . 74.11 113.461 -170.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.422 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.3 pt 25.05 -89.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 127.494 2.318 . . . . 74.34 115.6 174.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.422 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -89.82 105.4 17.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.821 1.648 . . . . 74.02 107.844 170.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.81 148.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.135 -1.061 . . . . 64.01 108.135 154.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.3 -162.63 0.76 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.359 2.664 . . . . 74.11 107.661 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -131.26 162.12 30.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.162 1.785 . . . . 72.55 109.561 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.63 -169.16 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.601 1.561 . . . . 74.12 109.455 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.01 132.47 41.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.991 2.116 . . . . 74.42 106.535 161.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.95 143.31 36.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.82 1.191 . . . . 72.05 110.489 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.53 30.74 1.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.969 0.729 . . . . 65.41 112.969 -163.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.59 -136.03 4.21 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.593 1.092 . . . . 54.44 111.739 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -99.25 170.06 8.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.384 -1.068 . . . . 74.02 109.824 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.3 pt -118.34 -73.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.037 -1.468 . . . . 73.53 107.037 173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 78.98 170.29 0.18 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.535 2.334 . . . . 74.12 107.553 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -162.91 153.96 17.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.425 1.49 . . . . 71.2 107.439 -170.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -123.04 141.21 52.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.457 1.103 . . . . 74.24 111.133 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.549 ' CG2' ' HE1' ' A' ' 78' ' ' TRP . 44.7 p -79.49 -70.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.751 0.657 . . . . 75.41 110.183 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t 43.11 73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.664 2.386 . . . . 65.22 111.844 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.05 -0.48 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 74.33 113.314 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.94 -38.72 83.2 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.599 -0.519 . . . . 73.44 109.599 -166.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.474 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 5.5 t30 -138.52 7.98 2.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.871 1.269 . . . . 71.41 111.99 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.5 m170 54.02 29.32 9.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.505 1.122 . . . . 74.12 111.424 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.422 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 2.3 p -142.91 144.77 32.56 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.628 -1.92 . . . . 73.33 109.135 178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -148.8 167.17 26.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.067 0.765 . . . . 75.35 113.067 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.2 mm -85.85 137.19 21.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 106.407 -1.701 . . . . 74.42 106.407 164.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -153.87 143.08 21.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.801 1.24 . . . . 75.31 108.072 162.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.55 -173.32 22.87 Favored Glycine 0 N--CA 1.462 0.431 0 C-N-CA 123.881 0.753 . . . . 54.35 111.585 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -90.95 167.87 12.09 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.47 -1.606 . . . . 74.12 110.261 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.08 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.542 2.337 . . . . 75.31 114.201 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.514 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 43.0 mt-10 -121.77 -7.94 8.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.558 1.143 . . . . 72.42 112.339 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.26 170.33 14.7 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 122.844 1.247 . . . . 73.42 111.874 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.514 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 12.8 m-85 -120.72 147.91 44.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.968 2.507 . . . . 74.31 106.98 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -90.79 103.94 16.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.542 -1.651 . . . . 73.35 106.542 177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.24 177.88 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.398 1.479 . . . . 65.21 109.176 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.8 t -67.34 144.4 55.86 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.47 2.708 . . . . 72.04 109.77 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -123.96 166.13 16.24 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.681 2.793 . . . . 75.21 107.013 162.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.99 171.58 3.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.613 -1.625 . . . . 72.42 106.613 160.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.6 m -94.92 53.18 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.096 -1.002 . . . . 72.32 109.832 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.93 -9.18 32.68 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.221 1.391 . . . . 62.3 112.916 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.5 p -79.82 164.48 23.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.703 2.001 . . . . 75.25 111.928 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.5 tp -111.17 75.44 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.735 0.814 . . . . 73.13 109.232 -166.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.52 -49.88 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.746 2.818 . . . . 74.45 111.878 -162.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 61.2 t60 57.85 -79.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.767 2.427 . . . . 73.23 113.542 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -154.44 170.43 21.39 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.598 1.09 . . . . 74.4 109.291 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -87.27 87.3 7.39 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.186 -1.042 . . . . 74.53 108.186 173.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -76.57 168.79 19.45 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.989 -1.115 . . . . 72.24 107.989 151.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 126.96 2.104 . . . . 74.41 107.622 -168.751 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mtt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 107.395 -1.335 . . . . 70.45 107.395 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.24 168.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.996 1.271 . . . . 75.15 110.563 -167.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -69.34 -43.0 74.54 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.131 -0.981 . . . . 71.32 110.362 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.78 92.38 2.24 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.284 -2.326 . . . . 73.2 107.284 -164.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.58 -73.33 0.47 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.229 -1.397 . . . . 72.22 107.229 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.13 157.07 16.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.846 -1.168 . . . . 75.13 107.846 159.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.57 101.73 1.73 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 106.331 -2.708 . . . . 75.2 106.331 -156.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -162.59 157.34 21.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.305 1.442 . . . . 62.13 108.102 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.41 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 72.42 110.508 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.05 152.97 43.78 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.763 -0.653 . . . . 70.53 109.804 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.6 t80 -53.81 -31.12 47.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.449 1.5 . . . . 75.02 112.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.45 ' CG ' ' HZ2' ' A' ' 167' ' ' LYS . 2.3 p-10 -103.93 14.67 30.28 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.753 1.221 . . . . 71.22 113.459 -171.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.34 119.96 79.28 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 106.013 -1.847 . . . . 75.5 106.013 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.0 139.79 75.43 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-N 120.427 1.188 . . . . 73.01 112.437 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.0 pt -90.21 140.3 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.022 -1.103 . . . . 73.23 108.022 161.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -102.43 83.26 2.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.409 -1.7 . . . . 73.3 106.409 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.3 164.59 18.08 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.308 0.575 . . . . 74.4 109.987 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.5 t -56.02 -39.34 71.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.095 0.958 . . . . 73.31 110.216 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -33.37 34.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.265 0.939 . . . . 55.53 111.089 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.68 46.07 2.37 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.865 0.745 . . . . 62.41 112.271 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -35.9 69.43 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.68 1.24 . . . . 71.35 111.72 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.4 mm 45.87 86.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 128.283 2.633 . . . . 74.15 107.325 -163.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.72 152.0 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.63 -1.618 . . . . 73.52 106.63 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.29 135.24 56.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.283 1.833 . . . . 65.13 109.351 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.491 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -50.9 -54.81 8.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.825 -1.176 . . . . 75.23 107.825 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.488 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -55.49 -45.19 84.89 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.944 -1.263 . . . . 74.35 109.944 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -71.83 -42.96 66.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.077 1.351 . . . . 73.03 112.599 -173.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -52.4 -49.26 64.82 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 122.038 0.923 . . . . 74.14 109.552 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.436 ' CG2' ' CE2' ' A' ' 153' ' ' TYR . 92.7 t -72.79 -42.1 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.836 -1.075 . . . . 74.13 109.886 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.24 -38.36 73.67 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.332 0.515 . . . . 72.1 111.289 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.8 -43.14 76.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.276 1.03 . . . . 74.41 109.347 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.39 -47.09 62.46 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 117.491 -1.242 . . . . 74.03 108.767 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.6 -38.2 66.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.447 1.476 . . . . 75.44 110.994 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -78.05 -30.82 50.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.837 -1.078 . . . . 74.41 111.781 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.43 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.5 ttmm -78.97 -63.12 1.49 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.742 -1.577 . . . . 72.0 106.742 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.33 39.77 0.53 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.266 2.627 . . . . 72.45 109.732 -172.654 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.81 -38.29 67.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 120.533 -1.354 . . . . 75.43 110.784 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -74.47 -12.85 60.6 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.198 0.814 . . . . 73.05 113.198 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -93.95 0.01 55.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.842 1.257 . . . . 74.52 112.32 174.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.59 95.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 119.638 1.108 . . . . 72.44 108.099 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -78.94 147.75 32.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.152 -1.425 . . . . 71.52 107.152 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 130.75 48.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.043 -2.577 . . . . 70.21 104.043 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 144.66 35.71 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.094 -1.817 . . . . 73.43 106.094 171.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.5 -40.26 86.46 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.124 1.769 . . . . 75.41 112.196 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.98 -5.8 28.83 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.214 1.006 . . . . 74.0 112.27 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.77 56.41 1.16 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 126.731 2.11 . . . . 50.11 110.24 160.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -120.33 -97.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.338 1.055 . . . . 73.12 109.048 -172.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.11 137.71 3.02 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.986 1.755 . . . . 62.42 109.855 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -150.01 170.55 18.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.185 0.992 . . . . 73.14 111.448 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 mt -149.26 144.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.085 2.154 . . . . 74.14 106.608 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 122.53 31.06 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.248 1.819 . . . . 61.2 108.889 168.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.514 ' C ' ' H ' ' A' ' 54' ' ' ASN . 2.2 pp -135.19 14.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.766 1.227 . . . . 70.54 111.876 -174.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 17.72 0.14 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.082 1.801 . . . . 73.44 114.69 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.514 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -119.75 -13.1 9.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 129.873 3.269 . . . . 75.54 111.022 -177.005 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.29 -20.92 65.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.361 0.982 . . . . 75.45 110.903 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.1 19.19 2.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.571 1.948 . . . . 74.24 113.068 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.33 148.36 12.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.32 1.448 . . . . 73.51 107.52 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -115.67 140.85 48.81 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.682 -0.858 . . . . 72.51 108.682 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.49 158.65 18.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.555 1.542 . . . . 75.23 107.71 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -66.01 145.21 56.14 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.968 -1.123 . . . . 73.15 107.968 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.72 -179.29 5.96 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.735 1.614 . . . . 70.23 107.795 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.98 121.85 7.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.842 -1.161 . . . . 72.54 109.417 173.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.84 114.63 9.1 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.507 1.123 . . . . 63.32 108.93 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.442 ' HE2' ' CG2' ' A' ' 162' ' ' THR . 18.0 mttt -62.35 -21.25 65.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.236 0.828 . . . . 75.21 113.236 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -37.8 -47.16 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.12 2.168 . . . . 75.34 109.807 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.4 17.71 2.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.53 1.132 . . . . 74.43 110.575 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 48.93 49.33 19.46 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.027 1.285 . . . . 75.2 112.222 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.74 149.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.544 1.538 . . . . 75.44 107.934 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.77 144.49 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.595 -1.261 . . . . 75.44 107.595 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -148.96 -177.58 5.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.194 2.197 . . . . 65.32 111.881 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.01 162.22 13.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.904 2.082 . . . . 73.31 109.991 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 149.95 22.69 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.909 -1.119 . . . . 75.0 111.572 156.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -78.9 162.54 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.974 -0.751 . . . . 75.13 108.974 159.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -94.09 168.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.208 1.803 . . . . 74.34 106.756 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.19 -58.31 2.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.265 1.826 . . . . 75.2 108.94 168.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -128.76 155.98 44.26 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.757 -0.59 . . . . 74.33 110.873 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.39 163.4 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 126.179 1.791 . . . . 55.21 108.331 173.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.35 176.72 8.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.84 1.656 . . . . 70.04 109.631 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -169.08 148.14 3.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.972 1.709 . . . . 75.44 109.168 163.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -142.43 169.99 16.55 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.605 1.562 . . . . 72.33 107.538 156.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 151' ' ' HIS . 80.5 tttt -91.41 152.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.711 -0.618 . . . . 72.33 109.408 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -146.93 147.89 31.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.439 0.696 . . . . 74.22 110.103 -170.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -157.7 126.84 5.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.444 -1.317 . . . . 75.12 107.444 155.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.52 -177.78 42.34 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.052 0.842 . . . . 75.25 112.56 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.593 ' H ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.89 127.47 32.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.03 -0.688 . . . . 74.11 110.86 171.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.96 157.98 17.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.848 -1.168 . . . . 75.52 107.848 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 mm -78.57 133.68 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.217 -1.401 . . . . 74.33 107.217 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -119.74 84.52 2.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.005 1.383 . . . . 75.15 107.645 164.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.67 130.39 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.143 -2.169 . . . . 73.21 105.143 154.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 4.9 m -100.15 -175.71 3.02 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 105.979 -1.86 . . . . 73.34 105.979 161.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 90' ' ' THR . 12.0 p -146.95 170.29 17.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.654 1.982 . . . . 74.2 108.716 165.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -56.92 -28.1 61.68 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.169 1.349 . . . . 73.54 112.433 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -72.3 3.4 4.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.623 0.971 . . . . 54.54 113.623 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 57.05 18.8 4.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.68 1.592 . . . . 72.32 111.591 -164.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 160.72 32.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.447 -1.686 . . . . 74.31 106.447 161.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.83 164.19 5.11 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.47 2.308 . . . . 72.41 106.857 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 4.5 pt -146.77 170.15 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 125.512 1.525 . . . . 74.33 108.521 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . 0.358 0.0 OUTLIER -151.63 96.49 2.26 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 126.624 1.97 . . . . 73.53 113.3 -175.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.411 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -161.79 179.4 8.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.153 1.781 . . . . 74.21 110.291 -166.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 p -66.72 166.92 12.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.959 0.885 . . . . 74.43 110.837 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.39 -14.13 62.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.533 -0.729 . . . . 73.15 112.239 175.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -125.15 37.88 4.3 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.741 1.616 . . . . 71.51 111.566 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.411 ' CG ' HD22 ' A' ' 99' ' ' LEU . 1.1 p-80 -76.77 141.74 68.94 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.076 -0.964 . . . . 74.11 108.487 164.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -70.92 127.24 13.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.308 3.339 . . . . 72.21 113.525 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.39 -177.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.279 1.831 . . . . 65.04 110.685 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -131.45 126.87 36.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.986 2.114 . . . . 73.41 108.502 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.51 163.02 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.244 0.929 . . . . 72.45 109.967 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.56 104.79 10.4 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.019 0.914 . . . . 74.23 110.612 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -86.01 79.85 9.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 104.248 -2.501 . . . . 74.41 104.248 161.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 55.45 19.65 3.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.428 1.269 . . . . 74.05 114.428 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.79 -0.89 41.88 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.168 -0.958 . . . . 74.55 113.642 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -91.66 129.11 37.69 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.075 -2.194 . . . . 75.33 105.075 156.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.24 130.37 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 74.24 108.885 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.42 148.44 42.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.892 0.877 . . . . 75.21 110.476 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -103.72 123.83 47.76 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.352 1.461 . . . . 71.51 111.289 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.51 -178.34 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.318 1.447 . . . . 74.54 111.325 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -86.27 145.38 26.97 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.634 1.974 . . . . 73.53 109.336 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -39.6 -51.75 2.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.228 2.211 . . . . 73.41 112.245 170.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -56.12 -21.43 22.34 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.521 1.528 . . . . 74.02 114.604 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.3 mtt -93.48 -19.21 21.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.279 1.032 . . . . 75.03 111.387 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.3 t -78.88 62.0 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 127.677 2.391 . . . . 74.32 109.277 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.76 -176.95 5.66 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.324 -0.86 . . . . 74.21 109.987 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.52 -11.47 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 126.413 1.885 . . . . 74.51 113.701 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.69 -3.11 71.59 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.536 -1.147 . . . . 72.54 112.965 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -123.98 145.7 49.01 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.956 1.878 . . . . 73.43 108.798 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -112.95 114.52 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.907 1.283 . . . . 72.14 107.682 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.5 tt -89.46 134.5 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.8 1.24 . . . . 74.0 108.944 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -69.72 107.26 3.4 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.837 -0.801 . . . . 73.13 108.837 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.46 157.81 39.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.909 1.284 . . . . 73.25 110.281 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.35 152.28 66.16 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.818 1.012 . . . . 65.3 110.13 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -119.82 178.82 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 156.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -23.81 -67.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.273 3.029 . . . . 75.25 114.888 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -120.88 -13.4 8.64 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.166 0.894 . . . . 74.01 113.389 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -139.07 168.66 19.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.253 -0.905 . . . . 73.51 110.834 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -78.33 156.89 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.778 -0.823 . . . . 65.33 108.778 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 -176.14 4.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.118 2.967 . . . . 71.11 105.441 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 mp -113.61 167.58 10.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.572 1.949 . . . . 70.44 109.07 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -157.54 154.27 28.31 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.676 -1.602 . . . . 70.43 106.676 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.93 141.34 28.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.699 1.2 . . . . 61.23 108.58 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 11.5 t -67.6 -22.2 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 114.735 1.384 . . . . 72.31 114.735 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.2 pt 50.52 -49.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 130.115 3.366 . . . . 74.42 118.013 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.78 133.19 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 131.466 3.906 . . . . 75.15 107.773 -161.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.64 109.31 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.379 -0.6 . . . . 75.23 109.379 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -151.11 -175.71 5.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.369 1.068 . . . . 73.43 108.969 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 134.65 47.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.473 1.109 . . . . 55.21 108.102 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.48 -176.14 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.811 -1.181 . . . . 72.34 107.811 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.71 155.93 30.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.419 -1.326 . . . . 74.54 107.419 152.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -147.6 162.0 40.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.065 0.946 . . . . 74.1 108.649 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.87 78.36 0.33 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.055 -1.461 . . . . 74.13 107.055 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.85 25.59 0.2 Allowed Glycine 0 N--CA 1.474 1.227 0 N-CA-C 118.966 2.346 . . . . 73.31 118.966 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.412 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 71.8 m80 61.13 159.78 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.403 2.281 . . . . 65.31 111.813 -167.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.5 pt -145.7 155.26 13.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.638 1.575 . . . . 75.33 108.594 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -156.42 168.68 26.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.881 0.472 . . . . 74.34 111.199 171.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -146.21 162.79 37.27 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.727 2.811 . . . . 74.32 106.726 -173.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.15 153.96 34.04 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.578 -1.326 . . . . 72.34 112.162 -163.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 -38.78 10.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.057 -0.974 . . . . 74.34 113.339 -162.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.257 2.1 t 22.89 64.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 129.567 3.147 . . . . 74.15 113.487 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -78.15 1.63 20.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.241 -0.912 . . . . 72.51 112.453 -169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -89.6 -48.27 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.638 2.775 . . . . 73.0 109.298 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -132.64 -3.61 3.31 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.103 0.779 . . . . 73.13 113.103 -173.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 69.03 8.44 6.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.143 1.377 . . . . 74.44 113.982 161.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.442 ' CG2' ' HE2' ' A' ' 64' ' ' LYS . 39.1 p -140.77 158.06 44.52 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.389 2.276 . . . . 75.42 107.248 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -144.86 -175.68 4.77 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.731 -1.23 . . . . 73.24 110.77 172.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.96 111.95 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.853 1.261 . . . . 75.52 108.081 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.47 158.47 44.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.131 1.373 . . . . 71.34 108.496 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.15 -158.06 25.15 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 107.379 -2.288 . . . . 74.41 107.379 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.45 ' HZ2' ' CG ' ' A' ' 12' ' ' ASP . 19.1 mttt -112.32 172.39 6.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.017 1.408 . . . . 73.24 111.212 173.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.58 -69.43 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.867 3.267 . . . . 72.41 114.164 -174.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -122.89 -11.0 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.783 2.033 . . . . 75.11 113.694 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.88 159.54 3.17 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 122.533 1.074 . . . . 73.11 112.119 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 97' ' ' ILE . 26.5 m-85 -104.38 156.1 18.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.752 2.021 . . . . 72.45 109.26 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -89.27 79.89 6.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.194 1.798 . . . . 73.23 107.599 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.97 176.8 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.58 -1.267 . . . . 74.55 107.58 -171.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.16 155.63 38.27 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.008 2.123 . . . . 73.21 111.049 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.56 39.78 1.17 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.05 2.54 . . . . 73.32 108.605 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 p -68.57 134.0 49.35 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.326 -0.99 . . . . 74.3 108.326 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.2 p -77.54 -4.5 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.297 1.591 . . . . 74.3 115.297 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.99 13.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.761 0.696 . . . . 53.31 113.536 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 p -55.07 155.05 4.91 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.497 1.149 . . . . 45.52 111.596 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 36.2 tp -61.52 -36.59 80.97 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.343 0.868 . . . . 74.43 113.343 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.5 -165.23 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.413 0.685 . . . . 70.32 110.996 -174.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -123.38 171.2 9.61 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.249 -1.389 . . . . 74.04 107.249 155.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -135.33 174.96 10.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.013 1.325 . . . . 71.24 108.1 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -144.24 159.54 42.49 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.322 . . . . 70.51 108.56 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 48.2 56.09 7.86 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.812 1.645 . . . . 75.45 112.269 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.951 0 C-N-CA 127.997 2.519 . . . . 75.41 110.71 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 110.038 -0.356 . . . . 74.12 110.038 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 59.65 177.01 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.792 1.637 . . . . 63.41 111.159 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.78 -70.25 0.79 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.484 -2.043 . . . . 72.43 105.484 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.13 -87.44 0.13 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.485 -1.046 . . . . 42.31 110.485 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -153.96 -52.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.891 0.876 . . . . 72.34 110.258 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.17 168.99 4.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.107 0.563 . . . . 75.01 111.735 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.2 87.68 1.11 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.21 1.386 . . . . 72.32 110.865 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -142.69 147.21 35.3 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.25 1.02 . . . . 75.14 108.503 166.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.77 160.2 30.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.072 1.749 . . . . 75.32 109.802 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.24 149.7 44.32 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.802 -0.444 . . . . 71.2 109.802 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -44.45 -39.51 4.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.903 1.681 . . . . 74.44 113.549 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -97.22 7.8 45.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.388 1.075 . . . . 74.01 113.088 -166.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.25 121.73 84.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.517 -1.29 . . . . 71.33 107.517 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.11 141.92 95.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.569 1.239 . . . . 61.44 112.336 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 pt -96.38 -8.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.369 0.877 . . . . 73.33 113.369 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 54.63 69.33 0.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.479 1.133 . . . . 75.35 110.075 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.3 mt -55.1 160.58 2.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.7 -0.682 . . . . 74.55 109.595 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -53.35 -40.54 64.99 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.736 0.814 . . . . 71.4 109.755 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.01 -37.38 84.67 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.265 1.026 . . . . 75.11 112.786 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.68 41.15 7.38 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.065 -1.022 . . . . 55.11 110.548 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.77 -11.95 61.26 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.786 0.835 . . . . 74.35 113.192 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.9 mm 40.57 70.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.97 2.908 . . . . 71.23 109.112 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.83 149.83 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 112.82 -1.991 . . . . 74.25 107.928 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.26 135.37 47.42 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.791 1.236 . . . . 74.31 109.52 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.69 -4.24 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.221 1.809 . . . . 75.04 114.556 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.62 -9.86 12.15 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-O 116.769 -2.129 . . . . 72.14 113.488 165.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -78.33 -49.71 13.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.278 2.039 . . . . 75.44 109.799 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -39.6 -54.88 1.95 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.202 1.801 . . . . 75.43 109.797 165.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG13 ' H ' ' A' ' 29' ' ' VAL . 0.6 OUTLIER -73.16 -30.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.976 -1.465 . . . . 74.15 110.379 -174.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.12 -31.83 73.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.512 -1.368 . . . . 73.12 111.125 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -52.2 61.09 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.361 0.664 . . . . 75.33 109.478 168.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -66.13 -44.18 84.96 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 117.57 -1.205 . . . . 62.33 109.24 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -54.41 -39.56 67.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 121.876 2.126 . . . . 75.42 112.786 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -27.33 56.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.74 -1.124 . . . . 74.32 111.509 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 3.8 mtpt -86.39 -59.93 2.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.456 -1.683 . . . . 74.02 106.456 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 3.8 m-30 -88.98 39.93 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.762 2.825 . . . . 73.25 108.769 -168.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.59 -35.09 71.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.598 -1.314 . . . . 74.23 112.089 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -31.11 72.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 72.41 112.816 172.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 m -79.56 -9.44 59.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.15 1.78 . . . . 53.32 111.246 -175.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.05 102.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.373 0 N-CA-C 106.554 -1.647 . . . . 74.23 106.554 168.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.81 167.27 12.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.389 -1.337 . . . . 74.24 107.389 158.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 145.64 45.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.212 -2.144 . . . . 72.55 105.212 167.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -78.3 168.83 19.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.29 -1.744 . . . . 75.13 106.29 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -33.09 74.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.496 0.718 . . . . 61.41 110.51 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.14 -0.35 18.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.426 0.899 . . . . 75.23 113.426 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.29 17.87 51.51 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 126.023 1.773 . . . . 61.14 113.259 161.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.96 -95.35 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.461 1.905 . . . . 74.43 109.974 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.51 129.07 1.41 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.783 -1.727 . . . . 63.13 108.783 -167.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -137.75 157.99 45.3 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 124.402 0.707 . . . . 71.33 109.487 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mt -139.36 141.83 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 104.97 -2.234 . . . . 74.35 104.97 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.38 137.28 32.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.678 0.791 . . . . 64.42 109.697 167.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.56 17.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.402 1.481 . . . . 73.22 112.748 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.97 -38.01 10.04 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.259 -0.745 . . . . 73.54 113.517 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -78.17 -6.23 54.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.202 1.501 . . . . 75.33 113.763 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.456 ' C ' ' H ' ' A' ' 57' ' ' ILE . 56.6 mm-40 -64.35 -26.96 68.7 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.361 1.437 . . . . 74.23 110.323 168.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 m120 58.76 -4.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.971 2.108 . . . . 73.32 114.318 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 ' H ' ' C ' ' A' ' 55' ' ' GLU . 93.5 mt -47.8 132.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 128.234 2.614 . . . . 62.3 108.058 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.75 150.57 22.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.255 1.026 . . . . 73.22 110.192 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.8 150.96 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.91 2.084 . . . . 74.43 107.014 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -61.77 120.7 11.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.844 -0.799 . . . . 75.13 108.844 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -114.18 -179.49 3.65 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.77 1.228 . . . . 73.44 108.505 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.471 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.1 OUTLIER -143.4 146.82 33.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.291 -1.374 . . . . 74.23 107.291 159.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.4 112.83 24.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.368 0.531 . . . . 72.4 109.952 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.38 -24.1 67.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.184 0.994 . . . . 75.25 112.384 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.7 -43.37 5.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.725 2.41 . . . . 74.42 111.733 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.96 18.88 1.79 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.247 1.019 . . . . 75.2 111.521 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp 39.72 66.12 0.62 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.312 2.245 . . . . 71.12 112.056 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 pt -121.02 156.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.958 1.703 . . . . 74.12 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.2 mm -86.57 126.18 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 126.989 2.116 . . . . 73.14 106.631 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -140.46 171.18 14.5 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.084 1.753 . . . . 73.11 107.842 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -112.76 141.1 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.975 1.71 . . . . 72.33 107.43 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 151.6 38.11 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.323 -0.861 . . . . 75.21 109.385 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -79.2 173.73 12.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.625 -0.88 . . . . 75.02 108.625 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.8 151.74 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.058 -1.46 . . . . 75.11 107.058 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -106.29 -41.93 5.19 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 117.645 -1.169 . . . . 75.23 110.385 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtm-85 -140.08 149.69 43.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.433 1.469 . . . . 75.21 111.427 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.97 155.9 7.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.451 1.501 . . . . 70.04 108.54 170.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -130.74 150.26 52.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.0 1.32 . . . . 75.01 109.045 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -151.84 140.64 20.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.973 0.909 . . . . 74.01 110.208 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -153.92 163.75 39.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.608 1.163 . . . . 74.14 108.81 163.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -92.37 139.68 30.35 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 120.808 -1.182 . . . . 74.25 110.148 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -134.46 168.36 19.08 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.327 1.451 . . . . 75.53 109.901 -165.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.75 109.09 1.6 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.195 -0.907 . . . . 72.21 111.338 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.82 -173.53 36.53 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.256 1.389 . . . . 74.34 112.49 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -86.64 109.33 19.09 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.314 -0.521 . . . . 74.03 111.336 -171.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.75 168.65 19.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.77 -0.826 . . . . 74.52 108.77 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.12 130.35 35.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.06 2.144 . . . . 60.13 108.185 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -115.8 85.57 2.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.09 -1.448 . . . . 71.43 107.09 161.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -66.26 120.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 104.008 -2.59 . . . . 75.42 104.008 153.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -104.5 164.58 11.65 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.469 -1.678 . . . . 74.53 106.469 161.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.5 p -134.03 170.24 15.94 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.05 -1.031 . . . . 70.44 109.758 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -65.06 -27.72 68.98 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.109 1.764 . . . . 74.23 110.46 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -68.25 1.04 3.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.927 1.691 . . . . 75.12 111.536 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 55.82 29.67 14.42 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.085 2.154 . . . . 74.54 111.785 -172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.476 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt-85 -75.84 168.49 19.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 118.224 -1.39 . . . . 73.43 109.085 162.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.6 169.26 18.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.916 1.385 . . . . 75.52 108.573 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.491 HG21 ' CE1' ' A' ' 171' ' ' PHE . 1.2 pt -146.16 169.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.959 2.104 . . . . 74.12 110.804 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 m -146.86 98.16 3.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.082 1.353 . . . . 64.05 110.454 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.71 174.93 13.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.065 1.746 . . . . 70.14 111.098 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 167.58 10.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.229 1.012 . . . . 74.4 110.935 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -70.14 -31.86 69.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.03 -0.73 . . . . 62.01 109.03 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -101.44 38.87 1.51 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 73.3 112.493 -168.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -107.91 143.52 27.5 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 120.801 -1.187 . . . . 74.43 110.882 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.46 125.65 12.01 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.986 3.124 . . . . 75.33 112.368 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.64 168.83 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.743 0.817 . . . . 75.32 108.866 168.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.32 140.68 37.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.351 0.66 . . . . 74.42 110.554 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.55 158.45 37.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.332 1.453 . . . . 74.53 108.275 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.6 p -88.78 134.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.122 0.963 . . . . 72.12 108.962 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 77.33 1.03 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.368 -1.716 . . . . 74.53 106.368 161.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 59.32 21.17 9.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 70.45 113.069 167.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.34 -19.84 5.94 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.211 -0.772 . . . . 72.14 111.693 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -87.15 141.11 28.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 104.4 -2.444 . . . . 73.54 104.4 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -86.72 139.6 17.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.677 -1.264 . . . . 74.52 108.051 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.92 159.95 37.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.953 -1.499 . . . . 74.22 106.953 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -126.18 112.2 15.51 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.333 1.053 . . . . 62.05 109.573 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.65 174.83 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.511 1.124 . . . . 74.11 111.111 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -76.84 136.31 38.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 117.862 -1.066 . . . . 72.44 109.489 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.03 -32.73 16.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 55.53 113.304 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.3 -16.29 63.53 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.192 1.553 . . . . 70.04 115.192 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.8 mtt -84.0 -28.09 27.97 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.446 0.566 . . . . 73.22 110.707 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.5 t -76.14 61.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 127.496 2.318 . . . . 62.43 109.786 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -91.63 -171.8 3.02 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.537 1.135 . . . . 74.43 108.079 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.61 -9.02 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.34 1.456 . . . . 74.42 114.236 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.89 2.36 69.32 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 116.793 -2.115 . . . . 73.41 113.495 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.78 135.56 43.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 121.12 2.46 . . . . 74.01 108.999 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -79.59 118.91 21.87 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.518 -0.919 . . . . 74.14 108.518 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.08 126.06 42.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.574 -1.269 . . . . 74.52 107.574 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.96 141.1 56.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.838 -0.801 . . . . 74.51 108.838 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.52 158.8 72.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.402 1.081 . . . . 74.24 112.013 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.56 150.7 31.96 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.621 2.214 . . . . 74.32 108.365 171.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.32 -174.77 3.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 105.869 -1.9 . . . . 73.21 105.869 162.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -28.33 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.267 2.227 . . . . 74.5 112.195 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.12 -3.47 9.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.227 1.811 . . . . 75.4 111.414 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 p -133.71 158.79 42.38 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.649 0.659 . . . . 61.42 111.581 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.91 152.88 4.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.937 -1.135 . . . . 74.42 107.937 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.37 179.86 6.69 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.575 1.95 . . . . 73.23 107.367 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.11 162.42 19.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.869 1.267 . . . . 74.13 107.914 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -150.52 160.19 43.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.258 -1.386 . . . . 75.31 107.258 158.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -63.09 -179.75 0.32 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.026 1.731 . . . . 73.53 109.699 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.47 1.66 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.165 1.786 . . . . 73.04 112.08 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.9 pt 26.51 -80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 128.235 2.614 . . . . 72.2 116.684 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.456 ' H ' HG13 ' A' ' 141' ' ' ILE . 16.3 tppt? -109.84 119.28 38.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.895 1.278 . . . . 73.54 108.157 173.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.9 p -114.65 115.71 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.659 1.219 . . . . 75.41 109.005 164.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.62 -172.29 2.45 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.203 2.601 . . . . 71.0 106.971 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.9 p -128.86 166.82 18.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.059 1.344 . . . . 75.1 110.893 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.77 124.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.024 0.93 . . . . 74.33 109.721 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.92 101.72 11.89 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.561 -0.903 . . . . 75.04 108.561 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.463 ' C ' HD21 ' A' ' 149' ' ' ASN . 9.3 t80 -107.38 133.62 51.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.056 0.942 . . . . 74.54 109.196 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.463 HD21 ' C ' ' A' ' 148' ' ' TYR . 1.3 m-80 -124.55 59.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.794 -1.188 . . . . 73.12 107.794 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -124.64 -166.68 12.48 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.683 2.087 . . . . 74.12 110.681 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.34 156.27 18.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.799 -0.815 . . . . 60.3 108.799 166.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 49.8 pt -136.02 152.79 30.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.177 1.391 . . . . 74.21 108.06 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -144.31 153.27 41.83 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.715 1.206 . . . . 75.42 109.201 -163.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -141.56 174.59 10.42 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.861 -0.525 . . . . 73.33 109.684 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.18 109.82 10.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.028 1.731 . . . . 74.23 109.261 -157.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -76.71 121.0 22.66 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.169 -1.789 . . . . 71.31 106.169 169.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 t -130.24 87.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.635 -1.617 . . . . 74.31 106.635 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -21.49 63.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.903 1.681 . . . . 71.51 113.031 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -95.72 -51.17 4.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.217 1.407 . . . . 64.42 110.045 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -124.23 103.58 8.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 101.715 -3.439 . . . . 75.5 101.715 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -66.94 28.55 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.794 0.838 . . . . 73.34 113.018 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.471 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 1.4 p -153.95 124.93 7.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.066 2.147 . . . . 55.1 107.727 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -129.92 166.02 20.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.299 1.44 . . . . 71.43 110.912 -169.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.17 135.05 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.214 -1.032 . . . . 73.21 108.214 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.77 29.33 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.509 1.124 . . . . 73.22 110.066 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.01 -156.61 22.25 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.565 0.621 . . . . 73.43 111.893 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -110.09 167.39 10.21 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.998 -1.295 . . . . 75.11 111.54 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.89 -76.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.718 2.807 . . . . 73.53 112.699 -165.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.31 -13.32 8.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.97 1.708 . . . . 74.3 113.641 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.36 176.53 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 123.294 1.496 . . . . 74.44 112.686 -173.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.491 ' CE1' HG21 ' A' ' 97' ' ' ILE . 8.7 m-85 -124.11 149.47 46.17 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.408 3.083 . . . . 73.11 104.874 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.37 81.04 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.802 -1.184 . . . . 75.23 107.802 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.0 m -88.49 179.87 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 O-C-N 121.78 -0.575 . . . . 73.44 110.58 -171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.59 158.45 23.06 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.794 -0.566 . . . . 74.23 110.443 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -144.28 175.13 10.31 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.992 2.117 . . . . 72.3 109.288 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 81.4 p -158.06 -128.09 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.327 -0.99 . . . . 63.05 108.327 157.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -143.33 86.19 1.89 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.724 1.609 . . . . 73.02 107.188 174.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.86 -83.55 0.39 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 126.924 2.202 . . . . 60.51 110.14 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 22.9 p -59.91 120.69 10.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.128 1.771 . . . . 71.45 109.844 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.43 -69.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 129.191 2.996 . . . . 73.14 112.123 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -132.36 154.66 49.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.48 -0.933 . . . . 74.32 108.48 164.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -119.5 -59.1 1.86 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.063 1.345 . . . . 62.23 109.475 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -57.46 -54.85 42.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.122 0.569 . . . . 73.44 111.721 -170.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -48.76 108.47 0.18 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.027 2.131 . . . . 75.24 109.95 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -148.22 158.49 44.11 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.212 2.205 . . . . 73.31 105.91 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.988 1.315 . . . . 74.54 110.823 -156.741 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 108.851 -0.796 . . . . 73.52 108.851 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.24 143.97 29.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.891 1.677 . . . . 73.5 108.376 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -71.74 -47.68 52.11 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.629 0.581 . . . . 72.25 110.706 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.97 -82.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 123.621 0.629 . . . . 75.02 111.586 -177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -81.52 111.18 17.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.801 -0.814 . . . . 75.55 108.801 -174.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.52 156.46 18.55 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.803 1.241 . . . . 62.24 107.851 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.46 -95.03 2.22 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.071 -0.849 . . . . 72.3 112.478 -162.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 154.9 157.77 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 131.373 3.869 . . . . 62.51 107.767 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.47 -177.42 4.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.474 -0.565 . . . . 74.54 109.474 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -166.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.219 1.408 . . . . 74.23 112.036 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -94.78 -50.38 5.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.434 1.494 . . . . 63.52 110.316 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.94 50.16 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.414 2.285 . . . . 61.14 108.094 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.02 131.84 19.03 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 106.936 -1.505 . . . . 73.1 106.936 -165.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -79.95 132.71 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.015 1.81 . . . . 72.25 112.305 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 pt -98.56 -6.16 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.904 0.882 . . . . 73.22 113.032 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 57.01 84.2 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.982 1.713 . . . . 64.32 112.135 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.29 156.66 1.12 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.833 164.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.9 t -55.54 -35.03 65.23 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 122.979 0.512 . . . . 72.55 109.855 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.75 -29.96 68.47 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.647 0.779 . . . . 64.04 112.297 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.21 36.21 7.2 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.194 1.378 . . . . 74.24 111.605 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -17.02 64.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.352 1.241 . . . . 75.3 114.352 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm 43.32 93.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 128.523 2.729 . . . . 72.31 111.19 -166.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.87 145.54 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.63 -1.623 . . . . 74.14 107.792 174.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.26 131.49 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 128.069 2.548 . . . . 72.33 108.396 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -49.92 -48.68 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.495 0.718 . . . . 74.1 110.526 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' A' ' 29' ' ' VAL . . . -86.81 4.56 86.19 Favored Glycine 0 C--O 1.221 -0.656 0 CA-C-O 116.986 -2.008 . . . . 75.44 113.419 -173.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -86.68 -53.35 4.99 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.512 1.656 . . . . 72.31 108.582 162.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -52.78 -54.42 34.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.765 1.226 . . . . 73.51 109.302 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' A' ' 26' ' ' GLY . 21.7 m -65.89 -33.4 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-O 117.753 -1.117 . . . . 74.31 110.174 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -41.92 95.99 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 121.545 1.975 . . . . 70.3 111.569 -173.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.89 -40.23 60.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.462 0.705 . . . . 73.42 110.469 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -77.68 -46.49 21.79 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.353 -1.308 . . . . 63.51 109.873 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -54.95 -36.07 64.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 122.517 2.417 . . . . 72.35 112.354 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -17.4 46.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.383 1.073 . . . . 74.34 113.204 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -88.54 -61.22 1.76 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.195 -1.409 . . . . 74.31 107.195 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -84.13 40.78 0.78 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.912 2.085 . . . . 71.34 108.726 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -50.95 -34.54 29.15 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 127.045 2.138 . . . . 75.03 110.706 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.95 -22.8 59.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.573 1.949 . . . . 74.32 113.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m -94.07 0.8 56.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.222 1.809 . . . . 74.34 112.157 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.16 101.02 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.595 0.758 . . . . 74.11 109.301 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.67 169.69 17.61 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.403 1.081 . . . . 73.32 110.244 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.65 132.3 27.22 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.996 1.319 . . . . 70.12 108.757 164.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -79.6 169.77 17.52 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.395 2.278 . . . . 72.32 110.017 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.01 -37.43 79.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.913 1.685 . . . . 74.24 109.867 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.72 -15.59 62.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.571 0.748 . . . . 74.4 111.827 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.35 3.18 57.66 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 126.313 1.911 . . . . 74.23 113.811 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -57.73 -87.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 129.172 2.989 . . . . 71.33 111.123 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.72 125.89 2.99 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.107 1.336 . . . . 74.31 109.964 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -136.3 168.39 19.5 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.393 1.077 . . . . 74.42 109.861 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.8 mt -146.08 153.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 127.182 2.193 . . . . 73.14 106.202 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 143.27 27.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.672 1.589 . . . . 75.41 109.553 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.66 -24.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 114.834 -2.508 . . . . 75.44 113.675 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 23.15 -72.67 0.0 OUTLIER Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.949 3.166 . . . . 62.13 115.927 159.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -13.12 15.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.883 3.273 . . . . 75.52 115.288 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.66 -20.37 65.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.189 0.596 . . . . 62.3 110.519 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.37 31.6 17.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.302 1.841 . . . . 73.21 113.283 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.9 mt -82.96 123.06 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.513 1.125 . . . . 74.34 108.821 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -86.39 143.46 27.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.382 1.473 . . . . 75.43 110.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.6 tp -125.86 159.13 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.259 -1.756 . . . . 75.44 106.259 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -63.78 140.38 58.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.405 -0.961 . . . . 73.25 108.405 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 p -139.61 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.962 0.505 . . . . 75.43 110.446 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.12 141.67 24.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.349 -0.845 . . . . 75.41 108.875 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 110.28 15.02 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.371 -1.344 . . . . 72.44 107.371 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -64.59 -16.98 63.55 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.638 0.775 . . . . 72.42 111.724 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -15.62 63.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.51 1.124 . . . . 74.01 113.941 171.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -155.59 6.01 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.38 0.991 . . . . 74.43 113.519 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.94 51.54 15.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.073 2.149 . . . . 73.52 111.636 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 pt -119.35 152.58 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.362 2.265 . . . . 73.03 108.76 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.37 145.25 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.315 -0.995 . . . . 74.24 108.315 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -150.67 178.03 9.49 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.138 2.575 . . . . 70.52 109.284 -166.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.18 157.78 17.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.873 1.669 . . . . 64.12 108.638 163.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.58 160.77 41.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.116 -0.99 . . . . 72.14 110.139 154.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.549 HH11 ' CD2' ' A' ' 75' ' ' LEU . 7.0 tmm_? -98.95 131.31 45.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.212 1.005 . . . . 73.11 110.268 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.64 156.53 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.943 1.297 . . . . 73.31 109.02 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.549 ' CD2' HH11 ' A' ' 73' ' ' ARG . 55.9 mt -123.75 -51.7 1.81 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.969 1.308 . . . . 70.01 110.889 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -135.43 163.81 29.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.079 1.352 . . . . 75.41 108.895 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.26 167.95 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.298 1.039 . . . . 73.54 108.974 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -137.71 151.24 48.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.712 1.205 . . . . 70.52 109.281 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -142.04 144.5 33.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.926 1.29 . . . . 75.35 109.929 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -144.83 158.98 43.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.751 -1.574 . . . . 64.03 106.751 165.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -89.96 151.26 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.955 -1.128 . . . . 74.32 107.955 167.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -146.8 154.79 41.78 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.468 1.507 . . . . 74.25 110.367 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.93 111.87 3.05 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.461 -1.311 . . . . 75.32 107.461 167.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.63 -160.02 33.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.619 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' N ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -113.89 117.23 30.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.481 1.112 . . . . 74.21 108.738 -173.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.4 165.13 11.99 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.587 1.155 . . . . 63.41 107.987 173.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 mm -78.85 132.76 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.458 1.903 . . . . 75.3 107.377 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -128.22 59.68 1.5 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.942 1.697 . . . . 74.21 107.357 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.8 mt -56.89 133.73 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.91 -2.256 . . . . 64.15 104.91 162.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -117.2 164.2 15.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.319 -1.734 . . . . 74.44 106.319 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.2 p -137.03 169.64 17.43 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 121.73 -0.606 . . . . 73.04 110.492 -168.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -60.99 -28.93 69.38 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 73.23 110.727 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.92 3.43 10.18 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.365 1.466 . . . . 74.51 112.521 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 59.28 13.13 2.92 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.473 1.909 . . . . 75.31 113.114 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 169' ' ' GLU . 0.1 OUTLIER -71.41 162.56 29.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 118.318 -1.353 . . . . 73.43 107.487 166.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -156.69 176.64 12.46 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 128.274 2.63 . . . . 73.3 106.463 171.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.441 ' C ' ' HG1' ' A' ' 98' ' ' THR . 1.7 pt -141.75 -179.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.637 1.575 . . . . 75.53 109.996 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.441 ' HG1' ' C ' ' A' ' 97' ' ' ILE . 28.5 m -150.56 97.35 2.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.58 1.152 . . . . 75.33 110.287 168.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.39 174.47 11.35 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.426 1.49 . . . . 74.32 111.035 -176.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -73.17 172.74 10.53 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.342 0.974 . . . . 74.23 108.65 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -77.36 7.53 5.21 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.06 -1.025 . . . . 72.55 112.001 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.42 39.24 2.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.245 0.929 . . . . 71.4 111.297 -167.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -99.13 137.58 20.45 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 117.059 -1.448 . . . . 75.03 112.368 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.23 94.93 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 124.317 3.344 . . . . 74.34 113.666 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.18 178.82 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.138 0.975 . . . . 73.43 109.192 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.48 134.26 50.98 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.499 -0.751 . . . . 75.53 110.791 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.01 155.86 38.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.106 1.362 . . . . 72.02 109.398 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -86.32 125.7 33.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.261 0.553 . . . . 54.31 110.945 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -98.4 89.43 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.525 -2.028 . . . . 73.41 105.525 153.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.98 31.16 8.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.789 1.236 . . . . 63.1 113.603 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.66 -8.32 39.96 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.432 -1.205 . . . . 72.35 113.951 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 159.83 27.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 104.651 -2.351 . . . . 65.42 104.651 160.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.262 7.3 p -106.93 104.35 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.093 0.957 . . . . 63.33 109.953 170.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -91.29 160.08 15.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.73 1.612 . . . . 75.34 107.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.62 115.2 20.43 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.336 1.854 . . . . 75.1 108.039 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.5 pt -143.85 172.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.753 1.621 . . . . 74.13 109.468 -174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.16 143.75 26.87 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.386 0.539 . . . . 73.11 111.565 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.71 -27.65 65.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.587 -0.72 . . . . 75.05 112.815 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -29.22 68.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.636 1.107 . . . . 73.5 111.953 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -79.58 -32.54 41.98 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.095 1.358 . . . . 74.43 111.661 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.99 63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 130.381 3.473 . . . . 71.42 110.906 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -95.93 -169.24 1.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.351 1.06 . . . . 75.14 108.991 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.0 -7.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.653 -1.279 . . . . 73.24 114.106 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.39 -12.81 69.32 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 117.799 -1.556 . . . . 62.34 111.687 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.06 119.63 35.36 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 121.132 2.466 . . . . 71.04 107.07 -164.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.37 115.52 21.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -79.9 159.24 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.405 1.082 . . . . 75.5 109.96 176.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.03 129.95 36.98 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.592 1.557 . . . . 73.43 110.883 167.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.5 155.44 47.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.811 1.645 . . . . 74.05 110.195 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -68.51 156.36 65.84 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.5 2.134 . . . . 72.01 110.313 165.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -141.04 -176.96 4.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.828 1.651 . . . . 75.13 107.634 164.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -25.17 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.014 2.526 . . . . 74.12 112.506 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -120.17 -4.95 9.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.325 -0.845 . . . . 73.55 113.091 170.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.6 p -132.67 170.06 15.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.24 1.382 . . . . 75.52 111.333 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.06 157.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.531 -0.731 . . . . 73.22 109.161 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.03 -177.25 4.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.587 2.755 . . . . 74.33 106.558 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 88.4 mt -126.12 160.86 29.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.162 0.985 . . . . 74.1 110.666 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -154.05 158.61 40.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.858 1.663 . . . . 65.12 111.858 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -106.04 150.65 25.54 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.226 1.411 . . . . 74.51 109.699 -172.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 41.9 t -95.6 1.28 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.907 1.283 . . . . 74.23 113.72 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.479 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.4 pt 24.82 -86.8 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 127.459 2.304 . . . . 74.3 116.655 171.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.6 OUTLIER -99.34 123.17 43.39 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 126.841 2.056 . . . . 71.21 107.811 172.209 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.47 119.97 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.388 -1.338 . . . . 74.32 107.388 170.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.25 -166.04 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.62 1.968 . . . . 75.24 108.196 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 p -133.18 165.22 25.29 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.047 1.739 . . . . 71.02 109.311 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.57 -175.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.182 1.393 . . . . 73.14 108.668 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -136.86 68.96 1.41 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.529 1.157 . . . . 75.5 109.394 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -80.21 133.56 36.03 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.019 -1.051 . . . . 71.43 111.029 -169.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -136.03 69.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.944 -1.132 . . . . 73.21 107.944 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.82 -120.56 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 74.31 110.115 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -121.73 163.28 19.34 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.002 -0.705 . . . . 73.13 110.041 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.55 147.02 28.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 127.379 2.272 . . . . 75.15 106.563 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -141.4 164.53 29.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.356 0.662 . . . . 72.44 109.296 -171.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.52 171.47 18.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 119.537 -0.268 . . . . 72.44 111.519 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.6 118.4 19.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.928 1.691 . . . . 74.53 109.413 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 57.6 m -73.08 112.77 9.43 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.025 -1.472 . . . . 74.44 107.025 166.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.94 75.41 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.516 -2.031 . . . . 70.43 105.516 169.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.11 -0.15 38.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.71 2.404 . . . . 75.32 114.134 -162.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.93 -77.32 0.1 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 128.283 2.633 . . . . 71.22 110.995 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -105.39 5.52 31.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.839 1.655 . . . . 74.0 111.694 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.6 m80 50.29 34.4 8.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.969 2.507 . . . . 64.41 112.035 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 p -148.51 155.33 41.01 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.425 1.89 . . . . 71.11 108.304 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -159.25 -168.13 2.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.256 1.022 . . . . 75.43 109.772 178.24 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.48 141.38 14.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 105.89 -1.893 . . . . 75.55 105.89 155.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -144.71 148.85 34.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 73.43 109.398 149.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 144.3 -165.92 27.32 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.109 -0.994 . . . . 61.33 112.119 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -111.26 166.82 10.77 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 119.708 -2.054 . . . . 72.22 111.232 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.24 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 128.319 2.648 . . . . 74.12 112.667 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 44.8 mt-10 -121.84 -18.34 7.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.689 1.196 . . . . 70.34 112.75 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.29 158.66 21.24 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.829 1.204 . . . . 70.04 113.537 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.445 ' CE1' ' HD2' ' A' ' 95' ' ' ARG . 78.7 m-85 -105.29 154.42 20.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 127.096 2.158 . . . . 73.02 109.686 -174.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.5 75.99 5.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.084 0.953 . . . . 62.44 108.448 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -93.5 178.92 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.832 1.253 . . . . 74.43 110.315 -173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.0 m -65.8 161.99 19.75 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.278 -0.889 . . . . 73.32 110.111 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -143.79 39.43 1.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.199 1.8 . . . . 75.15 108.295 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m -62.63 104.78 0.56 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.825 -1.176 . . . . 74.34 107.825 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 m -68.32 -47.59 67.15 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.245 1.018 . . . . 64.45 108.609 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.21 101.79 1.88 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.382 -1.087 . . . . 72.52 110.382 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 p -50.38 121.12 5.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.641 1.176 . . . . 75.04 110.01 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 15.3 tp 52.68 -71.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.596 2.758 . . . . 74.24 112.921 -165.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -79.63 114.12 18.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.507 1.123 . . . . 74.22 108.982 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.68 107.46 12.82 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.144 -1.058 . . . . 75.41 108.144 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 146.85 10.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.129 0.572 . . . . 74.54 112.423 -174.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -164.73 160.08 19.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.251 1.02 . . . . 74.3 109.956 155.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -68.13 122.19 17.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.452 -1.314 . . . . 74.02 107.452 155.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 7.6 m170 . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.461 1.905 . . . . 74.43 110.607 -173.646 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.658 -0.211 . . . . 74.23 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -74.99 -143.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.278 -1.378 . . . . 62.21 107.278 155.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m 95.55 3.96 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.797 2.839 . . . . 74.35 110.686 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -25.32 -71.81 0.02 OUTLIER Glycine 0 C--N 1.34 0.785 0 C-N-CA 130.581 3.944 . . . . 74.3 114.344 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 45.77 72.09 0.24 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.469 1.907 . . . . 73.0 111.276 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -136.06 172.21 13.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.288 1.035 . . . . 72.5 108.726 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.91 176.7 25.7 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 125.316 1.436 . . . . 74.45 111.437 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -177.91 164.13 1.87 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 129.226 3.01 . . . . 74.35 106.125 152.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.07 167.2 22.0 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.584 1.154 . . . . 72.3 109.582 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -140.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.659 0.784 . . . . 71.13 111.84 172.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.436 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 5.5 t80 -120.73 -38.97 2.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.618 1.567 . . . . 74.33 112.012 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.85 30.55 6.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.645 1.178 . . . . 73.3 111.496 -163.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 144.9 29.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 O-C-N 121.507 -0.746 . . . . 65.04 111.993 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.15 141.72 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.272 2.648 . . . . 74.12 113.786 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.5 pt -114.66 16.84 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.981 1.104 . . . . 75.41 113.981 -170.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 34.92 68.83 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.225 2.21 . . . . 73.01 113.964 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.0 mt -56.15 155.73 6.31 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.153 -0.684 . . . . 54.41 109.153 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -61.86 -27.2 68.62 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.186 -0.321 . . . . 72.41 111.166 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.38 -59.06 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.347 -0.612 . . . . 64.53 109.347 169.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.59 32.47 0.61 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.943 1.735 . . . . 71.14 111.219 -170.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 -11.27 59.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.299 -1.706 . . . . 70.53 114.933 -166.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 16.9 mm 44.58 74.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 127.205 2.202 . . . . 71.45 110.196 175.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.02 148.51 18.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 125.279 1.432 . . . . 64.53 108.789 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.67 131.75 50.02 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.846 2.458 . . . . 74.32 109.591 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.452 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.04 -57.57 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.731 1.613 . . . . 75.22 109.035 175.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -58.95 -45.9 94.46 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-O 118.395 -1.225 . . . . 61.43 110.057 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.4 -57.07 13.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.966 1.706 . . . . 65.24 111.636 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -47.74 -54.55 11.85 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.949 1.7 . . . . 75.35 110.334 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.475 HG22 ' CZ ' ' A' ' 153' ' ' TYR . 74.0 t -70.56 -43.45 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.055 -0.975 . . . . 61.41 110.552 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.93 -31.87 73.31 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 118.937 -1.105 . . . . 72.34 112.151 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -50.21 -46.91 54.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.449 1.5 . . . . 75.11 109.785 169.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -69.61 -44.54 70.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.907 -0.775 . . . . 75.13 108.907 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -58.26 -28.47 64.95 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.369 1.441 . . . . 74.2 112.301 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -85.0 -25.31 27.78 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 125.582 1.553 . . . . 64.44 112.58 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -93.97 -58.02 2.37 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.998 -1.853 . . . . 71.04 105.998 175.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -86.63 43.76 1.1 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.78 2.032 . . . . 73.35 108.943 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -49.59 -38.04 30.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 127.324 2.249 . . . . 75.42 111.255 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -95.08 -2.75 49.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.433 0.901 . . . . 71.53 113.433 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -82.1 -6.98 59.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.009 0.822 . . . . 71.02 112.365 165.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.07 99.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 119.579 1.081 . . . . 70.43 108.612 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -85.4 108.08 17.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.665 1.986 . . . . 74.31 107.741 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.53 124.72 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.412 -1.699 . . . . 74.41 106.412 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.94 137.82 37.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.92 -1.511 . . . . 74.02 106.92 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -65.73 -42.7 90.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.997 -0.281 . . . . 75.32 111.552 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -120.58 58.07 0.95 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.606 -1.627 . . . . 72.24 106.606 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.21 -133.83 1.55 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.174 -0.77 . . . . 65.13 111.174 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -101.27 0.42 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.083 0.772 . . . . 72.32 113.083 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.98 104.11 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 108.51 -1.836 . . . . 62.12 108.51 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -126.27 171.15 11.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.3 1.84 . . . . 75.24 111.249 -170.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mt -138.22 133.85 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.25 -2.129 . . . . 74.1 105.25 166.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 122.32 22.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.454 -1.684 . . . . 63.13 106.454 160.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.306 2.4 pp -126.84 23.92 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 123.091 1.424 . . . . 74.43 109.593 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -26.63 69.51 Favored Glycine 0 CA--C 1.523 0.555 0 O-C-N 120.537 -1.352 . . . . 72.22 112.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -12.41 61.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.186 1.794 . . . . 75.24 115.402 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.15 -14.75 63.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.011 1.278 . . . . 74.43 113.235 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 m120 60.77 11.26 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.266 2.626 . . . . 72.32 114.004 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.49 130.26 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.953 -1.092 . . . . 72.51 108.832 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.92 154.1 20.03 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.562 1.145 . . . . 74.41 110.976 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.79 150.19 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.129 2.172 . . . . 71.34 108.005 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.86 109.81 6.71 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.272 -1.381 . . . . 73.4 107.272 169.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -99.01 -175.2 2.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.058 1.743 . . . . 71.22 107.274 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 128.56 32.43 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.801 -1.926 . . . . 72.1 105.801 164.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -80.47 97.13 6.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.971 -1.492 . . . . 72.51 106.971 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 50.6 tttt -50.88 -23.15 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 117.835 -1.079 . . . . 75.12 112.543 169.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -43.05 -38.83 2.47 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.025 1.73 . . . . 72.23 113.483 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -142.82 15.12 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.767 1.227 . . . . 74.23 110.54 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt 56.57 44.59 23.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.987 1.315 . . . . 72.42 111.423 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -111.04 152.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.712 1.605 . . . . 74.33 108.521 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.14 118.33 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 106.477 -1.675 . . . . 75.11 106.477 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -144.36 175.8 9.83 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.5 1.52 . . . . 71.24 109.334 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.52 141.02 29.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.641 -1.287 . . . . 64.1 111.327 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 154.89 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.6 1.96 . . . . 74.32 108.686 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -91.21 156.71 17.64 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.181 -1.044 . . . . 71.24 108.181 168.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.52 154.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.793 1.237 . . . . 74.3 108.697 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.0 -52.12 2.81 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.904 1.682 . . . . 64.45 110.615 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.521 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 32.2 mtt85 -134.12 162.05 33.18 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.465 -0.772 . . . . 75.43 110.01 -171.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.1 155.96 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.548 1.539 . . . . 74.22 108.436 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.64 166.24 20.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.324 1.45 . . . . 74.44 108.165 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -137.4 143.94 42.17 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 73.24 109.224 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -141.21 164.46 30.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 130.161 3.384 . . . . 74.23 108.819 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -116.74 159.0 22.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.06 -1.65 . . . . 75.23 111.264 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -150.67 155.59 39.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.803 0.811 . . . . 75.53 113.164 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 117.58 2.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.428 1.891 . . . . 73.13 106.4 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.88 -165.23 32.07 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.607 1.549 . . . . 55.2 113.733 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -93.2 129.89 39.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.423 0.689 . . . . 74.44 110.513 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.9 mt -111.26 159.55 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.476 1.11 . . . . 74.51 109.702 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.21 135.17 26.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.967 1.307 . . . . 71.13 107.842 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -128.78 81.15 2.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.484 1.914 . . . . 75.22 105.961 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.97 110.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.19 -2.522 . . . . 73.12 104.19 158.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -85.98 162.57 18.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 161.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -142.88 164.69 29.4 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.371 1.869 . . . . 72.12 107.313 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 94' ' ' ARG . 28.8 ttmt -63.78 -26.83 68.81 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.449 -0.782 . . . . 75.34 112.205 -159.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -74.42 27.35 0.08 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.527 1.931 . . . . 72.2 111.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.422 ' H ' ' C ' ' A' ' 92' ' ' LYS . 2.6 mmt180 50.77 14.48 0.18 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.195 2.198 . . . . 75.2 113.641 -168.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.591 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 14.3 ttm105 -85.82 162.09 18.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.806 -1.184 . . . . 73.54 108.766 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.471 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 9.8 pt-20 -175.72 168.3 3.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.985 -1.007 . . . . 74.14 110.793 -168.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.477 ' CG2' ' CD1' ' A' ' 171' ' ' PHE . 8.4 pt -140.6 178.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.782 1.633 . . . . 73.14 109.179 -174.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.07 97.28 2.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.319 -1.734 . . . . 74.5 106.319 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.94 162.44 41.31 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 74.31 111.087 -172.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 m -70.25 153.16 43.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.747 -1.205 . . . . 73.34 107.747 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -73.64 -13.37 60.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.556 0.947 . . . . 75.52 113.556 -167.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.29 37.75 2.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.284 1.04 . . . . 71.44 109.564 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -97.03 129.84 31.36 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.925 1.29 . . . . 74.35 107.65 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.69 148.72 87.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.871 2.381 . . . . 74.42 112.359 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 m -144.53 169.13 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 129.565 3.146 . . . . 75.05 107.933 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -107.87 141.52 39.36 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.651 -0.655 . . . . 74.34 109.682 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.62 159.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.199 1.4 . . . . 64.31 109.042 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.454 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 17.2 t -93.39 134.66 35.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.197 1.475 . . . . 72.23 110.31 169.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -103.36 85.44 2.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 111.96 -2.382 . . . . 74.3 106.167 157.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.45 27.42 8.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.683 1.193 . . . . 61.24 113.66 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 119.32 -14.69 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.284 -1.287 . . . . 75.31 113.145 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 176.49 9.74 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.721 1.261 . . . . 73.44 108.009 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.43 118.89 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.894 1.278 . . . . 74.52 108.064 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.57 158.79 24.75 Favored 'General case' 0 CA--C 1.526 0.03 0 C-N-CA 123.988 0.915 . . . . 72.14 108.931 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.59 115.92 23.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.89 2.476 . . . . 74.34 104.505 -176.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.7 177.69 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.704 1.202 . . . . 74.53 109.258 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -94.07 153.67 18.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.859 0.754 . . . . 75.23 111.324 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.0 -22.95 42.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.977 1.311 . . . . 73.33 113.758 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -60.16 -43.67 95.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.958 1.254 . . . . 74.23 111.132 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.15 -22.95 57.77 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.224 0.92 . . . . 74.41 113.438 -170.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.21 62.87 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.904 2.081 . . . . 74.34 111.004 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -78.98 -177.95 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.054 1.342 . . . . 73.03 110.162 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -58.6 -4.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 127.573 2.349 . . . . 74.3 114.163 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 15.87 10.05 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.754 2.121 . . . . 74.54 112.155 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.2 159.27 34.79 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.487 1.643 . . . . 75.51 107.498 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -119.91 110.61 16.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.34 -0.985 . . . . 53.25 108.34 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.32 138.93 19.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 124.813 1.245 . . . . 71.41 108.438 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 108' ' ' SER . 11.1 m-85 -75.49 136.0 40.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.559 -0.904 . . . . 71.01 108.559 171.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.0 151.94 79.84 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 124.207 1.003 . . . . 74.33 112.735 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.35 138.32 29.9 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.106 2.537 . . . . 70.22 108.91 170.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -120.92 -157.47 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.524 2.329 . . . . 75.04 105.848 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -37.86 -74.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.179 1.792 . . . . 75.01 112.507 -169.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -121.4 -1.0 9.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.17 0.896 . . . . 72.54 113.24 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.6 p -123.64 169.93 10.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 124.636 1.174 . . . . 75.0 110.541 -168.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 tp -81.66 157.81 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.223 -0.658 . . . . 74.41 109.223 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.6 -176.54 5.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.078 2.951 . . . . 75.34 106.708 174.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.1 161.72 14.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.456 -1.313 . . . . 74.21 107.456 156.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -154.99 108.39 2.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.456 1.502 . . . . 74.12 108.135 173.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.02 144.73 33.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 129.929 3.292 . . . . 72.4 113.266 -162.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.2 t -77.5 0.41 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.561 1.144 . . . . 74.01 113.599 -170.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.445 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.2 pt 27.64 -75.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 118.078 2.621 . . . . 74.31 118.078 167.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.445 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.48 128.89 56.33 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.607 1.563 . . . . 73.05 107.986 170.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.27 131.5 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.683 -1.229 . . . . 74.0 107.683 167.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.67 171.62 14.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.318 1.847 . . . . 75.11 108.42 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.49 138.79 50.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.49 -168.41 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.668 1.187 . . . . 73.42 108.569 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -136.65 135.59 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.068 -1.456 . . . . 75.42 107.068 167.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.4 ' C ' HD21 ' A' ' 149' ' ' ASN . 1.1 t80 -142.55 134.73 27.45 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.581 0.753 . . . . 74.34 110.233 -170.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.4 HD21 ' C ' ' A' ' 148' ' ' TYR . 1.5 m-80 -138.1 70.89 1.39 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.756 -1.942 . . . . 74.11 105.756 -167.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.09 -166.61 12.14 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.524 1.059 . . . . 75.11 112.393 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -88.42 157.29 18.73 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.965 -1.315 . . . . 55.11 109.413 165.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 pt -126.55 170.34 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.609 1.564 . . . . 72.14 111.16 170.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.475 ' CZ ' HG22 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.9 147.69 13.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.156 -1.424 . . . . 73.42 107.156 -170.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -118.93 158.24 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.537 0.735 . . . . 65.3 110.692 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 19.7 tp -117.38 137.57 52.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.459 1.503 . . . . 72.43 109.231 -168.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.521 ' HG1' ' HB2' ' A' ' 76' ' ' ARG . 22.8 m -68.29 -59.47 3.18 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.353 0.597 . . . . 74.24 110.306 -167.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.325 3.2 t 40.67 67.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 128.975 2.91 . . . . 75.1 112.694 -170.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.61 -11.88 61.19 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.499 -0.773 . . . . 71.41 110.934 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -65.2 0.7 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.3 1.04 . . . . 74.54 109.682 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.13 2.34 12.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.137 0.575 . . . . 74.21 112.27 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.6 m170 54.99 31.34 15.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.402 1.481 . . . . 72.13 111.887 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.69 151.62 33.99 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.643 -1.286 . . . . 64.03 110.291 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -154.8 172.53 17.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.591 1.156 . . . . 75.45 110.511 -174.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.12 124.95 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.026 1.73 . . . . 72.34 108.929 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.93 148.46 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.726 0.811 . . . . 53.21 109.907 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 151.12 -175.47 30.04 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.26 -1.136 . . . . 74.3 110.26 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -90.94 166.05 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.307 -1.702 . . . . 74.21 110.24 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.06 -68.23 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 130.587 3.555 . . . . 75.1 113.054 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.591 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 12.7 mt-10 -122.06 -18.06 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.632 1.973 . . . . 75.35 114.174 175.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 79.29 166.74 32.49 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 124.249 0.928 . . . . 74.35 111.816 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 97' ' ' ILE . 25.3 m-85 -121.06 155.26 34.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.139 2.576 . . . . 75.45 105.774 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.03 141.14 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.833 -1.173 . . . . 75.13 107.833 167.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . 0.273 46.0 t -135.27 175.82 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.966 1.306 . . . . 75.23 107.6 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 52.7 m -95.89 133.61 39.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.324 1.45 . . . . 65.45 110.565 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -115.13 173.78 6.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.883 1.673 . . . . 54.33 107.108 168.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.4 m -165.53 -32.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.057 1.743 . . . . 64.5 110.134 160.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 44.6 p 63.65 174.52 0.17 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.01 2.124 . . . . 74.45 111.075 -151.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -119.74 77.95 0.31 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.056 -1.217 . . . . 74.32 110.056 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.4 t -138.77 -146.32 0.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.956 1.702 . . . . 72.04 108.467 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.8 tp -26.5 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.373 1 C-N-CA 132.963 4.505 . . . . 70.31 115.256 167.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.47 161.45 37.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.055 -1.831 . . . . 73.53 106.055 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -61.4 153.85 25.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.868 0.758 . . . . 74.35 109.254 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -70.82 131.54 43.95 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.527 -0.916 . . . . 75.42 108.527 -171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -71.17 156.41 39.61 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.824 -0.806 . . . . 74.41 108.824 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -128.04 -41.88 1.59 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.813 0.845 . . . . 74.33 111.951 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 52.4 t60 . . . . . 0 C--O 1.256 1.415 0 CA-C-O 116.649 -1.643 . . . . 71.34 108.691 -167.625 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtp . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 108.581 -0.896 . . . . 75.3 108.581 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.15 166.3 0.84 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.503 -0.925 . . . . 75.15 108.503 158.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -58.2 -72.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.329 -1.36 . . . . 75.31 107.329 157.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.43 67.03 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -1.669 . . . . 60.23 108.927 -165.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.88 143.43 28.23 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.694 -1.595 . . . . 75.21 106.694 164.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -163.34 139.5 6.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.825 1.65 . . . . 74.04 108.245 -174.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.97 -171.94 21.77 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.5 1.524 . . . . 62.4 111.095 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -154.99 -173.86 4.75 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.198 1.799 . . . . 74.14 109.614 -172.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.64 170.62 9.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.693 1.597 . . . . 75.35 110.041 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.75 162.33 19.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.445 -0.784 . . . . 72.04 111.927 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.452 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 13.6 t80 -47.65 -42.55 24.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.259 2.224 . . . . 74.04 113.538 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.97 16.34 26.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.462 1.483 . . . . 74.12 112.779 -160.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -86.98 120.16 71.41 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.946 2.099 . . . . 75.33 110.481 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -56.77 145.37 83.37 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.385 2.723 . . . . 72.13 113.981 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -107.87 -10.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.232 1.413 . . . . 71.51 113.156 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 56.14 79.43 0.17 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.393 1.077 . . . . 72.51 110.665 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 155.74 2.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.173 -0.954 . . . . 71.25 109.551 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.09 -38.32 51.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.011 0.925 . . . . 64.44 110.362 169.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.09 -17.05 61.0 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.355 0.872 . . . . 53.14 113.355 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.07 33.7 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 118.486 -1.175 . . . . 73.41 113.142 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.32 -33.06 63.0 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.253 1.575 . . . . 74.34 115.253 -159.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mm 49.21 88.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.294 2.238 . . . . 74.14 110.121 -167.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 148.09 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.95 2.5 . . . . 74.04 107.588 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.64 141.41 58.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.713 1.605 . . . . 74.14 108.143 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.472 HG12 ' HH ' ' A' ' 153' ' ' TYR . 0.0 OUTLIER -50.39 -51.67 17.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 169.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.452 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -57.23 -53.5 44.27 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 118.003 -1.443 . . . . 73.11 110.116 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -60.54 -43.86 96.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 1.166 . . . . 61.24 112.433 -173.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -58.4 -56.61 19.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.777 0.831 . . . . 70.15 109.34 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.411 HG23 ' CZ ' ' A' ' 153' ' ' TYR . 54.8 t -70.93 -41.69 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.983 -0.553 . . . . 72.32 109.973 -172.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -29.69 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.1 -0.953 . . . . 72.23 111.855 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.446 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.1 -43.88 78.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.3 1.864 . . . . 73.3 111.273 172.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.446 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 20.0 m-85 -67.64 -43.22 80.85 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.24 -34.88 75.86 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.407 1.458 . . . . 75.43 112.679 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -47.35 66.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.057 1.299 . . . . 74.21 108.928 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.7 mtpp -76.43 -56.9 4.21 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.31 -1.737 . . . . 74.43 106.31 -169.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.1 m-30 -91.32 40.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.39 1.876 . . . . 74.42 107.759 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -37.43 68.63 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 121.165 -0.96 . . . . 73.24 111.453 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.56 81.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.485 1.914 . . . . 71.35 110.382 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -80.51 0.26 34.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.628 1.571 . . . . 71.22 113.354 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.78 99.22 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.19 161.34 26.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.295 -1.372 . . . . 71.42 107.295 162.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.37 142.21 47.12 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.888 -1.523 . . . . 70.53 106.888 171.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.15 176.71 9.42 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.991 0.807 . . . . 73.13 110.315 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.28 -12.71 60.94 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.426 1.49 . . . . 70.33 111.693 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.47 5.45 17.71 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.978 -1.076 . . . . 74.31 111.359 162.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 30.21 77.28 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 126.922 2.201 . . . . 55.3 113.234 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.404 ' CE2' ' HD2' ' A' ' 80' ' ' LYS . 2.6 t80 -77.02 -100.12 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.342 1.857 . . . . 71.24 109.47 -170.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.84 127.95 2.02 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.915 -1.274 . . . . 72.41 109.915 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -155.47 161.41 40.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.164 0.982 . . . . 71.15 111.067 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.44 133.19 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.835 -1.913 . . . . 75.23 105.835 170.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.22 133.45 47.96 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.872 -1.158 . . . . 73.02 107.872 163.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.06 17.71 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.648 0.779 . . . . 75.31 109.785 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.89 8.66 4.34 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 126.083 1.802 . . . . 73.53 113.979 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.88 -15.41 14.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.691 1.596 . . . . 74.12 109.661 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.16 -34.09 69.92 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.198 0.999 . . . . 73.32 110.338 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 58.9 14.11 3.14 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.301 1.963 . . . . 71.23 116.301 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.84 127.65 29.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 127.977 2.511 . . . . 74.14 109.276 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -82.32 141.04 33.2 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.546 0.688 . . . . 74.2 111.372 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.9 153.57 17.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 127.848 2.459 . . . . 75.2 106.675 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -72.19 110.7 6.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.592 -1.633 . . . . 74.15 106.592 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 171.42 7.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.17 -1.419 . . . . 61.43 107.17 -174.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -140.25 122.7 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.337 -1.356 . . . . 74.44 107.337 -168.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.5 108.22 18.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.893 -1.151 . . . . 75.33 107.893 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 21.5 ttpp -51.48 -31.42 23.47 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.424 1.49 . . . . 74.23 112.789 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.76 -28.38 15.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.765 2.826 . . . . 74.5 112.957 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 t -150.05 23.06 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.461 -0.774 . . . . 74.32 111.487 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.87 40.2 8.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.414 1.485 . . . . 73.45 112.18 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.81 -172.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.8 0.84 . . . . 74.42 110.095 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -116.92 135.7 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.298 2.239 . . . . 75.5 105.79 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.02 167.51 21.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.113 2.165 . . . . 73.5 107.182 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -101.2 118.92 37.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.231 -1.766 . . . . 74.3 106.231 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -133.37 163.77 28.6 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.122 -1.436 . . . . 75.33 107.122 170.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -95.61 -160.92 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.293 0.951 . . . . 74.43 110.512 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.2 mt -132.62 146.26 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 105.572 -2.01 . . . . 73.2 105.572 173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.65 -45.52 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.507 1.123 . . . . 64.43 111.191 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.21 -1.556 . . . . 71.32 108.417 -173.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.14 158.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.991 -0.744 . . . . 71.35 108.991 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -129.11 179.33 5.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.587 1.555 . . . . 73.52 108.914 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -170.7 146.21 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.322 1.849 . . . . 73.03 108.982 158.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HD2' ' CE2' ' A' ' 47' ' ' PHE . 71.9 tttt -143.8 166.5 24.74 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.618 1.567 . . . . 75.04 107.455 164.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -89.02 165.65 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.46 -1.4 . . . . 72.43 109.223 168.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -150.64 158.17 43.83 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.839 1.255 . . . . 75.34 109.9 -170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 p -155.13 123.98 6.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.65 1.18 . . . . 61.32 107.848 160.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.8 178.19 35.51 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 120.036 1.289 . . . . 74.2 114.167 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.618 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.87 100.85 8.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.334 0.654 . . . . 74.31 110.789 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.13 152.13 23.61 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.81 -1.181 . . . . 75.44 107.81 167.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.93 137.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.791 1.636 . . . . 61.22 108.943 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -117.5 80.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.427 -1.715 . . . . 74.3 106.868 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.6 137.25 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.848 -1.908 . . . . 73.13 105.848 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.7 m -117.31 171.83 7.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.079 -1.822 . . . . 74.12 106.079 159.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -139.32 172.85 12.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.911 1.284 . . . . 74.22 109.106 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -63.7 -29.27 70.52 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.063 -1.023 . . . . 71.25 110.742 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.64 2.48 5.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.113 1.365 . . . . 75.51 113.945 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 62.58 16.69 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.494 1.518 . . . . 64.14 111.8 -168.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -70.0 153.46 43.19 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.814 -1.18 . . . . 54.32 107.814 168.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.57 163.29 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.942 1.697 . . . . 75.51 107.564 -170.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.587 HG22 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -148.96 172.64 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.02 1.728 . . . . 74.13 108.955 -170.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.3 m -146.12 92.43 2.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.666 -1.235 . . . . 70.12 107.666 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.88 170.21 18.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.315 1.446 . . . . 74.51 110.832 -172.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 p -70.19 166.99 18.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.964 1.256 . . . . 72.31 112.15 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.3 1.4 p-80 -67.84 -31.62 71.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.22 -0.925 . . . . 63.53 111.348 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -100.18 39.94 1.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.832 2.453 . . . . 72.33 111.293 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -95.3 128.36 38.82 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.609 -1.186 . . . . 75.54 111.829 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.46 121.77 8.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.551 2.834 . . . . 74.21 111.042 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.76 177.12 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.776 1.631 . . . . 75.02 108.752 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -112.43 149.53 32.44 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.179 -0.951 . . . . 75.13 111.545 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.46 170.32 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 126.006 1.722 . . . . 75.24 108.458 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 p -96.05 137.09 35.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.075 0.94 . . . . 73.21 110.261 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 79.8 1.87 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.776 -1.564 . . . . 74.43 106.776 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 65.42 4.01 2.56 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.196 1.184 . . . . 75.12 114.196 172.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -21.89 2.43 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 120.173 -1.579 . . . . 71.11 112.139 -169.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -102.66 160.58 14.45 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.148 1.379 . . . . 64.41 107.893 -171.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 t -112.91 119.24 60.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.378 -1.712 . . . . 75.13 106.378 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.67 137.2 48.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.445 -0.946 . . . . 44.24 108.445 -170.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -84.0 134.56 34.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.271 1.028 . . . . 72.44 109.519 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 pt -147.78 -179.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.454 1.502 . . . . 72.3 109.717 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -79.38 134.04 36.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.408 1.083 . . . . 74.41 110.225 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.37 -30.75 30.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.328 1.051 . . . . 63.33 113.04 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.65 -26.14 68.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.285 1.857 . . . . 75.54 113.625 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 36.7 mmt -80.89 -26.36 36.89 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.39 1.076 . . . . 74.04 111.554 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.95 63.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.006 2.522 . . . . 63.02 111.468 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' C ' ' H ' ' A' ' 124' ' ' GLY . 66.7 mmtt -78.96 -177.72 5.71 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.898 -1.126 . . . . 75.13 109.063 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.98 1.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.34 1.856 . . . . 72.02 112.964 159.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -90.11 -3.96 72.31 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 116.614 -2.214 . . . . 73.14 112.444 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 166.74 21.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.134 1.967 . . . . 74.41 107.734 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -98.38 155.74 17.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.011 -0.995 . . . . 73.0 108.79 163.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.8 tt -122.21 131.37 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.388 1.075 . . . . 74.14 109.462 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.7 117.77 13.7 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 118.585 -0.721 . . . . 74.31 109.909 176.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.1 pp -129.4 157.06 77.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.639 1.175 . . . . 75.42 112.99 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.31 147.3 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.57 2.18 . . . . 75.11 109.563 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.42 -178.36 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.262 -1.384 . . . . 74.14 107.262 163.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -24.12 -71.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.464 2.706 . . . . 73.44 112.802 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -121.01 1.22 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.382 2.673 . . . . 74.42 113.85 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.1 p -128.61 -173.88 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.828 1.651 . . . . 74.23 112.723 -168.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.25 157.45 5.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.868 -1.16 . . . . 72.04 107.868 166.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -140.92 -177.34 5.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.307 2.243 . . . . 71.54 107.209 165.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.76 157.66 18.36 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.555 1.142 . . . . 73.01 110.074 165.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . 0.306 39.5 p30 -142.79 164.67 29.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 114.396 1.258 . . . . 70.42 114.396 162.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -95.26 146.1 24.59 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.063 1.745 . . . . 73.24 107.5 -171.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -98.14 0.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 113.749 1.018 . . . . 75.03 113.749 -160.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 pt 35.31 -53.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 1 C-N-CA 133.019 4.528 . . . . 75.31 120.064 169.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -144.68 133.51 22.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.301 2.64 . . . . 75.12 107.908 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.96 127.28 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.263 1.03 . . . . 75.2 108.318 166.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -140.22 -158.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.392 1.477 . . . . 71.44 107.579 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -139.7 152.49 46.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.386 1.074 . . . . 73.04 108.952 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m -102.59 139.1 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.505 -1.665 . . . . 73.53 106.505 161.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.21 92.8 9.09 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.752 1.614 . . . . 74.43 106.972 166.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.415 ' C ' HD21 ' A' ' 149' ' ' ASN . 8.4 t80 -96.81 139.41 32.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.183 0.993 . . . . 75.14 111.345 -168.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.415 HD21 ' C ' ' A' ' 148' ' ' TYR . 3.6 m-80 -140.69 67.01 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.742 -1.577 . . . . 71.41 106.742 -165.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.0 -172.51 12.83 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 123.72 0.676 . . . . 75.13 111.99 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -81.3 144.47 31.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.178 -0.675 . . . . 71.42 109.178 162.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.54 158.18 34.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 127.638 2.375 . . . . 73.45 108.665 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.472 ' HH ' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -153.81 164.85 37.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.912 -0.773 . . . . 75.43 108.912 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -129.15 147.83 51.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.342 1.457 . . . . 75.22 108.994 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 tp -96.14 153.81 17.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.539 . . . . 74.12 110.686 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m -107.71 37.83 2.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.722 0.809 . . . . 74.03 111.615 -165.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.85 101.93 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 119.881 -1.762 . . . . 62.2 109.542 -172.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.59 -6.09 57.76 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.49 1.116 . . . . 64.45 110.311 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.35 -67.25 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.779 1.232 . . . . 74.23 108.58 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.453 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 6.5 t30 -112.13 4.43 17.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.753 0.821 . . . . 74.34 111.418 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.13 35.1 25.08 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.218 1.007 . . . . 71.23 109.592 -169.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.27 150.78 27.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.947 1.699 . . . . 75.33 108.57 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.67 -178.57 6.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.064 1.302 . . . . 74.12 110.555 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.2 mm -113.36 143.27 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.381 1.472 . . . . 75.14 108.634 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.34 38.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.341 1.056 . . . . 61.05 110.223 165.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 132.58 -169.2 22.45 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 119.035 0.834 . . . . 61.51 112.569 166.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -85.7 167.41 15.31 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.083 1.442 . . . . 74.41 111.841 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.45 -73.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.142 2.977 . . . . 71.23 113.762 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.21 -14.22 7.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.239 1.815 . . . . 73.24 112.493 175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 68.89 160.67 2.12 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 126.484 1.992 . . . . 64.03 112.571 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.587 ' CE1' HG22 ' A' ' 97' ' ' ILE . 37.5 m-85 -106.6 151.06 25.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.379 2.272 . . . . 74.21 107.07 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.6 129.56 34.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.407 -1.331 . . . . 71.54 107.407 162.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.01 176.34 7.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.419 -1.326 . . . . 72.03 107.419 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.2 t -65.98 164.52 15.01 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.644 -0.873 . . . . 74.32 108.644 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.38 132.9 20.81 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.544 -1.65 . . . . 70.41 106.544 164.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.9 76.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.436 -1.69 . . . . 75.43 106.436 159.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 t 56.51 21.85 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.727 2.121 . . . . 74.33 116.727 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.6 38.47 93.76 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.844 1.656 . . . . 70.22 111.208 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.98 -176.01 3.24 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.454 2.302 . . . . 64.43 106.305 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . 0.257 8.9 tt 63.59 121.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.117 1.767 . . . . 74.53 114.755 161.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -86.71 -67.06 0.84 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.776 -1.102 . . . . 75.14 109.74 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -129.56 -68.13 0.74 Allowed 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.076 -1.083 . . . . 70.53 108.076 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.9 136.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.952 2.101 . . . . 74.53 110.883 -171.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 42.7 m80 56.89 -179.11 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.074 1.35 . . . . 73.32 112.24 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -155.99 -78.17 0.09 Allowed 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.119 -0.988 . . . . 74.22 110.692 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 N-CA-C 103.642 -2.725 . . . . 73.31 103.642 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 117.904 -1.046 . . . . 72.52 109.058 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -150.39 163.95 37.09 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.522 1.51 . . . . 74.34 110.205 159.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.2 m -66.92 -51.0 60.56 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.673 1.989 . . . . 73.12 108.956 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.6 -165.05 25.35 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.577 2.513 . . . . 75.31 107.283 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -114.48 161.19 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.246 1.018 . . . . 72.13 108.525 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -141.71 -177.36 5.14 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.907 -1.145 . . . . 73.44 107.907 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.68 155.93 7.83 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.749 1.642 . . . . 44.34 112.925 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.88 167.65 3.06 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 128.492 2.717 . . . . 60.42 106.407 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt -101.89 166.65 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.572 1.549 . . . . 74.25 109.588 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -173.85 0.56 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.031 1.332 . . . . 73.31 110.858 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.86 -31.85 59.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.492 1.117 . . . . 75.24 111.062 171.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.96 31.64 6.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.714 2.405 . . . . 73.31 111.051 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -88.43 133.38 36.6 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.619 -1.252 . . . . 64.22 107.619 157.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.57 152.45 59.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.211 1.274 . . . . 75.1 113.676 168.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.04 -17.03 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 73.44 114.658 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.37 74.62 0.27 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.943 1.354 . . . . 74.15 111.755 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 mt -53.85 163.64 0.7 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.991 -1.004 . . . . 73.11 109.504 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -56.07 -36.37 68.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.676 -0.64 . . . . 71.23 110.266 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.96 -18.73 63.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.684 0.794 . . . . 74.44 112.948 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.3 44.85 26.85 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 125.436 1.493 . . . . 74.23 109.574 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.792 1.034 . . . . 63.32 113.792 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 mm 48.54 102.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.799 2.44 . . . . 61.23 109.987 -160.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.5 142.99 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.676 -1.601 . . . . 73.51 106.676 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.38 123.94 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.028 2.531 . . . . 73.04 106.989 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -51.18 -44.78 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 70.02 111.511 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.26 -27.53 73.59 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.938 -0.924 . . . . 74.23 111.751 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -73.94 -44.39 55.1 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.832 1.316 . . . . 74.03 110.079 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -53.86 -53.45 52.35 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.597 1.159 . . . . 75.01 109.115 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.455 HG12 ' CE1' ' A' ' 33' ' ' PHE . 93.0 t -56.51 -48.77 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.25 0.62 . . . . 75.02 111.033 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.13 -32.23 73.83 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.907 -1.12 . . . . 71.2 112.864 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.543 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.1 -36.74 19.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.742 1.217 . . . . 73.35 110.79 171.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 35.1 m-85 -84.79 -45.69 12.11 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.69 -0.856 . . . . 73.22 108.69 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.455 ' CE1' HG12 ' A' ' 29' ' ' VAL . 3.6 m-30 -68.43 -21.42 64.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.603 1.547 . . . . 73.41 111.62 -169.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.486 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 9.9 mtpt -86.87 -16.91 34.66 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.174 1.39 . . . . 74.41 112.029 172.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -57.43 2.18 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 120.587 1.539 . . . . 64.21 108.153 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.4 m-30 -86.12 40.01 0.85 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.125 1.77 . . . . 65.43 108.245 -174.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 33.0 mttt -49.99 -44.41 50.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.032 1.333 . . . . 62.54 108.639 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -56.63 -25.15 52.44 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 126.535 1.934 . . . . 73.23 114.229 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -112.93 12.39 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.645 1.578 . . . . 75.25 112.057 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.33 106.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.842 -1.54 . . . . 74.32 106.842 159.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.16 152.98 25.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.5 -0.926 . . . . 71.12 108.5 164.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -118.32 142.25 47.7 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.635 -2.358 . . . . 74.3 104.635 158.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.52 159.02 20.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.308 -1.738 . . . . 74.24 106.308 156.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.71 -37.7 85.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.253 1.421 . . . . 75.14 110.285 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.16 -27.47 61.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.167 0.987 . . . . 71.55 111.151 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.04 5.37 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.043 1.306 . . . . 74.25 114.432 159.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.9 -86.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.642 1.177 . . . . 63.41 110.726 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.48 137.04 4.76 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 120.795 -1.19 . . . . 74.24 110.539 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -142.62 167.77 21.3 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.98 0.89 . . . . 75.4 111.026 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.25 140.15 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.95 2.1 . . . . 74.12 105.464 163.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 126.96 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.169 1.788 . . . . 70.41 108.737 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.96 -3.51 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.845 1.258 . . . . 74.12 111.63 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.05 -16.61 57.77 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 120.373 1.442 . . . . 73.13 113.294 -170.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -23.95 66.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.461 1.131 . . . . 75.54 112.712 171.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.74 -15.16 26.36 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.546 1.538 . . . . 73.22 113.169 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.48 6.34 3.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.642 1.577 . . . . 73.11 114.924 173.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.49 148.44 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.907 2.083 . . . . 74.24 107.448 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.04 158.4 25.9 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.398 1.094 . . . . 73.01 110.96 169.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.25 161.28 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 129.027 2.931 . . . . 65.22 107.382 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -75.11 152.06 38.57 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.124 -0.985 . . . . 75.41 109.416 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -145.18 -171.91 3.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.703 0.801 . . . . 72.41 109.25 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.14 137.53 34.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.075 -1.454 . . . . 72.31 107.075 168.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.97 113.38 19.14 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.777 -1.194 . . . . 71.32 107.777 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.31 -29.87 71.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.341 0.656 . . . . 74.24 112.195 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -30.69 5.68 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.676 1.991 . . . . 73.33 112.732 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.28 11.53 1.74 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.437 0.695 . . . . 65.31 111.956 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.36 46.36 26.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.279 1.431 . . . . 64.55 112.252 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.0 163.28 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 126.086 1.754 . . . . 75.22 109.827 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.68 148.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.816 1.246 . . . . 73.15 109.281 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.91 -179.39 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.936 1.695 . . . . 61.3 110.741 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -86.17 172.26 10.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.341 1.456 . . . . 72.3 110.896 155.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.01 170.02 16.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.591 1.556 . . . . 65.15 108.226 141.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -99.46 -19.47 16.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.75 1.22 . . . . 73.23 113.846 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 mt 64.1 155.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.01 1.724 . . . . 74.42 110.145 -163.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.14 -63.89 1.29 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.6 -1.63 . . . . 73.0 106.6 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -130.21 152.45 49.62 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.9 0.88 . . . . 75.35 110.267 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.49 153.74 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 107.373 -1.344 . . . . 74.53 107.373 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.78 153.86 50.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.557 1.543 . . . . 74.24 108.184 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -145.36 160.39 41.61 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.753 -0.832 . . . . 73.31 108.753 173.41 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -151.83 161.47 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.733 -1.58 . . . . 75.53 106.733 162.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -91.29 150.13 21.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.427 -1.421 . . . . 71.31 109.286 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -141.63 164.43 30.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.145 0.978 . . . . 74.2 108.982 -177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.6 m -157.4 127.66 6.35 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.97 -1.863 . . . . 72.15 105.97 150.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.22 -169.14 37.48 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.873 1.215 . . . . 75.31 110.208 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.53 146.7 32.5 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.096 -0.65 . . . . 75.12 109.462 178.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.16 163.58 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.994 -1.484 . . . . 73.53 106.994 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.0 mm -78.86 132.78 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.975 -0.75 . . . . 74.54 108.975 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -111.37 80.59 1.33 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.965 -1.865 . . . . 73.42 105.965 169.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.48 123.94 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.175 -2.528 . . . . 73.54 104.175 158.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.3 m -114.68 161.89 17.53 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 105.906 -1.887 . . . . 73.25 105.906 160.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -139.75 163.35 32.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.949 1.299 . . . . 75.41 108.061 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.94 -27.76 61.43 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.899 1.227 . . . . 73.04 112.072 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -60.5 -8.16 2.59 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.229 1.811 . . . . 73.15 112.253 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 65.08 13.58 8.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.435 2.294 . . . . 75.52 110.977 -161.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 154.56 38.05 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.31 -1.367 . . . . 75.3 107.31 170.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.01 168.78 13.52 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.744 2.018 . . . . 74.52 108.744 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.558 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -152.08 -168.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.907 1.683 . . . . 75.34 110.452 -173.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.55 132.98 17.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 112.757 0.651 . . . . 75.35 112.757 169.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 159.31 41.47 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.826 1.25 . . . . 74.15 110.417 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.6 m -72.15 -0.12 11.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.262 1.208 . . . . 72.41 114.262 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 102' ' ' ASP 0.306 0.1 OUTLIER 96.19 -61.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 1 C-N-CA 132.399 4.28 . . . . 74.12 107.66 -155.695 . . . . . . . . 5 4 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' H ' ' CD2' ' A' ' 101' ' ' HIS . 81.1 m-20 -92.93 82.57 4.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.202 -1.777 . . . . 74.22 106.202 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -124.38 136.5 27.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.077 1.751 . . . . 73.5 107.938 158.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.08 134.21 33.41 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.162 2.574 . . . . 73.13 110.719 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.66 -172.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.955 1.302 . . . . 73.45 108.065 168.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -124.85 141.35 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.609 1.55 . . . . 65.02 110.644 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.76 163.11 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.666 1.186 . . . . 74.15 109.808 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 p -82.4 127.96 33.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.873 0.733 . . . . 73.34 109.298 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 92.9 4.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.396 -2.816 . . . . 73.45 103.396 154.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m 66.22 -13.73 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.43 2.692 . . . . 62.32 116.78 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.65 -0.24 4.99 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.547 0.594 . . . . 74.01 111.675 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 148.37 31.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.297 -1.001 . . . . 73.12 108.297 156.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.45 127.31 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.928 1.291 . . . . 74.2 107.809 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 tp -126.59 158.89 35.08 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.357 1.063 . . . . 73.3 108.376 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -124.2 106.02 9.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.846 2.459 . . . . 75.44 109.655 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -140.02 169.84 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.914 2.486 . . . . 74.01 109.317 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.81 144.81 29.88 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.353 0.661 . . . . 74.45 110.466 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.11 61.72 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.923 1.083 . . . . 74.43 113.923 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -21.98 65.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.998 0.919 . . . . 55.13 112.123 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.3 mtm -89.65 -26.87 20.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.516 1.053 . . . . 73.24 112.337 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.79 62.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 128.733 2.813 . . . . 62.01 110.698 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 124' ' ' GLY . 13.7 mmtp -79.86 -174.51 4.43 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.063 1.345 . . . . 72.54 109.536 175.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.09 0.22 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 127.142 2.177 . . . . 74.13 113.034 166.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -88.66 -3.52 77.41 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.96 1.743 . . . . 73.22 112.998 169.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.32 169.73 10.64 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.364 1.082 . . . . 71.43 111.887 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -123.17 113.13 18.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.905 2.882 . . . . 73.02 107.213 171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.93 136.83 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.467 1.107 . . . . 74.25 108.672 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -72.49 121.86 20.32 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.833 -0.803 . . . . 70.25 108.833 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.24 150.26 69.39 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.635 1.174 . . . . 74.31 111.472 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.28 138.19 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.49 2.793 . . . . 64.25 109.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -167.57 1.87 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.682 -1.599 . . . . 75.01 106.682 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -23.25 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 129.386 3.075 . . . . 75.11 112.317 -160.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -120.68 0.33 10.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.044 2.537 . . . . 74.43 110.134 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 48.8 p -139.01 165.3 27.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.368 1.067 . . . . 71.14 112.71 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -79.31 156.34 4.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.625 0.726 . . . . 74.52 109.67 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -139.48 -175.86 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.017 2.127 . . . . 72.5 107.981 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 89.6 mt -114.78 164.55 13.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.498 -0.927 . . . . 63.11 108.498 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -151.26 158.73 44.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.13 -1.063 . . . . 62.04 108.13 160.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -92.01 152.27 20.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.286 0.634 . . . . 75.31 109.346 -177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.01 1.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.241 1.416 . . . . 72.21 112.696 -168.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.478 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.9 pt 24.74 -83.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 128.325 2.65 . . . . 74.13 116.232 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.478 ' H ' HG13 ' A' ' 141' ' ' ILE . 8.2 tppt? -95.24 123.3 38.67 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.039 1.336 . . . . 74.21 108.225 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.21 104.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 123.606 1.67 . . . . 74.44 109.226 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.65 -156.28 0.75 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.965 1.706 . . . . 73.21 106.517 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -131.13 167.47 19.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.568 1.547 . . . . 73.14 108.232 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.59 178.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.708 1.603 . . . . 62.03 106.928 160.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -122.13 137.71 54.72 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.659 -1.237 . . . . 75.22 107.659 160.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.402 ' C ' HD21 ' A' ' 149' ' ' ASN . 44.6 t80 -141.53 134.11 28.43 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.523 1.929 . . . . 75.52 109.699 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.402 HD21 ' C ' ' A' ' 148' ' ' TYR . 2.7 m120 -132.45 28.07 4.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.377 1.444 . . . . 75.11 112.85 -160.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -132.94 -170.6 12.51 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.798 1.19 . . . . 55.32 110.953 -164.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.433 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 72.9 m80 -74.36 149.09 40.72 Favored 'General case' 0 CA--C 1.522 -0.107 0 O-C-N 121.033 -1.275 . . . . 72.31 109.704 168.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 25.6 pt -108.52 149.79 11.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 125.499 1.52 . . . . 74.22 107.661 173.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.51 147.14 52.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.857 1.263 . . . . 71.33 110.714 -161.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -144.81 152.49 40.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.249 1.019 . . . . 63.43 109.476 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.19 119.69 25.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.142 1.377 . . . . 75.53 108.767 -166.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -37.39 87.03 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.285 1.217 . . . . 61.21 114.285 -166.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.8 t 25.24 73.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.202 2.601 . . . . 72.13 113.971 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.13 -3.45 39.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.847 -1.158 . . . . 75.35 113.558 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.26 -61.18 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.841 1.256 . . . . 72.41 108.981 -165.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -108.48 -10.27 15.29 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.112 1.365 . . . . 72.41 111.839 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.0 m170 52.43 21.81 1.88 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.314 1.846 . . . . 75.54 112.152 -166.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -142.18 153.72 44.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.822 -1.174 . . . . 73.5 109.007 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 179.39 9.25 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.868 1.267 . . . . 74.0 111.035 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.3 mm -105.63 137.12 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.783 -1.562 . . . . 73.23 106.783 168.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.59 153.65 30.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.484 1.114 . . . . 75.12 108.463 169.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 136.51 -161.7 25.04 Favored Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.947 1.249 . . . . 74.23 112.254 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -101.82 170.48 8.12 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.167 1.984 . . . . 74.11 111.743 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.06 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.162 3.385 . . . . 75.03 112.51 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -121.66 -13.05 8.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.364 1.466 . . . . 74.43 112.108 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.2 176.47 39.14 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 122.782 1.212 . . . . 71.01 111.322 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.558 ' CE1' HG23 ' A' ' 97' ' ' ILE . 6.4 m-85 -123.84 161.39 25.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.405 2.282 . . . . 73.05 107.053 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -107.42 101.3 10.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.276 -1.75 . . . . 74.51 106.276 -171.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.12 173.26 12.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.586 0.63 . . . . 72.14 110.133 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.87 129.68 42.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.145 -1.428 . . . . 74.23 107.145 162.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.3 171.59 8.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.575 -2.009 . . . . 71.43 105.575 144.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.6 m -164.39 162.06 21.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.083 0.856 . . . . 71.22 109.754 145.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.0 t -72.02 -69.11 0.41 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.113 1.365 . . . . 61.35 109.551 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.72 55.34 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.755 -2.538 . . . . 75.21 106.755 -170.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.257 1.8 p 62.45 -177.62 0.14 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.709 3.204 . . . . 74.31 114.067 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.2 tp -78.76 93.97 5.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.754 -1.573 . . . . 73.42 106.754 164.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.34 -49.07 25.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.909 1.284 . . . . 75.51 111.168 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 86.3 t60 60.29 -75.46 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.723 2.409 . . . . 73.41 112.433 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.18 155.71 27.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.19 1.796 . . . . 65.44 108.229 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.7 m170 83.24 85.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.876 2.87 . . . . 75.15 109.165 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -71.42 -33.42 69.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.847 0.859 . . . . 74.34 111.521 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 113.887 1.069 . . . . 74.43 113.887 -144.802 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.539 -0.267 . . . . 74.13 110.385 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.91 147.01 35.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.685 1.194 . . . . 71.13 108.801 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.84 -80.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.868 1.667 . . . . 75.14 108.013 165.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.31 77.31 0.79 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 108.756 -1.738 . . . . 61.42 108.756 -156.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -74.17 -177.34 2.93 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.699 0.799 . . . . 73.15 109.992 167.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -77.26 -171.65 2.15 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.722 1.209 . . . . 71.12 110.323 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.34 133.99 2.27 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.15 1.357 . . . . 74.21 112.857 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.68 171.58 14.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.512 1.925 . . . . 72.13 109.999 -171.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -84.17 171.0 13.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.326 1.05 . . . . 75.33 110.887 174.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.07 156.75 17.17 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.801 -1.187 . . . . 73.13 110.679 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.0 t80 -44.75 -51.79 9.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.262 2.625 . . . . 74.24 110.439 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.97 10.3 19.35 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.189 0.811 . . . . 75.3 113.189 -167.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.23 118.56 72.77 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.375 -1.713 . . . . 62.31 106.375 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -66.53 130.48 23.73 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.437 2.091 . . . . 63.54 109.839 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 pt -93.29 160.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 73.55 109.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CE1' ' HA ' ' A' ' 169' ' ' GLU . 50.6 m-85 -114.85 72.9 0.8 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.084 -1.08 . . . . 74.33 108.084 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.48 160.38 5.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.073 -1.421 . . . . 74.45 108.592 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.05 -44.82 51.77 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.907 0.755 . . . . 64.34 109.731 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -94.31 -17.59 22.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.74 -0.664 . . . . 74.04 112.087 -168.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.04 32.74 4.56 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 121.444 -0.785 . . . . 61.42 113.851 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.59 -17.58 64.15 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.568 1.321 . . . . 73.43 114.568 -170.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 mm 39.73 92.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 129.041 2.936 . . . . 74.45 111.992 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 154.25 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.465 1.106 . . . . 72.22 108.455 -176.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -64.45 130.65 44.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.066 -1.457 . . . . 64.24 107.066 173.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -46.69 -46.91 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 122.489 1.138 . . . . 73.31 108.627 169.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.476 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -48.73 -64.7 3.04 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 128.484 2.945 . . . . 63.54 110.616 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -54.96 -49.05 72.34 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.014 2.126 . . . . 74.12 111.38 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -54.62 -49.19 71.09 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.787 0.835 . . . . 74.51 111.244 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 55.9 t -80.8 -38.27 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.983 -1.008 . . . . 73.12 109.45 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -55.17 -45.27 75.72 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.474 0.579 . . . . 65.33 110.68 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -31.07 70.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.783 -1.198 . . . . 74.21 112.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.91 -55.96 7.28 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 116.334 -1.793 . . . . 75.22 109.187 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.45 -44.43 45.67 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 123.104 2.683 . . . . 73.53 112.125 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -74.2 -18.87 60.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.126 2.17 . . . . 75.33 111.896 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -67.76 0.78 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.159 -2.163 . . . . 74.32 105.159 166.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -79.77 39.65 0.43 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.469 2.708 . . . . 72.41 110.999 -167.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -59.79 -28.05 67.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.211 -0.931 . . . . 61.41 111.52 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.46 -23.17 65.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.217 1.407 . . . . 74.45 113.222 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.85 8.05 28.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.812 1.245 . . . . 75.35 111.186 -168.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.22 96.81 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.087 -1.079 . . . . 74.21 108.087 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.78 157.56 27.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.432 -0.951 . . . . 74.54 108.432 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.09 157.7 18.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.632 -1.618 . . . . 71.25 106.632 168.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 169.31 17.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.771 -1.104 . . . . 61.1 109.556 163.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -63.04 1.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.777 2.031 . . . . 61.21 108.68 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -59.57 -21.15 59.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.041 1.336 . . . . 74.11 111.179 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.57 -26.86 2.63 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.208 -1.329 . . . . 74.02 114.168 155.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -25.39 -85.5 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.812 3.245 . . . . 73.31 114.699 -162.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.54 128.28 2.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.232 -1.547 . . . . 53.2 109.232 -166.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -153.6 162.55 41.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.875 1.337 . . . . 75.02 111.245 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -150.73 129.84 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.78 1.632 . . . . 73.45 107.419 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.86 130.62 43.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.024 0.829 . . . . 62.12 109.472 162.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -134.0 16.24 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.163 0.985 . . . . 72.41 111.284 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.98 -29.95 36.33 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.876 2.179 . . . . 74.25 114.433 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -69.68 -24.62 63.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.929 1.291 . . . . 64.24 113.925 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.97 -10.09 12.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.93 1.241 . . . . 74.31 113.805 -174.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.44 14.67 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.441 2.696 . . . . 74.33 115.119 173.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mt -68.75 117.59 11.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.484 1.114 . . . . 75.33 108.575 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.24 157.43 23.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.488 1.137 . . . . 74.11 110.24 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.8 tt -153.29 153.13 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.228 -1.768 . . . . 73.32 106.228 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -67.32 106.35 2.04 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.78 0.718 . . . . 73.04 109.561 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -87.44 172.79 9.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.418 1.087 . . . . 72.35 108.18 165.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.3 OUTLIER -141.83 136.74 30.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.069 -1.826 . . . . 72.21 106.069 167.879 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.57 119.36 24.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.345 -0.983 . . . . 74.25 108.345 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -63.15 -24.03 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 75.34 111.235 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.08 -33.48 2.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 128.541 2.736 . . . . 74.33 111.81 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 m -157.71 10.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.855 1.262 . . . . 63.23 112.768 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mp 55.75 54.32 8.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.423 1.489 . . . . 75.42 110.751 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.43 158.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.216 1.807 . . . . 74.25 109.619 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 119.73 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.086 1.354 . . . . 75.22 108.686 -164.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -132.4 157.74 43.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.833 1.253 . . . . 73.05 112.038 -168.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -104.85 106.84 17.51 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 126.322 1.849 . . . . 75.33 108.378 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.585 ' HB3' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -151.72 141.23 21.64 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.403 -1.702 . . . . 74.42 106.403 -174.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.91 175.06 6.79 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.098 -1.001 . . . . 74.11 110.936 -166.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.0 mt -97.44 148.49 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.052 1.741 . . . . 73.31 108.147 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.98 -55.2 2.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.214 -0.661 . . . . 74.14 109.214 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.421 HH12 ' CD ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -119.63 152.2 37.45 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.051 -1.03 . . . . 75.51 109.812 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.73 158.88 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.225 1.81 . . . . 72.01 107.546 171.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -129.53 175.68 8.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.031 1.333 . . . . 74.01 108.046 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.553 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 1.5 tmm_? -173.66 152.27 2.03 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.938 1.695 . . . . 74.0 109.297 157.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -140.61 161.72 37.09 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.161 2.185 . . . . 73.34 107.376 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -95.26 148.07 22.8 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.196 -0.94 . . . . 75.1 109.46 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -144.91 156.19 43.85 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.735 1.214 . . . . 74.04 108.949 -171.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -159.77 106.01 1.63 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.187 0.995 . . . . 63.11 109.784 165.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.69 -178.11 45.26 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.423 -0.671 . . . . 63.2 111.423 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.601 ' H ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.18 138.25 34.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.458 -0.782 . . . . 73.21 110.37 170.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.02 159.8 18.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.234 1.413 . . . . 75.52 109.399 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mm -83.51 139.97 16.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.624 1.169 . . . . 75.41 107.977 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -129.27 77.35 1.78 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.655 2.382 . . . . 75.21 106.662 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.1 138.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.896 -1.89 . . . . 64.52 105.896 159.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.1 m -119.06 155.29 31.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.407 -2.072 . . . . 74.1 105.407 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 p -131.78 171.76 13.12 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.794 -1.191 . . . . 62.25 108.361 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -56.5 -27.81 58.21 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.759 1.392 . . . . 75.14 114.759 -166.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.42 0.49 19.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.912 2.085 . . . . 75.4 113.935 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 61.49 17.79 8.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.256 1.423 . . . . 74.11 111.89 -163.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.59 158.82 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.064 -1.828 . . . . 75.31 106.064 159.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.82 163.59 1.43 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 128.342 2.657 . . . . 73.11 106.298 -171.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -145.36 169.04 7.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.816 1.646 . . . . 74.13 106.629 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.48 100.33 3.85 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.156 0.889 . . . . 74.34 109.954 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.54 168.87 26.05 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.506 -0.746 . . . . 72.35 112.612 -165.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.8 m -60.44 156.04 16.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.943 1.297 . . . . 73.54 107.784 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -73.64 6.11 3.39 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.219 -0.926 . . . . 74.32 111.013 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -136.86 36.93 2.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.063 1.345 . . . . 62.21 109.652 -171.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -105.7 129.29 24.89 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 126.071 1.748 . . . . 73.42 108.48 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -65.88 152.7 80.77 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.552 2.168 . . . . 74.33 114.096 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.18 173.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.531 2.732 . . . . 73.41 108.055 173.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.59 137.63 53.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.388 1.075 . . . . 73.34 108.556 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.99 162.42 36.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.848 1.259 . . . . 75.52 108.705 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.94 108.45 19.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.613 -0.884 . . . . 74.51 108.613 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -78.3 69.09 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.021 -1.474 . . . . 75.11 107.021 162.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 59.64 13.46 3.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.97 1.47 . . . . 75.32 114.97 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.93 -18.99 5.28 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 120.817 -1.177 . . . . 73.43 112.103 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.55 144.86 33.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.634 -1.988 . . . . 72.22 105.634 162.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -88.45 145.36 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.97 -0.752 . . . . 73.31 108.97 167.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.02 146.7 25.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.211 1.404 . . . . 74.44 108.153 -173.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -102.02 131.59 48.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 118.517 -0.754 . . . . 65.3 110.666 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.9 pt -143.14 -178.81 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.147 1.779 . . . . 74.12 108.625 168.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -78.37 156.15 29.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.781 -1.199 . . . . 75.21 112.989 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.66 -48.33 39.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.823 2.449 . . . . 72.03 111.128 164.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.37 -8.84 28.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.073 1.138 . . . . 75.13 114.073 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.1 mmt -94.31 -38.58 10.93 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.714 1.205 . . . . 73.11 110.968 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.11 60.93 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.853 1.661 . . . . 73.41 109.12 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -81.66 -171.86 3.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.618 1.567 . . . . 75.4 109.433 -178.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.07 -0.62 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 126.3 1.84 . . . . 72.2 113.045 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 122' ' ' LYS . . . -89.03 -14.19 61.05 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 116.838 -2.09 . . . . 73.35 112.206 171.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.82 179.64 4.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.786 2.293 . . . . 61.31 108.726 -163.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.48 136.71 53.65 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.475 0.71 . . . . 75.41 111.753 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 tt -111.4 150.15 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.36 1.464 . . . . 72.24 109.335 -170.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.49 103.47 15.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.2 1.0 . . . . 73.25 110.689 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.08 156.72 36.77 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.185 0.994 . . . . 74.14 111.168 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.77 154.08 38.67 Favored 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.486 -1.39 . . . . 74.02 108.486 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -119.38 -157.33 0.69 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.437 -2.06 . . . . 75.34 105.437 162.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -48.5 -71.27 0.07 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.531 1.132 . . . . 62.54 111.863 -171.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -120.37 0.12 10.5 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.874 1.669 . . . . 74.34 111.635 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.8 p -131.82 -172.55 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.217 1.807 . . . . 71.34 111.045 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.85 157.05 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.119 -1.437 . . . . 74.55 107.119 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -136.38 179.19 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.523 -1.658 . . . . 74.25 106.523 167.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 mp -108.06 162.19 14.27 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.672 0.749 . . . . 74.24 109.892 168.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -148.05 160.61 42.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.183 2.593 . . . . 72.22 107.687 171.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 140.48 43.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.621 1.968 . . . . 73.35 109.606 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.258 33.8 t -78.62 1.46 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 130.075 3.35 . . . . 74.14 115.005 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.443 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.4 pt 25.07 -70.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 130.096 3.358 . . . . 73.53 117.681 167.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' H ' HG13 ' A' ' 141' ' ' ILE . 9.8 ttmt -117.72 125.16 50.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.516 2.727 . . . . 74.32 107.467 172.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.77 128.36 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.397 -1.705 . . . . 74.25 106.397 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -143.14 -179.23 6.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.964 1.706 . . . . 73.12 107.902 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 p -134.2 157.07 47.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.306 1.042 . . . . 74.41 110.878 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 m -127.24 -175.57 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.849 1.66 . . . . 71.11 108.717 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.88 133.36 43.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.704 1.201 . . . . 74.04 109.963 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . 0.535 ' C ' HD21 ' A' ' 149' ' ' ASN . 1.3 t80 -146.95 124.61 11.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 122.481 0.312 . . . . 73.4 110.758 -165.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.535 HD21 ' C ' ' A' ' 148' ' ' TYR . 1.9 m120 -130.27 52.55 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.477 -0.765 . . . . 72.34 109.265 -162.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.78 -179.65 34.73 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.681 -0.968 . . . . 71.21 110.681 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.553 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 69.6 m80 -65.18 144.67 57.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.064 1.346 . . . . 75.12 113.045 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.5 pt -129.56 156.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.535 2.334 . . . . 74.23 109.018 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . 0.458 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.91 163.73 37.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.26 1.024 . . . . 73.23 110.301 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -116.53 -91.06 0.54 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.669 -1.234 . . . . 74.03 107.669 -172.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.7 mt 159.6 161.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 1 C-N-CA 133.274 4.63 . . . . 73.21 107.66 174.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -83.71 -82.93 0.15 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 167.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.524 ' CG1' ' HZ2' ' A' ' 72' ' ' LYS . 48.9 t 56.93 64.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 124.145 1.926 . . . . 73.43 110.688 -171.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 76' ' ' ARG . 3.0 pt-20 -81.54 0.23 39.04 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 113.467 -1.697 . . . . 73.41 114.039 -171.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.463 ' HB3' ' HE3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -86.16 -46.23 10.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.973 0.909 . . . . 74.23 110.453 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.45 -23.73 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.487 1.115 . . . . 73.54 110.228 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 53.67 21.26 2.53 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 128.47 2.708 . . . . 73.24 113.411 -159.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.442 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.1 p -149.89 151.81 34.05 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.088 -1.633 . . . . 64.32 111.743 -174.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.473 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.3 p90 -149.06 178.97 8.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.885 1.274 . . . . 75.31 111.285 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.95 119.01 58.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 C-N-CA 124.785 1.234 . . . . 70.42 108.859 171.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.39 158.41 43.69 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.098 -1.001 . . . . 71.31 110.806 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 142.42 -158.76 27.04 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.611 1.101 . . . . 63.44 110.646 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -99.55 176.53 5.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.785 1.293 . . . . 74.05 110.678 166.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.54 -91.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 128.559 2.743 . . . . 73.04 111.657 -168.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.449 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -122.78 -1.96 8.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.676 2.39 . . . . 72.41 113.366 176.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 82.66 165.9 37.85 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.382 1.468 . . . . 51.43 114.34 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' A' ' 97' ' ' ILE . 66.0 m-85 -108.68 151.78 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.823 2.449 . . . . 75.53 107.609 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.68 102.96 15.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.124 -1.435 . . . . 72.0 107.124 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.2 m -130.76 176.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 118.535 0.607 . . . . 75.35 111.457 -169.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -68.6 145.8 53.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.14 110.652 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.473 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -138.15 62.95 1.55 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.711 2.804 . . . . 73.21 107.092 168.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -75.76 163.49 27.22 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.357 -1.464 . . . . 71.13 109.103 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.4 p -88.92 19.59 4.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.125 1.37 . . . . 72.51 111.643 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 71.99 -16.05 1.66 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.405 1.479 . . . . 72.03 114.616 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.5 p -62.21 155.82 23.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.682 2.793 . . . . 73.44 112.766 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.9 tt -76.08 91.24 3.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.1 m170 61.19 -42.68 0.12 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.505 3.522 . . . . 72.4 116.292 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 54.86 -107.57 0.39 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.131 2.573 . . . . 74.43 110.813 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.44 ' HD1' ' C ' ' A' ' 186' ' ' HIS . 11.6 m-70 -63.85 135.84 56.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.852 1.205 . . . . 72.22 109.581 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -72.15 -50.51 27.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.721 1.208 . . . . 73.45 112.579 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -136.77 -41.73 0.6 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.547 1.139 . . . . 54.01 110.588 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.44 ' C ' ' HD1' ' A' ' 183' ' ' HIS . 49.5 t-80 . . . . . 0 C--O 1.245 0.829 0 C-N-CA 126.046 1.739 . . . . 73.24 107.214 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.241 0.63 0 N-CA-C 107.67 -1.233 . . . . 72.02 107.67 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.32 156.82 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.786 2.034 . . . . 72.35 110.345 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.12 158.93 27.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.025 0.441 . . . . 40.42 110.404 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.7 t80 -53.23 -36.98 61.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.743 1.617 . . . . 72.4 114.008 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.87 4.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.08 1.752 . . . . 71.33 110.995 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.38 124.16 70.28 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 107.51 -1.293 . . . . 64.3 107.51 162.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.17 156.82 42.97 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.463 2.109 . . . . 73.22 113.399 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.64 -5.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.786 1.634 . . . . 41.43 113.604 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.0 m-85 47.64 76.87 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.625 1.57 . . . . 64.14 113.158 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -52.69 160.19 0.95 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.814 -0.63 . . . . 74.24 110.065 168.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 0.32 0.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.712 1.205 . . . . 62.11 112.255 167.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.13 -16.85 9.72 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.883 2.073 . . . . 74.15 111.507 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.23 38.29 7.32 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.787 0.708 . . . . 14.3 112.457 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -16.42 64.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.717 1.377 . . . . 44.2 114.717 -167.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.269 31.3 mm 35.85 66.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.66 2.784 . . . . 64.22 110.514 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 151.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 127.965 2.506 . . . . 75.34 108.59 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.93 127.0 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.214 2.605 . . . . 73.23 107.779 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.23 -41.4 24.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.245 0.618 . . . . 74.04 111.386 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.44 -41.44 85.01 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.006 -0.886 . . . . 41.31 111.136 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.7 -40.97 92.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.661 1.23 . . . . 73.55 110.674 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.16 13.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.992 0.917 . . . . 72.41 108.845 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 77' ' ' VAL . 53.4 t -56.16 -50.9 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.131 -0.692 . . . . 73.52 109.131 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.35 -32.45 73.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.461 1.028 . . . . 63.3 112.028 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.6 tttt -48.18 -47.13 35.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.366 0.984 . . . . 75.45 108.874 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.6 -43.71 75.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.494 -0.928 . . . . 63.11 108.494 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD1' HD12 ' A' ' 50' ' ' ILE . 5.6 m-85 -63.93 -22.03 66.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.24 0.927 . . . . 73.34 112.132 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -93.9 -20.02 20.42 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.298 1.439 . . . . 72.13 112.507 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.46 -52.59 4.26 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 120.378 1.445 . . . . 70.54 107.701 173.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.13 43.02 1.12 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.891 2.076 . . . . 74.45 108.23 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -54.24 -42.18 69.6 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.923 1.689 . . . . 74.31 109.205 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -65.17 -27.89 69.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.849 0.86 . . . . 75.12 111.862 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.87 -5.16 58.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.004 1.721 . . . . 74.33 112.291 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.3 mt -59.47 95.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 120.829 1.65 . . . . 74.23 108.951 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -81.0 142.88 32.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.965 -1.495 . . . . 75.44 106.965 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.46 150.26 26.99 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.487 -1.301 . . . . 63.31 107.487 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.4 170.58 16.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.765 0.826 . . . . 72.45 108.805 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.19 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.58 0.752 . . . . 64.35 110.093 168.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.91 2.62 2.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.918 1.287 . . . . 63.44 112.457 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.56 46.46 54.94 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 125.919 1.723 . . . . 65.13 111.351 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.64 -100.26 0.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.126 -0.694 . . . . 74.14 109.126 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.4 112.44 1.08 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.343 1.925 . . . . 71.0 108.721 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.05 159.3 42.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.136 1.774 . . . . 73.44 108.418 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.424 HD12 ' CD1' ' A' ' 33' ' ' PHE . 39.6 mt -142.48 142.22 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 106.608 -1.627 . . . . 64.52 106.608 170.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 133.45 43.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.987 0.915 . . . . 71.32 108.788 165.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 52' ' ' ILE . 1.5 pp -129.95 12.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.799 -0.637 . . . . 73.33 110.573 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.59 -22.31 16.78 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.208 0.913 . . . . 63.04 112.184 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.97 -25.38 59.91 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.844 1.258 . . . . 63.14 112.454 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.35 -22.97 64.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.461 1.028 . . . . 74.44 110.558 167.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.56 -6.42 0.12 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.952 1.464 . . . . 73.25 114.952 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -45.78 143.81 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 128.377 2.671 . . . . 74.32 110.997 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -102.86 134.76 45.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.3 0.955 . . . . 73.53 112.137 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 13.4 tt -104.33 148.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.802 1.641 . . . . 74.15 107.581 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -69.99 112.84 6.67 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.436 -1.69 . . . . 74.23 106.436 165.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.43 -166.42 1.15 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.126 -1.435 . . . . 43.35 107.126 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.0 159.62 44.45 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.709 -1.589 . . . . 75.31 106.709 167.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.91 116.76 29.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.966 1.306 . . . . 62.5 110.374 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -57.32 -26.79 61.48 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.865 1.666 . . . . 64.42 113.148 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.25 -22.21 64.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.638 1.575 . . . . 74.53 112.453 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m -149.1 10.47 0.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.159 0.984 . . . . 61.13 112.436 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt 54.3 49.37 18.68 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.848 1.309 . . . . 75.13 109.542 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.7 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.876 1.27 . . . . 73.44 108.636 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.96 124.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.046 -1.835 . . . . 74.22 106.046 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.15 179.49 7.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.831 1.652 . . . . 73.22 107.758 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.97 168.83 19.14 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.967 0.907 . . . . 63.21 110.679 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.55 175.78 13.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.643 -1.243 . . . . 64.53 107.643 140.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.28 136.78 44.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.697 1.199 . . . . 74.23 108.72 168.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.89 157.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.742 1.217 . . . . 73.5 107.77 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 158' ' ' GLU . 37.4 mt -117.99 -43.65 2.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.261 0.624 . . . . 73.5 110.815 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.433 ' H ' ' HB ' ' A' ' 156' ' ' THR . 53.1 mtt180 -138.18 165.02 27.71 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.773 -1.204 . . . . 73.34 109.325 169.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.56 168.13 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.862 1.265 . . . . 53.04 108.924 173.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -135.7 155.6 50.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.798 1.239 . . . . 74.35 109.116 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.07 144.68 38.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.548 -1.278 . . . . 72.14 107.548 167.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.03 169.01 18.42 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.181 1.393 . . . . 71.12 107.774 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.92 147.41 27.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.224 -1.028 . . . . 75.11 108.224 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.91 149.32 34.02 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 125.757 1.623 . . . . 74.34 107.335 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 1.4 m -144.64 131.88 20.64 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.393 -1.706 . . . . 61.14 106.393 159.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.81 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.379 -1.088 . . . . 40.23 110.379 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 123.73 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.057 -0.719 . . . . 74.02 109.057 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 149.17 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.64 -0.874 . . . . 63.44 108.64 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 mm -79.48 138.88 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.205 1.802 . . . . 71.3 106.993 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -122.95 43.7 2.86 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.742 0.817 . . . . 72.21 112.527 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 8.8 mt -46.33 114.79 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 C-N-CA 126.894 2.077 . . . . 71.41 106.747 -175.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.6 169.17 11.23 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.721 -1.585 . . . . 54.15 106.721 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.7 p -133.9 171.94 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.136 -0.977 . . . . 73.44 108.927 157.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.82 -38.4 64.54 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.314 -0.866 . . . . 75.53 111.986 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.31 20.03 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.469 2.307 . . . . 74.14 112.473 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 49.23 27.08 1.71 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 128.1 2.56 . . . . 75.44 113.065 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.42 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -65.85 159.89 24.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 120.85 -1.156 . . . . 73.05 108.437 163.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 1.8 pp20? -170.37 167.08 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.98 1.712 . . . . 73.14 107.928 166.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -146.75 174.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 127.145 2.178 . . . . 71.45 107.88 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.13 1.88 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.861 -0.792 . . . . 65.22 108.861 -171.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -142.02 174.37 10.66 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.061 0.944 . . . . 64.33 112.58 -168.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 168.95 8.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.156 2.182 . . . . 73.32 111.684 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.95 -33.27 24.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.364 -0.606 . . . . 65.31 109.364 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -91.63 39.27 1.0 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.787 0.835 . . . . 71.42 110.872 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 99' ' ' LEU . 4.2 t60 -91.78 123.03 64.48 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.208 -1.377 . . . . 75.12 110.077 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.77 124.15 12.35 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.159 2.573 . . . . 63.01 110.412 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.28 173.69 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.746 1.619 . . . . 73.13 108.336 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.69 149.64 34.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.049 0.54 . . . . 74.43 110.761 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.12 164.38 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.973 1.309 . . . . 74.24 109.735 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.81 35.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.082 0.944 . . . . 64.3 108.474 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -109.1 78.06 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.812 -1.551 . . . . 72.52 106.812 153.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.38 14.96 6.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.511 1.524 . . . . 74.12 113.319 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.46 -24.48 3.2 Favored Glycine 0 CA--C 1.521 0.435 0 O-C-N 120.795 -1.191 . . . . 72.11 111.713 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.98 143.32 26.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.552 -1.277 . . . . 61.25 107.552 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.77 -1.937 . . . . 63.13 105.77 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 tp -125.93 159.24 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.653 -0.869 . . . . 73.13 108.653 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.91 119.49 33.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.207 1.803 . . . . 73.03 109.28 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 116' ' ' ILE . 6.9 pt -140.58 179.64 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.262 1.025 . . . . 71.03 110.688 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.6 139.57 34.95 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.62 1.968 . . . . 71.32 110.719 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.24 -41.07 36.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.397 1.479 . . . . 71.54 113.26 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.44 -19.94 65.14 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.932 1.242 . . . . 75.33 113.469 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.5 -22.79 30.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.697 0.799 . . . . 75.41 111.161 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.16 63.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 128.398 2.679 . . . . 64.24 111.527 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -91.42 -170.73 2.71 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.023 -1.048 . . . . 63.15 111.704 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.82 -1.55 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.106 2.162 . . . . 43.4 113.661 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.25 9.19 22.64 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-O 117.439 -1.756 . . . . 45.13 111.764 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 147.68 44.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.84 2.32 . . . . 72.42 108.988 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -94.89 105.09 16.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.241 -1.392 . . . . 73.04 107.241 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.42 118.13 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.601 1.16 . . . . 64.43 109.329 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.38 140.28 56.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.5 -0.75 . . . . 72.54 109.072 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.32 158.0 76.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.854 1.262 . . . . 73.34 111.079 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.54 161.32 42.51 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.669 2.246 . . . . 73.14 110.229 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.438 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -125.21 -145.59 0.33 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.318 -1.364 . . . . 64.44 107.318 166.243 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.99 -82.02 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.465 1.506 . . . . 74.23 109.06 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.46 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.02 0.43 35.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.888 1.675 . . . . 73.33 110.356 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 p -138.02 -172.91 3.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.428 1.491 . . . . 72.3 110.879 -151.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -125.98 143.26 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.187 -1.783 . . . . 75.42 106.187 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.8 177.53 7.8 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.901 -1.124 . . . . 64.1 108.023 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.1 145.7 41.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.897 1.279 . . . . 74.2 107.98 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -142.12 153.97 44.52 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.872 2.069 . . . . 72.13 109.933 170.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 142.02 27.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 118.463 -0.779 . . . . 72.44 110.078 -164.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.7 t -77.32 -5.56 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 114.567 1.321 . . . . 71.31 114.567 -163.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.32 -88.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 127.748 2.419 . . . . 65.21 116.108 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.488 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -85.95 128.58 34.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.901 2.08 . . . . 71.14 109.594 -175.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -129.01 99.07 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.032 1.333 . . . . 63.0 111.103 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -152.65 -169.44 3.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.219 2.608 . . . . 62.11 110.102 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.91 179.56 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.028 1.731 . . . . 74.14 110.107 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.6 163.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.927 2.091 . . . . 74.42 106.442 159.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.01 137.02 37.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.93 -1.878 . . . . 72.33 105.93 161.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.41 142.96 27.59 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.865 0.757 . . . . 64.15 110.058 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 10.5 m-20 -146.82 24.35 1.2 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.847 0.749 . . . . 74.34 112.705 -157.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.88 -111.64 3.39 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 110.318 -1.113 . . . . 54.33 110.318 -155.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -134.23 164.82 26.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.595 -1.631 . . . . 74.31 106.595 157.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 8' ' ' ALA . 20.7 pt -127.09 160.48 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.171 2.188 . . . . 72.35 109.13 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -142.93 151.53 41.06 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.495 1.118 . . . . 72.51 109.684 -168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.23 -178.76 6.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.764 -1.199 . . . . 70.42 107.764 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.3 mt -128.25 175.75 8.22 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.974 1.845 . . . . 75.11 110.995 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 76' ' ' ARG . 24.3 m -128.41 92.05 3.36 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.391 -2.448 . . . . 75.25 104.391 159.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.66 80.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 101.651 -3.463 . . . . 53.11 101.651 166.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 75' ' ' LEU . 14.6 pt-20 -76.5 -15.31 59.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.31 1.053 . . . . 73.3 111.218 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.53 -44.52 62.07 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.915 1.686 . . . . 71.13 109.885 -153.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -125.07 5.06 7.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.202 0.601 . . . . 75.34 111.933 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 52.15 36.75 19.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.939 0.791 . . . . 64.33 111.941 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 p -147.43 142.42 26.99 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.378 -1.451 . . . . 43.23 107.571 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.8 p90 -142.86 170.2 16.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.544 1.065 . . . . 75.32 110.349 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.26 137.93 24.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 107.008 -1.478 . . . . 74.21 107.008 160.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.25 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.314 1.045 . . . . 72.03 108.574 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 134.72 -168.19 23.67 Favored Glycine 0 N--CA 1.462 0.403 0 CA-C-N 118.555 0.616 . . . . 34.44 111.729 175.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.42 169.54 8.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.348 1.574 . . . . 74.34 110.318 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.31 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 C-N-CA 128.018 2.527 . . . . 63.31 113.272 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.479 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.423 1.089 . . . . 73.41 112.146 169.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.73 177.11 23.92 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 125.596 1.57 . . . . 65.24 111.432 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.549 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.0 m-85 -117.81 139.92 50.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 126.426 1.89 . . . . 74.43 108.104 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.39 99.31 9.98 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.572 3.149 . . . . 71.12 107.604 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.06 3.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.133 0.573 . . . . 65.41 110.246 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.43 148.93 49.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.227 -1.027 . . . . 72.23 108.227 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -120.76 166.74 13.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.06 -1.459 . . . . 55.11 107.06 158.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 92.2 p . . . . . 0 N--CA 1.441 -0.922 0 C-N-CA 119.777 -0.769 . . . . 42.43 111.1 171.05 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.672 0 N-CA-C 108.362 -0.977 . . . . 74.55 108.362 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.78 153.48 21.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.702 2.401 . . . . 72.32 109.608 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.66 163.3 28.02 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.37 0.668 . . . . 40.43 111.71 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -54.96 -38.59 67.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.088 1.355 . . . . 74.44 113.252 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -96.74 9.3 42.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.946 1.698 . . . . 71.14 112.412 -165.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.22 124.13 85.84 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.677 -1.601 . . . . 73.45 106.677 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -55.46 126.31 22.08 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.16 2.574 . . . . 52.32 111.287 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 pt -98.4 119.33 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.688 -1.227 . . . . 61.24 107.688 162.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -78.13 78.99 4.6 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.326 1.45 . . . . 72.33 107.942 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 mt -55.86 164.18 1.23 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 170.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.1 p -54.06 -36.16 62.81 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.168 0.44 . . . . 74.23 111.317 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.13 -22.55 48.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.413 0.685 . . . . 71.31 112.188 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.02 40.54 7.99 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.08 1.324 . . . . 65.44 110.774 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -10.35 52.31 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.906 1.076 . . . . 71.12 113.906 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.317 13.5 mm 52.23 30.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 125.575 2.607 . . . . 72.52 112.077 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.39 149.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.829 -1.532 . . . . 74.43 108.692 -172.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -62.17 122.7 16.23 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.306 -1.739 . . . . 60.52 106.306 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -50.14 -37.85 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.437 1.095 . . . . 64.53 111.087 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 -0.9 89.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.825 -0.986 . . . . 52.04 114.205 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.27 -47.56 6.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.758 1.779 . . . . 75.34 110.365 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -47.14 -53.49 12.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.945 1.298 . . . . 61.22 110.46 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 77' ' ' VAL . 44.6 t -67.1 -42.67 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.525 -0.761 . . . . 52.11 110.486 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -68.2 -24.82 64.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 119.042 -1.063 . . . . 74.53 111.302 -176.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -41.44 70.47 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.135 0.974 . . . . 73.21 110.628 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.85 -40.06 66.01 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.341 -1.314 . . . . 72.12 108.933 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.404 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 11.2 m-85 -56.05 -37.18 68.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.414 1.915 . . . . 72.14 112.436 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -31.36 64.32 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.718 -1.134 . . . . 44.34 111.275 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -90.23 -49.34 6.61 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 121.195 1.816 . . . . 62.15 108.28 -178.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 2.5 m-30 -94.44 39.31 1.09 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.773 2.029 . . . . 63.42 108.333 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -57.02 -31.92 65.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.065 1.346 . . . . 73.22 111.95 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -61.5 -35.51 77.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.722 1.209 . . . . 64.31 110.996 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.12 9.45 40.86 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.092 1.357 . . . . 64.11 112.105 -165.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.7 124.0 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.829 -1.545 . . . . 64.42 106.829 167.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -122.37 114.79 21.24 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.07 1.748 . . . . 74.45 107.496 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.64 146.72 28.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.004 -1.109 . . . . 73.44 108.004 168.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.47 172.46 13.76 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.835 0.854 . . . . 75.44 108.811 168.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.39 73.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 44.42 109.338 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.5 -6.28 35.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.785 1.234 . . . . 34.14 112.499 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.71 15.67 33.55 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.136 -0.977 . . . . 74.13 114.698 156.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.01 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.481 1.912 . . . . 53.43 111.892 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.77 121.43 2.19 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.064 2.269 . . . . 63.44 109.174 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -130.76 164.73 24.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.383 1.873 . . . . 60.54 109.906 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 33' ' ' PHE . 21.4 mt -142.26 138.98 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.291 2.236 . . . . 74.25 106.191 169.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.61 129.52 36.53 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.56 1.544 . . . . 60.24 109.719 166.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.74 16.84 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.264 1.425 . . . . 74.31 111.034 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.4 57.33 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.973 -1.079 . . . . 54.22 113.392 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -77.84 -10.78 59.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.928 1.364 . . . . 64.15 113.311 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -63.58 -33.65 76.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.663 1.12 . . . . 74.42 109.479 168.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 51.14 13.84 0.18 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.93 2.092 . . . . 71.43 113.183 -166.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mt -61.12 126.34 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.29 1.036 . . . . 73.33 108.472 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -83.33 144.22 29.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.637 1.175 . . . . 75.43 110.389 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.2 tt -127.75 150.78 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.792 1.637 . . . . 63.32 107.663 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -62.26 118.34 7.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.015 -1.846 . . . . 62.44 106.015 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -141.92 146.59 35.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.603 -2.74 . . . . 60.32 103.603 -172.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -116.12 126.99 54.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 126.211 1.805 . . . . 74.45 106.128 -171.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.82 121.23 16.87 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.266 -1.013 . . . . 74.12 108.266 172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -85.39 -20.29 30.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.665 0.786 . . . . 75.25 112.084 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -34.1 65.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.816 0.846 . . . . 65.51 111.033 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -135.93 8.83 3.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.683 0.793 . . . . 73.24 112.141 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.6 mt 57.02 47.84 16.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.8 1.64 . . . . 71.42 112.51 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 148.48 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.372 1.469 . . . . 64.13 108.964 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.6 144.2 11.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.033 -1.84 . . . . 71.12 106.033 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.66 -167.96 2.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.116 2.567 . . . . 64.42 107.052 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.8 153.4 42.56 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.258 -2.126 . . . . 64.15 105.258 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -153.99 162.6 41.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.127 1.371 . . . . 62.24 108.14 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -85.64 179.45 7.09 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.854 1.262 . . . . 72.51 112.828 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.62 155.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.917 2.087 . . . . 72.33 106.725 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.49 -42.68 1.63 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.868 0.867 . . . . 74.44 111.706 -170.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.622 ' CB ' HG21 ' A' ' 156' ' ' THR . 1.3 mtm-85 -127.08 -166.05 1.55 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.57 -0.9 . . . . 73.22 108.57 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -157.84 161.86 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.702 -1.962 . . . . 65.22 105.702 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 156' ' ' THR . 90.7 m95 -147.08 143.14 28.11 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.536 0.734 . . . . 75.23 110.025 178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.4 143.62 26.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.237 0.926 . . . . 75.31 109.538 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -146.38 162.02 39.11 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.847 -1.538 . . . . 75.34 106.847 166.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -85.1 156.01 21.25 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.133 -0.979 . . . . 65.42 108.694 172.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -136.32 163.35 30.64 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.009 2.124 . . . . 71.11 108.307 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 p -167.12 104.29 0.55 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.991 -1.485 . . . . 71.34 106.991 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.73 27.22 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.41 -0.9 . . . . 55.34 113.791 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 94.77 4.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.537 1.535 . . . . 64.21 109.459 -168.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.44 153.01 29.97 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 mm -79.06 131.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.386 1.874 . . . . 54.14 106.974 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -116.83 82.35 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.578 -1.638 . . . . 53.12 106.578 166.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -61.95 137.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.856 -1.905 . . . . 74.23 105.856 162.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -110.8 168.13 9.71 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.645 -1.613 . . . . 73.51 106.645 162.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.76 170.87 15.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.878 1.217 . . . . 75.42 109.361 159.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -58.32 -24.52 59.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.359 1.436 . . . . 74.22 111.962 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.21 -0.9 2.79 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.643 1.177 . . . . 71.33 112.259 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.93 13.75 8.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 128.149 2.58 . . . . 71.24 111.927 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 157.47 28.01 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 124.848 1.259 . . . . 65.41 108.205 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.71 171.17 17.23 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.661 1.585 . . . . 61.32 107.408 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.538 HG23 ' CE1' ' A' ' 171' ' ' PHE . 5.1 pt -147.53 173.09 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 126.664 1.986 . . . . 44.05 107.908 -174.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 104.5 4.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.422 -0.955 . . . . 71.33 108.422 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.15 166.97 27.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.302 1.041 . . . . 63.22 111.442 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -89.52 1.48 55.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 116.157 1.91 . . . . 35.34 116.157 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 96.33 -23.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 1 C-N-CA 138.787 6.835 . . . . 74.55 111.639 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -113.58 37.58 3.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.937 2.495 . . . . 72.31 110.238 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -101.0 139.36 20.44 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 125.04 1.336 . . . . 65.22 108.963 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.54 123.54 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.505 2.137 . . . . 62.25 110.53 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.94 173.55 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 61.34 109.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -119.62 139.71 51.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.103 . . . . 63.34 111.084 -168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.13 162.81 19.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.858 1.263 . . . . 72.54 110.103 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.404 ' HB3' HD21 ' A' ' 137' ' ' LEU . 94.4 p -95.48 105.99 18.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.261 0.351 . . . . 65.22 111.04 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -81.12 78.3 7.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.448 -1.686 . . . . 62.22 106.448 162.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 6.2 m 60.22 6.04 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.522 2.045 . . . . 75.51 116.522 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.32 -31.32 1.56 Allowed Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.712 -1.242 . . . . 72.24 110.057 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.7 142.7 36.89 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.362 -2.088 . . . . 64.51 105.362 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.05 132.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.577 -0.898 . . . . 60.32 108.577 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.24 152.31 48.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.81 1.644 . . . . 73.13 106.677 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.19 115.75 30.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.029 1.332 . . . . 73.44 109.61 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.52 175.26 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.745 0.818 . . . . 73.44 110.901 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -79.97 143.17 34.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.587 1.155 . . . . 71.21 109.226 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.0 -29.1 41.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.629 0.974 . . . . 64.33 113.629 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -24.26 65.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.14 -0.975 . . . . 75.53 112.661 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -86.74 -27.4 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.372 1.069 . . . . 74.13 111.927 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -71.43 61.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 127.921 2.488 . . . . 55.31 109.836 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -178.08 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.01 1.324 . . . . 74.22 108.509 170.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.48 0.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 127.364 2.266 . . . . 63.45 113.9 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.39 -18.88 70.25 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 117.506 -1.719 . . . . 11.25 111.989 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.56 169.82 12.08 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.214 2.007 . . . . 54.05 111.67 -163.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -124.0 119.09 28.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 126.256 1.822 . . . . 65.42 108.153 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -93.74 127.46 45.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.149 0.979 . . . . 73.24 108.776 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -67.8 115.58 7.52 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.906 -1.146 . . . . 75.42 107.906 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.4 154.42 59.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.386 1.074 . . . . 73.22 111.476 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 164' ' ' ILE . 50.7 Cg_exo -59.78 141.35 96.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.94 2.427 . . . . 74.32 110.138 172.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -113.48 -173.98 2.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.786 -1.19 . . . . 72.41 107.786 153.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -37.79 -64.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.189 1.796 . . . . 74.33 111.22 -168.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -120.59 -5.44 9.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.772 0.829 . . . . 74.34 112.122 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 p -125.33 -178.58 4.27 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.668 1.587 . . . . 60.24 111.67 -164.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 tp -100.39 147.25 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 O-C-N 120.171 -1.581 . . . . 53.25 107.574 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -137.94 -175.0 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.751 2.02 . . . . 52.23 107.938 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 108' ' ' SER . 18.9 mt -129.47 157.93 40.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.266 1.427 . . . . 41.25 107.649 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -153.87 159.3 41.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.692 1.597 . . . . 75.15 108.14 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.8 147.7 23.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.07 0.948 . . . . 63.25 110.605 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.97 -0.67 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.998 1.111 . . . . 72.42 113.998 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 26.51 -77.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.044 2.938 . . . . 71.53 117.062 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 141' ' ' ILE . 17.0 tppt? -103.21 117.29 34.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.049 1.74 . . . . 71.43 108.028 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.32 131.2 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.184 -1.043 . . . . 35.12 108.184 169.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -153.06 -179.45 7.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.942 1.697 . . . . 74.25 107.494 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.29 133.85 39.31 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.007 -0.738 . . . . 40.45 109.007 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.98 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.682 1.193 . . . . 64.31 108.494 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.29 113.39 14.34 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.447 -0.946 . . . . 62.11 108.447 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -128.72 135.32 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.074 1.35 . . . . 73.41 108.582 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -133.77 29.6 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.272 -0.893 . . . . 60.35 109.684 -161.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -126.86 -163.91 11.59 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.362 1.934 . . . . 42.24 111.411 -161.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -87.0 153.41 21.57 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.021 -1.281 . . . . 74.23 110.752 173.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.2 153.63 34.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 126.729 2.012 . . . . 72.34 107.877 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -142.47 154.38 44.48 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.344 1.058 . . . . 51.41 108.985 -170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.95 163.94 27.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.167 1.387 . . . . 52.51 108.288 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.73 140.13 42.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.943 1.701 . . . . 72.33 111.164 -163.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 78' ' ' TRP . 48.4 p -91.37 -46.68 7.89 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.576 0.954 . . . . 74.41 113.576 -156.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 2.7 t 23.12 64.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 130.111 3.364 . . . . 42.32 113.97 175.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.1 0.05 15.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.486 1.114 . . . . 73.41 113.511 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -34.91 41.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.352 -0.981 . . . . 60.13 108.352 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -127.94 -8.91 5.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.203 1.401 . . . . 55.41 113.712 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.57 23.96 14.25 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.475 1.91 . . . . 63.23 111.154 -175.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 p -141.36 164.84 29.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.342 2.657 . . . . 60.21 107.248 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 5.6 p90 -151.39 175.92 11.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.824 1.193 . . . . 72.44 110.372 165.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 62' ' ' PHE . 30.1 mm -109.37 126.17 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 74.21 108.831 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.21 160.46 43.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.729 0.812 . . . . 71.11 110.241 169.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.13 -165.11 25.5 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.167 -1.573 . . . . 31.11 109.167 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -100.72 172.83 6.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.111 1.455 . . . . 74.34 110.267 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.11 -85.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.177 2.591 . . . . 54.32 111.972 -171.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.88 -12.1 8.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.912 1.285 . . . . 74.55 112.878 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.06 174.59 39.31 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 122.877 1.265 . . . . 65.22 112.628 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.7 m-85 -121.18 154.5 36.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.454 2.702 . . . . 64.35 106.801 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.67 32.58 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.355 -1.35 . . . . 53.13 107.355 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.59 174.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 118.579 0.627 . . . . 74.41 109.651 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -72.42 155.2 40.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.111 0.564 . . . . 74.53 109.672 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.11 49.3 1.36 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.697 2.399 . . . . 60.45 108.644 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.538 0.5 0 O-C-N 120.098 -1.626 . . . . 61.54 107.159 176.301 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.391 0 N-CA-C 106.069 -1.826 . . . . 61.33 106.069 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.01 157.54 24.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.177 0.991 . . . . 63.01 109.557 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -68.38 -176.67 0.79 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.187 1.395 . . . . 73.14 110.947 169.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 14.4 t80 -84.67 -33.57 23.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.547 1.139 . . . . 65.13 113.169 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.81 38.53 1.71 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 71.03 110.197 -162.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -117.19 112.61 39.65 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 125.039 1.336 . . . . 74.12 110.947 -153.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.56 127.41 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.99 1.793 . . . . 74.32 113.557 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -100.36 24.53 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.626 1.97 . . . . 53.14 112.95 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 29.78 66.09 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.341 2.257 . . . . 74.43 115.403 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -53.17 155.59 2.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.315 -0.866 . . . . 60.2 111.507 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -43.62 61.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.51 1.124 . . . . 74.13 109.172 169.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.09 -47.34 77.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.105 0.962 . . . . 64.14 110.722 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.81 26.91 3.7 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.767 1.175 . . . . 74.3 112.65 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.68 -27.61 66.55 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.264 1.532 . . . . 72.32 114.118 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 mm 48.17 63.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.861 1.264 . . . . 73.24 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 147.97 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.903 1.281 . . . . 71.33 108.121 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -65.27 122.69 17.69 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.97 -1.493 . . . . 22.14 106.97 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.7 tt -46.55 -44.75 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 124.995 1.318 . . . . 63.11 110.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -70.54 -26.3 74.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-O 118.577 -1.124 . . . . 73.01 111.685 -173.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.41 -53.17 14.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.461 1.631 . . . . 63.33 109.716 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -43.87 -48.77 8.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.779 1.232 . . . . 72.41 109.555 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 77' ' ' VAL . 60.1 t -73.88 -44.9 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 118.361 -0.828 . . . . 63.55 111.645 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -65.03 -32.82 74.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.737 2.062 . . . . 71.2 111.585 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -40.49 65.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.714 1.606 . . . . 73.43 110.965 171.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -76.74 -36.66 56.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.492 1.517 . . . . 65.11 109.632 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -63.66 -41.77 98.15 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.334 1.879 . . . . 74.2 110.774 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -24.42 64.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.497 -0.752 . . . . 55.43 111.281 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 5.5 mttt -82.35 -59.19 2.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.996 -1.483 . . . . 54.54 106.996 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 8.0 m-85 -100.63 41.84 1.15 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.943 0.897 . . . . 61.34 109.949 -162.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -32.2 67.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.564 0.745 . . . . 63.32 111.772 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -73.83 -22.17 59.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.832 0.678 . . . . 75.2 112.832 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 t -90.04 -1.41 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.62 1.568 . . . . 64.14 111.59 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 96.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 124.744 1.217 . . . . 53.43 107.793 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -79.99 161.5 25.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.059 -1.089 . . . . 73.12 108.059 162.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -126.17 154.31 43.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.433 -1.692 . . . . 73.25 106.433 160.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.41 179.38 7.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.009 0.924 . . . . 62.24 110.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.84 -25.54 63.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.4 0.68 . . . . 73.22 111.442 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -13.85 59.81 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.873 -1.142 . . . . 62.25 111.346 165.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.96 55.69 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 120.441 -1.412 . . . . 53.04 112.35 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -52.35 -83.46 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.471 1.909 . . . . 71.21 112.874 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.82 107.32 0.64 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-O 117.977 -1.457 . . . . 75.44 110.131 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -123.31 162.34 22.89 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.107 1.453 . . . . 55.25 111.447 170.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mt -146.73 132.33 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.414 2.686 . . . . 71.44 103.952 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 126.8 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.104 -1.072 . . . . 75.44 108.104 164.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.83 13.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.142 1.377 . . . . 73.24 111.6 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.46 -31.57 36.32 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.291 -0.88 . . . . 75.53 113.472 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.37 -19.41 65.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.741 1.216 . . . . 63.44 112.721 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.81 -25.89 66.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.832 0.742 . . . . 62.21 110.87 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.5 36.02 25.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.752 1.221 . . . . 75.11 111.992 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -89.34 135.08 26.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.73 154.27 19.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.445 0.64 . . . . 73.31 109.305 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -132.89 148.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 125.663 1.585 . . . . 74.03 107.911 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -75.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.688 1.995 . . . . 74.22 110.349 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.16 173.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.047 2.539 . . . . 73.52 108.454 165.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -136.75 140.75 42.8 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.195 -0.94 . . . . 61.02 109.854 -174.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -87.5 121.01 29.39 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 126.064 1.745 . . . . 63.53 109.091 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -70.76 -27.81 64.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.72 0.808 . . . . 74.21 112.076 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -50.5 -42.03 54.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.075 1.35 . . . . 71.32 110.897 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -134.1 16.78 3.8 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.622 0.769 . . . . 55.14 111.357 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.28 49.57 17.6 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.771 1.228 . . . . 74.35 112.464 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.54 154.48 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.555 1.542 . . . . 74.43 109.529 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.98 145.77 8.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.52 -1.289 . . . . 74.01 107.52 165.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -141.06 -168.5 2.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.545 1.938 . . . . 71.43 107.774 163.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -92.24 149.14 21.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.439 -0.948 . . . . 65.32 108.439 153.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -154.13 152.69 30.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.627 2.371 . . . . 73.32 106.571 167.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -84.36 175.66 9.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.428 1.091 . . . . 74.24 109.938 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.69 141.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.829 2.052 . . . . 62.21 106.324 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 158' ' ' GLU . 1.9 mm? -111.74 -45.67 3.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.703 0.401 . . . . 63.53 112.03 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.38 144.83 49.83 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.53 -0.915 . . . . 55.54 108.53 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -108.87 158.7 8.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.393 1.477 . . . . 74.42 108.054 176.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -132.05 152.75 51.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.208 1.003 . . . . 75.42 108.953 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -149.53 152.53 35.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 165.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -150.08 167.96 25.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.094 1.757 . . . . 64.3 106.946 166.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -105.41 143.97 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.044 -1.035 . . . . 75.22 108.223 171.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -142.64 156.19 45.04 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.3 0.5 . . . . 74.54 111.25 -160.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -156.94 125.85 5.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 75.43 109.788 164.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.51 179.52 37.96 Favored Glycine 0 N--CA 1.465 0.587 0 N-CA-C 110.184 -1.167 . . . . 54.1 110.184 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -81.03 140.04 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.876 -0.779 . . . . 62.22 110.236 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.65 157.87 32.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.161 1.384 . . . . 72.53 107.625 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mm -79.67 141.6 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.678 1.191 . . . . 72.32 108.77 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 146' ' ' VAL . 55.7 mttt -123.66 86.28 2.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.341 1.456 . . . . 71.24 107.519 158.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 140' ' ' VAL . 31.8 mt -62.77 101.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.521 -1.659 . . . . 55.44 106.521 148.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.38 172.99 13.04 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.899 -1.519 . . . . 73.21 106.899 163.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -138.56 171.04 14.95 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.704 -1.247 . . . . 74.22 108.574 163.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -71.15 -25.17 62.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.539 2.336 . . . . 55.03 110.938 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -59.86 -11.24 5.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.93 1.692 . . . . 64.44 111.578 164.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 63.15 33.05 14.75 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.173 2.989 . . . . 72.23 111.617 -167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' CG ' ' A' ' 95' ' ' ARG . 2.1 mtt-85 -75.43 173.43 10.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 118.231 -1.388 . . . . 73.41 109.474 161.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.39 164.29 19.7 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.983 1.713 . . . . 75.45 106.522 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.52 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -132.25 -179.93 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.068 -1.086 . . . . 75.51 108.068 165.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.2 m -149.87 118.92 6.71 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.011 -1.68 . . . . 64.44 108.949 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 97' ' ' ILE . 1.1 pt? -166.25 172.13 11.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.963 -1.017 . . . . 65.32 111.261 -169.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 m -79.43 147.61 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.095 -1.076 . . . . 71.12 108.095 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -10.21 54.29 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.165 1.172 . . . . 72.53 114.165 -161.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.4 38.19 3.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.661 2.785 . . . . 65.02 110.156 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -82.63 140.95 44.43 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.071 -0.966 . . . . 52.44 109.525 159.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.02 118.53 5.63 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.124 3.216 . . . . 70.2 111.274 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.65 -166.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 120.876 -1.14 . . . . 74.54 110.128 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -135.07 134.68 40.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.747 1.219 . . . . 65.14 108.733 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.31 166.58 28.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 126.107 1.763 . . . . 73.41 107.944 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -89.9 143.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.096 0.475 . . . . 74.22 110.309 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -115.02 86.74 2.51 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.224 -1.769 . . . . 73.43 106.224 155.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.65 17.76 8.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.097 0.959 . . . . 63.32 113.407 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.43 -26.85 4.3 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.652 1.12 . . . . 71.05 111.187 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 148.62 32.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.557 -1.646 . . . . 60.55 106.557 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.7 t -85.32 114.46 25.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.558 -1.275 . . . . 73.2 107.558 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.46 40.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.89 -0.782 . . . . 71.22 108.89 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.67 120.02 36.22 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.87 2.068 . . . . 73.05 106.996 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.65 175.26 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.691 1.596 . . . . 54.43 109.803 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -78.03 144.5 36.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.53 -0.544 . . . . 70.33 109.53 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.03 22.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 71.12 112.201 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -17.29 62.99 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.151 1.167 . . . . 71.1 114.151 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.6 mtm -96.99 -15.24 21.18 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.161 0.985 . . . . 74.35 112.071 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.61 63.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.949 1.699 . . . . 62.43 109.217 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.63 176.82 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 63.33 109.291 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.36 -37.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.278 1.831 . . . . 65.11 112.721 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.79 11.03 63.09 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.419 -1.767 . . . . 62.35 114.185 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.15 169.9 8.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 121.018 2.409 . . . . 71.04 108.814 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 137' ' ' LEU . 29.4 m-85 -118.16 105.42 11.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 123.907 0.883 . . . . 73.45 109.182 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.0 125.69 39.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 62.43 108.795 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.63 123.46 19.36 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 72.53 107.067 173.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.85 157.74 56.54 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.694 1.598 . . . . 74.54 111.883 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.97 159.72 50.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.387 2.725 . . . . 74.45 111.8 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -141.81 -178.04 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.626 -1.62 . . . . 73.23 106.626 156.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -24.74 -67.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.318 2.647 . . . . 63.04 113.266 -170.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.68 -10.0 9.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.185 0.994 . . . . 31.5 113.447 165.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 p -131.3 148.15 52.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.818 1.19 . . . . 74.31 111.571 -162.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.94 143.31 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.263 -1.384 . . . . 73.42 107.263 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -142.91 -176.91 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.813 1.645 . . . . 74.11 108.391 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 126' ' ' TYR . 8.8 mt -125.38 165.46 18.34 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.413 1.101 . . . . 71.52 108.538 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -154.56 157.71 38.68 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 103.593 -2.743 . . . . 71.33 103.593 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 7.8 mt-10 -61.39 -177.7 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.026 1.33 . . . . 60.24 109.279 168.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 89' ' ' ILE 0.259 72.0 t -112.6 2.56 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.793 1.237 . . . . 75.54 111.904 176.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.1 pt 24.83 -70.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 130.422 3.489 . . . . 73.11 117.719 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.7 tptt -116.14 118.51 33.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.181 1.393 . . . . 65.43 107.462 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.43 119.53 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.998 -1.482 . . . . 65.23 106.998 156.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.14 -176.08 4.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.005 1.722 . . . . 75.32 107.816 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -130.76 159.93 35.84 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.155 -0.966 . . . . 52.12 109.868 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 88' ' ' LYS . 12.3 m -117.12 165.22 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.781 1.633 . . . . 61.2 107.794 171.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -122.7 71.02 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.086 1.354 . . . . 74.52 108.843 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.45 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.7 t80 -81.64 154.76 25.96 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.879 1.272 . . . . 74.52 110.798 -167.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.33 24.96 2.27 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.306 -0.871 . . . . 73.55 112.358 -172.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.58 -138.94 9.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 125.173 1.368 . . . . 62.44 111.942 -155.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -117.86 155.22 30.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.907 -1.146 . . . . 71.11 107.907 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.59 152.41 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.958 1.303 . . . . 74.41 109.928 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -142.57 168.81 18.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.062 1.345 . . . . 75.43 108.492 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -154.74 175.03 14.23 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.803 -1.184 . . . . 74.02 107.803 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 tp -135.14 119.39 17.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.781 1.173 . . . . 63.53 110.508 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.9 m -84.12 118.56 24.18 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.791 -0.818 . . . . 73.51 108.791 169.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 t -125.98 94.93 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.433 -2.062 . . . . 72.32 105.433 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.641 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.3 pt-20 -80.35 -8.65 59.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.336 -0.852 . . . . 73.54 113.236 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -88.55 -59.05 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.74 1.257 . . . . 74.02 108.454 -156.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.07 112.57 13.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 101.687 -3.449 . . . . 74.22 101.687 169.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.439 ' CG ' ' HA ' ' A' ' 176' ' ' SER . 23.8 m170 -69.31 50.39 0.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.606 1.962 . . . . 63.11 112.03 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -151.67 140.1 20.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.02 2.128 . . . . 54.04 108.697 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.81 178.79 8.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.077 1.351 . . . . 74.45 111.121 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 46.7 mm -112.19 135.79 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.481 -1.674 . . . . 74.41 106.481 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.08 159.85 43.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.682 -1.229 . . . . 71.41 107.682 160.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 140.47 -165.22 26.14 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.817 1.198 . . . . 73.13 111.043 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -110.91 170.65 7.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.365 1.078 . . . . 72.44 111.002 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.99 -80.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.146 2.578 . . . . 64.34 112.574 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.32 -3.95 8.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.477 . . . . 64.44 114.051 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 84.38 176.94 51.2 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 122.141 0.856 . . . . 51.11 111.927 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CE1' HG23 ' A' ' 97' ' ' ILE . 3.8 m-85 -127.76 146.86 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.187 2.595 . . . . 74.14 106.2 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.542 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -95.56 132.0 41.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 119.21 -0.424 . . . . 73.54 110.69 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 163' ' ' TYR . 5.4 m -145.71 167.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.19 0.996 . . . . 74.31 109.633 -169.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 71.3 m -63.02 142.81 58.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.167 1.787 . . . . 64.44 110.286 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -141.84 39.89 1.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.568 1.147 . . . . 75.42 111.623 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.439 ' HA ' ' CG ' ' A' ' 161' ' ' HIS . 70.9 m . . . . . 0 N--CA 1.457 -0.108 0 O-C-N 121.704 -0.622 . . . . 74.1 111.558 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.518 0 N-CA-C 108.024 -1.102 . . . . 73.43 108.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.49 151.82 21.78 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.253 1.421 . . . . 71.33 109.471 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.4 49.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.691 -0.686 . . . . 61.12 110.366 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -48.26 -31.51 6.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.651 1.98 . . . . 72.21 113.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -104.78 15.35 28.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.641 1.976 . . . . 74.31 112.23 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -79.46 114.24 43.65 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.551 -1.277 . . . . 72.54 107.551 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.02 136.33 29.37 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.422 2.748 . . . . 64.21 113.064 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.35 88.61 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.43 -1.322 . . . . 64.52 107.43 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -48.21 83.6 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.233 2.613 . . . . 73.43 113.347 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -65.44 163.97 14.76 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.243 1.017 . . . . 62.34 109.478 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 t -60.21 -39.77 87.74 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 119.027 -0.511 . . . . 50.3 109.812 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.9 -38.48 22.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.702 -0.799 . . . . 73.44 109.275 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.18 43.78 0.9 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 114.958 0.743 . . . . 74.53 114.958 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -8.66 23.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.135 1.902 . . . . 73.03 116.135 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.289 7.8 mm 61.49 25.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-O 124.648 2.166 . . . . 74.34 112.49 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 152.78 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 125.426 1.49 . . . . 74.54 108.915 -170.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.09 130.18 43.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.968 1.707 . . . . 75.12 108.851 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.7 tt -53.49 -33.43 21.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.23 1.412 . . . . 74.32 112.892 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -94.83 -13.67 52.36 Favored Glycine 0 C--O 1.219 -0.818 0 CA-C-O 117.28 -1.845 . . . . 40.1 112.782 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -73.47 -49.72 25.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.346 2.573 . . . . 65.24 109.073 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -49.2 -56.95 7.65 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.193 1.397 . . . . 74.23 109.568 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.671 HG22 ' HA2' ' A' ' 26' ' ' GLY . 34.4 m -67.6 -38.77 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 117.504 -1.236 . . . . 63.43 110.371 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -34.55 73.57 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 121.462 1.937 . . . . 61.43 111.334 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.1 pttt -52.25 -42.03 63.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.748 1.219 . . . . 75.02 111.249 171.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.465 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.8 m-85 -78.04 -47.25 18.81 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 117.703 -1.141 . . . . 62.23 110.507 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -53.86 -30.77 47.08 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.598 1.999 . . . . 64.42 112.358 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -57.94 4.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.528 1.531 . . . . 73.41 110.091 170.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -68.57 -58.33 4.44 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.802 -1.555 . . . . 73.13 106.802 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -86.81 40.17 0.89 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.494 1.517 . . . . 55.11 108.443 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -34.73 68.76 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.788 -1.195 . . . . 73.33 111.498 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.04 -28.19 65.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.272 0.471 . . . . 71.13 112.272 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.6 m -73.37 -2.1 20.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.721 0.637 . . . . 74.32 112.721 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.58 114.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.97 1.308 . . . . 71.15 109.433 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -114.06 113.33 24.6 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.492 -1.669 . . . . 74.3 106.492 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -73.45 142.18 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.045 -1.835 . . . . 70.3 106.045 164.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.96 176.78 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.571 -0.9 . . . . 64.44 108.571 159.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 -35.04 77.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.328 1.451 . . . . 73.52 112.306 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.2 -8.73 18.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.512 1.125 . . . . 72.52 112.67 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 7.82 64.37 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 127.939 2.685 . . . . 45.52 112.664 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.85 -83.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.977 1.711 . . . . 64.04 111.902 -160.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.48 101.49 1.13 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.623 -1.098 . . . . 52.32 111.805 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -108.16 163.35 13.24 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.598 0.823 . . . . 75.51 109.977 163.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.8 mt -145.45 143.54 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.427 1.891 . . . . 55.42 106.599 166.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.53 131.95 34.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.696 1.598 . . . . 53.45 111.148 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.82 -3.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.099 1.36 . . . . 75.24 112.768 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.95 -21.58 52.79 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 120.02 1.282 . . . . 54.11 114.627 -168.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -69.08 -5.41 21.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.759 1.224 . . . . 71.31 113.896 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.57 -19.29 62.01 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 119.649 -1.907 . . . . 74.33 112.201 164.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 m120 45.02 33.62 1.09 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.237 1.815 . . . . 72.05 112.576 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.56 169.04 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.595 1.958 . . . . 64.2 106.972 159.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.5 158.06 45.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.134 0.974 . . . . 72.31 109.151 166.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.03 157.14 33.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 126.138 1.775 . . . . 75.03 108.68 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 152.31 44.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.184 0.992 . . . . 75.2 108.56 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.1 p -147.53 -168.83 3.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 125.608 1.563 . . . . 63.22 106.96 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.853 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -152.3 137.71 17.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.066 -1.021 . . . . 64.4 108.742 177.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.6 114.9 18.88 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.426 -0.953 . . . . 72.42 108.426 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -61.83 -27.5 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.361 . . . . 74.23 111.25 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -35.67 -51.52 0.66 Allowed 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 129.324 3.05 . . . . 34.12 112.017 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.5 m -147.58 12.17 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.163 1.785 . . . . 74.54 110.694 -160.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt 52.82 41.93 31.82 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.447 1.499 . . . . 70.12 111.144 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.5 pt -96.61 173.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.261 1.024 . . . . 73.35 109.488 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.17 147.35 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.76 -1.57 . . . . 62.44 106.76 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -147.83 172.17 14.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 74.32 108.442 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -126.81 144.78 50.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.529 1.532 . . . . 63.31 107.168 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 161.56 35.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.312 0.645 . . . . 53.0 110.841 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -82.02 -35.24 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.239 0.829 . . . . 74.22 113.239 -170.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 mt 63.75 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 128.131 2.573 . . . . 63.44 109.685 -155.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 158' ' ' GLU . 29.2 mt -142.53 -65.63 0.4 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.227 1.811 . . . . 52.44 106.4 -164.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -127.75 164.27 22.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.6 1.56 . . . . 71.5 111.258 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.24 172.59 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.52 1.928 . . . . 70.01 109.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -141.58 137.48 31.96 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.298 1.039 . . . . 72.14 110.163 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -129.16 131.92 47.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.043 1.337 . . . . 64.23 110.989 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -141.92 176.28 9.06 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 72.35 109.593 166.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.75 148.16 31.93 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.741 1.216 . . . . 75.24 109.268 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -142.75 160.06 41.04 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.231 0.923 . . . . 73.42 112.677 -167.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.79 109.67 1.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.32 1.448 . . . . 63.24 110.441 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.31 -171.45 35.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.874 1.216 . . . . 74.43 112.426 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -90.07 151.85 21.43 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.949 -1.324 . . . . 72.42 110.729 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.6 mt -130.77 153.94 48.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.104 1.362 . . . . 73.34 108.941 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.98 130.85 35.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.396 -1.335 . . . . 53.21 107.396 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -121.51 77.94 1.39 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.459 1.504 . . . . 63.02 107.304 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 140' ' ' VAL . 30.0 mt -70.2 103.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.775 2.03 . . . . 74.44 107.594 166.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -85.1 163.76 18.59 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.106 -1.442 . . . . 72.22 107.106 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -136.38 167.76 20.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.389 0.995 . . . . 73.41 108.441 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.4 ttmt -58.67 -30.07 67.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.563 -1.336 . . . . 54.5 113.113 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -73.25 15.39 0.23 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.71 1.141 . . . . 72.11 112.283 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 92' ' ' LYS . 8.3 mmt180 47.69 35.47 4.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 128.776 2.83 . . . . 74.44 110.885 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.3 mtt-85 -73.63 167.32 21.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.002 -1.11 . . . . 73.33 108.002 157.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -170.93 161.12 6.93 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.46 1.904 . . . . 74.11 106.199 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -143.69 169.26 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 129.833 3.253 . . . . 65.33 109.268 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.431 ' C ' HD23 ' A' ' 99' ' ' LEU . 12.4 m -153.33 98.56 2.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.543 1.537 . . . . 71.22 110.564 -175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -159.64 173.25 16.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.733 1.613 . . . . 74.42 109.921 -170.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -68.83 167.93 14.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.267 1.027 . . . . 71.31 112.619 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.09 -46.61 67.33 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.841 -0.537 . . . . 75.12 110.608 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.1 38.87 1.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.439 -0.948 . . . . 64.2 108.439 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 99' ' ' LEU . 49.6 t-80 -84.26 134.62 42.84 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.315 -0.994 . . . . 73.24 108.315 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.48 133.62 38.0 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.258 1.972 . . . . 72.32 111.111 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 178.78 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.825 1.65 . . . . 73.12 108.554 167.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -116.48 142.65 46.59 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.572 -0.705 . . . . 72.34 109.704 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 121' ' ' VAL . 2.5 pp -133.77 165.15 32.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.44 1.496 . . . . 73.04 109.52 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 133.44 40.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.922 1.289 . . . . 71.41 107.91 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -122.66 74.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.109 1.364 . . . . 64.24 107.518 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m 65.85 7.64 4.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.975 1.31 . . . . 74.51 113.679 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.3 -9.71 4.4 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.312 0.958 . . . . 51.41 112.053 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -101.3 117.52 35.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.042 -1.836 . . . . 71.21 106.042 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.07 126.54 28.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.404 -1.332 . . . . 64.5 107.404 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.91 140.5 49.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.074 1.749 . . . . 74.11 107.084 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.15 131.61 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.115 -1.068 . . . . 74.42 108.115 166.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.2 pt -145.59 -167.09 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.78 2.032 . . . . 73.43 107.997 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.76 143.5 27.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.887 1.275 . . . . 71.51 110.091 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.63 -35.67 42.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.213 1.405 . . . . 53.44 113.125 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -17.6 64.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.216 1.191 . . . . 71.25 114.216 -172.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -25.57 28.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.489 1.116 . . . . 63.32 111.575 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 107' ' ' ILE . 3.7 t -72.18 63.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 128.805 2.842 . . . . 72.31 110.492 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -78.63 -178.42 5.88 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.029 -1.044 . . . . 73.4 109.152 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.52 -13.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.309 1.843 . . . . 74.33 113.755 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.73 4.38 66.05 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.559 -1.69 . . . . 72.34 113.435 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.09 135.53 39.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 120.275 2.038 . . . . 72.31 106.657 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -76.87 122.48 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.772 -1.566 . . . . 75.55 106.772 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.65 147.49 6.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.541 -1.651 . . . . 75.43 106.541 164.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.87 136.33 35.36 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.517 -1.29 . . . . 71.34 107.517 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.407 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.4 pp -126.83 154.51 76.04 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 124.568 1.147 . . . . 74.5 111.608 172.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.6 150.49 31.56 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.562 2.175 . . . . 75.0 108.548 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -123.69 -171.05 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.148 -1.797 . . . . 73.43 106.148 161.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -40.63 -68.58 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.311 1.445 . . . . 73.32 112.72 -168.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -120.95 -1.37 9.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.859 1.664 . . . . 72.54 111.266 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 64.3 p -139.94 165.51 27.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.131 0.878 . . . . 75.44 111.199 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -79.33 155.03 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.431 -1.322 . . . . 72.25 107.431 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.42 -178.04 5.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.272 1.429 . . . . 73.22 107.307 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.64 149.39 47.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.387 -1.709 . . . . 72.24 106.387 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -147.91 131.37 16.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.193 1.797 . . . . 65.32 106.729 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -62.44 157.2 20.69 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.211 0.46 . . . . 73.23 109.951 -176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 89' ' ' ILE . 78.7 t -93.76 2.1 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.993 1.717 . . . . 73.14 111.807 -171.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt 24.11 -86.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 128.985 2.914 . . . . 60.23 115.366 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -97.03 109.41 22.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.35 1.46 . . . . 72.41 107.44 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 p -110.76 119.07 58.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.883 -1.154 . . . . 61.45 107.883 164.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -133.77 -178.54 5.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.774 1.63 . . . . 75.34 108.558 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.66 136.1 52.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.084 0.954 . . . . 75.12 108.485 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.4 m -94.04 162.17 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.102 -1.073 . . . . 74.0 108.102 167.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 151.09 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.226 1.011 . . . . 73.42 108.488 159.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -159.07 131.8 6.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.513 1.051 . . . . 74.1 109.851 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -142.35 59.71 1.45 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.204 -0.935 . . . . 74.23 110.048 -167.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.96 -131.82 3.33 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.168 1.366 . . . . 72.31 112.703 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -114.84 161.7 17.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.074 1.35 . . . . 64.31 109.438 168.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.92 156.04 39.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 125.464 1.505 . . . . 72.31 109.05 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.406 ' CD2' HG21 ' A' ' 29' ' ' VAL . 4.7 m-85 -146.53 159.29 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.509 -0.923 . . . . 74.34 108.509 -168.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -148.38 173.5 13.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.101 -1.074 . . . . 73.12 108.101 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -131.73 134.92 46.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.226 1.41 . . . . 73.21 109.324 -163.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.3 m -70.85 -50.64 33.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 118.562 -0.732 . . . . 72.44 112.096 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 t 24.58 68.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.561 2.745 . . . . 74.1 111.385 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 75' ' ' LEU . 7.6 pt-20 -73.35 -6.16 44.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.255 1.026 . . . . 74.12 112.516 -166.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.88 -58.59 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.083 1.753 . . . . 75.04 108.874 -163.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -119.36 -1.12 10.81 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.024 1.33 . . . . 70.24 112.923 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 58.67 28.3 17.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.536 1.535 . . . . 73.22 112.17 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.423 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 22.2 p -141.64 140.82 33.36 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.378 -1.451 . . . . 72.31 111.208 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.502 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -134.89 175.16 9.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.705 1.202 . . . . 65.22 111.717 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.2 mm -107.14 122.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 N-CA-C 106.95 -1.5 . . . . 71.1 106.95 168.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.48 160.33 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.511 0.725 . . . . 53.54 109.245 170.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 137.37 -167.34 24.77 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 109.865 -1.294 . . . . 64.13 109.865 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -112.3 167.26 10.57 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 121.332 -1.099 . . . . 75.33 109.277 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 64.62 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.226 1.811 . . . . 74.11 112.38 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.04 -15.73 7.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.488 1.04 . . . . 72.14 112.787 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 174.6 46.61 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 123.286 1.492 . . . . 71.22 113.254 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.586 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -127.32 147.28 50.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.186 2.594 . . . . 73.23 106.949 -172.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.853 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -91.62 112.66 24.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.903 -1.517 . . . . 74.22 106.903 173.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.33 175.97 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.888 1.675 . . . . 74.13 109.045 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -61.08 138.59 58.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.842 0.857 . . . . 72.24 110.18 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -124.18 57.93 1.21 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 128.976 2.91 . . . . 65.24 107.473 169.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 105.315 -2.105 . . . . 61.43 105.315 -171.85 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 109.518 -0.549 . . . . 63.43 109.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -98.51 160.98 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.431 1.892 . . . . 71.5 110.233 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 154.76 30.64 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 123.211 0.605 . . . . 43.31 111.247 170.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -50.33 -32.09 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.353 1.861 . . . . 72.42 114.494 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -105.45 12.73 31.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.584 . . . . 70.43 112.946 -164.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -79.81 132.62 60.43 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.769 1.227 . . . . 71.52 108.974 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.49 149.55 90.55 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.551 2.834 . . . . 72.04 113.732 162.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 pt -114.47 -5.15 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.143 1.777 . . . . 73.45 112.862 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 55.53 73.38 0.43 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.452 1.024 . . . . 74.12 111.342 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.44 159.64 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.676 -0.64 . . . . 42.22 109.364 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 m -56.56 -34.03 66.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.379 -0.819 . . . . 73.44 112.247 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -86.93 -28.98 22.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.694 0.679 . . . . 72.03 110.295 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.05 41.32 1.97 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.717 1.151 . . . . 72.12 114.493 166.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.88 -27.14 62.99 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 115.209 1.559 . . . . 74.12 115.209 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mm 45.77 73.97 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.564 2.345 . . . . 71.34 108.69 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 174.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.791 2.036 . . . . 64.41 108.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.4 135.59 33.44 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.187 1.395 . . . . 73.32 107.811 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 tt -55.38 -28.75 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.079 -1.013 . . . . 72.25 112.08 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.86 -14.51 57.86 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 116.465 -2.297 . . . . 60.2 114.845 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -66.2 -50.01 65.32 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.122 2.461 . . . . 74.51 108.327 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -56.54 -59.17 5.38 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.626 1.97 . . . . 65.42 108.47 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 77' ' ' VAL . 69.1 t -56.77 -47.33 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.135 -0.484 . . . . 55.04 111.166 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -41.69 74.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.824 0.85 . . . . 75.11 110.809 -176.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -51.32 45.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.351 1.06 . . . . 64.43 109.328 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.64 -43.87 65.34 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.152 0.981 . . . . 73.13 108.449 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.4 m-85 -56.01 -38.74 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.323 1.42 . . . . 71.41 111.895 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -83.51 -22.45 32.48 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.507 1.123 . . . . 73.52 111.124 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 8.5 mttm -88.27 -58.65 2.48 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.969 -1.493 . . . . 53.42 106.969 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.5 m-30 -91.88 45.91 1.25 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 129.192 2.997 . . . . 75.2 108.313 -172.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -34.86 64.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.225 -0.922 . . . . 61.35 111.226 172.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -77.99 6.2 8.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.425 . . . . 73.43 112.979 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -106.29 -9.88 16.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 117.179 -1.391 . . . . 65.5 111.322 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.29 99.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 120.089 1.313 . . . . 73.02 108.618 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -85.2 159.84 20.03 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.72 -0.844 . . . . 54.31 108.72 160.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -136.48 133.74 36.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.889 -2.263 . . . . 71.13 104.889 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.77 177.3 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.755 0.659 . . . . 62.3 109.459 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -40.6 77.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.343 1.457 . . . . 50.13 112.237 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -19.54 63.43 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.362 -0.836 . . . . 61.54 111.46 174.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.43 65.1 1.7 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 107.775 -2.13 . . . . 75.04 107.775 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.64 -100.7 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.698 -1.964 . . . . 75.12 105.698 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.49 120.34 1.17 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.992 -2.043 . . . . 65.21 107.992 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -139.16 162.21 35.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.839 0.819 . . . . 72.43 110.092 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 33' ' ' PHE . 13.2 mt -143.93 139.99 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 126.508 1.923 . . . . 50.15 105.85 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.75 133.11 35.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.497 1.519 . . . . 71.15 109.163 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.32 4.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 125.841 1.657 . . . . 73.21 112.169 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.07 -10.82 7.52 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.855 1.207 . . . . 64.21 114.173 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.16 -15.74 56.42 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.337 -1.684 . . . . 63.1 112.507 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.45 -12.66 61.84 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.981 1.264 . . . . 75.2 113.407 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.53 -2.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.894 2.078 . . . . 72.02 113.705 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 141.33 16.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.169 1.387 . . . . 71.23 107.477 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.99 157.03 22.02 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.021 0.828 . . . . 60.13 109.547 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.23 144.54 28.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 126.645 1.978 . . . . 73.24 107.337 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -63.77 130.63 44.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.602 -1.629 . . . . 75.43 106.602 165.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.1 p -136.74 -169.18 2.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.632 -1.618 . . . . 64.3 106.632 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -146.17 143.76 29.5 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.31 -1.367 . . . . 65.03 107.31 171.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -86.41 116.22 24.42 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 124.964 1.306 . . . . 73.51 108.357 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.92 -27.98 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.676 0.79 . . . . 74.14 111.876 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.67 -22.42 65.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.637 0.653 . . . . 65.3 112.288 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m -137.57 3.0 2.5 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.746 1.218 . . . . 72.41 112.628 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.47 35.84 24.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.493 1.497 . . . . 54.23 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.47 154.91 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.203 1.801 . . . . 61.25 109.41 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.95 129.53 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.458 -1.682 . . . . 54.43 106.458 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -148.68 178.79 8.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.721 1.608 . . . . 74.14 108.443 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -105.77 150.1 25.84 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.465 -1.397 . . . . 74.22 109.287 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.6 160.11 39.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 169.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -92.4 -17.93 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.048 0.758 . . . . 63.0 113.048 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mt 58.7 147.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.883 2.073 . . . . 75.43 109.429 -160.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.14 -57.24 2.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.996 0.919 . . . . 73.23 108.7 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -129.76 150.76 50.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.364 0.983 . . . . 65.35 110.298 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -112.55 168.28 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 125.188 1.395 . . . . 71.43 109.204 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -135.44 153.2 51.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.177 0.991 . . . . 64.02 109.788 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.94 142.82 29.08 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.374 0.67 . . . . 70.04 109.612 169.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.47 156.64 47.91 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.403 -1.703 . . . . 70.32 106.403 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -84.24 159.18 21.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.117 -1.438 . . . . 74.22 107.117 165.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -139.9 153.94 47.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.196 0.998 . . . . 75.31 110.201 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -149.93 152.9 35.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 139.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.17 -171.66 32.13 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 109.394 -1.482 . . . . 64.13 109.394 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -89.5 120.31 30.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.757 -1.201 . . . . 64.33 107.757 170.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 160.58 15.96 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.617 -1.253 . . . . 71.4 107.617 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mm -79.34 140.71 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.162 1.385 . . . . 75.12 107.651 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -126.81 58.23 1.42 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.197 0.599 . . . . 73.05 110.287 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.9 mt -63.34 116.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 105.62 -1.993 . . . . 53.14 105.62 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -94.98 155.48 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 105.384 -2.08 . . . . 64.11 105.384 163.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -125.44 169.17 12.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.883 1.273 . . . . 74.51 108.221 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -67.57 -11.14 57.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.588 -1.32 . . . . 65.24 111.814 -172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -3.23 53.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.661 1.585 . . . . 72.44 113.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.09 12.77 8.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.701 1.6 . . . . 74.02 111.571 -171.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 165.57 17.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.262 -1.014 . . . . 75.44 108.262 163.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -173.19 164.14 4.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.768 2.027 . . . . 70.55 109.027 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.3 pt -144.84 165.99 11.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.033 2.133 . . . . 52.51 107.54 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -140.34 97.87 3.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.841 0.857 . . . . 75.51 109.256 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.84 172.25 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.762 1.625 . . . . 72.24 111.547 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.4 p -61.03 154.61 22.25 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.991 1.316 . . . . 75.53 110.754 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -74.14 -26.15 60.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.465 -0.772 . . . . 65.34 111.369 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -97.72 37.74 1.36 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.623 0.647 . . . . 64.43 110.054 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -90.94 123.38 64.92 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-O 117.807 -1.092 . . . . 73.51 108.108 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.67 139.01 61.48 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.659 1.573 . . . . 64.4 111.094 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.56 -162.3 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.766 1.627 . . . . 71.31 108.772 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -134.02 133.09 40.84 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.223 1.009 . . . . 64.13 110.56 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.45 161.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.383 1.473 . . . . 72.44 109.414 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.24 120.95 28.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.518 1.151 . . . . 60.1 110.751 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.37 77.51 9.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.264 1.826 . . . . 60.3 106.159 150.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.2 17.01 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.655 1.354 . . . . 44.11 114.655 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.48 -28.55 3.99 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 124.919 1.247 . . . . 63.42 111.398 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.06 20.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.635 -2.358 . . . . 74.44 104.635 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.55 134.7 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.288 -1.004 . . . . 72.54 108.288 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.517 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -130.39 153.18 48.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.501 -1.296 . . . . 71.43 107.501 176.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.517 ' H ' HD13 ' A' ' 114' ' ' LEU . 1.3 pm0 -112.63 114.16 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.377 1.471 . . . . 71.44 109.499 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -136.73 174.03 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.769 2.028 . . . . 73.13 108.596 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.03 148.78 21.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.073 0.851 . . . . 74.33 110.912 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.48 -29.21 9.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.207 1.803 . . . . 53.55 114.162 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.01 1.277 . . . . 61.22 111.928 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 22.6 mtm -87.35 -19.91 27.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.185 0.994 . . . . 71.14 111.613 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 t -71.19 63.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 129.516 3.126 . . . . 64.04 112.239 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -78.5 -179.95 6.69 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.764 -1.835 . . . . 65.42 110.35 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.49 -10.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.652 2.381 . . . . 75.31 113.995 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.88 -3.01 83.63 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 124.629 1.109 . . . . 61.23 112.892 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.89 152.65 31.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.45 -1.685 . . . . 72.12 106.45 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.62 131.68 55.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.645 -1.613 . . . . 73.42 106.645 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -106.89 126.84 62.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.793 0.837 . . . . 63.22 108.803 -168.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.57 122.35 17.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.674 1.19 . . . . 72.22 108.884 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.19 155.83 70.6 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 113.348 0.87 . . . . 70.4 113.348 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.33 151.97 82.25 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.549 2.166 . . . . 75.15 111.006 167.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.69 -160.34 0.86 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.007 1.723 . . . . 72.12 106.806 158.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -48.28 -61.58 1.92 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.316 1.046 . . . . 61.51 110.858 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -121.0 -17.86 7.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.088 1.355 . . . . 74.55 112.843 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -140.59 170.84 15.03 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.426 1.09 . . . . 75.54 110.742 -165.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -79.91 154.34 4.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.867 0.841 . . . . 73.2 110.662 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -143.89 -171.42 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.179 1.792 . . . . 54.14 106.829 166.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.1 mt -125.28 168.88 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.419 -0.956 . . . . 70.12 108.419 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.83 161.99 40.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.812 0.845 . . . . 62.11 110.937 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -74.7 140.68 44.33 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 127.32 2.248 . . . . 62.0 110.693 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.54 1.03 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.023 1.329 . . . . 75.23 112.61 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.517 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.7 pt 24.33 -75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 129.882 3.273 . . . . 71.42 117.238 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.517 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -93.12 126.09 38.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.909 2.484 . . . . 72.41 109.537 -170.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.18 121.91 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.316 0.646 . . . . 72.44 110.505 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.75 -171.9 0.49 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.238 3.015 . . . . 74.01 109.445 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.9 p -132.29 174.25 10.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.827 2.051 . . . . 73.42 107.98 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.0 m -110.18 -178.25 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.439 -1.319 . . . . 75.21 107.439 151.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.46 113.65 15.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.783 -1.562 . . . . 64.23 106.783 168.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -129.99 160.88 32.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.356 1.462 . . . . 70.31 109.806 -165.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.17 47.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.344 1.458 . . . . 52.5 109.663 -162.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -117.17 -150.57 9.23 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.964 1.745 . . . . 75.41 110.212 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.0 157.1 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.793 0.796 . . . . 73.4 109.797 159.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 19.2 pt -122.08 151.26 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 126.537 1.935 . . . . 74.13 107.929 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -136.87 151.18 48.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.791 1.236 . . . . 75.35 111.118 -170.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.0 -177.85 6.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.913 0.885 . . . . 75.34 111.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.76 121.98 9.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.311 1.844 . . . . 70.44 107.772 -152.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.53 -37.09 32.19 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-O 116.13 -1.891 . . . . 64.54 114.72 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p 24.61 73.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.771 2.028 . . . . 72.13 112.708 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.02 -10.06 36.33 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.492 -1.38 . . . . 74.1 113.602 -170.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.52 -72.37 0.17 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.825 2.05 . . . . 72.14 106.066 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.83 -19.25 17.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.685 1.594 . . . . 70.04 111.729 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 48.31 39.72 12.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.062 2.145 . . . . 72.24 112.658 -162.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 p -152.48 143.92 23.37 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.043 1.292 . . . . 74.43 109.32 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 4.0 p90 -136.08 172.88 12.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.488 1.515 . . . . 61.12 110.082 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.2 mm -103.32 138.26 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.915 -1.513 . . . . 63.53 106.915 157.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -163.15 160.23 23.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.048 0.939 . . . . 53.22 110.295 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 131.17 -163.02 23.63 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.279 1.418 . . . . 54.41 110.731 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -104.9 170.26 7.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.0 1.9 . . . . 72.54 112.049 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 56.9 -72.42 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 129.695 3.198 . . . . 75.32 111.685 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.62 -14.98 8.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.469 1.508 . . . . 65.11 113.493 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.04 171.75 9.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 122.726 1.181 . . . . 74.43 112.412 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 97' ' ' ILE . 39.0 m-85 -126.49 144.78 50.75 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 126.861 2.064 . . . . 75.34 109.118 -170.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -74.9 114.57 13.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.26 1.424 . . . . 72.23 108.243 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.92 -179.29 3.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.618 0.767 . . . . 60.14 110.789 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -72.65 144.25 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.79 0.836 . . . . 75.22 108.951 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.52 60.87 1.28 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.291 1.836 . . . . 74.14 109.425 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.238 0.466 0 CA-C-O 122.427 1.108 . . . . 64.23 111.466 -179.566 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.613 0 N-CA-C 106.048 -1.834 . . . . 52.32 106.048 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -113.93 178.09 4.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.774 1.63 . . . . 75.21 109.548 172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.17 -169.21 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.183 1.793 . . . . 70.42 113.667 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t80 -94.29 -45.67 7.39 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.947 1.299 . . . . 74.24 109.931 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.33 -0.41 56.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.434 1.493 . . . . 75.42 112.058 -167.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 156.6 76.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.03 -1.044 . . . . 65.33 110.579 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -92.92 143.8 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.334 3.356 . . . . 74.31 113.351 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.26 -2.0 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.325 1.231 . . . . 65.21 114.325 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 53.71 73.41 0.38 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.454 1.101 . . . . 63.0 111.974 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.64 162.83 1.06 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.476 -0.765 . . . . 73.4 109.596 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.9 t -49.03 -40.39 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.108 0.963 . . . . 52.33 110.732 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -81.24 -20.59 40.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.282 0.845 . . . . 74.34 113.282 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.21 28.93 8.25 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.518 1.056 . . . . 65.45 113.041 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -15.34 63.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 118.37 2.73 . . . . 72.34 118.37 -163.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 mm 43.79 78.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.014 2.525 . . . . 74.42 109.643 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.3 154.16 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.631 1.973 . . . . 55.13 107.487 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' HB2' ' H ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -62.26 129.63 41.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.889 1.276 . . . . 73.54 107.584 171.096 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -53.19 -39.4 34.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 109.569 -0.53 . . . . 72.32 109.569 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -46.19 -59.71 4.99 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 125.014 1.292 . . . . 63.43 111.337 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' H ' ' HB2' ' A' ' 24' ' ' ASN . 38.5 tp10 -69.14 -48.55 62.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.197 -0.906 . . . . 64.53 110.454 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -45.7 -53.1 9.89 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.554 1.142 . . . . 74.31 109.614 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.704 HG22 HG21 ' A' ' 77' ' ' VAL . 49.8 t -69.7 -45.36 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.485 -0.779 . . . . 74.53 109.486 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.87 -37.94 80.75 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.842 -1.161 . . . . 73.35 113.223 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -55.96 -38.13 69.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.903 1.681 . . . . 72.23 110.784 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 15.8 m-85 -73.84 -49.17 26.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.19 1.396 . . . . 75.23 108.638 172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.18 -37.98 62.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.177 1.808 . . . . 73.24 113.301 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.21 -30.34 57.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.01 -0.995 . . . . 53.13 111.829 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -85.08 -52.11 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 2.0 m-30 -93.5 41.36 1.08 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.716 2.007 . . . . 74.21 108.256 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -27.79 68.57 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.576 -1.328 . . . . 51.24 112.142 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -62.42 -27.98 69.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.944 1.698 . . . . 75.53 113.304 168.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.346 1.858 . . . . 75.15 112.86 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.3 mt -66.39 89.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.976 1.262 . . . . 70.24 109.764 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -79.71 161.27 25.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.992 1.717 . . . . 74.44 108.528 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -143.32 122.28 12.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.05 1.34 . . . . 62.15 108.884 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.92 169.76 17.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.651 -0.87 . . . . 75.44 108.651 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -54.47 34.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.91 2.084 . . . . 75.14 111.137 -173.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.04 3.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.356 1.462 . . . . 60.14 113.295 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.67 18.99 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 126.927 2.204 . . . . 73.34 110.853 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -86.0 -99.97 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.409 1.084 . . . . 74.25 108.156 -173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.01 111.01 0.68 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-O 117.754 -1.581 . . . . 73.41 110.726 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -114.19 164.6 13.65 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.229 1.514 . . . . 75.51 111.537 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mt -145.36 144.04 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 128.125 2.57 . . . . 74.12 105.266 164.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -83.06 114.7 21.47 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.81 -1.182 . . . . 71.33 107.81 166.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.96 13.59 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.854 0.862 . . . . 71.52 109.98 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.93 -31.91 82.41 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 120.19 -1.569 . . . . 62.21 111.334 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.64 -1.51 7.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.719 1.208 . . . . 72.3 114.245 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -74.67 -18.25 60.56 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.872 -0.518 . . . . 73.1 111.088 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t30 63.29 18.85 11.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.24 2.216 . . . . 41.44 113.624 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -82.33 131.03 34.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.292 -1.373 . . . . 75.1 107.292 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -96.67 161.58 13.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.362 1.465 . . . . 52.4 109.476 173.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.87 149.58 19.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.722 1.609 . . . . 61.31 108.72 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -68.99 121.43 16.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.278 -1.379 . . . . 74.42 107.278 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' TYR . 0.4 OUTLIER -117.81 -177.55 3.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.044 1.338 . . . . 54.42 108.384 171.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -137.71 132.22 32.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.369 -1.715 . . . . 73.54 106.369 169.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.17 106.35 13.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.321 -0.992 . . . . 64.35 108.321 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 71.5 tttt -55.84 -18.55 8.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.327 1.851 . . . . 73.14 113.984 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.95 -34.55 78.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.448 1.099 . . . . 53.31 112.121 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.3 m -125.51 -1.55 7.46 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.054 0.942 . . . . 73.03 112.501 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.81 44.09 17.41 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.122 -0.986 . . . . 61.44 110.487 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 pt -108.6 157.24 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.941 1.696 . . . . 42.31 109.151 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.65 128.71 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.03 -1.47 . . . . 72.53 107.03 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -135.71 175.21 9.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.491 1.116 . . . . 70.55 112.758 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.62 96.64 3.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.245 -2.131 . . . . 74.24 105.245 -157.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -125.14 172.0 9.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.079 0.952 . . . . 63.2 110.575 -165.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -116.28 153.08 32.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.93 0.786 . . . . 71.11 109.382 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.56 154.77 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.798 -1.186 . . . . 50.45 107.798 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 -20.62 6.75 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.918 0.781 . . . . 63.02 112.639 169.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -161.7 163.74 29.56 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.2 -1.563 . . . . 71.25 108.478 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -137.97 161.25 32.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.095 0.958 . . . . 52.14 109.11 179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -135.7 149.34 49.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.38 1.072 . . . . 74.31 110.416 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -146.2 142.24 28.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.124 0.875 . . . . 74.53 110.527 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -146.17 163.19 36.17 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.288 2.235 . . . . 62.32 107.274 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 4.7 tttm -107.48 156.4 19.02 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.612 -1.255 . . . . 72.42 107.612 164.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.4 t80 -153.64 163.08 40.6 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.975 1.31 . . . . 72.02 108.82 -166.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -151.67 113.92 4.53 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.116 -1.809 . . . . 75.32 106.116 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.52 -146.54 5.31 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 117.095 -2.479 . . . . 50.45 112.209 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 104.54 8.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.407 1.883 . . . . 72.41 107.801 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.559 HD13 HG22 ' A' ' 98' ' ' THR . 88.6 mt -83.69 162.91 20.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.73 1.612 . . . . 71.53 106.887 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 89' ' ' ILE . 34.8 mm -79.5 135.25 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 127.057 2.143 . . . . 63.1 107.37 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HE3' HG11 ' A' ' 146' ' ' VAL . 35.4 ttmt -125.4 79.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.635 -1.617 . . . . 64.13 106.635 161.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 140' ' ' VAL . 22.0 mt -59.21 141.07 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.345 -2.094 . . . . 65.42 105.345 152.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -115.16 164.28 14.43 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.621 -1.992 . . . . 65.51 105.621 163.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -136.02 169.73 17.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.822 1.192 . . . . 50.11 108.909 166.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.06 -21.63 66.3 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.675 -1.265 . . . . 73.2 112.759 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -66.49 -1.13 3.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.366 1.866 . . . . 60.33 112.72 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.3 22.41 10.75 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.025 1.73 . . . . 72.44 111.358 -165.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.79 168.71 19.33 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.865 -0.791 . . . . 61.11 108.865 163.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 174.6 163.15 0.22 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 129.05 2.94 . . . . 71.34 110.401 -167.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 3.0 pt -140.12 172.49 12.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.723 1.209 . . . . 51.42 110.436 -170.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.559 HG22 HD13 ' A' ' 86' ' ' LEU . 27.1 m -152.27 94.82 1.97 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.124 0.969 . . . . 75.03 109.713 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.438 HD21 HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -154.11 177.59 10.91 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 128.408 2.683 . . . . 72.44 109.261 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.9 p -78.4 171.49 15.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 120.649 1.568 . . . . 62.1 110.657 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -69.91 -19.67 63.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.13 0.972 . . . . 71.13 111.371 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -109.64 38.02 2.48 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.422 -0.799 . . . . 73.44 110.761 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -107.15 133.72 20.2 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.868 -0.79 . . . . 72.44 108.868 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.32 118.1 5.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.671 2.914 . . . . 65.52 113.251 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.35 -179.32 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.664 1.586 . . . . 64.43 109.954 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.17 144.72 49.17 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.223 0.92 . . . . 72.34 111.15 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 pt -134.88 165.49 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.112 0.965 . . . . 73.32 109.871 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.472 ' HB3' HD21 ' A' ' 137' ' ' LEU . 71.1 p -94.42 110.02 21.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.968 0.507 . . . . 64.34 109.666 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -85.8 81.35 8.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.578 -2.008 . . . . 72.34 105.578 167.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.1 32.47 4.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.473 1.109 . . . . 55.51 113.196 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.25 -9.42 42.36 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.693 -1.059 . . . . 52.2 114.339 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -84.5 131.21 34.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 119.389 1.595 . . . . 70.24 106.881 167.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.08 117.78 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.039 -1.467 . . . . 54.34 107.039 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 151.19 45.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.885 1.274 . . . . 74.44 108.65 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.2 121.3 44.92 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.53 1.132 . . . . 63.31 109.683 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 116' ' ' ILE . 15.6 pt -140.74 -175.96 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.789 0.836 . . . . 74.23 110.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -92.87 142.91 26.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.198 1.399 . . . . 72.25 108.704 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.11 65.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.35 0.977 . . . . 60.0 113.544 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -32.32 66.14 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.196 1.362 . . . . 71.22 112.596 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -23.85 36.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.563 1.145 . . . . 64.01 112.195 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.97 64.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.029 2.532 . . . . 74.45 111.653 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.79 -179.77 7.11 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.425 -1.422 . . . . 71.0 111.878 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 5.6 p -55.59 -9.86 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 128.421 2.689 . . . . 53.33 114.005 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.71 -15.97 79.92 Favored Glycine 0 CA--C 1.523 0.59 0 O-C-N 121.279 -0.888 . . . . 44.41 111.554 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.33 164.87 13.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.634 1.217 . . . . 64.41 108.92 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 13.1 m-85 -113.41 137.9 50.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.218 -1.401 . . . . 74.0 107.218 167.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.4 132.46 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.613 -1.255 . . . . 61.31 107.613 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.41 124.53 23.42 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.5 -0.926 . . . . 72.54 108.5 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -133.33 154.5 81.04 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.899 1.68 . . . . 72.33 110.096 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.57 149.43 84.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.401 1.401 . . . . 63.3 110.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -120.62 -145.39 0.36 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.568 -1.641 . . . . 72.42 106.568 149.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -56.85 -70.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.145 1.378 . . . . 72.53 111.155 -162.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -120.09 -2.79 10.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.596 0.758 . . . . 74.23 112.764 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 167.32 21.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.434 1.093 . . . . 75.32 111.257 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.2 tp -78.84 156.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.139 0.971 . . . . 64.32 108.686 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.93 -173.76 3.89 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 127.601 2.361 . . . . 73.51 107.226 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 108' ' ' SER . 40.6 mt -135.43 136.52 41.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.387 -2.079 . . . . 42.15 105.387 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -133.7 153.98 51.29 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.717 -1.216 . . . . 70.43 107.717 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 18.1 tt0 -96.77 136.87 36.7 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.841 2.056 . . . . 74.43 107.88 -161.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.455 HG13 HG23 ' A' ' 89' ' ' ILE 0.296 46.9 t -79.98 1.05 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 114.479 1.288 . . . . 73.21 114.479 -158.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pt 26.61 -98.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.158 2.583 . . . . 73.52 115.405 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -90.56 122.5 33.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.411 -1.43 . . . . 72.32 108.067 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.62 117.49 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.251 -1.388 . . . . 73.31 107.251 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.83 -165.57 2.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.832 1.653 . . . . 72.23 108.909 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 p -121.92 171.33 9.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.017 1.327 . . . . 55.15 110.179 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.426 HG11 ' HE3' ' A' ' 88' ' ' LYS . 30.3 m -130.56 131.75 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.712 -1.218 . . . . 53.33 107.712 167.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.02 109.54 17.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.374 -1.343 . . . . 75.33 107.374 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -133.23 136.18 45.43 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.802 2.041 . . . . 63.24 106.909 -163.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -140.63 43.86 1.85 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.784 -0.572 . . . . 65.41 110.233 -155.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.81 8.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.391 0.996 . . . . 54.32 112.897 -165.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.15 155.52 24.95 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.977 -0.719 . . . . 74.01 110.408 165.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.4 pt -132.36 147.21 32.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 127.712 2.405 . . . . 74.13 106.961 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.415 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 3.5 m-85 -132.79 164.68 26.28 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.786 -1.19 . . . . 75.0 107.786 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -153.66 177.39 11.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.528 -1.286 . . . . 72.33 107.528 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.9 mt -140.56 163.81 31.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.719 1.145 . . . . 73.42 110.819 -167.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.1 m -118.58 110.38 17.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.926 1.691 . . . . 64.33 107.054 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.2 77.72 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.808 2.043 . . . . 42.21 106.808 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.378 10.9 pt-20 -72.87 2.2 7.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.109 1.364 . . . . 72.41 113.995 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.5 -56.61 11.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 128.438 2.695 . . . . 71.13 109.74 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.6 t30 -133.24 -4.33 3.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.128 0.971 . . . . 72.43 111.861 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 66.65 21.34 10.65 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.284 1.434 . . . . 60.33 112.219 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.5 p -142.22 139.73 32.09 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.486 -0.931 . . . . 74.13 108.486 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -137.82 176.64 8.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.876 0.87 . . . . 43.01 110.281 -175.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.8 mm -98.76 120.1 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 165.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.26 133.79 24.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.947 -1.131 . . . . 63.55 107.947 167.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.54 177.05 33.3 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.723 2.106 . . . . 72.44 108.065 168.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -75.34 178.74 5.63 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.366 -2.255 . . . . 71.13 110.622 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.61 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.079 1.752 . . . . 70.32 112.468 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -122.13 -8.5 8.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.433 1.893 . . . . 61.03 114.177 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 88.1 164.13 39.91 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.549 1.547 . . . . 73.32 113.482 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.465 ' CD2' HG22 ' A' ' 129' ' ' ILE . 9.1 m-85 -108.19 159.66 16.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.32 1.448 . . . . 73.13 109.044 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -102.1 102.08 12.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.215 1.806 . . . . 64.14 106.7 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.74 177.08 6.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.243 1.017 . . . . 74.35 109.684 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 75.0 m -66.55 139.15 57.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.472 -0.936 . . . . 43.02 108.472 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -128.12 39.63 3.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.033 2.533 . . . . 64.42 109.28 172.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.691 -0.855 . . . . 74.43 108.691 177.715 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 109.312 -0.625 . . . . 74.23 109.312 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.73 166.69 10.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.281 3.032 . . . . 53.32 109.016 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 178.97 1.2 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.165 1.386 . . . . 74.02 112.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -75.84 -34.33 60.08 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.427 -0.796 . . . . 74.45 110.522 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.45 25.53 11.56 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.678 1.228 . . . . 74.52 112.436 -161.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.05 126.39 82.04 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 125.36 1.464 . . . . 53.24 109.141 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -67.14 102.76 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.33 2.687 . . . . 35.4 108.89 168.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 pt -78.17 140.88 16.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.818 1.19 . . . . 71.43 108.964 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 47.6 m-85 -96.14 83.32 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.525 -1.657 . . . . 74.54 106.525 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 86.8 mt -58.97 154.7 14.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.72 -0.845 . . . . 65.2 108.72 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -61.92 -20.4 63.73 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.2 -0.313 . . . . 52.32 110.188 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.74 -29.65 70.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.633 1.973 . . . . 61.43 112.736 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.88 4.61 67.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.238 1.399 . . . . 52.44 112.314 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.19 -39.36 72.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.632 1.716 . . . . 62.22 115.073 -156.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mm 57.02 96.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 127.73 2.412 . . . . 64.44 108.841 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 157.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.679 -1.971 . . . . 62.41 105.679 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -67.04 119.25 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.581 -1.637 . . . . 52.33 106.581 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -50.79 -35.85 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.292 0.637 . . . . 75.44 110.153 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.38 -30.94 63.97 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-O 118.2 -1.334 . . . . 43.35 112.734 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -63.36 -55.91 20.63 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 119.917 1.858 . . . . 75.35 108.894 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -48.48 -49.61 34.97 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 125.341 1.456 . . . . 65.42 110.397 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 77' ' ' VAL . 76.9 t -76.33 -40.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 118.087 -0.958 . . . . 73.13 110.109 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -64.58 -29.38 70.4 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 120.723 1.601 . . . . 72.54 110.873 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -43.85 52.67 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.871 1.268 . . . . 65.41 110.335 170.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.6 -46.18 22.95 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.325 -1.321 . . . . 74.21 110.03 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 8.4 m-85 -54.85 -34.32 62.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 122.182 2.264 . . . . 74.45 113.08 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -84.81 -22.39 29.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.637 1.175 . . . . 65.22 110.616 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -63.29 1.32 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.701 -1.222 . . . . 73.1 107.701 172.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -84.26 39.77 0.73 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.184 2.594 . . . . 74.0 109.192 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.5 -36.74 55.85 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 70.03 111.181 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -71.05 -13.49 62.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.306 1.842 . . . . 75.14 113.381 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.06 5.76 26.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.268 1.427 . . . . 63.2 112.379 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 105.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.518 -1.29 . . . . 64.41 107.518 171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -103.85 107.18 17.94 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.051 0.541 . . . . 64.11 109.72 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -70.69 154.7 41.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.745 -0.835 . . . . 42.52 108.745 168.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -113.85 171.64 7.47 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.246 1.818 . . . . 63.44 107.181 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -54.26 21.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.185 1.794 . . . . 65.55 111.239 -175.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.35 -18.79 65.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.82 0.848 . . . . 61.51 111.381 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.27 -1.78 22.35 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.867 1.699 . . . . 71.11 113.643 160.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -50.46 -79.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.305 1.842 . . . . 63.03 111.81 -164.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.48 110.43 2.85 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.055 -1.618 . . . . 73.33 109.055 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -110.62 168.78 9.21 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.233 1.013 . . . . 71.43 109.635 165.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mt -143.91 136.22 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.97 -1.863 . . . . 71.35 105.97 166.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.2 125.32 26.62 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.27 3.85 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.914 0.885 . . . . 63.23 110.768 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.22 -31.23 72.78 Favored Glycine 0 CA--C 1.524 0.65 0 O-C-N 121.331 -0.856 . . . . 72.15 113.188 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -60.45 -13.63 14.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.565 1.182 . . . . 64.15 113.025 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.62 -21.09 37.38 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.98 -1.075 . . . . 73.14 111.662 167.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.93 24.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.677 2.391 . . . . 73.33 113.441 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.32 113.66 9.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.773 -1.566 . . . . 54.14 106.773 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -79.16 150.78 31.61 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.162 0.585 . . . . 72.5 110.97 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 15.6 tt -112.36 157.83 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.65 1.58 . . . . 64.1 108.296 170.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -63.6 110.27 1.94 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.751 -1.944 . . . . 74.24 105.751 162.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.57 175.65 5.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.107 1.363 . . . . 63.31 107.807 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.95 120.72 7.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.452 -1.314 . . . . 62.11 107.452 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.82 118.67 17.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.202 -0.936 . . . . 71.33 109.547 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -63.86 -31.74 73.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.588 0.355 . . . . 74.51 110.989 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -41.74 6.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.164 1.785 . . . . 75.21 111.692 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -136.91 15.59 3.07 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 43.32 111.399 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.5 47.6 8.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.834 1.654 . . . . 74.41 112.51 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.06 160.54 3.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 124.875 1.27 . . . . 62.33 108.434 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.86 149.68 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.801 -1.555 . . . . 74.21 106.801 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -178.69 7.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.287 2.235 . . . . 54.03 110.227 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -124.98 130.96 53.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.047 1.339 . . . . 73.4 107.715 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -151.6 160.04 43.82 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.403 1.081 . . . . 65.34 108.78 163.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -83.36 178.11 8.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.152 0.981 . . . . 75.54 110.687 163.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -95.12 170.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.848 2.059 . . . . 54.23 106.194 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.66 -61.71 1.49 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.044 -1.465 . . . . 65.02 107.044 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -126.72 152.11 47.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.941 -1.133 . . . . 73.14 107.941 -171.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -124.17 159.74 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 125.46 1.504 . . . . 70.12 107.646 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -137.84 156.31 48.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.733 0.813 . . . . 75.41 112.071 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.7 139.54 26.61 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.394 1.478 . . . . 71.02 111.521 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -148.5 155.8 41.62 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.161 0.984 . . . . 72.13 108.901 168.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -79.62 153.28 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.818 -1.176 . . . . 63.24 109.248 170.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.94 157.37 43.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.605 1.562 . . . . 72.3 108.538 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 p -161.96 97.45 1.04 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.141 0.976 . . . . 54.1 111.681 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.2 -172.78 45.76 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.675 -1.266 . . . . 63.51 112.652 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -85.05 116.15 23.27 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.132 0.573 . . . . 65.42 110.845 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 98' ' ' THR . 26.9 mt -95.79 165.83 12.1 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.863 1.665 . . . . 62.23 109.214 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.91 134.4 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 126.053 1.741 . . . . 61.34 109.669 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -123.61 82.82 2.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.995 -1.483 . . . . 73.1 106.995 164.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.8 mt -57.96 132.6 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.173 -2.158 . . . . 74.44 105.173 153.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -106.08 166.0 10.82 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.119 -1.808 . . . . 72.15 106.119 159.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.09 169.89 16.48 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.579 1.081 . . . . 53.01 109.558 165.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -63.82 -25.24 68.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.071 -1.018 . . . . 60.34 112.022 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.94 -0.17 0.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.196 2.598 . . . . 55.5 113.133 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 59.85 22.46 11.4 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 127.06 2.144 . . . . 71.52 111.333 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.528 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 2.6 ttm180 -75.64 163.52 27.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.213 -0.929 . . . . 62.32 108.756 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 167.99 4.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.636 0.775 . . . . 61.13 110.093 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.8 pt -147.97 178.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.998 1.719 . . . . 62.11 110.993 -173.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' HD23 ' A' ' 99' ' ' LEU . 17.7 m -149.99 103.48 3.21 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.639 1.576 . . . . 72.33 110.788 173.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -145.11 169.54 17.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 119.584 -1.947 . . . . 61.13 112.615 -174.303 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -62.22 144.91 54.89 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.198 1.399 . . . . 72.41 109.203 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.95 -20.72 64.21 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.651 -1.281 . . . . 50.42 112.143 -169.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -101.12 39.65 1.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.353 1.461 . . . . 54.0 110.672 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.69 143.08 25.7 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.16 -1.588 . . . . 74.24 109.729 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.75 137.24 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.014 2.476 . . . . 55.23 111.842 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.17 -177.4 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.915 1.686 . . . . 73.43 108.376 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.28 141.92 51.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.382 1.446 . . . . 73.54 111.303 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 107' ' ' ILE . 2.5 pp -142.36 171.32 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.858 1.263 . . . . 73.52 109.644 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.1 p -103.32 96.65 6.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.819 0.848 . . . . 70.44 111.005 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -82.29 89.06 6.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.325 -2.102 . . . . 73.33 105.325 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 44.13 44.51 6.39 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.05 1.34 . . . . 72.51 112.012 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.15 -31.81 8.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 118.097 -1.391 . . . . 62.55 113.608 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -79.51 144.94 33.5 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 119.798 1.799 . . . . 74.11 108.063 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.18 123.06 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.937 -1.134 . . . . 44.34 107.937 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 tp -123.06 159.47 28.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.664 -0.865 . . . . 72.02 108.664 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.46 104.05 11.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.438 1.495 . . . . 64.11 110.875 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 pt -129.96 -178.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.178 0.991 . . . . 65.02 112.136 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.16 134.52 34.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.343 0.974 . . . . 71.43 108.808 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.68 -38.44 55.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.861 1.06 . . . . 72.14 113.861 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 1.5 pp20? -67.19 -16.7 64.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.817 1.043 . . . . 74.11 113.817 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 35.6 mtt -83.16 -25.18 32.1 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.773 0.829 . . . . 63.21 110.436 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.35 62.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 127.754 2.422 . . . . 75.51 109.453 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 24.7 mmtp -79.72 -174.17 4.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.416 1.087 . . . . 64.33 108.707 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.79 -12.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.249 2.22 . . . . 73.22 113.38 167.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.91 -4.76 89.63 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 117.97 -1.461 . . . . 64.41 112.063 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -132.14 172.39 12.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.909 1.854 . . . . 62.21 110.834 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 9.4 m-85 -116.66 119.45 35.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.171 1.788 . . . . 74.15 106.346 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 tp -83.19 130.32 35.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.851 -1.166 . . . . 72.12 107.851 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -70.73 116.46 11.06 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.146 -1.057 . . . . 61.1 108.146 170.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.8 153.09 63.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.224 1.41 . . . . 74.13 112.035 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 153.61 52.4 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.602 2.201 . . . . 73.31 110.867 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.69 179.24 6.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.053 2.541 . . . . 72.31 107.218 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -25.41 -67.08 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.499 2.32 . . . . 75.51 113.911 -169.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -120.35 -0.55 10.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.381 1.872 . . . . 74.04 111.298 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.0 p -143.21 -171.27 3.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.211 1.004 . . . . 73.32 111.972 -154.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.47 153.17 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.855 -1.165 . . . . 63.0 107.855 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -145.8 -175.64 4.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.604 2.761 . . . . 73.31 106.163 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.99 161.27 19.65 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.724 1.21 . . . . 73.11 110.377 170.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -148.13 152.91 38.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.277 2.231 . . . . 74.45 106.804 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.461 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 19.2 mt-10 -77.13 147.4 36.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.689 1.595 . . . . 74.32 110.029 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.13 1.04 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.012 0.745 . . . . 63.13 113.012 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.432 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 29.47 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 128.161 2.584 . . . . 74.43 116.176 170.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.432 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.3 tppt? -100.33 128.36 46.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 120.804 -1.185 . . . . 73.01 107.942 174.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.65 128.21 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.64 -1.245 . . . . 53.12 107.64 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.55 -177.75 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.406 2.282 . . . . 64.53 107.216 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.9 p -117.86 170.44 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.964 -1.085 . . . . 65.32 109.339 167.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.21 124.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 107.003 -1.48 . . . . 64.04 107.003 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -86.16 114.35 22.93 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.904 1.229 . . . . 73.43 107.826 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -120.16 139.16 53.04 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.645 1.578 . . . . 61.15 107.299 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.55 81.92 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.502 -0.925 . . . . 71.42 108.502 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.83 -121.06 1.12 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.13 1.824 . . . . 61.34 111.273 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -136.84 152.57 50.41 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.232 -1.157 . . . . 73.24 109.703 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.3 pt -116.82 156.3 18.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.363 1.865 . . . . 74.41 108.267 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -138.14 150.92 47.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.841 1.257 . . . . 73.31 107.942 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -129.08 166.5 19.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.744 0.702 . . . . 72.22 109.96 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 127.16 42.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.111 1.365 . . . . 63.01 108.894 -170.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.5 m -71.08 -58.0 3.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.758 -0.639 . . . . 52.22 110.773 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.2 t 25.94 64.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 129.516 3.126 . . . . 71.32 112.567 -170.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -72.58 0.17 11.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.923 1.689 . . . . 64.41 113.027 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.19 -70.65 0.32 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.964 1.305 . . . . 74.12 108.526 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -93.6 0.31 56.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.615 0.766 . . . . 63.44 111.151 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.9 m170 65.21 26.48 12.31 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.736 2.014 . . . . 51.32 111.835 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -145.16 167.09 23.6 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.915 -1.115 . . . . 73.41 109.952 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.37 171.4 17.25 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.779 1.632 . . . . 71.24 109.527 176.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.6 mm -105.84 119.46 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.619 -1.252 . . . . 65.51 107.619 167.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -150.82 146.7 26.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.176 0.99 . . . . 42.54 109.977 171.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.64 177.88 23.26 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 128.063 2.744 . . . . 61.41 109.015 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -73.46 166.55 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.238 -1.742 . . . . 72.43 110.347 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 70.01 -71.7 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.617 2.367 . . . . 63.2 114.808 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.427 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 pt-20 -124.28 -19.27 5.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.772 1.229 . . . . 73.41 114.241 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 164.22 40.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.969 2.223 . . . . 44.1 113.62 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 97' ' ' ILE . 56.6 m-85 -104.18 151.99 22.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.855 2.062 . . . . 72.12 108.302 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.22 111.71 23.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.785 2.034 . . . . 70.32 106.936 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 163' ' ' TYR . 2.3 m -139.27 166.97 20.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 119.065 0.848 . . . . 74.22 110.472 -169.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.3 t -66.25 139.97 58.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.281 1.432 . . . . 63.11 109.841 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -137.3 70.36 1.4 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.32 2.648 . . . . 75.32 106.969 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.469 0.487 0 O-C-N 119.964 -1.71 . . . . 73.05 111.821 -171.545 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' HG1' ' A' ' 100' ' ' THR . . . . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.028 0.442 . . . . 70.11 111.448 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -106.2 -178.03 3.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 129.538 3.135 . . . . 61.02 109.376 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.0 -156.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.472 1.109 . . . . 72.54 112.342 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.6 t80 -103.1 -30.58 10.64 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 65.44 110.414 164.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -116.72 29.67 7.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.768 2.427 . . . . 73.43 110.785 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -100.71 134.73 20.36 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.734 -0.839 . . . . 62.32 108.734 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.09 138.21 25.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.819 2.346 . . . . 72.51 112.921 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 25' ' ' ILE . 28.5 pt -102.11 7.09 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 114.974 1.472 . . . . 64.4 114.974 -172.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 36.28 74.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.287 1.835 . . . . 72.32 114.226 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 152.42 2.35 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.471 -0.937 . . . . 74.25 108.471 164.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -54.41 -36.19 63.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.193 0.451 . . . . 74.41 111.459 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.0 -19.53 62.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.958 1.303 . . . . 71.42 112.657 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.56 18.23 33.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 117.961 -1.466 . . . . 71.23 112.643 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -38.38 64.93 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.601 1.7 . . . . 73.05 113.821 -167.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.81 96.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.448 2.699 . . . . 70.44 108.977 -170.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.25 146.87 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.414 -1.699 . . . . 62.42 106.414 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.95 135.96 53.21 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.415 1.886 . . . . 63.14 108.079 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 15' ' ' ILE . 4.4 tt -51.3 -43.08 28.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.443 1.097 . . . . 62.34 110.812 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -71.36 -41.21 59.29 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-O 117.961 -1.466 . . . . 40.15 110.377 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -58.06 -44.06 87.25 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 120.78 2.29 . . . . 74.5 112.167 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.89 -59.71 4.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.656 1.582 . . . . 62.2 109.06 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG13 HG21 ' A' ' 77' ' ' VAL . 84.9 t -68.4 -44.54 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.402 -0.363 . . . . 61.34 110.589 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.24 -32.14 73.47 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.171 -0.956 . . . . 75.01 109.608 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -50.83 -52.54 40.37 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.43 -0.794 . . . . 62.42 109.882 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -66.21 -41.81 89.63 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.768 -1.197 . . . . 54.03 107.768 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.452 ' CD1' HD12 ' A' ' 50' ' ' ILE . 8.3 m-85 -60.71 -31.0 70.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.78 1.627 . . . . 70.22 112.827 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -19.03 32.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 125.387 1.475 . . . . 62.52 111.696 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 18.6 mttm -94.92 -63.75 1.14 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.269 -1.752 . . . . 74.22 106.269 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -82.02 43.28 0.77 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.355 2.662 . . . . 64.2 108.585 -173.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -50.89 -40.28 56.22 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.395 1.478 . . . . 73.14 110.187 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -59.02 -35.5 73.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.593 1.157 . . . . 74.1 112.965 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 m -77.17 -6.08 51.6 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.636 1.175 . . . . 72.31 113.768 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -65.37 95.26 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 119.807 1.185 . . . . 65.32 108.749 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -79.18 157.11 27.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.303 -1.74 . . . . 42.42 106.303 163.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -126.77 145.9 50.44 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.266 -2.124 . . . . 73.22 105.266 159.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.75 177.43 8.67 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.111 0.882 . . . . 62.33 110.332 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -49.23 -50.02 40.38 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.229 2.212 . . . . 61.2 111.911 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -70.66 -9.28 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.061 1.344 . . . . 73.11 112.137 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.37 56.18 2.89 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 127.235 2.35 . . . . 72.2 109.447 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -85.37 -100.19 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.609 -1.256 . . . . 75.22 107.609 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.85 123.77 0.99 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 107.79 -2.124 . . . . 74.43 107.79 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 160.35 41.34 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.276 1.538 . . . . 72.21 110.93 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' A' ' 33' ' ' PHE . 10.3 mt -143.2 149.71 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.822 2.049 . . . . 70.42 106.637 172.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.81 135.24 37.78 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.031 1.332 . . . . 63.52 109.575 165.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.09 25.52 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.33 2.252 . . . . 64.13 109.592 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.67 1.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 127.788 2.613 . . . . 63.32 115.694 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.06 -10.92 13.42 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.429 2.615 . . . . 50.15 114.785 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -28.44 63.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 121.347 1.885 . . . . 74.24 111.846 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 11.87 2.24 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.821 1.648 . . . . 70.25 113.339 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 mt -67.53 127.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.694 1.598 . . . . 73.23 109.48 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -94.6 142.83 26.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.564 1.146 . . . . 55.41 110.384 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.26 152.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.244 2.218 . . . . 73.0 106.961 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -68.49 105.67 2.29 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.265 -1.754 . . . . 64.1 106.265 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -96.36 -176.48 3.66 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.852 -1.166 . . . . 73.43 107.852 167.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.73 141.91 30.69 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.572 -1.64 . . . . 64.12 106.572 171.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.76 96.0 9.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -55.45 -21.21 15.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.644 0.778 . . . . 64.25 112.823 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -44.48 1.43 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.075 2.15 . . . . 65.04 112.024 167.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -139.03 0.91 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.088 0.955 . . . . 61.03 112.336 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mt 63.92 59.84 1.08 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.193 1.797 . . . . 73.44 110.743 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.73 153.09 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.768 1.627 . . . . 71.21 109.254 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.8 138.98 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.965 -1.124 . . . . 62.5 107.965 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -144.26 172.36 13.03 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.062 1.745 . . . . 72.23 107.977 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.34 131.68 54.33 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.286 -1.375 . . . . 64.04 107.286 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.3 mmpt? -141.33 155.74 45.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.587 -1.634 . . . . 75.43 106.587 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.71 124.42 49.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.95 0.795 . . . . 74.22 110.478 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.61 154.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.103 2.161 . . . . 73.4 109.084 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.2 -50.43 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.02 1.728 . . . . 72.43 110.504 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -134.2 160.04 39.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.0 1.727 . . . . 75.22 110.418 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.55 HG21 HG13 ' A' ' 29' ' ' VAL . 2.3 m -133.98 161.22 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 74.12 109.441 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.04 154.84 46.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.848 1.259 . . . . 74.21 110.417 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 148.78 19.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.378 0.99 . . . . 71.41 111.092 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -141.16 169.35 17.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.152 -1.425 . . . . 73.42 107.152 157.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -89.36 154.26 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.901 -1.148 . . . . 71.24 107.901 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -148.17 156.89 43.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.178 -1.045 . . . . 73.13 108.178 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -149.02 117.38 6.47 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.131 -1.433 . . . . 55.54 107.131 162.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.07 -179.1 44.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.382 -1.39 . . . . 45.34 112.057 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 98.98 11.7 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.515 1.126 . . . . 72.05 110.207 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.16 153.79 29.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.105 -1.442 . . . . 74.4 107.105 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.9 139.16 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.522 -0.918 . . . . 65.21 108.522 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HE2' ' OE1' ' A' ' 96' ' ' GLU . 48.8 tttm -130.54 70.69 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.476 1.51 . . . . 75.35 107.243 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.44 148.04 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 105.269 -2.123 . . . . 72.41 105.269 161.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 167.75 10.51 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 105.309 -2.108 . . . . 72.43 105.309 162.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.2 p -135.86 168.2 19.76 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.933 0.788 . . . . 72.11 109.696 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -24.17 67.65 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.728 1.149 . . . . 62.11 112.741 -168.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.31 4.38 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.043 1.337 . . . . 71.44 111.615 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 60.08 26.49 15.84 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.859 2.063 . . . . 72.45 112.229 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -76.45 173.09 11.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 165.112 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -177.61 167.28 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.854 1.662 . . . . 74.51 107.92 -175.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.8 pt -141.82 171.4 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 125.834 1.654 . . . . 71.32 108.688 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.92 101.28 3.02 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.776 -1.194 . . . . 73.53 107.776 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 168.62 24.7 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.874 1.27 . . . . 52.02 110.083 -171.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.537 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 9.9 p -58.29 147.5 30.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.215 1.006 . . . . 70.32 110.37 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.94 -16.33 63.72 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.002 0.741 . . . . 73.52 113.002 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -117.01 39.49 3.22 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.767 1.627 . . . . 75.12 110.563 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -77.57 131.22 71.73 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.77 -1.109 . . . . 75.2 110.262 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.4 101.12 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 125.026 3.817 . . . . 74.34 112.903 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.68 178.25 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.005 1.722 . . . . 52.13 109.783 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -122.85 139.21 54.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.557 -0.714 . . . . 71.12 111.144 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.78 163.98 35.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.591 1.156 . . . . 74.31 110.54 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.6 t -88.65 121.09 30.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.081 1.419 . . . . 54.42 111.676 172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.51 78.0 1.81 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.32 1.848 . . . . 73.11 106.854 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m 69.75 0.8 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.235 1.569 . . . . 72.14 115.235 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.76 -33.68 1.39 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.08 -1.608 . . . . 73.24 109.08 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.73 131.27 35.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.97 1.308 . . . . 62.44 108.525 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.04 99.0 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.31 -1.367 . . . . 73.35 107.31 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.37 161.49 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.393 0.677 . . . . 73.55 109.372 172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.95 126.42 49.94 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.762 2.025 . . . . 65.13 107.989 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.6 pt -149.54 176.99 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.926 1.291 . . . . 75.13 110.442 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.32 142.03 45.19 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.793 1.237 . . . . 71.54 108.434 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.8 20.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.998 0.919 . . . . 72.55 112.612 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.31 -11.38 60.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.928 1.24 . . . . 74.14 113.827 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.7 mmt -82.11 -28.43 32.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.921 1.237 . . . . 71.24 111.103 169.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.1 t -75.49 63.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 128.728 2.811 . . . . 62.34 111.585 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -79.16 -178.34 6.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.072 -1.017 . . . . 75.22 109.6 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.34 0.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 128.092 2.557 . . . . 73.51 114.033 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -99.32 -1.88 56.77 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 117.768 -1.573 . . . . 44.41 112.693 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.63 136.35 46.44 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 106.414 -1.699 . . . . 62.33 106.414 -163.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.66 109.94 21.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.824 1.25 . . . . 75.02 108.973 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.69 133.1 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.456 1.102 . . . . 74.45 108.714 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.3 132.21 46.08 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.028 -0.73 . . . . 73.5 109.028 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -126.28 155.87 73.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.357 1.863 . . . . 73.43 110.143 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.38 145.14 37.76 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.988 1.792 . . . . 74.44 109.382 172.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 -158.99 0.67 Allowed 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.976 -1.12 . . . . 62.41 107.976 167.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.51 -62.28 1.75 Allowed 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.89 0.876 . . . . 72.2 111.203 -160.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.3 0.69 9.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.799 1.037 . . . . 74.34 113.799 166.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.7 p -122.36 -167.02 1.49 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.51 1.524 . . . . 75.53 110.12 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.97 156.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.741 1.216 . . . . 72.25 107.778 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -144.87 -176.69 5.18 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.729 2.012 . . . . 72.42 108.406 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.1 mt -118.42 161.78 19.41 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.072 1.349 . . . . 73.45 108.148 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -152.02 154.84 36.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.569 1.548 . . . . 72.14 106.976 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -88.65 144.74 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.264 1.426 . . . . 71.35 108.918 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 -1.33 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 54.44 113.38 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 142' ' ' LYS . 4.1 pt 31.86 -76.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 129.171 2.989 . . . . 75.24 117.112 173.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' H ' HG13 ' A' ' 141' ' ' ILE . 39.7 ttmt -118.28 131.75 56.33 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.991 1.716 . . . . 70.21 108.459 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.65 121.72 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.634 1.174 . . . . 50.1 108.331 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -145.14 -169.47 3.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.361 1.464 . . . . 73.31 108.057 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -135.27 166.07 23.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.547 1.139 . . . . 73.52 109.572 -171.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.55 129.85 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.907 -1.516 . . . . 74.02 106.907 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.88 113.89 19.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.679 -1.971 . . . . 73.52 105.679 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -127.6 132.64 49.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.131 1.772 . . . . 74.11 108.864 -165.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -134.16 42.07 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.263 -0.898 . . . . 53.31 109.8 -157.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.0 -175.38 15.17 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.478 1.513 . . . . 70.42 111.44 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -72.15 147.46 46.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.72 -0.845 . . . . 75.25 108.72 161.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 27.7 pt -124.7 127.08 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.533 1.933 . . . . 72.52 106.472 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -112.83 162.12 16.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.815 -1.179 . . . . 73.41 107.815 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.28 164.09 35.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 44.1 109.601 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 67.5 mt -120.31 164.22 16.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.876 1.27 . . . . 64.32 111.137 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.7 m -101.31 -34.04 9.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.258 -1.337 . . . . 74.21 112.703 -164.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 17.5 t 24.52 74.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 130.325 3.45 . . . . 64.01 111.548 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -78.81 -9.0 59.31 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.307 -0.871 . . . . 75.01 112.043 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -62.15 1.75 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.116 2.166 . . . . 75.14 108.594 -168.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -120.73 5.17 10.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.639 0.977 . . . . 71.03 113.639 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.41 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 15.3 m170 52.97 23.9 3.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.673 1.589 . . . . 73.13 112.267 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.11 136.89 20.49 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 119.542 -1.974 . . . . 73.32 108.878 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 3.7 p90 -141.15 167.56 21.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.829 0.852 . . . . 74.41 110.981 -173.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 mm -103.12 134.13 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 124.37 1.068 . . . . 74.45 108.423 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.43 138.4 14.44 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.517 1.527 . . . . 73.45 108.702 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.72 170.96 20.35 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 125.338 1.446 . . . . 41.04 109.631 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -72.39 164.14 26.83 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.821 -1.988 . . . . 63.22 109.917 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 68.59 -74.47 0.08 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.474 2.309 . . . . 73.2 114.934 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -121.45 -15.65 8.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.316 1.446 . . . . 65.4 112.442 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 74.89 161.64 8.85 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 122.332 0.962 . . . . 71.14 114.128 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.582 ' CE1' HG23 ' A' ' 97' ' ' ILE . 19.1 m-85 -112.01 163.53 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.761 2.425 . . . . 45.41 107.228 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -92.57 117.19 29.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.062 0.846 . . . . 73.0 108.917 166.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.419 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 26.8 m -97.03 173.11 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 119.862 1.21 . . . . 71.51 108.989 173.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.0 m -66.56 147.83 52.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.107 -1.072 . . . . 64.44 108.107 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -121.79 159.99 25.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.943 0.897 . . . . 45.14 108.62 161.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 106.35 -1.722 . . . . 74.14 106.35 152.196 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 106.678 -1.601 . . . . 64.54 106.678 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.436 HD21 ' HB1' ' A' ' 165' ' ' ALA . 4.8 mp -88.33 157.9 18.59 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.752 0.821 . . . . 72.25 109.985 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -61.68 156.3 20.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.456 1.102 . . . . 53.1 111.13 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.04 -40.13 60.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.07 1.348 . . . . 72.02 112.63 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.63 1.9 54.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.267 -0.873 . . . . 72.41 112.714 -165.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' OE1' ' HE2' ' A' ' 167' ' ' LYS . 11.8 mm-40 -77.95 140.29 62.26 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 120.592 1.542 . . . . 73.24 111.336 -164.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.19 133.74 13.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.771 2.314 . . . . 73.32 112.056 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 pt -102.99 -2.09 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.163 1.171 . . . . 72.42 114.163 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 22' ' ' ILE . 49.5 m-85 55.48 66.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.591 1.156 . . . . 55.55 112.391 176.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.7 mt -58.25 153.31 15.47 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.683 -0.636 . . . . 74.32 110.709 167.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 m -62.98 -31.79 72.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.486 1.514 . . . . 73.1 113.288 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -28.67 41.47 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.26 0.936 . . . . 72.51 110.352 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.1 13.56 5.89 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.419 -0.656 . . . . 62.23 112.73 159.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -45.5 -53.33 9.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 127.705 2.402 . . . . 74.32 113.575 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.444 HD11 ' CE2' ' A' ' 16' ' ' TYR . 7.8 mm 56.69 111.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.842 2.457 . . . . 75.44 107.907 -157.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.98 161.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.702 -1.592 . . . . 51.25 106.702 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -71.14 129.79 39.84 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.279 1.032 . . . . 53.44 108.946 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 tt -48.68 -42.44 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.824 1.65 . . . . 72.1 110.839 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.66 -47.47 61.6 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.268 -1.295 . . . . 44.25 110.966 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -57.41 -46.62 83.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.345 1.573 . . . . 73.23 110.877 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.71 -55.59 32.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.058 0.943 . . . . 75.33 110.449 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 33' ' ' PHE . 52.6 t -56.83 -45.23 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.322 1.049 . . . . 51.32 110.057 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.93 -34.7 79.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.265 1.026 . . . . 63.03 111.501 -167.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 8.4 ttpt -51.96 -53.3 42.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.472 1.109 . . . . 44.4 108.545 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 29.4 m-85 -70.68 -34.19 71.72 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 118.967 -0.54 . . . . 72.23 109.723 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.5 m-30 -63.74 -39.54 94.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.088 1.313 . . . . 62.23 111.337 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -42.26 74.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.788 1.235 . . . . 73.03 110.535 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -78.95 -53.84 6.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.312 0.645 . . . . 64.34 109.49 -173.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.79 42.48 1.1 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.439 2.296 . . . . 74.43 107.028 -170.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.96 -34.34 59.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.666 -1.272 . . . . 71.31 111.521 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -60.21 -35.26 75.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.181 0.992 . . . . 74.34 112.406 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.48 -0.91 43.93 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.597 1.159 . . . . 42.25 112.91 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.77 94.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.394 -1.336 . . . . 62.35 107.394 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -79.54 154.9 28.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.792 -1.188 . . . . 75.11 107.792 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -111.88 156.96 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.086 -1.079 . . . . 51.21 108.086 160.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.33 168.78 12.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.955 -1.128 . . . . 60.3 107.955 159.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -59.57 -48.35 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.93 0.892 . . . . 71.35 109.39 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.09 -3.47 13.4 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.707 1.002 . . . . 52.22 113.707 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.87 20.84 45.15 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 121.302 -0.874 . . . . 75.44 114.187 159.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.73 -86.02 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.14 1.776 . . . . 74.03 110.14 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.43 125.42 2.73 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.074 1.321 . . . . 45.22 110.263 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -136.82 169.91 16.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 61.54 111.452 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 33' ' ' PHE . 19.5 mt -144.47 144.5 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.289 2.235 . . . . 73.42 106.398 164.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.91 125.8 34.26 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.217 1.407 . . . . 71.34 109.684 167.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.91 8.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.809 0.844 . . . . 74.34 111.054 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.22 -40.65 60.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.52 1.054 . . . . 41.53 112.346 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -59.98 -9.3 2.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.239 2.216 . . . . 75.15 114.402 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -70.05 -22.36 63.09 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.474 1.034 . . . . 72.03 112.588 170.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.13 7.03 3.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 120.125 1.33 . . . . 73.31 114.27 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.02 118.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.649 1.18 . . . . 74.24 108.117 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -85.44 155.17 21.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.411 1.1 . . . . 61.41 110.184 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 17.9 tt -135.07 155.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.652 1.981 . . . . 62.52 107.732 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 60' ' ' LYS . 5.9 mmpt? -69.4 118.94 12.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.709 -1.589 . . . . 44.44 106.709 167.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -110.73 -175.98 2.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.59 -2.004 . . . . 72.2 105.59 165.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 125.14 16.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.331 -1.729 . . . . 74.45 106.331 172.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -73.72 99.52 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.921 -1.14 . . . . 74.24 107.921 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -54.89 -23.23 17.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 124.849 1.26 . . . . 74.34 112.08 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -26.31 24.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.06 1.344 . . . . 75.23 112.605 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.0 m -144.95 16.43 1.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.482 1.113 . . . . 71.01 112.361 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp 53.41 45.6 28.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.835 1.198 . . . . 73.23 111.37 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -113.95 159.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.28 1.032 . . . . 52.12 109.945 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.7 mm -79.32 142.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.92 -1.511 . . . . 74.11 106.92 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -131.31 162.27 30.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.984 1.374 . . . . 65.24 110.667 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.07 127.96 36.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.207 -2.146 . . . . 71.12 105.207 165.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -154.43 148.26 25.51 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 117.005 -1.474 . . . . 73.22 107.823 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.97 161.73 18.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 122.351 2.342 . . . . 65.13 111.307 168.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.62 ' H ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -80.92 165.67 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.947 -1.501 . . . . 62.24 106.947 166.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.432 ' H ' HG22 ' A' ' 74' ' ' ILE . 17.9 mt -127.28 -42.75 1.67 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.493 1.517 . . . . 63.53 110.771 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -134.58 154.83 51.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.409 1.458 . . . . 73.41 110.231 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.413 HG21 HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -123.62 162.06 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.884 1.674 . . . . 74.44 108.404 177.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -137.31 158.94 43.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.478 1.111 . . . . 74.14 110.567 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -142.07 145.99 34.95 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.761 1.624 . . . . 64.34 107.159 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -147.53 151.58 36.57 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.887 -1.153 . . . . 72.0 107.887 160.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.96 140.91 47.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.631 -0.878 . . . . 44.13 108.631 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -144.76 150.05 36.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.878 1.671 . . . . 73.13 107.268 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.2 p -143.38 138.27 29.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 104.979 -2.23 . . . . 55.33 104.979 155.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.6 -178.4 35.73 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 120.781 1.628 . . . . 74.11 111.11 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 119.53 30.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.491 -0.417 . . . . 74.01 110.812 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -88.88 164.59 15.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.986 1.314 . . . . 63.21 108.209 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mm -78.35 142.63 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 106.615 -1.624 . . . . 72.13 106.615 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -133.04 74.65 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.423 -1.695 . . . . 72.45 106.423 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.1 mt -78.01 121.51 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.683 -2.34 . . . . 73.45 104.683 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 m -107.62 164.48 12.19 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.687 -1.598 . . . . 73.32 106.687 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -132.84 175.09 9.66 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.84 0.745 . . . . 65.31 111.306 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -66.34 -22.65 66.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.9 -1.125 . . . . 72.12 112.448 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -69.71 -1.07 8.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.889 0.876 . . . . 71.02 112.514 170.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 57.75 25.26 11.65 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.443 -1.411 . . . . 73.54 110.187 -162.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.24 24.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.491 -1.3 . . . . 64.31 107.491 165.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 22.5 mt-10 -161.42 162.01 30.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.443 -0.947 . . . . 74.31 108.443 -166.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.565 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -148.42 160.18 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.74 1.216 . . . . 74.43 110.268 174.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.91 96.52 2.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.172 1.389 . . . . 53.41 109.917 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.19 -179.86 7.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.14 2.176 . . . . 62.41 109.836 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 p -68.47 165.81 18.18 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.22 0.918 . . . . 62.41 111.323 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.28 -24.26 64.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.923 -0.486 . . . . 75.34 110.54 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -115.56 81.05 1.52 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.189 1.396 . . . . 74.03 107.896 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 156.72 76.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.691 -0.631 . . . . 75.12 111.427 150.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -89.48 149.82 5.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.27 3.313 . . . . 71.23 115.93 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 173' ' ' VAL . 0.4 OUTLIER -156.91 -173.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 111.459 -2.61 . . . . 73.42 107.7 -174.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -132.55 141.18 48.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.468 -1.696 . . . . 65.52 112.288 -171.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.73 157.82 26.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.015 0.926 . . . . 74.3 110.047 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.01 105.64 12.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.455 1.121 . . . . 64.43 109.24 173.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -76.37 66.68 2.47 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 107.155 -1.424 . . . . 73.35 107.155 148.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 1.0 OUTLIER 70.26 -15.13 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.989 2.515 . . . . 55.34 115.375 170.13 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.24 -21.08 0.12 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 126.288 1.899 . . . . 52.03 109.025 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -78.46 144.54 35.69 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 105.362 -2.088 . . . . 71.22 105.362 166.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -102.04 95.53 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.503 1.521 . . . . 73.2 107.835 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.3 154.46 17.18 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.833 1.253 . . . . 62.23 108.671 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -114.05 111.84 22.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.51 1.524 . . . . 64.13 111.881 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.09 179.39 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.214 1.005 . . . . 70.31 111.231 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -99.26 148.49 24.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.081 1.752 . . . . 75.24 109.936 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.4 -26.8 65.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 118.102 0.41 . . . . 73.31 110.385 -161.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.66 67.34 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.313 -0.867 . . . . 64.12 113.231 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.6 -29.64 46.19 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.328 1.051 . . . . 51.41 112.086 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 140' ' ' VAL . 11.4 t -73.83 63.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.508 2.323 . . . . 74.15 109.89 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -78.78 178.17 8.12 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.435 1.094 . . . . 74.53 108.187 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.03 -20.94 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.077 1.751 . . . . 63.3 113.666 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.18 -2.78 87.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.876 -1.513 . . . . 35.33 113.439 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.12 159.71 16.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.459 2.129 . . . . 71.24 111.039 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.5 103.53 11.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.72 1.608 . . . . 71.54 109.066 170.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.87 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.53 1.532 . . . . 65.34 107.327 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.13 115.36 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.789 -0.819 . . . . 74.43 108.789 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 pt -102.56 154.03 37.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 123.297 0.639 . . . . 73.22 110.766 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.7 138.26 28.81 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.117 1.878 . . . . 72.5 107.944 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.63 175.46 5.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.313 -1.366 . . . . 74.23 107.313 162.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -25.06 -61.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.873 2.069 . . . . 75.11 115.246 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -121.05 1.19 10.34 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.704 1.202 . . . . 72.1 113.077 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -143.74 -175.36 4.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.853 2.061 . . . . 73.42 109.353 -139.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -120.11 147.99 23.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.87 -1.159 . . . . 70.53 107.87 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -137.1 -178.18 5.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.856 2.462 . . . . 72.41 106.896 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.51 164.4 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.836 1.254 . . . . 75.23 108.115 168.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -156.85 159.12 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.183 -1.784 . . . . 71.12 106.183 167.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -104.29 138.16 41.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.103 1.361 . . . . 70.5 109.325 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.51 HG21 HG12 ' A' ' 121' ' ' VAL . 25.1 t -71.08 -0.27 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 114.146 1.165 . . . . 74.51 114.146 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 25.93 -89.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 127.029 2.131 . . . . 72.05 114.924 174.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -92.65 113.23 25.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.257 -0.902 . . . . 62.3 109.267 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.14 144.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.36 -0.978 . . . . 73.32 108.36 156.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -156.2 -172.14 3.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.904 2.482 . . . . 72.33 106.291 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -124.53 142.76 51.09 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.869 -1.16 . . . . 73.34 107.869 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.46 -179.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.628 1.171 . . . . 63.41 108.566 166.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -126.39 138.31 53.54 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.982 2.513 . . . . 73.42 106.75 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.4 t80 -151.49 151.23 31.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.448 1.099 . . . . 73.05 109.111 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.98 78.27 0.45 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.245 -1.761 . . . . 74.23 106.245 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -151.27 23.78 0.97 Allowed Glycine 0 N--CA 1.468 0.822 0 CA-C-N 113.807 -1.542 . . . . 74.5 113.886 -164.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 54.77 -179.29 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.479 0.712 . . . . 72.14 110.962 -151.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.2 pt -145.78 160.19 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.703 2.401 . . . . 73.2 106.699 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -137.21 147.52 45.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.197 1.799 . . . . 42.14 108.617 -166.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -147.7 167.56 24.33 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.669 1.122 . . . . 70.0 111.56 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.5 126.48 31.18 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 127.987 2.515 . . . . 70.04 108.149 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.6 m -61.61 -53.32 57.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.102 0.561 . . . . 72.02 112.46 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.305 3.5 t 24.38 64.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 128.018 2.527 . . . . 65.24 112.385 -164.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -79.2 0.06 29.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.958 1.303 . . . . 71.34 111.472 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -64.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.919 1.688 . . . . 71.12 110.887 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.7 -0.31 14.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.253 0.621 . . . . 63.1 111.841 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.2 m80 61.95 27.89 16.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.453 1.901 . . . . 73.14 110.734 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.1 143.22 24.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.619 1.568 . . . . 73.15 108.123 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.658 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 0.4 OUTLIER -145.6 -179.38 6.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.199 1.0 . . . . 70.54 111.261 -173.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.73 124.01 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 107.631 -1.248 . . . . 64.41 107.631 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -155.79 146.07 21.69 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.801 0.44 . . . . 63.42 110.528 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.91 -169.06 32.45 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 108.326 -1.91 . . . . 74.33 108.326 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.461 ' HE2' ' OE1' ' A' ' 13' ' ' GLU . 74.0 mttt -99.51 177.84 5.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 119.879 1.839 . . . . 62.32 110.039 162.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 60.26 -78.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 129.198 2.999 . . . . 74.24 113.037 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.57 -8.1 8.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.326 1.45 . . . . 75.51 113.866 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 67.4 153.04 0.3 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.106 1.336 . . . . 75.5 114.92 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 97' ' ' ILE . 43.9 m-85 -107.55 159.01 16.76 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.048 2.139 . . . . 70.54 108.662 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -96.58 74.58 2.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 127.11 2.164 . . . . 72.24 109.184 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 105' ' ' VAL . 3.2 m -105.03 171.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.827 -0.546 . . . . 61.31 110.687 -164.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 m -71.18 159.24 35.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.073 0.549 . . . . 75.14 110.676 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.658 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -136.03 165.49 25.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.587 2.755 . . . . 63.34 108.028 169.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 119.063 0.847 . . . . 74.41 109.655 150.523 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.666 -0.864 . . . . 74.41 108.666 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.5 157.13 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.943 1.697 . . . . 74.42 109.437 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.5 159.4 30.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.636 0.775 . . . . 64.42 112.024 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.1 t80 -54.52 -39.76 67.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.955 1.702 . . . . 65.15 112.916 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -101.59 19.82 17.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.238 1.815 . . . . 71.24 110.952 -170.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -77.64 121.61 84.55 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.223 -2.14 . . . . 74.42 105.223 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.6 138.51 54.62 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 120.52 0.813 . . . . 55.42 110.302 171.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 pt -108.54 143.25 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 122.647 1.213 . . . . 72.13 108.164 160.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.441 ' CE2' HD11 ' A' ' 22' ' ' ILE . 11.4 m-85 -103.3 99.41 9.25 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.925 -2.62 . . . . 65.45 103.925 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 1.8 mm? -52.45 165.77 0.23 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.186 -0.672 . . . . 74.24 109.186 166.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -48.89 -43.93 39.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.526 0.73 . . . . 63.4 109.516 166.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.71 -35.66 80.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.329 0.492 . . . . 65.4 112.329 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.0 9.12 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.243 0.925 . . . . 73.13 112.13 -171.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -20.96 15.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.49 1.516 . . . . 74.21 114.955 -170.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 16' ' ' TYR . 27.1 mm 46.95 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 128.35 2.66 . . . . 74.41 110.631 -168.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.2 144.29 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 114.841 -1.072 . . . . 73.42 108.383 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -61.78 126.3 26.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 105.913 -1.884 . . . . 64.01 105.913 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -49.89 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 63.53 108.953 165.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -56.65 -57.42 19.6 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-O 117.941 -1.477 . . . . 55.3 112.521 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -52.46 -51.57 58.64 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.486 1.914 . . . . 71.14 111.384 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.93 -52.04 61.87 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 125.837 1.655 . . . . 74.2 109.778 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 153' ' ' TYR . 73.4 t -76.86 -36.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.891 -1.05 . . . . 63.21 110.443 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.06 -36.05 80.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.661 0.664 . . . . 71.23 111.724 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -55.04 -42.69 72.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.323 1.049 . . . . 64.21 109.94 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -67.02 -43.99 81.4 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.1 -1.0 . . . . 75.11 110.093 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -60.07 -33.35 71.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.894 1.225 . . . . 71.34 112.497 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -61.5 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.282 1.433 . . . . 74.23 109.514 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -73.23 -47.85 39.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.714 -1.217 . . . . 73.51 107.714 -166.452 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -94.66 40.78 1.09 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.228 1.411 . . . . 63.01 109.887 -172.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.08 -39.88 29.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.042 -1.036 . . . . 65.13 111.636 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -72.07 -22.79 61.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.993 0.738 . . . . 43.23 112.993 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -85.99 -2.28 58.14 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.722 0.809 . . . . 73.43 111.822 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.4 mt -62.88 101.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.954 -1.499 . . . . 71.22 106.954 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.58 162.22 25.46 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.12 -1.437 . . . . 60.55 107.12 161.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.88 145.47 47.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.577 -1.638 . . . . 72.13 106.577 163.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 175.24 10.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.469 -0.567 . . . . 70.32 109.469 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -61.33 -45.09 95.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.363 1.065 . . . . 74.14 108.584 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.39 -19.79 66.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.355 0.662 . . . . 63.14 110.5 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 36.19 6.1 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 120.972 -1.08 . . . . 61.45 111.489 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 3.7 t80 -78.05 -86.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.595 1.158 . . . . 74.31 109.908 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.87 121.82 2.02 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.07 -2.012 . . . . 25.31 108.07 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.26 163.65 33.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.539 1.17 . . . . 72.2 112.231 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mt -143.98 140.04 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.72 -1.585 . . . . 73.41 106.72 172.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.6 134.75 33.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.625 1.17 . . . . 71.25 109.883 172.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.01 23.09 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.767 2.027 . . . . 62.25 111.581 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . -61.06 -7.13 8.12 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.393 -1.226 . . . . 64.13 115.69 -175.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.67 -27.92 13.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.38 1.59 . . . . 71.23 113.128 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.93 -23.65 33.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.304 1.002 . . . . 52.5 111.971 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.83 15.01 3.55 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.149 1.38 . . . . 70.41 112.867 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.97 101.31 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.568 1.147 . . . . 73.45 108.269 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.35 118.68 7.79 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.829 1.252 . . . . 72.3 110.009 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 14.1 tt -98.33 160.18 3.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 125.05 1.34 . . . . 72.21 107.751 165.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.01 124.19 22.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.731 -1.581 . . . . 74.34 106.731 168.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -128.92 178.77 6.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.558 1.143 . . . . 53.11 108.116 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -153.42 127.53 9.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.143 -0.688 . . . . 53.41 109.143 -171.564 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.73 112.35 20.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.943 -1.503 . . . . 74.03 106.943 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.66 -20.39 55.81 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 113.28 0.845 . . . . 64.24 113.28 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.61 -19.9 2.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.083 2.153 . . . . 63.42 112.682 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -154.04 20.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.418 0.554 . . . . 75.1 111.301 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.16 54.36 6.07 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.272 -1.517 . . . . 62.12 112.158 -167.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 pt -101.26 169.85 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.106 1.363 . . . . 41.53 108.627 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.25 150.09 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.853 1.261 . . . . 71.52 108.634 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -157.63 174.07 15.9 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.94 2.496 . . . . 75.35 107.65 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -87.85 145.67 25.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.257 -1.386 . . . . 73.24 107.257 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -148.79 144.72 27.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.347 -1.353 . . . . 70.35 107.347 164.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -78.14 -175.15 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.857 1.208 . . . . 64.25 112.19 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.5 152.04 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.087 2.155 . . . . 61.25 107.241 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.413 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 3.0 mm? -113.07 -40.76 3.87 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 113.346 0.869 . . . . 65.41 113.346 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -145.8 164.85 30.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.691 -1.225 . . . . 71.35 107.691 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -132.43 165.99 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.744 -1.206 . . . . 74.13 107.744 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -130.93 175.47 9.04 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.909 0.884 . . . . 74.5 108.943 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.48 145.92 5.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.03 1.732 . . . . 74.12 106.925 154.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HE3' ' CD2' ' A' ' 47' ' ' PHE . 5.4 ttmt -148.48 166.42 28.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.885 -1.154 . . . . 63.24 107.885 166.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -93.45 157.5 16.18 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.524 -0.735 . . . . 74.21 109.538 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.13 147.55 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.074 1.35 . . . . 73.21 109.634 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -143.39 117.9 9.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 160.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.52 -146.6 4.65 Favored Glycine 0 N--CA 1.463 0.481 0 N-CA-C 109.911 -1.276 . . . . 74.12 109.911 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -123.5 119.21 29.3 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.036 -1.459 . . . . 74.42 110.277 174.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.16 153.98 17.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 121.547 1.976 . . . . 73.4 106.78 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -79.94 139.79 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 126.784 2.033 . . . . 74.34 108.513 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -124.65 84.47 2.28 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.733 1.613 . . . . 73.35 106.748 161.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 32.3 mt -75.2 112.13 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.005 -1.85 . . . . 73.54 106.005 162.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -75.24 178.46 5.76 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.568 -0.901 . . . . 73.43 108.568 167.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -146.19 177.11 9.24 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.61 -1.306 . . . . 74.11 109.336 154.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.1 ttmt -60.41 -27.28 67.33 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 119.503 -1.998 . . . . 63.3 113.568 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.68 18.62 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.888 1.222 . . . . 70.34 112.752 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER 58.59 15.76 3.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.728 2.411 . . . . 73.03 111.415 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ttm105 -68.49 170.49 8.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.754 2.022 . . . . 72.43 108.463 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -176.17 172.1 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.155 1.382 . . . . 70.14 109.491 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 171' ' ' PHE . 3.8 pt -143.09 178.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.011 1.324 . . . . 61.2 107.838 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 98.11 2.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.723 -0.843 . . . . 72.0 108.723 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.79 173.21 17.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.691 1.596 . . . . 73.14 110.218 -172.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.3 p -74.26 163.7 27.5 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.1 -1.0 . . . . 71.35 111.551 -173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.4 -16.46 62.96 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.287 0.847 . . . . 71.32 113.287 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -116.72 38.82 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.97 0.805 . . . . 72.24 108.893 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -89.99 129.76 44.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 117.921 -1.038 . . . . 62.31 109.613 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -60.35 126.6 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.747 3.631 . . . . 73.52 111.293 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.91 175.96 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.693 1.597 . . . . 63.41 109.123 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.79 134.68 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.494 -0.754 . . . . 62.4 111.067 -169.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.96 161.58 40.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.451 1.501 . . . . 73.34 109.059 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.471 ' HB3' HD21 ' A' ' 137' ' ' LEU . 53.2 p -87.4 127.01 35.21 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 119.416 -0.326 . . . . 44.45 110.743 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HE3' HD13 ' A' ' 114' ' ' LEU . 2.3 ttmt -104.97 75.99 1.22 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.025 -1.472 . . . . 71.21 107.025 165.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m 59.51 16.98 5.66 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.857 1.663 . . . . 72.11 114.562 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -38.6 1.42 Allowed Glycine 0 N--CA 1.448 -0.536 0 O-C-N 120.682 -1.262 . . . . 60.01 110.194 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.76 148.86 31.3 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.359 -1.349 . . . . 72.14 107.359 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.19 117.51 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.699 -1.593 . . . . 73.25 106.699 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.686 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.7 tp -105.19 132.94 50.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.076 -1.083 . . . . 63.04 108.076 166.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -81.75 125.79 31.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.235 -1.024 . . . . 73.21 108.235 161.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.45 -179.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.48 1.512 . . . . 72.11 109.21 169.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.28 145.3 24.55 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.998 0.919 . . . . 73.02 109.285 -172.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -42.55 -47.11 5.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.637 1.975 . . . . 71.02 113.762 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -32.63 54.43 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.917 0.887 . . . . 50.33 113.053 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.2 mtt -75.6 -26.41 57.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.985 0.514 . . . . 73.31 112.159 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.259 5.7 t -79.11 63.2 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.695 2.398 . . . . 73.1 112.319 -169.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.759 ' HG3' ' H ' ' A' ' 124' ' ' GLY 0.259 0.0 OUTLIER -79.43 175.09 10.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 131.07 3.748 . . . . 72.13 111.632 -174.65 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.259 5.9 p -57.88 1.67 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 126.535 1.934 . . . . 71.12 114.616 167.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.759 ' H ' ' HG3' ' A' ' 122' ' ' LYS . . . -108.28 -1.84 33.37 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.772 2.606 . . . . 24.31 111.495 171.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 156.44 21.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.88 1.84 . . . . 64.54 108.02 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.6 104.97 12.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.517 -1.29 . . . . 74.11 107.517 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 tt -81.33 136.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.401 -0.818 . . . . 75.2 109.821 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.57 129.35 38.08 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.225 -0.898 . . . . 74.53 109.099 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 161.21 60.74 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.693 1.997 . . . . 74.12 111.164 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.55 173.04 14.98 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.726 2.284 . . . . 73.32 110.639 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -134.49 -134.8 0.16 Allowed 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 120.865 -1.147 . . . . 71.13 108.665 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -51.94 -84.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.609 1.164 . . . . 72.32 108.871 169.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -121.22 0.89 10.2 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.727 1.611 . . . . 73.32 112.431 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 p -131.58 151.34 51.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.879 0.872 . . . . 75.52 112.515 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.1 147.29 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -145.78 -176.21 5.04 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.704 2.002 . . . . 63.33 107.543 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 108' ' ' SER . 5.7 mt -124.82 166.23 16.61 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -154.26 140.79 18.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.765 -1.198 . . . . 73.54 107.765 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.8 141.34 46.21 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.528 -1.286 . . . . 64.24 107.528 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 89' ' ' ILE . 3.0 t -70.48 -23.48 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.529 1.531 . . . . 75.05 113.89 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.6 pt 47.19 -53.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 131.664 3.986 . . . . 54.51 116.398 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -140.28 132.51 28.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.689 2.395 . . . . 74.3 106.827 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.76 131.01 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 107.806 -1.183 . . . . 75.42 107.806 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.14 -164.79 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.932 1.293 . . . . 73.23 108.149 171.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 p -146.9 162.27 39.02 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.322 1.049 . . . . 72.31 109.517 -162.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 3.3 m -132.51 171.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 127.388 2.275 . . . . 73.24 108.687 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.48 92.41 3.42 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.051 -1.092 . . . . 73.44 108.051 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -97.63 136.91 37.33 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.509 2.723 . . . . 73.03 108.719 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -134.54 73.34 1.48 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.024 -1.473 . . . . 74.23 107.024 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.2 -159.24 7.84 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.086 0.85 . . . . 73.42 112.912 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -102.29 154.25 19.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.8 -0.815 . . . . 74.23 108.8 163.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.65 154.23 26.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.279 1.832 . . . . 63.55 107.295 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.692 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -153.38 160.28 42.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.599 0.76 . . . . 74.35 109.69 173.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -131.74 146.03 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.098 2.159 . . . . 75.54 107.524 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.91 143.85 27.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.904 1.684 . . . . 74.13 112.718 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 83.14 3.63 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.392 -1.336 . . . . 64.3 107.392 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.21 76.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 106.145 -1.798 . . . . 64.51 106.145 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.02 -5.19 20.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.769 -0.582 . . . . 73.2 111.694 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.26 -63.97 0.95 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.901 2.08 . . . . 75.41 107.631 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -125.53 -4.85 7.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.716 2.406 . . . . 62.31 111.861 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 54.18 25.86 6.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.256 2.223 . . . . 63.44 112.775 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 p -141.49 153.68 45.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.883 1.273 . . . . 64.53 109.11 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -163.7 178.07 8.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.412 1.085 . . . . 75.21 111.208 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.9 122.21 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.204 1.402 . . . . 73.13 109.317 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.04 154.93 43.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.56 1.144 . . . . 74.3 110.054 173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.51 -171.61 21.88 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.589 -0.605 . . . . 72.34 111.589 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -91.55 166.68 12.71 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.484 -1.598 . . . . 70.05 110.015 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 61.36 -76.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 129.693 3.197 . . . . 74.43 112.032 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.89 -13.77 8.18 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.417 1.487 . . . . 74.15 112.561 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.86 171.0 18.9 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.033 1.301 . . . . 73.31 112.42 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 97' ' ' ILE . 68.8 m-85 -112.12 157.09 21.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.737 3.615 . . . . 73.2 105.322 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.467 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -103.9 110.81 23.09 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.108 -1.812 . . . . 42.03 106.108 170.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.13 175.19 6.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.619 -0.882 . . . . 64.31 108.619 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 155.24 16.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.01 -0.737 . . . . 72.23 109.01 168.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -146.78 47.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.866 2.066 . . . . 63.23 107.012 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.297 -1.001 . . . . 60.52 108.297 -171.861 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 109.844 -0.428 . . . . 74.45 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.419 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 10.0 mp -79.74 158.6 26.86 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.413 1.485 . . . . 71.51 110.919 -167.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 159.53 21.37 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.052 0.541 . . . . 35.11 112.238 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -49.29 -49.34 44.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.111 1.764 . . . . 74.34 113.84 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -98.77 45.87 1.0 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.182 2.593 . . . . 72.24 109.424 -167.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 167' ' ' LYS . 65.5 mm-40 -109.47 110.11 59.97 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.55 1.54 . . . . 74.03 107.926 169.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -51.71 134.69 47.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.516 2.811 . . . . 62.45 113.3 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 pt -96.33 -2.79 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 114.452 1.278 . . . . 61.1 114.452 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 49.56 70.43 0.49 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.01 1.277 . . . . 64.13 113.587 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 mm? -52.0 159.03 0.94 Allowed 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.865 -1.147 . . . . 44.25 110.925 167.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -53.87 -45.09 70.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.082 -1.081 . . . . 40.23 108.082 168.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.76 -4.53 9.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.133 1.373 . . . . 75.04 114.184 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.72 12.5 66.49 Favored Glycine 0 CA--C 1.523 0.584 0 O-C-N 120.287 -1.508 . . . . 62.31 112.237 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.409 ' H ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.92 -4.9 14.42 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.009 2.225 . . . . 73.03 117.009 -156.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.1 mm 27.39 87.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 130.802 3.641 . . . . 73.23 110.117 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.24 145.53 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.616 -1.624 . . . . 71.23 106.616 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.26 130.71 44.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 128.108 2.563 . . . . 75.02 105.044 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -48.72 -43.4 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.434 0.694 . . . . 74.21 110.318 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.37 -4.9 83.12 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.49 -1.728 . . . . 50.21 114.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -82.54 -45.37 14.75 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.761 1.78 . . . . 74.42 108.788 167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -55.49 -55.43 31.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.275 0.63 . . . . 74.53 109.653 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG22 ' HA2' ' A' ' 26' ' ' GLY . 22.8 m -65.78 -34.76 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 118.428 -0.796 . . . . 55.44 110.186 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -45.73 72.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.923 1.238 . . . . 75.11 110.893 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.07 -37.48 53.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.765 0.826 . . . . 63.12 110.011 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -83.77 -45.01 13.81 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.564 -1.207 . . . . 64.12 110.829 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -54.72 -30.23 55.51 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 121.825 2.102 . . . . 74.04 112.708 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -94.36 -11.04 30.76 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.783 1.233 . . . . 64.2 112.495 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 17.6 mttm -95.89 -63.91 1.11 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.001 -1.111 . . . . 74.21 108.001 168.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 4.8 m-30 -84.84 39.73 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.185 2.994 . . . . 71.43 108.419 -168.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -49.52 -45.66 47.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.07 2.548 . . . . 61.32 109.506 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -62.88 -35.1 78.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.967 0.907 . . . . 73.43 110.925 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 t -79.87 -7.95 59.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.823 2.049 . . . . 54.31 113.42 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.39 107.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.961 -1.126 . . . . 72.01 107.961 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -84.49 155.21 22.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.626 -1.62 . . . . 75.23 106.626 162.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -121.21 135.05 55.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.741 -1.578 . . . . 62.44 106.741 164.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.79 176.96 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 125.665 1.853 . . . . 74.42 110.679 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.58 -38.5 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.666 1.987 . . . . 72.43 111.801 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.67 52.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.681 0.793 . . . . 73.12 111.738 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.68 12.76 62.11 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.785 1.66 . . . . 44.41 112.644 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.84 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.157 1.783 . . . . 64.33 111.423 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.76 124.96 2.55 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 118.263 -1.299 . . . . 50.25 110.406 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -140.71 166.32 25.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.456 1.128 . . . . 74.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -146.07 135.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.946 2.098 . . . . 64.53 106.636 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.19 128.97 36.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.396 0.678 . . . . 44.03 110.253 167.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.86 9.54 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.043 0.937 . . . . 64.34 111.268 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.07 -16.2 59.5 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 120.785 -1.197 . . . . 54.21 114.416 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -68.81 -32.42 72.12 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.261 1.53 . . . . 72.24 111.81 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.57 -13.09 38.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.479 0.582 . . . . 71.5 112.31 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.84 19.83 10.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.205 2.202 . . . . 74.52 112.756 172.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.24 119.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.905 1.282 . . . . 63.03 108.506 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -88.79 142.52 27.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.181 0.992 . . . . 71.32 111.5 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 6.7 tt -133.64 154.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.411 1.884 . . . . 74.04 108.641 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -73.01 126.73 30.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 110.133 -0.321 . . . . 71.41 110.133 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.04 166.84 16.23 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.562 1.945 . . . . 71.12 108.198 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.56 154.61 46.88 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.933 -1.506 . . . . 73.43 106.933 179.043 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.68 141.12 46.84 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 118.632 -1.227 . . . . 60.44 108.377 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -86.14 -22.9 26.81 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.583 -0.698 . . . . 75.33 112.019 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.7 -50.04 66.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.671 1.988 . . . . 73.15 110.64 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.0 m -141.27 9.6 2.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.567 1.947 . . . . 71.43 110.794 -162.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.05 52.17 15.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.207 2.203 . . . . 71.41 111.12 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.06 -175.62 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.352 0 O-C-N 124.185 0.928 . . . . 73.43 109.688 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mm -116.86 125.42 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 127.528 2.331 . . . . 72.43 104.883 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -142.85 169.27 17.89 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.869 1.268 . . . . 72.3 108.776 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -110.0 143.58 39.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.625 1.57 . . . . 74.44 110.011 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -150.92 168.08 25.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.657 1.983 . . . . 72.42 107.252 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -93.49 172.23 8.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.12 0.968 . . . . 70.15 110.38 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.04 144.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 105.507 -2.034 . . . . 62.43 105.507 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.8 -34.41 6.46 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.538 0.524 . . . . 64.41 111.217 -172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -144.44 137.75 27.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.97 1.259 . . . . 73.35 108.77 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.96 167.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 124.403 1.064 . . . . 61.23 109.714 168.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -138.13 159.96 40.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.321 1.048 . . . . 73.32 109.685 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 8.3 tmm_? -153.57 140.68 19.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.441 1.496 . . . . 64.44 108.881 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -146.1 161.38 40.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.846 -1.168 . . . . 62.55 107.846 165.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -92.02 146.47 23.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.073 -1.084 . . . . 54.41 108.073 168.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 86' ' ' LEU . 33.9 t80 -152.33 145.68 24.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.775 0.83 . . . . 70.43 110.007 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -142.33 114.8 8.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.854 1.662 . . . . 63.34 109.281 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.06 40.78 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.441 1.019 . . . . 71.42 111.528 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.58 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.05 142.55 36.43 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 122.122 -0.634 . . . . 75.02 110.353 -174.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 98' ' ' THR . 10.8 mp -127.69 160.38 31.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.81 1.644 . . . . 73.32 108.375 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 89' ' ' ILE . 21.5 mm -80.08 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.035 2.134 . . . . 61.23 108.229 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -128.78 75.23 1.63 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 159.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.493 ' H ' HG22 ' A' ' 87' ' ' ILE . 23.3 mt -62.85 139.33 21.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.943 -2.243 . . . . 60.21 104.943 158.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -114.33 172.0 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.699 -1.593 . . . . 40.13 106.699 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 p -136.91 175.81 9.28 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.919 -1.113 . . . . 72.45 110.566 162.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -62.51 -25.69 68.15 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.619 -0.676 . . . . 74.53 111.669 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.95 7.79 2.96 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.877 1.271 . . . . 62.12 112.969 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.56 20.58 7.74 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.216 1.407 . . . . 75.02 110.818 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -71.38 161.92 30.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.661 1.185 . . . . 63.25 108.058 166.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -176.17 171.0 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.003 0.921 . . . . 61.03 108.902 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.598 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.3 pt -145.82 170.92 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.722 1.609 . . . . 73.12 110.65 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 86' ' ' LEU . 2.3 m -148.09 95.23 2.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.278 1.431 . . . . 62.44 109.428 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.94 177.82 10.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.938 1.695 . . . . 70.04 110.498 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 p -66.62 164.02 17.65 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.569 1.148 . . . . 64.31 110.638 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.265 1.1 p-80 -68.51 -24.31 64.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.513 0.931 . . . . 62.12 113.513 173.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.93 36.49 2.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.229 1.377 . . . . 64.54 111.336 -168.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -88.17 137.52 31.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.922 -1.037 . . . . 51.41 110.156 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.69 125.42 13.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.208 2.606 . . . . 73.22 111.194 172.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.87 -173.79 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.569 1.947 . . . . 74.52 108.361 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -129.02 140.35 51.67 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.882 0.764 . . . . 71.32 111.146 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.26 172.45 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.961 1.305 . . . . 71.44 108.1 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 p -87.55 144.76 26.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.934 0.873 . . . . 63.44 112.2 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -118.21 80.37 1.51 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.617 -1.623 . . . . 71.1 106.617 158.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 m 62.51 8.58 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.34 1.456 . . . . 71.43 114.339 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.63 -20.3 3.3 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 120.839 -1.163 . . . . 71.44 111.314 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.17 136.73 37.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.23 -2.137 . . . . 63.5 105.23 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.12 117.76 18.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.219 -1.771 . . . . 72.0 106.219 164.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.63 138.99 53.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.508 1.523 . . . . 74.11 108.969 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.14 122.64 39.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.212 1.405 . . . . 72.51 109.314 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.9 pt -142.66 -178.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.76 1.224 . . . . 63.23 110.944 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.61 145.61 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.196 1.398 . . . . 62.54 110.704 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.87 45.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.801 1.64 . . . . 74.41 112.868 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -28.08 68.89 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.706 -1.246 . . . . 64.22 112.002 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -32.02 39.52 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.375 0.67 . . . . 52.44 112.323 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.296 7.9 p -76.92 63.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.507 1.123 . . . . 65.54 111.414 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -79.39 -175.34 4.66 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.698 1.199 . . . . 75.42 108.522 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.53 -0.61 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.564 1.546 . . . . 73.23 112.991 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.45 -1.13 75.21 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.506 -1.163 . . . . 55.53 112.229 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.09 175.91 8.04 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.732 1.766 . . . . 73.02 110.596 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.93 104.52 7.85 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.755 -1.942 . . . . 73.01 105.755 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.36 129.7 37.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.262 -1.755 . . . . 75.25 106.262 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -69.72 127.8 34.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.228 -1.397 . . . . 64.24 107.228 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 129' ' ' ILE . 1.8 pp -124.99 159.95 56.64 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.332 1.053 . . . . 72.22 112.81 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.89 145.1 49.72 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.219 1.946 . . . . 63.13 109.393 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.91 -167.8 1.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.498 -1.667 . . . . 45.53 106.498 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -24.07 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 128.595 2.758 . . . . 54.05 111.639 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -122.27 0.05 9.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.632 2.086 . . . . 54.11 116.632 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.5 p -138.07 169.23 18.15 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.2 0.6 . . . . 74.34 111.482 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.88 150.75 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.956 -1.09 . . . . 73.53 109.553 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -142.59 -176.64 4.94 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.293 1.837 . . . . 71.44 109.289 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.23 161.17 15.49 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.766 1.227 . . . . 72.13 111.915 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -158.02 136.0 10.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.254 1.822 . . . . 72.22 107.819 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.52 153.64 43.2 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.046 0.938 . . . . 61.42 110.341 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -93.25 -2.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 64.52 112.955 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pt 25.49 -91.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 128.023 2.529 . . . . 60.24 116.149 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -88.06 122.73 31.99 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.355 1.462 . . . . 62.44 107.46 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.97 102.83 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.709 -1.219 . . . . 74.1 107.709 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -131.57 -173.9 3.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 60.31 108.003 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 p -125.21 168.31 13.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.043 0.937 . . . . 53.23 110.013 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.37 174.07 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.276 2.231 . . . . 73.01 106.476 168.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -123.21 105.77 10.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.018 -1.475 . . . . 64.44 107.018 165.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -100.5 136.96 39.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.871 1.268 . . . . 64.15 110.096 -168.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.52 51.51 1.92 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.258 0.623 . . . . 74.42 109.994 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.09 -113.96 1.6 Allowed Glycine 0 N--CA 1.463 0.484 0 O-C-N 121.091 -1.006 . . . . 64.55 111.568 -167.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -139.7 157.51 45.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.428 1.891 . . . . 73.44 107.491 170.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.1 pt -124.55 153.97 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.281 1.432 . . . . 72.13 109.396 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.599 ' CD2' HG21 ' A' ' 29' ' ' VAL . 7.3 m-85 -148.72 165.88 30.08 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.819 1.648 . . . . 73.33 107.533 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -167.41 167.73 13.61 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.983 -0.747 . . . . 74.35 108.983 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.26 115.41 16.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.436 2.295 . . . . 74.42 108.501 -163.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.4 m -74.35 119.46 18.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.914 -1.513 . . . . 71.13 106.914 159.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.1 73.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.753 -2.314 . . . . 52.03 104.753 171.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.96 -3.08 3.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.221 1.408 . . . . 73.33 113.642 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -103.06 -42.11 5.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.686 2.394 . . . . 71.05 108.264 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 162' ' ' THR . 1.9 t30 -146.73 79.98 1.53 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.981 -2.229 . . . . 72.41 104.981 -168.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.25 13.94 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.701 2.401 . . . . 71.23 112.958 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.457 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 13.1 p -132.65 124.1 27.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.456 2.702 . . . . 74.3 106.602 -172.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.517 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.2 172.94 13.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.851 0.461 . . . . 74.24 112.186 -164.195 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 mm -108.0 121.49 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 106.925 -1.509 . . . . 60.13 106.925 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -146.98 152.68 39.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.58 -0.526 . . . . 70.22 109.58 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.82 -160.73 25.76 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.045 -1.222 . . . . 60.43 110.045 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.474 ' HE3' ' OE2' ' A' ' 13' ' ' GLU . 67.8 mttt -109.31 171.53 7.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.125 0.962 . . . . 63.03 110.946 172.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.01 -73.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.64 2.776 . . . . 75.22 112.301 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -121.49 -11.05 8.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.417 1.887 . . . . 74.34 113.587 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.67 7.99 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 122.522 1.068 . . . . 54.13 111.868 -167.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.598 ' CE1' HG23 ' A' ' 97' ' ' ILE . 35.6 m-85 -108.61 156.61 19.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.771 2.429 . . . . 71.4 105.753 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -100.48 113.62 26.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.394 -1.335 . . . . 63.04 107.394 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.9 m -144.13 -177.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.632 1.173 . . . . 74.44 109.662 -163.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.08 126.85 31.59 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.302 -0.874 . . . . 73.53 110.685 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -107.23 48.36 0.84 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.727 1.611 . . . . 42.41 107.403 156.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.674 -1.232 . . . . 72.1 107.674 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 108.594 -0.891 . . . . 72.14 108.594 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 165' ' ' ALA . 6.0 tp -98.44 -13.76 20.41 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 115.894 1.812 . . . . 74.31 115.894 -171.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . 96.63 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 1 C-N-CA 132.777 4.431 . . . . 60.52 111.644 -166.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.39 -39.83 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.651 2.78 . . . . 65.13 109.545 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.96 26.83 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.118 2.167 . . . . 43.33 110.026 -170.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.24 111.8 36.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 127.146 2.178 . . . . 73.53 108.777 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 106.31 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.443 2.762 . . . . 61.54 108.651 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.45 167.87 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.582 1.083 . . . . 65.25 110.142 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -128.21 64.48 1.4 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.477 1.111 . . . . 73.32 111.61 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -45.63 150.71 0.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 120.425 -1.422 . . . . 74.25 112.624 161.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -15.0 53.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.768 1.292 . . . . 51.15 112.98 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.44 -18.28 22.51 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.181 0.9 . . . . 72.21 112.62 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.87 38.32 8.75 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.125 1.345 . . . . 64.34 111.043 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.94 -18.62 64.42 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.614 1.207 . . . . 64.1 113.301 -170.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mm 47.85 87.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 128.488 2.715 . . . . 65.34 109.863 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 150.31 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 52.14 106.996 -170.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -61.08 130.26 45.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.729 -1.211 . . . . 65.32 107.729 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -53.73 -39.34 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.301 0.501 . . . . 62.12 110.018 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 10.27 63.95 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.833 -0.982 . . . . 74.11 114.26 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -55.45 3.75 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.785 1.793 . . . . 63.24 108.689 153.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -48.56 -52.58 22.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.733 1.613 . . . . 74.31 109.435 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 77' ' ' VAL . 49.1 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.709 -0.678 . . . . 74.22 110.916 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -30.46 70.9 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 120.914 -1.116 . . . . 71.44 110.871 -173.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -52.37 -49.7 63.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.294 0.952 . . . . 75.44 109.17 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -66.09 -43.55 86.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.04 -1.096 . . . . 63.22 108.04 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.54 -35.47 72.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.132 1.333 . . . . 74.45 112.388 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -83.22 -15.26 51.09 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.935 1.294 . . . . 73.55 111.704 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -97.98 -59.19 1.81 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.341 -1.355 . . . . 72.53 107.341 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -91.47 44.01 1.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.354 2.661 . . . . 74.14 107.808 -173.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -48.33 -45.12 34.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 125.738 1.615 . . . . 75.15 109.537 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -19.8 61.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.713 -0.66 . . . . 74.24 112.469 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 m -85.82 0.26 53.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.819 1.248 . . . . 61.34 112.45 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.68 94.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.15 1.341 . . . . 75.11 108.212 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -79.59 169.69 17.64 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.912 -1.144 . . . . 63.12 107.912 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.72 154.98 48.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.85 -1.537 . . . . 71.33 106.85 163.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -81.87 171.82 14.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.312 1.007 . . . . 62.35 110.437 159.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -45.45 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.28 2.632 . . . . 63.23 110.995 175.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -64.03 -10.06 19.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.275 1.43 . . . . 62.3 112.28 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.01 7.59 57.34 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 127.383 2.421 . . . . 52.25 112.696 163.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.39 -82.06 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.452 1.901 . . . . 75.54 110.625 -163.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.96 129.48 2.72 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.897 -1.681 . . . . 64.22 108.897 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -142.59 161.89 36.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.076 0.938 . . . . 74.41 111.263 167.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.0 145.98 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.167 -2.161 . . . . 63.44 105.167 164.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.45 123.28 29.54 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.027 0.931 . . . . 75.0 108.89 165.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.89 8.5 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.652 0.381 . . . . 43.4 111.35 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.28 -18.91 61.29 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 120.789 -1.194 . . . . 70.34 113.654 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.4 -13.52 60.73 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.872 1.669 . . . . 75.05 112.49 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -61.87 -22.14 65.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.531 0.732 . . . . 63.55 110.312 163.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 63.3 -10.55 0.11 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 128.057 2.543 . . . . 64.3 114.185 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.4 mt -43.71 113.98 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.8 2.44 . . . . 71.1 109.544 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -77.02 144.01 38.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.006 -0.543 . . . . 74.53 110.041 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.6 tt -112.02 156.65 13.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.041 1.736 . . . . 73.52 107.859 163.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -66.88 93.35 0.26 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.449 -1.315 . . . . 73.43 107.449 164.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -71.39 173.8 7.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.805 -1.554 . . . . 74.4 106.805 165.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.554 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -140.39 151.59 45.07 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.656 -1.903 . . . . 73.24 106.817 166.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.516 HD22 HD11 ' A' ' 68' ' ' ILE . 17.2 t30 -101.22 114.22 27.99 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.822 1.249 . . . . 72.41 108.212 -176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -70.4 -29.47 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.34 1.856 . . . . 75.34 112.024 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -48.19 73.79 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.065 1.346 . . . . 64.54 110.74 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 t -125.39 8.06 7.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.539 0.736 . . . . 72.43 111.63 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt 66.41 51.73 1.15 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.606 1.562 . . . . 62.42 110.961 170.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 63' ' ' ASN . 11.0 pt -123.97 154.35 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.242 0.617 . . . . 61.45 110.137 -171.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.92 131.93 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.421 1.488 . . . . 64.33 107.04 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.36 178.04 7.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.344 1.458 . . . . 60.21 108.961 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -139.08 122.37 17.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.805 -1.184 . . . . 74.44 108.387 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -138.58 147.02 42.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.858 0.863 . . . . 74.43 108.801 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -77.33 147.33 36.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.144 0.578 . . . . 73.05 110.898 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -71.69 164.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.072 -1.085 . . . . 74.03 108.072 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -117.7 -50.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.902 1.281 . . . . 75.05 110.078 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.593 ' CB ' HG21 ' A' ' 156' ' ' THR 0.343 3.1 ttm180 -116.98 -176.69 3.03 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 119.061 0.846 . . . . 74.11 111.779 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -149.71 145.98 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 107.924 -1.139 . . . . 45.03 107.924 170.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -118.4 156.11 29.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.42 1.088 . . . . 74.45 109.717 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.01 136.13 11.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.567 0.747 . . . . 72.05 108.986 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -145.02 160.96 40.54 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.896 -1.52 . . . . 70.24 106.896 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 148.59 22.74 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.903 -1.123 . . . . 72.52 108.407 173.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -143.9 154.07 42.96 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.955 1.302 . . . . 71.12 110.093 -163.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -153.9 154.73 34.4 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.047 -0.723 . . . . 72.11 109.047 154.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.38 -170.14 21.03 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.347 1.451 . . . . 73.42 110.672 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -86.53 125.43 33.76 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.674 1.19 . . . . 55.41 110.523 -171.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.11 165.85 10.93 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.94 -1.504 . . . . 71.21 106.94 171.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.8 mm -81.43 149.49 4.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.396 1.478 . . . . 72.01 108.146 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -127.45 79.9 1.92 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.722 2.009 . . . . 70.32 107.7 165.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.577 HG23 HG13 ' A' ' 140' ' ' VAL . 38.9 mt -61.81 130.98 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.623 -1.992 . . . . 73.13 105.623 150.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -114.5 162.94 16.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.28 -1.748 . . . . 75.55 106.28 157.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 p -135.61 169.96 16.71 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.591 -0.892 . . . . 65.34 108.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -38.38 55.57 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.678 -1.264 . . . . 63.3 111.877 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -0.98 7.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.493 1.517 . . . . 75.23 111.747 -172.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.6 mmt-85 61.49 24.33 14.45 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 126.936 2.094 . . . . 73.45 110.258 -167.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' CD ' ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -73.87 168.18 19.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.961 -1.126 . . . . 64.11 107.961 160.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 177.55 162.42 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.27 2.628 . . . . 64.54 107.812 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.671 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -147.18 177.26 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.945 2.098 . . . . 75.53 109.338 -174.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -145.67 74.94 1.41 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.177 0.513 . . . . 73.31 111.489 -167.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.436 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -141.56 163.57 32.58 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 119.522 -1.986 . . . . 75.14 112.271 -165.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 p -68.85 161.28 28.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.516 0.726 . . . . 72.13 110.696 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.09 14.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.422 0.897 . . . . 73.01 113.422 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.18 39.16 3.58 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.153 1.797 . . . . 75.51 110.8 159.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.436 ' CG ' HD22 ' A' ' 99' ' ' LEU . 3.4 t60 -84.99 125.88 69.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.674 -1.155 . . . . 74.22 109.451 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -63.6 114.77 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.21 3.274 . . . . 63.23 111.231 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.58 162.62 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.819 -1.178 . . . . 64.41 107.819 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -101.39 140.68 35.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.841 0.856 . . . . 71.23 109.151 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.49 164.07 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.996 0.918 . . . . 75.31 109.882 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.03 120.64 31.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.846 -1.168 . . . . 64.11 107.846 173.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.471 ' CD ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -99.38 81.27 2.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.862 -2.273 . . . . 72.22 104.862 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 m 56.45 17.61 3.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.206 1.002 . . . . 71.42 113.52 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.18 1.27 47.99 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.064 -1.022 . . . . 60.51 114.062 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.89 160.3 26.08 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 105.763 -1.94 . . . . 61.22 105.763 150.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.46 145.1 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.822 -0.807 . . . . 72.31 108.822 170.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD22 ' CD ' ' A' ' 109' ' ' LYS . 4.7 tp -142.06 170.9 14.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.986 1.315 . . . . 70.53 107.701 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -112.83 138.26 49.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.794 0.838 . . . . 72.44 108.844 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 pt -142.52 179.28 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.169 1.388 . . . . 71.34 108.81 171.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -72.04 132.06 43.74 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 107.597 -1.261 . . . . 53.34 107.597 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -43.23 -35.11 1.32 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.861 1.665 . . . . 64.42 113.163 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.4 67.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.817 1.247 . . . . 74.42 112.516 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.0 -31.91 56.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.033 -1.042 . . . . 71.33 111.266 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG11 ' A' ' 140' ' ' VAL . 7.4 t -76.57 62.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.124 1.769 . . . . 74.21 110.345 -173.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -86.72 -177.09 6.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.603 1.561 . . . . 61.01 108.534 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.82 0.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.859 2.064 . . . . 64.54 113.704 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.63 -13.43 80.04 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.366 -1.797 . . . . 61.52 112.479 167.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -124.3 170.15 11.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.839 1.819 . . . . 73.31 110.031 -166.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 139' ' ' GLU . 7.6 m-85 -112.86 155.62 24.34 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.391 1.476 . . . . 75.42 108.396 165.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.73 166.83 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.624 2.369 . . . . 74.03 107.589 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 112.26 22.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.85 1.26 . . . . 74.23 110.958 -166.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.48 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.6 pp -121.54 161.43 41.56 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 124.737 1.215 . . . . 75.0 113.191 -174.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.01 154.84 33.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.887 1.725 . . . . 70.0 109.732 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -117.91 -156.69 0.65 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.1 -1.444 . . . . 72.44 107.1 162.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -59.32 -57.75 11.63 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 122.986 0.514 . . . . 72.44 111.391 -166.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -121.52 0.48 9.95 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.522 0.934 . . . . 74.13 113.522 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -139.35 -173.96 3.74 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.504 1.522 . . . . 42.12 111.027 -160.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.4 149.38 15.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.51 1.124 . . . . 74.25 109.529 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -143.28 -178.32 5.8 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.996 2.118 . . . . 72.33 108.533 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 mt -118.39 165.81 13.42 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.277 1.031 . . . . 72.4 109.386 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 33.9 p-10 -153.96 147.87 25.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.89 1.276 . . . . 63.41 111.116 173.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 32.5 tt0 -97.38 148.36 23.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.345 1.858 . . . . 65.42 111.166 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.608 HG11 ' O ' ' A' ' 121' ' ' VAL . 18.4 t -87.19 2.17 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.725 0.639 . . . . 74.41 112.725 -160.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 pt 24.68 -88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 127.522 2.329 . . . . 73.11 116.112 171.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 124.55 35.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.493 1.517 . . . . 54.32 108.088 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -129.14 122.5 56.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.43 -0.581 . . . . 71.21 109.43 170.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.88 -167.96 2.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 127.351 2.26 . . . . 61.21 107.436 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -122.45 172.17 8.55 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.555 1.142 . . . . 74.12 109.76 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.36 161.81 22.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 130.565 3.546 . . . . 64.41 104.559 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.59 133.5 51.03 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.792 -1.558 . . . . 61.15 106.792 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -144.18 155.55 43.95 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.815 0.734 . . . . 72.53 111.587 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.39 47.21 0.75 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.535 0.607 . . . . 72.45 111.884 -169.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.44 -122.7 2.29 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.585 -0.697 . . . . 63.34 114.342 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -124.34 160.57 27.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.127 0.971 . . . . 74.11 109.491 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ALA . 11.6 pt -135.04 155.55 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.578 1.951 . . . . 74.34 108.239 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -138.87 168.52 19.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.522 1.929 . . . . 72.35 107.226 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -164.62 167.34 19.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.741 1.155 . . . . 75.24 109.921 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.3 tp -137.7 113.62 9.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.275 1.583 . . . . 75.1 115.275 -149.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.593 HG21 ' CB ' ' A' ' 76' ' ' ARG . 69.1 p -55.88 -50.85 69.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.427 1.491 . . . . 71.2 114.016 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.3 t 24.55 68.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 129.5 3.12 . . . . 64.13 112.012 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.3 -5.69 58.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.106 -1.406 . . . . 63.13 111.928 -168.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -47.08 74.29 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.52 2.328 . . . . 72.22 110.91 -175.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -125.83 1.34 7.4 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.863 0.69 . . . . 73.33 112.863 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' HIS . . . . . 0.482 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 6.9 m170 55.83 30.39 15.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.022 0.929 . . . . 75.22 111.81 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 p -151.49 154.9 37.46 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.065 1.302 . . . . 75.4 110.372 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 18.3 p90 -153.23 174.95 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.595 1.089 . . . . 72.02 111.542 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 mm -99.29 124.23 52.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 63.5 108.916 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -156.4 157.69 36.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.561 1.545 . . . . 54.53 108.742 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.37 -170.35 23.91 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.912 2.672 . . . . 74.42 107.953 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -89.71 167.28 13.02 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.639 -1.506 . . . . 61.35 111.346 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.19 -74.53 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.652 2.381 . . . . 73.11 114.132 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.77 -10.02 8.78 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.531 1.932 . . . . 52.03 112.541 171.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.82 165.85 29.57 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 122.673 1.152 . . . . 51.25 112.382 -168.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.671 ' CE1' HG23 ' A' ' 97' ' ' ILE . 14.7 m-85 -105.07 158.05 16.83 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.519 2.728 . . . . 73.0 105.943 172.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -87.78 108.62 19.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.186 -2.153 . . . . 74.31 105.186 169.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' A' ' 163' ' ' TYR . 16.3 m -120.75 178.5 2.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.427 1.091 . . . . 53.04 108.708 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -80.68 153.2 28.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.389 1.475 . . . . 43.34 110.277 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -137.41 -158.35 0.85 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.439 1.896 . . . . 73.5 107.737 167.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.237 0.417 1 C-N-CA 132.625 4.37 . . . . 54.22 104.758 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' CB ' HD12 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.234 0.259 0 N-CA-C 108.257 -1.016 . . . . 64.2 108.257 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.461 ' HG ' ' HG2' ' A' ' 13' ' ' GLU . 15.0 tp -102.09 -16.67 16.34 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.599 1.333 . . . . 74.41 114.599 -150.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.72 160.57 0.15 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 130.799 3.639 . . . . 73.21 112.319 -161.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.514 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 8.9 t80 -80.59 -49.0 11.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.667 1.587 . . . . 65.23 111.076 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -93.97 70.57 3.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.364 -2.088 . . . . 71.1 105.364 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -139.58 116.93 8.5 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 104.747 -2.316 . . . . 74.51 104.747 -169.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.89 124.36 13.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.33 2.687 . . . . 35.34 111.774 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 59' ' ' ILE . 10.4 pt -97.0 10.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.382 0.882 . . . . 63.15 113.382 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.8 m-85 38.66 72.73 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.471 1.508 . . . . 74.34 112.612 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 157.57 0.43 Allowed 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.173 -1.047 . . . . 73.51 108.173 167.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -17.6 48.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.103 0.779 . . . . 72.42 113.103 -169.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.29 -52.93 4.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.557 1.143 . . . . 74.11 109.953 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.87 55.46 0.1 OUTLIER Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.025 1.298 . . . . 65.41 113.496 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -22.7 66.33 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.665 1.732 . . . . 71.42 115.373 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 16' ' ' TYR 0.292 47.8 mm 38.68 46.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 130.121 3.368 . . . . 62.3 112.409 -171.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.33 154.41 3.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.912 1.285 . . . . 74.24 108.013 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.06 124.69 23.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.409 1.084 . . . . 62.05 108.471 168.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -39.24 14.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 123.218 0.607 . . . . 65.52 111.081 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -53.53 -50.94 51.21 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.747 -0.941 . . . . 24.13 110.747 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.61 -38.88 77.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.263 1.025 . . . . 72.0 111.952 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -57.29 -56.13 25.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.012 0.925 . . . . 75.44 109.401 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 77' ' ' VAL . 71.7 t -64.74 -38.51 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.475 -0.784 . . . . 72.43 109.522 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -36.91 84.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.148 1.34 . . . . 34.05 110.514 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -40.79 60.63 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.554 1.141 . . . . 74.32 110.281 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.2 -43.99 26.98 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 124.687 1.195 . . . . 64.1 109.309 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.2 m-85 -60.0 -22.23 62.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.871 2.123 . . . . 70.42 113.063 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -100.0 -10.37 21.68 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.547 1.539 . . . . 75.11 112.058 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -65.36 1.02 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.962 -1.866 . . . . 75.02 105.962 163.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -82.83 41.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.686 3.194 . . . . 71.33 110.074 -167.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.33 -30.23 68.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.387 1.875 . . . . 64.41 110.2 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -69.64 -21.13 63.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.159 1.784 . . . . 70.11 112.534 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.28 6.32 48.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.652 1.581 . . . . 70.45 112.271 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.69 84.18 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.652 1.215 . . . . 64.54 109.645 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.48 120.6 24.68 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.243 -1.762 . . . . 64.2 106.243 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -88.62 157.55 18.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.76 -1.941 . . . . 75.33 105.76 155.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.03 178.47 8.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.232 -1.396 . . . . 60.45 107.232 164.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.22 -36.88 83.33 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.656 1.182 . . . . 62.41 110.527 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -14.07 33.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.149 1.38 . . . . 74.32 112.586 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.16 33.41 26.32 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.143 2.306 . . . . 53.03 111.067 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD1' ' HE3' ' A' ' 80' ' ' LYS . 3.4 t80 -79.95 -90.97 0.05 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.036 1.334 . . . . 71.45 108.46 -171.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.19 128.16 2.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.087 -2.005 . . . . 60.02 108.087 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -139.99 168.51 19.64 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.719 1.208 . . . . 74.32 109.026 166.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 33' ' ' PHE . 14.2 mt -149.22 143.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.543 2.337 . . . . 62.43 105.51 168.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.38 130.48 37.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.369 1.468 . . . . 52.34 108.295 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.39 -2.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.907 0.883 . . . . 72.04 112.596 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.88 -20.38 52.9 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.535 1.061 . . . . 63.13 115.37 -169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -63.15 -20.52 65.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 128.111 2.564 . . . . 75.41 114.045 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.16 -20.16 62.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.662 0.785 . . . . 72.13 111.357 172.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.14 3.29 1.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.001 2.121 . . . . 72.45 113.685 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.05 138.42 15.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.381 1.472 . . . . 64.23 108.794 172.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.84 167.52 10.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.463 1.125 . . . . 75.01 110.635 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 74' ' ' ILE . 3.5 tt -135.38 160.28 40.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 125.714 1.606 . . . . 71.51 108.041 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -81.77 132.88 35.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.312 -1.736 . . . . 75.11 106.312 168.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.37 -174.08 3.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.963 -0.754 . . . . 71.32 108.963 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -138.1 139.54 39.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.401 -1.703 . . . . 73.0 106.401 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.52 107.71 19.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.529 -1.286 . . . . 71.43 107.529 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -56.49 -23.71 41.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.869 1.268 . . . . 73.13 111.607 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -23.06 5.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.473 1.909 . . . . 75.44 112.772 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -149.6 14.27 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.325 1.05 . . . . 60.32 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 37.7 53.82 1.48 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.217 1.807 . . . . 51.31 111.838 -163.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.2 pt -105.98 155.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.707 0.803 . . . . 62.5 109.366 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.7 mm -85.04 130.72 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.829 -1.545 . . . . 62.2 106.829 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.33 166.97 23.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.219 1.007 . . . . 74.45 112.238 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.89 113.0 25.24 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.732 2.013 . . . . 71.15 107.7 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -125.0 167.21 15.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.959 0.903 . . . . 74.24 109.824 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -106.22 177.36 4.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.4 0.68 . . . . 71.01 110.228 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 59' ' ' ILE . 64.4 mt -113.49 153.55 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 105.423 -2.066 . . . . 65.13 105.423 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.34 -58.52 1.7 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.799 1.239 . . . . 74.23 108.435 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.492 ' CB ' HG21 ' A' ' 156' ' ' THR 0.25 14.7 mtm180 -128.1 159.34 35.4 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.227 1.411 . . . . 71.51 112.756 -174.086 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 29' ' ' VAL . 3.2 m -133.97 165.66 31.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.385 1.474 . . . . 71.43 108.149 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.593 ' HE1' ' CG2' ' A' ' 156' ' ' THR . 68.4 m95 -139.07 163.73 31.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.926 0.49 . . . . 74.42 111.283 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.04 135.87 31.48 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.083 0.953 . . . . 64.11 110.592 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tppp? -142.95 141.45 31.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.031 -1.84 . . . . 70.12 106.031 162.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -86.51 152.38 22.7 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.689 0.795 . . . . 70.11 109.961 -163.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 110.21 3.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.913 -0.773 . . . . 63.25 108.913 169.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.95 46.35 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.394 0.543 . . . . 70.03 111.849 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.635 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.75 121.87 25.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.787 -0.82 . . . . 53.21 108.787 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.18 172.58 7.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.151 -1.796 . . . . 75.01 106.151 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 89' ' ' ILE . 9.2 mm -79.15 160.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.418 1.887 . . . . 63.43 107.912 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -137.27 79.64 1.76 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.1 -1.444 . . . . 71.3 107.1 157.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG23 HG13 ' A' ' 140' ' ' VAL . 48.4 mt -67.12 135.5 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 104.456 -2.424 . . . . 62.44 104.456 158.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -118.22 175.36 5.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.244 1.418 . . . . 73.15 107.311 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -142.33 176.84 8.68 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.919 1.236 . . . . 71.24 112.654 164.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -53.66 -35.17 60.74 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.307 1.043 . . . . 74.12 111.854 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.85 11.0 1.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.785 2.034 . . . . 73.34 111.677 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 47.37 33.54 2.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.153 1.781 . . . . 71.15 111.394 -166.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -83.48 168.35 16.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.818 -1.178 . . . . 65.21 107.818 165.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 179.24 163.55 0.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.5 1.92 . . . . 75.12 107.666 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.592 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -139.65 172.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.844 2.057 . . . . 63.53 110.201 -174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -137.81 99.67 3.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.34 1.856 . . . . 72.1 107.118 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.88 167.5 28.12 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.756 -0.59 . . . . 72.11 110.347 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 p -75.84 162.38 28.19 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.317 -0.864 . . . . 54.42 110.697 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.74 38.74 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.678 0.791 . . . . 73.25 112.736 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -157.47 37.04 0.28 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.963 0.801 . . . . 73.31 110.065 149.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -75.15 137.02 72.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 119.721 -1.862 . . . . 71.3 110.453 -174.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.35 121.92 9.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.229 2.619 . . . . 63.13 111.483 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.7 -177.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.914 1.286 . . . . 65.44 109.064 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -128.32 137.06 51.77 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.174 0.99 . . . . 73.4 108.894 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 127' ' ' ILE . 1.9 pt -141.82 167.6 15.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.511 1.124 . . . . 60.54 108.564 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 143.16 34.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.499 0.666 . . . . 62.0 111.797 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -115.14 53.99 0.8 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.384 1.074 . . . . 72.22 108.748 163.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER 96.36 -0.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 130.856 3.662 . . . . 75.53 114.328 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.75 -11.41 3.69 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.714 -0.955 . . . . 63.12 110.714 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -86.37 161.32 18.75 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 125.419 1.488 . . . . 72.35 112.713 161.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.43 HG22 ' CE2' ' A' ' 128' ' ' TYR . 62.5 t -106.49 106.64 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.036 1.334 . . . . 71.43 108.962 -166.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.59 158.58 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.214 1.006 . . . . 71.53 108.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -114.44 121.05 42.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.615 1.966 . . . . 72.23 107.037 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 pt -140.71 178.32 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.293 1.037 . . . . 73.24 109.826 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -77.37 140.39 39.93 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.087 1.755 . . . . 71.21 109.867 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.38 -29.81 61.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.198 1.399 . . . . 73.11 112.384 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -31.49 72.19 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.93 -0.481 . . . . 73.11 111.154 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -25.87 42.46 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.507 1.123 . . . . 75.44 111.316 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -72.75 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.3 2.24 . . . . 74.51 111.416 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.51 -178.35 5.78 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.933 -1.104 . . . . 61.24 108.962 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.18 -2.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 129.565 3.146 . . . . 72.44 114.569 166.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.88 -15.92 57.13 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.285 -1.509 . . . . 60.13 111.734 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.35 140.69 51.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.473 1.636 . . . . 73.13 107.954 -160.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.71 117.68 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.643 1.177 . . . . 65.23 107.944 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 107' ' ' ILE . 5.8 tt -82.88 142.99 12.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.044 -0.725 . . . . 74.32 109.044 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 113' ' ' VAL . 3.2 m-85 -74.21 121.43 21.22 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.51 -0.922 . . . . 73.24 108.51 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.418 HG23 HG23 ' A' ' 127' ' ' ILE . 2.7 pp -120.93 145.61 41.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.696 1.199 . . . . 63.02 110.296 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 148.01 47.39 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.999 1.799 . . . . 70.22 107.516 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -120.93 -169.81 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.346 -1.724 . . . . 62.45 106.346 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -34.53 -72.24 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.922 1.689 . . . . 74.31 112.17 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.48 1.31 10.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.655 1.182 . . . . 54.52 113.217 171.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.2 p -130.47 153.8 48.43 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.967 1.307 . . . . 72.14 112.263 -165.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 tp -84.33 147.46 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.163 -1.421 . . . . 71.4 107.163 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -147.7 -174.86 4.66 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.877 2.071 . . . . 65.21 107.693 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.0 mt -131.25 159.98 36.23 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.354 1.462 . . . . 65.4 108.007 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -149.37 159.0 44.65 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.886 0.874 . . . . 72.24 110.122 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.83 140.27 29.87 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.745 2.418 . . . . 73.05 109.975 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.629 HG13 HG23 ' A' ' 89' ' ' ILE . 49.8 t -81.89 -3.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.212 1.405 . . . . 74.11 113.461 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.3 pt 25.05 -89.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 127.494 2.318 . . . . 72.24 115.6 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -89.82 105.4 17.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.821 1.648 . . . . 73.1 107.844 170.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.81 148.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.135 -1.061 . . . . 62.42 108.135 154.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.3 -162.63 0.76 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.359 2.664 . . . . 70.22 107.661 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -131.26 162.12 30.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.162 1.785 . . . . 64.5 109.561 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.63 -169.16 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.601 1.561 . . . . 74.12 109.455 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.01 132.47 41.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.991 2.116 . . . . 74.31 106.535 161.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.95 143.31 36.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.82 1.191 . . . . 71.31 110.489 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.53 30.74 1.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.969 0.729 . . . . 55.44 112.969 -163.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.59 -136.03 4.21 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.593 1.092 . . . . 54.44 111.739 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -99.25 170.06 8.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.384 -1.068 . . . . 74.02 109.824 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.44 HD12 ' CB ' ' A' ' 8' ' ' ALA . 2.3 pt -118.34 -73.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.037 -1.468 . . . . 73.53 107.037 173.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 78.98 170.29 0.18 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.535 2.334 . . . . 74.12 107.553 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -162.91 153.96 17.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.425 1.49 . . . . 51.54 107.439 -170.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -123.04 141.21 52.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.457 1.103 . . . . 74.24 111.133 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.593 ' CG2' ' HE1' ' A' ' 78' ' ' TRP . 44.7 p -79.49 -70.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.751 0.657 . . . . 74.35 110.183 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t 43.11 73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.664 2.386 . . . . 51.34 111.844 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.05 -0.48 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 74.33 113.314 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.94 -38.72 83.2 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.599 -0.519 . . . . 72.24 109.599 -166.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -138.52 7.98 2.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.871 1.269 . . . . 71.41 111.99 171.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.5 m170 54.02 29.32 9.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.505 1.122 . . . . 74.12 111.424 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -142.91 144.77 32.56 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.628 -1.92 . . . . 73.33 109.135 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.1 p90 -148.8 167.17 26.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.067 0.765 . . . . 73.31 113.067 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.2 mm -85.85 137.19 21.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 106.407 -1.701 . . . . 71.34 106.407 164.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -153.87 143.08 21.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.801 1.24 . . . . 65.5 108.072 162.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.55 -173.32 22.87 Favored Glycine 0 N--CA 1.462 0.431 0 C-N-CA 123.881 0.753 . . . . 54.35 111.585 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -90.95 167.87 12.09 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.47 -1.606 . . . . 72.25 110.261 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.08 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.542 2.337 . . . . 75.31 114.201 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.529 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 43.0 mt-10 -121.77 -7.94 8.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.558 1.143 . . . . 72.34 112.339 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.26 170.33 14.7 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 122.844 1.247 . . . . 72.01 111.874 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.592 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -120.72 147.91 44.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.968 2.507 . . . . 74.31 106.98 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -90.79 103.94 16.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.542 -1.651 . . . . 73.22 106.542 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.24 177.88 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.398 1.479 . . . . 51.51 109.176 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.8 t -67.34 144.4 55.86 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.47 2.708 . . . . 72.04 109.77 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.683 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -123.96 166.13 16.24 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.681 2.793 . . . . 75.21 107.013 162.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 106.613 -1.625 . . . . 61.12 106.613 160.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.102 -1.073 . . . . 62.13 108.102 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.41 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 62.54 110.508 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.05 152.97 43.78 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.763 -0.653 . . . . 70.53 109.804 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.6 t80 -53.81 -31.12 47.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.449 1.5 . . . . 75.02 112.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -103.93 14.67 30.28 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.753 1.221 . . . . 71.22 113.459 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.34 119.96 79.28 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 106.013 -1.847 . . . . 75.33 106.013 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.0 139.79 75.43 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-N 120.427 1.188 . . . . 53.11 112.437 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.0 pt -90.21 140.3 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.022 -1.103 . . . . 72.31 108.022 161.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -102.43 83.26 2.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.409 -1.7 . . . . 73.3 106.409 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.3 164.59 18.08 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.308 0.575 . . . . 74.33 109.987 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.5 t -56.02 -39.34 71.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.095 0.958 . . . . 73.31 110.216 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -33.37 34.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.265 0.939 . . . . 55.53 111.089 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.68 46.07 2.37 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.865 0.745 . . . . 62.41 112.271 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -35.9 69.43 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.68 1.24 . . . . 70.45 111.72 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.4 mm 45.87 86.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 128.283 2.633 . . . . 74.15 107.325 -163.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.72 152.0 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.63 -1.618 . . . . 73.52 106.63 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.29 135.24 56.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.283 1.833 . . . . 65.13 109.351 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.558 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -50.9 -54.81 8.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.825 -1.176 . . . . 70.44 107.825 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -55.49 -45.19 84.89 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.944 -1.263 . . . . 74.35 109.944 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -71.83 -42.96 66.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.077 1.351 . . . . 73.03 112.599 -173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -52.4 -49.26 64.82 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 122.038 0.923 . . . . 64.12 109.552 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 153' ' ' TYR . 92.7 t -72.79 -42.1 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.836 -1.075 . . . . 74.13 109.886 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.24 -38.36 73.67 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.332 0.515 . . . . 72.1 111.289 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.8 -43.14 76.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.276 1.03 . . . . 74.41 109.347 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.39 -47.09 62.46 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 117.491 -1.242 . . . . 74.03 108.767 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.6 -38.2 66.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.447 1.476 . . . . 74.01 110.994 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -78.05 -30.82 50.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.837 -1.078 . . . . 74.41 111.781 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.5 ttmm -78.97 -63.12 1.49 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.742 -1.577 . . . . 72.0 106.742 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.33 39.77 0.53 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.266 2.627 . . . . 72.45 109.732 -172.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.81 -38.29 67.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 120.533 -1.354 . . . . 61.03 110.784 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -74.47 -12.85 60.6 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.198 0.814 . . . . 73.05 113.198 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -93.95 0.01 55.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.842 1.257 . . . . 74.52 112.32 174.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.59 95.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 119.638 1.108 . . . . 72.44 108.099 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -78.94 147.75 32.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.152 -1.425 . . . . 54.24 107.152 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 130.75 48.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.043 -2.577 . . . . 62.11 104.043 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 144.66 35.71 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.094 -1.817 . . . . 73.43 106.094 171.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.5 -40.26 86.46 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.124 1.769 . . . . 75.41 112.196 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.98 -5.8 28.83 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.214 1.006 . . . . 73.23 112.27 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.77 56.41 1.16 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 126.731 2.11 . . . . 50.02 110.24 160.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -120.33 -97.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.338 1.055 . . . . 41.14 109.048 -172.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.11 137.71 3.02 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.986 1.755 . . . . 62.42 109.855 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -150.01 170.55 18.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.185 0.992 . . . . 72.31 111.448 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 mt -149.26 144.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.085 2.154 . . . . 71.52 106.608 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 122.53 31.06 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.248 1.819 . . . . 60.4 108.889 168.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 54' ' ' ASN . 2.2 pp -135.19 14.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.766 1.227 . . . . 61.24 111.876 -174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 17.72 0.14 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.082 1.801 . . . . 73.44 114.69 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -119.75 -13.1 9.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 129.873 3.269 . . . . 71.13 111.022 -177.005 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.29 -20.92 65.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.361 0.982 . . . . 73.4 110.903 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.1 19.19 2.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.571 1.948 . . . . 74.24 113.068 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.33 148.36 12.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.32 1.448 . . . . 61.45 107.52 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -115.67 140.85 48.81 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.682 -0.858 . . . . 72.51 108.682 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.49 158.65 18.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.555 1.542 . . . . 75.23 107.71 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -66.01 145.21 56.14 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.968 -1.123 . . . . 71.12 107.968 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.72 -179.29 5.96 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.735 1.614 . . . . 54.5 107.795 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.449 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -151.98 121.85 7.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.842 -1.161 . . . . 72.54 109.417 173.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.84 114.63 9.1 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.507 1.123 . . . . 63.32 108.93 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 162' ' ' THR . 18.0 mttt -62.35 -21.25 65.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.236 0.828 . . . . 74.12 113.236 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -37.8 -47.16 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.12 2.168 . . . . 64.02 109.807 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.4 17.71 2.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.53 1.132 . . . . 74.43 110.575 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 48.93 49.33 19.46 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.027 1.285 . . . . 62.41 112.222 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.74 149.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.544 1.538 . . . . 75.44 107.934 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.77 144.49 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.595 -1.261 . . . . 74.52 107.595 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -148.96 -177.58 5.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.194 2.197 . . . . 64.04 111.881 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.01 162.22 13.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.904 2.082 . . . . 73.31 109.991 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 149.95 22.69 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.909 -1.119 . . . . 74.14 111.572 156.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -78.9 162.54 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.974 -0.751 . . . . 75.13 108.974 159.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -94.09 168.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.208 1.803 . . . . 72.13 106.756 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.8 mm? -117.19 -58.31 2.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.265 1.826 . . . . 74.03 108.94 168.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -128.76 155.98 44.26 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.757 -0.59 . . . . 62.15 110.873 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -123.39 163.4 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 126.179 1.791 . . . . 55.21 108.331 173.599 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.35 176.72 8.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.84 1.656 . . . . 65.11 109.631 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -169.08 148.14 3.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.972 1.709 . . . . 75.44 109.168 163.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE3' HD11 ' A' ' 152' ' ' ILE . 35.2 pttt -142.43 169.99 16.55 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.605 1.562 . . . . 72.33 107.538 156.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -91.41 152.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.711 -0.618 . . . . 72.33 109.408 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 152' ' ' ILE . 31.5 t80 -146.93 147.89 31.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.439 0.696 . . . . 74.22 110.103 -170.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -157.7 126.84 5.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.444 -1.317 . . . . 73.22 107.444 155.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.52 -177.78 42.34 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.052 0.842 . . . . 65.31 112.56 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.89 127.47 32.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.03 -0.688 . . . . 74.11 110.86 171.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.96 157.98 17.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.848 -1.168 . . . . 74.13 107.848 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' HIS . 2.8 mm -78.57 133.68 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.217 -1.401 . . . . 74.33 107.217 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 98' ' ' THR . 12.7 ttmt -119.74 84.52 2.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.005 1.383 . . . . 55.01 107.645 164.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.67 130.39 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.143 -2.169 . . . . 73.21 105.143 154.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 m -100.15 -175.71 3.02 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 105.979 -1.86 . . . . 63.12 105.979 161.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -146.95 170.29 17.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.654 1.982 . . . . 74.2 108.716 165.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -56.92 -28.1 61.68 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.169 1.349 . . . . 73.54 112.433 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -72.3 3.4 4.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.623 0.971 . . . . 54.54 113.623 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 57.05 18.8 4.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.68 1.592 . . . . 72.32 111.591 -164.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 160.72 32.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.447 -1.686 . . . . 74.31 106.447 161.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.83 164.19 5.11 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.47 2.308 . . . . 62.12 106.857 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.502 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.5 pt -146.77 170.15 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 125.512 1.525 . . . . 74.33 108.521 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.476 HG23 ' HE3' ' A' ' 88' ' ' LYS 0.358 0.0 OUTLIER -151.63 96.49 2.26 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 126.624 1.97 . . . . 54.05 113.3 -175.47 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.532 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -161.79 179.4 8.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.153 1.781 . . . . 74.21 110.291 -166.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 p -66.72 166.92 12.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.959 0.885 . . . . 74.43 110.837 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.408 ' HA ' HG13 ' A' ' 87' ' ' ILE . 1.5 p-80 -70.39 -14.13 62.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.533 -0.729 . . . . 73.15 112.239 175.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -125.15 37.88 4.3 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.741 1.616 . . . . 44.12 111.566 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.683 ' ND1' ' HB2' ' A' ' 118' ' ' ALA . 1.1 p-80 -76.77 141.74 68.94 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.076 -0.964 . . . . 64.24 108.487 164.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -70.92 127.24 13.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.308 3.339 . . . . 65.03 113.525 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 121' ' ' VAL . 30.0 m -115.39 -177.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.279 1.831 . . . . 65.04 110.685 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -131.45 126.87 36.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.986 2.114 . . . . 70.05 108.502 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.51 163.02 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.244 0.929 . . . . 72.45 109.967 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.56 104.79 10.4 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.019 0.914 . . . . 62.14 110.612 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -86.01 79.85 9.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 104.248 -2.501 . . . . 74.41 104.248 161.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 55.45 19.65 3.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.428 1.269 . . . . 73.11 114.428 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.79 -0.89 41.88 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.168 -0.958 . . . . 74.55 113.642 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -91.66 129.11 37.69 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.075 -2.194 . . . . 75.33 105.075 156.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.24 130.37 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 60.43 108.885 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.42 148.44 42.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.892 0.877 . . . . 75.21 110.476 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -103.72 123.83 47.76 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.352 1.461 . . . . 71.51 111.289 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.51 -178.34 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.318 1.447 . . . . 74.54 111.325 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -86.27 145.38 26.97 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.634 1.974 . . . . 65.13 109.336 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.683 ' HB2' ' ND1' ' A' ' 103' ' ' HIS . . . -39.6 -51.75 2.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.228 2.211 . . . . 73.41 112.245 170.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -56.12 -21.43 22.34 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.521 1.528 . . . . 62.12 114.604 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.3 mtt -93.48 -19.21 21.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.279 1.032 . . . . 71.54 111.387 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 105' ' ' VAL . 11.3 t -78.88 62.0 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 127.677 2.391 . . . . 74.32 109.277 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.76 -176.95 5.66 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.324 -0.86 . . . . 74.21 109.987 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.52 -11.47 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 126.413 1.885 . . . . 71.55 113.701 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.69 -3.11 71.59 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.536 -1.147 . . . . 62.5 112.965 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -123.98 145.7 49.01 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.956 1.878 . . . . 73.34 108.798 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -112.95 114.52 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.907 1.283 . . . . 72.14 107.682 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.5 tt -89.46 134.5 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.8 1.24 . . . . 63.3 108.944 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -69.72 107.26 3.4 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.837 -0.801 . . . . 64.42 108.837 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.46 157.81 39.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.909 1.284 . . . . 73.25 110.281 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.35 152.28 66.16 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.818 1.012 . . . . 65.3 110.13 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -119.82 178.82 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 156.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -23.81 -67.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.273 3.029 . . . . 75.25 114.888 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -120.88 -13.4 8.64 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.166 0.894 . . . . 63.13 113.389 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -139.07 168.66 19.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.253 -0.905 . . . . 52.21 110.834 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -78.33 156.89 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.778 -0.823 . . . . 65.33 108.778 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 -176.14 4.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.118 2.967 . . . . 71.11 105.441 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 mp -113.61 167.58 10.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.572 1.949 . . . . 70.44 109.07 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -157.54 154.27 28.31 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.676 -1.602 . . . . 70.43 106.676 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.93 141.34 28.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.699 1.2 . . . . 61.21 108.58 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.594 HG21 HG12 ' A' ' 121' ' ' VAL . 11.5 t -67.6 -22.2 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 114.735 1.384 . . . . 72.31 114.735 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.2 pt 50.52 -49.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 130.115 3.366 . . . . 74.42 118.013 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.78 133.19 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 131.466 3.906 . . . . 73.24 107.773 -161.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.64 109.31 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.379 -0.6 . . . . 75.23 109.379 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -151.11 -175.71 5.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.369 1.068 . . . . 61.11 108.969 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 134.65 47.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.473 1.109 . . . . 55.21 108.102 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.48 -176.14 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.811 -1.181 . . . . 65.21 107.811 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.71 155.93 30.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.419 -1.326 . . . . 74.54 107.419 152.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -147.6 162.0 40.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.065 0.946 . . . . 70.24 108.649 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -164.87 78.36 0.33 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.055 -1.461 . . . . 64.51 107.055 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.85 25.59 0.2 Allowed Glycine 0 N--CA 1.474 1.227 0 N-CA-C 118.966 2.346 . . . . 73.31 118.966 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 61.13 159.78 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.403 2.281 . . . . 64.2 111.813 -167.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.691 HD11 ' HE3' ' A' ' 80' ' ' LYS . 17.5 pt -145.7 155.26 13.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.638 1.575 . . . . 75.12 108.594 -174.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.696 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.42 168.68 26.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.881 0.472 . . . . 74.14 111.199 171.177 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -146.21 162.79 37.27 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.727 2.811 . . . . 65.43 106.726 -173.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.15 153.96 34.04 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.578 -1.326 . . . . 72.34 112.162 -163.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 -38.78 10.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.057 -0.974 . . . . 74.34 113.339 -162.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.257 2.1 t 22.89 64.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 129.567 3.147 . . . . 65.2 113.487 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.412 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.9 pt-20 -78.15 1.63 20.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.241 -0.912 . . . . 72.51 112.453 -169.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -89.6 -48.27 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.638 2.775 . . . . 73.0 109.298 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -132.64 -3.61 3.31 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.103 0.779 . . . . 73.13 113.103 -173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 69.03 8.44 6.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.143 1.377 . . . . 74.44 113.982 161.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.459 ' CG2' ' HE2' ' A' ' 64' ' ' LYS . 39.1 p -140.77 158.06 44.52 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.389 2.276 . . . . 75.42 107.248 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -144.86 -175.68 4.77 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.731 -1.23 . . . . 72.23 110.77 172.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.96 111.95 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.853 1.261 . . . . 73.11 108.081 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.47 158.47 44.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.131 1.373 . . . . 71.34 108.496 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.15 -158.06 25.15 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 107.379 -2.288 . . . . 74.41 107.379 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -112.32 172.39 6.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.017 1.408 . . . . 72.14 111.212 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.58 -69.43 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.867 3.267 . . . . 72.41 114.164 -174.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -122.89 -11.0 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.783 2.033 . . . . 61.22 113.694 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.88 159.54 3.17 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 122.533 1.074 . . . . 73.11 112.119 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 97' ' ' ILE . 26.5 m-85 -104.38 156.1 18.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.752 2.021 . . . . 72.45 109.26 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -89.27 79.89 6.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.194 1.798 . . . . 73.23 107.599 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -104.97 176.8 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.58 -1.267 . . . . 74.11 107.58 -171.233 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.16 155.63 38.27 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.008 2.123 . . . . 73.21 111.049 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.56 39.78 1.17 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.05 2.54 . . . . 72.54 108.605 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 108.326 -0.99 . . . . 64.33 108.326 179.497 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 N-CA-C 108.503 -0.925 . . . . 75.14 108.503 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.77 160.2 30.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.072 1.749 . . . . 75.32 109.802 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.24 149.7 44.32 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.802 -0.444 . . . . 71.2 109.802 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -44.45 -39.51 4.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.903 1.681 . . . . 74.44 113.549 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -97.22 7.8 45.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.388 1.075 . . . . 74.01 113.088 -166.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.25 121.73 84.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.517 -1.29 . . . . 71.33 107.517 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.11 141.92 95.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.569 1.239 . . . . 61.44 112.336 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 pt -96.38 -8.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.369 0.877 . . . . 71.54 113.369 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 54.63 69.33 0.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.479 1.133 . . . . 75.35 110.075 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.3 mt -55.1 160.58 2.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.7 -0.682 . . . . 74.55 109.595 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -53.35 -40.54 64.99 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.736 0.814 . . . . 63.41 109.755 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.01 -37.38 84.67 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.265 1.026 . . . . 75.11 112.786 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.68 41.15 7.38 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.065 -1.022 . . . . 55.11 110.548 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.77 -11.95 61.26 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.786 0.835 . . . . 74.35 113.192 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.9 mm 40.57 70.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.97 2.908 . . . . 61.54 109.112 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.83 149.83 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 112.82 -1.991 . . . . 74.14 107.928 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.26 135.37 47.42 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.791 1.236 . . . . 73.24 109.52 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.69 -4.24 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.221 1.809 . . . . 61.4 114.556 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.62 -9.86 12.15 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-O 116.769 -2.129 . . . . 72.02 113.488 165.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -78.33 -49.71 13.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.278 2.039 . . . . 75.44 109.799 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -39.6 -54.88 1.95 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.202 1.801 . . . . 75.43 109.797 165.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.495 ' CG1' HG21 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -73.16 -30.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.976 -1.465 . . . . 73.41 110.379 -174.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.12 -31.83 73.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.512 -1.368 . . . . 72.21 111.125 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -52.2 61.09 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.361 0.664 . . . . 74.4 109.478 168.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -66.13 -44.18 84.96 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 117.57 -1.205 . . . . 62.33 109.24 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -54.41 -39.56 67.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 121.876 2.126 . . . . 75.42 112.786 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -27.33 56.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.74 -1.124 . . . . 73.12 111.509 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 3.8 mtpt -86.39 -59.93 2.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.456 -1.683 . . . . 62.44 106.456 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 3.8 m-30 -88.98 39.93 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.762 2.825 . . . . 73.25 108.769 -168.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.59 -35.09 71.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.598 -1.314 . . . . 73.4 112.089 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -31.11 72.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 52.41 112.816 172.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 m -79.56 -9.44 59.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.15 1.78 . . . . 53.32 111.246 -175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.05 102.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.373 0 N-CA-C 106.554 -1.647 . . . . 73.25 106.554 168.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.81 167.27 12.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.389 -1.337 . . . . 74.24 107.389 158.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 145.64 45.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.212 -2.144 . . . . 55.12 105.212 167.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -78.3 168.83 19.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.29 -1.744 . . . . 75.13 106.29 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -33.09 74.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.496 0.718 . . . . 61.41 110.51 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.14 -0.35 18.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.426 0.899 . . . . 74.32 113.426 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.29 17.87 51.51 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 126.023 1.773 . . . . 44.11 113.259 161.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.96 -95.35 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.461 1.905 . . . . 74.43 109.974 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.51 129.07 1.41 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.783 -1.727 . . . . 63.13 108.783 -167.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -137.75 157.99 45.3 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 124.402 0.707 . . . . 71.33 109.487 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mt -139.36 141.83 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 104.97 -2.234 . . . . 74.35 104.97 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.38 137.28 32.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.678 0.791 . . . . 64.42 109.697 167.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.56 17.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.402 1.481 . . . . 65.24 112.748 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.97 -38.01 10.04 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.259 -0.745 . . . . 73.54 113.517 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -78.17 -6.23 54.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.202 1.501 . . . . 73.33 113.763 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 57' ' ' ILE . 56.6 mm-40 -64.35 -26.96 68.7 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.361 1.437 . . . . 74.23 110.323 168.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 m120 58.76 -4.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.971 2.108 . . . . 73.32 114.318 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' ' C ' ' A' ' 55' ' ' GLU . 93.5 mt -47.8 132.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 128.234 2.614 . . . . 55.05 108.058 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.75 150.57 22.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.255 1.026 . . . . 73.22 110.192 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.8 150.96 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.91 2.084 . . . . 51.34 107.014 177.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' O ' HD13 ' A' ' 59' ' ' ILE . 1.1 mtpt -61.77 120.7 11.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.844 -0.799 . . . . 74.22 108.844 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -114.18 -179.49 3.65 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.77 1.228 . . . . 73.44 108.505 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.4 146.82 33.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.291 -1.374 . . . . 62.11 107.291 159.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.4 112.83 24.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.368 0.531 . . . . 71.21 109.952 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.38 -24.1 67.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.184 0.994 . . . . 73.42 112.384 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.7 -43.37 5.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.725 2.41 . . . . 61.12 111.733 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.96 18.88 1.79 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.247 1.019 . . . . 70.33 111.521 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp 39.72 66.12 0.62 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.312 2.245 . . . . 62.4 112.056 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 pt -121.02 156.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.958 1.703 . . . . 74.12 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.2 mm -86.57 126.18 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 126.989 2.116 . . . . 63.41 106.631 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -140.46 171.18 14.5 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.084 1.753 . . . . 71.23 107.842 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -112.76 141.1 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.975 1.71 . . . . 72.33 107.43 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 151.6 38.11 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.323 -0.861 . . . . 61.34 109.385 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -79.2 173.73 12.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.625 -0.88 . . . . 75.02 108.625 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.8 151.74 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.058 -1.46 . . . . 54.41 107.058 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.1 mm? -106.29 -41.93 5.19 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 117.645 -1.169 . . . . 75.12 110.385 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtm-85 -140.08 149.69 43.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.433 1.469 . . . . 70.15 111.427 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -106.97 155.9 7.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.451 1.501 . . . . 70.04 108.54 170.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -130.74 150.26 52.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.0 1.32 . . . . 74.33 109.045 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -151.84 140.64 20.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.973 0.909 . . . . 71.04 110.208 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -153.92 163.75 39.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.608 1.163 . . . . 73.31 108.81 163.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -92.37 139.68 30.35 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 120.808 -1.182 . . . . 73.31 110.148 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -134.46 168.36 19.08 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.327 1.451 . . . . 70.13 109.901 -165.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.75 109.09 1.6 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.195 -0.907 . . . . 72.21 111.338 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.82 -173.53 36.53 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.256 1.389 . . . . 74.34 112.49 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -86.64 109.33 19.09 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.314 -0.521 . . . . 70.04 111.336 -171.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.75 168.65 19.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.77 -0.826 . . . . 61.32 108.77 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.12 130.35 35.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.06 2.144 . . . . 60.13 108.185 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -115.8 85.57 2.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.09 -1.448 . . . . 71.43 107.09 161.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -66.26 120.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 104.008 -2.59 . . . . 64.13 104.008 153.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -104.5 164.58 11.65 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.469 -1.678 . . . . 74.53 106.469 161.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.5 p -134.03 170.24 15.94 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.05 -1.031 . . . . 65.24 109.758 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -65.06 -27.72 68.98 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.109 1.764 . . . . 74.23 110.46 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -68.25 1.04 3.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.927 1.691 . . . . 75.12 111.536 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 55.82 29.67 14.42 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.085 2.154 . . . . 74.54 111.785 -172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt-85 -75.84 168.49 19.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 118.224 -1.39 . . . . 73.15 109.085 162.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.6 169.26 18.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.916 1.385 . . . . 75.52 108.573 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.567 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.2 pt -146.16 169.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.959 2.104 . . . . 64.15 110.804 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 m -146.86 98.16 3.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.082 1.353 . . . . 64.05 110.454 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.71 174.93 13.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.065 1.746 . . . . 70.14 111.098 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 167.58 10.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.229 1.012 . . . . 74.4 110.935 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -70.14 -31.86 69.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.03 -0.73 . . . . 62.01 109.03 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -101.44 38.87 1.51 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 65.34 112.493 -168.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -107.91 143.52 27.5 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 120.801 -1.187 . . . . 74.43 110.882 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.46 125.65 12.01 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.986 3.124 . . . . 70.02 112.368 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.64 168.83 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.743 0.817 . . . . 74.51 108.866 168.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.32 140.68 37.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.351 0.66 . . . . 74.42 110.554 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.55 158.45 37.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.332 1.453 . . . . 72.32 108.275 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.6 p -88.78 134.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.122 0.963 . . . . 52.51 108.962 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 77.33 1.03 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.368 -1.716 . . . . 64.1 106.368 161.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 59.32 21.17 9.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 70.45 113.069 167.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.34 -19.84 5.94 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.211 -0.772 . . . . 65.02 111.693 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -87.15 141.11 28.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 104.4 -2.444 . . . . 73.54 104.4 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -86.72 139.6 17.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.677 -1.264 . . . . 71.34 108.051 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.92 159.95 37.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.953 -1.499 . . . . 54.11 106.953 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -126.18 112.2 15.51 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.333 1.053 . . . . 55.3 109.573 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.65 174.83 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.511 1.124 . . . . 70.12 111.111 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -76.84 136.31 38.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 117.862 -1.066 . . . . 72.22 109.489 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.03 -32.73 16.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 55.53 113.304 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.3 -16.29 63.53 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.192 1.553 . . . . 55.25 115.192 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.8 mtt -84.0 -28.09 27.97 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.446 0.566 . . . . 61.4 110.707 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.5 t -76.14 61.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 127.496 2.318 . . . . 54.05 109.786 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 143' ' ' VAL . 1.7 mmmm -91.63 -171.8 3.02 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.537 1.135 . . . . 74.43 108.079 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.61 -9.02 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.34 1.456 . . . . 51.15 114.236 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.89 2.36 69.32 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 116.793 -2.115 . . . . 73.41 113.495 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.78 135.56 43.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 121.12 2.46 . . . . 54.44 108.999 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 139' ' ' GLU . 18.0 m-85 -79.59 118.91 21.87 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.518 -0.919 . . . . 63.35 108.518 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.08 126.06 42.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.574 -1.269 . . . . 74.52 107.574 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.96 141.1 56.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.838 -0.801 . . . . 71.4 108.838 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.52 158.8 72.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.402 1.081 . . . . 74.24 112.013 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.56 150.7 31.96 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.621 2.214 . . . . 72.23 108.365 171.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.32 -174.77 3.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 105.869 -1.9 . . . . 71.52 105.869 162.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -28.33 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.267 2.227 . . . . 74.5 112.195 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.12 -3.47 9.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.227 1.811 . . . . 75.4 111.414 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 p -133.71 158.79 42.38 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.649 0.659 . . . . 61.42 111.581 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.91 152.88 4.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.937 -1.135 . . . . 73.43 107.937 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.37 179.86 6.69 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.575 1.95 . . . . 73.23 107.367 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.11 162.42 19.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.869 1.267 . . . . 74.13 107.914 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -150.52 160.19 43.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.258 -1.386 . . . . 74.05 107.258 158.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 126' ' ' TYR . 5.6 mt-10 -63.09 -179.75 0.32 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.026 1.731 . . . . 73.53 109.699 170.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.47 1.66 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.165 1.786 . . . . 73.04 112.08 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pt 26.51 -80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 128.235 2.614 . . . . 65.4 116.684 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -109.84 119.28 38.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.895 1.278 . . . . 73.33 108.157 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 122' ' ' LYS . 2.9 p -114.65 115.71 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.659 1.219 . . . . 72.53 109.005 164.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.62 -172.29 2.45 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.203 2.601 . . . . 63.5 106.971 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.9 p -128.86 166.82 18.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.059 1.344 . . . . 75.1 110.893 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.77 124.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.024 0.93 . . . . 73.23 109.721 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.92 101.72 11.89 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.561 -0.903 . . . . 63.41 108.561 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -107.38 133.62 51.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.056 0.942 . . . . 70.5 109.196 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.55 59.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.794 -1.188 . . . . 73.12 107.794 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -124.64 -166.68 12.48 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.683 2.087 . . . . 21.33 110.681 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.34 156.27 18.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.799 -0.815 . . . . 60.3 108.799 166.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 49.8 pt -136.02 152.79 30.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.177 1.391 . . . . 74.21 108.06 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -144.31 153.27 41.83 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.715 1.206 . . . . 75.42 109.201 -163.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -141.56 174.59 10.42 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.861 -0.525 . . . . 73.33 109.684 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.18 109.82 10.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.028 1.731 . . . . 73.05 109.261 -157.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -76.71 121.0 22.66 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.169 -1.789 . . . . 71.31 106.169 169.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 t -130.24 87.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.635 -1.617 . . . . 74.31 106.635 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.516 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -61.11 -21.49 63.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.903 1.681 . . . . 71.51 113.031 177.734 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -95.72 -51.17 4.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.217 1.407 . . . . 64.42 110.045 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -124.23 103.58 8.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 101.715 -3.439 . . . . 74.21 101.715 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -66.94 28.55 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.794 0.838 . . . . 73.34 113.018 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.407 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 1.4 p -153.95 124.93 7.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.066 2.147 . . . . 54.43 107.727 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 6.8 p90 -129.92 166.02 20.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.299 1.44 . . . . 71.01 110.912 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.17 135.05 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.214 -1.032 . . . . 73.21 108.214 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.77 29.33 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.509 1.124 . . . . 73.22 110.066 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.01 -156.61 22.25 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.565 0.621 . . . . 73.43 111.893 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -110.09 167.39 10.21 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.998 -1.295 . . . . 72.23 111.54 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.89 -76.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.718 2.807 . . . . 73.53 112.699 -165.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.31 -13.32 8.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.97 1.708 . . . . 74.3 113.641 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.36 176.53 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 123.294 1.496 . . . . 74.44 112.686 -173.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.567 ' CE1' HG23 ' A' ' 97' ' ' ILE . 8.7 m-85 -124.11 149.47 46.17 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.408 3.083 . . . . 70.41 104.874 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -94.37 81.04 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.802 -1.184 . . . . 32.14 107.802 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.0 m -88.49 179.87 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 O-C-N 121.78 -0.575 . . . . 73.44 110.58 -171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.59 158.45 23.06 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.794 -0.566 . . . . 74.23 110.443 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.28 175.13 10.31 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.992 2.117 . . . . 72.3 109.288 173.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.327 -0.99 . . . . 63.05 108.327 157.443 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.405 0 N-CA-C 107.767 -1.197 . . . . 62.51 107.767 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.47 -177.42 4.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.474 -0.565 . . . . 63.13 109.474 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -166.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.219 1.408 . . . . 74.23 112.036 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -94.78 -50.38 5.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.434 1.494 . . . . 61.2 110.316 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.94 50.16 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.414 2.285 . . . . 61.14 108.094 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.02 131.84 19.03 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 106.936 -1.505 . . . . 72.25 106.936 -165.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -79.95 132.71 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.015 1.81 . . . . 72.25 112.305 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 pt -98.56 -6.16 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.904 0.882 . . . . 73.22 113.032 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 57.01 84.2 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.982 1.713 . . . . 52.01 112.135 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 59' ' ' ILE . 15.4 mt -51.29 156.66 1.12 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.833 164.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.9 t -55.54 -35.03 65.23 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 122.979 0.512 . . . . 72.55 109.855 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.75 -29.96 68.47 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.647 0.779 . . . . 64.04 112.297 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.21 36.21 7.2 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.194 1.378 . . . . 51.31 111.605 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -17.02 64.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.352 1.241 . . . . 65.44 114.352 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm 43.32 93.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 128.523 2.729 . . . . 72.31 111.19 -166.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.87 145.54 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.63 -1.623 . . . . 62.04 107.792 174.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.26 131.49 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 128.069 2.548 . . . . 72.33 108.396 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -49.92 -48.68 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.495 0.718 . . . . 63.11 110.526 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.81 4.56 86.19 Favored Glycine 0 C--O 1.221 -0.656 0 CA-C-O 116.986 -2.008 . . . . 75.44 113.419 -173.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -86.68 -53.35 4.99 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.512 1.656 . . . . 62.35 108.582 162.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -52.78 -54.42 34.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.765 1.226 . . . . 73.51 109.302 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.836 HG22 ' HA2' ' A' ' 26' ' ' GLY . 21.7 m -65.89 -33.4 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-O 117.753 -1.117 . . . . 70.11 110.174 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -41.92 95.99 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 121.545 1.975 . . . . 70.3 111.569 -173.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.89 -40.23 60.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.462 0.705 . . . . 53.41 110.469 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -77.68 -46.49 21.79 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.353 -1.308 . . . . 54.04 109.873 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -54.95 -36.07 64.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 122.517 2.417 . . . . 65.12 112.354 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -17.4 46.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.383 1.073 . . . . 72.14 113.204 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -88.54 -61.22 1.76 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.195 -1.409 . . . . 64.22 107.195 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -84.13 40.78 0.78 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.912 2.085 . . . . 63.13 108.726 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -50.95 -34.54 29.15 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 127.045 2.138 . . . . 75.03 110.706 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.95 -22.8 59.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.573 1.949 . . . . 61.21 113.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m -94.07 0.8 56.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.222 1.809 . . . . 74.34 112.157 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.16 101.02 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.595 0.758 . . . . 74.11 109.301 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.67 169.69 17.61 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.403 1.081 . . . . 70.35 110.244 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.65 132.3 27.22 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.996 1.319 . . . . 70.12 108.757 164.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -79.6 169.77 17.52 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.395 2.278 . . . . 72.32 110.017 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.01 -37.43 79.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.913 1.685 . . . . 74.24 109.867 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.72 -15.59 62.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.571 0.748 . . . . 74.4 111.827 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.35 3.18 57.66 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 126.313 1.911 . . . . 73.53 113.811 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -57.73 -87.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 129.172 2.989 . . . . 71.33 111.123 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.72 125.89 2.99 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.107 1.336 . . . . 44.14 109.964 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -136.3 168.39 19.5 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.393 1.077 . . . . 74.42 109.861 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.8 mt -146.08 153.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 127.182 2.193 . . . . 73.14 106.202 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 143.27 27.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.672 1.589 . . . . 64.15 109.553 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.66 -24.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 114.834 -2.508 . . . . 75.44 113.675 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 23.15 -72.67 0.0 OUTLIER Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.949 3.166 . . . . 33.21 115.927 159.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -13.12 15.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.883 3.273 . . . . 75.52 115.288 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.66 -20.37 65.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.189 0.596 . . . . 62.3 110.519 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.37 31.6 17.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.302 1.841 . . . . 71.41 113.283 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.9 mt -82.96 123.06 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.513 1.125 . . . . 74.34 108.821 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -86.39 143.46 27.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.382 1.473 . . . . 75.43 110.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.6 tp -125.86 159.13 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.259 -1.756 . . . . 75.44 106.259 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -63.78 140.38 58.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.405 -0.961 . . . . 55.23 108.405 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 p -139.61 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.962 0.505 . . . . 75.43 110.446 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.12 141.67 24.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.349 -0.845 . . . . 75.41 108.875 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 110.28 15.02 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.371 -1.344 . . . . 72.44 107.371 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -64.59 -16.98 63.55 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.638 0.775 . . . . 72.42 111.724 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -15.62 63.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.51 1.124 . . . . 74.01 113.941 171.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -155.59 6.01 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.38 0.991 . . . . 64.44 113.519 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.94 51.54 15.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.073 2.149 . . . . 73.52 111.636 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 pt -119.35 152.58 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.362 2.265 . . . . 42.15 108.76 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.37 145.25 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.315 -0.995 . . . . 74.24 108.315 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -150.67 178.03 9.49 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.138 2.575 . . . . 62.14 109.284 -166.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.18 157.78 17.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.873 1.669 . . . . 64.12 108.638 163.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.58 160.77 41.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.116 -0.99 . . . . 55.44 110.139 154.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.543 HH11 ' CD2' ' A' ' 75' ' ' LEU . 7.0 tmm_? -98.95 131.31 45.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.212 1.005 . . . . 73.11 110.268 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.64 156.53 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.943 1.297 . . . . 73.31 109.02 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.543 ' CD2' HH11 ' A' ' 73' ' ' ARG . 55.9 mt -123.75 -51.7 1.81 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.969 1.308 . . . . 70.01 110.889 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -135.43 163.81 29.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.079 1.352 . . . . 75.41 108.895 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.26 167.95 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.298 1.039 . . . . 73.54 108.974 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -137.71 151.24 48.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.712 1.205 . . . . 70.52 109.281 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 6.4 tmm_? -142.04 144.5 33.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.926 1.29 . . . . 72.13 109.929 170.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -144.83 158.98 43.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.751 -1.574 . . . . 64.03 106.751 165.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -89.96 151.26 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.955 -1.128 . . . . 64.1 107.955 167.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -146.8 154.79 41.78 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.468 1.507 . . . . 70.15 110.367 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.93 111.87 3.05 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.461 -1.311 . . . . 73.01 107.461 167.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.63 -160.02 33.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.619 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' N ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -113.89 117.23 30.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.481 1.112 . . . . 74.21 108.738 -173.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 148' ' ' TYR . 2.6 mm? -98.4 165.13 11.99 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.587 1.155 . . . . 50.1 107.987 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 mm -78.85 132.76 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.458 1.903 . . . . 75.3 107.377 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -128.22 59.68 1.5 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.942 1.697 . . . . 74.21 107.357 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.53 HG23 HG13 ' A' ' 140' ' ' VAL . 37.8 mt -56.89 133.73 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.91 -2.256 . . . . 64.15 104.91 162.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -117.2 164.2 15.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.319 -1.734 . . . . 74.44 106.319 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.2 p -137.03 169.64 17.43 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 121.73 -0.606 . . . . 22.32 110.492 -168.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -60.99 -28.93 69.38 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 73.23 110.727 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.92 3.43 10.18 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.365 1.466 . . . . 63.32 112.521 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 59.28 13.13 2.92 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.473 1.909 . . . . 75.31 113.114 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.553 ' HG3' HH11 ' A' ' 95' ' ' ARG . 0.1 OUTLIER -71.41 162.56 29.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 118.318 -1.353 . . . . 63.5 107.487 166.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -156.69 176.64 12.46 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 128.274 2.63 . . . . 73.3 106.463 171.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -141.75 -179.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.637 1.575 . . . . 71.24 109.996 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.5 m -150.56 97.35 2.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.58 1.152 . . . . 74.52 110.287 168.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -146.39 174.47 11.35 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.426 1.49 . . . . 74.32 111.035 -176.388 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -73.17 172.74 10.53 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.342 0.974 . . . . 53.32 108.65 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -77.36 7.53 5.21 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.06 -1.025 . . . . 72.55 112.001 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.42 39.24 2.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.245 0.929 . . . . 52.1 111.297 -167.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -99.13 137.58 20.45 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 117.059 -1.448 . . . . 72.13 112.368 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.23 94.93 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 124.317 3.344 . . . . 65.41 113.666 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.18 178.82 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.138 0.975 . . . . 73.22 109.192 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.48 134.26 50.98 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.499 -0.751 . . . . 75.53 110.791 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.01 155.86 38.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.106 1.362 . . . . 72.02 109.398 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -86.32 125.7 33.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.261 0.553 . . . . 45.23 110.945 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -98.4 89.43 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.525 -2.028 . . . . 73.41 105.525 153.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.98 31.16 8.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.789 1.236 . . . . 50.54 113.603 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.66 -8.32 39.96 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.432 -1.205 . . . . 72.35 113.951 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 159.83 27.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 104.651 -2.351 . . . . 65.42 104.651 160.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.262 7.3 p -106.93 104.35 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.093 0.957 . . . . 62.3 109.953 170.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -91.29 160.08 15.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.73 1.612 . . . . 75.34 107.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.62 115.2 20.43 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.336 1.854 . . . . 75.1 108.039 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 116' ' ' ILE . 1.5 pt -143.85 172.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.753 1.621 . . . . 74.13 109.468 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.16 143.75 26.87 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.386 0.539 . . . . 63.11 111.565 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.71 -27.65 65.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.587 -0.72 . . . . 74.43 112.815 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -29.22 68.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.636 1.107 . . . . 73.5 111.953 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -79.58 -32.54 41.98 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.095 1.358 . . . . 74.43 111.661 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.99 63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 130.381 3.473 . . . . 64.15 110.906 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -95.93 -169.24 1.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.351 1.06 . . . . 73.42 108.991 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.0 -7.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.653 -1.279 . . . . 71.24 114.106 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.39 -12.81 69.32 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 117.799 -1.556 . . . . 55.32 111.687 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.06 119.63 35.36 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 121.132 2.466 . . . . 62.41 107.07 -164.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.37 115.52 21.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.58 HG23 ' OD1' ' A' ' 138' ' ' ASP . 6.8 tt -79.9 159.24 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.405 1.082 . . . . 72.44 109.96 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.03 129.95 36.98 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.592 1.557 . . . . 73.43 110.883 167.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.5 155.44 47.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.811 1.645 . . . . 43.24 110.195 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -68.51 156.36 65.84 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.5 2.134 . . . . 70.24 110.313 165.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -141.04 -176.96 4.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.828 1.651 . . . . 74.53 107.634 164.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -25.17 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.014 2.526 . . . . 71.34 112.506 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -120.17 -4.95 9.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.325 -0.845 . . . . 72.21 113.091 170.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.6 p -132.67 170.06 15.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.24 1.382 . . . . 41.31 111.333 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.06 157.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.531 -0.731 . . . . 73.22 109.161 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.03 -177.25 4.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.587 2.755 . . . . 74.33 106.558 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 88.4 mt -126.12 160.86 29.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.162 0.985 . . . . 72.43 110.666 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.58 ' OD1' HG23 ' A' ' 127' ' ' ILE . 11.5 p-10 -154.05 158.61 40.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.858 1.663 . . . . 65.12 111.858 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -106.04 150.65 25.54 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.226 1.411 . . . . 74.51 109.699 -172.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 89' ' ' ILE . 41.9 t -95.6 1.28 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.907 1.283 . . . . 74.23 113.72 -166.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.4 pt 24.82 -86.8 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 127.459 2.304 . . . . 74.3 116.655 171.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.34 123.17 43.39 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 126.841 2.056 . . . . 51.33 107.811 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.47 119.97 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.388 -1.338 . . . . 74.32 107.388 170.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.25 -166.04 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.62 1.968 . . . . 75.21 108.196 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 p -133.18 165.22 25.29 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.047 1.739 . . . . 71.02 109.311 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.57 -175.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.182 1.393 . . . . 73.14 108.668 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -136.86 68.96 1.41 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.529 1.157 . . . . 72.01 109.394 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.43 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.8 t80 -80.21 133.56 36.03 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.019 -1.051 . . . . 55.12 111.029 -169.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -136.03 69.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.944 -1.132 . . . . 73.21 107.944 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.82 -120.56 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 51.3 110.115 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -121.73 163.28 19.34 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.002 -0.705 . . . . 73.13 110.041 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.55 147.02 28.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 127.379 2.272 . . . . 75.15 106.563 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.589 ' CD2' HG21 ' A' ' 29' ' ' VAL . 69.0 m-85 -141.4 164.53 29.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.356 0.662 . . . . 72.44 109.296 -171.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.52 171.47 18.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 119.537 -0.268 . . . . 72.44 111.519 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.6 118.4 19.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.928 1.691 . . . . 74.53 109.413 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 57.6 m -73.08 112.77 9.43 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.025 -1.472 . . . . 71.55 107.025 166.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.94 75.41 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.516 -2.031 . . . . 41.52 105.516 169.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.11 -0.15 38.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.71 2.404 . . . . 74.11 114.134 -162.058 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.93 -77.32 0.1 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 128.283 2.633 . . . . 71.22 110.995 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -105.39 5.52 31.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.839 1.655 . . . . 74.0 111.694 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.6 m80 50.29 34.4 8.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.969 2.507 . . . . 64.41 112.035 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 p -148.51 155.33 41.01 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.425 1.89 . . . . 71.11 108.304 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -159.25 -168.13 2.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.256 1.022 . . . . 73.42 109.772 178.24 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.48 141.38 14.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 105.89 -1.893 . . . . 75.55 105.89 155.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -144.71 148.85 34.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 72.41 109.398 149.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 144.3 -165.92 27.32 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.109 -0.994 . . . . 61.33 112.119 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -111.26 166.82 10.77 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 119.708 -2.054 . . . . 70.11 111.232 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.24 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 128.319 2.648 . . . . 74.12 112.667 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 44.8 mt-10 -121.84 -18.34 7.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.689 1.196 . . . . 70.34 112.75 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.29 158.66 21.24 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.829 1.204 . . . . 70.04 113.537 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.454 ' CE1' HG23 ' A' ' 97' ' ' ILE . 78.7 m-85 -105.29 154.42 20.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 127.096 2.158 . . . . 73.02 109.686 -174.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.5 75.99 5.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.084 0.953 . . . . 62.44 108.448 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 173' ' ' VAL . 11.8 m -93.5 178.92 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.832 1.253 . . . . 74.43 110.315 -173.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.0 m -65.8 161.99 19.75 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.278 -0.889 . . . . 63.0 110.111 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -143.79 39.43 1.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.199 1.8 . . . . 75.15 108.295 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 107.825 -1.176 . . . . 74.34 107.825 175.279 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.517 0 N-CA-C 106.125 -1.805 . . . . 74.35 106.125 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.07 167.2 22.0 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.584 1.154 . . . . 72.3 109.582 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . -71.71 -140.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.659 0.784 . . . . 61.43 111.84 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 5.5 t80 -120.73 -38.97 2.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.618 1.567 . . . . 74.33 112.012 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.85 30.55 6.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.645 1.178 . . . . 73.3 111.496 -163.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 144.9 29.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 O-C-N 121.507 -0.746 . . . . 62.32 111.993 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.15 141.72 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.272 2.648 . . . . 74.12 113.786 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 25' ' ' ILE . 13.5 pt -114.66 16.84 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.981 1.104 . . . . 73.14 113.981 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 34.92 68.83 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.225 2.21 . . . . 73.01 113.964 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.0 mt -56.15 155.73 6.31 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.153 -0.684 . . . . 51.23 109.153 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -61.86 -27.2 68.62 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.186 -0.321 . . . . 72.41 111.166 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.38 -59.06 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.347 -0.612 . . . . 64.53 109.347 169.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.59 32.47 0.61 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.943 1.735 . . . . 71.14 111.219 -170.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 -11.27 59.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.299 -1.706 . . . . 70.53 114.933 -166.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 16.9 mm 44.58 74.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 127.205 2.202 . . . . 71.45 110.196 175.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.02 148.51 18.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 125.279 1.432 . . . . 55.22 108.789 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.67 131.75 50.02 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.846 2.458 . . . . 74.32 109.591 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.515 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.04 -57.57 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.731 1.613 . . . . 75.22 109.035 175.726 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -58.95 -45.9 94.46 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-O 118.395 -1.225 . . . . 61.43 110.057 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.4 -57.07 13.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.966 1.706 . . . . 65.24 111.636 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -47.74 -54.55 11.85 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.949 1.7 . . . . 75.35 110.334 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 74.0 t -70.56 -43.45 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.055 -0.975 . . . . 61.14 110.552 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.93 -31.87 73.31 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 118.937 -1.105 . . . . 72.34 112.151 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -50.21 -46.91 54.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.449 1.5 . . . . 65.21 109.785 169.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -69.61 -44.54 70.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.907 -0.775 . . . . 75.13 108.907 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -58.26 -28.47 64.95 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.369 1.441 . . . . 74.2 112.301 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -85.0 -25.31 27.78 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 125.582 1.553 . . . . 64.44 112.58 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -93.97 -58.02 2.37 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.998 -1.853 . . . . 62.33 105.998 175.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -86.63 43.76 1.1 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.78 2.032 . . . . 71.12 108.943 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -49.59 -38.04 30.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 127.324 2.249 . . . . 62.32 111.255 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -95.08 -2.75 49.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.433 0.901 . . . . 61.0 113.433 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -82.1 -6.98 59.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.009 0.822 . . . . 63.42 112.365 165.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.07 99.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 119.579 1.081 . . . . 70.0 108.612 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -85.4 108.08 17.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.665 1.986 . . . . 72.11 107.741 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.53 124.72 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.412 -1.699 . . . . 72.1 106.412 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.94 137.82 37.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.92 -1.511 . . . . 74.02 106.92 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -65.73 -42.7 90.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.997 -0.281 . . . . 74.52 111.552 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -120.58 58.07 0.95 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.606 -1.627 . . . . 72.24 106.606 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.21 -133.83 1.55 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.174 -0.77 . . . . 65.13 111.174 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -101.27 0.42 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.083 0.772 . . . . 64.31 113.083 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.98 104.11 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 108.51 -1.836 . . . . 34.52 108.51 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -126.27 171.15 11.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.3 1.84 . . . . 74.21 111.249 -170.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mt -138.22 133.85 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.25 -2.129 . . . . 72.33 105.25 166.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 122.32 22.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.454 -1.684 . . . . 45.31 106.454 160.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.306 2.4 pp -126.84 23.92 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 123.091 1.424 . . . . 74.43 109.593 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -26.63 69.51 Favored Glycine 0 CA--C 1.523 0.555 0 O-C-N 120.537 -1.352 . . . . 72.22 112.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -12.41 61.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.186 1.794 . . . . 74.22 115.402 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.15 -14.75 63.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.011 1.278 . . . . 73.03 113.235 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 m120 60.77 11.26 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.266 2.626 . . . . 72.32 114.004 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.49 130.26 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.953 -1.092 . . . . 72.51 108.832 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.92 154.1 20.03 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.562 1.145 . . . . 74.41 110.976 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.79 150.19 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.129 2.172 . . . . 71.34 108.005 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -72.86 109.81 6.71 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.272 -1.381 . . . . 72.24 107.272 169.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -99.01 -175.2 2.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.058 1.743 . . . . 65.44 107.274 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.435 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -135.09 128.56 32.43 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.801 -1.926 . . . . 72.1 105.801 164.01 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -80.47 97.13 6.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.971 -1.492 . . . . 72.51 106.971 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB2' HG21 ' A' ' 162' ' ' THR . 50.6 tttt -50.88 -23.15 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 117.835 -1.079 . . . . 75.12 112.543 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -43.05 -38.83 2.47 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.025 1.73 . . . . 72.23 113.483 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -142.82 15.12 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.767 1.227 . . . . 74.23 110.54 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt 56.57 44.59 23.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.987 1.315 . . . . 62.24 111.423 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -111.04 152.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.712 1.605 . . . . 74.33 108.521 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.14 118.33 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 106.477 -1.675 . . . . 70.24 106.477 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' C ' ' HE2' ' A' ' 60' ' ' LYS . 8.7 mm-40 -144.36 175.8 9.83 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.5 1.52 . . . . 71.24 109.334 -175.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.52 141.02 29.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.641 -1.287 . . . . 64.1 111.327 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 154.89 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.6 1.96 . . . . 71.11 108.686 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -91.21 156.71 17.64 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.181 -1.044 . . . . 61.45 108.181 168.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.603 HG21 HD11 ' A' ' 155' ' ' LEU . 3.1 mp -95.52 154.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.793 1.237 . . . . 70.25 108.697 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.0 -52.12 2.81 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.904 1.682 . . . . 60.21 110.615 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -134.12 162.05 33.18 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.465 -0.772 . . . . 71.15 110.01 -171.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.632 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.1 155.96 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.548 1.539 . . . . 74.22 108.436 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.64 166.24 20.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.324 1.45 . . . . 74.44 108.165 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -137.4 143.94 42.17 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 73.24 109.224 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -141.21 164.46 30.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 130.161 3.384 . . . . 72.45 108.819 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -116.74 159.0 22.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.06 -1.65 . . . . 73.45 111.264 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -150.67 155.59 39.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.803 0.811 . . . . 72.52 113.164 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 117.58 2.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.428 1.891 . . . . 73.13 106.4 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.88 -165.23 32.07 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.607 1.549 . . . . 31.35 113.733 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -93.2 129.89 39.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.423 0.689 . . . . 74.44 110.513 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.9 mt -111.26 159.55 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.476 1.11 . . . . 71.2 109.702 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.21 135.17 26.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.967 1.307 . . . . 71.13 107.842 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -128.78 81.15 2.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.484 1.914 . . . . 75.22 105.961 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 140' ' ' VAL . 42.5 mt -63.97 110.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.19 -2.522 . . . . 73.12 104.19 158.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -85.98 162.57 18.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 161.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -142.88 164.69 29.4 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.371 1.869 . . . . 60.33 107.313 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.78 -26.83 68.81 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.449 -0.782 . . . . 71.33 112.205 -159.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.42 27.35 0.08 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.527 1.931 . . . . 72.2 111.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 50.77 14.48 0.18 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.195 2.198 . . . . 74.2 113.641 -168.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.593 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 14.3 ttm105 -85.82 162.09 18.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.806 -1.184 . . . . 73.32 108.766 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 9.8 pt-20 -175.72 168.3 3.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.985 -1.007 . . . . 74.14 110.793 -168.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 8.4 pt -140.6 178.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.782 1.633 . . . . 73.14 109.179 -174.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.07 97.28 2.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.319 -1.734 . . . . 74.5 106.319 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.94 162.44 41.31 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 74.14 111.087 -172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 m -70.25 153.16 43.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.747 -1.205 . . . . 73.34 107.747 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -73.64 -13.37 60.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.556 0.947 . . . . 54.43 113.556 -167.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.29 37.75 2.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.284 1.04 . . . . 61.13 109.564 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -97.03 129.84 31.36 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.925 1.29 . . . . 53.12 107.65 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.69 148.72 87.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.871 2.381 . . . . 74.42 112.359 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 m -144.53 169.13 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 129.565 3.146 . . . . 75.0 107.933 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -107.87 141.52 39.36 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.651 -0.655 . . . . 74.34 109.682 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.62 159.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.199 1.4 . . . . 64.31 109.042 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.478 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 17.2 t -93.39 134.66 35.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.197 1.475 . . . . 54.34 110.31 169.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -103.36 85.44 2.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 111.96 -2.382 . . . . 52.12 106.167 157.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.45 27.42 8.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.683 1.193 . . . . 61.24 113.66 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 119.32 -14.69 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.284 -1.287 . . . . 75.31 113.145 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 176.49 9.74 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.721 1.261 . . . . 55.45 108.009 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.43 118.89 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.894 1.278 . . . . 60.45 108.064 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -118.57 158.79 24.75 Favored 'General case' 0 CA--C 1.526 0.03 0 C-N-CA 123.988 0.915 . . . . 72.14 108.931 174.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -121.59 115.92 23.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.89 2.476 . . . . 74.34 104.505 -176.462 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.7 177.69 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.704 1.202 . . . . 74.53 109.258 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -94.07 153.67 18.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.859 0.754 . . . . 65.32 111.324 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.0 -22.95 42.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.977 1.311 . . . . 73.33 113.758 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -60.16 -43.67 95.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.958 1.254 . . . . 63.11 111.132 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.15 -22.95 57.77 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.224 0.92 . . . . 72.11 113.438 -170.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.21 62.87 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.904 2.081 . . . . 61.31 111.004 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -78.98 -177.95 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.054 1.342 . . . . 72.32 110.162 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 11.1 p -58.6 -4.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 127.573 2.349 . . . . 74.3 114.163 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 15.87 10.05 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.754 2.121 . . . . 73.34 112.155 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.2 159.27 34.79 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.487 1.643 . . . . 74.11 107.498 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -119.91 110.61 16.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.34 -0.985 . . . . 53.25 108.34 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.32 138.93 19.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 124.813 1.245 . . . . 63.24 108.438 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 108' ' ' SER . 11.1 m-85 -75.49 136.0 40.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.559 -0.904 . . . . 70.31 108.559 171.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.0 151.94 79.84 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 124.207 1.003 . . . . 40.45 112.735 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.35 138.32 29.9 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.106 2.537 . . . . 54.32 108.91 170.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -120.92 -157.47 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.524 2.329 . . . . 75.04 105.848 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -37.86 -74.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.179 1.792 . . . . 75.01 112.507 -169.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -121.4 -1.0 9.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.17 0.896 . . . . 72.54 113.24 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.6 p -123.64 169.93 10.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 124.636 1.174 . . . . 74.33 110.541 -168.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 tp -81.66 157.81 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.223 -0.658 . . . . 74.41 109.223 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.6 -176.54 5.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.078 2.951 . . . . 73.02 106.708 174.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.1 161.72 14.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.456 -1.313 . . . . 73.5 107.456 156.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -154.99 108.39 2.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.456 1.502 . . . . 74.12 108.135 173.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.02 144.73 33.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 129.929 3.292 . . . . 64.22 113.266 -162.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 89' ' ' ILE . 66.2 t -77.5 0.41 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.561 1.144 . . . . 74.01 113.599 -170.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.2 pt 27.64 -75.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 118.078 2.621 . . . . 74.31 118.078 167.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.48 128.89 56.33 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.607 1.563 . . . . 73.05 107.986 170.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.27 131.5 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.683 -1.229 . . . . 64.03 107.683 167.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.67 171.62 14.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.318 1.847 . . . . 75.11 108.42 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.49 138.79 50.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.49 -168.41 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.668 1.187 . . . . 73.42 108.569 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -136.65 135.59 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.068 -1.456 . . . . 63.2 107.068 167.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.55 134.73 27.45 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.581 0.753 . . . . 74.34 110.233 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.1 70.89 1.39 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.756 -1.942 . . . . 55.34 105.756 -167.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.09 -166.61 12.14 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.524 1.059 . . . . 75.11 112.393 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -88.42 157.29 18.73 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.965 -1.315 . . . . 54.21 109.413 165.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 10' ' ' ALA . 10.2 pt -126.55 170.34 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.609 1.564 . . . . 64.55 111.16 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.686 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.9 147.69 13.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.156 -1.424 . . . . 73.15 107.156 -170.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -118.93 158.24 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.537 0.735 . . . . 65.3 110.692 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.603 HD11 HG21 ' A' ' 74' ' ' ILE . 19.7 tp -117.38 137.57 52.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.459 1.503 . . . . 65.32 109.231 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.8 m -68.29 -59.47 3.18 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.353 0.597 . . . . 52.14 110.306 -167.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.325 3.2 t 40.67 67.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 128.975 2.91 . . . . 75.1 112.694 -170.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.61 -11.88 61.19 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.499 -0.773 . . . . 71.41 110.934 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -65.2 0.7 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.3 1.04 . . . . 74.54 109.682 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.13 2.34 12.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.137 0.575 . . . . 74.21 112.27 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.6 m170 54.99 31.34 15.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.402 1.481 . . . . 64.34 111.887 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -149.69 151.62 33.99 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.643 -1.286 . . . . 62.22 110.291 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.2 p90 -154.8 172.53 17.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.591 1.156 . . . . 75.45 110.511 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.12 124.95 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.026 1.73 . . . . 64.32 108.929 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.93 148.46 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.726 0.811 . . . . 53.21 109.907 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 151.12 -175.47 30.04 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.26 -1.136 . . . . 73.13 110.26 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -90.94 166.05 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.307 -1.702 . . . . 71.0 110.24 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.06 -68.23 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 130.587 3.555 . . . . 75.1 113.054 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.593 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 12.7 mt-10 -122.06 -18.06 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.632 1.973 . . . . 73.54 114.174 175.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 79.29 166.74 32.49 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 124.249 0.928 . . . . 74.35 111.816 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 25.3 m-85 -121.06 155.26 34.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.139 2.576 . . . . 75.45 105.774 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -77.03 141.14 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.833 -1.173 . . . . 75.13 107.833 167.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . 0.273 46.0 t -135.27 175.82 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.966 1.306 . . . . 75.23 107.6 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 52.7 m -95.89 133.61 39.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.324 1.45 . . . . 43.42 110.565 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -115.13 173.78 6.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.883 1.673 . . . . 54.33 107.108 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.466 0.375 0 C-N-CA 126.057 1.743 . . . . 64.5 110.134 160.268 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 109.614 -0.513 . . . . 54.41 109.614 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.64 170.62 9.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.693 1.597 . . . . 75.35 110.041 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.75 162.33 19.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.445 -0.784 . . . . 45.03 111.927 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 13.6 t80 -47.65 -42.55 24.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.259 2.224 . . . . 74.04 113.538 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.97 16.34 26.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.462 1.483 . . . . 74.12 112.779 -160.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -86.98 120.16 71.41 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.946 2.099 . . . . 75.33 110.481 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -56.77 145.37 83.37 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.385 2.723 . . . . 72.13 113.981 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.469 ' CG2' HG13 ' A' ' 25' ' ' ILE . 45.2 pt -107.87 -10.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.232 1.413 . . . . 60.45 113.156 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 56.14 79.43 0.17 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.393 1.077 . . . . 72.34 110.665 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 155.74 2.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.173 -0.954 . . . . 71.25 109.551 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.09 -38.32 51.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.011 0.925 . . . . 51.23 110.362 169.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.09 -17.05 61.0 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.355 0.872 . . . . 53.14 113.355 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.07 33.7 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 118.486 -1.175 . . . . 73.2 113.142 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.32 -33.06 63.0 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.253 1.575 . . . . 74.34 115.253 -159.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mm 49.21 88.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.294 2.238 . . . . 71.41 110.121 -167.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 148.09 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.95 2.5 . . . . 61.44 107.588 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.64 141.41 58.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.713 1.605 . . . . 70.54 108.143 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -50.39 -51.67 17.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 169.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -57.23 -53.5 44.27 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 118.003 -1.443 . . . . 73.11 110.116 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -60.54 -43.86 96.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 1.166 . . . . 61.14 112.433 -173.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -58.4 -56.61 19.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.777 0.831 . . . . 65.44 109.34 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 153' ' ' TYR . 54.8 t -70.93 -41.69 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.983 -0.553 . . . . 64.12 109.973 -172.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -29.69 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.1 -0.953 . . . . 72.23 111.855 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.1 -43.88 78.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.3 1.864 . . . . 72.42 111.273 172.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 20.0 m-85 -67.64 -43.22 80.85 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.24 -34.88 75.86 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.407 1.458 . . . . 75.43 112.679 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -47.35 66.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.057 1.299 . . . . 72.34 108.928 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.7 mtpp -76.43 -56.9 4.21 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.31 -1.737 . . . . 74.43 106.31 -169.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.1 m-30 -91.32 40.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.39 1.876 . . . . 74.42 107.759 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -37.43 68.63 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 121.165 -0.96 . . . . 73.24 111.453 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.56 81.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.485 1.914 . . . . 71.35 110.382 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -80.51 0.26 34.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.628 1.571 . . . . 55.34 113.354 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.78 99.22 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.02 -1.104 . . . . 63.34 108.02 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.19 161.34 26.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.295 -1.372 . . . . 71.42 107.295 162.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.37 142.21 47.12 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.888 -1.523 . . . . 70.53 106.888 171.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.15 176.71 9.42 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.991 0.807 . . . . 73.13 110.315 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.28 -12.71 60.94 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.426 1.49 . . . . 70.33 111.693 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.47 5.45 17.71 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.978 -1.076 . . . . 74.31 111.359 162.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 30.21 77.28 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 126.922 2.201 . . . . 55.3 113.234 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' A' ' 80' ' ' LYS . 2.6 t80 -77.02 -100.12 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.342 1.857 . . . . 71.11 109.47 -170.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.84 127.95 2.02 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.915 -1.274 . . . . 72.41 109.915 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -155.47 161.41 40.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.164 0.982 . . . . 64.3 111.067 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.44 133.19 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.835 -1.913 . . . . 64.2 105.835 170.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.22 133.45 47.96 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.872 -1.158 . . . . 73.02 107.872 163.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.06 17.71 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.648 0.779 . . . . 54.32 109.785 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.89 8.66 4.34 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 126.083 1.802 . . . . 71.33 113.979 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -109.88 -15.41 14.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.691 1.596 . . . . 74.12 109.661 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.16 -34.09 69.92 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.198 0.999 . . . . 73.32 110.338 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 58.9 14.11 3.14 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.301 1.963 . . . . 71.23 116.301 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.84 127.65 29.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 127.977 2.511 . . . . 71.41 109.276 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -82.32 141.04 33.2 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.546 0.688 . . . . 74.2 111.372 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.9 153.57 17.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 127.848 2.459 . . . . 75.2 106.675 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -72.19 110.7 6.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.592 -1.633 . . . . 74.15 106.592 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 171.42 7.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.17 -1.419 . . . . 61.43 107.17 -174.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -140.25 122.7 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.337 -1.356 . . . . 74.44 107.337 -168.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.5 108.22 18.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.893 -1.151 . . . . 70.23 107.893 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 21.5 ttpp -51.48 -31.42 23.47 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.424 1.49 . . . . 73.54 112.789 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.76 -28.38 15.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.765 2.826 . . . . 74.5 112.957 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 t -150.05 23.06 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.461 -0.774 . . . . 72.51 111.487 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.87 40.2 8.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.414 1.485 . . . . 52.14 112.18 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.81 -172.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.8 0.84 . . . . 70.54 110.095 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -116.92 135.7 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.298 2.239 . . . . 71.43 105.79 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.02 167.51 21.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.113 2.165 . . . . 73.5 107.182 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -101.2 118.92 37.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.231 -1.766 . . . . 63.52 106.231 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -133.37 163.77 28.6 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.122 -1.436 . . . . 65.14 107.122 170.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -95.61 -160.92 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.293 0.951 . . . . 73.13 110.512 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 155' ' ' LEU . 77.2 mt -132.62 146.26 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 105.572 -2.01 . . . . 71.51 105.572 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.65 -45.52 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.507 1.123 . . . . 64.43 111.191 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.595 ' HB2' HG21 ' A' ' 156' ' ' THR . 59.7 mtt180 -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.21 -1.556 . . . . 71.32 108.417 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.14 158.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.991 -0.744 . . . . 71.21 108.991 177.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -129.11 179.33 5.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.587 1.555 . . . . 72.2 108.914 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -170.7 146.21 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.322 1.849 . . . . 73.03 108.982 158.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 47' ' ' PHE . 71.9 tttt -143.8 166.5 24.74 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.618 1.567 . . . . 72.01 107.455 164.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 14.8 ttpt -89.02 165.65 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.46 -1.4 . . . . 70.42 109.223 168.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 91.9 t80 -150.64 158.17 43.83 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.839 1.255 . . . . 74.12 109.9 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 p -155.13 123.98 6.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.65 1.18 . . . . 51.23 107.848 160.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.8 178.19 35.51 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 120.036 1.289 . . . . 73.52 114.167 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.735 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.87 100.85 8.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.334 0.654 . . . . 61.05 110.789 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.13 152.13 23.61 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.81 -1.181 . . . . 63.23 107.81 167.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.93 137.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.791 1.636 . . . . 54.41 108.943 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -117.5 80.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.427 -1.715 . . . . 73.4 106.868 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.6 137.25 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.848 -1.908 . . . . 73.13 105.848 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.7 m -117.31 171.83 7.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.079 -1.822 . . . . 70.32 106.079 159.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -139.32 172.85 12.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.911 1.284 . . . . 74.22 109.106 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -63.7 -29.27 70.52 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.063 -1.023 . . . . 65.55 110.742 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.64 2.48 5.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.113 1.365 . . . . 74.32 113.945 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 62.58 16.69 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.494 1.518 . . . . 64.14 111.8 -168.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -70.0 153.46 43.19 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.814 -1.18 . . . . 54.32 107.814 168.169 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.57 163.29 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.942 1.697 . . . . 75.51 107.564 -170.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -148.96 172.64 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.02 1.728 . . . . 74.13 108.955 -170.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.3 m -146.12 92.43 2.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.666 -1.235 . . . . 70.12 107.666 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.88 170.21 18.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.315 1.446 . . . . 63.42 110.832 -172.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 p -70.19 166.99 18.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.964 1.256 . . . . 54.41 112.15 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.3 1.4 p-80 -67.84 -31.62 71.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.22 -0.925 . . . . 63.53 111.348 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -100.18 39.94 1.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.832 2.453 . . . . 72.33 111.293 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -95.3 128.36 38.82 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.609 -1.186 . . . . 74.41 111.829 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.46 121.77 8.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.551 2.834 . . . . 72.33 111.042 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.76 177.12 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.776 1.631 . . . . 74.22 108.752 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -112.43 149.53 32.44 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.179 -0.951 . . . . 75.13 111.545 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.46 170.32 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 126.006 1.722 . . . . 73.13 108.458 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 p -96.05 137.09 35.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.075 0.94 . . . . 73.21 110.261 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 79.8 1.87 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.776 -1.564 . . . . 73.3 106.776 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 65.42 4.01 2.56 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.196 1.184 . . . . 74.31 114.196 172.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -21.89 2.43 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 120.173 -1.579 . . . . 70.44 112.139 -169.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -102.66 160.58 14.45 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.148 1.379 . . . . 64.41 107.893 -171.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 t -112.91 119.24 60.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.378 -1.712 . . . . 75.13 106.378 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.67 137.2 48.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.445 -0.946 . . . . 43.42 108.445 -170.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -84.0 134.56 34.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.271 1.028 . . . . 72.44 109.519 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 pt -147.78 -179.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.454 1.502 . . . . 64.44 109.717 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -79.38 134.04 36.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.408 1.083 . . . . 74.41 110.225 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.37 -30.75 30.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.328 1.051 . . . . 63.33 113.04 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.65 -26.14 68.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.285 1.857 . . . . 73.43 113.625 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 36.7 mmt -80.89 -26.36 36.89 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.39 1.076 . . . . 72.41 111.554 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.95 63.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.006 2.522 . . . . 53.3 111.468 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -78.96 -177.72 5.71 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.898 -1.126 . . . . 73.15 109.063 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.98 1.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.34 1.856 . . . . 65.51 112.964 159.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.11 -3.96 72.31 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 116.614 -2.214 . . . . 63.23 112.444 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 166.74 21.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.134 1.967 . . . . 61.02 107.734 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 3.4 m-85 -98.38 155.74 17.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.011 -0.995 . . . . 72.43 108.79 163.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.8 tt -122.21 131.37 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.388 1.075 . . . . 55.03 109.462 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.8 m-85 -71.7 117.77 13.7 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 118.585 -0.721 . . . . 65.41 109.909 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.566 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.1 pp -129.4 157.06 77.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.639 1.175 . . . . 75.42 112.99 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.31 147.3 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.57 2.18 . . . . 63.03 109.563 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.42 -178.36 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.262 -1.384 . . . . 53.04 107.262 163.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -24.12 -71.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.464 2.706 . . . . 73.44 112.802 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -121.01 1.22 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.382 2.673 . . . . 74.42 113.85 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.1 p -128.61 -173.88 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.828 1.651 . . . . 65.04 112.723 -168.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.25 157.45 5.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.868 -1.16 . . . . 72.04 107.868 166.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -140.92 -177.34 5.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.307 2.243 . . . . 71.54 107.209 165.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 128' ' ' TYR . 1.1 tp -108.76 157.66 18.36 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.555 1.142 . . . . 70.04 110.074 165.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.566 ' CG ' HG12 ' A' ' 129' ' ' ILE 0.306 39.5 p30 -142.79 164.67 29.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 114.396 1.258 . . . . 70.42 114.396 162.309 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -95.26 146.1 24.59 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.063 1.745 . . . . 72.22 107.5 -171.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -98.14 0.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 113.749 1.018 . . . . 71.05 113.749 -160.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 pt 35.31 -53.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 1 C-N-CA 133.019 4.528 . . . . 75.31 120.064 169.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -144.68 133.51 22.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.301 2.64 . . . . 70.33 107.908 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.96 127.28 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.263 1.03 . . . . 75.2 108.318 166.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -140.22 -158.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.392 1.477 . . . . 70.11 107.579 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -139.7 152.49 46.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.386 1.074 . . . . 73.04 108.952 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m -102.59 139.1 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.505 -1.665 . . . . 70.22 106.505 161.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.21 92.8 9.09 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.752 1.614 . . . . 74.43 106.972 166.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -96.81 139.41 32.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.183 0.993 . . . . 75.14 111.345 -168.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -140.69 67.01 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.742 -1.577 . . . . 62.34 106.742 -165.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.0 -172.51 12.83 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 123.72 0.676 . . . . 72.5 111.99 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -81.3 144.47 31.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.178 -0.675 . . . . 71.02 109.178 162.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.54 158.18 34.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 127.638 2.375 . . . . 73.45 108.665 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.662 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -153.81 164.85 37.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.912 -0.773 . . . . 72.3 108.912 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -129.15 147.83 51.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.342 1.457 . . . . 75.22 108.994 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 74' ' ' ILE . 20.0 tp -96.14 153.81 17.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.539 . . . . 74.12 110.686 -171.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 76' ' ' ARG . 2.4 m -107.71 37.83 2.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.722 0.809 . . . . 70.31 111.615 -165.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.85 101.93 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 119.881 -1.762 . . . . 54.32 109.542 -172.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.59 -6.09 57.76 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.49 1.116 . . . . 63.44 110.311 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.35 -67.25 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.779 1.232 . . . . 74.23 108.58 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 6.5 t30 -112.13 4.43 17.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.753 0.821 . . . . 74.34 111.418 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.13 35.1 25.08 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.218 1.007 . . . . 70.31 109.592 -169.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.27 150.78 27.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.947 1.699 . . . . 75.33 108.57 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.67 -178.57 6.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.064 1.302 . . . . 62.03 110.555 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.2 mm -113.36 143.27 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.381 1.472 . . . . 75.14 108.634 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.34 38.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.341 1.056 . . . . 52.35 110.223 165.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 132.58 -169.2 22.45 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 119.035 0.834 . . . . 55.04 112.569 166.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -85.7 167.41 15.31 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.083 1.442 . . . . 70.31 111.841 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.45 -73.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.142 2.977 . . . . 71.23 113.762 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.21 -14.22 7.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.239 1.815 . . . . 62.44 112.493 175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 68.89 160.67 2.12 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 126.484 1.992 . . . . 64.03 112.571 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 97' ' ' ILE . 37.5 m-85 -106.6 151.06 25.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.379 2.272 . . . . 74.21 107.07 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.544 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -78.6 129.56 34.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.407 -1.331 . . . . 71.54 107.407 162.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.01 176.34 7.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.419 -1.326 . . . . 70.54 107.419 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.2 t -65.98 164.52 15.01 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.644 -0.873 . . . . 74.32 108.644 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.38 132.9 20.81 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.544 -1.65 . . . . 64.31 106.544 164.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 106.436 -1.69 . . . . 75.43 106.436 159.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.475 0 N-CA-C 106.407 -1.701 . . . . 60.42 106.407 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt -101.89 166.65 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.572 1.549 . . . . 74.25 109.588 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -173.85 0.56 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.031 1.332 . . . . 73.31 110.858 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.86 -31.85 59.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.492 1.117 . . . . 75.24 111.062 171.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.96 31.64 6.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.714 2.405 . . . . 25.41 111.051 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -88.43 133.38 36.6 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.619 -1.252 . . . . 63.54 107.619 157.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.57 152.45 59.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.211 1.274 . . . . 63.34 113.676 168.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.04 -17.03 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 72.4 114.658 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.37 74.62 0.27 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.943 1.354 . . . . 74.15 111.755 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 mt -53.85 163.64 0.7 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.991 -1.004 . . . . 73.03 109.504 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -56.07 -36.37 68.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.676 -0.64 . . . . 70.25 110.266 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.96 -18.73 63.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.684 0.794 . . . . 74.44 112.948 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.3 44.85 26.85 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 125.436 1.493 . . . . 74.23 109.574 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.792 1.034 . . . . 63.32 113.792 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 mm 48.54 102.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.799 2.44 . . . . 61.23 109.987 -160.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.5 142.99 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.676 -1.601 . . . . 73.51 106.676 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.38 123.94 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.028 2.531 . . . . 51.15 106.989 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -51.18 -44.78 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 70.02 111.511 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.26 -27.53 73.59 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.938 -0.924 . . . . 74.23 111.751 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -73.94 -44.39 55.1 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.832 1.316 . . . . 74.03 110.079 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -53.86 -53.45 52.35 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.597 1.159 . . . . 75.01 109.115 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 33' ' ' PHE . 93.0 t -56.51 -48.77 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.25 0.62 . . . . 60.1 111.033 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.13 -32.23 73.83 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.907 -1.12 . . . . 71.2 112.864 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.1 -36.74 19.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.742 1.217 . . . . 72.14 110.79 171.25 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.547 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 35.1 m-85 -84.79 -45.69 12.11 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.69 -0.856 . . . . 73.22 108.69 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.6 m-30 -68.43 -21.42 64.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.603 1.547 . . . . 72.4 111.62 -169.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 9.9 mtpt -86.87 -16.91 34.66 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.174 1.39 . . . . 74.21 112.029 172.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -57.43 2.18 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 120.587 1.539 . . . . 64.21 108.153 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.4 m-30 -86.12 40.01 0.85 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.125 1.77 . . . . 65.43 108.245 -174.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 33.0 mttt -49.99 -44.41 50.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.032 1.333 . . . . 35.11 108.639 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -56.63 -25.15 52.44 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 126.535 1.934 . . . . 73.23 114.229 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -112.93 12.39 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.645 1.578 . . . . 75.25 112.057 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.33 106.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.842 -1.54 . . . . 51.22 106.842 159.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.16 152.98 25.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.5 -0.926 . . . . 64.21 108.5 164.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -118.32 142.25 47.7 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.635 -2.358 . . . . 74.3 104.635 158.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.52 159.02 20.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.308 -1.738 . . . . 74.24 106.308 156.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.71 -37.7 85.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.253 1.421 . . . . 63.31 110.285 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.16 -27.47 61.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.167 0.987 . . . . 70.43 111.151 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.04 5.37 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.043 1.306 . . . . 74.25 114.432 159.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.9 -86.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.642 1.177 . . . . 61.12 110.726 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.48 137.04 4.76 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 120.795 -1.19 . . . . 61.1 110.539 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -142.62 167.77 21.3 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.98 0.89 . . . . 74.45 111.026 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 33' ' ' PHE . 5.3 mt -142.25 140.15 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.95 2.1 . . . . 74.12 105.464 163.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 126.96 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.169 1.788 . . . . 33.02 108.737 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.96 -3.51 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.845 1.258 . . . . 52.45 111.63 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.05 -16.61 57.77 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 120.373 1.442 . . . . 70.41 113.294 -170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -23.95 66.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.461 1.131 . . . . 73.42 112.712 171.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.74 -15.16 26.36 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.546 1.538 . . . . 52.4 113.169 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.48 6.34 3.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.642 1.577 . . . . 73.11 114.924 173.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.49 148.44 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.907 2.083 . . . . 72.2 107.448 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.04 158.4 25.9 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.398 1.094 . . . . 73.01 110.96 169.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.25 161.28 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 129.027 2.931 . . . . 63.14 107.382 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -75.11 152.06 38.57 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.124 -0.985 . . . . 75.41 109.416 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -145.18 -171.91 3.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.703 0.801 . . . . 71.34 109.25 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -140.14 137.53 34.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.075 -1.454 . . . . 71.32 107.075 168.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -80.97 113.38 19.14 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.777 -1.194 . . . . 71.32 107.777 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.31 -29.87 71.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.341 0.656 . . . . 74.24 112.195 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -30.69 5.68 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.676 1.991 . . . . 73.33 112.732 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.28 11.53 1.74 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.437 0.695 . . . . 65.31 111.956 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.36 46.36 26.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.279 1.431 . . . . 50.41 112.252 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.0 163.28 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 126.086 1.754 . . . . 73.22 109.827 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.68 148.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.816 1.246 . . . . 73.15 109.281 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.91 -179.39 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.936 1.695 . . . . 43.11 110.741 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' HE2' ' A' ' 72' ' ' LYS . 1.5 p30 -86.17 172.26 10.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.341 1.456 . . . . 51.35 110.896 155.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -145.01 170.02 16.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.591 1.556 . . . . 64.12 108.226 141.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -99.46 -19.47 16.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.75 1.22 . . . . 61.13 113.846 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 mt 64.1 155.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.01 1.724 . . . . 73.34 110.145 -163.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.14 -63.89 1.29 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.6 -1.63 . . . . 71.13 106.6 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -130.21 152.45 49.62 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.9 0.88 . . . . 72.41 110.267 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.49 153.74 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 107.373 -1.344 . . . . 74.53 107.373 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.78 153.86 50.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.557 1.543 . . . . 74.24 108.184 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 160.39 41.61 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.753 -0.832 . . . . 73.31 108.753 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -151.83 161.47 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.733 -1.58 . . . . 75.53 106.733 162.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 151' ' ' HIS . 18.5 ttpt -91.29 150.13 21.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.427 -1.421 . . . . 62.34 109.286 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -141.63 164.43 30.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.145 0.978 . . . . 74.2 108.982 -177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 67.6 m -157.4 127.66 6.35 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.97 -1.863 . . . . 72.15 105.97 150.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.22 -169.14 37.48 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.873 1.215 . . . . 75.31 110.208 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.536 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.53 146.7 32.5 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.096 -0.65 . . . . 75.12 109.462 178.283 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.16 163.58 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.994 -1.484 . . . . 73.53 106.994 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.0 mm -78.86 132.78 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.975 -0.75 . . . . 74.54 108.975 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -111.37 80.59 1.33 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.965 -1.865 . . . . 72.54 105.965 169.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.48 123.94 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.175 -2.528 . . . . 73.54 104.175 158.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.3 m -114.68 161.89 17.53 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 105.906 -1.887 . . . . 73.24 105.906 160.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -139.75 163.35 32.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.949 1.299 . . . . 75.41 108.061 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.94 -27.76 61.43 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.899 1.227 . . . . 52.41 112.072 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -60.5 -8.16 2.59 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.229 1.811 . . . . 73.15 112.253 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 65.08 13.58 8.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.435 2.294 . . . . 75.52 110.977 -161.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 154.56 38.05 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.31 -1.367 . . . . 65.12 107.31 170.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.01 168.78 13.52 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.744 2.018 . . . . 74.52 108.744 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.62 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -152.08 -168.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.907 1.683 . . . . 75.34 110.452 -173.605 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.55 132.98 17.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 112.757 0.651 . . . . 73.24 112.757 169.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 159.31 41.47 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.826 1.25 . . . . 72.25 110.417 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.6 m -72.15 -0.12 11.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.262 1.208 . . . . 71.3 114.262 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.306 0.3 OUTLIER 96.19 -61.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 1 C-N-CA 132.399 4.28 . . . . 72.22 107.66 -155.695 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -92.93 82.57 4.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.202 -1.777 . . . . 74.22 106.202 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -124.38 136.5 27.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.077 1.751 . . . . 73.5 107.938 158.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.08 134.21 33.41 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.162 2.574 . . . . 73.13 110.719 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.66 -172.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.955 1.302 . . . . 73.45 108.065 168.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -124.85 141.35 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.609 1.55 . . . . 64.35 110.644 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.76 163.11 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.666 1.186 . . . . 52.15 109.808 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 p -82.4 127.96 33.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.873 0.733 . . . . 60.55 109.298 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 92.9 4.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.396 -2.816 . . . . 73.45 103.396 154.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m 66.22 -13.73 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.43 2.692 . . . . 62.32 116.78 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.65 -0.24 4.99 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.547 0.594 . . . . 74.01 111.675 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 148.37 31.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.297 -1.001 . . . . 73.12 108.297 156.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.45 127.31 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.928 1.291 . . . . 74.2 107.809 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 tp -126.59 158.89 35.08 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.357 1.063 . . . . 73.3 108.376 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -124.2 106.02 9.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.846 2.459 . . . . 72.42 109.655 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -140.02 169.84 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.914 2.486 . . . . 74.01 109.317 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.81 144.81 29.88 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.353 0.661 . . . . 74.34 110.466 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.11 61.72 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.923 1.083 . . . . 74.12 113.923 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -21.98 65.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.998 0.919 . . . . 42.35 112.123 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.3 mtm -89.65 -26.87 20.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.516 1.053 . . . . 61.51 112.337 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.79 62.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 128.733 2.813 . . . . 55.35 110.698 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -79.86 -174.51 4.43 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.063 1.345 . . . . 72.54 109.536 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.09 0.22 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 127.142 2.177 . . . . 74.13 113.034 166.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.66 -3.52 77.41 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.96 1.743 . . . . 60.11 112.998 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.32 169.73 10.64 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.364 1.082 . . . . 70.3 111.887 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 6.9 m-85 -123.17 113.13 18.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.905 2.882 . . . . 71.1 107.213 171.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.93 136.83 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.467 1.107 . . . . 74.25 108.672 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -72.49 121.86 20.32 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.833 -0.803 . . . . 70.25 108.833 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.471 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.9 pp -126.24 150.26 69.39 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.635 1.174 . . . . 65.33 111.472 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.28 138.19 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.49 2.793 . . . . 64.25 109.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -167.57 1.87 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.682 -1.599 . . . . 65.14 106.682 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -23.25 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 129.386 3.075 . . . . 75.11 112.317 -160.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -120.68 0.33 10.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.044 2.537 . . . . 65.13 110.134 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 48.8 p -139.01 165.3 27.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.368 1.067 . . . . 71.14 112.71 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -79.31 156.34 4.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.625 0.726 . . . . 74.52 109.67 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -139.48 -175.86 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.017 2.127 . . . . 72.5 107.981 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 89.6 mt -114.78 164.55 13.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.498 -0.927 . . . . 61.32 108.498 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -151.26 158.73 44.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.13 -1.063 . . . . 62.04 108.13 160.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 14.6 tt0 -92.01 152.27 20.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.286 0.634 . . . . 75.31 109.346 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.01 1.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.241 1.416 . . . . 72.21 112.696 -168.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.9 pt 24.74 -83.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 128.325 2.65 . . . . 73.3 116.232 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.461 ' H ' HG13 ' A' ' 141' ' ' ILE . 8.2 tppt? -95.24 123.3 38.67 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.039 1.336 . . . . 63.01 108.225 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.21 104.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 123.606 1.67 . . . . 74.11 109.226 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.65 -156.28 0.75 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.965 1.706 . . . . 72.34 106.517 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -131.13 167.47 19.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.568 1.547 . . . . 73.14 108.232 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.59 178.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.708 1.603 . . . . 52.21 106.928 160.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -122.13 137.71 54.72 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.659 -1.237 . . . . 75.22 107.659 160.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -141.53 134.11 28.43 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.523 1.929 . . . . 73.01 109.699 -163.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 19.6 m-20 -132.45 28.07 4.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.377 1.444 . . . . 74.42 112.85 -160.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -132.94 -170.6 12.51 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.798 1.19 . . . . 55.32 110.953 -164.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 79.4 m-70 -74.36 149.09 40.72 Favored 'General case' 0 CA--C 1.522 -0.107 0 O-C-N 121.033 -1.275 . . . . 72.03 109.704 168.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 25.6 pt -108.52 149.79 11.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 125.499 1.52 . . . . 74.22 107.661 173.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.51 147.14 52.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.857 1.263 . . . . 71.33 110.714 -161.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -144.81 152.49 40.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.249 1.019 . . . . 63.43 109.476 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.19 119.69 25.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.142 1.377 . . . . 51.01 108.767 -166.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -37.39 87.03 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.285 1.217 . . . . 51.23 114.285 -166.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.8 t 25.24 73.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.202 2.601 . . . . 63.31 113.971 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.13 -3.45 39.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.847 -1.158 . . . . 75.35 113.558 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.26 -61.18 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.841 1.256 . . . . 72.41 108.981 -165.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -108.48 -10.27 15.29 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.112 1.365 . . . . 72.41 111.839 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.0 m170 52.43 21.81 1.88 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.314 1.846 . . . . 75.54 112.152 -166.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -142.18 153.72 44.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.822 -1.174 . . . . 73.5 109.007 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 179.39 9.25 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.868 1.267 . . . . 74.0 111.035 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.3 mm -105.63 137.12 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.783 -1.562 . . . . 73.23 106.783 168.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.59 153.65 30.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.484 1.114 . . . . 41.13 108.463 169.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 136.51 -161.7 25.04 Favored Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.947 1.249 . . . . 74.23 112.254 169.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -101.82 170.48 8.12 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.167 1.984 . . . . 74.11 111.743 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.06 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.162 3.385 . . . . 75.03 112.51 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -121.66 -13.05 8.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.364 1.466 . . . . 74.43 112.108 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.2 176.47 39.14 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 122.782 1.212 . . . . 44.22 111.322 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 97' ' ' ILE . 6.4 m-85 -123.84 161.39 25.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.405 2.282 . . . . 72.32 107.053 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -107.42 101.3 10.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.276 -1.75 . . . . 74.51 106.276 -171.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.12 173.26 12.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.586 0.63 . . . . 71.43 110.133 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.87 129.68 42.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.145 -1.428 . . . . 71.13 107.145 162.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.3 171.59 8.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.575 -2.009 . . . . 71.43 105.575 144.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.534 0.363 0 CA-C-N 119.083 0.856 . . . . 71.22 109.754 145.573 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.939 -0.553 . . . . 53.12 109.999 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.49 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 7.0 mp -84.17 171.0 13.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.326 1.05 . . . . 44.31 110.887 174.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.07 156.75 17.17 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.801 -1.187 . . . . 63.52 110.679 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.0 t80 -44.75 -51.79 9.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.262 2.625 . . . . 74.24 110.439 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.97 10.3 19.35 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.189 0.811 . . . . 75.3 113.189 -167.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.23 118.56 72.77 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.375 -1.713 . . . . 62.31 106.375 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -66.53 130.48 23.73 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.437 2.091 . . . . 62.55 109.839 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 pt -93.29 160.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 64.41 109.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' ' 169' ' ' GLU . 50.6 m-85 -114.85 72.9 0.8 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.084 -1.08 . . . . 74.33 108.084 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.48 160.38 5.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.073 -1.421 . . . . 74.45 108.592 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.05 -44.82 51.77 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.907 0.755 . . . . 32.01 109.731 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -94.31 -17.59 22.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.74 -0.664 . . . . 74.04 112.087 -168.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.04 32.74 4.56 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 121.444 -0.785 . . . . 61.42 113.851 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.59 -17.58 64.15 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.568 1.321 . . . . 73.33 114.568 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 mm 39.73 92.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 129.041 2.936 . . . . 41.4 111.992 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 154.25 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.465 1.106 . . . . 55.22 108.455 -176.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -64.45 130.65 44.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.066 -1.457 . . . . 64.24 107.066 173.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.401 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -46.69 -46.91 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 122.489 1.138 . . . . 72.23 108.627 169.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -48.73 -64.7 3.04 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 128.484 2.945 . . . . 44.22 110.616 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -54.96 -49.05 72.34 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.014 2.126 . . . . 74.12 111.38 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -54.62 -49.19 71.09 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.787 0.835 . . . . 70.33 111.244 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 55.9 t -80.8 -38.27 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.983 -1.008 . . . . 73.12 109.45 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -55.17 -45.27 75.72 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.474 0.579 . . . . 65.33 110.68 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -31.07 70.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.783 -1.198 . . . . 74.21 112.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.91 -55.96 7.28 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 116.334 -1.793 . . . . 74.51 109.187 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.45 -44.43 45.67 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 123.104 2.683 . . . . 73.53 112.125 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -74.2 -18.87 60.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.126 2.17 . . . . 71.53 111.896 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -67.76 0.78 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.159 -2.163 . . . . 74.12 105.159 166.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -79.77 39.65 0.43 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.469 2.708 . . . . 62.14 110.999 -167.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -59.79 -28.05 67.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.211 -0.931 . . . . 61.41 111.52 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.46 -23.17 65.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.217 1.407 . . . . 64.24 113.222 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.85 8.05 28.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.812 1.245 . . . . 65.3 111.186 -168.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.22 96.81 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.087 -1.079 . . . . 72.01 108.087 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.78 157.56 27.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.432 -0.951 . . . . 63.34 108.432 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.09 157.7 18.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.632 -1.618 . . . . 71.13 106.632 168.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 169.31 17.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.771 -1.104 . . . . 52.23 109.556 163.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -63.04 1.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.777 2.031 . . . . 61.21 108.68 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -59.57 -21.15 59.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.041 1.336 . . . . 74.11 111.179 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.57 -26.86 2.63 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.208 -1.329 . . . . 72.3 114.168 155.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -25.39 -85.5 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.812 3.245 . . . . 73.01 114.699 -162.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.54 128.28 2.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.232 -1.547 . . . . 42.4 109.232 -166.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -153.6 162.55 41.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.875 1.337 . . . . 73.54 111.245 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -150.73 129.84 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.78 1.632 . . . . 70.43 107.419 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.86 130.62 43.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.024 0.829 . . . . 62.12 109.472 162.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -134.0 16.24 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.163 0.985 . . . . 72.41 111.284 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.98 -29.95 36.33 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.876 2.179 . . . . 63.53 114.433 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -69.68 -24.62 63.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.929 1.291 . . . . 64.24 113.925 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.97 -10.09 12.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.93 1.241 . . . . 74.31 113.805 -174.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.44 14.67 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.441 2.696 . . . . 72.3 115.119 173.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mt -68.75 117.59 11.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.484 1.114 . . . . 75.33 108.575 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.24 157.43 23.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.488 1.137 . . . . 65.31 110.24 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.8 tt -153.29 153.13 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.228 -1.768 . . . . 73.32 106.228 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -67.32 106.35 2.04 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.78 0.718 . . . . 71.35 109.561 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -87.44 172.79 9.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.418 1.087 . . . . 52.44 108.18 165.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.3 OUTLIER -141.83 136.74 30.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.069 -1.826 . . . . 61.51 106.069 167.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.57 119.36 24.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.345 -0.983 . . . . 74.25 108.345 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -63.15 -24.03 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 74.4 111.235 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.08 -33.48 2.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 128.541 2.736 . . . . 74.33 111.81 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 m -157.71 10.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.855 1.262 . . . . 54.13 112.768 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mp 55.75 54.32 8.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.423 1.489 . . . . 75.42 110.751 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.43 158.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.216 1.807 . . . . 72.3 109.619 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 119.73 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.086 1.354 . . . . 75.22 108.686 -164.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -132.4 157.74 43.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.833 1.253 . . . . 73.05 112.038 -168.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -104.85 106.84 17.51 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 126.322 1.849 . . . . 75.33 108.378 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.614 ' NZ ' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -151.72 141.23 21.64 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.403 -1.702 . . . . 74.42 106.403 -174.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -94.91 175.06 6.79 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.098 -1.001 . . . . 73.25 110.936 -166.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.0 mt -97.44 148.49 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.052 1.741 . . . . 73.31 108.147 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.98 -55.2 2.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.214 -0.661 . . . . 74.14 109.214 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.415 HH11 ' HB2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -119.63 152.2 37.45 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.051 -1.03 . . . . 75.51 109.812 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.615 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.73 158.88 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.225 1.81 . . . . 65.22 107.546 171.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -129.53 175.68 8.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.031 1.333 . . . . 53.01 108.046 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 79' ' ' ARG . 1.5 tmm_? -173.66 152.27 2.03 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.938 1.695 . . . . 72.21 109.297 157.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -140.61 161.72 37.09 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.161 2.185 . . . . 73.34 107.376 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -95.26 148.07 22.8 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.196 -0.94 . . . . 71.13 109.46 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -144.91 156.19 43.85 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.735 1.214 . . . . 74.04 108.949 -171.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 2.4 p -159.77 106.01 1.63 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.187 0.995 . . . . 63.11 109.784 165.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.69 -178.11 45.26 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.423 -0.671 . . . . 63.2 111.423 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.18 138.25 34.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.458 -0.782 . . . . 71.33 110.37 170.531 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.02 159.8 18.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.234 1.413 . . . . 70.21 109.399 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mm -83.51 139.97 16.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.624 1.169 . . . . 75.41 107.977 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -129.27 77.35 1.78 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.655 2.382 . . . . 75.21 106.662 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.1 138.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.896 -1.89 . . . . 64.52 105.896 159.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.1 m -119.06 155.29 31.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.407 -2.072 . . . . 74.1 105.407 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 p -131.78 171.76 13.12 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.794 -1.191 . . . . 62.25 108.361 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -56.5 -27.81 58.21 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.759 1.392 . . . . 75.14 114.759 -166.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.42 0.49 19.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.912 2.085 . . . . 73.04 113.935 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 61.49 17.79 8.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.256 1.423 . . . . 65.23 111.89 -163.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.59 158.82 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.064 -1.828 . . . . 75.31 106.064 159.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.82 163.59 1.43 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 128.342 2.657 . . . . 71.0 106.298 -171.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -145.36 169.04 7.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.816 1.646 . . . . 65.32 106.629 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.48 100.33 3.85 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.156 0.889 . . . . 74.34 109.954 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.54 168.87 26.05 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.506 -0.746 . . . . 72.35 112.612 -165.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.8 m -60.44 156.04 16.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.943 1.297 . . . . 73.54 107.784 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.64 6.11 3.39 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.219 -0.926 . . . . 74.32 111.013 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -136.86 36.93 2.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.063 1.345 . . . . 62.21 109.652 -171.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -105.7 129.29 24.89 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 126.071 1.748 . . . . 73.42 108.48 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -65.88 152.7 80.77 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.552 2.168 . . . . 70.03 114.096 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -148.18 173.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.531 2.732 . . . . 41.23 108.055 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.59 137.63 53.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.388 1.075 . . . . 72.11 108.556 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.99 162.42 36.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.848 1.259 . . . . 75.52 108.705 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -87.94 108.45 19.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.613 -0.884 . . . . 70.02 108.613 172.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -78.3 69.09 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 162.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 59.64 13.46 3.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.97 1.47 . . . . 75.32 114.97 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.93 -18.99 5.28 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 120.817 -1.177 . . . . 73.43 112.103 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.55 144.86 33.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.634 -1.988 . . . . 72.22 105.634 162.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -88.45 145.36 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.97 -0.752 . . . . 73.31 108.97 167.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.02 146.7 25.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.211 1.404 . . . . 74.44 108.153 -173.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -102.02 131.59 48.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 118.517 -0.754 . . . . 65.3 110.666 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.9 pt -143.14 -178.81 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.147 1.779 . . . . 74.12 108.625 168.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -78.37 156.15 29.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.781 -1.199 . . . . 74.51 112.989 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.66 -48.33 39.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.823 2.449 . . . . 72.03 111.128 164.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.37 -8.84 28.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.073 1.138 . . . . 75.13 114.073 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.1 mmt -94.31 -38.58 10.93 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.714 1.205 . . . . 70.34 110.968 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.11 60.93 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.853 1.661 . . . . 71.34 109.12 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -171.86 3.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.618 1.567 . . . . 62.33 109.433 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.07 -0.62 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 126.3 1.84 . . . . 72.2 113.045 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.03 -14.19 61.05 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 116.838 -2.09 . . . . 73.35 112.206 171.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.82 179.64 4.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.786 2.293 . . . . 60.5 108.726 -163.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.48 136.71 53.65 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.475 0.71 . . . . 75.41 111.753 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.509 HG23 ' OD1' ' A' ' 138' ' ' ASP . 15.5 tt -111.4 150.15 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.36 1.464 . . . . 71.15 109.335 -170.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.49 103.47 15.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.2 1.0 . . . . 73.25 110.689 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.08 156.72 36.77 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.185 0.994 . . . . 64.41 111.168 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.77 154.08 38.67 Favored 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.486 -1.39 . . . . 51.33 108.486 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -119.38 -157.33 0.69 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.437 -2.06 . . . . 75.34 105.437 162.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -48.5 -71.27 0.07 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.531 1.132 . . . . 62.54 111.863 -171.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -120.37 0.12 10.5 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.874 1.669 . . . . 74.34 111.635 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.8 p -131.82 -172.55 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.217 1.807 . . . . 65.42 111.045 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.85 157.05 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.119 -1.437 . . . . 62.05 107.119 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -136.38 179.19 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.523 -1.658 . . . . 74.13 106.523 167.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 108' ' ' SER . 1.3 mp -108.06 162.19 14.27 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.672 0.749 . . . . 74.24 109.892 168.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 127' ' ' ILE . 20.4 p-10 -148.05 160.61 42.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.183 2.593 . . . . 71.42 107.687 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 140.48 43.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.621 1.968 . . . . 73.35 109.606 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.258 33.8 t -78.62 1.46 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 130.075 3.35 . . . . 74.14 115.005 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.4 pt 25.07 -70.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 130.096 3.358 . . . . 73.53 117.681 167.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.556 ' H ' HG13 ' A' ' 141' ' ' ILE . 9.8 ttmt -117.72 125.16 50.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.516 2.727 . . . . 61.43 107.467 172.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.77 128.36 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.397 -1.705 . . . . 74.25 106.397 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -143.14 -179.23 6.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.964 1.706 . . . . 73.12 107.902 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 p -134.2 157.07 47.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.306 1.042 . . . . 74.41 110.878 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 m -127.24 -175.57 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.849 1.66 . . . . 71.11 108.717 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.88 133.36 43.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.704 1.201 . . . . 74.04 109.963 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -146.95 124.61 11.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 122.481 0.312 . . . . 73.4 110.758 -165.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 27.6 m-20 -130.27 52.55 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.477 -0.765 . . . . 64.15 109.265 -162.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.78 -179.65 34.73 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.681 -0.968 . . . . 64.21 110.681 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -65.18 144.67 57.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.064 1.346 . . . . 75.12 113.045 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.5 pt -129.56 156.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.535 2.334 . . . . 74.23 109.018 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.91 163.73 37.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.26 1.024 . . . . 63.02 110.301 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 0.4 OUTLIER -116.53 -91.06 0.54 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.669 -1.234 . . . . 74.03 107.669 -172.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 5.7 mt 159.6 161.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 1 C-N-CA 133.274 4.63 . . . . 73.21 107.66 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -83.71 -82.93 0.15 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.189 -1.041 . . . . 70.13 108.189 167.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.614 HG13 ' NZ ' ' A' ' 72' ' ' LYS . 48.9 t 56.93 64.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 124.145 1.926 . . . . 54.23 110.688 -171.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' A' ' 76' ' ' ARG . 3.0 pt-20 -81.54 0.23 39.04 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 113.467 -1.697 . . . . 73.41 114.039 -171.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.511 ' HB3' ' HE3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -86.16 -46.23 10.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.973 0.909 . . . . 74.23 110.453 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.45 -23.73 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.487 1.115 . . . . 73.54 110.228 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 53.67 21.26 2.53 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 128.47 2.708 . . . . 71.31 113.411 -159.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.401 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.1 p -149.89 151.81 34.05 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.088 -1.633 . . . . 64.32 111.743 -174.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.759 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.3 p90 -149.06 178.97 8.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.885 1.274 . . . . 75.31 111.285 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.95 119.01 58.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 C-N-CA 124.785 1.234 . . . . 70.23 108.859 171.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -151.39 158.41 43.69 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.098 -1.001 . . . . 71.31 110.806 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 142.42 -158.76 27.04 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.611 1.101 . . . . 35.12 110.646 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -99.55 176.53 5.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.785 1.293 . . . . 73.34 110.678 166.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.54 -91.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 128.559 2.743 . . . . 73.04 111.657 -168.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.467 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -122.78 -1.96 8.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.676 2.39 . . . . 72.41 113.366 176.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 82.66 165.9 37.85 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.382 1.468 . . . . 51.43 114.34 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 66.0 m-85 -108.68 151.78 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.823 2.449 . . . . 74.33 107.609 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.68 102.96 15.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.124 -1.435 . . . . 72.0 107.124 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 105' ' ' VAL . 6.2 m -130.76 176.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 118.535 0.607 . . . . 74.43 111.457 -169.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -68.6 145.8 53.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.14 110.652 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -138.15 62.95 1.55 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.711 2.804 . . . . 73.21 107.092 168.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.532 0.28 0 O-C-N 120.357 -1.464 . . . . 71.13 109.103 174.738 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtm . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 106.345 -1.724 . . . . 64.44 106.345 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.34 173.65 11.38 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.284 0.564 . . . . 52.11 110.695 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 m -81.21 -63.04 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.414 1.086 . . . . 52.34 108.524 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.04 -150.37 1.83 Allowed Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.702 -1.359 . . . . 73.02 109.702 171.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 60.99 -174.18 0.13 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.62 1.168 . . . . 73.33 110.384 -166.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.4 84.48 0.1 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.125 1.77 . . . . 74.0 111.39 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.04 -169.03 39.42 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.477 1.513 . . . . 72.41 112.864 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . -177.44 170.75 2.04 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 128.078 2.551 . . . . 72.02 107.67 165.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.32 156.82 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.786 2.034 . . . . 72.35 110.345 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.12 158.93 27.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.025 0.441 . . . . 40.42 110.404 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.7 t80 -53.23 -36.98 61.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.743 1.617 . . . . 72.4 114.008 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.87 4.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.08 1.752 . . . . 71.33 110.995 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.38 124.16 70.28 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 107.51 -1.293 . . . . 64.3 107.51 162.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.17 156.82 42.97 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.463 2.109 . . . . 73.22 113.399 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.64 -5.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.786 1.634 . . . . 41.43 113.604 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.0 m-85 47.64 76.87 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.625 1.57 . . . . 64.14 113.158 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -52.69 160.19 0.95 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.814 -0.63 . . . . 74.24 110.065 168.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 0.32 0.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.712 1.205 . . . . 62.11 112.255 167.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.13 -16.85 9.72 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.883 2.073 . . . . 74.15 111.507 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.23 38.29 7.32 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.787 0.708 . . . . 14.3 112.457 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -16.42 64.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.717 1.377 . . . . 44.2 114.717 -167.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.269 31.3 mm 35.85 66.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.66 2.784 . . . . 64.22 110.514 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 151.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 127.965 2.506 . . . . 75.34 108.59 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.93 127.0 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.214 2.605 . . . . 73.23 107.779 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.23 -41.4 24.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.245 0.618 . . . . 74.04 111.386 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.44 -41.44 85.01 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.006 -0.886 . . . . 41.31 111.136 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.7 -40.97 92.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.661 1.23 . . . . 73.55 110.674 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.16 13.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.992 0.917 . . . . 72.41 108.845 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 77' ' ' VAL . 53.4 t -56.16 -50.9 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.131 -0.692 . . . . 73.52 109.131 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.35 -32.45 73.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.461 1.028 . . . . 63.3 112.028 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.6 tttt -48.18 -47.13 35.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.366 0.984 . . . . 75.45 108.874 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.6 -43.71 75.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.494 -0.928 . . . . 63.11 108.494 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD1' HD12 ' A' ' 50' ' ' ILE . 5.6 m-85 -63.93 -22.03 66.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.24 0.927 . . . . 73.34 112.132 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -93.9 -20.02 20.42 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.298 1.439 . . . . 72.13 112.507 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.46 -52.59 4.26 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 120.378 1.445 . . . . 70.54 107.701 173.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.13 43.02 1.12 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.891 2.076 . . . . 74.45 108.23 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -54.24 -42.18 69.6 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.923 1.689 . . . . 74.31 109.205 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -65.17 -27.89 69.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.849 0.86 . . . . 75.12 111.862 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.87 -5.16 58.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.004 1.721 . . . . 74.33 112.291 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.3 mt -59.47 95.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 120.829 1.65 . . . . 74.23 108.951 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -81.0 142.88 32.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.965 -1.495 . . . . 75.44 106.965 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.46 150.26 26.99 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.487 -1.301 . . . . 63.31 107.487 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.4 170.58 16.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.765 0.826 . . . . 72.45 108.805 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.19 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.58 0.752 . . . . 64.35 110.093 168.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.91 2.62 2.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.918 1.287 . . . . 63.44 112.457 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.56 46.46 54.94 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 125.919 1.723 . . . . 65.13 111.351 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.64 -100.26 0.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.126 -0.694 . . . . 74.14 109.126 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.4 112.44 1.08 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.343 1.925 . . . . 71.0 108.721 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.05 159.3 42.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.136 1.774 . . . . 73.44 108.418 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.424 HD12 ' CD1' ' A' ' 33' ' ' PHE . 39.6 mt -142.48 142.22 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 106.608 -1.627 . . . . 64.52 106.608 170.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 133.45 43.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.987 0.915 . . . . 71.32 108.788 165.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 52' ' ' ILE . 1.5 pp -129.95 12.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.799 -0.637 . . . . 73.33 110.573 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.59 -22.31 16.78 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.208 0.913 . . . . 63.04 112.184 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.97 -25.38 59.91 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.844 1.258 . . . . 63.14 112.454 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.35 -22.97 64.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.461 1.028 . . . . 74.44 110.558 167.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.56 -6.42 0.12 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.952 1.464 . . . . 73.25 114.952 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -45.78 143.81 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 128.377 2.671 . . . . 74.32 110.997 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -102.86 134.76 45.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.3 0.955 . . . . 73.53 112.137 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 13.4 tt -104.33 148.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.802 1.641 . . . . 74.15 107.581 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -69.99 112.84 6.67 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.436 -1.69 . . . . 74.23 106.436 165.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.43 -166.42 1.15 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.126 -1.435 . . . . 43.35 107.126 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.0 159.62 44.45 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.709 -1.589 . . . . 75.31 106.709 167.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.91 116.76 29.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.966 1.306 . . . . 62.5 110.374 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -57.32 -26.79 61.48 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.865 1.666 . . . . 64.42 113.148 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.25 -22.21 64.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.638 1.575 . . . . 74.53 112.453 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m -149.1 10.47 0.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.159 0.984 . . . . 61.13 112.436 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt 54.3 49.37 18.68 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.848 1.309 . . . . 75.13 109.542 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.7 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.876 1.27 . . . . 73.44 108.636 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.96 124.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.046 -1.835 . . . . 74.22 106.046 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.15 179.49 7.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.831 1.652 . . . . 73.22 107.758 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.97 168.83 19.14 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.967 0.907 . . . . 63.21 110.679 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.55 175.78 13.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.643 -1.243 . . . . 64.53 107.643 140.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.28 136.78 44.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.697 1.199 . . . . 74.23 108.72 168.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.89 157.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.742 1.217 . . . . 73.5 107.77 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 158' ' ' GLU . 37.4 mt -117.99 -43.65 2.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.261 0.624 . . . . 73.5 110.815 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.433 ' H ' ' HB ' ' A' ' 156' ' ' THR . 53.1 mtt180 -138.18 165.02 27.71 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.773 -1.204 . . . . 73.34 109.325 169.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.56 168.13 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.862 1.265 . . . . 53.04 108.924 173.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -135.7 155.6 50.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.798 1.239 . . . . 74.35 109.116 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.07 144.68 38.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.548 -1.278 . . . . 72.14 107.548 167.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.03 169.01 18.42 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.181 1.393 . . . . 71.12 107.774 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.92 147.41 27.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.224 -1.028 . . . . 75.11 108.224 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.91 149.32 34.02 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 125.757 1.623 . . . . 74.34 107.335 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 1.4 m -144.64 131.88 20.64 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.393 -1.706 . . . . 61.14 106.393 159.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.81 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.379 -1.088 . . . . 40.23 110.379 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 123.73 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.057 -0.719 . . . . 74.02 109.057 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 149.17 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.64 -0.874 . . . . 63.44 108.64 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 mm -79.48 138.88 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.205 1.802 . . . . 71.3 106.993 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -122.95 43.7 2.86 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.742 0.817 . . . . 72.21 112.527 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 8.8 mt -46.33 114.79 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 C-N-CA 126.894 2.077 . . . . 71.41 106.747 -175.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.6 169.17 11.23 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.721 -1.585 . . . . 54.15 106.721 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.7 p -133.9 171.94 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.136 -0.977 . . . . 73.44 108.927 157.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.82 -38.4 64.54 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.314 -0.866 . . . . 75.53 111.986 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -72.31 20.03 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.469 2.307 . . . . 74.14 112.473 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 49.23 27.08 1.71 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 128.1 2.56 . . . . 75.44 113.065 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.42 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -65.85 159.89 24.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 120.85 -1.156 . . . . 73.05 108.437 163.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 1.8 pp20? -170.37 167.08 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.98 1.712 . . . . 73.14 107.928 166.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -146.75 174.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 127.145 2.178 . . . . 71.45 107.88 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.13 1.88 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.861 -0.792 . . . . 65.22 108.861 -171.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -142.02 174.37 10.66 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.061 0.944 . . . . 64.33 112.58 -168.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 168.95 8.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.156 2.182 . . . . 73.32 111.684 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.95 -33.27 24.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.364 -0.606 . . . . 65.31 109.364 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -91.63 39.27 1.0 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.787 0.835 . . . . 71.42 110.872 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 99' ' ' LEU . 4.2 t60 -91.78 123.03 64.48 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.208 -1.377 . . . . 75.12 110.077 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.77 124.15 12.35 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.159 2.573 . . . . 63.01 110.412 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.28 173.69 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.746 1.619 . . . . 73.13 108.336 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.69 149.64 34.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.049 0.54 . . . . 74.43 110.761 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.12 164.38 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.973 1.309 . . . . 74.24 109.735 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.81 35.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.082 0.944 . . . . 64.3 108.474 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -109.1 78.06 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.812 -1.551 . . . . 72.52 106.812 153.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.38 14.96 6.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.511 1.524 . . . . 74.12 113.319 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.46 -24.48 3.2 Favored Glycine 0 CA--C 1.521 0.435 0 O-C-N 120.795 -1.191 . . . . 72.11 111.713 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.98 143.32 26.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.552 -1.277 . . . . 61.25 107.552 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.77 -1.937 . . . . 63.13 105.77 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 tp -125.93 159.24 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.653 -0.869 . . . . 73.13 108.653 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.91 119.49 33.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.207 1.803 . . . . 73.03 109.28 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 116' ' ' ILE . 6.9 pt -140.58 179.64 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.262 1.025 . . . . 71.03 110.688 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.6 139.57 34.95 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.62 1.968 . . . . 71.32 110.719 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.24 -41.07 36.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.397 1.479 . . . . 71.54 113.26 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.44 -19.94 65.14 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.932 1.242 . . . . 75.33 113.469 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.5 -22.79 30.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.697 0.799 . . . . 75.41 111.161 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.16 63.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 128.398 2.679 . . . . 64.24 111.527 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -91.42 -170.73 2.71 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.023 -1.048 . . . . 63.15 111.704 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.82 -1.55 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.106 2.162 . . . . 43.4 113.661 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.25 9.19 22.64 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-O 117.439 -1.756 . . . . 45.13 111.764 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 147.68 44.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.84 2.32 . . . . 72.42 108.988 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -94.89 105.09 16.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.241 -1.392 . . . . 73.04 107.241 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.42 118.13 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.601 1.16 . . . . 64.43 109.329 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.38 140.28 56.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.5 -0.75 . . . . 72.54 109.072 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.32 158.0 76.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.854 1.262 . . . . 73.34 111.079 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.54 161.32 42.51 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.669 2.246 . . . . 73.14 110.229 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.438 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -125.21 -145.59 0.33 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.318 -1.364 . . . . 64.44 107.318 166.243 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.99 -82.02 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.465 1.506 . . . . 74.23 109.06 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.46 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.02 0.43 35.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.888 1.675 . . . . 73.33 110.356 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 p -138.02 -172.91 3.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.428 1.491 . . . . 72.3 110.879 -151.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -125.98 143.26 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.187 -1.783 . . . . 75.42 106.187 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.8 177.53 7.8 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.901 -1.124 . . . . 64.1 108.023 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.1 145.7 41.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.897 1.279 . . . . 74.2 107.98 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -142.12 153.97 44.52 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.872 2.069 . . . . 72.13 109.933 170.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 142.02 27.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 118.463 -0.779 . . . . 72.44 110.078 -164.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.7 t -77.32 -5.56 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 114.567 1.321 . . . . 71.31 114.567 -163.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.32 -88.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 127.748 2.419 . . . . 65.21 116.108 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.488 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -85.95 128.58 34.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.901 2.08 . . . . 71.14 109.594 -175.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -129.01 99.07 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.032 1.333 . . . . 63.0 111.103 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -152.65 -169.44 3.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.219 2.608 . . . . 62.11 110.102 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.91 179.56 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.028 1.731 . . . . 74.14 110.107 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.6 163.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.927 2.091 . . . . 74.42 106.442 159.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.01 137.02 37.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.93 -1.878 . . . . 72.33 105.93 161.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.41 142.96 27.59 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.865 0.757 . . . . 64.15 110.058 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 10.5 m-20 -146.82 24.35 1.2 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.847 0.749 . . . . 74.34 112.705 -157.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.88 -111.64 3.39 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 110.318 -1.113 . . . . 54.33 110.318 -155.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -134.23 164.82 26.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.595 -1.631 . . . . 74.31 106.595 157.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 8' ' ' ALA . 20.7 pt -127.09 160.48 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.171 2.188 . . . . 72.35 109.13 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -142.93 151.53 41.06 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.495 1.118 . . . . 72.51 109.684 -168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.23 -178.76 6.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.764 -1.199 . . . . 70.42 107.764 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.3 mt -128.25 175.75 8.22 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.974 1.845 . . . . 75.11 110.995 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 76' ' ' ARG . 24.3 m -128.41 92.05 3.36 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.391 -2.448 . . . . 75.25 104.391 159.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.66 80.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 101.651 -3.463 . . . . 53.11 101.651 166.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 75' ' ' LEU . 14.6 pt-20 -76.5 -15.31 59.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.31 1.053 . . . . 73.3 111.218 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.53 -44.52 62.07 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.915 1.686 . . . . 71.13 109.885 -153.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -125.07 5.06 7.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.202 0.601 . . . . 75.34 111.933 167.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 52.15 36.75 19.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.939 0.791 . . . . 64.33 111.941 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 p -147.43 142.42 26.99 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.378 -1.451 . . . . 43.23 107.571 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.8 p90 -142.86 170.2 16.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.544 1.065 . . . . 75.32 110.349 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.26 137.93 24.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 107.008 -1.478 . . . . 74.21 107.008 160.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.25 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.314 1.045 . . . . 72.03 108.574 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 134.72 -168.19 23.67 Favored Glycine 0 N--CA 1.462 0.403 0 CA-C-N 118.555 0.616 . . . . 34.44 111.729 175.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.42 169.54 8.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.348 1.574 . . . . 74.34 110.318 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.31 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 C-N-CA 128.018 2.527 . . . . 63.31 113.272 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.479 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.423 1.089 . . . . 73.41 112.146 169.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.73 177.11 23.92 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 125.596 1.57 . . . . 65.24 111.432 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.549 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.0 m-85 -117.81 139.92 50.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 126.426 1.89 . . . . 74.43 108.104 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.39 99.31 9.98 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.572 3.149 . . . . 71.12 107.604 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.06 3.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.133 0.573 . . . . 65.41 110.246 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.43 148.93 49.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.227 -1.027 . . . . 72.23 108.227 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -120.76 166.74 13.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.06 -1.459 . . . . 55.11 107.06 158.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 92.2 p -149.27 -149.68 0.31 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.777 -0.769 . . . . 42.43 111.1 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.7 p -149.41 -106.3 0.07 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.851 2.06 . . . . 64.14 107.059 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -88.81 112.06 3.89 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 108.027 -2.029 . . . . 54.41 108.027 165.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.311 0.1 OUTLIER 68.23 -172.03 0.19 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.178 1.391 . . . . 72.22 112.03 159.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.64 81.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.763 -1.211 . . . . 54.22 109.343 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 50.02 56.28 8.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.903 2.481 . . . . 72.42 115.88 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.36 -48.66 12.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.845 1.424 . . . . 74.44 114.845 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.9 m170 31.71 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.679 2.791 . . . . 74.33 114.279 -163.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -104.29 90.41 3.55 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.499 0.72 . . . . 72.11 109.895 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.77 -128.22 0.22 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.488 1.115 . . . . 73.22 110.034 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.083 1.353 . . . . 70.23 110.02 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.812 -0.81 . . . . 64.34 108.812 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 152.19 178.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 130.412 3.485 . . . . 43.51 107.998 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -108.7 -54.34 2.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.739 1.216 . . . . 64.11 108.466 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.42 -139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.947 -1.661 . . . . 64.31 108.947 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 -70.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.865 -1.531 . . . . 75.41 106.865 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 t0 59.16 -171.94 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.98 1.312 . . . . 62.11 109.629 -169.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.82 -160.87 13.85 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.334 -0.853 . . . . 62.23 112.885 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 161.8 165.94 0.02 OUTLIER 'General case' 0 C--O 1.242 0.672 0 C-N-CA 129.704 3.201 . . . . 74.55 108.362 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.78 153.48 21.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.702 2.401 . . . . 72.32 109.608 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.66 163.3 28.02 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.37 0.668 . . . . 40.43 111.71 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -54.96 -38.59 67.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.088 1.355 . . . . 74.44 113.252 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -96.74 9.3 42.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.946 1.698 . . . . 71.14 112.412 -165.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.22 124.13 85.84 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.677 -1.601 . . . . 73.45 106.677 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -55.46 126.31 22.08 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.16 2.574 . . . . 52.32 111.287 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 pt -98.4 119.33 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.688 -1.227 . . . . 61.24 107.688 162.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -78.13 78.99 4.6 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.326 1.45 . . . . 72.33 107.942 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 mt -55.86 164.18 1.23 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 170.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.1 p -54.06 -36.16 62.81 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.168 0.44 . . . . 74.23 111.317 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.13 -22.55 48.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.413 0.685 . . . . 71.31 112.188 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.02 40.54 7.99 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.08 1.324 . . . . 65.44 110.774 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -10.35 52.31 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.906 1.076 . . . . 71.12 113.906 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.317 13.5 mm 52.23 30.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 125.575 2.607 . . . . 72.52 112.077 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.39 149.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.829 -1.532 . . . . 74.43 108.692 -172.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -62.17 122.7 16.23 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.306 -1.739 . . . . 60.52 106.306 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -50.14 -37.85 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.437 1.095 . . . . 64.53 111.087 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 -0.9 89.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.825 -0.986 . . . . 52.04 114.205 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.27 -47.56 6.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.758 1.779 . . . . 75.34 110.365 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -47.14 -53.49 12.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.945 1.298 . . . . 61.22 110.46 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 77' ' ' VAL . 44.6 t -67.1 -42.67 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.525 -0.761 . . . . 52.11 110.486 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -68.2 -24.82 64.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 119.042 -1.063 . . . . 74.53 111.302 -176.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -41.44 70.47 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.135 0.974 . . . . 73.21 110.628 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.85 -40.06 66.01 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.341 -1.314 . . . . 72.12 108.933 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.404 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 11.2 m-85 -56.05 -37.18 68.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.414 1.915 . . . . 72.14 112.436 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -31.36 64.32 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.718 -1.134 . . . . 44.34 111.275 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -90.23 -49.34 6.61 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 121.195 1.816 . . . . 62.15 108.28 -178.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 2.5 m-30 -94.44 39.31 1.09 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.773 2.029 . . . . 63.42 108.333 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -57.02 -31.92 65.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.065 1.346 . . . . 73.22 111.95 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -61.5 -35.51 77.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.722 1.209 . . . . 64.31 110.996 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.12 9.45 40.86 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.092 1.357 . . . . 64.11 112.105 -165.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.7 124.0 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.829 -1.545 . . . . 64.42 106.829 167.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -122.37 114.79 21.24 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.07 1.748 . . . . 74.45 107.496 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.64 146.72 28.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.004 -1.109 . . . . 73.44 108.004 168.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.47 172.46 13.76 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.835 0.854 . . . . 75.44 108.811 168.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.39 73.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 44.42 109.338 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.5 -6.28 35.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.785 1.234 . . . . 34.14 112.499 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.71 15.67 33.55 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.136 -0.977 . . . . 74.13 114.698 156.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.01 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.481 1.912 . . . . 53.43 111.892 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.77 121.43 2.19 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.064 2.269 . . . . 63.44 109.174 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -130.76 164.73 24.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.383 1.873 . . . . 60.54 109.906 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 33' ' ' PHE . 21.4 mt -142.26 138.98 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.291 2.236 . . . . 74.25 106.191 169.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.61 129.52 36.53 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.56 1.544 . . . . 60.24 109.719 166.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.74 16.84 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.264 1.425 . . . . 74.31 111.034 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.4 57.33 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.973 -1.079 . . . . 54.22 113.392 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -77.84 -10.78 59.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.928 1.364 . . . . 64.15 113.311 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -63.58 -33.65 76.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.663 1.12 . . . . 74.42 109.479 168.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 51.14 13.84 0.18 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.93 2.092 . . . . 71.43 113.183 -166.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mt -61.12 126.34 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.29 1.036 . . . . 73.33 108.472 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -83.33 144.22 29.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.637 1.175 . . . . 75.43 110.389 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.2 tt -127.75 150.78 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.792 1.637 . . . . 63.32 107.663 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -62.26 118.34 7.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.015 -1.846 . . . . 62.44 106.015 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -141.92 146.59 35.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.603 -2.74 . . . . 60.32 103.603 -172.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -116.12 126.99 54.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 126.211 1.805 . . . . 74.45 106.128 -171.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.82 121.23 16.87 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.266 -1.013 . . . . 74.12 108.266 172.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -85.39 -20.29 30.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.665 0.786 . . . . 75.25 112.084 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -34.1 65.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.816 0.846 . . . . 65.51 111.033 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -135.93 8.83 3.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.683 0.793 . . . . 73.24 112.141 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.6 mt 57.02 47.84 16.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.8 1.64 . . . . 71.42 112.51 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 148.48 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.372 1.469 . . . . 64.13 108.964 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.6 144.2 11.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.033 -1.84 . . . . 71.12 106.033 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.66 -167.96 2.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.116 2.567 . . . . 64.42 107.052 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.8 153.4 42.56 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.258 -2.126 . . . . 64.15 105.258 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -153.99 162.6 41.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.127 1.371 . . . . 62.24 108.14 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -85.64 179.45 7.09 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.854 1.262 . . . . 72.51 112.828 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.62 155.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.917 2.087 . . . . 72.33 106.725 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.49 -42.68 1.63 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.868 0.867 . . . . 74.44 111.706 -170.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.622 ' CB ' HG21 ' A' ' 156' ' ' THR . 1.3 mtm-85 -127.08 -166.05 1.55 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.57 -0.9 . . . . 73.22 108.57 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -157.84 161.86 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.702 -1.962 . . . . 65.22 105.702 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 156' ' ' THR . 90.7 m95 -147.08 143.14 28.11 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.536 0.734 . . . . 75.23 110.025 178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.4 143.62 26.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.237 0.926 . . . . 75.31 109.538 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -146.38 162.02 39.11 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.847 -1.538 . . . . 75.34 106.847 166.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -85.1 156.01 21.25 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.133 -0.979 . . . . 65.42 108.694 172.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -136.32 163.35 30.64 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.009 2.124 . . . . 71.11 108.307 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 p -167.12 104.29 0.55 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.991 -1.485 . . . . 71.34 106.991 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.73 27.22 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.41 -0.9 . . . . 55.34 113.791 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 94.77 4.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.537 1.535 . . . . 64.21 109.459 -168.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.44 153.01 29.97 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 mm -79.06 131.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.386 1.874 . . . . 54.14 106.974 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -116.83 82.35 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.578 -1.638 . . . . 53.12 106.578 166.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -61.95 137.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.856 -1.905 . . . . 74.23 105.856 162.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -110.8 168.13 9.71 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.645 -1.613 . . . . 73.51 106.645 162.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.76 170.87 15.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.878 1.217 . . . . 75.42 109.361 159.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -58.32 -24.52 59.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.359 1.436 . . . . 74.22 111.962 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.21 -0.9 2.79 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.643 1.177 . . . . 71.33 112.259 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.93 13.75 8.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 128.149 2.58 . . . . 71.24 111.927 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 157.47 28.01 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 124.848 1.259 . . . . 65.41 108.205 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.71 171.17 17.23 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.661 1.585 . . . . 61.32 107.408 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.538 HG23 ' CE1' ' A' ' 171' ' ' PHE . 5.1 pt -147.53 173.09 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 126.664 1.986 . . . . 44.05 107.908 -174.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 104.5 4.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.422 -0.955 . . . . 71.33 108.422 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.15 166.97 27.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.302 1.041 . . . . 63.22 111.442 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -89.52 1.48 55.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 116.157 1.91 . . . . 35.34 116.157 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 96.33 -23.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 1 C-N-CA 138.787 6.835 . . . . 74.55 111.639 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -113.58 37.58 3.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.937 2.495 . . . . 72.31 110.238 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -101.0 139.36 20.44 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 125.04 1.336 . . . . 65.22 108.963 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.54 123.54 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.505 2.137 . . . . 62.25 110.53 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.94 173.55 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 61.34 109.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -119.62 139.71 51.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.103 . . . . 63.34 111.084 -168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.13 162.81 19.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.858 1.263 . . . . 72.54 110.103 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.404 ' HB3' HD21 ' A' ' 137' ' ' LEU . 94.4 p -95.48 105.99 18.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.261 0.351 . . . . 65.22 111.04 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -81.12 78.3 7.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.448 -1.686 . . . . 62.22 106.448 162.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 6.2 m 60.22 6.04 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.522 2.045 . . . . 75.51 116.522 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.32 -31.32 1.56 Allowed Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.712 -1.242 . . . . 72.24 110.057 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.7 142.7 36.89 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.362 -2.088 . . . . 64.51 105.362 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.05 132.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.577 -0.898 . . . . 60.32 108.577 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.24 152.31 48.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.81 1.644 . . . . 73.13 106.677 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.19 115.75 30.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.029 1.332 . . . . 73.44 109.61 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.52 175.26 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.745 0.818 . . . . 73.44 110.901 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -79.97 143.17 34.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.587 1.155 . . . . 71.21 109.226 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.0 -29.1 41.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.629 0.974 . . . . 64.33 113.629 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -24.26 65.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.14 -0.975 . . . . 75.53 112.661 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -86.74 -27.4 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.372 1.069 . . . . 74.13 111.927 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -71.43 61.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 127.921 2.488 . . . . 55.31 109.836 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -178.08 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.01 1.324 . . . . 74.22 108.509 170.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.48 0.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 127.364 2.266 . . . . 63.45 113.9 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.39 -18.88 70.25 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 117.506 -1.719 . . . . 11.25 111.989 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.56 169.82 12.08 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.214 2.007 . . . . 54.05 111.67 -163.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -124.0 119.09 28.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 126.256 1.822 . . . . 65.42 108.153 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -93.74 127.46 45.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.149 0.979 . . . . 73.24 108.776 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -67.8 115.58 7.52 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.906 -1.146 . . . . 75.42 107.906 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.4 154.42 59.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.386 1.074 . . . . 73.22 111.476 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 164' ' ' ILE . 50.7 Cg_exo -59.78 141.35 96.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.94 2.427 . . . . 74.32 110.138 172.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -113.48 -173.98 2.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.786 -1.19 . . . . 72.41 107.786 153.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -37.79 -64.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.189 1.796 . . . . 74.33 111.22 -168.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -120.59 -5.44 9.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.772 0.829 . . . . 74.34 112.122 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 p -125.33 -178.58 4.27 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.668 1.587 . . . . 60.24 111.67 -164.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 tp -100.39 147.25 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 O-C-N 120.171 -1.581 . . . . 53.25 107.574 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -137.94 -175.0 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.751 2.02 . . . . 52.23 107.938 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 108' ' ' SER . 18.9 mt -129.47 157.93 40.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.266 1.427 . . . . 41.25 107.649 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -153.87 159.3 41.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.692 1.597 . . . . 75.15 108.14 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.8 147.7 23.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.07 0.948 . . . . 63.25 110.605 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.97 -0.67 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.998 1.111 . . . . 72.42 113.998 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 26.51 -77.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.044 2.938 . . . . 71.53 117.062 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 141' ' ' ILE . 17.0 tppt? -103.21 117.29 34.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.049 1.74 . . . . 71.43 108.028 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.32 131.2 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.184 -1.043 . . . . 35.12 108.184 169.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -153.06 -179.45 7.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.942 1.697 . . . . 74.25 107.494 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.29 133.85 39.31 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.007 -0.738 . . . . 40.45 109.007 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.98 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.682 1.193 . . . . 64.31 108.494 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.29 113.39 14.34 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.447 -0.946 . . . . 62.11 108.447 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -128.72 135.32 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.074 1.35 . . . . 73.41 108.582 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -133.77 29.6 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.272 -0.893 . . . . 60.35 109.684 -161.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -126.86 -163.91 11.59 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.362 1.934 . . . . 42.24 111.411 -161.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -87.0 153.41 21.57 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.021 -1.281 . . . . 74.23 110.752 173.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.2 153.63 34.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 126.729 2.012 . . . . 72.34 107.877 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -142.47 154.38 44.48 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.344 1.058 . . . . 51.41 108.985 -170.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.95 163.94 27.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.167 1.387 . . . . 52.51 108.288 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.73 140.13 42.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.943 1.701 . . . . 72.33 111.164 -163.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 78' ' ' TRP . 48.4 p -91.37 -46.68 7.89 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.576 0.954 . . . . 74.41 113.576 -156.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 2.7 t 23.12 64.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 130.111 3.364 . . . . 42.32 113.97 175.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.1 0.05 15.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.486 1.114 . . . . 73.41 113.511 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -34.91 41.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.352 -0.981 . . . . 60.13 108.352 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -127.94 -8.91 5.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.203 1.401 . . . . 55.41 113.712 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.57 23.96 14.25 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.475 1.91 . . . . 63.23 111.154 -175.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 p -141.36 164.84 29.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.342 2.657 . . . . 60.21 107.248 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 5.6 p90 -151.39 175.92 11.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.824 1.193 . . . . 72.44 110.372 165.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 62' ' ' PHE . 30.1 mm -109.37 126.17 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 74.21 108.831 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.21 160.46 43.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.729 0.812 . . . . 71.11 110.241 169.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.13 -165.11 25.5 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.167 -1.573 . . . . 31.11 109.167 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -100.72 172.83 6.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.111 1.455 . . . . 74.34 110.267 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.11 -85.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.177 2.591 . . . . 54.32 111.972 -171.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.88 -12.1 8.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.912 1.285 . . . . 74.55 112.878 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.06 174.59 39.31 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 122.877 1.265 . . . . 65.22 112.628 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.7 m-85 -121.18 154.5 36.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.454 2.702 . . . . 64.35 106.801 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.67 32.58 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.355 -1.35 . . . . 53.13 107.355 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.59 174.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 118.579 0.627 . . . . 74.41 109.651 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -72.42 155.2 40.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.111 0.564 . . . . 74.53 109.672 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.11 49.3 1.36 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.697 2.399 . . . . 60.45 108.644 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.4 m -79.87 108.4 13.42 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.098 -1.626 . . . . 61.54 107.159 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.6 p -60.77 8.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.045 2.938 . . . . 60.54 116.088 -169.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.32 45.8 10.89 Favored Glycine 0 CA--C 1.524 0.656 0 O-C-N 120.507 -1.37 . . . . 72.34 110.852 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.41 164.65 28.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.042 -1.466 . . . . 53.54 107.042 160.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.518 ' C ' HD23 ' A' ' 180' ' ' LEU 0.257 5.9 tt 66.05 121.86 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.81 1.644 . . . . 32.33 113.232 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -148.07 167.74 24.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.807 1.643 . . . . 74.13 109.058 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -153.29 178.11 10.12 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.301 1.44 . . . . 54.31 107.404 164.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -135.83 149.83 49.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.562 1.945 . . . . 71.25 107.358 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.98 52.38 0.44 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.606 -1.257 . . . . 43.33 107.606 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 63.63 178.24 0.16 Allowed 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.84 1.656 . . . . 64.44 109.51 -141.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 . . . . . 0 C--O 1.242 0.671 0 CA-C-O 117.094 -1.431 . . . . 71.23 108.423 -178.821 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.015 -0.517 . . . . 63.41 110.684 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m120 80.77 -179.56 0.08 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.23 1.812 . . . . 72.24 112.615 154.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 m -123.29 -33.48 3.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.167 1.787 . . . . 45.22 110.148 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.11 -73.6 0.46 Allowed Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.146 -1.582 . . . . 42.41 109.146 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -64.8 159.35 22.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.345 0.593 . . . . 73.25 110.187 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.17 169.12 18.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.936 -1.505 . . . . 72.23 106.936 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.43 -167.2 12.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.17 1.367 . . . . 62.13 112.273 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.94 155.07 40.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.069 -1.826 . . . . 61.33 106.069 140.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.01 157.54 24.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.177 0.991 . . . . 63.01 109.557 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -68.38 -176.67 0.79 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.187 1.395 . . . . 73.14 110.947 169.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 14.4 t80 -84.67 -33.57 23.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.547 1.139 . . . . 65.13 113.169 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.81 38.53 1.71 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 71.03 110.197 -162.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -117.19 112.61 39.65 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 125.039 1.336 . . . . 74.12 110.947 -153.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.56 127.41 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.99 1.793 . . . . 74.32 113.557 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -100.36 24.53 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.626 1.97 . . . . 53.14 112.95 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 29.78 66.09 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.341 2.257 . . . . 74.43 115.403 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -53.17 155.59 2.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.315 -0.866 . . . . 60.2 111.507 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -43.62 61.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.51 1.124 . . . . 74.13 109.172 169.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.09 -47.34 77.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.105 0.962 . . . . 64.14 110.722 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.81 26.91 3.7 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.767 1.175 . . . . 74.3 112.65 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.68 -27.61 66.55 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.264 1.532 . . . . 72.32 114.118 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 mm 48.17 63.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.861 1.264 . . . . 73.24 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 147.97 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.903 1.281 . . . . 71.33 108.121 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -65.27 122.69 17.69 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.97 -1.493 . . . . 22.14 106.97 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.7 tt -46.55 -44.75 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 124.995 1.318 . . . . 63.11 110.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -70.54 -26.3 74.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-O 118.577 -1.124 . . . . 73.01 111.685 -173.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.41 -53.17 14.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.461 1.631 . . . . 63.33 109.716 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -43.87 -48.77 8.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.779 1.232 . . . . 72.41 109.555 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 77' ' ' VAL . 60.1 t -73.88 -44.9 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 118.361 -0.828 . . . . 63.55 111.645 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -65.03 -32.82 74.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.737 2.062 . . . . 71.2 111.585 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -40.49 65.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.714 1.606 . . . . 73.43 110.965 171.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -76.74 -36.66 56.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.492 1.517 . . . . 65.11 109.632 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -63.66 -41.77 98.15 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.334 1.879 . . . . 74.2 110.774 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -24.42 64.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.497 -0.752 . . . . 55.43 111.281 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 5.5 mttt -82.35 -59.19 2.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.996 -1.483 . . . . 54.54 106.996 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 8.0 m-85 -100.63 41.84 1.15 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.943 0.897 . . . . 61.34 109.949 -162.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -32.2 67.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.564 0.745 . . . . 63.32 111.772 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -73.83 -22.17 59.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.832 0.678 . . . . 75.2 112.832 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 t -90.04 -1.41 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.62 1.568 . . . . 64.14 111.59 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 96.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 124.744 1.217 . . . . 53.43 107.793 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -79.99 161.5 25.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.059 -1.089 . . . . 73.12 108.059 162.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -126.17 154.31 43.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.433 -1.692 . . . . 73.25 106.433 160.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.41 179.38 7.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.009 0.924 . . . . 62.24 110.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.84 -25.54 63.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.4 0.68 . . . . 73.22 111.442 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.53 -13.85 59.81 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.873 -1.142 . . . . 62.25 111.346 165.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.96 55.69 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 120.441 -1.412 . . . . 53.04 112.35 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -52.35 -83.46 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.471 1.909 . . . . 71.21 112.874 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.82 107.32 0.64 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-O 117.977 -1.457 . . . . 75.44 110.131 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -123.31 162.34 22.89 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.107 1.453 . . . . 55.25 111.447 170.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mt -146.73 132.33 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.414 2.686 . . . . 71.44 103.952 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 126.8 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.104 -1.072 . . . . 75.44 108.104 164.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.83 13.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.142 1.377 . . . . 73.24 111.6 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.46 -31.57 36.32 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.291 -0.88 . . . . 75.53 113.472 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.37 -19.41 65.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.741 1.216 . . . . 63.44 112.721 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.81 -25.89 66.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.832 0.742 . . . . 62.21 110.87 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.5 36.02 25.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.752 1.221 . . . . 75.11 111.992 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -89.34 135.08 26.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.73 154.27 19.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.445 0.64 . . . . 73.31 109.305 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -132.89 148.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 125.663 1.585 . . . . 74.03 107.911 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -75.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.688 1.995 . . . . 74.22 110.349 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.16 173.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.047 2.539 . . . . 73.52 108.454 165.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -136.75 140.75 42.8 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.195 -0.94 . . . . 61.02 109.854 -174.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -87.5 121.01 29.39 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 126.064 1.745 . . . . 63.53 109.091 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -70.76 -27.81 64.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.72 0.808 . . . . 74.21 112.076 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -50.5 -42.03 54.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.075 1.35 . . . . 71.32 110.897 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -134.1 16.78 3.8 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.622 0.769 . . . . 55.14 111.357 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.28 49.57 17.6 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.771 1.228 . . . . 74.35 112.464 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.54 154.48 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.555 1.542 . . . . 74.43 109.529 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.98 145.77 8.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.52 -1.289 . . . . 74.01 107.52 165.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -141.06 -168.5 2.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.545 1.938 . . . . 71.43 107.774 163.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -92.24 149.14 21.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.439 -0.948 . . . . 65.32 108.439 153.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -154.13 152.69 30.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.627 2.371 . . . . 73.32 106.571 167.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -84.36 175.66 9.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.428 1.091 . . . . 74.24 109.938 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.69 141.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.829 2.052 . . . . 62.21 106.324 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 158' ' ' GLU . 1.9 mm? -111.74 -45.67 3.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.703 0.401 . . . . 63.53 112.03 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.38 144.83 49.83 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.53 -0.915 . . . . 55.54 108.53 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -108.87 158.7 8.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.393 1.477 . . . . 74.42 108.054 176.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -132.05 152.75 51.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.208 1.003 . . . . 75.42 108.953 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -149.53 152.53 35.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 165.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -150.08 167.96 25.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.094 1.757 . . . . 64.3 106.946 166.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -105.41 143.97 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.044 -1.035 . . . . 75.22 108.223 171.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -142.64 156.19 45.04 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.3 0.5 . . . . 74.54 111.25 -160.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -156.94 125.85 5.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 75.43 109.788 164.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.51 179.52 37.96 Favored Glycine 0 N--CA 1.465 0.587 0 N-CA-C 110.184 -1.167 . . . . 54.1 110.184 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -81.03 140.04 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.876 -0.779 . . . . 62.22 110.236 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.65 157.87 32.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.161 1.384 . . . . 72.53 107.625 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mm -79.67 141.6 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.678 1.191 . . . . 72.32 108.77 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 146' ' ' VAL . 55.7 mttt -123.66 86.28 2.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.341 1.456 . . . . 71.24 107.519 158.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 140' ' ' VAL . 31.8 mt -62.77 101.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.521 -1.659 . . . . 55.44 106.521 148.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.38 172.99 13.04 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.899 -1.519 . . . . 73.21 106.899 163.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -138.56 171.04 14.95 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.704 -1.247 . . . . 74.22 108.574 163.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -71.15 -25.17 62.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.539 2.336 . . . . 55.03 110.938 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -59.86 -11.24 5.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.93 1.692 . . . . 64.44 111.578 164.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 63.15 33.05 14.75 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.173 2.989 . . . . 72.23 111.617 -167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' CG ' ' A' ' 95' ' ' ARG . 2.1 mtt-85 -75.43 173.43 10.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 118.231 -1.388 . . . . 73.41 109.474 161.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.39 164.29 19.7 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.983 1.713 . . . . 75.45 106.522 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.52 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -132.25 -179.93 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.068 -1.086 . . . . 75.51 108.068 165.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.2 m -149.87 118.92 6.71 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.011 -1.68 . . . . 64.44 108.949 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 97' ' ' ILE . 1.1 pt? -166.25 172.13 11.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.963 -1.017 . . . . 65.32 111.261 -169.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 m -79.43 147.61 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.095 -1.076 . . . . 71.12 108.095 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -10.21 54.29 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.165 1.172 . . . . 72.53 114.165 -161.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.4 38.19 3.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.661 2.785 . . . . 65.02 110.156 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -82.63 140.95 44.43 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.071 -0.966 . . . . 52.44 109.525 159.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.02 118.53 5.63 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.124 3.216 . . . . 70.2 111.274 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.65 -166.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 120.876 -1.14 . . . . 74.54 110.128 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -135.07 134.68 40.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.747 1.219 . . . . 65.14 108.733 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.31 166.58 28.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 126.107 1.763 . . . . 73.41 107.944 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -89.9 143.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.096 0.475 . . . . 74.22 110.309 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -115.02 86.74 2.51 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.224 -1.769 . . . . 73.43 106.224 155.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.65 17.76 8.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.097 0.959 . . . . 63.32 113.407 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.43 -26.85 4.3 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.652 1.12 . . . . 71.05 111.187 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 148.62 32.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.557 -1.646 . . . . 60.55 106.557 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.7 t -85.32 114.46 25.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.558 -1.275 . . . . 73.2 107.558 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.46 40.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.89 -0.782 . . . . 71.22 108.89 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.67 120.02 36.22 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.87 2.068 . . . . 73.05 106.996 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.65 175.26 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.691 1.596 . . . . 54.43 109.803 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -78.03 144.5 36.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.53 -0.544 . . . . 70.33 109.53 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.03 22.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 71.12 112.201 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -17.29 62.99 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.151 1.167 . . . . 71.1 114.151 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.6 mtm -96.99 -15.24 21.18 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.161 0.985 . . . . 74.35 112.071 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.61 63.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.949 1.699 . . . . 62.43 109.217 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.63 176.82 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 63.33 109.291 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.36 -37.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.278 1.831 . . . . 65.11 112.721 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.79 11.03 63.09 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.419 -1.767 . . . . 62.35 114.185 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.15 169.9 8.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 121.018 2.409 . . . . 71.04 108.814 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 137' ' ' LEU . 29.4 m-85 -118.16 105.42 11.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 123.907 0.883 . . . . 73.45 109.182 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.0 125.69 39.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 62.43 108.795 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.63 123.46 19.36 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 72.53 107.067 173.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.85 157.74 56.54 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.694 1.598 . . . . 74.54 111.883 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.97 159.72 50.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.387 2.725 . . . . 74.45 111.8 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -141.81 -178.04 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.626 -1.62 . . . . 73.23 106.626 156.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -24.74 -67.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.318 2.647 . . . . 63.04 113.266 -170.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.68 -10.0 9.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.185 0.994 . . . . 31.5 113.447 165.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 p -131.3 148.15 52.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.818 1.19 . . . . 74.31 111.571 -162.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.94 143.31 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.263 -1.384 . . . . 73.42 107.263 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -142.91 -176.91 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.813 1.645 . . . . 74.11 108.391 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 126' ' ' TYR . 8.8 mt -125.38 165.46 18.34 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.413 1.101 . . . . 71.52 108.538 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -154.56 157.71 38.68 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 103.593 -2.743 . . . . 71.33 103.593 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 7.8 mt-10 -61.39 -177.7 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.026 1.33 . . . . 60.24 109.279 168.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 89' ' ' ILE 0.259 72.0 t -112.6 2.56 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.793 1.237 . . . . 75.54 111.904 176.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.1 pt 24.83 -70.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 130.422 3.489 . . . . 73.11 117.719 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.7 tptt -116.14 118.51 33.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.181 1.393 . . . . 65.43 107.462 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.43 119.53 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.998 -1.482 . . . . 65.23 106.998 156.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.14 -176.08 4.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.005 1.722 . . . . 75.32 107.816 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -130.76 159.93 35.84 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.155 -0.966 . . . . 52.12 109.868 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 88' ' ' LYS . 12.3 m -117.12 165.22 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.781 1.633 . . . . 61.2 107.794 171.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -122.7 71.02 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.086 1.354 . . . . 74.52 108.843 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.45 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.7 t80 -81.64 154.76 25.96 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.879 1.272 . . . . 74.52 110.798 -167.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.33 24.96 2.27 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.306 -0.871 . . . . 73.55 112.358 -172.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.58 -138.94 9.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 125.173 1.368 . . . . 62.44 111.942 -155.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -117.86 155.22 30.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.907 -1.146 . . . . 71.11 107.907 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.59 152.41 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.958 1.303 . . . . 74.41 109.928 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -142.57 168.81 18.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.062 1.345 . . . . 75.43 108.492 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -154.74 175.03 14.23 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.803 -1.184 . . . . 74.02 107.803 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 tp -135.14 119.39 17.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.781 1.173 . . . . 63.53 110.508 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.9 m -84.12 118.56 24.18 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.791 -0.818 . . . . 73.51 108.791 169.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 t -125.98 94.93 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.433 -2.062 . . . . 72.32 105.433 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.641 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.3 pt-20 -80.35 -8.65 59.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.336 -0.852 . . . . 73.54 113.236 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -88.55 -59.05 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.74 1.257 . . . . 74.02 108.454 -156.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.07 112.57 13.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 101.687 -3.449 . . . . 74.22 101.687 169.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.439 ' CG ' ' HA ' ' A' ' 176' ' ' SER . 23.8 m170 -69.31 50.39 0.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.606 1.962 . . . . 63.11 112.03 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -151.67 140.1 20.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.02 2.128 . . . . 54.04 108.697 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.81 178.79 8.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.077 1.351 . . . . 74.45 111.121 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 46.7 mm -112.19 135.79 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.481 -1.674 . . . . 74.41 106.481 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.08 159.85 43.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.682 -1.229 . . . . 71.41 107.682 160.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 140.47 -165.22 26.14 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.817 1.198 . . . . 73.13 111.043 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -110.91 170.65 7.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.365 1.078 . . . . 72.44 111.002 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.99 -80.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.146 2.578 . . . . 64.34 112.574 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.32 -3.95 8.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.477 . . . . 64.44 114.051 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 84.38 176.94 51.2 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 122.141 0.856 . . . . 51.11 111.927 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CE1' HG23 ' A' ' 97' ' ' ILE . 3.8 m-85 -127.76 146.86 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.187 2.595 . . . . 74.14 106.2 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.542 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -95.56 132.0 41.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 119.21 -0.424 . . . . 73.54 110.69 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 163' ' ' TYR . 5.4 m -145.71 167.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.19 0.996 . . . . 74.31 109.633 -169.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 71.3 m -63.02 142.81 58.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.167 1.787 . . . . 64.44 110.286 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -141.84 39.89 1.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.568 1.147 . . . . 75.42 111.623 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.439 ' HA ' ' CG ' ' A' ' 161' ' ' HIS . 70.9 m -60.06 124.29 19.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.704 -0.622 . . . . 74.1 111.558 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.8 p -59.18 -23.02 61.87 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.966 1.099 . . . . 74.12 113.966 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.19 118.2 5.5 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 106.898 -2.481 . . . . 52.24 106.898 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 14.6 t -64.8 -179.9 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.189 1.396 . . . . 74.31 110.302 175.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.9 tp 63.45 -89.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.256 1.822 . . . . 64.03 111.582 167.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -140.97 134.24 29.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.306 -2.479 . . . . 72.44 104.306 163.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -149.42 167.12 27.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.504 1.922 . . . . 72.44 106.614 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.77 154.49 44.28 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.753 0.821 . . . . 74.5 110.255 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.37 142.31 58.46 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.546 -0.909 . . . . 65.12 108.546 167.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.69 -170.74 2.99 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.035 1.334 . . . . 72.3 107.933 164.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.8 t60 . . . . . 0 C--O 1.248 0.979 0 N-CA-C 106.281 -1.748 . . . . 72.1 106.281 169.485 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.798 -0.445 . . . . 73.43 109.798 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -56.84 163.26 2.0 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.337 1.855 . . . . 74.43 108.838 160.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.5 t -69.64 -59.89 2.67 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.46 -0.775 . . . . 73.33 109.434 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.84 -133.17 7.5 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 104.678 -3.369 . . . . 75.52 104.678 -158.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -115.82 -79.37 0.59 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.531 -1.285 . . . . 63.14 107.531 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -153.17 160.77 42.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.195 0.598 . . . . 74.33 110.732 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.67 172.83 45.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.696 -1.762 . . . . 55.52 108.696 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -158.78 164.46 35.79 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.596 1.558 . . . . 73.43 108.024 162.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.49 151.82 21.78 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.253 1.421 . . . . 71.33 109.471 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.4 49.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.691 -0.686 . . . . 61.12 110.366 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -48.26 -31.51 6.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.651 1.98 . . . . 72.21 113.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -104.78 15.35 28.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.641 1.976 . . . . 74.31 112.23 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -79.46 114.24 43.65 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.551 -1.277 . . . . 72.54 107.551 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.02 136.33 29.37 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.422 2.748 . . . . 64.21 113.064 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.35 88.61 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.43 -1.322 . . . . 64.52 107.43 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -48.21 83.6 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.233 2.613 . . . . 73.43 113.347 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -65.44 163.97 14.76 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.243 1.017 . . . . 62.34 109.478 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 t -60.21 -39.77 87.74 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 119.027 -0.511 . . . . 50.3 109.812 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.9 -38.48 22.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.702 -0.799 . . . . 73.44 109.275 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.18 43.78 0.9 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 114.958 0.743 . . . . 74.53 114.958 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -8.66 23.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.135 1.902 . . . . 73.03 116.135 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.289 7.8 mm 61.49 25.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-O 124.648 2.166 . . . . 74.34 112.49 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 152.78 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 125.426 1.49 . . . . 74.54 108.915 -170.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.09 130.18 43.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.968 1.707 . . . . 75.12 108.851 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.7 tt -53.49 -33.43 21.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.23 1.412 . . . . 74.32 112.892 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -94.83 -13.67 52.36 Favored Glycine 0 C--O 1.219 -0.818 0 CA-C-O 117.28 -1.845 . . . . 40.1 112.782 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -73.47 -49.72 25.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.346 2.573 . . . . 65.24 109.073 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -49.2 -56.95 7.65 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.193 1.397 . . . . 74.23 109.568 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.671 HG22 ' HA2' ' A' ' 26' ' ' GLY . 34.4 m -67.6 -38.77 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 117.504 -1.236 . . . . 63.43 110.371 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -34.55 73.57 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 121.462 1.937 . . . . 61.43 111.334 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.1 pttt -52.25 -42.03 63.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.748 1.219 . . . . 75.02 111.249 171.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.8 m-85 -78.04 -47.25 18.81 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 117.703 -1.141 . . . . 62.23 110.507 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -53.86 -30.77 47.08 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.598 1.999 . . . . 64.42 112.358 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -57.94 4.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.528 1.531 . . . . 73.41 110.091 170.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -68.57 -58.33 4.44 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.802 -1.555 . . . . 73.13 106.802 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -86.81 40.17 0.89 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.494 1.517 . . . . 55.11 108.443 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -34.73 68.76 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.788 -1.195 . . . . 73.33 111.498 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.04 -28.19 65.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.272 0.471 . . . . 71.13 112.272 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.6 m -73.37 -2.1 20.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.721 0.637 . . . . 74.32 112.721 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.58 114.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.97 1.308 . . . . 71.15 109.433 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -114.06 113.33 24.6 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.492 -1.669 . . . . 74.3 106.492 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -73.45 142.18 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.045 -1.835 . . . . 70.3 106.045 164.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.96 176.78 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.571 -0.9 . . . . 64.44 108.571 159.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 -35.04 77.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.328 1.451 . . . . 73.52 112.306 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.2 -8.73 18.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.512 1.125 . . . . 72.52 112.67 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 7.82 64.37 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 127.939 2.685 . . . . 45.52 112.664 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.85 -83.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.977 1.711 . . . . 64.04 111.902 -160.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.48 101.49 1.13 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.623 -1.098 . . . . 52.32 111.805 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -108.16 163.35 13.24 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.598 0.823 . . . . 75.51 109.977 163.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.8 mt -145.45 143.54 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.427 1.891 . . . . 55.42 106.599 166.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.53 131.95 34.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.696 1.598 . . . . 53.45 111.148 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.82 -3.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.099 1.36 . . . . 75.24 112.768 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.95 -21.58 52.79 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 120.02 1.282 . . . . 54.11 114.627 -168.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -69.08 -5.41 21.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.759 1.224 . . . . 71.31 113.896 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.57 -19.29 62.01 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 119.649 -1.907 . . . . 74.33 112.201 164.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 m120 45.02 33.62 1.09 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.237 1.815 . . . . 72.05 112.576 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.56 169.04 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.595 1.958 . . . . 64.2 106.972 159.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.5 158.06 45.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.134 0.974 . . . . 72.31 109.151 166.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.03 157.14 33.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 126.138 1.775 . . . . 75.03 108.68 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 152.31 44.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.184 0.992 . . . . 75.2 108.56 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.1 p -147.53 -168.83 3.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 125.608 1.563 . . . . 63.22 106.96 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.853 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -152.3 137.71 17.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.066 -1.021 . . . . 64.4 108.742 177.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.6 114.9 18.88 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.426 -0.953 . . . . 72.42 108.426 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -61.83 -27.5 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.361 . . . . 74.23 111.25 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -35.67 -51.52 0.66 Allowed 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 129.324 3.05 . . . . 34.12 112.017 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.5 m -147.58 12.17 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.163 1.785 . . . . 74.54 110.694 -160.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt 52.82 41.93 31.82 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.447 1.499 . . . . 70.12 111.144 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.5 pt -96.61 173.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.261 1.024 . . . . 73.35 109.488 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.17 147.35 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.76 -1.57 . . . . 62.44 106.76 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -147.83 172.17 14.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 74.32 108.442 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -126.81 144.78 50.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.529 1.532 . . . . 63.31 107.168 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 161.56 35.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.312 0.645 . . . . 53.0 110.841 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -82.02 -35.24 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.239 0.829 . . . . 74.22 113.239 -170.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 mt 63.75 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 128.131 2.573 . . . . 63.44 109.685 -155.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 158' ' ' GLU . 29.2 mt -142.53 -65.63 0.4 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.227 1.811 . . . . 52.44 106.4 -164.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -127.75 164.27 22.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.6 1.56 . . . . 71.5 111.258 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.24 172.59 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.52 1.928 . . . . 70.01 109.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -141.58 137.48 31.96 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.298 1.039 . . . . 72.14 110.163 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -129.16 131.92 47.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.043 1.337 . . . . 64.23 110.989 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -141.92 176.28 9.06 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 72.35 109.593 166.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.75 148.16 31.93 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.741 1.216 . . . . 75.24 109.268 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -142.75 160.06 41.04 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.231 0.923 . . . . 73.42 112.677 -167.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.79 109.67 1.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.32 1.448 . . . . 63.24 110.441 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.31 -171.45 35.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.874 1.216 . . . . 74.43 112.426 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -90.07 151.85 21.43 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.949 -1.324 . . . . 72.42 110.729 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.6 mt -130.77 153.94 48.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.104 1.362 . . . . 73.34 108.941 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.98 130.85 35.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.396 -1.335 . . . . 53.21 107.396 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -121.51 77.94 1.39 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.459 1.504 . . . . 63.02 107.304 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 140' ' ' VAL . 30.0 mt -70.2 103.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.775 2.03 . . . . 74.44 107.594 166.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -85.1 163.76 18.59 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.106 -1.442 . . . . 72.22 107.106 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -136.38 167.76 20.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.389 0.995 . . . . 73.41 108.441 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.4 ttmt -58.67 -30.07 67.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.563 -1.336 . . . . 54.5 113.113 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -73.25 15.39 0.23 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.71 1.141 . . . . 72.11 112.283 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 92' ' ' LYS . 8.3 mmt180 47.69 35.47 4.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 128.776 2.83 . . . . 74.44 110.885 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.3 mtt-85 -73.63 167.32 21.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.002 -1.11 . . . . 73.33 108.002 157.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -170.93 161.12 6.93 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.46 1.904 . . . . 74.11 106.199 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -143.69 169.26 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 129.833 3.253 . . . . 65.33 109.268 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.431 ' C ' HD23 ' A' ' 99' ' ' LEU . 12.4 m -153.33 98.56 2.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.543 1.537 . . . . 71.22 110.564 -175.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -159.64 173.25 16.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.733 1.613 . . . . 74.42 109.921 -170.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -68.83 167.93 14.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.267 1.027 . . . . 71.31 112.619 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.09 -46.61 67.33 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.841 -0.537 . . . . 75.12 110.608 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.1 38.87 1.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.439 -0.948 . . . . 64.2 108.439 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 99' ' ' LEU . 49.6 t-80 -84.26 134.62 42.84 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.315 -0.994 . . . . 73.24 108.315 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.48 133.62 38.0 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.258 1.972 . . . . 72.32 111.111 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 178.78 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.825 1.65 . . . . 73.12 108.554 167.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -116.48 142.65 46.59 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.572 -0.705 . . . . 72.34 109.704 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 121' ' ' VAL . 2.5 pp -133.77 165.15 32.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.44 1.496 . . . . 73.04 109.52 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 133.44 40.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.922 1.289 . . . . 71.41 107.91 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -122.66 74.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.109 1.364 . . . . 64.24 107.518 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m 65.85 7.64 4.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.975 1.31 . . . . 74.51 113.679 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.3 -9.71 4.4 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.312 0.958 . . . . 51.41 112.053 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -101.3 117.52 35.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.042 -1.836 . . . . 71.21 106.042 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.07 126.54 28.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.404 -1.332 . . . . 64.5 107.404 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.91 140.5 49.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.074 1.749 . . . . 74.11 107.084 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.15 131.61 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.115 -1.068 . . . . 74.42 108.115 166.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.2 pt -145.59 -167.09 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.78 2.032 . . . . 73.43 107.997 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.76 143.5 27.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.887 1.275 . . . . 71.51 110.091 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.63 -35.67 42.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.213 1.405 . . . . 53.44 113.125 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -17.6 64.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.216 1.191 . . . . 71.25 114.216 -172.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -25.57 28.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.489 1.116 . . . . 63.32 111.575 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 107' ' ' ILE . 3.7 t -72.18 63.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 128.805 2.842 . . . . 72.31 110.492 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -78.63 -178.42 5.88 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.029 -1.044 . . . . 73.4 109.152 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.52 -13.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.309 1.843 . . . . 74.33 113.755 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.73 4.38 66.05 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.559 -1.69 . . . . 72.34 113.435 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.09 135.53 39.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 120.275 2.038 . . . . 72.31 106.657 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -76.87 122.48 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.772 -1.566 . . . . 75.55 106.772 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.65 147.49 6.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.541 -1.651 . . . . 75.43 106.541 164.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.87 136.33 35.36 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.517 -1.29 . . . . 71.34 107.517 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.407 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.4 pp -126.83 154.51 76.04 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 124.568 1.147 . . . . 74.5 111.608 172.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.6 150.49 31.56 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.562 2.175 . . . . 75.0 108.548 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -123.69 -171.05 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.148 -1.797 . . . . 73.43 106.148 161.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -40.63 -68.58 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.311 1.445 . . . . 73.32 112.72 -168.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -120.95 -1.37 9.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.859 1.664 . . . . 72.54 111.266 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 64.3 p -139.94 165.51 27.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.131 0.878 . . . . 75.44 111.199 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -79.33 155.03 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.431 -1.322 . . . . 72.25 107.431 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.42 -178.04 5.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.272 1.429 . . . . 73.22 107.307 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.64 149.39 47.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.387 -1.709 . . . . 72.24 106.387 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -147.91 131.37 16.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.193 1.797 . . . . 65.32 106.729 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -62.44 157.2 20.69 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.211 0.46 . . . . 73.23 109.951 -176.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 89' ' ' ILE . 78.7 t -93.76 2.1 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.993 1.717 . . . . 73.14 111.807 -171.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt 24.11 -86.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 128.985 2.914 . . . . 60.23 115.366 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -97.03 109.41 22.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.35 1.46 . . . . 72.41 107.44 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 p -110.76 119.07 58.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.883 -1.154 . . . . 61.45 107.883 164.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -133.77 -178.54 5.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.774 1.63 . . . . 75.34 108.558 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.66 136.1 52.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.084 0.954 . . . . 75.12 108.485 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.4 m -94.04 162.17 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.102 -1.073 . . . . 74.0 108.102 167.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 151.09 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.226 1.011 . . . . 73.42 108.488 159.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -159.07 131.8 6.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.513 1.051 . . . . 74.1 109.851 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -142.35 59.71 1.45 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.204 -0.935 . . . . 74.23 110.048 -167.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.96 -131.82 3.33 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.168 1.366 . . . . 72.31 112.703 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -114.84 161.7 17.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.074 1.35 . . . . 64.31 109.438 168.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.92 156.04 39.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 125.464 1.505 . . . . 72.31 109.05 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.406 ' CD2' HG21 ' A' ' 29' ' ' VAL . 4.7 m-85 -146.53 159.29 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.509 -0.923 . . . . 74.34 108.509 -168.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -148.38 173.5 13.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.101 -1.074 . . . . 73.12 108.101 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -131.73 134.92 46.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.226 1.41 . . . . 73.21 109.324 -163.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.3 m -70.85 -50.64 33.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 118.562 -0.732 . . . . 72.44 112.096 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 t 24.58 68.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.561 2.745 . . . . 74.1 111.385 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 75' ' ' LEU . 7.6 pt-20 -73.35 -6.16 44.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.255 1.026 . . . . 74.12 112.516 -166.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.88 -58.59 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.083 1.753 . . . . 75.04 108.874 -163.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -119.36 -1.12 10.81 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.024 1.33 . . . . 70.24 112.923 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 58.67 28.3 17.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.536 1.535 . . . . 73.22 112.17 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.423 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 22.2 p -141.64 140.82 33.36 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.378 -1.451 . . . . 72.31 111.208 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.502 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -134.89 175.16 9.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.705 1.202 . . . . 65.22 111.717 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.2 mm -107.14 122.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 N-CA-C 106.95 -1.5 . . . . 71.1 106.95 168.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.48 160.33 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.511 0.725 . . . . 53.54 109.245 170.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 137.37 -167.34 24.77 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 109.865 -1.294 . . . . 64.13 109.865 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -112.3 167.26 10.57 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 121.332 -1.099 . . . . 75.33 109.277 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 64.62 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.226 1.811 . . . . 74.11 112.38 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.04 -15.73 7.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.488 1.04 . . . . 72.14 112.787 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 174.6 46.61 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 123.286 1.492 . . . . 71.22 113.254 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.586 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -127.32 147.28 50.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.186 2.594 . . . . 73.23 106.949 -172.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.853 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -91.62 112.66 24.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.903 -1.517 . . . . 74.22 106.903 173.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.33 175.97 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.888 1.675 . . . . 74.13 109.045 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -61.08 138.59 58.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.842 0.857 . . . . 72.24 110.18 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -124.18 57.93 1.21 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 128.976 2.91 . . . . 65.24 107.473 169.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 42.4 m -103.29 110.96 23.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.315 -2.105 . . . . 61.43 105.315 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 7.7 t -50.11 -57.82 6.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.909 1.684 . . . . 74.42 110.839 -174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.7 48.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.376 0 N-CA-C 108.144 -1.982 . . . . 63.33 108.144 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.4 p -101.76 131.78 47.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.204 1.401 . . . . 74.42 109.021 -166.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 42.6 tp 65.24 -51.93 0.35 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.601 2.76 . . . . 65.5 113.218 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 73.2 158.77 0.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.442 2.697 . . . . 70.24 112.027 -171.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.496 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 1.3 t60 46.15 -138.13 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.662 1.585 . . . . 72.11 108.884 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.496 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 55.7 t60 -126.74 143.56 51.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.942 -1.503 . . . . 75.35 106.942 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -137.6 152.4 49.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.625 -1.25 . . . . 73.54 107.625 154.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -79.72 139.18 37.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.0 1.72 . . . . 74.12 106.744 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 . . . . . 0 C--O 1.254 1.302 0 N-CA-C 108.099 -1.075 . . . . 65.11 108.099 -170.053 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 118.398 -0.81 . . . . 75.21 110.946 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.53 162.47 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.728 2.011 . . . . 73.44 111.217 -161.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.9 m -75.67 -65.98 0.83 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.144 -0.687 . . . . 72.51 109.144 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.76 71.19 0.68 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.515 -0.634 . . . . 73.34 111.515 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -80.97 52.14 1.7 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.616 1.166 . . . . 75.24 112.724 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -128.08 153.23 47.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.114 -1.809 . . . . 72.14 106.114 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.57 -172.57 28.75 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.397 -1.439 . . . . 51.14 109.545 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 163.92 164.23 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.81 2.844 . . . . 63.43 109.518 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -98.51 160.98 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.431 1.892 . . . . 71.5 110.233 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 154.76 30.64 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 123.211 0.605 . . . . 43.31 111.247 170.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -50.33 -32.09 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.353 1.861 . . . . 72.42 114.494 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -105.45 12.73 31.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.584 . . . . 70.43 112.946 -164.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -79.81 132.62 60.43 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.769 1.227 . . . . 71.52 108.974 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.49 149.55 90.55 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.551 2.834 . . . . 72.04 113.732 162.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 pt -114.47 -5.15 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.143 1.777 . . . . 73.45 112.862 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 55.53 73.38 0.43 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.452 1.024 . . . . 74.12 111.342 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.44 159.64 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.676 -0.64 . . . . 42.22 109.364 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 m -56.56 -34.03 66.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.379 -0.819 . . . . 73.44 112.247 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -86.93 -28.98 22.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.694 0.679 . . . . 72.03 110.295 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.05 41.32 1.97 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.717 1.151 . . . . 72.12 114.493 166.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.88 -27.14 62.99 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 115.209 1.559 . . . . 74.12 115.209 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mm 45.77 73.97 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.564 2.345 . . . . 71.34 108.69 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 174.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.791 2.036 . . . . 64.41 108.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.4 135.59 33.44 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.187 1.395 . . . . 73.32 107.811 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 tt -55.38 -28.75 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.079 -1.013 . . . . 72.25 112.08 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.86 -14.51 57.86 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 116.465 -2.297 . . . . 60.2 114.845 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -66.2 -50.01 65.32 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.122 2.461 . . . . 74.51 108.327 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -56.54 -59.17 5.38 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.626 1.97 . . . . 65.42 108.47 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 77' ' ' VAL . 69.1 t -56.77 -47.33 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.135 -0.484 . . . . 55.04 111.166 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -41.69 74.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.824 0.85 . . . . 75.11 110.809 -176.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -51.32 45.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.351 1.06 . . . . 64.43 109.328 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.64 -43.87 65.34 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.152 0.981 . . . . 73.13 108.449 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.4 m-85 -56.01 -38.74 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.323 1.42 . . . . 71.41 111.895 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -83.51 -22.45 32.48 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.507 1.123 . . . . 73.52 111.124 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 8.5 mttm -88.27 -58.65 2.48 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.969 -1.493 . . . . 53.42 106.969 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.5 m-30 -91.88 45.91 1.25 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 129.192 2.997 . . . . 75.2 108.313 -172.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -34.86 64.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.225 -0.922 . . . . 61.35 111.226 172.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -77.99 6.2 8.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.425 . . . . 73.43 112.979 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -106.29 -9.88 16.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 117.179 -1.391 . . . . 65.5 111.322 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.29 99.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 120.089 1.313 . . . . 73.02 108.618 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -85.2 159.84 20.03 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.72 -0.844 . . . . 54.31 108.72 160.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -136.48 133.74 36.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.889 -2.263 . . . . 71.13 104.889 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.77 177.3 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.755 0.659 . . . . 62.3 109.459 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -40.6 77.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.343 1.457 . . . . 50.13 112.237 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -19.54 63.43 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.362 -0.836 . . . . 61.54 111.46 174.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.43 65.1 1.7 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 107.775 -2.13 . . . . 75.04 107.775 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.64 -100.7 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.698 -1.964 . . . . 75.12 105.698 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.49 120.34 1.17 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.992 -2.043 . . . . 65.21 107.992 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -139.16 162.21 35.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.839 0.819 . . . . 72.43 110.092 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 33' ' ' PHE . 13.2 mt -143.93 139.99 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 126.508 1.923 . . . . 50.15 105.85 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.75 133.11 35.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.497 1.519 . . . . 71.15 109.163 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.32 4.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 125.841 1.657 . . . . 73.21 112.169 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.07 -10.82 7.52 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.855 1.207 . . . . 64.21 114.173 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.16 -15.74 56.42 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.337 -1.684 . . . . 63.1 112.507 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.45 -12.66 61.84 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.981 1.264 . . . . 75.2 113.407 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.53 -2.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.894 2.078 . . . . 72.02 113.705 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 141.33 16.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.169 1.387 . . . . 71.23 107.477 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.99 157.03 22.02 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.021 0.828 . . . . 60.13 109.547 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.23 144.54 28.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 126.645 1.978 . . . . 73.24 107.337 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -63.77 130.63 44.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.602 -1.629 . . . . 75.43 106.602 165.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.1 p -136.74 -169.18 2.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.632 -1.618 . . . . 64.3 106.632 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -146.17 143.76 29.5 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.31 -1.367 . . . . 65.03 107.31 171.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -86.41 116.22 24.42 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 124.964 1.306 . . . . 73.51 108.357 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.92 -27.98 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.676 0.79 . . . . 74.14 111.876 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.67 -22.42 65.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.637 0.653 . . . . 65.3 112.288 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m -137.57 3.0 2.5 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.746 1.218 . . . . 72.41 112.628 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.47 35.84 24.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.493 1.497 . . . . 54.23 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.47 154.91 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.203 1.801 . . . . 61.25 109.41 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.95 129.53 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.458 -1.682 . . . . 54.43 106.458 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -148.68 178.79 8.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.721 1.608 . . . . 74.14 108.443 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -105.77 150.1 25.84 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.465 -1.397 . . . . 74.22 109.287 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.6 160.11 39.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 169.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -92.4 -17.93 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.048 0.758 . . . . 63.0 113.048 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mt 58.7 147.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.883 2.073 . . . . 75.43 109.429 -160.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.14 -57.24 2.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.996 0.919 . . . . 73.23 108.7 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -129.76 150.76 50.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.364 0.983 . . . . 65.35 110.298 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -112.55 168.28 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 125.188 1.395 . . . . 71.43 109.204 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -135.44 153.2 51.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.177 0.991 . . . . 64.02 109.788 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.94 142.82 29.08 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.374 0.67 . . . . 70.04 109.612 169.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.47 156.64 47.91 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.403 -1.703 . . . . 70.32 106.403 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -84.24 159.18 21.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.117 -1.438 . . . . 74.22 107.117 165.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -139.9 153.94 47.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.196 0.998 . . . . 75.31 110.201 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -149.93 152.9 35.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 139.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.17 -171.66 32.13 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 109.394 -1.482 . . . . 64.13 109.394 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -89.5 120.31 30.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.757 -1.201 . . . . 64.33 107.757 170.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 160.58 15.96 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.617 -1.253 . . . . 71.4 107.617 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mm -79.34 140.71 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.162 1.385 . . . . 75.12 107.651 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -126.81 58.23 1.42 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.197 0.599 . . . . 73.05 110.287 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.9 mt -63.34 116.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 105.62 -1.993 . . . . 53.14 105.62 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -94.98 155.48 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 105.384 -2.08 . . . . 64.11 105.384 163.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -125.44 169.17 12.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.883 1.273 . . . . 74.51 108.221 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -67.57 -11.14 57.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.588 -1.32 . . . . 65.24 111.814 -172.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -3.23 53.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.661 1.585 . . . . 72.44 113.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.09 12.77 8.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.701 1.6 . . . . 74.02 111.571 -171.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 165.57 17.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.262 -1.014 . . . . 75.44 108.262 163.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -173.19 164.14 4.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.768 2.027 . . . . 70.55 109.027 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.3 pt -144.84 165.99 11.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.033 2.133 . . . . 52.51 107.54 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -140.34 97.87 3.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.841 0.857 . . . . 75.51 109.256 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.84 172.25 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.762 1.625 . . . . 72.24 111.547 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.4 p -61.03 154.61 22.25 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.991 1.316 . . . . 75.53 110.754 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -74.14 -26.15 60.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.465 -0.772 . . . . 65.34 111.369 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -97.72 37.74 1.36 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.623 0.647 . . . . 64.43 110.054 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -90.94 123.38 64.92 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-O 117.807 -1.092 . . . . 73.51 108.108 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.67 139.01 61.48 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.659 1.573 . . . . 64.4 111.094 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.56 -162.3 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.766 1.627 . . . . 71.31 108.772 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -134.02 133.09 40.84 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.223 1.009 . . . . 64.13 110.56 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.45 161.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.383 1.473 . . . . 72.44 109.414 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.24 120.95 28.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.518 1.151 . . . . 60.1 110.751 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.37 77.51 9.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.264 1.826 . . . . 60.3 106.159 150.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.2 17.01 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.655 1.354 . . . . 44.11 114.655 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.48 -28.55 3.99 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 124.919 1.247 . . . . 63.42 111.398 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.06 20.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.635 -2.358 . . . . 74.44 104.635 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.55 134.7 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.288 -1.004 . . . . 72.54 108.288 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.517 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -130.39 153.18 48.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.501 -1.296 . . . . 71.43 107.501 176.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.517 ' H ' HD13 ' A' ' 114' ' ' LEU . 1.3 pm0 -112.63 114.16 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.377 1.471 . . . . 71.44 109.499 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -136.73 174.03 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.769 2.028 . . . . 73.13 108.596 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.03 148.78 21.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.073 0.851 . . . . 74.33 110.912 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.48 -29.21 9.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.207 1.803 . . . . 53.55 114.162 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.01 1.277 . . . . 61.22 111.928 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 22.6 mtm -87.35 -19.91 27.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.185 0.994 . . . . 71.14 111.613 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 t -71.19 63.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 129.516 3.126 . . . . 64.04 112.239 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -78.5 -179.95 6.69 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.764 -1.835 . . . . 65.42 110.35 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.49 -10.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.652 2.381 . . . . 75.31 113.995 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.88 -3.01 83.63 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 124.629 1.109 . . . . 61.23 112.892 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.89 152.65 31.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.45 -1.685 . . . . 72.12 106.45 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.62 131.68 55.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.645 -1.613 . . . . 73.42 106.645 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -106.89 126.84 62.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.793 0.837 . . . . 63.22 108.803 -168.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.57 122.35 17.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.674 1.19 . . . . 72.22 108.884 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.19 155.83 70.6 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 113.348 0.87 . . . . 70.4 113.348 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.33 151.97 82.25 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.549 2.166 . . . . 75.15 111.006 167.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.69 -160.34 0.86 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.007 1.723 . . . . 72.12 106.806 158.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -48.28 -61.58 1.92 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.316 1.046 . . . . 61.51 110.858 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -121.0 -17.86 7.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.088 1.355 . . . . 74.55 112.843 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -140.59 170.84 15.03 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.426 1.09 . . . . 75.54 110.742 -165.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -79.91 154.34 4.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.867 0.841 . . . . 73.2 110.662 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -143.89 -171.42 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.179 1.792 . . . . 54.14 106.829 166.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.1 mt -125.28 168.88 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.419 -0.956 . . . . 70.12 108.419 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.83 161.99 40.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.812 0.845 . . . . 62.11 110.937 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -74.7 140.68 44.33 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 127.32 2.248 . . . . 62.0 110.693 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.54 1.03 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.023 1.329 . . . . 75.23 112.61 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.517 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.7 pt 24.33 -75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 129.882 3.273 . . . . 71.42 117.238 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.517 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -93.12 126.09 38.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.909 2.484 . . . . 72.41 109.537 -170.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.18 121.91 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.316 0.646 . . . . 72.44 110.505 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.75 -171.9 0.49 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.238 3.015 . . . . 74.01 109.445 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.9 p -132.29 174.25 10.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.827 2.051 . . . . 73.42 107.98 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.0 m -110.18 -178.25 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.439 -1.319 . . . . 75.21 107.439 151.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.46 113.65 15.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.783 -1.562 . . . . 64.23 106.783 168.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -129.99 160.88 32.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.356 1.462 . . . . 70.31 109.806 -165.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.17 47.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.344 1.458 . . . . 52.5 109.663 -162.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -117.17 -150.57 9.23 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.964 1.745 . . . . 75.41 110.212 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -98.0 157.1 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.793 0.796 . . . . 73.4 109.797 159.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 19.2 pt -122.08 151.26 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 126.537 1.935 . . . . 74.13 107.929 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -136.87 151.18 48.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.791 1.236 . . . . 75.35 111.118 -170.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.0 -177.85 6.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.913 0.885 . . . . 75.34 111.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.76 121.98 9.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.311 1.844 . . . . 70.44 107.772 -152.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.53 -37.09 32.19 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-O 116.13 -1.891 . . . . 64.54 114.72 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p 24.61 73.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.771 2.028 . . . . 72.13 112.708 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 12.3 pt-20 -66.02 -10.06 36.33 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.492 -1.38 . . . . 74.1 113.602 -170.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.52 -72.37 0.17 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.825 2.05 . . . . 72.14 106.066 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.83 -19.25 17.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.685 1.594 . . . . 70.04 111.729 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.452 ' CD2' ' HA ' ' A' ' 158' ' ' GLU . 51.4 m170 48.31 39.72 12.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.062 2.145 . . . . 72.24 112.658 -162.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 p -152.48 143.92 23.37 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.043 1.292 . . . . 74.43 109.32 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 4.0 p90 -136.08 172.88 12.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.488 1.515 . . . . 61.12 110.082 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.2 mm -103.32 138.26 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.915 -1.513 . . . . 63.53 106.915 157.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -163.15 160.23 23.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.048 0.939 . . . . 53.22 110.295 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 131.17 -163.02 23.63 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.279 1.418 . . . . 54.41 110.731 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -104.9 170.26 7.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.0 1.9 . . . . 72.54 112.049 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 56.9 -72.42 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 129.695 3.198 . . . . 75.32 111.685 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.62 -14.98 8.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.469 1.508 . . . . 65.11 113.493 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.04 171.75 9.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 122.726 1.181 . . . . 74.43 112.412 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 97' ' ' ILE . 39.0 m-85 -126.49 144.78 50.75 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 126.861 2.064 . . . . 75.34 109.118 -170.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -74.9 114.57 13.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.26 1.424 . . . . 72.23 108.243 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.92 -179.29 3.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.618 0.767 . . . . 60.14 110.789 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -72.65 144.25 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.79 0.836 . . . . 75.22 108.951 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.52 60.87 1.28 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.291 1.836 . . . . 74.14 109.425 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.7 p -76.96 172.23 13.51 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 122.427 1.108 . . . . 64.23 111.466 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -53.83 128.91 31.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.979 0.912 . . . . 61.11 109.039 168.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.9 -63.63 5.09 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.282 -0.727 . . . . 62.13 111.282 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 p -80.31 165.31 22.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 64.22 111.241 171.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 182' ' ' HIS . 21.8 tp -66.56 -53.02 39.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.436 1.094 . . . . 73.31 110.509 168.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 60.39 28.47 18.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.613 1.565 . . . . 63.33 113.035 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' HIS . . . . . 0.423 ' H ' ' HG ' ' A' ' 180' ' ' LEU . 2.8 t60 -136.38 111.15 8.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.424 -1.325 . . . . 72.2 107.424 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.22 -170.75 0.11 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.014 1.325 . . . . 55.11 111.683 -173.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.16 -72.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.276 1.43 . . . . 72.54 107.683 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' HIS . . . . . 0.48 ' CG ' ' H ' ' A' ' 186' ' ' HIS . 2.4 t60 -144.63 -160.17 1.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.209 -1.404 . . . . 72.33 107.209 162.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.48 ' H ' ' CG ' ' A' ' 185' ' ' HIS . 1.7 t-80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 125.123 1.369 . . . . 61.41 110.131 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 120.534 0.207 . . . . 72.12 110.84 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -135.77 158.21 44.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.771 2.029 . . . . 74.22 107.298 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 m -71.18 -25.95 62.75 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.013 -0.429 . . . . 44.33 109.948 166.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.59 145.88 8.4 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 108.647 -1.781 . . . . 61.34 108.647 -168.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -140.31 -178.97 5.73 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.073 2.149 . . . . 64.25 105.858 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -103.86 -174.49 2.56 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.909 -1.145 . . . . 60.13 107.909 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.35 168.92 13.29 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 124.664 1.126 . . . . 43.35 110.958 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.23 174.8 3.29 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 128.781 2.832 . . . . 52.32 106.048 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -113.93 178.09 4.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.774 1.63 . . . . 75.21 109.548 172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.17 -169.21 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.183 1.793 . . . . 70.42 113.667 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t80 -94.29 -45.67 7.39 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.947 1.299 . . . . 74.24 109.931 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.33 -0.41 56.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.434 1.493 . . . . 75.42 112.058 -167.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 156.6 76.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.03 -1.044 . . . . 65.33 110.579 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -92.92 143.8 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.334 3.356 . . . . 74.31 113.351 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.26 -2.0 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.325 1.231 . . . . 65.21 114.325 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 53.71 73.41 0.38 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.454 1.101 . . . . 63.0 111.974 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.64 162.83 1.06 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.476 -0.765 . . . . 73.4 109.596 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.9 t -49.03 -40.39 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.108 0.963 . . . . 52.33 110.732 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -81.24 -20.59 40.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.282 0.845 . . . . 74.34 113.282 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.21 28.93 8.25 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.518 1.056 . . . . 65.45 113.041 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -15.34 63.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 118.37 2.73 . . . . 72.34 118.37 -163.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 mm 43.79 78.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.014 2.525 . . . . 74.42 109.643 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.3 154.16 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.631 1.973 . . . . 55.13 107.487 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' HB2' ' H ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -62.26 129.63 41.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.889 1.276 . . . . 73.54 107.584 171.096 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -53.19 -39.4 34.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 109.569 -0.53 . . . . 72.32 109.569 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -46.19 -59.71 4.99 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 125.014 1.292 . . . . 63.43 111.337 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' H ' ' HB2' ' A' ' 24' ' ' ASN . 38.5 tp10 -69.14 -48.55 62.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.197 -0.906 . . . . 64.53 110.454 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -45.7 -53.1 9.89 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.554 1.142 . . . . 74.31 109.614 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG22 HG21 ' A' ' 77' ' ' VAL . 49.8 t -69.7 -45.36 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.485 -0.779 . . . . 74.53 109.486 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.87 -37.94 80.75 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.842 -1.161 . . . . 73.35 113.223 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -55.96 -38.13 69.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.903 1.681 . . . . 72.23 110.784 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 15.8 m-85 -73.84 -49.17 26.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.19 1.396 . . . . 75.23 108.638 172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.18 -37.98 62.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.177 1.808 . . . . 73.24 113.301 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.21 -30.34 57.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.01 -0.995 . . . . 53.13 111.829 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -85.08 -52.11 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 2.0 m-30 -93.5 41.36 1.08 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.716 2.007 . . . . 74.21 108.256 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -27.79 68.57 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.576 -1.328 . . . . 51.24 112.142 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -62.42 -27.98 69.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.944 1.698 . . . . 75.53 113.304 168.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.346 1.858 . . . . 75.15 112.86 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.3 mt -66.39 89.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.976 1.262 . . . . 70.24 109.764 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -79.71 161.27 25.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.992 1.717 . . . . 74.44 108.528 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -143.32 122.28 12.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.05 1.34 . . . . 62.15 108.884 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.92 169.76 17.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.651 -0.87 . . . . 75.44 108.651 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -54.47 34.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.91 2.084 . . . . 75.14 111.137 -173.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.04 3.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.356 1.462 . . . . 60.14 113.295 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.67 18.99 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 126.927 2.204 . . . . 73.34 110.853 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -86.0 -99.97 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.409 1.084 . . . . 74.25 108.156 -173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.01 111.01 0.68 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-O 117.754 -1.581 . . . . 73.41 110.726 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -114.19 164.6 13.65 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.229 1.514 . . . . 75.51 111.537 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mt -145.36 144.04 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 128.125 2.57 . . . . 74.12 105.266 164.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -83.06 114.7 21.47 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.81 -1.182 . . . . 71.33 107.81 166.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.96 13.59 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.854 0.862 . . . . 71.52 109.98 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.93 -31.91 82.41 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 120.19 -1.569 . . . . 62.21 111.334 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.64 -1.51 7.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.719 1.208 . . . . 72.3 114.245 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -74.67 -18.25 60.56 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.872 -0.518 . . . . 73.1 111.088 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t30 63.29 18.85 11.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.24 2.216 . . . . 41.44 113.624 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -82.33 131.03 34.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.292 -1.373 . . . . 75.1 107.292 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -96.67 161.58 13.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.362 1.465 . . . . 52.4 109.476 173.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.87 149.58 19.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.722 1.609 . . . . 61.31 108.72 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -68.99 121.43 16.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.278 -1.379 . . . . 74.42 107.278 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' TYR . 0.4 OUTLIER -117.81 -177.55 3.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.044 1.338 . . . . 54.42 108.384 171.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -137.71 132.22 32.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.369 -1.715 . . . . 73.54 106.369 169.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.17 106.35 13.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.321 -0.992 . . . . 64.35 108.321 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 71.5 tttt -55.84 -18.55 8.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.327 1.851 . . . . 73.14 113.984 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.95 -34.55 78.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.448 1.099 . . . . 53.31 112.121 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.3 m -125.51 -1.55 7.46 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.054 0.942 . . . . 73.03 112.501 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.81 44.09 17.41 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.122 -0.986 . . . . 61.44 110.487 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 pt -108.6 157.24 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.941 1.696 . . . . 42.31 109.151 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.65 128.71 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.03 -1.47 . . . . 72.53 107.03 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -135.71 175.21 9.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.491 1.116 . . . . 70.55 112.758 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.62 96.64 3.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.245 -2.131 . . . . 74.24 105.245 -157.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -125.14 172.0 9.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.079 0.952 . . . . 63.2 110.575 -165.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -116.28 153.08 32.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.93 0.786 . . . . 71.11 109.382 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.56 154.77 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.798 -1.186 . . . . 50.45 107.798 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 -20.62 6.75 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.918 0.781 . . . . 63.02 112.639 169.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -161.7 163.74 29.56 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.2 -1.563 . . . . 71.25 108.478 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -137.97 161.25 32.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.095 0.958 . . . . 52.14 109.11 179.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -135.7 149.34 49.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.38 1.072 . . . . 74.31 110.416 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -146.2 142.24 28.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.124 0.875 . . . . 74.53 110.527 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -146.17 163.19 36.17 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.288 2.235 . . . . 62.32 107.274 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 4.7 tttm -107.48 156.4 19.02 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.612 -1.255 . . . . 72.42 107.612 164.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.4 t80 -153.64 163.08 40.6 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.975 1.31 . . . . 72.02 108.82 -166.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -151.67 113.92 4.53 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.116 -1.809 . . . . 75.32 106.116 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.52 -146.54 5.31 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 117.095 -2.479 . . . . 50.45 112.209 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 104.54 8.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.407 1.883 . . . . 72.41 107.801 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.559 HD13 HG22 ' A' ' 98' ' ' THR . 88.6 mt -83.69 162.91 20.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.73 1.612 . . . . 71.53 106.887 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 89' ' ' ILE . 34.8 mm -79.5 135.25 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 127.057 2.143 . . . . 63.1 107.37 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HE3' HG11 ' A' ' 146' ' ' VAL . 35.4 ttmt -125.4 79.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.635 -1.617 . . . . 64.13 106.635 161.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 140' ' ' VAL . 22.0 mt -59.21 141.07 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.345 -2.094 . . . . 65.42 105.345 152.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -115.16 164.28 14.43 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.621 -1.992 . . . . 65.51 105.621 163.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -136.02 169.73 17.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.822 1.192 . . . . 50.11 108.909 166.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.06 -21.63 66.3 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.675 -1.265 . . . . 73.2 112.759 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -66.49 -1.13 3.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.366 1.866 . . . . 60.33 112.72 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.3 22.41 10.75 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.025 1.73 . . . . 72.44 111.358 -165.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.79 168.71 19.33 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.865 -0.791 . . . . 61.11 108.865 163.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 174.6 163.15 0.22 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 129.05 2.94 . . . . 71.34 110.401 -167.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 3.0 pt -140.12 172.49 12.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.723 1.209 . . . . 51.42 110.436 -170.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.559 HG22 HD13 ' A' ' 86' ' ' LEU . 27.1 m -152.27 94.82 1.97 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.124 0.969 . . . . 75.03 109.713 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.438 HD21 HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -154.11 177.59 10.91 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 128.408 2.683 . . . . 72.44 109.261 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.9 p -78.4 171.49 15.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 120.649 1.568 . . . . 62.1 110.657 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -69.91 -19.67 63.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.13 0.972 . . . . 71.13 111.371 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -109.64 38.02 2.48 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.422 -0.799 . . . . 73.44 110.761 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -107.15 133.72 20.2 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.868 -0.79 . . . . 72.44 108.868 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.32 118.1 5.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.671 2.914 . . . . 65.52 113.251 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.35 -179.32 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.664 1.586 . . . . 64.43 109.954 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.17 144.72 49.17 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.223 0.92 . . . . 72.34 111.15 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 pt -134.88 165.49 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.112 0.965 . . . . 73.32 109.871 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.472 ' HB3' HD21 ' A' ' 137' ' ' LEU . 71.1 p -94.42 110.02 21.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.968 0.507 . . . . 64.34 109.666 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -85.8 81.35 8.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.578 -2.008 . . . . 72.34 105.578 167.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.1 32.47 4.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.473 1.109 . . . . 55.51 113.196 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.25 -9.42 42.36 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.693 -1.059 . . . . 52.2 114.339 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -84.5 131.21 34.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 119.389 1.595 . . . . 70.24 106.881 167.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.08 117.78 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.039 -1.467 . . . . 54.34 107.039 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 151.19 45.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.885 1.274 . . . . 74.44 108.65 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.2 121.3 44.92 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.53 1.132 . . . . 63.31 109.683 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 116' ' ' ILE . 15.6 pt -140.74 -175.96 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.789 0.836 . . . . 74.23 110.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -92.87 142.91 26.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.198 1.399 . . . . 72.25 108.704 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.11 65.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.35 0.977 . . . . 60.0 113.544 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -32.32 66.14 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.196 1.362 . . . . 71.22 112.596 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -23.85 36.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.563 1.145 . . . . 64.01 112.195 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.97 64.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.029 2.532 . . . . 74.45 111.653 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.79 -179.77 7.11 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.425 -1.422 . . . . 71.0 111.878 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 5.6 p -55.59 -9.86 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 128.421 2.689 . . . . 53.33 114.005 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.71 -15.97 79.92 Favored Glycine 0 CA--C 1.523 0.59 0 O-C-N 121.279 -0.888 . . . . 44.41 111.554 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.33 164.87 13.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.634 1.217 . . . . 64.41 108.92 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 13.1 m-85 -113.41 137.9 50.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.218 -1.401 . . . . 74.0 107.218 167.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.4 132.46 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.613 -1.255 . . . . 61.31 107.613 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.41 124.53 23.42 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.5 -0.926 . . . . 72.54 108.5 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -133.33 154.5 81.04 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.899 1.68 . . . . 72.33 110.096 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.57 149.43 84.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.401 1.401 . . . . 63.3 110.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -120.62 -145.39 0.36 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.568 -1.641 . . . . 72.42 106.568 149.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -56.85 -70.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.145 1.378 . . . . 72.53 111.155 -162.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -120.09 -2.79 10.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.596 0.758 . . . . 74.23 112.764 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 167.32 21.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.434 1.093 . . . . 75.32 111.257 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.2 tp -78.84 156.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.139 0.971 . . . . 64.32 108.686 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.93 -173.76 3.89 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 127.601 2.361 . . . . 73.51 107.226 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 108' ' ' SER . 40.6 mt -135.43 136.52 41.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.387 -2.079 . . . . 42.15 105.387 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -133.7 153.98 51.29 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.717 -1.216 . . . . 70.43 107.717 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 18.1 tt0 -96.77 136.87 36.7 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.841 2.056 . . . . 74.43 107.88 -161.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.455 HG13 HG23 ' A' ' 89' ' ' ILE 0.296 46.9 t -79.98 1.05 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 114.479 1.288 . . . . 73.21 114.479 -158.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pt 26.61 -98.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.158 2.583 . . . . 73.52 115.405 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -90.56 122.5 33.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.411 -1.43 . . . . 72.32 108.067 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.62 117.49 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.251 -1.388 . . . . 73.31 107.251 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.83 -165.57 2.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.832 1.653 . . . . 72.23 108.909 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 p -121.92 171.33 9.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.017 1.327 . . . . 55.15 110.179 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.426 HG11 ' HE3' ' A' ' 88' ' ' LYS . 30.3 m -130.56 131.75 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.712 -1.218 . . . . 53.33 107.712 167.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.02 109.54 17.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.374 -1.343 . . . . 75.33 107.374 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -133.23 136.18 45.43 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.802 2.041 . . . . 63.24 106.909 -163.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -140.63 43.86 1.85 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.784 -0.572 . . . . 65.41 110.233 -155.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.81 8.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.391 0.996 . . . . 54.32 112.897 -165.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.15 155.52 24.95 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.977 -0.719 . . . . 74.01 110.408 165.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.4 pt -132.36 147.21 32.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 127.712 2.405 . . . . 74.13 106.961 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.415 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 3.5 m-85 -132.79 164.68 26.28 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.786 -1.19 . . . . 75.0 107.786 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -153.66 177.39 11.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.528 -1.286 . . . . 72.33 107.528 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.9 mt -140.56 163.81 31.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.719 1.145 . . . . 73.42 110.819 -167.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.1 m -118.58 110.38 17.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.926 1.691 . . . . 64.33 107.054 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.2 77.72 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.808 2.043 . . . . 42.21 106.808 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.378 10.9 pt-20 -72.87 2.2 7.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.109 1.364 . . . . 72.41 113.995 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.5 -56.61 11.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 128.438 2.695 . . . . 71.13 109.74 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.6 t30 -133.24 -4.33 3.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.128 0.971 . . . . 72.43 111.861 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 66.65 21.34 10.65 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.284 1.434 . . . . 60.33 112.219 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.5 p -142.22 139.73 32.09 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.486 -0.931 . . . . 74.13 108.486 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -137.82 176.64 8.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.876 0.87 . . . . 43.01 110.281 -175.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.8 mm -98.76 120.1 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 165.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.26 133.79 24.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.947 -1.131 . . . . 63.55 107.947 167.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.54 177.05 33.3 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.723 2.106 . . . . 72.44 108.065 168.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -75.34 178.74 5.63 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.366 -2.255 . . . . 71.13 110.622 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.61 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.079 1.752 . . . . 70.32 112.468 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -122.13 -8.5 8.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.433 1.893 . . . . 61.03 114.177 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 88.1 164.13 39.91 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.549 1.547 . . . . 73.32 113.482 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.465 ' CD2' HG22 ' A' ' 129' ' ' ILE . 9.1 m-85 -108.19 159.66 16.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.32 1.448 . . . . 73.13 109.044 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -102.1 102.08 12.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.215 1.806 . . . . 64.14 106.7 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.74 177.08 6.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.243 1.017 . . . . 74.35 109.684 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 75.0 m -66.55 139.15 57.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.472 -0.936 . . . . 43.02 108.472 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -128.12 39.63 3.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.033 2.533 . . . . 64.42 109.28 172.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.1 p -59.76 130.78 48.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.691 -0.855 . . . . 74.43 108.691 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.1 p -77.65 168.11 20.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.139 0.427 . . . . 75.12 110.721 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.43 111.74 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 126.476 1.989 . . . . 73.11 109.917 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 172.77 0.12 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.876 2.47 . . . . 53.22 112.645 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 36.3 tp -56.88 -67.54 0.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.148 0.979 . . . . 74.13 110.744 -172.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -157.38 -35.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.666 0.667 . . . . 65.15 112.619 159.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 12.5 t60 57.98 22.77 9.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.65 2.78 . . . . 74.0 115.194 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.08 179.86 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.508 -0.745 . . . . 74.45 111.449 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -85.34 -61.64 1.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.509 -0.552 . . . . 64.11 109.509 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -72.27 155.94 39.65 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.336 1.065 . . . . 63.42 110.97 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 C--O 1.248 1.009 0 C-N-CA 130.775 3.63 . . . . 54.52 101.486 -174.535 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.675 -0.491 . . . . 72.34 109.675 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -153.88 0.16 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 70.31 110.234 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 m 75.62 15.38 2.67 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.526 1.93 . . . . 53.11 110.562 -167.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.99 19.18 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 1 C-N-CA 131.298 4.285 . . . . 60.1 117.089 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -136.54 87.04 2.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.481 1.912 . . . . 70.23 106.043 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -149.82 178.48 8.86 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.787 2.435 . . . . 71.34 109.383 -160.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.29 -132.95 7.9 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.554 1.074 . . . . 71.45 110.725 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 155.4 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.845 3.258 . . . . 74.23 109.312 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.73 166.69 10.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.281 3.032 . . . . 53.32 109.016 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 178.97 1.2 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.165 1.386 . . . . 74.02 112.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -75.84 -34.33 60.08 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.427 -0.796 . . . . 74.45 110.522 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.45 25.53 11.56 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.678 1.228 . . . . 74.52 112.436 -161.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.05 126.39 82.04 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 125.36 1.464 . . . . 53.24 109.141 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -67.14 102.76 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.33 2.687 . . . . 35.4 108.89 168.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 pt -78.17 140.88 16.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.818 1.19 . . . . 71.43 108.964 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 47.6 m-85 -96.14 83.32 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.525 -1.657 . . . . 74.54 106.525 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 86.8 mt -58.97 154.7 14.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.72 -0.845 . . . . 65.2 108.72 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -61.92 -20.4 63.73 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.2 -0.313 . . . . 52.32 110.188 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.74 -29.65 70.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.633 1.973 . . . . 61.43 112.736 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.88 4.61 67.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.238 1.399 . . . . 52.44 112.314 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.19 -39.36 72.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.632 1.716 . . . . 62.22 115.073 -156.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mm 57.02 96.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 127.73 2.412 . . . . 64.44 108.841 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 157.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.679 -1.971 . . . . 62.41 105.679 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -67.04 119.25 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.581 -1.637 . . . . 52.33 106.581 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -50.79 -35.85 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.292 0.637 . . . . 75.44 110.153 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.38 -30.94 63.97 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-O 118.2 -1.334 . . . . 43.35 112.734 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -63.36 -55.91 20.63 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 119.917 1.858 . . . . 75.35 108.894 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -48.48 -49.61 34.97 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 125.341 1.456 . . . . 65.42 110.397 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 77' ' ' VAL . 76.9 t -76.33 -40.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 118.087 -0.958 . . . . 73.13 110.109 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -64.58 -29.38 70.4 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 120.723 1.601 . . . . 72.54 110.873 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -43.85 52.67 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.871 1.268 . . . . 65.41 110.335 170.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.6 -46.18 22.95 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.325 -1.321 . . . . 74.21 110.03 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 8.4 m-85 -54.85 -34.32 62.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 122.182 2.264 . . . . 74.45 113.08 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -84.81 -22.39 29.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.637 1.175 . . . . 65.22 110.616 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -63.29 1.32 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.701 -1.222 . . . . 73.1 107.701 172.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -84.26 39.77 0.73 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.184 2.594 . . . . 74.0 109.192 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.5 -36.74 55.85 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 70.03 111.181 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -71.05 -13.49 62.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.306 1.842 . . . . 75.14 113.381 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.06 5.76 26.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.268 1.427 . . . . 63.2 112.379 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 105.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.518 -1.29 . . . . 64.41 107.518 171.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -103.85 107.18 17.94 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.051 0.541 . . . . 64.11 109.72 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -70.69 154.7 41.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.745 -0.835 . . . . 42.52 108.745 168.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -113.85 171.64 7.47 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.246 1.818 . . . . 63.44 107.181 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -54.26 21.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.185 1.794 . . . . 65.55 111.239 -175.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.35 -18.79 65.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.82 0.848 . . . . 61.51 111.381 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.27 -1.78 22.35 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.867 1.699 . . . . 71.11 113.643 160.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -50.46 -79.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.305 1.842 . . . . 63.03 111.81 -164.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.48 110.43 2.85 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.055 -1.618 . . . . 73.33 109.055 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -110.62 168.78 9.21 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.233 1.013 . . . . 71.43 109.635 165.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mt -143.91 136.22 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.97 -1.863 . . . . 71.35 105.97 166.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.2 125.32 26.62 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.27 3.85 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.914 0.885 . . . . 63.23 110.768 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.22 -31.23 72.78 Favored Glycine 0 CA--C 1.524 0.65 0 O-C-N 121.331 -0.856 . . . . 72.15 113.188 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -60.45 -13.63 14.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.565 1.182 . . . . 64.15 113.025 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.62 -21.09 37.38 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.98 -1.075 . . . . 73.14 111.662 167.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.93 24.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.677 2.391 . . . . 73.33 113.441 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.32 113.66 9.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.773 -1.566 . . . . 54.14 106.773 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -79.16 150.78 31.61 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.162 0.585 . . . . 72.5 110.97 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 15.6 tt -112.36 157.83 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.65 1.58 . . . . 64.1 108.296 170.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -63.6 110.27 1.94 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.751 -1.944 . . . . 74.24 105.751 162.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.57 175.65 5.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.107 1.363 . . . . 63.31 107.807 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.95 120.72 7.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.452 -1.314 . . . . 62.11 107.452 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.82 118.67 17.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.202 -0.936 . . . . 71.33 109.547 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -63.86 -31.74 73.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.588 0.355 . . . . 74.51 110.989 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -41.74 6.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.164 1.785 . . . . 75.21 111.692 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -136.91 15.59 3.07 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 43.32 111.399 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.5 47.6 8.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.834 1.654 . . . . 74.41 112.51 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.06 160.54 3.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 124.875 1.27 . . . . 62.33 108.434 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.86 149.68 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.801 -1.555 . . . . 74.21 106.801 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -178.69 7.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.287 2.235 . . . . 54.03 110.227 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -124.98 130.96 53.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.047 1.339 . . . . 73.4 107.715 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -151.6 160.04 43.82 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.403 1.081 . . . . 65.34 108.78 163.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -83.36 178.11 8.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.152 0.981 . . . . 75.54 110.687 163.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -95.12 170.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.848 2.059 . . . . 54.23 106.194 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.66 -61.71 1.49 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.044 -1.465 . . . . 65.02 107.044 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -126.72 152.11 47.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.941 -1.133 . . . . 73.14 107.941 -171.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -124.17 159.74 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 125.46 1.504 . . . . 70.12 107.646 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -137.84 156.31 48.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.733 0.813 . . . . 75.41 112.071 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.7 139.54 26.61 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.394 1.478 . . . . 71.02 111.521 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -148.5 155.8 41.62 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.161 0.984 . . . . 72.13 108.901 168.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -79.62 153.28 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.818 -1.176 . . . . 63.24 109.248 170.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.94 157.37 43.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.605 1.562 . . . . 72.3 108.538 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 p -161.96 97.45 1.04 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.141 0.976 . . . . 54.1 111.681 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.2 -172.78 45.76 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.675 -1.266 . . . . 63.51 112.652 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -85.05 116.15 23.27 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.132 0.573 . . . . 65.42 110.845 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 98' ' ' THR . 26.9 mt -95.79 165.83 12.1 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.863 1.665 . . . . 62.23 109.214 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.91 134.4 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 126.053 1.741 . . . . 61.34 109.669 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -123.61 82.82 2.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.995 -1.483 . . . . 73.1 106.995 164.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.8 mt -57.96 132.6 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.173 -2.158 . . . . 74.44 105.173 153.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -106.08 166.0 10.82 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.119 -1.808 . . . . 72.15 106.119 159.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.09 169.89 16.48 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.579 1.081 . . . . 53.01 109.558 165.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -63.82 -25.24 68.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.071 -1.018 . . . . 60.34 112.022 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.94 -0.17 0.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.196 2.598 . . . . 55.5 113.133 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 59.85 22.46 11.4 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 127.06 2.144 . . . . 71.52 111.333 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.528 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 2.6 ttm180 -75.64 163.52 27.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.213 -0.929 . . . . 62.32 108.756 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 167.99 4.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.636 0.775 . . . . 61.13 110.093 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.8 pt -147.97 178.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.998 1.719 . . . . 62.11 110.993 -173.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' HD23 ' A' ' 99' ' ' LEU . 17.7 m -149.99 103.48 3.21 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.639 1.576 . . . . 72.33 110.788 173.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -145.11 169.54 17.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 119.584 -1.947 . . . . 61.13 112.615 -174.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -62.22 144.91 54.89 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.198 1.399 . . . . 72.41 109.203 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.95 -20.72 64.21 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.651 -1.281 . . . . 50.42 112.143 -169.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -101.12 39.65 1.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.353 1.461 . . . . 54.0 110.672 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.69 143.08 25.7 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.16 -1.588 . . . . 74.24 109.729 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.75 137.24 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.014 2.476 . . . . 55.23 111.842 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.17 -177.4 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.915 1.686 . . . . 73.43 108.376 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.28 141.92 51.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.382 1.446 . . . . 73.54 111.303 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 107' ' ' ILE . 2.5 pp -142.36 171.32 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.858 1.263 . . . . 73.52 109.644 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.1 p -103.32 96.65 6.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.819 0.848 . . . . 70.44 111.005 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -82.29 89.06 6.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.325 -2.102 . . . . 73.33 105.325 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 44.13 44.51 6.39 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.05 1.34 . . . . 72.51 112.012 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.15 -31.81 8.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 118.097 -1.391 . . . . 62.55 113.608 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -79.51 144.94 33.5 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 119.798 1.799 . . . . 74.11 108.063 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.18 123.06 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.937 -1.134 . . . . 44.34 107.937 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 tp -123.06 159.47 28.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.664 -0.865 . . . . 72.02 108.664 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.46 104.05 11.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.438 1.495 . . . . 64.11 110.875 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 pt -129.96 -178.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.178 0.991 . . . . 65.02 112.136 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.16 134.52 34.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.343 0.974 . . . . 71.43 108.808 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.68 -38.44 55.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.861 1.06 . . . . 72.14 113.861 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 1.5 pp20? -67.19 -16.7 64.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.817 1.043 . . . . 74.11 113.817 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 35.6 mtt -83.16 -25.18 32.1 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.773 0.829 . . . . 63.21 110.436 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.35 62.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 127.754 2.422 . . . . 75.51 109.453 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 24.7 mmtp -79.72 -174.17 4.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.416 1.087 . . . . 64.33 108.707 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.79 -12.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.249 2.22 . . . . 73.22 113.38 167.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.91 -4.76 89.63 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 117.97 -1.461 . . . . 64.41 112.063 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -132.14 172.39 12.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.909 1.854 . . . . 62.21 110.834 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 9.4 m-85 -116.66 119.45 35.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.171 1.788 . . . . 74.15 106.346 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 tp -83.19 130.32 35.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.851 -1.166 . . . . 72.12 107.851 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -70.73 116.46 11.06 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.146 -1.057 . . . . 61.1 108.146 170.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.8 153.09 63.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.224 1.41 . . . . 74.13 112.035 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 153.61 52.4 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.602 2.201 . . . . 73.31 110.867 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.69 179.24 6.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.053 2.541 . . . . 72.31 107.218 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -25.41 -67.08 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.499 2.32 . . . . 75.51 113.911 -169.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -120.35 -0.55 10.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.381 1.872 . . . . 74.04 111.298 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.0 p -143.21 -171.27 3.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.211 1.004 . . . . 73.32 111.972 -154.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.47 153.17 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.855 -1.165 . . . . 63.0 107.855 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -145.8 -175.64 4.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.604 2.761 . . . . 73.31 106.163 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.99 161.27 19.65 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.724 1.21 . . . . 73.11 110.377 170.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -148.13 152.91 38.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.277 2.231 . . . . 74.45 106.804 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.461 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 19.2 mt-10 -77.13 147.4 36.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.689 1.595 . . . . 74.32 110.029 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.13 1.04 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.012 0.745 . . . . 63.13 113.012 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.432 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 29.47 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 128.161 2.584 . . . . 74.43 116.176 170.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.432 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.3 tppt? -100.33 128.36 46.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 120.804 -1.185 . . . . 73.01 107.942 174.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.65 128.21 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.64 -1.245 . . . . 53.12 107.64 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.55 -177.75 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.406 2.282 . . . . 64.53 107.216 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.9 p -117.86 170.44 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.964 -1.085 . . . . 65.32 109.339 167.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.21 124.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 107.003 -1.48 . . . . 64.04 107.003 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -86.16 114.35 22.93 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.904 1.229 . . . . 73.43 107.826 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -120.16 139.16 53.04 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.645 1.578 . . . . 61.15 107.299 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.55 81.92 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.502 -0.925 . . . . 71.42 108.502 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.83 -121.06 1.12 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.13 1.824 . . . . 61.34 111.273 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -136.84 152.57 50.41 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.232 -1.157 . . . . 73.24 109.703 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.3 pt -116.82 156.3 18.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.363 1.865 . . . . 74.41 108.267 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -138.14 150.92 47.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.841 1.257 . . . . 73.31 107.942 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -129.08 166.5 19.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.744 0.702 . . . . 72.22 109.96 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 127.16 42.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.111 1.365 . . . . 63.01 108.894 -170.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.5 m -71.08 -58.0 3.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.758 -0.639 . . . . 52.22 110.773 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.2 t 25.94 64.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 129.516 3.126 . . . . 71.32 112.567 -170.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -72.58 0.17 11.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.923 1.689 . . . . 64.41 113.027 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.19 -70.65 0.32 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.964 1.305 . . . . 74.12 108.526 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -93.6 0.31 56.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.615 0.766 . . . . 63.44 111.151 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.9 m170 65.21 26.48 12.31 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.736 2.014 . . . . 51.32 111.835 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -145.16 167.09 23.6 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.915 -1.115 . . . . 73.41 109.952 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.37 171.4 17.25 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.779 1.632 . . . . 71.24 109.527 176.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.6 mm -105.84 119.46 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.619 -1.252 . . . . 65.51 107.619 167.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -150.82 146.7 26.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.176 0.99 . . . . 42.54 109.977 171.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.64 177.88 23.26 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 128.063 2.744 . . . . 61.41 109.015 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -73.46 166.55 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.238 -1.742 . . . . 72.43 110.347 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 70.01 -71.7 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.617 2.367 . . . . 63.2 114.808 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.427 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 pt-20 -124.28 -19.27 5.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.772 1.229 . . . . 73.41 114.241 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 164.22 40.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.969 2.223 . . . . 44.1 113.62 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 97' ' ' ILE . 56.6 m-85 -104.18 151.99 22.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.855 2.062 . . . . 72.12 108.302 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.22 111.71 23.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.785 2.034 . . . . 70.32 106.936 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 163' ' ' TYR . 2.3 m -139.27 166.97 20.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 119.065 0.848 . . . . 74.22 110.472 -169.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.3 t -66.25 139.97 58.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.281 1.432 . . . . 63.11 109.841 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -137.3 70.36 1.4 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.32 2.648 . . . . 75.32 106.969 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.0 t -111.59 50.0 0.86 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.964 -1.71 . . . . 73.05 111.821 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . 0.251 97.5 p 60.33 59.8 2.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.597 1.959 . . . . 64.33 110.924 -174.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.55 80.75 0.12 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 125.343 1.449 . . . . 72.35 111.938 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.7 p 56.95 -172.63 0.08 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.991 2.516 . . . . 74.41 112.492 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 13.4 tp -128.73 26.39 5.58 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.051 -1.031 . . . . 64.12 113.028 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 95.84 165.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.945 3.298 . . . . 73.12 109.527 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.22 143.52 33.26 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.166 -0.959 . . . . 70.01 110.023 163.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.36 -102.7 0.28 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 116.868 -1.539 . . . . 54.22 110.181 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -142.31 95.86 2.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.497 1.953 . . . . 71.55 112.123 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.63 156.41 43.64 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.005 1.322 . . . . 71.03 108.231 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.2 m170 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 130.153 3.381 . . . . 74.24 107.696 -176.213 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 119.452 -0.308 . . . . 70.13 110.203 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 m120 54.12 -174.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.835 2.854 . . . . 64.55 113.144 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -103.54 -5.04 23.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.945 1.698 . . . . 61.05 111.018 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.67 2.2 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.427 -1.069 . . . . 62.34 110.427 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 56.8 -79.29 0.01 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.096 2.158 . . . . 75.31 110.773 -168.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.7 167.05 31.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.505 1.522 . . . . 73.24 109.305 -172.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.06 165.54 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.162 -0.775 . . . . 73.01 111.162 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -172.92 -174.45 1.09 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.347 1.859 . . . . 70.11 111.448 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -106.2 -178.03 3.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 129.538 3.135 . . . . 61.02 109.376 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.0 -156.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.472 1.109 . . . . 72.54 112.342 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.6 t80 -103.1 -30.58 10.64 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 65.44 110.414 164.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -116.72 29.67 7.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.768 2.427 . . . . 73.43 110.785 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -100.71 134.73 20.36 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.734 -0.839 . . . . 62.32 108.734 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.09 138.21 25.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.819 2.346 . . . . 72.51 112.921 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 25' ' ' ILE . 28.5 pt -102.11 7.09 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 114.974 1.472 . . . . 64.4 114.974 -172.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 36.28 74.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.287 1.835 . . . . 72.32 114.226 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 152.42 2.35 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.471 -0.937 . . . . 74.25 108.471 164.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -54.41 -36.19 63.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.193 0.451 . . . . 74.41 111.459 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.0 -19.53 62.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.958 1.303 . . . . 71.42 112.657 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.56 18.23 33.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 117.961 -1.466 . . . . 71.23 112.643 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -38.38 64.93 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.601 1.7 . . . . 73.05 113.821 -167.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.81 96.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.448 2.699 . . . . 70.44 108.977 -170.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.25 146.87 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.414 -1.699 . . . . 62.42 106.414 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.95 135.96 53.21 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.415 1.886 . . . . 63.14 108.079 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 15' ' ' ILE . 4.4 tt -51.3 -43.08 28.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.443 1.097 . . . . 62.34 110.812 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -71.36 -41.21 59.29 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-O 117.961 -1.466 . . . . 40.15 110.377 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -58.06 -44.06 87.25 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 120.78 2.29 . . . . 74.5 112.167 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.89 -59.71 4.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.656 1.582 . . . . 62.2 109.06 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG13 HG21 ' A' ' 77' ' ' VAL . 84.9 t -68.4 -44.54 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.402 -0.363 . . . . 61.34 110.589 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.24 -32.14 73.47 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.171 -0.956 . . . . 75.01 109.608 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -50.83 -52.54 40.37 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.43 -0.794 . . . . 62.42 109.882 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -66.21 -41.81 89.63 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.768 -1.197 . . . . 54.03 107.768 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.452 ' CD1' HD12 ' A' ' 50' ' ' ILE . 8.3 m-85 -60.71 -31.0 70.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.78 1.627 . . . . 70.22 112.827 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -19.03 32.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 125.387 1.475 . . . . 62.52 111.696 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 18.6 mttm -94.92 -63.75 1.14 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.269 -1.752 . . . . 74.22 106.269 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -82.02 43.28 0.77 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.355 2.662 . . . . 64.2 108.585 -173.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -50.89 -40.28 56.22 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.395 1.478 . . . . 73.14 110.187 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -59.02 -35.5 73.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.593 1.157 . . . . 74.1 112.965 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 m -77.17 -6.08 51.6 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.636 1.175 . . . . 72.31 113.768 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -65.37 95.26 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 119.807 1.185 . . . . 65.32 108.749 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -79.18 157.11 27.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.303 -1.74 . . . . 42.42 106.303 163.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -126.77 145.9 50.44 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.266 -2.124 . . . . 73.22 105.266 159.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.75 177.43 8.67 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.111 0.882 . . . . 62.33 110.332 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -49.23 -50.02 40.38 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.229 2.212 . . . . 61.2 111.911 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -70.66 -9.28 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.061 1.344 . . . . 73.11 112.137 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.37 56.18 2.89 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 127.235 2.35 . . . . 72.2 109.447 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -85.37 -100.19 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.609 -1.256 . . . . 75.22 107.609 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.85 123.77 0.99 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 107.79 -2.124 . . . . 74.43 107.79 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 160.35 41.34 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.276 1.538 . . . . 72.21 110.93 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' A' ' 33' ' ' PHE . 10.3 mt -143.2 149.71 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.822 2.049 . . . . 70.42 106.637 172.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.81 135.24 37.78 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.031 1.332 . . . . 63.52 109.575 165.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.09 25.52 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.33 2.252 . . . . 64.13 109.592 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.67 1.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 127.788 2.613 . . . . 63.32 115.694 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.06 -10.92 13.42 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.429 2.615 . . . . 50.15 114.785 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -28.44 63.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 121.347 1.885 . . . . 74.24 111.846 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 11.87 2.24 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.821 1.648 . . . . 70.25 113.339 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 mt -67.53 127.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.694 1.598 . . . . 73.23 109.48 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -94.6 142.83 26.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.564 1.146 . . . . 55.41 110.384 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.26 152.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.244 2.218 . . . . 73.0 106.961 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -68.49 105.67 2.29 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.265 -1.754 . . . . 64.1 106.265 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -96.36 -176.48 3.66 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.852 -1.166 . . . . 73.43 107.852 167.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.73 141.91 30.69 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.572 -1.64 . . . . 64.12 106.572 171.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.76 96.0 9.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -55.45 -21.21 15.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.644 0.778 . . . . 64.25 112.823 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -44.48 1.43 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.075 2.15 . . . . 65.04 112.024 167.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -139.03 0.91 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.088 0.955 . . . . 61.03 112.336 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mt 63.92 59.84 1.08 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.193 1.797 . . . . 73.44 110.743 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.73 153.09 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.768 1.627 . . . . 71.21 109.254 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.8 138.98 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.965 -1.124 . . . . 62.5 107.965 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -144.26 172.36 13.03 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.062 1.745 . . . . 72.23 107.977 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.34 131.68 54.33 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.286 -1.375 . . . . 64.04 107.286 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.3 mmpt? -141.33 155.74 45.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.587 -1.634 . . . . 75.43 106.587 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.71 124.42 49.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.95 0.795 . . . . 74.22 110.478 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.61 154.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.103 2.161 . . . . 73.4 109.084 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.2 -50.43 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.02 1.728 . . . . 72.43 110.504 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -134.2 160.04 39.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.0 1.727 . . . . 75.22 110.418 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.55 HG21 HG13 ' A' ' 29' ' ' VAL . 2.3 m -133.98 161.22 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 74.12 109.441 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.04 154.84 46.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.848 1.259 . . . . 74.21 110.417 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 148.78 19.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.378 0.99 . . . . 71.41 111.092 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -141.16 169.35 17.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.152 -1.425 . . . . 73.42 107.152 157.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -89.36 154.26 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.901 -1.148 . . . . 71.24 107.901 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -148.17 156.89 43.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.178 -1.045 . . . . 73.13 108.178 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -149.02 117.38 6.47 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.131 -1.433 . . . . 55.54 107.131 162.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.07 -179.1 44.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.382 -1.39 . . . . 45.34 112.057 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 98.98 11.7 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.515 1.126 . . . . 72.05 110.207 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.16 153.79 29.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.105 -1.442 . . . . 74.4 107.105 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.9 139.16 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.522 -0.918 . . . . 65.21 108.522 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HE2' ' OE1' ' A' ' 96' ' ' GLU . 48.8 tttm -130.54 70.69 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.476 1.51 . . . . 75.35 107.243 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.44 148.04 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 105.269 -2.123 . . . . 72.41 105.269 161.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 167.75 10.51 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 105.309 -2.108 . . . . 72.43 105.309 162.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.2 p -135.86 168.2 19.76 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.933 0.788 . . . . 72.11 109.696 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -24.17 67.65 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.728 1.149 . . . . 62.11 112.741 -168.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.31 4.38 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.043 1.337 . . . . 71.44 111.615 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 60.08 26.49 15.84 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.859 2.063 . . . . 72.45 112.229 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -76.45 173.09 11.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 165.112 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -177.61 167.28 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.854 1.662 . . . . 74.51 107.92 -175.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.8 pt -141.82 171.4 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 125.834 1.654 . . . . 71.32 108.688 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.92 101.28 3.02 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.776 -1.194 . . . . 73.53 107.776 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 168.62 24.7 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.874 1.27 . . . . 52.02 110.083 -171.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.9 p -58.29 147.5 30.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.215 1.006 . . . . 70.32 110.37 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.94 -16.33 63.72 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.002 0.741 . . . . 73.52 113.002 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -117.01 39.49 3.22 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.767 1.627 . . . . 75.12 110.563 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -77.57 131.22 71.73 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.77 -1.109 . . . . 75.2 110.262 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.4 101.12 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 125.026 3.817 . . . . 74.34 112.903 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.68 178.25 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.005 1.722 . . . . 52.13 109.783 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -122.85 139.21 54.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.557 -0.714 . . . . 71.12 111.144 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.78 163.98 35.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.591 1.156 . . . . 74.31 110.54 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.6 t -88.65 121.09 30.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.081 1.419 . . . . 54.42 111.676 172.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.51 78.0 1.81 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.32 1.848 . . . . 73.11 106.854 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m 69.75 0.8 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.235 1.569 . . . . 72.14 115.235 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.76 -33.68 1.39 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.08 -1.608 . . . . 73.24 109.08 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.73 131.27 35.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.97 1.308 . . . . 62.44 108.525 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.04 99.0 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.31 -1.367 . . . . 73.35 107.31 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.37 161.49 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.393 0.677 . . . . 73.55 109.372 172.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.95 126.42 49.94 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.762 2.025 . . . . 65.13 107.989 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.6 pt -149.54 176.99 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.926 1.291 . . . . 75.13 110.442 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.32 142.03 45.19 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.793 1.237 . . . . 71.54 108.434 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.8 20.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.998 0.919 . . . . 72.55 112.612 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.31 -11.38 60.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.928 1.24 . . . . 74.14 113.827 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.7 mmt -82.11 -28.43 32.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.921 1.237 . . . . 71.24 111.103 169.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.1 t -75.49 63.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 128.728 2.811 . . . . 62.34 111.585 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -79.16 -178.34 6.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.072 -1.017 . . . . 75.22 109.6 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.34 0.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 128.092 2.557 . . . . 73.51 114.033 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -99.32 -1.88 56.77 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 117.768 -1.573 . . . . 44.41 112.693 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.63 136.35 46.44 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 106.414 -1.699 . . . . 62.33 106.414 -163.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.66 109.94 21.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.824 1.25 . . . . 75.02 108.973 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.69 133.1 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.456 1.102 . . . . 74.45 108.714 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.3 132.21 46.08 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.028 -0.73 . . . . 73.5 109.028 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -126.28 155.87 73.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.357 1.863 . . . . 73.43 110.143 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.38 145.14 37.76 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.988 1.792 . . . . 74.44 109.382 172.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 -158.99 0.67 Allowed 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.976 -1.12 . . . . 62.41 107.976 167.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.51 -62.28 1.75 Allowed 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.89 0.876 . . . . 72.2 111.203 -160.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.3 0.69 9.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.799 1.037 . . . . 74.34 113.799 166.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.7 p -122.36 -167.02 1.49 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.51 1.524 . . . . 75.53 110.12 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.97 156.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.741 1.216 . . . . 72.25 107.778 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -144.87 -176.69 5.18 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.729 2.012 . . . . 72.42 108.406 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.1 mt -118.42 161.78 19.41 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.072 1.349 . . . . 73.45 108.148 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -152.02 154.84 36.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.569 1.548 . . . . 72.14 106.976 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -88.65 144.74 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.264 1.426 . . . . 71.35 108.918 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 -1.33 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 54.44 113.38 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 142' ' ' LYS . 4.1 pt 31.86 -76.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 129.171 2.989 . . . . 75.24 117.112 173.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' H ' HG13 ' A' ' 141' ' ' ILE . 39.7 ttmt -118.28 131.75 56.33 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.991 1.716 . . . . 70.21 108.459 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.65 121.72 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.634 1.174 . . . . 50.1 108.331 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -145.14 -169.47 3.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.361 1.464 . . . . 73.31 108.057 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -135.27 166.07 23.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.547 1.139 . . . . 73.52 109.572 -171.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.55 129.85 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.907 -1.516 . . . . 74.02 106.907 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.88 113.89 19.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.679 -1.971 . . . . 73.52 105.679 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -127.6 132.64 49.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.131 1.772 . . . . 74.11 108.864 -165.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -134.16 42.07 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.263 -0.898 . . . . 53.31 109.8 -157.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.0 -175.38 15.17 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.478 1.513 . . . . 70.42 111.44 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -72.15 147.46 46.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.72 -0.845 . . . . 75.25 108.72 161.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 27.7 pt -124.7 127.08 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.533 1.933 . . . . 72.52 106.472 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -112.83 162.12 16.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.815 -1.179 . . . . 73.41 107.815 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.28 164.09 35.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 44.1 109.601 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 67.5 mt -120.31 164.22 16.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.876 1.27 . . . . 64.32 111.137 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.7 m -101.31 -34.04 9.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.258 -1.337 . . . . 74.21 112.703 -164.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 17.5 t 24.52 74.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 130.325 3.45 . . . . 64.01 111.548 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -78.81 -9.0 59.31 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.307 -0.871 . . . . 75.01 112.043 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -62.15 1.75 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.116 2.166 . . . . 75.14 108.594 -168.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -120.73 5.17 10.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.639 0.977 . . . . 71.03 113.639 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.41 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 15.3 m170 52.97 23.9 3.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.673 1.589 . . . . 73.13 112.267 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.11 136.89 20.49 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 119.542 -1.974 . . . . 73.32 108.878 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 3.7 p90 -141.15 167.56 21.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.829 0.852 . . . . 74.41 110.981 -173.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 mm -103.12 134.13 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 124.37 1.068 . . . . 74.45 108.423 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.43 138.4 14.44 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.517 1.527 . . . . 73.45 108.702 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.72 170.96 20.35 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 125.338 1.446 . . . . 41.04 109.631 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -72.39 164.14 26.83 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.821 -1.988 . . . . 63.22 109.917 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 68.59 -74.47 0.08 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.474 2.309 . . . . 73.2 114.934 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -121.45 -15.65 8.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.316 1.446 . . . . 65.4 112.442 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 74.89 161.64 8.85 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 122.332 0.962 . . . . 71.14 114.128 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.582 ' CE1' HG23 ' A' ' 97' ' ' ILE . 19.1 m-85 -112.01 163.53 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.761 2.425 . . . . 45.41 107.228 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -92.57 117.19 29.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.062 0.846 . . . . 73.0 108.917 166.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.419 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 26.8 m -97.03 173.11 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 119.862 1.21 . . . . 71.51 108.989 173.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.0 m -66.56 147.83 52.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.107 -1.072 . . . . 64.44 108.107 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -121.79 159.99 25.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.943 0.897 . . . . 45.14 108.62 161.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.7 m -164.97 176.92 8.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.35 -1.722 . . . . 74.14 106.35 152.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 p -68.93 164.68 21.63 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.96 1.255 . . . . 34.11 109.267 150.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 26.36 98.71 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 129.46 3.41 . . . . 54.4 113.78 145.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.3 p -40.07 126.43 2.1 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.603 1.561 . . . . 70.35 110.752 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.8 tt -40.17 -51.34 2.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.54 1.936 . . . . 74.24 110.902 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -123.62 153.2 41.05 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.943 1.697 . . . . 72.52 108.446 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.92 168.5 21.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.248 1.419 . . . . 72.13 108.44 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -166.03 117.75 1.05 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.238 -1.023 . . . . 73.53 108.238 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -127.33 139.38 52.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.829 -1.545 . . . . 63.41 106.829 168.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -146.99 -22.28 0.41 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.285 0.634 . . . . 74.1 112.128 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 C-N-CA 127.132 2.173 . . . . 65.23 107.631 156.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 105.082 -2.192 . . . . 60.43 105.082 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.5 m120 30.59 88.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 128.216 2.606 . . . . 64.41 111.894 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.0 m -25.05 -60.62 0.06 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.54 2.736 . . . . 62.52 112.799 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.73 123.41 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.257 -1.137 . . . . 51.12 110.257 166.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -110.51 179.46 4.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.445 1.098 . . . . 74.55 110.723 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.9 123.28 20.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.653 -1.24 . . . . 51.33 107.653 166.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.3 174.0 36.16 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 108.939 -1.664 . . . . 40.21 108.939 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 166.27 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 128.334 2.654 . . . . 64.54 106.678 -163.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.436 HD21 ' HB1' ' A' ' 165' ' ' ALA . 4.8 mp -88.33 157.9 18.59 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.752 0.821 . . . . 72.25 109.985 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -61.68 156.3 20.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.456 1.102 . . . . 53.1 111.13 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.04 -40.13 60.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.07 1.348 . . . . 72.02 112.63 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.63 1.9 54.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.267 -0.873 . . . . 72.41 112.714 -165.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' OE1' ' HE2' ' A' ' 167' ' ' LYS . 11.8 mm-40 -77.95 140.29 62.26 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 120.592 1.542 . . . . 73.24 111.336 -164.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.19 133.74 13.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.771 2.314 . . . . 73.32 112.056 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 pt -102.99 -2.09 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.163 1.171 . . . . 72.42 114.163 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 22' ' ' ILE . 49.5 m-85 55.48 66.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.591 1.156 . . . . 55.55 112.391 176.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.7 mt -58.25 153.31 15.47 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.683 -0.636 . . . . 74.32 110.709 167.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 m -62.98 -31.79 72.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.486 1.514 . . . . 73.1 113.288 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -28.67 41.47 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.26 0.936 . . . . 72.51 110.352 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.1 13.56 5.89 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.419 -0.656 . . . . 62.23 112.73 159.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -45.5 -53.33 9.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 127.705 2.402 . . . . 74.32 113.575 -171.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.444 HD11 ' CE2' ' A' ' 16' ' ' TYR . 7.8 mm 56.69 111.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.842 2.457 . . . . 75.44 107.907 -157.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.98 161.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.702 -1.592 . . . . 51.25 106.702 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -71.14 129.79 39.84 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.279 1.032 . . . . 53.44 108.946 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 tt -48.68 -42.44 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.824 1.65 . . . . 72.1 110.839 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.66 -47.47 61.6 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.268 -1.295 . . . . 44.25 110.966 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -57.41 -46.62 83.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.345 1.573 . . . . 73.23 110.877 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.71 -55.59 32.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.058 0.943 . . . . 75.33 110.449 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 33' ' ' PHE . 52.6 t -56.83 -45.23 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.322 1.049 . . . . 51.32 110.057 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.93 -34.7 79.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.265 1.026 . . . . 63.03 111.501 -167.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 8.4 ttpt -51.96 -53.3 42.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.472 1.109 . . . . 44.4 108.545 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 29.4 m-85 -70.68 -34.19 71.72 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 118.967 -0.54 . . . . 72.23 109.723 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.5 m-30 -63.74 -39.54 94.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.088 1.313 . . . . 62.23 111.337 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -42.26 74.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.788 1.235 . . . . 73.03 110.535 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -78.95 -53.84 6.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.312 0.645 . . . . 64.34 109.49 -173.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.79 42.48 1.1 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.439 2.296 . . . . 74.43 107.028 -170.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.96 -34.34 59.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.666 -1.272 . . . . 71.31 111.521 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -60.21 -35.26 75.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.181 0.992 . . . . 74.34 112.406 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.48 -0.91 43.93 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.597 1.159 . . . . 42.25 112.91 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.77 94.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.394 -1.336 . . . . 62.35 107.394 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -79.54 154.9 28.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.792 -1.188 . . . . 75.11 107.792 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -111.88 156.96 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.086 -1.079 . . . . 51.21 108.086 160.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.33 168.78 12.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.955 -1.128 . . . . 60.3 107.955 159.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -59.57 -48.35 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.93 0.892 . . . . 71.35 109.39 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.09 -3.47 13.4 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.707 1.002 . . . . 52.22 113.707 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.87 20.84 45.15 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 121.302 -0.874 . . . . 75.44 114.187 159.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.73 -86.02 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.14 1.776 . . . . 74.03 110.14 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.43 125.42 2.73 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.074 1.321 . . . . 45.22 110.263 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -136.82 169.91 16.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 61.54 111.452 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 33' ' ' PHE . 19.5 mt -144.47 144.5 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.289 2.235 . . . . 73.42 106.398 164.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.91 125.8 34.26 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.217 1.407 . . . . 71.34 109.684 167.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.91 8.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.809 0.844 . . . . 74.34 111.054 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.22 -40.65 60.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.52 1.054 . . . . 41.53 112.346 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -59.98 -9.3 2.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.239 2.216 . . . . 75.15 114.402 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -70.05 -22.36 63.09 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.474 1.034 . . . . 72.03 112.588 170.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.13 7.03 3.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 120.125 1.33 . . . . 73.31 114.27 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.02 118.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.649 1.18 . . . . 74.24 108.117 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -85.44 155.17 21.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.411 1.1 . . . . 61.41 110.184 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 17.9 tt -135.07 155.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.652 1.981 . . . . 62.52 107.732 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 60' ' ' LYS . 5.9 mmpt? -69.4 118.94 12.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.709 -1.589 . . . . 44.44 106.709 167.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -110.73 -175.98 2.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.59 -2.004 . . . . 72.2 105.59 165.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 125.14 16.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.331 -1.729 . . . . 74.45 106.331 172.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -73.72 99.52 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.921 -1.14 . . . . 74.24 107.921 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -54.89 -23.23 17.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 124.849 1.26 . . . . 74.34 112.08 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -26.31 24.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.06 1.344 . . . . 75.23 112.605 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.0 m -144.95 16.43 1.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.482 1.113 . . . . 71.01 112.361 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp 53.41 45.6 28.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.835 1.198 . . . . 73.23 111.37 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -113.95 159.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.28 1.032 . . . . 52.12 109.945 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.7 mm -79.32 142.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.92 -1.511 . . . . 74.11 106.92 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -131.31 162.27 30.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.984 1.374 . . . . 65.24 110.667 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.07 127.96 36.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.207 -2.146 . . . . 71.12 105.207 165.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -154.43 148.26 25.51 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 117.005 -1.474 . . . . 73.22 107.823 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.97 161.73 18.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 122.351 2.342 . . . . 65.13 111.307 168.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.62 ' H ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -80.92 165.67 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.947 -1.501 . . . . 62.24 106.947 166.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' H ' HG22 ' A' ' 74' ' ' ILE . 17.9 mt -127.28 -42.75 1.67 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.493 1.517 . . . . 63.53 110.771 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -134.58 154.83 51.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.409 1.458 . . . . 73.41 110.231 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.413 HG21 HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -123.62 162.06 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.884 1.674 . . . . 74.44 108.404 177.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -137.31 158.94 43.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.478 1.111 . . . . 74.14 110.567 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -142.07 145.99 34.95 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.761 1.624 . . . . 64.34 107.159 172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -147.53 151.58 36.57 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.887 -1.153 . . . . 72.0 107.887 160.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.96 140.91 47.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.631 -0.878 . . . . 44.13 108.631 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -144.76 150.05 36.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.878 1.671 . . . . 73.13 107.268 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.2 p -143.38 138.27 29.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 104.979 -2.23 . . . . 55.33 104.979 155.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.6 -178.4 35.73 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 120.781 1.628 . . . . 74.11 111.11 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 119.53 30.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.491 -0.417 . . . . 74.01 110.812 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -88.88 164.59 15.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.986 1.314 . . . . 63.21 108.209 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mm -78.35 142.63 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 106.615 -1.624 . . . . 72.13 106.615 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -133.04 74.65 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.423 -1.695 . . . . 72.45 106.423 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.1 mt -78.01 121.51 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.683 -2.34 . . . . 73.45 104.683 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 m -107.62 164.48 12.19 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.687 -1.598 . . . . 73.32 106.687 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -132.84 175.09 9.66 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.84 0.745 . . . . 65.31 111.306 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -66.34 -22.65 66.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.9 -1.125 . . . . 72.12 112.448 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -69.71 -1.07 8.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.889 0.876 . . . . 71.02 112.514 170.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 57.75 25.26 11.65 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.443 -1.411 . . . . 73.54 110.187 -162.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.24 24.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.491 -1.3 . . . . 64.31 107.491 165.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 22.5 mt-10 -161.42 162.01 30.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.443 -0.947 . . . . 74.31 108.443 -166.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.565 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -148.42 160.18 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.74 1.216 . . . . 74.43 110.268 174.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.91 96.52 2.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.172 1.389 . . . . 53.41 109.917 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.19 -179.86 7.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.14 2.176 . . . . 62.41 109.836 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 p -68.47 165.81 18.18 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.22 0.918 . . . . 62.41 111.323 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.28 -24.26 64.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.923 -0.486 . . . . 75.34 110.54 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -115.56 81.05 1.52 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.189 1.396 . . . . 74.03 107.896 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 156.72 76.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.691 -0.631 . . . . 75.12 111.427 150.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -89.48 149.82 5.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.27 3.313 . . . . 71.23 115.93 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 173' ' ' VAL . 0.4 OUTLIER -156.91 -173.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 111.459 -2.61 . . . . 73.42 107.7 -174.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -132.55 141.18 48.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.468 -1.696 . . . . 65.52 112.288 -171.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.73 157.82 26.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.015 0.926 . . . . 74.3 110.047 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.01 105.64 12.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.455 1.121 . . . . 64.43 109.24 173.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -76.37 66.68 2.47 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 107.155 -1.424 . . . . 73.35 107.155 148.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 1.0 OUTLIER 70.26 -15.13 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.989 2.515 . . . . 55.34 115.375 170.13 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.24 -21.08 0.12 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 126.288 1.899 . . . . 52.03 109.025 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -78.46 144.54 35.69 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 105.362 -2.088 . . . . 71.22 105.362 166.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -102.04 95.53 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.503 1.521 . . . . 73.2 107.835 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.3 154.46 17.18 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.833 1.253 . . . . 62.23 108.671 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -114.05 111.84 22.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.51 1.524 . . . . 64.13 111.881 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.09 179.39 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.214 1.005 . . . . 70.31 111.231 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -99.26 148.49 24.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.081 1.752 . . . . 75.24 109.936 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.4 -26.8 65.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 118.102 0.41 . . . . 73.31 110.385 -161.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.66 67.34 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.313 -0.867 . . . . 64.12 113.231 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.6 -29.64 46.19 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.328 1.051 . . . . 51.41 112.086 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 140' ' ' VAL . 11.4 t -73.83 63.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.508 2.323 . . . . 74.15 109.89 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -78.78 178.17 8.12 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.435 1.094 . . . . 74.53 108.187 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.03 -20.94 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.077 1.751 . . . . 63.3 113.666 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.18 -2.78 87.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.876 -1.513 . . . . 35.33 113.439 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.12 159.71 16.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.459 2.129 . . . . 71.24 111.039 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.5 103.53 11.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.72 1.608 . . . . 71.54 109.066 170.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.87 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.53 1.532 . . . . 65.34 107.327 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.13 115.36 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.789 -0.819 . . . . 74.43 108.789 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 pt -102.56 154.03 37.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 123.297 0.639 . . . . 73.22 110.766 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.7 138.26 28.81 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.117 1.878 . . . . 72.5 107.944 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.63 175.46 5.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.313 -1.366 . . . . 74.23 107.313 162.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -25.06 -61.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.873 2.069 . . . . 75.11 115.246 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -121.05 1.19 10.34 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.704 1.202 . . . . 72.1 113.077 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -143.74 -175.36 4.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.853 2.061 . . . . 73.42 109.353 -139.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -120.11 147.99 23.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.87 -1.159 . . . . 70.53 107.87 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -137.1 -178.18 5.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.856 2.462 . . . . 72.41 106.896 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.51 164.4 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.836 1.254 . . . . 75.23 108.115 168.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -156.85 159.12 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.183 -1.784 . . . . 71.12 106.183 167.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -104.29 138.16 41.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.103 1.361 . . . . 70.5 109.325 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.51 HG21 HG12 ' A' ' 121' ' ' VAL . 25.1 t -71.08 -0.27 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 114.146 1.165 . . . . 74.51 114.146 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 25.93 -89.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 127.029 2.131 . . . . 72.05 114.924 174.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -92.65 113.23 25.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.257 -0.902 . . . . 62.3 109.267 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.14 144.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.36 -0.978 . . . . 73.32 108.36 156.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -156.2 -172.14 3.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.904 2.482 . . . . 72.33 106.291 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -124.53 142.76 51.09 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.869 -1.16 . . . . 73.34 107.869 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.46 -179.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.628 1.171 . . . . 63.41 108.566 166.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -126.39 138.31 53.54 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.982 2.513 . . . . 73.42 106.75 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.4 t80 -151.49 151.23 31.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.448 1.099 . . . . 73.05 109.111 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.98 78.27 0.45 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.245 -1.761 . . . . 74.23 106.245 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -151.27 23.78 0.97 Allowed Glycine 0 N--CA 1.468 0.822 0 CA-C-N 113.807 -1.542 . . . . 74.5 113.886 -164.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 54.77 -179.29 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.479 0.712 . . . . 72.14 110.962 -151.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.2 pt -145.78 160.19 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.703 2.401 . . . . 73.2 106.699 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -137.21 147.52 45.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.197 1.799 . . . . 42.14 108.617 -166.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -147.7 167.56 24.33 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.669 1.122 . . . . 70.0 111.56 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.5 126.48 31.18 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 127.987 2.515 . . . . 70.04 108.149 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 177' ' ' SER . 19.6 m -61.61 -53.32 57.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.102 0.561 . . . . 72.02 112.46 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.305 3.5 t 24.38 64.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 128.018 2.527 . . . . 65.24 112.385 -164.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -79.2 0.06 29.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.958 1.303 . . . . 71.34 111.472 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -64.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.919 1.688 . . . . 71.12 110.887 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.7 -0.31 14.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.253 0.621 . . . . 63.1 111.841 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.2 m80 61.95 27.89 16.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.453 1.901 . . . . 73.14 110.734 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.1 143.22 24.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.619 1.568 . . . . 73.15 108.123 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.658 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 0.4 OUTLIER -145.6 -179.38 6.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.199 1.0 . . . . 70.54 111.261 -173.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.73 124.01 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 107.631 -1.248 . . . . 64.41 107.631 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -155.79 146.07 21.69 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.801 0.44 . . . . 63.42 110.528 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.91 -169.06 32.45 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 108.326 -1.91 . . . . 74.33 108.326 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.461 ' HE2' ' OE1' ' A' ' 13' ' ' GLU . 74.0 mttt -99.51 177.84 5.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 119.879 1.839 . . . . 62.32 110.039 162.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 60.26 -78.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 129.198 2.999 . . . . 74.24 113.037 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.57 -8.1 8.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.326 1.45 . . . . 75.51 113.866 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 67.4 153.04 0.3 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.106 1.336 . . . . 75.5 114.92 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 97' ' ' ILE . 43.9 m-85 -107.55 159.01 16.76 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.048 2.139 . . . . 70.54 108.662 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -96.58 74.58 2.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 127.11 2.164 . . . . 72.24 109.184 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 105' ' ' VAL . 3.2 m -105.03 171.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.827 -0.546 . . . . 61.31 110.687 -164.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 m -71.18 159.24 35.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.073 0.549 . . . . 75.14 110.676 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.658 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -136.03 165.49 25.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.587 2.755 . . . . 63.34 108.028 169.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.9 t -164.43 168.7 18.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.063 0.847 . . . . 74.41 109.655 150.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.548 ' HA ' HG23 ' A' ' 156' ' ' THR . 3.6 p -72.65 -56.85 4.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.061 1.744 . . . . 54.3 113.508 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -138.31 76.28 0.36 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 107.431 -2.267 . . . . 65.0 107.431 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.2 p 57.74 -166.65 0.14 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.626 1.97 . . . . 60.24 111.737 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.55 -71.35 0.22 Allowed 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.105 -0.997 . . . . 72.31 108.697 171.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 66.56 155.21 0.09 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.405 2.282 . . . . 73.03 112.771 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 60.6 m170 32.88 62.45 0.35 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.003 2.121 . . . . 74.41 112.283 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -50.73 -54.97 18.93 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.419 1.266 . . . . 75.25 114.419 -159.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -165.19 -65.67 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.612 -1.255 . . . . 75.43 107.612 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -77.14 169.97 17.37 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.167 0.587 . . . . 64.31 109.623 166.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 127.783 2.433 . . . . 75.5 111.039 143.555 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.959 -0.386 . . . . 60.24 109.959 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -117.24 -143.32 0.37 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 106.109 -1.811 . . . . 65.3 106.109 164.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 m 79.48 -43.39 0.29 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.396 2.278 . . . . 75.41 108.424 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.13 73.5 0.71 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.927 -1.669 . . . . 64.54 108.927 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.251 3.4 t-80 54.45 -156.53 0.22 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.993 1.317 . . . . 62.2 110.106 -159.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -145.62 124.35 12.59 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.195 1.398 . . . . 71.54 109.057 -171.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.73 162.69 9.25 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 111.245 -0.742 . . . . 72.24 111.245 170.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.64 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.138 1.375 . . . . 74.41 108.666 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.5 157.13 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.943 1.697 . . . . 74.42 109.437 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.5 159.4 30.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.636 0.775 . . . . 64.42 112.024 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.1 t80 -54.52 -39.76 67.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.955 1.702 . . . . 65.15 112.916 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -101.59 19.82 17.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.238 1.815 . . . . 71.24 110.952 -170.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -77.64 121.61 84.55 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.223 -2.14 . . . . 74.42 105.223 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.6 138.51 54.62 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 120.52 0.813 . . . . 55.42 110.302 171.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 pt -108.54 143.25 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 122.647 1.213 . . . . 72.13 108.164 160.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.441 ' CE2' HD11 ' A' ' 22' ' ' ILE . 11.4 m-85 -103.3 99.41 9.25 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.925 -2.62 . . . . 65.45 103.925 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 1.8 mm? -52.45 165.77 0.23 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.186 -0.672 . . . . 74.24 109.186 166.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -48.89 -43.93 39.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.526 0.73 . . . . 63.4 109.516 166.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.71 -35.66 80.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.329 0.492 . . . . 65.4 112.329 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.0 9.12 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.243 0.925 . . . . 73.13 112.13 -171.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -20.96 15.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.49 1.516 . . . . 74.21 114.955 -170.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 16' ' ' TYR . 27.1 mm 46.95 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 128.35 2.66 . . . . 74.41 110.631 -168.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.2 144.29 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 114.841 -1.072 . . . . 73.42 108.383 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -61.78 126.3 26.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 105.913 -1.884 . . . . 64.01 105.913 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -49.89 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 63.53 108.953 165.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -56.65 -57.42 19.6 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-O 117.941 -1.477 . . . . 55.3 112.521 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -52.46 -51.57 58.64 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.486 1.914 . . . . 71.14 111.384 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.93 -52.04 61.87 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 125.837 1.655 . . . . 74.2 109.778 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 153' ' ' TYR . 73.4 t -76.86 -36.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.891 -1.05 . . . . 63.21 110.443 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.06 -36.05 80.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.661 0.664 . . . . 71.23 111.724 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -55.04 -42.69 72.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.323 1.049 . . . . 64.21 109.94 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -67.02 -43.99 81.4 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.1 -1.0 . . . . 75.11 110.093 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -60.07 -33.35 71.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.894 1.225 . . . . 71.34 112.497 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -61.5 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.282 1.433 . . . . 74.23 109.514 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -73.23 -47.85 39.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.714 -1.217 . . . . 73.51 107.714 -166.452 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -94.66 40.78 1.09 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.228 1.411 . . . . 63.01 109.887 -172.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.08 -39.88 29.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.042 -1.036 . . . . 65.13 111.636 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -72.07 -22.79 61.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.993 0.738 . . . . 43.23 112.993 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -85.99 -2.28 58.14 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.722 0.809 . . . . 73.43 111.822 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.4 mt -62.88 101.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.954 -1.499 . . . . 71.22 106.954 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.58 162.22 25.46 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.12 -1.437 . . . . 60.55 107.12 161.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.88 145.47 47.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.577 -1.638 . . . . 72.13 106.577 163.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 175.24 10.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.469 -0.567 . . . . 70.32 109.469 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -61.33 -45.09 95.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.363 1.065 . . . . 74.14 108.584 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.39 -19.79 66.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.355 0.662 . . . . 63.14 110.5 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 36.19 6.1 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 120.972 -1.08 . . . . 61.45 111.489 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 3.7 t80 -78.05 -86.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.595 1.158 . . . . 74.31 109.908 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.87 121.82 2.02 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.07 -2.012 . . . . 25.31 108.07 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.26 163.65 33.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.539 1.17 . . . . 72.2 112.231 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mt -143.98 140.04 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.72 -1.585 . . . . 73.41 106.72 172.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.6 134.75 33.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.625 1.17 . . . . 71.25 109.883 172.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.01 23.09 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.767 2.027 . . . . 62.25 111.581 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . -61.06 -7.13 8.12 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.393 -1.226 . . . . 64.13 115.69 -175.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.67 -27.92 13.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.38 1.59 . . . . 71.23 113.128 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.93 -23.65 33.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.304 1.002 . . . . 52.5 111.971 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.83 15.01 3.55 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.149 1.38 . . . . 70.41 112.867 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.97 101.31 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.568 1.147 . . . . 73.45 108.269 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.35 118.68 7.79 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.829 1.252 . . . . 72.3 110.009 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 14.1 tt -98.33 160.18 3.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 125.05 1.34 . . . . 72.21 107.751 165.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.01 124.19 22.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.731 -1.581 . . . . 74.34 106.731 168.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -128.92 178.77 6.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.558 1.143 . . . . 53.11 108.116 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -153.42 127.53 9.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.143 -0.688 . . . . 53.41 109.143 -171.564 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.73 112.35 20.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.943 -1.503 . . . . 74.03 106.943 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.66 -20.39 55.81 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 113.28 0.845 . . . . 64.24 113.28 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.61 -19.9 2.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.083 2.153 . . . . 63.42 112.682 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -154.04 20.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.418 0.554 . . . . 75.1 111.301 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.16 54.36 6.07 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.272 -1.517 . . . . 62.12 112.158 -167.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 pt -101.26 169.85 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.106 1.363 . . . . 41.53 108.627 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.25 150.09 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.853 1.261 . . . . 71.52 108.634 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -157.63 174.07 15.9 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.94 2.496 . . . . 75.35 107.65 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -87.85 145.67 25.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.257 -1.386 . . . . 73.24 107.257 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -148.79 144.72 27.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.347 -1.353 . . . . 70.35 107.347 164.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -78.14 -175.15 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.857 1.208 . . . . 64.25 112.19 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.5 152.04 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.087 2.155 . . . . 61.25 107.241 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.413 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 3.0 mm? -113.07 -40.76 3.87 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 113.346 0.869 . . . . 65.41 113.346 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -145.8 164.85 30.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.691 -1.225 . . . . 71.35 107.691 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -132.43 165.99 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.744 -1.206 . . . . 74.13 107.744 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -130.93 175.47 9.04 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.909 0.884 . . . . 74.5 108.943 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.48 145.92 5.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.03 1.732 . . . . 74.12 106.925 154.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HE3' ' CD2' ' A' ' 47' ' ' PHE . 5.4 ttmt -148.48 166.42 28.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.885 -1.154 . . . . 63.24 107.885 166.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -93.45 157.5 16.18 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.524 -0.735 . . . . 74.21 109.538 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.13 147.55 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.074 1.35 . . . . 73.21 109.634 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -143.39 117.9 9.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 160.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.52 -146.6 4.65 Favored Glycine 0 N--CA 1.463 0.481 0 N-CA-C 109.911 -1.276 . . . . 74.12 109.911 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -123.5 119.21 29.3 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.036 -1.459 . . . . 74.42 110.277 174.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.16 153.98 17.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 121.547 1.976 . . . . 73.4 106.78 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -79.94 139.79 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 126.784 2.033 . . . . 74.34 108.513 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -124.65 84.47 2.28 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.733 1.613 . . . . 73.35 106.748 161.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 32.3 mt -75.2 112.13 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.005 -1.85 . . . . 73.54 106.005 162.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -75.24 178.46 5.76 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.568 -0.901 . . . . 73.43 108.568 167.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -146.19 177.11 9.24 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.61 -1.306 . . . . 74.11 109.336 154.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.1 ttmt -60.41 -27.28 67.33 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 119.503 -1.998 . . . . 63.3 113.568 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.68 18.62 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.888 1.222 . . . . 70.34 112.752 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER 58.59 15.76 3.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.728 2.411 . . . . 73.03 111.415 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ttm105 -68.49 170.49 8.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.754 2.022 . . . . 72.43 108.463 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -176.17 172.1 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.155 1.382 . . . . 70.14 109.491 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 171' ' ' PHE . 3.8 pt -143.09 178.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.011 1.324 . . . . 61.2 107.838 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 98.11 2.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.723 -0.843 . . . . 72.0 108.723 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.79 173.21 17.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.691 1.596 . . . . 73.14 110.218 -172.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.3 p -74.26 163.7 27.5 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.1 -1.0 . . . . 71.35 111.551 -173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.4 -16.46 62.96 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.287 0.847 . . . . 71.32 113.287 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -116.72 38.82 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.97 0.805 . . . . 72.24 108.893 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -89.99 129.76 44.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 117.921 -1.038 . . . . 62.31 109.613 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -60.35 126.6 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.747 3.631 . . . . 73.52 111.293 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.91 175.96 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.693 1.597 . . . . 63.41 109.123 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.79 134.68 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.494 -0.754 . . . . 62.4 111.067 -169.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.96 161.58 40.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.451 1.501 . . . . 73.34 109.059 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.471 ' HB3' HD21 ' A' ' 137' ' ' LEU . 53.2 p -87.4 127.01 35.21 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 119.416 -0.326 . . . . 44.45 110.743 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HE3' HD13 ' A' ' 114' ' ' LEU . 2.3 ttmt -104.97 75.99 1.22 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.025 -1.472 . . . . 71.21 107.025 165.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m 59.51 16.98 5.66 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.857 1.663 . . . . 72.11 114.562 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -38.6 1.42 Allowed Glycine 0 N--CA 1.448 -0.536 0 O-C-N 120.682 -1.262 . . . . 60.01 110.194 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.76 148.86 31.3 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.359 -1.349 . . . . 72.14 107.359 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.19 117.51 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.699 -1.593 . . . . 73.25 106.699 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.686 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.7 tp -105.19 132.94 50.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.076 -1.083 . . . . 63.04 108.076 166.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -81.75 125.79 31.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.235 -1.024 . . . . 73.21 108.235 161.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.45 -179.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.48 1.512 . . . . 72.11 109.21 169.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.28 145.3 24.55 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.998 0.919 . . . . 73.02 109.285 -172.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -42.55 -47.11 5.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.637 1.975 . . . . 71.02 113.762 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -32.63 54.43 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.917 0.887 . . . . 50.33 113.053 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.2 mtt -75.6 -26.41 57.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.985 0.514 . . . . 73.31 112.159 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.259 5.7 t -79.11 63.2 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.695 2.398 . . . . 73.1 112.319 -169.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.759 ' HG3' ' H ' ' A' ' 124' ' ' GLY 0.259 0.0 OUTLIER -79.43 175.09 10.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 131.07 3.748 . . . . 72.13 111.632 -174.65 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.259 5.9 p -57.88 1.67 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 126.535 1.934 . . . . 71.12 114.616 167.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.759 ' H ' ' HG3' ' A' ' 122' ' ' LYS . . . -108.28 -1.84 33.37 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.772 2.606 . . . . 24.31 111.495 171.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 156.44 21.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.88 1.84 . . . . 64.54 108.02 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.6 104.97 12.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.517 -1.29 . . . . 74.11 107.517 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 tt -81.33 136.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.401 -0.818 . . . . 75.2 109.821 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.57 129.35 38.08 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.225 -0.898 . . . . 74.53 109.099 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 161.21 60.74 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.693 1.997 . . . . 74.12 111.164 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.55 173.04 14.98 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.726 2.284 . . . . 73.32 110.639 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -134.49 -134.8 0.16 Allowed 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 120.865 -1.147 . . . . 71.13 108.665 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -51.94 -84.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.609 1.164 . . . . 72.32 108.871 169.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -121.22 0.89 10.2 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.727 1.611 . . . . 73.32 112.431 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 p -131.58 151.34 51.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.879 0.872 . . . . 75.52 112.515 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.1 147.29 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -145.78 -176.21 5.04 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.704 2.002 . . . . 63.33 107.543 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 108' ' ' SER . 5.7 mt -124.82 166.23 16.61 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -154.26 140.79 18.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.765 -1.198 . . . . 73.54 107.765 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.8 141.34 46.21 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.528 -1.286 . . . . 64.24 107.528 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 89' ' ' ILE . 3.0 t -70.48 -23.48 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.529 1.531 . . . . 75.05 113.89 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.6 pt 47.19 -53.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 131.664 3.986 . . . . 54.51 116.398 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -140.28 132.51 28.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.689 2.395 . . . . 74.3 106.827 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.76 131.01 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 107.806 -1.183 . . . . 75.42 107.806 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.14 -164.79 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.932 1.293 . . . . 73.23 108.149 171.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 p -146.9 162.27 39.02 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.322 1.049 . . . . 72.31 109.517 -162.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 3.3 m -132.51 171.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 127.388 2.275 . . . . 73.24 108.687 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.48 92.41 3.42 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.051 -1.092 . . . . 73.44 108.051 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -97.63 136.91 37.33 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.509 2.723 . . . . 73.03 108.719 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -134.54 73.34 1.48 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.024 -1.473 . . . . 74.23 107.024 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.2 -159.24 7.84 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.086 0.85 . . . . 73.42 112.912 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -102.29 154.25 19.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.8 -0.815 . . . . 74.23 108.8 163.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.65 154.23 26.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.279 1.832 . . . . 63.55 107.295 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.692 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -153.38 160.28 42.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.599 0.76 . . . . 74.35 109.69 173.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -131.74 146.03 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.098 2.159 . . . . 75.54 107.524 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.91 143.85 27.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.904 1.684 . . . . 74.13 112.718 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 83.14 3.63 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.392 -1.336 . . . . 64.3 107.392 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.21 76.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 106.145 -1.798 . . . . 64.51 106.145 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.02 -5.19 20.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.769 -0.582 . . . . 73.2 111.694 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.26 -63.97 0.95 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.901 2.08 . . . . 75.41 107.631 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -125.53 -4.85 7.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.716 2.406 . . . . 62.31 111.861 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 54.18 25.86 6.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.256 2.223 . . . . 63.44 112.775 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 p -141.49 153.68 45.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.883 1.273 . . . . 64.53 109.11 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -163.7 178.07 8.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.412 1.085 . . . . 75.21 111.208 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.9 122.21 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.204 1.402 . . . . 73.13 109.317 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.04 154.93 43.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.56 1.144 . . . . 74.3 110.054 173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.51 -171.61 21.88 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.589 -0.605 . . . . 72.34 111.589 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -91.55 166.68 12.71 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.484 -1.598 . . . . 70.05 110.015 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 61.36 -76.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 129.693 3.197 . . . . 74.43 112.032 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.89 -13.77 8.18 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.417 1.487 . . . . 74.15 112.561 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.86 171.0 18.9 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.033 1.301 . . . . 73.31 112.42 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 97' ' ' ILE . 68.8 m-85 -112.12 157.09 21.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.737 3.615 . . . . 73.2 105.322 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.467 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -103.9 110.81 23.09 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.108 -1.812 . . . . 42.03 106.108 170.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.13 175.19 6.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.619 -0.882 . . . . 64.31 108.619 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 155.24 16.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.01 -0.737 . . . . 72.23 109.01 168.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -146.78 47.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.866 2.066 . . . . 63.23 107.012 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 p -66.42 119.02 10.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.297 -1.001 . . . . 60.52 108.297 -171.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 62.2 p -68.37 30.21 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.034 1.734 . . . . 71.31 113.197 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.54 64.17 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.149 -1.361 . . . . 74.01 115.427 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.6 173.25 6.41 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.784 1.792 . . . . 73.11 109.377 171.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 45.8 tp 70.5 147.01 0.07 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.528 2.731 . . . . 73.23 111.377 168.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 79.97 1.8 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.923 -1.139 . . . . 62.21 107.923 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 65.32 174.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.853 2.061 . . . . 74.43 114.214 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 54.3 -157.91 0.19 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.984 1.714 . . . . 73.54 110.094 -165.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.7 t60 56.94 48.06 16.54 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.502 1.921 . . . . 75.15 110.811 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 156.2 28.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.194 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.5 m170 . . . . . 0 C--O 1.246 0.903 0 C-N-CA 127.429 2.291 . . . . 75.22 105.755 167.843 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 mtm . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 107.526 -1.287 . . . . 75.32 107.526 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 13.5 4.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.05 1.13 . . . . 72.22 114.05 -165.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.9 m 91.59 -38.13 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.98 2.112 . . . . 51.23 110.472 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.66 61.93 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 120.163 1.347 . . . . 73.22 115.576 158.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 78.8 130.52 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.602 3.161 . . . . 65.23 110.633 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.505 ' HB3' HG21 ' A' ' 100' ' ' THR . 69.2 m-20 58.28 -176.65 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.522 1.929 . . . . 62.5 109.494 -156.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.1 75.88 0.41 Allowed Glycine 0 C--N 1.336 0.559 0 O-C-N 121.291 -0.881 . . . . 55.54 111.08 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.94 136.41 15.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.968 1.307 . . . . 74.45 109.844 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.419 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 10.0 mp -79.74 158.6 26.86 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.413 1.485 . . . . 71.51 110.919 -167.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 159.53 21.37 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.052 0.541 . . . . 35.11 112.238 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -49.29 -49.34 44.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.111 1.764 . . . . 74.34 113.84 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -98.77 45.87 1.0 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.182 2.593 . . . . 72.24 109.424 -167.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 167' ' ' LYS . 65.5 mm-40 -109.47 110.11 59.97 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.55 1.54 . . . . 74.03 107.926 169.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -51.71 134.69 47.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.516 2.811 . . . . 62.45 113.3 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 pt -96.33 -2.79 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 114.452 1.278 . . . . 61.1 114.452 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 49.56 70.43 0.49 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.01 1.277 . . . . 64.13 113.587 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 mm? -52.0 159.03 0.94 Allowed 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.865 -1.147 . . . . 44.25 110.925 167.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -53.87 -45.09 70.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.082 -1.081 . . . . 40.23 108.082 168.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.76 -4.53 9.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.133 1.373 . . . . 75.04 114.184 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.72 12.5 66.49 Favored Glycine 0 CA--C 1.523 0.584 0 O-C-N 120.287 -1.508 . . . . 62.31 112.237 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.409 ' H ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.92 -4.9 14.42 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.009 2.225 . . . . 73.03 117.009 -156.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.1 mm 27.39 87.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 130.802 3.641 . . . . 73.23 110.117 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.24 145.53 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.616 -1.624 . . . . 71.23 106.616 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.26 130.71 44.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 128.108 2.563 . . . . 75.02 105.044 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -48.72 -43.4 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.434 0.694 . . . . 74.21 110.318 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.37 -4.9 83.12 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.49 -1.728 . . . . 50.21 114.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -82.54 -45.37 14.75 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.761 1.78 . . . . 74.42 108.788 167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -55.49 -55.43 31.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.275 0.63 . . . . 74.53 109.653 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG22 ' HA2' ' A' ' 26' ' ' GLY . 22.8 m -65.78 -34.76 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 118.428 -0.796 . . . . 55.44 110.186 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -45.73 72.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.923 1.238 . . . . 75.11 110.893 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.07 -37.48 53.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.765 0.826 . . . . 63.12 110.011 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -83.77 -45.01 13.81 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.564 -1.207 . . . . 64.12 110.829 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -54.72 -30.23 55.51 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 121.825 2.102 . . . . 74.04 112.708 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -94.36 -11.04 30.76 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.783 1.233 . . . . 64.2 112.495 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 17.6 mttm -95.89 -63.91 1.11 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.001 -1.111 . . . . 74.21 108.001 168.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 4.8 m-30 -84.84 39.73 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.185 2.994 . . . . 71.43 108.419 -168.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -49.52 -45.66 47.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.07 2.548 . . . . 61.32 109.506 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -62.88 -35.1 78.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.967 0.907 . . . . 73.43 110.925 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 t -79.87 -7.95 59.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.823 2.049 . . . . 54.31 113.42 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.39 107.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.961 -1.126 . . . . 72.01 107.961 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -84.49 155.21 22.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.626 -1.62 . . . . 75.23 106.626 162.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -121.21 135.05 55.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.741 -1.578 . . . . 62.44 106.741 164.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.79 176.96 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 125.665 1.853 . . . . 74.42 110.679 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.58 -38.5 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.666 1.987 . . . . 72.43 111.801 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.67 52.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.681 0.793 . . . . 73.12 111.738 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.68 12.76 62.11 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.785 1.66 . . . . 44.41 112.644 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.84 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.157 1.783 . . . . 64.33 111.423 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.76 124.96 2.55 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 118.263 -1.299 . . . . 50.25 110.406 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -140.71 166.32 25.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.456 1.128 . . . . 74.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -146.07 135.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.946 2.098 . . . . 64.53 106.636 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.19 128.97 36.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.396 0.678 . . . . 44.03 110.253 167.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.86 9.54 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.043 0.937 . . . . 64.34 111.268 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.07 -16.2 59.5 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 120.785 -1.197 . . . . 54.21 114.416 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -68.81 -32.42 72.12 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.261 1.53 . . . . 72.24 111.81 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.57 -13.09 38.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.479 0.582 . . . . 71.5 112.31 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.84 19.83 10.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.205 2.202 . . . . 74.52 112.756 172.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.24 119.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.905 1.282 . . . . 63.03 108.506 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -88.79 142.52 27.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.181 0.992 . . . . 71.32 111.5 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 6.7 tt -133.64 154.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.411 1.884 . . . . 74.04 108.641 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -73.01 126.73 30.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 110.133 -0.321 . . . . 71.41 110.133 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.04 166.84 16.23 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.562 1.945 . . . . 71.12 108.198 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.56 154.61 46.88 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.933 -1.506 . . . . 73.43 106.933 179.043 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.68 141.12 46.84 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 118.632 -1.227 . . . . 60.44 108.377 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -86.14 -22.9 26.81 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.583 -0.698 . . . . 75.33 112.019 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.7 -50.04 66.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.671 1.988 . . . . 73.15 110.64 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.0 m -141.27 9.6 2.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.567 1.947 . . . . 71.43 110.794 -162.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.05 52.17 15.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.207 2.203 . . . . 71.41 111.12 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.06 -175.62 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.352 0 O-C-N 124.185 0.928 . . . . 73.43 109.688 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mm -116.86 125.42 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 127.528 2.331 . . . . 72.43 104.883 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -142.85 169.27 17.89 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.869 1.268 . . . . 72.3 108.776 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -110.0 143.58 39.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.625 1.57 . . . . 74.44 110.011 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -150.92 168.08 25.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.657 1.983 . . . . 72.42 107.252 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -93.49 172.23 8.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.12 0.968 . . . . 70.15 110.38 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.04 144.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 105.507 -2.034 . . . . 62.43 105.507 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.8 -34.41 6.46 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.538 0.524 . . . . 64.41 111.217 -172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -144.44 137.75 27.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.97 1.259 . . . . 73.35 108.77 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.96 167.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 124.403 1.064 . . . . 61.23 109.714 168.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -138.13 159.96 40.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.321 1.048 . . . . 73.32 109.685 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 8.3 tmm_? -153.57 140.68 19.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.441 1.496 . . . . 64.44 108.881 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -146.1 161.38 40.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.846 -1.168 . . . . 62.55 107.846 165.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -92.02 146.47 23.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.073 -1.084 . . . . 54.41 108.073 168.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 86' ' ' LEU . 33.9 t80 -152.33 145.68 24.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.775 0.83 . . . . 70.43 110.007 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -142.33 114.8 8.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.854 1.662 . . . . 63.34 109.281 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.06 40.78 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.441 1.019 . . . . 71.42 111.528 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.58 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.05 142.55 36.43 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 122.122 -0.634 . . . . 75.02 110.353 -174.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 98' ' ' THR . 10.8 mp -127.69 160.38 31.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.81 1.644 . . . . 73.32 108.375 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 89' ' ' ILE . 21.5 mm -80.08 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.035 2.134 . . . . 61.23 108.229 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -128.78 75.23 1.63 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 159.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.493 ' H ' HG22 ' A' ' 87' ' ' ILE . 23.3 mt -62.85 139.33 21.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.943 -2.243 . . . . 60.21 104.943 158.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -114.33 172.0 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.699 -1.593 . . . . 40.13 106.699 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 p -136.91 175.81 9.28 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.919 -1.113 . . . . 72.45 110.566 162.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -62.51 -25.69 68.15 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.619 -0.676 . . . . 74.53 111.669 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.95 7.79 2.96 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.877 1.271 . . . . 62.12 112.969 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.56 20.58 7.74 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.216 1.407 . . . . 75.02 110.818 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -71.38 161.92 30.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.661 1.185 . . . . 63.25 108.058 166.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -176.17 171.0 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.003 0.921 . . . . 61.03 108.902 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.598 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.3 pt -145.82 170.92 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.722 1.609 . . . . 73.12 110.65 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 86' ' ' LEU . 2.3 m -148.09 95.23 2.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.278 1.431 . . . . 62.44 109.428 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.94 177.82 10.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.938 1.695 . . . . 70.04 110.498 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 6' ' ' ASP . 6.6 p -66.62 164.02 17.65 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.569 1.148 . . . . 64.31 110.638 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.265 1.1 p-80 -68.51 -24.31 64.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.513 0.931 . . . . 62.12 113.513 173.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.93 36.49 2.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.229 1.377 . . . . 64.54 111.336 -168.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -88.17 137.52 31.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.922 -1.037 . . . . 51.41 110.156 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.69 125.42 13.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.208 2.606 . . . . 73.22 111.194 172.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.87 -173.79 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.569 1.947 . . . . 74.52 108.361 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -129.02 140.35 51.67 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.882 0.764 . . . . 71.32 111.146 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.26 172.45 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.961 1.305 . . . . 71.44 108.1 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 p -87.55 144.76 26.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.934 0.873 . . . . 63.44 112.2 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -118.21 80.37 1.51 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.617 -1.623 . . . . 71.1 106.617 158.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 m 62.51 8.58 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.34 1.456 . . . . 71.43 114.339 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.63 -20.3 3.3 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 120.839 -1.163 . . . . 71.44 111.314 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.17 136.73 37.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.23 -2.137 . . . . 63.5 105.23 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.12 117.76 18.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.219 -1.771 . . . . 72.0 106.219 164.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.63 138.99 53.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.508 1.523 . . . . 74.11 108.969 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.14 122.64 39.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.212 1.405 . . . . 72.51 109.314 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.9 pt -142.66 -178.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.76 1.224 . . . . 63.23 110.944 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.61 145.61 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.196 1.398 . . . . 62.54 110.704 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.87 45.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.801 1.64 . . . . 74.41 112.868 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -28.08 68.89 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.706 -1.246 . . . . 64.22 112.002 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -32.02 39.52 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.375 0.67 . . . . 52.44 112.323 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.296 7.9 p -76.92 63.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.507 1.123 . . . . 65.54 111.414 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -79.39 -175.34 4.66 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.698 1.199 . . . . 75.42 108.522 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.53 -0.61 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.564 1.546 . . . . 73.23 112.991 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.45 -1.13 75.21 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.506 -1.163 . . . . 55.53 112.229 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.09 175.91 8.04 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.732 1.766 . . . . 73.02 110.596 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.93 104.52 7.85 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.755 -1.942 . . . . 73.01 105.755 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.36 129.7 37.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.262 -1.755 . . . . 75.25 106.262 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -69.72 127.8 34.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.228 -1.397 . . . . 64.24 107.228 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 129' ' ' ILE . 1.8 pp -124.99 159.95 56.64 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.332 1.053 . . . . 72.22 112.81 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.89 145.1 49.72 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.219 1.946 . . . . 63.13 109.393 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.91 -167.8 1.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.498 -1.667 . . . . 45.53 106.498 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -24.07 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 128.595 2.758 . . . . 54.05 111.639 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -122.27 0.05 9.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.632 2.086 . . . . 54.11 116.632 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.5 p -138.07 169.23 18.15 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.2 0.6 . . . . 74.34 111.482 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.88 150.75 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.956 -1.09 . . . . 73.53 109.553 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -142.59 -176.64 4.94 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.293 1.837 . . . . 71.44 109.289 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.23 161.17 15.49 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.766 1.227 . . . . 72.13 111.915 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -158.02 136.0 10.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.254 1.822 . . . . 72.22 107.819 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.52 153.64 43.2 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.046 0.938 . . . . 61.42 110.341 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -93.25 -2.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 64.52 112.955 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pt 25.49 -91.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 128.023 2.529 . . . . 60.24 116.149 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -88.06 122.73 31.99 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.355 1.462 . . . . 62.44 107.46 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.97 102.83 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.709 -1.219 . . . . 74.1 107.709 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -131.57 -173.9 3.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 60.31 108.003 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 p -125.21 168.31 13.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.043 0.937 . . . . 53.23 110.013 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.37 174.07 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.276 2.231 . . . . 73.01 106.476 168.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -123.21 105.77 10.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.018 -1.475 . . . . 64.44 107.018 165.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -100.5 136.96 39.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.871 1.268 . . . . 64.15 110.096 -168.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.52 51.51 1.92 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.258 0.623 . . . . 74.42 109.994 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.09 -113.96 1.6 Allowed Glycine 0 N--CA 1.463 0.484 0 O-C-N 121.091 -1.006 . . . . 64.55 111.568 -167.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -139.7 157.51 45.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.428 1.891 . . . . 73.44 107.491 170.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.1 pt -124.55 153.97 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.281 1.432 . . . . 72.13 109.396 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.599 ' CD2' HG21 ' A' ' 29' ' ' VAL . 7.3 m-85 -148.72 165.88 30.08 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.819 1.648 . . . . 73.33 107.533 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -167.41 167.73 13.61 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.983 -0.747 . . . . 74.35 108.983 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.26 115.41 16.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.436 2.295 . . . . 74.42 108.501 -163.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.4 m -74.35 119.46 18.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.914 -1.513 . . . . 71.13 106.914 159.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.1 73.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.753 -2.314 . . . . 52.03 104.753 171.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.96 -3.08 3.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.221 1.408 . . . . 73.33 113.642 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -103.06 -42.11 5.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.686 2.394 . . . . 71.05 108.264 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 162' ' ' THR . 1.9 t30 -146.73 79.98 1.53 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.981 -2.229 . . . . 72.41 104.981 -168.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.25 13.94 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.701 2.401 . . . . 71.23 112.958 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.457 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 13.1 p -132.65 124.1 27.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.456 2.702 . . . . 74.3 106.602 -172.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.517 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.2 172.94 13.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.851 0.461 . . . . 74.24 112.186 -164.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 mm -108.0 121.49 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 106.925 -1.509 . . . . 60.13 106.925 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -146.98 152.68 39.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.58 -0.526 . . . . 70.22 109.58 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.82 -160.73 25.76 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.045 -1.222 . . . . 60.43 110.045 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.474 ' HE3' ' OE2' ' A' ' 13' ' ' GLU . 67.8 mttt -109.31 171.53 7.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.125 0.962 . . . . 63.03 110.946 172.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.01 -73.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.64 2.776 . . . . 75.22 112.301 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -121.49 -11.05 8.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.417 1.887 . . . . 74.34 113.587 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.67 7.99 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 122.522 1.068 . . . . 54.13 111.868 -167.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.598 ' CE1' HG23 ' A' ' 97' ' ' ILE . 35.6 m-85 -108.61 156.61 19.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.771 2.429 . . . . 71.4 105.753 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -100.48 113.62 26.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.394 -1.335 . . . . 63.04 107.394 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.9 m -144.13 -177.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.632 1.173 . . . . 74.44 109.662 -163.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.08 126.85 31.59 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.302 -0.874 . . . . 73.53 110.685 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -107.23 48.36 0.84 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.727 1.611 . . . . 42.41 107.403 156.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.27 157.76 28.14 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.674 -1.232 . . . . 72.1 107.674 171.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.5 m -57.92 152.18 16.69 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.157 0.503 . . . . 63.43 110.238 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -70.03 -52.68 17.62 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.544 -1.422 . . . . 73.42 109.544 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 62.8 p -89.87 145.84 24.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.647 -0.872 . . . . 63.43 108.647 169.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.8 tp -33.48 -71.35 0.06 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 128.642 2.777 . . . . 72.53 114.317 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.8 m80 59.89 169.71 0.08 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.216 1.406 . . . . 70.34 113.143 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 46.42 75.41 0.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.819 2.048 . . . . 74.33 113.213 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 84.42 94.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 1 C-N-CA 131.964 4.106 . . . . 73.2 109.956 -168.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -61.13 154.03 24.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.102 -0.954 . . . . 64.35 109.857 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.59 175.41 1.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.114 1.766 . . . . 74.32 113.025 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 124.593 1.157 . . . . 71.34 109.267 -178.602 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 117.207 -1.378 . . . . 75.54 111.4 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p30 49.02 -161.03 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.274 1.429 . . . . 51.14 112.95 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.8 m -141.86 -47.42 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.954 1.302 . . . . 75.05 109.625 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.91 129.97 1.07 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 119.668 1.122 . . . . 42.34 110.632 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 m170 -81.85 -22.49 36.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.475 1.11 . . . . 72.11 111.828 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.68 -144.88 0.32 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.334 1.054 . . . . 72.44 110.271 -175.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.87 179.65 41.66 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 120.874 1.67 . . . . 22.41 114.658 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . -174.15 -177.21 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.283 2.633 . . . . 72.14 108.594 177.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 165' ' ' ALA . 6.0 tp -98.44 -13.76 20.41 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 115.894 1.812 . . . . 74.31 115.894 -171.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . 96.63 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 1 C-N-CA 132.777 4.431 . . . . 60.52 111.644 -166.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.39 -39.83 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.651 2.78 . . . . 65.13 109.545 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.96 26.83 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.118 2.167 . . . . 43.33 110.026 -170.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.24 111.8 36.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 127.146 2.178 . . . . 73.53 108.777 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 106.31 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.443 2.762 . . . . 61.54 108.651 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.45 167.87 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.582 1.083 . . . . 65.25 110.142 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -128.21 64.48 1.4 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.477 1.111 . . . . 73.32 111.61 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -45.63 150.71 0.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 120.425 -1.422 . . . . 74.25 112.624 161.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -15.0 53.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.768 1.292 . . . . 51.15 112.98 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.44 -18.28 22.51 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.181 0.9 . . . . 72.21 112.62 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.87 38.32 8.75 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.125 1.345 . . . . 64.34 111.043 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.94 -18.62 64.42 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.614 1.207 . . . . 64.1 113.301 -170.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mm 47.85 87.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 128.488 2.715 . . . . 65.34 109.863 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 150.31 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 52.14 106.996 -170.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -61.08 130.26 45.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.729 -1.211 . . . . 65.32 107.729 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -53.73 -39.34 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.301 0.501 . . . . 62.12 110.018 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 10.27 63.95 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.833 -0.982 . . . . 74.11 114.26 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -55.45 3.75 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.785 1.793 . . . . 63.24 108.689 153.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -48.56 -52.58 22.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.733 1.613 . . . . 74.31 109.435 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 77' ' ' VAL . 49.1 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.709 -0.678 . . . . 74.22 110.916 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -30.46 70.9 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 120.914 -1.116 . . . . 71.44 110.871 -173.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -52.37 -49.7 63.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.294 0.952 . . . . 75.44 109.17 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -66.09 -43.55 86.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.04 -1.096 . . . . 63.22 108.04 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.54 -35.47 72.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.132 1.333 . . . . 74.45 112.388 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -83.22 -15.26 51.09 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.935 1.294 . . . . 73.55 111.704 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -97.98 -59.19 1.81 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.341 -1.355 . . . . 72.53 107.341 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -91.47 44.01 1.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.354 2.661 . . . . 74.14 107.808 -173.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -48.33 -45.12 34.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 125.738 1.615 . . . . 75.15 109.537 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -19.8 61.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.713 -0.66 . . . . 74.24 112.469 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 m -85.82 0.26 53.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.819 1.248 . . . . 61.34 112.45 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.68 94.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.15 1.341 . . . . 75.11 108.212 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -79.59 169.69 17.64 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.912 -1.144 . . . . 63.12 107.912 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.72 154.98 48.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.85 -1.537 . . . . 71.33 106.85 163.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -81.87 171.82 14.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.312 1.007 . . . . 62.35 110.437 159.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -45.45 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.28 2.632 . . . . 63.23 110.995 175.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -64.03 -10.06 19.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.275 1.43 . . . . 62.3 112.28 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.01 7.59 57.34 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 127.383 2.421 . . . . 52.25 112.696 163.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.39 -82.06 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.452 1.901 . . . . 75.54 110.625 -163.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.96 129.48 2.72 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.897 -1.681 . . . . 64.22 108.897 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -142.59 161.89 36.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.076 0.938 . . . . 74.41 111.263 167.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.0 145.98 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.167 -2.161 . . . . 63.44 105.167 164.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.45 123.28 29.54 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.027 0.931 . . . . 75.0 108.89 165.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.89 8.5 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.652 0.381 . . . . 43.4 111.35 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.28 -18.91 61.29 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 120.789 -1.194 . . . . 70.34 113.654 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.4 -13.52 60.73 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.872 1.669 . . . . 75.05 112.49 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -61.87 -22.14 65.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.531 0.732 . . . . 63.55 110.312 163.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 63.3 -10.55 0.11 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 128.057 2.543 . . . . 64.3 114.185 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.4 mt -43.71 113.98 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.8 2.44 . . . . 71.1 109.544 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -77.02 144.01 38.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.006 -0.543 . . . . 74.53 110.041 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.6 tt -112.02 156.65 13.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.041 1.736 . . . . 73.52 107.859 163.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -66.88 93.35 0.26 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.449 -1.315 . . . . 73.43 107.449 164.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -71.39 173.8 7.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.805 -1.554 . . . . 74.4 106.805 165.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.554 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -140.39 151.59 45.07 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.656 -1.903 . . . . 73.24 106.817 166.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.516 HD22 HD11 ' A' ' 68' ' ' ILE . 17.2 t30 -101.22 114.22 27.99 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.822 1.249 . . . . 72.41 108.212 -176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -70.4 -29.47 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.34 1.856 . . . . 75.34 112.024 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -48.19 73.79 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.065 1.346 . . . . 64.54 110.74 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 t -125.39 8.06 7.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.539 0.736 . . . . 72.43 111.63 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt 66.41 51.73 1.15 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.606 1.562 . . . . 62.42 110.961 170.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 63' ' ' ASN . 11.0 pt -123.97 154.35 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.242 0.617 . . . . 61.45 110.137 -171.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.92 131.93 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.421 1.488 . . . . 64.33 107.04 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.36 178.04 7.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.344 1.458 . . . . 60.21 108.961 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -139.08 122.37 17.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.805 -1.184 . . . . 74.44 108.387 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -138.58 147.02 42.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.858 0.863 . . . . 74.43 108.801 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -77.33 147.33 36.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.144 0.578 . . . . 73.05 110.898 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -71.69 164.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.072 -1.085 . . . . 74.03 108.072 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -117.7 -50.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.902 1.281 . . . . 75.05 110.078 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.593 ' CB ' HG21 ' A' ' 156' ' ' THR 0.343 3.1 ttm180 -116.98 -176.69 3.03 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 119.061 0.846 . . . . 74.11 111.779 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -149.71 145.98 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 107.924 -1.139 . . . . 45.03 107.924 170.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -118.4 156.11 29.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.42 1.088 . . . . 74.45 109.717 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.01 136.13 11.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.567 0.747 . . . . 72.05 108.986 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -145.02 160.96 40.54 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.896 -1.52 . . . . 70.24 106.896 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 148.59 22.74 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.903 -1.123 . . . . 72.52 108.407 173.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -143.9 154.07 42.96 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.955 1.302 . . . . 71.12 110.093 -163.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -153.9 154.73 34.4 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.047 -0.723 . . . . 72.11 109.047 154.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.38 -170.14 21.03 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.347 1.451 . . . . 73.42 110.672 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -86.53 125.43 33.76 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.674 1.19 . . . . 55.41 110.523 -171.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.11 165.85 10.93 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.94 -1.504 . . . . 71.21 106.94 171.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.8 mm -81.43 149.49 4.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.396 1.478 . . . . 72.01 108.146 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -127.45 79.9 1.92 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.722 2.009 . . . . 70.32 107.7 165.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.577 HG23 HG13 ' A' ' 140' ' ' VAL . 38.9 mt -61.81 130.98 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.623 -1.992 . . . . 73.13 105.623 150.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -114.5 162.94 16.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.28 -1.748 . . . . 75.55 106.28 157.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 p -135.61 169.96 16.71 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.591 -0.892 . . . . 65.34 108.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -38.38 55.57 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.678 -1.264 . . . . 63.3 111.877 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -0.98 7.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.493 1.517 . . . . 75.23 111.747 -172.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.6 mmt-85 61.49 24.33 14.45 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 126.936 2.094 . . . . 73.45 110.258 -167.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' CD ' ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -73.87 168.18 19.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.961 -1.126 . . . . 64.11 107.961 160.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 177.55 162.42 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.27 2.628 . . . . 64.54 107.812 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.671 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -147.18 177.26 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.945 2.098 . . . . 75.53 109.338 -174.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -145.67 74.94 1.41 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.177 0.513 . . . . 73.31 111.489 -167.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.436 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -141.56 163.57 32.58 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 119.522 -1.986 . . . . 75.14 112.271 -165.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 p -68.85 161.28 28.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.516 0.726 . . . . 72.13 110.696 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.09 14.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.422 0.897 . . . . 73.01 113.422 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.18 39.16 3.58 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.153 1.797 . . . . 75.51 110.8 159.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.436 ' CG ' HD22 ' A' ' 99' ' ' LEU . 3.4 t60 -84.99 125.88 69.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.674 -1.155 . . . . 74.22 109.451 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -63.6 114.77 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.21 3.274 . . . . 63.23 111.231 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.58 162.62 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.819 -1.178 . . . . 64.41 107.819 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -101.39 140.68 35.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.841 0.856 . . . . 71.23 109.151 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.49 164.07 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.996 0.918 . . . . 75.31 109.882 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.03 120.64 31.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.846 -1.168 . . . . 64.11 107.846 173.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' CD ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -99.38 81.27 2.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.862 -2.273 . . . . 72.22 104.862 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 m 56.45 17.61 3.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.206 1.002 . . . . 71.42 113.52 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.18 1.27 47.99 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.064 -1.022 . . . . 60.51 114.062 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.89 160.3 26.08 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 105.763 -1.94 . . . . 61.22 105.763 150.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.46 145.1 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.822 -0.807 . . . . 72.31 108.822 170.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD22 ' CD ' ' A' ' 109' ' ' LYS . 4.7 tp -142.06 170.9 14.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.986 1.315 . . . . 70.53 107.701 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -112.83 138.26 49.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.794 0.838 . . . . 72.44 108.844 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 pt -142.52 179.28 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.169 1.388 . . . . 71.34 108.81 171.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -72.04 132.06 43.74 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 107.597 -1.261 . . . . 53.34 107.597 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -43.23 -35.11 1.32 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.861 1.665 . . . . 64.42 113.163 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.4 67.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.817 1.247 . . . . 74.42 112.516 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.0 -31.91 56.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.033 -1.042 . . . . 71.33 111.266 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG11 ' A' ' 140' ' ' VAL . 7.4 t -76.57 62.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.124 1.769 . . . . 74.21 110.345 -173.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -86.72 -177.09 6.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.603 1.561 . . . . 61.01 108.534 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.82 0.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.859 2.064 . . . . 64.54 113.704 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.63 -13.43 80.04 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.366 -1.797 . . . . 61.52 112.479 167.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -124.3 170.15 11.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.839 1.819 . . . . 73.31 110.031 -166.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 139' ' ' GLU . 7.6 m-85 -112.86 155.62 24.34 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.391 1.476 . . . . 75.42 108.396 165.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.73 166.83 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.624 2.369 . . . . 74.03 107.589 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 112.26 22.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.85 1.26 . . . . 74.23 110.958 -166.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.48 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.6 pp -121.54 161.43 41.56 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 124.737 1.215 . . . . 75.0 113.191 -174.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.01 154.84 33.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.887 1.725 . . . . 70.0 109.732 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -117.91 -156.69 0.65 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.1 -1.444 . . . . 72.44 107.1 162.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -59.32 -57.75 11.63 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 122.986 0.514 . . . . 72.44 111.391 -166.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -121.52 0.48 9.95 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.522 0.934 . . . . 74.13 113.522 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -139.35 -173.96 3.74 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.504 1.522 . . . . 42.12 111.027 -160.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.4 149.38 15.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.51 1.124 . . . . 74.25 109.529 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -143.28 -178.32 5.8 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.996 2.118 . . . . 72.33 108.533 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 mt -118.39 165.81 13.42 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.277 1.031 . . . . 72.4 109.386 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 33.9 p-10 -153.96 147.87 25.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.89 1.276 . . . . 63.41 111.116 173.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 32.5 tt0 -97.38 148.36 23.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.345 1.858 . . . . 65.42 111.166 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.608 HG11 ' O ' ' A' ' 121' ' ' VAL . 18.4 t -87.19 2.17 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.725 0.639 . . . . 74.41 112.725 -160.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 pt 24.68 -88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 127.522 2.329 . . . . 73.11 116.112 171.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 124.55 35.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.493 1.517 . . . . 54.32 108.088 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -129.14 122.5 56.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.43 -0.581 . . . . 71.21 109.43 170.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.88 -167.96 2.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 127.351 2.26 . . . . 61.21 107.436 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -122.45 172.17 8.55 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.555 1.142 . . . . 74.12 109.76 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.36 161.81 22.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 130.565 3.546 . . . . 64.41 104.559 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.59 133.5 51.03 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.792 -1.558 . . . . 61.15 106.792 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -144.18 155.55 43.95 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.815 0.734 . . . . 72.53 111.587 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.39 47.21 0.75 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.535 0.607 . . . . 72.45 111.884 -169.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.44 -122.7 2.29 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.585 -0.697 . . . . 63.34 114.342 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -124.34 160.57 27.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.127 0.971 . . . . 74.11 109.491 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ALA . 11.6 pt -135.04 155.55 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.578 1.951 . . . . 74.34 108.239 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -138.87 168.52 19.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.522 1.929 . . . . 72.35 107.226 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -164.62 167.34 19.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.741 1.155 . . . . 75.24 109.921 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.3 tp -137.7 113.62 9.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.275 1.583 . . . . 75.1 115.275 -149.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.593 HG21 ' CB ' ' A' ' 76' ' ' ARG . 69.1 p -55.88 -50.85 69.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.427 1.491 . . . . 71.2 114.016 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.3 t 24.55 68.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 129.5 3.12 . . . . 64.13 112.012 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.3 -5.69 58.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.106 -1.406 . . . . 63.13 111.928 -168.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -47.08 74.29 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.52 2.328 . . . . 72.22 110.91 -175.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -125.83 1.34 7.4 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.863 0.69 . . . . 73.33 112.863 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.482 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 6.9 m170 55.83 30.39 15.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.022 0.929 . . . . 75.22 111.81 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 p -151.49 154.9 37.46 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.065 1.302 . . . . 75.4 110.372 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 18.3 p90 -153.23 174.95 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.595 1.089 . . . . 72.02 111.542 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 mm -99.29 124.23 52.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 63.5 108.916 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -156.4 157.69 36.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.561 1.545 . . . . 54.53 108.742 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.37 -170.35 23.91 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.912 2.672 . . . . 74.42 107.953 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -89.71 167.28 13.02 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.639 -1.506 . . . . 61.35 111.346 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.19 -74.53 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.652 2.381 . . . . 73.11 114.132 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.77 -10.02 8.78 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.531 1.932 . . . . 52.03 112.541 171.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.82 165.85 29.57 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 122.673 1.152 . . . . 51.25 112.382 -168.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.671 ' CE1' HG23 ' A' ' 97' ' ' ILE . 14.7 m-85 -105.07 158.05 16.83 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.519 2.728 . . . . 73.0 105.943 172.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -87.78 108.62 19.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.186 -2.153 . . . . 74.31 105.186 169.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' A' ' 163' ' ' TYR . 16.3 m -120.75 178.5 2.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.427 1.091 . . . . 53.04 108.708 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -80.68 153.2 28.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.389 1.475 . . . . 43.34 110.277 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -137.41 -158.35 0.85 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.439 1.896 . . . . 73.5 107.737 167.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 78.7 p 95.04 138.93 0.02 OUTLIER 'General case' 0 C--O 1.237 0.417 1 C-N-CA 132.625 4.37 . . . . 54.22 104.758 -165.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.8 m -65.84 -11.06 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.453 0.908 . . . . 71.2 113.453 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.91 -122.49 28.88 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 108.403 -1.879 . . . . 62.54 108.403 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 76.4 p 45.73 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.47 1.908 . . . . 73.33 111.508 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 67.79 -74.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 74.34 111.581 -172.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 123.04 25.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.574 -1.269 . . . . 71.42 107.574 -171.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 127.44 8.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.03 -1.044 . . . . 73.11 109.943 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.268 27.7 p-80 42.84 -152.65 0.02 OUTLIER 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.136 1.774 . . . . 73.13 111.855 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -107.98 -63.58 1.3 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.433 -0.951 . . . . 71.51 108.433 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.98 133.3 9.82 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.326 -0.62 . . . . 71.34 109.326 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 . . . . . 0 C--O 1.244 0.786 0 C-N-CA 126.153 1.781 . . . . 71.41 109.362 171.681 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.464 0 N-CA-C 107.098 -1.445 . . . . 70.35 107.098 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -149.93 134.96 17.9 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.279 -1.378 . . . . 64.54 107.279 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.1 m -65.25 -62.77 1.34 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.583 0.753 . . . . 64.33 109.202 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.96 -72.58 0.07 OUTLIER Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.741 -1.343 . . . . 54.01 109.741 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 m170 70.29 97.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.163 2.185 . . . . 64.31 108.186 -164.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.37 131.89 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.369 -0.832 . . . . 75.31 109.423 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.02 147.96 18.55 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 124.025 0.821 . . . . 53.5 111.07 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' CB ' HD12 ' A' ' 152' ' ' ILE . . . -151.06 172.68 15.36 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.925 1.69 . . . . 64.2 108.257 166.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.461 ' HG ' ' HG2' ' A' ' 13' ' ' GLU . 15.0 tp -102.09 -16.67 16.34 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.599 1.333 . . . . 74.41 114.599 -150.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.72 160.57 0.15 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 130.799 3.639 . . . . 73.21 112.319 -161.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 8.9 t80 -80.59 -49.0 11.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.667 1.587 . . . . 65.23 111.076 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -93.97 70.57 3.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.364 -2.088 . . . . 71.1 105.364 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -139.58 116.93 8.5 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 104.747 -2.316 . . . . 74.51 104.747 -169.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.89 124.36 13.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.33 2.687 . . . . 35.34 111.774 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 59' ' ' ILE . 10.4 pt -97.0 10.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.382 0.882 . . . . 63.15 113.382 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.8 m-85 38.66 72.73 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.471 1.508 . . . . 74.34 112.612 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 157.57 0.43 Allowed 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.173 -1.047 . . . . 73.51 108.173 167.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -17.6 48.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.103 0.779 . . . . 72.42 113.103 -169.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.29 -52.93 4.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.557 1.143 . . . . 74.11 109.953 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.87 55.46 0.1 OUTLIER Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.025 1.298 . . . . 65.41 113.496 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -22.7 66.33 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.665 1.732 . . . . 71.42 115.373 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 16' ' ' TYR 0.292 47.8 mm 38.68 46.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 130.121 3.368 . . . . 62.3 112.409 -171.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.33 154.41 3.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.912 1.285 . . . . 74.24 108.013 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.06 124.69 23.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.409 1.084 . . . . 62.05 108.471 168.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -39.24 14.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 123.218 0.607 . . . . 65.52 111.081 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -53.53 -50.94 51.21 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.747 -0.941 . . . . 24.13 110.747 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.61 -38.88 77.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.263 1.025 . . . . 72.0 111.952 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -57.29 -56.13 25.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.012 0.925 . . . . 75.44 109.401 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 77' ' ' VAL . 71.7 t -64.74 -38.51 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.475 -0.784 . . . . 72.43 109.522 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -36.91 84.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.148 1.34 . . . . 34.05 110.514 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -40.79 60.63 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.554 1.141 . . . . 74.32 110.281 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.2 -43.99 26.98 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 124.687 1.195 . . . . 64.1 109.309 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.2 m-85 -60.0 -22.23 62.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.871 2.123 . . . . 70.42 113.063 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -100.0 -10.37 21.68 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.547 1.539 . . . . 75.11 112.058 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -65.36 1.02 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.962 -1.866 . . . . 75.02 105.962 163.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -82.83 41.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.686 3.194 . . . . 71.33 110.074 -167.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.33 -30.23 68.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.387 1.875 . . . . 64.41 110.2 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -69.64 -21.13 63.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.159 1.784 . . . . 70.11 112.534 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.28 6.32 48.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.652 1.581 . . . . 70.45 112.271 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.69 84.18 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.652 1.215 . . . . 64.54 109.645 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.48 120.6 24.68 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.243 -1.762 . . . . 64.2 106.243 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -88.62 157.55 18.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.76 -1.941 . . . . 75.33 105.76 155.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.03 178.47 8.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.232 -1.396 . . . . 60.45 107.232 164.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.22 -36.88 83.33 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.656 1.182 . . . . 62.41 110.527 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -14.07 33.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.149 1.38 . . . . 74.32 112.586 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.16 33.41 26.32 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.143 2.306 . . . . 53.03 111.067 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD1' ' HE3' ' A' ' 80' ' ' LYS . 3.4 t80 -79.95 -90.97 0.05 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.036 1.334 . . . . 71.45 108.46 -171.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.19 128.16 2.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.087 -2.005 . . . . 60.02 108.087 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -139.99 168.51 19.64 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.719 1.208 . . . . 74.32 109.026 166.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 33' ' ' PHE . 14.2 mt -149.22 143.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.543 2.337 . . . . 62.43 105.51 168.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.38 130.48 37.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.369 1.468 . . . . 52.34 108.295 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.39 -2.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.907 0.883 . . . . 72.04 112.596 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.88 -20.38 52.9 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.535 1.061 . . . . 63.13 115.37 -169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -63.15 -20.52 65.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 128.111 2.564 . . . . 75.41 114.045 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.16 -20.16 62.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.662 0.785 . . . . 72.13 111.357 172.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.14 3.29 1.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.001 2.121 . . . . 72.45 113.685 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.05 138.42 15.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.381 1.472 . . . . 64.23 108.794 172.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.84 167.52 10.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.463 1.125 . . . . 75.01 110.635 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 74' ' ' ILE . 3.5 tt -135.38 160.28 40.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 125.714 1.606 . . . . 71.51 108.041 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -81.77 132.88 35.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.312 -1.736 . . . . 75.11 106.312 168.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.37 -174.08 3.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.963 -0.754 . . . . 71.32 108.963 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -138.1 139.54 39.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.401 -1.703 . . . . 73.0 106.401 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.52 107.71 19.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.529 -1.286 . . . . 71.43 107.529 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 ttpm? -56.49 -23.71 41.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.869 1.268 . . . . 73.13 111.607 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -23.06 5.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.473 1.909 . . . . 75.44 112.772 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -149.6 14.27 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.325 1.05 . . . . 60.32 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 37.7 53.82 1.48 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.217 1.807 . . . . 51.31 111.838 -163.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.2 pt -105.98 155.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.707 0.803 . . . . 62.5 109.366 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.7 mm -85.04 130.72 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.829 -1.545 . . . . 62.2 106.829 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.33 166.97 23.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.219 1.007 . . . . 74.45 112.238 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.89 113.0 25.24 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.732 2.013 . . . . 71.15 107.7 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -125.0 167.21 15.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.959 0.903 . . . . 74.24 109.824 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -106.22 177.36 4.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.4 0.68 . . . . 71.01 110.228 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 59' ' ' ILE . 64.4 mt -113.49 153.55 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 105.423 -2.066 . . . . 65.13 105.423 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.34 -58.52 1.7 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.799 1.239 . . . . 74.23 108.435 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.492 ' CB ' HG21 ' A' ' 156' ' ' THR 0.25 14.7 mtm180 -128.1 159.34 35.4 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.227 1.411 . . . . 71.51 112.756 -174.086 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 29' ' ' VAL . 3.2 m -133.97 165.66 31.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.385 1.474 . . . . 71.43 108.149 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.593 ' HE1' ' CG2' ' A' ' 156' ' ' THR . 68.4 m95 -139.07 163.73 31.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.926 0.49 . . . . 74.42 111.283 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.04 135.87 31.48 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.083 0.953 . . . . 64.11 110.592 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tppp? -142.95 141.45 31.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.031 -1.84 . . . . 70.12 106.031 162.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -86.51 152.38 22.7 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.689 0.795 . . . . 70.11 109.961 -163.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 110.21 3.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.913 -0.773 . . . . 63.25 108.913 169.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.95 46.35 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.394 0.543 . . . . 70.03 111.849 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.635 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.75 121.87 25.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.787 -0.82 . . . . 53.21 108.787 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.18 172.58 7.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.151 -1.796 . . . . 75.01 106.151 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 89' ' ' ILE . 9.2 mm -79.15 160.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.418 1.887 . . . . 63.43 107.912 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -137.27 79.64 1.76 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.1 -1.444 . . . . 71.3 107.1 157.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG23 HG13 ' A' ' 140' ' ' VAL . 48.4 mt -67.12 135.5 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 104.456 -2.424 . . . . 62.44 104.456 158.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -118.22 175.36 5.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.244 1.418 . . . . 73.15 107.311 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -142.33 176.84 8.68 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.919 1.236 . . . . 71.24 112.654 164.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -53.66 -35.17 60.74 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.307 1.043 . . . . 74.12 111.854 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.85 11.0 1.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.785 2.034 . . . . 73.34 111.677 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 47.37 33.54 2.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.153 1.781 . . . . 71.15 111.394 -166.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -83.48 168.35 16.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.818 -1.178 . . . . 65.21 107.818 165.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 179.24 163.55 0.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.5 1.92 . . . . 75.12 107.666 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.592 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -139.65 172.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.844 2.057 . . . . 63.53 110.201 -174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -137.81 99.67 3.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.34 1.856 . . . . 72.1 107.118 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.88 167.5 28.12 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.756 -0.59 . . . . 72.11 110.347 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 p -75.84 162.38 28.19 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.317 -0.864 . . . . 54.42 110.697 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.74 38.74 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.678 0.791 . . . . 73.25 112.736 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -157.47 37.04 0.28 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.963 0.801 . . . . 73.31 110.065 149.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -75.15 137.02 72.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 119.721 -1.862 . . . . 71.3 110.453 -174.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.35 121.92 9.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.229 2.619 . . . . 63.13 111.483 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.7 -177.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.914 1.286 . . . . 65.44 109.064 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -128.32 137.06 51.77 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.174 0.99 . . . . 73.4 108.894 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 127' ' ' ILE . 1.9 pt -141.82 167.6 15.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.511 1.124 . . . . 60.54 108.564 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 143.16 34.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.499 0.666 . . . . 62.0 111.797 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -115.14 53.99 0.8 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.384 1.074 . . . . 72.22 108.748 163.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER 96.36 -0.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 130.856 3.662 . . . . 75.53 114.328 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.75 -11.41 3.69 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.714 -0.955 . . . . 63.12 110.714 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -86.37 161.32 18.75 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 125.419 1.488 . . . . 72.35 112.713 161.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.43 HG22 ' CE2' ' A' ' 128' ' ' TYR . 62.5 t -106.49 106.64 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.036 1.334 . . . . 71.43 108.962 -166.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.59 158.58 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.214 1.006 . . . . 71.53 108.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -114.44 121.05 42.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.615 1.966 . . . . 72.23 107.037 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 pt -140.71 178.32 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.293 1.037 . . . . 73.24 109.826 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -77.37 140.39 39.93 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.087 1.755 . . . . 71.21 109.867 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.38 -29.81 61.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.198 1.399 . . . . 73.11 112.384 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -31.49 72.19 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.93 -0.481 . . . . 73.11 111.154 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -25.87 42.46 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.507 1.123 . . . . 75.44 111.316 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -72.75 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.3 2.24 . . . . 74.51 111.416 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.51 -178.35 5.78 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.933 -1.104 . . . . 61.24 108.962 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.18 -2.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 129.565 3.146 . . . . 72.44 114.569 166.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.88 -15.92 57.13 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.285 -1.509 . . . . 60.13 111.734 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.35 140.69 51.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.473 1.636 . . . . 73.13 107.954 -160.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.71 117.68 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.643 1.177 . . . . 65.23 107.944 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 107' ' ' ILE . 5.8 tt -82.88 142.99 12.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.044 -0.725 . . . . 74.32 109.044 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 113' ' ' VAL . 3.2 m-85 -74.21 121.43 21.22 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.51 -0.922 . . . . 73.24 108.51 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.418 HG23 HG23 ' A' ' 127' ' ' ILE . 2.7 pp -120.93 145.61 41.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.696 1.199 . . . . 63.02 110.296 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 148.01 47.39 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.999 1.799 . . . . 70.22 107.516 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -120.93 -169.81 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.346 -1.724 . . . . 62.45 106.346 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -34.53 -72.24 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.922 1.689 . . . . 74.31 112.17 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.48 1.31 10.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.655 1.182 . . . . 54.52 113.217 171.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.2 p -130.47 153.8 48.43 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.967 1.307 . . . . 72.14 112.263 -165.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 tp -84.33 147.46 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.163 -1.421 . . . . 71.4 107.163 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -147.7 -174.86 4.66 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.877 2.071 . . . . 65.21 107.693 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.0 mt -131.25 159.98 36.23 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.354 1.462 . . . . 65.4 108.007 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -149.37 159.0 44.65 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.886 0.874 . . . . 72.24 110.122 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.83 140.27 29.87 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.745 2.418 . . . . 73.05 109.975 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.629 HG13 HG23 ' A' ' 89' ' ' ILE . 49.8 t -81.89 -3.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.212 1.405 . . . . 74.11 113.461 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.3 pt 25.05 -89.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 127.494 2.318 . . . . 72.24 115.6 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -89.82 105.4 17.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.821 1.648 . . . . 73.1 107.844 170.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.81 148.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.135 -1.061 . . . . 62.42 108.135 154.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.3 -162.63 0.76 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.359 2.664 . . . . 70.22 107.661 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -131.26 162.12 30.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.162 1.785 . . . . 64.5 109.561 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.63 -169.16 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.601 1.561 . . . . 74.12 109.455 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.01 132.47 41.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.991 2.116 . . . . 74.31 106.535 161.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.95 143.31 36.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.82 1.191 . . . . 71.31 110.489 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.53 30.74 1.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.969 0.729 . . . . 55.44 112.969 -163.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.59 -136.03 4.21 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.593 1.092 . . . . 54.44 111.739 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -99.25 170.06 8.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.384 -1.068 . . . . 74.02 109.824 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.44 HD12 ' CB ' ' A' ' 8' ' ' ALA . 2.3 pt -118.34 -73.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.037 -1.468 . . . . 73.53 107.037 173.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 78.98 170.29 0.18 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.535 2.334 . . . . 74.12 107.553 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -162.91 153.96 17.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.425 1.49 . . . . 51.54 107.439 -170.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -123.04 141.21 52.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.457 1.103 . . . . 74.24 111.133 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.593 ' CG2' ' HE1' ' A' ' 78' ' ' TRP . 44.7 p -79.49 -70.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.751 0.657 . . . . 74.35 110.183 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t 43.11 73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.664 2.386 . . . . 51.34 111.844 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.05 -0.48 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 74.33 113.314 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.94 -38.72 83.2 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.599 -0.519 . . . . 72.24 109.599 -166.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -138.52 7.98 2.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.871 1.269 . . . . 71.41 111.99 171.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.5 m170 54.02 29.32 9.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.505 1.122 . . . . 74.12 111.424 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -142.91 144.77 32.56 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.628 -1.92 . . . . 73.33 109.135 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.1 p90 -148.8 167.17 26.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.067 0.765 . . . . 73.31 113.067 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.2 mm -85.85 137.19 21.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 106.407 -1.701 . . . . 71.34 106.407 164.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -153.87 143.08 21.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.801 1.24 . . . . 65.5 108.072 162.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.55 -173.32 22.87 Favored Glycine 0 N--CA 1.462 0.431 0 C-N-CA 123.881 0.753 . . . . 54.35 111.585 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -90.95 167.87 12.09 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.47 -1.606 . . . . 72.25 110.261 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.08 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.542 2.337 . . . . 75.31 114.201 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.529 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 43.0 mt-10 -121.77 -7.94 8.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.558 1.143 . . . . 72.34 112.339 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.26 170.33 14.7 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 122.844 1.247 . . . . 72.01 111.874 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.592 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -120.72 147.91 44.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.968 2.507 . . . . 74.31 106.98 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -90.79 103.94 16.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.542 -1.651 . . . . 73.22 106.542 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.24 177.88 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.398 1.479 . . . . 51.51 109.176 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.8 t -67.34 144.4 55.86 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.47 2.708 . . . . 72.04 109.77 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.683 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -123.96 166.13 16.24 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.681 2.793 . . . . 75.21 107.013 162.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.99 171.58 3.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.613 -1.625 . . . . 61.12 106.613 160.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.6 m -94.92 53.18 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.096 -1.002 . . . . 72.32 109.832 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.93 -9.18 32.68 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.221 1.391 . . . . 60.44 112.916 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.5 p -79.82 164.48 23.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.703 2.001 . . . . 75.25 111.928 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.5 tp -111.17 75.44 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.735 0.814 . . . . 64.43 109.232 -166.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.52 -49.88 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.746 2.818 . . . . 74.45 111.878 -162.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 61.2 t60 57.85 -79.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.767 2.427 . . . . 73.23 113.542 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -154.44 170.43 21.39 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.598 1.09 . . . . 72.03 109.291 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -87.27 87.3 7.39 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.186 -1.042 . . . . 74.53 108.186 173.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -76.57 168.79 19.45 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.989 -1.115 . . . . 72.24 107.989 151.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 126.96 2.104 . . . . 62.32 107.622 -168.751 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mtt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 107.395 -1.335 . . . . 70.45 107.395 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.24 168.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.996 1.271 . . . . 63.31 110.563 -167.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -69.34 -43.0 74.54 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.131 -0.981 . . . . 71.32 110.362 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.78 92.38 2.24 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.284 -2.326 . . . . 71.21 107.284 -164.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.58 -73.33 0.47 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.229 -1.397 . . . . 72.22 107.229 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.13 157.07 16.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.846 -1.168 . . . . 63.14 107.846 159.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.57 101.73 1.73 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 106.331 -2.708 . . . . 70.21 106.331 -156.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -162.59 157.34 21.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.305 1.442 . . . . 62.13 108.102 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.41 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 62.54 110.508 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.05 152.97 43.78 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.763 -0.653 . . . . 70.53 109.804 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.6 t80 -53.81 -31.12 47.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.449 1.5 . . . . 75.02 112.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -103.93 14.67 30.28 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.753 1.221 . . . . 71.22 113.459 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.34 119.96 79.28 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 106.013 -1.847 . . . . 75.33 106.013 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.0 139.79 75.43 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-N 120.427 1.188 . . . . 53.11 112.437 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.0 pt -90.21 140.3 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.022 -1.103 . . . . 72.31 108.022 161.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -102.43 83.26 2.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.409 -1.7 . . . . 73.3 106.409 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.3 164.59 18.08 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.308 0.575 . . . . 74.33 109.987 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.5 t -56.02 -39.34 71.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.095 0.958 . . . . 73.31 110.216 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -33.37 34.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.265 0.939 . . . . 55.53 111.089 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.68 46.07 2.37 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.865 0.745 . . . . 62.41 112.271 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -35.9 69.43 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.68 1.24 . . . . 70.45 111.72 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.4 mm 45.87 86.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 128.283 2.633 . . . . 74.15 107.325 -163.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.72 152.0 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.63 -1.618 . . . . 73.52 106.63 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.29 135.24 56.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.283 1.833 . . . . 65.13 109.351 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.558 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -50.9 -54.81 8.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.825 -1.176 . . . . 70.44 107.825 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -55.49 -45.19 84.89 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.944 -1.263 . . . . 74.35 109.944 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -71.83 -42.96 66.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.077 1.351 . . . . 73.03 112.599 -173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -52.4 -49.26 64.82 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 122.038 0.923 . . . . 64.12 109.552 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 153' ' ' TYR . 92.7 t -72.79 -42.1 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.836 -1.075 . . . . 74.13 109.886 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.24 -38.36 73.67 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.332 0.515 . . . . 72.1 111.289 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.8 -43.14 76.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.276 1.03 . . . . 74.41 109.347 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.39 -47.09 62.46 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 117.491 -1.242 . . . . 74.03 108.767 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.6 -38.2 66.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.447 1.476 . . . . 74.01 110.994 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -78.05 -30.82 50.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.837 -1.078 . . . . 74.41 111.781 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.5 ttmm -78.97 -63.12 1.49 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.742 -1.577 . . . . 72.0 106.742 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.33 39.77 0.53 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.266 2.627 . . . . 72.45 109.732 -172.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.81 -38.29 67.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 120.533 -1.354 . . . . 61.03 110.784 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -74.47 -12.85 60.6 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.198 0.814 . . . . 73.05 113.198 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -93.95 0.01 55.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.842 1.257 . . . . 74.52 112.32 174.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.59 95.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 119.638 1.108 . . . . 72.44 108.099 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -78.94 147.75 32.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.152 -1.425 . . . . 54.24 107.152 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 130.75 48.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.043 -2.577 . . . . 62.11 104.043 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 144.66 35.71 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.094 -1.817 . . . . 73.43 106.094 171.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.5 -40.26 86.46 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.124 1.769 . . . . 75.41 112.196 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.98 -5.8 28.83 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.214 1.006 . . . . 73.23 112.27 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.77 56.41 1.16 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 126.731 2.11 . . . . 50.02 110.24 160.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -120.33 -97.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.338 1.055 . . . . 41.14 109.048 -172.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.11 137.71 3.02 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.986 1.755 . . . . 62.42 109.855 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -150.01 170.55 18.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.185 0.992 . . . . 72.31 111.448 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 mt -149.26 144.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.085 2.154 . . . . 71.52 106.608 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 122.53 31.06 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.248 1.819 . . . . 60.4 108.889 168.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 54' ' ' ASN . 2.2 pp -135.19 14.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.766 1.227 . . . . 61.24 111.876 -174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 17.72 0.14 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.082 1.801 . . . . 73.44 114.69 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -119.75 -13.1 9.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 129.873 3.269 . . . . 71.13 111.022 -177.005 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.29 -20.92 65.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.361 0.982 . . . . 73.4 110.903 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.1 19.19 2.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.571 1.948 . . . . 74.24 113.068 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.33 148.36 12.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.32 1.448 . . . . 61.45 107.52 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -115.67 140.85 48.81 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.682 -0.858 . . . . 72.51 108.682 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.49 158.65 18.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.555 1.542 . . . . 75.23 107.71 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -66.01 145.21 56.14 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.968 -1.123 . . . . 71.12 107.968 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.72 -179.29 5.96 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.735 1.614 . . . . 54.5 107.795 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.449 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -151.98 121.85 7.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.842 -1.161 . . . . 72.54 109.417 173.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.84 114.63 9.1 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.507 1.123 . . . . 63.32 108.93 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 162' ' ' THR . 18.0 mttt -62.35 -21.25 65.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.236 0.828 . . . . 74.12 113.236 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -37.8 -47.16 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.12 2.168 . . . . 64.02 109.807 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.4 17.71 2.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.53 1.132 . . . . 74.43 110.575 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 48.93 49.33 19.46 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.027 1.285 . . . . 62.41 112.222 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.74 149.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.544 1.538 . . . . 75.44 107.934 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.77 144.49 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.595 -1.261 . . . . 74.52 107.595 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -148.96 -177.58 5.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.194 2.197 . . . . 64.04 111.881 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.01 162.22 13.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.904 2.082 . . . . 73.31 109.991 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 149.95 22.69 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.909 -1.119 . . . . 74.14 111.572 156.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -78.9 162.54 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.974 -0.751 . . . . 75.13 108.974 159.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -94.09 168.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.208 1.803 . . . . 72.13 106.756 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.8 mm? -117.19 -58.31 2.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.265 1.826 . . . . 74.03 108.94 168.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -128.76 155.98 44.26 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.757 -0.59 . . . . 62.15 110.873 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -123.39 163.4 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 126.179 1.791 . . . . 55.21 108.331 173.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.35 176.72 8.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.84 1.656 . . . . 65.11 109.631 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -169.08 148.14 3.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.972 1.709 . . . . 75.44 109.168 163.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE3' HD11 ' A' ' 152' ' ' ILE . 35.2 pttt -142.43 169.99 16.55 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.605 1.562 . . . . 72.33 107.538 156.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -91.41 152.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.711 -0.618 . . . . 72.33 109.408 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 152' ' ' ILE . 31.5 t80 -146.93 147.89 31.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.439 0.696 . . . . 74.22 110.103 -170.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -157.7 126.84 5.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.444 -1.317 . . . . 73.22 107.444 155.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.52 -177.78 42.34 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.052 0.842 . . . . 65.31 112.56 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.89 127.47 32.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.03 -0.688 . . . . 74.11 110.86 171.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.96 157.98 17.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.848 -1.168 . . . . 74.13 107.848 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' HIS . 2.8 mm -78.57 133.68 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.217 -1.401 . . . . 74.33 107.217 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 98' ' ' THR . 12.7 ttmt -119.74 84.52 2.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.005 1.383 . . . . 55.01 107.645 164.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.67 130.39 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.143 -2.169 . . . . 73.21 105.143 154.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 m -100.15 -175.71 3.02 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 105.979 -1.86 . . . . 63.12 105.979 161.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -146.95 170.29 17.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.654 1.982 . . . . 74.2 108.716 165.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -56.92 -28.1 61.68 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.169 1.349 . . . . 73.54 112.433 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -72.3 3.4 4.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.623 0.971 . . . . 54.54 113.623 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 57.05 18.8 4.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.68 1.592 . . . . 72.32 111.591 -164.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 160.72 32.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.447 -1.686 . . . . 74.31 106.447 161.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.83 164.19 5.11 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.47 2.308 . . . . 62.12 106.857 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.502 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.5 pt -146.77 170.15 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 125.512 1.525 . . . . 74.33 108.521 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.476 HG23 ' HE3' ' A' ' 88' ' ' LYS 0.358 0.0 OUTLIER -151.63 96.49 2.26 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 126.624 1.97 . . . . 54.05 113.3 -175.47 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.532 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -161.79 179.4 8.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.153 1.781 . . . . 74.21 110.291 -166.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 p -66.72 166.92 12.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.959 0.885 . . . . 74.43 110.837 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.408 ' HA ' HG13 ' A' ' 87' ' ' ILE . 1.5 p-80 -70.39 -14.13 62.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.533 -0.729 . . . . 73.15 112.239 175.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -125.15 37.88 4.3 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.741 1.616 . . . . 44.12 111.566 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.683 ' ND1' ' HB2' ' A' ' 118' ' ' ALA . 1.1 p-80 -76.77 141.74 68.94 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.076 -0.964 . . . . 64.24 108.487 164.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -70.92 127.24 13.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.308 3.339 . . . . 65.03 113.525 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 121' ' ' VAL . 30.0 m -115.39 -177.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.279 1.831 . . . . 65.04 110.685 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -131.45 126.87 36.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.986 2.114 . . . . 70.05 108.502 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.51 163.02 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.244 0.929 . . . . 72.45 109.967 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.56 104.79 10.4 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.019 0.914 . . . . 62.14 110.612 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -86.01 79.85 9.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 104.248 -2.501 . . . . 74.41 104.248 161.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 55.45 19.65 3.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.428 1.269 . . . . 73.11 114.428 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.79 -0.89 41.88 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.168 -0.958 . . . . 74.55 113.642 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -91.66 129.11 37.69 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.075 -2.194 . . . . 75.33 105.075 156.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.24 130.37 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 60.43 108.885 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.42 148.44 42.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.892 0.877 . . . . 75.21 110.476 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -103.72 123.83 47.76 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.352 1.461 . . . . 71.51 111.289 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.51 -178.34 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.318 1.447 . . . . 74.54 111.325 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -86.27 145.38 26.97 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.634 1.974 . . . . 65.13 109.336 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.683 ' HB2' ' ND1' ' A' ' 103' ' ' HIS . . . -39.6 -51.75 2.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.228 2.211 . . . . 73.41 112.245 170.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -56.12 -21.43 22.34 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.521 1.528 . . . . 62.12 114.604 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.3 mtt -93.48 -19.21 21.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.279 1.032 . . . . 71.54 111.387 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 105' ' ' VAL . 11.3 t -78.88 62.0 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 127.677 2.391 . . . . 74.32 109.277 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.76 -176.95 5.66 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.324 -0.86 . . . . 74.21 109.987 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.52 -11.47 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 126.413 1.885 . . . . 71.55 113.701 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.69 -3.11 71.59 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.536 -1.147 . . . . 62.5 112.965 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -123.98 145.7 49.01 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.956 1.878 . . . . 73.34 108.798 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -112.95 114.52 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.907 1.283 . . . . 72.14 107.682 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.5 tt -89.46 134.5 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.8 1.24 . . . . 63.3 108.944 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -69.72 107.26 3.4 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.837 -0.801 . . . . 64.42 108.837 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.46 157.81 39.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.909 1.284 . . . . 73.25 110.281 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.35 152.28 66.16 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.818 1.012 . . . . 65.3 110.13 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -119.82 178.82 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 156.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -23.81 -67.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.273 3.029 . . . . 75.25 114.888 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -120.88 -13.4 8.64 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.166 0.894 . . . . 63.13 113.389 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -139.07 168.66 19.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.253 -0.905 . . . . 52.21 110.834 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -78.33 156.89 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.778 -0.823 . . . . 65.33 108.778 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 -176.14 4.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.118 2.967 . . . . 71.11 105.441 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 mp -113.61 167.58 10.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.572 1.949 . . . . 70.44 109.07 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -157.54 154.27 28.31 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.676 -1.602 . . . . 70.43 106.676 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.93 141.34 28.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.699 1.2 . . . . 61.21 108.58 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.594 HG21 HG12 ' A' ' 121' ' ' VAL . 11.5 t -67.6 -22.2 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 114.735 1.384 . . . . 72.31 114.735 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.2 pt 50.52 -49.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 130.115 3.366 . . . . 74.42 118.013 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.78 133.19 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 131.466 3.906 . . . . 73.24 107.773 -161.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.64 109.31 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.379 -0.6 . . . . 75.23 109.379 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -151.11 -175.71 5.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.369 1.068 . . . . 61.11 108.969 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 134.65 47.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.473 1.109 . . . . 55.21 108.102 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.48 -176.14 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.811 -1.181 . . . . 65.21 107.811 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.71 155.93 30.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.419 -1.326 . . . . 74.54 107.419 152.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -147.6 162.0 40.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.065 0.946 . . . . 70.24 108.649 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -164.87 78.36 0.33 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.055 -1.461 . . . . 64.51 107.055 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.85 25.59 0.2 Allowed Glycine 0 N--CA 1.474 1.227 0 N-CA-C 118.966 2.346 . . . . 73.31 118.966 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 61.13 159.78 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.403 2.281 . . . . 64.2 111.813 -167.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.691 HD11 ' HE3' ' A' ' 80' ' ' LYS . 17.5 pt -145.7 155.26 13.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.638 1.575 . . . . 75.12 108.594 -174.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.696 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.42 168.68 26.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.881 0.472 . . . . 74.14 111.199 171.177 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -146.21 162.79 37.27 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.727 2.811 . . . . 65.43 106.726 -173.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.15 153.96 34.04 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.578 -1.326 . . . . 72.34 112.162 -163.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 -38.78 10.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.057 -0.974 . . . . 74.34 113.339 -162.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.257 2.1 t 22.89 64.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 129.567 3.147 . . . . 65.2 113.487 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.9 pt-20 -78.15 1.63 20.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.241 -0.912 . . . . 72.51 112.453 -169.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -89.6 -48.27 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.638 2.775 . . . . 73.0 109.298 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -132.64 -3.61 3.31 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.103 0.779 . . . . 73.13 113.103 -173.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 69.03 8.44 6.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.143 1.377 . . . . 74.44 113.982 161.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.459 ' CG2' ' HE2' ' A' ' 64' ' ' LYS . 39.1 p -140.77 158.06 44.52 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.389 2.276 . . . . 75.42 107.248 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -144.86 -175.68 4.77 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.731 -1.23 . . . . 72.23 110.77 172.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.96 111.95 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.853 1.261 . . . . 73.11 108.081 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.47 158.47 44.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.131 1.373 . . . . 71.34 108.496 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.15 -158.06 25.15 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 107.379 -2.288 . . . . 74.41 107.379 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -112.32 172.39 6.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.017 1.408 . . . . 72.14 111.212 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.58 -69.43 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.867 3.267 . . . . 72.41 114.164 -174.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -122.89 -11.0 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.783 2.033 . . . . 61.22 113.694 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.88 159.54 3.17 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 122.533 1.074 . . . . 73.11 112.119 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 97' ' ' ILE . 26.5 m-85 -104.38 156.1 18.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.752 2.021 . . . . 72.45 109.26 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -89.27 79.89 6.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.194 1.798 . . . . 73.23 107.599 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -104.97 176.8 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.58 -1.267 . . . . 74.11 107.58 -171.233 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.16 155.63 38.27 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.008 2.123 . . . . 73.21 111.049 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.56 39.78 1.17 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.05 2.54 . . . . 72.54 108.605 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 p -68.57 134.0 49.35 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.326 -0.99 . . . . 64.33 108.326 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.2 p -77.54 -4.5 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.297 1.591 . . . . 72.02 115.297 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.99 13.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.761 0.696 . . . . 44.24 113.536 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 p -55.07 155.05 4.91 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.497 1.149 . . . . 45.52 111.596 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 36.2 tp -61.52 -36.59 80.97 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.343 0.868 . . . . 74.43 113.343 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.5 -165.23 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.413 0.685 . . . . 70.32 110.996 -174.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -123.38 171.2 9.61 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.249 -1.389 . . . . 74.04 107.249 155.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -135.33 174.96 10.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.013 1.325 . . . . 63.14 108.1 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -144.24 159.54 42.49 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.322 . . . . 70.51 108.56 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 48.2 56.09 7.86 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.812 1.645 . . . . 71.22 112.269 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.951 0 C-N-CA 127.997 2.519 . . . . 75.41 110.71 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 110.038 -0.356 . . . . 70.1 110.038 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 59.65 177.01 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.792 1.637 . . . . 63.41 111.159 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.78 -70.25 0.79 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.484 -2.043 . . . . 72.43 105.484 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.13 -87.44 0.13 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.485 -1.046 . . . . 42.31 110.485 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -153.96 -52.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.891 0.876 . . . . 72.34 110.258 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.17 168.99 4.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.107 0.563 . . . . 75.01 111.735 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.2 87.68 1.11 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.21 1.386 . . . . 65.44 110.865 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -142.69 147.21 35.3 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.25 1.02 . . . . 75.14 108.503 166.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.77 160.2 30.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.072 1.749 . . . . 75.32 109.802 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.24 149.7 44.32 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.802 -0.444 . . . . 71.2 109.802 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -44.45 -39.51 4.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.903 1.681 . . . . 74.44 113.549 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -97.22 7.8 45.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.388 1.075 . . . . 74.01 113.088 -166.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.25 121.73 84.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.517 -1.29 . . . . 71.33 107.517 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.11 141.92 95.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.569 1.239 . . . . 61.44 112.336 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 pt -96.38 -8.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.369 0.877 . . . . 71.54 113.369 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 54.63 69.33 0.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.479 1.133 . . . . 75.35 110.075 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.3 mt -55.1 160.58 2.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.7 -0.682 . . . . 74.55 109.595 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -53.35 -40.54 64.99 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.736 0.814 . . . . 63.41 109.755 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.01 -37.38 84.67 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.265 1.026 . . . . 75.11 112.786 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.68 41.15 7.38 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.065 -1.022 . . . . 55.11 110.548 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.77 -11.95 61.26 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.786 0.835 . . . . 74.35 113.192 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.9 mm 40.57 70.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.97 2.908 . . . . 61.54 109.112 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.83 149.83 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 112.82 -1.991 . . . . 74.14 107.928 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.26 135.37 47.42 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.791 1.236 . . . . 73.24 109.52 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.69 -4.24 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.221 1.809 . . . . 61.4 114.556 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.62 -9.86 12.15 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-O 116.769 -2.129 . . . . 72.02 113.488 165.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -78.33 -49.71 13.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.278 2.039 . . . . 75.44 109.799 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -39.6 -54.88 1.95 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.202 1.801 . . . . 75.43 109.797 165.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.495 ' CG1' HG21 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -73.16 -30.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.976 -1.465 . . . . 73.41 110.379 -174.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.12 -31.83 73.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.512 -1.368 . . . . 72.21 111.125 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -52.2 61.09 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.361 0.664 . . . . 74.4 109.478 168.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -66.13 -44.18 84.96 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 117.57 -1.205 . . . . 62.33 109.24 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -54.41 -39.56 67.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 121.876 2.126 . . . . 75.42 112.786 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -27.33 56.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.74 -1.124 . . . . 73.12 111.509 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 3.8 mtpt -86.39 -59.93 2.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.456 -1.683 . . . . 62.44 106.456 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 3.8 m-30 -88.98 39.93 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.762 2.825 . . . . 73.25 108.769 -168.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.59 -35.09 71.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.598 -1.314 . . . . 73.4 112.089 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -31.11 72.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 52.41 112.816 172.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 m -79.56 -9.44 59.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.15 1.78 . . . . 53.32 111.246 -175.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.05 102.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.373 0 N-CA-C 106.554 -1.647 . . . . 73.25 106.554 168.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.81 167.27 12.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.389 -1.337 . . . . 74.24 107.389 158.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 145.64 45.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.212 -2.144 . . . . 55.12 105.212 167.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -78.3 168.83 19.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.29 -1.744 . . . . 75.13 106.29 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -33.09 74.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.496 0.718 . . . . 61.41 110.51 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.14 -0.35 18.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.426 0.899 . . . . 74.32 113.426 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.29 17.87 51.51 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 126.023 1.773 . . . . 44.11 113.259 161.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.96 -95.35 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.461 1.905 . . . . 74.43 109.974 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.51 129.07 1.41 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.783 -1.727 . . . . 63.13 108.783 -167.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -137.75 157.99 45.3 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 124.402 0.707 . . . . 71.33 109.487 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mt -139.36 141.83 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 104.97 -2.234 . . . . 74.35 104.97 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.38 137.28 32.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.678 0.791 . . . . 64.42 109.697 167.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.56 17.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.402 1.481 . . . . 65.24 112.748 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.97 -38.01 10.04 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.259 -0.745 . . . . 73.54 113.517 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -78.17 -6.23 54.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.202 1.501 . . . . 73.33 113.763 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 57' ' ' ILE . 56.6 mm-40 -64.35 -26.96 68.7 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.361 1.437 . . . . 74.23 110.323 168.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 m120 58.76 -4.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.971 2.108 . . . . 73.32 114.318 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' ' C ' ' A' ' 55' ' ' GLU . 93.5 mt -47.8 132.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 128.234 2.614 . . . . 55.05 108.058 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.75 150.57 22.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.255 1.026 . . . . 73.22 110.192 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.8 150.96 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.91 2.084 . . . . 51.34 107.014 177.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' O ' HD13 ' A' ' 59' ' ' ILE . 1.1 mtpt -61.77 120.7 11.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.844 -0.799 . . . . 74.22 108.844 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -114.18 -179.49 3.65 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.77 1.228 . . . . 73.44 108.505 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.4 146.82 33.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.291 -1.374 . . . . 62.11 107.291 159.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.4 112.83 24.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.368 0.531 . . . . 71.21 109.952 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.38 -24.1 67.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.184 0.994 . . . . 73.42 112.384 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.7 -43.37 5.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.725 2.41 . . . . 61.12 111.733 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.96 18.88 1.79 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.247 1.019 . . . . 70.33 111.521 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp 39.72 66.12 0.62 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.312 2.245 . . . . 62.4 112.056 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 pt -121.02 156.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.958 1.703 . . . . 74.12 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.2 mm -86.57 126.18 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 126.989 2.116 . . . . 63.41 106.631 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -140.46 171.18 14.5 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.084 1.753 . . . . 71.23 107.842 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -112.76 141.1 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.975 1.71 . . . . 72.33 107.43 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 151.6 38.11 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.323 -0.861 . . . . 61.34 109.385 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -79.2 173.73 12.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.625 -0.88 . . . . 75.02 108.625 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.8 151.74 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.058 -1.46 . . . . 54.41 107.058 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.1 mm? -106.29 -41.93 5.19 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 117.645 -1.169 . . . . 75.12 110.385 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtm-85 -140.08 149.69 43.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.433 1.469 . . . . 70.15 111.427 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -106.97 155.9 7.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.451 1.501 . . . . 70.04 108.54 170.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -130.74 150.26 52.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.0 1.32 . . . . 74.33 109.045 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -151.84 140.64 20.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.973 0.909 . . . . 71.04 110.208 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -153.92 163.75 39.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.608 1.163 . . . . 73.31 108.81 163.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -92.37 139.68 30.35 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 120.808 -1.182 . . . . 73.31 110.148 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -134.46 168.36 19.08 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.327 1.451 . . . . 70.13 109.901 -165.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.75 109.09 1.6 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.195 -0.907 . . . . 72.21 111.338 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.82 -173.53 36.53 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.256 1.389 . . . . 74.34 112.49 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -86.64 109.33 19.09 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.314 -0.521 . . . . 70.04 111.336 -171.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.75 168.65 19.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.77 -0.826 . . . . 61.32 108.77 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.12 130.35 35.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.06 2.144 . . . . 60.13 108.185 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -115.8 85.57 2.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.09 -1.448 . . . . 71.43 107.09 161.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -66.26 120.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 104.008 -2.59 . . . . 64.13 104.008 153.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -104.5 164.58 11.65 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.469 -1.678 . . . . 74.53 106.469 161.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.5 p -134.03 170.24 15.94 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.05 -1.031 . . . . 65.24 109.758 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -65.06 -27.72 68.98 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.109 1.764 . . . . 74.23 110.46 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -68.25 1.04 3.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.927 1.691 . . . . 75.12 111.536 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 55.82 29.67 14.42 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.085 2.154 . . . . 74.54 111.785 -172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt-85 -75.84 168.49 19.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 118.224 -1.39 . . . . 73.15 109.085 162.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.6 169.26 18.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.916 1.385 . . . . 75.52 108.573 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.567 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.2 pt -146.16 169.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.959 2.104 . . . . 64.15 110.804 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 m -146.86 98.16 3.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.082 1.353 . . . . 64.05 110.454 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.71 174.93 13.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.065 1.746 . . . . 70.14 111.098 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 167.58 10.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.229 1.012 . . . . 74.4 110.935 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -70.14 -31.86 69.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.03 -0.73 . . . . 62.01 109.03 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -101.44 38.87 1.51 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 65.34 112.493 -168.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -107.91 143.52 27.5 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 120.801 -1.187 . . . . 74.43 110.882 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.46 125.65 12.01 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.986 3.124 . . . . 70.02 112.368 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.64 168.83 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.743 0.817 . . . . 74.51 108.866 168.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.32 140.68 37.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.351 0.66 . . . . 74.42 110.554 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.55 158.45 37.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.332 1.453 . . . . 72.32 108.275 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.6 p -88.78 134.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.122 0.963 . . . . 52.51 108.962 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 77.33 1.03 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.368 -1.716 . . . . 64.1 106.368 161.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 59.32 21.17 9.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 70.45 113.069 167.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.34 -19.84 5.94 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.211 -0.772 . . . . 65.02 111.693 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -87.15 141.11 28.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 104.4 -2.444 . . . . 73.54 104.4 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -86.72 139.6 17.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.677 -1.264 . . . . 71.34 108.051 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.92 159.95 37.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.953 -1.499 . . . . 54.11 106.953 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -126.18 112.2 15.51 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.333 1.053 . . . . 55.3 109.573 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.65 174.83 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.511 1.124 . . . . 70.12 111.111 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -76.84 136.31 38.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 117.862 -1.066 . . . . 72.22 109.489 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.03 -32.73 16.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 55.53 113.304 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.3 -16.29 63.53 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.192 1.553 . . . . 55.25 115.192 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.8 mtt -84.0 -28.09 27.97 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.446 0.566 . . . . 61.4 110.707 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.5 t -76.14 61.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 127.496 2.318 . . . . 54.05 109.786 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 143' ' ' VAL . 1.7 mmmm -91.63 -171.8 3.02 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.537 1.135 . . . . 74.43 108.079 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.61 -9.02 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.34 1.456 . . . . 51.15 114.236 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.89 2.36 69.32 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 116.793 -2.115 . . . . 73.41 113.495 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.78 135.56 43.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 121.12 2.46 . . . . 54.44 108.999 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 139' ' ' GLU . 18.0 m-85 -79.59 118.91 21.87 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.518 -0.919 . . . . 63.35 108.518 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.08 126.06 42.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.574 -1.269 . . . . 74.52 107.574 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.96 141.1 56.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.838 -0.801 . . . . 71.4 108.838 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.52 158.8 72.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.402 1.081 . . . . 74.24 112.013 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.56 150.7 31.96 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.621 2.214 . . . . 72.23 108.365 171.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.32 -174.77 3.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 105.869 -1.9 . . . . 71.52 105.869 162.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -28.33 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.267 2.227 . . . . 74.5 112.195 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.12 -3.47 9.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.227 1.811 . . . . 75.4 111.414 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 p -133.71 158.79 42.38 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.649 0.659 . . . . 61.42 111.581 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.91 152.88 4.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.937 -1.135 . . . . 73.43 107.937 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.37 179.86 6.69 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.575 1.95 . . . . 73.23 107.367 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.11 162.42 19.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.869 1.267 . . . . 74.13 107.914 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -150.52 160.19 43.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.258 -1.386 . . . . 74.05 107.258 158.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 126' ' ' TYR . 5.6 mt-10 -63.09 -179.75 0.32 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.026 1.731 . . . . 73.53 109.699 170.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.47 1.66 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.165 1.786 . . . . 73.04 112.08 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pt 26.51 -80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 128.235 2.614 . . . . 65.4 116.684 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -109.84 119.28 38.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.895 1.278 . . . . 73.33 108.157 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 122' ' ' LYS . 2.9 p -114.65 115.71 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.659 1.219 . . . . 72.53 109.005 164.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.62 -172.29 2.45 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.203 2.601 . . . . 63.5 106.971 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.9 p -128.86 166.82 18.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.059 1.344 . . . . 75.1 110.893 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.77 124.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.024 0.93 . . . . 73.23 109.721 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.92 101.72 11.89 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.561 -0.903 . . . . 63.41 108.561 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -107.38 133.62 51.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.056 0.942 . . . . 70.5 109.196 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.55 59.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.794 -1.188 . . . . 73.12 107.794 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -124.64 -166.68 12.48 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.683 2.087 . . . . 21.33 110.681 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.34 156.27 18.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.799 -0.815 . . . . 60.3 108.799 166.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 49.8 pt -136.02 152.79 30.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.177 1.391 . . . . 74.21 108.06 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -144.31 153.27 41.83 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.715 1.206 . . . . 75.42 109.201 -163.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -141.56 174.59 10.42 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.861 -0.525 . . . . 73.33 109.684 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.18 109.82 10.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.028 1.731 . . . . 73.05 109.261 -157.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -76.71 121.0 22.66 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.169 -1.789 . . . . 71.31 106.169 169.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 t -130.24 87.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.635 -1.617 . . . . 74.31 106.635 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.516 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -61.11 -21.49 63.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.903 1.681 . . . . 71.51 113.031 177.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -95.72 -51.17 4.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.217 1.407 . . . . 64.42 110.045 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -124.23 103.58 8.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 101.715 -3.439 . . . . 74.21 101.715 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -66.94 28.55 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.794 0.838 . . . . 73.34 113.018 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.407 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 1.4 p -153.95 124.93 7.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.066 2.147 . . . . 54.43 107.727 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 6.8 p90 -129.92 166.02 20.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.299 1.44 . . . . 71.01 110.912 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.17 135.05 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.214 -1.032 . . . . 73.21 108.214 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.77 29.33 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.509 1.124 . . . . 73.22 110.066 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.01 -156.61 22.25 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.565 0.621 . . . . 73.43 111.893 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -110.09 167.39 10.21 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.998 -1.295 . . . . 72.23 111.54 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.89 -76.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.718 2.807 . . . . 73.53 112.699 -165.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.31 -13.32 8.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.97 1.708 . . . . 74.3 113.641 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.36 176.53 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 123.294 1.496 . . . . 74.44 112.686 -173.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.567 ' CE1' HG23 ' A' ' 97' ' ' ILE . 8.7 m-85 -124.11 149.47 46.17 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.408 3.083 . . . . 70.41 104.874 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -94.37 81.04 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.802 -1.184 . . . . 32.14 107.802 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.0 m -88.49 179.87 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 O-C-N 121.78 -0.575 . . . . 73.44 110.58 -171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.59 158.45 23.06 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.794 -0.566 . . . . 74.23 110.443 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.28 175.13 10.31 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.992 2.117 . . . . 72.3 109.288 173.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 81.4 p -158.06 -128.09 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.327 -0.99 . . . . 63.05 108.327 157.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -143.33 86.19 1.89 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.724 1.609 . . . . 73.02 107.188 174.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.86 -83.55 0.39 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 126.924 2.202 . . . . 60.51 110.14 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 22.9 p -59.91 120.69 10.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.128 1.771 . . . . 71.45 109.844 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.43 -69.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 129.191 2.996 . . . . 73.14 112.123 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -132.36 154.66 49.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.48 -0.933 . . . . 74.32 108.48 164.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -119.5 -59.1 1.86 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.063 1.345 . . . . 60.11 109.475 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -57.46 -54.85 42.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.122 0.569 . . . . 73.44 111.721 -170.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -48.76 108.47 0.18 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.027 2.131 . . . . 75.24 109.95 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -148.22 158.49 44.11 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.212 2.205 . . . . 73.31 105.91 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.988 1.315 . . . . 74.54 110.823 -156.741 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 108.851 -0.796 . . . . 63.52 108.851 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.24 143.97 29.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.891 1.677 . . . . 73.5 108.376 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -71.74 -47.68 52.11 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.629 0.581 . . . . 55.12 110.706 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 180' ' ' LEU . . . 162.97 -82.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 123.621 0.629 . . . . 71.03 111.586 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -81.52 111.18 17.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.801 -0.814 . . . . 70.44 108.801 -174.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.52 156.46 18.55 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.803 1.241 . . . . 62.24 107.851 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.46 -95.03 2.22 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.071 -0.849 . . . . 72.3 112.478 -162.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 154.9 157.77 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 131.373 3.869 . . . . 62.51 107.767 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.47 -177.42 4.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.474 -0.565 . . . . 63.13 109.474 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -166.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.219 1.408 . . . . 74.23 112.036 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -94.78 -50.38 5.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.434 1.494 . . . . 61.2 110.316 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.94 50.16 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.414 2.285 . . . . 61.14 108.094 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.02 131.84 19.03 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 106.936 -1.505 . . . . 72.25 106.936 -165.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -79.95 132.71 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.015 1.81 . . . . 72.25 112.305 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 pt -98.56 -6.16 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.904 0.882 . . . . 73.22 113.032 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 57.01 84.2 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.982 1.713 . . . . 52.01 112.135 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 59' ' ' ILE . 15.4 mt -51.29 156.66 1.12 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.833 164.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.9 t -55.54 -35.03 65.23 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 122.979 0.512 . . . . 72.55 109.855 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.75 -29.96 68.47 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.647 0.779 . . . . 64.04 112.297 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.21 36.21 7.2 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.194 1.378 . . . . 51.31 111.605 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -17.02 64.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.352 1.241 . . . . 65.44 114.352 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm 43.32 93.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 128.523 2.729 . . . . 72.31 111.19 -166.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.87 145.54 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.63 -1.623 . . . . 62.04 107.792 174.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.26 131.49 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 128.069 2.548 . . . . 72.33 108.396 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -49.92 -48.68 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.495 0.718 . . . . 63.11 110.526 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.81 4.56 86.19 Favored Glycine 0 C--O 1.221 -0.656 0 CA-C-O 116.986 -2.008 . . . . 75.44 113.419 -173.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -86.68 -53.35 4.99 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.512 1.656 . . . . 62.35 108.582 162.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -52.78 -54.42 34.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.765 1.226 . . . . 73.51 109.302 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.836 HG22 ' HA2' ' A' ' 26' ' ' GLY . 21.7 m -65.89 -33.4 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-O 117.753 -1.117 . . . . 70.11 110.174 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -41.92 95.99 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 121.545 1.975 . . . . 70.3 111.569 -173.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.89 -40.23 60.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.462 0.705 . . . . 53.41 110.469 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -77.68 -46.49 21.79 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.353 -1.308 . . . . 54.04 109.873 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -54.95 -36.07 64.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 122.517 2.417 . . . . 65.12 112.354 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -17.4 46.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.383 1.073 . . . . 72.14 113.204 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -88.54 -61.22 1.76 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.195 -1.409 . . . . 64.22 107.195 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -84.13 40.78 0.78 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.912 2.085 . . . . 63.13 108.726 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -50.95 -34.54 29.15 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 127.045 2.138 . . . . 75.03 110.706 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.95 -22.8 59.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.573 1.949 . . . . 61.21 113.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m -94.07 0.8 56.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.222 1.809 . . . . 74.34 112.157 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.16 101.02 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.595 0.758 . . . . 74.11 109.301 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.67 169.69 17.61 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.403 1.081 . . . . 70.35 110.244 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.65 132.3 27.22 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.996 1.319 . . . . 70.12 108.757 164.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -79.6 169.77 17.52 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.395 2.278 . . . . 72.32 110.017 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.01 -37.43 79.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.913 1.685 . . . . 74.24 109.867 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.72 -15.59 62.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.571 0.748 . . . . 74.4 111.827 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.35 3.18 57.66 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 126.313 1.911 . . . . 73.53 113.811 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -57.73 -87.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 129.172 2.989 . . . . 71.33 111.123 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.72 125.89 2.99 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.107 1.336 . . . . 44.14 109.964 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -136.3 168.39 19.5 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.393 1.077 . . . . 74.42 109.861 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.8 mt -146.08 153.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 127.182 2.193 . . . . 73.14 106.202 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 143.27 27.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.672 1.589 . . . . 64.15 109.553 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.66 -24.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 114.834 -2.508 . . . . 75.44 113.675 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 23.15 -72.67 0.0 OUTLIER Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.949 3.166 . . . . 33.21 115.927 159.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -13.12 15.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.883 3.273 . . . . 75.52 115.288 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.66 -20.37 65.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.189 0.596 . . . . 62.3 110.519 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.37 31.6 17.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.302 1.841 . . . . 71.41 113.283 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.9 mt -82.96 123.06 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.513 1.125 . . . . 74.34 108.821 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -86.39 143.46 27.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.382 1.473 . . . . 75.43 110.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.6 tp -125.86 159.13 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.259 -1.756 . . . . 75.44 106.259 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -63.78 140.38 58.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.405 -0.961 . . . . 55.23 108.405 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 p -139.61 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.962 0.505 . . . . 75.43 110.446 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.12 141.67 24.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.349 -0.845 . . . . 75.41 108.875 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 110.28 15.02 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.371 -1.344 . . . . 72.44 107.371 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -64.59 -16.98 63.55 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.638 0.775 . . . . 72.42 111.724 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -15.62 63.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.51 1.124 . . . . 74.01 113.941 171.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -155.59 6.01 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.38 0.991 . . . . 64.44 113.519 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.94 51.54 15.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.073 2.149 . . . . 73.52 111.636 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 pt -119.35 152.58 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.362 2.265 . . . . 42.15 108.76 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.37 145.25 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.315 -0.995 . . . . 74.24 108.315 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -150.67 178.03 9.49 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.138 2.575 . . . . 62.14 109.284 -166.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.18 157.78 17.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.873 1.669 . . . . 64.12 108.638 163.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.58 160.77 41.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.116 -0.99 . . . . 55.44 110.139 154.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.543 HH11 ' CD2' ' A' ' 75' ' ' LEU . 7.0 tmm_? -98.95 131.31 45.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.212 1.005 . . . . 73.11 110.268 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.64 156.53 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.943 1.297 . . . . 73.31 109.02 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' CD2' HH11 ' A' ' 73' ' ' ARG . 55.9 mt -123.75 -51.7 1.81 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.969 1.308 . . . . 70.01 110.889 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -135.43 163.81 29.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.079 1.352 . . . . 75.41 108.895 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.26 167.95 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.298 1.039 . . . . 73.54 108.974 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -137.71 151.24 48.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.712 1.205 . . . . 70.52 109.281 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 6.4 tmm_? -142.04 144.5 33.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.926 1.29 . . . . 72.13 109.929 170.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -144.83 158.98 43.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.751 -1.574 . . . . 64.03 106.751 165.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -89.96 151.26 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.955 -1.128 . . . . 64.1 107.955 167.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -146.8 154.79 41.78 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.468 1.507 . . . . 70.15 110.367 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.93 111.87 3.05 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.461 -1.311 . . . . 73.01 107.461 167.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.63 -160.02 33.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.619 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' N ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -113.89 117.23 30.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.481 1.112 . . . . 74.21 108.738 -173.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 148' ' ' TYR . 2.6 mm? -98.4 165.13 11.99 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.587 1.155 . . . . 50.1 107.987 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 mm -78.85 132.76 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.458 1.903 . . . . 75.3 107.377 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -128.22 59.68 1.5 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.942 1.697 . . . . 74.21 107.357 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.53 HG23 HG13 ' A' ' 140' ' ' VAL . 37.8 mt -56.89 133.73 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.91 -2.256 . . . . 64.15 104.91 162.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -117.2 164.2 15.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.319 -1.734 . . . . 74.44 106.319 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.2 p -137.03 169.64 17.43 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 121.73 -0.606 . . . . 22.32 110.492 -168.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -60.99 -28.93 69.38 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 73.23 110.727 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.92 3.43 10.18 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.365 1.466 . . . . 63.32 112.521 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 59.28 13.13 2.92 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.473 1.909 . . . . 75.31 113.114 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.553 ' HG3' HH11 ' A' ' 95' ' ' ARG . 0.1 OUTLIER -71.41 162.56 29.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 118.318 -1.353 . . . . 63.5 107.487 166.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -156.69 176.64 12.46 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 128.274 2.63 . . . . 73.3 106.463 171.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -141.75 -179.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.637 1.575 . . . . 71.24 109.996 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.5 m -150.56 97.35 2.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.58 1.152 . . . . 74.52 110.287 168.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -146.39 174.47 11.35 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.426 1.49 . . . . 74.32 111.035 -176.388 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -73.17 172.74 10.53 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.342 0.974 . . . . 53.32 108.65 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -77.36 7.53 5.21 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.06 -1.025 . . . . 72.55 112.001 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.42 39.24 2.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.245 0.929 . . . . 52.1 111.297 -167.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -99.13 137.58 20.45 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 117.059 -1.448 . . . . 72.13 112.368 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.23 94.93 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 124.317 3.344 . . . . 65.41 113.666 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.18 178.82 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.138 0.975 . . . . 73.22 109.192 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.48 134.26 50.98 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.499 -0.751 . . . . 75.53 110.791 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.01 155.86 38.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.106 1.362 . . . . 72.02 109.398 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -86.32 125.7 33.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.261 0.553 . . . . 45.23 110.945 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -98.4 89.43 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.525 -2.028 . . . . 73.41 105.525 153.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.98 31.16 8.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.789 1.236 . . . . 50.54 113.603 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.66 -8.32 39.96 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.432 -1.205 . . . . 72.35 113.951 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 159.83 27.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 104.651 -2.351 . . . . 65.42 104.651 160.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.262 7.3 p -106.93 104.35 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.093 0.957 . . . . 62.3 109.953 170.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -91.29 160.08 15.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.73 1.612 . . . . 75.34 107.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.62 115.2 20.43 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.336 1.854 . . . . 75.1 108.039 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 116' ' ' ILE . 1.5 pt -143.85 172.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.753 1.621 . . . . 74.13 109.468 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.16 143.75 26.87 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.386 0.539 . . . . 63.11 111.565 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.71 -27.65 65.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.587 -0.72 . . . . 74.43 112.815 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -29.22 68.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.636 1.107 . . . . 73.5 111.953 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -79.58 -32.54 41.98 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.095 1.358 . . . . 74.43 111.661 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.99 63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 130.381 3.473 . . . . 64.15 110.906 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -95.93 -169.24 1.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.351 1.06 . . . . 73.42 108.991 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.0 -7.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.653 -1.279 . . . . 71.24 114.106 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.39 -12.81 69.32 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 117.799 -1.556 . . . . 55.32 111.687 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.06 119.63 35.36 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 121.132 2.466 . . . . 62.41 107.07 -164.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.37 115.52 21.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.58 HG23 ' OD1' ' A' ' 138' ' ' ASP . 6.8 tt -79.9 159.24 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.405 1.082 . . . . 72.44 109.96 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.03 129.95 36.98 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.592 1.557 . . . . 73.43 110.883 167.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.5 155.44 47.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.811 1.645 . . . . 43.24 110.195 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -68.51 156.36 65.84 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.5 2.134 . . . . 70.24 110.313 165.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -141.04 -176.96 4.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.828 1.651 . . . . 74.53 107.634 164.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -25.17 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.014 2.526 . . . . 71.34 112.506 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -120.17 -4.95 9.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.325 -0.845 . . . . 72.21 113.091 170.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.6 p -132.67 170.06 15.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.24 1.382 . . . . 41.31 111.333 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.06 157.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.531 -0.731 . . . . 73.22 109.161 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.03 -177.25 4.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.587 2.755 . . . . 74.33 106.558 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 88.4 mt -126.12 160.86 29.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.162 0.985 . . . . 72.43 110.666 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.58 ' OD1' HG23 ' A' ' 127' ' ' ILE . 11.5 p-10 -154.05 158.61 40.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.858 1.663 . . . . 65.12 111.858 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -106.04 150.65 25.54 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.226 1.411 . . . . 74.51 109.699 -172.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 89' ' ' ILE . 41.9 t -95.6 1.28 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.907 1.283 . . . . 74.23 113.72 -166.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.4 pt 24.82 -86.8 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 127.459 2.304 . . . . 74.3 116.655 171.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.34 123.17 43.39 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 126.841 2.056 . . . . 51.33 107.811 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.47 119.97 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.388 -1.338 . . . . 74.32 107.388 170.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.25 -166.04 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.62 1.968 . . . . 75.21 108.196 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 p -133.18 165.22 25.29 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.047 1.739 . . . . 71.02 109.311 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.57 -175.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.182 1.393 . . . . 73.14 108.668 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -136.86 68.96 1.41 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.529 1.157 . . . . 72.01 109.394 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.43 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.8 t80 -80.21 133.56 36.03 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.019 -1.051 . . . . 55.12 111.029 -169.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -136.03 69.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.944 -1.132 . . . . 73.21 107.944 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.82 -120.56 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 51.3 110.115 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -121.73 163.28 19.34 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.002 -0.705 . . . . 73.13 110.041 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.55 147.02 28.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 127.379 2.272 . . . . 75.15 106.563 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.589 ' CD2' HG21 ' A' ' 29' ' ' VAL . 69.0 m-85 -141.4 164.53 29.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.356 0.662 . . . . 72.44 109.296 -171.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.52 171.47 18.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 119.537 -0.268 . . . . 72.44 111.519 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.6 118.4 19.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.928 1.691 . . . . 74.53 109.413 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 57.6 m -73.08 112.77 9.43 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.025 -1.472 . . . . 71.55 107.025 166.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.94 75.41 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.516 -2.031 . . . . 41.52 105.516 169.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.11 -0.15 38.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.71 2.404 . . . . 74.11 114.134 -162.058 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.93 -77.32 0.1 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 128.283 2.633 . . . . 71.22 110.995 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -105.39 5.52 31.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.839 1.655 . . . . 74.0 111.694 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.6 m80 50.29 34.4 8.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.969 2.507 . . . . 64.41 112.035 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 p -148.51 155.33 41.01 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.425 1.89 . . . . 71.11 108.304 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -159.25 -168.13 2.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.256 1.022 . . . . 73.42 109.772 178.24 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.48 141.38 14.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 105.89 -1.893 . . . . 75.55 105.89 155.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -144.71 148.85 34.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 72.41 109.398 149.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 144.3 -165.92 27.32 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.109 -0.994 . . . . 61.33 112.119 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -111.26 166.82 10.77 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 119.708 -2.054 . . . . 70.11 111.232 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.24 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 128.319 2.648 . . . . 74.12 112.667 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 44.8 mt-10 -121.84 -18.34 7.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.689 1.196 . . . . 70.34 112.75 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.29 158.66 21.24 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.829 1.204 . . . . 70.04 113.537 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.454 ' CE1' HG23 ' A' ' 97' ' ' ILE . 78.7 m-85 -105.29 154.42 20.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 127.096 2.158 . . . . 73.02 109.686 -174.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.5 75.99 5.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.084 0.953 . . . . 62.44 108.448 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 173' ' ' VAL . 11.8 m -93.5 178.92 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.832 1.253 . . . . 74.43 110.315 -173.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.0 m -65.8 161.99 19.75 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.278 -0.889 . . . . 63.0 110.111 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -143.79 39.43 1.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.199 1.8 . . . . 75.15 108.295 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m -62.63 104.78 0.56 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.825 -1.176 . . . . 74.34 107.825 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 m -68.32 -47.59 67.15 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.245 1.018 . . . . 64.31 108.609 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.21 101.79 1.88 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.382 -1.087 . . . . 72.52 110.382 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 p -50.38 121.12 5.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.641 1.176 . . . . 64.35 110.01 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.4 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.3 tp 52.68 -71.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.596 2.758 . . . . 73.15 112.921 -165.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -79.63 114.12 18.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.507 1.123 . . . . 74.22 108.982 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.68 107.46 12.82 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.144 -1.058 . . . . 70.15 108.144 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 146.85 10.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.129 0.572 . . . . 72.1 112.423 -174.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -164.73 160.08 19.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.251 1.02 . . . . 73.31 109.956 155.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -68.13 122.19 17.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.452 -1.314 . . . . 74.02 107.452 155.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.5 m80 . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.461 1.905 . . . . 74.43 110.607 -173.646 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.658 -0.211 . . . . 73.01 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -74.99 -143.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.278 -1.378 . . . . 62.21 107.278 155.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m 95.55 3.96 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.797 2.839 . . . . 72.41 110.686 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -25.32 -71.81 0.02 OUTLIER Glycine 0 C--N 1.34 0.785 0 C-N-CA 130.581 3.944 . . . . 74.3 114.344 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 45.77 72.09 0.24 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.469 1.907 . . . . 72.12 111.276 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -136.06 172.21 13.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.288 1.035 . . . . 62.31 108.726 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.91 176.7 25.7 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 125.316 1.436 . . . . 73.42 111.437 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -177.91 164.13 1.87 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 129.226 3.01 . . . . 74.35 106.125 152.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.07 167.2 22.0 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.584 1.154 . . . . 72.3 109.582 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . -71.71 -140.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.659 0.784 . . . . 61.43 111.84 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 5.5 t80 -120.73 -38.97 2.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.618 1.567 . . . . 74.33 112.012 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.85 30.55 6.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.645 1.178 . . . . 73.3 111.496 -163.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 144.9 29.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 O-C-N 121.507 -0.746 . . . . 62.32 111.993 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.15 141.72 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.272 2.648 . . . . 74.12 113.786 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 25' ' ' ILE . 13.5 pt -114.66 16.84 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.981 1.104 . . . . 73.14 113.981 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 34.92 68.83 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.225 2.21 . . . . 73.01 113.964 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.0 mt -56.15 155.73 6.31 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.153 -0.684 . . . . 51.23 109.153 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -61.86 -27.2 68.62 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.186 -0.321 . . . . 72.41 111.166 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.38 -59.06 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.347 -0.612 . . . . 64.53 109.347 169.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.59 32.47 0.61 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.943 1.735 . . . . 71.14 111.219 -170.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 -11.27 59.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.299 -1.706 . . . . 70.53 114.933 -166.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 16.9 mm 44.58 74.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 127.205 2.202 . . . . 71.45 110.196 175.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.02 148.51 18.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 125.279 1.432 . . . . 55.22 108.789 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.67 131.75 50.02 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.846 2.458 . . . . 74.32 109.591 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.515 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.04 -57.57 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.731 1.613 . . . . 75.22 109.035 175.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -58.95 -45.9 94.46 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-O 118.395 -1.225 . . . . 61.43 110.057 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.4 -57.07 13.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.966 1.706 . . . . 65.24 111.636 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -47.74 -54.55 11.85 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.949 1.7 . . . . 75.35 110.334 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 74.0 t -70.56 -43.45 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.055 -0.975 . . . . 61.14 110.552 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.93 -31.87 73.31 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 118.937 -1.105 . . . . 72.34 112.151 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -50.21 -46.91 54.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.449 1.5 . . . . 65.21 109.785 169.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -69.61 -44.54 70.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.907 -0.775 . . . . 75.13 108.907 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -58.26 -28.47 64.95 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.369 1.441 . . . . 74.2 112.301 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -85.0 -25.31 27.78 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 125.582 1.553 . . . . 64.44 112.58 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -93.97 -58.02 2.37 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.998 -1.853 . . . . 62.33 105.998 175.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -86.63 43.76 1.1 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.78 2.032 . . . . 71.12 108.943 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -49.59 -38.04 30.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 127.324 2.249 . . . . 62.32 111.255 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -95.08 -2.75 49.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.433 0.901 . . . . 61.0 113.433 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -82.1 -6.98 59.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.009 0.822 . . . . 63.42 112.365 165.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.07 99.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 119.579 1.081 . . . . 70.0 108.612 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -85.4 108.08 17.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.665 1.986 . . . . 72.11 107.741 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.53 124.72 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.412 -1.699 . . . . 72.1 106.412 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.94 137.82 37.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.92 -1.511 . . . . 74.02 106.92 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -65.73 -42.7 90.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.997 -0.281 . . . . 74.52 111.552 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -120.58 58.07 0.95 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.606 -1.627 . . . . 72.24 106.606 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.21 -133.83 1.55 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.174 -0.77 . . . . 65.13 111.174 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -101.27 0.42 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.083 0.772 . . . . 64.31 113.083 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.98 104.11 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 108.51 -1.836 . . . . 34.52 108.51 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -126.27 171.15 11.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.3 1.84 . . . . 74.21 111.249 -170.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mt -138.22 133.85 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.25 -2.129 . . . . 72.33 105.25 166.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 122.32 22.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.454 -1.684 . . . . 45.31 106.454 160.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.306 2.4 pp -126.84 23.92 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 123.091 1.424 . . . . 74.43 109.593 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -26.63 69.51 Favored Glycine 0 CA--C 1.523 0.555 0 O-C-N 120.537 -1.352 . . . . 72.22 112.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -12.41 61.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.186 1.794 . . . . 74.22 115.402 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.15 -14.75 63.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.011 1.278 . . . . 73.03 113.235 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 m120 60.77 11.26 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.266 2.626 . . . . 72.32 114.004 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.49 130.26 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.953 -1.092 . . . . 72.51 108.832 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.92 154.1 20.03 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.562 1.145 . . . . 74.41 110.976 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.79 150.19 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.129 2.172 . . . . 71.34 108.005 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -72.86 109.81 6.71 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.272 -1.381 . . . . 72.24 107.272 169.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -99.01 -175.2 2.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.058 1.743 . . . . 65.44 107.274 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.435 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -135.09 128.56 32.43 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.801 -1.926 . . . . 72.1 105.801 164.01 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -80.47 97.13 6.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.971 -1.492 . . . . 72.51 106.971 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB2' HG21 ' A' ' 162' ' ' THR . 50.6 tttt -50.88 -23.15 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 117.835 -1.079 . . . . 75.12 112.543 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -43.05 -38.83 2.47 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.025 1.73 . . . . 72.23 113.483 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -142.82 15.12 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.767 1.227 . . . . 74.23 110.54 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt 56.57 44.59 23.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.987 1.315 . . . . 62.24 111.423 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -111.04 152.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.712 1.605 . . . . 74.33 108.521 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.14 118.33 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 106.477 -1.675 . . . . 70.24 106.477 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' C ' ' HE2' ' A' ' 60' ' ' LYS . 8.7 mm-40 -144.36 175.8 9.83 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.5 1.52 . . . . 71.24 109.334 -175.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.52 141.02 29.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.641 -1.287 . . . . 64.1 111.327 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 154.89 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.6 1.96 . . . . 71.11 108.686 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -91.21 156.71 17.64 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.181 -1.044 . . . . 61.45 108.181 168.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.603 HG21 HD11 ' A' ' 155' ' ' LEU . 3.1 mp -95.52 154.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.793 1.237 . . . . 70.25 108.697 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.0 -52.12 2.81 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.904 1.682 . . . . 60.21 110.615 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -134.12 162.05 33.18 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.465 -0.772 . . . . 71.15 110.01 -171.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.632 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.1 155.96 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.548 1.539 . . . . 74.22 108.436 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.64 166.24 20.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.324 1.45 . . . . 74.44 108.165 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -137.4 143.94 42.17 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 73.24 109.224 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -141.21 164.46 30.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 130.161 3.384 . . . . 72.45 108.819 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -116.74 159.0 22.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.06 -1.65 . . . . 73.45 111.264 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -150.67 155.59 39.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.803 0.811 . . . . 72.52 113.164 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 117.58 2.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.428 1.891 . . . . 73.13 106.4 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.88 -165.23 32.07 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.607 1.549 . . . . 31.35 113.733 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -93.2 129.89 39.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.423 0.689 . . . . 74.44 110.513 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.9 mt -111.26 159.55 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.476 1.11 . . . . 71.2 109.702 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.21 135.17 26.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.967 1.307 . . . . 71.13 107.842 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -128.78 81.15 2.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.484 1.914 . . . . 75.22 105.961 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 140' ' ' VAL . 42.5 mt -63.97 110.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.19 -2.522 . . . . 73.12 104.19 158.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -85.98 162.57 18.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 161.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -142.88 164.69 29.4 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.371 1.869 . . . . 60.33 107.313 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.78 -26.83 68.81 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.449 -0.782 . . . . 71.33 112.205 -159.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -74.42 27.35 0.08 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.527 1.931 . . . . 72.2 111.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 50.77 14.48 0.18 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.195 2.198 . . . . 74.2 113.641 -168.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.593 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 14.3 ttm105 -85.82 162.09 18.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.806 -1.184 . . . . 73.32 108.766 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 9.8 pt-20 -175.72 168.3 3.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.985 -1.007 . . . . 74.14 110.793 -168.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 8.4 pt -140.6 178.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.782 1.633 . . . . 73.14 109.179 -174.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.07 97.28 2.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.319 -1.734 . . . . 74.5 106.319 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.94 162.44 41.31 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 74.14 111.087 -172.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 m -70.25 153.16 43.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.747 -1.205 . . . . 73.34 107.747 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -73.64 -13.37 60.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.556 0.947 . . . . 54.43 113.556 -167.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.29 37.75 2.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.284 1.04 . . . . 61.13 109.564 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -97.03 129.84 31.36 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.925 1.29 . . . . 53.12 107.65 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.69 148.72 87.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.871 2.381 . . . . 74.42 112.359 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 m -144.53 169.13 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 129.565 3.146 . . . . 75.0 107.933 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -107.87 141.52 39.36 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.651 -0.655 . . . . 74.34 109.682 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.62 159.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.199 1.4 . . . . 64.31 109.042 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.478 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 17.2 t -93.39 134.66 35.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.197 1.475 . . . . 54.34 110.31 169.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -103.36 85.44 2.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 111.96 -2.382 . . . . 52.12 106.167 157.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.45 27.42 8.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.683 1.193 . . . . 61.24 113.66 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 119.32 -14.69 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.284 -1.287 . . . . 75.31 113.145 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 176.49 9.74 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.721 1.261 . . . . 55.45 108.009 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.43 118.89 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.894 1.278 . . . . 60.45 108.064 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -118.57 158.79 24.75 Favored 'General case' 0 CA--C 1.526 0.03 0 C-N-CA 123.988 0.915 . . . . 72.14 108.931 174.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -121.59 115.92 23.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.89 2.476 . . . . 74.34 104.505 -176.462 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.7 177.69 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.704 1.202 . . . . 74.53 109.258 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -94.07 153.67 18.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.859 0.754 . . . . 65.32 111.324 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.0 -22.95 42.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.977 1.311 . . . . 73.33 113.758 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -60.16 -43.67 95.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.958 1.254 . . . . 63.11 111.132 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.15 -22.95 57.77 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.224 0.92 . . . . 72.11 113.438 -170.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.21 62.87 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.904 2.081 . . . . 61.31 111.004 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -78.98 -177.95 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.054 1.342 . . . . 72.32 110.162 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 11.1 p -58.6 -4.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 127.573 2.349 . . . . 74.3 114.163 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 15.87 10.05 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.754 2.121 . . . . 73.34 112.155 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.2 159.27 34.79 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.487 1.643 . . . . 74.11 107.498 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -119.91 110.61 16.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.34 -0.985 . . . . 53.25 108.34 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.32 138.93 19.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 124.813 1.245 . . . . 63.24 108.438 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 108' ' ' SER . 11.1 m-85 -75.49 136.0 40.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.559 -0.904 . . . . 70.31 108.559 171.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.0 151.94 79.84 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 124.207 1.003 . . . . 40.45 112.735 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.35 138.32 29.9 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.106 2.537 . . . . 54.32 108.91 170.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -120.92 -157.47 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.524 2.329 . . . . 75.04 105.848 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -37.86 -74.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.179 1.792 . . . . 75.01 112.507 -169.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -121.4 -1.0 9.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.17 0.896 . . . . 72.54 113.24 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.6 p -123.64 169.93 10.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 124.636 1.174 . . . . 74.33 110.541 -168.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 tp -81.66 157.81 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.223 -0.658 . . . . 74.41 109.223 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.6 -176.54 5.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.078 2.951 . . . . 73.02 106.708 174.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.1 161.72 14.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.456 -1.313 . . . . 73.5 107.456 156.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -154.99 108.39 2.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.456 1.502 . . . . 74.12 108.135 173.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.02 144.73 33.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 129.929 3.292 . . . . 64.22 113.266 -162.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 89' ' ' ILE . 66.2 t -77.5 0.41 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.561 1.144 . . . . 74.01 113.599 -170.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.2 pt 27.64 -75.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 118.078 2.621 . . . . 74.31 118.078 167.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.48 128.89 56.33 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.607 1.563 . . . . 73.05 107.986 170.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.27 131.5 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.683 -1.229 . . . . 64.03 107.683 167.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.67 171.62 14.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.318 1.847 . . . . 75.11 108.42 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.49 138.79 50.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.49 -168.41 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.668 1.187 . . . . 73.42 108.569 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -136.65 135.59 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.068 -1.456 . . . . 63.2 107.068 167.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -142.55 134.73 27.45 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.581 0.753 . . . . 74.34 110.233 -170.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -138.1 70.89 1.39 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.756 -1.942 . . . . 55.34 105.756 -167.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.09 -166.61 12.14 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.524 1.059 . . . . 75.11 112.393 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -88.42 157.29 18.73 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.965 -1.315 . . . . 54.21 109.413 165.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 10' ' ' ALA . 10.2 pt -126.55 170.34 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.609 1.564 . . . . 64.55 111.16 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.686 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.9 147.69 13.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.156 -1.424 . . . . 73.15 107.156 -170.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -118.93 158.24 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.537 0.735 . . . . 65.3 110.692 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.603 HD11 HG21 ' A' ' 74' ' ' ILE . 19.7 tp -117.38 137.57 52.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.459 1.503 . . . . 65.32 109.231 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 22.8 m -68.29 -59.47 3.18 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.353 0.597 . . . . 52.14 110.306 -167.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.325 3.2 t 40.67 67.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 128.975 2.91 . . . . 75.1 112.694 -170.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.61 -11.88 61.19 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.499 -0.773 . . . . 71.41 110.934 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -65.2 0.7 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.3 1.04 . . . . 74.54 109.682 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.13 2.34 12.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.137 0.575 . . . . 74.21 112.27 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.6 m170 54.99 31.34 15.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.402 1.481 . . . . 64.34 111.887 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -149.69 151.62 33.99 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.643 -1.286 . . . . 62.22 110.291 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.2 p90 -154.8 172.53 17.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.591 1.156 . . . . 75.45 110.511 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.12 124.95 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.026 1.73 . . . . 64.32 108.929 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.93 148.46 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.726 0.811 . . . . 53.21 109.907 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 151.12 -175.47 30.04 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.26 -1.136 . . . . 73.13 110.26 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -90.94 166.05 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.307 -1.702 . . . . 71.0 110.24 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.06 -68.23 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 130.587 3.555 . . . . 75.1 113.054 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.593 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 12.7 mt-10 -122.06 -18.06 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.632 1.973 . . . . 73.54 114.174 175.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 79.29 166.74 32.49 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 124.249 0.928 . . . . 74.35 111.816 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 25.3 m-85 -121.06 155.26 34.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.139 2.576 . . . . 75.45 105.774 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -77.03 141.14 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.833 -1.173 . . . . 75.13 107.833 167.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . 0.273 46.0 t -135.27 175.82 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.966 1.306 . . . . 75.23 107.6 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 52.7 m -95.89 133.61 39.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.324 1.45 . . . . 43.42 110.565 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -115.13 173.78 6.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.883 1.673 . . . . 54.33 107.108 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.4 m -165.53 -32.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.057 1.743 . . . . 64.5 110.134 160.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 44.6 p 63.65 174.52 0.17 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.01 2.124 . . . . 74.45 111.075 -151.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -119.74 77.95 0.31 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.056 -1.217 . . . . 53.45 110.056 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.4 t -138.77 -146.32 0.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.956 1.702 . . . . 72.04 108.467 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.8 tp -26.5 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.373 1 C-N-CA 132.963 4.505 . . . . 65.33 115.256 167.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.47 161.45 37.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.055 -1.831 . . . . 72.44 106.055 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -61.4 153.85 25.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.868 0.758 . . . . 74.35 109.254 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -70.82 131.54 43.95 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.527 -0.916 . . . . 75.42 108.527 -171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -71.17 156.41 39.61 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.824 -0.806 . . . . 72.52 108.824 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -128.04 -41.88 1.59 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.813 0.845 . . . . 74.33 111.951 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 52.4 t60 . . . . . 0 C--O 1.256 1.415 0 CA-C-O 116.649 -1.643 . . . . 71.34 108.691 -167.625 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtp . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 108.581 -0.896 . . . . 75.3 108.581 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.15 166.3 0.84 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.503 -0.925 . . . . 75.15 108.503 158.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -58.2 -72.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.329 -1.36 . . . . 63.45 107.329 157.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.43 67.03 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -1.669 . . . . 60.23 108.927 -165.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.88 143.43 28.23 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.694 -1.595 . . . . 64.54 106.694 164.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -163.34 139.5 6.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.825 1.65 . . . . 64.14 108.245 -174.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.97 -171.94 21.77 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.5 1.524 . . . . 53.2 111.095 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -154.99 -173.86 4.75 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.198 1.799 . . . . 54.41 109.614 -172.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.64 170.62 9.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.693 1.597 . . . . 75.35 110.041 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.75 162.33 19.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.445 -0.784 . . . . 45.03 111.927 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 13.6 t80 -47.65 -42.55 24.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.259 2.224 . . . . 74.04 113.538 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.97 16.34 26.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.462 1.483 . . . . 74.12 112.779 -160.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -86.98 120.16 71.41 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.946 2.099 . . . . 75.33 110.481 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -56.77 145.37 83.37 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.385 2.723 . . . . 72.13 113.981 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.469 ' CG2' HG13 ' A' ' 25' ' ' ILE . 45.2 pt -107.87 -10.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.232 1.413 . . . . 60.45 113.156 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 56.14 79.43 0.17 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.393 1.077 . . . . 72.34 110.665 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 155.74 2.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.173 -0.954 . . . . 71.25 109.551 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.09 -38.32 51.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.011 0.925 . . . . 51.23 110.362 169.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.09 -17.05 61.0 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.355 0.872 . . . . 53.14 113.355 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.07 33.7 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 118.486 -1.175 . . . . 73.2 113.142 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.32 -33.06 63.0 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.253 1.575 . . . . 74.34 115.253 -159.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mm 49.21 88.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.294 2.238 . . . . 71.41 110.121 -167.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 148.09 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.95 2.5 . . . . 61.44 107.588 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.64 141.41 58.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.713 1.605 . . . . 70.54 108.143 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -50.39 -51.67 17.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 169.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -57.23 -53.5 44.27 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 118.003 -1.443 . . . . 73.11 110.116 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -60.54 -43.86 96.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 1.166 . . . . 61.14 112.433 -173.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -58.4 -56.61 19.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.777 0.831 . . . . 65.44 109.34 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 153' ' ' TYR . 54.8 t -70.93 -41.69 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.983 -0.553 . . . . 64.12 109.973 -172.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -29.69 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.1 -0.953 . . . . 72.23 111.855 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.1 -43.88 78.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.3 1.864 . . . . 72.42 111.273 172.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 20.0 m-85 -67.64 -43.22 80.85 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.24 -34.88 75.86 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.407 1.458 . . . . 75.43 112.679 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -47.35 66.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.057 1.299 . . . . 72.34 108.928 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.7 mtpp -76.43 -56.9 4.21 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.31 -1.737 . . . . 74.43 106.31 -169.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.1 m-30 -91.32 40.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.39 1.876 . . . . 74.42 107.759 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -37.43 68.63 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 121.165 -0.96 . . . . 73.24 111.453 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.56 81.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.485 1.914 . . . . 71.35 110.382 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -80.51 0.26 34.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.628 1.571 . . . . 55.34 113.354 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.78 99.22 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.02 -1.104 . . . . 63.34 108.02 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.19 161.34 26.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.295 -1.372 . . . . 71.42 107.295 162.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.37 142.21 47.12 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.888 -1.523 . . . . 70.53 106.888 171.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.15 176.71 9.42 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.991 0.807 . . . . 73.13 110.315 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.28 -12.71 60.94 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.426 1.49 . . . . 70.33 111.693 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.47 5.45 17.71 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.978 -1.076 . . . . 74.31 111.359 162.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 30.21 77.28 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 126.922 2.201 . . . . 55.3 113.234 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' A' ' 80' ' ' LYS . 2.6 t80 -77.02 -100.12 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.342 1.857 . . . . 71.11 109.47 -170.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.84 127.95 2.02 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.915 -1.274 . . . . 72.41 109.915 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -155.47 161.41 40.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.164 0.982 . . . . 64.3 111.067 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.44 133.19 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.835 -1.913 . . . . 64.2 105.835 170.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.22 133.45 47.96 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.872 -1.158 . . . . 73.02 107.872 163.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.06 17.71 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.648 0.779 . . . . 54.32 109.785 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.89 8.66 4.34 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 126.083 1.802 . . . . 71.33 113.979 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -109.88 -15.41 14.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.691 1.596 . . . . 74.12 109.661 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.16 -34.09 69.92 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.198 0.999 . . . . 73.32 110.338 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 58.9 14.11 3.14 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.301 1.963 . . . . 71.23 116.301 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.84 127.65 29.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 127.977 2.511 . . . . 71.41 109.276 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -82.32 141.04 33.2 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.546 0.688 . . . . 74.2 111.372 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.9 153.57 17.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 127.848 2.459 . . . . 75.2 106.675 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -72.19 110.7 6.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.592 -1.633 . . . . 74.15 106.592 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 171.42 7.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.17 -1.419 . . . . 61.43 107.17 -174.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -140.25 122.7 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.337 -1.356 . . . . 74.44 107.337 -168.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.5 108.22 18.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.893 -1.151 . . . . 70.23 107.893 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 21.5 ttpp -51.48 -31.42 23.47 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.424 1.49 . . . . 73.54 112.789 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.76 -28.38 15.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.765 2.826 . . . . 74.5 112.957 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 t -150.05 23.06 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.461 -0.774 . . . . 72.51 111.487 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.87 40.2 8.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.414 1.485 . . . . 52.14 112.18 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.81 -172.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.8 0.84 . . . . 70.54 110.095 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -116.92 135.7 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.298 2.239 . . . . 71.43 105.79 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.02 167.51 21.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.113 2.165 . . . . 73.5 107.182 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -101.2 118.92 37.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.231 -1.766 . . . . 63.52 106.231 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -133.37 163.77 28.6 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.122 -1.436 . . . . 65.14 107.122 170.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -95.61 -160.92 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.293 0.951 . . . . 73.13 110.512 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 155' ' ' LEU . 77.2 mt -132.62 146.26 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 105.572 -2.01 . . . . 71.51 105.572 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.65 -45.52 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.507 1.123 . . . . 64.43 111.191 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.595 ' HB2' HG21 ' A' ' 156' ' ' THR . 59.7 mtt180 -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.21 -1.556 . . . . 71.32 108.417 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.14 158.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.991 -0.744 . . . . 71.21 108.991 177.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -129.11 179.33 5.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.587 1.555 . . . . 72.2 108.914 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -170.7 146.21 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.322 1.849 . . . . 73.03 108.982 158.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 47' ' ' PHE . 71.9 tttt -143.8 166.5 24.74 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.618 1.567 . . . . 72.01 107.455 164.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 14.8 ttpt -89.02 165.65 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.46 -1.4 . . . . 70.42 109.223 168.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 91.9 t80 -150.64 158.17 43.83 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.839 1.255 . . . . 74.12 109.9 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 p -155.13 123.98 6.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.65 1.18 . . . . 51.23 107.848 160.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.8 178.19 35.51 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 120.036 1.289 . . . . 73.52 114.167 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.735 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.87 100.85 8.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.334 0.654 . . . . 61.05 110.789 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.13 152.13 23.61 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.81 -1.181 . . . . 63.23 107.81 167.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.93 137.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.791 1.636 . . . . 54.41 108.943 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -117.5 80.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.427 -1.715 . . . . 73.4 106.868 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.6 137.25 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.848 -1.908 . . . . 73.13 105.848 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.7 m -117.31 171.83 7.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.079 -1.822 . . . . 70.32 106.079 159.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -139.32 172.85 12.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.911 1.284 . . . . 74.22 109.106 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -63.7 -29.27 70.52 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.063 -1.023 . . . . 65.55 110.742 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.64 2.48 5.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.113 1.365 . . . . 74.32 113.945 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 62.58 16.69 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.494 1.518 . . . . 64.14 111.8 -168.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -70.0 153.46 43.19 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.814 -1.18 . . . . 54.32 107.814 168.169 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.57 163.29 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.942 1.697 . . . . 75.51 107.564 -170.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -148.96 172.64 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.02 1.728 . . . . 74.13 108.955 -170.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.3 m -146.12 92.43 2.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.666 -1.235 . . . . 70.12 107.666 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.88 170.21 18.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.315 1.446 . . . . 63.42 110.832 -172.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 p -70.19 166.99 18.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.964 1.256 . . . . 54.41 112.15 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.3 1.4 p-80 -67.84 -31.62 71.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.22 -0.925 . . . . 63.53 111.348 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -100.18 39.94 1.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.832 2.453 . . . . 72.33 111.293 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -95.3 128.36 38.82 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.609 -1.186 . . . . 74.41 111.829 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.46 121.77 8.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.551 2.834 . . . . 72.33 111.042 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.76 177.12 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.776 1.631 . . . . 74.22 108.752 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -112.43 149.53 32.44 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.179 -0.951 . . . . 75.13 111.545 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.46 170.32 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 126.006 1.722 . . . . 73.13 108.458 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 p -96.05 137.09 35.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.075 0.94 . . . . 73.21 110.261 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 79.8 1.87 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.776 -1.564 . . . . 73.3 106.776 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 65.42 4.01 2.56 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.196 1.184 . . . . 74.31 114.196 172.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -21.89 2.43 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 120.173 -1.579 . . . . 70.44 112.139 -169.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -102.66 160.58 14.45 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.148 1.379 . . . . 64.41 107.893 -171.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 t -112.91 119.24 60.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.378 -1.712 . . . . 75.13 106.378 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.67 137.2 48.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.445 -0.946 . . . . 43.42 108.445 -170.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -84.0 134.56 34.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.271 1.028 . . . . 72.44 109.519 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 pt -147.78 -179.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.454 1.502 . . . . 64.44 109.717 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -79.38 134.04 36.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.408 1.083 . . . . 74.41 110.225 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.37 -30.75 30.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.328 1.051 . . . . 63.33 113.04 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.65 -26.14 68.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.285 1.857 . . . . 73.43 113.625 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 36.7 mmt -80.89 -26.36 36.89 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.39 1.076 . . . . 72.41 111.554 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.95 63.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.006 2.522 . . . . 53.3 111.468 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -78.96 -177.72 5.71 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.898 -1.126 . . . . 73.15 109.063 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.98 1.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.34 1.856 . . . . 65.51 112.964 159.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.11 -3.96 72.31 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 116.614 -2.214 . . . . 63.23 112.444 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 166.74 21.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.134 1.967 . . . . 61.02 107.734 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 3.4 m-85 -98.38 155.74 17.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.011 -0.995 . . . . 72.43 108.79 163.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.8 tt -122.21 131.37 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.388 1.075 . . . . 55.03 109.462 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.8 m-85 -71.7 117.77 13.7 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 118.585 -0.721 . . . . 65.41 109.909 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.566 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.1 pp -129.4 157.06 77.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.639 1.175 . . . . 75.42 112.99 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.31 147.3 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.57 2.18 . . . . 63.03 109.563 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.42 -178.36 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.262 -1.384 . . . . 53.04 107.262 163.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -24.12 -71.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.464 2.706 . . . . 73.44 112.802 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -121.01 1.22 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.382 2.673 . . . . 74.42 113.85 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.1 p -128.61 -173.88 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.828 1.651 . . . . 65.04 112.723 -168.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.25 157.45 5.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.868 -1.16 . . . . 72.04 107.868 166.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -140.92 -177.34 5.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.307 2.243 . . . . 71.54 107.209 165.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 128' ' ' TYR . 1.1 tp -108.76 157.66 18.36 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.555 1.142 . . . . 70.04 110.074 165.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.566 ' CG ' HG12 ' A' ' 129' ' ' ILE 0.306 39.5 p30 -142.79 164.67 29.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 114.396 1.258 . . . . 70.42 114.396 162.309 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -95.26 146.1 24.59 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.063 1.745 . . . . 72.22 107.5 -171.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -98.14 0.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 113.749 1.018 . . . . 71.05 113.749 -160.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 pt 35.31 -53.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 1 C-N-CA 133.019 4.528 . . . . 75.31 120.064 169.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -144.68 133.51 22.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.301 2.64 . . . . 70.33 107.908 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.96 127.28 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.263 1.03 . . . . 75.2 108.318 166.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -140.22 -158.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.392 1.477 . . . . 70.11 107.579 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -139.7 152.49 46.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.386 1.074 . . . . 73.04 108.952 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m -102.59 139.1 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.505 -1.665 . . . . 70.22 106.505 161.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.21 92.8 9.09 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.752 1.614 . . . . 74.43 106.972 166.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -96.81 139.41 32.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.183 0.993 . . . . 75.14 111.345 -168.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -140.69 67.01 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.742 -1.577 . . . . 62.34 106.742 -165.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.0 -172.51 12.83 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 123.72 0.676 . . . . 72.5 111.99 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -81.3 144.47 31.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.178 -0.675 . . . . 71.02 109.178 162.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.54 158.18 34.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 127.638 2.375 . . . . 73.45 108.665 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.662 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -153.81 164.85 37.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.912 -0.773 . . . . 72.3 108.912 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -129.15 147.83 51.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.342 1.457 . . . . 75.22 108.994 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 74' ' ' ILE . 20.0 tp -96.14 153.81 17.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.539 . . . . 74.12 110.686 -171.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 76' ' ' ARG . 2.4 m -107.71 37.83 2.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.722 0.809 . . . . 70.31 111.615 -165.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.85 101.93 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 119.881 -1.762 . . . . 54.32 109.542 -172.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.59 -6.09 57.76 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.49 1.116 . . . . 63.44 110.311 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.35 -67.25 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.779 1.232 . . . . 74.23 108.58 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 6.5 t30 -112.13 4.43 17.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.753 0.821 . . . . 74.34 111.418 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.13 35.1 25.08 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.218 1.007 . . . . 70.31 109.592 -169.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.27 150.78 27.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.947 1.699 . . . . 75.33 108.57 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.67 -178.57 6.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.064 1.302 . . . . 62.03 110.555 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.2 mm -113.36 143.27 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.381 1.472 . . . . 75.14 108.634 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.34 38.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.341 1.056 . . . . 52.35 110.223 165.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 132.58 -169.2 22.45 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 119.035 0.834 . . . . 55.04 112.569 166.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -85.7 167.41 15.31 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.083 1.442 . . . . 70.31 111.841 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.45 -73.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.142 2.977 . . . . 71.23 113.762 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.21 -14.22 7.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.239 1.815 . . . . 62.44 112.493 175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 68.89 160.67 2.12 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 126.484 1.992 . . . . 64.03 112.571 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 97' ' ' ILE . 37.5 m-85 -106.6 151.06 25.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.379 2.272 . . . . 74.21 107.07 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.544 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -78.6 129.56 34.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.407 -1.331 . . . . 71.54 107.407 162.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.01 176.34 7.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.419 -1.326 . . . . 70.54 107.419 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.2 t -65.98 164.52 15.01 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.644 -0.873 . . . . 74.32 108.644 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.38 132.9 20.81 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.544 -1.65 . . . . 64.31 106.544 164.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.9 76.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.436 -1.69 . . . . 75.43 106.436 159.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 t 56.51 21.85 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.727 2.121 . . . . 71.4 116.727 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.6 38.47 93.76 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.844 1.656 . . . . 21.42 111.208 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.98 -176.01 3.24 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.454 2.302 . . . . 51.25 106.305 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 180' ' ' LEU 0.257 8.9 tt 63.59 121.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.117 1.767 . . . . 61.44 114.755 161.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -86.71 -67.06 0.84 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.776 -1.102 . . . . 65.52 109.74 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -129.56 -68.13 0.74 Allowed 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.076 -1.083 . . . . 65.51 108.076 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.9 136.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.952 2.101 . . . . 74.53 110.883 -171.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 42.7 m80 56.89 -179.11 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.074 1.35 . . . . 73.32 112.24 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -155.99 -78.17 0.09 Allowed 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.119 -0.988 . . . . 74.22 110.692 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 N-CA-C 103.642 -2.725 . . . . 73.31 103.642 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 117.904 -1.046 . . . . 72.52 109.058 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -150.39 163.95 37.09 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.522 1.51 . . . . 74.34 110.205 159.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.2 m -66.92 -51.0 60.56 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.673 1.989 . . . . 61.24 108.956 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.6 -165.05 25.35 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.577 2.513 . . . . 75.31 107.283 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -114.48 161.19 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.246 1.018 . . . . 72.13 108.525 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -141.71 -177.36 5.14 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.907 -1.145 . . . . 73.44 107.907 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.68 155.93 7.83 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.749 1.642 . . . . 44.34 112.925 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.88 167.65 3.06 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 128.492 2.717 . . . . 60.42 106.407 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt -101.89 166.65 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.572 1.549 . . . . 74.25 109.588 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -173.85 0.56 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.031 1.332 . . . . 73.31 110.858 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.86 -31.85 59.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.492 1.117 . . . . 75.24 111.062 171.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.96 31.64 6.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.714 2.405 . . . . 25.41 111.051 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -88.43 133.38 36.6 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.619 -1.252 . . . . 63.54 107.619 157.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.57 152.45 59.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.211 1.274 . . . . 63.34 113.676 168.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.04 -17.03 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 72.4 114.658 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.37 74.62 0.27 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.943 1.354 . . . . 74.15 111.755 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 mt -53.85 163.64 0.7 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.991 -1.004 . . . . 73.03 109.504 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -56.07 -36.37 68.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.676 -0.64 . . . . 70.25 110.266 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.96 -18.73 63.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.684 0.794 . . . . 74.44 112.948 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.3 44.85 26.85 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 125.436 1.493 . . . . 74.23 109.574 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.792 1.034 . . . . 63.32 113.792 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 mm 48.54 102.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.799 2.44 . . . . 61.23 109.987 -160.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.5 142.99 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.676 -1.601 . . . . 73.51 106.676 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.38 123.94 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.028 2.531 . . . . 51.15 106.989 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -51.18 -44.78 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 70.02 111.511 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.26 -27.53 73.59 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.938 -0.924 . . . . 74.23 111.751 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -73.94 -44.39 55.1 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.832 1.316 . . . . 74.03 110.079 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -53.86 -53.45 52.35 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.597 1.159 . . . . 75.01 109.115 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 33' ' ' PHE . 93.0 t -56.51 -48.77 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.25 0.62 . . . . 60.1 111.033 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.13 -32.23 73.83 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.907 -1.12 . . . . 71.2 112.864 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.1 -36.74 19.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.742 1.217 . . . . 72.14 110.79 171.25 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.547 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 35.1 m-85 -84.79 -45.69 12.11 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.69 -0.856 . . . . 73.22 108.69 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.6 m-30 -68.43 -21.42 64.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.603 1.547 . . . . 72.4 111.62 -169.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 9.9 mtpt -86.87 -16.91 34.66 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.174 1.39 . . . . 74.21 112.029 172.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -57.43 2.18 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 120.587 1.539 . . . . 64.21 108.153 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.4 m-30 -86.12 40.01 0.85 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.125 1.77 . . . . 65.43 108.245 -174.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 33.0 mttt -49.99 -44.41 50.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.032 1.333 . . . . 35.11 108.639 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -56.63 -25.15 52.44 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 126.535 1.934 . . . . 73.23 114.229 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -112.93 12.39 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.645 1.578 . . . . 75.25 112.057 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.33 106.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.842 -1.54 . . . . 51.22 106.842 159.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.16 152.98 25.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.5 -0.926 . . . . 64.21 108.5 164.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -118.32 142.25 47.7 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.635 -2.358 . . . . 74.3 104.635 158.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.52 159.02 20.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.308 -1.738 . . . . 74.24 106.308 156.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.71 -37.7 85.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.253 1.421 . . . . 63.31 110.285 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.16 -27.47 61.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.167 0.987 . . . . 70.43 111.151 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.04 5.37 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.043 1.306 . . . . 74.25 114.432 159.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.9 -86.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.642 1.177 . . . . 61.12 110.726 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.48 137.04 4.76 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 120.795 -1.19 . . . . 61.1 110.539 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -142.62 167.77 21.3 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.98 0.89 . . . . 74.45 111.026 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 33' ' ' PHE . 5.3 mt -142.25 140.15 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.95 2.1 . . . . 74.12 105.464 163.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 126.96 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.169 1.788 . . . . 33.02 108.737 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.96 -3.51 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.845 1.258 . . . . 52.45 111.63 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.05 -16.61 57.77 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 120.373 1.442 . . . . 70.41 113.294 -170.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -23.95 66.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.461 1.131 . . . . 73.42 112.712 171.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.74 -15.16 26.36 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.546 1.538 . . . . 52.4 113.169 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.48 6.34 3.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.642 1.577 . . . . 73.11 114.924 173.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.49 148.44 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.907 2.083 . . . . 72.2 107.448 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.04 158.4 25.9 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.398 1.094 . . . . 73.01 110.96 169.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.25 161.28 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 129.027 2.931 . . . . 63.14 107.382 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -75.11 152.06 38.57 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.124 -0.985 . . . . 75.41 109.416 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -145.18 -171.91 3.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.703 0.801 . . . . 71.34 109.25 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -140.14 137.53 34.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.075 -1.454 . . . . 71.32 107.075 168.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -80.97 113.38 19.14 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.777 -1.194 . . . . 71.32 107.777 172.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.31 -29.87 71.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.341 0.656 . . . . 74.24 112.195 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -30.69 5.68 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.676 1.991 . . . . 73.33 112.732 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.28 11.53 1.74 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.437 0.695 . . . . 65.31 111.956 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.36 46.36 26.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.279 1.431 . . . . 50.41 112.252 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.0 163.28 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 126.086 1.754 . . . . 73.22 109.827 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.68 148.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.816 1.246 . . . . 73.15 109.281 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.91 -179.39 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.936 1.695 . . . . 43.11 110.741 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' HE2' ' A' ' 72' ' ' LYS . 1.5 p30 -86.17 172.26 10.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.341 1.456 . . . . 51.35 110.896 155.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -145.01 170.02 16.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.591 1.556 . . . . 64.12 108.226 141.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -99.46 -19.47 16.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.75 1.22 . . . . 61.13 113.846 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 mt 64.1 155.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.01 1.724 . . . . 73.34 110.145 -163.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.14 -63.89 1.29 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.6 -1.63 . . . . 71.13 106.6 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -130.21 152.45 49.62 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.9 0.88 . . . . 72.41 110.267 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.49 153.74 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 107.373 -1.344 . . . . 74.53 107.373 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.78 153.86 50.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.557 1.543 . . . . 74.24 108.184 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 160.39 41.61 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.753 -0.832 . . . . 73.31 108.753 173.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -151.83 161.47 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.733 -1.58 . . . . 75.53 106.733 162.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 151' ' ' HIS . 18.5 ttpt -91.29 150.13 21.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.427 -1.421 . . . . 62.34 109.286 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -141.63 164.43 30.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.145 0.978 . . . . 74.2 108.982 -177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 67.6 m -157.4 127.66 6.35 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.97 -1.863 . . . . 72.15 105.97 150.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.22 -169.14 37.48 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.873 1.215 . . . . 75.31 110.208 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.536 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.53 146.7 32.5 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.096 -0.65 . . . . 75.12 109.462 178.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.16 163.58 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.994 -1.484 . . . . 73.53 106.994 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.0 mm -78.86 132.78 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.975 -0.75 . . . . 74.54 108.975 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -111.37 80.59 1.33 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.965 -1.865 . . . . 72.54 105.965 169.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.48 123.94 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.175 -2.528 . . . . 73.54 104.175 158.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.3 m -114.68 161.89 17.53 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 105.906 -1.887 . . . . 73.24 105.906 160.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -139.75 163.35 32.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.949 1.299 . . . . 75.41 108.061 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.94 -27.76 61.43 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.899 1.227 . . . . 52.41 112.072 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -60.5 -8.16 2.59 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.229 1.811 . . . . 73.15 112.253 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 65.08 13.58 8.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.435 2.294 . . . . 75.52 110.977 -161.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 154.56 38.05 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.31 -1.367 . . . . 65.12 107.31 170.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.01 168.78 13.52 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.744 2.018 . . . . 74.52 108.744 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.62 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -152.08 -168.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.907 1.683 . . . . 75.34 110.452 -173.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.55 132.98 17.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 112.757 0.651 . . . . 73.24 112.757 169.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 159.31 41.47 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.826 1.25 . . . . 72.25 110.417 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.6 m -72.15 -0.12 11.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.262 1.208 . . . . 71.3 114.262 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.306 0.3 OUTLIER 96.19 -61.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 1 C-N-CA 132.399 4.28 . . . . 72.22 107.66 -155.695 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -92.93 82.57 4.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.202 -1.777 . . . . 74.22 106.202 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -124.38 136.5 27.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.077 1.751 . . . . 73.5 107.938 158.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.08 134.21 33.41 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.162 2.574 . . . . 73.13 110.719 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.66 -172.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.955 1.302 . . . . 73.45 108.065 168.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -124.85 141.35 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.609 1.55 . . . . 64.35 110.644 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.76 163.11 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.666 1.186 . . . . 52.15 109.808 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 p -82.4 127.96 33.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.873 0.733 . . . . 60.55 109.298 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 92.9 4.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.396 -2.816 . . . . 73.45 103.396 154.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m 66.22 -13.73 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.43 2.692 . . . . 62.32 116.78 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.65 -0.24 4.99 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.547 0.594 . . . . 74.01 111.675 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 148.37 31.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.297 -1.001 . . . . 73.12 108.297 156.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.45 127.31 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.928 1.291 . . . . 74.2 107.809 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 tp -126.59 158.89 35.08 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.357 1.063 . . . . 73.3 108.376 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -124.2 106.02 9.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.846 2.459 . . . . 72.42 109.655 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -140.02 169.84 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.914 2.486 . . . . 74.01 109.317 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.81 144.81 29.88 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.353 0.661 . . . . 74.34 110.466 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.11 61.72 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.923 1.083 . . . . 74.12 113.923 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -21.98 65.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.998 0.919 . . . . 42.35 112.123 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.3 mtm -89.65 -26.87 20.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.516 1.053 . . . . 61.51 112.337 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.79 62.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 128.733 2.813 . . . . 55.35 110.698 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -79.86 -174.51 4.43 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.063 1.345 . . . . 72.54 109.536 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.09 0.22 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 127.142 2.177 . . . . 74.13 113.034 166.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.66 -3.52 77.41 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.96 1.743 . . . . 60.11 112.998 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.32 169.73 10.64 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.364 1.082 . . . . 70.3 111.887 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 6.9 m-85 -123.17 113.13 18.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.905 2.882 . . . . 71.1 107.213 171.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.93 136.83 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.467 1.107 . . . . 74.25 108.672 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -72.49 121.86 20.32 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.833 -0.803 . . . . 70.25 108.833 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.471 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.9 pp -126.24 150.26 69.39 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.635 1.174 . . . . 65.33 111.472 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.28 138.19 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.49 2.793 . . . . 64.25 109.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -167.57 1.87 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.682 -1.599 . . . . 65.14 106.682 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -23.25 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 129.386 3.075 . . . . 75.11 112.317 -160.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -120.68 0.33 10.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.044 2.537 . . . . 65.13 110.134 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 48.8 p -139.01 165.3 27.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.368 1.067 . . . . 71.14 112.71 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -79.31 156.34 4.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.625 0.726 . . . . 74.52 109.67 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -139.48 -175.86 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.017 2.127 . . . . 72.5 107.981 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 89.6 mt -114.78 164.55 13.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.498 -0.927 . . . . 61.32 108.498 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -151.26 158.73 44.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.13 -1.063 . . . . 62.04 108.13 160.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 14.6 tt0 -92.01 152.27 20.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.286 0.634 . . . . 75.31 109.346 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.01 1.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.241 1.416 . . . . 72.21 112.696 -168.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.9 pt 24.74 -83.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 128.325 2.65 . . . . 73.3 116.232 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.461 ' H ' HG13 ' A' ' 141' ' ' ILE . 8.2 tppt? -95.24 123.3 38.67 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.039 1.336 . . . . 63.01 108.225 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.21 104.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 123.606 1.67 . . . . 74.11 109.226 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.65 -156.28 0.75 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.965 1.706 . . . . 72.34 106.517 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -131.13 167.47 19.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.568 1.547 . . . . 73.14 108.232 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.59 178.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.708 1.603 . . . . 52.21 106.928 160.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -122.13 137.71 54.72 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.659 -1.237 . . . . 75.22 107.659 160.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -141.53 134.11 28.43 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.523 1.929 . . . . 73.01 109.699 -163.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 19.6 m-20 -132.45 28.07 4.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.377 1.444 . . . . 74.42 112.85 -160.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -132.94 -170.6 12.51 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.798 1.19 . . . . 55.32 110.953 -164.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 79.4 m-70 -74.36 149.09 40.72 Favored 'General case' 0 CA--C 1.522 -0.107 0 O-C-N 121.033 -1.275 . . . . 72.03 109.704 168.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 25.6 pt -108.52 149.79 11.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 125.499 1.52 . . . . 74.22 107.661 173.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.51 147.14 52.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.857 1.263 . . . . 71.33 110.714 -161.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -144.81 152.49 40.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.249 1.019 . . . . 63.43 109.476 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.19 119.69 25.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.142 1.377 . . . . 51.01 108.767 -166.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -37.39 87.03 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.285 1.217 . . . . 51.23 114.285 -166.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.8 t 25.24 73.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.202 2.601 . . . . 63.31 113.971 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.13 -3.45 39.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.847 -1.158 . . . . 75.35 113.558 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.26 -61.18 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.841 1.256 . . . . 72.41 108.981 -165.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -108.48 -10.27 15.29 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.112 1.365 . . . . 72.41 111.839 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.0 m170 52.43 21.81 1.88 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.314 1.846 . . . . 75.54 112.152 -166.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -142.18 153.72 44.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.822 -1.174 . . . . 73.5 109.007 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 179.39 9.25 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.868 1.267 . . . . 74.0 111.035 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.3 mm -105.63 137.12 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.783 -1.562 . . . . 73.23 106.783 168.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.59 153.65 30.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.484 1.114 . . . . 41.13 108.463 169.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 136.51 -161.7 25.04 Favored Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.947 1.249 . . . . 74.23 112.254 169.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -101.82 170.48 8.12 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.167 1.984 . . . . 74.11 111.743 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.06 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.162 3.385 . . . . 75.03 112.51 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -121.66 -13.05 8.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.364 1.466 . . . . 74.43 112.108 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.2 176.47 39.14 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 122.782 1.212 . . . . 44.22 111.322 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 97' ' ' ILE . 6.4 m-85 -123.84 161.39 25.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.405 2.282 . . . . 72.32 107.053 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -107.42 101.3 10.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.276 -1.75 . . . . 74.51 106.276 -171.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.12 173.26 12.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.586 0.63 . . . . 71.43 110.133 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.87 129.68 42.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.145 -1.428 . . . . 71.13 107.145 162.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.3 171.59 8.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.575 -2.009 . . . . 71.43 105.575 144.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.6 m -164.39 162.06 21.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.083 0.856 . . . . 71.22 109.754 145.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.0 t -72.02 -69.11 0.41 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.113 1.365 . . . . 61.35 109.551 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.72 55.34 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.755 -2.538 . . . . 75.21 106.755 -170.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.257 1.8 p 62.45 -177.62 0.14 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.709 3.204 . . . . 73.22 114.067 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.2 tp -78.76 93.97 5.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.754 -1.573 . . . . 73.14 106.754 164.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.34 -49.07 25.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.909 1.284 . . . . 75.51 111.168 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 86.3 t60 60.29 -75.46 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.723 2.409 . . . . 60.1 112.433 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.18 155.71 27.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.19 1.796 . . . . 63.22 108.229 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.7 m170 83.24 85.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.876 2.87 . . . . 75.15 109.165 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -71.42 -33.42 69.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.847 0.859 . . . . 74.34 111.521 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 113.887 1.069 . . . . 64.35 113.887 -144.802 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.539 -0.267 . . . . 62.44 110.385 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.91 147.01 35.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.685 1.194 . . . . 70.24 108.801 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.84 -80.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.868 1.667 . . . . 64.22 108.013 165.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.31 77.31 0.79 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 108.756 -1.738 . . . . 61.14 108.756 -156.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -74.17 -177.34 2.93 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.699 0.799 . . . . 73.02 109.992 167.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -77.26 -171.65 2.15 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.722 1.209 . . . . 71.12 110.323 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.34 133.99 2.27 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.15 1.357 . . . . 74.21 112.857 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.68 171.58 14.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.512 1.925 . . . . 53.12 109.999 -171.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.49 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 7.0 mp -84.17 171.0 13.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.326 1.05 . . . . 44.31 110.887 174.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.07 156.75 17.17 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.801 -1.187 . . . . 63.52 110.679 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.0 t80 -44.75 -51.79 9.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.262 2.625 . . . . 74.24 110.439 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.97 10.3 19.35 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.189 0.811 . . . . 75.3 113.189 -167.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.23 118.56 72.77 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.375 -1.713 . . . . 62.31 106.375 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -66.53 130.48 23.73 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.437 2.091 . . . . 62.55 109.839 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 pt -93.29 160.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 64.41 109.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' ' 169' ' ' GLU . 50.6 m-85 -114.85 72.9 0.8 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.084 -1.08 . . . . 74.33 108.084 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.48 160.38 5.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.073 -1.421 . . . . 74.45 108.592 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.05 -44.82 51.77 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.907 0.755 . . . . 32.01 109.731 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -94.31 -17.59 22.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.74 -0.664 . . . . 74.04 112.087 -168.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.04 32.74 4.56 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 121.444 -0.785 . . . . 61.42 113.851 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -68.59 -17.58 64.15 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.568 1.321 . . . . 73.33 114.568 -170.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 mm 39.73 92.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 129.041 2.936 . . . . 41.4 111.992 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 154.25 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.465 1.106 . . . . 55.22 108.455 -176.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -64.45 130.65 44.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.066 -1.457 . . . . 64.24 107.066 173.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.401 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -46.69 -46.91 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 122.489 1.138 . . . . 72.23 108.627 169.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -48.73 -64.7 3.04 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 128.484 2.945 . . . . 44.22 110.616 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -54.96 -49.05 72.34 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.014 2.126 . . . . 74.12 111.38 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -54.62 -49.19 71.09 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.787 0.835 . . . . 70.33 111.244 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 55.9 t -80.8 -38.27 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.983 -1.008 . . . . 73.12 109.45 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -55.17 -45.27 75.72 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.474 0.579 . . . . 65.33 110.68 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -31.07 70.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.783 -1.198 . . . . 74.21 112.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.91 -55.96 7.28 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 116.334 -1.793 . . . . 74.51 109.187 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.45 -44.43 45.67 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 123.104 2.683 . . . . 73.53 112.125 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -74.2 -18.87 60.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.126 2.17 . . . . 71.53 111.896 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -67.76 0.78 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.159 -2.163 . . . . 74.12 105.159 166.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -79.77 39.65 0.43 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.469 2.708 . . . . 62.14 110.999 -167.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -59.79 -28.05 67.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.211 -0.931 . . . . 61.41 111.52 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.46 -23.17 65.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.217 1.407 . . . . 64.24 113.222 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.85 8.05 28.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.812 1.245 . . . . 65.3 111.186 -168.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.22 96.81 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.087 -1.079 . . . . 72.01 108.087 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.78 157.56 27.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.432 -0.951 . . . . 63.34 108.432 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.09 157.7 18.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.632 -1.618 . . . . 71.13 106.632 168.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 169.31 17.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.771 -1.104 . . . . 52.23 109.556 163.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -63.04 1.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.777 2.031 . . . . 61.21 108.68 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -59.57 -21.15 59.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.041 1.336 . . . . 74.11 111.179 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.57 -26.86 2.63 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.208 -1.329 . . . . 72.3 114.168 155.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -25.39 -85.5 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.812 3.245 . . . . 73.01 114.699 -162.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.54 128.28 2.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.232 -1.547 . . . . 42.4 109.232 -166.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -153.6 162.55 41.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.875 1.337 . . . . 73.54 111.245 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -150.73 129.84 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.78 1.632 . . . . 70.43 107.419 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.86 130.62 43.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.024 0.829 . . . . 62.12 109.472 162.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -134.0 16.24 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.163 0.985 . . . . 72.41 111.284 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.98 -29.95 36.33 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.876 2.179 . . . . 63.53 114.433 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -69.68 -24.62 63.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.929 1.291 . . . . 64.24 113.925 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.97 -10.09 12.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.93 1.241 . . . . 74.31 113.805 -174.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.44 14.67 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.441 2.696 . . . . 72.3 115.119 173.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mt -68.75 117.59 11.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.484 1.114 . . . . 75.33 108.575 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.24 157.43 23.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.488 1.137 . . . . 65.31 110.24 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.8 tt -153.29 153.13 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.228 -1.768 . . . . 73.32 106.228 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -67.32 106.35 2.04 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.78 0.718 . . . . 71.35 109.561 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -87.44 172.79 9.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.418 1.087 . . . . 52.44 108.18 165.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.3 OUTLIER -141.83 136.74 30.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.069 -1.826 . . . . 61.51 106.069 167.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.57 119.36 24.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.345 -0.983 . . . . 74.25 108.345 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -63.15 -24.03 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 74.4 111.235 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.08 -33.48 2.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 128.541 2.736 . . . . 74.33 111.81 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 m -157.71 10.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.855 1.262 . . . . 54.13 112.768 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mp 55.75 54.32 8.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.423 1.489 . . . . 75.42 110.751 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.43 158.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.216 1.807 . . . . 72.3 109.619 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 119.73 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.086 1.354 . . . . 75.22 108.686 -164.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -132.4 157.74 43.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.833 1.253 . . . . 73.05 112.038 -168.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -104.85 106.84 17.51 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 126.322 1.849 . . . . 75.33 108.378 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.614 ' NZ ' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -151.72 141.23 21.64 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.403 -1.702 . . . . 74.42 106.403 -174.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -94.91 175.06 6.79 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.098 -1.001 . . . . 73.25 110.936 -166.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.0 mt -97.44 148.49 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.052 1.741 . . . . 73.31 108.147 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.98 -55.2 2.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.214 -0.661 . . . . 74.14 109.214 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.415 HH11 ' HB2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -119.63 152.2 37.45 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.051 -1.03 . . . . 75.51 109.812 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.615 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.73 158.88 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.225 1.81 . . . . 65.22 107.546 171.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -129.53 175.68 8.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.031 1.333 . . . . 53.01 108.046 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 79' ' ' ARG . 1.5 tmm_? -173.66 152.27 2.03 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.938 1.695 . . . . 72.21 109.297 157.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -140.61 161.72 37.09 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.161 2.185 . . . . 73.34 107.376 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -95.26 148.07 22.8 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.196 -0.94 . . . . 71.13 109.46 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -144.91 156.19 43.85 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.735 1.214 . . . . 74.04 108.949 -171.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 2.4 p -159.77 106.01 1.63 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.187 0.995 . . . . 63.11 109.784 165.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.69 -178.11 45.26 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.423 -0.671 . . . . 63.2 111.423 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.18 138.25 34.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.458 -0.782 . . . . 71.33 110.37 170.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.02 159.8 18.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.234 1.413 . . . . 70.21 109.399 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mm -83.51 139.97 16.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.624 1.169 . . . . 75.41 107.977 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -129.27 77.35 1.78 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.655 2.382 . . . . 75.21 106.662 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.1 138.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.896 -1.89 . . . . 64.52 105.896 159.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.1 m -119.06 155.29 31.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.407 -2.072 . . . . 74.1 105.407 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 p -131.78 171.76 13.12 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.794 -1.191 . . . . 62.25 108.361 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -56.5 -27.81 58.21 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.759 1.392 . . . . 75.14 114.759 -166.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.42 0.49 19.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.912 2.085 . . . . 73.04 113.935 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 61.49 17.79 8.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.256 1.423 . . . . 65.23 111.89 -163.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.59 158.82 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.064 -1.828 . . . . 75.31 106.064 159.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.82 163.59 1.43 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 128.342 2.657 . . . . 71.0 106.298 -171.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -145.36 169.04 7.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.816 1.646 . . . . 65.32 106.629 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.48 100.33 3.85 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.156 0.889 . . . . 74.34 109.954 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.54 168.87 26.05 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.506 -0.746 . . . . 72.35 112.612 -165.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.8 m -60.44 156.04 16.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.943 1.297 . . . . 73.54 107.784 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.64 6.11 3.39 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.219 -0.926 . . . . 74.32 111.013 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -136.86 36.93 2.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.063 1.345 . . . . 62.21 109.652 -171.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -105.7 129.29 24.89 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 126.071 1.748 . . . . 73.42 108.48 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -65.88 152.7 80.77 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.552 2.168 . . . . 70.03 114.096 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -148.18 173.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.531 2.732 . . . . 41.23 108.055 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.59 137.63 53.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.388 1.075 . . . . 72.11 108.556 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.99 162.42 36.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.848 1.259 . . . . 75.52 108.705 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -87.94 108.45 19.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.613 -0.884 . . . . 70.02 108.613 172.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -78.3 69.09 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 162.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 59.64 13.46 3.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.97 1.47 . . . . 75.32 114.97 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.93 -18.99 5.28 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 120.817 -1.177 . . . . 73.43 112.103 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.55 144.86 33.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.634 -1.988 . . . . 72.22 105.634 162.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -88.45 145.36 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.97 -0.752 . . . . 73.31 108.97 167.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.02 146.7 25.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.211 1.404 . . . . 74.44 108.153 -173.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -102.02 131.59 48.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 118.517 -0.754 . . . . 65.3 110.666 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.9 pt -143.14 -178.81 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.147 1.779 . . . . 74.12 108.625 168.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -78.37 156.15 29.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.781 -1.199 . . . . 74.51 112.989 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.66 -48.33 39.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.823 2.449 . . . . 72.03 111.128 164.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.37 -8.84 28.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.073 1.138 . . . . 75.13 114.073 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.1 mmt -94.31 -38.58 10.93 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.714 1.205 . . . . 70.34 110.968 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.11 60.93 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.853 1.661 . . . . 71.34 109.12 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -171.86 3.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.618 1.567 . . . . 62.33 109.433 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.07 -0.62 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 126.3 1.84 . . . . 72.2 113.045 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.03 -14.19 61.05 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 116.838 -2.09 . . . . 73.35 112.206 171.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.82 179.64 4.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.786 2.293 . . . . 60.5 108.726 -163.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.48 136.71 53.65 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.475 0.71 . . . . 75.41 111.753 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.509 HG23 ' OD1' ' A' ' 138' ' ' ASP . 15.5 tt -111.4 150.15 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.36 1.464 . . . . 71.15 109.335 -170.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.49 103.47 15.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.2 1.0 . . . . 73.25 110.689 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.08 156.72 36.77 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.185 0.994 . . . . 64.41 111.168 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.77 154.08 38.67 Favored 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.486 -1.39 . . . . 51.33 108.486 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -119.38 -157.33 0.69 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.437 -2.06 . . . . 75.34 105.437 162.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -48.5 -71.27 0.07 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.531 1.132 . . . . 62.54 111.863 -171.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -120.37 0.12 10.5 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.874 1.669 . . . . 74.34 111.635 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.8 p -131.82 -172.55 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.217 1.807 . . . . 65.42 111.045 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.85 157.05 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.119 -1.437 . . . . 62.05 107.119 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -136.38 179.19 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.523 -1.658 . . . . 74.13 106.523 167.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 108' ' ' SER . 1.3 mp -108.06 162.19 14.27 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.672 0.749 . . . . 74.24 109.892 168.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 127' ' ' ILE . 20.4 p-10 -148.05 160.61 42.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.183 2.593 . . . . 71.42 107.687 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 140.48 43.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.621 1.968 . . . . 73.35 109.606 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.258 33.8 t -78.62 1.46 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 130.075 3.35 . . . . 74.14 115.005 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.4 pt 25.07 -70.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 130.096 3.358 . . . . 73.53 117.681 167.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.556 ' H ' HG13 ' A' ' 141' ' ' ILE . 9.8 ttmt -117.72 125.16 50.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.516 2.727 . . . . 61.43 107.467 172.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.77 128.36 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.397 -1.705 . . . . 74.25 106.397 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -143.14 -179.23 6.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.964 1.706 . . . . 73.12 107.902 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 p -134.2 157.07 47.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.306 1.042 . . . . 74.41 110.878 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 m -127.24 -175.57 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.849 1.66 . . . . 71.11 108.717 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.88 133.36 43.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.704 1.201 . . . . 74.04 109.963 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -146.95 124.61 11.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 122.481 0.312 . . . . 73.4 110.758 -165.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 27.6 m-20 -130.27 52.55 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.477 -0.765 . . . . 64.15 109.265 -162.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.78 -179.65 34.73 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.681 -0.968 . . . . 64.21 110.681 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -65.18 144.67 57.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.064 1.346 . . . . 75.12 113.045 -172.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.5 pt -129.56 156.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.535 2.334 . . . . 74.23 109.018 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.91 163.73 37.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.26 1.024 . . . . 63.02 110.301 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 0.4 OUTLIER -116.53 -91.06 0.54 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.669 -1.234 . . . . 74.03 107.669 -172.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 5.7 mt 159.6 161.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 1 C-N-CA 133.274 4.63 . . . . 73.21 107.66 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -83.71 -82.93 0.15 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.189 -1.041 . . . . 70.13 108.189 167.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.614 HG13 ' NZ ' ' A' ' 72' ' ' LYS . 48.9 t 56.93 64.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 124.145 1.926 . . . . 54.23 110.688 -171.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' A' ' 76' ' ' ARG . 3.0 pt-20 -81.54 0.23 39.04 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 113.467 -1.697 . . . . 73.41 114.039 -171.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.511 ' HB3' ' HE3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -86.16 -46.23 10.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.973 0.909 . . . . 74.23 110.453 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.45 -23.73 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.487 1.115 . . . . 73.54 110.228 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 53.67 21.26 2.53 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 128.47 2.708 . . . . 71.31 113.411 -159.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.401 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.1 p -149.89 151.81 34.05 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.088 -1.633 . . . . 64.32 111.743 -174.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.759 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.3 p90 -149.06 178.97 8.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.885 1.274 . . . . 75.31 111.285 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.95 119.01 58.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 C-N-CA 124.785 1.234 . . . . 70.23 108.859 171.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -151.39 158.41 43.69 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.098 -1.001 . . . . 71.31 110.806 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 142.42 -158.76 27.04 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.611 1.101 . . . . 35.12 110.646 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -99.55 176.53 5.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.785 1.293 . . . . 73.34 110.678 166.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.54 -91.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 128.559 2.743 . . . . 73.04 111.657 -168.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -122.78 -1.96 8.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.676 2.39 . . . . 72.41 113.366 176.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 82.66 165.9 37.85 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.382 1.468 . . . . 51.43 114.34 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 66.0 m-85 -108.68 151.78 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.823 2.449 . . . . 74.33 107.609 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.68 102.96 15.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.124 -1.435 . . . . 72.0 107.124 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 105' ' ' VAL . 6.2 m -130.76 176.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 118.535 0.607 . . . . 74.43 111.457 -169.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -68.6 145.8 53.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.14 110.652 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -138.15 62.95 1.55 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.711 2.804 . . . . 73.21 107.092 168.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -75.76 163.49 27.22 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.357 -1.464 . . . . 71.13 109.103 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.4 p -88.92 19.59 4.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.125 1.37 . . . . 64.42 111.643 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 71.99 -16.05 1.66 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.405 1.479 . . . . 72.03 114.616 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.5 p -62.21 155.82 23.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.682 2.793 . . . . 73.44 112.766 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.9 tt -76.08 91.24 3.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.1 m170 61.19 -42.68 0.12 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.505 3.522 . . . . 72.4 116.292 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 54.86 -107.57 0.39 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.131 2.573 . . . . 74.43 110.813 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.85 135.84 56.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.852 1.205 . . . . 72.22 109.581 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -72.15 -50.51 27.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.721 1.208 . . . . 73.45 112.579 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -136.77 -41.73 0.6 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.547 1.139 . . . . 53.14 110.588 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.245 0.829 0 C-N-CA 126.046 1.739 . . . . 73.24 107.214 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.241 0.63 0 N-CA-C 107.67 -1.233 . . . . 72.02 107.67 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.32 156.82 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.786 2.034 . . . . 72.35 110.345 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.12 158.93 27.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.025 0.441 . . . . 40.42 110.404 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.7 t80 -53.23 -36.98 61.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.743 1.617 . . . . 72.4 114.008 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.87 4.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.08 1.752 . . . . 71.33 110.995 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.38 124.16 70.28 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 107.51 -1.293 . . . . 64.3 107.51 162.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.17 156.82 42.97 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.463 2.109 . . . . 73.22 113.399 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.64 -5.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.786 1.634 . . . . 41.43 113.604 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.0 m-85 47.64 76.87 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.625 1.57 . . . . 64.14 113.158 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -52.69 160.19 0.95 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.814 -0.63 . . . . 74.24 110.065 168.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 0.32 0.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.712 1.205 . . . . 62.11 112.255 167.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.13 -16.85 9.72 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.883 2.073 . . . . 74.15 111.507 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.23 38.29 7.32 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.787 0.708 . . . . 14.3 112.457 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -16.42 64.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.717 1.377 . . . . 44.2 114.717 -167.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.269 31.3 mm 35.85 66.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.66 2.784 . . . . 64.22 110.514 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 151.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 127.965 2.506 . . . . 75.34 108.59 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.93 127.0 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.214 2.605 . . . . 73.23 107.779 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.23 -41.4 24.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.245 0.618 . . . . 74.04 111.386 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.44 -41.44 85.01 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.006 -0.886 . . . . 41.31 111.136 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.7 -40.97 92.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.661 1.23 . . . . 73.55 110.674 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.16 13.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.992 0.917 . . . . 72.41 108.845 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 77' ' ' VAL . 53.4 t -56.16 -50.9 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.131 -0.692 . . . . 73.52 109.131 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.35 -32.45 73.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.461 1.028 . . . . 63.3 112.028 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.6 tttt -48.18 -47.13 35.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.366 0.984 . . . . 75.45 108.874 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.6 -43.71 75.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.494 -0.928 . . . . 63.11 108.494 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD1' HD12 ' A' ' 50' ' ' ILE . 5.6 m-85 -63.93 -22.03 66.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.24 0.927 . . . . 73.34 112.132 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -93.9 -20.02 20.42 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.298 1.439 . . . . 72.13 112.507 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.46 -52.59 4.26 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 120.378 1.445 . . . . 70.54 107.701 173.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.13 43.02 1.12 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.891 2.076 . . . . 74.45 108.23 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -54.24 -42.18 69.6 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.923 1.689 . . . . 74.31 109.205 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -65.17 -27.89 69.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.849 0.86 . . . . 75.12 111.862 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.87 -5.16 58.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.004 1.721 . . . . 74.33 112.291 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.3 mt -59.47 95.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 120.829 1.65 . . . . 74.23 108.951 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -81.0 142.88 32.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.965 -1.495 . . . . 75.44 106.965 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.46 150.26 26.99 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.487 -1.301 . . . . 63.31 107.487 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.4 170.58 16.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.765 0.826 . . . . 72.45 108.805 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.19 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.58 0.752 . . . . 64.35 110.093 168.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.91 2.62 2.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.918 1.287 . . . . 63.44 112.457 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.56 46.46 54.94 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 125.919 1.723 . . . . 65.13 111.351 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.64 -100.26 0.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.126 -0.694 . . . . 74.14 109.126 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.4 112.44 1.08 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.343 1.925 . . . . 71.0 108.721 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.05 159.3 42.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.136 1.774 . . . . 73.44 108.418 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.424 HD12 ' CD1' ' A' ' 33' ' ' PHE . 39.6 mt -142.48 142.22 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 106.608 -1.627 . . . . 64.52 106.608 170.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 133.45 43.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.987 0.915 . . . . 71.32 108.788 165.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 52' ' ' ILE . 1.5 pp -129.95 12.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.799 -0.637 . . . . 73.33 110.573 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.59 -22.31 16.78 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.208 0.913 . . . . 63.04 112.184 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.97 -25.38 59.91 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.844 1.258 . . . . 63.14 112.454 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.35 -22.97 64.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.461 1.028 . . . . 74.44 110.558 167.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.56 -6.42 0.12 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.952 1.464 . . . . 73.25 114.952 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -45.78 143.81 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 128.377 2.671 . . . . 74.32 110.997 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -102.86 134.76 45.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.3 0.955 . . . . 73.53 112.137 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 13.4 tt -104.33 148.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.802 1.641 . . . . 74.15 107.581 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -69.99 112.84 6.67 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.436 -1.69 . . . . 74.23 106.436 165.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.43 -166.42 1.15 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.126 -1.435 . . . . 43.35 107.126 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.0 159.62 44.45 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.709 -1.589 . . . . 75.31 106.709 167.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.91 116.76 29.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.966 1.306 . . . . 62.5 110.374 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.7 ttpm? -57.32 -26.79 61.48 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.865 1.666 . . . . 64.42 113.148 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.25 -22.21 64.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.638 1.575 . . . . 74.53 112.453 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m -149.1 10.47 0.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.159 0.984 . . . . 61.13 112.436 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt 54.3 49.37 18.68 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.848 1.309 . . . . 75.13 109.542 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.7 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.876 1.27 . . . . 73.44 108.636 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.96 124.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.046 -1.835 . . . . 74.22 106.046 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.15 179.49 7.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.831 1.652 . . . . 73.22 107.758 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.97 168.83 19.14 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.967 0.907 . . . . 63.21 110.679 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.55 175.78 13.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.643 -1.243 . . . . 64.53 107.643 140.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.28 136.78 44.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.697 1.199 . . . . 74.23 108.72 168.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.89 157.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.742 1.217 . . . . 73.5 107.77 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 158' ' ' GLU . 37.4 mt -117.99 -43.65 2.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.261 0.624 . . . . 73.5 110.815 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.433 ' H ' ' HB ' ' A' ' 156' ' ' THR . 53.1 mtt180 -138.18 165.02 27.71 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.773 -1.204 . . . . 73.34 109.325 169.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.56 168.13 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.862 1.265 . . . . 53.04 108.924 173.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -135.7 155.6 50.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.798 1.239 . . . . 74.35 109.116 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.07 144.68 38.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.548 -1.278 . . . . 72.14 107.548 167.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.03 169.01 18.42 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.181 1.393 . . . . 71.12 107.774 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.92 147.41 27.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.224 -1.028 . . . . 75.11 108.224 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.91 149.32 34.02 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 125.757 1.623 . . . . 74.34 107.335 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 1.4 m -144.64 131.88 20.64 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.393 -1.706 . . . . 61.14 106.393 159.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.81 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.379 -1.088 . . . . 40.23 110.379 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 123.73 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.057 -0.719 . . . . 74.02 109.057 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 149.17 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.64 -0.874 . . . . 63.44 108.64 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 mm -79.48 138.88 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.205 1.802 . . . . 71.3 106.993 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -122.95 43.7 2.86 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.742 0.817 . . . . 72.21 112.527 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 8.8 mt -46.33 114.79 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 C-N-CA 126.894 2.077 . . . . 71.41 106.747 -175.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.6 169.17 11.23 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.721 -1.585 . . . . 54.15 106.721 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.7 p -133.9 171.94 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.136 -0.977 . . . . 73.44 108.927 157.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.82 -38.4 64.54 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.314 -0.866 . . . . 75.53 111.986 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.418 HD22 ' CG ' ' A' ' 138' ' ' ASP . 41.1 m-80 -72.31 20.03 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.469 2.307 . . . . 74.14 112.473 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 49.23 27.08 1.71 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 128.1 2.56 . . . . 75.44 113.065 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.42 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -65.85 159.89 24.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 120.85 -1.156 . . . . 73.05 108.437 163.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 1.8 pp20? -170.37 167.08 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.98 1.712 . . . . 73.14 107.928 166.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -146.75 174.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 127.145 2.178 . . . . 71.45 107.88 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.13 1.88 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.861 -0.792 . . . . 65.22 108.861 -171.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -142.02 174.37 10.66 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.061 0.944 . . . . 64.33 112.58 -168.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 168.95 8.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.156 2.182 . . . . 73.32 111.684 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.95 -33.27 24.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.364 -0.606 . . . . 65.31 109.364 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -91.63 39.27 1.0 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.787 0.835 . . . . 71.42 110.872 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 99' ' ' LEU . 4.2 t60 -91.78 123.03 64.48 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.208 -1.377 . . . . 75.12 110.077 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.77 124.15 12.35 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.159 2.573 . . . . 63.01 110.412 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.28 173.69 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.746 1.619 . . . . 73.13 108.336 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.69 149.64 34.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.049 0.54 . . . . 74.43 110.761 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.12 164.38 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.973 1.309 . . . . 74.24 109.735 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.81 35.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.082 0.944 . . . . 64.3 108.474 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -109.1 78.06 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.812 -1.551 . . . . 72.52 106.812 153.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.38 14.96 6.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.511 1.524 . . . . 74.12 113.319 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.46 -24.48 3.2 Favored Glycine 0 CA--C 1.521 0.435 0 O-C-N 120.795 -1.191 . . . . 72.11 111.713 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.98 143.32 26.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.552 -1.277 . . . . 61.25 107.552 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.77 -1.937 . . . . 63.13 105.77 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 tp -125.93 159.24 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.653 -0.869 . . . . 73.13 108.653 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.91 119.49 33.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.207 1.803 . . . . 73.03 109.28 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 116' ' ' ILE . 6.9 pt -140.58 179.64 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.262 1.025 . . . . 71.03 110.688 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.6 139.57 34.95 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.62 1.968 . . . . 71.32 110.719 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.24 -41.07 36.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.397 1.479 . . . . 71.54 113.26 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.44 -19.94 65.14 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.932 1.242 . . . . 75.33 113.469 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.5 -22.79 30.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.697 0.799 . . . . 75.41 111.161 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.16 63.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 128.398 2.679 . . . . 64.24 111.527 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -91.42 -170.73 2.71 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.023 -1.048 . . . . 63.15 111.704 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.82 -1.55 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.106 2.162 . . . . 43.4 113.661 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.25 9.19 22.64 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-O 117.439 -1.756 . . . . 45.13 111.764 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 147.68 44.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.84 2.32 . . . . 72.42 108.988 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -94.89 105.09 16.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.241 -1.392 . . . . 73.04 107.241 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.42 118.13 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.601 1.16 . . . . 64.43 109.329 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.38 140.28 56.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.5 -0.75 . . . . 72.54 109.072 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.32 158.0 76.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.854 1.262 . . . . 73.34 111.079 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.54 161.32 42.51 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.669 2.246 . . . . 73.14 110.229 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.438 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -125.21 -145.59 0.33 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.318 -1.364 . . . . 64.44 107.318 166.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.99 -82.02 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.465 1.506 . . . . 74.23 109.06 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.46 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.02 0.43 35.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.888 1.675 . . . . 73.33 110.356 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 p -138.02 -172.91 3.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.428 1.491 . . . . 72.3 110.879 -151.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -125.98 143.26 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.187 -1.783 . . . . 75.42 106.187 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.8 177.53 7.8 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.901 -1.124 . . . . 64.1 108.023 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.1 145.7 41.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.897 1.279 . . . . 74.2 107.98 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.418 ' CG ' HD22 ' A' ' 93' ' ' ASN . 32.4 t0 -142.12 153.97 44.52 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.872 2.069 . . . . 72.13 109.933 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 142.02 27.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 118.463 -0.779 . . . . 72.44 110.078 -164.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.7 t -77.32 -5.56 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 114.567 1.321 . . . . 71.31 114.567 -163.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.32 -88.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 127.748 2.419 . . . . 65.21 116.108 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.488 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -85.95 128.58 34.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.901 2.08 . . . . 71.14 109.594 -175.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -129.01 99.07 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.032 1.333 . . . . 63.0 111.103 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -152.65 -169.44 3.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.219 2.608 . . . . 62.11 110.102 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.91 179.56 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.028 1.731 . . . . 74.14 110.107 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.6 163.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.927 2.091 . . . . 74.42 106.442 159.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.01 137.02 37.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.93 -1.878 . . . . 72.33 105.93 161.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.41 142.96 27.59 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.865 0.757 . . . . 64.15 110.058 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 4.4 m120 -146.82 24.35 1.2 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.847 0.749 . . . . 74.34 112.705 -157.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.88 -111.64 3.39 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 110.318 -1.113 . . . . 54.33 110.318 -155.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -134.23 164.82 26.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.595 -1.631 . . . . 74.31 106.595 157.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 8' ' ' ALA . 20.7 pt -127.09 160.48 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.171 2.188 . . . . 72.35 109.13 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -142.93 151.53 41.06 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.495 1.118 . . . . 72.51 109.684 -168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.23 -178.76 6.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.764 -1.199 . . . . 70.42 107.764 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.3 mt -128.25 175.75 8.22 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.974 1.845 . . . . 75.11 110.995 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 76' ' ' ARG . 24.3 m -128.41 92.05 3.36 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.391 -2.448 . . . . 75.25 104.391 159.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.66 80.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 101.651 -3.463 . . . . 53.11 101.651 166.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 75' ' ' LEU . 14.6 pt-20 -76.5 -15.31 59.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.31 1.053 . . . . 73.3 111.218 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.53 -44.52 62.07 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.915 1.686 . . . . 71.13 109.885 -153.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.3 t30 -125.07 5.06 7.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.202 0.601 . . . . 75.34 111.933 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 34.9 m170 52.15 36.75 19.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.939 0.791 . . . . 64.33 111.941 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 p -147.43 142.42 26.99 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.378 -1.451 . . . . 43.23 107.571 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.8 p90 -142.86 170.2 16.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.544 1.065 . . . . 75.32 110.349 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.26 137.93 24.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 107.008 -1.478 . . . . 74.21 107.008 160.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.25 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.314 1.045 . . . . 72.03 108.574 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 134.72 -168.19 23.67 Favored Glycine 0 N--CA 1.462 0.403 0 CA-C-N 118.555 0.616 . . . . 34.44 111.729 175.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.42 169.54 8.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.348 1.574 . . . . 74.34 110.318 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.31 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 C-N-CA 128.018 2.527 . . . . 63.31 113.272 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.479 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.423 1.089 . . . . 73.41 112.146 169.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.73 177.11 23.92 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 125.596 1.57 . . . . 65.24 111.432 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.549 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.0 m-85 -117.81 139.92 50.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 126.426 1.89 . . . . 74.43 108.104 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.39 99.31 9.98 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.572 3.149 . . . . 71.12 107.604 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.06 3.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.133 0.573 . . . . 65.41 110.246 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.43 148.93 49.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.227 -1.027 . . . . 72.23 108.227 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -120.76 166.74 13.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.06 -1.459 . . . . 55.11 107.06 158.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.413 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 92.2 p . . . . . 0 N--CA 1.441 -0.922 0 C-N-CA 119.777 -0.769 . . . . 42.43 111.1 171.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.672 0 N-CA-C 108.362 -0.977 . . . . 74.55 108.362 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.78 153.48 21.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.702 2.401 . . . . 72.32 109.608 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.66 163.3 28.02 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.37 0.668 . . . . 40.43 111.71 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -54.96 -38.59 67.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.088 1.355 . . . . 74.44 113.252 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -96.74 9.3 42.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.946 1.698 . . . . 71.14 112.412 -165.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.22 124.13 85.84 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.677 -1.601 . . . . 73.45 106.677 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -55.46 126.31 22.08 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.16 2.574 . . . . 52.32 111.287 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 pt -98.4 119.33 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.688 -1.227 . . . . 61.24 107.688 162.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -78.13 78.99 4.6 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.326 1.45 . . . . 72.33 107.942 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 mt -55.86 164.18 1.23 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 170.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.1 p -54.06 -36.16 62.81 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.168 0.44 . . . . 74.23 111.317 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.13 -22.55 48.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.413 0.685 . . . . 71.31 112.188 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.02 40.54 7.99 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.08 1.324 . . . . 65.44 110.774 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -10.35 52.31 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.906 1.076 . . . . 71.12 113.906 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.317 13.5 mm 52.23 30.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 125.575 2.607 . . . . 72.52 112.077 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.39 149.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.829 -1.532 . . . . 74.43 108.692 -172.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -62.17 122.7 16.23 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.306 -1.739 . . . . 60.52 106.306 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -50.14 -37.85 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.437 1.095 . . . . 64.53 111.087 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 -0.9 89.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.825 -0.986 . . . . 52.04 114.205 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.27 -47.56 6.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.758 1.779 . . . . 75.34 110.365 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -47.14 -53.49 12.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.945 1.298 . . . . 61.22 110.46 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 77' ' ' VAL . 44.6 t -67.1 -42.67 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.525 -0.761 . . . . 52.11 110.486 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -68.2 -24.82 64.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 119.042 -1.063 . . . . 74.53 111.302 -176.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -41.44 70.47 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.135 0.974 . . . . 73.21 110.628 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.85 -40.06 66.01 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.341 -1.314 . . . . 72.12 108.933 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.404 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 11.2 m-85 -56.05 -37.18 68.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.414 1.915 . . . . 72.14 112.436 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -31.36 64.32 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.718 -1.134 . . . . 44.34 111.275 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -90.23 -49.34 6.61 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 121.195 1.816 . . . . 62.15 108.28 -178.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 2.5 m-30 -94.44 39.31 1.09 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.773 2.029 . . . . 63.42 108.333 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -57.02 -31.92 65.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.065 1.346 . . . . 73.22 111.95 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -61.5 -35.51 77.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.722 1.209 . . . . 64.31 110.996 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.12 9.45 40.86 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.092 1.357 . . . . 64.11 112.105 -165.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.7 124.0 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.829 -1.545 . . . . 64.42 106.829 167.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -122.37 114.79 21.24 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.07 1.748 . . . . 74.45 107.496 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.64 146.72 28.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.004 -1.109 . . . . 73.44 108.004 168.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.47 172.46 13.76 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.835 0.854 . . . . 75.44 108.811 168.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.39 73.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 44.42 109.338 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.5 -6.28 35.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.785 1.234 . . . . 34.14 112.499 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.71 15.67 33.55 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.136 -0.977 . . . . 74.13 114.698 156.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.01 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.481 1.912 . . . . 53.43 111.892 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.77 121.43 2.19 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.064 2.269 . . . . 63.44 109.174 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -130.76 164.73 24.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.383 1.873 . . . . 60.54 109.906 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 33' ' ' PHE . 21.4 mt -142.26 138.98 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.291 2.236 . . . . 74.25 106.191 169.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.61 129.52 36.53 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.56 1.544 . . . . 60.24 109.719 166.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.74 16.84 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.264 1.425 . . . . 74.31 111.034 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.4 57.33 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.973 -1.079 . . . . 54.22 113.392 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -77.84 -10.78 59.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.928 1.364 . . . . 64.15 113.311 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -63.58 -33.65 76.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.663 1.12 . . . . 74.42 109.479 168.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 51.14 13.84 0.18 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.93 2.092 . . . . 71.43 113.183 -166.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mt -61.12 126.34 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.29 1.036 . . . . 73.33 108.472 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -83.33 144.22 29.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.637 1.175 . . . . 75.43 110.389 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.2 tt -127.75 150.78 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.792 1.637 . . . . 63.32 107.663 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -62.26 118.34 7.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.015 -1.846 . . . . 62.44 106.015 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -141.92 146.59 35.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.603 -2.74 . . . . 60.32 103.603 -172.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -116.12 126.99 54.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 126.211 1.805 . . . . 74.45 106.128 -171.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.82 121.23 16.87 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.266 -1.013 . . . . 74.12 108.266 172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -85.39 -20.29 30.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.665 0.786 . . . . 75.25 112.084 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -34.1 65.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.816 0.846 . . . . 65.51 111.033 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -135.93 8.83 3.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.683 0.793 . . . . 73.24 112.141 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.6 mt 57.02 47.84 16.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.8 1.64 . . . . 71.42 112.51 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 148.48 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.372 1.469 . . . . 64.13 108.964 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.6 144.2 11.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.033 -1.84 . . . . 71.12 106.033 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.66 -167.96 2.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.116 2.567 . . . . 64.42 107.052 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.8 153.4 42.56 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.258 -2.126 . . . . 64.15 105.258 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -153.99 162.6 41.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.127 1.371 . . . . 62.24 108.14 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -85.64 179.45 7.09 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.854 1.262 . . . . 72.51 112.828 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.62 155.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.917 2.087 . . . . 72.33 106.725 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.49 -42.68 1.63 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.868 0.867 . . . . 74.44 111.706 -170.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.622 ' CB ' HG21 ' A' ' 156' ' ' THR . 1.3 mtm-85 -127.08 -166.05 1.55 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.57 -0.9 . . . . 73.22 108.57 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -157.84 161.86 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.702 -1.962 . . . . 65.22 105.702 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 156' ' ' THR . 90.7 m95 -147.08 143.14 28.11 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.536 0.734 . . . . 75.23 110.025 178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.4 143.62 26.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.237 0.926 . . . . 75.31 109.538 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -146.38 162.02 39.11 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.847 -1.538 . . . . 75.34 106.847 166.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -85.1 156.01 21.25 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.133 -0.979 . . . . 65.42 108.694 172.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -136.32 163.35 30.64 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.009 2.124 . . . . 71.11 108.307 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 p -167.12 104.29 0.55 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.991 -1.485 . . . . 71.34 106.991 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.73 27.22 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.41 -0.9 . . . . 55.34 113.791 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 94.77 4.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.537 1.535 . . . . 64.21 109.459 -168.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.44 153.01 29.97 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 mm -79.06 131.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.386 1.874 . . . . 54.14 106.974 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -116.83 82.35 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.578 -1.638 . . . . 53.12 106.578 166.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -61.95 137.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.856 -1.905 . . . . 74.23 105.856 162.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -110.8 168.13 9.71 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.645 -1.613 . . . . 73.51 106.645 162.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.76 170.87 15.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.878 1.217 . . . . 75.42 109.361 159.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -58.32 -24.52 59.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.359 1.436 . . . . 74.22 111.962 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.21 -0.9 2.79 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.643 1.177 . . . . 71.33 112.259 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.93 13.75 8.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 128.149 2.58 . . . . 71.24 111.927 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 157.47 28.01 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 124.848 1.259 . . . . 65.41 108.205 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.71 171.17 17.23 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.661 1.585 . . . . 61.32 107.408 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.538 HG23 ' CE1' ' A' ' 171' ' ' PHE . 5.1 pt -147.53 173.09 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 126.664 1.986 . . . . 44.05 107.908 -174.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 104.5 4.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.422 -0.955 . . . . 71.33 108.422 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.15 166.97 27.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.302 1.041 . . . . 63.22 111.442 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -89.52 1.48 55.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 116.157 1.91 . . . . 35.34 116.157 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 96.33 -23.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 1 C-N-CA 138.787 6.835 . . . . 74.55 111.639 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -113.58 37.58 3.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.937 2.495 . . . . 72.31 110.238 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -101.0 139.36 20.44 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 125.04 1.336 . . . . 65.22 108.963 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.54 123.54 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.505 2.137 . . . . 62.25 110.53 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.94 173.55 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 61.34 109.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -119.62 139.71 51.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.103 . . . . 63.34 111.084 -168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.13 162.81 19.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.858 1.263 . . . . 72.54 110.103 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.404 ' HB3' HD21 ' A' ' 137' ' ' LEU . 94.4 p -95.48 105.99 18.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.261 0.351 . . . . 65.22 111.04 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -81.12 78.3 7.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.448 -1.686 . . . . 62.22 106.448 162.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 6.2 m 60.22 6.04 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.522 2.045 . . . . 75.51 116.522 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.32 -31.32 1.56 Allowed Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.712 -1.242 . . . . 72.24 110.057 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.7 142.7 36.89 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.362 -2.088 . . . . 64.51 105.362 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.05 132.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.577 -0.898 . . . . 60.32 108.577 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.24 152.31 48.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.81 1.644 . . . . 73.13 106.677 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.19 115.75 30.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.029 1.332 . . . . 73.44 109.61 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.52 175.26 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.745 0.818 . . . . 73.44 110.901 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -79.97 143.17 34.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.587 1.155 . . . . 71.21 109.226 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.0 -29.1 41.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.629 0.974 . . . . 64.33 113.629 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -24.26 65.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.14 -0.975 . . . . 75.53 112.661 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -86.74 -27.4 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.372 1.069 . . . . 74.13 111.927 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -71.43 61.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 127.921 2.488 . . . . 55.31 109.836 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -178.08 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.01 1.324 . . . . 74.22 108.509 170.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.48 0.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 127.364 2.266 . . . . 63.45 113.9 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.39 -18.88 70.25 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 117.506 -1.719 . . . . 11.25 111.989 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.56 169.82 12.08 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.214 2.007 . . . . 54.05 111.67 -163.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -124.0 119.09 28.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 126.256 1.822 . . . . 65.42 108.153 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -93.74 127.46 45.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.149 0.979 . . . . 73.24 108.776 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -67.8 115.58 7.52 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.906 -1.146 . . . . 75.42 107.906 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.4 154.42 59.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.386 1.074 . . . . 73.22 111.476 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 164' ' ' ILE . 50.7 Cg_exo -59.78 141.35 96.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.94 2.427 . . . . 74.32 110.138 172.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -113.48 -173.98 2.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.786 -1.19 . . . . 72.41 107.786 153.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -37.79 -64.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.189 1.796 . . . . 74.33 111.22 -168.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -120.59 -5.44 9.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.772 0.829 . . . . 74.34 112.122 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 p -125.33 -178.58 4.27 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.668 1.587 . . . . 60.24 111.67 -164.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 tp -100.39 147.25 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 O-C-N 120.171 -1.581 . . . . 53.25 107.574 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -137.94 -175.0 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.751 2.02 . . . . 52.23 107.938 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 108' ' ' SER . 18.9 mt -129.47 157.93 40.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.266 1.427 . . . . 41.25 107.649 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -153.87 159.3 41.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.692 1.597 . . . . 75.15 108.14 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.8 147.7 23.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.07 0.948 . . . . 63.25 110.605 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.97 -0.67 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.998 1.111 . . . . 72.42 113.998 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 26.51 -77.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.044 2.938 . . . . 71.53 117.062 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 141' ' ' ILE . 17.0 tppt? -103.21 117.29 34.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.049 1.74 . . . . 71.43 108.028 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.32 131.2 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.184 -1.043 . . . . 35.12 108.184 169.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -153.06 -179.45 7.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.942 1.697 . . . . 74.25 107.494 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.29 133.85 39.31 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.007 -0.738 . . . . 40.45 109.007 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.98 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.682 1.193 . . . . 64.31 108.494 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.29 113.39 14.34 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.447 -0.946 . . . . 62.11 108.447 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -128.72 135.32 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.074 1.35 . . . . 73.41 108.582 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -133.77 29.6 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.272 -0.893 . . . . 60.35 109.684 -161.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -126.86 -163.91 11.59 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.362 1.934 . . . . 42.24 111.411 -161.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -87.0 153.41 21.57 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.021 -1.281 . . . . 74.23 110.752 173.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.2 153.63 34.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 126.729 2.012 . . . . 72.34 107.877 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -142.47 154.38 44.48 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.344 1.058 . . . . 51.41 108.985 -170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.95 163.94 27.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.167 1.387 . . . . 52.51 108.288 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.73 140.13 42.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.943 1.701 . . . . 72.33 111.164 -163.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 78' ' ' TRP . 48.4 p -91.37 -46.68 7.89 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.576 0.954 . . . . 74.41 113.576 -156.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 2.7 t 23.12 64.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 130.111 3.364 . . . . 42.32 113.97 175.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.1 0.05 15.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.486 1.114 . . . . 73.41 113.511 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -34.91 41.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.352 -0.981 . . . . 60.13 108.352 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -127.94 -8.91 5.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.203 1.401 . . . . 55.41 113.712 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.57 23.96 14.25 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.475 1.91 . . . . 63.23 111.154 -175.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 p -141.36 164.84 29.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.342 2.657 . . . . 60.21 107.248 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 5.6 p90 -151.39 175.92 11.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.824 1.193 . . . . 72.44 110.372 165.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 62' ' ' PHE . 30.1 mm -109.37 126.17 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 74.21 108.831 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.21 160.46 43.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.729 0.812 . . . . 71.11 110.241 169.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.13 -165.11 25.5 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.167 -1.573 . . . . 31.11 109.167 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -100.72 172.83 6.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.111 1.455 . . . . 74.34 110.267 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.11 -85.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.177 2.591 . . . . 54.32 111.972 -171.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.88 -12.1 8.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.912 1.285 . . . . 74.55 112.878 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.06 174.59 39.31 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 122.877 1.265 . . . . 65.22 112.628 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.7 m-85 -121.18 154.5 36.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.454 2.702 . . . . 64.35 106.801 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.67 32.58 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.355 -1.35 . . . . 53.13 107.355 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.59 174.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 118.579 0.627 . . . . 74.41 109.651 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -72.42 155.2 40.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.111 0.564 . . . . 74.53 109.672 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.11 49.3 1.36 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.697 2.399 . . . . 60.45 108.644 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 CA--C 1.538 0.5 0 O-C-N 120.098 -1.626 . . . . 61.54 107.159 176.301 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.391 0 N-CA-C 106.069 -1.826 . . . . 61.33 106.069 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.01 157.54 24.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.177 0.991 . . . . 63.01 109.557 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -68.38 -176.67 0.79 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.187 1.395 . . . . 73.14 110.947 169.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 14.4 t80 -84.67 -33.57 23.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.547 1.139 . . . . 65.13 113.169 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.81 38.53 1.71 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 71.03 110.197 -162.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -117.19 112.61 39.65 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 125.039 1.336 . . . . 74.12 110.947 -153.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.56 127.41 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.99 1.793 . . . . 74.32 113.557 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -100.36 24.53 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.626 1.97 . . . . 53.14 112.95 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 29.78 66.09 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.341 2.257 . . . . 74.43 115.403 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -53.17 155.59 2.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.315 -0.866 . . . . 60.2 111.507 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -43.62 61.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.51 1.124 . . . . 74.13 109.172 169.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.09 -47.34 77.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.105 0.962 . . . . 64.14 110.722 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.81 26.91 3.7 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.767 1.175 . . . . 74.3 112.65 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.68 -27.61 66.55 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.264 1.532 . . . . 72.32 114.118 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 mm 48.17 63.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.861 1.264 . . . . 73.24 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 147.97 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.903 1.281 . . . . 71.33 108.121 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -65.27 122.69 17.69 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.97 -1.493 . . . . 22.14 106.97 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.7 tt -46.55 -44.75 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 124.995 1.318 . . . . 63.11 110.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -70.54 -26.3 74.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-O 118.577 -1.124 . . . . 73.01 111.685 -173.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.41 -53.17 14.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.461 1.631 . . . . 63.33 109.716 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -43.87 -48.77 8.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.779 1.232 . . . . 72.41 109.555 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 77' ' ' VAL . 60.1 t -73.88 -44.9 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 118.361 -0.828 . . . . 63.55 111.645 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -65.03 -32.82 74.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.737 2.062 . . . . 71.2 111.585 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -40.49 65.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.714 1.606 . . . . 73.43 110.965 171.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -76.74 -36.66 56.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.492 1.517 . . . . 65.11 109.632 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -63.66 -41.77 98.15 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.334 1.879 . . . . 74.2 110.774 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -24.42 64.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.497 -0.752 . . . . 55.43 111.281 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 5.5 mttt -82.35 -59.19 2.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.996 -1.483 . . . . 54.54 106.996 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 8.0 m-85 -100.63 41.84 1.15 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.943 0.897 . . . . 61.34 109.949 -162.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -32.2 67.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.564 0.745 . . . . 63.32 111.772 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -73.83 -22.17 59.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.832 0.678 . . . . 75.2 112.832 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 t -90.04 -1.41 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.62 1.568 . . . . 64.14 111.59 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 96.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 124.744 1.217 . . . . 53.43 107.793 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -79.99 161.5 25.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.059 -1.089 . . . . 73.12 108.059 162.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -126.17 154.31 43.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.433 -1.692 . . . . 73.25 106.433 160.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.41 179.38 7.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.009 0.924 . . . . 62.24 110.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.84 -25.54 63.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.4 0.68 . . . . 73.22 111.442 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -77.53 -13.85 59.81 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.873 -1.142 . . . . 62.25 111.346 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.96 55.69 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 120.441 -1.412 . . . . 53.04 112.35 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -52.35 -83.46 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.471 1.909 . . . . 71.21 112.874 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.82 107.32 0.64 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-O 117.977 -1.457 . . . . 75.44 110.131 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -123.31 162.34 22.89 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.107 1.453 . . . . 55.25 111.447 170.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mt -146.73 132.33 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.414 2.686 . . . . 71.44 103.952 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 126.8 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.104 -1.072 . . . . 75.44 108.104 164.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.83 13.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.142 1.377 . . . . 73.24 111.6 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.46 -31.57 36.32 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.291 -0.88 . . . . 75.53 113.472 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.37 -19.41 65.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.741 1.216 . . . . 63.44 112.721 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.81 -25.89 66.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.832 0.742 . . . . 62.21 110.87 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.5 36.02 25.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.752 1.221 . . . . 75.11 111.992 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -89.34 135.08 26.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.73 154.27 19.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.445 0.64 . . . . 73.31 109.305 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -132.89 148.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 125.663 1.585 . . . . 74.03 107.911 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -75.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.688 1.995 . . . . 74.22 110.349 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.16 173.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.047 2.539 . . . . 73.52 108.454 165.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -136.75 140.75 42.8 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.195 -0.94 . . . . 61.02 109.854 -174.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -87.5 121.01 29.39 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 126.064 1.745 . . . . 63.53 109.091 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -70.76 -27.81 64.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.72 0.808 . . . . 74.21 112.076 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -50.5 -42.03 54.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.075 1.35 . . . . 71.32 110.897 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -134.1 16.78 3.8 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.622 0.769 . . . . 55.14 111.357 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.28 49.57 17.6 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.771 1.228 . . . . 74.35 112.464 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.54 154.48 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.555 1.542 . . . . 74.43 109.529 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.98 145.77 8.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.52 -1.289 . . . . 74.01 107.52 165.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -141.06 -168.5 2.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.545 1.938 . . . . 71.43 107.774 163.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -92.24 149.14 21.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.439 -0.948 . . . . 65.32 108.439 153.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -154.13 152.69 30.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.627 2.371 . . . . 73.32 106.571 167.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -84.36 175.66 9.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.428 1.091 . . . . 74.24 109.938 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.69 141.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.829 2.052 . . . . 62.21 106.324 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 158' ' ' GLU . 1.9 mm? -111.74 -45.67 3.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.703 0.401 . . . . 63.53 112.03 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.38 144.83 49.83 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.53 -0.915 . . . . 55.54 108.53 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -108.87 158.7 8.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.393 1.477 . . . . 74.42 108.054 176.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -132.05 152.75 51.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.208 1.003 . . . . 75.42 108.953 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -149.53 152.53 35.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 165.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -150.08 167.96 25.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.094 1.757 . . . . 64.3 106.946 166.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -105.41 143.97 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.044 -1.035 . . . . 75.22 108.223 171.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -142.64 156.19 45.04 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.3 0.5 . . . . 74.54 111.25 -160.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -156.94 125.85 5.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 75.43 109.788 164.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.51 179.52 37.96 Favored Glycine 0 N--CA 1.465 0.587 0 N-CA-C 110.184 -1.167 . . . . 54.1 110.184 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -81.03 140.04 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.876 -0.779 . . . . 62.22 110.236 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.65 157.87 32.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.161 1.384 . . . . 72.53 107.625 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mm -79.67 141.6 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.678 1.191 . . . . 72.32 108.77 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 146' ' ' VAL . 55.7 mttt -123.66 86.28 2.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.341 1.456 . . . . 71.24 107.519 158.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 140' ' ' VAL . 31.8 mt -62.77 101.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.521 -1.659 . . . . 55.44 106.521 148.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.38 172.99 13.04 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.899 -1.519 . . . . 73.21 106.899 163.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -138.56 171.04 14.95 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.704 -1.247 . . . . 74.22 108.574 163.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -71.15 -25.17 62.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.539 2.336 . . . . 55.03 110.938 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -59.86 -11.24 5.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.93 1.692 . . . . 64.44 111.578 164.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 63.15 33.05 14.75 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.173 2.989 . . . . 72.23 111.617 -167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' CG ' ' A' ' 95' ' ' ARG . 2.1 mtt-85 -75.43 173.43 10.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 118.231 -1.388 . . . . 73.41 109.474 161.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.39 164.29 19.7 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.983 1.713 . . . . 75.45 106.522 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.52 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -132.25 -179.93 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.068 -1.086 . . . . 75.51 108.068 165.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.2 m -149.87 118.92 6.71 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.011 -1.68 . . . . 64.44 108.949 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 97' ' ' ILE . 1.1 pt? -166.25 172.13 11.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.963 -1.017 . . . . 65.32 111.261 -169.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 m -79.43 147.61 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.095 -1.076 . . . . 71.12 108.095 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -10.21 54.29 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.165 1.172 . . . . 72.53 114.165 -161.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.4 38.19 3.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.661 2.785 . . . . 65.02 110.156 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -82.63 140.95 44.43 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.071 -0.966 . . . . 52.44 109.525 159.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.02 118.53 5.63 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.124 3.216 . . . . 70.2 111.274 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.65 -166.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 120.876 -1.14 . . . . 74.54 110.128 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -135.07 134.68 40.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.747 1.219 . . . . 65.14 108.733 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.31 166.58 28.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 126.107 1.763 . . . . 73.41 107.944 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -89.9 143.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.096 0.475 . . . . 74.22 110.309 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -115.02 86.74 2.51 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.224 -1.769 . . . . 73.43 106.224 155.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.65 17.76 8.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.097 0.959 . . . . 63.32 113.407 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.43 -26.85 4.3 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.652 1.12 . . . . 71.05 111.187 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 148.62 32.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.557 -1.646 . . . . 60.55 106.557 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.7 t -85.32 114.46 25.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.558 -1.275 . . . . 73.2 107.558 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.46 40.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.89 -0.782 . . . . 71.22 108.89 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.67 120.02 36.22 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.87 2.068 . . . . 73.05 106.996 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.65 175.26 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.691 1.596 . . . . 54.43 109.803 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -78.03 144.5 36.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.53 -0.544 . . . . 70.33 109.53 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.03 22.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 71.12 112.201 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -17.29 62.99 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.151 1.167 . . . . 71.1 114.151 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.6 mtm -96.99 -15.24 21.18 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.161 0.985 . . . . 74.35 112.071 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.61 63.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.949 1.699 . . . . 62.43 109.217 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.63 176.82 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 63.33 109.291 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.36 -37.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.278 1.831 . . . . 65.11 112.721 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.79 11.03 63.09 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.419 -1.767 . . . . 62.35 114.185 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.15 169.9 8.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 121.018 2.409 . . . . 71.04 108.814 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 137' ' ' LEU . 29.4 m-85 -118.16 105.42 11.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 123.907 0.883 . . . . 73.45 109.182 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.0 125.69 39.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 62.43 108.795 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.63 123.46 19.36 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 72.53 107.067 173.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.85 157.74 56.54 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.694 1.598 . . . . 74.54 111.883 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.97 159.72 50.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.387 2.725 . . . . 74.45 111.8 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -141.81 -178.04 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.626 -1.62 . . . . 73.23 106.626 156.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -24.74 -67.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.318 2.647 . . . . 63.04 113.266 -170.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.68 -10.0 9.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.185 0.994 . . . . 31.5 113.447 165.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 p -131.3 148.15 52.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.818 1.19 . . . . 74.31 111.571 -162.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.94 143.31 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.263 -1.384 . . . . 73.42 107.263 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -142.91 -176.91 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.813 1.645 . . . . 74.11 108.391 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 126' ' ' TYR . 8.8 mt -125.38 165.46 18.34 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.413 1.101 . . . . 71.52 108.538 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -154.56 157.71 38.68 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 103.593 -2.743 . . . . 71.33 103.593 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 7.8 mt-10 -61.39 -177.7 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.026 1.33 . . . . 60.24 109.279 168.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 89' ' ' ILE 0.259 72.0 t -112.6 2.56 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.793 1.237 . . . . 75.54 111.904 176.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.1 pt 24.83 -70.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 130.422 3.489 . . . . 73.11 117.719 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.7 tptt -116.14 118.51 33.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.181 1.393 . . . . 65.43 107.462 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.43 119.53 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.998 -1.482 . . . . 65.23 106.998 156.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.14 -176.08 4.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.005 1.722 . . . . 75.32 107.816 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -130.76 159.93 35.84 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.155 -0.966 . . . . 52.12 109.868 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 88' ' ' LYS . 12.3 m -117.12 165.22 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.781 1.633 . . . . 61.2 107.794 171.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -122.7 71.02 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.086 1.354 . . . . 74.52 108.843 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.45 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.7 t80 -81.64 154.76 25.96 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.879 1.272 . . . . 74.52 110.798 -167.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.33 24.96 2.27 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.306 -0.871 . . . . 73.55 112.358 -172.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.58 -138.94 9.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 125.173 1.368 . . . . 62.44 111.942 -155.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -117.86 155.22 30.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.907 -1.146 . . . . 71.11 107.907 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.59 152.41 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.958 1.303 . . . . 74.41 109.928 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -142.57 168.81 18.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.062 1.345 . . . . 75.43 108.492 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -154.74 175.03 14.23 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.803 -1.184 . . . . 74.02 107.803 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 tp -135.14 119.39 17.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.781 1.173 . . . . 63.53 110.508 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.9 m -84.12 118.56 24.18 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.791 -0.818 . . . . 73.51 108.791 169.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 t -125.98 94.93 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.433 -2.062 . . . . 72.32 105.433 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.641 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.3 pt-20 -80.35 -8.65 59.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.336 -0.852 . . . . 73.54 113.236 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -88.55 -59.05 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.74 1.257 . . . . 74.02 108.454 -156.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.07 112.57 13.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 101.687 -3.449 . . . . 74.22 101.687 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.439 ' CG ' ' HA ' ' A' ' 176' ' ' SER . 23.8 m170 -69.31 50.39 0.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.606 1.962 . . . . 63.11 112.03 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -151.67 140.1 20.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.02 2.128 . . . . 54.04 108.697 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.81 178.79 8.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.077 1.351 . . . . 74.45 111.121 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 46.7 mm -112.19 135.79 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.481 -1.674 . . . . 74.41 106.481 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.08 159.85 43.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.682 -1.229 . . . . 71.41 107.682 160.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 140.47 -165.22 26.14 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.817 1.198 . . . . 73.13 111.043 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -110.91 170.65 7.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.365 1.078 . . . . 72.44 111.002 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.99 -80.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.146 2.578 . . . . 64.34 112.574 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.32 -3.95 8.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.477 . . . . 64.44 114.051 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 84.38 176.94 51.2 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 122.141 0.856 . . . . 51.11 111.927 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CE1' HG23 ' A' ' 97' ' ' ILE . 3.8 m-85 -127.76 146.86 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.187 2.595 . . . . 74.14 106.2 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.542 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -95.56 132.0 41.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 119.21 -0.424 . . . . 73.54 110.69 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 163' ' ' TYR . 5.4 m -145.71 167.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.19 0.996 . . . . 74.31 109.633 -169.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 71.3 m -63.02 142.81 58.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.167 1.787 . . . . 64.44 110.286 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -141.84 39.89 1.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.568 1.147 . . . . 75.42 111.623 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.439 ' HA ' ' CG ' ' A' ' 161' ' ' HIS . 70.9 m . . . . . 0 N--CA 1.457 -0.108 0 O-C-N 121.704 -0.622 . . . . 74.1 111.558 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.518 0 N-CA-C 108.024 -1.102 . . . . 73.43 108.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.49 151.82 21.78 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.253 1.421 . . . . 71.33 109.471 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.4 49.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.691 -0.686 . . . . 61.12 110.366 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -48.26 -31.51 6.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.651 1.98 . . . . 72.21 113.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -104.78 15.35 28.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.641 1.976 . . . . 74.31 112.23 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -79.46 114.24 43.65 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.551 -1.277 . . . . 72.54 107.551 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.02 136.33 29.37 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.422 2.748 . . . . 64.21 113.064 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.35 88.61 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.43 -1.322 . . . . 64.52 107.43 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -48.21 83.6 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.233 2.613 . . . . 73.43 113.347 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -65.44 163.97 14.76 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.243 1.017 . . . . 62.34 109.478 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 t -60.21 -39.77 87.74 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 119.027 -0.511 . . . . 50.3 109.812 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.9 -38.48 22.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.702 -0.799 . . . . 73.44 109.275 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.18 43.78 0.9 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 114.958 0.743 . . . . 74.53 114.958 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -8.66 23.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.135 1.902 . . . . 73.03 116.135 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.289 7.8 mm 61.49 25.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-O 124.648 2.166 . . . . 74.34 112.49 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 152.78 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 125.426 1.49 . . . . 74.54 108.915 -170.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.09 130.18 43.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.968 1.707 . . . . 75.12 108.851 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.7 tt -53.49 -33.43 21.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.23 1.412 . . . . 74.32 112.892 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -94.83 -13.67 52.36 Favored Glycine 0 C--O 1.219 -0.818 0 CA-C-O 117.28 -1.845 . . . . 40.1 112.782 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -73.47 -49.72 25.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.346 2.573 . . . . 65.24 109.073 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -49.2 -56.95 7.65 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.193 1.397 . . . . 74.23 109.568 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.671 HG22 ' HA2' ' A' ' 26' ' ' GLY . 34.4 m -67.6 -38.77 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 117.504 -1.236 . . . . 63.43 110.371 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -34.55 73.57 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 121.462 1.937 . . . . 61.43 111.334 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.1 pttt -52.25 -42.03 63.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.748 1.219 . . . . 75.02 111.249 171.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.465 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.8 m-85 -78.04 -47.25 18.81 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 117.703 -1.141 . . . . 62.23 110.507 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -53.86 -30.77 47.08 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.598 1.999 . . . . 64.42 112.358 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -57.94 4.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.528 1.531 . . . . 73.41 110.091 170.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -68.57 -58.33 4.44 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.802 -1.555 . . . . 73.13 106.802 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -86.81 40.17 0.89 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.494 1.517 . . . . 55.11 108.443 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -34.73 68.76 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.788 -1.195 . . . . 73.33 111.498 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.04 -28.19 65.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.272 0.471 . . . . 71.13 112.272 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.6 m -73.37 -2.1 20.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.721 0.637 . . . . 74.32 112.721 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.58 114.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.97 1.308 . . . . 71.15 109.433 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -114.06 113.33 24.6 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.492 -1.669 . . . . 74.3 106.492 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -73.45 142.18 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.045 -1.835 . . . . 70.3 106.045 164.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.96 176.78 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.571 -0.9 . . . . 64.44 108.571 159.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 -35.04 77.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.328 1.451 . . . . 73.52 112.306 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.2 -8.73 18.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.512 1.125 . . . . 72.52 112.67 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 7.82 64.37 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 127.939 2.685 . . . . 45.52 112.664 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.85 -83.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.977 1.711 . . . . 64.04 111.902 -160.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.48 101.49 1.13 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.623 -1.098 . . . . 52.32 111.805 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -108.16 163.35 13.24 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.598 0.823 . . . . 75.51 109.977 163.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.8 mt -145.45 143.54 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.427 1.891 . . . . 55.42 106.599 166.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.53 131.95 34.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.696 1.598 . . . . 53.45 111.148 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.82 -3.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.099 1.36 . . . . 75.24 112.768 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.95 -21.58 52.79 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 120.02 1.282 . . . . 54.11 114.627 -168.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -69.08 -5.41 21.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.759 1.224 . . . . 71.31 113.896 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.57 -19.29 62.01 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 119.649 -1.907 . . . . 74.33 112.201 164.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 m120 45.02 33.62 1.09 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.237 1.815 . . . . 72.05 112.576 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.56 169.04 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.595 1.958 . . . . 64.2 106.972 159.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.5 158.06 45.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.134 0.974 . . . . 72.31 109.151 166.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.03 157.14 33.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 126.138 1.775 . . . . 75.03 108.68 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 152.31 44.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.184 0.992 . . . . 75.2 108.56 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.1 p -147.53 -168.83 3.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 125.608 1.563 . . . . 63.22 106.96 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.853 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -152.3 137.71 17.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.066 -1.021 . . . . 64.4 108.742 177.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.6 114.9 18.88 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.426 -0.953 . . . . 72.42 108.426 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -61.83 -27.5 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.361 . . . . 74.23 111.25 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -35.67 -51.52 0.66 Allowed 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 129.324 3.05 . . . . 34.12 112.017 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.5 m -147.58 12.17 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.163 1.785 . . . . 74.54 110.694 -160.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt 52.82 41.93 31.82 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.447 1.499 . . . . 70.12 111.144 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.5 pt -96.61 173.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.261 1.024 . . . . 73.35 109.488 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.17 147.35 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.76 -1.57 . . . . 62.44 106.76 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -147.83 172.17 14.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 74.32 108.442 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -126.81 144.78 50.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.529 1.532 . . . . 63.31 107.168 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 161.56 35.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.312 0.645 . . . . 53.0 110.841 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -82.02 -35.24 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.239 0.829 . . . . 74.22 113.239 -170.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 mt 63.75 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 128.131 2.573 . . . . 63.44 109.685 -155.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 158' ' ' GLU . 29.2 mt -142.53 -65.63 0.4 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.227 1.811 . . . . 52.44 106.4 -164.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -127.75 164.27 22.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.6 1.56 . . . . 71.5 111.258 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.24 172.59 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.52 1.928 . . . . 70.01 109.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -141.58 137.48 31.96 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.298 1.039 . . . . 72.14 110.163 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -129.16 131.92 47.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.043 1.337 . . . . 64.23 110.989 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -141.92 176.28 9.06 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 72.35 109.593 166.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.75 148.16 31.93 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.741 1.216 . . . . 75.24 109.268 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -142.75 160.06 41.04 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.231 0.923 . . . . 73.42 112.677 -167.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.79 109.67 1.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.32 1.448 . . . . 63.24 110.441 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.31 -171.45 35.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.874 1.216 . . . . 74.43 112.426 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -90.07 151.85 21.43 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.949 -1.324 . . . . 72.42 110.729 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.6 mt -130.77 153.94 48.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.104 1.362 . . . . 73.34 108.941 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.98 130.85 35.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.396 -1.335 . . . . 53.21 107.396 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -121.51 77.94 1.39 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.459 1.504 . . . . 63.02 107.304 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 140' ' ' VAL . 30.0 mt -70.2 103.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.775 2.03 . . . . 74.44 107.594 166.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -85.1 163.76 18.59 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.106 -1.442 . . . . 72.22 107.106 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -136.38 167.76 20.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.389 0.995 . . . . 73.41 108.441 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.4 ttmt -58.67 -30.07 67.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.563 -1.336 . . . . 54.5 113.113 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -73.25 15.39 0.23 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.71 1.141 . . . . 72.11 112.283 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 92' ' ' LYS . 8.3 mmt180 47.69 35.47 4.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 128.776 2.83 . . . . 74.44 110.885 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.3 mtt-85 -73.63 167.32 21.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.002 -1.11 . . . . 73.33 108.002 157.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -170.93 161.12 6.93 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.46 1.904 . . . . 74.11 106.199 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -143.69 169.26 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 129.833 3.253 . . . . 65.33 109.268 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.431 ' C ' HD23 ' A' ' 99' ' ' LEU . 12.4 m -153.33 98.56 2.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.543 1.537 . . . . 71.22 110.564 -175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -159.64 173.25 16.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.733 1.613 . . . . 74.42 109.921 -170.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -68.83 167.93 14.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.267 1.027 . . . . 71.31 112.619 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.09 -46.61 67.33 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.841 -0.537 . . . . 75.12 110.608 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.1 38.87 1.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.439 -0.948 . . . . 64.2 108.439 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 99' ' ' LEU . 49.6 t-80 -84.26 134.62 42.84 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.315 -0.994 . . . . 73.24 108.315 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.48 133.62 38.0 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.258 1.972 . . . . 72.32 111.111 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 178.78 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.825 1.65 . . . . 73.12 108.554 167.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -116.48 142.65 46.59 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.572 -0.705 . . . . 72.34 109.704 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 121' ' ' VAL . 2.5 pp -133.77 165.15 32.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.44 1.496 . . . . 73.04 109.52 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 133.44 40.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.922 1.289 . . . . 71.41 107.91 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -122.66 74.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.109 1.364 . . . . 64.24 107.518 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m 65.85 7.64 4.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.975 1.31 . . . . 74.51 113.679 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.3 -9.71 4.4 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.312 0.958 . . . . 51.41 112.053 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -101.3 117.52 35.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.042 -1.836 . . . . 71.21 106.042 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.07 126.54 28.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.404 -1.332 . . . . 64.5 107.404 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.91 140.5 49.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.074 1.749 . . . . 74.11 107.084 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.15 131.61 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.115 -1.068 . . . . 74.42 108.115 166.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.2 pt -145.59 -167.09 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.78 2.032 . . . . 73.43 107.997 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.76 143.5 27.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.887 1.275 . . . . 71.51 110.091 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.63 -35.67 42.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.213 1.405 . . . . 53.44 113.125 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -17.6 64.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.216 1.191 . . . . 71.25 114.216 -172.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -25.57 28.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.489 1.116 . . . . 63.32 111.575 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 107' ' ' ILE . 3.7 t -72.18 63.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 128.805 2.842 . . . . 72.31 110.492 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -78.63 -178.42 5.88 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.029 -1.044 . . . . 73.4 109.152 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.52 -13.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.309 1.843 . . . . 74.33 113.755 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.73 4.38 66.05 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.559 -1.69 . . . . 72.34 113.435 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.09 135.53 39.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 120.275 2.038 . . . . 72.31 106.657 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -76.87 122.48 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.772 -1.566 . . . . 75.55 106.772 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.65 147.49 6.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.541 -1.651 . . . . 75.43 106.541 164.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.87 136.33 35.36 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.517 -1.29 . . . . 71.34 107.517 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.407 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.4 pp -126.83 154.51 76.04 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 124.568 1.147 . . . . 74.5 111.608 172.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.6 150.49 31.56 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.562 2.175 . . . . 75.0 108.548 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -123.69 -171.05 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.148 -1.797 . . . . 73.43 106.148 161.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -40.63 -68.58 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.311 1.445 . . . . 73.32 112.72 -168.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -120.95 -1.37 9.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.859 1.664 . . . . 72.54 111.266 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 64.3 p -139.94 165.51 27.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.131 0.878 . . . . 75.44 111.199 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -79.33 155.03 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.431 -1.322 . . . . 72.25 107.431 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.42 -178.04 5.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.272 1.429 . . . . 73.22 107.307 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.64 149.39 47.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.387 -1.709 . . . . 72.24 106.387 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -147.91 131.37 16.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.193 1.797 . . . . 65.32 106.729 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -62.44 157.2 20.69 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.211 0.46 . . . . 73.23 109.951 -176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 89' ' ' ILE . 78.7 t -93.76 2.1 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.993 1.717 . . . . 73.14 111.807 -171.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt 24.11 -86.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 128.985 2.914 . . . . 60.23 115.366 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -97.03 109.41 22.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.35 1.46 . . . . 72.41 107.44 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 p -110.76 119.07 58.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.883 -1.154 . . . . 61.45 107.883 164.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -133.77 -178.54 5.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.774 1.63 . . . . 75.34 108.558 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.66 136.1 52.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.084 0.954 . . . . 75.12 108.485 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.4 m -94.04 162.17 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.102 -1.073 . . . . 74.0 108.102 167.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 151.09 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.226 1.011 . . . . 73.42 108.488 159.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -159.07 131.8 6.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.513 1.051 . . . . 74.1 109.851 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -142.35 59.71 1.45 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.204 -0.935 . . . . 74.23 110.048 -167.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.96 -131.82 3.33 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.168 1.366 . . . . 72.31 112.703 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -114.84 161.7 17.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.074 1.35 . . . . 64.31 109.438 168.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.92 156.04 39.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 125.464 1.505 . . . . 72.31 109.05 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.406 ' CD2' HG21 ' A' ' 29' ' ' VAL . 4.7 m-85 -146.53 159.29 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.509 -0.923 . . . . 74.34 108.509 -168.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -148.38 173.5 13.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.101 -1.074 . . . . 73.12 108.101 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -131.73 134.92 46.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.226 1.41 . . . . 73.21 109.324 -163.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.3 m -70.85 -50.64 33.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 118.562 -0.732 . . . . 72.44 112.096 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 t 24.58 68.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.561 2.745 . . . . 74.1 111.385 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 75' ' ' LEU . 7.6 pt-20 -73.35 -6.16 44.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.255 1.026 . . . . 74.12 112.516 -166.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.88 -58.59 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.083 1.753 . . . . 75.04 108.874 -163.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -119.36 -1.12 10.81 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.024 1.33 . . . . 70.24 112.923 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.9 m170 58.67 28.3 17.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.536 1.535 . . . . 73.22 112.17 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.423 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 22.2 p -141.64 140.82 33.36 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.378 -1.451 . . . . 72.31 111.208 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.502 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -134.89 175.16 9.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.705 1.202 . . . . 65.22 111.717 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.2 mm -107.14 122.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 N-CA-C 106.95 -1.5 . . . . 71.1 106.95 168.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.48 160.33 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.511 0.725 . . . . 53.54 109.245 170.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 137.37 -167.34 24.77 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 109.865 -1.294 . . . . 64.13 109.865 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -112.3 167.26 10.57 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 121.332 -1.099 . . . . 75.33 109.277 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 64.62 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.226 1.811 . . . . 74.11 112.38 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.04 -15.73 7.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.488 1.04 . . . . 72.14 112.787 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 174.6 46.61 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 123.286 1.492 . . . . 71.22 113.254 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.586 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -127.32 147.28 50.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.186 2.594 . . . . 73.23 106.949 -172.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.853 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -91.62 112.66 24.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.903 -1.517 . . . . 74.22 106.903 173.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.33 175.97 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.888 1.675 . . . . 74.13 109.045 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -61.08 138.59 58.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.842 0.857 . . . . 72.24 110.18 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -124.18 57.93 1.21 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 128.976 2.91 . . . . 65.24 107.473 169.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 42.4 m . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 105.315 -2.105 . . . . 61.43 105.315 -171.85 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 109.518 -0.549 . . . . 63.43 109.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -98.51 160.98 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.431 1.892 . . . . 71.5 110.233 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 154.76 30.64 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 123.211 0.605 . . . . 43.31 111.247 170.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -50.33 -32.09 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.353 1.861 . . . . 72.42 114.494 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -105.45 12.73 31.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.584 . . . . 70.43 112.946 -164.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -79.81 132.62 60.43 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.769 1.227 . . . . 71.52 108.974 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.49 149.55 90.55 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.551 2.834 . . . . 72.04 113.732 162.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 pt -114.47 -5.15 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.143 1.777 . . . . 73.45 112.862 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 55.53 73.38 0.43 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.452 1.024 . . . . 74.12 111.342 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.44 159.64 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.676 -0.64 . . . . 42.22 109.364 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 m -56.56 -34.03 66.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.379 -0.819 . . . . 73.44 112.247 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -86.93 -28.98 22.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.694 0.679 . . . . 72.03 110.295 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.05 41.32 1.97 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.717 1.151 . . . . 72.12 114.493 166.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.88 -27.14 62.99 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 115.209 1.559 . . . . 74.12 115.209 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mm 45.77 73.97 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.564 2.345 . . . . 71.34 108.69 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 174.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.791 2.036 . . . . 64.41 108.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.4 135.59 33.44 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.187 1.395 . . . . 73.32 107.811 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 tt -55.38 -28.75 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.079 -1.013 . . . . 72.25 112.08 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.86 -14.51 57.86 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 116.465 -2.297 . . . . 60.2 114.845 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -66.2 -50.01 65.32 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.122 2.461 . . . . 74.51 108.327 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -56.54 -59.17 5.38 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.626 1.97 . . . . 65.42 108.47 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 77' ' ' VAL . 69.1 t -56.77 -47.33 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.135 -0.484 . . . . 55.04 111.166 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -41.69 74.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.824 0.85 . . . . 75.11 110.809 -176.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -51.32 45.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.351 1.06 . . . . 64.43 109.328 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.64 -43.87 65.34 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.152 0.981 . . . . 73.13 108.449 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.4 m-85 -56.01 -38.74 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.323 1.42 . . . . 71.41 111.895 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -83.51 -22.45 32.48 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.507 1.123 . . . . 73.52 111.124 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 8.5 mttm -88.27 -58.65 2.48 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.969 -1.493 . . . . 53.42 106.969 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.5 m-30 -91.88 45.91 1.25 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 129.192 2.997 . . . . 75.2 108.313 -172.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -34.86 64.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.225 -0.922 . . . . 61.35 111.226 172.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -77.99 6.2 8.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.425 . . . . 73.43 112.979 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -106.29 -9.88 16.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 117.179 -1.391 . . . . 65.5 111.322 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.29 99.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 120.089 1.313 . . . . 73.02 108.618 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -85.2 159.84 20.03 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.72 -0.844 . . . . 54.31 108.72 160.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -136.48 133.74 36.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.889 -2.263 . . . . 71.13 104.889 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.77 177.3 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.755 0.659 . . . . 62.3 109.459 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -40.6 77.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.343 1.457 . . . . 50.13 112.237 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -19.54 63.43 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.362 -0.836 . . . . 61.54 111.46 174.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.43 65.1 1.7 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 107.775 -2.13 . . . . 75.04 107.775 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.64 -100.7 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.698 -1.964 . . . . 75.12 105.698 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.49 120.34 1.17 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.992 -2.043 . . . . 65.21 107.992 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -139.16 162.21 35.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.839 0.819 . . . . 72.43 110.092 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 33' ' ' PHE . 13.2 mt -143.93 139.99 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 126.508 1.923 . . . . 50.15 105.85 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.75 133.11 35.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.497 1.519 . . . . 71.15 109.163 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.32 4.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 125.841 1.657 . . . . 73.21 112.169 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.07 -10.82 7.52 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.855 1.207 . . . . 64.21 114.173 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.16 -15.74 56.42 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.337 -1.684 . . . . 63.1 112.507 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.45 -12.66 61.84 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.981 1.264 . . . . 75.2 113.407 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.53 -2.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.894 2.078 . . . . 72.02 113.705 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 141.33 16.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.169 1.387 . . . . 71.23 107.477 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.99 157.03 22.02 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.021 0.828 . . . . 60.13 109.547 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.23 144.54 28.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 126.645 1.978 . . . . 73.24 107.337 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -63.77 130.63 44.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.602 -1.629 . . . . 75.43 106.602 165.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.1 p -136.74 -169.18 2.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.632 -1.618 . . . . 64.3 106.632 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -146.17 143.76 29.5 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.31 -1.367 . . . . 65.03 107.31 171.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -86.41 116.22 24.42 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 124.964 1.306 . . . . 73.51 108.357 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.92 -27.98 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.676 0.79 . . . . 74.14 111.876 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.67 -22.42 65.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.637 0.653 . . . . 65.3 112.288 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m -137.57 3.0 2.5 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.746 1.218 . . . . 72.41 112.628 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.47 35.84 24.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.493 1.497 . . . . 54.23 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.47 154.91 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.203 1.801 . . . . 61.25 109.41 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.95 129.53 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.458 -1.682 . . . . 54.43 106.458 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -148.68 178.79 8.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.721 1.608 . . . . 74.14 108.443 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -105.77 150.1 25.84 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.465 -1.397 . . . . 74.22 109.287 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.6 160.11 39.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 169.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -92.4 -17.93 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.048 0.758 . . . . 63.0 113.048 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mt 58.7 147.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.883 2.073 . . . . 75.43 109.429 -160.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.14 -57.24 2.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.996 0.919 . . . . 73.23 108.7 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -129.76 150.76 50.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.364 0.983 . . . . 65.35 110.298 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -112.55 168.28 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 125.188 1.395 . . . . 71.43 109.204 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -135.44 153.2 51.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.177 0.991 . . . . 64.02 109.788 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.94 142.82 29.08 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.374 0.67 . . . . 70.04 109.612 169.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.47 156.64 47.91 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.403 -1.703 . . . . 70.32 106.403 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -84.24 159.18 21.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.117 -1.438 . . . . 74.22 107.117 165.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -139.9 153.94 47.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.196 0.998 . . . . 75.31 110.201 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -149.93 152.9 35.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 139.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.17 -171.66 32.13 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 109.394 -1.482 . . . . 64.13 109.394 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -89.5 120.31 30.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.757 -1.201 . . . . 64.33 107.757 170.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 160.58 15.96 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.617 -1.253 . . . . 71.4 107.617 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mm -79.34 140.71 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.162 1.385 . . . . 75.12 107.651 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -126.81 58.23 1.42 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.197 0.599 . . . . 73.05 110.287 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.9 mt -63.34 116.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 105.62 -1.993 . . . . 53.14 105.62 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -94.98 155.48 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 105.384 -2.08 . . . . 64.11 105.384 163.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -125.44 169.17 12.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.883 1.273 . . . . 74.51 108.221 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -67.57 -11.14 57.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.588 -1.32 . . . . 65.24 111.814 -172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -3.23 53.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.661 1.585 . . . . 72.44 113.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.09 12.77 8.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.701 1.6 . . . . 74.02 111.571 -171.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 165.57 17.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.262 -1.014 . . . . 75.44 108.262 163.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -173.19 164.14 4.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.768 2.027 . . . . 70.55 109.027 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.3 pt -144.84 165.99 11.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.033 2.133 . . . . 52.51 107.54 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -140.34 97.87 3.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.841 0.857 . . . . 75.51 109.256 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.84 172.25 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.762 1.625 . . . . 72.24 111.547 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.4 p -61.03 154.61 22.25 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.991 1.316 . . . . 75.53 110.754 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -74.14 -26.15 60.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.465 -0.772 . . . . 65.34 111.369 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -97.72 37.74 1.36 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.623 0.647 . . . . 64.43 110.054 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -90.94 123.38 64.92 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-O 117.807 -1.092 . . . . 73.51 108.108 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.67 139.01 61.48 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.659 1.573 . . . . 64.4 111.094 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.56 -162.3 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.766 1.627 . . . . 71.31 108.772 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -134.02 133.09 40.84 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.223 1.009 . . . . 64.13 110.56 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.45 161.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.383 1.473 . . . . 72.44 109.414 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.24 120.95 28.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.518 1.151 . . . . 60.1 110.751 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.37 77.51 9.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.264 1.826 . . . . 60.3 106.159 150.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.2 17.01 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.655 1.354 . . . . 44.11 114.655 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.48 -28.55 3.99 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 124.919 1.247 . . . . 63.42 111.398 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.06 20.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.635 -2.358 . . . . 74.44 104.635 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.55 134.7 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.288 -1.004 . . . . 72.54 108.288 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.517 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -130.39 153.18 48.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.501 -1.296 . . . . 71.43 107.501 176.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.517 ' H ' HD13 ' A' ' 114' ' ' LEU . 1.3 pm0 -112.63 114.16 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.377 1.471 . . . . 71.44 109.499 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -136.73 174.03 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.769 2.028 . . . . 73.13 108.596 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.03 148.78 21.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.073 0.851 . . . . 74.33 110.912 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.48 -29.21 9.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.207 1.803 . . . . 53.55 114.162 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.01 1.277 . . . . 61.22 111.928 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 22.6 mtm -87.35 -19.91 27.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.185 0.994 . . . . 71.14 111.613 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 t -71.19 63.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 129.516 3.126 . . . . 64.04 112.239 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -78.5 -179.95 6.69 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.764 -1.835 . . . . 65.42 110.35 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.49 -10.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.652 2.381 . . . . 75.31 113.995 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.88 -3.01 83.63 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 124.629 1.109 . . . . 61.23 112.892 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.89 152.65 31.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.45 -1.685 . . . . 72.12 106.45 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.62 131.68 55.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.645 -1.613 . . . . 73.42 106.645 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -106.89 126.84 62.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.793 0.837 . . . . 63.22 108.803 -168.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.57 122.35 17.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.674 1.19 . . . . 72.22 108.884 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.19 155.83 70.6 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 113.348 0.87 . . . . 70.4 113.348 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.33 151.97 82.25 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.549 2.166 . . . . 75.15 111.006 167.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 136' ' ' ASN . 0.0 OUTLIER -121.69 -160.34 0.86 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.007 1.723 . . . . 72.12 106.806 158.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -48.28 -61.58 1.92 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.316 1.046 . . . . 61.51 110.858 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -121.0 -17.86 7.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.088 1.355 . . . . 74.55 112.843 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -140.59 170.84 15.03 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.426 1.09 . . . . 75.54 110.742 -165.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -79.91 154.34 4.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.867 0.841 . . . . 73.2 110.662 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.531 HD22 ' HB2' ' A' ' 131' ' ' LYS . 15.5 m-80 -143.89 -171.42 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.179 1.792 . . . . 54.14 106.829 166.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.1 mt -125.28 168.88 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.419 -0.956 . . . . 70.12 108.419 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.83 161.99 40.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.812 0.845 . . . . 62.11 110.937 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -74.7 140.68 44.33 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 127.32 2.248 . . . . 62.0 110.693 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.54 1.03 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.023 1.329 . . . . 75.23 112.61 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.517 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.7 pt 24.33 -75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 129.882 3.273 . . . . 71.42 117.238 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.517 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -93.12 126.09 38.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.909 2.484 . . . . 72.41 109.537 -170.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.18 121.91 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.316 0.646 . . . . 72.44 110.505 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.75 -171.9 0.49 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.238 3.015 . . . . 74.01 109.445 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.9 p -132.29 174.25 10.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.827 2.051 . . . . 73.42 107.98 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.0 m -110.18 -178.25 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.439 -1.319 . . . . 75.21 107.439 151.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.46 113.65 15.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.783 -1.562 . . . . 64.23 106.783 168.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -129.99 160.88 32.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.356 1.462 . . . . 70.31 109.806 -165.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.17 47.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.344 1.458 . . . . 52.5 109.663 -162.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -117.17 -150.57 9.23 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.964 1.745 . . . . 75.41 110.212 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -98.0 157.1 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.793 0.796 . . . . 73.4 109.797 159.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 19.2 pt -122.08 151.26 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 126.537 1.935 . . . . 74.13 107.929 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -136.87 151.18 48.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.791 1.236 . . . . 75.35 111.118 -170.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.0 -177.85 6.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.913 0.885 . . . . 75.34 111.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.76 121.98 9.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.311 1.844 . . . . 70.44 107.772 -152.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.53 -37.09 32.19 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-O 116.13 -1.891 . . . . 64.54 114.72 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p 24.61 73.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.771 2.028 . . . . 72.13 112.708 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 12.3 pt-20 -66.02 -10.06 36.33 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.492 -1.38 . . . . 74.1 113.602 -170.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.52 -72.37 0.17 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.825 2.05 . . . . 72.14 106.066 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.83 -19.25 17.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.685 1.594 . . . . 70.04 111.729 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.452 ' CD2' ' HA ' ' A' ' 158' ' ' GLU . 51.4 m170 48.31 39.72 12.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.062 2.145 . . . . 72.24 112.658 -162.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 p -152.48 143.92 23.37 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.043 1.292 . . . . 74.43 109.32 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 4.0 p90 -136.08 172.88 12.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.488 1.515 . . . . 61.12 110.082 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.2 mm -103.32 138.26 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.915 -1.513 . . . . 63.53 106.915 157.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -163.15 160.23 23.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.048 0.939 . . . . 53.22 110.295 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 131.17 -163.02 23.63 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.279 1.418 . . . . 54.41 110.731 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -104.9 170.26 7.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.0 1.9 . . . . 72.54 112.049 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 56.9 -72.42 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 129.695 3.198 . . . . 75.32 111.685 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.62 -14.98 8.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.469 1.508 . . . . 65.11 113.493 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.04 171.75 9.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 122.726 1.181 . . . . 74.43 112.412 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 97' ' ' ILE . 39.0 m-85 -126.49 144.78 50.75 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 126.861 2.064 . . . . 75.34 109.118 -170.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -74.9 114.57 13.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.26 1.424 . . . . 72.23 108.243 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.92 -179.29 3.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.618 0.767 . . . . 60.14 110.789 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -72.65 144.25 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.79 0.836 . . . . 75.22 108.951 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.52 60.87 1.28 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.291 1.836 . . . . 74.14 109.425 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.238 0.466 0 CA-C-O 122.427 1.108 . . . . 64.23 111.466 -179.566 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.613 0 N-CA-C 106.048 -1.834 . . . . 52.32 106.048 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -113.93 178.09 4.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.774 1.63 . . . . 75.21 109.548 172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.17 -169.21 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.183 1.793 . . . . 70.42 113.667 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t80 -94.29 -45.67 7.39 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.947 1.299 . . . . 74.24 109.931 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.33 -0.41 56.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.434 1.493 . . . . 75.42 112.058 -167.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 156.6 76.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.03 -1.044 . . . . 65.33 110.579 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -92.92 143.8 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.334 3.356 . . . . 74.31 113.351 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.26 -2.0 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.325 1.231 . . . . 65.21 114.325 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 53.71 73.41 0.38 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.454 1.101 . . . . 63.0 111.974 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.64 162.83 1.06 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.476 -0.765 . . . . 73.4 109.596 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.9 t -49.03 -40.39 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.108 0.963 . . . . 52.33 110.732 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -81.24 -20.59 40.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.282 0.845 . . . . 74.34 113.282 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.21 28.93 8.25 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.518 1.056 . . . . 65.45 113.041 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -15.34 63.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 118.37 2.73 . . . . 72.34 118.37 -163.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 mm 43.79 78.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.014 2.525 . . . . 74.42 109.643 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.3 154.16 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.631 1.973 . . . . 55.13 107.487 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' HB2' ' H ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -62.26 129.63 41.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.889 1.276 . . . . 73.54 107.584 171.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -53.19 -39.4 34.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 109.569 -0.53 . . . . 72.32 109.569 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -46.19 -59.71 4.99 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 125.014 1.292 . . . . 63.43 111.337 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' H ' ' HB2' ' A' ' 24' ' ' ASN . 38.5 tp10 -69.14 -48.55 62.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.197 -0.906 . . . . 64.53 110.454 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -45.7 -53.1 9.89 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.554 1.142 . . . . 74.31 109.614 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.704 HG22 HG21 ' A' ' 77' ' ' VAL . 49.8 t -69.7 -45.36 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.485 -0.779 . . . . 74.53 109.486 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.87 -37.94 80.75 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.842 -1.161 . . . . 73.35 113.223 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -55.96 -38.13 69.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.903 1.681 . . . . 72.23 110.784 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 15.8 m-85 -73.84 -49.17 26.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.19 1.396 . . . . 75.23 108.638 172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.18 -37.98 62.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.177 1.808 . . . . 73.24 113.301 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.21 -30.34 57.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.01 -0.995 . . . . 53.13 111.829 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -85.08 -52.11 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 2.0 m-30 -93.5 41.36 1.08 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.716 2.007 . . . . 74.21 108.256 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -27.79 68.57 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.576 -1.328 . . . . 51.24 112.142 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -62.42 -27.98 69.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.944 1.698 . . . . 75.53 113.304 168.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.346 1.858 . . . . 75.15 112.86 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.3 mt -66.39 89.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.976 1.262 . . . . 70.24 109.764 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -79.71 161.27 25.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.992 1.717 . . . . 74.44 108.528 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -143.32 122.28 12.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.05 1.34 . . . . 62.15 108.884 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.92 169.76 17.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.651 -0.87 . . . . 75.44 108.651 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -54.47 34.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.91 2.084 . . . . 75.14 111.137 -173.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.04 3.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.356 1.462 . . . . 60.14 113.295 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.67 18.99 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 126.927 2.204 . . . . 73.34 110.853 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -86.0 -99.97 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.409 1.084 . . . . 74.25 108.156 -173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.01 111.01 0.68 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-O 117.754 -1.581 . . . . 73.41 110.726 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -114.19 164.6 13.65 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.229 1.514 . . . . 75.51 111.537 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mt -145.36 144.04 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 128.125 2.57 . . . . 74.12 105.266 164.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -83.06 114.7 21.47 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.81 -1.182 . . . . 71.33 107.81 166.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.96 13.59 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.854 0.862 . . . . 71.52 109.98 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.93 -31.91 82.41 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 120.19 -1.569 . . . . 62.21 111.334 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.64 -1.51 7.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.719 1.208 . . . . 72.3 114.245 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -74.67 -18.25 60.56 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.872 -0.518 . . . . 73.1 111.088 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.29 18.85 11.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.24 2.216 . . . . 41.44 113.624 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -82.33 131.03 34.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.292 -1.373 . . . . 75.1 107.292 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -96.67 161.58 13.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.362 1.465 . . . . 52.4 109.476 173.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.87 149.58 19.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.722 1.609 . . . . 61.31 108.72 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -68.99 121.43 16.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.278 -1.379 . . . . 74.42 107.278 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' TYR . 0.4 OUTLIER -117.81 -177.55 3.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.044 1.338 . . . . 54.42 108.384 171.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -137.71 132.22 32.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.369 -1.715 . . . . 73.54 106.369 169.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.17 106.35 13.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.321 -0.992 . . . . 64.35 108.321 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 71.5 tttt -55.84 -18.55 8.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.327 1.851 . . . . 73.14 113.984 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.95 -34.55 78.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.448 1.099 . . . . 53.31 112.121 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.3 m -125.51 -1.55 7.46 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.054 0.942 . . . . 73.03 112.501 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.81 44.09 17.41 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.122 -0.986 . . . . 61.44 110.487 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 pt -108.6 157.24 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.941 1.696 . . . . 42.31 109.151 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.65 128.71 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.03 -1.47 . . . . 72.53 107.03 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -135.71 175.21 9.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.491 1.116 . . . . 70.55 112.758 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.62 96.64 3.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.245 -2.131 . . . . 74.24 105.245 -157.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -125.14 172.0 9.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.079 0.952 . . . . 63.2 110.575 -165.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -116.28 153.08 32.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.93 0.786 . . . . 71.11 109.382 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.56 154.77 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.798 -1.186 . . . . 50.45 107.798 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 -20.62 6.75 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.918 0.781 . . . . 63.02 112.639 169.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -161.7 163.74 29.56 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.2 -1.563 . . . . 71.25 108.478 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -137.97 161.25 32.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.095 0.958 . . . . 52.14 109.11 179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -135.7 149.34 49.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.38 1.072 . . . . 74.31 110.416 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -146.2 142.24 28.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.124 0.875 . . . . 74.53 110.527 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -146.17 163.19 36.17 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.288 2.235 . . . . 62.32 107.274 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 4.7 tttm -107.48 156.4 19.02 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.612 -1.255 . . . . 72.42 107.612 164.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.4 t80 -153.64 163.08 40.6 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.975 1.31 . . . . 72.02 108.82 -166.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -151.67 113.92 4.53 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.116 -1.809 . . . . 75.32 106.116 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.52 -146.54 5.31 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 117.095 -2.479 . . . . 50.45 112.209 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 104.54 8.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.407 1.883 . . . . 72.41 107.801 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.559 HD13 HG22 ' A' ' 98' ' ' THR . 88.6 mt -83.69 162.91 20.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.73 1.612 . . . . 71.53 106.887 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 89' ' ' ILE . 34.8 mm -79.5 135.25 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 127.057 2.143 . . . . 63.1 107.37 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HE3' HG11 ' A' ' 146' ' ' VAL . 35.4 ttmt -125.4 79.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.635 -1.617 . . . . 64.13 106.635 161.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 140' ' ' VAL . 22.0 mt -59.21 141.07 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.345 -2.094 . . . . 65.42 105.345 152.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -115.16 164.28 14.43 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.621 -1.992 . . . . 65.51 105.621 163.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -136.02 169.73 17.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.822 1.192 . . . . 50.11 108.909 166.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.06 -21.63 66.3 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.675 -1.265 . . . . 73.2 112.759 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -66.49 -1.13 3.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.366 1.866 . . . . 60.33 112.72 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.3 22.41 10.75 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.025 1.73 . . . . 72.44 111.358 -165.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.79 168.71 19.33 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.865 -0.791 . . . . 61.11 108.865 163.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 174.6 163.15 0.22 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 129.05 2.94 . . . . 71.34 110.401 -167.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 3.0 pt -140.12 172.49 12.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.723 1.209 . . . . 51.42 110.436 -170.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.559 HG22 HD13 ' A' ' 86' ' ' LEU . 27.1 m -152.27 94.82 1.97 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.124 0.969 . . . . 75.03 109.713 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.438 HD21 HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -154.11 177.59 10.91 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 128.408 2.683 . . . . 72.44 109.261 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.9 p -78.4 171.49 15.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 120.649 1.568 . . . . 62.1 110.657 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -69.91 -19.67 63.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.13 0.972 . . . . 71.13 111.371 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -109.64 38.02 2.48 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.422 -0.799 . . . . 73.44 110.761 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -107.15 133.72 20.2 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.868 -0.79 . . . . 72.44 108.868 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.32 118.1 5.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.671 2.914 . . . . 65.52 113.251 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.35 -179.32 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.664 1.586 . . . . 64.43 109.954 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.17 144.72 49.17 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.223 0.92 . . . . 72.34 111.15 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 pt -134.88 165.49 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.112 0.965 . . . . 73.32 109.871 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.472 ' HB3' HD21 ' A' ' 137' ' ' LEU . 71.1 p -94.42 110.02 21.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.968 0.507 . . . . 64.34 109.666 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -85.8 81.35 8.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.578 -2.008 . . . . 72.34 105.578 167.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.1 32.47 4.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.473 1.109 . . . . 55.51 113.196 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.25 -9.42 42.36 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.693 -1.059 . . . . 52.2 114.339 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -84.5 131.21 34.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 119.389 1.595 . . . . 70.24 106.881 167.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.08 117.78 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.039 -1.467 . . . . 54.34 107.039 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 151.19 45.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.885 1.274 . . . . 74.44 108.65 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.2 121.3 44.92 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.53 1.132 . . . . 63.31 109.683 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 116' ' ' ILE . 15.6 pt -140.74 -175.96 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.789 0.836 . . . . 74.23 110.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -92.87 142.91 26.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.198 1.399 . . . . 72.25 108.704 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.11 65.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.35 0.977 . . . . 60.0 113.544 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -32.32 66.14 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.196 1.362 . . . . 71.22 112.596 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -23.85 36.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.563 1.145 . . . . 64.01 112.195 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.97 64.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.029 2.532 . . . . 74.45 111.653 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.79 -179.77 7.11 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.425 -1.422 . . . . 71.0 111.878 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 5.6 p -55.59 -9.86 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 128.421 2.689 . . . . 53.33 114.005 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.71 -15.97 79.92 Favored Glycine 0 CA--C 1.523 0.59 0 O-C-N 121.279 -0.888 . . . . 44.41 111.554 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.33 164.87 13.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.634 1.217 . . . . 64.41 108.92 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 13.1 m-85 -113.41 137.9 50.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.218 -1.401 . . . . 74.0 107.218 167.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.4 132.46 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.613 -1.255 . . . . 61.31 107.613 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.41 124.53 23.42 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.5 -0.926 . . . . 72.54 108.5 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -133.33 154.5 81.04 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.899 1.68 . . . . 72.33 110.096 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.57 149.43 84.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.401 1.401 . . . . 63.3 110.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -120.62 -145.39 0.36 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.568 -1.641 . . . . 72.42 106.568 149.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.85 -70.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.145 1.378 . . . . 72.53 111.155 -162.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -120.09 -2.79 10.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.596 0.758 . . . . 74.23 112.764 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 167.32 21.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.434 1.093 . . . . 75.32 111.257 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.2 tp -78.84 156.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.139 0.971 . . . . 64.32 108.686 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.93 -173.76 3.89 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 127.601 2.361 . . . . 73.51 107.226 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 108' ' ' SER . 40.6 mt -135.43 136.52 41.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.387 -2.079 . . . . 42.15 105.387 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -133.7 153.98 51.29 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.717 -1.216 . . . . 70.43 107.717 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 18.1 tt0 -96.77 136.87 36.7 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.841 2.056 . . . . 74.43 107.88 -161.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.455 HG13 HG23 ' A' ' 89' ' ' ILE 0.296 46.9 t -79.98 1.05 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 114.479 1.288 . . . . 73.21 114.479 -158.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pt 26.61 -98.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.158 2.583 . . . . 73.52 115.405 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -90.56 122.5 33.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.411 -1.43 . . . . 72.32 108.067 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.62 117.49 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.251 -1.388 . . . . 73.31 107.251 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.83 -165.57 2.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.832 1.653 . . . . 72.23 108.909 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 p -121.92 171.33 9.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.017 1.327 . . . . 55.15 110.179 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.426 HG11 ' HE3' ' A' ' 88' ' ' LYS . 30.3 m -130.56 131.75 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.712 -1.218 . . . . 53.33 107.712 167.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.02 109.54 17.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.374 -1.343 . . . . 75.33 107.374 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -133.23 136.18 45.43 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.802 2.041 . . . . 63.24 106.909 -163.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -140.63 43.86 1.85 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.784 -0.572 . . . . 65.41 110.233 -155.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.81 8.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.391 0.996 . . . . 54.32 112.897 -165.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.15 155.52 24.95 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.977 -0.719 . . . . 74.01 110.408 165.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.4 pt -132.36 147.21 32.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 127.712 2.405 . . . . 74.13 106.961 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.415 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 3.5 m-85 -132.79 164.68 26.28 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.786 -1.19 . . . . 75.0 107.786 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -153.66 177.39 11.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.528 -1.286 . . . . 72.33 107.528 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.9 mt -140.56 163.81 31.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.719 1.145 . . . . 73.42 110.819 -167.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.1 m -118.58 110.38 17.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.926 1.691 . . . . 64.33 107.054 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.2 77.72 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.808 2.043 . . . . 42.21 106.808 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.378 10.9 pt-20 -72.87 2.2 7.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.109 1.364 . . . . 72.41 113.995 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.5 -56.61 11.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 128.438 2.695 . . . . 71.13 109.74 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.6 t30 -133.24 -4.33 3.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.128 0.971 . . . . 72.43 111.861 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.4 m80 66.65 21.34 10.65 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.284 1.434 . . . . 60.33 112.219 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.5 p -142.22 139.73 32.09 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.486 -0.931 . . . . 74.13 108.486 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -137.82 176.64 8.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.876 0.87 . . . . 43.01 110.281 -175.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.8 mm -98.76 120.1 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 165.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.26 133.79 24.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.947 -1.131 . . . . 63.55 107.947 167.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.54 177.05 33.3 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.723 2.106 . . . . 72.44 108.065 168.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -75.34 178.74 5.63 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.366 -2.255 . . . . 71.13 110.622 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.61 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.079 1.752 . . . . 70.32 112.468 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -122.13 -8.5 8.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.433 1.893 . . . . 61.03 114.177 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 88.1 164.13 39.91 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.549 1.547 . . . . 73.32 113.482 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.465 ' CD2' HG22 ' A' ' 129' ' ' ILE . 9.1 m-85 -108.19 159.66 16.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.32 1.448 . . . . 73.13 109.044 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -102.1 102.08 12.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.215 1.806 . . . . 64.14 106.7 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.74 177.08 6.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.243 1.017 . . . . 74.35 109.684 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 75.0 m -66.55 139.15 57.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.472 -0.936 . . . . 43.02 108.472 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -128.12 39.63 3.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.033 2.533 . . . . 64.42 109.28 172.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.691 -0.855 . . . . 74.43 108.691 177.715 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.608 0 N-CA-C 109.312 -0.625 . . . . 74.23 109.312 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.73 166.69 10.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.281 3.032 . . . . 53.32 109.016 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 178.97 1.2 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.165 1.386 . . . . 74.02 112.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -75.84 -34.33 60.08 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.427 -0.796 . . . . 74.45 110.522 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.45 25.53 11.56 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.678 1.228 . . . . 74.52 112.436 -161.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.05 126.39 82.04 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 125.36 1.464 . . . . 53.24 109.141 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -67.14 102.76 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.33 2.687 . . . . 35.4 108.89 168.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 pt -78.17 140.88 16.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.818 1.19 . . . . 71.43 108.964 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 47.6 m-85 -96.14 83.32 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.525 -1.657 . . . . 74.54 106.525 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 86.8 mt -58.97 154.7 14.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.72 -0.845 . . . . 65.2 108.72 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -61.92 -20.4 63.73 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.2 -0.313 . . . . 52.32 110.188 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.74 -29.65 70.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.633 1.973 . . . . 61.43 112.736 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.88 4.61 67.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.238 1.399 . . . . 52.44 112.314 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.19 -39.36 72.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.632 1.716 . . . . 62.22 115.073 -156.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mm 57.02 96.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 127.73 2.412 . . . . 64.44 108.841 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 157.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.679 -1.971 . . . . 62.41 105.679 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -67.04 119.25 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.581 -1.637 . . . . 52.33 106.581 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -50.79 -35.85 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.292 0.637 . . . . 75.44 110.153 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.38 -30.94 63.97 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-O 118.2 -1.334 . . . . 43.35 112.734 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -63.36 -55.91 20.63 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 119.917 1.858 . . . . 75.35 108.894 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -48.48 -49.61 34.97 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 125.341 1.456 . . . . 65.42 110.397 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 77' ' ' VAL . 76.9 t -76.33 -40.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 118.087 -0.958 . . . . 73.13 110.109 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -64.58 -29.38 70.4 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 120.723 1.601 . . . . 72.54 110.873 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -43.85 52.67 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.871 1.268 . . . . 65.41 110.335 170.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.6 -46.18 22.95 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.325 -1.321 . . . . 74.21 110.03 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 8.4 m-85 -54.85 -34.32 62.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 122.182 2.264 . . . . 74.45 113.08 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -84.81 -22.39 29.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.637 1.175 . . . . 65.22 110.616 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -63.29 1.32 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.701 -1.222 . . . . 73.1 107.701 172.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -84.26 39.77 0.73 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.184 2.594 . . . . 74.0 109.192 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.5 -36.74 55.85 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 70.03 111.181 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -71.05 -13.49 62.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.306 1.842 . . . . 75.14 113.381 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.06 5.76 26.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.268 1.427 . . . . 63.2 112.379 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 105.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.518 -1.29 . . . . 64.41 107.518 171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -103.85 107.18 17.94 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.051 0.541 . . . . 64.11 109.72 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -70.69 154.7 41.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.745 -0.835 . . . . 42.52 108.745 168.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -113.85 171.64 7.47 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.246 1.818 . . . . 63.44 107.181 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -54.26 21.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.185 1.794 . . . . 65.55 111.239 -175.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.35 -18.79 65.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.82 0.848 . . . . 61.51 111.381 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.27 -1.78 22.35 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.867 1.699 . . . . 71.11 113.643 160.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -50.46 -79.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.305 1.842 . . . . 63.03 111.81 -164.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.48 110.43 2.85 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.055 -1.618 . . . . 73.33 109.055 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -110.62 168.78 9.21 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.233 1.013 . . . . 71.43 109.635 165.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mt -143.91 136.22 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.97 -1.863 . . . . 71.35 105.97 166.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.2 125.32 26.62 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.27 3.85 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.914 0.885 . . . . 63.23 110.768 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.22 -31.23 72.78 Favored Glycine 0 CA--C 1.524 0.65 0 O-C-N 121.331 -0.856 . . . . 72.15 113.188 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -60.45 -13.63 14.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.565 1.182 . . . . 64.15 113.025 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.62 -21.09 37.38 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.98 -1.075 . . . . 73.14 111.662 167.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.93 24.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.677 2.391 . . . . 73.33 113.441 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.32 113.66 9.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.773 -1.566 . . . . 54.14 106.773 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -79.16 150.78 31.61 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.162 0.585 . . . . 72.5 110.97 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 15.6 tt -112.36 157.83 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.65 1.58 . . . . 64.1 108.296 170.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -63.6 110.27 1.94 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.751 -1.944 . . . . 74.24 105.751 162.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.57 175.65 5.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.107 1.363 . . . . 63.31 107.807 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.95 120.72 7.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.452 -1.314 . . . . 62.11 107.452 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.82 118.67 17.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.202 -0.936 . . . . 71.33 109.547 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -63.86 -31.74 73.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.588 0.355 . . . . 74.51 110.989 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -41.74 6.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.164 1.785 . . . . 75.21 111.692 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -136.91 15.59 3.07 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 43.32 111.399 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.5 47.6 8.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.834 1.654 . . . . 74.41 112.51 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.06 160.54 3.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 124.875 1.27 . . . . 62.33 108.434 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.86 149.68 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.801 -1.555 . . . . 74.21 106.801 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -178.69 7.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.287 2.235 . . . . 54.03 110.227 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -124.98 130.96 53.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.047 1.339 . . . . 73.4 107.715 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -151.6 160.04 43.82 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.403 1.081 . . . . 65.34 108.78 163.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -83.36 178.11 8.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.152 0.981 . . . . 75.54 110.687 163.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -95.12 170.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.848 2.059 . . . . 54.23 106.194 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.66 -61.71 1.49 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.044 -1.465 . . . . 65.02 107.044 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -126.72 152.11 47.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.941 -1.133 . . . . 73.14 107.941 -171.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -124.17 159.74 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 125.46 1.504 . . . . 70.12 107.646 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -137.84 156.31 48.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.733 0.813 . . . . 75.41 112.071 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.7 139.54 26.61 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.394 1.478 . . . . 71.02 111.521 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -148.5 155.8 41.62 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.161 0.984 . . . . 72.13 108.901 168.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -79.62 153.28 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.818 -1.176 . . . . 63.24 109.248 170.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.94 157.37 43.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.605 1.562 . . . . 72.3 108.538 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 p -161.96 97.45 1.04 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.141 0.976 . . . . 54.1 111.681 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.2 -172.78 45.76 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.675 -1.266 . . . . 63.51 112.652 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -85.05 116.15 23.27 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.132 0.573 . . . . 65.42 110.845 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 98' ' ' THR . 26.9 mt -95.79 165.83 12.1 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.863 1.665 . . . . 62.23 109.214 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.91 134.4 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 126.053 1.741 . . . . 61.34 109.669 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -123.61 82.82 2.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.995 -1.483 . . . . 73.1 106.995 164.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.8 mt -57.96 132.6 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.173 -2.158 . . . . 74.44 105.173 153.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -106.08 166.0 10.82 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.119 -1.808 . . . . 72.15 106.119 159.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.09 169.89 16.48 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.579 1.081 . . . . 53.01 109.558 165.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -63.82 -25.24 68.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.071 -1.018 . . . . 60.34 112.022 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.94 -0.17 0.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.196 2.598 . . . . 55.5 113.133 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 59.85 22.46 11.4 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 127.06 2.144 . . . . 71.52 111.333 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.528 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 2.6 ttm180 -75.64 163.52 27.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.213 -0.929 . . . . 62.32 108.756 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 167.99 4.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.636 0.775 . . . . 61.13 110.093 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.8 pt -147.97 178.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.998 1.719 . . . . 62.11 110.993 -173.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' HD23 ' A' ' 99' ' ' LEU . 17.7 m -149.99 103.48 3.21 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.639 1.576 . . . . 72.33 110.788 173.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -145.11 169.54 17.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 119.584 -1.947 . . . . 61.13 112.615 -174.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -62.22 144.91 54.89 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.198 1.399 . . . . 72.41 109.203 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.95 -20.72 64.21 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.651 -1.281 . . . . 50.42 112.143 -169.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -101.12 39.65 1.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.353 1.461 . . . . 54.0 110.672 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.69 143.08 25.7 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.16 -1.588 . . . . 74.24 109.729 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.75 137.24 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.014 2.476 . . . . 55.23 111.842 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.17 -177.4 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.915 1.686 . . . . 73.43 108.376 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.28 141.92 51.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.382 1.446 . . . . 73.54 111.303 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 107' ' ' ILE . 2.5 pp -142.36 171.32 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.858 1.263 . . . . 73.52 109.644 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.1 p -103.32 96.65 6.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.819 0.848 . . . . 70.44 111.005 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -82.29 89.06 6.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.325 -2.102 . . . . 73.33 105.325 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 44.13 44.51 6.39 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.05 1.34 . . . . 72.51 112.012 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.15 -31.81 8.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 118.097 -1.391 . . . . 62.55 113.608 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -79.51 144.94 33.5 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 119.798 1.799 . . . . 74.11 108.063 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.18 123.06 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.937 -1.134 . . . . 44.34 107.937 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 tp -123.06 159.47 28.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.664 -0.865 . . . . 72.02 108.664 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.46 104.05 11.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.438 1.495 . . . . 64.11 110.875 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 pt -129.96 -178.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.178 0.991 . . . . 65.02 112.136 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.16 134.52 34.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.343 0.974 . . . . 71.43 108.808 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.68 -38.44 55.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.861 1.06 . . . . 72.14 113.861 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 1.5 pp20? -67.19 -16.7 64.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.817 1.043 . . . . 74.11 113.817 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 35.6 mtt -83.16 -25.18 32.1 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.773 0.829 . . . . 63.21 110.436 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.35 62.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 127.754 2.422 . . . . 75.51 109.453 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 24.7 mmtp -79.72 -174.17 4.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.416 1.087 . . . . 64.33 108.707 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.79 -12.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.249 2.22 . . . . 73.22 113.38 167.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.91 -4.76 89.63 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 117.97 -1.461 . . . . 64.41 112.063 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -132.14 172.39 12.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.909 1.854 . . . . 62.21 110.834 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 9.4 m-85 -116.66 119.45 35.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.171 1.788 . . . . 74.15 106.346 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 tp -83.19 130.32 35.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.851 -1.166 . . . . 72.12 107.851 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -70.73 116.46 11.06 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.146 -1.057 . . . . 61.1 108.146 170.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.8 153.09 63.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.224 1.41 . . . . 74.13 112.035 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 153.61 52.4 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.602 2.201 . . . . 73.31 110.867 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.69 179.24 6.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.053 2.541 . . . . 72.31 107.218 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -25.41 -67.08 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.499 2.32 . . . . 75.51 113.911 -169.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -120.35 -0.55 10.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.381 1.872 . . . . 74.04 111.298 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.0 p -143.21 -171.27 3.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.211 1.004 . . . . 73.32 111.972 -154.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.47 153.17 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.855 -1.165 . . . . 63.0 107.855 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -145.8 -175.64 4.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.604 2.761 . . . . 73.31 106.163 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.99 161.27 19.65 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.724 1.21 . . . . 73.11 110.377 170.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -148.13 152.91 38.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.277 2.231 . . . . 74.45 106.804 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.461 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 19.2 mt-10 -77.13 147.4 36.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.689 1.595 . . . . 74.32 110.029 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.13 1.04 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.012 0.745 . . . . 63.13 113.012 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.432 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 29.47 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 128.161 2.584 . . . . 74.43 116.176 170.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.432 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.3 tppt? -100.33 128.36 46.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 120.804 -1.185 . . . . 73.01 107.942 174.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.65 128.21 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.64 -1.245 . . . . 53.12 107.64 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.55 -177.75 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.406 2.282 . . . . 64.53 107.216 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.9 p -117.86 170.44 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.964 -1.085 . . . . 65.32 109.339 167.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.21 124.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 107.003 -1.48 . . . . 64.04 107.003 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -86.16 114.35 22.93 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.904 1.229 . . . . 73.43 107.826 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -120.16 139.16 53.04 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.645 1.578 . . . . 61.15 107.299 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.55 81.92 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.502 -0.925 . . . . 71.42 108.502 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.83 -121.06 1.12 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.13 1.824 . . . . 61.34 111.273 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -136.84 152.57 50.41 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.232 -1.157 . . . . 73.24 109.703 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.3 pt -116.82 156.3 18.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.363 1.865 . . . . 74.41 108.267 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -138.14 150.92 47.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.841 1.257 . . . . 73.31 107.942 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -129.08 166.5 19.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.744 0.702 . . . . 72.22 109.96 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 127.16 42.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.111 1.365 . . . . 63.01 108.894 -170.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.5 m -71.08 -58.0 3.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.758 -0.639 . . . . 52.22 110.773 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.2 t 25.94 64.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 129.516 3.126 . . . . 71.32 112.567 -170.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -72.58 0.17 11.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.923 1.689 . . . . 64.41 113.027 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.19 -70.65 0.32 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.964 1.305 . . . . 74.12 108.526 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -93.6 0.31 56.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.615 0.766 . . . . 63.44 111.151 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.9 m170 65.21 26.48 12.31 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.736 2.014 . . . . 51.32 111.835 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -145.16 167.09 23.6 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.915 -1.115 . . . . 73.41 109.952 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.37 171.4 17.25 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.779 1.632 . . . . 71.24 109.527 176.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.6 mm -105.84 119.46 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.619 -1.252 . . . . 65.51 107.619 167.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -150.82 146.7 26.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.176 0.99 . . . . 42.54 109.977 171.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.64 177.88 23.26 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 128.063 2.744 . . . . 61.41 109.015 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -73.46 166.55 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.238 -1.742 . . . . 72.43 110.347 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 70.01 -71.7 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.617 2.367 . . . . 63.2 114.808 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.427 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 pt-20 -124.28 -19.27 5.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.772 1.229 . . . . 73.41 114.241 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 164.22 40.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.969 2.223 . . . . 44.1 113.62 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 97' ' ' ILE . 56.6 m-85 -104.18 151.99 22.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.855 2.062 . . . . 72.12 108.302 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.22 111.71 23.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.785 2.034 . . . . 70.32 106.936 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 163' ' ' TYR . 2.3 m -139.27 166.97 20.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 119.065 0.848 . . . . 74.22 110.472 -169.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.3 t -66.25 139.97 58.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.281 1.432 . . . . 63.11 109.841 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -137.3 70.36 1.4 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.32 2.648 . . . . 75.32 106.969 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.469 0.487 0 O-C-N 119.964 -1.71 . . . . 73.05 111.821 -171.545 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' HG1' ' A' ' 100' ' ' THR . . . . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 121.028 0.442 . . . . 70.11 111.448 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -106.2 -178.03 3.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 129.538 3.135 . . . . 61.02 109.376 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.0 -156.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.472 1.109 . . . . 72.54 112.342 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.6 t80 -103.1 -30.58 10.64 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 65.44 110.414 164.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -116.72 29.67 7.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.768 2.427 . . . . 73.43 110.785 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -100.71 134.73 20.36 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.734 -0.839 . . . . 62.32 108.734 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.09 138.21 25.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.819 2.346 . . . . 72.51 112.921 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 25' ' ' ILE . 28.5 pt -102.11 7.09 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 114.974 1.472 . . . . 64.4 114.974 -172.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 36.28 74.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.287 1.835 . . . . 72.32 114.226 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 152.42 2.35 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.471 -0.937 . . . . 74.25 108.471 164.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -54.41 -36.19 63.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.193 0.451 . . . . 74.41 111.459 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.0 -19.53 62.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.958 1.303 . . . . 71.42 112.657 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.56 18.23 33.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 117.961 -1.466 . . . . 71.23 112.643 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -38.38 64.93 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.601 1.7 . . . . 73.05 113.821 -167.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.81 96.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.448 2.699 . . . . 70.44 108.977 -170.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.25 146.87 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.414 -1.699 . . . . 62.42 106.414 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.95 135.96 53.21 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.415 1.886 . . . . 63.14 108.079 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 15' ' ' ILE . 4.4 tt -51.3 -43.08 28.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.443 1.097 . . . . 62.34 110.812 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -71.36 -41.21 59.29 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-O 117.961 -1.466 . . . . 40.15 110.377 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -58.06 -44.06 87.25 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 120.78 2.29 . . . . 74.5 112.167 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.89 -59.71 4.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.656 1.582 . . . . 62.2 109.06 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG13 HG21 ' A' ' 77' ' ' VAL . 84.9 t -68.4 -44.54 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.402 -0.363 . . . . 61.34 110.589 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.24 -32.14 73.47 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.171 -0.956 . . . . 75.01 109.608 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -50.83 -52.54 40.37 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.43 -0.794 . . . . 62.42 109.882 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -66.21 -41.81 89.63 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.768 -1.197 . . . . 54.03 107.768 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.452 ' CD1' HD12 ' A' ' 50' ' ' ILE . 8.3 m-85 -60.71 -31.0 70.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.78 1.627 . . . . 70.22 112.827 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -19.03 32.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 125.387 1.475 . . . . 62.52 111.696 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 18.6 mttm -94.92 -63.75 1.14 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.269 -1.752 . . . . 74.22 106.269 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -82.02 43.28 0.77 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.355 2.662 . . . . 64.2 108.585 -173.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -50.89 -40.28 56.22 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.395 1.478 . . . . 73.14 110.187 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -59.02 -35.5 73.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.593 1.157 . . . . 74.1 112.965 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 m -77.17 -6.08 51.6 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.636 1.175 . . . . 72.31 113.768 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -65.37 95.26 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 119.807 1.185 . . . . 65.32 108.749 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -79.18 157.11 27.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.303 -1.74 . . . . 42.42 106.303 163.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -126.77 145.9 50.44 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.266 -2.124 . . . . 73.22 105.266 159.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.75 177.43 8.67 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.111 0.882 . . . . 62.33 110.332 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -49.23 -50.02 40.38 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.229 2.212 . . . . 61.2 111.911 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -70.66 -9.28 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.061 1.344 . . . . 73.11 112.137 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.37 56.18 2.89 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 127.235 2.35 . . . . 72.2 109.447 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -85.37 -100.19 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.609 -1.256 . . . . 75.22 107.609 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.85 123.77 0.99 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 107.79 -2.124 . . . . 74.43 107.79 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 160.35 41.34 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.276 1.538 . . . . 72.21 110.93 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' A' ' 33' ' ' PHE . 10.3 mt -143.2 149.71 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.822 2.049 . . . . 70.42 106.637 172.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.81 135.24 37.78 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.031 1.332 . . . . 63.52 109.575 165.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.09 25.52 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.33 2.252 . . . . 64.13 109.592 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.67 1.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 127.788 2.613 . . . . 63.32 115.694 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.06 -10.92 13.42 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.429 2.615 . . . . 50.15 114.785 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -28.44 63.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 121.347 1.885 . . . . 74.24 111.846 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 11.87 2.24 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.821 1.648 . . . . 70.25 113.339 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 mt -67.53 127.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.694 1.598 . . . . 73.23 109.48 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -94.6 142.83 26.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.564 1.146 . . . . 55.41 110.384 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.26 152.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.244 2.218 . . . . 73.0 106.961 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -68.49 105.67 2.29 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.265 -1.754 . . . . 64.1 106.265 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -96.36 -176.48 3.66 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.852 -1.166 . . . . 73.43 107.852 167.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.73 141.91 30.69 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.572 -1.64 . . . . 64.12 106.572 171.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.76 96.0 9.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -55.45 -21.21 15.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.644 0.778 . . . . 64.25 112.823 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -44.48 1.43 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.075 2.15 . . . . 65.04 112.024 167.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -139.03 0.91 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.088 0.955 . . . . 61.03 112.336 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mt 63.92 59.84 1.08 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.193 1.797 . . . . 73.44 110.743 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.73 153.09 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.768 1.627 . . . . 71.21 109.254 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.8 138.98 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.965 -1.124 . . . . 62.5 107.965 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -144.26 172.36 13.03 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.062 1.745 . . . . 72.23 107.977 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.34 131.68 54.33 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.286 -1.375 . . . . 64.04 107.286 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.3 mmpt? -141.33 155.74 45.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.587 -1.634 . . . . 75.43 106.587 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.71 124.42 49.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.95 0.795 . . . . 74.22 110.478 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.61 154.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.103 2.161 . . . . 73.4 109.084 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.2 -50.43 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.02 1.728 . . . . 72.43 110.504 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -134.2 160.04 39.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.0 1.727 . . . . 75.22 110.418 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.55 HG21 HG13 ' A' ' 29' ' ' VAL . 2.3 m -133.98 161.22 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 74.12 109.441 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.04 154.84 46.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.848 1.259 . . . . 74.21 110.417 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 148.78 19.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.378 0.99 . . . . 71.41 111.092 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -141.16 169.35 17.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.152 -1.425 . . . . 73.42 107.152 157.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -89.36 154.26 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.901 -1.148 . . . . 71.24 107.901 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -148.17 156.89 43.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.178 -1.045 . . . . 73.13 108.178 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -149.02 117.38 6.47 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.131 -1.433 . . . . 55.54 107.131 162.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.07 -179.1 44.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.382 -1.39 . . . . 45.34 112.057 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 98.98 11.7 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.515 1.126 . . . . 72.05 110.207 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.16 153.79 29.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.105 -1.442 . . . . 74.4 107.105 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.9 139.16 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.522 -0.918 . . . . 65.21 108.522 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HE2' ' OE1' ' A' ' 96' ' ' GLU . 48.8 tttm -130.54 70.69 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.476 1.51 . . . . 75.35 107.243 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.44 148.04 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 105.269 -2.123 . . . . 72.41 105.269 161.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 167.75 10.51 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 105.309 -2.108 . . . . 72.43 105.309 162.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.2 p -135.86 168.2 19.76 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.933 0.788 . . . . 72.11 109.696 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -24.17 67.65 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.728 1.149 . . . . 62.11 112.741 -168.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.31 4.38 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.043 1.337 . . . . 71.44 111.615 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 60.08 26.49 15.84 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.859 2.063 . . . . 72.45 112.229 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -76.45 173.09 11.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 165.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -177.61 167.28 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.854 1.662 . . . . 74.51 107.92 -175.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.8 pt -141.82 171.4 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 125.834 1.654 . . . . 71.32 108.688 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.92 101.28 3.02 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.776 -1.194 . . . . 73.53 107.776 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 168.62 24.7 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.874 1.27 . . . . 52.02 110.083 -171.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.537 ' HG1' ' N ' ' A' ' 8' ' ' ALA . 9.9 p -58.29 147.5 30.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.215 1.006 . . . . 70.32 110.37 179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.94 -16.33 63.72 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.002 0.741 . . . . 73.52 113.002 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -117.01 39.49 3.22 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.767 1.627 . . . . 75.12 110.563 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -77.57 131.22 71.73 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.77 -1.109 . . . . 75.2 110.262 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.4 101.12 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 125.026 3.817 . . . . 74.34 112.903 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.68 178.25 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.005 1.722 . . . . 52.13 109.783 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -122.85 139.21 54.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.557 -0.714 . . . . 71.12 111.144 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.78 163.98 35.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.591 1.156 . . . . 74.31 110.54 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.6 t -88.65 121.09 30.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.081 1.419 . . . . 54.42 111.676 172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.51 78.0 1.81 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.32 1.848 . . . . 73.11 106.854 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m 69.75 0.8 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.235 1.569 . . . . 72.14 115.235 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.76 -33.68 1.39 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.08 -1.608 . . . . 73.24 109.08 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.73 131.27 35.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.97 1.308 . . . . 62.44 108.525 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.04 99.0 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.31 -1.367 . . . . 73.35 107.31 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.37 161.49 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.393 0.677 . . . . 73.55 109.372 172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.95 126.42 49.94 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.762 2.025 . . . . 65.13 107.989 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.6 pt -149.54 176.99 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.926 1.291 . . . . 75.13 110.442 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.32 142.03 45.19 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.793 1.237 . . . . 71.54 108.434 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.8 20.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.998 0.919 . . . . 72.55 112.612 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.31 -11.38 60.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.928 1.24 . . . . 74.14 113.827 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.7 mmt -82.11 -28.43 32.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.921 1.237 . . . . 71.24 111.103 169.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.1 t -75.49 63.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 128.728 2.811 . . . . 62.34 111.585 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -79.16 -178.34 6.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.072 -1.017 . . . . 75.22 109.6 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.34 0.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 128.092 2.557 . . . . 73.51 114.033 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -99.32 -1.88 56.77 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 117.768 -1.573 . . . . 44.41 112.693 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.63 136.35 46.44 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 106.414 -1.699 . . . . 62.33 106.414 -163.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.66 109.94 21.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.824 1.25 . . . . 75.02 108.973 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.69 133.1 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.456 1.102 . . . . 74.45 108.714 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.3 132.21 46.08 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.028 -0.73 . . . . 73.5 109.028 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -126.28 155.87 73.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.357 1.863 . . . . 73.43 110.143 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.38 145.14 37.76 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.988 1.792 . . . . 74.44 109.382 172.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 -158.99 0.67 Allowed 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.976 -1.12 . . . . 62.41 107.976 167.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.51 -62.28 1.75 Allowed 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.89 0.876 . . . . 72.2 111.203 -160.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.3 0.69 9.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.799 1.037 . . . . 74.34 113.799 166.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.7 p -122.36 -167.02 1.49 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.51 1.524 . . . . 75.53 110.12 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.97 156.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.741 1.216 . . . . 72.25 107.778 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -144.87 -176.69 5.18 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.729 2.012 . . . . 72.42 108.406 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.1 mt -118.42 161.78 19.41 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.072 1.349 . . . . 73.45 108.148 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -152.02 154.84 36.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.569 1.548 . . . . 72.14 106.976 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -88.65 144.74 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.264 1.426 . . . . 71.35 108.918 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 -1.33 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 54.44 113.38 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 142' ' ' LYS . 4.1 pt 31.86 -76.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 129.171 2.989 . . . . 75.24 117.112 173.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' H ' HG13 ' A' ' 141' ' ' ILE . 39.7 ttmt -118.28 131.75 56.33 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.991 1.716 . . . . 70.21 108.459 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.65 121.72 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.634 1.174 . . . . 50.1 108.331 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -145.14 -169.47 3.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.361 1.464 . . . . 73.31 108.057 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -135.27 166.07 23.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.547 1.139 . . . . 73.52 109.572 -171.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.55 129.85 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.907 -1.516 . . . . 74.02 106.907 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.88 113.89 19.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.679 -1.971 . . . . 73.52 105.679 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.524 ' C ' HD22 ' A' ' 149' ' ' ASN . 28.8 t80 -127.6 132.64 49.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.131 1.772 . . . . 74.11 108.864 -165.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 148' ' ' TYR . 2.4 m120 -134.16 42.07 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.263 -0.898 . . . . 53.31 109.8 -157.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.0 -175.38 15.17 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.478 1.513 . . . . 70.42 111.44 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -72.15 147.46 46.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.72 -0.845 . . . . 75.25 108.72 161.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 27.7 pt -124.7 127.08 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.533 1.933 . . . . 72.52 106.472 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -112.83 162.12 16.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.815 -1.179 . . . . 73.41 107.815 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.28 164.09 35.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 44.1 109.601 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 67.5 mt -120.31 164.22 16.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.876 1.27 . . . . 64.32 111.137 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.7 m -101.31 -34.04 9.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.258 -1.337 . . . . 74.21 112.703 -164.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 17.5 t 24.52 74.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 130.325 3.45 . . . . 64.01 111.548 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -78.81 -9.0 59.31 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.307 -0.871 . . . . 75.01 112.043 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -62.15 1.75 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.116 2.166 . . . . 75.14 108.594 -168.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -120.73 5.17 10.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.639 0.977 . . . . 71.03 113.639 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.41 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 15.3 m170 52.97 23.9 3.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.673 1.589 . . . . 73.13 112.267 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.11 136.89 20.49 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 119.542 -1.974 . . . . 73.32 108.878 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 3.7 p90 -141.15 167.56 21.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.829 0.852 . . . . 74.41 110.981 -173.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 mm -103.12 134.13 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 124.37 1.068 . . . . 74.45 108.423 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.43 138.4 14.44 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.517 1.527 . . . . 73.45 108.702 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.72 170.96 20.35 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 125.338 1.446 . . . . 41.04 109.631 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -72.39 164.14 26.83 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.821 -1.988 . . . . 63.22 109.917 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 68.59 -74.47 0.08 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.474 2.309 . . . . 73.2 114.934 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -121.45 -15.65 8.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.316 1.446 . . . . 65.4 112.442 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 74.89 161.64 8.85 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 122.332 0.962 . . . . 71.14 114.128 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.582 ' CE1' HG23 ' A' ' 97' ' ' ILE . 19.1 m-85 -112.01 163.53 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.761 2.425 . . . . 45.41 107.228 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -92.57 117.19 29.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.062 0.846 . . . . 73.0 108.917 166.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.419 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 26.8 m -97.03 173.11 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 119.862 1.21 . . . . 71.51 108.989 173.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.0 m -66.56 147.83 52.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.107 -1.072 . . . . 64.44 108.107 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -121.79 159.99 25.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.943 0.897 . . . . 45.14 108.62 161.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.323 -0.561 0 N-CA-C 106.35 -1.722 . . . . 74.14 106.35 152.196 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 106.678 -1.601 . . . . 64.54 106.678 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.436 HD21 ' HB1' ' A' ' 165' ' ' ALA . 4.8 mp -88.33 157.9 18.59 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.752 0.821 . . . . 72.25 109.985 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -61.68 156.3 20.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.456 1.102 . . . . 53.1 111.13 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.04 -40.13 60.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.07 1.348 . . . . 72.02 112.63 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.63 1.9 54.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.267 -0.873 . . . . 72.41 112.714 -165.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' OE1' ' HE2' ' A' ' 167' ' ' LYS . 11.8 mm-40 -77.95 140.29 62.26 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 120.592 1.542 . . . . 73.24 111.336 -164.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.19 133.74 13.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.771 2.314 . . . . 73.32 112.056 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 pt -102.99 -2.09 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.163 1.171 . . . . 72.42 114.163 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 22' ' ' ILE . 49.5 m-85 55.48 66.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.591 1.156 . . . . 55.55 112.391 176.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.7 mt -58.25 153.31 15.47 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.683 -0.636 . . . . 74.32 110.709 167.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 m -62.98 -31.79 72.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.486 1.514 . . . . 73.1 113.288 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -28.67 41.47 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.26 0.936 . . . . 72.51 110.352 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.1 13.56 5.89 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.419 -0.656 . . . . 62.23 112.73 159.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -45.5 -53.33 9.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 127.705 2.402 . . . . 74.32 113.575 -171.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.444 HD11 ' CE2' ' A' ' 16' ' ' TYR . 7.8 mm 56.69 111.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.842 2.457 . . . . 75.44 107.907 -157.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.98 161.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.702 -1.592 . . . . 51.25 106.702 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -71.14 129.79 39.84 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.279 1.032 . . . . 53.44 108.946 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 tt -48.68 -42.44 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.824 1.65 . . . . 72.1 110.839 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.66 -47.47 61.6 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.268 -1.295 . . . . 44.25 110.966 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -57.41 -46.62 83.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.345 1.573 . . . . 73.23 110.877 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.71 -55.59 32.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.058 0.943 . . . . 75.33 110.449 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 33' ' ' PHE . 52.6 t -56.83 -45.23 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.322 1.049 . . . . 51.32 110.057 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.93 -34.7 79.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.265 1.026 . . . . 63.03 111.501 -167.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 8.4 ttpt -51.96 -53.3 42.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.472 1.109 . . . . 44.4 108.545 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 29.4 m-85 -70.68 -34.19 71.72 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 118.967 -0.54 . . . . 72.23 109.723 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.5 m-30 -63.74 -39.54 94.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.088 1.313 . . . . 62.23 111.337 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -42.26 74.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.788 1.235 . . . . 73.03 110.535 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -78.95 -53.84 6.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.312 0.645 . . . . 64.34 109.49 -173.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.79 42.48 1.1 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.439 2.296 . . . . 74.43 107.028 -170.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.96 -34.34 59.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.666 -1.272 . . . . 71.31 111.521 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -60.21 -35.26 75.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.181 0.992 . . . . 74.34 112.406 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.48 -0.91 43.93 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.597 1.159 . . . . 42.25 112.91 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.77 94.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.394 -1.336 . . . . 62.35 107.394 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -79.54 154.9 28.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.792 -1.188 . . . . 75.11 107.792 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -111.88 156.96 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.086 -1.079 . . . . 51.21 108.086 160.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.33 168.78 12.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.955 -1.128 . . . . 60.3 107.955 159.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -59.57 -48.35 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.93 0.892 . . . . 71.35 109.39 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.09 -3.47 13.4 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.707 1.002 . . . . 52.22 113.707 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.87 20.84 45.15 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 121.302 -0.874 . . . . 75.44 114.187 159.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.73 -86.02 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.14 1.776 . . . . 74.03 110.14 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.43 125.42 2.73 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.074 1.321 . . . . 45.22 110.263 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -136.82 169.91 16.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 61.54 111.452 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 33' ' ' PHE . 19.5 mt -144.47 144.5 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.289 2.235 . . . . 73.42 106.398 164.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.91 125.8 34.26 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.217 1.407 . . . . 71.34 109.684 167.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.91 8.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.809 0.844 . . . . 74.34 111.054 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.22 -40.65 60.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.52 1.054 . . . . 41.53 112.346 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -9.3 2.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.239 2.216 . . . . 75.15 114.402 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -70.05 -22.36 63.09 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.474 1.034 . . . . 72.03 112.588 170.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.13 7.03 3.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 120.125 1.33 . . . . 73.31 114.27 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.02 118.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.649 1.18 . . . . 74.24 108.117 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -85.44 155.17 21.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.411 1.1 . . . . 61.41 110.184 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 17.9 tt -135.07 155.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.652 1.981 . . . . 62.52 107.732 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 60' ' ' LYS . 5.9 mmpt? -69.4 118.94 12.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.709 -1.589 . . . . 44.44 106.709 167.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -110.73 -175.98 2.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.59 -2.004 . . . . 72.2 105.59 165.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 125.14 16.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.331 -1.729 . . . . 74.45 106.331 172.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -73.72 99.52 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.921 -1.14 . . . . 74.24 107.921 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -54.89 -23.23 17.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 124.849 1.26 . . . . 74.34 112.08 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -26.31 24.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.06 1.344 . . . . 75.23 112.605 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.0 m -144.95 16.43 1.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.482 1.113 . . . . 71.01 112.361 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp 53.41 45.6 28.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.835 1.198 . . . . 73.23 111.37 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -113.95 159.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.28 1.032 . . . . 52.12 109.945 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.7 mm -79.32 142.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.92 -1.511 . . . . 74.11 106.92 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -131.31 162.27 30.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.984 1.374 . . . . 65.24 110.667 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.07 127.96 36.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.207 -2.146 . . . . 71.12 105.207 165.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -154.43 148.26 25.51 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 117.005 -1.474 . . . . 73.22 107.823 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.97 161.73 18.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 122.351 2.342 . . . . 65.13 111.307 168.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.62 ' H ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -80.92 165.67 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.947 -1.501 . . . . 62.24 106.947 166.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.432 ' H ' HG22 ' A' ' 74' ' ' ILE . 17.9 mt -127.28 -42.75 1.67 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.493 1.517 . . . . 63.53 110.771 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -134.58 154.83 51.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.409 1.458 . . . . 73.41 110.231 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.413 HG21 HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -123.62 162.06 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.884 1.674 . . . . 74.44 108.404 177.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -137.31 158.94 43.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.478 1.111 . . . . 74.14 110.567 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HD2' ' CD2' ' A' ' 151' ' ' HIS . 3.8 tpp85 -142.07 145.99 34.95 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.761 1.624 . . . . 64.34 107.159 172.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -147.53 151.58 36.57 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.887 -1.153 . . . . 72.0 107.887 160.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.96 140.91 47.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.631 -0.878 . . . . 44.13 108.631 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -144.76 150.05 36.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.878 1.671 . . . . 73.13 107.268 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.2 p -143.38 138.27 29.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 104.979 -2.23 . . . . 55.33 104.979 155.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.6 -178.4 35.73 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 120.781 1.628 . . . . 74.11 111.11 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 119.53 30.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.491 -0.417 . . . . 74.01 110.812 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -88.88 164.59 15.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.986 1.314 . . . . 63.21 108.209 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mm -78.35 142.63 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 106.615 -1.624 . . . . 72.13 106.615 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -133.04 74.65 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.423 -1.695 . . . . 72.45 106.423 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.1 mt -78.01 121.51 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.683 -2.34 . . . . 73.45 104.683 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 m -107.62 164.48 12.19 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.687 -1.598 . . . . 73.32 106.687 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -132.84 175.09 9.66 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.84 0.745 . . . . 65.31 111.306 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -66.34 -22.65 66.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.9 -1.125 . . . . 72.12 112.448 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -69.71 -1.07 8.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.889 0.876 . . . . 71.02 112.514 170.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 57.75 25.26 11.65 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.443 -1.411 . . . . 73.54 110.187 -162.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.24 24.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.491 -1.3 . . . . 64.31 107.491 165.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 22.5 mt-10 -161.42 162.01 30.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.443 -0.947 . . . . 74.31 108.443 -166.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.565 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -148.42 160.18 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.74 1.216 . . . . 74.43 110.268 174.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.91 96.52 2.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.172 1.389 . . . . 53.41 109.917 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.19 -179.86 7.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.14 2.176 . . . . 62.41 109.836 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 p -68.47 165.81 18.18 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.22 0.918 . . . . 62.41 111.323 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.28 -24.26 64.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.923 -0.486 . . . . 75.34 110.54 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -115.56 81.05 1.52 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.189 1.396 . . . . 74.03 107.896 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 156.72 76.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.691 -0.631 . . . . 75.12 111.427 150.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -89.48 149.82 5.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.27 3.313 . . . . 71.23 115.93 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 173' ' ' VAL . 0.4 OUTLIER -156.91 -173.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 111.459 -2.61 . . . . 73.42 107.7 -174.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -132.55 141.18 48.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.468 -1.696 . . . . 65.52 112.288 -171.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.73 157.82 26.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.015 0.926 . . . . 74.3 110.047 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.01 105.64 12.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.455 1.121 . . . . 64.43 109.24 173.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -76.37 66.68 2.47 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 107.155 -1.424 . . . . 73.35 107.155 148.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 1.0 OUTLIER 70.26 -15.13 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.989 2.515 . . . . 55.34 115.375 170.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.24 -21.08 0.12 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 126.288 1.899 . . . . 52.03 109.025 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -78.46 144.54 35.69 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 105.362 -2.088 . . . . 71.22 105.362 166.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -102.04 95.53 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.503 1.521 . . . . 73.2 107.835 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.3 154.46 17.18 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.833 1.253 . . . . 62.23 108.671 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -114.05 111.84 22.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.51 1.524 . . . . 64.13 111.881 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.09 179.39 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.214 1.005 . . . . 70.31 111.231 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -99.26 148.49 24.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.081 1.752 . . . . 75.24 109.936 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.4 -26.8 65.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 118.102 0.41 . . . . 73.31 110.385 -161.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.66 67.34 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.313 -0.867 . . . . 64.12 113.231 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.6 -29.64 46.19 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.328 1.051 . . . . 51.41 112.086 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 140' ' ' VAL . 11.4 t -73.83 63.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.508 2.323 . . . . 74.15 109.89 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -78.78 178.17 8.12 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.435 1.094 . . . . 74.53 108.187 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.03 -20.94 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.077 1.751 . . . . 63.3 113.666 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.18 -2.78 87.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.876 -1.513 . . . . 35.33 113.439 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.12 159.71 16.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.459 2.129 . . . . 71.24 111.039 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.5 103.53 11.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.72 1.608 . . . . 71.54 109.066 170.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.87 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.53 1.532 . . . . 65.34 107.327 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.13 115.36 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.789 -0.819 . . . . 74.43 108.789 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 pt -102.56 154.03 37.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 123.297 0.639 . . . . 73.22 110.766 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.7 138.26 28.81 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.117 1.878 . . . . 72.5 107.944 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.63 175.46 5.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.313 -1.366 . . . . 74.23 107.313 162.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -25.06 -61.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.873 2.069 . . . . 75.11 115.246 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -121.05 1.19 10.34 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.704 1.202 . . . . 72.1 113.077 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -143.74 -175.36 4.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.853 2.061 . . . . 73.42 109.353 -139.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -120.11 147.99 23.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.87 -1.159 . . . . 70.53 107.87 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -137.1 -178.18 5.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.856 2.462 . . . . 72.41 106.896 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.51 164.4 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.836 1.254 . . . . 75.23 108.115 168.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -156.85 159.12 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.183 -1.784 . . . . 71.12 106.183 167.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -104.29 138.16 41.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.103 1.361 . . . . 70.5 109.325 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.51 HG21 HG12 ' A' ' 121' ' ' VAL . 25.1 t -71.08 -0.27 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 114.146 1.165 . . . . 74.51 114.146 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 25.93 -89.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 127.029 2.131 . . . . 72.05 114.924 174.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -92.65 113.23 25.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.257 -0.902 . . . . 62.3 109.267 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.14 144.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.36 -0.978 . . . . 73.32 108.36 156.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -156.2 -172.14 3.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.904 2.482 . . . . 72.33 106.291 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -124.53 142.76 51.09 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.869 -1.16 . . . . 73.34 107.869 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.46 -179.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.628 1.171 . . . . 63.41 108.566 166.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -126.39 138.31 53.54 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.982 2.513 . . . . 73.42 106.75 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.4 t80 -151.49 151.23 31.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.448 1.099 . . . . 73.05 109.111 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.98 78.27 0.45 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.245 -1.761 . . . . 74.23 106.245 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -151.27 23.78 0.97 Allowed Glycine 0 N--CA 1.468 0.822 0 CA-C-N 113.807 -1.542 . . . . 74.5 113.886 -164.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.416 ' CD2' ' HD2' ' A' ' 79' ' ' ARG . 54.7 m80 54.77 -179.29 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.479 0.712 . . . . 72.14 110.962 -151.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.2 pt -145.78 160.19 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.703 2.401 . . . . 73.2 106.699 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -137.21 147.52 45.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.197 1.799 . . . . 42.14 108.617 -166.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -147.7 167.56 24.33 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.669 1.122 . . . . 70.0 111.56 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.5 126.48 31.18 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 127.987 2.515 . . . . 70.04 108.149 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 19.6 m -61.61 -53.32 57.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.102 0.561 . . . . 72.02 112.46 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.305 3.5 t 24.38 64.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 128.018 2.527 . . . . 65.24 112.385 -164.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -79.2 0.06 29.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.958 1.303 . . . . 71.34 111.472 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -64.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.919 1.688 . . . . 71.12 110.887 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.7 -0.31 14.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.253 0.621 . . . . 63.1 111.841 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.2 m80 61.95 27.89 16.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.453 1.901 . . . . 73.14 110.734 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.1 143.22 24.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.619 1.568 . . . . 73.15 108.123 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.658 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 0.4 OUTLIER -145.6 -179.38 6.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.199 1.0 . . . . 70.54 111.261 -173.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.73 124.01 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 107.631 -1.248 . . . . 64.41 107.631 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -155.79 146.07 21.69 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.801 0.44 . . . . 63.42 110.528 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.91 -169.06 32.45 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 108.326 -1.91 . . . . 74.33 108.326 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.461 ' HE2' ' OE1' ' A' ' 13' ' ' GLU . 74.0 mttt -99.51 177.84 5.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 119.879 1.839 . . . . 62.32 110.039 162.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 60.26 -78.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 129.198 2.999 . . . . 74.24 113.037 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.57 -8.1 8.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.326 1.45 . . . . 75.51 113.866 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 67.4 153.04 0.3 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.106 1.336 . . . . 75.5 114.92 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 97' ' ' ILE . 43.9 m-85 -107.55 159.01 16.76 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.048 2.139 . . . . 70.54 108.662 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -96.58 74.58 2.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 127.11 2.164 . . . . 72.24 109.184 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 105' ' ' VAL . 3.2 m -105.03 171.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.827 -0.546 . . . . 61.31 110.687 -164.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 m -71.18 159.24 35.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.073 0.549 . . . . 75.14 110.676 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.658 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -136.03 165.49 25.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.587 2.755 . . . . 63.34 108.028 169.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 119.063 0.847 . . . . 74.41 109.655 150.523 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.666 -0.864 . . . . 74.41 108.666 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.5 157.13 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.943 1.697 . . . . 74.42 109.437 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.5 159.4 30.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.636 0.775 . . . . 64.42 112.024 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.1 t80 -54.52 -39.76 67.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.955 1.702 . . . . 65.15 112.916 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -101.59 19.82 17.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.238 1.815 . . . . 71.24 110.952 -170.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -77.64 121.61 84.55 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.223 -2.14 . . . . 74.42 105.223 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.6 138.51 54.62 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 120.52 0.813 . . . . 55.42 110.302 171.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 pt -108.54 143.25 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 122.647 1.213 . . . . 72.13 108.164 160.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.441 ' CE2' HD11 ' A' ' 22' ' ' ILE . 11.4 m-85 -103.3 99.41 9.25 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.925 -2.62 . . . . 65.45 103.925 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 1.8 mm? -52.45 165.77 0.23 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.186 -0.672 . . . . 74.24 109.186 166.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -48.89 -43.93 39.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.526 0.73 . . . . 63.4 109.516 166.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.71 -35.66 80.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.329 0.492 . . . . 65.4 112.329 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.0 9.12 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.243 0.925 . . . . 73.13 112.13 -171.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -20.96 15.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.49 1.516 . . . . 74.21 114.955 -170.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 16' ' ' TYR . 27.1 mm 46.95 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 128.35 2.66 . . . . 74.41 110.631 -168.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.2 144.29 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 114.841 -1.072 . . . . 73.42 108.383 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -61.78 126.3 26.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 105.913 -1.884 . . . . 64.01 105.913 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -49.89 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 63.53 108.953 165.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -56.65 -57.42 19.6 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-O 117.941 -1.477 . . . . 55.3 112.521 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -52.46 -51.57 58.64 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.486 1.914 . . . . 71.14 111.384 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.93 -52.04 61.87 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 125.837 1.655 . . . . 74.2 109.778 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 153' ' ' TYR . 73.4 t -76.86 -36.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.891 -1.05 . . . . 63.21 110.443 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.06 -36.05 80.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.661 0.664 . . . . 71.23 111.724 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -55.04 -42.69 72.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.323 1.049 . . . . 64.21 109.94 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -67.02 -43.99 81.4 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.1 -1.0 . . . . 75.11 110.093 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -60.07 -33.35 71.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.894 1.225 . . . . 71.34 112.497 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -61.5 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.282 1.433 . . . . 74.23 109.514 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -73.23 -47.85 39.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.714 -1.217 . . . . 73.51 107.714 -166.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -94.66 40.78 1.09 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.228 1.411 . . . . 63.01 109.887 -172.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.08 -39.88 29.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.042 -1.036 . . . . 65.13 111.636 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -72.07 -22.79 61.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.993 0.738 . . . . 43.23 112.993 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -85.99 -2.28 58.14 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.722 0.809 . . . . 73.43 111.822 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.4 mt -62.88 101.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.954 -1.499 . . . . 71.22 106.954 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.58 162.22 25.46 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.12 -1.437 . . . . 60.55 107.12 161.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.88 145.47 47.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.577 -1.638 . . . . 72.13 106.577 163.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 175.24 10.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.469 -0.567 . . . . 70.32 109.469 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -61.33 -45.09 95.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.363 1.065 . . . . 74.14 108.584 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.39 -19.79 66.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.355 0.662 . . . . 63.14 110.5 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 36.19 6.1 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 120.972 -1.08 . . . . 61.45 111.489 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.474 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 3.7 t80 -78.05 -86.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.595 1.158 . . . . 74.31 109.908 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.87 121.82 2.02 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.07 -2.012 . . . . 25.31 108.07 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.26 163.65 33.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.539 1.17 . . . . 72.2 112.231 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mt -143.98 140.04 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.72 -1.585 . . . . 73.41 106.72 172.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.6 134.75 33.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.625 1.17 . . . . 71.25 109.883 172.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.01 23.09 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.767 2.027 . . . . 62.25 111.581 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . -61.06 -7.13 8.12 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.393 -1.226 . . . . 64.13 115.69 -175.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -98.67 -27.92 13.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.38 1.59 . . . . 71.23 113.128 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.93 -23.65 33.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.304 1.002 . . . . 52.5 111.971 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.83 15.01 3.55 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.149 1.38 . . . . 70.41 112.867 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.97 101.31 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.568 1.147 . . . . 73.45 108.269 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.35 118.68 7.79 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.829 1.252 . . . . 72.3 110.009 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 14.1 tt -98.33 160.18 3.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 125.05 1.34 . . . . 72.21 107.751 165.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.01 124.19 22.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.731 -1.581 . . . . 74.34 106.731 168.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -128.92 178.77 6.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.558 1.143 . . . . 53.11 108.116 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -153.42 127.53 9.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.143 -0.688 . . . . 53.41 109.143 -171.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.73 112.35 20.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.943 -1.503 . . . . 74.03 106.943 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.66 -20.39 55.81 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 113.28 0.845 . . . . 64.24 113.28 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.61 -19.9 2.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.083 2.153 . . . . 63.42 112.682 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -154.04 20.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.418 0.554 . . . . 75.1 111.301 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.16 54.36 6.07 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.272 -1.517 . . . . 62.12 112.158 -167.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 pt -101.26 169.85 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.106 1.363 . . . . 41.53 108.627 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.25 150.09 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.853 1.261 . . . . 71.52 108.634 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -157.63 174.07 15.9 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.94 2.496 . . . . 75.35 107.65 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -87.85 145.67 25.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.257 -1.386 . . . . 73.24 107.257 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -148.79 144.72 27.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.347 -1.353 . . . . 70.35 107.347 164.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -78.14 -175.15 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.857 1.208 . . . . 64.25 112.19 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.5 152.04 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.087 2.155 . . . . 61.25 107.241 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.413 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 3.0 mm? -113.07 -40.76 3.87 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 113.346 0.869 . . . . 65.41 113.346 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -145.8 164.85 30.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.691 -1.225 . . . . 71.35 107.691 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -132.43 165.99 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.744 -1.206 . . . . 74.13 107.744 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -130.93 175.47 9.04 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.909 0.884 . . . . 74.5 108.943 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.48 145.92 5.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.03 1.732 . . . . 74.12 106.925 154.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HE3' ' CD2' ' A' ' 47' ' ' PHE . 5.4 ttmt -148.48 166.42 28.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.885 -1.154 . . . . 63.24 107.885 166.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -93.45 157.5 16.18 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.524 -0.735 . . . . 74.21 109.538 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.13 147.55 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.074 1.35 . . . . 73.21 109.634 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -143.39 117.9 9.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 160.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.52 -146.6 4.65 Favored Glycine 0 N--CA 1.463 0.481 0 N-CA-C 109.911 -1.276 . . . . 74.12 109.911 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -123.5 119.21 29.3 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.036 -1.459 . . . . 74.42 110.277 174.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.16 153.98 17.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 121.547 1.976 . . . . 73.4 106.78 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -79.94 139.79 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 126.784 2.033 . . . . 74.34 108.513 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -124.65 84.47 2.28 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.733 1.613 . . . . 73.35 106.748 161.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 32.3 mt -75.2 112.13 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.005 -1.85 . . . . 73.54 106.005 162.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -75.24 178.46 5.76 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.568 -0.901 . . . . 73.43 108.568 167.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -146.19 177.11 9.24 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.61 -1.306 . . . . 74.11 109.336 154.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.1 ttmt -60.41 -27.28 67.33 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 119.503 -1.998 . . . . 63.3 113.568 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.68 18.62 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.888 1.222 . . . . 70.34 112.752 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER 58.59 15.76 3.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.728 2.411 . . . . 73.03 111.415 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ttm105 -68.49 170.49 8.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.754 2.022 . . . . 72.43 108.463 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -176.17 172.1 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.155 1.382 . . . . 70.14 109.491 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 171' ' ' PHE . 3.8 pt -143.09 178.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.011 1.324 . . . . 61.2 107.838 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 98.11 2.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.723 -0.843 . . . . 72.0 108.723 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.79 173.21 17.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.691 1.596 . . . . 73.14 110.218 -172.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.3 p -74.26 163.7 27.5 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.1 -1.0 . . . . 71.35 111.551 -173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.4 -16.46 62.96 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.287 0.847 . . . . 71.32 113.287 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -116.72 38.82 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.97 0.805 . . . . 72.24 108.893 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -89.99 129.76 44.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 117.921 -1.038 . . . . 62.31 109.613 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -60.35 126.6 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.747 3.631 . . . . 73.52 111.293 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.91 175.96 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.693 1.597 . . . . 63.41 109.123 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.79 134.68 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.494 -0.754 . . . . 62.4 111.067 -169.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.96 161.58 40.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.451 1.501 . . . . 73.34 109.059 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.471 ' HB3' HD21 ' A' ' 137' ' ' LEU . 53.2 p -87.4 127.01 35.21 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 119.416 -0.326 . . . . 44.45 110.743 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HE3' HD13 ' A' ' 114' ' ' LEU . 2.3 ttmt -104.97 75.99 1.22 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.025 -1.472 . . . . 71.21 107.025 165.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m 59.51 16.98 5.66 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.857 1.663 . . . . 72.11 114.562 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -38.6 1.42 Allowed Glycine 0 N--CA 1.448 -0.536 0 O-C-N 120.682 -1.262 . . . . 60.01 110.194 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.76 148.86 31.3 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.359 -1.349 . . . . 72.14 107.359 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.19 117.51 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.699 -1.593 . . . . 73.25 106.699 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.686 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.7 tp -105.19 132.94 50.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.076 -1.083 . . . . 63.04 108.076 166.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -81.75 125.79 31.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.235 -1.024 . . . . 73.21 108.235 161.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.45 -179.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.48 1.512 . . . . 72.11 109.21 169.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.28 145.3 24.55 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.998 0.919 . . . . 73.02 109.285 -172.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -42.55 -47.11 5.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.637 1.975 . . . . 71.02 113.762 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -32.63 54.43 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.917 0.887 . . . . 50.33 113.053 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.2 mtt -75.6 -26.41 57.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.985 0.514 . . . . 73.31 112.159 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.259 5.7 t -79.11 63.2 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.695 2.398 . . . . 73.1 112.319 -169.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.759 ' HG3' ' H ' ' A' ' 124' ' ' GLY 0.259 0.0 OUTLIER -79.43 175.09 10.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 131.07 3.748 . . . . 72.13 111.632 -174.65 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.259 5.9 p -57.88 1.67 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 126.535 1.934 . . . . 71.12 114.616 167.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.759 ' H ' ' HG3' ' A' ' 122' ' ' LYS . . . -108.28 -1.84 33.37 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.772 2.606 . . . . 24.31 111.495 171.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 156.44 21.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.88 1.84 . . . . 64.54 108.02 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.6 104.97 12.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.517 -1.29 . . . . 74.11 107.517 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 tt -81.33 136.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.401 -0.818 . . . . 75.2 109.821 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.57 129.35 38.08 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.225 -0.898 . . . . 74.53 109.099 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 161.21 60.74 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.693 1.997 . . . . 74.12 111.164 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.55 173.04 14.98 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.726 2.284 . . . . 73.32 110.639 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -134.49 -134.8 0.16 Allowed 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 120.865 -1.147 . . . . 71.13 108.665 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -51.94 -84.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.609 1.164 . . . . 72.32 108.871 169.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -121.22 0.89 10.2 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.727 1.611 . . . . 73.32 112.431 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 p -131.58 151.34 51.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.879 0.872 . . . . 75.52 112.515 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.1 147.29 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -145.78 -176.21 5.04 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.704 2.002 . . . . 63.33 107.543 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 108' ' ' SER . 5.7 mt -124.82 166.23 16.61 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -154.26 140.79 18.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.765 -1.198 . . . . 73.54 107.765 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.8 141.34 46.21 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.528 -1.286 . . . . 64.24 107.528 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 89' ' ' ILE . 3.0 t -70.48 -23.48 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.529 1.531 . . . . 75.05 113.89 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.6 pt 47.19 -53.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 131.664 3.986 . . . . 54.51 116.398 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -140.28 132.51 28.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.689 2.395 . . . . 74.3 106.827 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.76 131.01 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 107.806 -1.183 . . . . 75.42 107.806 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.14 -164.79 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.932 1.293 . . . . 73.23 108.149 171.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 p -146.9 162.27 39.02 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.322 1.049 . . . . 72.31 109.517 -162.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 3.3 m -132.51 171.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 127.388 2.275 . . . . 73.24 108.687 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.48 92.41 3.42 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.051 -1.092 . . . . 73.44 108.051 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -97.63 136.91 37.33 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.509 2.723 . . . . 73.03 108.719 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -134.54 73.34 1.48 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.024 -1.473 . . . . 74.23 107.024 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.2 -159.24 7.84 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.086 0.85 . . . . 73.42 112.912 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -102.29 154.25 19.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.8 -0.815 . . . . 74.23 108.8 163.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.65 154.23 26.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.279 1.832 . . . . 63.55 107.295 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.692 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -153.38 160.28 42.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.599 0.76 . . . . 74.35 109.69 173.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -131.74 146.03 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.098 2.159 . . . . 75.54 107.524 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.91 143.85 27.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.904 1.684 . . . . 74.13 112.718 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 83.14 3.63 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.392 -1.336 . . . . 64.3 107.392 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.21 76.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 106.145 -1.798 . . . . 64.51 106.145 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.02 -5.19 20.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.769 -0.582 . . . . 73.2 111.694 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.26 -63.97 0.95 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.901 2.08 . . . . 75.41 107.631 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -125.53 -4.85 7.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.716 2.406 . . . . 62.31 111.861 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 54.18 25.86 6.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.256 2.223 . . . . 63.44 112.775 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 p -141.49 153.68 45.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.883 1.273 . . . . 64.53 109.11 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -163.7 178.07 8.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.412 1.085 . . . . 75.21 111.208 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.9 122.21 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.204 1.402 . . . . 73.13 109.317 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.04 154.93 43.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.56 1.144 . . . . 74.3 110.054 173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.51 -171.61 21.88 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.589 -0.605 . . . . 72.34 111.589 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -91.55 166.68 12.71 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.484 -1.598 . . . . 70.05 110.015 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 61.36 -76.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 129.693 3.197 . . . . 74.43 112.032 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.89 -13.77 8.18 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.417 1.487 . . . . 74.15 112.561 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.86 171.0 18.9 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.033 1.301 . . . . 73.31 112.42 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 97' ' ' ILE . 68.8 m-85 -112.12 157.09 21.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.737 3.615 . . . . 73.2 105.322 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.467 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -103.9 110.81 23.09 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.108 -1.812 . . . . 42.03 106.108 170.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.13 175.19 6.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.619 -0.882 . . . . 64.31 108.619 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 155.24 16.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.01 -0.737 . . . . 72.23 109.01 168.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -146.78 47.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.866 2.066 . . . . 63.23 107.012 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.297 -1.001 . . . . 60.52 108.297 -171.861 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 109.844 -0.428 . . . . 74.45 109.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.419 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 10.0 mp -79.74 158.6 26.86 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.413 1.485 . . . . 71.51 110.919 -167.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 159.53 21.37 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.052 0.541 . . . . 35.11 112.238 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -49.29 -49.34 44.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.111 1.764 . . . . 74.34 113.84 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -98.77 45.87 1.0 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.182 2.593 . . . . 72.24 109.424 -167.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 167' ' ' LYS . 65.5 mm-40 -109.47 110.11 59.97 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.55 1.54 . . . . 74.03 107.926 169.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -51.71 134.69 47.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.516 2.811 . . . . 62.45 113.3 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 pt -96.33 -2.79 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 114.452 1.278 . . . . 61.1 114.452 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 49.56 70.43 0.49 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.01 1.277 . . . . 64.13 113.587 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 mm? -52.0 159.03 0.94 Allowed 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.865 -1.147 . . . . 44.25 110.925 167.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -53.87 -45.09 70.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.082 -1.081 . . . . 40.23 108.082 168.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.76 -4.53 9.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.133 1.373 . . . . 75.04 114.184 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.72 12.5 66.49 Favored Glycine 0 CA--C 1.523 0.584 0 O-C-N 120.287 -1.508 . . . . 62.31 112.237 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.409 ' H ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.92 -4.9 14.42 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.009 2.225 . . . . 73.03 117.009 -156.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.1 mm 27.39 87.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 130.802 3.641 . . . . 73.23 110.117 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.24 145.53 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.616 -1.624 . . . . 71.23 106.616 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.26 130.71 44.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 128.108 2.563 . . . . 75.02 105.044 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -48.72 -43.4 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.434 0.694 . . . . 74.21 110.318 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.37 -4.9 83.12 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.49 -1.728 . . . . 50.21 114.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -82.54 -45.37 14.75 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.761 1.78 . . . . 74.42 108.788 167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -55.49 -55.43 31.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.275 0.63 . . . . 74.53 109.653 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG22 ' HA2' ' A' ' 26' ' ' GLY . 22.8 m -65.78 -34.76 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 118.428 -0.796 . . . . 55.44 110.186 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -45.73 72.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.923 1.238 . . . . 75.11 110.893 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.07 -37.48 53.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.765 0.826 . . . . 63.12 110.011 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -83.77 -45.01 13.81 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.564 -1.207 . . . . 64.12 110.829 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -54.72 -30.23 55.51 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 121.825 2.102 . . . . 74.04 112.708 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -94.36 -11.04 30.76 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.783 1.233 . . . . 64.2 112.495 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 17.6 mttm -95.89 -63.91 1.11 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.001 -1.111 . . . . 74.21 108.001 168.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 4.8 m-30 -84.84 39.73 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.185 2.994 . . . . 71.43 108.419 -168.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -49.52 -45.66 47.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.07 2.548 . . . . 61.32 109.506 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -62.88 -35.1 78.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.967 0.907 . . . . 73.43 110.925 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 t -79.87 -7.95 59.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.823 2.049 . . . . 54.31 113.42 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.39 107.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.961 -1.126 . . . . 72.01 107.961 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -84.49 155.21 22.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.626 -1.62 . . . . 75.23 106.626 162.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -121.21 135.05 55.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.741 -1.578 . . . . 62.44 106.741 164.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.79 176.96 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 125.665 1.853 . . . . 74.42 110.679 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.58 -38.5 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.666 1.987 . . . . 72.43 111.801 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.67 52.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.681 0.793 . . . . 73.12 111.738 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.68 12.76 62.11 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.785 1.66 . . . . 44.41 112.644 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.84 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.157 1.783 . . . . 64.33 111.423 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.76 124.96 2.55 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 118.263 -1.299 . . . . 50.25 110.406 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -140.71 166.32 25.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.456 1.128 . . . . 74.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -146.07 135.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.946 2.098 . . . . 64.53 106.636 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.19 128.97 36.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.396 0.678 . . . . 44.03 110.253 167.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.86 9.54 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.043 0.937 . . . . 64.34 111.268 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.07 -16.2 59.5 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 120.785 -1.197 . . . . 54.21 114.416 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -68.81 -32.42 72.12 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.261 1.53 . . . . 72.24 111.81 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.57 -13.09 38.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.479 0.582 . . . . 71.5 112.31 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.84 19.83 10.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.205 2.202 . . . . 74.52 112.756 172.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.24 119.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.905 1.282 . . . . 63.03 108.506 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -88.79 142.52 27.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.181 0.992 . . . . 71.32 111.5 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 6.7 tt -133.64 154.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.411 1.884 . . . . 74.04 108.641 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -73.01 126.73 30.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 110.133 -0.321 . . . . 71.41 110.133 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.04 166.84 16.23 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.562 1.945 . . . . 71.12 108.198 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.56 154.61 46.88 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.933 -1.506 . . . . 73.43 106.933 179.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.68 141.12 46.84 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 118.632 -1.227 . . . . 60.44 108.377 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -86.14 -22.9 26.81 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.583 -0.698 . . . . 75.33 112.019 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.7 -50.04 66.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.671 1.988 . . . . 73.15 110.64 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.0 m -141.27 9.6 2.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.567 1.947 . . . . 71.43 110.794 -162.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.05 52.17 15.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.207 2.203 . . . . 71.41 111.12 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.06 -175.62 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.352 0 O-C-N 124.185 0.928 . . . . 73.43 109.688 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mm -116.86 125.42 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 127.528 2.331 . . . . 72.43 104.883 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -142.85 169.27 17.89 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.869 1.268 . . . . 72.3 108.776 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -110.0 143.58 39.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.625 1.57 . . . . 74.44 110.011 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -150.92 168.08 25.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.657 1.983 . . . . 72.42 107.252 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -93.49 172.23 8.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.12 0.968 . . . . 70.15 110.38 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.04 144.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 105.507 -2.034 . . . . 62.43 105.507 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.8 -34.41 6.46 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.538 0.524 . . . . 64.41 111.217 -172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -144.44 137.75 27.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.97 1.259 . . . . 73.35 108.77 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.96 167.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 124.403 1.064 . . . . 61.23 109.714 168.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -138.13 159.96 40.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.321 1.048 . . . . 73.32 109.685 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 8.3 tmm_? -153.57 140.68 19.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.441 1.496 . . . . 64.44 108.881 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -146.1 161.38 40.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.846 -1.168 . . . . 62.55 107.846 165.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -92.02 146.47 23.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.073 -1.084 . . . . 54.41 108.073 168.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 86' ' ' LEU . 33.9 t80 -152.33 145.68 24.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.775 0.83 . . . . 70.43 110.007 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -142.33 114.8 8.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.854 1.662 . . . . 63.34 109.281 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.06 40.78 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.441 1.019 . . . . 71.42 111.528 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.58 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.05 142.55 36.43 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 122.122 -0.634 . . . . 75.02 110.353 -174.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 98' ' ' THR . 10.8 mp -127.69 160.38 31.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.81 1.644 . . . . 73.32 108.375 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 89' ' ' ILE . 21.5 mm -80.08 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.035 2.134 . . . . 61.23 108.229 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -128.78 75.23 1.63 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 159.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.493 ' H ' HG22 ' A' ' 87' ' ' ILE . 23.3 mt -62.85 139.33 21.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.943 -2.243 . . . . 60.21 104.943 158.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -114.33 172.0 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.699 -1.593 . . . . 40.13 106.699 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 p -136.91 175.81 9.28 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.919 -1.113 . . . . 72.45 110.566 162.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -62.51 -25.69 68.15 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.619 -0.676 . . . . 74.53 111.669 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.95 7.79 2.96 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.877 1.271 . . . . 62.12 112.969 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.56 20.58 7.74 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.216 1.407 . . . . 75.02 110.818 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -71.38 161.92 30.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.661 1.185 . . . . 63.25 108.058 166.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -176.17 171.0 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.003 0.921 . . . . 61.03 108.902 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.598 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.3 pt -145.82 170.92 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.722 1.609 . . . . 73.12 110.65 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 86' ' ' LEU . 2.3 m -148.09 95.23 2.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.278 1.431 . . . . 62.44 109.428 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.94 177.82 10.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.938 1.695 . . . . 70.04 110.498 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.6 p -66.62 164.02 17.65 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.569 1.148 . . . . 64.31 110.638 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.265 1.1 p-80 -68.51 -24.31 64.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.513 0.931 . . . . 62.12 113.513 173.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.93 36.49 2.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.229 1.377 . . . . 64.54 111.336 -168.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -88.17 137.52 31.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.922 -1.037 . . . . 51.41 110.156 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.69 125.42 13.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.208 2.606 . . . . 73.22 111.194 172.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.87 -173.79 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.569 1.947 . . . . 74.52 108.361 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -129.02 140.35 51.67 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.882 0.764 . . . . 71.32 111.146 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.26 172.45 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.961 1.305 . . . . 71.44 108.1 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 p -87.55 144.76 26.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.934 0.873 . . . . 63.44 112.2 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -118.21 80.37 1.51 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.617 -1.623 . . . . 71.1 106.617 158.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 m 62.51 8.58 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.34 1.456 . . . . 71.43 114.339 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.63 -20.3 3.3 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 120.839 -1.163 . . . . 71.44 111.314 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.17 136.73 37.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.23 -2.137 . . . . 63.5 105.23 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.12 117.76 18.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.219 -1.771 . . . . 72.0 106.219 164.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.63 138.99 53.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.508 1.523 . . . . 74.11 108.969 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.14 122.64 39.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.212 1.405 . . . . 72.51 109.314 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.9 pt -142.66 -178.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.76 1.224 . . . . 63.23 110.944 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.61 145.61 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.196 1.398 . . . . 62.54 110.704 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.87 45.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.801 1.64 . . . . 74.41 112.868 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -28.08 68.89 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.706 -1.246 . . . . 64.22 112.002 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -32.02 39.52 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.375 0.67 . . . . 52.44 112.323 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.296 7.9 p -76.92 63.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.507 1.123 . . . . 65.54 111.414 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -79.39 -175.34 4.66 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.698 1.199 . . . . 75.42 108.522 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.53 -0.61 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.564 1.546 . . . . 73.23 112.991 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.45 -1.13 75.21 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.506 -1.163 . . . . 55.53 112.229 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.09 175.91 8.04 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.732 1.766 . . . . 73.02 110.596 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.93 104.52 7.85 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.755 -1.942 . . . . 73.01 105.755 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.36 129.7 37.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.262 -1.755 . . . . 75.25 106.262 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -69.72 127.8 34.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.228 -1.397 . . . . 64.24 107.228 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 129' ' ' ILE . 1.8 pp -124.99 159.95 56.64 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.332 1.053 . . . . 72.22 112.81 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.89 145.1 49.72 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.219 1.946 . . . . 63.13 109.393 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.91 -167.8 1.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.498 -1.667 . . . . 45.53 106.498 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -24.07 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 128.595 2.758 . . . . 54.05 111.639 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -122.27 0.05 9.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.632 2.086 . . . . 54.11 116.632 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.5 p -138.07 169.23 18.15 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.2 0.6 . . . . 74.34 111.482 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.88 150.75 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.956 -1.09 . . . . 73.53 109.553 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -142.59 -176.64 4.94 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.293 1.837 . . . . 71.44 109.289 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.23 161.17 15.49 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.766 1.227 . . . . 72.13 111.915 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -158.02 136.0 10.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.254 1.822 . . . . 72.22 107.819 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.52 153.64 43.2 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.046 0.938 . . . . 61.42 110.341 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -93.25 -2.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 64.52 112.955 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pt 25.49 -91.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 128.023 2.529 . . . . 60.24 116.149 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -88.06 122.73 31.99 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.355 1.462 . . . . 62.44 107.46 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.97 102.83 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.709 -1.219 . . . . 74.1 107.709 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -131.57 -173.9 3.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 60.31 108.003 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 p -125.21 168.31 13.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.043 0.937 . . . . 53.23 110.013 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.37 174.07 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.276 2.231 . . . . 73.01 106.476 168.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -123.21 105.77 10.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.018 -1.475 . . . . 64.44 107.018 165.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -100.5 136.96 39.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.871 1.268 . . . . 64.15 110.096 -168.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.52 51.51 1.92 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.258 0.623 . . . . 74.42 109.994 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.09 -113.96 1.6 Allowed Glycine 0 N--CA 1.463 0.484 0 O-C-N 121.091 -1.006 . . . . 64.55 111.568 -167.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -139.7 157.51 45.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.428 1.891 . . . . 73.44 107.491 170.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.1 pt -124.55 153.97 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.281 1.432 . . . . 72.13 109.396 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.599 ' CD2' HG21 ' A' ' 29' ' ' VAL . 7.3 m-85 -148.72 165.88 30.08 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.819 1.648 . . . . 73.33 107.533 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -167.41 167.73 13.61 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.983 -0.747 . . . . 74.35 108.983 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.26 115.41 16.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.436 2.295 . . . . 74.42 108.501 -163.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.4 m -74.35 119.46 18.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.914 -1.513 . . . . 71.13 106.914 159.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.1 73.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.753 -2.314 . . . . 52.03 104.753 171.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.96 -3.08 3.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.221 1.408 . . . . 73.33 113.642 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -103.06 -42.11 5.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.686 2.394 . . . . 71.05 108.264 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 162' ' ' THR . 1.9 t30 -146.73 79.98 1.53 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.981 -2.229 . . . . 72.41 104.981 -168.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.25 13.94 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.701 2.401 . . . . 71.23 112.958 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.457 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 13.1 p -132.65 124.1 27.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.456 2.702 . . . . 74.3 106.602 -172.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.517 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.2 172.94 13.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.851 0.461 . . . . 74.24 112.186 -164.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 mm -108.0 121.49 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 106.925 -1.509 . . . . 60.13 106.925 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -146.98 152.68 39.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.58 -0.526 . . . . 70.22 109.58 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.82 -160.73 25.76 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.045 -1.222 . . . . 60.43 110.045 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.474 ' HE3' ' OE2' ' A' ' 13' ' ' GLU . 67.8 mttt -109.31 171.53 7.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.125 0.962 . . . . 63.03 110.946 172.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.01 -73.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.64 2.776 . . . . 75.22 112.301 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -121.49 -11.05 8.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.417 1.887 . . . . 74.34 113.587 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.67 7.99 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 122.522 1.068 . . . . 54.13 111.868 -167.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.598 ' CE1' HG23 ' A' ' 97' ' ' ILE . 35.6 m-85 -108.61 156.61 19.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.771 2.429 . . . . 71.4 105.753 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -100.48 113.62 26.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.394 -1.335 . . . . 63.04 107.394 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.9 m -144.13 -177.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.632 1.173 . . . . 74.44 109.662 -163.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.08 126.85 31.59 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.302 -0.874 . . . . 73.53 110.685 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -107.23 48.36 0.84 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.727 1.611 . . . . 42.41 107.403 156.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.674 -1.232 . . . . 72.1 107.674 171.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 108.594 -0.891 . . . . 72.14 108.594 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 165' ' ' ALA . 6.0 tp -98.44 -13.76 20.41 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 115.894 1.812 . . . . 74.31 115.894 -171.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . 96.63 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 1 C-N-CA 132.777 4.431 . . . . 60.52 111.644 -166.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.39 -39.83 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.651 2.78 . . . . 65.13 109.545 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.96 26.83 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.118 2.167 . . . . 43.33 110.026 -170.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.24 111.8 36.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 127.146 2.178 . . . . 73.53 108.777 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 106.31 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.443 2.762 . . . . 61.54 108.651 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.45 167.87 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.582 1.083 . . . . 65.25 110.142 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -128.21 64.48 1.4 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.477 1.111 . . . . 73.32 111.61 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -45.63 150.71 0.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 120.425 -1.422 . . . . 74.25 112.624 161.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -15.0 53.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.768 1.292 . . . . 51.15 112.98 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.44 -18.28 22.51 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.181 0.9 . . . . 72.21 112.62 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.87 38.32 8.75 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.125 1.345 . . . . 64.34 111.043 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.94 -18.62 64.42 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.614 1.207 . . . . 64.1 113.301 -170.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mm 47.85 87.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 128.488 2.715 . . . . 65.34 109.863 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 150.31 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 52.14 106.996 -170.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -61.08 130.26 45.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.729 -1.211 . . . . 65.32 107.729 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -53.73 -39.34 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.301 0.501 . . . . 62.12 110.018 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 10.27 63.95 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.833 -0.982 . . . . 74.11 114.26 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -55.45 3.75 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.785 1.793 . . . . 63.24 108.689 153.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -48.56 -52.58 22.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.733 1.613 . . . . 74.31 109.435 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 77' ' ' VAL . 49.1 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.709 -0.678 . . . . 74.22 110.916 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -30.46 70.9 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 120.914 -1.116 . . . . 71.44 110.871 -173.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -52.37 -49.7 63.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.294 0.952 . . . . 75.44 109.17 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -66.09 -43.55 86.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.04 -1.096 . . . . 63.22 108.04 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.54 -35.47 72.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.132 1.333 . . . . 74.45 112.388 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -83.22 -15.26 51.09 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.935 1.294 . . . . 73.55 111.704 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -97.98 -59.19 1.81 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.341 -1.355 . . . . 72.53 107.341 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -91.47 44.01 1.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.354 2.661 . . . . 74.14 107.808 -173.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -48.33 -45.12 34.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 125.738 1.615 . . . . 75.15 109.537 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -19.8 61.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.713 -0.66 . . . . 74.24 112.469 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 m -85.82 0.26 53.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.819 1.248 . . . . 61.34 112.45 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.68 94.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.15 1.341 . . . . 75.11 108.212 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -79.59 169.69 17.64 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.912 -1.144 . . . . 63.12 107.912 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.72 154.98 48.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.85 -1.537 . . . . 71.33 106.85 163.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -81.87 171.82 14.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.312 1.007 . . . . 62.35 110.437 159.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -45.45 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.28 2.632 . . . . 63.23 110.995 175.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -64.03 -10.06 19.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.275 1.43 . . . . 62.3 112.28 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.01 7.59 57.34 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 127.383 2.421 . . . . 52.25 112.696 163.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.39 -82.06 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.452 1.901 . . . . 75.54 110.625 -163.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.96 129.48 2.72 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.897 -1.681 . . . . 64.22 108.897 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -142.59 161.89 36.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.076 0.938 . . . . 74.41 111.263 167.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.0 145.98 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.167 -2.161 . . . . 63.44 105.167 164.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.45 123.28 29.54 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.027 0.931 . . . . 75.0 108.89 165.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.89 8.5 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.652 0.381 . . . . 43.4 111.35 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.28 -18.91 61.29 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 120.789 -1.194 . . . . 70.34 113.654 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.4 -13.52 60.73 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.872 1.669 . . . . 75.05 112.49 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -61.87 -22.14 65.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.531 0.732 . . . . 63.55 110.312 163.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 63.3 -10.55 0.11 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 128.057 2.543 . . . . 64.3 114.185 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.4 mt -43.71 113.98 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.8 2.44 . . . . 71.1 109.544 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -77.02 144.01 38.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.006 -0.543 . . . . 74.53 110.041 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.6 tt -112.02 156.65 13.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.041 1.736 . . . . 73.52 107.859 163.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -66.88 93.35 0.26 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.449 -1.315 . . . . 73.43 107.449 164.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -71.39 173.8 7.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.805 -1.554 . . . . 74.4 106.805 165.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.554 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -140.39 151.59 45.07 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.656 -1.903 . . . . 73.24 106.817 166.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.516 HD22 HD11 ' A' ' 68' ' ' ILE . 17.2 t30 -101.22 114.22 27.99 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.822 1.249 . . . . 72.41 108.212 -176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -70.4 -29.47 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.34 1.856 . . . . 75.34 112.024 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -48.19 73.79 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.065 1.346 . . . . 64.54 110.74 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 t -125.39 8.06 7.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.539 0.736 . . . . 72.43 111.63 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt 66.41 51.73 1.15 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.606 1.562 . . . . 62.42 110.961 170.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 63' ' ' ASN . 11.0 pt -123.97 154.35 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.242 0.617 . . . . 61.45 110.137 -171.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.92 131.93 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.421 1.488 . . . . 64.33 107.04 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.36 178.04 7.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.344 1.458 . . . . 60.21 108.961 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -139.08 122.37 17.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.805 -1.184 . . . . 74.44 108.387 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -138.58 147.02 42.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.858 0.863 . . . . 74.43 108.801 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -77.33 147.33 36.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.144 0.578 . . . . 73.05 110.898 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -71.69 164.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.072 -1.085 . . . . 74.03 108.072 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -117.7 -50.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.902 1.281 . . . . 75.05 110.078 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.593 ' CB ' HG21 ' A' ' 156' ' ' THR 0.343 3.1 ttm180 -116.98 -176.69 3.03 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 119.061 0.846 . . . . 74.11 111.779 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -149.71 145.98 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 107.924 -1.139 . . . . 45.03 107.924 170.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -118.4 156.11 29.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.42 1.088 . . . . 74.45 109.717 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.01 136.13 11.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.567 0.747 . . . . 72.05 108.986 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -145.02 160.96 40.54 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.896 -1.52 . . . . 70.24 106.896 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 148.59 22.74 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.903 -1.123 . . . . 72.52 108.407 173.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -143.9 154.07 42.96 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.955 1.302 . . . . 71.12 110.093 -163.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -153.9 154.73 34.4 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.047 -0.723 . . . . 72.11 109.047 154.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.38 -170.14 21.03 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.347 1.451 . . . . 73.42 110.672 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -86.53 125.43 33.76 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.674 1.19 . . . . 55.41 110.523 -171.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.11 165.85 10.93 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.94 -1.504 . . . . 71.21 106.94 171.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.8 mm -81.43 149.49 4.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.396 1.478 . . . . 72.01 108.146 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -127.45 79.9 1.92 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.722 2.009 . . . . 70.32 107.7 165.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.577 HG23 HG13 ' A' ' 140' ' ' VAL . 38.9 mt -61.81 130.98 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.623 -1.992 . . . . 73.13 105.623 150.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -114.5 162.94 16.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.28 -1.748 . . . . 75.55 106.28 157.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 p -135.61 169.96 16.71 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.591 -0.892 . . . . 65.34 108.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -38.38 55.57 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.678 -1.264 . . . . 63.3 111.877 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -0.98 7.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.493 1.517 . . . . 75.23 111.747 -172.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.6 mmt-85 61.49 24.33 14.45 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 126.936 2.094 . . . . 73.45 110.258 -167.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.441 ' CD ' ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -73.87 168.18 19.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.961 -1.126 . . . . 64.11 107.961 160.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 177.55 162.42 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.27 2.628 . . . . 64.54 107.812 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.671 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -147.18 177.26 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.945 2.098 . . . . 75.53 109.338 -174.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -145.67 74.94 1.41 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.177 0.513 . . . . 73.31 111.489 -167.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.436 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -141.56 163.57 32.58 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 119.522 -1.986 . . . . 75.14 112.271 -165.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 p -68.85 161.28 28.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.516 0.726 . . . . 72.13 110.696 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.09 14.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.422 0.897 . . . . 73.01 113.422 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.18 39.16 3.58 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.153 1.797 . . . . 75.51 110.8 159.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.436 ' CG ' HD22 ' A' ' 99' ' ' LEU . 3.4 t60 -84.99 125.88 69.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.674 -1.155 . . . . 74.22 109.451 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -63.6 114.77 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.21 3.274 . . . . 63.23 111.231 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.58 162.62 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.819 -1.178 . . . . 64.41 107.819 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -101.39 140.68 35.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.841 0.856 . . . . 71.23 109.151 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.49 164.07 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.996 0.918 . . . . 75.31 109.882 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.03 120.64 31.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.846 -1.168 . . . . 64.11 107.846 173.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.471 ' CD ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -99.38 81.27 2.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.862 -2.273 . . . . 72.22 104.862 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 m 56.45 17.61 3.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.206 1.002 . . . . 71.42 113.52 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.18 1.27 47.99 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.064 -1.022 . . . . 60.51 114.062 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.89 160.3 26.08 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 105.763 -1.94 . . . . 61.22 105.763 150.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.46 145.1 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.822 -0.807 . . . . 72.31 108.822 170.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD22 ' CD ' ' A' ' 109' ' ' LYS . 4.7 tp -142.06 170.9 14.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.986 1.315 . . . . 70.53 107.701 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -112.83 138.26 49.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.794 0.838 . . . . 72.44 108.844 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 pt -142.52 179.28 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.169 1.388 . . . . 71.34 108.81 171.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -72.04 132.06 43.74 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 107.597 -1.261 . . . . 53.34 107.597 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -43.23 -35.11 1.32 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.861 1.665 . . . . 64.42 113.163 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.4 67.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.817 1.247 . . . . 74.42 112.516 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.0 -31.91 56.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.033 -1.042 . . . . 71.33 111.266 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG11 ' A' ' 140' ' ' VAL . 7.4 t -76.57 62.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.124 1.769 . . . . 74.21 110.345 -173.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -86.72 -177.09 6.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.603 1.561 . . . . 61.01 108.534 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.82 0.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.859 2.064 . . . . 64.54 113.704 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.63 -13.43 80.04 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.366 -1.797 . . . . 61.52 112.479 167.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -124.3 170.15 11.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.839 1.819 . . . . 73.31 110.031 -166.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 139' ' ' GLU . 7.6 m-85 -112.86 155.62 24.34 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.391 1.476 . . . . 75.42 108.396 165.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.73 166.83 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.624 2.369 . . . . 74.03 107.589 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 112.26 22.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.85 1.26 . . . . 74.23 110.958 -166.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.48 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.6 pp -121.54 161.43 41.56 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 124.737 1.215 . . . . 75.0 113.191 -174.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.01 154.84 33.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.887 1.725 . . . . 70.0 109.732 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -117.91 -156.69 0.65 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.1 -1.444 . . . . 72.44 107.1 162.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -59.32 -57.75 11.63 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 122.986 0.514 . . . . 72.44 111.391 -166.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -121.52 0.48 9.95 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.522 0.934 . . . . 74.13 113.522 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -139.35 -173.96 3.74 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.504 1.522 . . . . 42.12 111.027 -160.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.4 149.38 15.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.51 1.124 . . . . 74.25 109.529 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -143.28 -178.32 5.8 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.996 2.118 . . . . 72.33 108.533 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 mt -118.39 165.81 13.42 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.277 1.031 . . . . 72.4 109.386 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 33.9 p-10 -153.96 147.87 25.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.89 1.276 . . . . 63.41 111.116 173.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 32.5 tt0 -97.38 148.36 23.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.345 1.858 . . . . 65.42 111.166 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.608 HG11 ' O ' ' A' ' 121' ' ' VAL . 18.4 t -87.19 2.17 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.725 0.639 . . . . 74.41 112.725 -160.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 pt 24.68 -88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 127.522 2.329 . . . . 73.11 116.112 171.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 124.55 35.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.493 1.517 . . . . 54.32 108.088 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -129.14 122.5 56.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.43 -0.581 . . . . 71.21 109.43 170.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.88 -167.96 2.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 127.351 2.26 . . . . 61.21 107.436 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -122.45 172.17 8.55 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.555 1.142 . . . . 74.12 109.76 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.36 161.81 22.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 130.565 3.546 . . . . 64.41 104.559 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.59 133.5 51.03 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.792 -1.558 . . . . 61.15 106.792 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -144.18 155.55 43.95 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.815 0.734 . . . . 72.53 111.587 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.39 47.21 0.75 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.535 0.607 . . . . 72.45 111.884 -169.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.44 -122.7 2.29 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.585 -0.697 . . . . 63.34 114.342 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -124.34 160.57 27.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.127 0.971 . . . . 74.11 109.491 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ALA . 11.6 pt -135.04 155.55 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.578 1.951 . . . . 74.34 108.239 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -138.87 168.52 19.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.522 1.929 . . . . 72.35 107.226 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -164.62 167.34 19.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.741 1.155 . . . . 75.24 109.921 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.3 tp -137.7 113.62 9.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.275 1.583 . . . . 75.1 115.275 -149.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.593 HG21 ' CB ' ' A' ' 76' ' ' ARG . 69.1 p -55.88 -50.85 69.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.427 1.491 . . . . 71.2 114.016 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.3 t 24.55 68.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 129.5 3.12 . . . . 64.13 112.012 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.3 -5.69 58.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.106 -1.406 . . . . 63.13 111.928 -168.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -47.08 74.29 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.52 2.328 . . . . 72.22 110.91 -175.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -125.83 1.34 7.4 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.863 0.69 . . . . 73.33 112.863 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . 0.482 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 6.9 m170 55.83 30.39 15.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.022 0.929 . . . . 75.22 111.81 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 p -151.49 154.9 37.46 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.065 1.302 . . . . 75.4 110.372 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 18.3 p90 -153.23 174.95 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.595 1.089 . . . . 72.02 111.542 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 mm -99.29 124.23 52.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 63.5 108.916 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -156.4 157.69 36.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.561 1.545 . . . . 54.53 108.742 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.37 -170.35 23.91 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.912 2.672 . . . . 74.42 107.953 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -89.71 167.28 13.02 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.639 -1.506 . . . . 61.35 111.346 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.19 -74.53 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.652 2.381 . . . . 73.11 114.132 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.77 -10.02 8.78 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.531 1.932 . . . . 52.03 112.541 171.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.82 165.85 29.57 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 122.673 1.152 . . . . 51.25 112.382 -168.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.671 ' CE1' HG23 ' A' ' 97' ' ' ILE . 14.7 m-85 -105.07 158.05 16.83 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.519 2.728 . . . . 73.0 105.943 172.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -87.78 108.62 19.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.186 -2.153 . . . . 74.31 105.186 169.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' A' ' 163' ' ' TYR . 16.3 m -120.75 178.5 2.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.427 1.091 . . . . 53.04 108.708 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -80.68 153.2 28.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.389 1.475 . . . . 43.34 110.277 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -137.41 -158.35 0.85 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.439 1.896 . . . . 73.5 107.737 167.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.237 0.417 1 C-N-CA 132.625 4.37 . . . . 54.22 104.758 -165.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' CB ' HD12 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.234 0.259 0 N-CA-C 108.257 -1.016 . . . . 64.2 108.257 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.461 ' HG ' ' HG2' ' A' ' 13' ' ' GLU . 15.0 tp -102.09 -16.67 16.34 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.599 1.333 . . . . 74.41 114.599 -150.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.72 160.57 0.15 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 130.799 3.639 . . . . 73.21 112.319 -161.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.514 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 8.9 t80 -80.59 -49.0 11.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.667 1.587 . . . . 65.23 111.076 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -93.97 70.57 3.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.364 -2.088 . . . . 71.1 105.364 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -139.58 116.93 8.5 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 104.747 -2.316 . . . . 74.51 104.747 -169.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.89 124.36 13.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.33 2.687 . . . . 35.34 111.774 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 59' ' ' ILE . 10.4 pt -97.0 10.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.382 0.882 . . . . 63.15 113.382 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.8 m-85 38.66 72.73 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.471 1.508 . . . . 74.34 112.612 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 157.57 0.43 Allowed 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.173 -1.047 . . . . 73.51 108.173 167.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -17.6 48.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.103 0.779 . . . . 72.42 113.103 -169.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.29 -52.93 4.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.557 1.143 . . . . 74.11 109.953 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.87 55.46 0.1 OUTLIER Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.025 1.298 . . . . 65.41 113.496 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -22.7 66.33 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.665 1.732 . . . . 71.42 115.373 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 16' ' ' TYR 0.292 47.8 mm 38.68 46.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 130.121 3.368 . . . . 62.3 112.409 -171.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.33 154.41 3.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.912 1.285 . . . . 74.24 108.013 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.06 124.69 23.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.409 1.084 . . . . 62.05 108.471 168.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -39.24 14.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 123.218 0.607 . . . . 65.52 111.081 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -53.53 -50.94 51.21 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.747 -0.941 . . . . 24.13 110.747 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.61 -38.88 77.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.263 1.025 . . . . 72.0 111.952 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -57.29 -56.13 25.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.012 0.925 . . . . 75.44 109.401 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 77' ' ' VAL . 71.7 t -64.74 -38.51 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.475 -0.784 . . . . 72.43 109.522 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -36.91 84.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.148 1.34 . . . . 34.05 110.514 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -40.79 60.63 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.554 1.141 . . . . 74.32 110.281 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.2 -43.99 26.98 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 124.687 1.195 . . . . 64.1 109.309 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.2 m-85 -60.0 -22.23 62.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.871 2.123 . . . . 70.42 113.063 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -100.0 -10.37 21.68 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.547 1.539 . . . . 75.11 112.058 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -65.36 1.02 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.962 -1.866 . . . . 75.02 105.962 163.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -82.83 41.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.686 3.194 . . . . 71.33 110.074 -167.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.33 -30.23 68.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.387 1.875 . . . . 64.41 110.2 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -69.64 -21.13 63.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.159 1.784 . . . . 70.11 112.534 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.28 6.32 48.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.652 1.581 . . . . 70.45 112.271 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.69 84.18 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.652 1.215 . . . . 64.54 109.645 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.48 120.6 24.68 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.243 -1.762 . . . . 64.2 106.243 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -88.62 157.55 18.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.76 -1.941 . . . . 75.33 105.76 155.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.03 178.47 8.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.232 -1.396 . . . . 60.45 107.232 164.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.22 -36.88 83.33 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.656 1.182 . . . . 62.41 110.527 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -14.07 33.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.149 1.38 . . . . 74.32 112.586 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.16 33.41 26.32 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.143 2.306 . . . . 53.03 111.067 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD1' ' HE3' ' A' ' 80' ' ' LYS . 3.4 t80 -79.95 -90.97 0.05 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.036 1.334 . . . . 71.45 108.46 -171.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.19 128.16 2.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.087 -2.005 . . . . 60.02 108.087 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -139.99 168.51 19.64 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.719 1.208 . . . . 74.32 109.026 166.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 33' ' ' PHE . 14.2 mt -149.22 143.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.543 2.337 . . . . 62.43 105.51 168.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.38 130.48 37.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.369 1.468 . . . . 52.34 108.295 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.39 -2.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.907 0.883 . . . . 72.04 112.596 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.88 -20.38 52.9 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.535 1.061 . . . . 63.13 115.37 -169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -63.15 -20.52 65.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 128.111 2.564 . . . . 75.41 114.045 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.16 -20.16 62.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.662 0.785 . . . . 72.13 111.357 172.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.14 3.29 1.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.001 2.121 . . . . 72.45 113.685 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.05 138.42 15.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.381 1.472 . . . . 64.23 108.794 172.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.84 167.52 10.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.463 1.125 . . . . 75.01 110.635 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 74' ' ' ILE . 3.5 tt -135.38 160.28 40.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 125.714 1.606 . . . . 71.51 108.041 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -81.77 132.88 35.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.312 -1.736 . . . . 75.11 106.312 168.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.37 -174.08 3.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.963 -0.754 . . . . 71.32 108.963 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -138.1 139.54 39.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.401 -1.703 . . . . 73.0 106.401 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.52 107.71 19.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.529 -1.286 . . . . 71.43 107.529 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 3.7 ttpm? -56.49 -23.71 41.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.869 1.268 . . . . 73.13 111.607 173.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -23.06 5.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.473 1.909 . . . . 75.44 112.772 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -149.6 14.27 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.325 1.05 . . . . 60.32 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 37.7 53.82 1.48 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.217 1.807 . . . . 51.31 111.838 -163.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.2 pt -105.98 155.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.707 0.803 . . . . 62.5 109.366 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.7 mm -85.04 130.72 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.829 -1.545 . . . . 62.2 106.829 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.33 166.97 23.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.219 1.007 . . . . 74.45 112.238 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.89 113.0 25.24 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.732 2.013 . . . . 71.15 107.7 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -125.0 167.21 15.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.959 0.903 . . . . 74.24 109.824 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -106.22 177.36 4.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.4 0.68 . . . . 71.01 110.228 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 59' ' ' ILE . 64.4 mt -113.49 153.55 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 105.423 -2.066 . . . . 65.13 105.423 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.34 -58.52 1.7 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.799 1.239 . . . . 74.23 108.435 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.492 ' CB ' HG21 ' A' ' 156' ' ' THR 0.25 14.7 mtm180 -128.1 159.34 35.4 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.227 1.411 . . . . 71.51 112.756 -174.086 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 29' ' ' VAL . 3.2 m -133.97 165.66 31.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.385 1.474 . . . . 71.43 108.149 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.593 ' HE1' ' CG2' ' A' ' 156' ' ' THR . 68.4 m95 -139.07 163.73 31.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.926 0.49 . . . . 74.42 111.283 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.04 135.87 31.48 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.083 0.953 . . . . 64.11 110.592 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tppp? -142.95 141.45 31.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.031 -1.84 . . . . 70.12 106.031 162.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -86.51 152.38 22.7 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.689 0.795 . . . . 70.11 109.961 -163.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 110.21 3.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.913 -0.773 . . . . 63.25 108.913 169.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.95 46.35 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.394 0.543 . . . . 70.03 111.849 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.635 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.75 121.87 25.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.787 -0.82 . . . . 53.21 108.787 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.18 172.58 7.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.151 -1.796 . . . . 75.01 106.151 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 89' ' ' ILE . 9.2 mm -79.15 160.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.418 1.887 . . . . 63.43 107.912 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -137.27 79.64 1.76 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.1 -1.444 . . . . 71.3 107.1 157.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.629 HG23 HG13 ' A' ' 140' ' ' VAL . 48.4 mt -67.12 135.5 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 104.456 -2.424 . . . . 62.44 104.456 158.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -118.22 175.36 5.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.244 1.418 . . . . 73.15 107.311 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -142.33 176.84 8.68 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.919 1.236 . . . . 71.24 112.654 164.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -53.66 -35.17 60.74 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.307 1.043 . . . . 74.12 111.854 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.85 11.0 1.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.785 2.034 . . . . 73.34 111.677 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 47.37 33.54 2.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.153 1.781 . . . . 71.15 111.394 -166.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -83.48 168.35 16.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.818 -1.178 . . . . 65.21 107.818 165.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 179.24 163.55 0.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.5 1.92 . . . . 75.12 107.666 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.592 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -139.65 172.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.844 2.057 . . . . 63.53 110.201 -174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -137.81 99.67 3.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.34 1.856 . . . . 72.1 107.118 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.88 167.5 28.12 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.756 -0.59 . . . . 72.11 110.347 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 p -75.84 162.38 28.19 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.317 -0.864 . . . . 54.42 110.697 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.74 38.74 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.678 0.791 . . . . 73.25 112.736 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -157.47 37.04 0.28 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.963 0.801 . . . . 73.31 110.065 149.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -75.15 137.02 72.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 119.721 -1.862 . . . . 71.3 110.453 -174.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.35 121.92 9.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.229 2.619 . . . . 63.13 111.483 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.7 -177.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.914 1.286 . . . . 65.44 109.064 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -128.32 137.06 51.77 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.174 0.99 . . . . 73.4 108.894 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 127' ' ' ILE . 1.9 pt -141.82 167.6 15.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.511 1.124 . . . . 60.54 108.564 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 143.16 34.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.499 0.666 . . . . 62.0 111.797 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -115.14 53.99 0.8 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.384 1.074 . . . . 72.22 108.748 163.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER 96.36 -0.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 130.856 3.662 . . . . 75.53 114.328 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.75 -11.41 3.69 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.714 -0.955 . . . . 63.12 110.714 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -86.37 161.32 18.75 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 125.419 1.488 . . . . 72.35 112.713 161.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.43 HG22 ' CE2' ' A' ' 128' ' ' TYR . 62.5 t -106.49 106.64 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.036 1.334 . . . . 71.43 108.962 -166.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.59 158.58 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.214 1.006 . . . . 71.53 108.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -114.44 121.05 42.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.615 1.966 . . . . 72.23 107.037 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 pt -140.71 178.32 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.293 1.037 . . . . 73.24 109.826 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -77.37 140.39 39.93 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.087 1.755 . . . . 71.21 109.867 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.38 -29.81 61.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.198 1.399 . . . . 73.11 112.384 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -31.49 72.19 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.93 -0.481 . . . . 73.11 111.154 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -25.87 42.46 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.507 1.123 . . . . 75.44 111.316 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -72.75 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.3 2.24 . . . . 74.51 111.416 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.51 -178.35 5.78 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.933 -1.104 . . . . 61.24 108.962 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.18 -2.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 129.565 3.146 . . . . 72.44 114.569 166.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.88 -15.92 57.13 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.285 -1.509 . . . . 60.13 111.734 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.35 140.69 51.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.473 1.636 . . . . 73.13 107.954 -160.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.71 117.68 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.643 1.177 . . . . 65.23 107.944 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 107' ' ' ILE . 5.8 tt -82.88 142.99 12.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.044 -0.725 . . . . 74.32 109.044 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 113' ' ' VAL . 3.2 m-85 -74.21 121.43 21.22 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.51 -0.922 . . . . 73.24 108.51 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.418 HG23 HG23 ' A' ' 127' ' ' ILE . 2.7 pp -120.93 145.61 41.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.696 1.199 . . . . 63.02 110.296 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 148.01 47.39 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.999 1.799 . . . . 70.22 107.516 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -120.93 -169.81 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.346 -1.724 . . . . 62.45 106.346 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -34.53 -72.24 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.922 1.689 . . . . 74.31 112.17 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.48 1.31 10.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.655 1.182 . . . . 54.52 113.217 171.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.2 p -130.47 153.8 48.43 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.967 1.307 . . . . 72.14 112.263 -165.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 tp -84.33 147.46 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.163 -1.421 . . . . 71.4 107.163 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -147.7 -174.86 4.66 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.877 2.071 . . . . 65.21 107.693 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.0 mt -131.25 159.98 36.23 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.354 1.462 . . . . 65.4 108.007 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -149.37 159.0 44.65 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.886 0.874 . . . . 72.24 110.122 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.83 140.27 29.87 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.745 2.418 . . . . 73.05 109.975 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.629 HG13 HG23 ' A' ' 89' ' ' ILE . 49.8 t -81.89 -3.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.212 1.405 . . . . 74.11 113.461 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.3 pt 25.05 -89.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 127.494 2.318 . . . . 72.24 115.6 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -89.82 105.4 17.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.821 1.648 . . . . 73.1 107.844 170.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.81 148.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.135 -1.061 . . . . 62.42 108.135 154.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.3 -162.63 0.76 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.359 2.664 . . . . 70.22 107.661 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -131.26 162.12 30.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.162 1.785 . . . . 64.5 109.561 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.63 -169.16 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.601 1.561 . . . . 74.12 109.455 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.01 132.47 41.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.991 2.116 . . . . 74.31 106.535 161.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.95 143.31 36.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.82 1.191 . . . . 71.31 110.489 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.53 30.74 1.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.969 0.729 . . . . 55.44 112.969 -163.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.59 -136.03 4.21 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.593 1.092 . . . . 54.44 111.739 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -99.25 170.06 8.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.384 -1.068 . . . . 74.02 109.824 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.44 HD12 ' CB ' ' A' ' 8' ' ' ALA . 2.3 pt -118.34 -73.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.037 -1.468 . . . . 73.53 107.037 173.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 78.98 170.29 0.18 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.535 2.334 . . . . 74.12 107.553 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -162.91 153.96 17.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.425 1.49 . . . . 51.54 107.439 -170.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -123.04 141.21 52.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.457 1.103 . . . . 74.24 111.133 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.593 ' CG2' ' HE1' ' A' ' 78' ' ' TRP . 44.7 p -79.49 -70.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.751 0.657 . . . . 74.35 110.183 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t 43.11 73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.664 2.386 . . . . 51.34 111.844 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.05 -0.48 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 74.33 113.314 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.94 -38.72 83.2 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.599 -0.519 . . . . 72.24 109.599 -166.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 5.5 t30 -138.52 7.98 2.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.871 1.269 . . . . 71.41 111.99 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.5 m170 54.02 29.32 9.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.505 1.122 . . . . 74.12 111.424 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -142.91 144.77 32.56 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.628 -1.92 . . . . 73.33 109.135 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.1 p90 -148.8 167.17 26.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.067 0.765 . . . . 73.31 113.067 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.2 mm -85.85 137.19 21.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 106.407 -1.701 . . . . 71.34 106.407 164.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -153.87 143.08 21.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.801 1.24 . . . . 65.5 108.072 162.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.55 -173.32 22.87 Favored Glycine 0 N--CA 1.462 0.431 0 C-N-CA 123.881 0.753 . . . . 54.35 111.585 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -90.95 167.87 12.09 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.47 -1.606 . . . . 72.25 110.261 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.08 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.542 2.337 . . . . 75.31 114.201 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.529 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 43.0 mt-10 -121.77 -7.94 8.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.558 1.143 . . . . 72.34 112.339 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.26 170.33 14.7 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 122.844 1.247 . . . . 72.01 111.874 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.592 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -120.72 147.91 44.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.968 2.507 . . . . 74.31 106.98 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -90.79 103.94 16.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.542 -1.651 . . . . 73.22 106.542 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.24 177.88 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.398 1.479 . . . . 51.51 109.176 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.8 t -67.34 144.4 55.86 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.47 2.708 . . . . 72.04 109.77 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.683 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -123.96 166.13 16.24 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.681 2.793 . . . . 75.21 107.013 162.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 106.613 -1.625 . . . . 61.12 106.613 160.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 108.102 -1.073 . . . . 62.13 108.102 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.41 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 62.54 110.508 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.05 152.97 43.78 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.763 -0.653 . . . . 70.53 109.804 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.6 t80 -53.81 -31.12 47.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.449 1.5 . . . . 75.02 112.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -103.93 14.67 30.28 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.753 1.221 . . . . 71.22 113.459 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.34 119.96 79.28 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 106.013 -1.847 . . . . 75.33 106.013 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.0 139.79 75.43 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-N 120.427 1.188 . . . . 53.11 112.437 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.0 pt -90.21 140.3 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.022 -1.103 . . . . 72.31 108.022 161.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -102.43 83.26 2.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.409 -1.7 . . . . 73.3 106.409 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.3 164.59 18.08 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.308 0.575 . . . . 74.33 109.987 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.5 t -56.02 -39.34 71.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.095 0.958 . . . . 73.31 110.216 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -33.37 34.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.265 0.939 . . . . 55.53 111.089 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.68 46.07 2.37 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.865 0.745 . . . . 62.41 112.271 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -35.9 69.43 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.68 1.24 . . . . 70.45 111.72 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.4 mm 45.87 86.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 128.283 2.633 . . . . 74.15 107.325 -163.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.72 152.0 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.63 -1.618 . . . . 73.52 106.63 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.29 135.24 56.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.283 1.833 . . . . 65.13 109.351 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.558 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -50.9 -54.81 8.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.825 -1.176 . . . . 70.44 107.825 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -55.49 -45.19 84.89 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.944 -1.263 . . . . 74.35 109.944 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -71.83 -42.96 66.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.077 1.351 . . . . 73.03 112.599 -173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -52.4 -49.26 64.82 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 122.038 0.923 . . . . 64.12 109.552 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 153' ' ' TYR . 92.7 t -72.79 -42.1 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.836 -1.075 . . . . 74.13 109.886 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.24 -38.36 73.67 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.332 0.515 . . . . 72.1 111.289 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.8 -43.14 76.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.276 1.03 . . . . 74.41 109.347 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.39 -47.09 62.46 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 117.491 -1.242 . . . . 74.03 108.767 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.6 -38.2 66.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.447 1.476 . . . . 74.01 110.994 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -78.05 -30.82 50.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.837 -1.078 . . . . 74.41 111.781 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.5 ttmm -78.97 -63.12 1.49 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.742 -1.577 . . . . 72.0 106.742 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.33 39.77 0.53 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.266 2.627 . . . . 72.45 109.732 -172.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.81 -38.29 67.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 120.533 -1.354 . . . . 61.03 110.784 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -74.47 -12.85 60.6 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.198 0.814 . . . . 73.05 113.198 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -93.95 0.01 55.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.842 1.257 . . . . 74.52 112.32 174.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.59 95.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 119.638 1.108 . . . . 72.44 108.099 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -78.94 147.75 32.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.152 -1.425 . . . . 54.24 107.152 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 130.75 48.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.043 -2.577 . . . . 62.11 104.043 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 144.66 35.71 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.094 -1.817 . . . . 73.43 106.094 171.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.5 -40.26 86.46 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.124 1.769 . . . . 75.41 112.196 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.98 -5.8 28.83 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.214 1.006 . . . . 73.23 112.27 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.77 56.41 1.16 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 126.731 2.11 . . . . 50.02 110.24 160.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -120.33 -97.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.338 1.055 . . . . 41.14 109.048 -172.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.11 137.71 3.02 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.986 1.755 . . . . 62.42 109.855 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -150.01 170.55 18.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.185 0.992 . . . . 72.31 111.448 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 mt -149.26 144.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.085 2.154 . . . . 71.52 106.608 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 122.53 31.06 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.248 1.819 . . . . 60.4 108.889 168.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 54' ' ' ASN . 2.2 pp -135.19 14.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.766 1.227 . . . . 61.24 111.876 -174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 17.72 0.14 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.082 1.801 . . . . 73.44 114.69 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -119.75 -13.1 9.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 129.873 3.269 . . . . 71.13 111.022 -177.005 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.29 -20.92 65.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.361 0.982 . . . . 73.4 110.903 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.1 19.19 2.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.571 1.948 . . . . 74.24 113.068 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.33 148.36 12.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.32 1.448 . . . . 61.45 107.52 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -115.67 140.85 48.81 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.682 -0.858 . . . . 72.51 108.682 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.49 158.65 18.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.555 1.542 . . . . 75.23 107.71 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -66.01 145.21 56.14 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.968 -1.123 . . . . 71.12 107.968 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.72 -179.29 5.96 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.735 1.614 . . . . 54.5 107.795 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.449 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -151.98 121.85 7.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.842 -1.161 . . . . 72.54 109.417 173.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.84 114.63 9.1 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.507 1.123 . . . . 63.32 108.93 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 162' ' ' THR . 18.0 mttt -62.35 -21.25 65.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.236 0.828 . . . . 74.12 113.236 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -37.8 -47.16 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.12 2.168 . . . . 64.02 109.807 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.4 17.71 2.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.53 1.132 . . . . 74.43 110.575 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 48.93 49.33 19.46 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.027 1.285 . . . . 62.41 112.222 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.74 149.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.544 1.538 . . . . 75.44 107.934 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.77 144.49 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.595 -1.261 . . . . 74.52 107.595 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -148.96 -177.58 5.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.194 2.197 . . . . 64.04 111.881 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.01 162.22 13.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.904 2.082 . . . . 73.31 109.991 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 149.95 22.69 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.909 -1.119 . . . . 74.14 111.572 156.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -78.9 162.54 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.974 -0.751 . . . . 75.13 108.974 159.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -94.09 168.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.208 1.803 . . . . 72.13 106.756 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.8 mm? -117.19 -58.31 2.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.265 1.826 . . . . 74.03 108.94 168.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -128.76 155.98 44.26 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.757 -0.59 . . . . 62.15 110.873 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -123.39 163.4 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 126.179 1.791 . . . . 55.21 108.331 173.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.35 176.72 8.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.84 1.656 . . . . 65.11 109.631 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -169.08 148.14 3.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.972 1.709 . . . . 75.44 109.168 163.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE3' HD11 ' A' ' 152' ' ' ILE . 35.2 pttt -142.43 169.99 16.55 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.605 1.562 . . . . 72.33 107.538 156.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 151' ' ' HIS . 80.5 tttt -91.41 152.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.711 -0.618 . . . . 72.33 109.408 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 152' ' ' ILE . 31.5 t80 -146.93 147.89 31.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.439 0.696 . . . . 74.22 110.103 -170.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -157.7 126.84 5.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.444 -1.317 . . . . 73.22 107.444 155.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.52 -177.78 42.34 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.052 0.842 . . . . 65.31 112.56 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.89 127.47 32.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.03 -0.688 . . . . 74.11 110.86 171.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.96 157.98 17.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.848 -1.168 . . . . 74.13 107.848 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' HIS . 2.8 mm -78.57 133.68 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.217 -1.401 . . . . 74.33 107.217 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 98' ' ' THR . 12.7 ttmt -119.74 84.52 2.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.005 1.383 . . . . 55.01 107.645 164.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.67 130.39 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.143 -2.169 . . . . 73.21 105.143 154.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 m -100.15 -175.71 3.02 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 105.979 -1.86 . . . . 63.12 105.979 161.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -146.95 170.29 17.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.654 1.982 . . . . 74.2 108.716 165.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -56.92 -28.1 61.68 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.169 1.349 . . . . 73.54 112.433 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -72.3 3.4 4.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.623 0.971 . . . . 54.54 113.623 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 57.05 18.8 4.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.68 1.592 . . . . 72.32 111.591 -164.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 160.72 32.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.447 -1.686 . . . . 74.31 106.447 161.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.83 164.19 5.11 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.47 2.308 . . . . 62.12 106.857 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.502 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.5 pt -146.77 170.15 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 125.512 1.525 . . . . 74.33 108.521 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.476 HG23 ' HE3' ' A' ' 88' ' ' LYS 0.358 0.0 OUTLIER -151.63 96.49 2.26 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 126.624 1.97 . . . . 54.05 113.3 -175.47 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.532 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -161.79 179.4 8.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.153 1.781 . . . . 74.21 110.291 -166.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 p -66.72 166.92 12.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.959 0.885 . . . . 74.43 110.837 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.408 ' HA ' HG13 ' A' ' 87' ' ' ILE . 1.5 p-80 -70.39 -14.13 62.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.533 -0.729 . . . . 73.15 112.239 175.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -125.15 37.88 4.3 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.741 1.616 . . . . 44.12 111.566 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.683 ' ND1' ' HB2' ' A' ' 118' ' ' ALA . 1.1 p-80 -76.77 141.74 68.94 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.076 -0.964 . . . . 64.24 108.487 164.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -70.92 127.24 13.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.308 3.339 . . . . 65.03 113.525 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 121' ' ' VAL . 30.0 m -115.39 -177.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.279 1.831 . . . . 65.04 110.685 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -131.45 126.87 36.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.986 2.114 . . . . 70.05 108.502 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.51 163.02 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.244 0.929 . . . . 72.45 109.967 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.56 104.79 10.4 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.019 0.914 . . . . 62.14 110.612 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -86.01 79.85 9.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 104.248 -2.501 . . . . 74.41 104.248 161.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 55.45 19.65 3.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.428 1.269 . . . . 73.11 114.428 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.79 -0.89 41.88 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.168 -0.958 . . . . 74.55 113.642 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -91.66 129.11 37.69 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.075 -2.194 . . . . 75.33 105.075 156.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.24 130.37 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 60.43 108.885 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.42 148.44 42.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.892 0.877 . . . . 75.21 110.476 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -103.72 123.83 47.76 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.352 1.461 . . . . 71.51 111.289 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.51 -178.34 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.318 1.447 . . . . 74.54 111.325 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -86.27 145.38 26.97 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.634 1.974 . . . . 65.13 109.336 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.683 ' HB2' ' ND1' ' A' ' 103' ' ' HIS . . . -39.6 -51.75 2.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.228 2.211 . . . . 73.41 112.245 170.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -56.12 -21.43 22.34 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.521 1.528 . . . . 62.12 114.604 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.3 mtt -93.48 -19.21 21.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.279 1.032 . . . . 71.54 111.387 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 105' ' ' VAL . 11.3 t -78.88 62.0 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 127.677 2.391 . . . . 74.32 109.277 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.76 -176.95 5.66 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.324 -0.86 . . . . 74.21 109.987 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.52 -11.47 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 126.413 1.885 . . . . 71.55 113.701 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.69 -3.11 71.59 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.536 -1.147 . . . . 62.5 112.965 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -123.98 145.7 49.01 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.956 1.878 . . . . 73.34 108.798 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -112.95 114.52 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.907 1.283 . . . . 72.14 107.682 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.5 tt -89.46 134.5 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.8 1.24 . . . . 63.3 108.944 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -69.72 107.26 3.4 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.837 -0.801 . . . . 64.42 108.837 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.46 157.81 39.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.909 1.284 . . . . 73.25 110.281 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.35 152.28 66.16 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.818 1.012 . . . . 65.3 110.13 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -119.82 178.82 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 156.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -23.81 -67.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.273 3.029 . . . . 75.25 114.888 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -120.88 -13.4 8.64 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.166 0.894 . . . . 63.13 113.389 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -139.07 168.66 19.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.253 -0.905 . . . . 52.21 110.834 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -78.33 156.89 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.778 -0.823 . . . . 65.33 108.778 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 -176.14 4.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.118 2.967 . . . . 71.11 105.441 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 mp -113.61 167.58 10.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.572 1.949 . . . . 70.44 109.07 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -157.54 154.27 28.31 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.676 -1.602 . . . . 70.43 106.676 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.93 141.34 28.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.699 1.2 . . . . 61.21 108.58 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.594 HG21 HG12 ' A' ' 121' ' ' VAL . 11.5 t -67.6 -22.2 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 114.735 1.384 . . . . 72.31 114.735 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.2 pt 50.52 -49.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 130.115 3.366 . . . . 74.42 118.013 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.78 133.19 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 131.466 3.906 . . . . 73.24 107.773 -161.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.64 109.31 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.379 -0.6 . . . . 75.23 109.379 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -151.11 -175.71 5.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.369 1.068 . . . . 61.11 108.969 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 134.65 47.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.473 1.109 . . . . 55.21 108.102 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.48 -176.14 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.811 -1.181 . . . . 65.21 107.811 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.71 155.93 30.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.419 -1.326 . . . . 74.54 107.419 152.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -147.6 162.0 40.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.065 0.946 . . . . 70.24 108.649 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.87 78.36 0.33 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.055 -1.461 . . . . 64.51 107.055 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.85 25.59 0.2 Allowed Glycine 0 N--CA 1.474 1.227 0 N-CA-C 118.966 2.346 . . . . 73.31 118.966 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 71.8 m80 61.13 159.78 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.403 2.281 . . . . 64.2 111.813 -167.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.691 HD11 ' HE3' ' A' ' 80' ' ' LYS . 17.5 pt -145.7 155.26 13.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.638 1.575 . . . . 75.12 108.594 -174.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.696 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.42 168.68 26.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.881 0.472 . . . . 74.14 111.199 171.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -146.21 162.79 37.27 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.727 2.811 . . . . 65.43 106.726 -173.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.15 153.96 34.04 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.578 -1.326 . . . . 72.34 112.162 -163.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 -38.78 10.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.057 -0.974 . . . . 74.34 113.339 -162.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.257 2.1 t 22.89 64.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 129.567 3.147 . . . . 65.2 113.487 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.412 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.9 pt-20 -78.15 1.63 20.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.241 -0.912 . . . . 72.51 112.453 -169.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -89.6 -48.27 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.638 2.775 . . . . 73.0 109.298 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -132.64 -3.61 3.31 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.103 0.779 . . . . 73.13 113.103 -173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 69.03 8.44 6.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.143 1.377 . . . . 74.44 113.982 161.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.459 ' CG2' ' HE2' ' A' ' 64' ' ' LYS . 39.1 p -140.77 158.06 44.52 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.389 2.276 . . . . 75.42 107.248 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -144.86 -175.68 4.77 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.731 -1.23 . . . . 72.23 110.77 172.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.96 111.95 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.853 1.261 . . . . 73.11 108.081 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.47 158.47 44.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.131 1.373 . . . . 71.34 108.496 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.15 -158.06 25.15 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 107.379 -2.288 . . . . 74.41 107.379 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -112.32 172.39 6.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.017 1.408 . . . . 72.14 111.212 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.58 -69.43 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.867 3.267 . . . . 72.41 114.164 -174.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -122.89 -11.0 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.783 2.033 . . . . 61.22 113.694 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.88 159.54 3.17 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 122.533 1.074 . . . . 73.11 112.119 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 97' ' ' ILE . 26.5 m-85 -104.38 156.1 18.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.752 2.021 . . . . 72.45 109.26 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -89.27 79.89 6.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.194 1.798 . . . . 73.23 107.599 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -104.97 176.8 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.58 -1.267 . . . . 74.11 107.58 -171.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.16 155.63 38.27 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.008 2.123 . . . . 73.21 111.049 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.56 39.78 1.17 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.05 2.54 . . . . 72.54 108.605 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 108.326 -0.99 . . . . 64.33 108.326 179.497 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 N-CA-C 108.503 -0.925 . . . . 75.14 108.503 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.77 160.2 30.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.072 1.749 . . . . 75.32 109.802 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.24 149.7 44.32 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.802 -0.444 . . . . 71.2 109.802 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -44.45 -39.51 4.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.903 1.681 . . . . 74.44 113.549 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -97.22 7.8 45.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.388 1.075 . . . . 74.01 113.088 -166.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.25 121.73 84.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.517 -1.29 . . . . 71.33 107.517 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.11 141.92 95.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.569 1.239 . . . . 61.44 112.336 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 pt -96.38 -8.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.369 0.877 . . . . 71.54 113.369 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 54.63 69.33 0.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.479 1.133 . . . . 75.35 110.075 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.3 mt -55.1 160.58 2.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.7 -0.682 . . . . 74.55 109.595 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -53.35 -40.54 64.99 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.736 0.814 . . . . 63.41 109.755 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.01 -37.38 84.67 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.265 1.026 . . . . 75.11 112.786 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.68 41.15 7.38 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.065 -1.022 . . . . 55.11 110.548 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.77 -11.95 61.26 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.786 0.835 . . . . 74.35 113.192 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.9 mm 40.57 70.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.97 2.908 . . . . 61.54 109.112 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.83 149.83 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 112.82 -1.991 . . . . 74.14 107.928 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.26 135.37 47.42 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.791 1.236 . . . . 73.24 109.52 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.69 -4.24 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.221 1.809 . . . . 61.4 114.556 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.62 -9.86 12.15 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-O 116.769 -2.129 . . . . 72.02 113.488 165.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -78.33 -49.71 13.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.278 2.039 . . . . 75.44 109.799 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -39.6 -54.88 1.95 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.202 1.801 . . . . 75.43 109.797 165.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.495 ' CG1' HG21 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -73.16 -30.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.976 -1.465 . . . . 73.41 110.379 -174.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.12 -31.83 73.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.512 -1.368 . . . . 72.21 111.125 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -52.2 61.09 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.361 0.664 . . . . 74.4 109.478 168.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -66.13 -44.18 84.96 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 117.57 -1.205 . . . . 62.33 109.24 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -54.41 -39.56 67.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 121.876 2.126 . . . . 75.42 112.786 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -27.33 56.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.74 -1.124 . . . . 73.12 111.509 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 3.8 mtpt -86.39 -59.93 2.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.456 -1.683 . . . . 62.44 106.456 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 3.8 m-30 -88.98 39.93 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.762 2.825 . . . . 73.25 108.769 -168.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.59 -35.09 71.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.598 -1.314 . . . . 73.4 112.089 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -31.11 72.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 52.41 112.816 172.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 m -79.56 -9.44 59.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.15 1.78 . . . . 53.32 111.246 -175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.05 102.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.373 0 N-CA-C 106.554 -1.647 . . . . 73.25 106.554 168.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.81 167.27 12.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.389 -1.337 . . . . 74.24 107.389 158.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 145.64 45.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.212 -2.144 . . . . 55.12 105.212 167.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -78.3 168.83 19.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.29 -1.744 . . . . 75.13 106.29 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -33.09 74.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.496 0.718 . . . . 61.41 110.51 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.14 -0.35 18.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.426 0.899 . . . . 74.32 113.426 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.29 17.87 51.51 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 126.023 1.773 . . . . 44.11 113.259 161.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.96 -95.35 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.461 1.905 . . . . 74.43 109.974 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.51 129.07 1.41 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.783 -1.727 . . . . 63.13 108.783 -167.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -137.75 157.99 45.3 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 124.402 0.707 . . . . 71.33 109.487 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mt -139.36 141.83 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 104.97 -2.234 . . . . 74.35 104.97 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.38 137.28 32.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.678 0.791 . . . . 64.42 109.697 167.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.56 17.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.402 1.481 . . . . 65.24 112.748 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.97 -38.01 10.04 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.259 -0.745 . . . . 73.54 113.517 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -78.17 -6.23 54.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.202 1.501 . . . . 73.33 113.763 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 57' ' ' ILE . 56.6 mm-40 -64.35 -26.96 68.7 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.361 1.437 . . . . 74.23 110.323 168.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 m120 58.76 -4.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.971 2.108 . . . . 73.32 114.318 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' ' C ' ' A' ' 55' ' ' GLU . 93.5 mt -47.8 132.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 128.234 2.614 . . . . 55.05 108.058 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.75 150.57 22.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.255 1.026 . . . . 73.22 110.192 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.8 150.96 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.91 2.084 . . . . 51.34 107.014 177.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' O ' HD13 ' A' ' 59' ' ' ILE . 1.1 mtpt -61.77 120.7 11.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.844 -0.799 . . . . 74.22 108.844 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -114.18 -179.49 3.65 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.77 1.228 . . . . 73.44 108.505 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.4 146.82 33.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.291 -1.374 . . . . 62.11 107.291 159.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.4 112.83 24.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.368 0.531 . . . . 71.21 109.952 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.38 -24.1 67.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.184 0.994 . . . . 73.42 112.384 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.7 -43.37 5.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.725 2.41 . . . . 61.12 111.733 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.96 18.88 1.79 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.247 1.019 . . . . 70.33 111.521 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp 39.72 66.12 0.62 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.312 2.245 . . . . 62.4 112.056 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 pt -121.02 156.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.958 1.703 . . . . 74.12 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.2 mm -86.57 126.18 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 126.989 2.116 . . . . 63.41 106.631 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -140.46 171.18 14.5 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.084 1.753 . . . . 71.23 107.842 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -112.76 141.1 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.975 1.71 . . . . 72.33 107.43 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 151.6 38.11 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.323 -0.861 . . . . 61.34 109.385 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -79.2 173.73 12.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.625 -0.88 . . . . 75.02 108.625 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.8 151.74 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.058 -1.46 . . . . 54.41 107.058 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.1 mm? -106.29 -41.93 5.19 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 117.645 -1.169 . . . . 75.12 110.385 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtm-85 -140.08 149.69 43.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.433 1.469 . . . . 70.15 111.427 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -106.97 155.9 7.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.451 1.501 . . . . 70.04 108.54 170.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -130.74 150.26 52.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.0 1.32 . . . . 74.33 109.045 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -151.84 140.64 20.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.973 0.909 . . . . 71.04 110.208 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -153.92 163.75 39.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.608 1.163 . . . . 73.31 108.81 163.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -92.37 139.68 30.35 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 120.808 -1.182 . . . . 73.31 110.148 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -134.46 168.36 19.08 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.327 1.451 . . . . 70.13 109.901 -165.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.75 109.09 1.6 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.195 -0.907 . . . . 72.21 111.338 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.82 -173.53 36.53 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.256 1.389 . . . . 74.34 112.49 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -86.64 109.33 19.09 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.314 -0.521 . . . . 70.04 111.336 -171.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.75 168.65 19.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.77 -0.826 . . . . 61.32 108.77 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.12 130.35 35.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.06 2.144 . . . . 60.13 108.185 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -115.8 85.57 2.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.09 -1.448 . . . . 71.43 107.09 161.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -66.26 120.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 104.008 -2.59 . . . . 64.13 104.008 153.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -104.5 164.58 11.65 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.469 -1.678 . . . . 74.53 106.469 161.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.5 p -134.03 170.24 15.94 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.05 -1.031 . . . . 65.24 109.758 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -65.06 -27.72 68.98 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.109 1.764 . . . . 74.23 110.46 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -68.25 1.04 3.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.927 1.691 . . . . 75.12 111.536 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 55.82 29.67 14.42 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.085 2.154 . . . . 74.54 111.785 -172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt-85 -75.84 168.49 19.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 118.224 -1.39 . . . . 73.15 109.085 162.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.6 169.26 18.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.916 1.385 . . . . 75.52 108.573 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.567 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.2 pt -146.16 169.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.959 2.104 . . . . 64.15 110.804 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 m -146.86 98.16 3.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.082 1.353 . . . . 64.05 110.454 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.71 174.93 13.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.065 1.746 . . . . 70.14 111.098 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 167.58 10.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.229 1.012 . . . . 74.4 110.935 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -70.14 -31.86 69.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.03 -0.73 . . . . 62.01 109.03 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HA ' HD22 ' A' ' 117' ' ' ASN . 3.0 t70 -101.44 38.87 1.51 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 65.34 112.493 -168.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -107.91 143.52 27.5 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 120.801 -1.187 . . . . 74.43 110.882 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.46 125.65 12.01 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.986 3.124 . . . . 70.02 112.368 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.64 168.83 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.743 0.817 . . . . 74.51 108.866 168.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.32 140.68 37.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.351 0.66 . . . . 74.42 110.554 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.55 158.45 37.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.332 1.453 . . . . 72.32 108.275 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.6 p -88.78 134.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.122 0.963 . . . . 52.51 108.962 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 77.33 1.03 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.368 -1.716 . . . . 64.1 106.368 161.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 59.32 21.17 9.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 70.45 113.069 167.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.34 -19.84 5.94 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.211 -0.772 . . . . 65.02 111.693 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -87.15 141.11 28.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 104.4 -2.444 . . . . 73.54 104.4 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -86.72 139.6 17.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.677 -1.264 . . . . 71.34 108.051 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.92 159.95 37.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.953 -1.499 . . . . 54.11 106.953 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -126.18 112.2 15.51 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.333 1.053 . . . . 55.3 109.573 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.65 174.83 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.511 1.124 . . . . 70.12 111.111 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' A' ' 102' ' ' ASP . 22.3 m120 -76.84 136.31 38.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 117.862 -1.066 . . . . 72.22 109.489 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.03 -32.73 16.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 55.53 113.304 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.3 -16.29 63.53 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.192 1.553 . . . . 55.25 115.192 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.8 mtt -84.0 -28.09 27.97 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.446 0.566 . . . . 61.4 110.707 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.5 t -76.14 61.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 127.496 2.318 . . . . 54.05 109.786 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 143' ' ' VAL . 1.7 mmmm -91.63 -171.8 3.02 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.537 1.135 . . . . 74.43 108.079 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.61 -9.02 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.34 1.456 . . . . 51.15 114.236 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.89 2.36 69.32 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 116.793 -2.115 . . . . 73.41 113.495 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.78 135.56 43.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 121.12 2.46 . . . . 54.44 108.999 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 139' ' ' GLU . 18.0 m-85 -79.59 118.91 21.87 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.518 -0.919 . . . . 63.35 108.518 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.08 126.06 42.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.574 -1.269 . . . . 74.52 107.574 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.96 141.1 56.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.838 -0.801 . . . . 71.4 108.838 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.52 158.8 72.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.402 1.081 . . . . 74.24 112.013 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.56 150.7 31.96 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.621 2.214 . . . . 72.23 108.365 171.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.32 -174.77 3.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 105.869 -1.9 . . . . 71.52 105.869 162.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -28.33 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.267 2.227 . . . . 74.5 112.195 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.12 -3.47 9.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.227 1.811 . . . . 75.4 111.414 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 p -133.71 158.79 42.38 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.649 0.659 . . . . 61.42 111.581 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.91 152.88 4.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.937 -1.135 . . . . 73.43 107.937 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.37 179.86 6.69 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.575 1.95 . . . . 73.23 107.367 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.11 162.42 19.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.869 1.267 . . . . 74.13 107.914 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -150.52 160.19 43.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.258 -1.386 . . . . 74.05 107.258 158.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 126' ' ' TYR . 5.6 mt-10 -63.09 -179.75 0.32 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.026 1.731 . . . . 73.53 109.699 170.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.47 1.66 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.165 1.786 . . . . 73.04 112.08 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pt 26.51 -80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 128.235 2.614 . . . . 65.4 116.684 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -109.84 119.28 38.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.895 1.278 . . . . 73.33 108.157 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 122' ' ' LYS . 2.9 p -114.65 115.71 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.659 1.219 . . . . 72.53 109.005 164.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.62 -172.29 2.45 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.203 2.601 . . . . 63.5 106.971 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.9 p -128.86 166.82 18.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.059 1.344 . . . . 75.1 110.893 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.77 124.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.024 0.93 . . . . 73.23 109.721 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.92 101.72 11.89 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.561 -0.903 . . . . 63.41 108.561 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.468 ' C ' HD22 ' A' ' 149' ' ' ASN . 9.3 t80 -107.38 133.62 51.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.056 0.942 . . . . 70.5 109.196 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.468 HD22 ' C ' ' A' ' 148' ' ' TYR . 1.3 m-80 -124.55 59.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.794 -1.188 . . . . 73.12 107.794 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -124.64 -166.68 12.48 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.683 2.087 . . . . 21.33 110.681 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.34 156.27 18.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.799 -0.815 . . . . 60.3 108.799 166.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 49.8 pt -136.02 152.79 30.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.177 1.391 . . . . 74.21 108.06 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -144.31 153.27 41.83 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.715 1.206 . . . . 75.42 109.201 -163.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -141.56 174.59 10.42 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.861 -0.525 . . . . 73.33 109.684 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.18 109.82 10.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.028 1.731 . . . . 73.05 109.261 -157.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -76.71 121.0 22.66 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.169 -1.789 . . . . 71.31 106.169 169.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 t -130.24 87.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.635 -1.617 . . . . 74.31 106.635 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.516 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -61.11 -21.49 63.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.903 1.681 . . . . 71.51 113.031 177.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -95.72 -51.17 4.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.217 1.407 . . . . 64.42 110.045 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -124.23 103.58 8.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 101.715 -3.439 . . . . 74.21 101.715 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -66.94 28.55 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.794 0.838 . . . . 73.34 113.018 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.407 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 1.4 p -153.95 124.93 7.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.066 2.147 . . . . 54.43 107.727 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 6.8 p90 -129.92 166.02 20.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.299 1.44 . . . . 71.01 110.912 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.17 135.05 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.214 -1.032 . . . . 73.21 108.214 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.77 29.33 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.509 1.124 . . . . 73.22 110.066 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.01 -156.61 22.25 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.565 0.621 . . . . 73.43 111.893 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -110.09 167.39 10.21 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.998 -1.295 . . . . 72.23 111.54 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.89 -76.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.718 2.807 . . . . 73.53 112.699 -165.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.31 -13.32 8.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.97 1.708 . . . . 74.3 113.641 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.36 176.53 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 123.294 1.496 . . . . 74.44 112.686 -173.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.567 ' CE1' HG23 ' A' ' 97' ' ' ILE . 8.7 m-85 -124.11 149.47 46.17 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.408 3.083 . . . . 70.41 104.874 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -94.37 81.04 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.802 -1.184 . . . . 32.14 107.802 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.0 m -88.49 179.87 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 O-C-N 121.78 -0.575 . . . . 73.44 110.58 -171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.59 158.45 23.06 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.794 -0.566 . . . . 74.23 110.443 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.28 175.13 10.31 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.992 2.117 . . . . 72.3 109.288 173.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 81.4 p . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.327 -0.99 . . . . 63.05 108.327 157.443 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.405 0 N-CA-C 107.767 -1.197 . . . . 62.51 107.767 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.47 -177.42 4.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.474 -0.565 . . . . 63.13 109.474 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -166.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.219 1.408 . . . . 74.23 112.036 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -94.78 -50.38 5.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.434 1.494 . . . . 61.2 110.316 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.94 50.16 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.414 2.285 . . . . 61.14 108.094 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.02 131.84 19.03 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 106.936 -1.505 . . . . 72.25 106.936 -165.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -79.95 132.71 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.015 1.81 . . . . 72.25 112.305 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 pt -98.56 -6.16 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.904 0.882 . . . . 73.22 113.032 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 57.01 84.2 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.982 1.713 . . . . 52.01 112.135 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 59' ' ' ILE . 15.4 mt -51.29 156.66 1.12 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.833 164.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.9 t -55.54 -35.03 65.23 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 122.979 0.512 . . . . 72.55 109.855 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.75 -29.96 68.47 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.647 0.779 . . . . 64.04 112.297 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.21 36.21 7.2 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.194 1.378 . . . . 51.31 111.605 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -17.02 64.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.352 1.241 . . . . 65.44 114.352 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm 43.32 93.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 128.523 2.729 . . . . 72.31 111.19 -166.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.87 145.54 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.63 -1.623 . . . . 62.04 107.792 174.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.26 131.49 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 128.069 2.548 . . . . 72.33 108.396 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -49.92 -48.68 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.495 0.718 . . . . 63.11 110.526 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.81 4.56 86.19 Favored Glycine 0 C--O 1.221 -0.656 0 CA-C-O 116.986 -2.008 . . . . 75.44 113.419 -173.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -86.68 -53.35 4.99 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.512 1.656 . . . . 62.35 108.582 162.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -52.78 -54.42 34.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.765 1.226 . . . . 73.51 109.302 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.836 HG22 ' HA2' ' A' ' 26' ' ' GLY . 21.7 m -65.89 -33.4 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-O 117.753 -1.117 . . . . 70.11 110.174 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -41.92 95.99 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 121.545 1.975 . . . . 70.3 111.569 -173.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.89 -40.23 60.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.462 0.705 . . . . 53.41 110.469 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -77.68 -46.49 21.79 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.353 -1.308 . . . . 54.04 109.873 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -54.95 -36.07 64.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 122.517 2.417 . . . . 65.12 112.354 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -17.4 46.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.383 1.073 . . . . 72.14 113.204 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -88.54 -61.22 1.76 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.195 -1.409 . . . . 64.22 107.195 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -84.13 40.78 0.78 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.912 2.085 . . . . 63.13 108.726 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -50.95 -34.54 29.15 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 127.045 2.138 . . . . 75.03 110.706 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.95 -22.8 59.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.573 1.949 . . . . 61.21 113.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m -94.07 0.8 56.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.222 1.809 . . . . 74.34 112.157 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.16 101.02 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.595 0.758 . . . . 74.11 109.301 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.67 169.69 17.61 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.403 1.081 . . . . 70.35 110.244 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.65 132.3 27.22 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.996 1.319 . . . . 70.12 108.757 164.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -79.6 169.77 17.52 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.395 2.278 . . . . 72.32 110.017 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.01 -37.43 79.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.913 1.685 . . . . 74.24 109.867 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.72 -15.59 62.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.571 0.748 . . . . 74.4 111.827 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.35 3.18 57.66 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 126.313 1.911 . . . . 73.53 113.811 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -57.73 -87.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 129.172 2.989 . . . . 71.33 111.123 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.72 125.89 2.99 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.107 1.336 . . . . 44.14 109.964 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -136.3 168.39 19.5 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.393 1.077 . . . . 74.42 109.861 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.8 mt -146.08 153.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 127.182 2.193 . . . . 73.14 106.202 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 143.27 27.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.672 1.589 . . . . 64.15 109.553 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.66 -24.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 114.834 -2.508 . . . . 75.44 113.675 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 23.15 -72.67 0.0 OUTLIER Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.949 3.166 . . . . 33.21 115.927 159.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -13.12 15.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.883 3.273 . . . . 75.52 115.288 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.66 -20.37 65.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.189 0.596 . . . . 62.3 110.519 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.37 31.6 17.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.302 1.841 . . . . 71.41 113.283 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.9 mt -82.96 123.06 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.513 1.125 . . . . 74.34 108.821 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -86.39 143.46 27.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.382 1.473 . . . . 75.43 110.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.6 tp -125.86 159.13 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.259 -1.756 . . . . 75.44 106.259 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -63.78 140.38 58.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.405 -0.961 . . . . 55.23 108.405 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 p -139.61 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.962 0.505 . . . . 75.43 110.446 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.12 141.67 24.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.349 -0.845 . . . . 75.41 108.875 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 110.28 15.02 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.371 -1.344 . . . . 72.44 107.371 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -64.59 -16.98 63.55 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.638 0.775 . . . . 72.42 111.724 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -15.62 63.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.51 1.124 . . . . 74.01 113.941 171.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -155.59 6.01 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.38 0.991 . . . . 64.44 113.519 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.94 51.54 15.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.073 2.149 . . . . 73.52 111.636 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 pt -119.35 152.58 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.362 2.265 . . . . 42.15 108.76 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.37 145.25 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.315 -0.995 . . . . 74.24 108.315 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -150.67 178.03 9.49 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.138 2.575 . . . . 62.14 109.284 -166.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.18 157.78 17.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.873 1.669 . . . . 64.12 108.638 163.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.58 160.77 41.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.116 -0.99 . . . . 55.44 110.139 154.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.543 HH11 ' CD2' ' A' ' 75' ' ' LEU . 7.0 tmm_? -98.95 131.31 45.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.212 1.005 . . . . 73.11 110.268 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.64 156.53 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.943 1.297 . . . . 73.31 109.02 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.543 ' CD2' HH11 ' A' ' 73' ' ' ARG . 55.9 mt -123.75 -51.7 1.81 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.969 1.308 . . . . 70.01 110.889 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -135.43 163.81 29.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.079 1.352 . . . . 75.41 108.895 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.26 167.95 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.298 1.039 . . . . 73.54 108.974 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -137.71 151.24 48.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.712 1.205 . . . . 70.52 109.281 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 6.4 tmm_? -142.04 144.5 33.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.926 1.29 . . . . 72.13 109.929 170.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -144.83 158.98 43.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.751 -1.574 . . . . 64.03 106.751 165.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -89.96 151.26 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.955 -1.128 . . . . 64.1 107.955 167.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -146.8 154.79 41.78 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.468 1.507 . . . . 70.15 110.367 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.93 111.87 3.05 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.461 -1.311 . . . . 73.01 107.461 167.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.63 -160.02 33.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.619 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' N ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -113.89 117.23 30.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.481 1.112 . . . . 74.21 108.738 -173.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 148' ' ' TYR . 2.6 mm? -98.4 165.13 11.99 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.587 1.155 . . . . 50.1 107.987 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 mm -78.85 132.76 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.458 1.903 . . . . 75.3 107.377 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -128.22 59.68 1.5 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.942 1.697 . . . . 74.21 107.357 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.53 HG23 HG13 ' A' ' 140' ' ' VAL . 37.8 mt -56.89 133.73 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.91 -2.256 . . . . 64.15 104.91 162.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -117.2 164.2 15.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.319 -1.734 . . . . 74.44 106.319 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.2 p -137.03 169.64 17.43 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 121.73 -0.606 . . . . 22.32 110.492 -168.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -60.99 -28.93 69.38 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 73.23 110.727 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.92 3.43 10.18 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.365 1.466 . . . . 63.32 112.521 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 59.28 13.13 2.92 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.473 1.909 . . . . 75.31 113.114 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.553 ' HG3' HH11 ' A' ' 95' ' ' ARG . 0.1 OUTLIER -71.41 162.56 29.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 118.318 -1.353 . . . . 63.5 107.487 166.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -156.69 176.64 12.46 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 128.274 2.63 . . . . 73.3 106.463 171.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -141.75 -179.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.637 1.575 . . . . 71.24 109.996 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.5 m -150.56 97.35 2.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.58 1.152 . . . . 74.52 110.287 168.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -146.39 174.47 11.35 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.426 1.49 . . . . 74.32 111.035 -176.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -73.17 172.74 10.53 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.342 0.974 . . . . 53.32 108.65 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -77.36 7.53 5.21 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.06 -1.025 . . . . 72.55 112.001 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.42 39.24 2.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.245 0.929 . . . . 52.1 111.297 -167.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -99.13 137.58 20.45 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 117.059 -1.448 . . . . 72.13 112.368 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.23 94.93 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 124.317 3.344 . . . . 65.41 113.666 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.18 178.82 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.138 0.975 . . . . 73.22 109.192 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.48 134.26 50.98 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.499 -0.751 . . . . 75.53 110.791 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.01 155.86 38.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.106 1.362 . . . . 72.02 109.398 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -86.32 125.7 33.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.261 0.553 . . . . 45.23 110.945 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -98.4 89.43 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.525 -2.028 . . . . 73.41 105.525 153.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.98 31.16 8.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.789 1.236 . . . . 50.54 113.603 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.66 -8.32 39.96 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.432 -1.205 . . . . 72.35 113.951 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 159.83 27.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 104.651 -2.351 . . . . 65.42 104.651 160.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.262 7.3 p -106.93 104.35 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.093 0.957 . . . . 62.3 109.953 170.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -91.29 160.08 15.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.73 1.612 . . . . 75.34 107.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.62 115.2 20.43 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.336 1.854 . . . . 75.1 108.039 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 116' ' ' ILE . 1.5 pt -143.85 172.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.753 1.621 . . . . 74.13 109.468 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.16 143.75 26.87 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.386 0.539 . . . . 63.11 111.565 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.71 -27.65 65.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.587 -0.72 . . . . 74.43 112.815 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -29.22 68.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.636 1.107 . . . . 73.5 111.953 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -79.58 -32.54 41.98 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.095 1.358 . . . . 74.43 111.661 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.99 63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 130.381 3.473 . . . . 64.15 110.906 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -95.93 -169.24 1.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.351 1.06 . . . . 73.42 108.991 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.0 -7.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.653 -1.279 . . . . 71.24 114.106 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.39 -12.81 69.32 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 117.799 -1.556 . . . . 55.32 111.687 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.06 119.63 35.36 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 121.132 2.466 . . . . 62.41 107.07 -164.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.37 115.52 21.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.58 HG23 ' OD1' ' A' ' 138' ' ' ASP . 6.8 tt -79.9 159.24 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.405 1.082 . . . . 72.44 109.96 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.03 129.95 36.98 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.592 1.557 . . . . 73.43 110.883 167.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.5 155.44 47.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.811 1.645 . . . . 43.24 110.195 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -68.51 156.36 65.84 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.5 2.134 . . . . 70.24 110.313 165.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -141.04 -176.96 4.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.828 1.651 . . . . 74.53 107.634 164.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -25.17 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.014 2.526 . . . . 71.34 112.506 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -120.17 -4.95 9.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.325 -0.845 . . . . 72.21 113.091 170.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.6 p -132.67 170.06 15.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.24 1.382 . . . . 41.31 111.333 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.06 157.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.531 -0.731 . . . . 73.22 109.161 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.03 -177.25 4.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.587 2.755 . . . . 74.33 106.558 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 88.4 mt -126.12 160.86 29.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.162 0.985 . . . . 72.43 110.666 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.58 ' OD1' HG23 ' A' ' 127' ' ' ILE . 11.5 p-10 -154.05 158.61 40.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.858 1.663 . . . . 65.12 111.858 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -106.04 150.65 25.54 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.226 1.411 . . . . 74.51 109.699 -172.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 89' ' ' ILE . 41.9 t -95.6 1.28 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.907 1.283 . . . . 74.23 113.72 -166.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.4 pt 24.82 -86.8 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 127.459 2.304 . . . . 74.3 116.655 171.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.34 123.17 43.39 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 126.841 2.056 . . . . 51.33 107.811 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.47 119.97 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.388 -1.338 . . . . 74.32 107.388 170.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.25 -166.04 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.62 1.968 . . . . 75.21 108.196 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 p -133.18 165.22 25.29 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.047 1.739 . . . . 71.02 109.311 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.57 -175.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.182 1.393 . . . . 73.14 108.668 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -136.86 68.96 1.41 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.529 1.157 . . . . 72.01 109.394 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.43 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.8 t80 -80.21 133.56 36.03 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.019 -1.051 . . . . 55.12 111.029 -169.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -136.03 69.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.944 -1.132 . . . . 73.21 107.944 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.82 -120.56 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 51.3 110.115 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -121.73 163.28 19.34 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.002 -0.705 . . . . 73.13 110.041 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.55 147.02 28.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 127.379 2.272 . . . . 75.15 106.563 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.589 ' CD2' HG21 ' A' ' 29' ' ' VAL . 69.0 m-85 -141.4 164.53 29.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.356 0.662 . . . . 72.44 109.296 -171.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.52 171.47 18.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 119.537 -0.268 . . . . 72.44 111.519 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.6 118.4 19.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.928 1.691 . . . . 74.53 109.413 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 57.6 m -73.08 112.77 9.43 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.025 -1.472 . . . . 71.55 107.025 166.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.94 75.41 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.516 -2.031 . . . . 41.52 105.516 169.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.11 -0.15 38.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.71 2.404 . . . . 74.11 114.134 -162.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.93 -77.32 0.1 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 128.283 2.633 . . . . 71.22 110.995 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -105.39 5.52 31.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.839 1.655 . . . . 74.0 111.694 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.6 m80 50.29 34.4 8.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.969 2.507 . . . . 64.41 112.035 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 p -148.51 155.33 41.01 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.425 1.89 . . . . 71.11 108.304 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -159.25 -168.13 2.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.256 1.022 . . . . 73.42 109.772 178.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.48 141.38 14.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 105.89 -1.893 . . . . 75.55 105.89 155.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -144.71 148.85 34.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 72.41 109.398 149.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 144.3 -165.92 27.32 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.109 -0.994 . . . . 61.33 112.119 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -111.26 166.82 10.77 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 119.708 -2.054 . . . . 70.11 111.232 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.24 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 128.319 2.648 . . . . 74.12 112.667 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 44.8 mt-10 -121.84 -18.34 7.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.689 1.196 . . . . 70.34 112.75 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.29 158.66 21.24 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.829 1.204 . . . . 70.04 113.537 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.454 ' CE1' HG23 ' A' ' 97' ' ' ILE . 78.7 m-85 -105.29 154.42 20.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 127.096 2.158 . . . . 73.02 109.686 -174.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.5 75.99 5.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.084 0.953 . . . . 62.44 108.448 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 173' ' ' VAL . 11.8 m -93.5 178.92 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.832 1.253 . . . . 74.43 110.315 -173.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.0 m -65.8 161.99 19.75 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.278 -0.889 . . . . 63.0 110.111 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -143.79 39.43 1.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.199 1.8 . . . . 75.15 108.295 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 107.825 -1.176 . . . . 74.34 107.825 175.279 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.517 0 N-CA-C 106.125 -1.805 . . . . 74.35 106.125 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.07 167.2 22.0 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.584 1.154 . . . . 72.3 109.582 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . -71.71 -140.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.659 0.784 . . . . 61.43 111.84 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 5.5 t80 -120.73 -38.97 2.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.618 1.567 . . . . 74.33 112.012 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.85 30.55 6.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.645 1.178 . . . . 73.3 111.496 -163.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 144.9 29.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 O-C-N 121.507 -0.746 . . . . 62.32 111.993 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.15 141.72 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.272 2.648 . . . . 74.12 113.786 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 25' ' ' ILE . 13.5 pt -114.66 16.84 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.981 1.104 . . . . 73.14 113.981 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 34.92 68.83 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.225 2.21 . . . . 73.01 113.964 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.0 mt -56.15 155.73 6.31 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.153 -0.684 . . . . 51.23 109.153 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -61.86 -27.2 68.62 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.186 -0.321 . . . . 72.41 111.166 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.38 -59.06 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.347 -0.612 . . . . 64.53 109.347 169.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.59 32.47 0.61 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.943 1.735 . . . . 71.14 111.219 -170.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 -11.27 59.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.299 -1.706 . . . . 70.53 114.933 -166.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 16.9 mm 44.58 74.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 127.205 2.202 . . . . 71.45 110.196 175.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.02 148.51 18.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 125.279 1.432 . . . . 55.22 108.789 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.67 131.75 50.02 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.846 2.458 . . . . 74.32 109.591 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.515 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.04 -57.57 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.731 1.613 . . . . 75.22 109.035 175.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -58.95 -45.9 94.46 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-O 118.395 -1.225 . . . . 61.43 110.057 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.4 -57.07 13.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.966 1.706 . . . . 65.24 111.636 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -47.74 -54.55 11.85 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.949 1.7 . . . . 75.35 110.334 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 74.0 t -70.56 -43.45 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.055 -0.975 . . . . 61.14 110.552 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.93 -31.87 73.31 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 118.937 -1.105 . . . . 72.34 112.151 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -50.21 -46.91 54.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.449 1.5 . . . . 65.21 109.785 169.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -69.61 -44.54 70.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.907 -0.775 . . . . 75.13 108.907 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -58.26 -28.47 64.95 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.369 1.441 . . . . 74.2 112.301 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -85.0 -25.31 27.78 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 125.582 1.553 . . . . 64.44 112.58 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -93.97 -58.02 2.37 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.998 -1.853 . . . . 62.33 105.998 175.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -86.63 43.76 1.1 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.78 2.032 . . . . 71.12 108.943 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -49.59 -38.04 30.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 127.324 2.249 . . . . 62.32 111.255 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -95.08 -2.75 49.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.433 0.901 . . . . 61.0 113.433 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -82.1 -6.98 59.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.009 0.822 . . . . 63.42 112.365 165.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.07 99.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 119.579 1.081 . . . . 70.0 108.612 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -85.4 108.08 17.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.665 1.986 . . . . 72.11 107.741 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.53 124.72 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.412 -1.699 . . . . 72.1 106.412 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.94 137.82 37.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.92 -1.511 . . . . 74.02 106.92 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -65.73 -42.7 90.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.997 -0.281 . . . . 74.52 111.552 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -120.58 58.07 0.95 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.606 -1.627 . . . . 72.24 106.606 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.21 -133.83 1.55 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.174 -0.77 . . . . 65.13 111.174 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -101.27 0.42 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.083 0.772 . . . . 64.31 113.083 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.98 104.11 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 108.51 -1.836 . . . . 34.52 108.51 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -126.27 171.15 11.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.3 1.84 . . . . 74.21 111.249 -170.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mt -138.22 133.85 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.25 -2.129 . . . . 72.33 105.25 166.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 122.32 22.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.454 -1.684 . . . . 45.31 106.454 160.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.306 2.4 pp -126.84 23.92 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 123.091 1.424 . . . . 74.43 109.593 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -26.63 69.51 Favored Glycine 0 CA--C 1.523 0.555 0 O-C-N 120.537 -1.352 . . . . 72.22 112.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -12.41 61.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.186 1.794 . . . . 74.22 115.402 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.15 -14.75 63.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.011 1.278 . . . . 73.03 113.235 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 m120 60.77 11.26 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.266 2.626 . . . . 72.32 114.004 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.49 130.26 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.953 -1.092 . . . . 72.51 108.832 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.92 154.1 20.03 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.562 1.145 . . . . 74.41 110.976 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.79 150.19 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.129 2.172 . . . . 71.34 108.005 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -72.86 109.81 6.71 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.272 -1.381 . . . . 72.24 107.272 169.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -99.01 -175.2 2.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.058 1.743 . . . . 65.44 107.274 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.435 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -135.09 128.56 32.43 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.801 -1.926 . . . . 72.1 105.801 164.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -80.47 97.13 6.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.971 -1.492 . . . . 72.51 106.971 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB2' HG21 ' A' ' 162' ' ' THR . 50.6 tttt -50.88 -23.15 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 117.835 -1.079 . . . . 75.12 112.543 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -43.05 -38.83 2.47 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.025 1.73 . . . . 72.23 113.483 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -142.82 15.12 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.767 1.227 . . . . 74.23 110.54 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt 56.57 44.59 23.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.987 1.315 . . . . 62.24 111.423 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -111.04 152.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.712 1.605 . . . . 74.33 108.521 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.14 118.33 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 106.477 -1.675 . . . . 70.24 106.477 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' C ' ' HE2' ' A' ' 60' ' ' LYS . 8.7 mm-40 -144.36 175.8 9.83 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.5 1.52 . . . . 71.24 109.334 -175.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.52 141.02 29.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.641 -1.287 . . . . 64.1 111.327 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 154.89 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.6 1.96 . . . . 71.11 108.686 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -91.21 156.71 17.64 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.181 -1.044 . . . . 61.45 108.181 168.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.603 HG21 HD11 ' A' ' 155' ' ' LEU . 3.1 mp -95.52 154.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.793 1.237 . . . . 70.25 108.697 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.0 -52.12 2.81 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.904 1.682 . . . . 60.21 110.615 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -134.12 162.05 33.18 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.465 -0.772 . . . . 71.15 110.01 -171.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.632 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.1 155.96 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.548 1.539 . . . . 74.22 108.436 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.64 166.24 20.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.324 1.45 . . . . 74.44 108.165 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -137.4 143.94 42.17 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 73.24 109.224 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -141.21 164.46 30.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 130.161 3.384 . . . . 72.45 108.819 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -116.74 159.0 22.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.06 -1.65 . . . . 73.45 111.264 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -150.67 155.59 39.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.803 0.811 . . . . 72.52 113.164 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 117.58 2.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.428 1.891 . . . . 73.13 106.4 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.88 -165.23 32.07 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.607 1.549 . . . . 31.35 113.733 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -93.2 129.89 39.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.423 0.689 . . . . 74.44 110.513 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.9 mt -111.26 159.55 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.476 1.11 . . . . 71.2 109.702 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.21 135.17 26.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.967 1.307 . . . . 71.13 107.842 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -128.78 81.15 2.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.484 1.914 . . . . 75.22 105.961 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 140' ' ' VAL . 42.5 mt -63.97 110.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.19 -2.522 . . . . 73.12 104.19 158.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -85.98 162.57 18.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 161.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -142.88 164.69 29.4 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.371 1.869 . . . . 60.33 107.313 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.78 -26.83 68.81 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.449 -0.782 . . . . 71.33 112.205 -159.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -74.42 27.35 0.08 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.527 1.931 . . . . 72.2 111.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 50.77 14.48 0.18 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.195 2.198 . . . . 74.2 113.641 -168.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.593 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 14.3 ttm105 -85.82 162.09 18.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.806 -1.184 . . . . 73.32 108.766 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 9.8 pt-20 -175.72 168.3 3.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.985 -1.007 . . . . 74.14 110.793 -168.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 8.4 pt -140.6 178.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.782 1.633 . . . . 73.14 109.179 -174.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.07 97.28 2.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.319 -1.734 . . . . 74.5 106.319 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.94 162.44 41.31 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 74.14 111.087 -172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 m -70.25 153.16 43.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.747 -1.205 . . . . 73.34 107.747 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -73.64 -13.37 60.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.556 0.947 . . . . 54.43 113.556 -167.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.29 37.75 2.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.284 1.04 . . . . 61.13 109.564 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -97.03 129.84 31.36 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.925 1.29 . . . . 53.12 107.65 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.69 148.72 87.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.871 2.381 . . . . 74.42 112.359 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 m -144.53 169.13 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 129.565 3.146 . . . . 75.0 107.933 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -107.87 141.52 39.36 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.651 -0.655 . . . . 74.34 109.682 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.62 159.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.199 1.4 . . . . 64.31 109.042 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.478 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 17.2 t -93.39 134.66 35.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.197 1.475 . . . . 54.34 110.31 169.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -103.36 85.44 2.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 111.96 -2.382 . . . . 52.12 106.167 157.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.45 27.42 8.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.683 1.193 . . . . 61.24 113.66 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 119.32 -14.69 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.284 -1.287 . . . . 75.31 113.145 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 176.49 9.74 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.721 1.261 . . . . 55.45 108.009 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.43 118.89 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.894 1.278 . . . . 60.45 108.064 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -118.57 158.79 24.75 Favored 'General case' 0 CA--C 1.526 0.03 0 C-N-CA 123.988 0.915 . . . . 72.14 108.931 174.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -121.59 115.92 23.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.89 2.476 . . . . 74.34 104.505 -176.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.7 177.69 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.704 1.202 . . . . 74.53 109.258 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -94.07 153.67 18.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.859 0.754 . . . . 65.32 111.324 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.0 -22.95 42.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.977 1.311 . . . . 73.33 113.758 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -60.16 -43.67 95.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.958 1.254 . . . . 63.11 111.132 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.15 -22.95 57.77 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.224 0.92 . . . . 72.11 113.438 -170.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.21 62.87 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.904 2.081 . . . . 61.31 111.004 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -78.98 -177.95 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.054 1.342 . . . . 72.32 110.162 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 11.1 p -58.6 -4.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 127.573 2.349 . . . . 74.3 114.163 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 15.87 10.05 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.754 2.121 . . . . 73.34 112.155 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.2 159.27 34.79 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.487 1.643 . . . . 74.11 107.498 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -119.91 110.61 16.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.34 -0.985 . . . . 53.25 108.34 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.32 138.93 19.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 124.813 1.245 . . . . 63.24 108.438 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 108' ' ' SER . 11.1 m-85 -75.49 136.0 40.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.559 -0.904 . . . . 70.31 108.559 171.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.0 151.94 79.84 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 124.207 1.003 . . . . 40.45 112.735 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.35 138.32 29.9 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.106 2.537 . . . . 54.32 108.91 170.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -120.92 -157.47 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.524 2.329 . . . . 75.04 105.848 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -37.86 -74.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.179 1.792 . . . . 75.01 112.507 -169.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -121.4 -1.0 9.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.17 0.896 . . . . 72.54 113.24 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.6 p -123.64 169.93 10.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 124.636 1.174 . . . . 74.33 110.541 -168.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 tp -81.66 157.81 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.223 -0.658 . . . . 74.41 109.223 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.6 -176.54 5.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.078 2.951 . . . . 73.02 106.708 174.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.1 161.72 14.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.456 -1.313 . . . . 73.5 107.456 156.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -154.99 108.39 2.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.456 1.502 . . . . 74.12 108.135 173.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.02 144.73 33.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 129.929 3.292 . . . . 64.22 113.266 -162.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 89' ' ' ILE . 66.2 t -77.5 0.41 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.561 1.144 . . . . 74.01 113.599 -170.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.2 pt 27.64 -75.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 118.078 2.621 . . . . 74.31 118.078 167.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.48 128.89 56.33 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.607 1.563 . . . . 73.05 107.986 170.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.27 131.5 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.683 -1.229 . . . . 64.03 107.683 167.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.67 171.62 14.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.318 1.847 . . . . 75.11 108.42 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.49 138.79 50.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.49 -168.41 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.668 1.187 . . . . 73.42 108.569 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -136.65 135.59 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.068 -1.456 . . . . 63.2 107.068 167.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.401 ' C ' HD22 ' A' ' 149' ' ' ASN . 1.1 t80 -142.55 134.73 27.45 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.581 0.753 . . . . 74.34 110.233 -170.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.401 HD22 ' C ' ' A' ' 148' ' ' TYR . 1.5 m-80 -138.1 70.89 1.39 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.756 -1.942 . . . . 55.34 105.756 -167.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.09 -166.61 12.14 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.524 1.059 . . . . 75.11 112.393 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -88.42 157.29 18.73 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.965 -1.315 . . . . 54.21 109.413 165.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 10' ' ' ALA . 10.2 pt -126.55 170.34 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.609 1.564 . . . . 64.55 111.16 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.686 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.9 147.69 13.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.156 -1.424 . . . . 73.15 107.156 -170.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -118.93 158.24 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.537 0.735 . . . . 65.3 110.692 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.603 HD11 HG21 ' A' ' 74' ' ' ILE . 19.7 tp -117.38 137.57 52.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.459 1.503 . . . . 65.32 109.231 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 22.8 m -68.29 -59.47 3.18 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.353 0.597 . . . . 52.14 110.306 -167.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.325 3.2 t 40.67 67.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 128.975 2.91 . . . . 75.1 112.694 -170.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.61 -11.88 61.19 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.499 -0.773 . . . . 71.41 110.934 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -65.2 0.7 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.3 1.04 . . . . 74.54 109.682 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.13 2.34 12.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.137 0.575 . . . . 74.21 112.27 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.6 m170 54.99 31.34 15.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.402 1.481 . . . . 64.34 111.887 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -149.69 151.62 33.99 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.643 -1.286 . . . . 62.22 110.291 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.2 p90 -154.8 172.53 17.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.591 1.156 . . . . 75.45 110.511 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.12 124.95 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.026 1.73 . . . . 64.32 108.929 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.93 148.46 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.726 0.811 . . . . 53.21 109.907 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 151.12 -175.47 30.04 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.26 -1.136 . . . . 73.13 110.26 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -90.94 166.05 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.307 -1.702 . . . . 71.0 110.24 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.06 -68.23 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 130.587 3.555 . . . . 75.1 113.054 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.593 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 12.7 mt-10 -122.06 -18.06 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.632 1.973 . . . . 73.54 114.174 175.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 79.29 166.74 32.49 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 124.249 0.928 . . . . 74.35 111.816 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 25.3 m-85 -121.06 155.26 34.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.139 2.576 . . . . 75.45 105.774 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -77.03 141.14 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.833 -1.173 . . . . 75.13 107.833 167.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . 0.273 46.0 t -135.27 175.82 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.966 1.306 . . . . 75.23 107.6 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 52.7 m -95.89 133.61 39.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.324 1.45 . . . . 43.42 110.565 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -115.13 173.78 6.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.883 1.673 . . . . 54.33 107.108 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.466 0.375 0 C-N-CA 126.057 1.743 . . . . 64.5 110.134 160.268 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 109.614 -0.513 . . . . 54.41 109.614 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.64 170.62 9.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.693 1.597 . . . . 75.35 110.041 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.75 162.33 19.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.445 -0.784 . . . . 45.03 111.927 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 13.6 t80 -47.65 -42.55 24.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.259 2.224 . . . . 74.04 113.538 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.97 16.34 26.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.462 1.483 . . . . 74.12 112.779 -160.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -86.98 120.16 71.41 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.946 2.099 . . . . 75.33 110.481 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -56.77 145.37 83.37 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.385 2.723 . . . . 72.13 113.981 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.469 ' CG2' HG13 ' A' ' 25' ' ' ILE . 45.2 pt -107.87 -10.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.232 1.413 . . . . 60.45 113.156 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 56.14 79.43 0.17 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.393 1.077 . . . . 72.34 110.665 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 155.74 2.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.173 -0.954 . . . . 71.25 109.551 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.09 -38.32 51.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.011 0.925 . . . . 51.23 110.362 169.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.09 -17.05 61.0 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.355 0.872 . . . . 53.14 113.355 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.07 33.7 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 118.486 -1.175 . . . . 73.2 113.142 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.32 -33.06 63.0 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.253 1.575 . . . . 74.34 115.253 -159.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mm 49.21 88.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.294 2.238 . . . . 71.41 110.121 -167.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 148.09 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.95 2.5 . . . . 61.44 107.588 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.64 141.41 58.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.713 1.605 . . . . 70.54 108.143 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -50.39 -51.67 17.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 169.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -57.23 -53.5 44.27 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 118.003 -1.443 . . . . 73.11 110.116 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -60.54 -43.86 96.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 1.166 . . . . 61.14 112.433 -173.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -58.4 -56.61 19.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.777 0.831 . . . . 65.44 109.34 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 153' ' ' TYR . 54.8 t -70.93 -41.69 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.983 -0.553 . . . . 64.12 109.973 -172.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -29.69 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.1 -0.953 . . . . 72.23 111.855 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.1 -43.88 78.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.3 1.864 . . . . 72.42 111.273 172.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 20.0 m-85 -67.64 -43.22 80.85 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.24 -34.88 75.86 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.407 1.458 . . . . 75.43 112.679 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -47.35 66.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.057 1.299 . . . . 72.34 108.928 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.7 mtpp -76.43 -56.9 4.21 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.31 -1.737 . . . . 74.43 106.31 -169.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.1 m-30 -91.32 40.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.39 1.876 . . . . 74.42 107.759 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -37.43 68.63 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 121.165 -0.96 . . . . 73.24 111.453 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.56 81.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.485 1.914 . . . . 71.35 110.382 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -80.51 0.26 34.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.628 1.571 . . . . 55.34 113.354 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.78 99.22 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.02 -1.104 . . . . 63.34 108.02 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.19 161.34 26.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.295 -1.372 . . . . 71.42 107.295 162.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.37 142.21 47.12 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.888 -1.523 . . . . 70.53 106.888 171.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.15 176.71 9.42 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.991 0.807 . . . . 73.13 110.315 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.28 -12.71 60.94 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.426 1.49 . . . . 70.33 111.693 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.47 5.45 17.71 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.978 -1.076 . . . . 74.31 111.359 162.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 30.21 77.28 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 126.922 2.201 . . . . 55.3 113.234 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' A' ' 80' ' ' LYS . 2.6 t80 -77.02 -100.12 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.342 1.857 . . . . 71.11 109.47 -170.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.84 127.95 2.02 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.915 -1.274 . . . . 72.41 109.915 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -155.47 161.41 40.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.164 0.982 . . . . 64.3 111.067 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.44 133.19 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.835 -1.913 . . . . 64.2 105.835 170.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.22 133.45 47.96 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.872 -1.158 . . . . 73.02 107.872 163.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.06 17.71 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.648 0.779 . . . . 54.32 109.785 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.89 8.66 4.34 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 126.083 1.802 . . . . 71.33 113.979 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.88 -15.41 14.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.691 1.596 . . . . 74.12 109.661 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.16 -34.09 69.92 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.198 0.999 . . . . 73.32 110.338 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 58.9 14.11 3.14 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.301 1.963 . . . . 71.23 116.301 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.84 127.65 29.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 127.977 2.511 . . . . 71.41 109.276 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -82.32 141.04 33.2 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.546 0.688 . . . . 74.2 111.372 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.9 153.57 17.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 127.848 2.459 . . . . 75.2 106.675 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -72.19 110.7 6.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.592 -1.633 . . . . 74.15 106.592 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 171.42 7.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.17 -1.419 . . . . 61.43 107.17 -174.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -140.25 122.7 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.337 -1.356 . . . . 74.44 107.337 -168.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.5 108.22 18.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.893 -1.151 . . . . 70.23 107.893 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 21.5 ttpp -51.48 -31.42 23.47 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.424 1.49 . . . . 73.54 112.789 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.76 -28.38 15.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.765 2.826 . . . . 74.5 112.957 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 t -150.05 23.06 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.461 -0.774 . . . . 72.51 111.487 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.87 40.2 8.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.414 1.485 . . . . 52.14 112.18 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.81 -172.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.8 0.84 . . . . 70.54 110.095 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -116.92 135.7 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.298 2.239 . . . . 71.43 105.79 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.02 167.51 21.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.113 2.165 . . . . 73.5 107.182 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -101.2 118.92 37.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.231 -1.766 . . . . 63.52 106.231 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -133.37 163.77 28.6 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.122 -1.436 . . . . 65.14 107.122 170.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -95.61 -160.92 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.293 0.951 . . . . 73.13 110.512 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 155' ' ' LEU . 77.2 mt -132.62 146.26 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 105.572 -2.01 . . . . 71.51 105.572 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.65 -45.52 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.507 1.123 . . . . 64.43 111.191 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.595 ' HB2' HG21 ' A' ' 156' ' ' THR . 59.7 mtt180 -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.21 -1.556 . . . . 71.32 108.417 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.14 158.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.991 -0.744 . . . . 71.21 108.991 177.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -129.11 179.33 5.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.587 1.555 . . . . 72.2 108.914 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -170.7 146.21 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.322 1.849 . . . . 73.03 108.982 158.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 47' ' ' PHE . 71.9 tttt -143.8 166.5 24.74 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.618 1.567 . . . . 72.01 107.455 164.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 14.8 ttpt -89.02 165.65 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.46 -1.4 . . . . 70.42 109.223 168.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 91.9 t80 -150.64 158.17 43.83 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.839 1.255 . . . . 74.12 109.9 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 p -155.13 123.98 6.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.65 1.18 . . . . 51.23 107.848 160.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.8 178.19 35.51 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 120.036 1.289 . . . . 73.52 114.167 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.735 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.87 100.85 8.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.334 0.654 . . . . 61.05 110.789 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.13 152.13 23.61 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.81 -1.181 . . . . 63.23 107.81 167.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.93 137.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.791 1.636 . . . . 54.41 108.943 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -117.5 80.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.427 -1.715 . . . . 73.4 106.868 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.6 137.25 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.848 -1.908 . . . . 73.13 105.848 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.7 m -117.31 171.83 7.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.079 -1.822 . . . . 70.32 106.079 159.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -139.32 172.85 12.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.911 1.284 . . . . 74.22 109.106 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -63.7 -29.27 70.52 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.063 -1.023 . . . . 65.55 110.742 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.64 2.48 5.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.113 1.365 . . . . 74.32 113.945 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 62.58 16.69 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.494 1.518 . . . . 64.14 111.8 -168.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -70.0 153.46 43.19 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.814 -1.18 . . . . 54.32 107.814 168.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.57 163.29 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.942 1.697 . . . . 75.51 107.564 -170.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -148.96 172.64 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.02 1.728 . . . . 74.13 108.955 -170.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.3 m -146.12 92.43 2.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.666 -1.235 . . . . 70.12 107.666 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.88 170.21 18.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.315 1.446 . . . . 63.42 110.832 -172.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 p -70.19 166.99 18.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.964 1.256 . . . . 54.41 112.15 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.3 1.4 p-80 -67.84 -31.62 71.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.22 -0.925 . . . . 63.53 111.348 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -100.18 39.94 1.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.832 2.453 . . . . 72.33 111.293 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -95.3 128.36 38.82 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.609 -1.186 . . . . 74.41 111.829 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.46 121.77 8.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.551 2.834 . . . . 72.33 111.042 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.76 177.12 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.776 1.631 . . . . 74.22 108.752 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -112.43 149.53 32.44 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.179 -0.951 . . . . 75.13 111.545 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.46 170.32 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 126.006 1.722 . . . . 73.13 108.458 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 p -96.05 137.09 35.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.075 0.94 . . . . 73.21 110.261 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 79.8 1.87 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.776 -1.564 . . . . 73.3 106.776 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 65.42 4.01 2.56 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.196 1.184 . . . . 74.31 114.196 172.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -21.89 2.43 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 120.173 -1.579 . . . . 70.44 112.139 -169.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -102.66 160.58 14.45 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.148 1.379 . . . . 64.41 107.893 -171.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 t -112.91 119.24 60.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.378 -1.712 . . . . 75.13 106.378 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.67 137.2 48.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.445 -0.946 . . . . 43.42 108.445 -170.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -84.0 134.56 34.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.271 1.028 . . . . 72.44 109.519 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 pt -147.78 -179.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.454 1.502 . . . . 64.44 109.717 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -79.38 134.04 36.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.408 1.083 . . . . 74.41 110.225 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.37 -30.75 30.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.328 1.051 . . . . 63.33 113.04 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.65 -26.14 68.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.285 1.857 . . . . 73.43 113.625 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 36.7 mmt -80.89 -26.36 36.89 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.39 1.076 . . . . 72.41 111.554 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.95 63.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.006 2.522 . . . . 53.3 111.468 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -78.96 -177.72 5.71 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.898 -1.126 . . . . 73.15 109.063 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.98 1.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.34 1.856 . . . . 65.51 112.964 159.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.11 -3.96 72.31 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 116.614 -2.214 . . . . 63.23 112.444 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 166.74 21.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.134 1.967 . . . . 61.02 107.734 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 3.4 m-85 -98.38 155.74 17.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.011 -0.995 . . . . 72.43 108.79 163.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.8 tt -122.21 131.37 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.388 1.075 . . . . 55.03 109.462 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.8 m-85 -71.7 117.77 13.7 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 118.585 -0.721 . . . . 65.41 109.909 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.566 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.1 pp -129.4 157.06 77.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.639 1.175 . . . . 75.42 112.99 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.31 147.3 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.57 2.18 . . . . 63.03 109.563 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.42 -178.36 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.262 -1.384 . . . . 53.04 107.262 163.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -24.12 -71.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.464 2.706 . . . . 73.44 112.802 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -121.01 1.22 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.382 2.673 . . . . 74.42 113.85 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.1 p -128.61 -173.88 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.828 1.651 . . . . 65.04 112.723 -168.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.25 157.45 5.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.868 -1.16 . . . . 72.04 107.868 166.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -140.92 -177.34 5.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.307 2.243 . . . . 71.54 107.209 165.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 128' ' ' TYR . 1.1 tp -108.76 157.66 18.36 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.555 1.142 . . . . 70.04 110.074 165.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.566 ' CG ' HG12 ' A' ' 129' ' ' ILE 0.306 39.5 p30 -142.79 164.67 29.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 114.396 1.258 . . . . 70.42 114.396 162.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -95.26 146.1 24.59 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.063 1.745 . . . . 72.22 107.5 -171.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -98.14 0.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 113.749 1.018 . . . . 71.05 113.749 -160.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 pt 35.31 -53.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 1 C-N-CA 133.019 4.528 . . . . 75.31 120.064 169.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -144.68 133.51 22.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.301 2.64 . . . . 70.33 107.908 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.96 127.28 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.263 1.03 . . . . 75.2 108.318 166.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -140.22 -158.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.392 1.477 . . . . 70.11 107.579 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -139.7 152.49 46.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.386 1.074 . . . . 73.04 108.952 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m -102.59 139.1 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.505 -1.665 . . . . 70.22 106.505 161.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.21 92.8 9.09 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.752 1.614 . . . . 74.43 106.972 166.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -96.81 139.41 32.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.183 0.993 . . . . 75.14 111.345 -168.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -140.69 67.01 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.742 -1.577 . . . . 62.34 106.742 -165.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.0 -172.51 12.83 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 123.72 0.676 . . . . 72.5 111.99 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -81.3 144.47 31.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.178 -0.675 . . . . 71.02 109.178 162.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.54 158.18 34.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 127.638 2.375 . . . . 73.45 108.665 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.662 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -153.81 164.85 37.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.912 -0.773 . . . . 72.3 108.912 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -129.15 147.83 51.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.342 1.457 . . . . 75.22 108.994 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 74' ' ' ILE . 20.0 tp -96.14 153.81 17.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.539 . . . . 74.12 110.686 -171.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 76' ' ' ARG . 2.4 m -107.71 37.83 2.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.722 0.809 . . . . 70.31 111.615 -165.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.85 101.93 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 119.881 -1.762 . . . . 54.32 109.542 -172.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.59 -6.09 57.76 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.49 1.116 . . . . 63.44 110.311 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.35 -67.25 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.779 1.232 . . . . 74.23 108.58 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 6.5 t30 -112.13 4.43 17.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.753 0.821 . . . . 74.34 111.418 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.13 35.1 25.08 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.218 1.007 . . . . 70.31 109.592 -169.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.27 150.78 27.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.947 1.699 . . . . 75.33 108.57 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.67 -178.57 6.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.064 1.302 . . . . 62.03 110.555 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.2 mm -113.36 143.27 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.381 1.472 . . . . 75.14 108.634 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.34 38.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.341 1.056 . . . . 52.35 110.223 165.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 132.58 -169.2 22.45 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 119.035 0.834 . . . . 55.04 112.569 166.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -85.7 167.41 15.31 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.083 1.442 . . . . 70.31 111.841 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.45 -73.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.142 2.977 . . . . 71.23 113.762 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.21 -14.22 7.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.239 1.815 . . . . 62.44 112.493 175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 68.89 160.67 2.12 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 126.484 1.992 . . . . 64.03 112.571 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 97' ' ' ILE . 37.5 m-85 -106.6 151.06 25.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.379 2.272 . . . . 74.21 107.07 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.544 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -78.6 129.56 34.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.407 -1.331 . . . . 71.54 107.407 162.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.01 176.34 7.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.419 -1.326 . . . . 70.54 107.419 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.2 t -65.98 164.52 15.01 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.644 -0.873 . . . . 74.32 108.644 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.38 132.9 20.81 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.544 -1.65 . . . . 64.31 106.544 164.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 106.436 -1.69 . . . . 75.43 106.436 159.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.475 0 N-CA-C 106.407 -1.701 . . . . 60.42 106.407 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt -101.89 166.65 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.572 1.549 . . . . 74.25 109.588 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -173.85 0.56 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.031 1.332 . . . . 73.31 110.858 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.86 -31.85 59.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.492 1.117 . . . . 75.24 111.062 171.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.96 31.64 6.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.714 2.405 . . . . 25.41 111.051 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -88.43 133.38 36.6 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.619 -1.252 . . . . 63.54 107.619 157.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.57 152.45 59.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.211 1.274 . . . . 63.34 113.676 168.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.04 -17.03 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 72.4 114.658 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.37 74.62 0.27 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.943 1.354 . . . . 74.15 111.755 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 mt -53.85 163.64 0.7 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.991 -1.004 . . . . 73.03 109.504 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -56.07 -36.37 68.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.676 -0.64 . . . . 70.25 110.266 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.96 -18.73 63.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.684 0.794 . . . . 74.44 112.948 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.3 44.85 26.85 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 125.436 1.493 . . . . 74.23 109.574 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.792 1.034 . . . . 63.32 113.792 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 mm 48.54 102.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.799 2.44 . . . . 61.23 109.987 -160.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.5 142.99 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.676 -1.601 . . . . 73.51 106.676 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.38 123.94 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.028 2.531 . . . . 51.15 106.989 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -51.18 -44.78 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 70.02 111.511 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.26 -27.53 73.59 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.938 -0.924 . . . . 74.23 111.751 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -73.94 -44.39 55.1 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.832 1.316 . . . . 74.03 110.079 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -53.86 -53.45 52.35 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.597 1.159 . . . . 75.01 109.115 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 33' ' ' PHE . 93.0 t -56.51 -48.77 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.25 0.62 . . . . 60.1 111.033 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.13 -32.23 73.83 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.907 -1.12 . . . . 71.2 112.864 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.1 -36.74 19.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.742 1.217 . . . . 72.14 110.79 171.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.547 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 35.1 m-85 -84.79 -45.69 12.11 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.69 -0.856 . . . . 73.22 108.69 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.6 m-30 -68.43 -21.42 64.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.603 1.547 . . . . 72.4 111.62 -169.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 9.9 mtpt -86.87 -16.91 34.66 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.174 1.39 . . . . 74.21 112.029 172.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -57.43 2.18 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 120.587 1.539 . . . . 64.21 108.153 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.4 m-30 -86.12 40.01 0.85 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.125 1.77 . . . . 65.43 108.245 -174.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 33.0 mttt -49.99 -44.41 50.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.032 1.333 . . . . 35.11 108.639 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -56.63 -25.15 52.44 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 126.535 1.934 . . . . 73.23 114.229 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -112.93 12.39 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.645 1.578 . . . . 75.25 112.057 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.33 106.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.842 -1.54 . . . . 51.22 106.842 159.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.16 152.98 25.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.5 -0.926 . . . . 64.21 108.5 164.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -118.32 142.25 47.7 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.635 -2.358 . . . . 74.3 104.635 158.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.52 159.02 20.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.308 -1.738 . . . . 74.24 106.308 156.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.71 -37.7 85.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.253 1.421 . . . . 63.31 110.285 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.16 -27.47 61.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.167 0.987 . . . . 70.43 111.151 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.04 5.37 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.043 1.306 . . . . 74.25 114.432 159.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.9 -86.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.642 1.177 . . . . 61.12 110.726 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.48 137.04 4.76 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 120.795 -1.19 . . . . 61.1 110.539 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -142.62 167.77 21.3 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.98 0.89 . . . . 74.45 111.026 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 33' ' ' PHE . 5.3 mt -142.25 140.15 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.95 2.1 . . . . 74.12 105.464 163.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 126.96 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.169 1.788 . . . . 33.02 108.737 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.96 -3.51 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.845 1.258 . . . . 52.45 111.63 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.05 -16.61 57.77 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 120.373 1.442 . . . . 70.41 113.294 -170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -23.95 66.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.461 1.131 . . . . 73.42 112.712 171.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.74 -15.16 26.36 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.546 1.538 . . . . 52.4 113.169 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.48 6.34 3.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.642 1.577 . . . . 73.11 114.924 173.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.49 148.44 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.907 2.083 . . . . 72.2 107.448 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.04 158.4 25.9 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.398 1.094 . . . . 73.01 110.96 169.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.25 161.28 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 129.027 2.931 . . . . 63.14 107.382 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -75.11 152.06 38.57 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.124 -0.985 . . . . 75.41 109.416 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -145.18 -171.91 3.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.703 0.801 . . . . 71.34 109.25 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -140.14 137.53 34.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.075 -1.454 . . . . 71.32 107.075 168.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.97 113.38 19.14 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.777 -1.194 . . . . 71.32 107.777 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.31 -29.87 71.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.341 0.656 . . . . 74.24 112.195 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -30.69 5.68 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.676 1.991 . . . . 73.33 112.732 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.28 11.53 1.74 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.437 0.695 . . . . 65.31 111.956 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.36 46.36 26.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.279 1.431 . . . . 50.41 112.252 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.0 163.28 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 126.086 1.754 . . . . 73.22 109.827 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.68 148.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.816 1.246 . . . . 73.15 109.281 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.91 -179.39 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.936 1.695 . . . . 43.11 110.741 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' HE2' ' A' ' 72' ' ' LYS . 1.5 p30 -86.17 172.26 10.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.341 1.456 . . . . 51.35 110.896 155.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -145.01 170.02 16.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.591 1.556 . . . . 64.12 108.226 141.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -99.46 -19.47 16.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.75 1.22 . . . . 61.13 113.846 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 mt 64.1 155.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.01 1.724 . . . . 73.34 110.145 -163.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.14 -63.89 1.29 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.6 -1.63 . . . . 71.13 106.6 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -130.21 152.45 49.62 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.9 0.88 . . . . 72.41 110.267 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.49 153.74 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 107.373 -1.344 . . . . 74.53 107.373 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.78 153.86 50.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.557 1.543 . . . . 74.24 108.184 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.567 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -145.36 160.39 41.61 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.753 -0.832 . . . . 73.31 108.753 173.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -151.83 161.47 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.733 -1.58 . . . . 75.53 106.733 162.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 151' ' ' HIS . 18.5 ttpt -91.29 150.13 21.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.427 -1.421 . . . . 62.34 109.286 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -141.63 164.43 30.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.145 0.978 . . . . 74.2 108.982 -177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 67.6 m -157.4 127.66 6.35 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.97 -1.863 . . . . 72.15 105.97 150.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.22 -169.14 37.48 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.873 1.215 . . . . 75.31 110.208 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.536 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.53 146.7 32.5 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.096 -0.65 . . . . 75.12 109.462 178.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.16 163.58 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.994 -1.484 . . . . 73.53 106.994 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.0 mm -78.86 132.78 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.975 -0.75 . . . . 74.54 108.975 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -111.37 80.59 1.33 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.965 -1.865 . . . . 72.54 105.965 169.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.48 123.94 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.175 -2.528 . . . . 73.54 104.175 158.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.3 m -114.68 161.89 17.53 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 105.906 -1.887 . . . . 73.24 105.906 160.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -139.75 163.35 32.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.949 1.299 . . . . 75.41 108.061 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.94 -27.76 61.43 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.899 1.227 . . . . 52.41 112.072 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -60.5 -8.16 2.59 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.229 1.811 . . . . 73.15 112.253 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 65.08 13.58 8.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.435 2.294 . . . . 75.52 110.977 -161.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 154.56 38.05 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.31 -1.367 . . . . 65.12 107.31 170.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.01 168.78 13.52 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.744 2.018 . . . . 74.52 108.744 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.62 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -152.08 -168.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.907 1.683 . . . . 75.34 110.452 -173.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.55 132.98 17.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 112.757 0.651 . . . . 73.24 112.757 169.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 159.31 41.47 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.826 1.25 . . . . 72.25 110.417 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.6 m -72.15 -0.12 11.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.262 1.208 . . . . 71.3 114.262 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.553 ' CD2' ' H ' ' A' ' 102' ' ' ASP 0.306 0.1 OUTLIER 96.19 -61.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 1 C-N-CA 132.399 4.28 . . . . 72.22 107.66 -155.695 . . . . . . . . 5 4 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.553 ' H ' ' CD2' ' A' ' 101' ' ' HIS . 81.1 m-20 -92.93 82.57 4.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.202 -1.777 . . . . 74.22 106.202 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -124.38 136.5 27.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.077 1.751 . . . . 73.5 107.938 158.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.08 134.21 33.41 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.162 2.574 . . . . 73.13 110.719 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.66 -172.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.955 1.302 . . . . 73.45 108.065 168.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -124.85 141.35 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.609 1.55 . . . . 64.35 110.644 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.76 163.11 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.666 1.186 . . . . 52.15 109.808 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 p -82.4 127.96 33.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.873 0.733 . . . . 60.55 109.298 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 92.9 4.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.396 -2.816 . . . . 73.45 103.396 154.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m 66.22 -13.73 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.43 2.692 . . . . 62.32 116.78 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.65 -0.24 4.99 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.547 0.594 . . . . 74.01 111.675 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 148.37 31.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.297 -1.001 . . . . 73.12 108.297 156.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.45 127.31 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.928 1.291 . . . . 74.2 107.809 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 tp -126.59 158.89 35.08 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.357 1.063 . . . . 73.3 108.376 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -124.2 106.02 9.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.846 2.459 . . . . 72.42 109.655 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -140.02 169.84 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.914 2.486 . . . . 74.01 109.317 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.81 144.81 29.88 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.353 0.661 . . . . 74.34 110.466 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.11 61.72 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.923 1.083 . . . . 74.12 113.923 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -21.98 65.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.998 0.919 . . . . 42.35 112.123 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.3 mtm -89.65 -26.87 20.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.516 1.053 . . . . 61.51 112.337 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.79 62.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 128.733 2.813 . . . . 55.35 110.698 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -79.86 -174.51 4.43 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.063 1.345 . . . . 72.54 109.536 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.09 0.22 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 127.142 2.177 . . . . 74.13 113.034 166.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.66 -3.52 77.41 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.96 1.743 . . . . 60.11 112.998 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.32 169.73 10.64 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.364 1.082 . . . . 70.3 111.887 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 6.9 m-85 -123.17 113.13 18.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.905 2.882 . . . . 71.1 107.213 171.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.93 136.83 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.467 1.107 . . . . 74.25 108.672 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -72.49 121.86 20.32 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.833 -0.803 . . . . 70.25 108.833 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.471 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.9 pp -126.24 150.26 69.39 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.635 1.174 . . . . 65.33 111.472 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.28 138.19 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.49 2.793 . . . . 64.25 109.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -167.57 1.87 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.682 -1.599 . . . . 65.14 106.682 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -23.25 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 129.386 3.075 . . . . 75.11 112.317 -160.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -120.68 0.33 10.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.044 2.537 . . . . 65.13 110.134 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 48.8 p -139.01 165.3 27.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.368 1.067 . . . . 71.14 112.71 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -79.31 156.34 4.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.625 0.726 . . . . 74.52 109.67 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -139.48 -175.86 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.017 2.127 . . . . 72.5 107.981 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 89.6 mt -114.78 164.55 13.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.498 -0.927 . . . . 61.32 108.498 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -151.26 158.73 44.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.13 -1.063 . . . . 62.04 108.13 160.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 14.6 tt0 -92.01 152.27 20.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.286 0.634 . . . . 75.31 109.346 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.01 1.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.241 1.416 . . . . 72.21 112.696 -168.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.9 pt 24.74 -83.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 128.325 2.65 . . . . 73.3 116.232 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.461 ' H ' HG13 ' A' ' 141' ' ' ILE . 8.2 tppt? -95.24 123.3 38.67 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.039 1.336 . . . . 63.01 108.225 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.21 104.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 123.606 1.67 . . . . 74.11 109.226 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.65 -156.28 0.75 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.965 1.706 . . . . 72.34 106.517 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -131.13 167.47 19.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.568 1.547 . . . . 73.14 108.232 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.59 178.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.708 1.603 . . . . 52.21 106.928 160.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -122.13 137.71 54.72 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.659 -1.237 . . . . 75.22 107.659 160.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.532 ' C ' HD22 ' A' ' 149' ' ' ASN . 44.6 t80 -141.53 134.11 28.43 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.523 1.929 . . . . 73.01 109.699 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.532 HD22 ' C ' ' A' ' 148' ' ' TYR . 2.7 m120 -132.45 28.07 4.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.377 1.444 . . . . 74.42 112.85 -160.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -132.94 -170.6 12.51 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.798 1.19 . . . . 55.32 110.953 -164.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.567 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 72.9 m80 -74.36 149.09 40.72 Favored 'General case' 0 CA--C 1.522 -0.107 0 O-C-N 121.033 -1.275 . . . . 72.03 109.704 168.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 25.6 pt -108.52 149.79 11.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 125.499 1.52 . . . . 74.22 107.661 173.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.51 147.14 52.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.857 1.263 . . . . 71.33 110.714 -161.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -144.81 152.49 40.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.249 1.019 . . . . 63.43 109.476 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.19 119.69 25.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.142 1.377 . . . . 51.01 108.767 -166.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -37.39 87.03 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.285 1.217 . . . . 51.23 114.285 -166.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.8 t 25.24 73.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.202 2.601 . . . . 63.31 113.971 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.13 -3.45 39.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.847 -1.158 . . . . 75.35 113.558 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.26 -61.18 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.841 1.256 . . . . 72.41 108.981 -165.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -108.48 -10.27 15.29 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.112 1.365 . . . . 72.41 111.839 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.0 m170 52.43 21.81 1.88 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.314 1.846 . . . . 75.54 112.152 -166.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -142.18 153.72 44.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.822 -1.174 . . . . 73.5 109.007 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 179.39 9.25 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.868 1.267 . . . . 74.0 111.035 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.3 mm -105.63 137.12 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.783 -1.562 . . . . 73.23 106.783 168.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.59 153.65 30.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.484 1.114 . . . . 41.13 108.463 169.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 136.51 -161.7 25.04 Favored Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.947 1.249 . . . . 74.23 112.254 169.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -101.82 170.48 8.12 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.167 1.984 . . . . 74.11 111.743 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.06 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.162 3.385 . . . . 75.03 112.51 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -121.66 -13.05 8.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.364 1.466 . . . . 74.43 112.108 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.2 176.47 39.14 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 122.782 1.212 . . . . 44.22 111.322 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 97' ' ' ILE . 6.4 m-85 -123.84 161.39 25.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.405 2.282 . . . . 72.32 107.053 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -107.42 101.3 10.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.276 -1.75 . . . . 74.51 106.276 -171.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.12 173.26 12.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.586 0.63 . . . . 71.43 110.133 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.87 129.68 42.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.145 -1.428 . . . . 71.13 107.145 162.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.3 171.59 8.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.575 -2.009 . . . . 71.43 105.575 144.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.534 0.363 0 CA-C-N 119.083 0.856 . . . . 71.22 109.754 145.573 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 118.939 -0.553 . . . . 53.12 109.999 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.49 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 7.0 mp -84.17 171.0 13.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.326 1.05 . . . . 44.31 110.887 174.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.07 156.75 17.17 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.801 -1.187 . . . . 63.52 110.679 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.53 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.0 t80 -44.75 -51.79 9.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.262 2.625 . . . . 74.24 110.439 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.97 10.3 19.35 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.189 0.811 . . . . 75.3 113.189 -167.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.23 118.56 72.77 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.375 -1.713 . . . . 62.31 106.375 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -66.53 130.48 23.73 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.437 2.091 . . . . 62.55 109.839 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 pt -93.29 160.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 64.41 109.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' ' 169' ' ' GLU . 50.6 m-85 -114.85 72.9 0.8 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.084 -1.08 . . . . 74.33 108.084 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.48 160.38 5.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.073 -1.421 . . . . 74.45 108.592 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.05 -44.82 51.77 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.907 0.755 . . . . 32.01 109.731 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -94.31 -17.59 22.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.74 -0.664 . . . . 74.04 112.087 -168.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.04 32.74 4.56 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 121.444 -0.785 . . . . 61.42 113.851 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.59 -17.58 64.15 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.568 1.321 . . . . 73.33 114.568 -170.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 mm 39.73 92.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 129.041 2.936 . . . . 41.4 111.992 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 154.25 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.465 1.106 . . . . 55.22 108.455 -176.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -64.45 130.65 44.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.066 -1.457 . . . . 64.24 107.066 173.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.401 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -46.69 -46.91 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 122.489 1.138 . . . . 72.23 108.627 169.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -48.73 -64.7 3.04 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 128.484 2.945 . . . . 44.22 110.616 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -54.96 -49.05 72.34 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.014 2.126 . . . . 74.12 111.38 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -54.62 -49.19 71.09 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.787 0.835 . . . . 70.33 111.244 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 55.9 t -80.8 -38.27 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.983 -1.008 . . . . 73.12 109.45 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -55.17 -45.27 75.72 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.474 0.579 . . . . 65.33 110.68 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -31.07 70.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.783 -1.198 . . . . 74.21 112.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.91 -55.96 7.28 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 116.334 -1.793 . . . . 74.51 109.187 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.45 -44.43 45.67 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 123.104 2.683 . . . . 73.53 112.125 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -74.2 -18.87 60.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.126 2.17 . . . . 71.53 111.896 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -67.76 0.78 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.159 -2.163 . . . . 74.12 105.159 166.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -79.77 39.65 0.43 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.469 2.708 . . . . 62.14 110.999 -167.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -59.79 -28.05 67.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.211 -0.931 . . . . 61.41 111.52 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.46 -23.17 65.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.217 1.407 . . . . 64.24 113.222 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.85 8.05 28.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.812 1.245 . . . . 65.3 111.186 -168.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.22 96.81 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.087 -1.079 . . . . 72.01 108.087 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.78 157.56 27.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.432 -0.951 . . . . 63.34 108.432 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.09 157.7 18.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.632 -1.618 . . . . 71.13 106.632 168.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 169.31 17.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.771 -1.104 . . . . 52.23 109.556 163.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -63.04 1.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.777 2.031 . . . . 61.21 108.68 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -59.57 -21.15 59.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.041 1.336 . . . . 74.11 111.179 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.57 -26.86 2.63 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.208 -1.329 . . . . 72.3 114.168 155.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -25.39 -85.5 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.812 3.245 . . . . 73.01 114.699 -162.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.54 128.28 2.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.232 -1.547 . . . . 42.4 109.232 -166.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -153.6 162.55 41.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.875 1.337 . . . . 73.54 111.245 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -150.73 129.84 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.78 1.632 . . . . 70.43 107.419 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.86 130.62 43.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.024 0.829 . . . . 62.12 109.472 162.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -134.0 16.24 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.163 0.985 . . . . 72.41 111.284 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.98 -29.95 36.33 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.876 2.179 . . . . 63.53 114.433 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -69.68 -24.62 63.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.929 1.291 . . . . 64.24 113.925 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.97 -10.09 12.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.93 1.241 . . . . 74.31 113.805 -174.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.44 14.67 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.441 2.696 . . . . 72.3 115.119 173.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mt -68.75 117.59 11.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.484 1.114 . . . . 75.33 108.575 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.24 157.43 23.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.488 1.137 . . . . 65.31 110.24 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.8 tt -153.29 153.13 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.228 -1.768 . . . . 73.32 106.228 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -67.32 106.35 2.04 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.78 0.718 . . . . 71.35 109.561 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -87.44 172.79 9.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.418 1.087 . . . . 52.44 108.18 165.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.3 OUTLIER -141.83 136.74 30.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.069 -1.826 . . . . 61.51 106.069 167.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.57 119.36 24.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.345 -0.983 . . . . 74.25 108.345 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -63.15 -24.03 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 74.4 111.235 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.08 -33.48 2.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 128.541 2.736 . . . . 74.33 111.81 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 m -157.71 10.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.855 1.262 . . . . 54.13 112.768 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mp 55.75 54.32 8.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.423 1.489 . . . . 75.42 110.751 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.43 158.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.216 1.807 . . . . 72.3 109.619 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 119.73 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.086 1.354 . . . . 75.22 108.686 -164.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -132.4 157.74 43.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.833 1.253 . . . . 73.05 112.038 -168.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -104.85 106.84 17.51 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 126.322 1.849 . . . . 75.33 108.378 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.614 ' NZ ' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -151.72 141.23 21.64 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.403 -1.702 . . . . 74.42 106.403 -174.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -94.91 175.06 6.79 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.098 -1.001 . . . . 73.25 110.936 -166.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.0 mt -97.44 148.49 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.052 1.741 . . . . 73.31 108.147 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.98 -55.2 2.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.214 -0.661 . . . . 74.14 109.214 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.415 HH11 ' HB2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -119.63 152.2 37.45 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.051 -1.03 . . . . 75.51 109.812 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.615 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.73 158.88 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.225 1.81 . . . . 65.22 107.546 171.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -129.53 175.68 8.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.031 1.333 . . . . 53.01 108.046 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.579 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 1.5 tmm_? -173.66 152.27 2.03 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.938 1.695 . . . . 72.21 109.297 157.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -140.61 161.72 37.09 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.161 2.185 . . . . 73.34 107.376 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -95.26 148.07 22.8 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.196 -0.94 . . . . 71.13 109.46 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -144.91 156.19 43.85 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.735 1.214 . . . . 74.04 108.949 -171.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 2.4 p -159.77 106.01 1.63 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.187 0.995 . . . . 63.11 109.784 165.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.69 -178.11 45.26 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.423 -0.671 . . . . 63.2 111.423 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.18 138.25 34.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.458 -0.782 . . . . 71.33 110.37 170.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.02 159.8 18.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.234 1.413 . . . . 70.21 109.399 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mm -83.51 139.97 16.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.624 1.169 . . . . 75.41 107.977 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -129.27 77.35 1.78 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.655 2.382 . . . . 75.21 106.662 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.1 138.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.896 -1.89 . . . . 64.52 105.896 159.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.1 m -119.06 155.29 31.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.407 -2.072 . . . . 74.1 105.407 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 p -131.78 171.76 13.12 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.794 -1.191 . . . . 62.25 108.361 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -56.5 -27.81 58.21 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.759 1.392 . . . . 75.14 114.759 -166.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.42 0.49 19.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.912 2.085 . . . . 73.04 113.935 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 61.49 17.79 8.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.256 1.423 . . . . 65.23 111.89 -163.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.59 158.82 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.064 -1.828 . . . . 75.31 106.064 159.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.82 163.59 1.43 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 128.342 2.657 . . . . 71.0 106.298 -171.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -145.36 169.04 7.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.816 1.646 . . . . 65.32 106.629 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.48 100.33 3.85 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.156 0.889 . . . . 74.34 109.954 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.54 168.87 26.05 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.506 -0.746 . . . . 72.35 112.612 -165.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.8 m -60.44 156.04 16.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.943 1.297 . . . . 73.54 107.784 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -73.64 6.11 3.39 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.219 -0.926 . . . . 74.32 111.013 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -136.86 36.93 2.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.063 1.345 . . . . 62.21 109.652 -171.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -105.7 129.29 24.89 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 126.071 1.748 . . . . 73.42 108.48 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -65.88 152.7 80.77 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.552 2.168 . . . . 70.03 114.096 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -148.18 173.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.531 2.732 . . . . 41.23 108.055 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.59 137.63 53.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.388 1.075 . . . . 72.11 108.556 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.99 162.42 36.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.848 1.259 . . . . 75.52 108.705 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -87.94 108.45 19.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.613 -0.884 . . . . 70.02 108.613 172.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -78.3 69.09 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 162.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 59.64 13.46 3.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.97 1.47 . . . . 75.32 114.97 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.93 -18.99 5.28 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 120.817 -1.177 . . . . 73.43 112.103 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.55 144.86 33.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.634 -1.988 . . . . 72.22 105.634 162.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -88.45 145.36 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.97 -0.752 . . . . 73.31 108.97 167.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.02 146.7 25.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.211 1.404 . . . . 74.44 108.153 -173.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -102.02 131.59 48.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 118.517 -0.754 . . . . 65.3 110.666 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.9 pt -143.14 -178.81 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.147 1.779 . . . . 74.12 108.625 168.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -78.37 156.15 29.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.781 -1.199 . . . . 74.51 112.989 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.66 -48.33 39.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.823 2.449 . . . . 72.03 111.128 164.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.37 -8.84 28.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.073 1.138 . . . . 75.13 114.073 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.1 mmt -94.31 -38.58 10.93 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.714 1.205 . . . . 70.34 110.968 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.11 60.93 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.853 1.661 . . . . 71.34 109.12 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -171.86 3.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.618 1.567 . . . . 62.33 109.433 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.07 -0.62 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 126.3 1.84 . . . . 72.2 113.045 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.03 -14.19 61.05 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 116.838 -2.09 . . . . 73.35 112.206 171.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.82 179.64 4.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.786 2.293 . . . . 60.5 108.726 -163.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.48 136.71 53.65 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.475 0.71 . . . . 75.41 111.753 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.509 HG23 ' OD1' ' A' ' 138' ' ' ASP . 15.5 tt -111.4 150.15 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.36 1.464 . . . . 71.15 109.335 -170.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.49 103.47 15.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.2 1.0 . . . . 73.25 110.689 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.08 156.72 36.77 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.185 0.994 . . . . 64.41 111.168 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.77 154.08 38.67 Favored 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.486 -1.39 . . . . 51.33 108.486 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -119.38 -157.33 0.69 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.437 -2.06 . . . . 75.34 105.437 162.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -48.5 -71.27 0.07 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.531 1.132 . . . . 62.54 111.863 -171.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -120.37 0.12 10.5 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.874 1.669 . . . . 74.34 111.635 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.8 p -131.82 -172.55 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.217 1.807 . . . . 65.42 111.045 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.85 157.05 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.119 -1.437 . . . . 62.05 107.119 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -136.38 179.19 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.523 -1.658 . . . . 74.13 106.523 167.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 108' ' ' SER . 1.3 mp -108.06 162.19 14.27 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.672 0.749 . . . . 74.24 109.892 168.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 127' ' ' ILE . 20.4 p-10 -148.05 160.61 42.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.183 2.593 . . . . 71.42 107.687 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 140.48 43.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.621 1.968 . . . . 73.35 109.606 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.258 33.8 t -78.62 1.46 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 130.075 3.35 . . . . 74.14 115.005 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.4 pt 25.07 -70.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 130.096 3.358 . . . . 73.53 117.681 167.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.556 ' H ' HG13 ' A' ' 141' ' ' ILE . 9.8 ttmt -117.72 125.16 50.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.516 2.727 . . . . 61.43 107.467 172.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.77 128.36 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.397 -1.705 . . . . 74.25 106.397 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -143.14 -179.23 6.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.964 1.706 . . . . 73.12 107.902 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 p -134.2 157.07 47.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.306 1.042 . . . . 74.41 110.878 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 m -127.24 -175.57 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.849 1.66 . . . . 71.11 108.717 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.88 133.36 43.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.704 1.201 . . . . 74.04 109.963 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.616 ' C ' HD22 ' A' ' 149' ' ' ASN . 1.3 t80 -146.95 124.61 11.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 122.481 0.312 . . . . 73.4 110.758 -165.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.616 HD22 ' C ' ' A' ' 148' ' ' TYR . 1.9 m120 -130.27 52.55 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.477 -0.765 . . . . 64.15 109.265 -162.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.78 -179.65 34.73 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.681 -0.968 . . . . 64.21 110.681 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' HIS . . . . . 0.579 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 69.6 m80 -65.18 144.67 57.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.064 1.346 . . . . 75.12 113.045 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.5 pt -129.56 156.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.535 2.334 . . . . 74.23 109.018 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.91 163.73 37.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.26 1.024 . . . . 63.02 110.301 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 0.4 OUTLIER -116.53 -91.06 0.54 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.669 -1.234 . . . . 74.03 107.669 -172.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 5.7 mt 159.6 161.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 1 C-N-CA 133.274 4.63 . . . . 73.21 107.66 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -83.71 -82.93 0.15 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.189 -1.041 . . . . 70.13 108.189 167.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.614 HG13 ' NZ ' ' A' ' 72' ' ' LYS . 48.9 t 56.93 64.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 124.145 1.926 . . . . 54.23 110.688 -171.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' A' ' 76' ' ' ARG . 3.0 pt-20 -81.54 0.23 39.04 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 113.467 -1.697 . . . . 73.41 114.039 -171.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.511 ' HB3' ' HE3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -86.16 -46.23 10.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.973 0.909 . . . . 74.23 110.453 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.45 -23.73 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.487 1.115 . . . . 73.54 110.228 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 53.67 21.26 2.53 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 128.47 2.708 . . . . 71.31 113.411 -159.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.401 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.1 p -149.89 151.81 34.05 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.088 -1.633 . . . . 64.32 111.743 -174.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.759 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.3 p90 -149.06 178.97 8.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.885 1.274 . . . . 75.31 111.285 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.95 119.01 58.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 C-N-CA 124.785 1.234 . . . . 70.23 108.859 171.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -151.39 158.41 43.69 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.098 -1.001 . . . . 71.31 110.806 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 142.42 -158.76 27.04 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.611 1.101 . . . . 35.12 110.646 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -99.55 176.53 5.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.785 1.293 . . . . 73.34 110.678 166.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.54 -91.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 128.559 2.743 . . . . 73.04 111.657 -168.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.467 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -122.78 -1.96 8.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.676 2.39 . . . . 72.41 113.366 176.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 82.66 165.9 37.85 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.382 1.468 . . . . 51.43 114.34 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 66.0 m-85 -108.68 151.78 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.823 2.449 . . . . 74.33 107.609 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.68 102.96 15.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.124 -1.435 . . . . 72.0 107.124 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 105' ' ' VAL . 6.2 m -130.76 176.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 118.535 0.607 . . . . 74.43 111.457 -169.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -68.6 145.8 53.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.14 110.652 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -138.15 62.95 1.55 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.711 2.804 . . . . 73.21 107.092 168.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t . . . . . 0 CA--C 1.532 0.28 0 O-C-N 120.357 -1.464 . . . . 71.13 109.103 174.738 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtm . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 106.345 -1.724 . . . . 64.44 106.345 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.34 173.65 11.38 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.284 0.564 . . . . 52.11 110.695 -175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.8 m -81.21 -63.04 1.49 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.414 1.086 . . . . 52.34 108.524 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.04 -150.37 1.83 Allowed Glycine 0 C--N 1.341 0.829 0 N-CA-C 109.702 -1.359 . . . . 73.02 109.702 171.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 60.99 -174.18 0.13 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.62 1.168 . . . . 73.33 110.384 -166.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.4 84.48 0.1 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.125 1.77 . . . . 74.0 111.39 -174.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.04 -169.03 39.42 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.477 1.513 . . . . 72.41 112.864 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . -177.44 170.75 2.04 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 128.078 2.551 . . . . 72.02 107.67 165.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.32 156.82 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.786 2.034 . . . . 72.35 110.345 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.12 158.93 27.31 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.025 0.441 . . . . 40.42 110.404 172.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 26.7 t80 -53.23 -36.98 61.65 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.743 1.617 . . . . 72.4 114.008 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -111.49 33.87 4.46 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.08 1.752 . . . . 71.33 110.995 -170.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.38 124.16 70.28 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 107.51 -1.293 . . . . 64.3 107.51 162.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -61.17 156.82 42.97 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.463 2.109 . . . . 73.22 113.399 164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.64 -5.05 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.786 1.634 . . . . 41.43 113.604 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 11.0 m-85 47.64 76.87 0.1 Allowed 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.625 1.57 . . . . 64.14 113.158 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.5 OUTLIER -52.69 160.19 0.95 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.814 -0.63 . . . . 74.24 110.065 168.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.59 0.32 0.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.712 1.205 . . . . 62.11 112.255 167.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -118.13 -16.85 9.72 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 126.883 2.073 . . . . 74.15 111.507 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.23 38.29 7.32 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.787 0.708 . . . . 14.3 112.457 169.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.19 -16.42 64.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.717 1.377 . . . . 44.2 114.717 -167.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.269 31.3 mm 35.85 66.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 128.66 2.784 . . . . 64.22 110.514 -174.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.39 151.83 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 127.965 2.506 . . . . 75.34 108.59 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -64.93 127.0 29.77 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.214 2.605 . . . . 73.23 107.779 172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -51.23 -41.4 24.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.245 0.618 . . . . 74.04 111.386 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -68.44 -41.44 85.01 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.006 -0.886 . . . . 41.31 111.136 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.7 -40.97 92.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.661 1.23 . . . . 73.55 110.674 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -57.34 -57.16 13.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 123.992 0.917 . . . . 72.41 108.845 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG13 HG21 ' A' ' 77' ' ' VAL . 53.4 t -56.16 -50.9 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 109.131 -0.692 . . . . 73.52 109.131 175.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.35 -32.45 73.84 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.461 1.028 . . . . 63.3 112.028 -167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.6 tttt -48.18 -47.13 35.43 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 119.366 0.984 . . . . 75.45 108.874 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 24.7 m-85 -68.6 -43.71 75.88 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 108.494 -0.928 . . . . 63.11 108.494 -178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CD1' HD12 ' A' ' 50' ' ' ILE . 5.6 m-85 -63.93 -22.03 66.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 119.24 0.927 . . . . 73.34 112.132 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -93.9 -20.02 20.42 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 125.298 1.439 . . . . 72.13 112.507 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -94.46 -52.59 4.26 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 120.378 1.445 . . . . 70.54 107.701 173.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.2 m-30 -90.13 43.02 1.12 Allowed 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 126.891 2.076 . . . . 74.45 108.23 -175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -54.24 -42.18 69.6 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.923 1.689 . . . . 74.31 109.205 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.3 p30 -65.17 -27.89 69.02 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.849 0.86 . . . . 75.12 111.862 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.87 -5.16 58.21 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.004 1.721 . . . . 74.33 112.291 -176.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.3 mt -59.47 95.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 120.829 1.65 . . . . 74.23 108.951 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -81.0 142.88 32.97 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.965 -1.495 . . . . 75.44 106.965 168.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.8 mmtm -107.46 150.26 26.99 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.487 -1.301 . . . . 63.31 107.487 164.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.4 170.58 16.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.765 0.826 . . . . 72.45 108.805 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -61.19 -42.68 99.0 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.58 0.752 . . . . 64.35 110.093 168.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.91 2.62 2.49 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.918 1.287 . . . . 63.44 112.457 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.56 46.46 54.94 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 125.919 1.723 . . . . 65.13 111.351 169.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.64 -100.26 0.07 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 109.126 -0.694 . . . . 74.14 109.126 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 138.4 112.44 1.08 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 126.343 1.925 . . . . 71.0 108.721 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -137.05 159.3 42.29 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.136 1.774 . . . . 73.44 108.418 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.424 HD12 ' CD1' ' A' ' 33' ' ' PHE . 39.6 mt -142.48 142.22 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 106.608 -1.627 . . . . 64.52 106.608 170.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 133.45 43.34 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.987 0.915 . . . . 71.32 108.788 165.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 52' ' ' ILE . 1.5 pp -129.95 12.22 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.799 -0.637 . . . . 73.33 110.573 172.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.59 -22.31 16.78 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.208 0.913 . . . . 63.04 112.184 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -73.97 -25.38 59.91 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.844 1.258 . . . . 63.14 112.454 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.35 -22.97 64.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.461 1.028 . . . . 74.44 110.558 167.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m120 61.56 -6.42 0.12 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.952 1.464 . . . . 73.25 114.952 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -45.78 143.81 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 128.377 2.671 . . . . 74.32 110.997 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -102.86 134.76 45.73 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.3 0.955 . . . . 73.53 112.137 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 13.4 tt -104.33 148.38 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.802 1.641 . . . . 74.15 107.581 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -69.99 112.84 6.67 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 106.436 -1.69 . . . . 74.23 106.436 165.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 t -107.43 -166.42 1.15 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.126 -1.435 . . . . 43.35 107.126 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.0 159.62 44.45 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.709 -1.589 . . . . 75.31 106.709 167.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -113.91 116.76 29.77 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.966 1.306 . . . . 62.5 110.374 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.7 ttpm? -57.32 -26.79 61.48 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.865 1.666 . . . . 64.42 113.148 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 mt -61.25 -22.21 64.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.638 1.575 . . . . 74.53 112.453 -174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.2 m -149.1 10.47 0.79 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.159 0.984 . . . . 61.13 112.436 172.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt 54.3 49.37 18.68 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.848 1.309 . . . . 75.13 109.542 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.7 pt -108.44 151.7 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 C-N-CA 124.876 1.27 . . . . 73.44 108.636 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.96 124.15 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.046 -1.835 . . . . 74.22 106.046 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -143.15 179.49 7.03 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.831 1.652 . . . . 73.22 107.758 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -78.97 168.83 19.14 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.967 0.907 . . . . 63.21 110.679 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.55 175.78 13.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.643 -1.243 . . . . 64.53 107.643 140.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -105.28 136.78 44.17 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.697 1.199 . . . . 74.23 108.72 168.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.89 157.29 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.742 1.217 . . . . 73.5 107.77 170.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 158' ' ' GLU . 37.4 mt -117.99 -43.65 2.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.261 0.624 . . . . 73.5 110.815 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.433 ' H ' ' HB ' ' A' ' 156' ' ' THR . 53.1 mtt180 -138.18 165.02 27.71 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.773 -1.204 . . . . 73.34 109.325 169.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.457 HG21 HG13 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -128.56 168.13 22.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 124.862 1.265 . . . . 53.04 108.924 173.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -135.7 155.6 50.15 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.798 1.239 . . . . 74.35 109.116 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -139.07 144.68 38.87 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.548 -1.278 . . . . 72.14 107.548 167.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -141.03 169.01 18.42 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.181 1.393 . . . . 71.12 107.774 169.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.1 tttt -103.92 147.41 27.37 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.224 -1.028 . . . . 75.11 108.224 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -145.91 149.32 34.02 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 125.757 1.623 . . . . 74.34 107.335 -173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 1.4 m -144.64 131.88 20.64 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 106.393 -1.706 . . . . 61.14 106.393 159.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.77 -169.57 40.81 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.379 -1.088 . . . . 40.23 110.379 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 123.73 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.057 -0.719 . . . . 74.02 109.057 176.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 93.7 mt -102.31 149.17 24.61 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.64 -0.874 . . . . 63.44 108.64 175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.6 mm -79.48 138.88 19.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 126.205 1.802 . . . . 71.3 106.993 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -122.95 43.7 2.86 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.742 0.817 . . . . 72.21 112.527 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 96' ' ' GLU . 8.8 mt -46.33 114.79 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.656 0 C-N-CA 126.894 2.077 . . . . 71.41 106.747 -175.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 m -90.6 169.17 11.23 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.721 -1.585 . . . . 54.15 106.721 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.7 p -133.9 171.94 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 O-C-N 121.136 -0.977 . . . . 73.44 108.927 157.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -53.82 -38.4 64.54 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.314 -0.866 . . . . 75.53 111.986 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.418 HD22 ' CG ' ' A' ' 138' ' ' ASP . 41.1 m-80 -72.31 20.03 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.469 2.307 . . . . 74.14 112.473 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 49.23 27.08 1.71 Allowed 'General case' 0 C--O 1.233 0.235 0 C-N-CA 128.1 2.56 . . . . 75.44 113.065 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.42 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -65.85 159.89 24.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 O-C-N 120.85 -1.156 . . . . 73.05 108.437 163.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' ILE . 1.8 pp20? -170.37 167.08 8.47 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.98 1.712 . . . . 73.14 107.928 166.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.549 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -146.75 174.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 127.145 2.178 . . . . 71.45 107.88 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -141.72 84.13 1.88 Allowed 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.861 -0.792 . . . . 65.22 108.861 -171.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.528 HD22 ' CD2' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -142.02 174.37 10.66 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.061 0.944 . . . . 64.33 112.58 -168.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 168.95 8.57 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.156 2.182 . . . . 73.32 111.684 -176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.95 -33.27 24.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.364 -0.606 . . . . 65.31 109.364 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -91.63 39.27 1.0 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.787 0.835 . . . . 71.42 110.872 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.528 ' CD2' HD22 ' A' ' 99' ' ' LEU . 4.2 t60 -91.78 123.03 64.48 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.208 -1.377 . . . . 75.12 110.077 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.77 124.15 12.35 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.159 2.573 . . . . 63.01 110.412 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.1 m -141.28 173.69 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 125.746 1.619 . . . . 73.13 108.336 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -113.69 149.64 34.43 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 123.049 0.54 . . . . 74.43 110.761 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.12 164.38 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.973 1.309 . . . . 74.24 109.735 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.1 p -79.93 131.81 35.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.082 0.944 . . . . 64.3 108.474 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -109.1 78.06 1.11 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.812 -1.551 . . . . 72.52 106.812 153.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m 61.38 14.96 6.15 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.511 1.524 . . . . 74.12 113.319 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 136.46 -24.48 3.2 Favored Glycine 0 CA--C 1.521 0.435 0 O-C-N 120.795 -1.191 . . . . 72.11 111.713 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -89.98 143.32 26.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.552 -1.277 . . . . 61.25 107.552 176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -78.18 126.64 38.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.77 -1.937 . . . . 63.13 105.77 166.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.0 tp -125.93 159.24 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.653 -0.869 . . . . 73.13 108.653 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -119.91 119.49 33.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 126.207 1.803 . . . . 73.03 109.28 -171.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 116' ' ' ILE . 6.9 pt -140.58 179.64 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.262 1.025 . . . . 71.03 110.688 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -81.6 139.57 34.95 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.62 1.968 . . . . 71.32 110.719 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.24 -41.07 36.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.397 1.479 . . . . 71.54 113.26 174.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -63.44 -19.94 65.14 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.932 1.242 . . . . 75.33 113.469 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.5 mmt -84.5 -22.79 30.09 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.697 0.799 . . . . 75.41 111.161 177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 t -76.16 63.69 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 128.398 2.679 . . . . 64.24 111.527 -177.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.431 ' HA ' HG11 ' A' ' 143' ' ' VAL . 0.9 OUTLIER -91.42 -170.73 2.71 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.023 -1.048 . . . . 63.15 111.704 -178.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.8 p -58.82 -1.55 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.106 2.162 . . . . 43.4 113.661 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.25 9.19 22.64 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-O 117.439 -1.756 . . . . 45.13 111.764 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.27 147.68 44.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.84 2.32 . . . . 72.42 108.988 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -94.89 105.09 16.99 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.241 -1.392 . . . . 73.04 107.241 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.6 tt -78.42 118.13 25.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.601 1.16 . . . . 64.43 109.329 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -59.38 140.28 56.27 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.5 -0.75 . . . . 72.54 109.072 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.32 158.0 76.22 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 124.854 1.262 . . . . 73.34 111.079 174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.54 161.32 42.51 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.669 2.246 . . . . 73.14 110.229 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.438 ' HA ' ' CE ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -125.21 -145.59 0.33 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.318 -1.364 . . . . 64.44 107.318 166.243 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 133' ' ' ASN . 1.5 p-10 -59.99 -82.02 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 125.465 1.506 . . . . 74.23 109.06 -175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.46 ' H ' ' ND2' ' A' ' 132' ' ' ASN . 6.4 m120 -102.02 0.43 35.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.888 1.675 . . . . 73.33 110.356 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 8.0 p -138.02 -172.91 3.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.428 1.491 . . . . 72.3 110.879 -151.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 tp -125.98 143.26 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.187 -1.783 . . . . 75.42 106.187 -178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.8 177.53 7.8 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.901 -1.124 . . . . 64.1 108.023 -178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 87.3 mt -114.1 145.7 41.26 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.897 1.279 . . . . 74.2 107.98 170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.418 ' CG ' HD22 ' A' ' 93' ' ' ASN . 32.4 t0 -142.12 153.97 44.52 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.872 2.069 . . . . 72.13 109.933 170.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.87 142.02 27.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 118.463 -0.779 . . . . 72.44 110.078 -164.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 22.7 t -77.32 -5.56 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 114.567 1.321 . . . . 71.31 114.567 -163.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.4 pt 29.32 -88.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 127.748 2.419 . . . . 65.21 116.108 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.488 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.8 OUTLIER -85.95 128.58 34.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.901 2.08 . . . . 71.14 109.594 -175.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -129.01 99.07 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 125.032 1.333 . . . . 63.0 111.103 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -152.65 -169.44 3.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.219 2.608 . . . . 62.11 110.102 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -133.91 179.56 6.17 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.028 1.731 . . . . 74.14 110.107 -172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 12.3 m -123.6 163.78 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 126.927 2.091 . . . . 74.42 106.442 159.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.01 137.02 37.44 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.93 -1.878 . . . . 72.33 105.93 161.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.41 142.96 27.59 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.865 0.757 . . . . 64.15 110.058 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 83' ' ' SER . 4.4 m120 -146.82 24.35 1.2 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.847 0.749 . . . . 74.34 112.705 -157.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -109.88 -111.64 3.39 Favored Glycine 0 CA--C 1.517 0.183 0 N-CA-C 110.318 -1.113 . . . . 54.33 110.318 -155.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -134.23 164.82 26.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 106.595 -1.631 . . . . 74.31 106.595 157.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 8' ' ' ALA . 20.7 pt -127.09 160.48 35.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.171 2.188 . . . . 72.35 109.13 174.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -142.93 151.53 41.06 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 124.495 1.118 . . . . 72.51 109.684 -168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -149.23 -178.76 6.58 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.764 -1.199 . . . . 70.42 107.764 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 77.3 mt -128.25 175.75 8.22 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.974 1.845 . . . . 75.11 110.995 -167.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 76' ' ' ARG . 24.3 m -128.41 92.05 3.36 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.391 -2.448 . . . . 75.25 104.391 159.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.6 t -109.66 80.21 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 101.651 -3.463 . . . . 53.11 101.651 166.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 75' ' ' LEU . 14.6 pt-20 -76.5 -15.31 59.92 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 122.31 1.053 . . . . 73.3 111.218 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -72.53 -44.52 62.07 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 125.915 1.686 . . . . 71.13 109.885 -153.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.3 t30 -125.07 5.06 7.92 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.202 0.601 . . . . 75.34 111.933 167.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.413 ' CD2' ' HA ' ' A' ' 176' ' ' SER . 34.9 m170 52.15 36.75 19.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.939 0.791 . . . . 64.33 111.941 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.9 p -147.43 142.42 26.99 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.378 -1.451 . . . . 43.23 107.571 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.8 p90 -142.86 170.2 16.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.544 1.065 . . . . 75.32 110.349 175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 24.1 mm -98.26 137.93 24.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 107.008 -1.478 . . . . 74.21 107.008 160.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -159.7 161.25 34.81 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.314 1.045 . . . . 72.03 108.574 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 134.72 -168.19 23.67 Favored Glycine 0 N--CA 1.462 0.403 0 CA-C-N 118.555 0.616 . . . . 34.44 111.729 175.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -102.42 169.54 8.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.348 1.574 . . . . 74.34 110.318 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 68.31 -85.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 C-N-CA 128.018 2.527 . . . . 63.31 113.272 -173.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.479 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 0.3 OUTLIER -122.68 -23.49 5.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.423 1.089 . . . . 73.41 112.146 169.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 105.73 177.11 23.92 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 125.596 1.57 . . . . 65.24 111.432 167.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.549 ' CE1' HG23 ' A' ' 97' ' ' ILE . 51.0 m-85 -117.81 139.92 50.42 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 126.426 1.89 . . . . 74.43 108.104 -175.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -83.39 99.31 9.98 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.572 3.149 . . . . 71.12 107.604 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.96 179.06 3.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.133 0.573 . . . . 65.41 110.246 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.7 t -64.43 148.93 49.46 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.227 -1.027 . . . . 72.23 108.227 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -120.76 166.74 13.31 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.06 -1.459 . . . . 55.11 107.06 158.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.413 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 92.2 p -149.27 -149.68 0.31 Allowed 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.777 -0.769 . . . . 42.43 111.1 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.7 p -149.41 -106.3 0.07 Allowed 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 126.851 2.06 . . . . 64.14 107.059 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -88.81 112.06 3.89 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 108.027 -2.029 . . . . 54.41 108.027 165.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.311 0.1 OUTLIER 68.23 -172.03 0.19 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 125.178 1.391 . . . . 72.22 112.03 159.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.64 81.68 0.18 Allowed 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.763 -1.211 . . . . 54.22 109.343 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 p-80 50.02 56.28 8.14 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.903 2.481 . . . . 72.42 115.88 172.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -80.36 -48.66 12.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.845 1.424 . . . . 74.44 114.845 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 61.9 m170 31.71 92.65 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 128.679 2.791 . . . . 74.33 114.279 -163.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -104.29 90.41 3.55 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.499 0.72 . . . . 72.11 109.895 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.77 -128.22 0.22 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.488 1.115 . . . . 73.22 110.034 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 16.8 p80 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.083 1.353 . . . . 70.23 110.02 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttt . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.812 -0.81 . . . . 64.34 108.812 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 152.19 178.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 130.412 3.485 . . . . 43.51 107.998 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.9 m -108.7 -54.34 2.53 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.739 1.216 . . . . 64.11 108.466 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.42 -139.5 2.79 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.947 -1.661 . . . . 64.31 108.947 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.53 -70.84 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.865 -1.531 . . . . 75.41 106.865 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 t0 59.16 -171.94 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.98 1.312 . . . . 62.11 109.629 -169.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.82 -160.87 13.85 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 121.334 -0.853 . . . . 62.23 112.885 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 161.8 165.94 0.02 OUTLIER 'General case' 0 C--O 1.242 0.672 0 C-N-CA 129.704 3.201 . . . . 74.55 108.362 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.6 mt -87.78 153.48 21.31 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 127.702 2.401 . . . . 72.32 109.608 173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.66 163.3 28.02 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 123.37 0.668 . . . . 40.43 111.71 173.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -54.96 -38.59 67.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.088 1.355 . . . . 74.44 113.252 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -96.74 9.3 42.1 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.946 1.698 . . . . 71.14 112.412 -165.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -78.22 124.13 85.84 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 106.677 -1.601 . . . . 73.45 106.677 -175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -55.46 126.31 22.08 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.16 2.574 . . . . 52.32 111.287 171.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.7 pt -98.4 119.33 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.688 -1.227 . . . . 61.24 107.688 162.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -78.13 78.99 4.6 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.326 1.45 . . . . 72.33 107.942 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 92.9 mt -55.86 164.18 1.23 Allowed 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 170.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 73.1 p -54.06 -36.16 62.81 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 118.168 0.44 . . . . 74.23 111.317 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -78.13 -22.55 48.66 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.413 0.685 . . . . 71.31 112.188 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.02 40.54 7.99 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 125.08 1.324 . . . . 65.44 110.774 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -10.35 52.31 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 113.906 1.076 . . . . 71.12 113.906 -174.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.317 13.5 mm 52.23 30.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 125.575 2.607 . . . . 72.52 112.077 171.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.39 149.41 5.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 113.829 -1.532 . . . . 74.43 108.692 -172.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -62.17 122.7 16.23 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 106.306 -1.739 . . . . 60.52 106.306 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 tt -50.14 -37.85 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.437 1.095 . . . . 64.53 111.087 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.89 -0.9 89.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.825 -0.986 . . . . 52.04 114.205 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -95.27 -47.56 6.27 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.758 1.779 . . . . 75.34 110.365 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -47.14 -53.49 12.83 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.945 1.298 . . . . 61.22 110.46 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG22 ' CG2' ' A' ' 77' ' ' VAL . 44.6 t -67.1 -42.67 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 115.525 -0.761 . . . . 52.11 110.486 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.1 OUTLIER -68.2 -24.82 64.99 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 119.042 -1.063 . . . . 74.53 111.302 -176.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 -41.44 70.47 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.135 0.974 . . . . 73.21 110.628 170.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.85 -40.06 66.01 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.341 -1.314 . . . . 72.12 108.933 174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.404 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 11.2 m-85 -56.05 -37.18 68.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 121.414 1.915 . . . . 72.14 112.436 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -31.36 64.32 Favored 'General case' 0 C--N 1.339 0.119 0 CA-C-O 117.718 -1.134 . . . . 44.34 111.275 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -90.23 -49.34 6.61 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 121.195 1.816 . . . . 62.15 108.28 -178.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 2.5 m-30 -94.44 39.31 1.09 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.773 2.029 . . . . 63.42 108.333 -171.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.7 pttt -57.02 -31.92 65.63 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.065 1.346 . . . . 73.22 111.95 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -61.5 -35.51 77.88 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.722 1.209 . . . . 64.31 110.996 172.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.12 9.45 40.86 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.092 1.357 . . . . 64.11 112.105 -165.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.7 124.0 18.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 106.829 -1.545 . . . . 64.42 106.829 167.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -122.37 114.79 21.24 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.07 1.748 . . . . 74.45 107.496 173.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.64 146.72 28.95 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 108.004 -1.109 . . . . 73.44 108.004 168.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.47 172.46 13.76 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 123.835 0.854 . . . . 75.44 108.811 168.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -49.39 73.15 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 125.155 1.382 . . . . 44.42 109.338 172.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -70.5 -6.28 35.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.785 1.234 . . . . 34.14 112.499 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.71 15.67 33.55 Favored Glycine 0 CA--C 1.526 0.739 0 O-C-N 121.136 -0.977 . . . . 74.13 114.698 156.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.01 -90.8 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.481 1.912 . . . . 53.43 111.892 -170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.77 121.43 2.19 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 127.064 2.269 . . . . 63.44 109.174 -174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -130.76 164.73 24.47 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.383 1.873 . . . . 60.54 109.906 169.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.402 HD12 ' CD1' ' A' ' 33' ' ' PHE . 21.4 mt -142.26 138.98 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 127.291 2.236 . . . . 74.25 106.191 169.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.61 129.52 36.53 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.56 1.544 . . . . 60.24 109.719 166.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -135.74 16.84 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 125.264 1.425 . . . . 74.31 111.034 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.83 -28.4 57.33 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 120.973 -1.079 . . . . 54.22 113.392 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -77.84 -10.78 59.73 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 118.928 1.364 . . . . 64.15 113.311 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -63.58 -33.65 76.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 119.663 1.12 . . . . 74.42 109.479 168.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 51.14 13.84 0.18 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.93 2.092 . . . . 71.43 113.183 -166.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mt -61.12 126.34 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 124.29 1.036 . . . . 73.33 108.472 -172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -83.33 144.22 29.83 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.637 1.175 . . . . 75.43 110.389 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.2 tt -127.75 150.78 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.792 1.637 . . . . 63.32 107.663 174.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -62.26 118.34 7.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 106.015 -1.846 . . . . 62.44 106.015 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 t -141.92 146.59 35.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.603 -2.74 . . . . 60.32 103.603 -172.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.433 ' HB3' HD11 ' A' ' 164' ' ' ILE . 0.1 OUTLIER -116.12 126.99 54.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 126.211 1.805 . . . . 74.45 106.128 -171.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -69.82 121.23 16.87 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.266 -1.013 . . . . 74.12 108.266 172.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -85.39 -20.29 30.09 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.665 0.786 . . . . 75.25 112.084 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.89 -34.1 65.23 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.816 0.846 . . . . 65.51 111.033 175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 m -135.93 8.83 3.27 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.683 0.793 . . . . 73.24 112.141 -177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.6 mt 57.02 47.84 16.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.8 1.64 . . . . 71.42 112.51 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 148.48 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.372 1.469 . . . . 64.13 108.964 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.4 mp -79.6 144.2 11.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.033 -1.84 . . . . 71.12 106.033 176.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.66 -167.96 2.9 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 128.116 2.567 . . . . 64.42 107.052 -171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.8 153.4 42.56 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.258 -2.126 . . . . 64.15 105.258 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.0 mmtt -153.99 162.6 41.09 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.127 1.371 . . . . 62.24 108.14 163.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -85.64 179.45 7.09 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.854 1.262 . . . . 72.51 112.828 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.9 mt -116.62 155.61 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 126.917 2.087 . . . . 72.33 106.725 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.49 -42.68 1.63 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.868 0.867 . . . . 74.44 111.706 -170.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.622 ' CB ' HG21 ' A' ' 156' ' ' THR . 1.3 mtm-85 -127.08 -166.05 1.55 Allowed 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 108.57 -0.9 . . . . 73.22 108.57 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.506 ' CG2' HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -157.84 161.86 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 105.702 -1.962 . . . . 65.22 105.702 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.742 ' HE1' HG22 ' A' ' 156' ' ' THR . 90.7 m95 -147.08 143.14 28.11 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.536 0.734 . . . . 75.23 110.025 178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.4 143.62 26.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.237 0.926 . . . . 75.31 109.538 176.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -146.38 162.02 39.11 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.847 -1.538 . . . . 75.34 106.847 166.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -85.1 156.01 21.25 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 121.133 -0.979 . . . . 65.42 108.694 172.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -136.32 163.35 30.64 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.009 2.124 . . . . 71.11 108.307 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.0 p -167.12 104.29 0.55 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.991 -1.485 . . . . 71.34 106.991 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 165.75 -155.73 27.22 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.41 -0.9 . . . . 55.34 113.791 -172.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 94.77 4.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.537 1.535 . . . . 64.21 109.459 -168.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 79.4 mt -79.44 153.01 29.97 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.8 mm -79.06 131.32 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 126.386 1.874 . . . . 54.14 106.974 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -116.83 82.35 1.78 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.578 -1.638 . . . . 53.12 106.578 166.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 mt -61.95 137.15 24.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.856 -1.905 . . . . 74.23 105.856 162.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -110.8 168.13 9.71 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 106.645 -1.613 . . . . 73.51 106.645 162.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.76 170.87 15.17 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.878 1.217 . . . . 75.42 109.361 159.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -58.32 -24.52 59.91 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.359 1.436 . . . . 74.22 111.962 -175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.21 -0.9 2.79 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.643 1.177 . . . . 71.33 112.259 175.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 64.93 13.75 8.81 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 128.149 2.58 . . . . 71.24 111.927 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.94 157.47 28.01 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 124.848 1.259 . . . . 65.41 108.205 167.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.71 171.17 17.23 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.661 1.585 . . . . 61.32 107.408 172.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.538 HG23 ' CE1' ' A' ' 171' ' ' PHE . 5.1 pt -147.53 173.09 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 126.664 1.986 . . . . 44.05 107.908 -174.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.8 104.5 4.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.422 -0.955 . . . . 71.33 108.422 175.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.15 166.97 27.21 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.302 1.041 . . . . 63.22 111.442 -173.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 47.4 m -89.52 1.48 55.86 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 116.157 1.91 . . . . 35.34 116.157 -147.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 96.33 -23.98 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.822 1 C-N-CA 138.787 6.835 . . . . 74.55 111.639 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -113.58 37.58 3.19 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.937 2.495 . . . . 72.31 110.238 -169.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -101.0 139.36 20.44 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 125.04 1.336 . . . . 65.22 108.963 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.54 123.54 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.505 2.137 . . . . 62.25 110.53 177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.94 173.55 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 61.34 109.526 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -119.62 139.71 51.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.459 1.103 . . . . 63.34 111.084 -168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -142.13 162.81 19.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 124.858 1.263 . . . . 72.54 110.103 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.404 ' HB3' HD21 ' A' ' 137' ' ' LEU . 94.4 p -95.48 105.99 18.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 123.261 0.351 . . . . 65.22 111.04 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -81.12 78.3 7.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.448 -1.686 . . . . 62.22 106.448 162.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 6.2 m 60.22 6.04 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 116.522 2.045 . . . . 75.51 116.522 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.32 -31.32 1.56 Allowed Glycine 0 CA--C 1.519 0.299 0 O-C-N 120.712 -1.242 . . . . 72.24 110.057 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -78.7 142.7 36.89 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.362 -2.088 . . . . 64.51 105.362 174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.6 p -84.05 132.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 108.577 -0.898 . . . . 60.32 108.577 164.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.24 152.31 48.24 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.81 1.644 . . . . 73.13 106.677 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.19 115.75 30.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.029 1.332 . . . . 73.44 109.61 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.5 pt -132.52 175.26 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.745 0.818 . . . . 73.44 110.901 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -79.97 143.17 34.38 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.587 1.155 . . . . 71.21 109.226 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.0 -29.1 41.96 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.629 0.974 . . . . 64.33 113.629 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -24.26 65.29 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.14 -0.975 . . . . 75.53 112.661 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -86.74 -27.4 23.68 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.372 1.069 . . . . 74.13 111.927 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -71.43 61.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 127.921 2.488 . . . . 55.31 109.836 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -178.08 6.93 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.01 1.324 . . . . 74.22 108.509 170.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.5 p -55.48 0.06 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 127.364 2.266 . . . . 63.45 113.9 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.39 -18.88 70.25 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 117.506 -1.719 . . . . 11.25 111.989 170.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.56 169.82 12.08 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 120.214 2.007 . . . . 54.05 111.67 -163.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -124.0 119.09 28.54 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 126.256 1.822 . . . . 65.42 108.153 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 tt -93.74 127.46 45.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.149 0.979 . . . . 73.24 108.776 -173.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -67.8 115.58 7.52 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.906 -1.146 . . . . 75.42 107.906 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.4 154.42 59.25 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.386 1.074 . . . . 73.22 111.476 -176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.43 ' HG3' HD12 ' A' ' 164' ' ' ILE . 50.7 Cg_exo -59.78 141.35 96.65 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.94 2.427 . . . . 74.32 110.138 172.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -113.48 -173.98 2.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.786 -1.19 . . . . 72.41 107.786 153.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -37.79 -64.29 0.4 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.189 1.796 . . . . 74.33 111.22 -168.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -120.59 -5.44 9.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.772 0.829 . . . . 74.34 112.122 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.5 p -125.33 -178.58 4.27 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.668 1.587 . . . . 60.24 111.67 -164.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.5 tp -100.39 147.25 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 O-C-N 120.171 -1.581 . . . . 53.25 107.574 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -137.94 -175.0 3.94 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.751 2.02 . . . . 52.23 107.938 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' A' ' 108' ' ' SER . 18.9 mt -129.47 157.93 40.62 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.266 1.427 . . . . 41.25 107.649 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -153.87 159.3 41.74 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 125.692 1.597 . . . . 75.15 108.14 170.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -94.8 147.7 23.07 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.07 0.948 . . . . 63.25 110.605 -170.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 70.9 t -81.97 -0.67 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 113.998 1.111 . . . . 72.42 113.998 -171.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.46 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 26.51 -77.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.044 2.938 . . . . 71.53 117.062 170.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.46 ' H ' HG13 ' A' ' 141' ' ' ILE . 17.0 tppt? -103.21 117.29 34.19 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 126.049 1.74 . . . . 71.43 108.028 174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.32 131.2 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.184 -1.043 . . . . 35.12 108.184 169.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -153.06 -179.45 7.7 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 125.942 1.697 . . . . 74.25 107.494 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.29 133.85 39.31 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.007 -0.738 . . . . 40.45 109.007 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.98 -177.67 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 124.682 1.193 . . . . 64.31 108.494 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -130.29 113.39 14.34 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.447 -0.946 . . . . 62.11 108.447 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -128.72 135.32 49.06 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.074 1.35 . . . . 73.41 108.582 -161.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -133.77 29.6 3.81 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.272 -0.893 . . . . 60.35 109.684 -161.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -126.86 -163.91 11.59 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 126.362 1.934 . . . . 42.24 111.411 -161.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -87.0 153.41 21.57 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.021 -1.281 . . . . 74.23 110.752 173.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.2 pt -126.2 153.63 34.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 126.729 2.012 . . . . 72.34 107.877 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -142.47 154.38 44.48 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.344 1.058 . . . . 51.41 108.985 -170.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -131.95 163.94 27.25 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.167 1.387 . . . . 52.51 108.288 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 tp -136.73 140.13 42.4 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 120.943 1.701 . . . . 72.33 111.164 -163.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.742 HG22 ' HE1' ' A' ' 78' ' ' TRP . 48.4 p -91.37 -46.68 7.89 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.576 0.954 . . . . 74.41 113.576 -156.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.266 2.7 t 23.12 64.66 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 130.111 3.364 . . . . 42.32 113.97 175.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -74.1 0.05 15.03 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.486 1.114 . . . . 73.41 113.511 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.36 -34.91 41.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.352 -0.981 . . . . 60.13 108.352 -173.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -127.94 -8.91 5.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.203 1.401 . . . . 55.41 113.712 171.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 62.57 23.96 14.25 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.475 1.91 . . . . 63.23 111.154 -175.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.2 p -141.36 164.84 29.16 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.342 2.657 . . . . 60.21 107.248 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 5.6 p90 -151.39 175.92 11.78 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.824 1.193 . . . . 72.44 110.372 165.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 62' ' ' PHE . 30.1 mm -109.37 126.17 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 74.21 108.831 168.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -152.21 160.46 43.37 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.729 0.812 . . . . 71.11 110.241 169.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.13 -165.11 25.5 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.167 -1.573 . . . . 31.11 109.167 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -100.72 172.83 6.83 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 119.111 1.455 . . . . 74.34 110.267 175.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.11 -85.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 128.177 2.591 . . . . 54.32 111.972 -171.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -121.88 -12.1 8.45 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.912 1.285 . . . . 74.55 112.878 170.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.06 174.59 39.31 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-O 122.877 1.265 . . . . 65.22 112.628 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.7 m-85 -121.18 154.5 36.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.454 2.702 . . . . 64.35 106.801 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -93.11 119.67 32.58 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.355 -1.35 . . . . 53.13 107.355 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.59 174.71 12.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 CA-C-N 118.579 0.627 . . . . 74.41 109.651 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t -72.42 155.2 40.38 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.111 0.564 . . . . 74.53 109.672 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.561 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.11 49.3 1.36 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.697 2.399 . . . . 60.45 108.644 172.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.4 m -79.87 108.4 13.42 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.098 -1.626 . . . . 61.54 107.159 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.6 p -60.77 8.62 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.045 2.938 . . . . 60.54 116.088 -169.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.32 45.8 10.89 Favored Glycine 0 CA--C 1.524 0.656 0 O-C-N 120.507 -1.37 . . . . 72.34 110.852 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.41 164.65 28.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.042 -1.466 . . . . 53.54 107.042 160.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.518 ' C ' HD23 ' A' ' 180' ' ' LEU 0.257 5.9 tt 66.05 121.86 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.81 1.644 . . . . 32.33 113.232 171.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -148.07 167.74 24.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.807 1.643 . . . . 74.13 109.058 169.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -153.29 178.11 10.12 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.301 1.44 . . . . 54.31 107.404 164.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -135.83 149.83 49.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.562 1.945 . . . . 71.25 107.358 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -157.98 52.38 0.44 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.606 -1.257 . . . . 43.33 107.606 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 37.9 m-70 63.63 178.24 0.16 Allowed 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.84 1.656 . . . . 64.44 109.51 -141.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 . . . . . 0 C--O 1.242 0.671 0 CA-C-O 117.094 -1.431 . . . . 71.23 108.423 -178.821 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.015 -0.517 . . . . 63.41 110.684 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m120 80.77 -179.56 0.08 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.23 1.812 . . . . 72.24 112.615 154.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.6 m -123.29 -33.48 3.27 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.167 1.787 . . . . 45.22 110.148 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.11 -73.6 0.46 Allowed Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.146 -1.582 . . . . 42.41 109.146 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.2 m-70 -64.8 159.35 22.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.345 0.593 . . . . 73.25 110.187 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.17 169.12 18.21 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.936 -1.505 . . . . 72.23 106.936 170.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.43 -167.2 12.79 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 125.17 1.367 . . . . 62.13 112.273 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.94 155.07 40.32 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.069 -1.826 . . . . 61.33 106.069 140.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.01 157.54 24.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.177 0.991 . . . . 63.01 109.557 175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -68.38 -176.67 0.79 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.187 1.395 . . . . 73.14 110.947 169.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.462 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 14.4 t80 -84.67 -33.57 23.19 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.547 1.139 . . . . 65.13 113.169 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -102.81 38.53 1.71 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.97 1.708 . . . . 71.03 110.197 -162.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -117.19 112.61 39.65 Favored Pre-proline 0 N--CA 1.453 -0.325 0 C-N-CA 125.039 1.336 . . . . 74.12 110.947 -153.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -67.56 127.41 16.35 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.99 1.793 . . . . 74.32 113.557 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.2 pt -100.36 24.53 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.626 1.97 . . . . 53.14 112.95 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 29.78 66.09 0.12 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 127.341 2.257 . . . . 74.43 115.403 169.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -53.17 155.59 2.57 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.315 -0.866 . . . . 60.2 111.507 174.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -43.62 61.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.51 1.124 . . . . 74.13 109.172 169.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.09 -47.34 77.59 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.105 0.962 . . . . 64.14 110.722 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.81 26.91 3.7 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.767 1.175 . . . . 74.3 112.65 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -59.68 -27.61 66.55 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 119.264 1.532 . . . . 72.32 114.118 -175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.0 mm 48.17 63.37 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.861 1.264 . . . . 73.24 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.7 147.97 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 C-N-CA 124.903 1.281 . . . . 71.33 108.121 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -65.27 122.69 17.69 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 106.97 -1.493 . . . . 22.14 106.97 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.7 tt -46.55 -44.75 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 C-N-CA 124.995 1.318 . . . . 63.11 110.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -70.54 -26.3 74.33 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-O 118.577 -1.124 . . . . 73.01 111.685 -173.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -71.41 -53.17 14.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.461 1.631 . . . . 63.33 109.716 171.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -43.87 -48.77 8.42 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.779 1.232 . . . . 72.41 109.555 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.629 HG22 HG21 ' A' ' 77' ' ' VAL . 60.1 t -73.88 -44.9 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 118.361 -0.828 . . . . 63.55 111.645 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -65.03 -32.82 74.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.737 2.062 . . . . 71.2 111.585 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.64 -40.49 65.89 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.714 1.606 . . . . 73.43 110.965 171.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -76.74 -36.66 56.96 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.492 1.517 . . . . 65.11 109.632 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -63.66 -41.77 98.15 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 121.334 1.879 . . . . 74.2 110.774 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -24.42 64.75 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.497 -0.752 . . . . 55.43 111.281 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 5.5 mttt -82.35 -59.19 2.62 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.996 -1.483 . . . . 54.54 106.996 174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 8.0 m-85 -100.63 41.84 1.15 Allowed 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 123.943 0.897 . . . . 61.34 109.949 -162.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.71 -32.2 67.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.564 0.745 . . . . 63.32 111.772 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -73.83 -22.17 59.88 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 112.832 0.678 . . . . 75.2 112.832 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.2 t -90.04 -1.41 57.95 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.62 1.568 . . . . 64.14 111.59 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 96.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 124.744 1.217 . . . . 53.43 107.793 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -79.99 161.5 25.42 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.059 -1.089 . . . . 73.12 108.059 162.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -126.17 154.31 43.4 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.433 -1.692 . . . . 73.25 106.433 160.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.41 179.38 7.47 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.009 0.924 . . . . 62.24 110.125 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.84 -25.54 63.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.4 0.68 . . . . 73.22 111.442 173.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -77.53 -13.85 59.81 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.873 -1.142 . . . . 62.25 111.346 165.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.14 7.96 55.69 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 120.441 -1.412 . . . . 53.04 112.35 175.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -52.35 -83.46 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.471 1.909 . . . . 71.21 112.874 -164.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 141.82 107.32 0.64 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-O 117.977 -1.457 . . . . 75.44 110.131 -176.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -123.31 162.34 22.89 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 119.107 1.453 . . . . 55.25 111.447 170.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.9 mt -146.73 132.33 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.414 2.686 . . . . 71.44 103.952 168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 126.8 31.44 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.104 -1.072 . . . . 75.44 108.104 164.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.83 13.76 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.142 1.377 . . . . 73.24 111.6 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.46 -31.57 36.32 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.291 -0.88 . . . . 75.53 113.472 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -67.37 -19.41 65.42 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 124.741 1.216 . . . . 63.44 112.721 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -60.81 -25.89 66.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.832 0.742 . . . . 62.21 110.87 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.5 36.02 25.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.752 1.221 . . . . 75.11 111.992 177.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -89.34 135.08 26.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.352 -1.351 . . . . 75.14 107.352 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -102.73 154.27 19.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.445 0.64 . . . . 73.31 109.305 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.1 tt -132.89 148.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 125.663 1.585 . . . . 74.03 107.911 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -75.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.688 1.995 . . . . 74.22 110.349 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.16 173.2 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.047 2.539 . . . . 73.52 108.454 165.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -136.75 140.75 42.8 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.195 -0.94 . . . . 61.02 109.854 -174.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -87.5 121.01 29.39 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 126.064 1.745 . . . . 63.53 109.091 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -70.76 -27.81 64.22 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.72 0.808 . . . . 74.21 112.076 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -50.5 -42.03 54.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.075 1.35 . . . . 71.32 110.897 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t -134.1 16.78 3.8 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.622 0.769 . . . . 55.14 111.357 -177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.28 49.57 17.6 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.771 1.228 . . . . 74.35 112.464 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.0 pt -115.54 154.48 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 125.555 1.542 . . . . 74.43 109.529 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.98 145.77 8.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.52 -1.289 . . . . 74.01 107.52 165.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -141.06 -168.5 2.62 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.545 1.938 . . . . 71.43 107.774 163.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -92.24 149.14 21.63 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.439 -0.948 . . . . 65.32 108.439 153.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -154.13 152.69 30.71 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.627 2.371 . . . . 73.32 106.571 167.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -84.36 175.66 9.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.428 1.091 . . . . 74.24 109.938 178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.7 mt -119.69 141.99 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.829 2.052 . . . . 62.21 106.324 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 158' ' ' GLU . 1.9 mm? -111.74 -45.67 3.33 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.703 0.401 . . . . 63.53 112.03 -171.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.38 144.83 49.83 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.53 -0.915 . . . . 55.54 108.53 -175.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -108.87 158.7 8.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.393 1.477 . . . . 74.42 108.054 176.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -132.05 152.75 51.0 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.208 1.003 . . . . 75.42 108.953 173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -149.53 152.53 35.72 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.764 -0.828 . . . . 73.14 108.764 165.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -150.08 167.96 25.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.094 1.757 . . . . 64.3 106.946 166.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -105.41 143.97 32.84 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.044 -1.035 . . . . 75.22 108.223 171.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -142.64 156.19 45.04 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.3 0.5 . . . . 74.54 111.25 -160.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -156.94 125.85 5.89 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 75.43 109.788 164.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.51 179.52 37.96 Favored Glycine 0 N--CA 1.465 0.587 0 N-CA-C 110.184 -1.167 . . . . 54.1 110.184 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -81.03 140.04 35.39 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.876 -0.779 . . . . 62.22 110.236 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.65 157.87 32.82 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.161 1.384 . . . . 72.53 107.625 176.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mm -79.67 141.6 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 124.678 1.191 . . . . 72.32 108.77 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 146' ' ' VAL . 55.7 mttt -123.66 86.28 2.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.341 1.456 . . . . 71.24 107.519 158.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 140' ' ' VAL . 31.8 mt -62.77 101.68 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.521 -1.659 . . . . 55.44 106.521 148.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.3 m -80.38 172.99 13.04 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 106.899 -1.519 . . . . 73.21 106.899 163.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 62.4 p -138.56 171.04 14.95 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.704 -1.247 . . . . 74.22 108.574 163.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -71.15 -25.17 62.44 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 127.539 2.336 . . . . 55.03 110.938 -176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -59.86 -11.24 5.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.93 1.692 . . . . 64.44 111.578 164.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 63.15 33.05 14.75 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 129.173 2.989 . . . . 72.23 111.617 -167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' CG ' ' A' ' 95' ' ' ARG . 2.1 mtt-85 -75.43 173.43 10.96 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 118.231 -1.388 . . . . 73.41 109.474 161.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -165.39 164.29 19.7 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.983 1.713 . . . . 75.45 106.522 169.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.52 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -132.25 -179.93 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 108.068 -1.086 . . . . 75.51 108.068 165.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 52.2 m -149.87 118.92 6.71 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.011 -1.68 . . . . 64.44 108.949 170.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.486 HD22 ' CG1' ' A' ' 97' ' ' ILE . 1.1 pt? -166.25 172.13 11.46 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.963 -1.017 . . . . 65.32 111.261 -169.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 m -79.43 147.61 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.095 -1.076 . . . . 71.12 108.095 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -10.21 54.29 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.165 1.172 . . . . 72.53 114.165 -161.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -115.4 38.19 3.32 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.661 2.785 . . . . 65.02 110.156 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.5 t60 -82.63 140.95 44.43 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-O 118.071 -0.966 . . . . 52.44 109.525 159.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.02 118.53 5.63 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.124 3.216 . . . . 70.2 111.274 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.8 m -114.65 -166.04 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 O-C-N 120.876 -1.14 . . . . 74.54 110.128 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -135.07 134.68 40.58 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.747 1.219 . . . . 65.14 108.733 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.31 166.58 28.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 126.107 1.763 . . . . 73.41 107.944 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.6 p -89.9 143.29 26.91 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.096 0.475 . . . . 74.22 110.309 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -115.02 86.74 2.51 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.224 -1.769 . . . . 73.43 106.224 155.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.65 17.76 8.94 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.097 0.959 . . . . 63.32 113.407 175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.43 -26.85 4.3 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.652 1.12 . . . . 71.05 111.187 -175.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 148.62 32.46 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 106.557 -1.646 . . . . 60.55 106.557 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.7 t -85.32 114.46 25.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.558 -1.275 . . . . 73.2 107.558 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.46 40.5 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.89 -0.782 . . . . 71.22 108.89 -175.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -96.67 120.02 36.22 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 126.87 2.068 . . . . 73.05 106.996 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.5 pt -141.65 175.26 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.691 1.596 . . . . 54.43 109.803 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -78.03 144.5 36.6 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 109.53 -0.544 . . . . 70.33 109.53 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.03 22.18 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.087 0.955 . . . . 71.12 112.201 175.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -17.29 62.99 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.151 1.167 . . . . 71.1 114.151 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 20.6 mtm -96.99 -15.24 21.18 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.161 0.985 . . . . 74.35 112.071 173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.5 t -80.61 63.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.949 1.699 . . . . 62.43 109.217 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.63 176.82 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.744 -0.662 . . . . 63.33 109.291 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 1.4 p -44.36 -37.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.278 1.831 . . . . 65.11 112.721 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.79 11.03 63.09 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 117.419 -1.767 . . . . 62.35 114.185 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -115.15 169.9 8.77 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 121.018 2.409 . . . . 71.04 108.814 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.504 ' HB3' HD22 ' A' ' 137' ' ' LEU . 29.4 m-85 -118.16 105.42 11.79 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 123.907 0.883 . . . . 73.45 109.182 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.6 tt -80.0 125.69 39.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.795 -0.817 . . . . 62.43 108.795 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -64.63 123.46 19.36 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 72.53 107.067 173.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.85 157.74 56.54 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.694 1.598 . . . . 74.54 111.883 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -66.97 159.72 50.53 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.387 2.725 . . . . 74.45 111.8 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -141.81 -178.04 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.626 -1.62 . . . . 73.23 106.626 156.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -24.74 -67.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 128.318 2.647 . . . . 63.04 113.266 -170.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -120.68 -10.0 9.26 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.185 0.994 . . . . 31.5 113.447 165.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.7 p -131.3 148.15 52.65 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.818 1.19 . . . . 74.31 111.571 -162.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.94 143.31 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.263 -1.384 . . . . 73.42 107.263 -168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -142.91 -176.91 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 125.813 1.645 . . . . 74.11 108.391 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 126' ' ' TYR . 8.8 mt -125.38 165.46 18.34 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.413 1.101 . . . . 71.52 108.538 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -154.56 157.71 38.68 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 103.593 -2.743 . . . . 71.33 103.593 166.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 7.8 mt-10 -61.39 -177.7 0.1 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.026 1.33 . . . . 60.24 109.279 168.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 89' ' ' ILE 0.259 72.0 t -112.6 2.56 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 124.793 1.237 . . . . 75.54 111.904 176.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.1 pt 24.83 -70.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 130.422 3.489 . . . . 73.11 117.719 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.7 tptt -116.14 118.51 33.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.181 1.393 . . . . 65.43 107.462 171.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.2 p -104.43 119.53 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.998 -1.482 . . . . 65.23 106.998 156.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -135.14 -176.08 4.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.005 1.722 . . . . 75.32 107.816 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.0 p -130.76 159.93 35.84 Favored 'General case' 0 C--O 1.237 0.425 0 O-C-N 121.155 -0.966 . . . . 52.12 109.868 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 88' ' ' LYS . 12.3 m -117.12 165.22 12.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 125.781 1.633 . . . . 61.2 107.794 171.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -122.7 71.02 1.01 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.086 1.354 . . . . 74.52 108.843 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.45 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.7 t80 -81.64 154.76 25.96 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.879 1.272 . . . . 74.52 110.798 -167.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.33 24.96 2.27 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 121.306 -0.871 . . . . 73.55 112.358 -172.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -106.58 -138.94 9.22 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 125.173 1.368 . . . . 62.44 111.942 -155.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -117.86 155.22 30.5 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.907 -1.146 . . . . 71.11 107.907 168.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.7 pt -131.59 152.41 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.958 1.303 . . . . 74.41 109.928 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -142.57 168.81 18.84 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.062 1.345 . . . . 75.43 108.492 -171.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -154.74 175.03 14.23 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.803 -1.184 . . . . 74.02 107.803 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 tp -135.14 119.39 17.74 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.781 1.173 . . . . 63.53 110.508 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 18.9 m -84.12 118.56 24.18 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.791 -0.818 . . . . 73.51 108.791 169.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 16.0 t -125.98 94.93 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 105.433 -2.062 . . . . 72.32 105.433 177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.641 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.3 pt-20 -80.35 -8.65 59.59 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.336 -0.852 . . . . 73.54 113.236 -175.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -88.55 -59.05 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.74 1.257 . . . . 74.02 108.454 -156.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -131.07 112.57 13.01 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 101.687 -3.449 . . . . 74.22 101.687 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.439 ' CG ' ' HA ' ' A' ' 176' ' ' SER . 23.8 m170 -69.31 50.39 0.09 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.606 1.962 . . . . 63.11 112.03 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -151.67 140.1 20.52 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.02 2.128 . . . . 54.04 108.697 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.559 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.81 178.79 8.2 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.077 1.351 . . . . 74.45 111.121 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.41 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 46.7 mm -112.19 135.79 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.481 -1.674 . . . . 74.41 106.481 173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.08 159.85 43.49 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.682 -1.229 . . . . 71.41 107.682 160.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 140.47 -165.22 26.14 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.817 1.198 . . . . 73.13 111.043 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -110.91 170.65 7.96 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.365 1.078 . . . . 72.44 111.002 172.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.99 -80.27 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.146 2.578 . . . . 64.34 112.574 -172.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -122.32 -3.95 8.91 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.391 1.477 . . . . 64.44 114.051 168.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 84.38 176.94 51.2 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 122.141 0.856 . . . . 51.11 111.927 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CE1' HG23 ' A' ' 97' ' ' ILE . 3.8 m-85 -127.76 146.86 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.187 2.595 . . . . 74.14 106.2 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.542 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -95.56 132.0 41.15 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 119.21 -0.424 . . . . 73.54 110.69 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 163' ' ' TYR . 5.4 m -145.71 167.19 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.19 0.996 . . . . 74.31 109.633 -169.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 71.3 m -63.02 142.81 58.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.167 1.787 . . . . 64.44 110.286 175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -141.84 39.89 1.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.568 1.147 . . . . 75.42 111.623 -176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.439 ' HA ' ' CG ' ' A' ' 161' ' ' HIS . 70.9 m -60.06 124.29 19.78 Favored 'General case' 0 N--CA 1.457 -0.108 0 O-C-N 121.704 -0.622 . . . . 74.1 111.558 -172.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.8 p -59.18 -23.02 61.87 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 113.966 1.099 . . . . 74.12 113.966 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -107.19 118.2 5.5 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 106.898 -2.481 . . . . 52.24 106.898 170.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 14.6 t -64.8 -179.9 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.189 1.396 . . . . 74.31 110.302 175.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 22.9 tp 63.45 -89.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.256 1.822 . . . . 64.03 111.582 167.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -140.97 134.24 29.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 104.306 -2.479 . . . . 72.44 104.306 163.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -149.42 167.12 27.06 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 126.504 1.922 . . . . 72.44 106.614 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.77 154.49 44.28 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.753 0.821 . . . . 74.5 110.255 -170.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -64.37 142.31 58.46 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.546 -0.909 . . . . 65.12 108.546 167.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -139.69 -170.74 2.99 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.035 1.334 . . . . 72.3 107.933 164.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 64.8 t60 . . . . . 0 C--O 1.248 0.979 0 N-CA-C 106.281 -1.748 . . . . 72.1 106.281 169.485 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.474 0.764 0 N-CA-C 109.798 -0.445 . . . . 73.43 109.798 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -56.84 163.26 2.0 Allowed 'General case' 0 C--O 1.236 0.377 0 C-N-CA 126.337 1.855 . . . . 74.43 108.838 160.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.5 t -69.64 -59.89 2.67 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.46 -0.775 . . . . 73.33 109.434 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.84 -133.17 7.5 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 104.678 -3.369 . . . . 75.52 104.678 -158.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -115.82 -79.37 0.59 Allowed 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.531 -1.285 . . . . 63.14 107.531 169.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -153.17 160.77 42.9 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 123.195 0.598 . . . . 74.33 110.732 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.67 172.83 45.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.696 -1.762 . . . . 55.52 108.696 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -158.78 164.46 35.79 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.596 1.558 . . . . 73.43 108.024 162.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.49 151.82 21.78 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 125.253 1.421 . . . . 71.33 109.471 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.76 148.4 49.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.691 -0.686 . . . . 61.12 110.366 172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -48.26 -31.51 6.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.651 1.98 . . . . 72.21 113.897 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -104.78 15.35 28.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.641 1.976 . . . . 74.31 112.23 -168.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -79.46 114.24 43.65 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 107.551 -1.277 . . . . 72.54 107.551 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.02 136.33 29.37 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.422 2.748 . . . . 64.21 113.064 170.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.35 88.61 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 107.43 -1.322 . . . . 64.52 107.43 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -48.21 83.6 0.0 OUTLIER 'General case' 0 C--O 1.237 0.421 0 C-N-CA 128.233 2.613 . . . . 73.43 113.347 -177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.1 mt -65.44 163.97 14.76 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.243 1.017 . . . . 62.34 109.478 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.2 t -60.21 -39.77 87.74 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 119.027 -0.511 . . . . 50.3 109.812 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.9 -38.48 22.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 119.702 -0.799 . . . . 73.44 109.275 173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.18 43.78 0.9 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 114.958 0.743 . . . . 74.53 114.958 164.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -8.66 23.26 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 116.135 1.902 . . . . 73.03 116.135 -177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.289 7.8 mm 61.49 25.85 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-O 124.648 2.166 . . . . 74.34 112.49 167.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 152.78 4.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 125.426 1.49 . . . . 74.54 108.915 -170.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -63.09 130.18 43.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.968 1.707 . . . . 75.12 108.851 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 8.7 tt -53.49 -33.43 21.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.23 1.412 . . . . 74.32 112.892 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.671 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -94.83 -13.67 52.36 Favored Glycine 0 C--O 1.219 -0.818 0 CA-C-O 117.28 -1.845 . . . . 40.1 112.782 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -73.47 -49.72 25.33 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 121.346 2.573 . . . . 65.24 109.073 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -49.2 -56.95 7.65 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.193 1.397 . . . . 74.23 109.568 176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.671 HG22 ' HA2' ' A' ' 26' ' ' GLY . 34.4 m -67.6 -38.77 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 CA-C-O 117.504 -1.236 . . . . 63.43 110.371 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -34.55 73.57 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 121.462 1.937 . . . . 61.43 111.334 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 4.1 pttt -52.25 -42.03 63.3 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.748 1.219 . . . . 75.02 111.249 171.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 19.8 m-85 -78.04 -47.25 18.81 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-O 117.703 -1.141 . . . . 62.23 110.507 175.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -53.86 -30.77 47.08 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 121.598 1.999 . . . . 64.42 112.358 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -57.94 4.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.528 1.531 . . . . 73.41 110.091 170.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -68.57 -58.33 4.44 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.802 -1.555 . . . . 73.13 106.802 -169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 -86.81 40.17 0.89 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.494 1.517 . . . . 55.11 108.443 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.17 -34.73 68.76 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.788 -1.195 . . . . 73.33 111.498 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.04 -28.19 65.26 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.272 0.471 . . . . 71.13 112.272 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.6 m -73.37 -2.1 20.82 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.721 0.637 . . . . 74.32 112.721 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.2 mt -59.58 114.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.97 1.308 . . . . 71.15 109.433 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -114.06 113.33 24.6 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.492 -1.669 . . . . 74.3 106.492 168.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -73.45 142.18 46.85 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.045 -1.835 . . . . 70.3 106.045 164.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.96 176.78 9.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.571 -0.9 . . . . 64.44 108.571 159.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.21 -35.04 77.66 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.328 1.451 . . . . 73.52 112.306 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -65.2 -8.73 18.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.512 1.125 . . . . 72.52 112.67 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.69 7.82 64.37 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 127.939 2.685 . . . . 45.52 112.664 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.85 -83.54 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.977 1.711 . . . . 64.04 111.902 -160.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 127.48 101.49 1.13 Allowed Glycine 0 C--N 1.336 0.557 0 CA-C-O 118.623 -1.098 . . . . 52.32 111.805 -177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -108.16 163.35 13.24 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.598 0.823 . . . . 75.51 109.977 163.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.8 mt -145.45 143.54 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 126.427 1.891 . . . . 55.42 106.599 166.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -87.53 131.95 34.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.696 1.598 . . . . 53.45 111.148 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.82 -3.16 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.099 1.36 . . . . 75.24 112.768 -174.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.95 -21.58 52.79 Favored Glycine 0 CA--C 1.536 1.388 0 CA-C-N 120.02 1.282 . . . . 54.11 114.627 -168.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -69.08 -5.41 21.9 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.759 1.224 . . . . 71.31 113.896 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -61.57 -19.29 62.01 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 119.649 -1.907 . . . . 74.33 112.201 164.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.1 m120 45.02 33.62 1.09 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.237 1.815 . . . . 72.05 112.576 -172.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.56 169.04 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.595 1.958 . . . . 64.2 106.972 159.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.5 158.06 45.21 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.134 0.974 . . . . 72.31 109.151 166.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -125.03 157.14 33.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 126.138 1.775 . . . . 75.03 108.68 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.04 152.31 44.93 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 122.184 0.992 . . . . 75.2 108.56 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 99.1 p -147.53 -168.83 3.17 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 125.608 1.563 . . . . 63.22 106.96 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.853 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -152.3 137.71 17.63 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.066 -1.021 . . . . 64.4 108.742 177.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -79.6 114.9 18.88 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.426 -0.953 . . . . 72.42 108.426 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -61.83 -27.5 68.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.405 -0.361 . . . . 74.23 111.25 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -35.67 -51.52 0.66 Allowed 'General case' 0 N--CA 1.461 0.09 0 C-N-CA 129.324 3.05 . . . . 34.12 112.017 176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.5 m -147.58 12.17 1.01 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.163 1.785 . . . . 74.54 110.694 -160.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt 52.82 41.93 31.82 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.447 1.499 . . . . 70.12 111.144 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.5 pt -96.61 173.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.261 1.024 . . . . 73.35 109.488 178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.3 mp -89.17 147.35 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 106.76 -1.57 . . . . 62.44 106.76 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -147.83 172.17 14.57 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.676 1.59 . . . . 74.32 108.442 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -126.81 144.78 50.86 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.529 1.532 . . . . 63.31 107.168 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.54 161.56 35.52 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.312 0.645 . . . . 53.0 110.841 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ttm-85 -82.02 -35.24 29.04 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.239 0.829 . . . . 74.22 113.239 -170.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.9 mt 63.75 156.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 128.131 2.573 . . . . 63.44 109.685 -155.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.401 ' CD1' ' HG2' ' A' ' 158' ' ' GLU . 29.2 mt -142.53 -65.63 0.4 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.227 1.811 . . . . 52.44 106.4 -164.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -127.75 164.27 22.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.6 1.56 . . . . 71.5 111.258 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.24 172.59 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.52 1.928 . . . . 70.01 109.5 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -141.58 137.48 31.96 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.298 1.039 . . . . 72.14 110.163 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.8 tmm_? -129.16 131.92 47.24 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.043 1.337 . . . . 64.23 110.989 172.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -141.92 176.28 9.06 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.614 1.166 . . . . 72.35 109.593 166.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -109.75 148.16 31.93 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.741 1.216 . . . . 75.24 109.268 -171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -142.75 160.06 41.04 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.231 0.923 . . . . 73.42 112.677 -167.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -162.79 109.67 1.23 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.32 1.448 . . . . 63.24 110.441 174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.31 -171.45 35.8 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.874 1.216 . . . . 74.43 112.426 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -90.07 151.85 21.43 Favored 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 120.949 -1.324 . . . . 72.42 110.729 -177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.6 mt -130.77 153.94 48.52 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.104 1.362 . . . . 73.34 108.941 -175.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.0 mm -78.98 130.85 35.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.396 -1.335 . . . . 53.21 107.396 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttt -121.51 77.94 1.39 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 125.459 1.504 . . . . 63.02 107.304 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.519 HG23 HG13 ' A' ' 140' ' ' VAL . 30.0 mt -70.2 103.11 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.775 2.03 . . . . 74.44 107.594 166.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -85.1 163.76 18.59 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.106 -1.442 . . . . 72.22 107.106 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.2 p -136.38 167.76 20.73 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.389 0.995 . . . . 73.41 108.441 164.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.4 ttmt -58.67 -30.07 67.07 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.563 -1.336 . . . . 54.5 113.113 -173.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -73.25 15.39 0.23 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.71 1.141 . . . . 72.11 112.283 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 92' ' ' LYS . 8.3 mmt180 47.69 35.47 4.58 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 128.776 2.83 . . . . 74.44 110.885 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.3 mtt-85 -73.63 167.32 21.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.002 -1.11 . . . . 73.33 108.002 157.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -170.93 161.12 6.93 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.46 1.904 . . . . 74.11 106.199 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -143.69 169.26 10.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 129.833 3.253 . . . . 65.33 109.268 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.431 ' C ' HD23 ' A' ' 99' ' ' LEU . 12.4 m -153.33 98.56 2.27 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.543 1.537 . . . . 71.22 110.564 -175.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.562 HD21 HG13 ' A' ' 97' ' ' ILE . 0.4 OUTLIER -159.64 173.25 16.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.733 1.613 . . . . 74.42 109.921 -170.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.9 p -68.83 167.93 14.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.267 1.027 . . . . 71.31 112.619 -172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.09 -46.61 67.33 Favored 'General case' 0 C--N 1.342 0.242 0 O-C-N 121.841 -0.537 . . . . 75.12 110.608 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.1 38.87 1.12 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.439 -0.948 . . . . 64.2 108.439 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.446 ' CG ' HD12 ' A' ' 99' ' ' LEU . 49.6 t-80 -84.26 134.62 42.84 Favored Pre-proline 0 C--O 1.237 0.426 0 N-CA-C 108.315 -0.994 . . . . 73.24 108.315 174.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.48 133.62 38.0 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.258 1.972 . . . . 72.32 111.111 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.98 178.78 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.825 1.65 . . . . 73.12 108.554 167.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -116.48 142.65 46.59 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.572 -0.705 . . . . 72.34 109.704 177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 121' ' ' VAL . 2.5 pp -133.77 165.15 32.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.44 1.496 . . . . 73.04 109.52 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.0 133.44 40.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.922 1.289 . . . . 71.41 107.91 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -122.66 74.43 1.19 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.109 1.364 . . . . 64.24 107.518 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m 65.85 7.64 4.74 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.975 1.31 . . . . 74.51 113.679 168.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 135.3 -9.71 4.4 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 124.312 0.958 . . . . 51.41 112.053 -172.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -101.3 117.52 35.13 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.042 -1.836 . . . . 71.21 106.042 171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -68.07 126.54 28.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 107.404 -1.332 . . . . 64.5 107.404 161.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 16.1 tp -118.91 140.5 49.88 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.074 1.749 . . . . 74.11 107.084 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -93.15 131.61 38.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.115 -1.068 . . . . 74.42 108.115 166.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 43.2 pt -145.59 -167.09 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.78 2.032 . . . . 73.43 107.997 172.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -96.76 143.5 27.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.887 1.275 . . . . 71.51 110.091 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.63 -35.67 42.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.213 1.405 . . . . 53.44 113.125 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -17.6 64.51 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.216 1.191 . . . . 71.25 114.216 -172.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -84.58 -25.57 28.56 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.489 1.116 . . . . 63.32 111.575 173.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.443 HG22 HG21 ' A' ' 107' ' ' ILE . 3.7 t -72.18 63.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 128.805 2.842 . . . . 72.31 110.492 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -78.63 -178.42 5.88 Favored 'General case' 0 C--O 1.223 -0.298 0 O-C-N 121.029 -1.044 . . . . 73.4 109.152 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.52 -13.57 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.309 1.843 . . . . 74.33 113.755 169.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.73 4.38 66.05 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 117.559 -1.69 . . . . 72.34 113.435 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -136.09 135.53 39.41 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 120.275 2.038 . . . . 72.31 106.657 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -76.87 122.48 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.772 -1.566 . . . . 75.55 106.772 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.65 147.49 6.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.541 -1.651 . . . . 75.43 106.541 164.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -81.87 136.33 35.36 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.517 -1.29 . . . . 71.34 107.517 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.407 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.4 pp -126.83 154.51 76.04 Favored Pre-proline 0 N--CA 1.467 0.401 0 C-N-CA 124.568 1.147 . . . . 74.5 111.608 172.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.6 150.49 31.56 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.562 2.175 . . . . 75.0 108.548 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 tptt -123.69 -171.05 2.24 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.148 -1.797 . . . . 73.43 106.148 161.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -40.63 -68.58 0.17 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.311 1.445 . . . . 73.32 112.72 -168.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -120.95 -1.37 9.89 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.859 1.664 . . . . 72.54 111.266 -178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 64.3 p -139.94 165.51 27.13 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 119.131 0.878 . . . . 75.44 111.199 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -79.33 155.03 4.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.431 -1.322 . . . . 72.25 107.431 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.42 -178.04 5.56 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.272 1.429 . . . . 73.22 107.307 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 17.5 mt -124.64 149.39 47.17 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.387 -1.709 . . . . 72.24 106.387 175.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -147.91 131.37 16.69 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.193 1.797 . . . . 65.32 106.729 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -62.44 157.2 20.69 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.211 0.46 . . . . 73.23 109.951 -176.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.519 HG13 HG23 ' A' ' 89' ' ' ILE . 78.7 t -93.76 2.1 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 125.993 1.717 . . . . 73.14 111.807 -171.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.6 pt 24.11 -86.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 128.985 2.914 . . . . 60.23 115.366 170.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -97.03 109.41 22.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.35 1.46 . . . . 72.41 107.44 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 p -110.76 119.07 58.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.883 -1.154 . . . . 61.45 107.883 164.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -133.77 -178.54 5.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.774 1.63 . . . . 75.34 108.558 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -126.66 136.1 52.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.084 0.954 . . . . 75.12 108.485 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.4 m -94.04 162.17 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.102 -1.073 . . . . 74.0 108.102 167.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.97 151.09 20.12 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.226 1.011 . . . . 73.42 108.488 159.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -159.07 131.8 6.91 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 119.513 1.051 . . . . 74.1 109.851 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -142.35 59.71 1.45 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.204 -0.935 . . . . 74.23 110.048 -167.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -130.96 -131.82 3.33 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.168 1.366 . . . . 72.31 112.703 -175.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -114.84 161.7 17.87 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.074 1.35 . . . . 64.31 109.438 168.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.92 156.04 39.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 125.464 1.505 . . . . 72.31 109.05 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.406 ' CD2' HG21 ' A' ' 29' ' ' VAL . 4.7 m-85 -146.53 159.29 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.509 -0.923 . . . . 74.34 108.509 -168.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -148.38 173.5 13.01 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.101 -1.074 . . . . 73.12 108.101 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -131.73 134.92 46.4 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.226 1.41 . . . . 73.21 109.324 -163.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 5.3 m -70.85 -50.64 33.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 118.562 -0.732 . . . . 72.44 112.096 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.9 t 24.58 68.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 128.561 2.745 . . . . 74.1 111.385 -176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.401 ' HG2' ' CD1' ' A' ' 75' ' ' LEU . 7.6 pt-20 -73.35 -6.16 44.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 122.255 1.026 . . . . 74.12 112.516 -166.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -69.88 -58.59 3.69 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.083 1.753 . . . . 75.04 108.874 -163.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -119.36 -1.12 10.81 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.024 1.33 . . . . 70.24 112.923 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.9 m170 58.67 28.3 17.02 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.536 1.535 . . . . 73.22 112.17 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.423 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 22.2 p -141.64 140.82 33.36 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 120.378 -1.451 . . . . 72.31 111.208 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.502 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -134.89 175.16 9.82 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.705 1.202 . . . . 65.22 111.717 -177.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 48.2 mm -107.14 122.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.341 0.219 0 N-CA-C 106.95 -1.5 . . . . 71.1 106.95 168.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.48 160.33 42.71 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.511 0.725 . . . . 53.54 109.245 170.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 137.37 -167.34 24.77 Favored Glycine 0 CA--C 1.518 0.271 0 N-CA-C 109.865 -1.294 . . . . 64.13 109.865 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -112.3 167.26 10.57 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 121.332 -1.099 . . . . 75.33 109.277 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 64.62 -83.64 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.226 1.811 . . . . 74.11 112.38 -171.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -122.04 -15.73 7.71 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 119.488 1.04 . . . . 72.14 112.787 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 174.6 46.61 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-O 123.286 1.492 . . . . 71.22 113.254 174.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.586 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -127.32 147.28 50.25 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 128.186 2.594 . . . . 73.23 106.949 -172.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.853 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -91.62 112.66 24.67 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.903 -1.517 . . . . 74.22 106.903 173.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 m -138.33 175.97 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.888 1.675 . . . . 74.13 109.045 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -61.08 138.59 58.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.842 0.857 . . . . 72.24 110.18 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.502 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -124.18 57.93 1.21 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 128.976 2.91 . . . . 65.24 107.473 169.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 42.4 m -103.29 110.96 23.14 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 105.315 -2.105 . . . . 61.43 105.315 -171.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 7.7 t -50.11 -57.82 6.85 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.909 1.684 . . . . 74.42 110.839 -174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.7 48.99 0.04 OUTLIER Glycine 0 C--N 1.333 0.376 0 N-CA-C 108.144 -1.982 . . . . 63.33 108.144 -175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.4 p -101.76 131.78 47.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.204 1.401 . . . . 74.42 109.021 -166.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 42.6 tp 65.24 -51.93 0.35 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.601 2.76 . . . . 65.5 113.218 -174.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 73.2 158.77 0.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 128.442 2.697 . . . . 70.24 112.027 -171.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.496 ' CG ' ' H ' ' A' ' 183' ' ' HIS . 23.7 t-160 46.15 -138.13 0.59 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.662 1.585 . . . . 72.11 108.884 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.496 ' H ' ' CG ' ' A' ' 182' ' ' HIS . 52.1 t-80 -126.74 143.56 51.21 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.942 -1.503 . . . . 75.35 106.942 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -137.6 152.4 49.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.625 -1.25 . . . . 73.54 107.625 154.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 -79.72 139.18 37.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.0 1.72 . . . . 74.12 106.744 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 . . . . . 0 C--O 1.254 1.302 0 N-CA-C 108.099 -1.075 . . . . 65.11 108.099 -170.053 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.475 0.803 0 CA-C-O 118.398 -0.81 . . . . 75.21 110.946 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 66.53 162.47 0.17 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.728 2.011 . . . . 73.44 111.217 -161.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.9 m -75.67 -65.98 0.83 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.144 -0.687 . . . . 72.51 109.144 174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.76 71.19 0.68 Allowed Glycine 0 C--N 1.333 0.413 0 N-CA-C 111.515 -0.634 . . . . 73.34 111.515 -167.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -80.97 52.14 1.7 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.616 1.166 . . . . 75.24 112.724 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -128.08 153.23 47.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.114 -1.809 . . . . 72.14 106.114 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.57 -172.57 28.75 Favored Glycine 0 CA--C 1.518 0.224 0 O-C-N 120.397 -1.439 . . . . 51.14 109.545 -172.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 163.92 164.23 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.81 2.844 . . . . 63.43 109.518 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 19.5 mt -98.51 160.98 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.431 1.892 . . . . 71.5 110.233 176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 154.76 30.64 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 123.211 0.605 . . . . 43.31 111.247 170.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -50.33 -32.09 16.28 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.353 1.861 . . . . 72.42 114.494 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -105.45 12.73 31.13 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.659 1.584 . . . . 70.43 112.946 -164.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -79.81 132.62 60.43 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.769 1.227 . . . . 71.52 108.974 174.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.49 149.55 90.55 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.551 2.834 . . . . 72.04 113.732 162.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.6 pt -114.47 -5.15 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.143 1.777 . . . . 73.45 112.862 174.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 55.53 73.38 0.43 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.452 1.024 . . . . 74.12 111.342 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.5 mt -56.44 159.64 3.57 Favored 'General case' 0 C--O 1.236 0.372 0 O-C-N 121.676 -0.64 . . . . 42.22 109.364 169.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.0 m -56.56 -34.03 66.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 118.379 -0.819 . . . . 73.44 112.247 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -86.93 -28.98 22.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.694 0.679 . . . . 72.03 110.295 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.05 41.32 1.97 Allowed Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.717 1.151 . . . . 72.12 114.493 166.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.88 -27.14 62.99 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 115.209 1.559 . . . . 74.12 115.209 -175.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mm 45.77 73.97 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.564 2.345 . . . . 71.34 108.69 -170.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 174.8 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.791 2.036 . . . . 64.41 108.32 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -86.4 135.59 33.44 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.187 1.395 . . . . 73.32 107.811 173.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 tt -55.38 -28.75 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 121.079 -1.013 . . . . 72.25 112.08 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.86 -14.51 57.86 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 116.465 -2.297 . . . . 60.2 114.845 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -66.2 -50.01 65.32 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 121.122 2.461 . . . . 74.51 108.327 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -56.54 -59.17 5.38 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 126.626 1.97 . . . . 65.42 108.47 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 77' ' ' VAL . 69.1 t -56.77 -47.33 82.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 116.135 -0.484 . . . . 55.04 111.166 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.76 -41.69 74.37 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.824 0.85 . . . . 75.11 110.809 -176.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.21 -51.32 45.1 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.351 1.06 . . . . 64.43 109.328 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -71.64 -43.87 65.34 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.152 0.981 . . . . 73.13 108.449 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.4 m-85 -56.01 -38.74 70.9 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 120.323 1.42 . . . . 71.41 111.895 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -83.51 -22.45 32.48 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.507 1.123 . . . . 73.52 111.124 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 8.5 mttm -88.27 -58.65 2.48 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.969 -1.493 . . . . 53.42 106.969 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.5 m-30 -91.88 45.91 1.25 Allowed 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 129.192 2.997 . . . . 75.2 108.313 -172.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.39 -34.86 64.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 121.225 -0.922 . . . . 61.35 111.226 172.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -77.99 6.2 8.29 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.261 1.425 . . . . 73.43 112.979 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -106.29 -9.88 16.63 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 117.179 -1.391 . . . . 65.5 111.322 168.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.3 mt -64.29 99.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.587 0 CA-C-N 120.089 1.313 . . . . 73.02 108.618 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -85.2 159.84 20.03 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.72 -0.844 . . . . 54.31 108.72 160.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -136.48 133.74 36.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.889 -2.263 . . . . 71.13 104.889 168.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -78.77 177.3 8.78 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.755 0.659 . . . . 62.3 109.459 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -40.6 77.39 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.343 1.457 . . . . 50.13 112.237 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -19.54 63.43 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.362 -0.836 . . . . 61.54 111.46 174.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.43 65.1 1.7 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 107.775 -2.13 . . . . 75.04 107.775 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -94.64 -100.7 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 105.698 -1.964 . . . . 75.12 105.698 171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.49 120.34 1.17 Allowed Glycine 0 C--N 1.331 0.293 0 N-CA-C 107.992 -2.043 . . . . 65.21 107.992 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.5 p-90 -139.16 162.21 35.51 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 117.839 0.819 . . . . 72.43 110.092 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 33' ' ' PHE . 13.2 mt -143.93 139.99 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 126.508 1.923 . . . . 50.15 105.85 171.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.75 133.11 35.31 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.497 1.519 . . . . 71.15 109.163 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -132.32 4.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 125.841 1.657 . . . . 73.21 112.169 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -58.07 -10.82 7.52 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.855 1.207 . . . . 64.21 114.173 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -80.16 -15.74 56.42 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 120.337 -1.684 . . . . 63.1 112.507 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -69.45 -12.66 61.84 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.981 1.264 . . . . 75.2 113.407 -176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.53 -2.13 0.68 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.894 2.078 . . . . 72.02 113.705 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.58 141.33 16.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 125.169 1.387 . . . . 71.23 107.477 178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -112.99 157.03 22.02 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.021 0.828 . . . . 60.13 109.547 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 tt -120.23 144.54 28.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 126.645 1.978 . . . . 73.24 107.337 175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -63.77 130.63 44.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.602 -1.629 . . . . 75.43 106.602 165.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 83.1 p -136.74 -169.18 2.41 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.632 -1.618 . . . . 64.3 106.632 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.427 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.4 OUTLIER -146.17 143.76 29.5 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.31 -1.367 . . . . 65.03 107.31 171.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -86.41 116.22 24.42 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 124.964 1.306 . . . . 73.51 108.357 172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -67.92 -27.98 67.1 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 123.676 0.79 . . . . 74.14 111.876 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.67 -22.42 65.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.637 0.653 . . . . 65.3 112.288 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.9 m -137.57 3.0 2.5 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.746 1.218 . . . . 72.41 112.628 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.4 mt 58.47 35.84 24.94 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.493 1.497 . . . . 54.23 111.732 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.47 154.91 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 126.203 1.801 . . . . 61.25 109.41 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.95 129.53 37.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.458 -1.682 . . . . 54.43 106.458 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -148.68 178.79 8.34 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.721 1.608 . . . . 74.14 108.443 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -105.77 150.1 25.84 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.465 -1.397 . . . . 74.22 109.287 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.6 160.11 39.11 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.296 -1.001 . . . . 74.43 108.296 169.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ttm-85 -92.4 -17.93 23.95 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.048 0.758 . . . . 63.0 113.048 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 mt 58.7 147.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.883 2.073 . . . . 75.43 109.429 -160.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.14 -57.24 2.1 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.996 0.919 . . . . 73.23 108.7 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -129.76 150.76 50.93 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.364 0.983 . . . . 65.35 110.298 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.412 HG21 HG13 ' A' ' 29' ' ' VAL . 0.9 OUTLIER -112.55 168.28 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 C-N-CA 125.188 1.395 . . . . 71.43 109.204 176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -135.44 153.2 51.85 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.177 0.991 . . . . 64.02 109.788 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.94 142.82 29.08 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.374 0.67 . . . . 70.04 109.612 169.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -137.47 156.64 47.91 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.403 -1.703 . . . . 70.32 106.403 168.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -84.24 159.18 21.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.117 -1.438 . . . . 74.22 107.117 165.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -139.9 153.94 47.11 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.196 0.998 . . . . 75.31 110.201 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 96.5 p -149.93 152.9 35.74 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 139.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.17 -171.66 32.13 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 109.394 -1.482 . . . . 64.13 109.394 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' HE3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -89.5 120.31 30.7 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.757 -1.201 . . . . 64.33 107.757 170.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.45 160.58 15.96 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.617 -1.253 . . . . 71.4 107.617 170.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.8 mm -79.34 140.71 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 125.162 1.385 . . . . 75.12 107.651 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -126.81 58.23 1.42 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.197 0.599 . . . . 73.05 110.287 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.9 mt -63.34 116.65 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 N-CA-C 105.62 -1.993 . . . . 53.14 105.62 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -94.98 155.48 16.72 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 105.384 -2.08 . . . . 64.11 105.384 163.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.1 p -125.44 169.17 12.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.883 1.273 . . . . 74.51 108.221 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.3 ttpt -67.57 -11.14 57.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 120.588 -1.32 . . . . 65.24 111.814 -172.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -3.23 53.96 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 125.661 1.585 . . . . 72.44 113.665 172.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.09 12.77 8.63 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.701 1.6 . . . . 74.02 111.571 -171.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 165.57 17.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.262 -1.014 . . . . 75.44 108.262 163.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -173.19 164.14 4.74 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 126.768 2.027 . . . . 70.55 109.027 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.534 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.3 pt -144.84 165.99 11.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 127.033 2.133 . . . . 52.51 107.54 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.9 m -140.34 97.87 3.31 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.841 0.857 . . . . 75.51 109.256 174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.84 172.25 13.1 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.762 1.625 . . . . 72.24 111.547 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.4 p -61.03 154.61 22.25 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.991 1.316 . . . . 75.53 110.754 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -74.14 -26.15 60.15 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.465 -0.772 . . . . 65.34 111.369 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -97.72 37.74 1.36 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.623 0.647 . . . . 64.43 110.054 174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -90.94 123.38 64.92 Favored Pre-proline 0 C--O 1.239 0.522 0 CA-C-O 117.807 -1.092 . . . . 73.51 108.108 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -64.67 139.01 61.48 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 121.659 1.573 . . . . 64.4 111.094 173.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.56 -162.3 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.766 1.627 . . . . 71.31 108.772 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -134.02 133.09 40.84 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.223 1.009 . . . . 64.13 110.56 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.45 161.45 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 125.383 1.473 . . . . 72.44 109.414 -178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.24 120.95 28.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 122.518 1.151 . . . . 60.1 110.751 173.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.37 77.51 9.93 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.264 1.826 . . . . 60.3 106.159 150.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.2 17.01 3.32 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.655 1.354 . . . . 44.11 114.655 175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.48 -28.55 3.99 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 124.919 1.247 . . . . 63.42 111.398 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.69 118.06 20.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 104.635 -2.358 . . . . 74.44 104.635 176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.55 134.7 29.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.288 -1.004 . . . . 72.54 108.288 175.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.517 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -130.39 153.18 48.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.501 -1.296 . . . . 71.43 107.501 176.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.517 ' H ' HD13 ' A' ' 114' ' ' LEU . 1.3 pm0 -112.63 114.16 26.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.377 1.471 . . . . 71.44 109.499 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -136.73 174.03 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 126.769 2.028 . . . . 73.13 108.596 -174.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -94.03 148.78 21.83 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.073 0.851 . . . . 74.33 110.912 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.48 -29.21 9.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.207 1.803 . . . . 53.55 114.162 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -33.43 69.63 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.01 1.277 . . . . 61.22 111.928 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 22.6 mtm -87.35 -19.91 27.5 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.185 0.994 . . . . 71.14 111.613 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.4 t -71.19 63.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 129.516 3.126 . . . . 64.04 112.239 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -78.5 -179.95 6.69 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.764 -1.835 . . . . 65.42 110.35 170.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.49 -10.81 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 127.652 2.381 . . . . 75.31 113.995 171.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.88 -3.01 83.63 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 124.629 1.109 . . . . 61.23 112.892 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -114.89 152.65 31.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.45 -1.685 . . . . 72.12 106.45 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.62 131.68 55.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.645 -1.613 . . . . 73.42 106.645 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -106.89 126.84 62.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 123.793 0.837 . . . . 63.22 108.803 -168.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -65.57 122.35 17.03 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.674 1.19 . . . . 72.22 108.884 -173.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.19 155.83 70.6 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 113.348 0.87 . . . . 70.4 113.348 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.33 151.97 82.25 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.549 2.166 . . . . 75.15 111.006 167.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.531 ' HB2' HD22 ' A' ' 136' ' ' ASN . 0.0 OUTLIER -121.69 -160.34 0.86 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.007 1.723 . . . . 72.12 106.806 158.54 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -48.28 -61.58 1.92 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.316 1.046 . . . . 61.51 110.858 -174.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -121.0 -17.86 7.69 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.088 1.355 . . . . 74.55 112.843 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.0 p -140.59 170.84 15.03 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.426 1.09 . . . . 75.54 110.742 -165.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -79.91 154.34 4.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-O 121.867 0.841 . . . . 73.2 110.662 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.531 HD22 ' HB2' ' A' ' 131' ' ' LYS . 15.5 m-80 -143.89 -171.42 3.54 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.179 1.792 . . . . 54.14 106.829 166.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.1 mt -125.28 168.88 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.419 -0.956 . . . . 70.12 108.419 172.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -155.83 161.99 40.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.812 0.845 . . . . 62.11 110.937 163.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -74.7 140.68 44.33 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 127.32 2.248 . . . . 62.0 110.693 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.9 t -85.54 1.03 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.023 1.329 . . . . 75.23 112.61 -175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.517 HG13 ' H ' ' A' ' 142' ' ' LYS . 3.7 pt 24.33 -75.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 129.882 3.273 . . . . 71.42 117.238 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.517 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -93.12 126.09 38.05 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.909 2.484 . . . . 72.41 109.537 -170.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.18 121.91 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 123.316 0.646 . . . . 72.44 110.505 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -175.75 -171.9 0.49 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 129.238 3.015 . . . . 74.01 109.445 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.9 p -132.29 174.25 10.42 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.827 2.051 . . . . 73.42 107.98 -174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 33.0 m -110.18 -178.25 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 107.439 -1.319 . . . . 75.21 107.439 151.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.46 113.65 15.79 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.783 -1.562 . . . . 64.23 106.783 168.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -129.99 160.88 32.29 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.356 1.462 . . . . 70.31 109.806 -165.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.17 47.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.344 1.458 . . . . 52.5 109.663 -162.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -117.17 -150.57 9.23 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 125.964 1.745 . . . . 75.41 110.212 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -98.0 157.1 16.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.793 0.796 . . . . 73.4 109.797 159.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 19.2 pt -122.08 151.26 25.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 126.537 1.935 . . . . 74.13 107.929 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -136.87 151.18 48.81 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.791 1.236 . . . . 75.35 111.118 -170.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -153.0 -177.85 6.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.913 0.885 . . . . 75.34 111.567 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.7 mp -147.76 121.98 9.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.311 1.844 . . . . 70.44 107.772 -152.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.53 -37.09 32.19 Favored 'General case' 0 C--O 1.216 -0.688 0 CA-C-O 116.13 -1.891 . . . . 64.54 114.72 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.4 p 24.61 73.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.771 2.028 . . . . 72.13 112.708 -173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 12.3 pt-20 -66.02 -10.06 36.33 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.492 -1.38 . . . . 74.1 113.602 -170.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.52 -72.37 0.17 Allowed 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.825 2.05 . . . . 72.14 106.066 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.83 -19.25 17.51 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.685 1.594 . . . . 70.04 111.729 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.452 ' CD2' ' HA ' ' A' ' 158' ' ' GLU . 51.4 m170 48.31 39.72 12.9 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.062 2.145 . . . . 72.24 112.658 -162.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.0 p -152.48 143.92 23.37 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.043 1.292 . . . . 74.43 109.32 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 4.0 p90 -136.08 172.88 12.37 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.488 1.515 . . . . 61.12 110.082 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.2 mm -103.32 138.26 28.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.915 -1.513 . . . . 63.53 106.915 157.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -163.15 160.23 23.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.048 0.939 . . . . 53.22 110.295 166.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 131.17 -163.02 23.63 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.279 1.418 . . . . 54.41 110.731 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -104.9 170.26 7.97 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.0 1.9 . . . . 72.54 112.049 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 56.9 -72.42 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.1 0 C-N-CA 129.695 3.198 . . . . 75.32 111.685 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.62 -14.98 8.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.469 1.508 . . . . 65.11 113.493 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.04 171.75 9.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 122.726 1.181 . . . . 74.43 112.412 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 97' ' ' ILE . 39.0 m-85 -126.49 144.78 50.75 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 126.861 2.064 . . . . 75.34 109.118 -170.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -74.9 114.57 13.51 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.26 1.424 . . . . 72.23 108.243 166.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.1 m -134.92 -179.29 3.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.618 0.767 . . . . 60.14 110.789 176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.6 t -72.65 144.25 47.84 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.79 0.836 . . . . 75.22 108.951 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.52 60.87 1.28 Allowed 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.291 1.836 . . . . 74.14 109.425 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 8.7 p -76.96 172.23 13.51 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 122.427 1.108 . . . . 64.23 111.466 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -53.83 128.91 31.77 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.979 0.912 . . . . 61.11 109.039 168.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.9 -63.63 5.09 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.282 -0.727 . . . . 62.13 111.282 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 p -80.31 165.31 22.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 64.22 111.241 171.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 182' ' ' HIS . 21.8 tp -66.56 -53.02 39.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.436 1.094 . . . . 73.31 110.509 168.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 60.39 28.47 18.11 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.613 1.565 . . . . 63.33 113.035 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . 0.423 ' H ' ' HG ' ' A' ' 180' ' ' LEU . 2.8 t60 -136.38 111.15 8.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.424 -1.325 . . . . 72.2 107.424 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 58.22 -170.75 0.11 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.014 1.325 . . . . 55.11 111.683 -173.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.16 -72.04 0.28 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.276 1.43 . . . . 72.54 107.683 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . 0.48 ' CG ' ' H ' ' A' ' 186' ' ' HIS . 2.4 t60 -144.63 -160.17 1.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.209 -1.404 . . . . 72.33 107.209 162.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.48 ' H ' ' CG ' ' A' ' 185' ' ' HIS . 1.7 t-80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 125.123 1.369 . . . . 61.41 110.131 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 120.534 0.207 . . . . 72.12 110.84 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -135.77 158.21 44.95 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.771 2.029 . . . . 74.22 107.298 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.8 m -71.18 -25.95 62.75 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 122.013 -0.429 . . . . 44.33 109.948 166.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.59 145.88 8.4 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 108.647 -1.781 . . . . 61.34 108.647 -168.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -140.31 -178.97 5.73 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 127.073 2.149 . . . . 64.25 105.858 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -103.86 -174.49 2.56 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.909 -1.145 . . . . 60.13 107.909 171.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.35 168.92 13.29 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 124.664 1.126 . . . . 43.35 110.958 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.23 174.8 3.29 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 128.781 2.832 . . . . 52.32 106.048 160.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mt -113.93 178.09 4.41 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.774 1.63 . . . . 75.21 109.548 172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.17 -169.21 0.06 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.183 1.793 . . . . 70.42 113.667 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CD1' ' HA3' ' A' ' 26' ' ' GLY . 6.5 t80 -94.29 -45.67 7.39 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.947 1.299 . . . . 74.24 109.931 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -87.33 -0.41 56.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.434 1.493 . . . . 75.42 112.058 -167.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.02 156.6 76.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.03 -1.044 . . . . 65.33 110.579 -171.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -92.92 143.8 2.26 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.334 3.356 . . . . 74.31 113.351 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.5 pt -111.26 -2.0 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 114.325 1.231 . . . . 65.21 114.325 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 53.71 73.41 0.38 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.454 1.101 . . . . 63.0 111.974 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.0 mt -54.64 162.83 1.06 Allowed 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.476 -0.765 . . . . 73.4 109.596 167.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.9 t -49.03 -40.39 30.98 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.108 0.963 . . . . 52.33 110.732 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -81.24 -20.59 40.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.282 0.845 . . . . 74.34 113.282 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.21 28.93 8.25 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.518 1.056 . . . . 65.45 113.041 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.11 -15.34 63.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 118.37 2.73 . . . . 72.34 118.37 -163.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 mm 43.79 78.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 128.014 2.525 . . . . 74.42 109.643 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.3 154.16 20.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 126.631 1.973 . . . . 55.13 107.487 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' HB2' ' H ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -62.26 129.63 41.62 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.889 1.276 . . . . 73.54 107.584 171.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -53.19 -39.4 34.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 109.569 -0.53 . . . . 72.32 109.569 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 11' ' ' TYR . . . -46.19 -59.71 4.99 Favored Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 125.014 1.292 . . . . 63.43 111.337 176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' H ' ' HB2' ' A' ' 24' ' ' ASN . 38.5 tp10 -69.14 -48.55 62.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.197 -0.906 . . . . 64.53 110.454 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -45.7 -53.1 9.89 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.554 1.142 . . . . 74.31 109.614 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.704 HG22 HG21 ' A' ' 77' ' ' VAL . 49.8 t -69.7 -45.36 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-N 115.485 -0.779 . . . . 74.53 109.486 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -59.87 -37.94 80.75 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 120.842 -1.161 . . . . 73.35 113.223 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.484 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.3 OUTLIER -55.96 -38.13 69.97 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.903 1.681 . . . . 72.23 110.784 177.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 15.8 m-85 -73.84 -49.17 26.4 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.19 1.396 . . . . 75.23 108.638 172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -53.18 -37.98 62.41 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 121.177 1.808 . . . . 73.24 113.301 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.21 -30.34 57.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.01 -0.995 . . . . 53.13 111.829 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -85.08 -52.11 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 -177.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' CE1' ' HB3' ' A' ' 35' ' ' LYS . 2.0 m-30 -93.5 41.36 1.08 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.716 2.007 . . . . 74.21 108.256 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -27.79 68.57 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.576 -1.328 . . . . 51.24 112.142 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -62.42 -27.98 69.48 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.944 1.698 . . . . 75.53 113.304 168.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 t -90.55 -1.25 57.88 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.346 1.858 . . . . 75.15 112.86 -176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.3 mt -66.39 89.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 119.976 1.262 . . . . 70.24 109.764 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.8 mmtm -79.71 161.27 25.88 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.992 1.717 . . . . 74.44 108.528 169.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -143.32 122.28 12.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.05 1.34 . . . . 62.15 108.884 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -77.92 169.76 17.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.651 -0.87 . . . . 75.44 108.651 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 -54.47 34.65 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.91 2.084 . . . . 75.14 111.137 -173.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.04 3.97 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.356 1.462 . . . . 60.14 113.295 175.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.08 39.67 18.99 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 126.927 2.204 . . . . 73.34 110.853 159.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -86.0 -99.97 0.07 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 124.409 1.084 . . . . 74.25 108.156 -173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 146.01 111.01 0.68 Allowed Glycine 0 CA--C 1.523 0.551 0 CA-C-O 117.754 -1.581 . . . . 73.41 110.726 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 p-90 -114.19 164.6 13.65 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.229 1.514 . . . . 75.51 111.537 170.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.6 mt -145.36 144.04 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 128.125 2.57 . . . . 74.12 105.266 164.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -83.06 114.7 21.47 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.81 -1.182 . . . . 71.33 107.81 166.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -121.96 13.59 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 123.854 0.862 . . . . 71.52 109.98 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.93 -31.91 82.41 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 120.19 -1.569 . . . . 62.21 111.334 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -68.64 -1.51 7.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.719 1.208 . . . . 72.3 114.245 174.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -74.67 -18.25 60.56 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 121.872 -0.518 . . . . 73.1 111.088 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.29 18.85 11.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 127.24 2.216 . . . . 41.44 113.624 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -82.33 131.03 34.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.292 -1.373 . . . . 75.1 107.292 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -96.67 161.58 13.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.362 1.465 . . . . 52.4 109.476 173.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 tt -141.87 149.58 19.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.722 1.609 . . . . 61.31 108.72 -171.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -68.99 121.43 16.61 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.278 -1.379 . . . . 74.42 107.278 173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' TYR . 0.4 OUTLIER -117.81 -177.55 3.28 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.044 1.338 . . . . 54.42 108.384 171.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.2 OUTLIER -137.71 132.22 32.52 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.369 -1.715 . . . . 73.54 106.369 169.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.17 106.35 13.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.321 -0.992 . . . . 64.35 108.321 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.423 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 71.5 tttt -55.84 -18.55 8.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.327 1.851 . . . . 73.14 113.984 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -64.95 -34.55 78.7 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.448 1.099 . . . . 53.31 112.121 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.3 m -125.51 -1.55 7.46 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.054 0.942 . . . . 73.03 112.501 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.81 44.09 17.41 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.122 -0.986 . . . . 61.44 110.487 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 pt -108.6 157.24 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 125.941 1.696 . . . . 42.31 109.151 -175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.65 128.71 38.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.03 -1.47 . . . . 72.53 107.03 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -135.71 175.21 9.8 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.491 1.116 . . . . 70.55 112.758 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.62 96.64 3.87 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.245 -2.131 . . . . 74.24 105.245 -157.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.8 mmtt -125.14 172.0 9.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.079 0.952 . . . . 63.2 110.575 -165.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -116.28 153.08 32.57 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.93 0.786 . . . . 71.11 109.382 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.56 154.77 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.798 -1.186 . . . . 50.45 107.798 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -121.07 -20.62 6.75 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.918 0.781 . . . . 63.02 112.639 169.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -161.7 163.74 29.56 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.2 -1.563 . . . . 71.25 108.478 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.704 HG21 HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -137.97 161.25 32.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.095 0.958 . . . . 52.14 109.11 179.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -135.7 149.34 49.21 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.38 1.072 . . . . 74.31 110.416 -174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -146.2 142.24 28.21 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.124 0.875 . . . . 74.53 110.527 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.1 tttt -146.17 163.19 36.17 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 127.288 2.235 . . . . 62.32 107.274 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 4.7 tttm -107.48 156.4 19.02 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.612 -1.255 . . . . 72.42 107.612 164.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 3.4 t80 -153.64 163.08 40.6 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.975 1.31 . . . . 72.02 108.82 -166.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.3 p -151.67 113.92 4.53 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.116 -1.809 . . . . 75.32 106.116 168.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.52 -146.54 5.31 Favored Glycine 0 CA--C 1.499 -0.956 0 C-N-CA 117.095 -2.479 . . . . 50.45 112.209 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.43 104.54 8.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.407 1.883 . . . . 72.41 107.801 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.559 HD13 HG22 ' A' ' 98' ' ' THR . 88.6 mt -83.69 162.91 20.56 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.73 1.612 . . . . 71.53 106.887 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 89' ' ' ILE . 34.8 mm -79.5 135.25 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 127.057 2.143 . . . . 63.1 107.37 174.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HE3' HG11 ' A' ' 146' ' ' VAL . 35.4 ttmt -125.4 79.68 1.83 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.635 -1.617 . . . . 64.13 106.635 161.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.455 HG23 HG13 ' A' ' 140' ' ' VAL . 22.0 mt -59.21 141.07 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.345 -2.094 . . . . 65.42 105.345 152.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -115.16 164.28 14.43 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 105.621 -1.992 . . . . 65.51 105.621 163.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.8 p -136.02 169.73 17.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 119.822 1.192 . . . . 50.11 108.909 166.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -63.06 -21.63 66.3 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 120.675 -1.265 . . . . 73.2 112.759 -169.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -66.49 -1.13 3.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.366 1.866 . . . . 60.33 112.72 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.3 22.41 10.75 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.025 1.73 . . . . 72.44 111.358 -165.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -74.79 168.71 19.33 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.865 -0.791 . . . . 61.11 108.865 163.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 174.6 163.15 0.22 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 129.05 2.94 . . . . 71.34 110.401 -167.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.449 ' CG2' ' CE1' ' A' ' 171' ' ' PHE . 3.0 pt -140.12 172.49 12.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.723 1.209 . . . . 51.42 110.436 -170.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.559 HG22 HD13 ' A' ' 86' ' ' LEU . 27.1 m -152.27 94.82 1.97 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.124 0.969 . . . . 75.03 109.713 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.438 HD21 HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -154.11 177.59 10.91 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 128.408 2.683 . . . . 72.44 109.261 -174.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.9 p -78.4 171.49 15.02 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 120.649 1.568 . . . . 62.1 110.657 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -69.91 -19.67 63.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.13 0.972 . . . . 71.13 111.371 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -109.64 38.02 2.48 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.422 -0.799 . . . . 73.44 110.761 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -107.15 133.72 20.2 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.868 -0.79 . . . . 72.44 108.868 -175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.32 118.1 5.41 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.671 2.914 . . . . 65.52 113.251 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.35 -179.32 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.664 1.586 . . . . 64.43 109.954 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.17 144.72 49.17 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.223 0.92 . . . . 72.34 111.15 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 pt -134.88 165.49 31.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.112 0.965 . . . . 73.32 109.871 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.472 ' HB3' HD21 ' A' ' 137' ' ' LEU . 71.1 p -94.42 110.02 21.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.968 0.507 . . . . 64.34 109.666 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -85.8 81.35 8.61 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.578 -2.008 . . . . 72.34 105.578 167.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 49.1 32.47 4.07 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.473 1.109 . . . . 55.51 113.196 -172.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.25 -9.42 42.36 Favored Glycine 0 CA--C 1.521 0.439 0 CA-C-O 118.693 -1.059 . . . . 52.2 114.339 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -84.5 131.21 34.67 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 119.389 1.595 . . . . 70.24 106.881 167.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.1 t -74.08 117.78 18.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.039 -1.467 . . . . 54.34 107.039 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.92 151.19 45.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.885 1.274 . . . . 74.44 108.65 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.2 121.3 44.92 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.53 1.132 . . . . 63.31 109.683 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 116' ' ' ILE . 15.6 pt -140.74 -175.96 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.789 0.836 . . . . 74.23 110.498 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -92.87 142.91 26.8 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.198 1.399 . . . . 72.25 108.704 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.47 -20.11 65.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.35 0.977 . . . . 60.0 113.544 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -32.32 66.14 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.196 1.362 . . . . 71.22 112.596 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -23.85 36.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.563 1.145 . . . . 64.01 112.195 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 t -71.97 64.02 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.029 2.532 . . . . 74.45 111.653 -174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -79.79 -179.77 7.11 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 120.425 -1.422 . . . . 71.0 111.878 175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 5.6 p -55.59 -9.86 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 128.421 2.689 . . . . 53.33 114.005 173.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.71 -15.97 79.92 Favored Glycine 0 CA--C 1.523 0.59 0 O-C-N 121.279 -0.888 . . . . 44.41 111.554 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -114.33 164.87 13.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.634 1.217 . . . . 64.41 108.92 -174.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.406 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 13.1 m-85 -113.41 137.9 50.85 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.218 -1.401 . . . . 74.0 107.218 167.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -102.4 132.46 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.613 -1.255 . . . . 61.31 107.613 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -67.41 124.53 23.42 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.5 -0.926 . . . . 72.54 108.5 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.465 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -133.33 154.5 81.04 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 125.899 1.68 . . . . 72.33 110.096 -175.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.57 149.43 84.2 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.401 1.401 . . . . 63.3 110.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 ttmt -120.62 -145.39 0.36 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.568 -1.641 . . . . 72.42 106.568 149.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -56.85 -70.86 0.11 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.145 1.378 . . . . 72.53 111.155 -162.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -120.09 -2.79 10.16 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.596 0.758 . . . . 74.23 112.764 171.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 167.32 21.65 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.434 1.093 . . . . 75.32 111.257 -177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 5.2 tp -78.84 156.76 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.139 0.971 . . . . 64.32 108.686 -172.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.93 -173.76 3.89 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 127.601 2.361 . . . . 73.51 107.226 173.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' A' ' 108' ' ' SER . 40.6 mt -135.43 136.52 41.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.387 -2.079 . . . . 42.15 105.387 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -133.7 153.98 51.29 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.717 -1.216 . . . . 70.43 107.717 171.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 18.1 tt0 -96.77 136.87 36.7 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 126.841 2.056 . . . . 74.43 107.88 -161.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.455 HG13 HG23 ' A' ' 89' ' ' ILE 0.296 46.9 t -79.98 1.05 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 114.479 1.288 . . . . 73.21 114.479 -158.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.7 pt 26.61 -98.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.158 2.583 . . . . 73.52 115.405 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -90.56 122.5 33.43 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 120.411 -1.43 . . . . 72.32 108.067 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.4 p -130.62 117.49 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 N-CA-C 107.251 -1.388 . . . . 73.31 107.251 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -144.83 -165.57 2.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.832 1.653 . . . . 72.23 108.909 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.3 p -121.92 171.33 9.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.017 1.327 . . . . 55.15 110.179 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.426 HG11 ' HE3' ' A' ' 88' ' ' LYS . 30.3 m -130.56 131.75 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 107.712 -1.218 . . . . 53.33 107.712 167.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -84.02 109.54 17.74 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.374 -1.343 . . . . 75.33 107.374 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -133.23 136.18 45.43 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.802 2.041 . . . . 63.24 106.909 -163.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -140.63 43.86 1.85 Allowed 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.784 -0.572 . . . . 65.41 110.233 -155.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -133.52 -156.81 8.13 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.391 0.996 . . . . 54.32 112.897 -165.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.15 155.52 24.95 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.977 -0.719 . . . . 74.01 110.408 165.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.4 pt -132.36 147.21 32.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 C-N-CA 127.712 2.405 . . . . 74.13 106.961 172.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.415 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 3.5 m-85 -132.79 164.68 26.28 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.786 -1.19 . . . . 75.0 107.786 -175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -153.66 177.39 11.01 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.528 -1.286 . . . . 72.33 107.528 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 16.9 mt -140.56 163.81 31.84 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.719 1.145 . . . . 73.42 110.819 -167.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 20.1 m -118.58 110.38 17.28 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.926 1.691 . . . . 64.33 107.054 169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.2 77.72 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.808 2.043 . . . . 42.21 106.808 172.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.378 10.9 pt-20 -72.87 2.2 7.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.109 1.364 . . . . 72.41 113.995 -175.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.5 -56.61 11.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 128.438 2.695 . . . . 71.13 109.74 -175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 4.6 t30 -133.24 -4.33 3.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.128 0.971 . . . . 72.43 111.861 176.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 12.4 m80 66.65 21.34 10.65 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.284 1.434 . . . . 60.33 112.219 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 4.5 p -142.22 139.73 32.09 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.486 -0.931 . . . . 74.13 108.486 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -137.82 176.64 8.52 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.876 0.87 . . . . 43.01 110.281 -175.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 29.8 mm -98.76 120.1 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 165.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -143.26 133.79 24.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.947 -1.131 . . . . 63.55 107.947 167.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 160.54 177.05 33.3 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.723 2.106 . . . . 72.44 108.065 168.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -75.34 178.74 5.63 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 119.366 -2.255 . . . . 71.13 110.622 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.61 -86.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.079 1.752 . . . . 70.32 112.468 171.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -122.13 -8.5 8.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.433 1.893 . . . . 61.03 114.177 171.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 88.1 164.13 39.91 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.549 1.547 . . . . 73.32 113.482 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.465 ' CD2' HG22 ' A' ' 129' ' ' ILE . 9.1 m-85 -108.19 159.66 16.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.32 1.448 . . . . 73.13 109.044 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -102.1 102.08 12.5 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 126.215 1.806 . . . . 64.14 106.7 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.74 177.08 6.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 124.243 1.017 . . . . 74.35 109.684 -170.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 75.0 m -66.55 139.15 57.9 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.472 -0.936 . . . . 43.02 108.472 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.499 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -128.12 39.63 3.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.033 2.533 . . . . 64.42 109.28 172.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 7.1 p -59.76 130.78 48.49 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.691 -0.855 . . . . 74.43 108.691 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 92.1 p -77.65 168.11 20.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 118.139 0.427 . . . . 75.12 110.721 172.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -44.43 111.74 0.54 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 126.476 1.989 . . . . 73.11 109.917 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -55.16 172.77 0.12 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.876 2.47 . . . . 53.22 112.645 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 36.3 tp -56.88 -67.54 0.3 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.148 0.979 . . . . 74.13 110.744 -172.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -157.38 -35.03 0.08 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 118.666 0.667 . . . . 65.15 112.619 159.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 12.5 t60 57.98 22.77 9.17 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 128.65 2.78 . . . . 74.0 115.194 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.08 179.86 5.84 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.508 -0.745 . . . . 74.45 111.449 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -85.34 -61.64 1.72 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.509 -0.552 . . . . 64.11 109.509 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -72.27 155.94 39.65 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 122.336 1.065 . . . . 63.42 110.97 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 C--O 1.248 1.009 0 C-N-CA 130.775 3.63 . . . . 54.52 101.486 -174.535 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 109.675 -0.491 . . . . 72.34 109.675 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.25 -153.88 0.16 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.536 0.735 . . . . 70.31 110.234 -170.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 m 75.62 15.38 2.67 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.526 1.93 . . . . 53.11 110.562 -167.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -53.99 19.18 0.01 OUTLIER Glycine 0 CA--C 1.536 1.394 1 C-N-CA 131.298 4.285 . . . . 60.1 117.089 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -136.54 87.04 2.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.481 1.912 . . . . 70.23 106.043 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -149.82 178.48 8.86 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 127.787 2.435 . . . . 71.34 109.383 -160.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.29 -132.95 7.9 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.554 1.074 . . . . 71.45 110.725 -173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 155.4 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.845 3.258 . . . . 74.23 109.312 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.9 mt -110.73 166.69 10.81 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.281 3.032 . . . . 53.32 109.016 173.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.88 178.97 1.2 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.165 1.386 . . . . 74.02 112.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -75.84 -34.33 60.08 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.427 -0.796 . . . . 74.45 110.522 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -108.45 25.53 11.56 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 122.678 1.228 . . . . 74.52 112.436 -161.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -79.05 126.39 82.04 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 125.36 1.464 . . . . 53.24 109.141 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -67.14 102.76 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.33 2.687 . . . . 35.4 108.89 168.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 pt -78.17 140.88 16.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 119.818 1.19 . . . . 71.43 108.964 165.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 169' ' ' GLU . 47.6 m-85 -96.14 83.32 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.525 -1.657 . . . . 74.54 106.525 -177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 86.8 mt -58.97 154.7 14.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.72 -0.845 . . . . 65.2 108.72 168.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.3 t -61.92 -20.4 63.73 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.2 -0.313 . . . . 52.32 110.188 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -65.74 -29.65 70.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 126.633 1.973 . . . . 61.43 112.736 170.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.88 4.61 67.08 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 125.238 1.399 . . . . 52.44 112.314 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.19 -39.36 72.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.632 1.716 . . . . 62.22 115.073 -156.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.7 mm 57.02 96.98 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.193 0 C-N-CA 127.73 2.412 . . . . 64.44 108.841 -172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.86 157.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.679 -1.971 . . . . 62.41 105.679 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -67.04 119.25 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.581 -1.637 . . . . 52.33 106.581 170.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.2 tt -50.79 -35.85 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.292 0.637 . . . . 75.44 110.153 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.38 -30.94 63.97 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-O 118.2 -1.334 . . . . 43.35 112.734 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -63.36 -55.91 20.63 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 119.917 1.858 . . . . 75.35 108.894 171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -48.48 -49.61 34.97 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 125.341 1.456 . . . . 65.42 110.397 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 77' ' ' VAL . 76.9 t -76.33 -40.64 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-O 118.087 -0.958 . . . . 73.13 110.109 -174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 33' ' ' PHE . 0.2 OUTLIER -64.58 -29.38 70.4 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 120.723 1.601 . . . . 72.54 110.873 178.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -43.85 52.67 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.871 1.268 . . . . 65.41 110.335 170.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -77.6 -46.18 22.95 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 117.325 -1.321 . . . . 74.21 110.03 176.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.423 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . 8.4 m-85 -54.85 -34.32 62.77 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 122.182 2.264 . . . . 74.45 113.08 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -84.81 -22.39 29.53 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.637 1.175 . . . . 65.22 110.616 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -63.29 1.32 Allowed 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.701 -1.222 . . . . 73.1 107.701 172.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -84.26 39.77 0.73 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 128.184 2.594 . . . . 74.0 109.192 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -52.5 -36.74 55.85 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.667 1.587 . . . . 70.03 111.181 173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -71.05 -13.49 62.0 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.306 1.842 . . . . 75.14 113.381 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -108.06 5.76 26.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.268 1.427 . . . . 63.2 112.379 179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.88 105.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 N-CA-C 107.518 -1.29 . . . . 64.41 107.518 171.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -103.85 107.18 17.94 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 123.051 0.541 . . . . 64.11 109.72 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -70.69 154.7 41.6 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.745 -0.835 . . . . 42.52 108.745 168.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -113.85 171.64 7.47 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 126.246 1.818 . . . . 63.44 107.181 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.01 -54.26 21.3 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.185 1.794 . . . . 65.55 111.239 -175.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.35 -18.79 65.56 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.82 0.848 . . . . 61.51 111.381 -177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.27 -1.78 22.35 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 125.867 1.699 . . . . 71.11 113.643 160.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -50.46 -79.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.305 1.842 . . . . 63.03 111.81 -164.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.48 110.43 2.85 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 109.055 -1.618 . . . . 73.33 109.055 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.4 p-90 -110.62 168.78 9.21 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.233 1.013 . . . . 71.43 109.635 165.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mt -143.91 136.22 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 105.97 -1.863 . . . . 71.35 105.97 166.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -71.2 125.32 26.62 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 161.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -133.27 3.85 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 123.914 0.885 . . . . 63.23 110.768 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -60.22 -31.23 72.78 Favored Glycine 0 CA--C 1.524 0.65 0 O-C-N 121.331 -0.856 . . . . 72.15 113.188 -172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -60.45 -13.63 14.66 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.565 1.182 . . . . 64.15 113.025 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.62 -21.09 37.38 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.98 -1.075 . . . . 73.14 111.662 167.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 46.93 24.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.677 2.391 . . . . 73.33 113.441 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.9 mt -72.32 113.66 9.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.773 -1.566 . . . . 54.14 106.773 172.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -79.16 150.78 31.61 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.162 0.585 . . . . 72.5 110.97 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 15.6 tt -112.36 157.83 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 125.65 1.58 . . . . 64.1 108.296 170.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -63.6 110.27 1.94 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.751 -1.944 . . . . 74.24 105.751 162.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.57 175.65 5.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.107 1.363 . . . . 63.31 107.807 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.95 120.72 7.57 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.452 -1.314 . . . . 62.11 107.452 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -73.82 118.67 17.05 Favored 'General case' 0 N--CA 1.442 -0.86 0 O-C-N 121.202 -0.936 . . . . 71.33 109.547 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -63.86 -31.74 73.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.588 0.355 . . . . 74.51 110.989 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -44.66 -41.74 6.94 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 126.164 1.785 . . . . 75.21 111.692 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 t -136.91 15.59 3.07 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 43.32 111.399 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.5 47.6 8.33 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.834 1.654 . . . . 74.41 112.51 -175.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.6 pt -99.06 160.54 3.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 C-N-CA 124.875 1.27 . . . . 62.33 108.434 175.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.86 149.68 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 106.801 -1.555 . . . . 74.21 106.801 162.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -178.69 7.49 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.287 2.235 . . . . 54.03 110.227 -176.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -124.98 130.96 53.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.047 1.339 . . . . 73.4 107.715 -173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -151.6 160.04 43.82 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.403 1.081 . . . . 65.34 108.78 163.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -83.36 178.11 8.19 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.152 0.981 . . . . 75.54 110.687 163.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 mt -95.12 170.85 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 126.848 2.059 . . . . 54.23 106.194 175.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.66 -61.71 1.49 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.044 -1.465 . . . . 65.02 107.044 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -126.72 152.11 47.26 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.941 -1.133 . . . . 73.14 107.941 -171.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -124.17 159.74 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 125.46 1.504 . . . . 70.12 107.646 175.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -137.84 156.31 48.07 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.733 0.813 . . . . 75.41 112.071 -176.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.7 139.54 26.61 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.394 1.478 . . . . 71.02 111.521 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -148.5 155.8 41.62 Favored 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.161 0.984 . . . . 72.13 108.901 168.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -79.62 153.28 29.51 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.818 -1.176 . . . . 63.24 109.248 170.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -149.94 157.37 43.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.605 1.562 . . . . 72.3 108.538 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.4 p -161.96 97.45 1.04 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.141 0.976 . . . . 54.1 111.681 173.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 176.2 -172.78 45.76 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 120.675 -1.266 . . . . 63.51 112.652 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.5 mtmm -85.05 116.15 23.27 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.132 0.573 . . . . 65.42 110.845 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 98' ' ' THR . 26.9 mt -95.79 165.83 12.1 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.863 1.665 . . . . 62.23 109.214 173.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.7 mm -81.91 134.4 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 126.053 1.741 . . . . 61.34 109.669 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.9 tttt -123.61 82.82 2.06 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.995 -1.483 . . . . 73.1 106.995 164.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.8 mt -57.96 132.6 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.173 -2.158 . . . . 74.44 105.173 153.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -106.08 166.0 10.82 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.119 -1.808 . . . . 72.15 106.119 159.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 p -134.09 169.89 16.48 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 119.579 1.081 . . . . 53.01 109.558 165.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.8 ttmm -63.82 -25.24 68.08 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.071 -1.018 . . . . 60.34 112.022 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.94 -0.17 0.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 128.196 2.598 . . . . 55.5 113.133 172.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 25.5 mmt-85 59.85 22.46 11.4 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 127.06 2.144 . . . . 71.52 111.333 -164.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.528 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 2.6 ttm180 -75.64 163.52 27.24 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 121.213 -0.929 . . . . 62.32 108.756 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.47 167.99 4.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.636 0.775 . . . . 61.13 110.093 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.539 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.8 pt -147.97 178.56 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 125.998 1.719 . . . . 62.11 110.993 -173.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.627 ' C ' HD23 ' A' ' 99' ' ' LEU . 17.7 m -149.99 103.48 3.21 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 125.639 1.576 . . . . 72.33 110.788 173.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -145.11 169.54 17.94 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 119.584 -1.947 . . . . 61.13 112.615 -174.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 p -62.22 144.91 54.89 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.198 1.399 . . . . 72.41 109.203 171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.95 -20.72 64.21 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.651 -1.281 . . . . 50.42 112.143 -169.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -101.12 39.65 1.38 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.353 1.461 . . . . 54.0 110.672 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -98.69 143.08 25.7 Favored Pre-proline 0 C--O 1.239 0.517 0 O-C-N 120.16 -1.588 . . . . 74.24 109.729 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.75 137.24 24.44 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.014 2.476 . . . . 55.23 111.842 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.17 -177.4 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.915 1.686 . . . . 73.43 108.376 170.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -123.28 141.92 51.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 120.382 1.446 . . . . 73.54 111.303 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 107' ' ' ILE . 2.5 pp -142.36 171.32 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.858 1.263 . . . . 73.52 109.644 -172.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 87.1 p -103.32 96.65 6.9 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 123.819 0.848 . . . . 70.44 111.005 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -82.29 89.06 6.51 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 105.325 -2.102 . . . . 73.33 105.325 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 44.13 44.51 6.39 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 125.05 1.34 . . . . 72.51 112.012 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 105.15 -31.81 8.16 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-O 118.097 -1.391 . . . . 62.55 113.608 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -79.51 144.94 33.5 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 119.798 1.799 . . . . 74.11 108.063 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 t -74.18 123.06 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 107.937 -1.134 . . . . 44.34 107.937 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 18.5 tp -123.06 159.47 28.38 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.664 -0.865 . . . . 72.02 108.664 173.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -114.46 104.05 11.65 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.438 1.495 . . . . 64.11 110.875 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.9 pt -129.96 -178.81 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 124.178 0.991 . . . . 65.02 112.136 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -85.16 134.52 34.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.343 0.974 . . . . 71.43 108.808 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -51.68 -38.44 55.03 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.861 1.06 . . . . 72.14 113.861 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.427 ' O ' ' HE3' ' A' ' 122' ' ' LYS . 1.5 pp20? -67.19 -16.7 64.46 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.817 1.043 . . . . 74.11 113.817 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 35.6 mtt -83.16 -25.18 32.1 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.773 0.829 . . . . 63.21 110.436 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.35 62.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 127.754 2.422 . . . . 75.51 109.453 -178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 119' ' ' GLU . 24.7 mmtp -79.72 -174.17 4.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.416 1.087 . . . . 64.33 108.707 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -51.79 -12.38 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.249 2.22 . . . . 73.22 113.38 167.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.91 -4.76 89.63 Favored Glycine 0 CA--C 1.525 0.656 0 CA-C-O 117.97 -1.461 . . . . 64.41 112.063 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -132.14 172.39 12.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 119.909 1.854 . . . . 62.21 110.834 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 9.4 m-85 -116.66 119.45 35.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 126.171 1.788 . . . . 74.15 106.346 178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 tp -83.19 130.32 35.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.851 -1.166 . . . . 72.12 107.851 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -70.73 116.46 11.06 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 108.146 -1.057 . . . . 61.1 108.146 170.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.8 153.09 63.38 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.224 1.41 . . . . 74.13 112.035 -174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 153.61 52.4 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.602 2.201 . . . . 73.31 110.867 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.69 179.24 6.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 128.053 2.541 . . . . 72.31 107.218 167.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -25.41 -67.08 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.499 2.32 . . . . 75.51 113.911 -169.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -120.35 -0.55 10.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.381 1.872 . . . . 74.04 111.298 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 29.0 p -143.21 -171.27 3.45 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.211 1.004 . . . . 73.32 111.972 -154.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -115.47 153.17 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.855 -1.165 . . . . 63.0 107.855 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -145.8 -175.64 4.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 128.604 2.761 . . . . 73.31 106.163 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.99 161.27 19.65 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.724 1.21 . . . . 73.11 110.377 170.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -148.13 152.91 38.11 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.277 2.231 . . . . 74.45 106.804 165.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.461 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 19.2 mt-10 -77.13 147.4 36.58 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.689 1.595 . . . . 74.32 110.029 176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.1 t -85.13 1.04 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 113.012 0.745 . . . . 63.13 113.012 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.432 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.7 pt 29.47 -89.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 128.161 2.584 . . . . 74.43 116.176 170.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.432 ' H ' HG13 ' A' ' 141' ' ' ILE . 15.3 tppt? -100.33 128.36 46.42 Favored 'General case' 0 CA--C 1.508 -0.635 0 O-C-N 120.804 -1.185 . . . . 73.01 107.942 174.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.1 p -133.65 128.21 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 N-CA-C 107.64 -1.245 . . . . 53.12 107.64 174.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.55 -177.75 5.08 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.406 2.282 . . . . 64.53 107.216 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 15.9 p -117.86 170.44 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 120.964 -1.085 . . . . 65.32 109.339 167.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.21 124.79 50.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 107.003 -1.48 . . . . 64.04 107.003 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -86.16 114.35 22.93 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.904 1.229 . . . . 73.43 107.826 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -120.16 139.16 53.04 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.645 1.578 . . . . 61.15 107.299 -172.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.55 81.92 1.85 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.502 -0.925 . . . . 71.42 108.502 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.83 -121.06 1.12 Allowed Glycine 0 CA--C 1.53 1.024 0 C-N-CA 126.13 1.824 . . . . 61.34 111.273 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -136.84 152.57 50.41 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.232 -1.157 . . . . 73.24 109.703 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.3 pt -116.82 156.3 18.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.363 1.865 . . . . 74.41 108.267 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -138.14 150.92 47.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 124.841 1.257 . . . . 73.31 107.942 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -129.08 166.5 19.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 118.744 0.702 . . . . 72.22 109.96 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 mt -128.39 127.16 42.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.111 1.365 . . . . 63.01 108.894 -170.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 17.5 m -71.08 -58.0 3.98 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.758 -0.639 . . . . 52.22 110.773 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 1.2 t 25.94 64.48 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 129.516 3.126 . . . . 71.32 112.567 -170.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -72.58 0.17 11.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.923 1.689 . . . . 64.41 113.027 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.19 -70.65 0.32 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.964 1.305 . . . . 74.12 108.526 -166.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -93.6 0.31 56.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.615 0.766 . . . . 63.44 111.151 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.9 m170 65.21 26.48 12.31 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.736 2.014 . . . . 51.32 111.835 -173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -145.16 167.09 23.6 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 120.915 -1.115 . . . . 73.41 109.952 -175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -162.37 171.4 17.25 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.779 1.632 . . . . 71.24 109.527 176.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.6 mm -105.84 119.46 55.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.619 -1.252 . . . . 65.51 107.619 167.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -150.82 146.7 26.53 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.176 0.99 . . . . 42.54 109.977 171.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 148.64 177.88 23.26 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 128.063 2.744 . . . . 61.41 109.015 177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -73.46 166.55 23.0 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 120.238 -1.742 . . . . 72.43 110.347 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 70.01 -71.7 0.12 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.617 2.367 . . . . 63.2 114.808 168.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.427 ' HA ' ' CE2' ' A' ' 16' ' ' TYR . 1.1 pt-20 -124.28 -19.27 5.57 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.772 1.229 . . . . 73.41 114.241 165.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 89.07 164.22 40.13 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.969 2.223 . . . . 44.1 113.62 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.539 ' CE1' HG23 ' A' ' 97' ' ' ILE . 56.6 m-85 -104.18 151.99 22.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 126.855 2.062 . . . . 72.12 108.302 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -91.22 111.71 23.3 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.785 2.034 . . . . 70.32 106.936 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.409 HG23 ' CE1' ' A' ' 163' ' ' TYR . 2.3 m -139.27 166.97 20.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 119.065 0.848 . . . . 74.22 110.472 -169.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.3 t -66.25 139.97 58.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.281 1.432 . . . . 63.11 109.841 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -137.3 70.36 1.4 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.32 2.648 . . . . 75.32 106.969 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.0 t -111.59 50.0 0.86 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 119.964 -1.71 . . . . 73.05 111.821 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . 0.251 97.5 p 60.33 59.8 2.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.597 1.959 . . . . 64.33 110.924 -174.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 63.55 80.75 0.12 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 125.343 1.449 . . . . 72.35 111.938 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.7 p 56.95 -172.63 0.08 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.991 2.516 . . . . 74.41 112.492 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 13.4 tp -128.73 26.39 5.58 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.051 -1.031 . . . . 64.12 113.028 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 95.84 165.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 129.945 3.298 . . . . 73.12 109.527 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.22 143.52 33.26 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.166 -0.959 . . . . 70.01 110.023 163.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.36 -102.7 0.28 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 116.868 -1.539 . . . . 54.22 110.181 -177.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.2 p-80 -142.31 95.86 2.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 121.497 1.953 . . . . 71.55 112.123 -170.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.63 156.41 43.64 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.005 1.322 . . . . 71.03 108.231 173.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 5.2 m170 . . . . . 0 C--O 1.25 1.117 0 C-N-CA 130.153 3.381 . . . . 74.24 107.696 -176.213 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 119.452 -0.308 . . . . 70.13 110.203 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.4 m120 54.12 -174.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.835 2.854 . . . . 64.55 113.144 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.6 m -103.54 -5.04 23.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.945 1.698 . . . . 61.05 111.018 -174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.47 -67.67 2.2 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 110.427 -1.069 . . . . 62.34 110.427 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 86.4 t60 56.8 -79.29 0.01 OUTLIER 'General case' 0 C--O 1.233 0.184 0 C-N-CA 127.096 2.158 . . . . 75.31 110.773 -168.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.7 167.05 31.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.505 1.522 . . . . 73.24 109.305 -172.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.06 165.54 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.162 -0.775 . . . . 73.01 111.162 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -172.92 -174.45 1.09 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.347 1.859 . . . . 70.11 111.448 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -106.2 -178.03 3.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 129.538 3.135 . . . . 61.02 109.376 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.0 -156.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.472 1.109 . . . . 72.54 112.342 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.491 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.6 t80 -103.1 -30.58 10.64 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.406 1.482 . . . . 65.44 110.414 164.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -116.72 29.67 7.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 127.768 2.427 . . . . 73.43 110.785 -162.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -100.71 134.73 20.36 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.734 -0.839 . . . . 62.32 108.734 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -74.09 138.21 25.1 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.819 2.346 . . . . 72.51 112.921 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 25' ' ' ILE . 28.5 pt -102.11 7.09 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 114.974 1.472 . . . . 64.4 114.974 -172.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 36.28 74.79 0.07 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.287 1.835 . . . . 72.32 114.226 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 152.42 2.35 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.471 -0.937 . . . . 74.25 108.471 164.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.0 m -54.41 -36.19 63.69 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.193 0.451 . . . . 74.41 111.459 174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.0 -19.53 62.51 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.958 1.303 . . . . 71.42 112.657 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.56 18.23 33.57 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 117.961 -1.466 . . . . 71.23 112.643 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -38.38 64.93 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.601 1.7 . . . . 73.05 113.821 -167.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.81 96.24 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.448 2.699 . . . . 70.44 108.977 -170.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.25 146.87 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 106.414 -1.699 . . . . 62.42 106.414 -177.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -67.95 135.96 53.21 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.415 1.886 . . . . 63.14 108.079 177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 15' ' ' ILE . 4.4 tt -51.3 -43.08 28.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 124.443 1.097 . . . . 62.34 110.812 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -71.36 -41.21 59.29 Favored Glycine 0 N--CA 1.433 -1.516 0 CA-C-O 117.961 -1.466 . . . . 40.15 110.377 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -58.06 -44.06 87.25 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 120.78 2.29 . . . . 74.5 112.167 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -57.89 -59.71 4.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.656 1.582 . . . . 62.2 109.06 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG13 HG21 ' A' ' 77' ' ' VAL . 84.9 t -68.4 -44.54 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 116.402 -0.363 . . . . 61.34 110.589 -171.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -63.24 -32.14 73.47 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.171 -0.956 . . . . 75.01 109.608 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -50.83 -52.54 40.37 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 121.43 -0.794 . . . . 62.42 109.882 170.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -66.21 -41.81 89.63 Favored 'General case' 0 C--O 1.216 -0.699 0 N-CA-C 107.768 -1.197 . . . . 54.03 107.768 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.452 ' CD1' HD12 ' A' ' 50' ' ' ILE . 8.3 m-85 -60.71 -31.0 70.3 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 120.78 1.627 . . . . 70.22 112.827 176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -19.03 32.24 Favored 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 125.387 1.475 . . . . 62.52 111.696 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 18.6 mttm -94.92 -63.75 1.14 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.269 -1.752 . . . . 74.22 106.269 173.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -82.02 43.28 0.77 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.355 2.662 . . . . 64.2 108.585 -173.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -50.89 -40.28 56.22 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 125.395 1.478 . . . . 73.14 110.187 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -59.02 -35.5 73.37 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.593 1.157 . . . . 74.1 112.965 175.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 m -77.17 -6.08 51.6 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.636 1.175 . . . . 72.31 113.768 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 79.4 mt -65.37 95.26 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 119.807 1.185 . . . . 65.32 108.749 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mmtm -79.18 157.11 27.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 106.303 -1.74 . . . . 42.42 106.303 163.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -126.77 145.9 50.44 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.266 -2.124 . . . . 73.22 105.266 159.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.75 177.43 8.67 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 124.111 0.882 . . . . 62.33 110.332 174.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -49.23 -50.02 40.38 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.229 2.212 . . . . 61.2 111.911 -175.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -70.66 -9.28 56.71 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.061 1.344 . . . . 73.11 112.137 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.37 56.18 2.89 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 127.235 2.35 . . . . 72.2 109.447 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -85.37 -100.19 0.06 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.609 -1.256 . . . . 75.22 107.609 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.85 123.77 0.99 Allowed Glycine 0 CA--C 1.521 0.411 0 N-CA-C 107.79 -2.124 . . . . 74.43 107.79 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 37.3 p-90 -144.67 160.35 41.34 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 119.276 1.538 . . . . 72.21 110.93 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' A' ' 33' ' ' PHE . 10.3 mt -143.2 149.71 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 126.822 2.049 . . . . 70.42 106.637 172.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -95.81 135.24 37.78 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.031 1.332 . . . . 63.52 109.575 165.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.09 25.52 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.33 2.252 . . . . 64.13 109.592 170.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.67 1.63 0.02 OUTLIER Glycine 0 CA--C 1.528 0.905 0 C-N-CA 127.788 2.613 . . . . 63.32 115.694 171.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -113.06 -10.92 13.42 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 121.429 2.615 . . . . 50.15 114.785 167.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.6 -28.44 63.62 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 121.347 1.885 . . . . 74.24 111.846 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 11.87 2.24 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.821 1.648 . . . . 70.25 113.339 -177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.9 mt -67.53 127.19 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 125.694 1.598 . . . . 73.23 109.48 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -94.6 142.83 26.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.564 1.146 . . . . 55.41 110.384 175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -121.26 152.58 24.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.244 2.218 . . . . 73.0 106.961 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -68.49 105.67 2.29 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.265 -1.754 . . . . 64.1 106.265 168.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 m -96.36 -176.48 3.66 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.852 -1.166 . . . . 73.43 107.852 167.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.73 141.91 30.69 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.572 -1.64 . . . . 64.12 106.572 171.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.76 96.0 9.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.31 -1.367 . . . . 73.14 107.31 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -55.45 -21.21 15.14 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.644 0.778 . . . . 64.25 112.823 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -39.52 -44.48 1.43 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.075 2.15 . . . . 65.04 112.024 167.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -139.03 0.91 1.99 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.088 0.955 . . . . 61.03 112.336 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.1 mt 63.92 59.84 1.08 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.193 1.797 . . . . 73.44 110.743 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 16.8 pt -129.73 153.09 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 125.768 1.627 . . . . 71.21 109.254 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.8 mm -80.8 138.98 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.965 -1.124 . . . . 62.5 107.965 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -144.26 172.36 13.03 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.062 1.745 . . . . 72.23 107.977 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.34 131.68 54.33 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 107.286 -1.375 . . . . 64.04 107.286 172.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.3 mmpt? -141.33 155.74 45.92 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 106.587 -1.634 . . . . 75.43 106.587 175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.71 124.42 49.58 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 118.95 0.795 . . . . 74.22 110.478 -176.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.61 154.12 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.103 2.161 . . . . 73.4 109.084 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.2 -50.43 2.02 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.02 1.728 . . . . 72.43 110.504 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -134.2 160.04 39.06 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 121.0 1.727 . . . . 75.22 110.418 -172.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.55 HG21 HG13 ' A' ' 29' ' ' VAL . 2.3 m -133.98 161.22 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 74.12 109.441 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -141.04 154.84 46.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.848 1.259 . . . . 74.21 110.417 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.54 148.78 19.88 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.378 0.99 . . . . 71.41 111.092 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -141.16 169.35 17.77 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.152 -1.425 . . . . 73.42 107.152 157.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.3 ttpt -89.36 154.26 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.901 -1.148 . . . . 71.24 107.901 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -148.17 156.89 43.12 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.178 -1.045 . . . . 73.13 108.178 -171.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 p -149.02 117.38 6.47 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.131 -1.433 . . . . 55.54 107.131 162.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 173.07 -179.1 44.71 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 119.382 -1.39 . . . . 45.34 112.057 -172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 98.98 11.7 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.515 1.126 . . . . 72.05 110.207 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.16 153.79 29.79 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.105 -1.442 . . . . 74.4 107.105 171.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.9 139.16 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.522 -0.918 . . . . 65.21 108.522 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HE2' ' OE1' ' A' ' 96' ' ' GLU . 48.8 tttm -130.54 70.69 1.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.476 1.51 . . . . 75.35 107.243 171.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 31.3 mt -56.44 148.04 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 105.269 -2.123 . . . . 72.41 105.269 161.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.86 167.75 10.51 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 105.309 -2.108 . . . . 72.43 105.309 162.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 23.2 p -135.86 168.2 19.76 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 118.933 0.788 . . . . 72.11 109.696 164.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.8 -24.17 67.65 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 119.728 1.149 . . . . 62.11 112.741 -168.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -69.31 4.38 1.74 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.043 1.337 . . . . 71.44 111.615 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 60.08 26.49 15.84 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.859 2.063 . . . . 72.45 112.229 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -76.45 173.09 11.92 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.905 -0.776 . . . . 74.35 108.905 165.112 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' OE1' ' HE2' ' A' ' 88' ' ' LYS . 0.4 OUTLIER -177.61 167.28 2.21 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.854 1.662 . . . . 74.51 107.92 -175.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.8 pt -141.82 171.4 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 C-N-CA 125.834 1.654 . . . . 71.32 108.688 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.92 101.28 3.02 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.776 -1.194 . . . . 73.53 107.776 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.12 168.62 24.7 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.874 1.27 . . . . 52.02 110.083 -171.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.9 p -58.29 147.5 30.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.215 1.006 . . . . 70.32 110.37 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.94 -16.33 63.72 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.002 0.741 . . . . 73.52 113.002 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -117.01 39.49 3.22 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.767 1.627 . . . . 75.12 110.563 174.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -77.57 131.22 71.73 Favored Pre-proline 0 CA--C 1.553 1.059 0 CA-C-O 117.77 -1.109 . . . . 75.2 110.262 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.4 101.12 1.44 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 125.026 3.817 . . . . 74.34 112.903 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.68 178.25 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 126.005 1.722 . . . . 52.13 109.783 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -122.85 139.21 54.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.557 -0.714 . . . . 71.12 111.144 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 pt -131.78 163.98 35.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.591 1.156 . . . . 74.31 110.54 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.6 t -88.65 121.09 30.66 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 123.081 1.419 . . . . 54.42 111.676 172.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -101.51 78.0 1.81 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.32 1.848 . . . . 73.11 106.854 165.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m 69.75 0.8 3.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 115.235 1.569 . . . . 72.14 115.235 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 146.76 -33.68 1.39 Allowed Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 109.08 -1.608 . . . . 73.24 109.08 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -79.73 131.27 35.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.97 1.308 . . . . 62.44 108.525 -174.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 61.6 t -77.04 99.0 2.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 107.31 -1.367 . . . . 73.35 107.31 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.7 tp -95.37 161.49 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.393 0.677 . . . . 73.55 109.372 172.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.95 126.42 49.94 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.762 2.025 . . . . 65.13 107.989 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 11.6 pt -149.54 176.99 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 124.926 1.291 . . . . 75.13 110.442 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.32 142.03 45.19 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.793 1.237 . . . . 71.54 108.434 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.8 20.67 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.998 0.919 . . . . 72.55 112.612 169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -69.31 -11.38 60.77 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 119.928 1.24 . . . . 74.14 113.827 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 12.7 mmt -82.11 -28.43 32.26 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.921 1.237 . . . . 71.24 111.103 169.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.1 t -75.49 63.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 128.728 2.811 . . . . 62.34 111.585 -172.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -79.16 -178.34 6.12 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.072 -1.017 . . . . 75.22 109.6 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.34 0.71 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 128.092 2.557 . . . . 73.51 114.033 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -99.32 -1.88 56.77 Favored Glycine 0 CA--C 1.522 0.486 0 CA-C-O 117.768 -1.573 . . . . 44.41 112.693 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.63 136.35 46.44 Favored 'General case' 0 C--O 1.231 0.089 0 N-CA-C 106.414 -1.699 . . . . 62.33 106.414 -163.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.66 109.94 21.83 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 124.824 1.25 . . . . 75.02 108.973 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 20.1 tt -79.69 133.1 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 C-N-CA 124.456 1.102 . . . . 74.45 108.714 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.3 132.21 46.08 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 109.028 -0.73 . . . . 73.5 109.028 171.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.466 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.7 pp -126.28 155.87 73.3 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 126.357 1.863 . . . . 73.43 110.143 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.38 145.14 37.76 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.988 1.792 . . . . 74.44 109.382 172.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 -158.99 0.67 Allowed 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.976 -1.12 . . . . 62.41 107.976 167.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -53.51 -62.28 1.75 Allowed 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 123.89 0.876 . . . . 72.2 111.203 -160.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.3 0.69 9.56 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.799 1.037 . . . . 74.34 113.799 166.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 24.7 p -122.36 -167.02 1.49 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.51 1.524 . . . . 75.53 110.12 -174.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.97 156.43 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.741 1.216 . . . . 72.25 107.778 175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -144.87 -176.69 5.18 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.729 2.012 . . . . 72.42 108.406 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.1 mt -118.42 161.78 19.41 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.072 1.349 . . . . 73.45 108.148 171.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -152.02 154.84 36.78 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.569 1.548 . . . . 72.14 106.976 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -88.65 144.74 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.264 1.426 . . . . 71.35 108.918 -174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.8 t -80.64 -1.33 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.737 1.215 . . . . 54.44 113.38 -172.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.514 HG13 ' H ' ' A' ' 142' ' ' LYS . 4.1 pt 31.86 -76.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 129.171 2.989 . . . . 75.24 117.112 173.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' H ' HG13 ' A' ' 141' ' ' ILE . 39.7 ttmt -118.28 131.75 56.33 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 125.991 1.716 . . . . 70.21 108.459 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.65 121.72 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 124.634 1.174 . . . . 50.1 108.331 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -145.14 -169.47 3.2 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.361 1.464 . . . . 73.31 108.057 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -135.27 166.07 23.98 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.547 1.139 . . . . 73.52 109.572 -171.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -130.55 129.85 64.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.907 -1.516 . . . . 74.02 106.907 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -80.88 113.89 19.39 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.679 -1.971 . . . . 73.52 105.679 169.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.524 ' C ' HD22 ' A' ' 149' ' ' ASN . 28.8 t80 -127.6 132.64 49.78 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 126.131 1.772 . . . . 74.11 108.864 -165.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.524 HD22 ' C ' ' A' ' 148' ' ' TYR . 2.4 m120 -134.16 42.07 2.92 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.263 -0.898 . . . . 53.31 109.8 -157.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -121.0 -175.38 15.17 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.478 1.513 . . . . 70.42 111.44 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -72.15 147.46 46.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.72 -0.845 . . . . 75.25 108.72 161.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 27.7 pt -124.7 127.08 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 C-N-CA 126.533 1.933 . . . . 72.52 106.472 176.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -112.83 162.12 16.15 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.815 -1.179 . . . . 73.41 107.815 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -149.28 164.09 35.83 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 123.983 0.913 . . . . 44.1 109.601 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 67.5 mt -120.31 164.22 16.63 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.876 1.27 . . . . 64.32 111.137 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 10.7 m -101.31 -34.04 9.79 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.258 -1.337 . . . . 74.21 112.703 -164.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.25 17.5 t 24.52 74.01 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 130.325 3.45 . . . . 64.01 111.548 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -78.81 -9.0 59.31 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.307 -0.871 . . . . 75.01 112.043 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.17 -62.15 1.75 Allowed 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.116 2.166 . . . . 75.14 108.594 -168.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -120.73 5.17 10.53 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.639 0.977 . . . . 71.03 113.639 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.41 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 15.3 m170 52.97 23.9 3.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.673 1.589 . . . . 73.13 112.267 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.11 136.89 20.49 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 119.542 -1.974 . . . . 73.32 108.878 176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 3.7 p90 -141.15 167.56 21.9 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.829 0.852 . . . . 74.41 110.981 -173.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.0 mm -103.12 134.13 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 124.37 1.068 . . . . 74.45 108.423 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -156.43 138.4 14.44 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.517 1.527 . . . . 73.45 108.702 173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.72 170.96 20.35 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 125.338 1.446 . . . . 41.04 109.631 163.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 16.3 mmtt -72.39 164.14 26.83 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 119.821 -1.988 . . . . 63.22 109.917 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 68.59 -74.47 0.08 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.474 2.309 . . . . 73.2 114.934 173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -121.45 -15.65 8.01 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.316 1.446 . . . . 65.4 112.442 172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 74.89 161.64 8.85 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 122.332 0.962 . . . . 71.14 114.128 -176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.582 ' CE1' HG23 ' A' ' 97' ' ' ILE . 19.1 m-85 -112.01 163.53 14.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.761 2.425 . . . . 45.41 107.228 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.453 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -92.57 117.19 29.7 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.062 0.846 . . . . 73.0 108.917 166.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.419 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 26.8 m -97.03 173.11 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 CA-C-N 119.862 1.21 . . . . 71.51 108.989 173.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.0 m -66.56 147.83 52.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.107 -1.072 . . . . 64.44 108.107 164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.62 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -121.79 159.99 25.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.943 0.897 . . . . 45.14 108.62 161.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.7 m -164.97 176.92 8.21 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.35 -1.722 . . . . 74.14 106.35 152.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 p -68.93 164.68 21.63 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 119.96 1.255 . . . . 34.11 109.267 150.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 26.36 98.71 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 129.46 3.41 . . . . 54.4 113.78 145.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 37.3 p -40.07 126.43 2.1 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.603 1.561 . . . . 70.35 110.752 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.8 tt -40.17 -51.34 2.67 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.54 1.936 . . . . 74.24 110.902 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 153.2 41.05 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.943 1.697 . . . . 72.52 108.446 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.92 168.5 21.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.248 1.419 . . . . 72.13 108.44 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -166.03 117.75 1.05 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.238 -1.023 . . . . 73.53 108.238 -178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -127.33 139.38 52.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.829 -1.545 . . . . 63.41 106.829 168.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -146.99 -22.28 0.41 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.285 0.634 . . . . 74.1 112.128 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.034 0 C-N-CA 127.132 2.173 . . . . 65.23 107.631 156.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 105.082 -2.192 . . . . 60.43 105.082 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.5 m120 30.59 88.16 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 128.216 2.606 . . . . 64.41 111.894 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.0 m -25.05 -60.62 0.06 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.54 2.736 . . . . 62.52 112.799 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.73 123.41 1.15 Allowed Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.257 -1.137 . . . . 51.12 110.257 166.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -110.51 179.46 4.07 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.445 1.098 . . . . 74.55 110.723 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -136.9 123.28 20.71 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.653 -1.24 . . . . 51.33 107.653 166.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.3 174.0 36.16 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 108.939 -1.664 . . . . 40.21 108.939 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 166.27 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 128.334 2.654 . . . . 64.54 106.678 -163.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.436 HD21 ' HB1' ' A' ' 165' ' ' ALA . 4.8 mp -88.33 157.9 18.59 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.752 0.821 . . . . 72.25 109.985 -175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB1' ' CZ ' ' A' ' 148' ' ' TYR . . . -61.68 156.3 20.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.456 1.102 . . . . 53.1 111.13 172.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -52.04 -40.13 60.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.07 1.348 . . . . 72.02 112.63 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -88.63 1.9 54.17 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.267 -0.873 . . . . 72.41 112.714 -165.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' OE1' ' HE2' ' A' ' 167' ' ' LYS . 11.8 mm-40 -77.95 140.29 62.26 Favored Pre-proline 0 N--CA 1.463 0.222 0 CA-C-N 120.592 1.542 . . . . 73.24 111.336 -164.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.19 133.74 13.7 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.771 2.314 . . . . 73.32 112.056 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 pt -102.99 -2.09 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.163 1.171 . . . . 72.42 114.163 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CE2' HD11 ' A' ' 22' ' ' ILE . 49.5 m-85 55.48 66.4 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.591 1.156 . . . . 55.55 112.391 176.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 96.7 mt -58.25 153.31 15.47 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 121.683 -0.636 . . . . 74.32 110.709 167.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.5 m -62.98 -31.79 72.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.486 1.514 . . . . 73.1 113.288 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.49 -28.67 41.47 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.26 0.936 . . . . 72.51 110.352 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 120.1 13.56 5.89 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 119.419 -0.656 . . . . 62.23 112.73 159.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -45.5 -53.33 9.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 127.705 2.402 . . . . 74.32 113.575 -171.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.444 HD11 ' CE2' ' A' ' 16' ' ' TYR . 7.8 mm 56.69 111.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.842 2.457 . . . . 75.44 107.907 -157.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -139.98 161.77 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.702 -1.592 . . . . 51.25 106.702 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -71.14 129.79 39.84 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.279 1.032 . . . . 53.44 108.946 170.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.4 tt -48.68 -42.44 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.824 1.65 . . . . 72.1 110.839 173.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -67.66 -47.47 61.6 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.268 -1.295 . . . . 44.25 110.966 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -57.41 -46.62 83.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.345 1.573 . . . . 73.23 110.877 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -56.71 -55.59 32.22 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.058 0.943 . . . . 75.33 110.449 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 33' ' ' PHE . 52.6 t -56.83 -45.23 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.322 1.049 . . . . 51.32 110.057 174.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.93 -34.7 79.02 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.265 1.026 . . . . 63.03 111.501 -167.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HE3' ' CZ ' ' A' ' 32' ' ' PHE . 8.4 ttpt -51.96 -53.3 42.99 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.472 1.109 . . . . 44.4 108.545 172.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.473 ' CZ ' ' HE3' ' A' ' 31' ' ' LYS . 29.4 m-85 -70.68 -34.19 71.72 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 118.967 -0.54 . . . . 72.23 109.723 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.5 m-30 -63.74 -39.54 94.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 120.088 1.313 . . . . 62.23 111.337 178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -42.26 74.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.788 1.235 . . . . 73.03 110.535 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -78.95 -53.84 6.64 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 123.312 0.645 . . . . 64.34 109.49 -173.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.79 42.48 1.1 Allowed 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 127.439 2.296 . . . . 74.43 107.028 -170.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -53.96 -34.34 59.44 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.666 -1.272 . . . . 71.31 111.521 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -60.21 -35.26 75.03 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.181 0.992 . . . . 74.34 112.406 172.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -81.48 -0.91 43.93 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 124.597 1.159 . . . . 42.25 112.91 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.77 94.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.394 -1.336 . . . . 62.35 107.394 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -79.54 154.9 28.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.792 -1.188 . . . . 75.11 107.792 170.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -111.88 156.96 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.086 -1.079 . . . . 51.21 108.086 160.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.33 168.78 12.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.955 -1.128 . . . . 60.3 107.955 159.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -59.57 -48.35 81.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.93 0.892 . . . . 71.35 109.39 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -69.09 -3.47 13.4 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.707 1.002 . . . . 52.22 113.707 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.87 20.84 45.15 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 121.302 -0.874 . . . . 75.44 114.187 159.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.73 -86.02 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.14 1.776 . . . . 74.03 110.14 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 129.43 125.42 2.73 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.074 1.321 . . . . 45.22 110.263 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -136.82 169.91 16.97 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 117.825 0.813 . . . . 61.54 111.452 177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 33' ' ' PHE . 19.5 mt -144.47 144.5 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 127.289 2.235 . . . . 73.42 106.398 164.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -86.91 125.8 34.26 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.217 1.407 . . . . 71.34 109.684 167.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -127.91 8.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 123.809 0.844 . . . . 74.34 111.054 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.22 -40.65 60.34 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 119.52 1.054 . . . . 41.53 112.346 -176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.98 -9.3 2.93 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.239 2.216 . . . . 75.15 114.402 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -70.05 -22.36 63.09 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 119.474 1.034 . . . . 72.03 112.588 170.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 65.13 7.03 3.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 120.125 1.33 . . . . 73.31 114.27 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 93.8 mt -70.02 118.88 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.649 1.18 . . . . 74.24 108.117 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -85.44 155.17 21.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.411 1.1 . . . . 61.41 110.184 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 17.9 tt -135.07 155.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.652 1.981 . . . . 62.52 107.732 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 60' ' ' LYS . 5.9 mmpt? -69.4 118.94 12.91 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 106.709 -1.589 . . . . 44.44 106.709 167.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.1 t -110.73 -175.98 2.85 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.59 -2.004 . . . . 72.2 105.59 165.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.98 125.14 16.35 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.331 -1.729 . . . . 74.45 106.331 172.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -73.72 99.52 3.16 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.921 -1.14 . . . . 74.24 107.921 174.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.1 ttpm? -54.89 -23.23 17.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 124.849 1.26 . . . . 74.34 112.08 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.93 -26.31 24.7 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.06 1.344 . . . . 75.23 112.605 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.0 m -144.95 16.43 1.57 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.482 1.113 . . . . 71.01 112.361 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp 53.41 45.6 28.0 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.835 1.198 . . . . 73.23 111.37 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.1 pt -113.95 159.01 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 124.28 1.032 . . . . 52.12 109.945 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.7 mm -79.32 142.58 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 106.92 -1.511 . . . . 74.11 106.92 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -131.31 162.27 30.45 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.984 1.374 . . . . 65.24 110.667 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.07 127.96 36.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.207 -2.146 . . . . 71.12 105.207 165.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -154.43 148.26 25.51 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-O 117.005 -1.474 . . . . 73.22 107.823 172.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -85.97 161.73 18.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 122.351 2.342 . . . . 65.13 111.307 168.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.62 ' H ' HD12 ' A' ' 74' ' ' ILE . 1.3 mp -80.92 165.67 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.947 -1.501 . . . . 62.24 106.947 166.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' H ' HG22 ' A' ' 74' ' ' ILE . 17.9 mt -127.28 -42.75 1.67 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.493 1.517 . . . . 63.53 110.771 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -134.58 154.83 51.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.409 1.458 . . . . 73.41 110.231 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.413 HG21 HG13 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -123.62 162.06 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.884 1.674 . . . . 74.44 108.404 177.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.9 m95 -137.31 158.94 43.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.478 1.111 . . . . 74.14 110.567 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HD2' ' CD2' ' A' ' 151' ' ' HIS . 3.8 tpp85 -142.07 145.99 34.95 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.761 1.624 . . . . 64.34 107.159 172.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -147.53 151.58 36.57 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 107.887 -1.153 . . . . 72.0 107.887 160.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.96 140.91 47.72 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.631 -0.878 . . . . 44.13 108.631 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -144.76 150.05 36.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.878 1.671 . . . . 73.13 107.268 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 82.2 p -143.38 138.27 29.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 104.979 -2.23 . . . . 55.33 104.979 155.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.6 -178.4 35.73 Favored Glycine 0 C--O 1.237 0.304 0 CA-C-N 120.781 1.628 . . . . 74.11 111.11 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.76 119.53 30.24 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 122.491 -0.417 . . . . 74.01 110.812 175.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.0 mt -88.88 164.59 15.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.986 1.314 . . . . 63.21 108.209 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.3 mm -78.35 142.63 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 106.615 -1.624 . . . . 72.13 106.615 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -133.04 74.65 1.58 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.423 -1.695 . . . . 72.45 106.423 172.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.1 mt -78.01 121.51 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.683 -2.34 . . . . 73.45 104.683 168.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 m -107.62 164.48 12.19 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.687 -1.598 . . . . 73.32 106.687 170.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 39.1 p -132.84 175.09 9.66 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.84 0.745 . . . . 65.31 111.306 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -66.34 -22.65 66.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.9 -1.125 . . . . 72.12 112.448 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -69.71 -1.07 8.09 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.889 0.876 . . . . 71.02 112.514 170.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 57.75 25.26 11.65 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 120.443 -1.411 . . . . 73.54 110.187 -162.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.24 24.75 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.491 -1.3 . . . . 64.31 107.491 165.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 167' ' ' LYS . 22.5 mt-10 -161.42 162.01 30.44 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.443 -0.947 . . . . 74.31 108.443 -166.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.565 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -148.42 160.18 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.74 1.216 . . . . 74.43 110.268 174.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.91 96.52 2.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.172 1.389 . . . . 53.41 109.917 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.19 -179.86 7.7 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.14 2.176 . . . . 62.41 109.836 -173.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.1 p -68.47 165.81 18.18 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.22 0.918 . . . . 62.41 111.323 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -68.28 -24.26 64.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 121.923 -0.486 . . . . 75.34 110.54 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -115.56 81.05 1.52 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.189 1.396 . . . . 74.03 107.896 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.13 156.72 76.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.691 -0.631 . . . . 75.12 111.427 150.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -89.48 149.82 5.28 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 124.27 3.313 . . . . 71.23 115.93 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.437 HG22 HG12 ' A' ' 173' ' ' VAL . 0.4 OUTLIER -156.91 -173.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 111.459 -2.61 . . . . 73.42 107.7 -174.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -132.55 141.18 48.62 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 113.468 -1.696 . . . . 65.52 112.288 -171.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -139.73 157.82 26.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 124.015 0.926 . . . . 74.3 110.047 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.01 105.64 12.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 122.455 1.121 . . . . 64.43 109.24 173.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -76.37 66.68 2.47 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 107.155 -1.424 . . . . 73.35 107.155 148.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.25 1.0 OUTLIER 70.26 -15.13 0.36 Allowed 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.989 2.515 . . . . 55.34 115.375 170.13 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.24 -21.08 0.12 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 126.288 1.899 . . . . 52.03 109.025 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -78.46 144.54 35.69 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 105.362 -2.088 . . . . 71.22 105.362 166.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.9 p -102.04 95.53 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.503 1.521 . . . . 73.2 107.835 174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -95.3 154.46 17.18 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 124.833 1.253 . . . . 62.23 108.671 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -114.05 111.84 22.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.51 1.524 . . . . 64.13 111.881 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 10.6 pt -136.09 179.39 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.214 1.005 . . . . 70.31 111.231 -177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 -99.26 148.49 24.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 126.081 1.752 . . . . 75.24 109.936 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.4 -26.8 65.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 118.102 0.41 . . . . 73.31 110.385 -161.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.66 67.34 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.313 -0.867 . . . . 64.12 113.231 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.6 -29.64 46.19 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.328 1.051 . . . . 51.41 112.086 172.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.51 HG12 HG21 ' A' ' 140' ' ' VAL . 11.4 t -73.83 63.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 127.508 2.323 . . . . 74.15 109.89 -176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -78.78 178.17 8.12 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.435 1.094 . . . . 74.53 108.187 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.03 -20.94 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 126.077 1.751 . . . . 63.3 113.666 174.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -85.18 -2.78 87.8 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 117.876 -1.513 . . . . 35.33 113.439 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.12 159.71 16.67 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 120.459 2.129 . . . . 71.24 111.039 -174.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -114.5 103.53 11.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.72 1.608 . . . . 71.54 109.066 170.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.41 132.87 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.53 1.532 . . . . 65.34 107.327 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -69.13 115.36 8.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 108.789 -0.819 . . . . 74.43 108.789 174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 pt -102.56 154.03 37.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 123.297 0.639 . . . . 73.22 110.766 176.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -72.7 138.26 28.81 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.117 1.878 . . . . 72.5 107.944 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.63 175.46 5.63 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.313 -1.366 . . . . 74.23 107.313 162.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -25.06 -61.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.873 2.069 . . . . 75.11 115.246 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -121.05 1.19 10.34 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.704 1.202 . . . . 72.1 113.077 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 1.1 p -143.74 -175.36 4.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 126.853 2.061 . . . . 73.42 109.353 -139.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.2 tp -120.11 147.99 23.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.87 -1.159 . . . . 70.53 107.87 174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -137.1 -178.18 5.09 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 127.856 2.462 . . . . 72.41 106.896 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.1 mt -116.51 164.4 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.836 1.254 . . . . 75.23 108.115 168.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -156.85 159.12 37.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.183 -1.784 . . . . 71.12 106.183 167.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -104.29 138.16 41.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.103 1.361 . . . . 70.5 109.325 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.51 HG21 HG12 ' A' ' 121' ' ' VAL . 25.1 t -71.08 -0.27 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 114.146 1.165 . . . . 74.51 114.146 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 25.93 -89.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 127.029 2.131 . . . . 72.05 114.924 174.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -92.65 113.23 25.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.257 -0.902 . . . . 62.3 109.267 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.14 144.45 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.36 -0.978 . . . . 73.32 108.36 156.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -156.2 -172.14 3.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.904 2.482 . . . . 72.33 106.291 173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -124.53 142.76 51.09 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.869 -1.16 . . . . 73.34 107.869 169.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 16.7 m -94.46 -179.21 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 124.628 1.171 . . . . 63.41 108.566 166.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -126.39 138.31 53.54 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.982 2.513 . . . . 73.42 106.75 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.523 ' CZ ' ' HB1' ' A' ' 10' ' ' ALA . 1.4 t80 -151.49 151.23 31.34 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.448 1.099 . . . . 73.05 109.111 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.98 78.27 0.45 Allowed 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 106.245 -1.761 . . . . 74.23 106.245 177.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -151.27 23.78 0.97 Allowed Glycine 0 N--CA 1.468 0.822 0 CA-C-N 113.807 -1.542 . . . . 74.5 113.886 -164.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.416 ' CD2' ' HD2' ' A' ' 79' ' ' ARG . 54.7 m80 54.77 -179.29 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.479 0.712 . . . . 72.14 110.962 -151.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.2 pt -145.78 160.19 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.703 2.401 . . . . 73.2 106.699 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -137.21 147.52 45.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.197 1.799 . . . . 42.14 108.617 -166.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -147.7 167.56 24.33 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.669 1.122 . . . . 70.0 111.56 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 mp -133.5 126.48 31.18 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 127.987 2.515 . . . . 70.04 108.149 -162.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 177' ' ' SER . 19.6 m -61.61 -53.32 57.85 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.102 0.561 . . . . 72.02 112.46 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.305 3.5 t 24.38 64.29 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 128.018 2.527 . . . . 65.24 112.385 -164.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -79.2 0.06 29.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.958 1.303 . . . . 71.34 111.472 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -64.13 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.919 1.688 . . . . 71.12 110.887 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.7 -0.31 14.32 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.253 0.621 . . . . 63.1 111.841 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.2 m80 61.95 27.89 16.94 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.453 1.901 . . . . 73.14 110.734 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.1 143.22 24.95 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.619 1.568 . . . . 73.15 108.123 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.658 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 0.4 OUTLIER -145.6 -179.38 6.63 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.199 1.0 . . . . 70.54 111.261 -173.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.0 mm -111.73 124.01 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 107.631 -1.248 . . . . 64.41 107.631 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.436 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -155.79 146.07 21.69 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.801 0.44 . . . . 63.42 110.528 175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 153.91 -169.06 32.45 Favored Glycine 0 C--O 1.224 -0.503 0 N-CA-C 108.326 -1.91 . . . . 74.33 108.326 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.461 ' HE2' ' OE1' ' A' ' 13' ' ' GLU . 74.0 mttt -99.51 177.84 5.05 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 119.879 1.839 . . . . 62.32 110.039 162.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 60.26 -78.4 0.02 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 129.198 2.999 . . . . 74.24 113.037 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -122.57 -8.1 8.56 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.326 1.45 . . . . 75.51 113.866 177.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 67.4 153.04 0.3 Allowed Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.106 1.336 . . . . 75.5 114.92 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.565 ' CE1' HG23 ' A' ' 97' ' ' ILE . 43.9 m-85 -107.55 159.01 16.76 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 127.048 2.139 . . . . 70.54 108.662 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -96.58 74.58 2.79 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 127.11 2.164 . . . . 72.24 109.184 -171.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 105' ' ' VAL . 3.2 m -105.03 171.95 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 121.827 -0.546 . . . . 61.31 110.687 -164.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.6 m -71.18 159.24 35.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.073 0.549 . . . . 75.14 110.676 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.658 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -136.03 165.49 25.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 128.587 2.755 . . . . 63.34 108.028 169.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.9 t -164.43 168.7 18.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.063 0.847 . . . . 74.41 109.655 150.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.548 ' HA ' HG23 ' A' ' 156' ' ' THR . 3.6 p -72.65 -56.85 4.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.061 1.744 . . . . 54.3 113.508 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -138.31 76.28 0.36 Allowed Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 107.431 -2.267 . . . . 65.0 107.431 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.2 p 57.74 -166.65 0.14 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.626 1.97 . . . . 60.24 111.737 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 15.6 tp -68.55 -71.35 0.22 Allowed 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.105 -0.997 . . . . 72.31 108.697 171.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 66.56 155.21 0.09 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.405 2.282 . . . . 73.03 112.771 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 60.6 m170 32.88 62.45 0.35 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.003 2.121 . . . . 74.41 112.283 -173.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -50.73 -54.97 18.93 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.419 1.266 . . . . 75.25 114.419 -159.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -165.19 -65.67 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 N-CA-C 107.612 -1.255 . . . . 75.43 107.612 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -77.14 169.97 17.37 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 123.167 0.587 . . . . 64.31 109.623 166.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 . . . . . 0 C--O 1.247 0.957 0 C-N-CA 127.783 2.433 . . . . 75.5 111.039 143.555 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 109.959 -0.386 . . . . 60.24 109.959 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -117.24 -143.32 0.37 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 106.109 -1.811 . . . . 65.3 106.109 164.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.4 m 79.48 -43.39 0.29 Allowed 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 127.396 2.278 . . . . 75.41 108.424 -174.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 111.13 73.5 0.71 Allowed Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 108.927 -1.669 . . . . 64.54 108.927 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.251 2.0 t60 54.45 -156.53 0.22 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.993 1.317 . . . . 62.2 110.106 -159.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -145.62 124.35 12.59 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.195 1.398 . . . . 71.54 109.057 -171.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.73 162.69 9.25 Favored Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 111.245 -0.742 . . . . 72.24 111.245 170.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.64 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.138 1.375 . . . . 74.41 108.666 -174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.5 157.13 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.943 1.697 . . . . 74.42 109.437 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.5 159.4 30.41 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.636 0.775 . . . . 64.42 112.024 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.1 t80 -54.52 -39.76 67.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.955 1.702 . . . . 65.15 112.916 -177.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -101.59 19.82 17.3 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 126.238 1.815 . . . . 71.24 110.952 -170.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -77.64 121.61 84.55 Favored Pre-proline 0 C--O 1.236 0.377 0 N-CA-C 105.223 -2.14 . . . . 74.42 105.223 170.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -65.6 138.51 54.62 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 C-N-CA 120.52 0.813 . . . . 55.42 110.302 171.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 pt -108.54 143.25 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 122.647 1.213 . . . . 72.13 108.164 160.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.441 ' CE2' HD11 ' A' ' 22' ' ' ILE . 11.4 m-85 -103.3 99.41 9.25 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 103.925 -2.62 . . . . 65.45 103.925 -173.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 1.8 mm? -52.45 165.77 0.23 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.186 -0.672 . . . . 74.24 109.186 166.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t -48.89 -43.93 39.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.526 0.73 . . . . 63.4 109.516 166.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.71 -35.66 80.45 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.329 0.492 . . . . 65.4 112.329 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.0 9.12 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.243 0.925 . . . . 73.13 112.13 -171.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.61 -20.96 15.39 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.49 1.516 . . . . 74.21 114.955 -170.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.441 HD11 ' CE2' ' A' ' 16' ' ' TYR . 27.1 mm 46.95 93.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 128.35 2.66 . . . . 74.41 110.631 -168.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.2 144.29 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 114.841 -1.072 . . . . 73.42 108.383 -176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -61.78 126.3 26.87 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 105.913 -1.884 . . . . 64.01 105.913 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -44.78 -49.89 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.662 0.785 . . . . 63.53 108.953 165.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -56.65 -57.42 19.6 Favored Glycine 0 N--CA 1.437 -1.273 0 CA-C-O 117.941 -1.477 . . . . 55.3 112.521 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -52.46 -51.57 58.64 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.486 1.914 . . . . 71.14 111.384 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.93 -52.04 61.87 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 125.837 1.655 . . . . 74.2 109.778 -173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CE2' ' A' ' 153' ' ' TYR . 73.4 t -76.86 -36.17 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 114.891 -1.05 . . . . 63.21 110.443 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -62.06 -36.05 80.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.661 0.664 . . . . 71.23 111.724 -178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -55.04 -42.69 72.99 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.323 1.049 . . . . 64.21 109.94 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -67.02 -43.99 81.4 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.1 -1.0 . . . . 75.11 110.093 176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -60.07 -33.35 71.95 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.894 1.225 . . . . 71.34 112.497 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -61.5 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.282 1.433 . . . . 74.23 109.514 171.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -73.23 -47.85 39.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.714 -1.217 . . . . 73.51 107.714 -166.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -94.66 40.78 1.09 Allowed 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.228 1.411 . . . . 63.01 109.887 -172.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -49.08 -39.88 29.65 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.042 -1.036 . . . . 65.13 111.636 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -72.07 -22.79 61.32 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.993 0.738 . . . . 43.23 112.993 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.0 m -85.99 -2.28 58.14 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.722 0.809 . . . . 73.43 111.822 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.4 mt -62.88 101.18 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.954 -1.499 . . . . 71.22 106.954 173.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -79.58 162.22 25.46 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.12 -1.437 . . . . 60.55 107.12 161.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.88 145.47 47.61 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.577 -1.638 . . . . 72.13 106.577 163.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.96 175.24 10.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.469 -0.567 . . . . 70.32 109.469 177.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -61.33 -45.09 95.88 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.363 1.065 . . . . 74.14 108.584 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -65.39 -19.79 66.1 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.355 0.662 . . . . 63.14 110.5 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.98 36.19 6.1 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 120.972 -1.08 . . . . 61.45 111.489 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.474 ' CD2' ' HE3' ' A' ' 80' ' ' LYS . 3.7 t80 -78.05 -86.46 0.06 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.595 1.158 . . . . 74.31 109.908 -174.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.87 121.82 2.02 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 108.07 -2.012 . . . . 25.31 108.07 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.26 163.65 33.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.539 1.17 . . . . 72.2 112.231 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mt -143.98 140.04 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.72 -1.585 . . . . 73.41 106.72 172.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.6 134.75 33.61 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.625 1.17 . . . . 71.25 109.883 172.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pt -139.01 23.09 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.767 2.027 . . . . 62.25 111.581 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . -61.06 -7.13 8.12 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-O 118.393 -1.226 . . . . 64.13 115.69 -175.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -98.67 -27.92 13.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 119.38 1.59 . . . . 71.23 113.128 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.93 -23.65 33.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.304 1.002 . . . . 52.5 111.971 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 58.83 15.01 3.55 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.149 1.38 . . . . 70.41 112.867 174.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.9 mt -66.97 101.31 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 124.568 1.147 . . . . 73.45 108.269 -170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -62.35 118.68 7.79 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 124.829 1.252 . . . . 72.3 110.009 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 14.1 tt -98.33 160.18 3.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 125.05 1.34 . . . . 72.21 107.751 165.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.01 124.19 22.72 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.731 -1.581 . . . . 74.34 106.731 168.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -128.92 178.77 6.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.558 1.143 . . . . 53.11 108.116 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -153.42 127.53 9.05 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.143 -0.688 . . . . 53.41 109.143 -171.564 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.73 112.35 20.97 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.943 -1.503 . . . . 74.03 106.943 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -59.66 -20.39 55.81 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 113.28 0.845 . . . . 64.24 113.28 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.61 -19.9 2.66 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.083 2.153 . . . . 63.42 112.682 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t -154.04 20.68 0.51 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.418 0.554 . . . . 75.1 111.301 161.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 44.16 54.36 6.07 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 120.272 -1.517 . . . . 62.12 112.158 -167.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 pt -101.26 169.85 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.106 1.363 . . . . 41.53 108.627 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.25 150.09 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.853 1.261 . . . . 71.52 108.634 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -157.63 174.07 15.9 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.94 2.496 . . . . 75.35 107.65 169.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -87.85 145.67 25.96 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.257 -1.386 . . . . 73.24 107.257 168.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -148.79 144.72 27.19 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.347 -1.353 . . . . 70.35 107.347 164.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -78.14 -175.15 3.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 119.857 1.208 . . . . 64.25 112.19 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.5 152.04 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 127.087 2.155 . . . . 61.25 107.241 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.413 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 3.0 mm? -113.07 -40.76 3.87 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 113.346 0.869 . . . . 65.41 113.346 -177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -145.8 164.85 30.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.691 -1.225 . . . . 71.35 107.691 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.627 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -132.43 165.99 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.744 -1.206 . . . . 74.13 107.744 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -130.93 175.47 9.04 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.909 0.884 . . . . 74.5 108.943 174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.48 145.92 5.78 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.03 1.732 . . . . 74.12 106.925 154.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.474 ' HE3' ' CD2' ' A' ' 47' ' ' PHE . 5.4 ttmt -148.48 166.42 28.24 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.885 -1.154 . . . . 63.24 107.885 166.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -93.45 157.5 16.18 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.524 -0.735 . . . . 74.21 109.538 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -160.13 147.55 16.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.074 1.35 . . . . 73.21 109.634 -170.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.5 p -143.39 117.9 9.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 160.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.52 -146.6 4.65 Favored Glycine 0 N--CA 1.463 0.481 0 N-CA-C 109.911 -1.276 . . . . 74.12 109.911 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 0.0 OUTLIER -123.5 119.21 29.3 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 117.036 -1.459 . . . . 74.42 110.277 174.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.3 mt -97.16 153.98 17.65 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 121.547 1.976 . . . . 73.4 106.78 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mm -79.94 139.79 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 126.784 2.033 . . . . 74.34 108.513 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -124.65 84.47 2.28 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.733 1.613 . . . . 73.35 106.748 161.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.45 HG23 HG13 ' A' ' 140' ' ' VAL . 32.3 mt -75.2 112.13 12.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 106.005 -1.85 . . . . 73.54 106.005 162.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -75.24 178.46 5.76 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 108.568 -0.901 . . . . 73.43 108.568 167.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 50.4 p -146.19 177.11 9.24 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 120.61 -1.306 . . . . 74.11 109.336 154.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 94' ' ' ARG . 35.1 ttmt -60.41 -27.28 67.33 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 119.503 -1.998 . . . . 63.3 113.568 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.68 18.62 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.888 1.222 . . . . 70.34 112.752 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.404 ' H ' ' C ' ' A' ' 92' ' ' LYS . 0.9 OUTLIER 58.59 15.76 3.85 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.728 2.411 . . . . 73.03 111.415 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HD2' ' CZ ' ' A' ' 171' ' ' PHE . 2.0 ttm105 -68.49 170.49 8.96 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 126.754 2.022 . . . . 72.43 108.463 176.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -176.17 172.1 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 125.155 1.382 . . . . 70.14 109.491 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.626 HG23 ' CE1' ' A' ' 171' ' ' PHE . 3.8 pt -143.09 178.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.011 1.324 . . . . 61.2 107.838 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.91 98.11 2.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.723 -0.843 . . . . 72.0 108.723 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.79 173.21 17.08 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.691 1.596 . . . . 73.14 110.218 -172.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 21.3 p -74.26 163.7 27.5 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.1 -1.0 . . . . 71.35 111.551 -173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -70.4 -16.46 62.96 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.287 0.847 . . . . 71.32 113.287 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -116.72 38.82 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.97 0.805 . . . . 72.24 108.893 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -89.99 129.76 44.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 117.921 -1.038 . . . . 62.31 109.613 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -60.35 126.6 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.747 3.631 . . . . 73.52 111.293 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.91 175.96 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.693 1.597 . . . . 63.41 109.123 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -114.79 134.68 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.494 -0.754 . . . . 62.4 111.067 -169.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.96 161.58 40.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.451 1.501 . . . . 73.34 109.059 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.471 ' HB3' HD21 ' A' ' 137' ' ' LEU . 53.2 p -87.4 127.01 35.21 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 119.416 -0.326 . . . . 44.45 110.743 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.686 ' HE3' HD13 ' A' ' 114' ' ' LEU . 2.3 ttmt -104.97 75.99 1.22 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.025 -1.472 . . . . 71.21 107.025 165.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m 59.51 16.98 5.66 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.857 1.663 . . . . 72.11 114.562 176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.75 -38.6 1.42 Allowed Glycine 0 N--CA 1.448 -0.536 0 O-C-N 120.682 -1.262 . . . . 60.01 110.194 -172.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -79.76 148.86 31.3 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.359 -1.349 . . . . 72.14 107.359 -173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.4 t -82.19 117.51 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.699 -1.593 . . . . 73.25 106.699 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.686 HD13 ' HE3' ' A' ' 109' ' ' LYS . 4.7 tp -105.19 132.94 50.77 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.076 -1.083 . . . . 63.04 108.076 166.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -81.75 125.79 31.05 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.235 -1.024 . . . . 73.21 108.235 161.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.9 pt -142.45 -179.9 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.48 1.512 . . . . 72.11 109.21 169.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -93.28 145.3 24.55 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.998 0.919 . . . . 73.02 109.285 -172.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -42.55 -47.11 5.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.637 1.975 . . . . 71.02 113.762 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -32.63 54.43 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.917 0.887 . . . . 50.33 113.053 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 54.2 mtt -75.6 -26.41 57.82 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.985 0.514 . . . . 73.31 112.159 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.259 5.7 t -79.11 63.2 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.695 2.398 . . . . 73.1 112.319 -169.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.759 ' HG3' ' H ' ' A' ' 124' ' ' GLY 0.259 0.0 OUTLIER -79.43 175.09 10.93 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 131.07 3.748 . . . . 72.13 111.632 -174.65 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.259 5.9 p -57.88 1.67 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 126.535 1.934 . . . . 71.12 114.616 167.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.759 ' H ' ' HG3' ' A' ' 122' ' ' LYS . . . -108.28 -1.84 33.37 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 127.772 2.606 . . . . 24.31 111.495 171.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.69 156.44 21.01 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.88 1.84 . . . . 64.54 108.02 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -115.6 104.97 12.25 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 107.517 -1.29 . . . . 74.11 107.517 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 tt -81.33 136.11 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.401 -0.818 . . . . 75.2 109.821 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.57 129.35 38.08 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.225 -0.898 . . . . 74.53 109.099 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.76 161.21 60.74 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.693 1.997 . . . . 74.12 111.164 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.55 173.04 14.98 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.726 2.284 . . . . 73.32 110.639 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 tptt -134.49 -134.8 0.16 Allowed 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 120.865 -1.147 . . . . 71.13 108.665 167.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -51.94 -84.0 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.609 1.164 . . . . 72.32 108.871 169.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -121.22 0.89 10.2 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.727 1.611 . . . . 73.32 112.431 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.7 p -131.58 151.34 51.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.879 0.872 . . . . 75.52 112.515 -171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.1 147.29 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 -176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -145.78 -176.21 5.04 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.704 2.002 . . . . 63.33 107.543 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 108' ' ' SER . 5.7 mt -124.82 166.23 16.61 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.822 -0.807 . . . . 74.3 108.822 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -154.26 140.79 18.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.765 -1.198 . . . . 73.54 107.765 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.8 141.34 46.21 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.528 -1.286 . . . . 64.24 107.528 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 89' ' ' ILE . 3.0 t -70.48 -23.48 24.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.529 1.531 . . . . 75.05 113.89 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.6 pt 47.19 -53.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 131.664 3.986 . . . . 54.51 116.398 -177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.5 tptt -140.28 132.51 28.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.689 2.395 . . . . 74.3 106.827 -172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.4 p -136.76 131.01 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 107.806 -1.183 . . . . 75.42 107.806 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -150.14 -164.79 2.1 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.932 1.293 . . . . 73.23 108.149 171.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.6 p -146.9 162.27 39.02 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 124.322 1.049 . . . . 72.31 109.517 -162.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 3.3 m -132.51 171.04 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 127.388 2.275 . . . . 73.24 108.687 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -128.48 92.41 3.42 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.051 -1.092 . . . . 73.44 108.051 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -97.63 136.91 37.33 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.509 2.723 . . . . 73.03 108.719 -173.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -134.54 73.34 1.48 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.024 -1.473 . . . . 74.23 107.024 -174.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.2 -159.24 7.84 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.086 0.85 . . . . 73.42 112.912 -167.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -102.29 154.25 19.22 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.8 -0.815 . . . . 74.23 108.8 163.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.5 pt -138.65 154.23 26.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 126.279 1.832 . . . . 63.55 107.295 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.692 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -153.38 160.28 42.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.599 0.76 . . . . 74.35 109.69 173.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -131.74 146.03 51.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.098 2.159 . . . . 75.54 107.524 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 21.3 tp -96.91 143.85 27.4 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 120.904 1.684 . . . . 74.13 112.718 -165.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.9 83.14 3.63 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.392 -1.336 . . . . 64.3 107.392 -177.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 19.3 t -97.21 76.72 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 106.145 -1.798 . . . . 64.51 106.145 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.02 -5.19 20.25 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.769 -0.582 . . . . 73.2 111.694 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -68.26 -63.97 0.95 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.901 2.08 . . . . 75.41 107.631 -173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -125.53 -4.85 7.14 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 127.716 2.406 . . . . 62.31 111.861 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 54.18 25.86 6.13 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.256 2.223 . . . . 63.44 112.775 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 p -141.49 153.68 45.07 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.883 1.273 . . . . 64.53 109.11 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.437 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -163.7 178.07 8.19 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.412 1.085 . . . . 75.21 111.208 176.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 40.3 mm -106.9 122.21 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 125.204 1.402 . . . . 73.13 109.317 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.04 154.93 43.03 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.56 1.144 . . . . 74.3 110.054 173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.51 -171.61 21.88 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.589 -0.605 . . . . 72.34 111.589 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 34.6 mmtt -91.55 166.68 12.71 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.484 -1.598 . . . . 70.05 110.015 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 61.36 -76.63 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 129.693 3.197 . . . . 74.43 112.032 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.89 -13.77 8.18 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 125.417 1.487 . . . . 74.15 112.561 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.86 171.0 18.9 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 125.033 1.301 . . . . 73.31 112.42 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.626 ' CE1' HG23 ' A' ' 97' ' ' ILE . 68.8 m-85 -112.12 157.09 21.23 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.737 3.615 . . . . 73.2 105.322 175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.467 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -103.9 110.81 23.09 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.108 -1.812 . . . . 42.03 106.108 170.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.13 175.19 6.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.619 -0.882 . . . . 64.31 108.619 -170.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.3 m -59.89 155.24 16.83 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.01 -0.737 . . . . 72.23 109.01 168.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -146.78 47.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 126.866 2.066 . . . . 63.23 107.012 173.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 p -66.42 119.02 10.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.297 -1.001 . . . . 60.52 108.297 -171.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 62.2 p -68.37 30.21 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.034 1.734 . . . . 71.31 113.197 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.54 64.17 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.149 -1.361 . . . . 74.01 115.427 169.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.6 173.25 6.41 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.784 1.792 . . . . 73.11 109.377 171.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 45.8 tp 70.5 147.01 0.07 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.528 2.731 . . . . 73.23 111.377 168.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.8 79.97 1.8 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.923 -1.139 . . . . 62.21 107.923 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 65.32 174.06 0.21 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.853 2.061 . . . . 74.43 114.214 172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 54.3 -157.91 0.19 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.984 1.714 . . . . 73.54 110.094 -165.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.7 t60 56.94 48.06 16.54 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.502 1.921 . . . . 75.15 110.811 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 156.2 28.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.203 -0.453 . . . . 75.43 110.194 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 38.5 m170 . . . . . 0 C--O 1.246 0.903 0 C-N-CA 127.429 2.291 . . . . 75.22 105.755 167.843 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 mtm . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 107.526 -1.287 . . . . 75.32 107.526 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -133.28 13.5 4.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 114.05 1.13 . . . . 72.22 114.05 -165.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.9 m 91.59 -38.13 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.98 2.112 . . . . 51.23 110.472 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.66 61.93 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 120.163 1.347 . . . . 73.22 115.576 158.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 78.8 130.52 0.05 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 129.602 3.161 . . . . 65.23 110.633 -177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.505 ' HB3' HG21 ' A' ' 100' ' ' THR . 69.2 m-20 58.28 -176.65 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.522 1.929 . . . . 62.5 109.494 -156.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.1 75.88 0.41 Allowed Glycine 0 C--N 1.336 0.559 0 O-C-N 121.291 -0.881 . . . . 55.54 111.08 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -152.94 136.41 15.9 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.968 1.307 . . . . 74.45 109.844 170.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.419 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 10.0 mp -79.74 158.6 26.86 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.413 1.485 . . . . 71.51 110.919 -167.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 159.53 21.37 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.052 0.541 . . . . 35.11 112.238 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -49.29 -49.34 44.14 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.111 1.764 . . . . 74.34 113.84 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -98.77 45.87 1.0 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 128.182 2.593 . . . . 72.24 109.424 -167.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' OE2' ' HE3' ' A' ' 167' ' ' LYS . 65.5 mm-40 -109.47 110.11 59.97 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.55 1.54 . . . . 74.03 107.926 169.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -51.71 134.69 47.98 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.516 2.811 . . . . 62.45 113.3 175.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.8 pt -96.33 -2.79 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 114.452 1.278 . . . . 61.1 114.452 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 49.56 70.43 0.49 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 120.01 1.277 . . . . 64.13 113.587 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 3.2 mm? -52.0 159.03 0.94 Allowed 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 120.865 -1.147 . . . . 44.25 110.925 167.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -53.87 -45.09 70.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.082 -1.081 . . . . 40.23 108.082 168.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.76 -4.53 9.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.133 1.373 . . . . 75.04 114.184 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.72 12.5 66.49 Favored Glycine 0 CA--C 1.523 0.584 0 O-C-N 120.287 -1.508 . . . . 62.31 112.237 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.409 ' H ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -67.92 -4.9 14.42 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 117.009 2.225 . . . . 73.03 117.009 -156.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.1 mm 27.39 87.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 130.802 3.641 . . . . 73.23 110.117 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.24 145.53 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 N-CA-C 106.616 -1.624 . . . . 71.23 106.616 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.26 130.71 44.92 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 128.108 2.563 . . . . 75.02 105.044 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -48.72 -43.4 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 123.434 0.694 . . . . 74.21 110.318 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.813 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.37 -4.9 83.12 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 117.49 -1.728 . . . . 50.21 114.424 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -82.54 -45.37 14.75 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.761 1.78 . . . . 74.42 108.788 167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -55.49 -55.43 31.86 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 123.275 0.63 . . . . 74.53 109.653 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG22 ' HA2' ' A' ' 26' ' ' GLY . 22.8 m -65.78 -34.76 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-O 118.428 -0.796 . . . . 55.44 110.186 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -45.73 72.98 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.923 1.238 . . . . 75.11 110.893 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.07 -37.48 53.98 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.765 0.826 . . . . 63.12 110.011 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -83.77 -45.01 13.81 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-O 117.564 -1.207 . . . . 64.12 110.829 176.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -54.72 -30.23 55.51 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 121.825 2.102 . . . . 74.04 112.708 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -94.36 -11.04 30.76 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.783 1.233 . . . . 64.2 112.495 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 17.6 mttm -95.89 -63.91 1.11 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.001 -1.111 . . . . 74.21 108.001 168.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.516 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 4.8 m-30 -84.84 39.73 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 129.185 2.994 . . . . 71.43 108.419 -168.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -49.52 -45.66 47.56 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 128.07 2.548 . . . . 61.32 109.506 174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -62.88 -35.1 78.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.967 0.907 . . . . 73.43 110.925 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.5 t -79.87 -7.95 59.02 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.823 2.049 . . . . 54.31 113.42 -175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.39 107.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 107.961 -1.126 . . . . 72.01 107.961 177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -84.49 155.21 22.27 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 106.626 -1.62 . . . . 75.23 106.626 162.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -121.21 135.05 55.2 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.741 -1.578 . . . . 62.44 106.741 164.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -79.79 176.96 9.25 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 125.665 1.853 . . . . 74.42 110.679 176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.58 -38.5 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.666 1.987 . . . . 72.43 111.801 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -76.59 -6.67 52.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.681 0.793 . . . . 73.12 111.738 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.68 12.76 62.11 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.785 1.66 . . . . 44.41 112.644 169.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -63.84 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.157 1.783 . . . . 64.33 111.423 -165.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 133.76 124.96 2.55 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-O 118.263 -1.299 . . . . 50.25 110.406 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -140.71 166.32 25.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 118.456 1.128 . . . . 74.0 111.219 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.9 mt -146.07 135.87 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.946 2.098 . . . . 64.53 106.636 172.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.19 128.97 36.9 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.396 0.678 . . . . 44.03 110.253 167.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.86 9.54 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 C-N-CA 124.043 0.937 . . . . 64.34 111.268 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.07 -16.2 59.5 Favored Glycine 0 CA--C 1.527 0.814 0 O-C-N 120.785 -1.197 . . . . 54.21 114.416 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -68.81 -32.42 72.12 Favored 'General case' 0 C--O 1.227 -0.121 0 CA-C-N 119.261 1.53 . . . . 72.24 111.81 170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.57 -13.09 38.35 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.479 0.582 . . . . 71.5 112.31 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.84 19.83 10.05 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 127.205 2.202 . . . . 74.52 112.756 172.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.8 mt -79.24 119.09 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 124.905 1.282 . . . . 63.03 108.506 -171.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -88.79 142.52 27.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.181 0.992 . . . . 71.32 111.5 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 6.7 tt -133.64 154.98 39.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.411 1.884 . . . . 74.04 108.641 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -73.01 126.73 30.64 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 110.133 -0.321 . . . . 71.41 110.133 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.04 166.84 16.23 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.562 1.945 . . . . 71.12 108.198 178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.457 ' CE1' ' HB ' ' A' ' 162' ' ' THR . 0.0 OUTLIER -129.56 154.61 46.88 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 106.933 -1.506 . . . . 73.43 106.933 179.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.68 141.12 46.84 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 118.632 -1.227 . . . . 60.44 108.377 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -86.14 -22.9 26.81 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.583 -0.698 . . . . 75.33 112.019 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.7 -50.04 66.75 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.671 1.988 . . . . 73.15 110.64 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.0 m -141.27 9.6 2.08 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.567 1.947 . . . . 71.43 110.794 -162.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 51.05 52.17 15.52 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 127.207 2.203 . . . . 71.41 111.12 176.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 pt -107.06 -175.62 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.352 0 O-C-N 124.185 0.928 . . . . 73.43 109.688 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.0 mm -116.86 125.42 73.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 127.528 2.331 . . . . 72.43 104.883 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -142.85 169.27 17.89 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.869 1.268 . . . . 72.3 108.776 173.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -110.0 143.58 39.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.625 1.57 . . . . 74.44 110.011 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 mmtm -150.92 168.08 25.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.657 1.983 . . . . 72.42 107.252 171.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -93.49 172.23 8.41 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.12 0.968 . . . . 70.15 110.38 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -104.04 144.1 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 105.507 -2.034 . . . . 62.43 105.507 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -109.8 -34.41 6.46 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.538 0.524 . . . . 64.41 111.217 -172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -144.44 137.75 27.2 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.97 1.259 . . . . 73.35 108.77 173.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 m -90.96 167.74 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 124.403 1.064 . . . . 61.23 109.714 168.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -138.13 159.96 40.66 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.321 1.048 . . . . 73.32 109.685 173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 8.3 tmm_? -153.57 140.68 19.39 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.441 1.496 . . . . 64.44 108.881 172.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -146.1 161.38 40.29 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.846 -1.168 . . . . 62.55 107.846 165.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -92.02 146.47 23.7 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.073 -1.084 . . . . 54.41 108.073 168.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' CE1' HD11 ' A' ' 86' ' ' LEU . 33.9 t80 -152.33 145.68 24.77 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.775 0.83 . . . . 70.43 110.007 -170.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -142.33 114.8 8.44 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.854 1.662 . . . . 63.34 109.281 173.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.06 40.78 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.441 1.019 . . . . 71.42 111.528 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.58 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.05 142.55 36.43 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 122.122 -0.634 . . . . 75.02 110.353 -174.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.492 ' CD2' HG22 ' A' ' 98' ' ' THR . 10.8 mp -127.69 160.38 31.83 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.81 1.644 . . . . 73.32 108.375 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 89' ' ' ILE . 21.5 mm -80.08 141.97 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 127.035 2.134 . . . . 61.23 108.229 175.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.5 tttp -128.78 75.23 1.63 Allowed 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.023 -1.843 . . . . 72.33 106.023 159.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.493 ' H ' HG22 ' A' ' 87' ' ' ILE . 23.3 mt -62.85 139.33 21.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 104.943 -2.243 . . . . 60.21 104.943 158.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.1 m -114.33 172.0 7.28 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.699 -1.593 . . . . 40.13 106.699 167.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.4 p -136.91 175.81 9.28 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 120.919 -1.113 . . . . 72.45 110.566 162.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -62.51 -25.69 68.15 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 121.619 -0.676 . . . . 74.53 111.669 -177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.95 7.79 2.96 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.877 1.271 . . . . 62.12 112.969 173.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.56 20.58 7.74 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.216 1.407 . . . . 75.02 110.818 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.4 ttm105 -71.38 161.92 30.28 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 124.661 1.185 . . . . 63.25 108.058 166.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -176.17 171.0 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.003 0.921 . . . . 61.03 108.902 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.598 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.3 pt -145.82 170.92 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.722 1.609 . . . . 73.12 110.65 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.492 HG22 ' CD2' ' A' ' 86' ' ' LEU . 2.3 m -148.09 95.23 2.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.278 1.431 . . . . 62.44 109.428 174.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.94 177.82 10.06 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.938 1.695 . . . . 70.04 110.498 -175.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.505 HG21 ' HB3' ' A' ' 6' ' ' ASP . 6.6 p -66.62 164.02 17.65 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.569 1.148 . . . . 64.31 110.638 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.265 1.1 p-80 -68.51 -24.31 64.64 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.513 0.931 . . . . 62.12 113.513 173.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.93 36.49 2.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 120.229 1.377 . . . . 64.54 111.336 -168.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -88.17 137.52 31.09 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 117.922 -1.037 . . . . 51.41 110.156 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.69 125.42 13.23 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.208 2.606 . . . . 73.22 111.194 172.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.87 -173.79 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 126.569 1.947 . . . . 74.52 108.361 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -129.02 140.35 51.67 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 118.882 0.764 . . . . 71.32 111.146 -174.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 pt -138.26 172.45 14.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.961 1.305 . . . . 71.44 108.1 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.7 p -87.55 144.76 26.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.934 0.873 . . . . 63.44 112.2 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -118.21 80.37 1.51 Allowed 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.617 -1.623 . . . . 71.1 106.617 158.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 m 62.51 8.58 2.95 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.34 1.456 . . . . 71.43 114.339 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.63 -20.3 3.3 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 120.839 -1.163 . . . . 71.44 111.314 -174.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.17 136.73 37.89 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 105.23 -2.137 . . . . 63.5 105.23 177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.12 117.76 18.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.219 -1.771 . . . . 72.0 106.219 164.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.63 138.99 53.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.508 1.523 . . . . 74.11 108.969 -173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.14 122.64 39.2 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.212 1.405 . . . . 72.51 109.314 -177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.9 pt -142.66 -178.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.76 1.224 . . . . 63.23 110.944 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.61 145.61 25.13 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.196 1.398 . . . . 62.54 110.704 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.87 45.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.801 1.64 . . . . 74.41 112.868 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.57 -28.08 68.89 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.706 -1.246 . . . . 64.22 112.002 -177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.04 -32.02 39.52 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.375 0.67 . . . . 52.44 112.323 -178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.296 7.9 p -76.92 63.58 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 124.507 1.123 . . . . 65.54 111.414 -176.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -79.39 -175.34 4.66 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.698 1.199 . . . . 75.42 108.522 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.53 -0.61 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.564 1.546 . . . . 73.23 112.991 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.45 -1.13 75.21 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-O 118.506 -1.163 . . . . 55.53 112.229 170.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -128.09 175.91 8.04 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.732 1.766 . . . . 73.02 110.596 -177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -127.93 104.52 7.85 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.755 -1.942 . . . . 73.01 105.755 -174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.36 129.7 37.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 106.262 -1.755 . . . . 75.25 106.262 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -69.72 127.8 34.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.228 -1.397 . . . . 64.24 107.228 175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 129' ' ' ILE . 1.8 pp -124.99 159.95 56.64 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.332 1.053 . . . . 72.22 112.81 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -70.89 145.1 49.72 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.219 1.946 . . . . 63.13 109.393 173.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.91 -167.8 1.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 106.498 -1.667 . . . . 45.53 106.498 171.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -24.07 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 128.595 2.758 . . . . 54.05 111.639 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -122.27 0.05 9.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 116.632 2.086 . . . . 54.11 116.632 170.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 16.5 p -138.07 169.23 18.15 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.2 0.6 . . . . 74.34 111.482 -174.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.6 tp -83.88 150.75 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.956 -1.09 . . . . 73.53 109.553 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -142.59 -176.64 4.94 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.293 1.837 . . . . 71.44 109.289 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.23 161.17 15.49 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.766 1.227 . . . . 72.13 111.915 171.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -158.02 136.0 10.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.254 1.822 . . . . 72.22 107.819 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.52 153.64 43.2 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.046 0.938 . . . . 61.42 110.341 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -93.25 -2.48 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 124.395 1.078 . . . . 64.52 112.955 -176.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.6 pt 25.49 -91.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 128.023 2.529 . . . . 60.24 116.149 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -88.06 122.73 31.99 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.355 1.462 . . . . 62.44 107.46 172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.97 102.83 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 107.709 -1.219 . . . . 74.1 107.709 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -131.57 -173.9 3.25 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.805 1.642 . . . . 60.31 108.003 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.2 p -125.21 168.31 13.64 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.043 0.937 . . . . 53.23 110.013 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.37 174.07 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.276 2.231 . . . . 73.01 106.476 168.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -123.21 105.77 10.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.018 -1.475 . . . . 64.44 107.018 165.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -100.5 136.96 39.57 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.871 1.268 . . . . 64.15 110.096 -168.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -137.52 51.51 1.92 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.258 0.623 . . . . 74.42 109.994 -166.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -131.09 -113.96 1.6 Allowed Glycine 0 N--CA 1.463 0.484 0 O-C-N 121.091 -1.006 . . . . 64.55 111.568 -167.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -139.7 157.51 45.65 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.428 1.891 . . . . 73.44 107.491 170.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 9.1 pt -124.55 153.97 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 125.281 1.432 . . . . 72.13 109.396 171.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.599 ' CD2' HG21 ' A' ' 29' ' ' VAL . 7.3 m-85 -148.72 165.88 30.08 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.819 1.648 . . . . 73.33 107.533 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -167.41 167.73 13.61 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.983 -0.747 . . . . 74.35 108.983 -169.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 mp -130.26 115.41 16.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.436 2.295 . . . . 74.42 108.501 -163.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 24.4 m -74.35 119.46 18.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.914 -1.513 . . . . 71.13 106.914 159.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 15.0 t -122.1 73.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 104.753 -2.314 . . . . 52.03 104.753 171.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.96 -3.08 3.1 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.221 1.408 . . . . 73.33 113.642 -172.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -103.06 -42.11 5.89 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.686 2.394 . . . . 71.05 108.264 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.445 ' C ' ' H ' ' A' ' 162' ' ' THR . 1.9 t30 -146.73 79.98 1.53 Allowed 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.981 -2.229 . . . . 72.41 104.981 -168.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -62.25 13.94 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 127.701 2.401 . . . . 71.23 112.958 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.457 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 13.1 p -132.65 124.1 27.63 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.456 2.702 . . . . 74.3 106.602 -172.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.517 ' CG ' ' HB2' ' A' ' 175' ' ' ALA . 0.1 OUTLIER -147.2 172.94 13.04 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.851 0.461 . . . . 74.24 112.186 -164.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 35.8 mm -108.0 121.49 61.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 106.925 -1.509 . . . . 60.13 106.925 176.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -146.98 152.68 39.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.58 -0.526 . . . . 70.22 109.58 172.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.82 -160.73 25.76 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.045 -1.222 . . . . 60.43 110.045 179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.474 ' HE3' ' OE2' ' A' ' 13' ' ' GLU . 67.8 mttt -109.31 171.53 7.39 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.125 0.962 . . . . 63.03 110.946 172.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 63.01 -73.32 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 128.64 2.776 . . . . 75.22 112.301 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -121.49 -11.05 8.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.417 1.887 . . . . 74.34 113.587 172.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.67 7.99 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 122.522 1.068 . . . . 54.13 111.868 -167.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.598 ' CE1' HG23 ' A' ' 97' ' ' ILE . 35.6 m-85 -108.61 156.61 19.34 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.771 2.429 . . . . 71.4 105.753 175.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -100.48 113.62 26.55 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.394 -1.335 . . . . 63.04 107.394 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.9 m -144.13 -177.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.632 1.173 . . . . 74.44 109.662 -163.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.08 126.85 31.59 Favored 'General case' 0 C--N 1.34 0.161 0 O-C-N 121.302 -0.874 . . . . 73.53 110.685 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.517 ' HB2' ' CG ' ' A' ' 163' ' ' TYR . . . -107.23 48.36 0.84 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.727 1.611 . . . . 42.41 107.403 156.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.27 157.76 28.14 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.674 -1.232 . . . . 72.1 107.674 171.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 73.5 m -57.92 152.18 16.69 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.157 0.503 . . . . 63.43 110.238 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -70.03 -52.68 17.62 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 109.544 -1.422 . . . . 73.42 109.544 -177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 62.8 p -89.87 145.84 24.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.647 -0.872 . . . . 63.43 108.647 169.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.8 tp -33.48 -71.35 0.06 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 128.642 2.777 . . . . 72.53 114.317 -177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.8 m80 59.89 169.71 0.08 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.216 1.406 . . . . 70.34 113.143 -171.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 46.42 75.41 0.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.819 2.048 . . . . 74.33 113.213 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 84.42 94.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.222 1 C-N-CA 131.964 4.106 . . . . 73.2 109.956 -168.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -61.13 154.03 24.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.102 -0.954 . . . . 64.35 109.857 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -63.59 175.41 1.07 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.114 1.766 . . . . 74.32 113.025 -176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 . . . . . 0 C--O 1.246 0.872 0 C-N-CA 124.593 1.157 . . . . 71.34 109.267 -178.602 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.4 ttt . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 117.207 -1.378 . . . . 75.54 111.4 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.3 p30 49.02 -161.03 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.274 1.429 . . . . 51.14 112.95 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.8 m -141.86 -47.42 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.954 1.302 . . . . 75.05 109.625 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.91 129.97 1.07 Allowed Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 119.668 1.122 . . . . 42.34 110.632 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 m170 -81.85 -22.49 36.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.475 1.11 . . . . 72.11 111.828 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 47.68 -144.88 0.32 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.334 1.054 . . . . 72.44 110.271 -175.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.87 179.65 41.66 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 120.874 1.67 . . . . 22.41 114.658 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 152' ' ' ILE . . . -174.15 -177.21 1.26 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.283 2.633 . . . . 72.14 108.594 177.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.588 HD21 ' HB1' ' A' ' 165' ' ' ALA . 6.0 tp -98.44 -13.76 20.41 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 115.894 1.812 . . . . 74.31 115.894 -171.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . 96.63 -162.19 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 1 C-N-CA 132.777 4.431 . . . . 60.52 111.644 -166.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.39 -39.83 2.74 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.651 2.78 . . . . 65.13 109.545 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.96 26.83 1.99 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.118 2.167 . . . . 43.33 110.026 -170.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -84.24 111.8 36.45 Favored Pre-proline 0 C--N 1.327 -0.391 0 C-N-CA 127.146 2.178 . . . . 73.53 108.777 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.92 106.31 0.76 Allowed 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.443 2.762 . . . . 61.54 108.651 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.7 pt -80.45 167.87 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 119.582 1.083 . . . . 65.25 110.142 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -128.21 64.48 1.4 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.477 1.111 . . . . 73.32 111.61 -170.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -45.63 150.71 0.47 Allowed 'General case' 0 N--CA 1.422 -1.873 0 O-C-N 120.425 -1.422 . . . . 74.25 112.624 161.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -15.0 53.24 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.768 1.292 . . . . 51.15 112.98 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.44 -18.28 22.51 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.181 0.9 . . . . 72.21 112.62 171.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.87 38.32 8.75 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 125.125 1.345 . . . . 64.34 111.043 169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.94 -18.62 64.42 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.614 1.207 . . . . 64.1 113.301 -170.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.0 mm 47.85 87.44 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 128.488 2.715 . . . . 65.34 109.863 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -141.73 150.31 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.996 -1.483 . . . . 52.14 106.996 -170.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -61.08 130.26 45.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.729 -1.211 . . . . 65.32 107.729 171.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 tt -53.73 -39.34 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 118.301 0.501 . . . . 62.12 110.018 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.15 10.27 63.95 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.833 -0.982 . . . . 74.11 114.26 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.02 -55.45 3.75 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 119.785 1.793 . . . . 63.24 108.689 153.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -48.56 -52.58 22.06 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 125.733 1.613 . . . . 74.31 109.435 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 77' ' ' VAL . 49.1 t -69.99 -42.73 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.709 -0.678 . . . . 74.22 110.916 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.25 -30.46 70.9 Favored 'General case' 0 C--O 1.226 -0.155 0 O-C-N 120.914 -1.116 . . . . 71.44 110.871 -173.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -52.37 -49.7 63.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.294 0.952 . . . . 75.44 109.17 170.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -66.09 -43.55 86.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.04 -1.096 . . . . 63.22 108.04 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -58.54 -35.47 72.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.132 1.333 . . . . 74.45 112.388 175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -83.22 -15.26 51.09 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.935 1.294 . . . . 73.55 111.704 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -97.98 -59.19 1.81 Allowed 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.341 -1.355 . . . . 72.53 107.341 176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -91.47 44.01 1.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.354 2.661 . . . . 74.14 107.808 -173.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -48.33 -45.12 34.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 C-N-CA 125.738 1.615 . . . . 75.15 109.537 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.59 -19.8 61.41 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 118.713 -0.66 . . . . 74.24 112.469 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.9 m -85.82 0.26 53.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.819 1.248 . . . . 61.34 112.45 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.0 mt -65.68 94.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 120.15 1.341 . . . . 75.11 108.212 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -79.59 169.69 17.64 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.912 -1.144 . . . . 63.12 107.912 168.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -131.72 154.98 48.46 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.85 -1.537 . . . . 71.33 106.85 163.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -81.87 171.82 14.03 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 124.312 1.007 . . . . 62.35 110.437 159.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -45.45 67.21 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.28 2.632 . . . . 63.23 110.995 175.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -64.03 -10.06 19.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.275 1.43 . . . . 62.3 112.28 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.01 7.59 57.34 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 127.383 2.421 . . . . 52.25 112.696 163.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -61.39 -82.06 0.02 OUTLIER 'General case' 0 C--O 1.235 0.335 0 C-N-CA 126.452 1.901 . . . . 75.54 110.625 -163.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 137.96 129.48 2.72 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.897 -1.681 . . . . 64.22 108.897 -173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -142.59 161.89 36.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 118.076 0.938 . . . . 74.41 111.263 167.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.4 mt -139.0 145.98 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 105.167 -2.161 . . . . 63.44 105.167 164.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.45 123.28 29.54 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.027 0.931 . . . . 75.0 108.89 165.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -130.89 8.5 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 122.652 0.381 . . . . 43.4 111.35 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.28 -18.91 61.29 Favored Glycine 0 CA--C 1.528 0.889 0 O-C-N 120.789 -1.194 . . . . 70.34 113.654 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.4 -13.52 60.73 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.872 1.669 . . . . 75.05 112.49 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -61.87 -22.14 65.29 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.531 0.732 . . . . 63.55 110.312 163.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 63.3 -10.55 0.11 Allowed 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 128.057 2.543 . . . . 64.3 114.185 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.4 mt -43.71 113.98 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 127.8 2.44 . . . . 71.1 109.544 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -77.02 144.01 38.96 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 116.006 -0.543 . . . . 74.53 110.041 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 17' ' ' LEU . 19.6 tt -112.02 156.65 13.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 126.041 1.736 . . . . 73.52 107.859 163.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -66.88 93.35 0.26 Allowed 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.449 -1.315 . . . . 73.43 107.449 164.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -71.39 173.8 7.38 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.805 -1.554 . . . . 74.4 106.805 165.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.554 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -140.39 151.59 45.07 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 119.656 -1.903 . . . . 73.24 106.817 166.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.516 HD22 HD11 ' A' ' 68' ' ' ILE . 17.2 t30 -101.22 114.22 27.99 Favored 'General case' 0 N--CA 1.436 -1.175 0 C-N-CA 124.822 1.249 . . . . 72.41 108.212 -176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -70.4 -29.47 66.12 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 126.34 1.856 . . . . 75.34 112.024 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -48.19 73.79 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.065 1.346 . . . . 64.54 110.74 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.8 t -125.39 8.06 7.76 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.539 0.736 . . . . 72.43 111.63 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mt 66.41 51.73 1.15 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.606 1.562 . . . . 62.42 110.961 170.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.516 HD11 HD22 ' A' ' 63' ' ' ASN . 11.0 pt -123.97 154.35 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.242 0.617 . . . . 61.45 110.137 -171.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.92 131.93 33.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 125.421 1.488 . . . . 64.33 107.04 -175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -137.36 178.04 7.4 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.344 1.458 . . . . 60.21 108.961 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -139.08 122.37 17.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.805 -1.184 . . . . 74.44 108.387 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.564 ' HE3' ' HA ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -138.58 147.02 42.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.858 0.863 . . . . 74.43 108.801 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -77.33 147.33 36.22 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.144 0.578 . . . . 73.05 110.898 170.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.522 ' H ' HD12 ' A' ' 74' ' ' ILE . 2.8 mp -71.69 164.45 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 N-CA-C 108.072 -1.085 . . . . 74.03 108.072 171.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -117.7 -50.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.902 1.281 . . . . 75.05 110.078 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.593 ' CB ' HG21 ' A' ' 156' ' ' THR 0.343 3.1 ttm180 -116.98 -176.69 3.03 Favored 'General case' 0 C--N 1.348 0.515 0 CA-C-N 119.061 0.846 . . . . 74.11 111.779 -177.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG21 HG22 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -149.71 145.98 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 107.924 -1.139 . . . . 45.03 107.924 170.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -118.4 156.11 29.54 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.42 1.088 . . . . 74.45 109.717 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.01 136.13 11.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 123.567 0.747 . . . . 72.05 108.986 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -145.02 160.96 40.54 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.896 -1.52 . . . . 70.24 106.896 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.75 148.59 22.74 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.903 -1.123 . . . . 72.52 108.407 173.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -143.9 154.07 42.96 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.955 1.302 . . . . 71.12 110.093 -163.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.7 p -153.9 154.73 34.4 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.047 -0.723 . . . . 72.11 109.047 154.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.38 -170.14 21.03 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 125.347 1.451 . . . . 73.42 110.672 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.1 mttt -86.53 125.43 33.76 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.674 1.19 . . . . 55.41 110.523 -171.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.0 mt -102.11 165.85 10.93 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 106.94 -1.504 . . . . 71.21 106.94 171.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.8 mm -81.43 149.49 4.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.396 1.478 . . . . 72.01 108.146 178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -127.45 79.9 1.92 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.722 2.009 . . . . 70.32 107.7 165.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.577 HG23 HG13 ' A' ' 140' ' ' VAL . 38.9 mt -61.81 130.98 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 105.623 -1.992 . . . . 73.13 105.623 150.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.8 m -114.5 162.94 16.05 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 106.28 -1.748 . . . . 75.55 106.28 157.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 p -135.61 169.96 16.71 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.591 -0.892 . . . . 65.34 108.591 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -38.38 55.57 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.678 -1.264 . . . . 63.3 111.877 -174.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.56 -0.98 7.54 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.493 1.517 . . . . 75.23 111.747 -172.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.6 mmt-85 61.49 24.33 14.45 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 126.936 2.094 . . . . 73.45 110.258 -167.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' CD ' ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -73.87 168.18 19.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.961 -1.126 . . . . 64.11 107.961 160.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 177.55 162.42 0.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.27 2.628 . . . . 64.54 107.812 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.671 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -147.18 177.26 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 126.945 2.098 . . . . 75.53 109.338 -174.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.6 m -145.67 74.94 1.41 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.177 0.513 . . . . 73.31 111.489 -167.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.436 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -141.56 163.57 32.58 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 119.522 -1.986 . . . . 75.14 112.271 -165.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.4 p -68.85 161.28 28.94 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.516 0.726 . . . . 72.13 110.696 -174.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -74.09 14.61 0.4 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.422 0.897 . . . . 73.01 113.422 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -131.18 39.16 3.58 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.153 1.797 . . . . 75.51 110.8 159.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.436 ' CG ' HD22 ' A' ' 99' ' ' LEU . 3.4 t60 -84.99 125.88 69.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.674 -1.155 . . . . 74.22 109.451 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -63.6 114.77 2.69 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 124.21 3.274 . . . . 63.23 111.231 174.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.58 162.62 28.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.819 -1.178 . . . . 64.41 107.819 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -101.39 140.68 35.35 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.841 0.856 . . . . 71.23 109.151 -172.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.49 164.07 35.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.996 0.918 . . . . 75.31 109.882 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -90.03 120.64 31.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.846 -1.168 . . . . 64.11 107.846 173.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.471 ' CD ' HD22 ' A' ' 114' ' ' LEU . 0.2 OUTLIER -99.38 81.27 2.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 104.862 -2.273 . . . . 72.22 104.862 169.054 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 m 56.45 17.61 3.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.206 1.002 . . . . 71.42 113.52 -173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 103.18 1.27 47.99 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 121.064 -1.022 . . . . 60.51 114.062 -177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.89 160.3 26.08 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 105.763 -1.94 . . . . 61.22 105.763 150.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.5 p -101.46 145.1 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.822 -0.807 . . . . 72.31 108.822 170.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD22 ' CD ' ' A' ' 109' ' ' LYS . 4.7 tp -142.06 170.9 14.85 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.986 1.315 . . . . 70.53 107.701 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -112.83 138.26 49.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.794 0.838 . . . . 72.44 108.844 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.5 pt -142.52 179.28 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 125.169 1.388 . . . . 71.34 108.81 171.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -72.04 132.06 43.74 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 107.597 -1.261 . . . . 53.34 107.597 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -43.23 -35.11 1.32 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.861 1.665 . . . . 64.42 113.163 165.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -24.4 67.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.817 1.247 . . . . 74.42 112.516 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.0 -31.91 56.82 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.033 -1.042 . . . . 71.33 111.266 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.608 ' O ' HG11 ' A' ' 140' ' ' VAL . 7.4 t -76.57 62.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 126.124 1.769 . . . . 74.21 110.345 -173.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -86.72 -177.09 6.04 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.603 1.561 . . . . 61.01 108.534 173.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.82 0.03 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.859 2.064 . . . . 64.54 113.704 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.63 -13.43 80.04 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 117.366 -1.797 . . . . 61.52 112.479 167.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -124.3 170.15 11.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.839 1.819 . . . . 73.31 110.031 -166.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 139' ' ' GLU . 7.6 m-85 -112.86 155.62 24.34 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 125.391 1.476 . . . . 75.42 108.396 165.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 10.2 tt -124.73 166.83 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.624 2.369 . . . . 74.03 107.589 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 112.26 22.47 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.85 1.26 . . . . 74.23 110.958 -166.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.48 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.6 pp -121.54 161.43 41.56 Favored Pre-proline 0 N--CA 1.465 0.325 0 C-N-CA 124.737 1.215 . . . . 75.0 113.191 -174.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.01 154.84 33.54 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.887 1.725 . . . . 70.0 109.732 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -117.91 -156.69 0.65 Allowed 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.1 -1.444 . . . . 72.44 107.1 162.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -59.32 -57.75 11.63 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 122.986 0.514 . . . . 72.44 111.391 -166.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -121.52 0.48 9.95 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.522 0.934 . . . . 74.13 113.522 174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 18.0 p -139.35 -173.96 3.74 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 125.504 1.522 . . . . 42.12 111.027 -160.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.4 149.38 15.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.51 1.124 . . . . 74.25 109.529 -176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -143.28 -178.32 5.8 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.996 2.118 . . . . 72.33 108.533 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 mt -118.39 165.81 13.42 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.277 1.031 . . . . 72.4 109.386 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CG ' HG12 ' A' ' 129' ' ' ILE . 33.9 p-10 -153.96 147.87 25.52 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.89 1.276 . . . . 63.41 111.116 173.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 126' ' ' TYR . 32.5 tt0 -97.38 148.36 23.25 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.345 1.858 . . . . 65.42 111.166 -172.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.608 HG11 ' O ' ' A' ' 121' ' ' VAL . 18.4 t -87.19 2.17 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.725 0.639 . . . . 74.41 112.725 -160.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.5 pt 24.68 -88.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 127.522 2.329 . . . . 73.11 116.112 171.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 124.55 35.06 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.493 1.517 . . . . 54.32 108.088 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -129.14 122.5 56.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.43 -0.581 . . . . 71.21 109.43 170.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.88 -167.96 2.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 127.351 2.26 . . . . 61.21 107.436 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -122.45 172.17 8.55 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.555 1.142 . . . . 74.12 109.76 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -122.36 161.81 22.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 130.565 3.546 . . . . 64.41 104.559 172.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -126.59 133.5 51.03 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 106.792 -1.558 . . . . 61.15 106.792 172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -144.18 155.55 43.95 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 118.815 0.734 . . . . 72.53 111.587 -171.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.39 47.21 0.75 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.535 0.607 . . . . 72.45 111.884 -169.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.44 -122.7 2.29 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 121.585 -0.697 . . . . 63.34 114.342 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -124.34 160.57 27.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.127 0.971 . . . . 74.11 109.491 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 10' ' ' ALA . 11.6 pt -135.04 155.55 38.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 126.578 1.951 . . . . 74.34 108.239 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -138.87 168.52 19.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.522 1.929 . . . . 72.35 107.226 -174.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -164.62 167.34 19.31 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.741 1.155 . . . . 75.24 109.921 -176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.3 tp -137.7 113.62 9.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 115.275 1.583 . . . . 75.1 115.275 -149.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.593 HG21 ' CB ' ' A' ' 76' ' ' ARG . 69.1 p -55.88 -50.85 69.5 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.427 1.491 . . . . 71.2 114.016 -168.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 5.3 t 24.55 68.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 129.5 3.12 . . . . 64.13 112.012 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.3 -5.69 58.74 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 114.106 -1.406 . . . . 63.13 111.928 -168.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.45 -47.08 74.29 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.52 2.328 . . . . 72.22 110.91 -175.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -125.83 1.34 7.4 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.863 0.69 . . . . 73.33 112.863 171.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.482 ' C ' ' HB3' ' A' ' 175' ' ' ALA . 6.9 m170 55.83 30.39 15.73 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.022 0.929 . . . . 75.22 111.81 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 1.8 p -151.49 154.9 37.46 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 120.065 1.302 . . . . 75.4 110.372 176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 18.3 p90 -153.23 174.95 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.595 1.089 . . . . 72.02 111.542 176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 37.1 mm -99.29 124.23 52.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 123.884 0.874 . . . . 63.5 108.916 169.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HB1' HD21 ' A' ' 9' ' ' LEU . . . -156.4 157.69 36.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.561 1.545 . . . . 54.53 108.742 169.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 138.37 -170.35 23.91 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 127.912 2.672 . . . . 74.42 107.953 -175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -89.71 167.28 13.02 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.639 -1.506 . . . . 61.35 111.346 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 67.19 -74.53 0.07 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.652 2.381 . . . . 73.11 114.132 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -121.77 -10.02 8.78 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.531 1.932 . . . . 52.03 112.541 171.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 78.82 165.85 29.57 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 122.673 1.152 . . . . 51.25 112.382 -168.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.671 ' CE1' HG23 ' A' ' 97' ' ' ILE . 14.7 m-85 -105.07 158.05 16.83 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 128.519 2.728 . . . . 73.0 105.943 172.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.554 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -87.78 108.62 19.22 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.186 -2.153 . . . . 74.31 105.186 169.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.415 HG23 ' CE1' ' A' ' 163' ' ' TYR . 16.3 m -120.75 178.5 2.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.427 1.091 . . . . 53.04 108.708 -175.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 9.5 t -80.68 153.2 28.04 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.389 1.475 . . . . 43.34 110.277 -172.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.614 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -137.41 -158.35 0.85 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.439 1.896 . . . . 73.5 107.737 167.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 78.7 p 95.04 138.93 0.02 OUTLIER 'General case' 0 C--O 1.237 0.417 1 C-N-CA 132.625 4.37 . . . . 54.22 104.758 -165.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.8 m -65.84 -11.06 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.453 0.908 . . . . 71.2 113.453 -171.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.91 -122.49 28.88 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 108.403 -1.879 . . . . 62.54 108.403 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 76.4 p 45.73 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.47 1.908 . . . . 73.33 111.508 -171.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 67.79 -74.33 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 126.373 1.869 . . . . 74.34 111.581 -172.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.1 123.04 25.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.574 -1.269 . . . . 71.42 107.574 -171.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 127.44 8.24 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.03 -1.044 . . . . 73.11 109.943 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.268 27.7 p-80 42.84 -152.65 0.02 OUTLIER 'General case' 0 C--O 1.239 0.55 0 C-N-CA 126.136 1.774 . . . . 73.13 111.855 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 -107.98 -63.58 1.3 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.433 -0.951 . . . . 71.51 108.433 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.98 133.3 9.82 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 109.326 -0.62 . . . . 71.34 109.326 174.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 . . . . . 0 C--O 1.244 0.786 0 C-N-CA 126.153 1.781 . . . . 71.41 109.362 171.681 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.464 0 N-CA-C 107.098 -1.445 . . . . 70.35 107.098 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -149.93 134.96 17.9 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.279 -1.378 . . . . 64.54 107.279 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.1 m -65.25 -62.77 1.34 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.583 0.753 . . . . 64.33 109.202 170.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.96 -72.58 0.07 OUTLIER Glycine 0 C--N 1.337 0.634 0 N-CA-C 109.741 -1.343 . . . . 54.01 109.741 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.4 m170 70.29 97.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.163 2.185 . . . . 64.31 108.186 -164.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.37 131.89 40.55 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.369 -0.832 . . . . 75.31 109.423 177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.02 147.96 18.55 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 124.025 0.821 . . . . 53.5 111.07 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' CB ' HD12 ' A' ' 152' ' ' ILE . . . -151.06 172.68 15.36 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.925 1.69 . . . . 64.2 108.257 166.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.461 ' HG ' ' HG2' ' A' ' 13' ' ' GLU . 15.0 tp -102.09 -16.67 16.34 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.599 1.333 . . . . 74.41 114.599 -150.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 66.72 160.57 0.15 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 130.799 3.639 . . . . 73.21 112.319 -161.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.514 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 8.9 t80 -80.59 -49.0 11.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.667 1.587 . . . . 65.23 111.076 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -93.97 70.57 3.97 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.364 -2.088 . . . . 71.1 105.364 -174.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -139.58 116.93 8.5 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 104.747 -2.316 . . . . 74.51 104.747 -169.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.89 124.36 13.45 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.33 2.687 . . . . 35.34 111.774 172.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.418 ' HB ' HD11 ' A' ' 59' ' ' ILE . 10.4 pt -97.0 10.19 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.382 0.882 . . . . 63.15 113.382 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.8 m-85 38.66 72.73 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.471 1.508 . . . . 74.34 112.612 178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.14 157.57 0.43 Allowed 'General case' 0 C--N 1.345 0.381 0 N-CA-C 108.173 -1.047 . . . . 73.51 108.173 167.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.69 -17.6 48.99 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.103 0.779 . . . . 72.42 113.103 -169.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -88.29 -52.93 4.95 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.557 1.143 . . . . 74.11 109.953 170.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.87 55.46 0.1 OUTLIER Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.025 1.298 . . . . 65.41 113.496 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -66.24 -22.7 66.33 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.665 1.732 . . . . 71.42 115.373 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.423 HD11 ' CD2' ' A' ' 16' ' ' TYR 0.292 47.8 mm 38.68 46.12 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 130.121 3.368 . . . . 62.3 112.409 -171.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.33 154.41 3.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.912 1.285 . . . . 74.24 108.013 175.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -66.06 124.69 23.26 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.409 1.084 . . . . 62.05 108.471 168.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -49.87 -39.24 14.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 C-N-CA 123.218 0.607 . . . . 65.52 111.081 173.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.514 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -53.53 -50.94 51.21 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.747 -0.941 . . . . 24.13 110.747 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.61 -38.88 77.42 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.263 1.025 . . . . 72.0 111.952 -177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -57.29 -56.13 25.81 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 124.012 0.925 . . . . 75.44 109.401 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 77' ' ' VAL . 71.7 t -64.74 -38.51 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 CA-C-N 115.475 -0.784 . . . . 72.43 109.522 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -36.91 84.2 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 120.148 1.34 . . . . 34.05 110.514 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.65 -40.79 60.63 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.554 1.141 . . . . 74.32 110.281 175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -78.2 -43.99 26.98 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 124.687 1.195 . . . . 64.1 109.309 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.508 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.2 m-85 -60.0 -22.23 62.31 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 121.871 2.123 . . . . 70.42 113.063 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -100.0 -10.37 21.68 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.547 1.539 . . . . 75.11 112.058 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.78 -65.36 1.02 Allowed 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.962 -1.866 . . . . 75.02 105.962 163.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -82.83 41.04 0.71 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.686 3.194 . . . . 71.33 110.074 -167.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -59.33 -30.23 68.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.387 1.875 . . . . 64.41 110.2 176.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -69.64 -21.13 63.58 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.159 1.784 . . . . 70.11 112.534 173.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.28 6.32 48.55 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.652 1.581 . . . . 70.45 112.271 -176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 96.8 mt -73.69 84.18 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 122.652 1.215 . . . . 64.54 109.645 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mmtt -80.48 120.6 24.68 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.243 -1.762 . . . . 64.2 106.243 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -88.62 157.55 18.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.76 -1.941 . . . . 75.33 105.76 155.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -79.03 178.47 8.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.232 -1.396 . . . . 60.45 107.232 164.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -62.22 -36.88 83.33 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.656 1.182 . . . . 62.41 110.527 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -14.07 33.18 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.149 1.38 . . . . 74.32 112.586 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.16 33.41 26.32 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.143 2.306 . . . . 53.03 111.067 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CD1' ' HE3' ' A' ' 80' ' ' LYS . 3.4 t80 -79.95 -90.97 0.05 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.036 1.334 . . . . 71.45 108.46 -171.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.19 128.16 2.52 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 108.087 -2.005 . . . . 60.02 108.087 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 65.6 p-90 -139.99 168.51 19.64 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.719 1.208 . . . . 74.32 109.026 166.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.508 HD12 ' CD1' ' A' ' 33' ' ' PHE . 14.2 mt -149.22 143.13 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 127.543 2.337 . . . . 62.43 105.51 168.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.38 130.48 37.23 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.369 1.468 . . . . 52.34 108.295 169.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.39 -2.43 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.907 0.883 . . . . 72.04 112.596 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -59.88 -20.38 52.9 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-N 119.535 1.061 . . . . 63.13 115.37 -169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -63.15 -20.52 65.46 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 128.111 2.564 . . . . 75.41 114.045 171.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.16 -20.16 62.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.662 0.785 . . . . 72.13 111.357 172.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 m120 64.14 3.29 1.69 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.001 2.121 . . . . 72.45 113.685 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.05 138.42 15.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 125.381 1.472 . . . . 64.23 108.794 172.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -109.84 167.52 10.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.463 1.125 . . . . 75.01 110.635 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.443 HD12 HD11 ' A' ' 74' ' ' ILE . 3.5 tt -135.38 160.28 40.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 125.714 1.606 . . . . 71.51 108.041 -178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -81.77 132.88 35.29 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.312 -1.736 . . . . 75.11 106.312 168.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.37 -174.08 3.93 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.963 -0.754 . . . . 71.32 108.963 174.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -138.1 139.54 39.53 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.401 -1.703 . . . . 73.0 106.401 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -93.52 107.71 19.51 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.529 -1.286 . . . . 71.43 107.529 174.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.4 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 3.7 ttpm? -56.49 -23.71 41.15 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.869 1.268 . . . . 73.13 111.607 173.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -23.06 5.58 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.473 1.909 . . . . 75.44 112.772 176.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -149.6 14.27 0.85 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.325 1.05 . . . . 60.32 111.952 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 37.7 53.82 1.48 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.217 1.807 . . . . 51.31 111.838 -163.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.2 pt -105.98 155.25 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.707 0.803 . . . . 62.5 109.366 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 32.7 mm -85.04 130.72 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 106.829 -1.545 . . . . 62.2 106.829 171.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.33 166.97 23.28 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.219 1.007 . . . . 74.45 112.238 -174.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -99.89 113.0 25.24 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.732 2.013 . . . . 71.15 107.7 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.5 mptt -125.0 167.21 15.05 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.959 0.903 . . . . 74.24 109.824 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -106.22 177.36 4.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.4 0.68 . . . . 71.01 110.228 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.443 HD11 HD12 ' A' ' 59' ' ' ILE . 64.4 mt -113.49 153.55 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 105.423 -2.066 . . . . 65.13 105.423 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.34 -58.52 1.7 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 124.799 1.239 . . . . 74.23 108.435 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.492 ' CB ' HG21 ' A' ' 156' ' ' THR 0.25 14.7 mtm180 -128.1 159.34 35.4 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.227 1.411 . . . . 71.51 112.756 -174.086 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.539 HG21 HG13 ' A' ' 29' ' ' VAL . 3.2 m -133.97 165.66 31.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.385 1.474 . . . . 71.43 108.149 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.593 ' HE1' ' CG2' ' A' ' 156' ' ' THR . 68.4 m95 -139.07 163.73 31.64 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 122.926 0.49 . . . . 74.42 111.283 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.04 135.87 31.48 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.083 0.953 . . . . 64.11 110.592 174.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 1.2 tppp? -142.95 141.45 31.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.031 -1.84 . . . . 70.12 106.031 162.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -86.51 152.38 22.7 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.505 -1.294 . . . . 75.42 107.505 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.33 150.35 33.44 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.689 0.795 . . . . 70.11 109.961 -163.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.18 110.21 3.02 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.913 -0.773 . . . . 63.25 108.913 169.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.95 46.35 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 118.394 0.543 . . . . 70.03 111.849 -174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.635 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.75 121.87 25.89 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.787 -0.82 . . . . 53.21 108.787 175.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 72.9 mt -97.18 172.58 7.73 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 106.151 -1.796 . . . . 75.01 106.151 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 89' ' ' ILE . 9.2 mm -79.15 160.37 4.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 126.418 1.887 . . . . 63.43 107.912 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -137.27 79.64 1.76 Allowed 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.1 -1.444 . . . . 71.3 107.1 157.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.629 HG23 HG13 ' A' ' 140' ' ' VAL . 48.4 mt -67.12 135.5 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 104.456 -2.424 . . . . 62.44 104.456 158.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -118.22 175.36 5.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.244 1.418 . . . . 73.15 107.311 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -142.33 176.84 8.68 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 119.919 1.236 . . . . 71.24 112.654 164.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -53.66 -35.17 60.74 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.307 1.043 . . . . 74.12 111.854 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -74.85 11.0 1.17 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.785 2.034 . . . . 73.34 111.677 -176.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 47.37 33.54 2.77 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.153 1.781 . . . . 71.15 111.394 -166.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -83.48 168.35 16.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 107.818 -1.178 . . . . 65.21 107.818 165.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 179.24 163.55 0.88 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.5 1.92 . . . . 75.12 107.666 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.592 HG23 ' CE1' ' A' ' 171' ' ' PHE . 2.0 pt -139.65 172.24 12.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 126.844 2.057 . . . . 63.53 110.201 -174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.3 m -137.81 99.67 3.98 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.34 1.856 . . . . 72.1 107.118 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.88 167.5 28.12 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.756 -0.59 . . . . 72.11 110.347 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 p -75.84 162.38 28.19 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.317 -0.864 . . . . 54.42 110.697 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -76.74 38.74 0.2 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.678 0.791 . . . . 73.25 112.736 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -157.47 37.04 0.28 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.963 0.801 . . . . 73.31 110.065 149.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -75.15 137.02 72.32 Favored Pre-proline 0 N--CA 1.471 0.616 0 O-C-N 119.721 -1.862 . . . . 71.3 110.453 -174.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.35 121.92 9.68 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.229 2.619 . . . . 63.13 111.483 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.5 m -131.7 -177.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.914 1.286 . . . . 65.44 109.064 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -128.32 137.06 51.77 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.174 0.99 . . . . 73.4 108.894 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 127' ' ' ILE . 1.9 pt -141.82 167.6 15.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 124.511 1.124 . . . . 60.54 108.564 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.62 143.16 34.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.499 0.666 . . . . 62.0 111.797 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 109' ' ' LYS . 0.6 OUTLIER -115.14 53.99 0.8 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.384 1.074 . . . . 72.22 108.748 163.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . 0.28 0.2 OUTLIER 96.36 -0.05 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 130.856 3.662 . . . . 75.53 114.328 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 137.75 -11.41 3.69 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.714 -0.955 . . . . 63.12 110.714 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -86.37 161.32 18.75 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 125.419 1.488 . . . . 72.35 112.713 161.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.43 HG22 ' CE2' ' A' ' 128' ' ' TYR . 62.5 t -106.49 106.64 20.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.036 1.334 . . . . 71.43 108.962 -166.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.59 158.58 15.65 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.214 1.006 . . . . 71.53 108.409 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -114.44 121.05 42.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.615 1.966 . . . . 72.23 107.037 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.6 pt -140.71 178.32 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.293 1.037 . . . . 73.24 109.826 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -77.37 140.39 39.93 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.087 1.755 . . . . 71.21 109.867 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.38 -29.81 61.93 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.198 1.399 . . . . 73.11 112.384 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -31.49 72.19 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.93 -0.481 . . . . 73.11 111.154 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.27 -25.87 42.46 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.507 1.123 . . . . 75.44 111.316 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.6 t -72.75 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.3 2.24 . . . . 74.51 111.416 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.51 -178.35 5.78 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 120.933 -1.104 . . . . 61.24 108.962 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.18 -2.3 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 129.565 3.146 . . . . 72.44 114.569 166.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.88 -15.92 57.13 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 120.285 -1.509 . . . . 60.13 111.734 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.35 140.69 51.73 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.473 1.636 . . . . 73.13 107.954 -160.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.71 117.68 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.643 1.177 . . . . 65.23 107.944 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 107' ' ' ILE . 5.8 tt -82.88 142.99 12.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 109.044 -0.725 . . . . 74.32 109.044 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.43 ' CE2' HG22 ' A' ' 113' ' ' VAL . 3.2 m-85 -74.21 121.43 21.22 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.51 -0.922 . . . . 73.24 108.51 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.418 HG23 HG23 ' A' ' 127' ' ' ILE . 2.7 pp -120.93 145.61 41.93 Favored Pre-proline 0 N--CA 1.45 -0.428 0 C-N-CA 124.696 1.199 . . . . 63.02 110.296 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.48 148.01 47.39 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 121.999 1.799 . . . . 70.22 107.516 169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -120.93 -169.81 1.9 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.346 -1.724 . . . . 62.45 106.346 169.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -34.53 -72.24 0.06 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.922 1.689 . . . . 74.31 112.17 -174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -121.48 1.31 10.1 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.655 1.182 . . . . 54.52 113.217 171.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.2 p -130.47 153.8 48.43 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 124.967 1.307 . . . . 72.14 112.263 -165.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.2 tp -84.33 147.46 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 107.163 -1.421 . . . . 71.4 107.163 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -147.7 -174.86 4.66 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.877 2.071 . . . . 65.21 107.693 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 14.0 mt -131.25 159.98 36.23 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.354 1.462 . . . . 65.4 108.007 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -149.37 159.0 44.65 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.886 0.874 . . . . 72.24 110.122 171.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -93.83 140.27 29.87 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 127.745 2.418 . . . . 73.05 109.975 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.629 HG13 HG23 ' A' ' 89' ' ' ILE . 49.8 t -81.89 -3.14 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 125.212 1.405 . . . . 74.11 113.461 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.3 pt 25.05 -89.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 C-N-CA 127.494 2.318 . . . . 72.24 115.6 174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -89.82 105.4 17.77 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.821 1.648 . . . . 73.1 107.844 170.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.81 148.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.135 -1.061 . . . . 62.42 108.135 154.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -163.3 -162.63 0.76 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.359 2.664 . . . . 70.22 107.661 172.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 p -131.26 162.12 30.73 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.162 1.785 . . . . 64.5 109.561 176.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.5 m -108.63 -169.16 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.601 1.561 . . . . 74.12 109.455 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -133.01 132.47 41.91 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.991 2.116 . . . . 74.31 106.535 161.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.95 143.31 36.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.82 1.191 . . . . 71.31 110.489 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.53 30.74 1.51 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.969 0.729 . . . . 55.44 112.969 -163.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.59 -136.03 4.21 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.593 1.092 . . . . 54.44 111.739 -167.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -99.25 170.06 8.93 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.384 -1.068 . . . . 74.02 109.824 167.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.44 HD12 ' CB ' ' A' ' 8' ' ' ALA . 2.3 pt -118.34 -73.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 107.037 -1.468 . . . . 73.53 107.037 173.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 78.98 170.29 0.18 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.535 2.334 . . . . 74.12 107.553 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -162.91 153.96 17.17 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.425 1.49 . . . . 51.54 107.439 -170.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 mt -123.04 141.21 52.22 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.457 1.103 . . . . 74.24 111.133 -166.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.593 ' CG2' ' HE1' ' A' ' 78' ' ' TRP . 44.7 p -79.49 -70.34 0.52 Allowed 'General case' 0 CA--C 1.536 0.409 0 O-C-N 123.751 0.657 . . . . 74.35 110.183 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 6.3 t 43.11 73.88 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 127.664 2.386 . . . . 51.34 111.844 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.05 -0.48 40.0 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.272 -0.876 . . . . 74.33 113.314 -176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -67.94 -38.72 83.2 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.599 -0.519 . . . . 72.24 109.599 -166.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 5.5 t30 -138.52 7.98 2.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.871 1.269 . . . . 71.41 111.99 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.5 m170 54.02 29.32 9.98 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.505 1.122 . . . . 74.12 111.424 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.3 p -142.91 144.77 32.56 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 119.628 -1.92 . . . . 73.33 109.135 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.683 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.1 p90 -148.8 167.17 26.34 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 113.067 0.765 . . . . 73.31 113.067 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.2 mm -85.85 137.19 21.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 N-CA-C 106.407 -1.701 . . . . 71.34 106.407 164.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -153.87 143.08 21.4 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.801 1.24 . . . . 65.5 108.072 162.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.55 -173.32 22.87 Favored Glycine 0 N--CA 1.462 0.431 0 C-N-CA 123.881 0.753 . . . . 54.35 111.585 167.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 54.3 mttt -90.95 167.87 12.09 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.47 -1.606 . . . . 72.25 110.261 -176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 65.08 -75.2 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.542 2.337 . . . . 75.31 114.201 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.529 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 43.0 mt-10 -121.77 -7.94 8.99 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.558 1.143 . . . . 72.34 112.339 169.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 72.26 170.33 14.7 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-O 122.844 1.247 . . . . 72.01 111.874 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.592 ' CE1' HG23 ' A' ' 97' ' ' ILE . 12.8 m-85 -120.72 147.91 44.67 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.968 2.507 . . . . 74.31 106.98 -174.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -90.79 103.94 16.58 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 106.542 -1.651 . . . . 73.22 106.542 177.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.5 m -121.24 177.88 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.398 1.479 . . . . 51.51 109.176 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.8 t -67.34 144.4 55.86 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 128.47 2.708 . . . . 72.04 109.77 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.683 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -123.96 166.13 16.24 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 128.681 2.793 . . . . 75.21 107.013 162.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -174.99 171.58 3.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.613 -1.625 . . . . 61.12 106.613 160.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 34.6 m -94.92 53.18 1.55 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.096 -1.002 . . . . 72.32 109.832 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.93 -9.18 32.68 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.221 1.391 . . . . 60.44 112.916 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.5 p -79.82 164.48 23.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.703 2.001 . . . . 75.25 111.928 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.5 tp -111.17 75.44 0.92 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.735 0.814 . . . . 64.43 109.232 -166.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.52 -49.88 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.746 2.818 . . . . 74.45 111.878 -162.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 61.2 t60 57.85 -79.66 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.767 2.427 . . . . 73.23 113.542 -173.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -154.44 170.43 21.39 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 119.598 1.09 . . . . 72.03 109.291 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -87.27 87.3 7.39 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.186 -1.042 . . . . 74.53 108.186 173.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -76.57 168.79 19.45 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.989 -1.115 . . . . 72.24 107.989 151.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 C--O 1.25 1.083 0 C-N-CA 126.96 2.104 . . . . 62.32 107.622 -168.751 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mtt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 107.395 -1.335 . . . . 70.45 107.395 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.1 m120 58.24 168.51 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.996 1.271 . . . . 63.31 110.563 -167.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.5 t -69.34 -43.0 74.54 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.131 -0.981 . . . . 71.32 110.362 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.78 92.38 2.24 Favored Glycine 0 C--N 1.337 0.597 0 N-CA-C 107.284 -2.326 . . . . 71.21 107.284 -164.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -86.58 -73.33 0.47 Allowed 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.229 -1.397 . . . . 72.22 107.229 169.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.13 157.07 16.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 107.846 -1.168 . . . . 63.14 107.846 159.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 121.57 101.73 1.73 Allowed Glycine 0 CA--C 1.521 0.408 0 N-CA-C 106.331 -2.708 . . . . 70.21 106.331 -156.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -162.59 157.34 21.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.305 1.442 . . . . 62.13 108.102 166.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.41 158.26 17.17 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.4 1.48 . . . . 62.54 110.508 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.05 152.97 43.78 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.763 -0.653 . . . . 70.53 109.804 171.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.489 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 2.6 t80 -53.81 -31.12 47.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.449 1.5 . . . . 75.02 112.326 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -103.93 14.67 30.28 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.753 1.221 . . . . 71.22 113.459 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -78.34 119.96 79.28 Favored Pre-proline 0 C--O 1.233 0.23 0 N-CA-C 106.013 -1.847 . . . . 75.33 106.013 173.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.0 139.79 75.43 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 CA-C-N 120.427 1.188 . . . . 53.11 112.437 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.0 pt -90.21 140.3 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.022 -1.103 . . . . 72.31 108.022 161.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -102.43 83.26 2.28 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.409 -1.7 . . . . 73.3 106.409 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.2 mt -67.3 164.59 18.08 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.308 0.575 . . . . 74.33 109.987 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 27.5 t -56.02 -39.34 71.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.095 0.958 . . . . 73.31 110.216 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.81 -33.37 34.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.265 0.939 . . . . 55.53 111.089 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.68 46.07 2.37 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.865 0.745 . . . . 62.41 112.271 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.86 -35.9 69.43 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.68 1.24 . . . . 70.45 111.72 173.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.4 mm 45.87 86.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 128.283 2.633 . . . . 74.15 107.325 -163.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.72 152.0 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.63 -1.618 . . . . 73.52 106.63 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -57.29 135.24 56.46 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.283 1.833 . . . . 65.13 109.351 176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.558 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.1 OUTLIER -50.9 -54.81 8.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 107.825 -1.176 . . . . 70.44 107.825 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.489 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -55.49 -45.19 84.89 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.944 -1.263 . . . . 74.35 109.944 -171.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -71.83 -42.96 66.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.077 1.351 . . . . 73.03 112.599 -173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -52.4 -49.26 64.82 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 122.038 0.923 . . . . 64.12 109.552 177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.696 HG21 ' CE2' ' A' ' 153' ' ' TYR . 92.7 t -72.79 -42.1 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 114.836 -1.075 . . . . 74.13 109.886 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.24 -38.36 73.67 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.332 0.515 . . . . 72.1 111.289 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 tttt -55.8 -43.14 76.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.276 1.03 . . . . 74.41 109.347 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.39 -47.09 62.46 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-O 117.491 -1.242 . . . . 74.03 108.767 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -54.6 -38.2 66.49 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.447 1.476 . . . . 74.01 110.994 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -78.05 -30.82 50.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 117.837 -1.078 . . . . 74.41 111.781 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.5 ttmm -78.97 -63.12 1.49 Allowed 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 106.742 -1.577 . . . . 72.0 106.742 173.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.33 39.77 0.53 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 128.266 2.627 . . . . 72.45 109.732 -172.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 pttt -54.81 -38.29 67.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 120.533 -1.354 . . . . 61.03 110.784 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -74.47 -12.85 60.6 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 113.198 0.814 . . . . 73.05 113.198 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.9 m -93.95 0.01 55.84 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.842 1.257 . . . . 74.52 112.32 174.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 80.3 mt -64.59 95.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 119.638 1.108 . . . . 72.44 108.099 175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -78.94 147.75 32.89 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.152 -1.425 . . . . 54.24 107.152 173.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 130.75 48.45 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.043 -2.577 . . . . 62.11 104.043 170.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.4 144.66 35.71 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.094 -1.817 . . . . 73.43 106.094 171.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -59.5 -40.26 86.46 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.124 1.769 . . . . 75.41 112.196 -176.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -69.98 -5.8 28.83 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.214 1.006 . . . . 73.23 112.27 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.77 56.41 1.16 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 126.731 2.11 . . . . 50.02 110.24 160.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -120.33 -97.51 0.46 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.338 1.055 . . . . 41.14 109.048 -172.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 147.11 137.71 3.02 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 125.986 1.755 . . . . 62.42 109.855 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -150.01 170.55 18.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.185 0.992 . . . . 72.31 111.448 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.6 mt -149.26 144.18 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.085 2.154 . . . . 71.52 106.608 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 122.53 31.06 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 126.248 1.819 . . . . 60.4 108.889 168.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' C ' ' H ' ' A' ' 54' ' ' ASN . 2.2 pp -135.19 14.02 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.766 1.227 . . . . 61.24 111.876 -174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.07 17.72 0.14 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 126.082 1.801 . . . . 73.44 114.69 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -119.75 -13.1 9.14 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 129.873 3.269 . . . . 71.13 111.022 -177.005 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -63.29 -20.92 65.91 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 119.361 0.982 . . . . 73.4 110.903 170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.1 19.19 2.68 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.571 1.948 . . . . 74.24 113.068 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.33 148.36 12.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.32 1.448 . . . . 61.45 107.52 174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -115.67 140.85 48.81 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.682 -0.858 . . . . 72.51 108.682 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.9 tt -117.49 158.65 18.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.555 1.542 . . . . 75.23 107.71 175.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -66.01 145.21 56.14 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.968 -1.123 . . . . 71.12 107.968 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.72 -179.29 5.96 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.735 1.614 . . . . 54.5 107.795 -176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.449 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -151.98 121.85 7.04 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 120.842 -1.161 . . . . 72.54 109.417 173.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -70.84 114.63 9.1 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.507 1.123 . . . . 63.32 108.93 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HE2' ' CG2' ' A' ' 162' ' ' THR . 18.0 mttt -62.35 -21.25 65.16 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 113.236 0.828 . . . . 74.12 113.236 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -37.8 -47.16 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.12 2.168 . . . . 64.02 109.807 176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.4 17.71 2.05 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.53 1.132 . . . . 74.43 110.575 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 48.93 49.33 19.46 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.027 1.285 . . . . 62.41 112.222 -173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.6 pt -106.74 149.43 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 125.544 1.538 . . . . 75.44 107.934 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.77 144.49 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 107.595 -1.261 . . . . 74.52 107.595 -177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -148.96 -177.58 5.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.194 2.197 . . . . 64.04 111.881 -174.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -97.01 162.22 13.48 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.904 2.082 . . . . 73.31 109.991 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.57 149.95 22.69 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 120.909 -1.119 . . . . 74.14 111.572 156.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.1 ttp180 -78.9 162.54 25.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.974 -0.751 . . . . 75.13 108.974 159.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 48.9 mt -94.09 168.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 126.208 1.803 . . . . 72.13 106.756 167.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.8 mm? -117.19 -58.31 2.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.265 1.826 . . . . 74.03 108.94 168.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.4 ttm180 -128.76 155.98 44.26 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 121.757 -0.59 . . . . 62.15 110.873 -170.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -123.39 163.4 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 126.179 1.791 . . . . 55.21 108.331 173.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.35 176.72 8.35 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.84 1.656 . . . . 65.11 109.631 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -169.08 148.14 3.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.972 1.709 . . . . 75.44 109.168 163.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.691 ' HE3' HD11 ' A' ' 152' ' ' ILE . 35.2 pttt -142.43 169.99 16.55 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.605 1.562 . . . . 72.33 107.538 156.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 151' ' ' HIS . 80.5 tttt -91.41 152.31 20.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.711 -0.618 . . . . 72.33 109.408 177.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' CD2' HD13 ' A' ' 152' ' ' ILE . 31.5 t80 -146.93 147.89 31.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.439 0.696 . . . . 74.22 110.103 -170.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -157.7 126.84 5.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.444 -1.317 . . . . 73.22 107.444 155.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.52 -177.78 42.34 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 119.052 0.842 . . . . 65.31 112.56 -170.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.89 127.47 32.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.03 -0.688 . . . . 74.11 110.86 171.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -106.96 157.98 17.37 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.848 -1.168 . . . . 74.13 107.848 170.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' HIS . 2.8 mm -78.57 133.68 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 107.217 -1.401 . . . . 74.33 107.217 176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.476 ' HE3' HG23 ' A' ' 98' ' ' THR . 12.7 ttmt -119.74 84.52 2.22 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 123.005 1.383 . . . . 55.01 107.645 164.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.2 mt -69.67 130.39 34.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.143 -2.169 . . . . 73.21 105.143 154.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.9 m -100.15 -175.71 3.02 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 105.979 -1.86 . . . . 63.12 105.979 161.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.0 p -146.95 170.29 17.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.654 1.982 . . . . 74.2 108.716 165.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -56.92 -28.1 61.68 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 120.169 1.349 . . . . 73.54 112.433 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -72.3 3.4 4.72 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 113.623 0.971 . . . . 54.54 113.623 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 57.05 18.8 4.23 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.68 1.592 . . . . 72.32 111.591 -164.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 160.72 32.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.447 -1.686 . . . . 74.31 106.447 161.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -172.83 164.19 5.11 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 127.47 2.308 . . . . 62.12 106.857 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.502 HG23 ' CE1' ' A' ' 171' ' ' PHE . 4.5 pt -146.77 170.15 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 C-N-CA 125.512 1.525 . . . . 74.33 108.521 -175.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.476 HG23 ' HE3' ' A' ' 88' ' ' LYS 0.358 0.0 OUTLIER -151.63 96.49 2.26 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 126.624 1.97 . . . . 54.05 113.3 -175.47 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.532 HD22 ' CG ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER -161.79 179.4 8.13 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.153 1.781 . . . . 74.21 110.291 -166.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 p -66.72 166.92 12.14 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.959 0.885 . . . . 74.43 110.837 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.408 ' HA ' HG13 ' A' ' 87' ' ' ILE . 1.5 p-80 -70.39 -14.13 62.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 121.533 -0.729 . . . . 73.15 112.239 175.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.8 p-10 -125.15 37.88 4.3 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.741 1.616 . . . . 44.12 111.566 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.683 ' ND1' ' HB2' ' A' ' 118' ' ' ALA . 1.1 p-80 -76.77 141.74 68.94 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.076 -0.964 . . . . 64.24 108.487 164.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -70.92 127.24 13.41 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.308 3.339 . . . . 65.03 113.525 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 121' ' ' VAL . 30.0 m -115.39 -177.49 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 126.279 1.831 . . . . 65.04 110.685 172.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -131.45 126.87 36.17 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.986 2.114 . . . . 70.05 108.502 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -136.51 163.02 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 119.244 0.929 . . . . 72.45 109.967 -176.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.56 104.79 10.4 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.019 0.914 . . . . 62.14 110.612 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.2 tptp -86.01 79.85 9.04 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 104.248 -2.501 . . . . 74.41 104.248 161.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 55.45 19.65 3.26 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.428 1.269 . . . . 73.11 114.428 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 104.79 -0.89 41.88 Favored Glycine 0 CA--C 1.527 0.827 0 O-C-N 121.168 -0.958 . . . . 74.55 113.642 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -91.66 129.11 37.69 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.075 -2.194 . . . . 75.33 105.075 156.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 p -74.24 130.37 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 108.885 -0.783 . . . . 60.43 108.885 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.42 148.44 42.79 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.892 0.877 . . . . 75.21 110.476 -173.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -103.72 123.83 47.76 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.352 1.461 . . . . 71.51 111.289 -167.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.4 pt -142.51 -178.34 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.318 1.447 . . . . 74.54 111.325 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -86.27 145.38 26.97 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.634 1.974 . . . . 65.13 109.336 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.683 ' HB2' ' ND1' ' A' ' 103' ' ' HIS . . . -39.6 -51.75 2.23 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.228 2.211 . . . . 73.41 112.245 170.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -56.12 -21.43 22.34 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.521 1.528 . . . . 62.12 114.604 -174.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.3 mtt -93.48 -19.21 21.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.279 1.032 . . . . 71.54 111.387 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.802 HG21 HG21 ' A' ' 105' ' ' VAL . 11.3 t -78.88 62.0 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 127.677 2.391 . . . . 74.32 109.277 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.76 -176.95 5.66 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 121.324 -0.86 . . . . 74.21 109.987 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.52 -11.47 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 126.413 1.885 . . . . 71.55 113.701 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.69 -3.11 71.59 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 118.536 -1.147 . . . . 62.5 112.965 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -123.98 145.7 49.01 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.956 1.878 . . . . 73.34 108.798 -174.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -112.95 114.52 27.04 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.907 1.283 . . . . 72.14 107.682 -175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.5 tt -89.46 134.5 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.8 1.24 . . . . 63.3 108.944 -173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -69.72 107.26 3.4 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.837 -0.801 . . . . 64.42 108.837 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.46 157.81 39.1 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 124.909 1.284 . . . . 73.25 110.281 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -70.35 152.28 66.16 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.818 1.012 . . . . 65.3 110.13 175.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 15.1 tttt -119.82 178.82 4.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.911 -1.885 . . . . 74.25 105.911 156.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -23.81 -67.31 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.273 3.029 . . . . 75.25 114.888 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -120.88 -13.4 8.64 Favored 'General case' 0 C--N 1.346 0.436 0 CA-C-N 119.166 0.894 . . . . 63.13 113.389 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 23.6 p -139.07 168.66 19.34 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.253 -0.905 . . . . 52.21 110.834 -173.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -78.33 156.89 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.778 -0.823 . . . . 65.33 108.778 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.26 -176.14 4.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 129.118 2.967 . . . . 71.11 105.441 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 mp -113.61 167.58 10.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 126.572 1.949 . . . . 70.44 109.07 172.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -157.54 154.27 28.31 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.676 -1.602 . . . . 70.43 106.676 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.93 141.34 28.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.699 1.2 . . . . 61.21 108.58 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.594 HG21 HG12 ' A' ' 121' ' ' VAL . 11.5 t -67.6 -22.2 28.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 114.735 1.384 . . . . 72.31 114.735 -177.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.2 pt 50.52 -49.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 130.115 3.366 . . . . 74.42 118.013 -177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -135.78 133.19 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 131.466 3.906 . . . . 73.24 107.773 -161.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.8 t -139.64 109.31 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.379 -0.6 . . . . 75.23 109.379 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -151.11 -175.71 5.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.369 1.068 . . . . 61.11 108.969 177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -130.01 134.65 47.56 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.473 1.109 . . . . 55.21 108.102 -175.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.48 -176.14 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.811 -1.181 . . . . 65.21 107.811 167.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.71 155.93 30.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.419 -1.326 . . . . 74.54 107.419 152.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -147.6 162.0 40.0 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 124.065 0.946 . . . . 70.24 108.649 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.87 78.36 0.33 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.055 -1.461 . . . . 64.51 107.055 -176.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -163.85 25.59 0.2 Allowed Glycine 0 N--CA 1.474 1.227 0 N-CA-C 118.966 2.346 . . . . 73.31 118.966 -170.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 81' ' ' LYS . 71.8 m80 61.13 159.78 0.05 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.403 2.281 . . . . 64.2 111.813 -167.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.691 HD11 ' HE3' ' A' ' 80' ' ' LYS . 17.5 pt -145.7 155.26 13.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 125.638 1.575 . . . . 75.12 108.594 -174.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.696 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -156.42 168.68 26.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.881 0.472 . . . . 74.14 111.199 171.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -146.21 162.79 37.27 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 128.727 2.811 . . . . 65.43 106.726 -173.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.3 mt -119.15 153.96 34.04 Favored 'General case' 0 C--O 1.232 0.165 0 O-C-N 120.578 -1.326 . . . . 72.34 112.162 -163.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 4.2 m -96.15 -38.78 10.01 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.057 -0.974 . . . . 74.34 113.339 -162.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.257 2.1 t 22.89 64.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 129.567 3.147 . . . . 65.2 113.487 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.412 ' H ' HD23 ' A' ' 75' ' ' LEU . 4.9 pt-20 -78.15 1.63 20.67 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.241 -0.912 . . . . 72.51 112.453 -169.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -89.6 -48.27 7.41 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.638 2.775 . . . . 73.0 109.298 -173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -132.64 -3.61 3.31 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.103 0.779 . . . . 73.13 113.103 -173.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.8 m80 69.03 8.44 6.84 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.143 1.377 . . . . 74.44 113.982 161.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.459 ' CG2' ' HE2' ' A' ' 64' ' ' LYS . 39.1 p -140.77 158.06 44.52 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.389 2.276 . . . . 75.42 107.248 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.0 OUTLIER -144.86 -175.68 4.77 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.731 -1.23 . . . . 72.23 110.77 172.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 25.7 mm -119.96 111.95 34.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 124.853 1.261 . . . . 73.11 108.081 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -147.47 158.47 44.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.131 1.373 . . . . 71.34 108.496 169.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 139.15 -158.06 25.15 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 107.379 -2.288 . . . . 74.41 107.379 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -112.32 172.39 6.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.017 1.408 . . . . 72.14 111.212 173.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.58 -69.43 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 129.867 3.267 . . . . 72.41 114.164 -174.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -122.89 -11.0 8.19 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.783 2.033 . . . . 61.22 113.694 171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 70.88 159.54 3.17 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 122.533 1.074 . . . . 73.11 112.119 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 97' ' ' ILE . 26.5 m-85 -104.38 156.1 18.22 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.752 2.021 . . . . 72.45 109.26 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.449 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -89.27 79.89 6.98 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.194 1.798 . . . . 73.23 107.599 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.497 HG12 ' CE1' ' A' ' 163' ' ' TYR . 0.5 OUTLIER -104.97 176.8 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.58 -1.267 . . . . 74.11 107.58 -171.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.16 155.63 38.27 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 127.008 2.123 . . . . 73.21 111.049 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.567 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -145.56 39.78 1.17 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 128.05 2.54 . . . . 72.54 108.605 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.4 p -68.57 134.0 49.35 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.326 -0.99 . . . . 64.33 108.326 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.2 p -77.54 -4.5 46.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.297 1.591 . . . . 72.02 115.297 -170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.99 13.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 123.761 0.696 . . . . 44.24 113.536 -169.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.5 p -55.07 155.05 4.91 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.497 1.149 . . . . 45.52 111.596 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 36.2 tp -61.52 -36.59 80.97 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.343 0.868 . . . . 74.43 113.343 -172.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.5 -165.23 0.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.413 0.685 . . . . 70.32 110.996 -174.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -123.38 171.2 9.61 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 107.249 -1.389 . . . . 74.04 107.249 155.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -135.33 174.96 10.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.013 1.325 . . . . 63.14 108.1 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -144.24 159.54 42.49 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.322 . . . . 70.51 108.56 173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 48.2 56.09 7.86 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.812 1.645 . . . . 71.22 112.269 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.951 0 C-N-CA 127.997 2.519 . . . . 75.41 110.71 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 110.038 -0.356 . . . . 70.1 110.038 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 59.65 177.01 0.08 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.792 1.637 . . . . 63.41 111.159 -176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.78 -70.25 0.79 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 105.484 -2.043 . . . . 72.43 105.484 -175.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 153.13 -87.44 0.13 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.485 -1.046 . . . . 42.31 110.485 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -153.96 -52.16 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.891 0.876 . . . . 72.34 110.258 -173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.17 168.99 4.85 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.107 0.563 . . . . 75.01 111.735 -174.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.2 87.68 1.11 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.21 1.386 . . . . 65.44 110.865 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -142.69 147.21 35.3 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.25 1.02 . . . . 75.14 108.503 166.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -75.77 160.2 30.25 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.072 1.749 . . . . 75.32 109.802 -178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.24 149.7 44.32 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.802 -0.444 . . . . 71.2 109.802 173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -44.45 -39.51 4.81 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.903 1.681 . . . . 74.44 113.549 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -97.22 7.8 45.85 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.388 1.075 . . . . 74.01 113.088 -166.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -78.25 121.73 84.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.517 -1.29 . . . . 71.33 107.517 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -61.11 141.92 95.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.569 1.239 . . . . 61.44 112.336 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.4 pt -96.38 -8.73 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 113.369 0.877 . . . . 71.54 113.369 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 54.63 69.33 0.74 Allowed 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.479 1.133 . . . . 75.35 110.075 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.3 mt -55.1 160.58 2.03 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.7 -0.682 . . . . 74.55 109.595 169.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -53.35 -40.54 64.99 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.736 0.814 . . . . 63.41 109.755 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -62.01 -37.38 84.67 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.265 1.026 . . . . 75.11 112.786 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.68 41.15 7.38 Favored Glycine 0 CA--C 1.524 0.644 0 O-C-N 121.065 -1.022 . . . . 55.11 110.548 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -70.77 -11.95 61.26 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.786 0.835 . . . . 74.35 113.192 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.9 mm 40.57 70.81 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.97 2.908 . . . . 61.54 109.112 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.83 149.83 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 112.82 -1.991 . . . . 74.14 107.928 -169.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -71.26 135.37 47.42 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.791 1.236 . . . . 73.24 109.52 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.1 tt -68.69 -4.24 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.221 1.809 . . . . 61.4 114.556 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.62 -9.86 12.15 Favored Glycine 0 C--O 1.226 -0.37 0 CA-C-O 116.769 -2.129 . . . . 72.02 113.488 165.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -78.33 -49.71 13.13 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.278 2.039 . . . . 75.44 109.799 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -39.6 -54.88 1.95 Allowed 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 126.202 1.801 . . . . 75.43 109.797 165.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.495 ' CG1' HG21 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -73.16 -30.8 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.976 -1.465 . . . . 73.41 110.379 -174.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.12 -31.83 73.22 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 120.512 -1.368 . . . . 72.21 111.125 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.82 -52.2 61.09 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.361 0.664 . . . . 74.4 109.478 168.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -66.13 -44.18 84.96 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 117.57 -1.205 . . . . 62.33 109.24 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -54.41 -39.56 67.42 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 121.876 2.126 . . . . 75.42 112.786 174.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -27.33 56.33 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 117.74 -1.124 . . . . 73.12 111.509 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 3.8 mtpt -86.39 -59.93 2.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.456 -1.683 . . . . 62.44 106.456 177.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 3.8 m-30 -88.98 39.93 0.95 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 128.762 2.825 . . . . 73.25 108.769 -168.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.59 -35.09 71.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 120.598 -1.314 . . . . 73.4 112.089 177.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.98 -31.11 72.18 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.816 0.673 . . . . 52.41 112.816 172.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.9 m -79.56 -9.44 59.62 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.15 1.78 . . . . 53.32 111.246 -175.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 73.2 mt -63.05 102.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.373 0 N-CA-C 106.554 -1.647 . . . . 73.25 106.554 168.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -89.81 167.27 12.99 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 107.389 -1.337 . . . . 74.24 107.389 158.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.11 145.64 45.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.212 -2.144 . . . . 55.12 105.212 167.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -78.3 168.83 19.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 106.29 -1.744 . . . . 75.13 106.29 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -33.09 74.85 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.496 0.718 . . . . 61.41 110.51 176.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-20 -75.14 -0.35 18.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.426 0.899 . . . . 74.32 113.426 170.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.29 17.87 51.51 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 126.023 1.773 . . . . 44.11 113.259 161.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -72.96 -95.35 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.461 1.905 . . . . 74.43 109.974 -171.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 152.51 129.07 1.41 Allowed Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 108.783 -1.727 . . . . 63.13 108.783 -167.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 48.2 p-90 -137.75 157.99 45.3 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 124.402 0.707 . . . . 71.33 109.487 162.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mt -139.36 141.83 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 104.97 -2.234 . . . . 74.35 104.97 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.38 137.28 32.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.678 0.791 . . . . 64.42 109.697 167.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.56 17.13 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.402 1.481 . . . . 65.24 112.748 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -46.97 -38.01 10.04 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.259 -0.745 . . . . 73.54 113.517 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -78.17 -6.23 54.15 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.202 1.501 . . . . 73.33 113.763 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 57' ' ' ILE . 56.6 mm-40 -64.35 -26.96 68.7 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 120.361 1.437 . . . . 74.23 110.323 168.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 m120 58.76 -4.9 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.971 2.108 . . . . 73.32 114.318 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.407 ' H ' ' C ' ' A' ' 55' ' ' GLU . 93.5 mt -47.8 132.84 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 128.234 2.614 . . . . 55.05 108.058 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -99.75 150.57 22.18 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.255 1.026 . . . . 73.22 110.192 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -135.8 150.96 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 126.91 2.084 . . . . 51.34 107.014 177.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' O ' HD13 ' A' ' 59' ' ' ILE . 1.1 mtpt -61.77 120.7 11.18 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.844 -0.799 . . . . 74.22 108.844 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.6 p -114.18 -179.49 3.65 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.77 1.228 . . . . 73.44 108.505 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' CD1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -143.4 146.82 33.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.291 -1.374 . . . . 62.11 107.291 159.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.4 112.83 24.44 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.368 0.531 . . . . 71.21 109.952 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -63.38 -24.1 67.69 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.184 0.994 . . . . 73.42 112.384 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.7 -43.37 5.88 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 127.725 2.41 . . . . 61.12 111.733 175.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.96 18.88 1.79 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.247 1.019 . . . . 70.33 111.521 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp 39.72 66.12 0.62 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 127.312 2.245 . . . . 62.4 112.056 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 pt -121.02 156.27 24.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.958 1.703 . . . . 74.12 109.752 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 20.2 mm -86.57 126.18 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 126.989 2.116 . . . . 63.41 106.631 173.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -140.46 171.18 14.5 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 126.084 1.753 . . . . 71.23 107.842 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -112.76 141.1 46.95 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 125.975 1.71 . . . . 72.33 107.43 174.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.91 151.6 38.11 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.323 -0.861 . . . . 61.34 109.385 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -79.2 173.73 12.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.625 -0.88 . . . . 75.02 108.625 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.8 151.74 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.058 -1.46 . . . . 54.41 107.058 171.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 158' ' ' GLU . 2.1 mm? -106.29 -41.93 5.19 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-O 117.645 -1.169 . . . . 75.12 110.385 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mtm-85 -140.08 149.69 43.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 120.433 1.469 . . . . 70.15 111.427 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.495 HG21 ' CG1' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -106.97 155.9 7.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.451 1.501 . . . . 70.04 108.54 170.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -130.74 150.26 52.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.0 1.32 . . . . 74.33 109.045 174.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -151.84 140.64 20.94 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.973 0.909 . . . . 71.04 110.208 178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -153.92 163.75 39.54 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.608 1.163 . . . . 73.31 108.81 163.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -92.37 139.68 30.35 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 120.808 -1.182 . . . . 73.31 110.148 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -134.46 168.36 19.08 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.327 1.451 . . . . 70.13 109.901 -165.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.75 109.09 1.6 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.195 -0.907 . . . . 72.21 111.338 174.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.82 -173.53 36.53 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 120.256 1.389 . . . . 74.34 112.49 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -86.64 109.33 19.09 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 122.314 -0.521 . . . . 70.04 111.336 -171.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -79.75 168.65 19.03 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.77 -0.826 . . . . 61.32 108.77 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.12 130.35 35.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.06 2.144 . . . . 60.13 108.185 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -115.8 85.57 2.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.09 -1.448 . . . . 71.43 107.09 161.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 mt -66.26 120.54 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 104.008 -2.59 . . . . 64.13 104.008 153.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 87.5 m -104.5 164.58 11.65 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 106.469 -1.678 . . . . 74.53 106.469 161.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 42.5 p -134.03 170.24 15.94 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.05 -1.031 . . . . 65.24 109.758 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -65.06 -27.72 68.98 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.109 1.764 . . . . 74.23 110.46 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -68.25 1.04 3.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.927 1.691 . . . . 75.12 111.536 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 55.82 29.67 14.42 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 127.085 2.154 . . . . 74.54 111.785 -172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 95' ' ' ARG . 1.7 mtt-85 -75.84 168.49 19.93 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 118.224 -1.39 . . . . 73.15 109.085 162.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.6 169.26 18.88 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.916 1.385 . . . . 75.52 108.573 171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.567 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.2 pt -146.16 169.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 126.959 2.104 . . . . 64.15 110.804 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.2 m -146.86 98.16 3.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.082 1.353 . . . . 64.05 110.454 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.71 174.93 13.86 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.065 1.746 . . . . 70.14 111.098 -176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 167.58 10.38 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.229 1.012 . . . . 74.4 110.935 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -70.14 -31.86 69.57 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 109.03 -0.73 . . . . 62.01 109.03 172.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.412 ' HA ' HD22 ' A' ' 117' ' ' ASN . 3.0 t70 -101.44 38.87 1.51 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.59 0.756 . . . . 65.34 112.493 -168.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -107.91 143.52 27.5 Favored Pre-proline 0 N--CA 1.474 0.737 0 O-C-N 120.801 -1.187 . . . . 74.43 110.882 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.46 125.65 12.01 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.986 3.124 . . . . 70.02 112.368 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.6 m -132.64 168.83 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 123.743 0.817 . . . . 74.51 108.866 168.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -104.32 140.68 37.54 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.351 0.66 . . . . 74.42 110.554 -173.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.55 158.45 37.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.332 1.453 . . . . 72.32 108.275 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 86.6 p -88.78 134.74 33.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.122 0.963 . . . . 52.51 108.962 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.93 77.33 1.03 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.368 -1.716 . . . . 64.1 106.368 161.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 59.32 21.17 9.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.934 0.894 . . . . 70.45 113.069 167.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 127.34 -19.84 5.94 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 119.211 -0.772 . . . . 65.02 111.693 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -87.15 141.11 28.89 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 104.4 -2.444 . . . . 73.54 104.4 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -86.72 139.6 17.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 O-C-N 120.677 -1.264 . . . . 71.34 108.051 163.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.92 159.95 37.18 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.953 -1.499 . . . . 54.11 106.953 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -126.18 112.2 15.51 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.333 1.053 . . . . 55.3 109.573 -170.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.65 174.83 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.511 1.124 . . . . 70.12 111.111 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' A' ' 102' ' ' ASP . 22.3 m120 -76.84 136.31 38.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 117.862 -1.066 . . . . 72.22 109.489 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -50.03 -32.73 16.09 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 55.53 113.304 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -69.3 -16.29 63.53 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.192 1.553 . . . . 55.25 115.192 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 2.8 mtt -84.0 -28.09 27.97 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.446 0.566 . . . . 61.4 110.707 169.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.5 t -76.14 61.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 127.496 2.318 . . . . 54.05 109.786 -173.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.422 ' HA ' HG11 ' A' ' 143' ' ' VAL . 1.7 mmmm -91.63 -171.8 3.02 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 124.537 1.135 . . . . 74.43 108.079 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.61 -9.02 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.34 1.456 . . . . 51.15 114.236 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.89 2.36 69.32 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 116.793 -2.115 . . . . 73.41 113.495 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -133.78 135.56 43.96 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 121.12 2.46 . . . . 54.44 108.999 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 139' ' ' GLU . 18.0 m-85 -79.59 118.91 21.87 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.518 -0.919 . . . . 63.35 108.518 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 tt -90.08 126.06 42.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.574 -1.269 . . . . 74.52 107.574 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.96 141.1 56.18 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.838 -0.801 . . . . 71.4 108.838 171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.52 158.8 72.62 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.402 1.081 . . . . 74.24 112.013 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -76.56 150.7 31.96 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.621 2.214 . . . . 72.23 108.365 171.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.32 -174.77 3.14 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 105.869 -1.9 . . . . 71.52 105.869 162.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -28.33 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.267 2.227 . . . . 74.5 112.195 -169.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -121.12 -3.47 9.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.227 1.811 . . . . 75.4 111.414 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 46.6 p -133.71 158.79 42.38 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 118.649 0.659 . . . . 61.42 111.581 -170.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.3 tp -80.91 152.88 4.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.937 -1.135 . . . . 73.43 107.937 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.37 179.86 6.69 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.575 1.95 . . . . 73.23 107.367 176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.11 162.42 19.33 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.869 1.267 . . . . 74.13 107.914 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -150.52 160.19 43.96 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.258 -1.386 . . . . 74.05 107.258 158.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 126' ' ' TYR . 5.6 mt-10 -63.09 -179.75 0.32 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.026 1.731 . . . . 73.53 109.699 170.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.5 t -115.47 1.66 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.165 1.786 . . . . 73.04 112.08 176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.9 pt 26.51 -80.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 128.235 2.614 . . . . 65.4 116.684 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -109.84 119.28 38.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.895 1.278 . . . . 73.33 108.157 173.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.422 HG11 ' HA ' ' A' ' 122' ' ' LYS . 2.9 p -114.65 115.71 50.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.659 1.219 . . . . 72.53 109.005 164.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -122.62 -172.29 2.45 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.203 2.601 . . . . 63.5 106.971 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.9 p -128.86 166.82 18.34 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.059 1.344 . . . . 75.1 110.893 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 15.8 m -135.77 124.82 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.024 0.93 . . . . 73.23 109.721 175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -83.92 101.72 11.89 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.561 -0.903 . . . . 63.41 108.561 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.468 ' C ' HD22 ' A' ' 149' ' ' ASN . 9.3 t80 -107.38 133.62 51.64 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.056 0.942 . . . . 70.5 109.196 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.468 HD22 ' C ' ' A' ' 148' ' ' TYR . 1.3 m-80 -124.55 59.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.794 -1.188 . . . . 73.12 107.794 178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -124.64 -166.68 12.48 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 126.683 2.087 . . . . 21.33 110.681 -173.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -89.34 156.27 18.82 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.799 -0.815 . . . . 60.3 108.799 166.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 49.8 pt -136.02 152.79 30.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 125.177 1.391 . . . . 74.21 108.06 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -144.31 153.27 41.83 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 124.715 1.206 . . . . 75.42 109.201 -163.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -141.56 174.59 10.42 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 121.861 -0.525 . . . . 73.33 109.684 170.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.18 109.82 10.21 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.028 1.731 . . . . 73.05 109.261 -157.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -76.71 121.0 22.66 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 106.169 -1.789 . . . . 71.31 106.169 169.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.4 t -130.24 87.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.635 -1.617 . . . . 74.31 106.635 172.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.516 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -61.11 -21.49 63.76 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.903 1.681 . . . . 71.51 113.031 177.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -95.72 -51.17 4.62 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.217 1.407 . . . . 64.42 110.045 -159.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -124.23 103.58 8.33 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 101.715 -3.439 . . . . 74.21 101.715 168.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -66.94 28.55 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.794 0.838 . . . . 73.34 113.018 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.407 ' HB ' ' CE1' ' A' ' 62' ' ' PHE . 1.4 p -153.95 124.93 7.28 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.066 2.147 . . . . 54.43 107.727 -174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.613 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 6.8 p90 -129.92 166.02 20.88 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.299 1.44 . . . . 71.01 110.912 -169.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 21.4 mm -96.17 135.05 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.214 -1.032 . . . . 73.21 108.214 173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.77 29.33 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.509 1.124 . . . . 73.22 110.066 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 133.01 -156.61 22.25 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 118.565 0.621 . . . . 73.43 111.893 170.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -110.09 167.39 10.21 Favored 'General case' 0 C--O 1.239 0.5 0 O-C-N 120.998 -1.295 . . . . 72.23 111.54 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 55.89 -76.16 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.718 2.807 . . . . 73.53 112.699 -165.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.31 -13.32 8.1 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.97 1.708 . . . . 74.3 113.641 174.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.36 176.53 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 123.294 1.496 . . . . 74.44 112.686 -173.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.567 ' CE1' HG23 ' A' ' 97' ' ' ILE . 8.7 m-85 -124.11 149.47 46.17 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.408 3.083 . . . . 70.41 104.874 -177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -94.37 81.04 3.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.802 -1.184 . . . . 32.14 107.802 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 25.0 m -88.49 179.87 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.615 0 O-C-N 121.78 -0.575 . . . . 73.44 110.58 -171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.59 158.45 23.06 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.794 -0.566 . . . . 74.23 110.443 -175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.613 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -144.28 175.13 10.31 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.992 2.117 . . . . 72.3 109.288 173.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 81.4 p -158.06 -128.09 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.327 -0.99 . . . . 63.05 108.327 157.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 t -143.33 86.19 1.89 Allowed 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.724 1.609 . . . . 73.02 107.188 174.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.86 -83.55 0.39 Allowed Glycine 0 CA--C 1.522 0.491 0 C-N-CA 126.924 2.202 . . . . 60.51 110.14 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 22.9 p -59.91 120.69 10.09 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.128 1.771 . . . . 71.45 109.844 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.43 -69.14 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 129.191 2.996 . . . . 73.14 112.123 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -132.36 154.66 49.54 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.48 -0.933 . . . . 74.32 108.48 164.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -119.5 -59.1 1.86 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.063 1.345 . . . . 60.11 109.475 171.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -57.46 -54.85 42.18 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.122 0.569 . . . . 73.44 111.721 -170.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -48.76 108.47 0.18 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.027 2.131 . . . . 75.24 109.95 178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -148.22 158.49 44.11 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.212 2.205 . . . . 73.31 105.91 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 C--O 1.248 0.998 0 C-N-CA 124.988 1.315 . . . . 74.54 110.823 -156.741 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 108.851 -0.796 . . . . 63.52 108.851 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -146.24 143.97 29.56 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.891 1.677 . . . . 73.5 108.376 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -71.74 -47.68 52.11 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.629 0.581 . . . . 55.12 110.706 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 180' ' ' LEU . . . 162.97 -82.45 0.12 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 123.621 0.629 . . . . 71.03 111.586 -177.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -81.52 111.18 17.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.801 -0.814 . . . . 70.44 108.801 -174.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -106.52 156.46 18.55 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.803 1.241 . . . . 62.24 107.851 167.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.46 -95.03 2.22 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-O 119.071 -0.849 . . . . 72.3 112.478 -162.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 154.9 157.77 0.01 OUTLIER 'General case' 0 C--O 1.237 0.405 0 C-N-CA 131.373 3.869 . . . . 62.51 107.767 -175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.47 -177.42 4.6 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.474 -0.565 . . . . 63.13 109.474 168.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.6 -166.49 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.219 1.408 . . . . 74.23 112.036 173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -94.78 -50.38 5.18 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.434 1.494 . . . . 61.2 110.316 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -93.94 50.16 1.4 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 127.414 2.285 . . . . 61.14 108.094 -167.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -136.02 131.84 19.03 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 106.936 -1.505 . . . . 72.25 106.936 -165.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -79.95 132.71 9.7 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.015 1.81 . . . . 72.25 112.305 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.4 pt -98.56 -6.16 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.904 0.882 . . . . 73.22 113.032 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 57.01 84.2 0.09 Allowed 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.982 1.713 . . . . 52.01 112.135 174.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HA ' HD12 ' A' ' 59' ' ' ILE . 15.4 mt -51.29 156.66 1.12 Allowed 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.387 -0.824 . . . . 73.34 109.833 164.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 29.9 t -55.54 -35.03 65.23 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 122.979 0.512 . . . . 72.55 109.855 177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -68.75 -29.96 68.47 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.647 0.779 . . . . 64.04 112.297 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.21 36.21 7.2 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.194 1.378 . . . . 51.31 111.605 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.95 -17.02 64.39 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 114.352 1.241 . . . . 65.44 114.352 -169.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.3 mm 43.32 93.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 128.523 2.729 . . . . 72.31 111.19 -166.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.87 145.54 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 113.63 -1.623 . . . . 62.04 107.792 174.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.26 131.49 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 128.069 2.548 . . . . 72.33 108.396 171.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -49.92 -48.68 22.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 123.495 0.718 . . . . 63.11 110.526 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.836 ' HA2' HG22 ' A' ' 29' ' ' VAL . . . -86.81 4.56 86.19 Favored Glycine 0 C--O 1.221 -0.656 0 CA-C-O 116.986 -2.008 . . . . 75.44 113.419 -173.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -86.68 -53.35 4.99 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 119.512 1.656 . . . . 62.35 108.582 162.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -52.78 -54.42 34.35 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 124.765 1.226 . . . . 73.51 109.302 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.836 HG22 ' HA2' ' A' ' 26' ' ' GLY . 21.7 m -65.89 -33.4 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.061 0 CA-C-O 117.753 -1.117 . . . . 70.11 110.174 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.66 -41.92 95.99 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 121.545 1.975 . . . . 70.3 111.569 -173.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.89 -40.23 60.32 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.462 0.705 . . . . 53.41 110.469 176.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -77.68 -46.49 21.79 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 117.353 -1.308 . . . . 54.04 109.873 177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -54.95 -36.07 64.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 122.517 2.417 . . . . 65.12 112.354 176.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -17.4 46.23 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.383 1.073 . . . . 72.14 113.204 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -88.54 -61.22 1.76 Allowed 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.195 -1.409 . . . . 64.22 107.195 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -84.13 40.78 0.78 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.912 2.085 . . . . 63.13 108.726 -172.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -50.95 -34.54 29.15 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 127.045 2.138 . . . . 75.03 110.706 172.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.95 -22.8 59.52 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.573 1.949 . . . . 61.21 113.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.5 m -94.07 0.8 56.13 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.222 1.809 . . . . 74.34 112.157 -175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 90.2 mt -65.16 101.02 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 123.595 0.758 . . . . 74.11 109.301 -178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.67 169.69 17.61 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.403 1.081 . . . . 70.35 110.244 172.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.65 132.3 27.22 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.996 1.319 . . . . 70.12 108.757 164.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -79.6 169.77 17.52 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 127.395 2.278 . . . . 72.32 110.017 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.01 -37.43 79.69 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.913 1.685 . . . . 74.24 109.867 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -71.72 -15.59 62.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.571 0.748 . . . . 74.4 111.827 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.35 3.18 57.66 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 126.313 1.911 . . . . 73.53 113.811 166.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -57.73 -87.22 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 129.172 2.989 . . . . 71.33 111.123 -168.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.72 125.89 2.99 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 125.107 1.336 . . . . 44.14 109.964 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -136.3 168.39 19.5 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.393 1.077 . . . . 74.42 109.861 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.8 mt -146.08 153.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 127.182 2.193 . . . . 73.14 106.202 173.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.73 143.27 27.12 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.672 1.589 . . . . 64.15 109.553 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.66 -24.91 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 CA-C-O 114.834 -2.508 . . . . 75.44 113.675 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 23.15 -72.67 0.0 OUTLIER Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.949 3.166 . . . . 33.21 115.927 159.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.12 -13.12 15.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 129.883 3.273 . . . . 75.52 115.288 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -66.66 -20.37 65.97 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.189 0.596 . . . . 62.3 110.519 167.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 55.37 31.6 17.1 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.302 1.841 . . . . 71.41 113.283 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 67.9 mt -82.96 123.06 38.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 124.513 1.125 . . . . 74.34 108.821 -175.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -86.39 143.46 27.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.382 1.473 . . . . 75.43 110.227 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 17' ' ' LEU . 3.6 tp -125.86 159.13 34.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 N-CA-C 106.259 -1.756 . . . . 75.44 106.259 175.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -63.78 140.38 58.86 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.405 -0.961 . . . . 55.23 108.405 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 p -139.61 175.68 9.36 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.962 0.505 . . . . 75.43 110.446 -177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.12 141.67 24.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 121.349 -0.845 . . . . 75.41 108.875 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -79.81 110.28 15.02 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.371 -1.344 . . . . 72.44 107.371 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -64.59 -16.98 63.55 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.638 0.775 . . . . 72.42 111.724 169.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -15.62 63.41 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.51 1.124 . . . . 74.01 113.941 171.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t -155.59 6.01 0.22 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.38 0.991 . . . . 64.44 113.519 -177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.94 51.54 15.9 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.073 2.149 . . . . 73.52 111.636 -176.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 13.7 pt -119.35 152.58 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 127.362 2.265 . . . . 42.15 108.76 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.6 mp -82.37 145.25 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.315 -0.995 . . . . 74.24 108.315 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -150.67 178.03 9.49 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.138 2.575 . . . . 62.14 109.284 -166.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.18 157.78 17.31 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.873 1.669 . . . . 64.12 108.638 163.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.58 160.77 41.68 Favored 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 121.116 -0.99 . . . . 55.44 110.139 154.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.543 HH11 ' CD2' ' A' ' 75' ' ' LEU . 7.0 tmm_? -98.95 131.31 45.11 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.212 1.005 . . . . 73.11 110.268 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.2 mt -72.64 156.53 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.943 1.297 . . . . 73.31 109.02 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.543 ' CD2' HH11 ' A' ' 73' ' ' ARG . 55.9 mt -123.75 -51.7 1.81 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.969 1.308 . . . . 70.01 110.889 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -135.43 163.81 29.2 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.079 1.352 . . . . 75.41 108.895 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.26 167.95 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.298 1.039 . . . . 73.54 108.974 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -137.71 151.24 48.01 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.712 1.205 . . . . 70.52 109.281 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 153' ' ' TYR . 6.4 tmm_? -142.04 144.5 33.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.926 1.29 . . . . 72.13 109.929 170.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 20.6 ttmt -144.83 158.98 43.6 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.751 -1.574 . . . . 64.03 106.751 165.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -89.96 151.26 21.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.955 -1.128 . . . . 64.1 107.955 167.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -146.8 154.79 41.78 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.468 1.507 . . . . 70.15 110.367 -167.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.93 111.87 3.05 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.461 -1.311 . . . . 73.01 107.461 167.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 169.63 -160.02 33.0 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.84 -0.695 . . . . 72.53 111.619 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' N ' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -113.89 117.23 30.8 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.481 1.112 . . . . 74.21 108.738 -173.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 148' ' ' TYR . 2.6 mm? -98.4 165.13 11.99 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.587 1.155 . . . . 50.1 107.987 173.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.7 mm -78.85 132.76 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.458 1.903 . . . . 75.3 107.377 -175.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -128.22 59.68 1.5 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.942 1.697 . . . . 74.21 107.357 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.53 HG23 HG13 ' A' ' 140' ' ' VAL . 37.8 mt -56.89 133.73 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.91 -2.256 . . . . 64.15 104.91 162.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -117.2 164.2 15.14 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 106.319 -1.734 . . . . 74.44 106.319 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.2 p -137.03 169.64 17.43 Favored 'General case' 0 C--O 1.241 0.608 0 O-C-N 121.73 -0.606 . . . . 22.32 110.492 -168.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -60.99 -28.93 69.38 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 118.468 -0.777 . . . . 73.23 110.727 176.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.92 3.43 10.18 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.365 1.466 . . . . 63.32 112.521 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.4 mmt85 59.28 13.13 2.92 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.473 1.909 . . . . 75.31 113.114 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.553 ' HG3' HH11 ' A' ' 95' ' ' ARG . 0.1 OUTLIER -71.41 162.56 29.24 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 118.318 -1.353 . . . . 63.5 107.487 166.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -156.69 176.64 12.46 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 128.274 2.63 . . . . 73.3 106.463 171.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.7 pt -141.75 -179.95 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.637 1.575 . . . . 71.24 109.996 -176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.5 m -150.56 97.35 2.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.58 1.152 . . . . 74.52 110.287 168.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -146.39 174.47 11.35 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.426 1.49 . . . . 74.32 111.035 -176.388 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.0 p -73.17 172.74 10.53 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 119.342 0.974 . . . . 53.32 108.65 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -77.36 7.53 5.21 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.06 -1.025 . . . . 72.55 112.001 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.42 39.24 2.46 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 119.245 0.929 . . . . 52.1 111.297 -167.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -99.13 137.58 20.45 Favored Pre-proline 0 N--CA 1.478 0.932 0 CA-C-O 117.059 -1.448 . . . . 72.13 112.368 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -67.23 94.93 0.36 Allowed 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 124.317 3.344 . . . . 65.41 113.666 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.4 m -101.18 178.82 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.138 0.975 . . . . 73.22 109.192 171.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -126.48 134.26 50.98 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.499 -0.751 . . . . 75.53 110.791 -174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.01 155.86 38.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 125.106 1.362 . . . . 72.02 109.398 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.4 t -86.32 125.7 33.81 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.261 0.553 . . . . 45.23 110.945 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -98.4 89.43 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.525 -2.028 . . . . 73.41 105.525 153.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.98 31.16 8.22 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.789 1.236 . . . . 50.54 113.603 176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 106.66 -8.32 39.96 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 118.432 -1.205 . . . . 72.35 113.951 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.05 159.83 27.39 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 104.651 -2.351 . . . . 65.42 104.651 160.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . 0.262 7.3 p -106.93 104.35 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.093 0.957 . . . . 62.3 109.953 170.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 13.5 tp -91.29 160.08 15.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.73 1.612 . . . . 75.34 107.823 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -124.62 115.2 20.43 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.336 1.854 . . . . 75.1 108.039 -174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 116' ' ' ILE . 1.5 pt -143.85 172.14 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.753 1.621 . . . . 74.13 109.468 -174.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -88.16 143.75 26.87 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.386 0.539 . . . . 63.11 111.565 178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.71 -27.65 65.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.587 -0.72 . . . . 74.43 112.815 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -29.22 68.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 119.636 1.107 . . . . 73.5 111.953 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 24.9 mmt -79.58 -32.54 41.98 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.095 1.358 . . . . 74.43 111.661 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.99 63.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 130.381 3.473 . . . . 64.15 110.906 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -95.93 -169.24 1.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.351 1.06 . . . . 73.42 108.991 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.0 -7.15 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 120.653 -1.279 . . . . 71.24 114.106 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -86.39 -12.81 69.32 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-O 117.799 -1.556 . . . . 55.32 111.687 172.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -118.06 119.63 35.36 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 121.132 2.466 . . . . 62.41 107.07 -164.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -82.37 115.52 21.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.407 -0.961 . . . . 73.44 108.407 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.58 HG23 ' OD1' ' A' ' 138' ' ' ASP . 6.8 tt -79.9 159.24 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.405 1.082 . . . . 72.44 109.96 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -91.03 129.95 36.98 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.592 1.557 . . . . 73.43 110.883 167.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.5 155.44 47.22 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 125.811 1.645 . . . . 43.24 110.195 168.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -68.51 156.36 65.84 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.5 2.134 . . . . 70.24 110.313 165.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -141.04 -176.96 4.88 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.828 1.651 . . . . 74.53 107.634 164.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -25.17 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.014 2.526 . . . . 71.34 112.506 -166.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -120.17 -4.95 9.98 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 118.325 -0.845 . . . . 72.21 113.091 170.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 21.6 p -132.67 170.06 15.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 120.24 1.382 . . . . 41.31 111.333 -172.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.06 157.2 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 O-C-N 121.531 -0.731 . . . . 73.22 109.161 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.03 -177.25 4.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 128.587 2.755 . . . . 74.33 106.558 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 88.4 mt -126.12 160.86 29.02 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.162 0.985 . . . . 72.43 110.666 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.58 ' OD1' HG23 ' A' ' 127' ' ' ILE . 11.5 p-10 -154.05 158.61 40.79 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.858 1.663 . . . . 65.12 111.858 -178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -106.04 150.65 25.54 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.226 1.411 . . . . 74.51 109.699 -172.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.53 HG13 HG23 ' A' ' 89' ' ' ILE . 41.9 t -95.6 1.28 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.907 1.283 . . . . 74.23 113.72 -166.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.4 pt 24.82 -86.8 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 127.459 2.304 . . . . 74.3 116.655 171.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.34 123.17 43.39 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 126.841 2.056 . . . . 51.33 107.811 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -123.47 119.97 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 107.388 -1.338 . . . . 74.32 107.388 170.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -145.25 -166.04 2.32 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.62 1.968 . . . . 75.21 108.196 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 p -133.18 165.22 25.29 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.047 1.739 . . . . 71.02 109.311 -176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.57 -175.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.182 1.393 . . . . 73.14 108.668 165.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -136.86 68.96 1.41 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 122.529 1.157 . . . . 72.01 109.394 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.43 ' HB2' HD23 ' A' ' 86' ' ' LEU . 1.8 t80 -80.21 133.56 36.03 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.019 -1.051 . . . . 55.12 111.029 -169.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -136.03 69.29 1.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.944 -1.132 . . . . 73.21 107.944 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.82 -120.56 0.73 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.115 -1.194 . . . . 51.3 110.115 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -121.73 163.28 19.34 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 122.002 -0.705 . . . . 73.13 110.041 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.2 pt -135.55 147.02 28.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 127.379 2.272 . . . . 75.15 106.563 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.589 ' CD2' HG21 ' A' ' 29' ' ' VAL . 69.0 m-85 -141.4 164.53 29.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.356 0.662 . . . . 72.44 109.296 -171.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -152.52 171.47 18.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 119.537 -0.268 . . . . 72.44 111.519 178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.2 mp -132.6 118.4 19.14 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.928 1.691 . . . . 74.53 109.413 -164.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 57.6 m -73.08 112.77 9.43 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 107.025 -1.472 . . . . 71.55 107.025 166.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.94 75.41 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 105.516 -2.031 . . . . 41.52 105.516 169.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -81.11 -0.15 38.82 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.71 2.404 . . . . 74.11 114.134 -162.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.93 -77.32 0.1 Allowed 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 128.283 2.633 . . . . 71.22 110.995 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -105.39 5.52 31.8 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.839 1.655 . . . . 74.0 111.694 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.6 m80 50.29 34.4 8.82 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.969 2.507 . . . . 64.41 112.035 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.5 p -148.51 155.33 41.01 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.425 1.89 . . . . 71.11 108.304 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.524 ' CD1' ' HB2' ' A' ' 175' ' ' ALA . 0.0 OUTLIER -159.25 -168.13 2.25 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.256 1.022 . . . . 73.42 109.772 178.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.48 141.38 14.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.107 0 N-CA-C 105.89 -1.893 . . . . 75.55 105.89 155.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -144.71 148.85 34.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.398 -0.593 . . . . 72.41 109.398 149.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 144.3 -165.92 27.32 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.109 -0.994 . . . . 61.33 112.119 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -111.26 166.82 10.77 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 119.708 -2.054 . . . . 70.11 111.232 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 60.24 -74.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 128.319 2.648 . . . . 74.12 112.667 -170.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 95' ' ' ARG . 44.8 mt-10 -121.84 -18.34 7.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.689 1.196 . . . . 70.34 112.75 176.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 81.29 158.66 21.24 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.829 1.204 . . . . 70.04 113.537 177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.454 ' CE1' HG23 ' A' ' 97' ' ' ILE . 78.7 m-85 -105.29 154.42 20.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 127.096 2.158 . . . . 73.02 109.686 -174.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -92.5 75.99 5.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.084 0.953 . . . . 62.44 108.448 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 173' ' ' VAL . 11.8 m -93.5 178.92 0.54 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 124.832 1.253 . . . . 74.43 110.315 -173.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 16.0 m -65.8 161.99 19.75 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.278 -0.889 . . . . 63.0 110.111 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.524 ' HB2' ' CD1' ' A' ' 163' ' ' TYR . . . -143.79 39.43 1.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.199 1.8 . . . . 75.15 108.295 170.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.2 m -62.63 104.78 0.56 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 107.825 -1.176 . . . . 74.34 107.825 175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.0 m -68.32 -47.59 67.15 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.245 1.018 . . . . 64.31 108.609 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.21 101.79 1.88 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 110.382 -1.087 . . . . 72.52 110.382 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.6 p -50.38 121.12 5.23 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.641 1.176 . . . . 64.35 110.01 169.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.4 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 15.3 tp 52.68 -71.88 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.596 2.758 . . . . 73.15 112.921 -165.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -79.63 114.12 18.31 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.507 1.123 . . . . 74.22 108.982 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.68 107.46 12.82 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.144 -1.058 . . . . 70.15 108.144 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.26 146.85 10.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.129 0.572 . . . . 72.1 112.423 -174.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -164.73 160.08 19.41 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.251 1.02 . . . . 73.31 109.956 155.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -68.13 122.19 17.75 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.452 -1.314 . . . . 74.02 107.452 155.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 7.6 m170 . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.461 1.905 . . . . 74.43 110.607 -173.646 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 119.658 -0.211 . . . . 73.01 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -74.99 -143.01 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.278 -1.378 . . . . 62.21 107.278 155.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.4 m 95.55 3.96 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 128.797 2.839 . . . . 72.41 110.686 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -25.32 -71.81 0.02 OUTLIER Glycine 0 C--N 1.34 0.785 0 C-N-CA 130.581 3.944 . . . . 74.3 114.344 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 45.77 72.09 0.24 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.469 1.907 . . . . 72.12 111.276 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -136.06 172.21 13.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.288 1.035 . . . . 62.31 108.726 161.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.91 176.7 25.7 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 125.316 1.436 . . . . 73.42 111.437 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -177.91 164.13 1.87 Allowed 'General case' 0 C--O 1.239 0.517 0 C-N-CA 129.226 3.01 . . . . 74.35 106.125 152.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 mt -74.07 167.2 22.0 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.584 1.154 . . . . 72.3 109.582 170.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 152' ' ' ILE . . . -71.71 -140.64 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.659 0.784 . . . . 61.43 111.84 172.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.444 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 5.5 t80 -120.73 -38.97 2.78 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.618 1.567 . . . . 74.33 112.012 -169.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.85 30.55 6.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.645 1.178 . . . . 73.3 111.496 -163.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 144.9 29.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 O-C-N 121.507 -0.746 . . . . 62.32 111.993 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.15 141.72 40.26 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.272 2.648 . . . . 74.12 113.786 178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.429 HG21 ' HA ' ' A' ' 25' ' ' ILE . 13.5 pt -114.66 16.84 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 113.981 1.104 . . . . 73.14 113.981 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 34.92 68.83 0.18 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 127.225 2.21 . . . . 73.01 113.964 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.0 mt -56.15 155.73 6.31 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.153 -0.684 . . . . 51.23 109.153 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 t -61.86 -27.2 68.62 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 122.186 -0.321 . . . . 72.41 111.166 -174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -66.38 -59.06 4.04 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.347 -0.612 . . . . 64.53 109.347 169.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 128.59 32.47 0.61 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.943 1.735 . . . . 71.14 111.219 -170.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -76.61 -11.27 59.83 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 120.299 -1.706 . . . . 70.53 114.933 -166.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 16.9 mm 44.58 74.59 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 127.205 2.202 . . . . 71.45 110.196 175.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.02 148.51 18.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 C-N-CA 125.279 1.432 . . . . 55.22 108.789 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.67 131.75 50.02 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 127.846 2.458 . . . . 74.32 109.591 174.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.515 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -51.04 -57.57 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 125.731 1.613 . . . . 75.22 109.035 175.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -58.95 -45.9 94.46 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-O 118.395 -1.225 . . . . 61.43 110.057 -172.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.4 -57.07 13.37 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.966 1.706 . . . . 65.24 111.636 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -47.74 -54.55 11.85 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.949 1.7 . . . . 75.35 110.334 -174.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.686 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 74.0 t -70.56 -43.45 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 115.055 -0.975 . . . . 61.14 110.552 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -64.93 -31.87 73.31 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 118.937 -1.105 . . . . 72.34 112.151 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -50.21 -46.91 54.93 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.449 1.5 . . . . 65.21 109.785 169.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -69.61 -44.54 70.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.907 -0.775 . . . . 75.13 108.907 178.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -58.26 -28.47 64.95 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 120.369 1.441 . . . . 74.2 112.301 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -85.0 -25.31 27.78 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 125.582 1.553 . . . . 64.44 112.58 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -93.97 -58.02 2.37 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.998 -1.853 . . . . 62.33 105.998 175.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.42 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -86.63 43.76 1.1 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.78 2.032 . . . . 71.12 108.943 -173.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -49.59 -38.04 30.01 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 127.324 2.249 . . . . 62.32 111.255 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -95.08 -2.75 49.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.433 0.901 . . . . 61.0 113.433 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.6 t -82.1 -6.98 59.58 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.009 0.822 . . . . 63.42 112.365 165.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.6 mt -63.07 99.72 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 119.579 1.081 . . . . 70.0 108.612 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -85.4 108.08 17.69 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 126.665 1.986 . . . . 72.11 107.741 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.53 124.72 29.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.412 -1.699 . . . . 72.1 106.412 172.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -78.94 137.82 37.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.92 -1.511 . . . . 74.02 106.92 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -65.73 -42.7 90.72 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.997 -0.281 . . . . 74.52 111.552 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -120.58 58.07 0.95 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.606 -1.627 . . . . 72.24 106.606 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.21 -133.83 1.55 Allowed Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.174 -0.77 . . . . 65.13 111.174 178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.45 -101.27 0.42 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 113.083 0.772 . . . . 64.31 113.083 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.98 104.11 0.18 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 108.51 -1.836 . . . . 34.52 108.51 -160.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -126.27 171.15 11.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.3 1.84 . . . . 74.21 111.249 -170.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mt -138.22 133.85 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.25 -2.129 . . . . 72.33 105.25 166.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.69 122.32 22.16 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 106.454 -1.684 . . . . 45.31 106.454 160.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.306 2.4 pp -126.84 23.92 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-O 123.091 1.424 . . . . 74.43 109.593 168.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.21 -26.63 69.51 Favored Glycine 0 CA--C 1.523 0.555 0 O-C-N 120.537 -1.352 . . . . 72.22 112.868 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.7 -12.41 61.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 126.186 1.794 . . . . 74.22 115.402 175.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.15 -14.75 63.22 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 120.011 1.278 . . . . 73.03 113.235 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.2 m120 60.77 11.26 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.266 2.626 . . . . 72.32 114.004 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.8 mt -73.49 130.26 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 O-C-N 120.953 -1.092 . . . . 72.51 108.832 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -103.92 154.1 20.03 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.562 1.145 . . . . 74.41 110.976 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -134.79 150.19 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 127.129 2.172 . . . . 71.34 108.005 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.424 ' HE2' ' C ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -72.86 109.81 6.71 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.272 -1.381 . . . . 72.24 107.272 169.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -99.01 -175.2 2.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.058 1.743 . . . . 65.44 107.274 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.435 ' CE1' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -135.09 128.56 32.43 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.801 -1.926 . . . . 72.1 105.801 164.01 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -80.47 97.13 6.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.971 -1.492 . . . . 72.51 106.971 174.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HB2' HG21 ' A' ' 162' ' ' THR . 50.6 tttt -50.88 -23.15 2.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 117.835 -1.079 . . . . 75.12 112.543 169.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.4 tp -43.05 -38.83 2.47 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 126.025 1.73 . . . . 72.23 113.483 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t -142.82 15.12 1.93 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.767 1.227 . . . . 74.23 110.54 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.9 mt 56.57 44.59 23.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.987 1.315 . . . . 62.24 111.423 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.5 pt -111.04 152.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.712 1.605 . . . . 74.33 108.521 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.14 118.33 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 106.477 -1.675 . . . . 70.24 106.477 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' C ' ' HE2' ' A' ' 60' ' ' LYS . 8.7 mm-40 -144.36 175.8 9.83 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.5 1.52 . . . . 71.24 109.334 -175.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -95.52 141.02 29.54 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 120.641 -1.287 . . . . 64.1 111.327 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.24 154.89 49.06 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.6 1.96 . . . . 71.11 108.686 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttp180 -91.21 156.71 17.64 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 108.181 -1.044 . . . . 61.45 108.181 168.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.603 HG21 HD11 ' A' ' 155' ' ' LEU . 3.1 mp -95.52 154.2 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.793 1.237 . . . . 70.25 108.697 172.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.0 -52.12 2.81 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.904 1.682 . . . . 60.21 110.615 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -134.12 162.05 33.18 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.465 -0.772 . . . . 71.15 110.01 -171.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.632 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.1 155.96 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 125.548 1.539 . . . . 74.22 108.436 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.64 166.24 20.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.324 1.45 . . . . 74.44 108.165 174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -137.4 143.94 42.17 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 73.24 109.224 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -141.21 164.46 30.2 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 130.161 3.384 . . . . 72.45 108.819 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -116.74 159.0 22.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 120.06 -1.65 . . . . 73.45 111.264 176.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -150.67 155.59 39.66 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.803 0.811 . . . . 72.52 113.164 -173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.22 117.58 2.21 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.428 1.891 . . . . 73.13 106.4 167.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 154.88 -165.23 32.07 Favored Glycine 0 C--N 1.341 0.843 0 CA-C-N 120.607 1.549 . . . . 31.35 113.733 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -93.2 129.89 39.07 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.423 0.689 . . . . 74.44 110.513 -175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.9 mt -111.26 159.55 17.82 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.476 1.11 . . . . 71.2 109.702 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 35.0 mm -79.21 135.17 26.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.967 1.307 . . . . 71.13 107.842 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -128.78 81.15 2.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.484 1.914 . . . . 75.22 105.961 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.541 HG23 HG13 ' A' ' 140' ' ' VAL . 42.5 mt -63.97 110.07 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 104.19 -2.522 . . . . 73.12 104.19 158.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 m -85.98 162.57 18.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 107.361 -1.348 . . . . 73.32 107.361 161.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -142.88 164.69 29.4 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.371 1.869 . . . . 60.33 107.313 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.8 ttmt -63.78 -26.83 68.81 Favored 'General case' 0 C--O 1.225 -0.191 0 O-C-N 121.449 -0.782 . . . . 71.33 112.205 -159.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -74.42 27.35 0.08 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.527 1.931 . . . . 72.2 111.259 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 50.77 14.48 0.18 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.195 2.198 . . . . 74.2 113.641 -168.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.593 ' HE ' ' HB2' ' A' ' 169' ' ' GLU . 14.3 ttm105 -85.82 162.09 18.82 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.806 -1.184 . . . . 73.32 108.766 -172.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 95' ' ' ARG . 9.8 pt-20 -175.72 168.3 3.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.985 -1.007 . . . . 74.14 110.793 -168.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 8.4 pt -140.6 178.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 125.782 1.633 . . . . 73.14 109.179 -174.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -154.07 97.28 2.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.319 -1.734 . . . . 74.5 106.319 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.94 162.44 41.31 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.808 0.843 . . . . 74.14 111.087 -172.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 m -70.25 153.16 43.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.747 -1.205 . . . . 73.34 107.747 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -73.64 -13.37 60.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.556 0.947 . . . . 54.43 113.556 -167.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.29 37.75 2.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.284 1.04 . . . . 61.13 109.564 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -97.03 129.84 31.36 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.925 1.29 . . . . 53.12 107.65 172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -65.69 148.72 87.2 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.871 2.381 . . . . 74.42 112.359 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.7 m -144.53 169.13 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 129.565 3.146 . . . . 75.0 107.933 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -107.87 141.52 39.36 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.651 -0.655 . . . . 74.34 109.682 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 pp -132.62 159.82 42.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.199 1.4 . . . . 64.31 109.042 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.478 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 17.2 t -93.39 134.66 35.39 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 123.197 1.475 . . . . 54.34 110.31 169.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mttm -103.36 85.44 2.48 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 111.96 -2.382 . . . . 52.12 106.167 157.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.45 27.42 8.23 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.683 1.193 . . . . 61.24 113.66 170.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 119.32 -14.69 10.91 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.284 -1.287 . . . . 75.31 113.145 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.61 176.49 9.74 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 118.721 1.261 . . . . 55.45 108.009 172.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -116.43 118.89 60.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.894 1.278 . . . . 60.45 108.064 173.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -118.57 158.79 24.75 Favored 'General case' 0 CA--C 1.526 0.03 0 C-N-CA 123.988 0.915 . . . . 72.14 108.931 174.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.5 OUTLIER -121.59 115.92 23.67 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.89 2.476 . . . . 74.34 104.505 -176.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.7 177.69 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.704 1.202 . . . . 74.53 109.258 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -94.07 153.67 18.02 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.859 0.754 . . . . 65.32 111.324 -175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.0 -22.95 42.6 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.977 1.311 . . . . 73.33 113.758 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -60.16 -43.67 95.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.958 1.254 . . . . 63.11 111.132 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.15 -22.95 57.77 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.224 0.92 . . . . 72.11 113.438 -170.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.21 62.87 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 126.904 2.081 . . . . 61.31 111.004 -171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -78.98 -177.95 5.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.054 1.342 . . . . 72.32 110.162 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 140' ' ' VAL . 11.1 p -58.6 -4.04 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 127.573 2.349 . . . . 74.3 114.163 178.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -120.2 15.87 10.05 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.754 2.121 . . . . 73.34 112.155 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.2 159.27 34.79 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.487 1.643 . . . . 74.11 107.498 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -119.91 110.61 16.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.34 -0.985 . . . . 53.25 108.34 -167.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.2 tt -79.32 138.93 19.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 124.813 1.245 . . . . 63.24 108.438 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 108' ' ' SER . 11.1 m-85 -75.49 136.0 40.65 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.559 -0.904 . . . . 70.31 108.559 171.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.9 pp -131.0 151.94 79.84 Favored Pre-proline 0 N--CA 1.467 0.386 0 C-N-CA 124.207 1.003 . . . . 40.45 112.735 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.35 138.32 29.9 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.106 2.537 . . . . 54.32 108.91 170.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -120.92 -157.47 0.72 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 127.524 2.329 . . . . 75.04 105.848 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -37.86 -74.2 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.179 1.792 . . . . 75.01 112.507 -169.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -121.4 -1.0 9.7 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.17 0.896 . . . . 72.54 113.24 161.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.6 p -123.64 169.93 10.98 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 124.636 1.174 . . . . 74.33 110.541 -168.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.5 tp -81.66 157.81 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 109.223 -0.658 . . . . 74.41 109.223 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.6 -176.54 5.0 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 129.078 2.951 . . . . 73.02 106.708 174.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mp -107.1 161.72 14.5 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.456 -1.313 . . . . 73.5 107.456 156.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -154.99 108.39 2.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.456 1.502 . . . . 74.12 108.135 173.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.02 144.73 33.07 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 129.929 3.292 . . . . 64.22 113.266 -162.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.541 HG13 HG23 ' A' ' 89' ' ' ILE . 66.2 t -77.5 0.41 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.561 1.144 . . . . 74.01 113.599 -170.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.425 HG13 ' H ' ' A' ' 142' ' ' LYS . 1.2 pt 27.64 -75.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 118.078 2.621 . . . . 74.31 118.078 167.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.425 ' H ' HG13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -115.48 128.89 56.33 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 125.607 1.563 . . . . 73.05 107.986 170.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.9 p -124.27 131.5 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.683 -1.229 . . . . 64.03 107.683 167.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.67 171.62 14.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.318 1.847 . . . . 75.11 108.42 -179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.49 138.79 50.67 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.256 -1.016 . . . . 75.12 108.256 171.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.49 -168.41 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 124.668 1.187 . . . . 73.42 108.569 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -136.65 135.59 38.41 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.068 -1.456 . . . . 63.2 107.068 167.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.401 ' C ' HD22 ' A' ' 149' ' ' ASN . 1.1 t80 -142.55 134.73 27.45 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 123.581 0.753 . . . . 74.34 110.233 -170.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.401 HD22 ' C ' ' A' ' 148' ' ' TYR . 1.5 m-80 -138.1 70.89 1.39 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.756 -1.942 . . . . 55.34 105.756 -167.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.09 -166.61 12.14 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.524 1.059 . . . . 75.11 112.393 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -88.42 157.29 18.73 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.965 -1.315 . . . . 54.21 109.413 165.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' HA ' ' A' ' 10' ' ' ALA . 10.2 pt -126.55 170.34 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.164 0 C-N-CA 125.609 1.564 . . . . 64.55 111.16 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.686 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -161.9 147.69 13.42 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.156 -1.424 . . . . 73.15 107.156 -170.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -118.93 158.24 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.537 0.735 . . . . 65.3 110.692 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.603 HD11 HG21 ' A' ' 74' ' ' ILE . 19.7 tp -117.38 137.57 52.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.459 1.503 . . . . 65.32 109.231 -168.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 177' ' ' SER . 22.8 m -68.29 -59.47 3.18 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.353 0.597 . . . . 52.14 110.306 -167.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . 0.325 3.2 t 40.67 67.22 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 128.975 2.91 . . . . 75.1 112.694 -170.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -69.61 -11.88 61.19 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.499 -0.773 . . . . 71.41 110.934 -179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.55 -65.2 0.7 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.3 1.04 . . . . 74.54 109.682 -169.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -118.13 2.34 12.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.137 0.575 . . . . 74.21 112.27 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.6 m170 54.99 31.34 15.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.402 1.481 . . . . 64.34 111.887 -169.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -149.69 151.62 33.99 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.643 -1.286 . . . . 62.22 110.291 179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.2 p90 -154.8 172.53 17.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.591 1.156 . . . . 75.45 110.511 -174.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 46.5 mm -107.12 124.95 63.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.026 1.73 . . . . 64.32 108.929 171.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.93 148.46 32.81 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.726 0.811 . . . . 53.21 109.907 169.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 151.12 -175.47 30.04 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.26 -1.136 . . . . 73.13 110.26 173.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -90.94 166.05 13.25 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 120.307 -1.702 . . . . 71.0 110.24 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.06 -68.23 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 130.587 3.555 . . . . 75.1 113.054 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.593 ' HB2' ' HE ' ' A' ' 95' ' ' ARG . 12.7 mt-10 -122.06 -18.06 7.04 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.632 1.973 . . . . 73.54 114.174 175.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 79.29 166.74 32.49 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 124.249 0.928 . . . . 74.35 111.816 -171.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 25.3 m-85 -121.06 155.26 34.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 128.139 2.576 . . . . 75.45 105.774 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.435 ' HB1' ' CE1' ' A' ' 62' ' ' PHE . . . -77.03 141.14 40.46 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.833 -1.173 . . . . 75.13 107.833 167.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . 0.273 46.0 t -135.27 175.82 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 124.966 1.306 . . . . 75.23 107.6 -171.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 52.7 m -95.89 133.61 39.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.324 1.45 . . . . 43.42 110.565 170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.421 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -115.13 173.78 6.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.883 1.673 . . . . 54.33 107.108 168.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 26.4 m -165.53 -32.22 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 126.057 1.743 . . . . 64.5 110.134 160.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 156' ' ' THR . 44.6 p 63.65 174.52 0.17 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.01 2.124 . . . . 74.45 111.075 -151.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -119.74 77.95 0.31 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.056 -1.217 . . . . 53.45 110.056 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 11.4 t -138.77 -146.32 0.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.956 1.702 . . . . 72.04 108.467 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.8 tp -26.5 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.373 1 C-N-CA 132.963 4.505 . . . . 65.33 115.256 167.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.47 161.45 37.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.055 -1.831 . . . . 72.44 106.055 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -61.4 153.85 25.81 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 118.868 0.758 . . . . 74.35 109.254 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -70.82 131.54 43.95 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.527 -0.916 . . . . 75.42 108.527 -171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -71.17 156.41 39.61 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.824 -0.806 . . . . 72.52 108.824 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -128.04 -41.88 1.59 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.813 0.845 . . . . 74.33 111.951 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 52.4 t60 . . . . . 0 C--O 1.256 1.415 0 CA-C-O 116.649 -1.643 . . . . 71.34 108.691 -167.625 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtp . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 108.581 -0.896 . . . . 75.3 108.581 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.15 166.3 0.84 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.503 -0.925 . . . . 75.15 108.503 158.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.2 m -58.2 -72.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.329 -1.36 . . . . 63.45 107.329 157.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.43 67.03 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.927 -1.669 . . . . 60.23 108.927 -165.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -85.88 143.43 28.23 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.694 -1.595 . . . . 64.54 106.694 164.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -163.34 139.5 6.94 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.825 1.65 . . . . 64.14 108.245 -174.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -107.97 -171.94 21.77 Favored Glycine 0 CA--C 1.522 0.496 0 C-N-CA 125.5 1.524 . . . . 53.2 111.095 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -154.99 -173.86 4.75 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.198 1.799 . . . . 54.41 109.614 -172.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.64 170.62 9.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.693 1.597 . . . . 75.35 110.041 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.75 162.33 19.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.445 -0.784 . . . . 45.03 111.927 173.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.47 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 13.6 t80 -47.65 -42.55 24.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.259 2.224 . . . . 74.04 113.538 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.97 16.34 26.92 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 120.462 1.483 . . . . 74.12 112.779 -160.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -86.98 120.16 71.41 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 126.946 2.099 . . . . 75.33 110.481 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -56.77 145.37 83.37 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.385 2.723 . . . . 72.13 113.981 171.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.469 ' CG2' HG13 ' A' ' 25' ' ' ILE . 45.2 pt -107.87 -10.13 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.232 1.413 . . . . 60.45 113.156 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 56.14 79.43 0.17 Allowed 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.393 1.077 . . . . 72.34 110.665 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 155.74 2.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 121.173 -0.954 . . . . 71.25 109.551 165.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.09 -38.32 51.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.011 0.925 . . . . 51.23 110.362 169.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.09 -17.05 61.0 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.355 0.872 . . . . 53.14 113.355 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.92 17.07 33.7 Favored Glycine 0 CA--C 1.523 0.574 0 CA-C-O 118.486 -1.175 . . . . 73.2 113.142 171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.32 -33.06 63.0 Favored 'General case' 0 C--N 1.344 0.364 0 N-CA-C 115.253 1.575 . . . . 74.34 115.253 -159.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mm 49.21 88.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.294 2.238 . . . . 71.41 110.121 -167.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 148.09 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.95 2.5 . . . . 61.44 107.588 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.64 141.41 58.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.713 1.605 . . . . 70.54 108.143 177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CG2' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -50.39 -51.67 17.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.097 -0.705 . . . . 72.15 109.097 169.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -57.23 -53.5 44.27 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-O 118.003 -1.443 . . . . 73.11 110.116 -176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -60.54 -43.86 96.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.532 1.166 . . . . 61.14 112.433 -173.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -58.4 -56.61 19.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.777 0.831 . . . . 65.44 109.34 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.662 HG21 ' CE2' ' A' ' 153' ' ' TYR . 54.8 t -70.93 -41.69 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 115.983 -0.553 . . . . 64.12 109.973 -172.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -29.69 68.36 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.1 -0.953 . . . . 72.23 111.855 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -56.1 -43.88 78.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.3 1.864 . . . . 72.42 111.273 172.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' CD1' ' HE2' ' A' ' 31' ' ' LYS . 20.0 m-85 -67.64 -43.22 80.85 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.738 -0.838 . . . . 72.54 108.738 174.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.24 -34.88 75.86 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 120.407 1.458 . . . . 75.43 112.679 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -47.35 66.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.057 1.299 . . . . 72.34 108.928 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB3' ' CD1' ' A' ' 36' ' ' TYR . 1.7 mtpp -76.43 -56.9 4.21 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 106.31 -1.737 . . . . 74.43 106.31 -169.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 35' ' ' LYS . 1.1 m-30 -91.32 40.69 1.04 Allowed 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.39 1.876 . . . . 74.42 107.759 -171.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -37.43 68.63 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 121.165 -0.96 . . . . 73.24 111.453 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -35.56 81.04 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.485 1.914 . . . . 71.35 110.382 175.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.5 m -80.51 0.26 34.47 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.628 1.571 . . . . 55.34 113.354 -175.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.78 99.22 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.02 -1.104 . . . . 63.34 108.02 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtt -79.19 161.34 26.46 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.295 -1.372 . . . . 71.42 107.295 162.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -134.37 142.21 47.12 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 106.888 -1.523 . . . . 70.53 106.888 171.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.15 176.71 9.42 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.991 0.807 . . . . 73.13 110.315 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.28 -12.71 60.94 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.426 1.49 . . . . 70.33 111.693 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.47 5.45 17.71 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.978 -1.076 . . . . 74.31 111.359 162.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 30.21 77.28 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 126.922 2.201 . . . . 55.3 113.234 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' A' ' 80' ' ' LYS . 2.6 t80 -77.02 -100.12 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.342 1.857 . . . . 71.11 109.47 -170.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 144.84 127.95 2.02 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.915 -1.274 . . . . 72.41 109.915 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -155.47 161.41 40.96 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.164 0.982 . . . . 64.3 111.067 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mt -142.44 133.19 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 105.835 -1.913 . . . . 64.2 105.835 170.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.22 133.45 47.96 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.872 -1.158 . . . . 73.02 107.872 163.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -133.06 17.71 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.648 0.779 . . . . 54.32 109.785 176.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.89 8.66 4.34 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 126.083 1.802 . . . . 71.33 113.979 -173.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -109.88 -15.41 14.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.691 1.596 . . . . 74.12 109.661 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.16 -34.09 69.92 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.198 0.999 . . . . 73.32 110.338 170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 58.9 14.11 3.14 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.301 1.963 . . . . 71.23 116.301 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 72.3 mt -67.84 127.65 29.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 127.977 2.511 . . . . 71.41 109.276 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -82.32 141.04 33.2 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.546 0.688 . . . . 74.2 111.372 178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 tt -115.9 153.57 17.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 127.848 2.459 . . . . 75.2 106.675 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -72.19 110.7 6.82 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.592 -1.633 . . . . 74.15 106.592 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.49 171.42 7.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.17 -1.419 . . . . 61.43 107.17 -174.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.544 ' CE2' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -140.25 122.7 16.08 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.337 -1.356 . . . . 74.44 107.337 -168.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.5 108.22 18.93 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 107.893 -1.151 . . . . 70.23 107.893 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.475 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 21.5 ttpp -51.48 -31.42 23.47 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.424 1.49 . . . . 73.54 112.789 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -51.76 -28.38 15.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.765 2.826 . . . . 74.5 112.957 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.6 t -150.05 23.06 0.86 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.461 -0.774 . . . . 72.51 111.487 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 46.87 40.2 8.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.414 1.485 . . . . 52.14 112.18 -177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.2 pt -91.81 -172.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 123.8 0.84 . . . . 70.54 110.095 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.8 mm -116.92 135.7 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 127.298 2.239 . . . . 71.43 105.79 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -143.02 167.51 21.89 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.113 2.165 . . . . 73.5 107.182 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -101.2 118.92 37.95 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 106.231 -1.766 . . . . 63.52 106.231 164.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -133.37 163.77 28.6 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.122 -1.436 . . . . 65.14 107.122 170.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -95.61 -160.92 0.82 Allowed 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 119.293 0.951 . . . . 73.13 110.512 -171.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 155' ' ' LEU . 77.2 mt -132.62 146.26 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 105.572 -2.01 . . . . 71.51 105.572 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.65 -45.52 3.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.507 1.123 . . . . 64.43 111.191 -171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.595 ' HB2' HG21 ' A' ' 156' ' ' THR . 59.7 mtt180 -139.79 156.22 46.87 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 120.21 -1.556 . . . . 71.32 108.417 -173.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -134.14 158.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.991 -0.744 . . . . 71.21 108.991 177.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -129.11 179.33 5.82 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.587 1.555 . . . . 72.2 108.914 -176.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -170.7 146.21 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.322 1.849 . . . . 73.03 108.982 158.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 47' ' ' PHE . 71.9 tttt -143.8 166.5 24.74 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.618 1.567 . . . . 72.01 107.455 164.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.45 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 14.8 ttpt -89.02 165.65 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 120.46 -1.4 . . . . 70.42 109.223 168.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' H ' ' HG2' ' A' ' 81' ' ' LYS . 91.9 t80 -150.64 158.17 43.83 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.839 1.255 . . . . 74.12 109.9 -170.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.8 p -155.13 123.98 6.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.65 1.18 . . . . 51.23 107.848 160.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.8 178.19 35.51 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 120.036 1.289 . . . . 73.52 114.167 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.735 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.87 100.85 8.23 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.334 0.654 . . . . 61.05 110.789 179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.13 152.13 23.61 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.81 -1.181 . . . . 63.23 107.81 167.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.93 137.19 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.791 1.636 . . . . 54.41 108.943 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -117.5 80.67 1.53 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 113.427 -1.715 . . . . 73.4 106.868 169.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 25.6 mt -60.6 137.25 23.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 105.848 -1.908 . . . . 73.13 105.848 154.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.7 m -117.31 171.83 7.71 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 106.079 -1.822 . . . . 70.32 106.079 159.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 40.2 p -139.32 172.85 12.22 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.911 1.284 . . . . 74.22 109.106 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -63.7 -29.27 70.52 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.063 -1.023 . . . . 65.55 110.742 -172.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.64 2.48 5.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.113 1.365 . . . . 74.32 113.945 175.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.1 mmt-85 62.58 16.69 9.01 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.494 1.518 . . . . 64.14 111.8 -168.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.554 ' HD2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -70.0 153.46 43.19 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.814 -1.18 . . . . 54.32 107.814 168.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.57 163.29 12.32 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 125.942 1.697 . . . . 75.51 107.564 -170.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.661 HG23 ' CE1' ' A' ' 171' ' ' PHE . 1.5 pt -148.96 172.64 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 126.02 1.728 . . . . 74.13 108.955 -170.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.3 m -146.12 92.43 2.19 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.666 -1.235 . . . . 70.12 107.666 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.88 170.21 18.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.315 1.446 . . . . 63.42 110.832 -172.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 p -70.19 166.99 18.81 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 119.964 1.256 . . . . 54.41 112.15 -175.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . 0.3 1.4 p-80 -67.84 -31.62 71.58 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.22 -0.925 . . . . 63.53 111.348 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -100.18 39.94 1.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.832 2.453 . . . . 72.33 111.293 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -95.3 128.36 38.82 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 117.609 -1.186 . . . . 74.41 111.829 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -68.46 121.77 8.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.551 2.834 . . . . 72.33 111.042 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.9 m -135.76 177.12 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.776 1.631 . . . . 74.22 108.752 173.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -112.43 149.53 32.44 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 121.179 -0.951 . . . . 75.13 111.545 -175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -140.46 170.32 14.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 126.006 1.722 . . . . 73.13 108.458 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 18.7 p -96.05 137.09 35.62 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 122.075 0.94 . . . . 73.21 110.261 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.29 79.8 1.87 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 106.776 -1.564 . . . . 73.3 106.776 172.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 m 65.42 4.01 2.56 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.196 1.184 . . . . 74.31 114.196 172.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 142.22 -21.89 2.43 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 120.173 -1.579 . . . . 70.44 112.139 -169.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -102.66 160.58 14.45 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 125.148 1.379 . . . . 64.41 107.893 -171.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.2 t -112.91 119.24 60.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.378 -1.712 . . . . 75.13 106.378 -171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.67 137.2 48.21 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.445 -0.946 . . . . 43.42 108.445 -170.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -84.0 134.56 34.64 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.271 1.028 . . . . 72.44 109.519 174.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.2 pt -147.78 -179.95 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.454 1.502 . . . . 64.44 109.717 170.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -79.38 134.04 36.58 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.408 1.083 . . . . 74.41 110.225 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.37 -30.75 30.44 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.328 1.051 . . . . 63.33 113.04 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.65 -26.14 68.49 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 121.285 1.857 . . . . 73.43 113.625 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 36.7 mmt -80.89 -26.36 36.89 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 124.39 1.076 . . . . 72.41 111.554 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 2.9 t -67.95 63.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 128.006 2.522 . . . . 53.3 111.468 171.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -78.96 -177.72 5.71 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 120.898 -1.126 . . . . 73.15 109.063 172.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.98 1.79 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 C-N-CA 126.34 1.856 . . . . 65.51 112.964 159.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.11 -3.96 72.31 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-O 116.614 -2.214 . . . . 63.23 112.444 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.72 166.74 21.93 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 120.134 1.967 . . . . 61.02 107.734 -176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.435 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 3.4 m-85 -98.38 155.74 17.08 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.011 -0.995 . . . . 72.43 108.79 163.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.8 tt -122.21 131.37 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 124.388 1.075 . . . . 55.03 109.462 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.8 m-85 -71.7 117.77 13.7 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 118.585 -0.721 . . . . 65.41 109.909 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.566 HG12 ' CG ' ' A' ' 138' ' ' ASP . 2.1 pp -129.4 157.06 77.44 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.639 1.175 . . . . 75.42 112.99 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.31 147.3 32.63 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.57 2.18 . . . . 63.03 109.563 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -122.42 -178.36 3.87 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.262 -1.384 . . . . 53.04 107.262 163.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -24.12 -71.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.464 2.706 . . . . 73.44 112.802 -168.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 17.5 p-10 -121.01 1.22 10.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 128.382 2.673 . . . . 74.42 113.85 175.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 41.1 p -128.61 -173.88 3.09 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.828 1.651 . . . . 65.04 112.723 -168.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.0 tp -104.25 157.45 5.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.868 -1.16 . . . . 72.04 107.868 166.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -140.92 -177.34 5.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.307 2.243 . . . . 71.54 107.209 165.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 128' ' ' TYR . 1.1 tp -108.76 157.66 18.36 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 124.555 1.142 . . . . 70.04 110.074 165.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.566 ' CG ' HG12 ' A' ' 129' ' ' ILE 0.306 39.5 p30 -142.79 164.67 29.46 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 114.396 1.258 . . . . 70.42 114.396 162.309 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -95.26 146.1 24.59 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.063 1.745 . . . . 72.22 107.5 -171.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -98.14 0.92 10.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 113.749 1.018 . . . . 71.05 113.749 -160.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 26.5 pt 35.31 -53.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.977 1 C-N-CA 133.019 4.528 . . . . 75.31 120.064 169.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -144.68 133.51 22.43 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.301 2.64 . . . . 70.33 107.908 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.96 127.28 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.263 1.03 . . . . 75.2 108.318 166.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -140.22 -158.15 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.392 1.477 . . . . 70.11 107.579 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -139.7 152.49 46.73 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.386 1.074 . . . . 73.04 108.952 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m -102.59 139.1 24.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 106.505 -1.665 . . . . 70.22 106.505 161.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -90.21 92.8 9.09 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.752 1.614 . . . . 74.43 106.972 166.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -96.81 139.41 32.89 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 124.183 0.993 . . . . 75.14 111.345 -168.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -140.69 67.01 1.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.742 -1.577 . . . . 62.34 106.742 -165.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.0 -172.51 12.83 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 123.72 0.676 . . . . 72.5 111.99 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -81.3 144.47 31.5 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.178 -0.675 . . . . 71.02 109.178 162.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.2 pt -125.54 158.18 34.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 127.638 2.375 . . . . 73.45 108.665 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.662 ' CE2' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -153.81 164.85 37.67 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.912 -0.773 . . . . 72.3 108.912 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -129.15 147.83 51.04 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.342 1.457 . . . . 75.22 108.994 175.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 74' ' ' ILE . 20.0 tp -96.14 153.81 17.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.233 0.539 . . . . 74.12 110.686 -171.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.595 HG21 ' HB2' ' A' ' 76' ' ' ARG . 2.4 m -107.71 37.83 2.33 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.722 0.809 . . . . 70.31 111.615 -165.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.85 101.93 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 O-C-N 119.881 -1.762 . . . . 54.32 109.542 -172.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -88.59 -6.09 57.76 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.49 1.116 . . . . 63.44 110.311 172.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.35 -67.25 0.43 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.779 1.232 . . . . 74.23 108.58 -167.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.475 ' ND2' ' H ' ' A' ' 64' ' ' LYS . 6.5 t30 -112.13 4.43 17.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.753 0.821 . . . . 74.34 111.418 170.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.13 35.1 25.08 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.218 1.007 . . . . 70.31 109.592 -169.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -155.27 150.78 27.29 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.947 1.699 . . . . 75.33 108.57 174.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.67 -178.57 6.63 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.064 1.302 . . . . 62.03 110.555 -178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 38.2 mm -113.36 143.27 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.381 1.472 . . . . 75.14 108.634 176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.5 157.34 38.22 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.341 1.056 . . . . 52.35 110.223 165.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 132.58 -169.2 22.45 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 119.035 0.834 . . . . 55.04 112.569 166.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -85.7 167.41 15.31 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 119.083 1.442 . . . . 70.31 111.841 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 63.45 -73.63 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 129.142 2.977 . . . . 71.23 113.762 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -122.21 -14.22 7.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.239 1.815 . . . . 62.44 112.493 175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 68.89 160.67 2.12 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 126.484 1.992 . . . . 64.03 112.571 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.661 ' CE1' HG23 ' A' ' 97' ' ' ILE . 37.5 m-85 -106.6 151.06 25.54 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.379 2.272 . . . . 74.21 107.07 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.544 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -78.6 129.56 34.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.407 -1.331 . . . . 71.54 107.407 162.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.01 176.34 7.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 N-CA-C 107.419 -1.326 . . . . 70.54 107.419 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 7.2 t -65.98 164.52 15.01 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.644 -0.873 . . . . 74.32 108.644 171.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -145.38 132.9 20.81 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 106.544 -1.65 . . . . 64.31 106.544 164.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.9 76.72 0.24 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 106.436 -1.69 . . . . 75.43 106.436 159.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.4 t 56.51 21.85 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.727 2.121 . . . . 71.4 116.727 172.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.6 38.47 93.76 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-N 120.844 1.656 . . . . 21.42 111.208 -171.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.98 -176.01 3.24 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.454 2.302 . . . . 51.25 106.305 172.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 180' ' ' LEU 0.257 8.9 tt 63.59 121.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 126.117 1.767 . . . . 61.44 114.755 161.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -86.71 -67.06 0.84 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 114.776 -1.102 . . . . 65.52 109.74 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -129.56 -68.13 0.74 Allowed 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.076 -1.083 . . . . 65.51 108.076 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.9 136.67 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.952 2.101 . . . . 74.53 110.883 -171.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 42.7 m80 56.89 -179.11 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.074 1.35 . . . . 73.32 112.24 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -155.99 -78.17 0.09 Allowed 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.119 -0.988 . . . . 74.22 110.692 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.032 0 N-CA-C 103.642 -2.725 . . . . 73.31 103.642 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 117.904 -1.046 . . . . 72.52 109.058 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -150.39 163.95 37.09 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 120.522 1.51 . . . . 74.34 110.205 159.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.2 m -66.92 -51.0 60.56 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.673 1.989 . . . . 61.24 108.956 167.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.6 -165.05 25.35 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.577 2.513 . . . . 75.31 107.283 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -114.48 161.19 18.32 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.246 1.018 . . . . 72.13 108.525 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -141.71 -177.36 5.14 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.907 -1.145 . . . . 73.44 107.907 176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.68 155.93 7.83 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 125.749 1.642 . . . . 44.34 112.925 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.88 167.65 3.06 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 128.492 2.717 . . . . 60.42 106.407 162.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt -101.89 166.65 10.53 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.572 1.549 . . . . 74.25 109.588 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.09 -173.85 0.56 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.031 1.332 . . . . 73.31 110.858 172.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.86 -31.85 59.48 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.492 1.117 . . . . 75.24 111.062 171.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -113.96 31.64 6.41 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.714 2.405 . . . . 25.41 111.051 -164.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -88.43 133.38 36.6 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 107.619 -1.252 . . . . 63.54 107.619 157.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -71.57 152.45 59.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.211 1.274 . . . . 63.34 113.676 168.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.2 pt -106.04 -17.03 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 114.658 1.355 . . . . 72.4 114.658 -176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 52.37 74.62 0.27 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 122.943 1.354 . . . . 74.15 111.755 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.6 mt -53.85 163.64 0.7 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.991 -1.004 . . . . 73.03 109.504 169.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.2 t -56.07 -36.37 68.02 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.676 -0.64 . . . . 70.25 110.266 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.96 -18.73 63.37 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.684 0.794 . . . . 74.44 112.948 177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.3 44.85 26.85 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 125.436 1.493 . . . . 74.23 109.574 -178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.87 -22.69 60.73 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 113.792 1.034 . . . . 63.32 113.792 -169.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 mm 48.54 102.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.799 2.44 . . . . 61.23 109.987 -160.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.5 142.99 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.676 -1.601 . . . . 73.51 106.676 177.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -59.38 123.94 18.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.028 2.531 . . . . 51.15 106.989 173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -51.18 -44.78 30.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 124.672 1.189 . . . . 70.02 111.511 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -69.26 -27.53 73.59 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-O 118.938 -0.924 . . . . 74.23 111.751 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -73.94 -44.39 55.1 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.832 1.316 . . . . 74.03 110.079 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -53.86 -53.45 52.35 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.597 1.159 . . . . 75.01 109.115 173.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 33' ' ' PHE . 93.0 t -56.51 -48.77 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 123.25 0.62 . . . . 60.1 111.033 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.13 -32.23 73.83 Favored 'General case' 0 N--CA 1.463 0.219 0 O-C-N 120.907 -1.12 . . . . 71.2 112.864 -175.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HE2' ' CE1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -49.1 -36.74 19.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.742 1.217 . . . . 72.14 110.79 171.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.547 ' CE1' ' HE2' ' A' ' 31' ' ' LYS . 35.1 m-85 -84.79 -45.69 12.11 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.69 -0.856 . . . . 73.22 108.69 174.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CD1' HD12 ' A' ' 50' ' ' ILE . 3.6 m-30 -68.43 -21.42 64.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 120.603 1.547 . . . . 72.4 111.62 -169.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 9.9 mtpt -86.87 -16.91 34.66 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.174 1.39 . . . . 74.21 112.029 172.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 -57.43 2.18 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 120.587 1.539 . . . . 64.21 108.153 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.4 m-30 -86.12 40.01 0.85 Allowed 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.125 1.77 . . . . 65.43 108.245 -174.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 33.0 mttt -49.99 -44.41 50.94 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.032 1.333 . . . . 35.11 108.639 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -56.63 -25.15 52.44 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 126.535 1.934 . . . . 73.23 114.229 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -112.93 12.39 19.35 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.645 1.578 . . . . 75.25 112.057 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.5 mt -62.33 106.05 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 106.842 -1.54 . . . . 51.22 106.842 159.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.16 152.98 25.02 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.5 -0.926 . . . . 64.21 108.5 164.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -118.32 142.25 47.7 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 104.635 -2.358 . . . . 74.3 104.635 158.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.52 159.02 20.01 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.308 -1.738 . . . . 74.24 106.308 156.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -66.71 -37.7 85.22 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.253 1.421 . . . . 63.31 110.285 -169.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -57.16 -27.47 61.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.167 0.987 . . . . 70.43 111.151 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.04 5.37 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 125.043 1.306 . . . . 74.25 114.432 159.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.9 -86.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.642 1.177 . . . . 61.12 110.726 -169.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 124.48 137.04 4.76 Favored Glycine 0 C--N 1.337 0.615 0 O-C-N 120.795 -1.19 . . . . 61.1 110.539 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -142.62 167.77 21.3 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 117.98 0.89 . . . . 74.45 111.026 169.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.57 HD12 ' CD1' ' A' ' 33' ' ' PHE . 5.3 mt -142.25 140.15 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.95 2.1 . . . . 74.12 105.464 163.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 126.96 35.16 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 126.169 1.788 . . . . 33.02 108.737 165.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -129.96 -3.51 2.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.845 1.258 . . . . 52.45 111.63 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.05 -16.61 57.77 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 120.373 1.442 . . . . 70.41 113.294 -170.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.21 -23.95 66.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.461 1.131 . . . . 73.42 112.712 171.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.74 -15.16 26.36 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.546 1.538 . . . . 52.4 113.169 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 65.48 6.34 3.69 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.642 1.577 . . . . 73.11 114.924 173.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 73.3 mt -60.49 148.44 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 126.907 2.083 . . . . 72.2 107.448 168.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -119.04 158.4 25.9 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.398 1.094 . . . . 73.01 110.96 169.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.5 tt -129.25 161.28 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 129.027 2.931 . . . . 63.14 107.382 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -75.11 152.06 38.57 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 121.124 -0.985 . . . . 75.41 109.416 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -145.18 -171.91 3.75 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.703 0.801 . . . . 71.34 109.25 173.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CD2' ' HB1' ' A' ' 172' ' ' ALA . 0.3 OUTLIER -140.14 137.53 34.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.075 -1.454 . . . . 71.32 107.075 168.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.97 113.38 19.14 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 107.777 -1.194 . . . . 71.32 107.777 172.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -63.31 -29.87 71.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 123.341 0.656 . . . . 74.24 112.195 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -30.69 5.68 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.676 1.991 . . . . 73.33 112.732 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.28 11.53 1.74 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.437 0.695 . . . . 65.31 111.956 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 52.36 46.36 26.82 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.279 1.431 . . . . 50.41 112.252 -176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.0 163.28 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 126.086 1.754 . . . . 73.22 109.827 -177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.0 mm -86.68 148.09 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.816 1.246 . . . . 73.15 109.281 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -150.91 -179.39 7.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.936 1.695 . . . . 43.11 110.741 -177.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' HE2' ' A' ' 72' ' ' LYS . 1.5 p30 -86.17 172.26 10.68 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.341 1.456 . . . . 51.35 110.896 155.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 71' ' ' ASP . 0.1 OUTLIER -145.01 170.02 16.98 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.591 1.556 . . . . 64.12 108.226 141.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -99.46 -19.47 16.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.75 1.22 . . . . 61.13 113.846 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.9 mt 64.1 155.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 126.01 1.724 . . . . 73.34 110.145 -163.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -121.14 -63.89 1.29 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.6 -1.63 . . . . 71.13 106.6 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -130.21 152.45 49.62 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.9 0.88 . . . . 72.41 110.267 -173.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -120.49 153.74 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 107.373 -1.344 . . . . 74.53 107.373 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -132.78 153.86 50.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.557 1.543 . . . . 74.24 108.184 -174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.567 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 0.0 OUTLIER -145.36 160.39 41.61 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 108.753 -0.832 . . . . 73.31 108.753 173.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -151.83 161.47 42.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.733 -1.58 . . . . 75.53 106.733 162.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 151' ' ' HIS . 18.5 ttpt -91.29 150.13 21.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.427 -1.421 . . . . 62.34 109.286 -172.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -141.63 164.43 30.24 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.145 0.978 . . . . 74.2 108.982 -177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 67.6 m -157.4 127.66 6.35 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.97 -1.863 . . . . 72.15 105.97 150.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.22 -169.14 37.48 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 119.873 1.215 . . . . 75.31 110.208 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.536 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -79.53 146.7 32.5 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.096 -0.65 . . . . 75.12 109.462 178.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.16 163.58 24.36 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.994 -1.484 . . . . 73.53 106.994 171.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.0 mm -78.86 132.78 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 N-CA-C 108.975 -0.75 . . . . 74.54 108.975 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -111.37 80.59 1.33 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.965 -1.865 . . . . 72.54 105.965 169.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.3 mt -68.48 123.94 23.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 104.175 -2.528 . . . . 73.54 104.175 158.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.3 m -114.68 161.89 17.53 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 105.906 -1.887 . . . . 73.24 105.906 160.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 33.3 p -139.75 163.35 32.84 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.949 1.299 . . . . 75.41 108.061 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -56.94 -27.76 61.43 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.899 1.227 . . . . 52.41 112.072 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -60.5 -8.16 2.59 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 126.229 1.811 . . . . 73.15 112.253 176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 65.08 13.58 8.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.435 2.294 . . . . 75.52 110.977 -161.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.97 154.56 38.05 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 107.31 -1.367 . . . . 65.12 107.31 170.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -167.01 168.78 13.52 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 126.744 2.018 . . . . 74.52 108.744 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.62 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -152.08 -168.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.907 1.683 . . . . 75.34 110.452 -173.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.55 132.98 17.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 112.757 0.651 . . . . 73.24 112.757 169.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.41 159.31 41.47 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.826 1.25 . . . . 72.25 110.417 -173.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 20.6 m -72.15 -0.12 11.1 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.262 1.208 . . . . 71.3 114.262 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.553 ' CD2' ' H ' ' A' ' 102' ' ' ASP 0.306 0.1 OUTLIER 96.19 -61.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.561 1 C-N-CA 132.399 4.28 . . . . 72.22 107.66 -155.695 . . . . . . . . 5 4 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.553 ' H ' ' CD2' ' A' ' 101' ' ' HIS . 81.1 m-20 -92.93 82.57 4.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.202 -1.777 . . . . 74.22 106.202 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -124.38 136.5 27.8 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 126.077 1.751 . . . . 73.5 107.938 158.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.08 134.21 33.41 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.162 2.574 . . . . 73.13 110.719 173.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -134.66 -172.47 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.955 1.302 . . . . 73.45 108.065 168.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -124.85 141.35 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.609 1.55 . . . . 64.35 110.644 175.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.76 163.11 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.666 1.186 . . . . 52.15 109.808 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 1.6 p -82.4 127.96 33.78 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.873 0.733 . . . . 60.55 109.298 171.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.99 92.9 4.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 103.396 -2.816 . . . . 73.45 103.396 154.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.2 m 66.22 -13.73 0.16 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.43 2.692 . . . . 62.32 116.78 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 131.65 -0.24 4.99 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.547 0.594 . . . . 74.01 111.675 -169.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 148.37 31.67 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.297 -1.001 . . . . 73.12 108.297 156.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.45 127.31 40.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 124.928 1.291 . . . . 74.2 107.809 171.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 12.8 tp -126.59 158.89 35.08 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.357 1.063 . . . . 73.3 108.376 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -124.2 106.02 9.97 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.846 2.459 . . . . 72.42 109.655 -174.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 1.4 pt -140.02 169.84 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.914 2.486 . . . . 74.01 109.317 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -82.81 144.81 29.88 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.353 0.661 . . . . 74.34 110.466 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -29.11 61.72 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 113.923 1.083 . . . . 74.12 113.923 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -21.98 65.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.998 0.919 . . . . 42.35 112.123 175.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 6.3 mtm -89.65 -26.87 20.51 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 119.516 1.053 . . . . 61.51 112.337 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.79 62.89 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 128.733 2.813 . . . . 55.35 110.698 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -79.86 -174.51 4.43 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.063 1.345 . . . . 72.54 109.536 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.6 p -57.09 0.22 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 127.142 2.177 . . . . 74.13 113.034 166.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.66 -3.52 77.41 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.96 1.743 . . . . 60.11 112.998 169.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -122.32 169.73 10.64 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 118.364 1.082 . . . . 70.3 111.887 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 139' ' ' GLU . 6.9 m-85 -123.17 113.13 18.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 128.905 2.882 . . . . 71.1 107.213 171.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.2 tt -84.93 136.83 21.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.467 1.107 . . . . 74.25 108.672 -177.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -72.49 121.86 20.32 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.833 -0.803 . . . . 70.25 108.833 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.471 HG22 ' CD2' ' A' ' 171' ' ' PHE . 2.9 pp -126.24 150.26 69.39 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.635 1.174 . . . . 65.33 111.472 -175.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.28 138.19 22.07 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.49 2.793 . . . . 64.25 109.821 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -167.57 1.87 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.682 -1.599 . . . . 65.14 106.682 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -23.25 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 129.386 3.075 . . . . 75.11 112.317 -160.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -120.68 0.33 10.38 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.044 2.537 . . . . 65.13 110.134 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 48.8 p -139.01 165.3 27.49 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.368 1.067 . . . . 71.14 112.71 -171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.1 tp -79.31 156.34 4.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-O 121.625 0.726 . . . . 74.52 109.67 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -139.48 -175.86 4.34 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 127.017 2.127 . . . . 72.5 107.981 170.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 89.6 mt -114.78 164.55 13.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.498 -0.927 . . . . 61.32 108.498 169.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -151.26 158.73 44.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.13 -1.063 . . . . 62.04 108.13 160.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' HG3' ' CE1' ' A' ' 126' ' ' TYR . 14.6 tt0 -92.01 152.27 20.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.286 0.634 . . . . 75.31 109.346 -177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.3 t -89.01 1.16 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.241 1.416 . . . . 72.21 112.696 -168.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.9 pt 24.74 -83.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 128.325 2.65 . . . . 73.3 116.232 168.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.461 ' H ' HG13 ' A' ' 141' ' ' ILE . 8.2 tppt? -95.24 123.3 38.67 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.039 1.336 . . . . 63.01 108.225 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.21 104.82 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 123.606 1.67 . . . . 74.11 109.226 170.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -128.65 -156.28 0.75 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.965 1.706 . . . . 72.34 106.517 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.2 p -131.13 167.47 19.07 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.568 1.547 . . . . 73.14 108.232 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.59 178.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 125.708 1.603 . . . . 52.21 106.928 160.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -122.13 137.71 54.72 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.659 -1.237 . . . . 75.22 107.659 160.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.532 ' C ' HD22 ' A' ' 149' ' ' ASN . 44.6 t80 -141.53 134.11 28.43 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.523 1.929 . . . . 73.01 109.699 -163.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.532 HD22 ' C ' ' A' ' 148' ' ' TYR . 2.7 m120 -132.45 28.07 4.36 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.377 1.444 . . . . 74.42 112.85 -160.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -132.94 -170.6 12.51 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.798 1.19 . . . . 55.32 110.953 -164.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.567 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 72.9 m80 -74.36 149.09 40.72 Favored 'General case' 0 CA--C 1.522 -0.107 0 O-C-N 121.033 -1.275 . . . . 72.03 109.704 168.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 25.6 pt -108.52 149.79 11.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 125.499 1.52 . . . . 74.22 107.661 173.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -131.51 147.14 52.52 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.857 1.263 . . . . 71.33 110.714 -161.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -144.81 152.49 40.39 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.249 1.019 . . . . 63.43 109.476 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.8 tp -128.19 119.69 25.74 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.142 1.377 . . . . 51.01 108.767 -166.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -37.39 87.03 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.285 1.217 . . . . 51.23 114.285 -166.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 2.8 t 25.24 73.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 128.202 2.601 . . . . 63.31 113.971 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.13 -3.45 39.45 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 120.847 -1.158 . . . . 75.35 113.558 -175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -81.26 -61.18 2.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.841 1.256 . . . . 72.41 108.981 -165.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -108.48 -10.27 15.29 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.112 1.365 . . . . 72.41 111.839 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 6.0 m170 52.43 21.81 1.88 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.314 1.846 . . . . 75.54 112.152 -166.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -142.18 153.72 44.26 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.822 -1.174 . . . . 73.5 109.007 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 179.39 9.25 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.868 1.267 . . . . 74.0 111.035 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 39.3 mm -105.63 137.12 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.783 -1.562 . . . . 73.23 106.783 168.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -155.59 153.65 30.45 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.484 1.114 . . . . 41.13 108.463 169.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.408 ' HA3' HG22 ' A' ' 97' ' ' ILE . . . 136.51 -161.7 25.04 Favored Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.947 1.249 . . . . 74.23 112.254 169.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -101.82 170.48 8.12 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 120.167 1.984 . . . . 74.11 111.743 173.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 62.06 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 130.162 3.385 . . . . 75.03 112.51 -170.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -121.66 -13.05 8.4 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.364 1.466 . . . . 74.43 112.108 168.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.2 176.47 39.14 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-O 122.782 1.212 . . . . 44.22 111.322 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CE1' HG23 ' A' ' 97' ' ' ILE . 6.4 m-85 -123.84 161.39 25.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.405 2.282 . . . . 72.32 107.053 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.423 ' HB1' ' CD2' ' A' ' 62' ' ' PHE . . . -107.42 101.3 10.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 106.276 -1.75 . . . . 74.51 106.276 -171.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.12 173.26 12.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 118.586 0.63 . . . . 71.43 110.133 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.87 129.68 42.09 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.145 -1.428 . . . . 71.13 107.145 162.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -95.3 171.59 8.62 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.575 -2.009 . . . . 71.43 105.575 144.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 3.6 m -164.39 162.06 21.94 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.083 0.856 . . . . 71.22 109.754 145.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 5.0 t -72.02 -69.11 0.41 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.113 1.365 . . . . 61.35 109.551 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.72 55.34 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.755 -2.538 . . . . 75.21 106.755 -170.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . 0.257 1.8 p 62.45 -177.62 0.14 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.709 3.204 . . . . 73.22 114.067 -177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 24.2 tp -78.76 93.97 5.04 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.754 -1.573 . . . . 73.14 106.754 164.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -47.34 -49.07 25.06 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.909 1.284 . . . . 75.51 111.168 -178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 86.3 t60 60.29 -75.46 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.723 2.409 . . . . 60.1 112.433 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -159.18 155.71 27.62 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.19 1.796 . . . . 63.22 108.229 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 14.7 m170 83.24 85.97 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 128.876 2.87 . . . . 75.15 109.165 174.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -71.42 -33.42 69.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.847 0.859 . . . . 74.34 111.521 169.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 113.887 1.069 . . . . 64.35 113.887 -144.802 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.539 -0.267 . . . . 62.44 110.385 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -58.91 147.01 35.63 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.685 1.194 . . . . 70.24 108.801 173.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.84 -80.38 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.868 1.667 . . . . 64.22 108.013 165.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.31 77.31 0.79 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 108.756 -1.738 . . . . 61.14 108.756 -156.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.5 m170 -74.17 -177.34 2.93 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.699 0.799 . . . . 73.02 109.992 167.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -77.26 -171.65 2.15 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.722 1.209 . . . . 71.12 110.323 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.34 133.99 2.27 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 125.15 1.357 . . . . 74.21 112.857 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.68 171.58 14.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.512 1.925 . . . . 53.12 109.999 -171.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.49 ' CD2' ' HB1' ' A' ' 165' ' ' ALA . 7.0 mp -84.17 171.0 13.22 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.326 1.05 . . . . 44.31 110.887 174.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.07 156.75 17.17 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 120.801 -1.187 . . . . 63.52 110.679 175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.53 ' CD2' ' HA3' ' A' ' 26' ' ' GLY . 6.0 t80 -44.75 -51.79 9.01 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 128.262 2.625 . . . . 74.24 110.439 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.97 10.3 19.35 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.189 0.811 . . . . 75.3 113.189 -167.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -77.23 118.56 72.77 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 106.375 -1.713 . . . . 62.31 106.375 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -66.53 130.48 23.73 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.437 2.091 . . . . 62.55 109.839 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.8 pt -93.29 160.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.487 1.115 . . . . 64.41 109.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.467 ' CE1' ' HA ' ' A' ' 169' ' ' GLU . 50.6 m-85 -114.85 72.9 0.8 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.084 -1.08 . . . . 74.33 108.084 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.48 160.38 5.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.073 -1.421 . . . . 74.45 108.592 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.05 -44.82 51.77 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 123.907 0.755 . . . . 32.01 109.731 -177.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -94.31 -17.59 22.46 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.74 -0.664 . . . . 74.04 112.087 -168.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.04 32.74 4.56 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 121.444 -0.785 . . . . 61.42 113.851 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.59 -17.58 64.15 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.568 1.321 . . . . 73.33 114.568 -170.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.7 mm 39.73 92.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 129.041 2.936 . . . . 41.4 111.992 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 154.25 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 124.465 1.106 . . . . 55.22 108.455 -176.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -64.45 130.65 44.56 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.066 -1.457 . . . . 64.24 107.066 173.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.401 HG12 ' CE2' ' A' ' 153' ' ' TYR . 0.2 OUTLIER -46.69 -46.91 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 122.489 1.138 . . . . 72.23 108.627 169.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.53 ' HA3' ' CD2' ' A' ' 11' ' ' TYR . . . -48.73 -64.7 3.04 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 128.484 2.945 . . . . 44.22 110.616 176.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -54.96 -49.05 72.34 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.014 2.126 . . . . 74.12 111.38 -177.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -54.62 -49.19 71.09 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 123.787 0.835 . . . . 70.33 111.244 -174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG21 ' CZ ' ' A' ' 153' ' ' TYR . 55.9 t -80.8 -38.27 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.983 -1.008 . . . . 73.12 109.45 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -55.17 -45.27 75.72 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 118.474 0.579 . . . . 65.33 110.68 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -31.07 70.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.783 -1.198 . . . . 74.21 112.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.91 -55.96 7.28 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-O 116.334 -1.793 . . . . 74.51 109.187 168.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -49.45 -44.43 45.67 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 123.104 2.683 . . . . 73.53 112.125 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -74.2 -18.87 60.7 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.126 2.17 . . . . 71.53 111.896 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.86 -67.76 0.78 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.159 -2.163 . . . . 74.12 105.159 166.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 m-30 -79.77 39.65 0.43 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 128.469 2.708 . . . . 62.14 110.999 -167.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -59.79 -28.05 67.1 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.211 -0.931 . . . . 61.41 111.52 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.46 -23.17 65.48 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.217 1.407 . . . . 64.24 113.222 172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.85 8.05 28.45 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.812 1.245 . . . . 65.3 111.186 -168.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 78.8 mt -69.22 96.81 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.087 -1.079 . . . . 72.01 108.087 174.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -79.78 157.56 27.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.432 -0.951 . . . . 63.34 108.432 164.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.09 157.7 18.47 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.632 -1.618 . . . . 71.13 106.632 168.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.09 169.31 17.6 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 114.771 -1.104 . . . . 52.23 109.556 163.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -63.04 1.19 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 126.777 2.031 . . . . 61.21 108.68 178.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -59.57 -21.15 59.9 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.041 1.336 . . . . 74.11 111.179 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.57 -26.86 2.63 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.208 -1.329 . . . . 72.3 114.168 155.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -25.39 -85.5 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 129.812 3.245 . . . . 73.01 114.699 -162.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 131.54 128.28 2.93 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.232 -1.547 . . . . 42.4 109.232 -166.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -153.6 162.55 41.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.875 1.337 . . . . 73.54 111.245 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 mt -150.73 129.84 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.78 1.632 . . . . 70.43 107.419 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.86 130.62 43.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.024 0.829 . . . . 62.12 109.472 162.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -134.0 16.24 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.163 0.985 . . . . 72.41 111.284 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.98 -29.95 36.33 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 126.876 2.179 . . . . 63.53 114.433 -171.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -69.68 -24.62 63.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.929 1.291 . . . . 64.24 113.925 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.97 -10.09 12.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.93 1.241 . . . . 74.31 113.805 -174.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 55.44 14.67 1.2 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.441 2.696 . . . . 72.3 115.119 173.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.7 mt -68.75 117.59 11.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 124.484 1.114 . . . . 75.33 108.575 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -82.24 157.43 23.91 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 122.488 1.137 . . . . 65.31 110.24 169.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.8 tt -153.29 153.13 9.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 106.228 -1.768 . . . . 73.32 106.228 -178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -67.32 106.35 2.04 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 118.78 0.718 . . . . 71.35 109.561 -177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.2 m -87.44 172.79 9.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 124.418 1.087 . . . . 52.44 108.18 165.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.401 ' CE2' ' HB ' ' A' ' 162' ' ' THR . 0.3 OUTLIER -141.83 136.74 30.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.069 -1.826 . . . . 61.51 106.069 167.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -82.57 119.36 24.15 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.345 -0.983 . . . . 74.25 108.345 176.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? -63.15 -24.03 67.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.028 1.331 . . . . 74.4 111.235 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.08 -33.48 2.16 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 128.541 2.736 . . . . 74.33 111.81 178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.6 m -157.71 10.65 0.19 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.855 1.262 . . . . 54.13 112.768 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mp 55.75 54.32 8.38 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.423 1.489 . . . . 75.42 110.751 -177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.43 158.98 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.216 1.807 . . . . 72.3 109.619 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.68 119.73 51.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 125.086 1.354 . . . . 75.22 108.686 -164.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -132.4 157.74 43.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.833 1.253 . . . . 73.05 112.038 -168.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -104.85 106.84 17.51 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 126.322 1.849 . . . . 75.33 108.378 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.614 ' NZ ' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -151.72 141.23 21.64 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 106.403 -1.702 . . . . 74.42 106.403 -174.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -94.91 175.06 6.79 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 121.098 -1.001 . . . . 73.25 110.936 -166.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.0 mt -97.44 148.49 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.052 1.741 . . . . 73.31 108.147 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.98 -55.2 2.53 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.214 -0.661 . . . . 74.14 109.214 -178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.415 HH11 ' HB2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -119.63 152.2 37.45 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.051 -1.03 . . . . 75.51 109.812 179.127 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.615 HG21 HG22 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.73 158.88 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.225 1.81 . . . . 65.22 107.546 171.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -129.53 175.68 8.59 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.031 1.333 . . . . 53.01 108.046 176.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.579 ' HD3' ' CD2' ' A' ' 151' ' ' HIS . 1.5 tmm_? -173.66 152.27 2.03 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.938 1.695 . . . . 72.21 109.297 157.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -140.61 161.72 37.09 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.161 2.185 . . . . 73.34 107.376 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -95.26 148.07 22.8 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.196 -0.94 . . . . 71.13 109.46 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -144.91 156.19 43.85 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.735 1.214 . . . . 74.04 108.949 -171.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 149' ' ' ASN . 2.4 p -159.77 106.01 1.63 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.187 0.995 . . . . 63.11 109.784 165.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -175.69 -178.11 45.26 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 111.423 -0.671 . . . . 63.2 111.423 -174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.564 ' HE2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.18 138.25 34.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.458 -0.782 . . . . 71.33 110.37 170.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.1 mt -113.02 159.8 18.78 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.234 1.413 . . . . 70.21 109.399 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.1 mm -83.51 139.97 16.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 124.624 1.169 . . . . 75.41 107.977 169.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -129.27 77.35 1.78 Allowed 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.655 2.382 . . . . 75.21 106.662 172.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.2 mt -54.1 138.47 13.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.896 -1.89 . . . . 64.52 105.896 159.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.1 m -119.06 155.29 31.74 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.407 -2.072 . . . . 74.1 105.407 159.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 28.9 p -131.78 171.76 13.12 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.794 -1.191 . . . . 62.25 108.361 175.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -56.5 -27.81 58.21 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.759 1.392 . . . . 75.14 114.759 -166.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.42 0.49 19.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.912 2.085 . . . . 73.04 113.935 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 61.49 17.79 8.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.256 1.423 . . . . 65.23 111.89 -163.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.59 158.82 31.18 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.064 -1.828 . . . . 75.31 106.064 159.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.82 163.59 1.43 Allowed 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 128.342 2.657 . . . . 71.0 106.298 -171.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.546 HG23 ' CE1' ' A' ' 171' ' ' PHE . 0.1 OUTLIER -145.36 169.04 7.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.816 1.646 . . . . 65.32 106.629 -179.227 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.48 100.33 3.85 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.156 0.889 . . . . 74.34 109.954 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.54 168.87 26.05 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.506 -0.746 . . . . 72.35 112.612 -165.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 56.8 m -60.44 156.04 16.91 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.943 1.297 . . . . 73.54 107.784 -175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -73.64 6.11 3.39 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.219 -0.926 . . . . 74.32 111.013 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -136.86 36.93 2.61 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.063 1.345 . . . . 62.21 109.652 -171.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -105.7 129.29 24.89 Favored Pre-proline 0 C--O 1.239 0.506 0 C-N-CA 126.071 1.748 . . . . 73.42 108.48 175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -65.88 152.7 80.77 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.552 2.168 . . . . 70.03 114.096 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -148.18 173.85 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 C-N-CA 128.531 2.732 . . . . 41.23 108.055 173.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -118.59 137.63 53.12 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.388 1.075 . . . . 72.11 108.556 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -128.99 162.42 36.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.848 1.259 . . . . 75.52 108.705 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.4 ' HB3' HD11 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -87.94 108.45 19.2 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.613 -0.884 . . . . 70.02 108.613 172.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -78.3 69.09 4.45 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.021 -1.474 . . . . 73.11 107.021 162.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m 59.64 13.46 3.41 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.97 1.47 . . . . 75.32 114.97 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 129.93 -18.99 5.28 Favored Glycine 0 CA--C 1.522 0.475 0 O-C-N 120.817 -1.177 . . . . 73.43 112.103 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -79.55 144.86 33.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.634 -1.988 . . . . 72.22 105.634 162.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.3 p -88.45 145.36 7.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.97 -0.752 . . . . 73.31 108.97 167.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.02 146.7 25.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.211 1.404 . . . . 74.44 108.153 -173.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -102.02 131.59 48.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 118.517 -0.754 . . . . 65.3 110.666 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 12.9 pt -143.14 -178.81 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.147 1.779 . . . . 74.12 108.625 168.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -78.37 156.15 29.67 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.781 -1.199 . . . . 74.51 112.989 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.66 -48.33 39.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.823 2.449 . . . . 72.03 111.128 164.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -66.37 -8.84 28.17 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.073 1.138 . . . . 75.13 114.073 -174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . . . . . . . . . 1.1 mmt -94.31 -38.58 10.93 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.714 1.205 . . . . 70.34 110.968 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.11 60.93 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.853 1.661 . . . . 71.34 109.12 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.66 -171.86 3.55 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.618 1.567 . . . . 62.33 109.433 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.07 -0.62 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 126.3 1.84 . . . . 72.2 113.045 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.03 -14.19 61.05 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-O 116.838 -2.09 . . . . 73.35 112.206 171.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -119.82 179.64 4.19 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.786 2.293 . . . . 60.5 108.726 -163.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -125.48 136.71 53.65 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.475 0.71 . . . . 75.41 111.753 170.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.509 HG23 ' OD1' ' A' ' 138' ' ' ASP . 15.5 tt -111.4 150.15 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 125.36 1.464 . . . . 71.15 109.335 -170.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -95.49 103.47 15.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.2 1.0 . . . . 73.25 110.689 -177.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 1.1 pt -96.08 156.72 36.77 Favored Pre-proline 0 N--CA 1.468 0.468 0 C-N-CA 124.185 0.994 . . . . 64.41 111.168 169.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.77 154.08 38.67 Favored 'Trans proline' 0 N--CA 1.444 -1.382 0 N-CA-C 108.486 -1.39 . . . . 51.33 108.486 173.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -119.38 -157.33 0.69 Allowed 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 105.437 -2.06 . . . . 75.34 105.437 162.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -48.5 -71.27 0.07 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.531 1.132 . . . . 62.54 111.863 -171.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -120.37 0.12 10.5 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.874 1.669 . . . . 74.34 111.635 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.8 p -131.82 -172.55 2.9 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.217 1.807 . . . . 65.42 111.045 -173.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.8 tp -105.85 157.05 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.119 -1.437 . . . . 62.05 107.119 176.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -136.38 179.19 6.51 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.523 -1.658 . . . . 74.13 106.523 167.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 108' ' ' SER . 1.3 mp -108.06 162.19 14.27 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.672 0.749 . . . . 74.24 109.892 168.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 127' ' ' ILE . 20.4 p-10 -148.05 160.61 42.67 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.183 2.593 . . . . 71.42 107.687 171.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 140.48 43.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.621 1.968 . . . . 73.35 109.606 -175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . 0.258 33.8 t -78.62 1.46 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 130.075 3.35 . . . . 74.14 115.005 -172.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.556 HG13 ' H ' ' A' ' 142' ' ' LYS . 2.4 pt 25.07 -70.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 130.096 3.358 . . . . 73.53 117.681 167.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.556 ' H ' HG13 ' A' ' 141' ' ' ILE . 9.8 ttmt -117.72 125.16 50.15 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 128.516 2.727 . . . . 61.43 107.467 172.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.77 128.36 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 106.397 -1.705 . . . . 74.25 106.397 169.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -143.14 -179.23 6.26 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.964 1.706 . . . . 73.12 107.902 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 p -134.2 157.07 47.2 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.306 1.042 . . . . 74.41 110.878 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 m -127.24 -175.57 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.849 1.66 . . . . 71.11 108.717 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.88 133.36 43.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.704 1.201 . . . . 74.04 109.963 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.616 ' C ' HD22 ' A' ' 149' ' ' ASN . 1.3 t80 -146.95 124.61 11.8 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 122.481 0.312 . . . . 73.4 110.758 -165.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.616 HD22 ' C ' ' A' ' 148' ' ' TYR . 1.9 m120 -130.27 52.55 2.01 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.477 -0.765 . . . . 64.15 109.265 -162.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -159.78 -179.65 34.73 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 110.681 -0.968 . . . . 64.21 110.681 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.579 ' CD2' ' HD3' ' A' ' 79' ' ' ARG . 69.6 m80 -65.18 144.67 57.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.064 1.346 . . . . 75.12 113.045 -172.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 33.5 pt -129.56 156.64 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 127.535 2.334 . . . . 74.23 109.018 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . 0.702 ' CZ ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -157.91 163.73 37.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.26 1.024 . . . . 63.02 110.301 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 155' ' ' LEU . 0.4 OUTLIER -116.53 -91.06 0.54 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.669 -1.234 . . . . 74.03 107.669 -172.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.442 ' H ' ' HB2' ' A' ' 154' ' ' ASP . 5.7 mt 159.6 161.93 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 1 C-N-CA 133.274 4.63 . . . . 73.21 107.66 174.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.5 m -83.71 -82.93 0.15 Allowed 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 108.189 -1.041 . . . . 70.13 108.189 167.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.614 HG13 ' NZ ' ' A' ' 72' ' ' LYS . 48.9 t 56.93 64.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 124.145 1.926 . . . . 54.23 110.688 -171.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' A' ' 76' ' ' ARG . 3.0 pt-20 -81.54 0.23 39.04 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 113.467 -1.697 . . . . 73.41 114.039 -171.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.511 ' HB3' ' HE3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -86.16 -46.23 10.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.973 0.909 . . . . 74.23 110.453 178.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -102.45 -23.73 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.487 1.115 . . . . 73.54 110.228 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 53.67 21.26 2.53 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 128.47 2.708 . . . . 71.31 113.411 -159.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.401 ' HB ' ' CE2' ' A' ' 62' ' ' PHE . 1.1 p -149.89 151.81 34.05 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 120.088 -1.633 . . . . 64.32 111.743 -174.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.759 ' CD2' ' HB2' ' A' ' 175' ' ' ALA . 1.3 p90 -149.06 178.97 8.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.885 1.274 . . . . 75.31 111.285 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 36.1 mm -110.95 119.01 58.66 Favored 'Isoleucine or valine' 0 C--N 1.345 0.377 0 C-N-CA 124.785 1.234 . . . . 70.23 108.859 171.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.49 ' HB1' ' CD2' ' A' ' 9' ' ' LEU . . . -151.39 158.41 43.69 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.098 -1.001 . . . . 71.31 110.806 176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 142.42 -158.76 27.04 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 124.611 1.101 . . . . 35.12 110.646 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -99.55 176.53 5.46 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.785 1.293 . . . . 73.34 110.678 166.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 57.54 -91.92 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 128.559 2.743 . . . . 73.04 111.657 -168.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' HA ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -122.78 -1.96 8.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.676 2.39 . . . . 72.41 113.366 176.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 82.66 165.9 37.85 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.382 1.468 . . . . 51.43 114.34 174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.546 ' CE1' HG23 ' A' ' 97' ' ' ILE . 66.0 m-85 -108.68 151.78 25.7 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.823 2.449 . . . . 74.33 107.609 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -88.68 102.96 15.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.124 -1.435 . . . . 72.0 107.124 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.44 HG12 HG12 ' A' ' 105' ' ' VAL . 6.2 m -130.76 176.02 9.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 118.535 0.607 . . . . 74.43 111.457 -169.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 2.9 t -68.6 145.8 53.62 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.297 0.57 . . . . 73.14 110.652 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 163' ' ' TYR . . . -138.15 62.95 1.55 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 128.711 2.804 . . . . 73.21 107.092 168.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -75.76 163.49 27.22 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.357 -1.464 . . . . 71.13 109.103 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 2.4 p -88.92 19.59 4.03 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.125 1.37 . . . . 64.42 111.643 -174.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 71.99 -16.05 1.66 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.405 1.479 . . . . 72.03 114.616 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.5 p -62.21 155.82 23.59 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 128.682 2.793 . . . . 73.44 112.766 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.9 tt -76.08 91.24 3.1 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.1 -0.704 . . . . 73.25 109.1 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 30.1 m170 61.19 -42.68 0.12 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 130.505 3.522 . . . . 72.4 116.292 176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 54.86 -107.57 0.39 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.131 2.573 . . . . 74.43 110.813 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.85 135.84 56.91 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.852 1.205 . . . . 72.22 109.581 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -72.15 -50.51 27.26 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.721 1.208 . . . . 73.45 112.579 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -136.77 -41.73 0.6 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.547 1.139 . . . . 53.14 110.588 -175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.245 0.829 0 C-N-CA 126.046 1.739 . . . . 73.24 107.214 179.904 . . . . . . . . 0 0 . 1 stop_ save_